PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Coardoba-Dona, JA; Escolar-Pujolar, A; Sebastian, MS; Gustafsson, PE				Coardoba-Dona, Juan Antonio; Escolar-Pujolar, Antonio; Sebastian, Miguel San; Gustafsson, Per E.			Withstanding austerity: Equity in health services utilisation in the first stage of the economic recession in Southern Spain	PLOS ONE			English	Article							INCOME-RELATED INEQUALITIES; FINANCIAL CRISIS; CARE SERVICES; OECD COUNTRIES; MENTAL-HEALTH; DELIVERY; EUROPE; SYSTEM; SECTOR; POPULATION	Scant research is available on the impact of the current economic crisis and austerity policies on inequality in health services utilisation in Europe. This study aimed to describe the trends in horizontal inequity in the use of health services in Andalusia, Spain, during the early years of the Great Recession, and the contribution of demographic, economic and social factors. Consultation with a general practitioner (GP) and specialist, hospitalisation and emergency care were studied through the Andalusian Health Survey 2007 (pre-crisis) and 2011-2012 (crisis), using a composite income index as socioeconomic status (SES) indicator. Horizontal inequity indices (HII) were calculated to take differential healthcare needs into account, and a decomposition analysis of change in inequality between periods was performed. Results showed that before the crisis, the HII was positive (greater access for people with higher SES) for specialist visits but negative (greater access for people with lower SES) in the other three utilisation models. During the crisis no change was observed in inequalities in GP visits, but a pro-poor development was seen for the other types of utilisation, with hospital and emergency care showing significant inequality in favour of low income groups. Overall, the main contributors to pro-poor changes in utilisation were socioeconomic variables and poor mental health, due to changes in their elasticities. Our findings show that inequalities in healthcare utilisation largely remained in favour of the less well-off, despite the cuts in welfare benefits and health services provision during the early years of the recession in Andalusia. Further research is needed to monitor the potential impact of such measures in subsequent years.	[Coardoba-Dona, Juan Antonio; Escolar-Pujolar, Antonio] Delegac Terr Consejeria Salud Junta Andalucia, Cadiz, Spain; [Coardoba-Dona, Juan Antonio; Sebastian, Miguel San; Gustafsson, Per E.] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden	Umea University	Coardoba-Dona, JA (corresponding author), Delegac Terr Consejeria Salud Junta Andalucia, Cadiz, Spain.; Coardoba-Dona, JA (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden.	jantonio.cordoba@juntadeandalucia.es	Córdoba-Doña, Juan Antonio/L-4909-2019; Gustafsson, Per/AAY-5068-2021	Córdoba-Doña, Juan Antonio/0000-0002-1755-6510; 	Swedish Research Council for Health, Working Life and Welfare [2006-1512, 2014-0451]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by the Swedish Research Council for Health, Working Life and Welfare. Grant No. 2006-1512 and the Swedish Research Council for Health, Working Life and Welfare. Grant No. 2014-0451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo I, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0630-y; Abasolo I, 2008, HACIENDA PUBLICA ESP, P87; [Anonymous], B EST PERS ADM PUBL; [Anonymous], 2008, ANAL HLTH EQUITY USI; Cordoba-Dona JA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2934-z; Bacigalupe A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-52; Bartoll X, 2014, EUR J PUBLIC HEALTH, V24, P415, DOI 10.1093/eurpub/ckt208; Cavagnero E, 2010, J HEALTH ECON, V29, P479, DOI 10.1016/j.jhealeco.2010.03.008; Cervero-Liceras F, 2015, HEALTH POLICY, V119, P100, DOI 10.1016/j.healthpol.2014.11.003; Correia T, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0256-6; Coveney M, 2016, HEALTH ECON, V25, P141, DOI 10.1002/hec.3375; Crespo-Cebada E, 2012, HEALTH POLICY, V104, P193, DOI 10.1016/j.healthpol.2011.10.007; Cutler DM., 2006, ED HLTH EVALUATING T; de Belvis AG, 2012, HEALTH POLICY, V106, P10, DOI 10.1016/j.healthpol.2012.04.003; Devaux M, 2015, EUR J HEALTH ECON, V16, P21, DOI 10.1007/s10198-013-0546-4; Economou A, 2008, HEALTH SERV MANAG RE, V21, P40, DOI 10.1258/hsmr.2007.007013; Pujolar AE, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0329-5; Eurofound, 2014, ACC HEALTHC TIM CRIS; Federacion de Asociaciones para la Defensa de la Sanidad Publica, 2012, SERV SAN CCAA; Galenkamp H, 2013, EUR J PUBLIC HEALTH, V23, P511, DOI 10.1093/eurpub/cks031; Garcia-Subirats I, 2014, INT J ENV RES PUB HE, V11, P10182, DOI 10.3390/ijerph111010182; Gill SC, 2007, PSYCHIAT RES, V152, P63, DOI 10.1016/j.psychres.2006.11.005; Giovanella L, 2014, CAD SAUDE PUBLICA, V30, P2263, DOI 10.1590/0102-311X00021314; Hanratty B, 2007, INT J HEALTH SERV, V37, P89, DOI 10.2190/TTX2-3572-UL81-62W7; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Instituto Nacional de Estadistica, 2012, EV CAL DAT ENC PRES; Instituto Nacional de Estadistica: Encuesta de Poblacion Activa, EC ACT POP SURV; Janlert U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-235; Junta de Andalucia, CONS SAL ENC SAL AND; Karanikolos M, 2016, INT J HEALTH SERV, V46, P208, DOI 10.1177/0020731416637160; Kentikelenis AE., 2017, SOC SCI MED; Keramidou I, 2017, HLTH POLICY; Keskimaki I, 2003, SOC SCI MED, V56, P1517, DOI 10.1016/S0277-9536(02)00153-3; Kondilis E, 2013, AM J PUBLIC HEALTH, V103, P973, DOI 10.2105/AJPH.2012.301126; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Lopez-Pereira P, 2016, INT J HLTH SERV; Maika A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078809; Margerison-Zilko Claire, 2016, Curr Epidemiol Rep, V3, P81; Ministerio de Sanidad Servicios Sociales e Igualdad, BAR SAN; Ministerio de Sanidad Servicios Sociales e Igualdad, SIST INF LIST ESP; Palencia L, 2013, EUR J HEALTH ECON, V14, P211, DOI 10.1007/s10198-011-0362-7; Reeves A, 2014, HEALTH POLICY, V115, P1, DOI 10.1016/j.healthpol.2013.11.008; Ruckert A, 2017, SOC SCI MED; Servicio Andaluz de Salud, INF BAS; Siegel M, 2014, SOC SCI MED, V108, P10, DOI 10.1016/j.socscimed.2014.02.022; Simou E, 2014, HEALTH POLICY, V115, P111, DOI 10.1016/j.healthpol.2014.02.002; Stirbu I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-288; Thomas S, 2014, LANCET, V383, P1545, DOI 10.1016/S0140-6736(14)60744-3; UCL Institute of Equity, 2013, REPORT TASK GROUP OL; Urbanos Garrido Rosa, 2014, Gac Sanit, V28 Suppl 1, P81, DOI 10.1016/j.gaceta.2014.02.013; Urbanos R, 2015, SANIDAD DESIGUALDAD, P155; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; van Doorslaer E, 2000, J HEALTH ECON, V19, P553, DOI 10.1016/S0167-6296(00)00050-3; van Gool K., 2014, OECD HLTH WORKING PA, V76; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076; Villalba Mora E, 2013, JRCENTRE SCI POLICY; WAGSTAFF A, 1991, J HEALTH ECON, V10, P169, DOI 10.1016/0167-6296(91)90003-6; Wagstaff A, 2000, J HUM RESOUR, V35, P716, DOI 10.2307/146369; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Wagstaff A, 2003, HEALTH ECON, V12, P885, DOI 10.1002/hec.805; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6	62	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195293	10.1371/journal.pone.0195293	http://dx.doi.org/10.1371/journal.pone.0195293			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB1XW	29601609	Green Submitted, Green Published, gold			2022-12-27	WOS:000428845900026
J	Guo, L; Yang, Z; Zhi, ST; Feng, Z; Lei, C; Zhou, Y				Guo, Lei; Yang, Zhen; Zhi, Shaotao; Feng, Zhu; Lei, Chong; Zhou, Yong			A sensitive and innovative detection method for rapid C-reactive proteins analysis based on a micro-fluxgate sensor system	PLOS ONE			English	Article							LABEL-FREE DETECTION; CRP DETECTION; IMMUNOASSAY; BIOSENSOR; CANCER; IMMUNOSENSOR; DIAGNOSIS; BIOMARKER; PLATFORM; DISEASE	A sensitive and innovative assay system based on a micro-MEMS-fluxgate sensor and immunomagnetic beads-labels was developed for the rapid analysis of C-reactive proteins (CRP). The fluxgate sensor presented in this study was fabricated through standard micro-electro-mechanical system technology. A multi-loop magnetic core made of Fe-based amorphous ribbon was employed as the sensing element, and 3-D solenoid copper coils were used to control the sensing core. Antibody-conjugated immunomagnetic microbeads were strategically utilized as signal tags to label the CRP via the specific conjugation of CRP to polyclonal CRP antibodies. Separate Au film substrates were applied as immunoplatforms to immobilize CRP-beads labels through classical sandwich assays. Detection and quantification of the CRP at different concentrations were implemented by detecting the stray field of CRP labeled magnetic beads using the newly-developed micro-fluxgate sensor. The resulting system exhibited the required sensitivity, stability, reproducibility, and selectivity. A detection limit as low as 0.002 mu g/mL CRP with a linearity range from 0.002 mu g/mL to 10 mu g/mL was achieved, and this suggested that the proposed biosystem possesses high sensitivity. In addition to the extremely low detection limit, the proposed method can be easily manipulated and possesses a quick response time. The response time of our sensor was less than 5 s, and the entire detection period for CRP analysis can be completed in less than 30 min using the current method. Given the detection performance and other advantages such as miniaturization, excellent stability and specificity, the proposed biosensor can be considered as a potential candidate for the rapid analysis of CRP, especially for point-of-care platforms.	[Guo, Lei; Zhi, Shaotao; Feng, Zhu; Lei, Chong; Zhou, Yong] Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Minist Educ, Key Lab Thin Film & Microfahricat, Shanghai, Peoples R China; [Yang, Zhen] Xinyang Normal Univ, Sch Phys & Elect Engn, Xinyang, Peoples R China	Shanghai Jiao Tong University; Xinyang Normal University	Guo, L (corresponding author), Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Minist Educ, Key Lab Thin Film & Microfahricat, Shanghai, Peoples R China.	g2252330@sjtu.edu.cn			National Natural Science Foundation of China [61273065]; National Science and Technology Support Program [2012BAK08B05]; Natural Science Foundation of Shanghai [13ZR1420800]; Shanghai Jiao Tong University [AgriX2015005]; Joint research center for advanced aerospace technology of Shanghai Academy of Spaceflight Technology-Shanghai Jiao Tong University [USCAST2015-2]; Natural Science Foundation of Henan Province [162300410233]; Support fund of aerospace technology [15GFZ-JJ02-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Jiao Tong University; Joint research center for advanced aerospace technology of Shanghai Academy of Spaceflight Technology-Shanghai Jiao Tong University; Natural Science Foundation of Henan Province; Support fund of aerospace technology	This work is funded by The National Natural Science Foundation of China (No.61273065), National Science and Technology Support Program (2012BAK08B05), Natural Science Foundation of Shanghai (13ZR1420800), Support fund of Shanghai Jiao Tong University (AgriX2015005), Support fund of Joint research center for advanced aerospace technology of Shanghai Academy of Spaceflight Technology-Shanghai Jiao Tong University (USCAST2015-2), Natural Science Foundation of Henan Province (162300410233), Support fund of aerospace technology (15GFZ-JJ02-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MU, 2014, CRIT REV BIOTECHNOL, V34, P180, DOI 10.3109/07388551.2013.778228; Andersson PO, 2016, ANAL BIOANAL CHEM, V408, P3675, DOI 10.1007/s00216-016-9485-0; [Anonymous], 2014, IEEE T MAGN; Baschirotto A, 2006, SENSOR ACTUAT A-PHYS, V132, P90, DOI 10.1016/j.sna.2006.04.043; Bjerner J, 2005, CLIN CHEM, V51, P9, DOI 10.1373/clinchem.2004.042994; Bryan T, 2013, BIOSENS BIOELECTRON, V39, P94, DOI 10.1016/j.bios.2012.06.051; Fu S, 2017, IEEE INT C SOFTW ENG, P485; Funano S, 2015, ANALYST, V140, P1459, DOI 10.1039/c4an01781a; Guo L, 2017, SENSOR ACTUAT B-CHEM, V247, P1, DOI 10.1016/j.snb.2017.01.095; Gupta RK, 2014, BIOSENS BIOELECTRON, V59, P112, DOI 10.1016/j.bios.2014.03.027; Hu J, 2016, ANAL CHEM, V88, P6577, DOI 10.1021/acs.analchem.6b01427; Issadore D, 2014, LAB CHIP, V14, P2385, DOI 10.1039/c4lc00314d; Jebrail MJ, 2010, CURR OPIN CHEM BIOL, V14, P574, DOI 10.1016/j.cbpa.2010.06.187; Joung HA, 2014, BIOSENS BIOELECTRON, V53, P330, DOI 10.1016/j.bios.2013.10.004; Kokkinis G, 2017, SENSOR ACTUAT B-CHEM, V241, P438, DOI 10.1016/j.snb.2016.09.189; Lee J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172666; Lee SH, 2017, SENSOR ACTUAT B-CHEM, V246, P471, DOI 10.1016/j.snb.2017.01.188; Lei C, 2013, MICROSYST TECHNOL, V19, P591, DOI 10.1007/s00542-012-1669-8; Lei C, 2013, MICROSYST TECHNOL, V19, P167, DOI 10.1007/s00542-012-1523-z; Liu TZ, 2016, ANAL CHEM, V88, P12516, DOI 10.1021/acs.analchem.6b04191; Magnelind PE, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/4/044031; Makino A., 2008, MAT T, V50, P204; Meyer MHF, 2006, BIOSENS BIOELECTRON, V21, P1987, DOI 10.1016/j.bios.2005.09.010; Mirus JE, 2015, CLIN CANCER RES, V21, P1764, DOI 10.1158/1078-0432.CCR-13-3474; Nooney R, 2017, ANAL METHODS-UK, V9, P994, DOI 10.1039/c6ay03362h; Oh YK, 2013, LAB CHIP, V13, P768, DOI 10.1039/c2lc41016h; Okayasu I, 2014, J CLIN LAB ANAL, V28, P32, DOI 10.1002/jcla.21640; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Park J, 2017, SENSOR ACTUAT B-CHEM, V246, P1049, DOI 10.1016/j.snb.2017.02.150; Qian XB, 2005, IEEE T MAGN, V41, P3715, DOI 10.1109/TMAG.2005.854919; Reitz C, 2006, ALZHEIMERS DEMENT, V2, pS424; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Song KS, 2017, ANALYST, V142, P3816, DOI 10.1039/c7an01389b; Su HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102418; Sun XC, 2015, SENSOR ACTUAT B-CHEM, V221, P985, DOI 10.1016/j.snb.2015.07.040; Vermeeren V, 2011, SENSOR ACTUAT B-CHEM, V157, P130, DOI 10.1016/j.snb.2011.03.037; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Wei Gao, 2011, Proceedings of the 2011 IEEE International Conference on Mechatronics and Automation (ICMA 2011), P2386, DOI 10.1109/ICMA.2011.5986360; Wright EK, 2015, GASTROENTEROLOGY, V148, P938, DOI 10.1053/j.gastro.2015.01.026; Wu L, 2015, CHEM SOC REV, V44, P2963, DOI 10.1039/c4cs00370e; Yanbaeva DG, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-23; Yang Z, 2015, ANAL METHODS-UK, V7, P2391, DOI 10.1039/c4ay02727b; Zhang X, 2016, ANAL METHODS-UK, V8, P6202, DOI 10.1039/c6ay01464j	43	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194631	10.1371/journal.pone.0194631	http://dx.doi.org/10.1371/journal.pone.0194631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601593	Green Published, gold, Green Submitted			2022-12-27	WOS:000428845900007
J	Bordignon, DW; Caorsi, VZ; Colombo, P; Abadie, M; Brack, IV; Dasoler, BT; Borges-Martins, M				Bordignon, Debora Wolff; Caorsi, Valentina Zaffaroni; Colombo, Patrick; Abadie, Michelle; Brack, Ismael Verrastro; Dasoler, Bibiana Terra; Borges-Martins, Mario			Are the unken reflex and the aposematic colouration of Red-Bellied Toads efficient against bird predation?	PLOS ONE			English	Article							POISON FROG; MELANOPHRYNISCUS; BEHAVIOR; ANURA; CONSPICUOUSNESS; DIVERSITY; BUFONIDAE; ALKALOIDS; DEFENSES; SIGNALS	Aposematic signals as well as body behaviours may be important anti-predator defences. Species of the genus Melanophryniscus are characterised by having toxic lipophilic alkaloids in the skin and for presenting a red ventral colouration, which can be observed when they perform the behaviour called the unken reflex. Both the reflex behaviour and the colouration pattern are described as defence mechanisms. However, there are currently no studies testing their effectiveness against predators. This study aimed to test experimentally if both ventral conspicuous colouration and the unken reflex in Melanophryniscus cambaraensis function as aposematic signals against visually oriented predators (birds). We simulated the species studied using three different clay toad models as follows: (a) in a normal position with green coloured bodies, (b) in the unken reflex position with green coloured body and extremities and (c) in the unken reflex position with a green body and red extremities. Models were distributed on a known M. cambaraensis breeding site and in the adjacent forest. More than half of the attacks on the models were from birds; however, there was no preference for any model type. Thus, just the presence of the red colour associated with the motionless unken reflex position does not seem to prevent attacks from potential predators. It is possible that the effective aposematic signal in Melanophryniscus is achieved through the unken reflex movement together with the subsequent exhibition of the warning colouration and the secretion of toxins.	[Bordignon, Debora Wolff; Caorsi, Valentina Zaffaroni; Borges-Martins, Mario] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Dept Zool, Inst Biociencias, Porto Alegre, RS, Brazil; [Colombo, Patrick] Fundacao Zoobot Rio Grande Sul, Museu Ciencias Nat, Porto Alegre, RS, Brazil; [Abadie, Michelle; Brack, Ismael Verrastro; Dasoler, Bibiana Terra] Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, Inst Biociencias, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Bordignon, DW (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Dept Zool, Inst Biociencias, Porto Alegre, RS, Brazil.	deborawbordignon@gmail.com	Caorsi, Valentina Zaffaroni/AAD-1093-2019; Bordignon, Debora Wolff/AAC-8975-2019; Colombo, Patrick/D-2989-2013; Borges-Martins, Marcio/I-3274-2012	Bordignon, Debora Wolff/0000-0002-7306-7025; Borges-Martins, Marcio/0000-0001-9328-5794; Dasoler de Oliveira, Bibiana Terra/0000-0001-7466-6719; Colombo, Patrick/0000-0003-3957-3255; Brack, Ismael/0000-0003-2988-9811; Zaffaroni-Caorsi, Valentina/0000-0003-4166-9600				Almeida-Santos Patricia, 2010, Herpetological Review, V41, P200; Andreone Franco, 2002, Herpetological Review, V33, P299; Angulo Ariadne, 2006, Herpetological Review, V37, P203; Backes A., 2005, Acta Bot. Bras., V19, P155, DOI 10.1590/S0102-33062005000100015; BAJGER J, 1980, HERPETOLOGICA, V36, P133; Bell WJ, 1984, CHEM ECOLOGY INSECTS; Blount JD, 2009, P ROY SOC B-BIOL SCI, V276, P871, DOI 10.1098/rspb.2008.1407; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Braun PC., 1979, SERIE ZOOLOGIA, V54, P7; BRODIE ED, 1977, COPEIA, P523, DOI 10.2307/1443271; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Brusquetti Francisco, 2007, Check List, V3, P141; Caorsi Valentina Zaffaroni, 2014, Herpetology Notes, V7, P585; Caorsi Valentina Zaffaroni, 2012, South American Journal of Herpetology, V7, P79; Caorsi VZ, 2014, ESTUDO TAXONOMICO FI; Caro T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0344; Carretero Miguel A., 2011, Herpetology Notes, V4, P67; Comeault AA, 2011, J EVOLUTION BIOL, V24, P1374, DOI 10.1111/j.1420-9101.2011.02258.x; Cott H.B., 1940, ADAPTIVE COLORATION; Cuthill Innes C., 2006, P3; Daly JW, 2007, J CHEM ECOL, V33, P871, DOI 10.1007/s10886-007-9261-x; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; DALY JW, 1992, TOXICON, V30, P887, DOI 10.1016/0041-0101(92)90387-K; Darst CR, 2006, P NATL ACAD SCI USA, V103, P5852, DOI 10.1073/pnas.0600625103; Das Indraneil, 2004, Herpetological Review, V35, P373; Di-Bernardo M, 2006, J HERPETOL, V40, P261, DOI 10.1670/05-008.1; Duong Le Thi Thuy, 2010, Herpetological Review, V41, P342; Edmunds M., 1974, DEFENCE ANIMALS; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Fernandez K, 1927, BOLET N ACAD NACL CI, V29, P271; FIRSCHEIN IL, 1951, COPEIA, P74; Forsman A, 2004, BEHAV ECOL, V15, P141, DOI 10.1093/beheco/arg092; Frost D.R., 2017, AMPHIBIAN SPECIES WO; GARCIA PCA, 2003, LIVRO VERMELHO FAUNA, P147; Greenbaum Eli, 2012, Herpetological Review, V43, P320; Griffiths RA, 1996, NEWTS SALAMANDERS EU; Haberl Werner, 1997, British Herpetological Society Bulletin, V61, P16; Hegna RH, 2013, EVOL ECOL, V27, P831, DOI 10.1007/s10682-012-9605-z; Hegna RH, 2011, ANN ZOOL FENN, V48, P29, DOI 10.5735/086.048.0103; HINSCHE GEORG, 1926, BIOL ZENTRALBL, V46, P296; Jablonski D, 2009, ZIVA, V57, P228; Jablonski Daniel, 2014, Herpetology Notes, V7, P141; Jeckel AM, 2015, J CHEM ECOL, V41, P505, DOI 10.1007/s10886-015-0578-6; JOHNSON JA, 1975, AM MIDL NAT, V93, P139, DOI 10.2307/2424112; Kuchta SR, 2005, COPEIA, P265, DOI 10.1643/CH-04-173R; Kwet Axel, 2005, Salamandra, V41, P3; Lanza B., 1966, ETHOLOGY, V23, P855; Lindstedt C, 2008, ANIM BEHAV, V75, P1703, DOI 10.1016/j.anbehav.2007.10.024; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; MADSEN T, 1987, OIKOS, V48, P265, DOI 10.2307/3565512; Maluf J.R.T., 2000, REV BRASILEIRA AGROM, V8, P141, DOI DOI 10.5902/198050981940; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Marco Adolfo, 2001, Revista Espanola de Herpetologia, V15, P5; Master TL, 1999, WILSON BULL, V111, P439; Mcelroy MT, 2016, BIOL J LINN SOC, V117, P285, DOI 10.1111/bij.12669; Means D. Bruce, 2004, Herpetological Review, V35, P163; Mebs D, 2005, TOXICON, V46, P641, DOI 10.1016/j.toxicon.2005.07.004; Ministerio do Meio Ambiente-MMA, 2014, DIARIO OFICIAL UNIAO, V126, P121; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; Paluh DJ, 2015, COPEIA, V103, P58, DOI 10.1643/CE-13-126; Paluh DJ, 2014, J HERPETOL, V48, P249, DOI 10.1670/13-027; Poulton E., 1890, COLOUR ANIMALS, P360; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Santos RR, 2011, EVOL ECOL, V25, P249, DOI 10.1007/s10682-010-9407-0; Santos RR, 2010, J TROP ECOL, V26, P415, DOI 10.1017/S0266467410000180; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Schluepmann Martin, 2000, Zeitschrift fuer Feldherpetologie, V7, P29; Skelhorn J, 2016, ANIM BEHAV, V113, pE1, DOI 10.1016/j.anbehav.2015.07.021; SMITH SM, 1976, BEHAVIOUR, V56, P309, DOI 10.1163/156853976X00082; SMITH SM, 1973, BEHAVIOUR, V44, P113, DOI 10.1163/156853973X00355; Sonego Rubia Cristina, 2007, Acta Bot. Bras., V21, P943, DOI 10.1590/S0102-33062007000400019; Streicher Jeffrey W., 2011, Herpetological Review, V42, P590; Toledo LF, 2011, ETHOL ECOL EVOL, V23, P1, DOI 10.1080/03949370.2010.534321; Umbers KDL, 2016, ANIM BEHAV, V113, pE5, DOI 10.1016/j.anbehav.2016.01.002; Utzeri Carlo, 2005, Herpetozoa, V18, P182; Vander Wall SB, 1998, ECOLOGY, V79, P233, DOI 10.2307/176878; Williams CR, 2000, J HERPETOL, V34, P431, DOI 10.2307/1565367; Zank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094625	78	8	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193551	10.1371/journal.pone.0193551	http://dx.doi.org/10.1371/journal.pone.0193551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596437	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000010
J	Teixeira, MA; Sela, N; Atamian, HS; Bao, E; Chaudhary, R; MacWilliams, J; He, JM; Mantelin, S; Girke, T; Kaloshian, I				Teixeira, Marcella A.; Sela, Noa; Atamian, Hagop S.; Bao, Ergude; Chaudhary, Ritu; MacWilliams, Jacob; He, Jiangman; Mantelin, Sophie; Girke, Thomas; Kaloshian, Isgouhi			Sequence analysis of the potato aphid Macrosiphum euphorbiae transcriptome identified two new viruses	PLOS ONE			English	Article							NEMATODE-RESISTANCE GENE; TOMATO; MI; EXPRESSION; EFFECTORS	The potato aphid, Macrosiphum euphorbiae, is an important agricultural pest that causes economic losses to potato and tomato production. To establish the transcriptome for this aphid, RNA-Seq libraries constructed from aphids maintained on tomato plants were used in Illumina sequencing generating 52.6 million 75-105 bp paired-end reads. The reads were assembled using Velvet/Oases software with SEED preprocessing resulting in 22,137 contigs with an N50 value of 2,003bp. After removal of contigs from tomato host origin, 20,254 contigs were annotated using BLASTx searches against the non-redundant protein database from the National Center for Biotechnology Information (NCBI) as well as IntereProS-can. This identified matches for 74% of the potato aphid contigs. The highest ranking hits for over 12,700 contigs were against the related pea aphid, Acyrthosiphon pisum. Gene Ontology (GO) was used to classify the identified M. euphorbiae contigs into biological process, cellular component and molecular function. Among the contigs, sequences of microbial origin were identified. Sixty five contigs were from the aphid bacterial obligate endosymbiont Buchnera aphidicola origin and two contigs had amino acid similarities to viruses. The latter two were named Macrosiphum euphorbiae virus 2 (MeV-2) and Macrosiphum euphorbiae virus 3 (MeV-3). The highest sequence identity to MeV-2 had the Dysaphis plantaginea densovirus, while to MeV-3 is the Hubei sobemo-like virus 49. Characterization of MeV-2 and MeV-3 indicated that both are transmitted vertically from adult aphids to nymphs. MeV-2 peptides were detected in the aphid saliva and only MeV-2 and not MeV-3 nucleic acids were detected inside tomato leaves exposed to virus-infected aphids. However, MeV-2 nucleic acids did not persist in tomato leaf tissues, after clearing the plants from aphids, indicating that MeV-2 is likely an aphid virus.	[Teixeira, Marcella A.; Atamian, Hagop S.; Chaudhary, Ritu; MacWilliams, Jacob; He, Jiangman; Mantelin, Sophie; Kaloshian, Isgouhi] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Sela, Noa] Volcani Ctr, Dept Plant Pathol & Weed Res, Bet Dagan, Israel; [Bao, Ergude] Univ Calif Riverside, Grad Program Comp Sci & Engn, Riverside, CA 92521 USA; [Girke, Thomas] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Girke, Thomas; Kaloshian, Isgouhi] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Kaloshian, Isgouhi] Univ Calif Riverside, Ctr Infect Dis Vector Res, Riverside, CA 92521 USA; [Teixeira, Marcella A.] Minist Agr Livestock & Food Supply, Brasilia, DF, Brazil; [Atamian, Hagop S.] Chapman Univ, Schmid Coll Sci & Technol, Orange, CA USA; [Bao, Ergude] Beijing Jiaotong Univ, Sch Software Engn, Beijing, Peoples R China; [Chaudhary, Ritu] NIH, Bldg 10, Bethesda, MD 20892 USA; [Mantelin, Sophie] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland	University of California System; University of California Riverside; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Chapman University System; Chapman University; Beijing Jiaotong University; National Institutes of Health (NIH) - USA; James Hutton Institute	Kaloshian, I (corresponding author), Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA.; Kaloshian, I (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.; Kaloshian, I (corresponding author), Univ Calif Riverside, Ctr Infect Dis Vector Res, Riverside, CA 92521 USA.	isgouhi.kaloshian@ucr.edu	Atamian, Hagop S/H-5595-2019; Sela, Noa/C-5133-2008	Sela, Noa/0000-0002-8282-215X; Girke, Thomas/0000-0003-0710-3777; Kaloshian, Isgouhi/0000-0002-9873-2810	NIH HHS [S10 OD016290] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016290] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agunbiade TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079929; Atamian HS, 2013, MOL PLANT MICROBE IN, V26, P67, DOI 10.1094/MPMI-06-12-0144-FI; Atamian Hagop S, 2012, Methods Mol Biol, V883, P47, DOI 10.1007/978-1-61779-839-9_3; Bao E, 2011, BIOINFORMATICS, V27, P2502, DOI 10.1093/bioinformatics/btr447; Bhattarai KK, 2007, MOL PLANT MICROBE IN, V20, P276, DOI 10.1094/MPMI-20-3-0276; Bhattarai KK, 2010, PLANT J, V63, P229, DOI 10.1111/j.1365-313X.2010.04232.x; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Chaudhary R, 2015, J PROTEOME RES, V14, P1762, DOI 10.1021/pr501128k; Chaudhary R, 2014, P NATL ACAD SCI USA, V111, P8919, DOI 10.1073/pnas.1407687111; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; Elzinga DA, 2014, MOL PLANT MICROBE IN, V27, P747, DOI 10.1094/MPMI-01-14-0018-R; Hebert SL, 2007, ENVIRON ENTOMOL, V36, P458, DOI 10.1603/0046-225X(2007)36[458:QDIAVA]2.0.CO;2; Kaloshian I, 1997, ENTOMOL EXP APPL, V83, P181, DOI 10.1023/A:1002923104371; KALOSHIAN I, 1995, P NATL ACAD SCI USA, V92, P622, DOI 10.1073/pnas.92.2.622; Kaloshian I, 2016, J INTEGR PLANT BIOL, V58, P350, DOI 10.1111/jipb.12438; Katis NI, 2007, APHIDS AS CROP PESTS, P353, DOI 10.1079/9780851998190.0353; Kettles GJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01142; Leonardo TE, 2003, P ROY SOC B-BIOL SCI, V270, pS209, DOI 10.1098/rsbl.2003.0064; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Liu S, 2016, VIRUSES, V8; Liu S., 2015, J SPECTROSC, V2015, P8; Liu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045161; Liu SJ, 2011, VIRUSES-BASEL, V3, P1849, DOI 10.3390/v3101849; Mathers TC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1145-3; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Nicholson SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1525-1; Radcliffe EB, 2002, AM J POTATO RES, V79, P353, DOI 10.1007/BF02870173; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Ryabov EV, 2009, P NATL ACAD SCI USA, V106, P8465, DOI 10.1073/pnas.0901389106; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; TATTERSALL P, 2005, VIRUS TAXONOMY, P353; Teixeira M, 2016, J GEN VIROL, V97, P1261, DOI 10.1099/jgv.0.000414; Thorpe P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2496-6; van Munster M, 2003, J INVERTEBR PATHOL, V84, P6, DOI 10.1016/S0022-2011(03)00013-2; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2; Webster CL, 2016, EVOL BIOINFORM, V12, P13, DOI 10.4137/EBO.S39454; Wenger J.A., 2017, INSECT BIOCH MOL BIO; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16092-z; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	49	6	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193239	10.1371/journal.pone.0193239	http://dx.doi.org/10.1371/journal.pone.0193239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596449	gold, Green Published			2022-12-27	WOS:000428630000007
J	Wolff, H; Bode, HB				Wolff, Hendrik; Bode, Helge B.			The benzodiazepine-like natural product tilivalline is produced by the entomopathogenic bacterium Xenorhabdus eapokensis	PLOS ONE			English	Article							KLEBSIELLA-OXYTOCA; PROLINE DEHYDROGENASE; PHOTORHABDUS; SIBIROMYCIN; TOMAYMYCIN; BIOSYNTHESIS; ANTHRAMYCIN; MICROBIOTA; MODELS	The pyrrolobenzodiazepine tilivalline (1) was originally identified in the human gut pathobiont Klebsiella oxytoca, the causative agent of antibiotic-associated hemorrhagic colitis. Here we show the identification of tilivalline and analogs thereof in the entomopathogenic bacterium Xenorhabdus eapokensis as well as the identification of its biosynthesis gene cluster encoding a bimodular non-ribosomal peptide synthetase. Heterologous expression of both genes in E. coli resulted in the production of 1 and from mutasynthesis and precursor directed biosynthesis 11 new tilivalline analogs were identified in X. eapokensis. These results allowed the prediction of the tilivalline biosynthesis being similar to that in K. oxytoca.	[Wolff, Hendrik; Bode, Helge B.] Goethe Univ Frankfurt, Mol Biotechnol, Fachbereich Biowissensch, Frankfurt, Germany; [Bode, Helge B.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Bode, HB (corresponding author), Goethe Univ Frankfurt, Mol Biotechnol, Fachbereich Biowissensch, Frankfurt, Germany.; Bode, HB (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909				ARIMA K, 1972, J ANTIBIOT, V25, P437, DOI 10.7164/antibiotics.25.437; Beaugerie L, 2003, CLIN GASTROENTEROL H, V1, P370, DOI 10.1053/S1542-3565(03)00183-6; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Bozhuyuk KAJ, 2017, CURR TOP MICROBIOL, V402, P55, DOI 10.1007/82_2016_24; BRAZHNIKOVA MG, 1972, J ANTIBIOT, V25, P668, DOI 10.7164/antibiotics.25.668; Challinor VL, 2015, ANN NY ACAD SCI, V1354, P82, DOI 10.1111/nyas.12954; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Darby A, 2014, PLOONE PUBLIC LIB, V9; Dornisch E, 2017, ANGEW CHEM INT EDIT, P1; Duncan KR, 2015, CHEM BIOL, V22, P460, DOI 10.1016/j.chembiol.2015.03.010; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; FRANZA T, 1991, J BACTERIOL, V173, P6874, DOI 10.1128/jb.173.21.6874-6881.1991; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Haslinger K, 2015, NATURE, V521, P105, DOI 10.1038/nature14141; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; Hogenauer C, 2006, NEW ENGL J MED, V355, P2418, DOI 10.1056/NEJMoa054765; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; HURLEY LH, 1977, J ANTIBIOT, V30, P349, DOI 10.7164/antibiotics.30.349; Jackson PJM, 2014, ACS CHEM BIOL, V9, P2432, DOI 10.1021/cb5002203; Kampfer P, 2017, INT J SYST EVOL MICR, V67, P1107, DOI 10.1099/ijsem.0.001770; KOPKA ML, 1994, BIOCHEMISTRY-US, V33, P13593, DOI 10.1021/bi00250a011; LEIMGRUBER W, 1965, J AM CHEM SOC, V87, P5791, DOI 10.1021/ja00952a050; Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; LING MF, 1994, J MOL BIOL, V243, P950, DOI 10.1006/jmbi.1994.1696; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; MOHR N, 1982, TETRAHEDRON, V38, P147, DOI 10.1016/0040-4020(82)85058-8; Mohr N, 1981, LIEBIGS ANN CHEM, V1981, P1515; Nagasaka T, 1998, J ORG CHEM, V63, P6797, DOI 10.1021/jo972158g; Richards GR, 2010, APPL ENVIRON MICROB, V76, P221, DOI 10.1128/AEM.01715-09; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Schimming O., 2015, ANGEW CHEM, V127, P12893; Schneditz G, 2014, P NATL ACAD SCI USA, V111, P13181, DOI 10.1073/pnas.1403274111; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi Y-M, 2018, NAT PROD REP ROYAL S, P1; Somvanshi VS, 2006, SYST APPL MICROBIOL, V29, P519, DOI 10.1016/j.syapm.2006.01.004; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; TENDLER MD, 1963, NATURE, V199, P501, DOI 10.1038/199501a0; Tercel M, 2003, J MED CHEM, V46, P2132, DOI 10.1021/jm020526p; Tobias NJ, 2017, NAT MICROBIOL, V2, P1676, DOI 10.1038/s41564-017-0039-9; TOZUKA Z, 1983, J ANTIBIOT, V36, P142, DOI 10.7164/antibiotics.36.142; Tse H, 2017, J BIOL CHEM AM SOC B, V292; Tsunematsu Y, 2013, NAT PROD REP, V30, P1139, DOI 10.1039/c3np70037b; vonTesmar A, 2017, CELL CHEM BIOL; vonTesmar A, 2018, ACS CHEM BIOL; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Yonemoto IT, 2012, ACS CHEM BIOL, V7, P973, DOI 10.1021/cb200544u; Zhang XS, 2015, J AM CHEM SOC, V137, P1388, DOI 10.1021/ja5103986; Zollner-Schwetz I, 2015, DIGEST DIS SCI, V60, P3393, DOI 10.1007/s10620-015-3765-y	55	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194297	10.1371/journal.pone.0194297	http://dx.doi.org/10.1371/journal.pone.0194297			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596433	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000021
J	Boyd, M; Wilson, N				Boyd, Matt; Wilson, Nick			Just ask Siri? A pilot study comparing smartphone digital assistants and laptop Google searches for smoking cessation advice	PLOS ONE			English	Article								Objective To compare voice-activated internet searches by smartphone (two digital assistants) with laptop ones for information and advice related to smoking cessation. Design Responses to 80 questions on a range of topics related to smoking cessation (including the FAQ from a NHS website), compared for quality. Setting Smartphone and internet searches as performed in New Zealand. Main outcome measures Ranked responses to the questions. Results Google laptop internet searches came first (or first equal) for best quality smoking cessation advice for 83% (66/80) of the responses. Voiced questions to Google Assistant ("OK Google") came first/first equal 76% of the time vs Siri (Apple) at 28%. Google and Google Assistant were statistically significantly better than Siri searches (odds ratio 12.4 and 8.5 respectively, p<0.0001 in each comparison). When asked FAQs from the National Health Service website, or to find information the Centers for Disease Control has made videos on, the best search results used expert sources 59% (31/52) of the time, "some expertise" (eg, Wikipedia) 18% of the time, but also magazines and other low quality sources 19% of the time. Using all three methods failed to find relevant information 8% (6/80) of the time, with Siri having the most failed responses (53% of the time). Conclusion Google Internet searches and Google Assistant were found to be significantly superior to the Siri digital assistant for smoking cessation information. While expert content was returned over half the time, there is still substantial room for improvement in how these software systems deliver smoking cessation advice.	[Boyd, Matt] Adapt Res Ltd, Reefton, New Zealand; [Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Otago	Boyd, M (corresponding author), Adapt Res Ltd, Reefton, New Zealand.	matt@adaptresearchwriting.com		Boyd, Matt/0000-0002-1387-5047				Centers for Disease Control and Prevention, TIPS FORM SMOK VID; Domegan C., 2011, LIT REV HLTH INFORM; Dunn J., 2016, BUSINESS INSIDER; Gibbs S, 2015, GUARDIAN; Hachman M., 2016, PCWORLD; Miner AS, 2016, JAMA INTERN MED, V176, P619, DOI 10.1001/jamainternmed.2016.0400; National health Service, SMOK NHS FREQ ASK QU; Ofcom, 2020, AD MED US ATT; Stevens L, 2017, DIGITAL HLTH	9	26	26	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194811	10.1371/journal.pone.0194811	http://dx.doi.org/10.1371/journal.pone.0194811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590168	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100074
J	Kaur, A; Kapil, A; Elangovan, R; Jha, S; Kalyanasundaram, D				Kaur, Avinash; Kapil, Arti; Elangovan, Ravikrishnan; Jha, Sandeep; Kalyanasundaram, Dinesh			Highly-sensitive detection of Salmonella typhi in clinical blood samples by magnetic nanoparticle-based enrichment and in-situ measurement of isothermal amplification of nucleic acids	PLOS ONE			English	Article							IMMUNOMAGNETIC SEPARATION; RAPID DETECTION; DIAGNOSIS; CULTURE; FEVER; FOODS; ASSAY; DNA	Enteric fever continues to be a major cause of mortality and morbidity globally, particularly in poor resource settings. Lack of rapid diagnostic assays is a major driving factor for the empirical treatment of enteric fever. In this work, a rapid and sensitive method 'Miod 'has been developed. Miod includes a magnetic nanoparticle-based enrichment of target bacterial cells, followed by cell lysis and loop-mediated isothermal amplification (LAMP) of nucleic acids for signal augmentation along with concurrent measurement of signal via an in situ optical detection system. To identify positive/negative enteric fever infections in clinical blood samples, the samples were processed using Miod at time = 0 hours and time = 4 hours post-incubation in blood culture media. Primers specific for the STY2879 gene were used to amplify the nucleic acids isolated from S. typhicells. A limit of detection of 5 CFU/mL was achieved. No cross-reactivity of the primers were observed against 106 CFU/mL of common pathogenic bacterial species found in blood such as E. coli, P. aeruginosa, S. aureus, A. baumanni, E. faecalis, S. Paratyphi A and K. pneumonia. Miod was tested on 28 human clinical blood samples. The detection of both pre- and post-four-hours incubation confirmed the presence of viable S. typhicells and allowed clinical correlation of infection. The positive and negative samples were successfully detected in less than 6 hours with 100% sensitivity and specificity.	[Kaur, Avinash; Jha, Sandeep; Kalyanasundaram, Dinesh] Indian Inst Technol Delhi, Ctr Biomed Engn, New Delhi, India; [Kapil, Arti] All India Inst Med Sci, Dept Microbiol, New Delhi, India; [Elangovan, Ravikrishnan] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Jha, Sandeep; Kalyanasundaram, Dinesh] All India Inst Med Sci, Dept Biomed Engn, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Kalyanasundaram, D (corresponding author), Indian Inst Technol Delhi, Ctr Biomed Engn, New Delhi, India.; Kalyanasundaram, D (corresponding author), All India Inst Med Sci, Dept Biomed Engn, New Delhi, India.	dineshk@cbme.iitc.ac.in	Kalyanasundaram, Dinesh/AAE-8420-2019; Kalyanasundaram, Dinesh/AAY-7593-2021	Kalyanasundaram, Dinesh/0000-0001-5127-4122; Kaur, Avinash/0000-0003-2667-8146	Naval research board [NRB/4003/PG/359]; Department of Science and Technology [YSS/2014/000880]; Indo-German Science and Technology	Naval research board; Department of Science and Technology(Department of Science & Technology (India)); Indo-German Science and Technology	The funding agencies are: Naval research board (NRB/4003/PG/359); Department of Science and Technology (YSS/2014/000880); Indo-German Science and Technology (IGSTC/Call 2014/Sound4All/24/2015-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah J, 2014, BRAZ J MICROBIOL, V45, P1385, DOI 10.1590/S1517-83822014000400032; Alba S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155286; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Bozorgmehr A, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-016-3657-x; Carter C, 2017, J VIROL METHODS, V244, P32, DOI 10.1016/j.jviromet.2017.02.013; Crichton PB, 1996, MACKIE MCCARTNEY PRA, V14, P361; CUDJOE KS, 1995, INT J FOOD MICROBIOL, V27, P11, DOI 10.1016/0168-1605(94)00134-R; da Silva FRC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162345; Dahiya S, 2017, INDIAN J MED MICROBI, V35, P61, DOI [10.4103/ijmm.IJMM_16_382, 10.4103/ijmm.ijmm_16_382]; Darton TC, 2017, J INFECTION, V74, P358, DOI 10.1016/j.jinf.2017.01.006; Dutta S., 2014, PLOS ONE, V9; Hejazian M, 2015, LAB CHIP, V15, P959, DOI 10.1039/c4lc01422g; Kang JH, 2015, SMALL, V11, P5657, DOI 10.1002/smll.201501820; Kim J, 2011, BIOANALYSIS, V3, P227, DOI 10.4155/BIO.10.172; Kivlehan F, 2011, ANALYST, V136, P3635, DOI 10.1039/c1an15289k; Kokkinos PA, 2014, FOOD ANAL METHOD, V7, P512, DOI 10.1007/s12161-013-9748-8; Kumar S, 2005, WORLD J MICROB BIOT, V21, P625, DOI 10.1007/s11274-004-3553-x; Lee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122922; Liu YC, 2001, SENSOR ACTUAT B-CHEM, V72, P214, DOI 10.1016/S0925-4005(00)00663-8; Maan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163014; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Martiny D, 2013, CLIN MICROBIOL INFEC, V19, pE568, DOI 10.1111/1469-0691.12282; Mogasale V, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0147-z; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Paolucci M, 2010, INT J ANTIMICROB AG, V36, pS6, DOI 10.1016/j.ijantimicag.2010.11.010; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; Perera RS, 2017, PLOS ONE, P12; Phumkhachorn P, 2017, EMIR J FOOD AGR, V29, P1; Ranjbar R, 2017, IRAN J PUBLIC HEALTH, V46, P103; Ravan H, 2013, ANAL BIOCHEM, V439, P102, DOI 10.1016/j.ab.2013.04.014; Singh J, 2015, ANAL METHODS-UK, V7, P9281, DOI [10.1039/C5AY02271A, 10.1039/c5ay02271a]; Singh S, 2016, ANALYST, V141, P3358, DOI [10.1039/C6AN00291A, 10.1039/c6an00291a]; Toley BJ, 2015, ANALYST, V140, P7540, DOI 10.1039/c5an01632k; WHO, 2015, INT PHARM, P1; Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e; Yin Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115120	38	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194817	10.1371/journal.pone.0194817	http://dx.doi.org/10.1371/journal.pone.0194817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590194	Green Submitted, gold, Green Published			2022-12-27	WOS:000428603100076
J	Kumbhar, BV; Panda, D; Kunwar, A				Kumbhar, Bajarang Vasant; Panda, Dulal; Kunwar, Ambarish			Interaction of microtubule depolymerizing agent indanocine with different human alpha beta tubulin isotypes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; CANCER-CELLS; EXPRESSION; BINDING; COLCHICINE; SIMULATIONS; RESISTANCE; CARCINOMA; APOPTOSIS; SITE	Tubulin isotypes are known to regulate the stability and dynamics of microtubules, and are also involved in the development of resistance against microtubule-targeted cancer drugs. Indanocine, a potent microtubule depolymerizing agent, is highly active against multidrug-resistant (MDR) cancer cells without affecting normal cells. It is known to disrupt microtubule dynamics in cells and induce apoptotic cell death. Indanocine is reported to bind to tubulin at the colchicine site i.e. at the interface of alpha beta tubulin heterodimer. However, it's precise binding mode, involved molecular interactions and the binding affinities with different alpha beta-tubulin isotypes present in MDR cells are not well understood. Here, the binding affinities of human alpha beta-tubulin isotypes with indanocine were examined, employing the molecular modeling approach i.e. docking, molecular dynamics simulation and binding energy calculations. Multiple sequence analysis suggests that the amino acid sequences are different in the indanocine binding pockets of beta I,beta IIa, beta III and beta VI isotypes. However, such differences are not observed in the amino acid sequences of beta IVa, beta IVb, and beta V tubulin isotypes at indanocine binding pockets. Docking and molecular dynamics simulation results show that indanocine prefers the interface binding pocket of alpha beta IIa, alpha beta III, alpha beta IVb, alpha beta V, and alpha beta VI tubulin isotypes; whereas it is expelled from the interface binding pocket of alpha beta IVa and alpha beta I-tubulin isotypes. Further, binding free energy calculations show that alpha beta VI has the highest binding affinity and alpha beta I has the lowest binding affinity for indanocine among all beta-tubulin isotypes. The binding free energy decreases in the order of alpha beta VI > alpha beta IVb > alpha beta IIa > alpha beta III > alpha beta V > alpha beta IVa > alpha beta I. Thus, our study provides a significant understanding of involved molecular interactions of indanocine with tubulin isotypes, which may help to design potent indanocine analogues for specific tubulin isotypes in MDR cells in future.	[Kumbhar, Bajarang Vasant; Panda, Dulal; Kunwar, Ambarish] Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kunwar, A (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	akunwar@iitb.ac.in	Kumbhar, Bajarang/AAR-3309-2020; Kunwar, Ambarish/AAD-3618-2022	Kumbhar, Bajarang/0000-0002-3839-9809; Kunwar, Ambarish/0000-0002-8671-7816	Indian Institute of Technology Bombay; Department of Biotechnology, Government of India; Pilot Project Grants, Program for young investigators in cancer biology from the Department of Biotechnology, Government of India [6242-P12/RGCB/PMD/DBT/AMBK/2015]	Indian Institute of Technology Bombay; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Pilot Project Grants, Program for young investigators in cancer biology from the Department of Biotechnology, Government of India	BVK is thankful to Indian Institute of Technology Bombay for Post Doctoral Fellowship. DP is thankful for the Tata Innovation Fellowship from the Department of Biotechnology, Government of India. AK is supported by Pilot Project Grants, Program for young investigators in cancer biology (Grant No. 6242-P12/RGCB/PMD/DBT/AMBK/2015) from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; BANERJEE A, 1992, J BIOL CHEM, V267, P13335; Case D. A., 2012, AMBERTOOLS12 REFEREN; Chakraborti S, 2012, BIOCHEMISTRY-US, V51, P7138, DOI 10.1021/bi300474q; Christoph DC, 2012, BRIT J CANCER, V107, P823, DOI 10.1038/bjc.2012.324; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Das L, 2009, BIOCHEMISTRY-US, V48, P1628, DOI 10.1021/bi801575e; DeLano W.L, PYMOL MOL GRAPHICS S; Derry WB, 1997, BIOCHEMISTRY-US, V36, P3554, DOI 10.1021/bi962724m; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Goujon M., 2010, NUCL ACIDS RES, V38; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kapoor S, 2012, BIOCHEM PHARMACOL, V83, P1495, DOI 10.1016/j.bcp.2012.02.012; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kumbhar BV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156048; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leoni LM, 2000, JNCI-J NATL CANCER I, V92, P217, DOI 10.1093/jnci/92.3.217; Luchko T, 2008, BIOPHYS J, V94, P1971, DOI 10.1529/biophysj.107.115113; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Luduena Richard E., 2008, P123, DOI 10.1007/978-1-59745-336-3_6; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ohishi Y, 2007, GYNECOL ONCOL, V105, P586, DOI 10.1016/j.ygyno.2007.01.044; Pamula MC, 2016, J CELL BIOL, V213, P425, DOI 10.1083/jcb.201603050; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Pandey RK, 2017, J BIOMOL STRUCT DYN, V35, P141, DOI 10.1080/07391102.2015.1135298; Parker AL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071434; Rai A, 2013, BIOCHEM PHARMACOL, V86, P378, DOI 10.1016/j.bcp.2013.05.024; Ranganathan S, 1998, BRIT J CANCER, V77, P562, DOI 10.1038/bjc.1998.91; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; Vemu A, 2017, MOL BIOL CELL; Venghateri JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075182; Xu K, 2002, DRUG DEVELOP RES, V55, P91, DOI 10.1002/ddr.10023	40	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194934	10.1371/journal.pone.0194934	http://dx.doi.org/10.1371/journal.pone.0194934			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584771	Green Published, gold			2022-12-27	WOS:000428373000050
J	Nguyen, CP; Adang, EMM				Chi Phuong Nguyen; Adang, Eddy M. M.			Cost-effectiveness of breast cancer screening using mammography in Vietnamese women	PLOS ONE			English	Article							PROGRAM; IMPACT	Background The incidence rate of breast cancer is increasing and has become the most common cancer in Vietnamese women while the survival rate is lower than that of developed countries. Early detection to improve breast cancer survival as well as reducing risk factors remains the cornerstone of breast cancer control according to the World Health Organization (WHO). This study aims to evaluate the costs and outcomes of introducing a mammography screening program for Vietnamese women aged 45-64 years, compared to the current situation of no screening. Methods Decision analytical modeling using Markov chain analysis was used to estimate costs and health outcomes over a lifetime horizon. Model inputs were derived from published literature and the results were reported as incremental cost-effectiveness ratios (ICERs) and/or incremental net monetary benefits (INMBs). One-way sensitivity analyses and probabilistic sensitivity analyses were performed to assess parameter uncertainty. Results The ICER per life year gained of the first round of mammography screening was US $3647.06 and US$4405.44 for women aged 50-54 years and 55-59 years, respectively. In probabilistic sensitivity analyses, mammography screening in the 50-54 age group and the 55-59 age group were cost-effective in 100% of cases at a threshold of three times the Vietnamese Gross Domestic Product (GDP) i.e., US$6332.70. However, less than 50% of the cases in the 60-64 age group and 0% of the cases in the 45-49 age group were cost effective at the WHO threshold. The ICERs were sensitive to the discount rate, mammography sensitivity, and transition probability from remission to distant recurrence in stage II for all age groups. Conclusion From the healthcare payer viewpoint, offering the first round of mammography screening to Vietnamese women aged 50-59 years should be considered, with the given threshold of three times the Vietnamese GDP per capita.	[Chi Phuong Nguyen] Hanoi Univ Pharm, Dept Pharmaceut Adm & Econ, Hanoi, Vietnam; [Chi Phuong Nguyen; Adang, Eddy M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands	Hanoi University of Pharmacy; Radboud University Nijmegen	Nguyen, CP (corresponding author), Hanoi Univ Pharm, Dept Pharmaceut Adm & Econ, Hanoi, Vietnam.	chinguyen@hup.edu.vn	Adang, E.M.M./L-4169-2015	Nguyen, Chi/0000-0002-8159-6680				Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Azami-Aghdash Saber, 2015, Asian Pac J Cancer Prev, V16, P3463; Carles M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-192; CARTER R, 1993, AUST J PUBLIC HEALTH, V17, P42; de Gelder R, 2009, EUR J CANCER, V45, P127, DOI 10.1016/j.ejca.2008.09.015; DEKONING HJ, 1991, INT J CANCER, V49, P531, DOI 10.1002/ijc.2910490410; Duc NB, 2010, VIET J ONCOL, P21; Dung Phuong, 2015, CANCER BIOL MED, V12, P238; Edejer T, 2003, MAKING CHOICES HLTH; European Commission Intiative on Breast Cancer, 2018, SHOULD ORGANISED MAM; General statistics office of Vietnam, 2017, CONS PRIC IND 2017; General statistics office of Vietnam, 2011, CENSUS OF POPULATION; Gocgun Y, 2015, BREAST, V24, P440, DOI 10.1016/j.breast.2015.03.012; Hamashima C, 2016, JPN J CLIN ONCOL, V46, P482, DOI 10.1093/jjco/hyw008; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Hung NT., 2012, J PRACT MED, V4, P61; International Agency for Research on Cancer, 2012, BREAST CANC EST INC; International Agency for Research on Cancer, 2017, GLOBOCAN 2012 EST CA; Kang MH, 2013, ASIAN PAC J CANCER P, V14, P2059, DOI 10.7314/APJCP.2013.14.3.2059; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; Knaul Felicia M, 2010, J ONCOLOGY; Lan NH, 2013, GLOBAL HEALTH ACTION, V6, P23, DOI 10.3402/gha.v6i0.18860; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lee EH, 2016, KOREAN J RADIOL, V17, P489, DOI 10.3348/kjr.2016.17.4.489; Linsell L, 2010, J MED SCREEN, V17, P176, DOI 10.1258/jms.2010.010037; Michael FD., 2015, METHODS EC EVALUATIO, VFourth Edi; Ministry of Health Singapore, 2010, CANC SCREEN MOH CLIN; Morris E, 2015, POPUL HEALTH MANAG, V18, pS3, DOI 10.1089/pop.2015.29023.mor; Lan NH, 2013, GLOBAL HEALTH ACTION, V6, P32, DOI 10.3402/gha.v6i0.18872; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Okonkwo QL, 2008, JNCI-J NATL CANCER I, V100, P1290, DOI 10.1093/jnci/djn292; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Parvin Yavari, 2016, IRAN J CANC PREV, V9; Rosenquist CJ, 1998, CANCER, V82, P2235, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2235::AID-CNCR19>3.0.CO;2-V; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Suzuki A, 2008, CANCER SCI, V99, P2264, DOI 10.1111/j.1349-7006.2008.00926.x; [The International Agency for Research on Cancer (IARC) World Health Organisation], 2008, GLOBOCAN 2008 CANC I; Thomson MD, 2015, WOMEN HEALTH ISS, V25, P128, DOI 10.1016/j.whi.2014.11.003; Thuan TV, 2011, J PRACTICAL MED, V756, P29; van den Ende C, 2017, INT J CANCER, V141, P1295, DOI 10.1002/ijc.30794; Vietnamese Ministry of Health Vietnamese Ministry of Finance, 2015, 372015TTLTBYTBTC VIE; WHO, 2017, BREAST CANC PREV CON; Wong IOL, 2007, CANCER-AM CANCER SOC, V110, P885, DOI 10.1002/cncr.22848; Woo PPS, 2007, J CLIN ONCOL, V25, P617, DOI 10.1200/JCO.2006.06.0210; World Bank, 2017, GDP PER CAP CURR US	46	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194996	10.1371/journal.pone.0194996	http://dx.doi.org/10.1371/journal.pone.0194996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579131	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800075
J	Park, HY; Berkowitz, O; Symes, K; Dasgupta, S				Park, Hee-Young; Berkowitz, Oren; Symes, Karen; Dasgupta, Shoumita			The art and science of selecting graduate students in the biomedical sciences: Performance in doctoral study of the foundational sciences	PLOS ONE			English	Article							DEFINING SUCCESS; EDUCATION	The goal of this study was to investigate associations between admissions criteria and performance in Ph.D. programs at Boston University School of Medicine. The initial phase of this project examined student performance in the classroom component of a newly established curriculum named "Foundations in Biomedical Sciences (FIBS)". Quantitative measures including undergraduate grade point average (GPA), graduate record examination (GRE; a standardized, computer-based test) scores for the verbal (assessment of test takers' ability to analyze, evaluate, and synthesize information and concepts provided in writing) and quantitative (assessment of test takers' problem-solving ability) components of the examination, previous research experience, and competitiveness of previous research institution were used in the study. These criteria were compared with competencies in the program defined as students who pass the curriculum as well as students categorized as High Performers. These data indicated that there is a significant positive correlation between FIBS performance and undergraduate GPA, GRE scores, and competitiveness of undergraduate institution. No significant correlations were found between FIBS performance and research background. By taking a data-driven approach to examine admissions and performance, we hope to refine our admissions criteria to facilitate an unbiased approach to recruitment of students in the life sciences and to share our strategy to support similar goals at other institutions.	[Park, Hee-Young] Boston Univ, Sch Med, Dept Med Sci & Educ, Boston, MA 02118 USA; [Berkowitz, Oren] Ariel Univ, Dept Hlth Syst Management, Ariel, Israel; [Symes, Karen] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Dasgupta, Shoumita] Boston Univ, Sch Med, Dept Med, Biomed Genet Sect, Boston, MA 02118 USA	Boston University; Ariel University; Boston University; Boston University	Park, HY (corresponding author), Boston Univ, Sch Med, Dept Med Sci & Educ, Boston, MA 02118 USA.	hypark@bu.edu	Berkowitz, Oren/L-5006-2019	Berkowitz, Oren/0000-0002-4919-4921; Park, Hee-Young/0000-0001-8981-6484				Albanese MA, 2005, ADV HEALTH SCI EDUC, V10, P89, DOI 10.1007/s10459-004-1122-6; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; [Anonymous], 2015, BARRONS ED SERIES IC; Beilock S, 2016, SCIENCE, V351, P1159, DOI 10.1126/science.aaf2200; Bell SM, 2014, MOL BIOL CELL, V25, P1942, DOI 10.1091/mbc.E14-03-0793; Burmeister J, 2014, J APPL CLIN MED PHYS, V15, P375, DOI 10.1120/jacmp.v15i1.4451; Dasgupta S, 2015, BIOCHEM MOL BIOL EDU, V43, P126, DOI 10.1002/bmb.20862; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gibbs KD, 2014, PLOS ONE, P9; Gibbs KD, 2013, CBE-LIFE SCI EDUC, V12, P711, DOI 10.1187/cbe.13-02-0021; Hall JD, 2017, BIOBIOMEDICAL GRADUA; Hall JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169121; Miller C., 2014, NATURE, V510, P303, DOI [10.1038/nj7504-303a, DOI 10.1038/NJ7504-303A]; Moneta-Koehler L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166742; Posselt JR, INSIDE GRADUATE ADMI; Weiner O, 2014, MOL BIOL CELL, V25, P1945, DOI 10.1091/mbc.E14-04-0921; Weiner OD, 2014, MOL BIOL CELL, V25, P429, DOI 10.1091/mbc.E13-11-0646; Witzburg RA, 2013, NEW ENGL J MED, V368, P1565, DOI 10.1056/NEJMp1300411	18	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0193901	10.1371/journal.pone.0193901	http://dx.doi.org/10.1371/journal.pone.0193901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614110	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600007
J	Duron, S; Panjo, H; Bohet, A; Bigaillon, C; Sicard, S; Bajos, N; Meynard, JB; Merens, A; Moreau, C				Duron, Sandrine; Panjo, Henri; Bohet, Aline; Bigaillon, Christine; Sicard, Sebastien; Bajos, Nathalie; Meynard, Jean-Baptiste; Merens, Audrey; Moreau, Caroline			Prevalence and risk factors of sexually transmitted infections among French service members	PLOS ONE			English	Article							UNITED-STATES; ALCOHOL-USE; MILITARY; BEHAVIOR; HIV; PREVENTION; DEPRESSION; PERSONNEL; DISEASES; INCOME	Introduction Sexually Transmitted Infections (STIs) have always represented a public health concern in the military, yet most studies rely on self-reports among non-random samples of military populations. In addition, most of the studies exploring STI rates among the military focus on US service members. This paper assesses the prevalence and correlates of STIs in the French military using biomarkers and compares self-reported versus diagnosed STIs. Methods Data are drawn from the COSEMIL study, a national sexual health survey conducted in the French military in 2014 and 2015. A random sample of 784 men and 141 women aged 1857 years completed a self-administered questionnaire and provided biological samples for STI testing. We used logistic regression modeling to identify the correlates of STI diagnosis and self-reports. Results The prevalence of diagnosed STIs was 4.7% [3.8-5.9], mostly due to Chlamydia trachomatis. This rate was four times higher than the 12 months self-reported rate of 1.1% [0.6-2.3]. Reported STI rates were similar among men and women (1.1% versus 1.8%), but diagnosed STI rates were twice as high among females versus males (10.4% versus 4.1%, p = 0.007). There were significant differences in the determinants of reported versus diagnosed STIs. In particular, age and sexual orientation were associated with reported STIs, but not with diagnosed STIs. Conversely, STI counseling and depression were associated with STI diagnosis but not with STI reports. Conclusion This study underlines the need to use biomarkers in population-based surveys, given the differential and substantial underreporting of STIs. Results also highlight the need for programmatic adaptation to address gender inequalities in STI rates, by developing women's health services in the French military. Addressing such needs not only benefits women but could also serve as a strategy to reduce overall STI rates as most military women have military partners, increasing the risk of internal transmission.	[Duron, Sandrine; Sicard, Sebastien; Meynard, Jean-Baptiste] French Mil Ctr Epidemiol & Publ Hlth, Marseille, France; [Duron, Sandrine; Sicard, Sebastien; Meynard, Jean-Baptiste] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France; [Panjo, Henri; Bohet, Aline; Bajos, Nathalie; Moreau, Caroline] INSERM, Gender Sexual & Reprod Hlth, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Bigaillon, Christine; Merens, Audrey] French Mil Hosp Begin, Med Biol Lab, St Mande, France; [Meynard, Jean-Baptiste; Merens, Audrey] Ecole Val de Grace, French Mil Med Acad, Paris, France; [Moreau, Caroline] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moreau, C (corresponding author), INSERM, Gender Sexual & Reprod Hlth, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France.; Moreau, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	cmoreau2@jhu.edu	Bajos, Nathalie/M-4170-2018; Moreau, Caroline/A-8989-2019	Bajos, Nathalie/0000-0001-8073-9056; Moreau, Caroline/0000-0002-8637-6249	"Agence Nationale de recherche sur le Sida et les hepatites virales" (ANRS); "Institut national pour la prevention et l'education pour la sante" (INPES); "Caisse nationale militaire de securite sociale" (CNMSS)	"Agence Nationale de recherche sur le Sida et les hepatites virales" (ANRS)(ANRSFrench National Research Agency (ANR)); "Institut national pour la prevention et l'education pour la sante" (INPES); "Caisse nationale militaire de securite sociale" (CNMSS)	This work was supported by the following French institutions/agencies: "Agence Nationale de recherche sur le Sida et les hepatites virales" (ANRS), "Institut national pour la prevention et l'education pour la sante" (INPES), "Caisse nationale militaire de securite sociale" (CNMSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino K., 1997, MASCULINITY SEXUALIT; Allsep LM, 2013, J HOMOSEXUAL, V60, P381, DOI 10.1080/00918369.2013.744928; Anastario MP, 2013, CULT MED PSYCHIAT, V37, P737, DOI 10.1007/s11013-013-9335-x; Anastario MP, 2010, REV PANAM SALUD PUBL, V28, P361; Anderson P, 2005, ALCOHOL PRIMARY HLTH, P172; [Anonymous], 2012, PSYCH ASP DEPL HLTH; Avery AK, 2015, MICROBIOL SPECTR, P3; Barrett Frank J., 1996, GENDER WORK ORGAN, V3, p129?142; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; Chai SJ, 2010, SEX TRANSM DIS, V37, P756, DOI 10.1097/OLQ.0b013e3181e3d771; Chemto D, 2017, ISR J HEALTH POLICY, V6, DOI 10.1186/s13584-017-0141-8; Cole MJ, 2015, BMC INFECT DIS, P15; Darrow WW, 1997, GENITOURIN MED, V73, P88; de Santi VP, 2009, ANN DERMATOL VENER, V136, P775, DOI 10.1016/j.annder.2009.09.007; Deiss R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167892; Essien EJ, 2006, MIL MED, V171, P1027, DOI 10.7205/MILMED.171.10.1027; Gaydos JC, 2015, SEX TRANSM INFECT, V91, P536, DOI 10.1136/sextrans-2015-052256; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Goyal V, 2012, J WOMENS HEALTH, V21, P1155, DOI 10.1089/jwh.2012.3605; Gual A, 2002, ALCOHOL ALCOHOLISM, V37, P591, DOI 10.1093/alcalc/37.6.591; Hakre S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-181; Harbertson J, 2013, TROP MED INT HEALTH, V18, P925, DOI 10.1111/tmi.12129; Harbertson J, 2013, AIDS BEHAV, V17, P1734, DOI 10.1007/s10461-012-0343-6; Harling G, 2014, SOC SCI MED, V102, P174, DOI 10.1016/j.socscimed.2013.11.025; Hong Y, 2011, J WOMENS HEALTH, V20, P129, DOI 10.1089/jwh.2010.2139; Jordan Nikki N, 2013, MSMR, V20, P15; Jordan NN, 2011, MIL MED, V176, P312, DOI 10.7205/MILMED-D-10-00212; Khan MR, 2009, ARCH PEDIAT ADOL MED, V163, P644, DOI 10.1001/archpediatrics.2009.95; Legleye S, 2011, REV EPIDEMIOL SANTE, V59, P223, DOI 10.1016/j.respe.2011.02.103; Lloyd J, 2014, SEX TRANSM INFECT, V90, P382, DOI 10.1136/sextrans-2013-051463; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; MacQueen KM, 1996, MED ANTHROPOL Q, V10, P402, DOI 10.1525/maq.1996.10.3.02a00070; Mankayi N, 2011, AJAR-AFR J AIDS RES, V10, P43, DOI 10.2989/16085906.2011.575547; Marbac-Delon V, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14101; Marshall BDL, 2013, J TRAUMA STRESS, V26, P64, DOI 10.1002/jts.21777; Mgbere O, 2013, AIDS BEHAV, V17, P1159, DOI 10.1007/s10461-011-0126-5; O'Connell CM, 2016, MICROB CELL, V3, P390, DOI 10.15698/mic2016.09.525; Rasnake Mark S, 2005, Mil Med, V170, P61; Sanchez JL, 2013, MIL MED, V178, P1271, DOI 10.7205/MILMED-D-13-00137; Sena AC, 2000, CLIN INFECT DIS, V30, P742, DOI 10.1086/313742; Shanks GD, 2014, LANCET, V384, P1699, DOI 10.1016/S0140-6736(14)61786-4; Stahlman S, 2015, SEX HEALTH, V12, P272, DOI 10.1071/SH14211; Stahlman S, 2014, SEX TRANSM DIS, V41, P359, DOI 10.1097/OLQ.0000000000000133; Suay-Garcia B, 2017, EUR J CLIN MICROBIOL, V36, P1065, DOI 10.1007/s10096-017-2931-x; Taft AJ, 2008, BMC PUBLIC HEALTH, P8; Thompson JC, 2005, PREV MED, V41, P247, DOI 10.1016/j.ypmed.2004.11.008; Tourdot Laura E, 2016, MSMR, V23, P29; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; Warszawski J, 2012, SEXUALITY FRANCE, P425; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201; Yavorsky RL, 2014, CLIN PEDIATR, V53, P890, DOI 10.1177/0009922814533816; Zablocka R, 2017, J COMMUN HEALTH, V42, P160, DOI 10.1007/s10900-016-0243-1; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040793	55	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195158	10.1371/journal.pone.0195158	http://dx.doi.org/10.1371/journal.pone.0195158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608617	gold, Green Published, Green Submitted			2022-12-27	WOS:000428988800029
J	Giavazzi, M; Sambin, S; de Diego-Balaguer, R; Le Stanc, L; Bachoud-Levi, AC; Jacquemot, C				Giavazzi, Maria; Sambin, Sara; de Diego-Balaguer, Ruth; Le Stanc, Lorna; Bachoud-Levi, Anne-Catherine; Jacquemot, Charlotte			Structural priming in sentence comprehension: A single prime is enough	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; SYNTACTIC INFORMATION; PERSISTENCE; CONSTRAINTS; ADAPTATION; ERROR; FMRI	Experiencing a syntactic structure affects how we process subsequent instances of that structure. This phenomenon, called structural priming, is observed both in language production and in language comprehension. However, while abstract syntactic structures can be primed independent of lexical overlap in sentence production, evidence for structural priming in comprehension is more elusive. In addition, when structural priming in comprehension is found, it can often be accounted for in terms of participants' explicit expectations. Participants may use the structural repetition over several sentences and build expectations, which create a priming effect. Here, we use a new experimental paradigm to investigate structural priming in sentence comprehension independent of lexical overlap and of participants' expectations. We use an outcome dependent variable instead of commonly used online measures, which allows us to more directly compare these effects with those found in sentence production studies. We test priming effects in syntactically homogeneous and heterogeneous conditions on a sentence-picture matching task that forces participants to fully parse the sentences. We observe that, while participants learn the structural regularity in the homogeneous condition, structural priming is also found in the heterogeneous condition, in which participants do not expect any particular structure. In fact, we find that a single prime is enough to trigger priming. Our results indicate that-like in sentence production-structural priming can be observed in sentence comprehension without lexical repetition and independent of participants' expectation.	[Giavazzi, Maria; Le Stanc, Lorna; Bachoud-Levi, Anne-Catherine; Jacquemot, Charlotte] PSL Res Univ, Dept Etud Cognit, Ecole Normale Super, Paris, France; [Giavazzi, Maria; Le Stanc, Lorna; Bachoud-Levi, Anne-Catherine; Jacquemot, Charlotte] INSERM, U955, Lab NeuroPsychol Intervent, Equipe 01, Creteil, France; [Giavazzi, Maria; Le Stanc, Lorna; Bachoud-Levi, Anne-Catherine; Jacquemot, Charlotte] Univ Paris Est, Fac Med, Creteil, France; [Sambin, Sara] Univ Libre Bruxelles, Dept Neurol, Hop Erasme, Brussels, Belgium; [de Diego-Balaguer, Ruth] ICREA, Barcelona, Spain; [de Diego-Balaguer, Ruth] IDIBELL, Cognit & Brain Plast Unit, Barcelona, Spain; [de Diego-Balaguer, Ruth] Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain; [de Diego-Balaguer, Ruth] Univ Barcelona, Inst Neurosci, Barcelona, Spain; [Bachoud-Levi, Anne-Catherine] Hop Henri Mondor, AP HP, Ctr Reference Malad Huntington, Creteil, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Libre de Bruxelles; ICREA; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Bachoud-Levi, AC (corresponding author), PSL Res Univ, Dept Etud Cognit, Ecole Normale Super, Paris, France.; Bachoud-Levi, AC (corresponding author), INSERM, U955, Lab NeuroPsychol Intervent, Equipe 01, Creteil, France.; Bachoud-Levi, AC (corresponding author), Univ Paris Est, Fac Med, Creteil, France.; Bachoud-Levi, AC (corresponding author), Hop Henri Mondor, AP HP, Ctr Reference Malad Huntington, Creteil, France.	bachoud@gmail.com	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; de Diego-Balaguer, Ruth/V-2131-2017	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; Le Stanc, Lorna/0000-0002-2511-9070; de Diego-Balaguer, Ruth/0000-0002-2357-5195; Jacquemot, Charlotte/0000-0002-6611-0742	Agence Nationale de la recherche grant [ANR-11-JSH2-0006]; Ecole doctorale Universite Paris-Est Creteil Sciences de la Vie et de la Sante, doctoral scholarship [27433-2007, 2015/58]; French Ministry of Health (Reference Center for Huntingtons Disease) (ACBL); INSERM Contrat dinterface (ACBL); Assistance Publique - Hopitaux de Paris: biomarker program [NCT01412125]; Gobierno de Espana, Ministerio de Ciencia e Innovacion (MICINN) [PSI2011-23624]; Institut dEtudes Cognitives (ENS, Paris) [ANR-11-0001-02 PSL*, ANR-10-LABX-0087]	Agence Nationale de la recherche grant(French National Research Agency (ANR)); Ecole doctorale Universite Paris-Est Creteil Sciences de la Vie et de la Sante, doctoral scholarship; French Ministry of Health (Reference Center for Huntingtons Disease) (ACBL); INSERM Contrat dinterface (ACBL); Assistance Publique - Hopitaux de Paris: biomarker program; Gobierno de Espana, Ministerio de Ciencia e Innovacion (MICINN); Institut dEtudes Cognitives (ENS, Paris)	This work was supported by the Agence Nationale de la recherche grant ANR-11-JSH2-0006 (http://www.agence-nationale-recherche.fr/?Projet=ANR-11-JSH2-0006) (CJ); Ecole doctorale Universite Paris-Est Creteil Sciences de la Vie et de la Sante, doctoral scholarship (bourse MRT) 27433-2007 (SS) and doctoral scholarship 2015/58 (http://www.univ-paris-est.fr/fr/-ecole-doctorale-sciences-de-la-vie-et-de-la-sante-svs-/); French Ministry of Health (Reference Center for Huntingtons Disease) (ACBL), INSERM Contrat dinterface (ACBL); Assistance Publique - Hopitaux de Paris: biomarker program NCT01412125 (ACBL); Gobierno de Espana, Ministerio de Ciencia e Innovacion (MICINN) PSI2011-23624 (RDDB); Research was conducted at the Institut dEtudes Cognitives (ENS, Paris), which is supported by grants ANR-11-0001-02 PSL* and ANR-10-LABX-0087 (http://www.cognition.ens.fr/ProjetLabex.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2007, COGNITIVE PSYCHOL, V54, P218, DOI 10.1016/j.cogpsych.2006.07.001; Bachoud-Levi AC, 1998, THESIS; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bever T. G., 1970, COGNITION DEV LANGUA, P279, DOI 10.1093/acprof:oso/9780199677139.003.0001; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; BOCK K, 1992, PSYCHOL REV, V99, P150, DOI 10.1037/0033-295X.99.1.150; BOCK K, 1989, COGNITION, V31, P163, DOI 10.1016/0010-0277(89)90022-X; Bock K, 2000, J EXP PSYCHOL GEN, V129, P177, DOI 10.1037//0096-3445.129.2.177; BOCK K, 1990, COGNITION, V35, P1, DOI 10.1016/0010-0277(90)90035-I; Bock K, 2007, COGNITION, V104, P437, DOI 10.1016/j.cognition.2006.07.003; Branigan HP, 2016, COGNITION, V157, P250, DOI 10.1016/j.cognition.2016.09.004; Branigan HP, 2005, J EXP PSYCHOL LEARN, V31, P468, DOI 10.1037/0278-7393.31.3.468; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chang F, 2000, J PSYCHOLINGUIST RES, V29, P217, DOI 10.1023/A:1005101313330; Chen BG, 2013, SECOND LANG RES, V29, DOI 10.1177/0267658313491962; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; Corley M, 2002, PSYCHON B REV, V9, P126, DOI 10.3758/BF03196267; Devauchelle AD, 2009, J COGNITIVE NEUROSCI, V21, P1000, DOI 10.1162/jocn.2009.21070; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Ferreira VS, 2008, PSYCHOL SCI, V19, P940, DOI 10.1111/j.1467-9280.2008.02180.x; Ferreira VS, 2006, LANG COGNITIVE PROC, V21, P1011, DOI 10.1080/016909600824609; Fine AB, 2016, J EXP PSYCHOL LEARN, V42, P1362, DOI 10.1037/xlm0000236; Fine AB, 2013, COGNITIVE SCI, V37, P578, DOI 10.1111/cogs.12022; FRAZIER L, 1984, MEM COGNITION, V12, P421, DOI 10.3758/BF03198303; Frazier L, 2000, J PSYCHOLINGUIST RES, V29, P343, DOI 10.1023/A:1005156427600; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; Hale J, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P159; Hare M, 2003, J MEM LANG, V48, P281, DOI 10.1016/S0749-596X(02)00516-8; Hartsuiker RJ, 2008, J MEM LANG, V58, P214, DOI 10.1016/j.jml.2007.07.003; Indefrey P, 2004, BRAIN LANG, V89, P312, DOI 10.1016/S0093-934X(03)00352-3; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; Jaeger TF, 2013, COGNITION, V127, P57, DOI 10.1016/j.cognition.2012.10.013; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; Kim CS, 2014, LANG SPEECH, V57, P181, DOI 10.1177/0023830913496052; Konopka A, 2005, 18 ANN CUNY SENT PRO; Ledoux K, 2007, PSYCHOL SCI, V18, P135, DOI 10.1111/j.1467-9280.2007.01863.x; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; MEHLER J, 1968, PERCEPT PSYCHOPHYS, V3, P109, DOI 10.3758/BF03212776; MEHLER J, 1967, J VERB LEARN VERB BE, V6, P335, DOI 10.1016/S0022-5371(67)80122-1; Menenti L, 2012, BRAIN LANG, V122, P71, DOI 10.1016/j.bandl.2012.04.012; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; Noppeney U, 2004, J COGNITIVE NEUROSCI, V16, P702, DOI 10.1162/089892904323057399; Pickering M. J., 2004, CUNY SENT PROC C COL; Pickering MJ, 2013, J EXP PSYCHOL LEARN, V39, P890, DOI 10.1037/a0029181; Pickering MJ, 1999, TRENDS COGN SCI, V3, P136, DOI 10.1016/S1364-6613(99)01293-0; Pickering MJ, 1998, J MEM LANG, V39, P633, DOI 10.1006/jmla.1998.2592; Pickering MJ, 2000, J PSYCHOLINGUIST RES, V29, P205, DOI 10.1023/A:1005149129259; Potter MC, 1998, J MEM LANG, V38, P265, DOI 10.1006/jmla.1997.2546; Rowland CF, 2012, COGNITION, V125, P49, DOI 10.1016/j.cognition.2012.06.008; Scheepers C, 2004, ON-LINE STUDY OF SENTENCE COMPREHENSION, P167; Segaert K, 2013, BRAIN LANG, V124, P174, DOI 10.1016/j.bandl.2012.12.003; Segaert K, 2012, CEREB CORTEX, V22, P1662, DOI 10.1093/cercor/bhr249; Smolensky Paul, 2006, HARMONIC MIND NEURAL; Thothathiri M, 2008, COGNITION, V108, P51, DOI 10.1016/j.cognition.2007.12.012; Thothathiri M, 2008, J MEM LANG, V58, P188, DOI 10.1016/j.jml.2007.06.012; Tooley KM, 2014, COGNITION, V132, P101, DOI 10.1016/j.cognition.2014.04.002; Tooley KM, 2010, LANG LINGUIST COMPAS, V4, P925, DOI 10.1111/j.1749-818x.2010.00249.x; Tooley KM, 2009, J EXP PSYCHOL LEARN, V35, P19, DOI 10.1037/a0013984; Traxler MJ, 2008, LANG COGNITIVE PROC, V23, P609, DOI 10.1080/01690960701639898; Traxler MJ, 2008, PSYCHON B REV, V15, P149, DOI 10.3758/PBR.15.1.149; TRUESWELL JC, 1993, J EXP PSYCHOL LEARN, V19, P528, DOI 10.1037/0278-7393.19.3.528; Weber K, 2009, NEUROIMAGE, V46, P1164, DOI 10.1016/j.neuroimage.2009.03.040; Wheeldon LR, 2011, J EXP PSYCHOL LEARN, V37, P1051, DOI 10.1037/a0023435	67	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194959	10.1371/journal.pone.0194959	http://dx.doi.org/10.1371/journal.pone.0194959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608612	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800020
J	O'Brien, A; Sherrard-Smith, E; Sile, B; Watts, C; Simms, I				O'Brien, Allen; Sherrard-Smith, Ellie; Sile, Bersabeh; Watts, Charlotte; Simms, Ian			Spatial clusters of gonorrhoea in England with particular reference to the outcome of partner notification: 2012 and 2013	PLOS ONE			English	Article							ANTIMICROBIALS SURVEILLANCE PROGRAM; SEXUALLY-TRANSMITTED INFECTIONS; GONOCOCCAL RESISTANCE; HEALTH-CARE; WALES; RISK; INTERVENTIONS; EPIDEMIOLOGY; ENVIRONMENTS; SERVICES	Background This study explored spatial-temporal variation in diagnoses of gonorrhoea to identify and quantify endemic areas and clusters in relation to patient characteristics and outcomes of partner notification (PN) across England, UK. Methods Endemic areas and clusters were identified using a two-stage analysis with Kulldorff's scan statistics (SaTScan). Results Of 2,571,838 tests, 53,547 diagnoses were gonorrhoea positive (positivity = 2.08%). The proportion of diagnoses in heterosexual males was 1.5 times that in heterosexual females. Among index cases, men who have sex with men (MSM) were 8 times more likely to be diagnosed with gonorrhoea than heterosexual males (p<0.0001). After controlling for age, gender, ethnicity and deprivation rank, 4 endemic areas were identified including 11,047 diagnoses, 86% of which occurred in London. 33 clusters included 17,629 diagnoses (34% of total diagnoses in 2012 and 2013) and spanned 21 locations, some of which were dominated by heterosexually acquired infection, whilst others were MSM focused. Of the 53,547 diagnoses, 14.5% (7,775) were the result of PN. The proportion of patients who attended services as a result of PN varied from 0% to 61% within different age, gender and sexual orientation cohorts. A third of tests resulting from PN were positive for gonorrhoea. 25% of Local Authorities (n = 81, 95% CI: 20.2, 29.5) had a higher than expected proportion for female PN diagnoses as compared to 16% for males (n = 52, 95% CI: 12.0, 19.9). Conclusions The English gonorrhoea epidemic is characterised by spatial-temporal variation. PN success varied between endemic areas and clusters. Greater emphasis should be placed on the role of PN in the control of gonorrhoea to reduce the risk of onward transmission, reinfection, and complications of infection.	[O'Brien, Allen; Watts, Charlotte] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Sherrard-Smith, Ellie; Sile, Bersabeh; Simms, Ian] Publ Hlth England, Natl Infect Serv, HIV & STI Dept, London, England; [O'Brien, Allen] Univ British Columbia, Sch Engn, Kelowna, BC, Canada; [Sherrard-Smith, Ellie] Imperial Coll London, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England; University of British Columbia; Imperial College London	O'Brien, A (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.; O'Brien, A (corresponding author), Univ British Columbia, Sch Engn, Kelowna, BC, Canada.	allen.obrien@ubc.ca	Simms, Ian/P-1454-2019; Simms, Ian/AAA-8740-2019	Simms, Ian/0000-0003-4519-5684; Sherrard-Smith, Ellie/0000-0001-8317-7992	MRC [MR/R015600/1] Funding Source: UKRI; Medical Research Council [MR/R015600/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aicken CRH, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-30; Blanchard JF, 2010, SEX TRANSM INFECT, V86, P4, DOI 10.1136/sti.2010.046037; Chen MI, 2008, SEX TRANSM DIS, V35, P435, DOI 10.1097/OLQ.0b013e3181612d33; Chisholm SA, 2015, SEX TRANSM INFECT; Communities and Local Government, 2011, ENGL IND DEPR 2010 S; De Waroux OL, 2014, EPIDEMIOL INFECT, V142, P211, DOI 10.1017/S0950268813000745; Estcourt C, 2007, SEX TRANSM INFECT, V83, P169, DOI 10.1136/sti.2007.025056; Foster K, 2016, SEX TRANSM INFECT; Furegato M, 2016, EPIDEMIOL INFECT, V144, P3253, DOI 10.1017/S0950268816001679; Geanuracos CG, 2007, AM J PUBLIC HEALTH, V97, P1974, DOI 10.2105/AJPH.2005.076851; Gesink DC, 2013, SEX TRANSM DIS, V40, P32, DOI 10.1097/OLQ.0b013e3182762524; Gilbart VL, 2015, SEX TRANSM INFECT, V91, P598, DOI 10.1136/sextrans-2015-052014; Gov. UK, GEN MED CLIN ACT DAT; GOV. UK, 2010, ENGL IND DEPR 2010; GOV. UK, SEX TRANSM INF STIS; Health Protection Agency, GEN MED CLIN ACT DAT; Hook EW, 2013, MMWR-MORBID MORTAL W, V62, P103; Hughes G, 2015, FUTURE MICROBIOL, V10, P35, DOI 10.2217/fmb.14.110; Ison CA, 2013, LANCET INFECT DIS, V13, P762, DOI 10.1016/S1473-3099(13)70143-9; Jebbari H, 2011, SEX TRANSM INFECT, V87, P191, DOI 10.1136/sti.2009.040139; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2014, SATSCANTM V9 2 SOFTW; Mercer CH, 2012, SEX TRANSM INFECT, V88, P9, DOI 10.1136/sextrans-2011-050257; Petersen J, 2016, SEX TRANSM INFECT; Public Health England, 2013, GUMCADV2 GUID CLIN S; Public Health England, 2017, SEX TRANSM INF CHLAM; Public Health England, 2014, HLTH PROT REP SEX TR; Rothenberg R, 2007, SEX TRANSM INFECT, V83, P10, DOI 10.1136/sti.2006.017269; Schleihauf E, 2009, SEX TRANSM INFECT, V85, P45, DOI 10.1136/sti.2008.030197; Simms I, 2014, SEX TRANSM INFECT, V90, P442, DOI 10.1136/sextrans-2014-051695; StataCorp, 2013, STATA STAT SOFTW REL; Town K, 2017, EPIDEMIOL INFECT, V145, P1682, DOI 10.1017/S0950268817000024; Town K, 2017, SEX TRANSM INFECT, V93, P39, DOI 10.1136/sextrans-2016-052583; Wi T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002344	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195178	10.1371/journal.pone.0195178	http://dx.doi.org/10.1371/journal.pone.0195178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608588	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000428988800032
J	Allam, O; Samarani, S; Mehraj, V; Jenabian, MA; Tremblay, C; Routy, JP; Amre, D; Ahmad, A				Allam, Ossama; Samarani, Suzanne; Mehraj, Vikram; Jenabian, Mohammad-Ali; Tremblay, Cecile; Routy, Jean-Pierre; Amre, Devendra; Ahmad, Ali			HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL BARRIER DYSFUNCTION; IFN-GAMMA; INFECTED INDIVIDUALS; BINDING-PROTEIN; HIV-1-INFECTED PATIENTS; VIRAL REPLICATION; MONOCYTIC CELLS; ELEVATED LEVELS	Interleukin-18 (IL-18) is a pleiotropic cytokine of the IL-1 family with multiple context dependent functions. We and others have shown that HIV infection is accompanied by increased circulating levels of IL-18 along with decreased levels of its antagonist, Interleukin-18 Binding Protein (IL-18BP). The infection is also accompanied by intestinal inflammation and decreased intestinal integrity as measured by intestinal permeability, regeneration and repair. However, little is known concerning the relation between high level of IL-18 associated with the viral infection and intestinal permeability. Here we demonstrate that HIV treatment increases production of IL-18 and decreases that of IL-18BP production in human intestinal epithelial cell (IEC) lines. IL-18 causes apoptosis of the IEC by activating caspase-1 and caspase-3. It induces epithelial barrier hyperpermeability by decreasing and disrupting both tight and adherens junction proteins, occludin, claudin 2 and beta-catenin. Disorganization of F-actin was also observed in the IEC that were exposed to the cytokine. Moreover IL-18 decreases transepithelial electrical resistance (TEER) in Caco-2 and increases permeability in HT29 monolayers. The cells' treatment with IL-18 causes an increase in the expression of phosphorylated myosin II regulatory light-chain (p-MLC) and myosin light-chain kinase (MLCK), and a decrease in phosphorylated Signal Transducer and Activator of Transcription (p-STAT)-5. This increase in p-MLC is suppressed by a Rhokinase (ROCK)-specific inhibitor. Interestingly, the levels of the cytokine correlate with those of LPS in the circulation in three different categories of HIV infected patients (HAART-naive and HAART-treated HIV-infected individuals, and Elite controls) as well as in healthy controls. Collectively, these results suggest that the HIV-induced IL-18 plays a role in increased intestinal permeability and microbial translocation observed in HIV-infected individuals.	[Allam, Ossama; Samarani, Suzanne; Ahmad, Ali] Univ Montreal, Dept Microbiol Infect Dis & Immunol, CHU Ste Justine Res Ctr, Lab Innate Immun, Montreal, PQ, Canada; [Mehraj, Vikram; Routy, Jean-Pierre] McGill Univ, Div Hematol, Montreal, PQ, Canada; [Mehraj, Vikram; Routy, Jean-Pierre] McGill Univ, Chron Viral Illness Serv, Montreal, PQ, Canada; [Jenabian, Mohammad-Ali] Univ Quebec Montreal, Dept Biol Sci, Montreal, PQ, Canada; [Tremblay, Cecile] Univ Montreal, Dept Microbiol Infect Dis & Immunol, CHUM, Montreal, PQ, Canada; [Amre, Devendra] Univ Montreal, Dept Pediat, CHU Ste Justine Res Ctr, Montreal, PQ, Canada	Universite de Montreal; McGill University; McGill University; University of Quebec; University of Quebec Montreal; Universite de Montreal; Universite de Montreal	Ahmad, A (corresponding author), Univ Montreal, Dept Microbiol Infect Dis & Immunol, CHU Ste Justine Res Ctr, Lab Innate Immun, Montreal, PQ, Canada.	ali.ahmad@recherche-ste-justine.qc.ca			Ste-Justine Foundation; "Fondation des etoiles"	Ste-Justine Foundation; "Fondation des etoiles"	The work was not funded by any specific grant. However, the first author, Ossama Allam, had received a PhD scholarship from Ste-Justine Foundation and from "Fondation des etoiles" for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002; Ahmad R, 2006, AIDS, V20, P1907, DOI 10.1097/01.aids.0000244217.46445.45; Al-Sadi R, 2013, J IMMUNOL, V190, P6596, DOI 10.4049/jimmunol.1201876; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Allam O, 2017, CYTOKINE, V90, P144, DOI 10.1016/j.cyto.2016.10.016; Amoozadeh Y, 2015, AM J PHYSIOL-CELL PH, V309, pC38, DOI 10.1152/ajpcell.00388.2014; Atluri VSR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00212; Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Bai L, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-77; Batman PA, 2007, AIDS, V21, P433, DOI 10.1097/QAD.0b013e3280142ee8; Ben Haij N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129425; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buccigrossi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029436; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Chandrasekar B, 2006, BIOCHEM BIOPH RES CO, V339, P956, DOI 10.1016/j.bbrc.2005.11.100; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Chiozzini C, 2016, CURR DRUG TARGETS, V17, P33, DOI 10.2174/1389450116666150825110658; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Clark E, 2017, ONCOTARGET, V8, P27569, DOI 10.18632/oncotarget.15174; DAYANITHI G, 1995, CELL CALCIUM, V18, P9, DOI 10.1016/0143-4160(95)90041-1; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Du LJ, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/7374197; Epple HJ, 2010, GASTROENTEROLOGY, V139, P1289, DOI 10.1053/j.gastro.2010.06.065; Gauthier S, 2010, ANTIVIR RES, V88, P207, DOI 10.1016/j.antiviral.2010.08.015; Gilbert S, 2012, EMBO MOL MED, V4, P109, DOI 10.1002/emmm.201100192; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; He F, 2012, CYTOKINE, V59, P264, DOI 10.1016/j.cyto.2012.04.008; Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; Iannello A, 2011, VIRAL IMMUNOL, V24, P11, DOI 10.1089/vim.2010.0083; Iannello A, 2010, J INFECT DIS, V201, P608, DOI 10.1086/650314; Iannello A, 2009, AIDS REV, V11, P115; Iannello A, 2009, J VIROL, V83, P5999, DOI 10.1128/JVI.02350-08; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Kalina U, 2002, EUR J IMMUNOL, V32, P2635, DOI 10.1002/1521-4141(200209)32:9<2635::AID-IMMU2635>3.0.CO;2-N; Kanai T, 2013, CURR DRUG TARGETS, V14, P1392, DOI 10.2174/13894501113149990006; Kimura K, 2009, INVEST OPHTH VIS SCI, V50, P597, DOI 10.1167/iovs.08-2606; Kitaura H, 2011, CALCIFIED TISSUE INT, V89, P65, DOI 10.1007/s00223-011-9494-0; Klein SA, 2000, EUR CYTOKINE NETW, V11, P47; Leonard F, 2010, MOL PHARMACEUT, V7, P2103, DOI 10.1021/mp1000795; Lindegaard B, 2004, JAIDS-J ACQ IMM DEF, V36, P588, DOI 10.1097/00126334-200405010-00006; Liu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068547; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Marks MA, 2013, AIDS, V27, P469, DOI 10.1097/QAD.0b013e32835c1333; Massanella M, 2013, EXPERT REV CLIN IMMU, V9, P1135, DOI 10.1586/1744666X.2013.842897; Mavigner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007658; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Monforte AD, 2004, AIDS, V18, P1811, DOI 10.1097/00002030-200409030-00010; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; NAKAMURA K, 1993, INFECT IMMUN, V61, P64, DOI 10.1128/IAI.61.1.64-70.1993; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V64, P425, DOI 10.1097/QAI.0b013e31829f919d; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Samarani S, 2016, CYTOKINE, V82, P38, DOI 10.1016/j.cyto.2016.01.006; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P12550, DOI 10.1073/pnas.95.21.12550; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Song W, 2006, CLIN EXP IMMUNOL, V144, P117, DOI 10.1111/j.1365-2249.2006.03050.x; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Stylianou E, 2003, CLIN EXP IMMUNOL, V132, P462, DOI 10.1046/j.1365-2249.2003.02179.x; Sugama S, 2008, BRAIN RES REV, V58, P85, DOI 10.1016/j.brainresrev.2007.11.003; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Terme M, 2012, CANCER RES, V72, P2757, DOI 10.1158/0008-5472.CAN-11-3379; Torre D, 2000, AIDS, V14, P2211, DOI 10.1097/00002030-200009290-00023; Tugizov S, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1159276; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Villarroya F, 2007, INT J OBESITY, V31, P1763, DOI 10.1038/sj.ijo.0803698; Ward, 2000, Pharm Sci Technol Today, V3, P346, DOI 10.1016/S1461-5347(00)00302-3; Wirtz S, 2002, J IMMUNOL, V168, P411, DOI 10.4049/jimmunol.168.1.411; Xing JJ, 2011, J APPL PHYSIOL, V110, P213, DOI 10.1152/japplphysiol.00284.2010; Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2; Zhou GY, 2009, VASC PHARMACOL, V50, P171, DOI 10.1016/j.vph.2009.01.006	89	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194185	10.1371/journal.pone.0194185	http://dx.doi.org/10.1371/journal.pone.0194185			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601578	Green Submitted, Green Published, gold			2022-12-27	WOS:000428845900005
J	Balyura, M; Gelfgat, E; Steenblock, C; Androutsellis-Theotokis, A; Ruiz-Babot, G; Guasti, L; Werdermann, M; Ludwig, B; Bornstein, T; Schally, AV; Brennand, A; Bornstein, SR				Balyura, Mariya; Gelfgat, Evgeny; Steenblock, Charlotte; Androutsellis-Theotokis, Andreas; Ruiz-Babot, Gerard; Guasti, Leonardo; Werdermann, Martin; Ludwig, Barbara; Bornstein, Tobias; Schally, Andrew V.; Brennand, Ana; Bornstein, Stefan R.			Expression of progenitor markers is associated with the functionality of a bioartificial adrenal cortex	PLOS ONE			English	Article							HORMONE-RELEASING-HORMONE; TUMOR-NECROSIS-FACTOR; ADRENOCORTICAL-CELLS; STEM-CELLS; NESTIN EXPRESSION; PANCREATIC-ISLETS; GENE-EXPRESSION; GROWTH; PROLIFERATION; STEROIDOGENESIS	Encapsulation of primary bovine adrenocortical cells in alginate is an efficacious model of a bioartificial adrenal cortex. Such a bioartificial adrenal cortex can be used for the restoration of lost adrenal function in vivo as well as for in vitro modeling of the adrenal microenvironment and for investigation of cell-cell interactions in the adrenals. The aim of this work was the optimization of a bioartificial adrenal cortex, that is the generation of a highly productive, self-regenerating, long-term functioning and immune tolerant bioartificial organ. To achieve this, it is necessary that adrenocortical stem and progenitor cells are present in the bioartificial gland, as these undifferentiated cells play important roles in the function of the mature gland. Here, we verified the presence of adrenocortical progenitors in cultures of bovine adrenocortical cells, studied the dynamics of their appearance and growth and determined the optimal time point for cell encapsulation. These procedures increased the functional life span and reduced the immunogenicity of the bioartificial adrenal cortex. This model allows the use of the luteinizing hormone-releasing hormone (LHRH) agonist triptorelin, the neuropeptide bombesin, and retinoic acid to alter cell number and the release of cortisol over long periods of time.	[Balyura, Mariya; Gelfgat, Evgeny; Steenblock, Charlotte; Androutsellis-Theotokis, Andreas; Werdermann, Martin; Ludwig, Barbara; Bornstein, Tobias; Brennand, Ana; Bornstein, Stefan R.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, Dresden, Germany; [Ruiz-Babot, Gerard; Guasti, Leonardo] Queen Mary Univ London, William Harvey Res Inst, Ctr Endocrinol, London, England; [Ludwig, Barbara; Bornstein, Stefan R.] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich,Fac Med, Dresden, Germany; [Ludwig, Barbara; Bornstein, Stefan R.] Tech Univ Dresden, Ctr Regenerat Therapies, Dresden, Germany; [Bornstein, Tobias; Brennand, Ana; Bornstein, Stefan R.] Kings Coll London, Diabet & Nutrit Sci Div, London, England; [Schally, Andrew V.] Univ Miami, Miller Sch Med, Div Endocrinol, Dept Med, Miami, FL 33136 USA; [Schally, Andrew V.] Univ Miami, Miller Sch Med, Div Hematol Oncol, Dept Med, Miami, FL 33136 USA; [Schally, Andrew V.] Univ Miami, Miller Sch Med, Div Endocrinol, Dept Pathol, Miami, FL 33136 USA; [Schally, Andrew V.] Univ Miami, Miller Sch Med, Div Hematol Oncol, Dept Pathol, Miami, FL 33136 USA; [Schally, Andrew V.] Vet Affairs Med Ctr, Miami, FL 33125 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of London; Queen Mary University London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of London; King's College London; University of Miami; University of Miami; University of Miami; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Balyura, M (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, Dresden, Germany.	mariya.balyura@uniklinikum-dresden.de	Steenblock, Charlotte/C-9038-2018	Steenblock, Charlotte/0000-0002-9635-4860; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589				Babu PS, 2002, ENDOCRINOLOGY, V143, P665, DOI 10.1210/en.143.2.665; Balyura M, 2015, P NATL ACAD SCI USA, V112, P2527, DOI 10.1073/pnas.1500242112; Barney M, 2000, ENDOCRINE, V13, P369, DOI 10.1385/ENDO:13:3:369; Benjamins JA, 2014, J NEUROSCI RES, V92, P1243, DOI 10.1002/jnr.23416; Bertelli E, 2002, HISTOCHEM CELL BIOL, V117, P371, DOI 10.1007/s00418-002-0386-2; Call GB, 2000, GEN COMP ENDOCR, V118, P249, DOI 10.1006/gcen.2000.7458; Castellone MD, 2015, ONCOGENE, V34, P1679, DOI 10.1038/onc.2014.104; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chang SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081865; Chung KF, 2011, MOL CELL ENDOCRINOL, V336, P141, DOI 10.1016/j.mce.2010.11.028; de Celis MFR, 2015, STEM CELLS, V33, P2037, DOI 10.1002/stem.2002; Doga M, 2001, ANN ONCOL, V12, pS89, DOI 10.1093/annonc/12.suppl_2.S89; Dubois-Pot-Schneider H, 2014, HEPATOLOGY, V60, P2077, DOI 10.1002/hep.27353; Dunn JCY, 2009, J SURG RES, V156, P317, DOI 10.1016/j.jss.2009.04.021; Finco I, 2015, ANNU REV PHYSIOL, V77, P105, DOI 10.1146/annurev-physiol-061214-111754; Florea V, 2014, P NATL ACAD SCI USA, V111, P17260, DOI 10.1073/pnas.1420375111; Freddi S, 2005, CLIN ENDOCRINOL, V62, P533, DOI 10.1111/j.1365-2265.2005.02253.x; Guasti L, 2011, MOL CELL ENDOCRINOL, V336, P117, DOI 10.1016/j.mce.2010.11.010; Guzman C., 2010, OPEN NEUROENDOCRINOL, V3, P161, DOI [10.2174/1876528901003010161, DOI 10.2174/1876528901003010161]; Haidan A, 1998, ENDOCRINOLOGY, V139, P772, DOI 10.1210/en.139.2.772; HANLEY N, 1992, J MOL ENDOCRINOL, V8, P131, DOI 10.1677/jme.0.0080131; HORNSBY PJ, 1980, J BIOL CHEM, V255, P4020; HORNSBY PJ, 1992, J STEROID BIOCHEM, V43, P951, DOI 10.1016/0960-0760(92)90323-B; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; King P, 2009, P NATL ACAD SCI USA, V106, P21185, DOI 10.1073/pnas.0909471106; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Ludwig B, 2010, TRANSPL INT, V23, P61; Ludwig B, 2012, P NATL ACAD SCI USA, V109, P5022, DOI 10.1073/pnas.1201868109; MALENDOWICZ LK, 1991, RES EXP MED, V191, P121, DOI 10.1007/BF02576667; Merke DP, 1999, NEW ENGL J MED, V340, P1121, DOI 10.1056/NEJM199904083401416; Merke DP, 2005, LANCET, V365, P2125, DOI 10.1016/S0140-6736(05)66736-0; Mikhaylova IV, 2007, ENDOCRINOLOGY, V148, P386, DOI 10.1210/en.2006-0726; Mukai K, 1998, EUR J BIOCHEM, V256, P190, DOI 10.1046/j.1432-1327.1998.2560190.x; NEKOLA MV, 1981, BIOL REPROD, V24, P505, DOI 10.1095/biolreprod24.3.505; Romero E, 2012, J PHARMACOL EXP THER, V342, P788, DOI 10.1124/jpet.112.195560; Sewer MB, 2002, ENDOCRINOLOGY, V143, P1280, DOI 10.1210/en.143.4.1280; Steenblock C, 2016, MOL CELL ENDOCRINOL; Toti P, 2005, HISTOL HISTOPATHOL, V20, P1115, DOI 10.14670/HH-20.1115; Walczak E.M., 2014, NAT REV ENDOCRINOL; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Ziegler CG, 2009, P NATL ACAD SCI USA, V106, P15879, DOI 10.1073/pnas.0907843106; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	43	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194643	10.1371/journal.pone.0194643	http://dx.doi.org/10.1371/journal.pone.0194643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596439	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000428630000036
J	Thierauf, J; Weissinger, SE; Veit, JA; Affolter, A; Laureano, NK; Beutner, D; Heiduschka, G; Kadletz, L; Meyer, M; Quaas, A; Plinkert, P; Hoffmann, TK; Hess, J				Thierauf, Julia; Weissinger, Stephanie E.; Veit, Johannes A.; Affolter, Annette; Laureano, Natalia K.; Beutner, Dirk; Heiduschka, Gregor; Kadletz, Lorenz; Meyer, Moritz; Quaas, Alexander; Plinkert, Peter; Hoffmann, Thomas K.; Hess, Jochen			Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER; SURVIVAL; LUNG	Introduction The transcription factor SOX2 has been identified as a lineage survival oncogene in squamous cell carcinoma and copy number gain is a common event in several human malignancies including head and neck cancer. However, the regulation and function of SOX2 during carcinogenesis as well as its prognostic value appears to be highly context dependent. As an example, high SOX2 expression in lung squamous cell carcinoma (SCC) is related to a favorable prognosis, while it is associated with poor outcome in lung adenocarcinoma. More recently, higher SOX2 levels and improved survival was also reported for head and neck SCC (HNSCC), and silencing of SOX2 expression in HNSCC cell lines revealed a mesenchymal- like phenotype with prominent vimentin expression. So far, SOX2 expression and its clinical relevance for other head and neck cancers, such as adenoid cystic carcinoma (HNACC) have not been sufficiently investigated. Material and methods SOX2, vimentin and E-cadherin expression was assessed by immunohistochemical staining on serial sections from formalin fixed and paraffin embedded tissue samples of a patient cohort (n = 45) with primary ACC and correlated with patient and tumor characteristics as well as survival. Results High SOX2 expression was found in 14 (31%) primary tumor specimens and was significantly correlated with a N0 lymph node status (p = 0.04), while low SOX2 expression was correlated with a solid growth pattern (p = 0.031). Of the 45 patients, 27 tumor samples resembled an EMT-like phenotype, as assessed by high vimentin and low E-cadherin levels. However, in HNACC SOX2 levels were neither correlated with vimentin nor with E-cadherin expression, further supporting a context dependent regulation and function of SOX2 in distinct tumor entities. Conclusion The absence of SOX2 was predominantly found in solid HNACC, which are characterized by a more aggressive phenotype in ACC. However, the underlying molecular mechanisms of SOX2 regulation and function in distinct HNACC subgroups remain to be fully elucidated.	[Thierauf, Julia; Affolter, Annette; Laureano, Natalia K.; Plinkert, Peter; Hess, Jochen] Heidelberg Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany; [Thierauf, Julia; Veit, Johannes A.; Hoffmann, Thomas K.] Univ Med Ctr Ulm, Dept Otorhinolaryngol Head & Neck Surg, Ulm, Germany; [Weissinger, Stephanie E.] Univ Med Ctr Ulm, Inst Pathol, Ulm, Germany; [Affolter, Annette] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany; [Laureano, Natalia K.; Hess, Jochen] German Canc Res Ctr, Res Grp Mol Mech Head & Neck Tumors, Heidelberg, Germany; [Laureano, Natalia K.] Univ Fed Rio Grande do Sul, Dept Oral Pathol, Porto Alegre, RS, Brazil; [Beutner, Dirk; Meyer, Moritz] Univ Hosp Cologne, Dept Otorhinolaryngol Head & Neck Surg, Cologne, Germany; [Beutner, Dirk] Univ Med Ctr Gottingen, Dept Otorhinolaryngol Head & Neck Surg, Gottingen, Germany; [Heiduschka, Gregor; Kadletz, Lorenz] Vienna Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria; [Quaas, Alexander] Univ Hosp Cologne, Inst Pathol, Cologne, Germany	Ruprecht Karls University Heidelberg; Ulm University; Ulm University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Universidade Federal do Rio Grande do Sul; University of Cologne; University of Gottingen; University of Cologne	Thierauf, J (corresponding author), Heidelberg Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany.; Thierauf, J (corresponding author), Univ Med Ctr Ulm, Dept Otorhinolaryngol Head & Neck Surg, Ulm, Germany.	JuliaCara.Thierauf@med.uni-heidelberg.de	Hess, Jochen/ABE-1144-2021	Hess, Jochen/0000-0003-3493-1711				Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bayo P, 2015, MOL ONCOL, V9, P1704, DOI 10.1016/j.molonc.2015.05.006; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Coca-Pelaz A, 2015, ORAL ONCOL, V51, P652, DOI 10.1016/j.oraloncology.2015.04.005; Dai W, 2014, INT J MOL SCI, V15, P8393, DOI 10.3390/ijms15058393; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Honing J, 2014, ANN SURG ONCOL, V21, pS657, DOI 10.1245/s10434-014-3763-x; Huang YH, 2014, HISTOPATHOLOGY, V64, P494, DOI 10.1111/his.12257; Kim BW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2015-1; Moskaluk CA, 2013, HEAD NECK PATHOL, V7, P17, DOI 10.1007/s12105-013-0426-3; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Siegle JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5511; Siu A, 2012, ANTICANCER RES, V32, P3683; Tam WL, 2014, CANCER CELL, V26, P3, DOI 10.1016/j.ccr.2014.06.024; Thierauf J, 2015, MELANOMA RES; Toschi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095303; Wuebben E. L., 2017, ONCOTARGET; Zullig L, 2013, EUR J CANCER, V49, P1915, DOI 10.1016/j.ejca.2013.01.005	18	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194989	10.1371/journal.pone.0194989	http://dx.doi.org/10.1371/journal.pone.0194989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596469	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000062
J	Ziegler, SJ; Liu, C; Landau, M; Buzovetsky, O; Desimmie, BA; Zhao, Q; Sasaki, T; Burdick, RC; Pathak, VK; Anderson, KS; Xiong, Y				Ziegler, Samantha J.; Liu, Chang; Landau, Mark; Buzovetsky, Olga; Desimmie, Belete A.; Zhao, Qi; Sasaki, Tomoaki; Burdick, Ryan C.; Pathak, Vinay K.; Anderson, Karen S.; Xiong, Yong			Insights into DNA substrate selection by APOBEC3G from structural, biochemical, and functional studies	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; INDUCED CYTIDINE DEAMINASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; HIV-1 INFECTION; RETROVIRAL RESTRICTION; REVERSE-TRANSCRIPTASE; AID/APOBEC FAMILY; TYPE-1 VIF	Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3 (A3) proteins are a family of cytidine deaminases that catalyze the conversion of deoxycytidine (dC) to deoxyuridine (dU) in single-stranded DNA (ssDNA). A3 proteins act in the innate immune response to viral infection by mutating the viral ssDNA. One of the most well-studied human A3 family members is A3G, which is a potent inhibitor of HIV-1. Each A3 protein prefers a specific substrate sequence for catalysis D for example, A3G deaminates the third dC in the CCCA sequence motif. However, the interaction between A3G and ssDNA is difficult to characterize due to poor solution behavior of the full-length protein and loss of DNA affinity of the truncated protein. Here, we present a novel DNA-anchoring fusion strategy using the protection of telomeres protein 1 (Pot1) which has nanomolar affinity for ssDNA, with which we captured an A3G-ssDNA interaction. We crystallized a non-preferred adenine in the -1 nucleotide-binding pocket of A3G. The structure reveals a unique conformation of the catalytic site loops that sheds light onto how the enzyme scans substrate in the -1 pocket. Furthermore, our biochemistry and virology studies provide evidence that the nucleotidebinding pockets on A3G influence each other in selecting the preferred DNA substrate. Together, the results provide insights into the mechanism by which A3G selects and deaminates its preferred substrates and help define how A3 proteins are tailored to recognize specific DNA sequences. This knowledge contributes to a better understanding of the mechanism of DNA substrate selection by A3G, as well as A3G antiviral activity against HIV-1.	[Ziegler, Samantha J.; Liu, Chang; Landau, Mark; Buzovetsky, Olga; Zhao, Qi; Anderson, Karen S.; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Landau, Mark; Sasaki, Tomoaki; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Desimmie, Belete A.; Burdick, Ryan C.; Pathak, Vinay K.] NCI, Ctr Canc Res, HIV Dynam & Replicat Program, Viral Mutat Sect, Frederick, MD 21701 USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu		Pathak, Vinay/0000-0003-2441-8412; Desimmie, Belete/0000-0002-1157-4224; Ziegler, Samantha/0000-0003-2480-513X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049551, T32GM007223] Funding Source: NIH RePORTER; NCI NIH HHS [F31 CA203254] Funding Source: Medline; NIAID NIH HHS [T32 AI007019, R01 AI116313, R37 AI116313] Funding Source: Medline; NIGMS NIH HHS [T32 GM007223, R01 GM049551] Funding Source: Medline; NIH HHS [5T32AI007019-40, GM49551, 1F31CA203254-01, T32GM007223] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2010, PYMOL MOL GRAPHICS S; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chen ZG, 2012, J IMMUNOL, V189, P3970, DOI 10.4049/jimmunol.1200416; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Delviks-Frankenberry KA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005646; Desimmie BA, 2016, NUCLEIC ACIDS RES, V44, P7848, DOI 10.1093/nar/gkw653; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa Ayako, 2009, Nucleic Acids Symp Ser (Oxf), P87, DOI 10.1093/nass/nrp044; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kouno T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15024; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shindo Keisuke, 2012, Biology (Basel), V1, P260, DOI 10.3390/biology1020260; Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296; Smith JL, 2014, J VIROL, V88, P9893, DOI 10.1128/JVI.01318-14; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Truckses DM, 1996, PROTEIN SCI, V5, P1907, DOI 10.1002/pro.5560050917; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	59	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195048	10.1371/journal.pone.0195048	http://dx.doi.org/10.1371/journal.pone.0195048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596531	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000072
J	Genschow, O; Klomfar, S; d'Haene, I; Brass, M				Genschow, Oliver; Klomfar, Sophie; d'Haene, Ine; Brass, Marcel			Mimicking and anticipating others' actions is linked to Social Information Processing	PLOS ONE			English	Article							BEHAVIORAL CONSEQUENCES; EMOTIONAL MIMICRY; FACIAL REACTIONS; MOTOR; PERCEPTION; CHAMELEON; INTELLIGENCE; MECHANISMS; EXECUTION; MOVEMENT	It is widely known that individuals frequently imitate each other in social situations and that such mimicry fulfills an important social role in the sense that it functions as a social glue. With reference to the anticipated action effect, it has recently been demonstrated that individuals do not only imitate others, but also engage in anticipated action before the observed person starts engaging in that action. Interestingly, both phenomena (i.e., mimicry and anticipated action) rely on tracking others' social behavior. Therefore, in the present research we investigated whether mimicry and anticipated action are related to social abilities as indicated by measures of social intelligence. The results demonstrate for the first time that mimicry as well as anticipated action is correlated with an important aspect of social intelligence namely the ability to process social information. Theoretical implications and limitations are discussed.	[Genschow, Oliver] Univ Cologne, Social Cognit Ctr Cologne, Cologne, Germany; [Klomfar, Sophie] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [d'Haene, Ine; Brass, Marcel] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	University of Cologne; Medical University of Vienna; Ghent University	Genschow, O (corresponding author), Univ Cologne, Social Cognit Ctr Cologne, Cologne, Germany.	oliver.genschow@uni-koeln.de	Brass, Marcel/J-7082-2012	Brass, Marcel/0000-0002-3364-4019	Swiss National Science Foundation [PZ00P1_168007]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation (www.snf.ch), grant number PZ00P1_168007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; CAPPELLA JN, 1981, HUM COMMUN RES, V7, P117, DOI 10.1111/j.1468-2958.1981.tb00564.x; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Chartrand T.L., 2009, PSYCHOL ACTION MECH, VVol. 2, P893; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cracco E., 2018, PSYCHOL B, DOI 10. 1037. bul0000143; Cracco E, 2018, COGNITION, V170, P179, DOI 10.1016/j.cognition.2017.09.019; Decety J., 2011, EMPATHY PHILOS PSYCH, P58, DOI DOI 10.1093/ACPROF:OSO/9780199539956.003.0006; Deli L., 2011, PSYCHOL TOPICS, V20, P477, DOI DOI 10.1521/PEDI.17.3.188.22146; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dogan T, 2009, KURAM UYGUL EGIT BIL, V9, P709; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Genschow O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183784; Genschow O, 2016, PSYCHON B REV, V23, P1257, DOI 10.3758/s13423-015-0983-4; Genschow O, 2015, J EXP PSYCHOL HUMAN, V41, P265, DOI 10.1037/xhp0000035; Genschow O, 2014, J EXP PSYCHOL HUMAN, V40, P904, DOI 10.1037/a0035430; Genschow O, 2013, J EXP PSYCHOL GEN, V142, P763, DOI 10.1037/a0029795; Giles H., 1975, EUROPEAN MONOGRAPHS; GREENWALD AG, 1970, PSYCHOL REV, V77, P73, DOI 10.1037/h0028689; Hale J, 2016, NEUROSCI BIOBEHAV R, V63, P106, DOI 10.1016/j.neubiorev.2016.02.006; Hansen J, 2016, J EXP PSYCHOL HUMAN, V42, P320, DOI 10.1037/xhp0000150; Hess U, 2014, SOC PERSONAL PSYCHOL, V8, P45, DOI 10.1111/spc3.12083; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hofree G, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00364, 10.3389/fnhum.2015.00364]; Kavanagh LC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00458; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Keysers C, 2010, CURR BIOL, V20, pR353, DOI 10.1016/j.cub.2010.03.013; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kinga S., 2013, ERDELYI PSZICHOLOGIA, V14, P255; LaFrance Marianne, 1982, INTERACTION RHYTHMS, P279; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Lamm C, 2007, NEUROPSYCHOLOGIA, V45, P2480, DOI 10.1016/j.neuropsychologia.2007.03.024; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Meijs N, 2010, J YOUTH ADOLESCENCE, V39, P62, DOI 10.1007/s10964-008-9373-9; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Prinz W., 1990, RELATIONSHIPS PERCEP, DOI DOI 10.1007/978-3-642-75348-0_7; Schmidt Annie M.G., 1971, PLUK PETTEFLET; Silvera DH, 2001, SCAND J PSYCHOL, V42, P313, DOI 10.1111/1467-9450.00242; van Baaren RB, 2004, J PERS SOC PSYCHOL, V86, P453, DOI 10.1037/0022-3514.86.3.453; van Baaren RB, 2003, J PERS SOC PSYCHOL, V84, P1093, DOI 10.1037/0022-3514.84.5.1093; van Baaren RB, 2003, J EXP SOC PSYCHOL, V39, P393, DOI 10.1016/S0022-1031(03)00014-3; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Wang Y, 2015, SOC COGN AFFECT NEUR, V10, P486, DOI 10.1093/scan/nsu076; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060249; Webb J. T., 1972, STUDIES DYADIC COMMU, P115; WEBB JT, 1969, LANG SPEECH, V12, P54, DOI 10.1177/002383096901200105; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Winkielman P., 2016, EMOTIONAL MIMICRY SO, P162	56	10	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193743	10.1371/journal.pone.0193743	http://dx.doi.org/10.1371/journal.pone.0193743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590127	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100028
J	Khalilova, IS; Dickerhof, N; Mocatta, TJ; Bhagra, CJ; McClean, DR; Obinger, C; Kettle, AJ				Khalilova, Irada S.; Dickerhof, Nina; Mocatta, Tessa J.; Bhagra, Catriona J.; McClean, Dougal R.; Obinger, Christian; Kettle, Anthony J.			A myeloperoxidase precursor, promyeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients	PLOS ONE			English	Article							ACID RESPONSE ELEMENT; CHLORINATING ACTIVITY; LIPID-PEROXIDATION; OXIDATION; KINETICS; RECEPTOR; ATHEROSCLEROSIS; BIOSYNTHESIS; MACROPHAGES; LACTOFERRIN	Myeloperoxidase (MPO)-derived oxidants have emerged as a key contributor to tissue damage in inflammatory conditions such as cardiovascular disease. Pro-myeloperoxidase (pro-MPO), an enzymatically active precursor of myeloperoxidase (MPO), is known to be secreted from cultured bone marrow and promyelocytic leukemia cells, but evidence for the presence of pro-MPO in circulation is lacking. In the present study, we used a LC-MS/MS in addition to immunoblot analyses to show that pro-MPO is present in human blood plasma. Furthermore, we found that pro-MPO was more frequently detected in plasma from patients with myocardial infarction compared to plasma from control donors. Our study suggests that in addition to mature MPO, circulating pro-MPO may cause oxidative modifications of proteins thereby contributing to cardiovascular disease.	[Khalilova, Irada S.; Dickerhof, Nina; Mocatta, Tessa J.; Kettle, Anthony J.] Univ Otago Christchurch, Dept Pathol, Ctr Free Radical Res, Christchurch, New Zealand; [Bhagra, Catriona J.; McClean, Dougal R.] Christchurch Hosp, Cardiol Dept, Christchurch, New Zealand; [Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Div Biochem, Dept Chem, Vienna, Austria; [Khalilova, Irada S.] Khazar Univ, Dept Biol Sci, Ctr Cell Pathol Res, Baku, Azerbaijan; [Bhagra, Catriona J.] Papworth Hosp NHS Fdn Trust, Cambridge, England	University of Otago; Christchurch Hospital New Zealand; University of Natural Resources & Life Sciences, Vienna; Ministry of Education of Azerbaijan Republic; Khazar University; Papworth Hospital	Dickerhof, N (corresponding author), Univ Otago Christchurch, Dept Pathol, Ctr Free Radical Res, Christchurch, New Zealand.	nina.dickerhof@otago.ac.nz	Khalilova, Irada/I-5103-2015; Obinger, Christian/AAV-3173-2021; Khalilova, Irada/AGF-0824-2022; Bhagra, Catriona/AAZ-2180-2020; Bhagra, Catriona/HGA-8106-2022	Khalilova, Irada/0000-0002-4238-3113; Bhagra, Catriona/0000-0002-3960-9273; Bhagra, Catriona/0000-0002-3960-9273; Obinger, Christian/0000-0002-7133-3430; Dickerhof, Nina/0000-0003-2269-4595; Kettle, Tony/0000-0002-8218-7766	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	This research was supported by the Health Research Council of New Zealand.	Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Auchere F, 1999, BIOCHEM J, V343, P603, DOI 10.1042/0264-6021:3430603; BAKKENIST ARJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P45, DOI 10.1016/0005-2744(78)90101-8; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; Grishkovskaya I, 2017, J BIOL CHEM, V292, P8244, DOI 10.1074/jbc.M117.775031; Gullberg U, 1999, J IMMUNOL METHODS, V232, P201, DOI 10.1016/S0022-1759(99)00177-5; HANSEN NE, 1975, ACTA MED SCAND, V198, P437; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Heinecke JW, 2003, AM J CARDIOL, V91, p12A; Kettle AJ, 2014, BBA-GEN SUBJECTS, V1840, P781, DOI 10.1016/j.bbagen.2013.07.004; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Marshall CJ, 2010, AM J CARDIOL, V106, P316, DOI 10.1016/j.amjcard.2010.03.028; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; NAUSEEF WM, 1992, BLOOD, V80, P2622; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; OLSEN RL, 1986, BIOCHEM J, V237, P559, DOI 10.1042/bj2370559; OLSSON I, 1984, BIOCHEM J, V223, P911, DOI 10.1042/bj2230911; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; SEGAL AW, 1980, J CELL BIOL, V85, P42, DOI 10.1083/jcb.85.1.42; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; vanDalen CJ, 1997, BIOCHEM J, V327, P487; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; VENGE P, 1984, CLIN CHIM ACTA, V136, P121, DOI 10.1016/0009-8981(84)90283-3; YAMADA M, 1990, BIOCHEM BIOPH RES CO, V166, P852, DOI 10.1016/0006-291X(90)90888-T; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810	37	12	13	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192952	10.1371/journal.pone.0192952	http://dx.doi.org/10.1371/journal.pone.0192952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590135	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100011
J	Szczesny, RJ; Kowalska, K; Klosowska-Kosicka, K; Chlebowski, A; Owczarek, EP; Warkocki, Z; Kulinski, TM; Adamska, D; Affek, K; Jedroszkowiak, A; Kotrys, AV; Tomecki, R; Krawczyk, PS; Borowski, LS; Dziembowski, A				Szczesny, Roman J.; Kowalska, Katarzyna; Klosowska-Kosicka, Kamila; Chlebowski, Aleksander; Owczarek, Ewelina P.; Warkocki, Zbigniew; Kulinski, Tomasz M.; Adamska, Dorota; Affek, Kamila; Jedroszkowiak, Agata; Kotrys, Anna V.; Tomecki, Rafal; Krawczyk, Pawel S.; Borowski, Lukasz S.; Dziembowski, Andrzej			Versatile approach for functional analysis of human proteins and efficient stable cell line generation using FLP-mediated recombination system	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; MAMMALIAN-CELLS; FLUORESCENT PROTEIN; LIVING CELLS; HELA-CELLS; IN-VIVO; TRANSCRIPTION FACTORS; ENHANCED DETECTION; PROTEOMIC ANALYSIS; TRANSGENIC MICE	Deciphering a function of a given protein requires investigating various biological aspects. Usually, the protein of interest is expressed with a fusion tag that aids or allows subsequent analyses. Additionally, downregulation or inactivation of the studied gene enables functional studies. Development of the CRISPR/Cas9 methodology opened many possibilities but in many cases it is restricted to non-essential genes. Recombinase-dependent gene integration methods, like the Flp-In system, are very good alternatives. The system is widely used in different research areas, which calls for the existence of compatible vectors and efficient protocols that ensure straightforward DNA cloning and generation of stable cell lines. We have created and validated a robust series of 52 vectors for streamlined generation of stable mammalian cell lines using the FLP recombinase-based methodology. Using the sequence independent DNA cloning method all constructs for a given coding-sequence can be made with just three universal PCR primers. Our collection allows tetracycline-inducible expression of proteins with various tags suitable for protein localization, FRET, bimolecular fluorescence complementation (BiFC), protein dynamics studies (FRAP), co-immunoprecipitation, the RNA tethering assay and cell sorting. Some of the vectors contain a bidirectional promoter for concomitant expression of miRNA and mRNA, so that a gene can be silenced and its product replaced by a mutated miRNA-insensitive version. Our toolkit and protocols have allowed us to create more than 500 constructs with ease. We demonstrate the efficacy of our vectors by creating stable cell lines with various tagged proteins (numatrin, fibrillarin, coilin, centrin, THOC5, PCNA). We have analysed transgene expression over time to provide a guideline for future experiments and compared the effectiveness of commonly used inducers for tetracycline-responsive promoters. As proof of concept we examined the role of the exoribonuclease XRN2 in transcription termination by RNAseq.	[Szczesny, Roman J.; Kowalska, Katarzyna; Klosowska-Kosicka, Kamila; Chlebowski, Aleksander; Owczarek, Ewelina P.; Warkocki, Zbigniew; Kulinski, Tomasz M.; Adamska, Dorota; Affek, Kamila; Jedroszkowiak, Agata; Kotrys, Anna V.; Tomecki, Rafal; Krawczyk, Pawel S.; Borowski, Lukasz S.; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Lab RNA Biol & Funct Genom, Warsaw, Poland; [Szczesny, Roman J.; Chlebowski, Aleksander; Tomecki, Rafal; Borowski, Lukasz S.; Dziembowski, Andrzej] Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Szczesny, RJ; Dziembowski, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Lab RNA Biol & Funct Genom, Warsaw, Poland.; Szczesny, RJ; Dziembowski, A (corresponding author), Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, Warsaw, Poland.	rszczesny@ibb.waw.pl; andrzejd@ibb.waw.pl	Kuliński, Tomasz/E-3292-2019; Borowski, Lukasz S./GRF-4642-2022; Tomecki, Rafal/Y-8438-2019; Krawczyk, Pawel/K-3463-2019	Kuliński, Tomasz/0000-0003-2830-9491; Borowski, Lukasz S./0000-0003-3766-0726; Krawczyk, Pawel/0000-0001-9531-1298; Chlebowski, Aleksander/0000-0001-5018-6294; Jabczynska, Agata/0000-0003-1528-8812; Szczesny, Roman/0000-0002-0686-1632; Adamska, Dorota/0000-0001-6223-1021; Affek, Kamila/0000-0003-4040-3288; Dziembowski, Andrzej/0000-0001-8492-7572; Owczarek, Ewelina Patrycja/0000-0002-1064-1245; Warkocki, Zbigniew/0000-0002-1684-1635; Kotrys, Anna/0000-0003-4983-1414; Tomecki, Rafal/0000-0003-2473-5004; Prokop, Katarzyna/0000-0002-8107-185X	Ministry of Science and Higher Education of Poland [IP2012 046372]; National Science Centre, Poland [UMO-2014/13/D/NZ2/01114, UMO-2012/04/S/NZ1/00036]; Foundation for Polish Science [TEAM/2016-1/3]; European Union - the European Regional Development Fund [POIG.02.02.00-14-024/08-00]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); National Science Centre, Poland(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union - the European Regional Development Fund	This work was mainly supported by the Ministry of Science and Higher Education of Poland (IP2012 046372 to RJS, www.nauka.gov.pl) and cosupported by the National Science Centre, Poland (UMO-2014/13/D/NZ2/01114 to RJS, UMO-2012/04/S/NZ1/00036 to ZW, www.ncn.gov.pl) and the Foundation for Polish Science (TEAM/2016-1/3 to AD, www.fnp.org.pl). Experiments were carried out with the use of CePT infrastructure financed by the European Union - the European Regional Development Fund (Innovative economy 2007-13, Agreement POIG.02.02.00-14-024/08-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BY, 2013, CELL CYCLE, V12, P3640, DOI 10.4161/cc.26580; Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391; Arfelt KN, 2017, CELL SIGNAL, V30, P9, DOI 10.1016/j.cellsig.2016.11.009; Bajar BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20889; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; Berens C, 2003, EUR J BIOCHEM, V270, P3109, DOI 10.1046/j.1432-1033.2003.03694.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boros J, 2009, NUCLEIC ACIDS RES, V37, P7368, DOI 10.1093/nar/gkp804; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cesaratto F, 2016, J BIOTECHNOL, V231, P239, DOI 10.1016/j.jbiotec.2016.06.012; Chaudhry MA, 2002, ONCOGENE, V21, P1934, DOI 10.1038/sj.onc.1205264; Chu J, 2016, NAT BIOTECHNOL, V34, P760, DOI 10.1038/nbt.3550; Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Domanski Michal, 2012, Biotechniques, V0, P1, DOI 10.2144/000113864; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Durisic N, 2014, NAT METHODS, V11, P156, DOI [10.1038/NMETH.2784, 10.1038/nmeth.2784]; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Emmott E, 2008, VIROLOGY, V380, P191, DOI 10.1016/j.virol.2008.05.032; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fong N, 2015, MOL CELL, V60, P256, DOI 10.1016/j.molcel.2015.09.026; Frattini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15377; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hakhverdyan Z, 2015, NAT METHODS, V12, P553, DOI 10.1038/nmeth.3395; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Krueger C, 2004, BIOTECHNIQUES, V37, P546, DOI 10.2144/04374BM04; Kuzmenko A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00195; Labno A, 2016, NUCLEIC ACIDS RES, V44, P10437, DOI 10.1093/nar/gkw649; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lee AV, 1997, BIOTECHNIQUES, V23, P1062, DOI 10.2144/97236st02; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lieu PT, 2009, J BIOMOL SCREEN, V14, P1207, DOI 10.1177/1087057109348941; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu HS, 1998, BIOTECHNIQUES, V24, P624, DOI 10.2144/98244st03; Lu HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017297; Lucey BP, 2009, ARCH PATHOL LAB MED, V133, P1463, DOI 10.1043/1543-2165-133.9.1463; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Martin RM, 2013, CELL REP, V4, P1144, DOI 10.1016/j.celrep.2013.08.013; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; Meyer-Ficca ML, 2004, ANAL BIOCHEM, V334, P9, DOI 10.1016/j.ab.2004.07.011; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Niewiadomski P, 2013, CELL SIGNAL, V25, P2222, DOI 10.1016/j.cellsig.2013.07.012; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; Paoletti A, 1996, J CELL SCI, V109, P3089; Park J, 2015, CURR PROTOC MOL BIOL, V110, P20; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pina AS, 2014, BIOTECHNOL ADV, V32, P366, DOI 10.1016/j.biotechadv.2013.12.001; POSTLE K, 1984, NUCLEIC ACIDS RES, V12, P4849, DOI 10.1093/nar/12.12.4849; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saez E, 1997, CURR OPIN BIOTECH, V8, P608, DOI 10.1016/S0958-1669(97)80037-7; Sammarco MC, 2005, ANAL BIOCHEM, V346, P210, DOI 10.1016/j.ab.2005.08.033; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Sultan M, 2012, BIOCHEM BIOPH RES CO, V422, P643, DOI 10.1016/j.bbrc.2012.05.043; Sun YS, 2012, METHOD ENZYMOL, V504, P371, DOI 10.1016/B978-0-12-391857-4.00019-7; Szczepinska T, 2015, GENOME RES, V25, P1622, DOI 10.1101/gr.189597.115; Szczesny RJ, 2007, BIOL CELL, V99, P323, DOI 10.1042/BC20060108; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tomecki R, 2015, RNA BIOL, V12, P1010, DOI 10.1080/15476286.2015.1073437; Tomecki R, 2014, NUCLEIC ACIDS RES, V42, P1270, DOI 10.1093/nar/gkt930; Tran DDH, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-3; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Vickers ER, 2002, METHODS, V26, P270, DOI 10.1016/S1046-2023(02)00031-2; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Wyborski DL, 1996, ENVIRON MOL MUTAGEN, V28, P447, DOI 10.1002/(SICI)1098-2280(1996)28:4<447::AID-EM22>3.0.CO;2-E; Wydro M, 2010, NUCLEIC ACIDS RES, V38, P3732, DOI 10.1093/nar/gkq068; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573; Zhang L, 2001, MOL BIOTECHNOL, V19, P313, DOI 10.1385/MB:19:3:313; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	122	19	19	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194887	10.1371/journal.pone.0194887	http://dx.doi.org/10.1371/journal.pone.0194887			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590189	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100085
J	Ballotari, P; Venturelli, F; Manicardi, V; Ferrarl, F; Vicentini, M; Greci, M; Pignatti, F; Storani, S; Rossi, PG				Ballotari, Paola; Venturelli, Francesco; Manicardi, Valeria; Ferrarl, Francesca; Vicentini, Massimo; Greci, Marina; Pignatti, Fabio; Storani, Simone; Rossi, Paolo Giorgi			Effectiveness of integrated care model for type 2 diabetes: A population-based study in Reggio Emilia (Italy)	PLOS ONE			English	Article							MELLITUS; ADULTS	Aims To compare the effectiveness of integrated care with that of the diabetes clinic care model in terms of mortality and hospitalisation of type 2 diabetes patients with low risk of complications. Methods Out of 27234 people with type 2 diabetes residing in the province of Reggio Emilia on 31/12/2011, 3071 were included in this cohort study as eligible for integrated care (i.e., low risk of complications) and cared for with the same care model for at least two years. These patients were followed up from 2012 to 2016, for all-cause and diabetes-related mortality and hospital admissions. We performed a Poisson regression model, using the proportion of eligible patients included in the integrated care model for each general practitioner as an instrumental variable. Results 1700 patients were cared for by integrated care and 1371 by diabetes clinics. Mortality rate ratios were 0.83 (95%CI 0.60-1.13) and 0.95 (95%CI 0.54-1.70) for all-cause and cardiovascular mortality, respectively, and incidence rate ratios were 0.90 (95%CI 0.76-1.06) and 0.91 (95%CI 0.69-1.20) for all-cause and cardiovascular disease hospitalisation, respectively. Conclusion For low risk patients with type 2 diabetes, the integrated care model involving both general practitioner and diabetes clinic professionals showed similar mortality and hospitalisation as a model with higher use of specialized care in an exclusively diabetes clinic setting.	[Ballotari, Paola; Venturelli, Francesco; Ferrarl, Francesca; Vicentini, Massimo; Rossi, Paolo Giorgi] Local Hlth Author Reggio Emilia IRCCS, Epidemiol Unit, Reggio Emilia, Italy; [Venturelli, Francesco] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Specializat Sch Hyg & Prevent Med, Modena, Italy; [Venturelli, Francesco] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy; [Manicardi, Valeria] Local Hlth Author Reggio Emilia IRCCS Reggio Emil, Dept Internal Med, Hosp Montecchio, Reggio Emilia, Italy; [Greci, Marina; Pignatti, Fabio; Storani, Simone] Local Hlth Author Reggio EmiliaIRCCS Reggio Emili, Primary Hlth Care, Reggio Emilia, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Venturelli, F (corresponding author), Local Hlth Author Reggio Emilia IRCCS, Epidemiol Unit, Reggio Emilia, Italy.; Venturelli, F (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Specializat Sch Hyg & Prevent Med, Modena, Italy.; Venturelli, F (corresponding author), Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy.	venturelli.dr.francesco@gmail.com	Rossi, Paolo Giorgi/K-6367-2016; Venturelli, Francesco/T-6468-2017	Rossi, Paolo Giorgi/0000-0001-9703-2460; Venturelli, Francesco/0000-0002-9190-8668	AMD - Associazione Medici Diabetologi (Italian Association of Clinical Diabetologists)	AMD - Associazione Medici Diabetologi (Italian Association of Clinical Diabetologists)	The study was partially funded through a scholarship by AMD - Associazione Medici Diabetologi (Italian Association of Clinical Diabetologists). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appalachian Trail Conservancy, 2017, 2000 MILERS RECENT Y; Baldo V, 2015, PRIM CARE DIABETES, V9, P54, DOI 10.1016/j.pcd.2014.03.005; Ballotari P, 2014, DIABETES RES CLIN PR, V103, P79, DOI 10.1016/j.diabres.2013.11.020; DICE Team, 1994, BMJ, V308; Duran A, 2008, BMC ENDOCR DISORD, V8; Emilia-Romagna Regional Committee, 2009, LIN GUID REG GEST IN, P2; Fox CS, 2015, DIABETES CARE, V38, P1777, DOI 10.2337/dci15-0012; Giorda C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033839; Goderis G, 2010, DIABETES RES CLIN PR, V88, P56, DOI 10.1016/j.diabres.2009.12.012; GUARIGUATA L, 2014, DIABETES RES CLIN PR, V103; Guo Z, 2014, STAT MED, V33, P3528, DOI 10.1002/sim.6227; Hoskins PL, DIABET MED, V10; HURWITZ B, 1993, BRIT MED J, V306, P624, DOI 10.1136/bmj.306.6878.624; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Katon WJ, 2010, N ENGL J MED, V363; Lancet T., 2015, LANCET, V386, pe3, DOI 10.1016/S0140-6736(15)60692-4; Levey AS, 2006, ANN INTERN MED, V145; McAlister FA, 2007, QUAL SAF HEALTH CARE, V16, P6, DOI 10.1136/qshc.2006.018648; Munch L, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1409-y; Petitti DB, 2005, AM J EPIDEMIOL, V162, P415, DOI 10.1093/aje/kwi224; Prentice RL, 2005, AM J EPIDEMIOL, V162; Schneeweiss S, 2013, J CLIN EPIDEMIOL S, V66; Smith S, 2004, FAM PRACT, V21, P39, DOI 10.1093/fampra/cmh109; Smith SA, 2008, MAYO CLIN P, V83; Smith SM, 2017, COCHRANE DATABASE SY; Smith SM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004910.pub3; Stukel TA, 2007, JAMA, V297; Vervoort GM, 2013, BR J GEN PRACT, V63; WHO, 2002, INNOVATIVE CARE CHRO	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194784	10.1371/journal.pone.0194784	http://dx.doi.org/10.1371/journal.pone.0194784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584749	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000035
J	Chudecka-Glaz, A; Cymbaluk-Ploska, A; Wezowska, M; Menkiszak, J				Chudecka-Glaz, Anita; Cymbaluk-Ploska, Aneta; Wezowska, Matgorzata; Menkiszak, Janusz			Could HE4 level measurements during first line chemotherapy predict response to treatment among ovarian cancer patients?	PLOS ONE			English	Article							EPIDIDYMIS PROTEIN 4; SERUM HE-4; OPTIMAL DEBULKING; PROGNOSTIC-FACTOR; CARCINOMA; CA125; DIAGNOSIS; BIOMARKER; OVCAD; ROMA	Background This study assessed the prognostic value of HE4 marker measurements at various stages of first-line chemotherapy for ovarian cancer. Methods The study consisted of 90 ovarian cancer patients, including 48 women undergoing primary surgical treatment and 42 patients qualified for neoadjuvant chemotherapy. Each patient underwent HE4 and CA 125 level measurements at the time of diagnosis and subsequently as follows: after surgical treatment, after the third course of adjuvant chemotherapy, before interval cytoreductive surgery and after chemotherapy. The HE4 value was assessed based on the PSF, OS, DFS, surgical outcome, two-year survival and platinum sensitivity. Results Preoperative HE4 levels were a predictor of platinum sensitivity (AUC-0.644; p = 0.035) and DFS (AUC = 0.637; p = 0.0492). A univariate logistic regression analysis showed that serum HE4 significantly correlated with PFS (baseline results over median HR = 2.96, p = 0.0009; baseline over 75 percentile HR = 2.44, p = 0.0062; normalization after treatment HR = 0.46, p = 0.0125; 50% reduction before IDS HR = 0.64, p = 0.0017). In the multivariate analysis, normalization after treatment and 50% reduction before IDS significantly influenced the PFS (HR = 0.29, p = 0.00008; HR = 0.23, p = 0.0024). The HE4 levels also correlated with the OS as follows: values below the median (HR = 1.88, p = 0.0087), normalization after chemotherapy (HR = 0.08, p = 0.0003), and 50% reduction before IDS (HR = 0.39, p = 0.0496). Conclusions The significant effect of the normalization of the HE4 marker after therapy and 50% reduction of HE4 levels before interval cytoreductive surgery on PFS and OS confirmed that HE4 might be an independent prognostic factor of treatment response. HE4 measurements performed during first-line treatment of ovarian cancer may have prognostic significance.	[Chudecka-Glaz, Anita; Cymbaluk-Ploska, Aneta; Wezowska, Matgorzata; Menkiszak, Janusz] Pomeranian Med Univ, Dept Gynecol Surg & Gynecol Oncol Adults & Adoles, Szczecin, Poland	Pomeranian Medical University	Chudecka-Glaz, A (corresponding author), Pomeranian Med Univ, Dept Gynecol Surg & Gynecol Oncol Adults & Adoles, Szczecin, Poland.	anitagl@poczta.onet.pl	Menkiszak, Janusz JM/I-4036-2014; Chudecka-Glaz, Anita/A-5813-2015	Menkiszak, Janusz JM/0000-0001-8279-7196; Chudecka-Glaz, Anita/0000-0003-2784-7968	Pomeranian Medical University of Szczecin, Poland [WLA-119-01/S/12/2016]	Pomeranian Medical University of Szczecin, Poland	The study was supported by grants No WLA-119-01/S/12/2016 from Pomeranian Medical University of Szczecin, Poland.	Anastasi E, 2010, TUMOR BIOL, V31, P113, DOI 10.1007/s13277-009-0015-y; Angioli R, 2013, GYNECOL ONCOL, V128, P579, DOI 10.1016/j.ygyno.2012.11.040; Armstrong DK., 2001, ONCOLOGIST S7, P20; Braicu EI, 2013, GYNECOL ONCOL, V128, P245, DOI 10.1016/j.ygyno.2012.11.023; Braicu EI, 2014, ANN SURG ONCOL, V21, P955, DOI 10.1245/s10434-013-3347-1; Chen WT, 2014, ASIAN PAC J CANCER P, V15, P101, DOI 10.7314/APJCP.2014.15.1.101; Chhikara N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047672; Chudecka-Glaz A, 2012, EUR J GYNAECOL ONCOL, V33, P382; Chudecka-Glaz AM, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-62; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hellstrom I, 2003, CANCER RES, V63, P3695; Hynninen J, 2011, INT J GYNECOL CANCER, V21, P1573, DOI 10.1097/IGC.0b013e3182225509; Kaijser J, 2014, INT J GYNECOL CANCER, V24, P1173, DOI 10.1097/IGC.0000000000000181; Kalapotharakos G, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-20; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; Kong SY, 2012, ANN SURG ONCOL, V19, P1707, DOI 10.1245/s10434-011-1943-5; Langmar Z, 2011, EUR J GYNAECOL ONCOL, V32, P605; Lu RQ, 2012, BIOCHEM BIOPH RES CO, V419, P274, DOI 10.1016/j.bbrc.2012.02.008; Manganaro L, 2013, ONCOL REP, V30, P2481, DOI 10.3892/or.2013.2682; Markowska J, 2013, CURR GYNECOL ONCOL, V11, P9; Nassir M, 2016, TUMOR BIOL, V37, P3009, DOI 10.1007/s13277-015-4031-9; Paek J, 2011, EUR J OBSTET GYN R B, V158, P338, DOI 10.1016/j.ejogrb.2011.05.021; Plotti F, 2012, TUMOR BIOL, V33, P2117, DOI 10.1007/s13277-012-0471-7; Ribeiro JR, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0240-0; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Steffensen KD, 2012, INT J GYNECOL CANCER, V22, P1474, DOI 10.1097/IGC.0b013e3182681cfd; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1040, DOI 10.1097/IGC.0b013e31821e052e; Trudel D, 2012, GYNECOL ONCOL, V127, P511, DOI 10.1016/j.ygyno.2012.09.003; Unterscheider J, 2012, AM J OBSTET GYNECOL, V206, pS309, DOI 10.1016/j.ajog.2011.12.028; Vallius T, 2014, TUMOR BIOL, V35, P12389, DOI 10.1007/s13277-014-2553-1; Wang JW, 2014, TUMOR BIOL, V35, P6127, DOI 10.1007/s13277-014-1811-6; Wu L, 2012, INT J GYNECOL CANCER, V22, P1106, DOI 10.1097/IGC.0b013e318263efa2; Yang ZJ, 2013, ONCOL LETT, V6, P28, DOI 10.3892/ol.2013.1339	33	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194270	10.1371/journal.pone.0194270	http://dx.doi.org/10.1371/journal.pone.0194270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584739	Green Submitted, gold, Green Published			2022-12-27	WOS:000428373000020
J	Hoffmann, I; Diefenbach, C; Graf, C; Konig, J; Schmidt, MF; Schnick-Vollmer, K; Blettner, M; Urschitz, MS				Hoffmann, Isabel; Diefenbach, Christiane; Graef, Christine; Koenig, Jochem; Schmidt, Martina F.; Schnick-Vollmer, Kathleen; Blettner, Maria; Urschitz, Michael S.		IkIdS Study Grp	Chronic health conditions and school performance in first graders: A prospective cohort study	PLOS ONE			English	Article							CARE NEEDS; STUDENT PERFORMANCE; ACADEMIC-ACHIEVEMENT; EDUCATIONAL-ATTAINMENT; IDENTIFYING CHILDREN; ADOLESCENTS; CHILDHOOD; OUTCOMES; DISORDERS; IMPAIRMENT	Objective Children with chronic health conditions may perform poorer at school. Associations may be confounded by numerous social factors. We aimed to estimate the effects of a chronic health condition on overall school performance in first graders with an emphasis on rigorous adjustment for potential confounders. Methods A population-based cohort study was performed in the area of Mainz-Bingen (Germany). In 2015 all preschoolers were approached and the presence of a chronic health condition was assessed by parental questionnaires and preschool health examination data. The identification of a chronic health condition was based on special health care needs and presence of a doctor's diagnosis out of 24 school-relevant diseases. At the end of the first school year, overall school performance was assessed by teachers and rated on a 5-item scale ranging from -10 to +10. Results Of 3683 children approached, 2003 were enrolled. Overall school performance was available for 1462 children (51% boys). Of these, 52% suffered from a chronic health condition. Compared to children without a chronic health condition, children with special health care needs (15%) performed worse at school (adjusted mean difference:-0.95, 95% CI: [-1.55; -0.35], P=0.002). Children with a doctor's diagnosis but without special health care needs (37%) did not perform worse at school. The effect was further analysed considering the extent of special health care needed. Conclusions Chronic health conditions affect overall school performance early in primary school. To identify academically at-risk children, a chronic health condition identification based on special health care needs may be used.	[Hoffmann, Isabel; Diefenbach, Christiane; Graef, Christine; Koenig, Jochem; Schmidt, Martina F.; Schnick-Vollmer, Kathleen; Urschitz, Michael S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Div Paediat Epidemiol, Mainz, Germany; [Blettner, Maria] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Div Epidemiol Methodol & Radiat Res, Mainz, Germany; [Hoffmann, Isabel] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Langenbeckstr 1, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Urschitz, MS (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Div Paediat Epidemiol, Mainz, Germany.	urschitz@uni-mainz.de	Simon, Perikles D/B-2293-2013; König, Jochem/T-3500-2019	Simon, Perikles D/0000-0002-7996-4034; König, Jochem/0000-0003-4683-0360	German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung) [01ER1302]	German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung)(Federal Ministry of Education & Research (BMBF))	The study was funded by a research grant of the German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, www.brnbf.de, grant number 01ER1302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Bethell CD, 2002, AMBUL PEDIATR, V2, P49, DOI 10.1367/1539-4409(2002)002<0049:COTCWS>2.0.CO;2; Bethell CD, 2002, AMBUL PEDIATR, V2, P38, DOI 10.1367/1539-4409(2002)002<0038:ICWSHC>2.0.CO;2; Bethell CD, 2008, MATERN CHILD HLTH J, V12, P1, DOI 10.1007/s10995-007-0220-5; Bettge S, 2014, DTSCH ARZTEBL INT, V111, P337, DOI 10.3238/arztebl.2014.0337; Blaiss MS, 2004, CURR MED RES OPIN, V20, P1937, DOI 10.1185/030079904X13266; Blossfeld HP, 2011, Z ERZIEHWISS, V14, P5, DOI 10.1007/s11618-011-0178-3; Blumberg Stephen J, 2008, Vital Health Stat 1, P1; Cohen AK, 2013, OBES REV, V14, P989, DOI 10.1111/obr.12062; Crump C, 2013, ANN EPIDEMIOL, V23, P179, DOI 10.1016/j.annepidem.2013.01.001; Currie J., 2008, 1398 NAT BUR EC RES; Dadaczynski K, 2012, Z GESUNDHEITSPSYCHOL, V20, P141, DOI 10.1026/0943-8149/a000072; De Silva AP, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0372-y; Esch P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0237-4; Forrest CB, 2011, PEDIATRICS, V128, P303, DOI 10.1542/peds.2010-3347; Gurney JG, 2009, J CLIN ONCOL, V27, P2390, DOI 10.1200/JCO.2008.21.1458; Kaestner R, 2009, ECON EDUC REV, V28, P651, DOI 10.1016/j.econedurev.2009.03.002; Leger J, 2001, ACTA PAEDIATR, V90, P1249; Lieu JEC, 2012, LARYNGOSCOPE, V122, P2088, DOI 10.1002/lary.23454; Martinez YJ, 2009, CHILD CARE HLTH DEV, V35, P391, DOI 10.1111/j.1365-2214.2008.00916.x; McDougall J, 2004, DISABIL REHABIL, V26, P35, DOI 10.1080/09638280410001645076; Miller J E, 2001, Vital Health Stat 2, P1; Mokkink LB, 2008, EUR J PEDIATR, V167, P1441, DOI 10.1007/s00431-008-0697-y; Moreira RS, 2014, J PEDIAT-BRAZIL, V90, P119, DOI 10.1016/j.jped.2013.05.010; O'Connell EJ, 2004, ALLERGY, V59, P7, DOI 10.1111/j.1398-9995.2004.00563.x; Polderman TJC, 2010, ACTA PSYCHIAT SCAND, V122, P271, DOI 10.1111/j.1600-0447.2010.01568.x; Quach J, 2015, ACAD PEDIATR, V15, P89, DOI 10.1016/j.acap.2014.08.004; Reuben CA, 2013, DISABIL HEALTH J, V6, P325, DOI 10.1016/j.dhjo.2013.03.003; Scheidt-Nave C, 2008, BUNDESGESUNDHEITSBLA, V51, P592, DOI 10.1007/s00103-008-0535-4; Scheidt-Nave C, 2007, BUNDESGESUNDHEITSBLA, V50, P750, DOI 10.1007/s00103-007-0237-3; Schmidt S, 2004, EUR J PEDIATR, V163, P517, DOI 10.1007/s00431-004-1458-1; STABLER B, 1994, J DEV BEHAV PEDIATR, V15, P1, DOI 10.1097/00004703-199402000-00001; Stoeckel RE, 2013, J DEV BEHAV PEDIATR, V34, P38, DOI 10.1097/DBP.0b013e31827ba22a; Suhrcke M, IMPACT HLTH HLTH BEH; Taras H, 2005, J SCHOOL HEALTH, V75, P291, DOI 10.1111/j.1746-1561.2005.00040.x; Taras H, 2005, J SCHOOL HEALTH, V75, P296, DOI 10.1111/j.1746-1561.2005.00041.x; Taras H, 2005, J SCHOOL HEALTH, V75, P255, DOI 10.1111/j.1746-1561.2005.00034.x; Taras H, 2005, J SCHOOL HEALTH, V75, P248, DOI 10.1111/j.1746-1561.2005.00033.x; Troyb E, 2014, AUTISM, V18, P233, DOI 10.1177/1362361312473519; Uiters E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1104; Urschitz MS, 2004, PEDIATRICS, V114, P1041, DOI 10.1542/peds.2003-1145-L; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Lee JH, 2007, JAMA-J AM MED ASSOC, V297, P2741, DOI 10.1001/jama.297.24.2741; WRIGHT M, 1994, ARCH DIS CHILD, V71, P64, DOI 10.1136/adc.71.1.64	44	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194846	10.1371/journal.pone.0194846	http://dx.doi.org/10.1371/journal.pone.0194846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584786	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000043
J	Katz, D; Tengekyon, AJ; Kahan, NR; Calderon-Margalit, R				Katz, Daniela; Tengekyon, Angela J.; Kahan, Natan R.; Calderon-Margalit, Ronit			Patient and physician characteristics affect adherence to screening mammography: A population-based cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; REPEAT MAMMOGRAPHY; UNITED-STATES; CANCER INCIDENCE; PREVENTIVE CARE; BREAST; WOMEN; SERVICES; PATTERNS; RECOMMENDATIONS	Background Screening mammograms are widely recommended biennially for women between the ages of 50 and 74. Despite the benefits of screening mammograms, full adherence to recommendations falls below 75% in most developed countries. Many studies have identified individual (obesity, smoking, socio-economic status, and co-morbid conditions) and primary-care physician parameters (physician age, gender, clinic size and cost) that influence adherence, but little data exists from large population studies regarding the interaction of these individual factors. Methods We performed a historical cohort study of 44,318 Israeli women age 56-74 using data captured from electronic medical records of a large Israeli health maintenance organization. Univariate analysis was used to examine the association between each factor and adherence (none, partial or full) with screening recommendations between 2008-2014. Multivariate analysis was used to examine the significance of these factors in combination, using binary and multinomial logistic regression. Results Among 44,318 women, 42%, 43% and 15% were fully, partially and non-adherent to screening recommendations, respectively. Factors associated with inferior adherence identified in our population included: smoking, obesity, low body weight, low socio-economic status, depression, diabetes mellitus and infrequent physician visits, while, women with ischemic heart disease, female physicians, physicians between the ages of 40 and 60, and mediumsized clinics were associated with higher screening rates. Most factors remained significant in the multivariate analysis. Conclusions Both individual and primary-care physician factors contribute to adherence to mammography screening guidelines. Strategies to improve adherence and address disparities in mammography utilization will need to address these factors.	[Katz, Daniela] Assaf Harofeh Med Ctr, Inst Oncol, Zerifin, Israel; [Tengekyon, Angela J.; Calderon-Margalit, Ronit] Joseph H & Belle R Braun Hebrew Univ, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Kahan, Natan R.] Leumit Hlth Serv, Med Div, Tel Aviv, Israel; [Kahan, Natan R.] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Katz, D (corresponding author), Assaf Harofeh Med Ctr, Inst Oncol, Zerifin, Israel.	katzd@asaf.health.gov.il			Israel Cancer Association	Israel Cancer Association	This study was supported by the Israel Cancer Association, prevention grant 2015, http://en.cancer.org.il/. The sponsor approved the study proposal and the had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford Sharon Hensley, 2015, Prev Med Rep, V2, P15, DOI 10.1016/j.pmedr.2014.11.004; [Anonymous], 2009, Ann Intern Med, V151, pI, DOI 10.7326/0003-4819-151-9-200911030-00002; Bandera EV, 2015, ADV NUTR, V6, P803, DOI 10.3945/an.115.009647; Bhosle M, 2007, BREAST CANCER RES TR, V103, P53, DOI 10.1007/s10549-006-9344-3; Blackwell DL, 2008, WOMEN HEALTH ISS, V18, P85, DOI 10.1016/j.whi.2007.10.006; Boyd NF, 2006, CANCER EPIDEM BIOMAR, V15, P2086, DOI 10.1158/1055-9965.EPI-06-0345; Bryan L, 2014, NICOTINE TOB RES, V16, P1183, DOI 10.1093/ntr/ntu047; BURNS RB, 1995, J GEN INTERN MED, V10, P520, DOI 10.1007/BF02602407; Coyle C, 2014, J MED SCREEN, V21, P98, DOI 10.1177/0969141314533677; Elmore JG, 2004, ARCH INTERN MED, V164, P1140, DOI 10.1001/archinte.164.10.1140; Engelman KK, 2004, PREV MED, V39, P491, DOI 10.1016/j.ypmed.2004.05.020; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrante JM, 2007, AM J PREV MED, V32, P525, DOI 10.1016/j.amepre.2007.02.004; Fontaine KR, 2001, J WOMEN HEALTH GEN-B, V10, P463, DOI 10.1089/152460901300233939; Halabi S, 2000, J FAM PRACTICE, V49, P1104; Hellmann SS, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1296-8; Herman CJ, 1999, J COMMUN HEALTH, V24, P253, DOI 10.1023/A:1018790104934; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jimenez-Garcia R, 2009, DIABETES CARE, V32, P1470, DOI 10.2337/dc09-0479; Klabunde Carrie N., 2012, Morbidity and Mortality Weekly Report, V61, P41; Lagerlund M, 2002, CANCER CAUSE CONTROL, V13, P73, DOI 10.1023/A:1013978421073; Liu BY, 2014, J AM BOARD FAM MED, V27, P669, DOI 10.3122/jabfm.2014.05.140005; Lofters AK, 2015, CANCER MED-US, V4, P212, DOI 10.1002/cam4.358; Lopez EDS, 2009, WOMEN HEALTH ISS, V19, P434, DOI 10.1016/j.whi.2009.07.008; Lurie N, 1997, J GEN INTERN MED, V12, P34; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; Ly D, 2013, INT J CANCER, V132, P1918, DOI 10.1002/ijc.27841; Madadi M, 2014, BREAST CANCER RES TR, V144, P193, DOI 10.1007/s10549-014-2850-9; Mayne L, 2003, J RURAL HEALTH, V19, P63, DOI 10.1111/j.1748-0361.2003.tb00543.x; McBean AM, 2007, DIABETES CARE, V30, P1466, DOI 10.2337/dc06-2233; Morere JF, 2011, EUR J CANCER PREV, V20, pS8, DOI 10.1097/01.cej.0000391562.18512.4a; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Ornstein SM, 2013, ANN FAM MED, V11, P344, DOI 10.1370/afm.1502; Paskett ED, 1996, CANCER EPIDEM BIOMAR, V5, P721; Peppercorn J, 2015, BREAST CANCER RES TR, V153, P659, DOI 10.1007/s10549-015-3566-1; Rakowski W, 2006, CANCER EPIDEM BIOMAR, V15, P2093, DOI 10.1158/1055-9965.EPI-06-0301; Sabatino Susan A, 2009, Open Health Serv Policy J, V2, P57; School of Public Health and Community Medicine HU-H, 2012, NAT PROGR QUAL IND C; Schueler KM, 2008, J WOMENS HEALTH, V17, P1477, DOI 10.1089/jwh.2007.0603; Tabaei BP, 2005, DIABETES CARE, V28, P2644, DOI 10.2337/diacare.28.11.2644; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Wells Kristen J, 2007, Cancer Control, V14, P369; Wilf-Miron R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-376; Wilson RT, 2011, PUBLIC HEALTH REP, V126, P806, DOI 10.1177/003335491112600606; Yood MU, 1999, CANCER EPIDEM BIOMAR, V8, P595; Zhu KM, 2006, PREV MED, V42, P381, DOI 10.1016/j.ypmed.2006.01.020	48	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194409	10.1371/journal.pone.0194409	http://dx.doi.org/10.1371/journal.pone.0194409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584742	Green Submitted, gold, Green Published			2022-12-27	WOS:000428373000022
J	Villanueva, B; Arteaga, A; Maiz, A; Cortes, VA				Villanueva, Beatriz; Arteaga, Antonio; Maiz, Alberto; Cortes, Victor A.			Abdominal obesity is a common finding in normal and overweight subjects of Chile and is associated with increased frequency of cardiometabolic risk factors	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; ADIPOSE-TISSUE; CONSENSUS STATEMENT; FAT; PATHOPHYSIOLOGY; PARTICIPANTS; MANAGEMENT	Background/Objectives Abdominal obesity (AO) is associated with elevated risk for cardiovascular diseases; however, this association is less clear for non-obese people. We estimated the association of AO and cardiovascular risk factors (CVRF) and disease in non-obese adult individuals from Chile. Subjects/Methods 5248 adults (15 years of age or older) of both sexes from the Chilean National Health Survey (October 2009 September 2010, response rate 85%.) were included. Information on myocardial infarction and stroke was self-reported. BMI, waist circumference (WC), arterial pressure, plasma glucose, and cholesterol levels were measured. Predictive accuracy of WC was evaluated by area under curve of receiver operating characteristic analysis and cut off points were established by Youden Index. Relationship between AO and CVRF was analyzed by Chi-squared tests. Results Normal weight/overweight/obesity were present in 34.4%/45.2%/18.1% of men and 33.4%/33.6%/27.5% of women. Predictive accuracy of WC to identify at least one CVRF was 0.70/0.67 and optimal cutoff points for WC in non-obese subjects were 91/83 cm in men/women, respectively. AO was present in 98.2%/99.1% of obese, 70.5%/77.4% of overweight and 12.4%/16.4% of normal weight men/women. AO was associated with increased frequency of CVRF in overweight men (6/8 and stroke) and women (4/8) and higher frequency in normal weight men (8/8 and myocardial infarction/stroke) and women (6/8 and myocardial infarction). Conclusions WC cutoff points calculated for non-obese chilean population discriminate more differences in CVRF in normal weight woman. AO significantly increases the frequency of CVRF and diseases in overweight and especially normal weight individuals. WC can be used as a low cost, feasible and reproducible predictor for CVRF in non-obese individuals in most clinical settings.	[Villanueva, Beatriz; Arteaga, Antonio; Maiz, Alberto; Cortes, Victor A.] Pontificia Univ Catolica Chile, Escuela Med, Dept Nutr Diabet & Metab, Santiago, Chile	Pontificia Universidad Catolica de Chile	Cortes, VA (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Nutr Diabet & Metab, Santiago, Chile.	vcortesm@uc.cl		Cortes, Victor/0000-0002-1658-0965	Comision Nacional de Ciencia y tecnologia, Fondecyt [1141134]	Comision Nacional de Ciencia y tecnologia, Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funded by Comision Nacional de Ciencia y tecnologia, Fondecyt grant 1141134 http:/www.conicyt.cl/fondecyt/.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2014, OBESITY, V22, P20660; [Anonymous], 2000, PRACT GUID ID EV TRE; Ashwell M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0207-1; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Czernichow S, 2007, INT J OBESITY, V31, P791, DOI 10.1038/sj.ijo.0803477; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Fasce H Eduardo, 2010, Rev Chil Cardiol, V29, P11; Gradmark AMI, 2010, BRIT J NUTR, V104, P582, DOI 10.1017/S0007114510000796; Grundy SM, 2015, EUR J CLIN INVEST, V45, P1209, DOI 10.1111/eci.12519; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; Hermsdorff HHM, 2014, EUR J PREV CARDIOL, V21, P884, DOI 10.1177/2047487312472420; Hermsdorff HHM, 2012, INFLAMM RES, V61, P427, DOI 10.1007/s00011-011-0429-z; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Keys A, 1981, Prog Clin Biol Res, V67, P31; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Lanas F, 2017, J CLIN EPIDEMIOL, V86, P111, DOI 10.1016/j.jclinepi.2016.04.018; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li C, 2006, INT J OBESITY, V30, P1775, DOI 10.1038/sj.ijo.0803339; Lofgren I, 2004, J NUTR, V134, P1071, DOI 10.1093/jn/134.5.1071; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; Millan J, 2007, CLIN INVEST ARTERIOS, V19, P61, DOI 10.1016/S0214-9168(07)74175-X; Muller MJ, 2016, P NUTR SOC, V75, P181, DOI 10.1017/S0029665115004206; Ray I, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00157; Salud Md, ENCUESTA NACL SALUD; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Soutelo J, 2013, Rev. argent. endocrinol. metab., V50, P25; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; World Health Organization (WHO), 2011, WAIST CIRCUMFERENCE; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yang L, 2008, J INTERN MED, V264, P39, DOI 10.1111/j.1365-2796.2007.01907.x	37	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194644	10.1371/journal.pone.0194644	http://dx.doi.org/10.1371/journal.pone.0194644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579094	Green Published, Green Submitted, gold			2022-12-27	WOS:000428351800040
J	Liu, M; Degner, J; Davis, JW; Idler, KB; Nader, A; Mostafa, NM; Waring, JF				Liu, Mohan; Degner, Jacob; Davis, Justin Wade; Idler, Kenneth B.; Nader, Ahmed; Mostafa, Nael M.; Waring, Jeffrey F.			Identification of HLA-DRB1 association to adalimumab immunogenicity	PLOS ONE			English	Article							HIDRADENITIS SUPPURATIVA; MULTIPLE-SCLEROSIS; INTERFERON-BETA; ANTIBODIES; ALPHA; MECHANISMS; INFLIXIMAB; THERAPY	Anti-drug antibody formation occurs with most biological agents across disease states, but the mechanism by which they are formed is unknown. The formation of anti-drug antibodies to adalimumab (AAA) may decrease its therapeutic effects in some patients. HLA alleles have been reported to be associated with autoantibody formation against interferons and other TNF inhibitors, but not adalimumab. We analyzed samples from 634 subjects with either rheumatoid arthritis (RA) or hidradenitis suppurativa (HS): 37 subjects (17 RA and 20 HS) developed AAA (AAA+) during adalimumab treatment and 597 subjects (348 RA, 249 HS) did not develop AAA (AAA-) during the clinical trials. Using next-generation sequencing-based HLA typing, we identified three protective HLA alleles (HLA-DQB1*05, HLA-DRB1*01,and HLA-DRB1*07) that were less prevalent in AAA+ than AAA subjects (ORs: 0.4, 0.25 and 0.28, respectively; and P values: 0.012, 0.012 and 0.018, respectively) and two risk HLA alleles (HLA-DRB1*03 and HLA-DRB1*011) that were more abundant in AAA+ than AAA subjects (ORs: 2.52, and 2.64, respectively; and P values: 0.006 and 0.019). Similar to the finding of Billiet et al. who found that carriage of the HLA-DRB1*03 allele was more prevalent in those with anti-infliximab antibodies (OR = 3.6, p = 0.002, 95% CI: [1.5,8.6]).), we found HLA-DRB1*03 allele was also more prevalent in anti-adalimumab positive (OR = 2.52, p = 0.006, 95% CI: [1.37,4.63]). The results suggest that specific HLA alleles may play a key role in developing AAAs in RA and HS patients treated with adalimumab.	[Liu, Mohan; Degner, Jacob; Davis, Justin Wade; Idler, Kenneth B.; Waring, Jeffrey F.] AbbVie Inc, Genom Res Ctr, Pharmacogenet & Human Genet, N Chicago, IL 60064 USA; [Nader, Ahmed; Mostafa, Nael M.] AbbVie Inc, Clin Pharmacol & Pharmacometr, N Chicago, IL USA	AbbVie; AbbVie	Liu, M (corresponding author), AbbVie Inc, Genom Res Ctr, Pharmacogenet & Human Genet, N Chicago, IL 60064 USA.	mohan.liu@abbvie.com		Liu, Mohan/0000-0003-0653-7397	AbbVie	AbbVie(AbbVie)	This work was supported by AbbVie in the form of salaries for all authors. The roles of the authors are articulated in the "author contributions section." AbbVie participated in the interpretation of data, review, and approval of the publication.	Bartelds GM, 2006, ANN RHEUM DIS, V65, P1249, DOI 10.1136/ard.2005.049858; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Billiet T, 2015, GUT, V64, P1344, DOI 10.1136/gutjnl-2015-309698; Buck D, 2011, ARCH NEUROL-CHICAGO, V68, P480, DOI 10.1001/archneurol.2011.65; Burmester G-R, 2014, ANN RHEUM DIS, P1037; Burmester GR, 2016, RHEUMATOLOGY, V55, P49, DOI 10.1093/rheumatology/kev258; Caufriez A, 2007, ANN ENDOCRINOL-PARIS, V68, P241, DOI 10.1016/j.ando.2007.06.015; Garces S, 2012, ANN RHEUM DIS; Heinze G, 2013, STAT MED, V32, P5062, DOI 10.1002/sim.5899; Hernandez-Frederick CJ, 2014, TISSUE ANTIGENS, V83, P184, DOI 10.1111/tan.12304; Hoffmann S, 2008, AM J HUM GENET, V83, P219, DOI 10.1016/j.ajhg.2008.07.006; Hu S, 2013, J BIOL CHEM, V288, P27059, DOI 10.1074/jbc.M113.491530; Jawa V, 2013, CLIN IMMUNOL, V149, P534, DOI 10.1016/j.clim.2013.09.006; Kaeley GS, 2016, J RHEUMATOL, V43, P1480, DOI 10.3899/jrheum.151009; Kimball AB, 2016, NEW ENGL J MED, V375, P422, DOI 10.1056/NEJMoa1504370; Link J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090479; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Morris DL, 2014, GENES IMMUN, V15, P210, DOI 10.1038/gene.2014.6; Nazary M, 2011, EUR J PHARMACOL, V672, P1, DOI 10.1016/j.ejphar.2011.08.047; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Schaeverbeke T, 2015, RHEUMATOLOGY, P210; Thomas SS, 2015, BIODRUGS, V29, P241, DOI 10.1007/s40259-015-0134-5; van der Zee HH, 2011, BRIT J DERMATOL, V164, P1292, DOI 10.1111/j.1365-2133.2011.10254.x; Walter SD, 1987, PHILOS SCI METHODOLO, V38	24	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195325	10.1371/journal.pone.0195325	http://dx.doi.org/10.1371/journal.pone.0195325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614084	gold, Green Submitted, Green Published			2022-12-27	WOS:000429081600047
J	Sullivan, LL; Ballen, CJ; Cotner, S				Sullivan, Lauren L.; Ballen, Cissy J.; Cotner, Sehoya			Small group gender ratios impact biology class performance and peer evaluations	PLOS ONE			English	Article							STEREOTYPE THREAT; WOMEN; PARTICIPATION; FEMALE; MATH; PERCEPTIONS; MOTIVATION; SCIENCE; ABILITY; GAP	Women are underrepresented in science, technology, engineering, and mathematics (STEM) disciplines. Evidence suggests the microclimate of the classroom is an important factor influencing female course grades and interest, which encourages retention of women in STEM fields. Here, we test whether the gender composition of small (8-9 person) learning groups impacts course performance, sense of social belonging, and intragroup peer evaluations of intellectual contributions. Across two undergraduate active learning courses in introductory biology, we manipulated the classroom microclimate by varying the gender ratios of learning groups, ranging from 0% female to 100% female. We found that as the percent of women in groups increased, so did overall course performance for all students, regardless of gender. Additionally, women assigned higher peer- evaluations in groups with more women than groups with less women. Our work demonstrates an added benefit of the retention of women in STEM: increased performance for all, and positive peer perceptions for women.	[Sullivan, Lauren L.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Ballen, Cissy J.; Cotner, Sehoya] Univ Minnesota, Dept Biol Teaching & Learning, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sullivan, LL (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	lsulliva@umn.edu		Sullivan, Lauren L./0000-0002-4198-3483; Ballen, Cissy/0000-0002-4693-6117	Legislative Citizen Commission on Minnesota Resources (LCCMR) Environmental and Natural Resources Trust Fund (ENRTF) [186]; Department of Biology Teaching and Learning at the University of Minnesota	Legislative Citizen Commission on Minnesota Resources (LCCMR) Environmental and Natural Resources Trust Fund (ENRTF); Department of Biology Teaching and Learning at the University of Minnesota	LLS was supported by the Legislative Citizen Commission on Minnesota Resources (LCCMR) Environmental and Natural Resources Trust Fund (ENRTF) Grant (M.L. 2016, Chp. 186, Sec. 2, Subd. 08b). CJB and SH were supported by the Department of Biology Teaching and Learning at the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GM, 2013, J EDUC PSYCHOL, V105, P129, DOI 10.1037/a0028496; Amelink C., 2009, LIT OVERVIEW GENDER, P1; Aronson J., 1998, PREJUDICE, V40, P83, DOI [10.1016/b978-012679130-3/50039-9, DOI 10.1016/B978-012679130-3/50039-9]; Ballen CJ, PLOS ONE IN PRESS; Bartol KM, 1986, SOCIAL PSYCHOL FEMAL, P259; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baugh SG, 1997, GROUP ORGAN MANAGE, V22, P366, DOI 10.1177/1059601197223004; Beasley MA, 2012, SOC PSYCHOL EDUC, V15, P427, DOI 10.1007/s11218-012-9185-3; Beede D.N., 2011, WOMEN STEM GENDER GA, P4, DOI [DOI 10.2139/SSRN.1964782, 10.2139/ssrn.1964782]; Bian L, 2017, SCIENCE, V355, P389, DOI 10.1126/science.aah6524; Bryan RE, 2005, ANN ACAD MED SINGAP, V34, P486; Chen X., 2014, J APPL MATH, V2014, P1, DOI DOI 10.1061/(ASCE)MT.1943-5533.0000778; Cheryan S, 2009, J PERS SOC PSYCHOL, V97, P1045, DOI 10.1037/a0016239; Chichilnisky G, 2008, INT LABOUR REV, V147, P297, DOI 10.1111/j.1564-913X.2008.00038.x; Clance P.R., 1985, IMPOSTOR PHENOMENON, P20; Clark B.J., 2005, GENDER ED, V17, P369, DOI DOI 10.1080/09540250500145072; Cotner S., 2011, J COLL SCI TEACH, V40, P96; Cotner S., 2013, J COLL SCI TEACH, V42, P82, DOI DOI 10.2505/4/JCST13_042_06_82; Cotner S, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-11-0329; CRAWFORD M, 1990, SEX ROLES, V23, P101, DOI 10.1007/BF00289859; Dasgupta N, 2015, P NATL ACAD SCI USA, V112, P4988, DOI 10.1073/pnas.1422822112; De Welde K., 2011, INT J GEND SCI TECHN, V3, P571; Eddy SL, 2014, CBE-LIFE SCI EDUC, V13, P478, DOI 10.1187/cbe.13-10-0204; Espinosa LL, 2011, HARVARD EDUC REV, V81, P209, DOI 10.17763/haer.81.2.92315ww157656k3u; Gainen J, 1995, NEW DIRECTIONS TEACH, V1995, P5, DOI [10.1002/tl.37219956104, DOI 10.1002/TL.37219956104]; Good C, 2012, J PERS SOC PSYCHOL, V102, P700, DOI 10.1037/a0026659; Graham MJ, 2013, SCIENCE, V341, P1455, DOI 10.1126/science.1240487; Hall RobertaM., 1982, CLASSROOM CLIMATE CH; Heilman ME, 2001, J SOC ISSUES, V57, P657, DOI 10.1111/0022-4537.00234; Hollingshead AB, 2003, J EXP SOC PSYCHOL, V39, P355, DOI 10.1016/S0022-1031(02)00549-8; Hughes WJ, 2000, J WOMEN MINOR SCI EN, V6; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Lariviere Vincent, 2013, Nature, V504, P211; Lorenzo M, 2006, AM J PHYS, V74, P118, DOI 10.1119/1.2162549; Luckenbill-Edds L, 2002, BIOSCIENCE, V52, P513, DOI 10.1641/0006-3568(2002)052[0513:TEPFWI]2.0.CO;2; MAMOLA C, 1979, SMALL GROUP BEHAV, V10, P431, DOI 10.1177/104649647901000310; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Myaskovsky L, 2005, SEX ROLES, V52, P645, DOI 10.1007/s11199-005-3732-8; Oh SS, 2011, SOC SCI J, V48, P397, DOI 10.1016/j.soscij.2010.11.008; Oncu S, 2015, EURASIA J MATH SCI T, V11, P535; President's Council of Advisors on Science and Technology, 2012, ENG EXC PROD ON MILL; R Development Core Team, 2009, R LANG ENV STAT COMP; Rask K, 2008, ECON EDUC REV, V27, P676, DOI 10.1016/j.econedurev.2007.09.010; Rodriguez I, 2016, PHYS REV PHYS EDUC R, V12, DOI 10.1103/PhysRevPhysEducRes.12.020118; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Shackelford S, 1996, SOC PSYCHOL Q, P248; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele J, 2002, PSYCHOL WOMEN QUART, V26, P46, DOI 10.1111/1471-6402.00042; Stout JG, 2013, AIP CONF PROC, V1513, P402, DOI 10.1063/1.4789737; West TV, 2012, J EXP SOC PSYCHOL, V48, P1209, DOI 10.1016/j.jesp.2012.04.012; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Xu Y., 2015, J HIGHER ED, V86	52	8	8	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195129	10.1371/journal.pone.0195129	http://dx.doi.org/10.1371/journal.pone.0195129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614091	Green Submitted, gold, Green Published			2022-12-27	WOS:000429081600034
J	Marinoni, DT; Valentini, N; Portis, E; Acquadro, A; Beltramo, C; Mehlenbacher, SA; Mockler, TC; Rowley, ER; Botta, R				Marinoni, Daniela Torello; Valentini, Nadia; Portis, Ezio; Acquadro, Alberto; Beltramo, Chiara; Mehlenbacher, Shawn A.; Mockler, Todd C.; Rowley, Erik R.; Botta, Roberto			High density SNP mapping and QTL analysis for time of leaf budburst in Corylus avellana L.	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC-LINKAGE MAP; SINGLE NUCLEOTIDE POLYMORPHISMS; COASTAL DOUGLAS-FIR; MICROSATELLITE MARKERS; TRANSLOCATION BREAKPOINTS; ENVIRONMENTAL-CONTROL; 9-LIPOXYGENASE GENE; ADAPTIVE TRAITS; CANDIDATE GENES	The growing area of European hazelnut (Corylus avellana L.) is increasing, as well as the number of producing countries, and there is a pressing need for new improved cultivars. Hazelnut conventional breeding process is slow, due to the length of juvenile phase and the high heterozygosity level. The development of genetic linkage maps and the identification of molecular markers tightly linked to QTL (quantitative trait loci) of agronomic interest are essential tools for speeding up the selection of seedlings carrying desired traits through marker-assisted selection. The objectives of this study were to enrich a previous linkage map and confirm QTL related to time of leaf budburst, using an F1 population obtained by crossing Tonda Gentile delle Langhe with Merveille de Bollwiller. Genotyping-by-Sequencing was used to identify a total of 9,999 single nucleotide polymorphism markers. Well saturated linkage maps were constructed for each parent using the double pseudo-testcross mapping strategy. A reciprocal translocation was detected in Tonda Gentile delle Langhe between two non-homologous chromosomes. Applying a bioinformatic approach, we were able to disentangle 'pseudo-linkage' between markers, removing markers around the trans location breakpoints and obtain a linear order of the markers for the two chromosomes arms, for each linkage group involved in the translocation. Twenty-nine QTL for time of leaf budburst were identified, including a stably expressed region on LG_O2 of the Tonda Gentile delle Langhe map. The stability of these QTL and their coding sequence content indicates promise for the identification of specific chromosomal regions carrying key genes involved in leaf budburst.	[Marinoni, Daniela Torello; Valentini, Nadia; Portis, Ezio; Acquadro, Alberto; Beltramo, Chiara; Botta, Roberto] Univ Torino, Dipartimento Sci Agr Forestali & Alimentari, Turin, Italy; [Mehlenbacher, Shawn A.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Mockler, Todd C.; Rowley, Erik R.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	University of Turin; Oregon State University; Donald Danforth Plant Science Center	Portis, E (corresponding author), Univ Torino, Dipartimento Sci Agr Forestali & Alimentari, Turin, Italy.	ezio.portis@unito.it	valentini, nadia/AAY-9815-2020; Valentini, Nadia Cristina/I-5520-2013; Mockler, Todd C/L-2609-2013; Beltramo, Chiara/K-7917-2016	Valentini, Nadia Cristina/0000-0001-6412-5206; Mockler, Todd C/0000-0002-0462-5775; Beltramo, Chiara/0000-0002-7861-4171; VALENTINI, Nadia/0000-0002-8820-9006; PORTIS, Ezio/0000-0002-1548-6096; ACQUADRO, Alberto/0000-0002-5322-9701	Ferrero Hazelnut Company	Ferrero Hazelnut Company	Financial support granted by Ferrero Hazelnut Company is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball AD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-218; Batley J, 2009, METHODS MOL BIOL, V537, P303, DOI 10.1007/978-1-59745-251-9_15; Beltramo C, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0450-6; Bhattarai G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178061; Bielenberg DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139406; Boccacci P, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0195-7; BRADSHAW HD, 1995, GENETICS, V139, P963; Bregaglio S, 2016, ECOL MODEL, V329, P86, DOI 10.1016/j.ecolmodel.2016.03.006; Bushakra JM, 2015, THEOR APPL GENET, V128, P1631, DOI 10.1007/s00122-015-2541-x; Casasoli M, 2004, PLANT CELL ENVIRON, V27, P1088, DOI 10.1111/j.1365-3040.2004.01214.x; Catarino S, 2006, CHROMOSOME RES, V14, P755, DOI 10.1007/s10577-006-1089-7; Cervera MT, 2001, GENETICS, V158, P787; Charrier G, 2011, INT J BIOMETEOROL, V55, P763, DOI 10.1007/s00484-011-0470-1; CHURCHILL GA, 1994, GENETICS, V138, P963; Colburn BC, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0616-2; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cooke JEK, 2012, PLANT CELL ENVIRON, V35, P1707, DOI 10.1111/j.1365-3040.2012.02552.x; Crepinsek Z, 2012, INT J BIOMETEOROL, V56, P681, DOI 10.1007/s00484-011-0469-7; Cristofori V, 2008, J SCI FOOD AGR, V88, P1091, DOI 10.1002/jsfa.3203; Derory J, 2010, HEREDITY, V105, P401, DOI 10.1038/hdy.2009.170; Doucleff M, 2004, THEOR APPL GENET, V109, P1178, DOI 10.1007/s00122-004-1728-3; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eun MH, 2016, HORTIC ENVIRON BIOTE, V57, P589, DOI 10.1007/s13580-016-0128-3; Farre A, 2011, THEOR APPL GENET, V122, P1029, DOI 10.1007/s00122-010-1507-2; Germain E, 2004, LE NOISETIER; Ghelardini L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-31; Grzeskowiak L, 2013, THEOR APPL GENET, V126, P2763, DOI 10.1007/s00122-013-2170-1; Guajardo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127750; Gurcan K, 2010, MOL BREEDING, V26, P551, DOI 10.1007/s11032-010-9464-7; Gurcan K, 2010, TREE GENET GENOMES, V6, P513, DOI 10.1007/s11295-010-0269-y; Gurcan K, 2010, J AM SOC HORTIC SCI, V135, P159, DOI 10.21273/JASHS.135.2.159; Hassidim M, 2007, PLANT J, V51, P551, DOI 10.1111/j.1365-313X.2007.03160.x; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hu TZ, 2013, PLANT MOL BIOL REP, V31, P1141, DOI 10.1007/s11105-013-0581-4; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Jaganathan D, 2015, MOL GENET GENOMICS, V290, P559, DOI 10.1007/s00438-014-0932-3; JANSEN RC, 1994, GENETICS, V136, P1447; Jauregui B, 2001, THEOR APPL GENET, V102, P1169, DOI 10.1007/s001220000511; Jermstad KD, 2001, THEOR APPL GENET, V102, P1142, DOI 10.1007/s001220000505; Kenis K, 2005, MOL BREEDING, V15, P205, DOI 10.1007/s11032-004-5592-2; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; KONISHI T, 1988, THEOR APPL GENET, V75, P237, DOI 10.1007/BF00303959; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; LANDER ES, 1989, GENETICS, V121, P185; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lehmensiek A, 2005, AUST J AGR RES, V56, P1347, DOI 10.1071/AR05126; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI P, 1993, CAN J FOREST RES, V23, P1043, DOI 10.1139/x93-133; Li Z, 2001, THEOR APPL GENET, V103, P1167, DOI 10.1007/s001220100672; Lian QL, 2011, SCI HORTIC-AMSTERDAM, V130, P468, DOI 10.1016/j.scienta.2011.07.016; Livingstone KD, 2000, J HERED, V91, P423, DOI 10.1093/jhered/91.6.423; Longhi S, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.1; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Ma BQ, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-015-0959-6; Mahama AA, 2003, CROP SCI, V43, P1602, DOI 10.2135/cropsci2003.1602; Maschietto V, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0970-1; McCallum S, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0443-5; ME G, 1989, HORTSCIENCE, V24, P122; MEHLENBACHER SA, 1991, SCI HORTIC-AMSTERDAM, V47, P271, DOI 10.1016/0304-4238(91)90010-V; Mehlenbacher SA, 2006, GENOME, V49, P122, DOI 10.1139/G05-091; Ozturk SC, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-016-1098-4; Pilet-Nayel ML, 2002, THEOR APPL GENET, V106, P28, DOI 10.1007/s00122-002-0985-2; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pootakham W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00367; Portis E, 2009, THEOR APPL GENET, V120, P59, DOI 10.1007/s00122-009-1159-2; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Ros E, 2010, NUTRIENTS, V2, P652, DOI 10.3390/nu2070652; Rowley E., 2016, THESIS; Rowley ER, 2012, CROP SCI, V52, P2679, DOI 10.2135/cropsci2012.02.0065; SALESSES G, 1988, CYTOLOGIA, V53, P407, DOI 10.1508/cytologia.53.407; SALESSES G, 1973, ANN AMELIOR PLANT, V23, P59; Santino A, 2005, PLANT SCI, V168, P699, DOI 10.1016/j.plantsci.2004.10.001; SARAVITZ DM, 1995, PLANT PHYSIOL, V107, P535, DOI 10.1104/pp.107.2.535; Scotti-Saintagne C, 2004, THEOR APPL GENET, V109, P1648, DOI 10.1007/s00122-004-1789-3; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Talukder ZI, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.03.0035; *UPOV, 1979, TG713 UPOV; Van Ooijen, 2004, MAPQTL 5 SOFTWARE MA; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WEEDEN NF, 1994, CUR T PL M, P57; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595	90	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195408	10.1371/journal.pone.0195408	http://dx.doi.org/10.1371/journal.pone.0195408			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608620	gold, Green Submitted, Green Published			2022-12-27	WOS:000428988800052
J	Ameri, R; Laville, E; Potocki-Veronese, G; Trabelsi, S; Mezghani, M; Elgharbi, F; Bejar, S				Ameri, Rihab; Laville, Elisabeth; Potocki-Veronese, Gabrielle; Trabelsi, Sahar; Mezghani, Monia; Elgharbi, Fatma; Bejar, Samir			Two new gene clusters involved in the degradation of plant cell wall from the fecal microbiota of Tunisian dromedary	PLOS ONE			English	Article							CAMEL CAMELUS-DROMEDARIUS; POLYSACCHARIDE UTILIZATION; MOLECULAR DIVERSITY; BROILER-CHICKENS; HUMAN GUT; BACTERIA; RUMEN; IDENTIFICATION; MICROFLORA; EXPRESSION	Dromedaries are capable of digesting plant cell wall with high content of lignocellulose of poor digestibility. Consequently, their intestinal microbiota can be a source of novel carbohydrate-active enzymes (CAZymes). To the best of our knowledge, no data are available describing the biochemical analysis of enzymes in dromedary intestinal microbiota. To investigate new hydrolytic enzymes from the dromedary gut, a fosmid library was constructed using metagenomic DNA from feces of non-domestic adult dromedary camels living in the Tunisian desert. High-throughput functional screening of 13756 clones resulted in 47 hit clones active on a panel of various chromogenic and non-chromogenic glycan substrates. Two of them, harboring multiple activities, were retained for further analysis. Clone 26H3 displayed activity on AZO-CM-cellulose, AZCL Carob galactomannan and Tween 20, while clone 36A23 was active on AZCL carob galactomannan and AZCL barley beta-glucan. The functional annotation of their sequences highlighted original metagenomic loci originating from bacteria of the Bacteroidetes/Chlorobi group, involved in the metabolization of mannosides and beta-glucans thanks to a complete battery of endoand exo-acting glycoside hydrolases, esterases, phosphorylases and transporters.	[Ameri, Rihab; Trabelsi, Sahar; Mezghani, Monia; Elgharbi, Fatma; Bejar, Samir] Univ Sfax, LBMIE, CBS, Sfax, Tunisia; [Laville, Elisabeth; Potocki-Veronese, Gabrielle] Univ Toulouse, CNRS, LISBP, INRA,INSAT, Toulouse, France	Centre de Biotechnologie de Sfax; Universite de Sfax; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Bejar, S (corresponding author), Univ Sfax, LBMIE, CBS, Sfax, Tunisia.	samir.bejar@cbs.rnrt.tn	elgharbi, fatma/T-3409-2019; Veronese, Gabrielle/GTF-3473-2022		Tunisian Ministry of Higher Education and Scientific Research contract program CBS-LMBEE [LR15CBS06_2015-2018]; Region Midi-Pyrenees; European Regional Development Fund; Institut National de la Recherche Agronomique (INRA)	Tunisian Ministry of Higher Education and Scientific Research contract program CBS-LMBEE; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Regional Development Fund(European Commission); Institut National de la Recherche Agronomique (INRA)	Grant from the Tunisian Ministry of Higher Education and Scientific Research contract program CBS-LMBEE/code: LR15CBS06_2015-2018. The high throughput screening work carried out at the Laboratory for BioSystems & Process Engineering (Toulouse, France) with the equipments of the ICEO facility, dedicated to the screening and the discovery of enzymes. ICEO is supported by grants from the Region Midi-Pyrenees, the European Regional Development Fund and the Institut National de la Recherche Agronomique (INRA).	Andre I, 2014, CURR OPIN CHEM BIOL, V19, P17, DOI 10.1016/j.cbpa.2013.11.014; Bastien G, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-78; Beckmann L, 2006, J BASIC MICROB, V46, P175, DOI 10.1002/jobm.200510107; Bhatt VD, 2013, MOL BIOL REP, V40, P3363, DOI 10.1007/s11033-012-2411-4; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005; Donnell MMO, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S12; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Ghanem ME, 2010, J PLANT PHYSIOL, V167, P382, DOI 10.1016/j.jplph.2009.10.012; Gharechahi J, 2015, SYST APPL MICROBIOL, V38, P67, DOI 10.1016/j.syapm.2014.09.004; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jouany JP., 1989, OPT MEDITERR, V2, P89; KAYOULI C, 1993, ANIM FEED SCI TECH, V40, P343, DOI 10.1016/0377-8401(93)90063-P; Krah M, 1998, EUR J BIOCHEM, V257, P101, DOI 10.1046/j.1432-1327.1998.2570101.x; Lahteinen T, 2010, ANAEROBE, V16, P293, DOI 10.1016/j.anaerobe.2009.08.002; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Mathlouthi N, 2002, ANIM RES, V51, P395, DOI 10.1051/animres:2002034; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ming L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173062; MITSUSHIMA K, 1995, APPL ENVIRON MICROB, V61, P2224, DOI 10.1128/AEM.61.6.2224-2229.1995; Patel DD, 2014, GENE, V545, P88, DOI 10.1016/j.gene.2014.05.003; Rai R, 2016, BIORESOURCE TECHNOL, V216, P958, DOI 10.1016/j.biortech.2016.06.040; Rakhimov D. A., 1993, Chemistry of Natural Compounds, V29, P674, DOI 10.1007/BF00630223; Sambrook J aRDW, 2001, FIREFIGHTERS HDB; Samsudin AA, 2012, APPL ENVIRON MICROB, V78, P8836, DOI 10.1128/AEM.02420-12; Samsudin AA, 2011, ENVIRON MICROBIOL, V13, P3024, DOI 10.1111/j.1462-2920.2011.02579.x; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Turnbull KL, 2012, RES VET SCI, V93, P246, DOI 10.1016/j.rvsc.2011.08.013; Ufarte L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00563; Wang SH, 2014, J AGR FOOD CHEM, V62, P8460, DOI 10.1021/jf501328n; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zhang ML, 2014, MICROB ECOL, V68, P416, DOI 10.1007/s00248-014-0388-3	41	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194621	10.1371/journal.pone.0194621	http://dx.doi.org/10.1371/journal.pone.0194621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601586	Green Published, gold, Green Submitted			2022-12-27	WOS:000428845900006
J	Xu, MH; Sun, JY; Wang, Q; Zhang, QW; Wei, CS; Lai, DM				Xu, Minhua; Sun, Junyan; Wang, Qian; Zhang, Qiuwan; Wei, Chunsheng; Lai, Dongmei			Chronic restraint stress induces excessive activation of primordial follicles in mice ovaries	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; BINDING PROTEIN SYSTEM; ANTI-MULLERIAN HORMONE; FOLLICULAR DEVELOPMENT; CLINICAL-IMPLICATIONS; PSYCHOLOGICAL STRESS; MENSTRUAL-CYCLE; GRANULOSA-CELLS; KIT-LIGAND; GROWTH	Chronic stress is an important factor influencing people's health. It usually causes endocrinal disorders and a decline in reproduction in females. Although studies of both human and animals suggest a detrimental effect of stress on reproduction, the influence of chronic stress on the ovarian reservation and follicular development is still not clear. In this study, a chronic restraint stress (CRS) mouse model was used to investigate the effect of stress on ovarian reservation and follicular development and explore the underlying mechanism. In this study, after 8 weeks of CRS, primordial follicles were excessively activated in the ovaries of the CRS group compared with the control group. Further results showed that the activation of primordial follicles induced by CRS was involved in the increasing expression level of Kit ligand and its receptor Kit and the activation of phosphatidylinositol 3-kinase (PI3K)/phosphatase and tensin homolog deleted on chromosome 10 (PTEN)/protein kinase B (Akt) pathway. The corticotropin-releasing hormone (CRH) is a neuropeptide released due to stress, which plays an important role in regulating follicle development. A high level of serum CRH was detected in the CRS mouse model, and the real-time polymerase chain reaction assay showed that the mRNA level of its main receptor CRHR1 increased in the ovaries of the CRS mouse group. Moreover, 100nM CRH significantly improved the activation of primordial follicles in newborn mouse ovaries in vitro. These results demonstrated that CRS could induce immoderate activation of primordial follicles accompanied by the activation of Kit-PI3K signaling, in which CRH might be an important endocrine factor.	[Xu, Minhua; Sun, Junyan; Wang, Qian; Zhang, Qiuwan; Lai, Dongmei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Wei, Chunsheng] Fudan Univ, Eye & ENT Hosp, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University	Lai, DM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China.; Wei, CS (corresponding author), Fudan Univ, Eye & ENT Hosp, Shanghai, Peoples R China.	weics2003@hotmail.com; laidongmei@hotmail.com		Lai, Dongmei/0000-0003-3810-2136	National Natural Science Foundation of China [81370678]; Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant [20152236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant	This research was supported by fund from National Natural Science Foundation of China (No. 81370678) to Dongmei Lai and Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant (No. 20152236) to Dongmei Lai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Azuma K, 2015, INT J MED SCI, V12, P952, DOI 10.7150/ijms.13298; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Daviu N, 2014, STRESS, V17, P176, DOI 10.3109/10253890.2014.880834; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Dinopoulou V, 2013, ENDOCRINOLOGY, V154, P222, DOI 10.1210/en.2012-1838; Dorfman A, 2003, BIOL REPROD, V68, P2038, DOI 10.1095/biolreprod.102.008318; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Feng ZH, 2012, P NATL ACAD SCI USA, V109, P7013, DOI 10.1073/pnas.1203930109; Ghizzoni L, 1997, ENDOCRINOLOGY, V138, P4806, DOI 10.1210/en.138.11.4806; Hackett RA, 2017, NAT REV ENDOCRINOL, V13, P547, DOI 10.1038/nrendo.2017.64; Huang CTF, 2001, BIOL REPROD, V64, P451, DOI 10.1095/biolreprod64.2.451; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Jezova D, 2008, ANN NY ACAD SCI, V1148, P495, DOI 10.1196/annals.1410.050; John GB, 2009, DEV BIOL, V331, P292, DOI 10.1016/j.ydbio.2009.05.546; Kalantaridou SN, 2010, J REPROD IMMUNOL, V85, P33, DOI 10.1016/j.jri.2010.02.005; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Kasahara E, 2015, REDOX REP, V20, DOI 10.1179/1351000214Y.0000000107; Kiapekou E, 2011, FERTIL STERIL, V95, P1497, DOI 10.1016/j.fertnstert.2010.12.023; Kim Jin Yeong, 2012, Clin Exp Reprod Med, V39, P10, DOI 10.5653/cerm.2012.39.1.10; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; Liang B, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110619; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061574; Luisi S, 2015, J ENDOCRINOL INVEST, V38, P597, DOI 10.1007/s40618-014-0231-1; Marin MF, 2011, NEUROBIOL LEARN MEM, V96, P583, DOI 10.1016/j.nlm.2011.02.016; Merkwitz C, 2011, PROG HISTOCHEM CYTO, V46, P131, DOI 10.1016/j.proghi.2011.09.001; Moniruzzaman M, 2007, J REPROD DEVELOP, V53, P1273, DOI 10.1262/jrd.19107; Moniruzzaman M, 2010, REPRODUCTION, V139, P337, DOI 10.1530/REP-09-0207; Parrott JA, 1997, ENDOCRINOLOGY, V138, P3819, DOI 10.1210/en.138.9.3819; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Ren Y, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0151-3; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Roth Z, 2000, J REPROD FERTIL, V120, P83, DOI 10.1530/reprod/120.1.83; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Sumner JA, 2015, CIRCULATION, V132, P251, DOI 10.1161/CIRCULATIONAHA.114.014492; Upton DH, 2016, HORM CANCER-US, V7, P316, DOI 10.1007/s12672-016-0272-3; VANDERHYDEN BC, 1992, BIOL REPROD, V46, P1196, DOI 10.1095/biolreprod46.6.1196; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Wang S, 2013, CELL TISSUE RES, V354, P609, DOI 10.1007/s00441-013-1678-7; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Wood MA, 2013, SEMIN REPROD MED, V31, P399, DOI 10.1055/s-0033-1356476; Wu LM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093468; Wu L, 2016, CELL METAB, V23, P735, DOI 10.1016/j.cmet.2016.01.014; Xu J, 2006, J CLIN ENDOCR METAB, V91, P1544, DOI 10.1210/jc.2005-2776; Xu J, 2007, ENDOCRINOLOGY, V148, P5385, DOI 10.1210/en.2007-0541; Yang SX, 2016, CANCER TREAT REV, V45, P87, DOI 10.1016/j.ctrv.2016.03.004; Ye YH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-26; Yoshida M, 2009, J TOXICOL SCI, V34; Zhang H, 2015, HUM REPROD UPDATE, V21, P779, DOI 10.1093/humupd/dmv037; Zhang H, 2014, CURR BIOL, V24, P2501, DOI 10.1016/j.cub.2014.09.023	57	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194894	10.1371/journal.pone.0194894	http://dx.doi.org/10.1371/journal.pone.0194894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601583	Green Published, gold, Green Submitted			2022-12-27	WOS:000428845900012
J	Lai, YH; Chen, HL; Yang, SN; Chang, SJ; Chuang, LY; Wu, WC				Lai, Yu-Hung; Chen, Hsiu-Lin; Yang, San-Nan; Chang, Shun-Jen; Chuang, Lea-Yea; Wu, Wen-Chuan			The characteristics of premature infants with transient corneal haze	PLOS ONE			English	Article							INTERNATIONAL CLASSIFICATION; SCREENING EXAMINATION; CATARACT-SURGERY; MATERNAL AGE; RISK-FACTORS; RETINOPATHY; CHILDREN; DISEASE; TRANSPARENCY; CRITERIA	Background The etiology of transient corneal haze in premature infants is not known and how it relates to clinical outcomes in premature infants is not clear. Objectives To study associated factors of transient corneal haze in premature infants. Methods We performed a retrospective study of 261 premature infants from retinopathy of prematurity (ROP) screening in the neonatal intensive care unit at a tertiary referral hospital. Characteristics of premature infants with and without corneal haze were analyzed by correlation tests, Chi-square tests, and logistic regressions were used for statistical analyses. Associations between corneal haze and birth weight (BW), gestational age at birth (GA), central corneal thickness, intraocular pressure, and other systemic and ophthalmic data were evaluated. Results The incidence of corneal haze was 13.4%. Lower BW, lower GA, packed red blood cells (RBC) transfusion, more days on oxygen, older maternal age, bronchopulmonary disease, and stage 3 ROP are associated with corneal haze. The severity of corneal haze decreased with infants' postmenstrual age. Multivariate logistic regression analyses revealed that BW and maternal age are the most important predictors of corneal haze. Conclusion Low BW and older maternal age are the most important predictors of corneal haze in premature infants. Premature infants with corneal haze could carry more systemic and ocular morbidities. Hence they may require more clinical attention. Corneal haze is unlikely to hinder the treatment of ROP. However, it is possible that corneal haze could hinder the examination of ROP in some infants. If corneal haze does interfere with ROP screening, a closer, more conservative follow-up schedule with a senior ophthalmologist experienced in managing ROP is recommended.	[Lai, Yu-Hung; Wu, Wen-Chuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Lai, Yu-Hung; Wu, Wen-Chuan] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Kaohsiung, Taiwan; [Lai, Yu-Hung; Chuang, Lea-Yea; Wu, Wen-Chuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Hsiu-Lin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Hsiu-Lin] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Yang, San-Nan] I Shou Univ, E DA Hosp, Dept Pediat, Kaohsiung, Taiwan; [Yang, San-Nan] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Chang, Shun-Jen] Natl Univ Kaohsiung, Coll Humanities & Social Sci, Dept Kinesiol Hlth & Leisure Studies, Kaohsiung, Taiwan; [Chuang, Lea-Yea] Kaohsiung Med Univ, Coll Med, Dept Biochem, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; E-Da Hospital; I Shou University; I Shou University; National University Kaohsiung; Kaohsiung Medical University	Wu, WC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.; Wu, WC (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Kaohsiung, Taiwan.; Wu, WC (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.	wuoph@cc.kmu.edu.tw	Chen, Hsiu-Lin/S-8325-2019; Chen, Hsiu-Lin/B-9238-2012; Chen, Hsiu-Lin/GRY-7492-2022; Lai, Yu-Hung/HGA-2767-2022	Chen, Hsiu-Lin/0000-0002-0565-4631; Chen, Hsiu-Lin/0000-0002-0565-4631; Lai, Yu-Hung/0000-0003-1997-0587				[Anonymous], 1984, Br J Ophthalmol, V68, P690; Armitage P., 2001, STAT METHODS MED RES; Austeng D, 2011, ARCH OPHTHALMOL-CHIC, V129, P167, DOI 10.1001/archophthalmol.2010.346; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chiambaretta F, 2004, MOL VIS, V10, P901; Cook A, 2008, INVEST OPHTH VIS SCI, V49, P5199, DOI 10.1167/iovs.06-0114; Ecsedy M, 2014, J PEDIAT OPHTH STRAB, V51, P235, DOI 10.3928/01913913-20140521-04; Edelhauser HF, 2006, INVEST OPHTH VIS SCI, V47, P1755, DOI 10.1167/iovs.05-1139; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; FRETTS RC, 1995, NEW ENGL J MED, V333, P953, DOI 10.1056/NEJM199510123331501; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Huynh SC, 2006, BRIT J OPHTHALMOL, V90, P597, DOI 10.1136/bjo.2005.083154; Ishikawa A, 2002, J CATARACT REFR SURG, V28, P1982, DOI 10.1016/S0886-3350(02)01502-X; Kirwan C, 2005, ACTA OPHTHALMOL SCAN, V83, P751, DOI 10.1111/j.1600-0420.2005.00559.x; Lai YH, 2013, OPHTHALMOLOGY, V120, P271, DOI 10.1016/j.ophtha.2012.08.009; Lai YH, 2012, KAOHSIUNG J MED SCI, V28, P601, DOI 10.1016/j.kjms.2012.04.026; Lai YH, 2012, BRIT J OPHTHALMOL, V96, P679, DOI 10.1136/bjophthalmol-2011-300632; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; McCormick AQ, 1994, THE EYE IN INFANCY, P67; MCWHAE JA, 1991, OPHTHALMOLOGY, V98, P666; PATZ A, 1987, ARCH OPHTHALMOL-CHIC, V105, P905, DOI 10.1001/archopht.1987.01060070041024; Qazi Y, 2010, BRAIN RES BULL, V81, P198, DOI 10.1016/j.brainresbull.2009.05.019; QUINN GE, 1992, OPHTHALMOLOGY, V99, P329; Reynolds JD, 2002, ARCH OPHTHALMOL-CHIC, V120, P1470, DOI 10.1001/archopht.120.11.1470; Rezende RA, 2005, CORNEA, P311; Sevel D, 1988, Trans Am Ophthalmol Soc, V86, P178; Soler N, 2015, J CATARACT REFR SURG, V41, P313, DOI 10.1016/j.jcrs.2014.04.043; Tornqvist K, 2002, ACTA OPHTHALMOL SCAN, V80, P300, DOI 10.1034/j.1600-0420.2002.800313.x	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195300	10.1371/journal.pone.0195300	http://dx.doi.org/10.1371/journal.pone.0195300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596534	gold, Green Submitted, Green Published			2022-12-27	WOS:000428630000104
J	Wallaert, E; Perez, T; Prevotat, A; Reychler, G; Wallaert, B; Le Rouzic, O				Wallaert, Elliot; Perez, Thierry; Prevotat, Anne; Reychler, Gregory; Wallaert, Benoit; Le Rouzic, Olivier			The immediate effects of a single autogenic drainage session on ventilatory mechanics in adult subjects with cystic fibrosis	PLOS ONE			English	Article							FORCED OSCILLATION TECHNIQUE; AIRWAY CLEARANCE; PHYSIOTHERAPY; VARIABILITY; SPIROMETRY; IMPEDANCE; VALUES; RANGE	Introduction The aim of this study was to gain insight into the physiological changes occurring in subjects with cystic fibrosis (CF) after autogenic drainage (AD). Changes in respiratory system resistance (Rrs), reactance (Xrs), and spirometry were analyzed in adult CF subjects after a single AD physiotherapy session. Methods This prospective observational study was conducted during the annual check-up of adult CF subjects in stable condition. Spirometry and Rrs and Xrs measurements using the forced oscillations technique at 5, 11, and 19 hertz (Hz) were performed before and 30 min after a 20-min AD session. Control CF subjects were tested at baseline and 50 min without AD. Results are expressed as mean +/- standard deviation or median [interquartile range]. Results Thirty subjects were included in the physiotherapy group (age 29 [25-34] years, forced expiratory volume in 1 s (FEV1) 40.3 [30.1-57.9]% predicted) and 11 in the control group (age 31 [28.5-36.5] years, FEV1 43.6 [31.1-51.9]% predicted). No significant changes in any parameter were observed in the control group. AD modestly but significantly increased the forced vital capacity (FVC) and FEV1 (p<0.001). Inspiratory resistance was also significantly improved by AD: Rrs(5) from 5.74 +/- 2.39 to 5.24 +/- 2.17 cmH(2)O/L/s, p<0.05; Rrs(11) from 4.83 +/- 1.98 to 4.32 +/- 1.7 cmH(2)O/L/s, p = 0.003; and Rrs(19) from 4.18 [3.46 +/- 5.07] to 3.86 [2.76-4.98] cmH(2)O/L/s, p<0.001. In contrast, AD had no significant effects on frequency dependence of resistance (Rrs(5)-Rrs(19)) or expiratory resistance. Inspiratory Xrs(5), but not Delta Xrs(5) (expiratory-inspiratory Xrs), was improved by AD (p<0.05). Moderate correlations were detected between the improvement in FEV1 and FVC and inspiratory resistance (r = 0.53, p = 0.005 and r = 0.44, p = 0.02, respectively). Conclusion A single session of AD improved inspiratory airway resistance, except in the distal airways. The forced oscillations technique provides a new tool for understanding the pathophysiological effects of airway clearance physiotherapy in CF.	[Wallaert, Elliot] Catholic Univ Louvain, Fac Sci Motricite, Louvain La Neuve, Belgium; [Perez, Thierry; Prevotat, Anne; Wallaert, Benoit; Le Rouzic, Olivier] CHU Lille, Hop Calmette, Serv Pneumol & Immunoallergol, Ctr Ressource & Competence Mucoviscidose, Lille, France; [Perez, Thierry; Prevotat, Anne; Wallaert, Benoit; Le Rouzic, Olivier] Univ Lille, Lille, France; [Reychler, Gregory] Catholic Univ Louvain, Serv Med Phys & Readaptat, Clin Univ St Luc, Brussels, Belgium; [Reychler, Gregory] Catholic Univ Louvain, Pole Pneumol ORL & Dermatol, IREC, Brussels, Belgium	Universite Catholique Louvain; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Wallaert, B (corresponding author), CHU Lille, Hop Calmette, Serv Pneumol & Immunoallergol, Ctr Ressource & Competence Mucoviscidose, Lille, France.; Wallaert, B (corresponding author), Univ Lille, Lille, France.	benoit.wallaert@chru-lille.fr	Thierry, PEREZ/AAB-4853-2020	Le Rouzic, Olivier/0000-0003-4439-2950				Aarli BB, 2015, EUR RESPIR J, V45, P625, DOI 10.1183/09031936.00051214; [Anonymous], 2012, REV BRAS FISIOTER SA, V16, P108; BAIER H, 1977, Journal of Applied Physiology Respiratory Environmental and Exercise Physiology, V43, P603; Bradley JM, 2006, RESP MED, V100, P191, DOI 10.1016/j.rmed.2005.11.028; Brashier B, 2015, BREATHE, V11, P57, DOI 10.1183/20734735.020514; Cabillic M, 2014, KINESITHERAPIE REV, V14, P43, DOI DOI 10.1016/J.KINE.2014.09.009; Chevallier J., 1984, AUTOGENIC DRAINAGE C, P235; Dab I, 1979, Monogr Paediatr, V10, P50; Dellaca RL, 2004, EUR RESPIR J, V23, P232, DOI 10.1183/09031936.04.00046804; Downie SR, 2013, J APPL PHYSIOL, V114, P770, DOI 10.1152/japplphysiol.01198.2012; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Figueiredo PHS, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.507; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Guimaraes FS, 2012, BRAZ J PHYS THER, V16, P108, DOI 10.1590/S1413-35552012005000016; Guimaraes FS, 2014, J PHYS THER SCI, V26, P813, DOI 10.1589/jpts.26.813; HIGENBOTTAM T, 1982, AM REV RESPIR DIS, V125, P746; Hortal MCR, 2014, RESP CARE, V59, P1537, DOI 10.4187/respcare.02823; Jones PW, 2014, AM J RESP CRIT CARE, V189, P250, DOI 10.1164/rccm.201310-1863PP; Kaczka David W., 2011, Critical Reviews in Biomedical Engineering, V39, P337, DOI 10.1615/CritRevBiomedEng.v39.i4.60; Komarow HD, 2011, ANN ALLERG ASTHMA IM, V106, P191, DOI 10.1016/j.anai.2010.11.011; Lima AN, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0007-7; Main E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002011.pub2; McCormack P, 2017, COCHRANE DB SYST REV, V10; McIlwaine M, 2010, PEDIATR PULM, V45, P1064, DOI 10.1002/ppul.21247; Mcllwaine MP, 2014, CURR OPIN PULM MED, V20, P613, DOI 10.1097/MCP.0000000000000110; MORTENSEN J, 1993, CHEST, V103, P805, DOI 10.1378/chest.103.3.805; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Oostveen E, 2013, EUR RESPIR J, V42, P1513, DOI 10.1183/09031936.00126212; Pfleger A, 2015, J CYST FIBROS, V14, P627, DOI 10.1016/j.jcf.2014.12.017; Pryor JA, 1999, EUR RESPIR J, V14, P1418, DOI 10.1183/09031936.99.14614189; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Reychler G, 2014, REV MAL RESPIR, V31, P691, DOI 10.1016/j.rmr.2014.07.008; Saadeh C, 2014, PULM MED, V2014, DOI 10.1155/2014/376890; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Sokol G, 2015, RESP CARE, V60, P1819, DOI 10.4187/respcare.04008; Timmins SC, 2013, RESP PHYSIOL NEUROBI, V185, P416, DOI 10.1016/j.resp.2012.08.017	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195154	10.1371/journal.pone.0195154	http://dx.doi.org/10.1371/journal.pone.0195154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596479	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000086
J	Zhang, JF; Xu, YQ; Dong, JM; Peng, LN; Feng, X; Wang, X; Li, F; Miao, Y; Yao, SK; Zhao, QQ; Feng, SS; Hu, BZ; Li, FL				Zhang, Jun-Feng; Xu, Yong-Qing; Dong, Jia-Min; Peng, Li-Na; Feng, Xu; Wang, Xu; Li, Fei; Miao, Yu; Yao, Shu-Kuan; Zhao, Qiao-Qin; Feng, Shan-Shan; Hu, Bao-Zhong; Li, Feng-Lan			Genome-wide identification of wheat (Triticum aestivum) expansins and expansin expression analysis in cold-tolerant and cold-sensitive wheat cultivars	PLOS ONE			English	Article							BETA-EXPANSIN; MOLECULAR-CLONING; PLANT EXPANSINS; ALPHA-EXPANSIN; GENE; OVEREXPRESSION; GROWTH; SUPERFAMILY; ELONGATION; PROTEINS	Plant expansins are proteins involved in cell wall loosening, plant growth, and development, as well as in response to plant diseases and other stresses. In this study, we identified 128 expansin coding sequences from the wheat (Triticum aestivum) genome. These sequences belong to 45 homoeologous copies of TaEXPs, including 26 TaEXPAs, 15 TaEXPBs and four TaEXLAs. No TaEXLB was identified. Gene expression and sub-expression profiles revealed that most of the TaEXPs were expressed either only in root tissues or in multiple organs. Real-time qPCR analysis showed that many TaEXPs were differentially expressed in four different tissues of the two wheat cultivars-the cold-sensitive 'Chinese Spring (CS)' and the cold-tolerant 'Dongnongdongmai 1 (D1)' cultivars. Our results suggest that the differential expression of TaEXPs could be related to low-temperature tolerance or sensitivity of different wheat cultivars. Our study expands our knowledge on wheat expansins and sheds new light on the functions of expansins in plant development and stress response.	[Zhang, Jun-Feng; Xu, Yong-Qing; Dong, Jia-Min; Peng, Li-Na; Feng, Xu; Wang, Xu; Li, Fei; Miao, Yu; Yao, Shu-Kuan; Zhao, Qiao-Qin; Feng, Shan-Shan; Li, Feng-Lan] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Hu, Bao-Zhong] Harbin Univ, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Harbin University	Li, FL (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China.; Hu, BZ (corresponding author), Harbin Univ, Harbin, Heilongjiang, Peoples R China.	bzhu@neau.edu.cn; lifenglan@neau.edu.cn	Feng, Xu/AAQ-6397-2021					Bae JM, 2014, TRANSGENIC RES, V23, P657, DOI 10.1007/s11248-014-9804-1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Breen J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-99; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Carey RE, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-4; Cheuk A, 2016, MOL GENET GENOMICS, V291, P873, DOI 10.1007/s00438-015-1152-1; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dal Santo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062206; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Ding AM, 2016, MOL GENET GENOMICS, V291, P1891, DOI 10.1007/s00438-016-1226-8; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Fredslund J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-369; Gao Q, 2008, PROTOPLASMA, V233, P73, DOI 10.1007/s00709-008-0303-1; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063667; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Igarashi M, 2014, BIOCHEM BIOPH RES CO, V443, P852, DOI 10.1016/j.bbrc.2013.12.059; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kuluev B R, 2014, Genetika, V50, P560; Kuluev B R, 2012, Genetika, V48, P1162; Kwasniewski M, 2006, PLANT PHYSIOL, V141, P1149, DOI 10.1104/pp.106.078626; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HW, 2013, PLANT CELL PHYSIOL, V54, P1600, DOI 10.1093/pcp/pct105; Lee HW, 2013, PLANT J, V73, P212, DOI 10.1111/tpj.12013; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; Lin Z, 2005, MOL GENET GENOMICS, V274, P548, DOI 10.1007/s00438-005-0029-0; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu Y, 2007, GENOMICS, V90, P516, DOI 10.1016/j.ygeno.2007.06.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PT, 2013, PLANTA, V237, P1547, DOI 10.1007/s00425-013-1867-3; Lu YG, 2016, MOL GENET GENOMICS, V291, P597, DOI 10.1007/s00438-015-1133-4; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; O'Neill MA., 2003, ANN PLANT REV, P1; Pacheco-Villalobos D, 2016, PLANT CELL, V28, P1009, DOI 10.1105/tpc.15.01057; Pingault L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0601-9; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Rose JKC, 1997, P NATL ACAD SCI USA, V94, P5955, DOI 10.1073/pnas.94.11.5955; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sampedro J, 2015, PLANT J, V81, P108, DOI 10.1111/tpj.12715; Schreiber AW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-492; Sharma R, 2012, ALCOHOL CLIN EXP RES, V36, p183A; Shitsukawa N, 2007, GENES GENET SYST, V82, P167, DOI 10.1266/ggs.82.167; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tello-Ruiz MK, 2016, METHODS MOL BIOL, V1374, P141, DOI 10.1007/978-1-4939-3167-5_7; Wang GF, 2011, PLANT BIOTECHNOL J, V9, P486, DOI 10.1111/j.1467-7652.2010.00569.x; Yan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085208; Yu Jing, 2009, Yingyong Shengtai Xuebao, V20, P1092; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zhang WL, 2014, MOL GENET GENOMICS, V289, P373, DOI 10.1007/s00438-014-0814-8; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhou J, 2014, PHYSIOL PLANTARUM, V150, P194, DOI 10.1111/ppl.12077; Zhu Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-93	63	17	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195138	10.1371/journal.pone.0195138	http://dx.doi.org/10.1371/journal.pone.0195138			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596529	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000084
J	Barsov, EV; Trivett, MT; Minang, JT; Sun, HS; Ohlen, C; Ott, DE				Barsov, Eugene V.; Trivett, Matthew T.; Minang, Jacob T.; Sun, Haosi; Ohlen, Claes; Ott, David E.			Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication (vol 6, e23703, 2011)	PLOS ONE			English	Correction																		Barsov EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023703	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195246	10.1371/journal.pone.0195246	http://dx.doi.org/10.1371/journal.pone.0195246			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590210	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100107
J	Palaniappan, M; Edwards, D; Creighton, CJ; Medina, D; Conneely, OM				Palaniappan, Murugesan; Edwards, David; Creighton, Chad J.; Medina, Daniel; Conneely, Orla M.			Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; SURGICAL ADJUVANT BREAST; RECEPTOR-B ISOFORM; BOWEL PROJECT P-1; MOLECULAR PORTRAITS; CANCER PREVENTION; GLAND DEVELOPMENT; GENE-EXPRESSION; MICE LACKING; ER-ALPHA	The tumor suppressor gene p53 is frequently mutated in human breast cancer and is a marker for poor prognosis and resistance to chemotherapy. Transplantation of p53 null mouse mammary epithelium into syngeneic wild-type mice leads to normal mammary gland development followed by spontaneous mammary tumors that recapitulate many of the phenotypic, molecular and genetic features of human breast cancer. Transient exposure of p53 null mice to the anti-estrogen, tamoxifen leads to sustained and robust protection against tumor development. However the mechanism underlying this anti-tumor activity remains poorly understood. Here we demonstrate that transient exposure to tamoxifen leads to a reduction in mammary ductal side-branching and epithelial cell proliferation after tamoxifen withdrawal. Global gene expression analysis showed that transient tamoxifen exposure leads to persistent changes in the expression of a subset of estrogen regulated gene signatures in mammary epithelial cells (MECs). Among these was the protein tyrosine phosphatase, non-receptor type 5 (Ptpn5). We show that Ptpn5 is a novel tamoxifen regulated target gene which is upregulated in MECs after transient tamoxifen exposure and displays tumor suppressor activity in human breast cancer cells. Further, PTPNS expression is strongly associated with good clinical outcome in tamoxifen treated human breast cancer patients suggesting that PTPNS may represent a novel biomarker of tamoxifen response in human breast cancer.	[Palaniappan, Murugesan; Edwards, David; Medina, Daniel; Conneely, Orla M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Palaniappan, Murugesan] Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Conneely, OM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	orlac@bcm.edu		PALANIAPPAN, MURUGESAN/0000-0003-4916-6565	CPRIT [RP110471-P3]	CPRIT	This work was supported by funding from CPRIT grant RP110471-P3 to OMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaz CM, 2002, ONCOGENE, V21, P6366, DOI 10.1038/sj.onc.1205816; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bertheau P, 2013, BREAST, V22, pS27, DOI 10.1016/j.breast.2013.07.005; Brisken C, 2015, WIRES DEV BIOL, V4, P181, DOI 10.1002/wdev.172; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Cuzick J, 2014, LANCET, V383, P1041, DOI 10.1016/S0140-6736(13)62292-8; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dupont S, 2000, DEVELOPMENT, V127, P4277; Finlay-Schultz J, 2015, J MAMMARY GLAND BIOL, V20, P39, DOI 10.1007/s10911-015-9340-5; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fox JL, 2010, EMBO J, V29, P3853, DOI 10.1038/emboj.2010.244; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Goepfert TM, 2000, FASEB J, V14, P2221, DOI 10.1096/fj.00-0165com; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jansen MPHM, 2013, CANCER RES, V73, P6632, DOI 10.1158/0008-5472.CAN-13-0704; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jerry DJ, 1998, ONCOGENE, V17, P2305, DOI 10.1038/sj.onc.1202157; Jordan VC, 2015, BRIT J CLIN PHARMACO, V79, P254, DOI 10.1111/bcp.12440; Jordan VC, 2014, ENDOCR-RELAT CANCER, V21, pR235, DOI 10.1530/ERC-14-0092; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lain AR, 2013, MOL ENDOCRINOL, V27, P1743, DOI 10.1210/me.2013-1144; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Magnani L, 2013, P NATL ACAD SCI USA, V110, pE1490, DOI 10.1073/pnas.1219992110; Medina D, 2005, CANCER RES, V65, P3493, DOI 10.1158/0008.5472.CAN-04-3869; Medina D, 2003, CANCER RES, V63, P1067; Medina D, 2002, FASEB J, V16, P881, DOI 10.1096/fj.01-0885fje; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Namba R, 2004, MOL CANCER RES, V2, P453; Nunes-Xavier CE, 2013, BBA-REV CANCER, V1836, P211, DOI 10.1016/j.bbcan.2013.06.001; Palaniappan M, 2012, MOL ENDOCRINOL, V26, P1732, DOI 10.1210/me.2012-1106; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfefferle AD, 2016, DIS MODEL MECH, V9, P749, DOI 10.1242/dmm.025239; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Thewes V, 2015, CANCER RES, V75, P720, DOI 10.1158/0008-5472.CAN-14-0652; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074	59	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194913	10.1371/journal.pone.0194913	http://dx.doi.org/10.1371/journal.pone.0194913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590203	gold, Green Published, Green Submitted			2022-12-27	WOS:000428603100088
J	O'Geen, H; Ren, CH; Coggins, NB; Bates, SL; Segal, DJ				O'Geen, Henriette; Ren, Chonghua; Coggins, Nicole B.; Bates, Sofie L.; Segal, David J.			Unexpected binding behaviors of bacterial Argonautes in human cells cast doubts on their use as targetable gene regulators	PLOS ONE			English	Article							GUIDE RNA; CRISPR-CAS9; SYSTEM	Prokaryotic Argonaute proteins (pAgos) have been proposed as an alternative to the CRISPR/Cas9 platform for gene editing. Although Argonaute from Natronobacterium gregoryi (NgAgo) was recently shown unable to cleave genomic DNA in mammalian cells, the utility of NgAgo or other pAgos as a targetable DNA-binding platform for epigenetic editing has not been explored. In this report, we evaluated the utility of two prokaryotic Argonautes (NgAgo and TtAgo) as DNA-guided DNA-binding proteins. NgAgo showed no meaningful binding to chromosomal targets, while TtAgo displayed seemingly non-specific binding to chromosomal DNA even in the absence of guide DNA. The observed lack of DNA-guided targeting and unexpected guide-independent genome sampling under the conditions in this study provide evidence that these pAgos might be suitable for neither gene nor epigenome editing in mammalian cells.	[O'Geen, Henriette; Ren, Chonghua; Coggins, Nicole B.; Bates, Sofie L.; Segal, David J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Segal, David J.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Ren, Chonghua] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; Northwest A&F University - China	Segal, DJ (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Segal, DJ (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	djsegal@ucdavis.edu	Ren, Chonghua/E-3870-2018	Ren, Chonghua/0000-0001-8221-0957; Halmai, Nicole/0000-0002-0790-6548	University of California, Davis, Academic Senate Faculty Research Grant; China State-Sponsored Postgraduates Study Abroad Program - Chinese Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	University of California, Davis, Academic Senate Faculty Research Grant; China State-Sponsored Postgraduates Study Abroad Program - Chinese Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a University of California, Davis, Academic Senate Faculty Research Grant. C.R. was supported by the China State-Sponsored Postgraduates Study Abroad Program provided by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a University of California, Davis, Academic Senate Faculty Research Grant. C.R. was supported by the China State-Sponsored Postgraduates Study Abroad Program provided by the Chinese Scholarship Council.	[Anonymous], 2017, NAT BIOTECHNOL, V35, P689, DOI 10.1038/nbt.3938; Braff JL, 2016, COLD SPRING HARBOR P; Brocken DJW, 2017, CRISPR/CAS SYSTEM: EMERGING TECHNOLOGY AND APPLICATION, P15, DOI 10.21775/9781910190630.02; Burgess S, 2016, PROTEIN CELL, V7, P913, DOI 10.1007/s13238-016-0343-9; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gao L, 2017, NATURE BIOTECHNOLOGY; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hegge JW, 2017, NATURE REV MICROBIOL; Javidi-Parsijani P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177444; Kaya E, 2016, P NATL ACAD SCI USA, V113, P4057, DOI 10.1073/pnas.1524385113; Khin NC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178768; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; O'Geen H, 2017, NUCLEIC ACIDS RES, V45, P9901, DOI 10.1093/nar/gkx578; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Qi JL, 2016, CELL RES, V26, P1349, DOI 10.1038/cr.2016.134; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Swarts DC, 2017, MOL CELL, V65, P985, DOI 10.1016/j.molcel.2017.01.033; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124880; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tak YE, 2017, NATURE METHODS; Vogel J, 2014, SCIENCE, V344, P972, DOI 10.1126/science.1252962; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu ZC, 2017, ANTIVIR RES, V145, P20, DOI 10.1016/j.antiviral.2017.07.005; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Ye S, 2017, BIORXIV	33	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193818	10.1371/journal.pone.0193818	http://dx.doi.org/10.1371/journal.pone.0193818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584750	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000010
J	Chang, LC; Huang, CF; Lai, MS; Shen, LJ; Wu, FLL; Cheng, WF				Chang, Lin-Chau; Huang, Chih-Fen; Lai, Mei-Shu; Shen, Li-Jiuan; Wu, Fe-Lin Lin; Cheng, Wen-Fang			Prognostic factors in epithelial ovarian cancer: A population-based study	PLOS ONE			English	Article							CLEAR-CELL; SURVIVAL; CHEMOTHERAPY; PATHOGENESIS; CARCINOMAS; PREVENTION; HISTOLOGY; CENTERS; TRENDS; WOMEN	The overall survival (OS) of patients with ovarian cancer is poor while epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer. The aim of the present study was to evaluate the clinico-pathologic characteristics, especially the prognostic factors, for patients with epithelial ovarian cancer (EOC) in Taiwan. Information about newly diagnosed patients with EOC from 2009 to 2012 was retrieved from the database of the Taiwan Cancer Registry. Data from 2009 to 2013 for the respective cases from the claims database of Taiwan's National Health Insurance and National Death Registry were then retrieved. Potential prognostic factors were analyzed. The mean age at diagnosis of the 2,498 patients was 52.8 years. Serous carcinoma and clear cell carcinoma were diagnosed in 43.3% and 22.8% of the total patients, respectively. For patients with early-stage disease, taxane-based adjuvant chemotherapy, stage I, and younger age at diagnosis led to better overall survival (p = 0.030, p = 0.002, p<0.001, respectively) in multivariable analysis. For advanced-stage patients, histology (endometrioid type), taxane-based adjuvant chemotherapy, stage, and age at diagnosis had a significant impact on OS (p<0.001, p = 0.020, p<0.001, p<0.001, respectively). In conclusion, taxane-based chemotherapy impacts the outcome of patients with EOC. Personalized medicine may be needed for different histological types of EOC because of their different outcomes.	[Chang, Lin-Chau; Huang, Chih-Fen; Shen, Li-Jiuan; Wu, Fe-Lin Lin] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Huang, Chih-Fen; Shen, Li-Jiuan] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Shen, Li-Jiuan; Wu, Fe-Lin Lin] Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan.; Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan.; Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	wenfangcheng@yahoo.com		Chang, Lin-Chau/0000-0001-7441-9355	Ministry of Health and Welfare [A1021017]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	Prof. Mei-Shu Lai received grant number A1021017 from Ministry of Health and Welfare. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer (AJCC), 2010, AJCC 7 ED CANC STAG; Anuradha S, 2016, ACTA ONCOL, V55, P226, DOI 10.3109/0284186X.2015.1054950; Bristow RE, 2015, J AM COLL SURGEONS, V220, P940, DOI 10.1016/j.jamcollsurg.2015.01.056; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Chiang YC, 2013, J GYNECOL ONCOL, V24, P342, DOI 10.3802/jgo.2013.24.4.342; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gonzalez-Martin A, 2014, DRUGS, V74, P879, DOI 10.1007/s40265-014-0221-9; Health Promotion Administration, 2017, CANC REG ANN REP 201; Jordan S, 2013, GYNECOL ONCOL, V129, P310, DOI 10.1016/j.ygyno.2013.02.007; Kajiyama H, 2014, J GYNECOL ONCOL, V25, P43, DOI 10.3802/jgo.2014.25.1.43; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Kurosaki A, 2016, INT J CANCER, V138, P1994, DOI 10.1002/ijc.29937; Lai MS, 2012, J FORMOS MED ASSOC, V111, P587, DOI 10.1016/j.jfma.2012.08.016; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; National Health Insurance Administration Ministry of Health and Welfare Taiwan, 2016, PROGR OV; Nezhat FR, 2015, AM J OBSTET GYNECOL, V213, P262, DOI 10.1016/j.ajog.2015.03.044; O'Malley CD, 2012, J WOMENS HEALTH, V21, P887, DOI 10.1089/jwh.2012.3781; Polterauer S, 2012, INT J GYNECOL CANCER, V22, P380, DOI 10.1097/IGC.0b013e31823de6ae; Rooth Carolyn, 2013, Br J Nurs, V22, pS23; Schnack TH, 2016, INT J GYNECOL CANCER, V26, P82, DOI 10.1097/IGC.0000000000000585; Taiwan Cancer Registry, 2008, INTRODUCTION; Timmers PJ, 2009, INT J GYNECOL CANCER, V19, P88, DOI 10.1111/IGC.0b013e3181991546; Wei W, 2017, ONCOTARGET, V8, P23862, DOI 10.18632/oncotarget.13317; World Health Organization, 2000, CLASS INT CLASS DIS; Wright JD, 2015, OBSTET GYNECOL, V125, P1345, DOI 10.1097/AOG.0000000000000854; Ye S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133498	28	46	46	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194993	10.1371/journal.pone.0194993	http://dx.doi.org/10.1371/journal.pone.0194993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579127	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800074
J	Wang, W; Duclot, F; Groveman, BR; Carrier, N; Qiao, HF; Fang, XQ; Wang, H; Xin, WK; Jiang, XH; Salter, MW; Ding, XS; Kabbaj, M; Yu, XM				Wang, Wei; Duclot, Florian; Groveman, Bradley R.; Carrier, Nicole; Qiao, Haifa; Fang, Xiao-Qian; Wang, Hui; Xin, Wenkuan; Jiang, Xing-Hong; Salter, Michael W.; Ding, Xin-Sheng; Kabbaj, Mohamed; Yu, Xian-Min			Hippocampal protein kinase D1 is necessary for DHPG-induced learning and memory impairments in rats	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM POTENTIATION; SPONTANEOUS OBJECT RECOGNITION; NMDA RECEPTORS; SYNAPTIC PLASTICITY; IN-VIVO; ASSOCIATIVE RECOGNITION; SELECTIVE IMPAIRMENT; NOVELTY ACQUISITION; CELL-SURFACE	Background Understanding molecular mechanisms underlying the induction of learning and memory impairments remains a challenge. Recent investigations have shown that the activation of group I mGluRs (mGluR1 and mGluR5) in cultured hippocampal neurons by application of (S)-3,5-Dihydroxyphenylglycine (DHPG) causes the regulated internalization of N-methylD-aspartate receptors (NMDARs), which subsequently activates protein kinase D1 (PKD1). Through phosphorylating the C-terminals of the NMDAR GluN2 subunits, PKD1 down-regulates the activity of remaining (non-internalized) surface NMDARs. The knockdown of PKD1 does not affect the DHPG-induced inhibition of AMPA receptor-mediated miniature excitatory post-synaptic currents (mEPSCs) but prevents the DHPG-induced inhibition of NMDAR-mediated mEPSCs in vitro. Thus, we investigated the in vivo effects of bilateral infusions of DHPG into the hippocampal CA1 area of rats in the Morris water maze (MWM) and the novel object discrimination (NOD) tests. Methods A total of 300 adult male Sprague Dawley rats (250-280 g) were used for behavioral tests. One hundred ninety four were used in MWM test and the other 106 rats in the NOD test. Following one week of habituation to the vivarium, rats were bilaterally implanted under deep anesthesia with cannulas aimed at the CA1 area of the hippocampus (CA1 coordinates in mm from Bregma: AP-3.14; lateral +/-2; DV-3.0). Through implanted cannulas artificial cerebrospinal fluid (ACSF), the groupl mGluR antagonist 6-Methyl-2-(phenylethynyl)pyridine (MPEP), the dynamin-dependent internalization inhibitor Dynasore, or the PKD1 inhibitor CID755673 were infused into the bilateral hippocampal CA1 areas (2 mu L per side, over 5 min). The effects of these infusions and the effects of PKD1 knockdown were examined in MWM or NOD test. Results DHPG infusion increased the latency to reach the platform in the MWM test and reduced the preference for the novel object in the NOD task. We found that the DHPG effects were dose-dependent and could be maintained for up to 2 days. Notably, these effects could be prevented by pre-infusion of the group1 mGluR antagonist MPEP, the dynamin-dependent internalization inhibitor Dynasore, the PKD1 inhibitor CID755673, or by PKD1 knockdown in the hippocampal CA1 area. Conclusion Altogether, these findings provide direct evidence that PKD1-mediated signaling may play a critical role in the induction of learning and memory impairments by DHPG infusion into the hippocampal CA1 area.	[Wang, Wei; Ding, Xin-Sheng] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Wang, Wei; Ding, Xin-Sheng; Yu, Xian-Min] Nanjing Med Univ, BenQ Affiliated Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Wei; Ding, Xin-Sheng; Yu, Xian-Min] Nanjing Med Univ, Neurol Inst, Nanjing, Jiangsu, Peoples R China; [Duclot, Florian; Groveman, Bradley R.; Carrier, Nicole; Qiao, Haifa; Fang, Xiao-Qian; Wang, Hui; Kabbaj, Mohamed; Yu, Xian-Min] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Fang, Xiao-Qian] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Edinburg, TX USA; [Xin, Wenkuan] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China; [Jiang, Xing-Hong; Yu, Xian-Min] Soochow Univ, Med Coll, Dept Physiol & Neurobiol, Suzhou, Peoples R China; [Salter, Michael W.] Univ Toronto, Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; State University System of Florida; Florida State University; University of Texas System; University of Texas Rio Grande Valley; Southwest University - China; Soochow University - China; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ding, XS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China.; Ding, XS; Yu, XM (corresponding author), Nanjing Med Univ, BenQ Affiliated Hosp, Nanjing, Jiangsu, Peoples R China.; Ding, XS; Yu, XM (corresponding author), Nanjing Med Univ, Neurol Inst, Nanjing, Jiangsu, Peoples R China.; Kabbaj, M; Yu, XM (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.; Yu, XM (corresponding author), Soochow Univ, Med Coll, Dept Physiol & Neurobiol, Suzhou, Peoples R China.	ding-xs@139.com; mohamed.kabbaj@med.fsu.edu; yuxianminyu1981@hotmail.com	Duclot, Florian/E-4669-2013	Duclot, Florian/0000-0003-0121-5807	NIH [R01 NS053567]; National Natural Science Foundation of China: NSFC [30971022, 31271258, 81771187]; CIHR [MT-12682]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China: NSFC(National Natural Science Foundation of China (NSFC)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by the NIH: R01 NS053567 to XMY, and National Natural Science Foundation of China: NSFC #30971022 to XD, NSFC #31271258 and #81771187 to XHJ. MWS is supported in part by CIHR grant MT-12682 and holds a Canada Research Chair (Tier I) in Neuroplasticity and Pain, and is the Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1992, J BIOL CHEM, V267, P13361; Ainge JA, 2006, BEHAV BRAIN RES, V167, P183, DOI 10.1016/j.bbr.2005.09.005; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Barker GRI, 2015, CEREB CORTEX, V25, P472, DOI 10.1093/cercor/bht245; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Baskys A, 2005, ANN NY ACAD SCI, V1053, P55, DOI 10.1196/annals.1344.006; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; Blaser R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00183; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carrasquero LMG, 2010, GLIA, V58, P984, DOI 10.1002/glia.20980; Day M, 2001, SCIENCE, V293, pU1; De Leonibus E, 2009, NEUROPSYCHOPHARMACOL, V34, P729, DOI 10.1038/npp.2008.129; Di Sebastiano AR, 2016, J BIOL CHEM, V291, P17602, DOI 10.1074/jbc.M116.722355; Duclot F, 2013, J NEUROSCI, V33, P11048, DOI 10.1523/JNEUROSCI.0199-13.2013; Eales KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5701; Eichenbaum H, 2017, NEURON, V95, P1007, DOI 10.1016/j.neuron.2017.06.036; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fang XQ, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0167-1; Fitzjohn S, 2016, CURR NEUROPHARMACOL, V14, P435, DOI 10.2174/1570159X13666150615221502; Gabel LA, 2004, J NEUROSCI, V24, P10579, DOI 10.1523/JNEUROSCI.2185-04.2004; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; George Kara M, 2011, Pharmaceutics, V3, P186, DOI 10.3390/pharmaceutics3020186; Goeldner C, 2008, J NEUROSCI, V28, P2190, DOI 10.1523/JNEUROSCI.3711-07.2008; Goh JJ, 2013, HIPPOCAMPUS, V23, P129, DOI 10.1002/hipo.22072; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hamilton A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-40; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Iwamura E, 2016, BEHAV BRAIN RES, V307, P92, DOI 10.1016/j.bbr.2016.03.048; Jin DZ, 2015, BRAIN RES, V1624, P414, DOI 10.1016/j.brainres.2015.07.053; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Krueger DD, 2010, J MOL NEUROSCI, V42, P1, DOI 10.1007/s12031-010-9338-9; Kumar A, 2014, HIPPOCAMPUS, V24, P466, DOI 10.1002/hipo.22240; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mahato PK, 2015, NEUROSCIENCE, V306, P138, DOI 10.1016/j.neuroscience.2015.08.031; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mello-Carpes PB, 2013, NEUROBIOL LEARN MEM, V100, P56, DOI 10.1016/j.nlm.2012.12.002; Menard C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00182; Micheli F, 2000, Curr Opin Investig Drugs, V1, P355; Moldrich RX, 2003, EUR J PHARMACOL, V476, P3, DOI 10.1016/S0014-2999(03)02149-6; Montgomery JM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-48; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Morris RGM, 2013, NEUROPHARMACOLOGY, V74, P32, DOI 10.1016/j.neuropharm.2013.04.014; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Ocampo AC, 2017, LEARN MEMORY, V24, P563, DOI 10.1101/lm.045781.117; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Pandey S, 2014, J NEUROCHEM, V131, P602, DOI 10.1111/jnc.12930; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sanderson TM, 2016, J NEUROCHEM, V139, P200, DOI 10.1111/jnc.13592; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stemmelin J, 2008, NEUROPSYCHOPHARMACOL, V33, P574, DOI 10.1038/sj.npp.1301424; Sugita M, 2015, BRAIN RES, V1624, P370, DOI 10.1016/j.brainres.2015.08.001; Taylor AM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0149; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Venardos K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120934; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Warburton EC, 2013, NEUROPHARMACOLOGY, V74, P41, DOI 10.1016/j.neuropharm.2013.04.013; Wisniewski K, 2002, CNS DRUG REV, V8, P101; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yu XM, 2016, NEUROTRANSMITTER, V3, pe1192; Zalewska-Winska A, 2000, PHARMACOL RES, V42, P239, DOI 10.1006/phrs.2000.0683; Zhang SJ, 2014, HIPPOCAMPUS, V24, P1330, DOI 10.1002/hipo.22314	95	4	3	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195095	10.1371/journal.pone.0195095	http://dx.doi.org/10.1371/journal.pone.0195095			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614089	Green Submitted, gold, Green Published			2022-12-27	WOS:000429081600030
J	Aghamohammadi, A; Ang, MC; Sundararajan, EA; Ng, KW; Mogharrebi, M; Banihashem, SY				Aghamohammadi, Amirhossein; Ang, Mei Choo; Sundararajan, Elankovan A.; Ng, Kok Weng; Mogharrebi, Marzieh; Banihashem, Seyed Yashar			A parallel spatiotemporal saliency and discriminative online learning method for visual target tracking in aerial videos (vol 13, e0192246, 2018)	PLOS ONE			English	Correction													Ang, Mei Choo/G-5520-2010; Ng, Kok Weng/AAF-1676-2019; Ng, Kok Weng/C-5757-2009	Ang, Mei Choo/0000-0001-5316-3936; Ng, Kok Weng/0000-0001-6910-0040				Aghamohammadi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192246	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195418	10.1371/journal.pone.0195418	http://dx.doi.org/10.1371/journal.pone.0195418			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596537	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000110
J	Ballespi, S; Perez-Domingo, A; Vives, J; Sharp, C; Barrantes-Vidal, N				Ballespi, Sergi; Perez-Domingo, Ariadna; Vives, Jaume; Sharp, Carla; Barrantes-Vidal, Neus			Childhood behavioral inhibition is associated with impaired mentalizing in adolescence	PLOS ONE			English	Article							SOCIAL-ANXIETY-DISORDER; BORDERLINE PERSONALITY-DISORDER; PSYCHOMETRIC PROPERTIES; MIND; COGNITION; ATTACHMENT; DEPRESSION; SELF; TEMPERAMENT; PHOBIA	Recent advances suggest that impairment in social cognition (SC) may play a role in the development of social anxiety (SA). However, very few studies have analyzed whether SA fosters poorer social-cognitive development as it leads to social avoidance. This study aimed to analyze whether retrospectively assessed behavioral inhibition (BI) (i.e., an early form of SA) in childhood is associated with a deficit in social cognition operationalized as impairment of mentalizing (MZ) in adolescence. A sample of 256 adolescents (range: 12-18 years; mean age: 14.7 years; SD = 1.7) from general population were assessed for MZ capacities and retrospective BI through self-report and interview measures. Results comparing three groups of adolescents with different levels of childhood BI (low, moderate or high) and controlling for concurrent SA and depression reveal that the higher the level of BI, the lower the level of MZ. These results were consistent for almost all mentalization measures, including when both extreme (i.e., high vs. low BI) and non-extreme (i.e., high vs. moderate BI) were compared in both self-report and interview measures and in both dimensions of MZ (i.e., MZ referred to others' and to own mental states). These findings support that childhood forms of SA are associated to deficit in SC in adolescence. A possible bidirectional relationship between SA and SC, and the role that it may play in the pathway to clinical SA are discussed.	[Ballespi, Sergi; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Barcelona, Catalunya, Spain; [Perez-Domingo, Ariadna; Barrantes-Vidal, Neus] Fdn Sanitaria St Pere Claver, Dept Mental Hlth, Barcelona, Catalunya, Spain; [Perez-Domingo, Ariadna] Fdn Sanitaria St Pere Claver, Inst Docent, Barcelona, Catalunya, Spain; [Vives, Jaume] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, Barcelona, Catalunya, Spain; [Sharp, Carla] Univ Houston, Dev Psychopathol Lab, Houston, TX USA; [Barrantes-Vidal, Neus] Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Houston System; University of Houston; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Vives, J (corresponding author), Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, Barcelona, Catalunya, Spain.	Jaume.Vives@uab.cat	Barrantes-Vidal, Neus/A-9578-2013; Vives, Jaume/B-5651-2008	Barrantes-Vidal, Neus/0000-0002-8671-1238; Vives, Jaume/0000-0001-5412-7275				Allen J.G., 2008, MENTALIZING CLIN PRA; Bak PL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00753; Balestrieri M, 2015, EAT WEIGHT DISORD-ST, V20, P525, DOI 10.1007/s40519-015-0204-1; Ballespi S, 2015, EUR CHILD ADOLES PSY, V24, pS225; Ballespi S, 2015, EUR CHILD ADOLES PSY, V24, pS218; Ballespi S, 2015, EUR CHILD ADOLES PSY, V24, pS213; Banerjee R, 2001, SOC DEV, V10, P558, DOI 10.1111/1467-9507.00180; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; BARON-COHEN S, 1990, International Review of Psychiatry, V2, P81, DOI 10.3109/09540269009028274; Baron-Cohen S, 1997, ADV INFANCY RES, V11, P193; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Bateman A., 2012, HDB MENTALIZING MENT; Bateman A, 2008, J CLIN PSYCHOL, V64, P181, DOI 10.1002/jclp.20451; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903; BERNARD HR, 1984, ANNU REV ANTHROPOL, V13, P495, DOI 10.1146/annurev.an.13.100184.002431; Bora E, 2016, J AFFECT DISORDERS, V191, P49, DOI 10.1016/j.jad.2015.11.023; Broeren S, 2009, J CHILD FAM STUD, V18, P702, DOI 10.1007/s10826-009-9276-8; Buhlmann U, 2015, J ANXIETY DISORD, V34, P107, DOI 10.1016/j.janxdis.2015.06.003; Buzzell GA, 2017, J AM ACAD CHILD PSY, V56, P1097, DOI 10.1016/j.jaac.2017.10.007; Calvete E, 2016, J SOC CLIN PSYCHOL, V35, P807, DOI 10.1521/jscp.2016.35.10.807; Choi-Kain LW, 2008, AM J PSYCHIAT, V165, P1127, DOI 10.1176/appi.ajp.2008.07081360; Chung YS, 2014, SCHIZOPHRENIA BULL, V40, P602, DOI 10.1093/schbul/sbt048; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Clauss JA, 2012, J AM ACAD CHILD PSY, V51, P1066, DOI 10.1016/j.jaac.2012.08.002; Colonnesi C, 2017, J ABNORM CHILD PSYCH, V45, P997, DOI 10.1007/s10802-016-0206-0; Cui Q, 2017, SOC COGN AFFECT NEUR, V12, P1284, DOI 10.1093/scan/nsx050; Das P, 2012, SCHIZOPHR RES, V134, P158, DOI 10.1016/j.schres.2011.08.019; Debbane M, 2016, FRONT HUM NEUROSCI, V10, DOI [10.3389/finhum.2016.00406, 10.3389/fnhum.2016.00406]; Dell'Osso L, 2003, EUR ARCH PSY CLIN N, V253, P286, DOI 10.1007/s00406-003-0442-5; Dolan M, 2004, PSYCHOL MED, V34, P1093, DOI 10.1017/S0033291704002028; Fernandez-Berrocal P, 2004, PSYCHOL REP, V94, P751; Flavell JH., 1976, NAT INTELL; Fleming SM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00443; Fonagy P, 1997, DEV PSYCHOPATHOL, V9, P679, DOI 10.1017/S0954579497001399; Fonagy P, 2012, HDB MENTALIZATION ME; Fonagy P., 2002, AFFECT REGULATION ME; Fonagy P, 2008, J PERS DISORD, V22, P4, DOI 10.1521/pedi.2008.22.1.4; Fonagy P, 2016, COMPR PSYCHIAT, V64, P59, DOI 10.1016/j.comppsych.2015.11.006; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Fox NA, 2005, ANNU REV PSYCHOL, V56, P235, DOI 10.1146/annurev.psych.55.090902.141532; Fox NA, 2001, CHILD DEV, V72, P1, DOI 10.1111/1467-8624.00262; Freeman C, 2016, BRIT J PSYCHOTHER, V32, P189, DOI 10.1111/bjp.12220; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Garcia-Lopez LJ, 2001, J PSYCHOPATHOL BEHAV, V23, P51, DOI 10.1023/A:1011043607878; Gardner H, 1983, FRAMES MIND THEORY M; Gergely G, 1996, INT J PSYCHOANAL, V77, P1181; Gkika S, 2018, CLIN PSYCHOL PSYCHOT, V25, P10, DOI 10.1002/cpp.2127; Gladstone GL, 2006, J AFFECT DISORDERS, V95, P85, DOI 10.1016/j.jad.2006.04.015; Hare B, 2007, CURR DIR PSYCHOL SCI, V16, P60, DOI 10.1111/j.1467-8721.2007.00476.x; Hausberg MC, 2012, PSYCHOTHER RES, V22, P699, DOI 10.1080/10503307.2012.709325; Heeren A, 2015, CLIN PSYCHOL REV, V40, P76, DOI 10.1016/j.cpr.2015.06.001; Hezel DM, 2014, BEHAV THER, V45, P530, DOI 10.1016/j.beth.2014.02.010; Ibanez A, 2013, PERS INDIV DIFFER, V54, P616, DOI 10.1016/j.paid.2012.11.022; IBM Corp, 2011, IBM SPSS STAT WIND V; Jacobson Nicholas C, 2017, Psychol Bull, V143, P1155, DOI 10.1037/bul0000111; KAGAN J, 1987, CHILD DEV, V58, P1459, DOI 10.1111/j.1467-8624.1987.tb03858.x; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kagan J, 2007, MONOGR SOC RES CHILD, V72, P1; Katznelson H, 2014, CLIN PSYCHOL REV, V34, P107, DOI 10.1016/j.cpr.2013.12.003; Kim S, 2015, PERSONAL DISORD, V6, P356, DOI 10.1037/per0000102; Kokkinos CM, 2016, SOC PSYCHOL EDUC, V19, P117, DOI 10.1007/s11218-015-9317-7; La Bounty J, 2017, IFANT CHILD DEV, V26, P1; La Greca AM, 1998, J ABNORM CHILD PSYCH, V26, P83, DOI 10.1023/A:1022684520514; Lane JD, 2013, DEV PSYCHOL, V49, P825, DOI 10.1037/a0028825; Luyten P, 2015, PERSONAL DISORD, V6, P366, DOI 10.1037/per0000117; Maat A, 2012, SCHIZOPHR RES, V137, P212, DOI 10.1016/j.schres.2012.02.017; McGauley G, 2011, EUR J PSYCHOTHER COU, V13, P371, DOI 10.1080/13642537.2011.629118; Mink D, 2014, INFANT BEHAV DEV, V37, P66, DOI 10.1016/j.infbeh.2013.12.001; Morken K, 2014, J CONTEMP PSYCHOTHER, V44, P117, DOI 10.1007/s10879-013-9246-8; Moskowitz G.B., 2005, SOCIAL COGNITION UND; Neal JA, 2003, CLIN PSYCHOL REV, V23, P761, DOI 10.1016/S0272-7358(03)00076-X; Nolte T, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00055; O'Toole MS, 2013, J ANXIETY DISORD, V27, P98, DOI 10.1016/j.janxdis.2012.09.005; Perdig?n AL., 2003, CLIN SALUD, V14, P249, DOI DOI 10.1016/S1130-5474(14)70025-8; Plana I, 2014, J ANXIETY DISORD, V28, P169, DOI 10.1016/j.janxdis.2013.09.005; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ranta K, 2016, J CHILD FAM STUD, V25, P3497, DOI 10.1007/s10826-016-0519-1; Rapee RM, 2004, CLIN PSYCHOL REV, V24, P737, DOI 10.1016/j.cpr.2004.06.004; Rubin KH, 2009, ANNU REV PSYCHOL, V60, P141, DOI 10.1146/annurev.psych.60.110707.163642; Rubin KH, 1997, CHILD DEV, V68, P467, DOI 10.2307/1131672; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Salovey P, 1995, EMOTION DISCLOSURE H; Samson AC, 2012, J BEHAV THER EXP PSY, V43, P625, DOI 10.1016/j.jbtep.2011.08.007; Schneier FR, 2002, PSYCHIAT CLIN N AM, V25, P757, DOI 10.1016/S0193-953X(02)00018-7; Schwartz CE, 2012, MOL PSYCHIATR, V17, P1042, DOI 10.1038/mp.2011.96; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Sharp C, 2015, PERSONAL DISORD, V6, P347, DOI 10.1037/per0000106; Sharp C, 2014, J PERS DISORD, V28, P78, DOI 10.1521/pedi.2014.28.1.78; Sharp C, 2013, J PERS DISORD, V27, P3, DOI 10.1521/pedi.2013.27.1.3; Sharp C, 2011, J AM ACAD CHILD PSY, V50, P563, DOI 10.1016/j.jaac.2011.01.017; Sripada CS, 2009, NEUROREPORT, V20, P984, DOI 10.1097/WNR.0b013e32832d0a67; Stein DJ, 2004, J CLIN PSYCHIAT, V65, P27; Stein MB, 2001, ARCH GEN PSYCHIAT, V58, P251, DOI 10.1001/archpsyc.58.3.251; Suchman NE, 2017, DEV PSYCHOPATHOL, V29, P617, DOI 10.1017/S0954579417000220; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Sutterby SR, 2012, PSYCHIAT RES, V197, P242, DOI 10.1016/j.psychres.2012.02.014; Suway JG, 2012, SOC DEV, V21, P331, DOI 10.1111/j.1467-9507.2011.00634.x; Thompson K, 2017, BIOL PSYCHIAT, V81, pS372, DOI 10.1016/j.biopsych.2017.02.646; Thorndike E.L., 1920, HARPERS MAGAZINE, V140, P227, DOI DOI 10.1234/12345678; Tibi-Elhanany Y, 2011, ISR J PSYCHIATR REL, V48, P98; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; van Brakel AML, 2006, J PSYCHOPATHOL BEHAV, V28, P79, DOI 10.1007/s10862-006-7485-7; Washburn D, 2016, J ANXIETY DISORD, V37, P71, DOI 10.1016/j.janxdis.2015.11.004; Wellman HM, 2011, DEVELOPMENTAL SCI, V14, P319, DOI 10.1111/j.1467-7687.2010.00977.x; Yager JA, 2006, PSYCHIATRY, V69, P47, DOI 10.1521/psyc.2006.69.1.47	107	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195303	10.1371/journal.pone.0195303	http://dx.doi.org/10.1371/journal.pone.0195303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596505	gold, Green Submitted, Green Published			2022-12-27	WOS:000428630000105
J	Brady, RA; Mocca, CP; Plaut, RD; Takeda, K; Burns, DL				Brady, Rebecca A.; Mocca, Christopher P.; Plaut, Roger D.; Takeda, Kazuyo; Burns, Drusilla L.			Comparison of the immune response during acute and chronic Staphylococcus aureus infection	PLOS ONE			English	Article							BIOFILM INFECTION; IN-VIVO; BACTERIAL BIOFILMS; REAL-TIME; PROTEIN; MODEL; OSTEOMYELITIS; LYMPHOCYTES; CHEMOKINES; BIOLOGY	Staphylococcus aureus bacteria are able to grow in a planktonic state that is associated with acute infections and in biofilms that are associated with chronic infections. Acute infections, such as skin infections, are often self-limiting. However, chronic infections, such as implant infections, can be difficult to clear and may require surgical intervention. The host immune response may contribute to the different outcomes often associated with these two disease types. We used proteomic arrays and two murine models for an initial, descriptive characterization of the contribution of the host immune response to outcomes of acute versus chronic S. aureus disease. We compared the immune responses between a model of self-limiting skin and soft tissue infection caused by the planktonic form of S. aureus versus a model of surgical mesh implant infection, which we show to be caused by a bacterial biofilm. The significantly altered host cytokines and chemokines were largely different in the two models, with responses diminished by 21 days post-implantation in surgical mesh infection. Because bacterial levels remained constant during the 21 days that the surgical mesh infection was followed, those cytokines that are significantly increased during chronic infection are not likely effective in eradicating biofilm. Comparison of the levels of cytokines and chemokines in acute versus chronic S. aureus infection can provide a starting point for evaluation of the role of specific immune factors that are present in one disease manifestation but not the other.	[Brady, Rebecca A.; Mocca, Christopher P.; Plaut, Roger D.; Burns, Drusilla L.] US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Takeda, Kazuyo] US FDA, Microscopy & Imaging Core Facil, Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Brady, RA (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Rebecca.Brady@fda.hhs.gov	Plaut, Roger D./B-2340-2013	Plaut, Roger D./0000-0002-0883-972X				Alunno A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00554; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Brady RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124877; Brady RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063040; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Gonzalez MJ, 2015, EUR J IMMUNOL, V45, P2615, DOI 10.1002/eji.201545514; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Harro JM, 2013, GENOME ANNOUNC, V1; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Krespi YP, 2012, AM J OTOLARYNG, V33, P572, DOI 10.1016/j.amjoto.2012.02.002; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; Lister JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00178; MAIZA H, 1993, J EXP MED, V178, P1121, DOI 10.1084/jem.178.3.1121; McNamara Peter J., 2008, P89; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Nishitani K, 2015, J ORTHOP RES, V33, P1311, DOI 10.1002/jor.22907; Plaut RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142758; Plaut RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059232; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Prabhakara R, 2011, INFECT IMMUN, V79, P5010, DOI 10.1128/IAI.05571-11; Prabhakara R, 2011, INFECT IMMUN, V79, P1789, DOI 10.1128/IAI.01386-10; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Walton KD, 2014, COMPARATIVE MED, V64, P25	35	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195342	10.1371/journal.pone.0195342	http://dx.doi.org/10.1371/journal.pone.0195342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596507	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000106
J	Gomes, IR; Gomes, CR; Gomes, HS; Cavalcante, GPD				Gomes, Igor Ruiz; Gomes, Cristiane Ruiz; Gomes, Herminio Simoes; dos Santos Cavalcante, Gervasio Protasio			Empirical radio propagation model for DTV applied to non-homogeneous paths and different climates using machine learning techniques	PLOS ONE			English	Article							WAVE PROPAGATION; MIXED PATHS	The establishment and improvement of transmission systems rely on models that take into account, (among other factors), the geographical features of the region, as these can lead to signal degradation. This is particularly important in Brazil, where there is a great diversity of scenery and climates. This article proposes an outdoor empirical radio propagation model for Ultra High Frequency (UHF) band, that estimates received power values that can be applied to non-homogeneous paths and different climates, this last being of an innovative character for the UHF band. Different artificial intelligence techniques were chosen on a theoretical and computational basis and made it possible to introduce, organize and describe quantitative and qualitative data quickly and efficiently, and thus determine the received power in a wide range of settings and climates. The proposed model was applied to a city in the Amazon region with heterogeneous paths, wooded urban areas and fractions of freshwater among other factors. Measurement campaigns were conducted to obtain data signals from two digital TV stations in the metropolitan area of the city of Belem, in the State of Para A, to design, compare and validate the model. The results are consistent since the model shows a clear difference between the two seasons of the studied year and small RMS errors in all the cases studied.	[Gomes, Igor Ruiz] Fed Univ Para, Dept Computat, Belem, Para, Brazil; [Gomes, Cristiane Ruiz; Gomes, Herminio Simoes] Fed Univ Para, Dept Math, Belem, Para, Brazil; [dos Santos Cavalcante, Gervasio Protasio] Fed Univ Para, Dept Telecommun, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Gomes, IR (corresponding author), Fed Univ Para, Dept Computat, Belem, Para, Brazil.	ruiz.igor@gmail.com	Gomes, Cristiane Ruiz/AAJ-5752-2021	Gomes, Igor/0000-0001-7391-1903; Gomes, Cristiane/0000-0001-9368-6248				[Anonymous], 2012, ITURRP8337; [Anonymous], 2007, IRP6189 INT COMM UN; [Anonymous], 1995, IRP3707 INT TEL UN; [Anonymous], 2009, IRP15464 INT COMM UN; [Anonymous], 2012, IRP837 INT COMM UN; [Anonymous], 2013, IP53015; [Anonymous], 2001, IRP8393 INT COMM UN; [Anonymous], 2005, IRP15462 INT COMM UN; Castro Bruno S. L., 2011, J. Microw. Optoelectron. Electromagn. Appl., V10, P106, DOI 10.1590/S2179-10742011000100011; CASTRO Bruno Souza Lyra, 2010, MODELO PROPAGACAO RE; CAVALCANTE GPD, 1983, RADIO SCI, V18, P691, DOI 10.1029/RS018i005p00691; CAVALCANTE GPD, 1982, RADIO SCI, V17, P503, DOI 10.1029/RS017i003p00503; CAVALCANTE GPS, 1983, IEEE T ANTENN PROPAG, V31, P141, DOI 10.1109/TAP.1983.1142985; Cavalcante GPS, 1982, THESIS; Chee KL, 2011, IEEE T ANTENN PROPAG, V59, P2698, DOI 10.1109/TAP.2011.2152340; de Souza JF, 2009, MICROW OPT TECHN LET, V51, P1133, DOI 10.1002/mop.24212; Dias MHC, 2011, IEEE LAT AM T, V9, P288, DOI 10.1109/TLA.2011.5893774; Faruk N, 2013, 2013 IEEE EUROCON, P602, DOI 10.1109/EUROCON.2013.6625043; Gomes C, 2012, P MOMAG 2012; Gomes Cristiane R., 2015, J. Microw. Optoelectron. Electromagn. Appl., V14, P60, DOI 10.1590/2179-10742015v14i1427; HATA M, 1980, IEEE T VEH TECHNOL, V29, P317, DOI 10.1109/T-VT.1980.23859; Kawano T, 2008, IEEE ANTENNAS PROP, P400; Kirk Matthew, 2014, THOUGHTFUL MACHINE L; Li L, 1986, CHIN J RADIO SCI, V1, P10; Mandeep J. S., 2011, 2011 Proceedings of the International Conference on Space Science and Communication (IconSpace 2011), P89, DOI 10.1109/IConSpace.2011.6015858; Mayrink MAS, 2005, 2005 SBMO/IEEE MTT-S International Microwave and Optoelectronics Conference (IMOC), P394; Meng YS, 2009, PROG ELECTROMAGN RES, V99, P149, DOI 10.2528/PIER09102201; Meng YS, 2008, IEEE ANTENN WIREL PR, V7, P159, DOI 10.1109/LAWP.2008.922052; Meng YS, 2009, IEEE T VEH TECHNOL, V58, P4023, DOI 10.1109/TVT.2009.2021480; Meza Wilyam D. T., 2014, J. Microw. Optoelectron. Electromagn. Appl., V13, P97; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Negnevitsky M., 2005, ARTIF INTELL, V2nd ed.; Oliveira RAN, 2013, PROC EUR CONF ANTENN, P964; Russell S., 1995, ARTIFICIAL INTELLIGE; Silva D, 2014, P WIR TEL S; Soni S, 2011, MICROW OPT TECHN LET, V53, P1875, DOI 10.1002/mop.26152; TAMIR T, 1977, IEEE T ANTENN PROPAG, V25, P471, DOI 10.1109/TAP.1977.1141620; TAMIR T, 1967, IEEE T ANTENN PROPAG, VAP15, P806, DOI 10.1109/TAP.1967.1139054; Thorvaldsen P, 2014, RADIO SCI, V49, P531, DOI 10.1002/2013RS005338; Witvliet B. A., 2011, 2011 IEEE-APS Topical Conference on Antennas and Propagation in Wireless Communications, P303, DOI 10.1109/APWC.2011.6046762; Wu K, 2004, IEEE MILIT COMMUN C, P1515; Yeo JX, 2009 7 INT C INF COM; Zhang QL, 2013, IEEE T ELECTROMAGN C, V55, P733, DOI 10.1109/TEMC.2012.2235444	44	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194511	10.1371/journal.pone.0194511	http://dx.doi.org/10.1371/journal.pone.0194511			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596503	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000027
J	Park, B; Min, C; Choi, HG				Park, Bumjung; Min, Chanyang; Choi, Hyo Geun			Neck dissection does not increases the risk of stroke in thyroid cancer: A national cohort study	PLOS ONE			English	Article							PERIOPERATIVE STROKE; HEAD; POPULATION	Objectives The purpose of this study is to evaluate the risk of stroke (hemorrhagic or ischemic) after neck dissection in thyroid cancer patients in Korea using national cohort data. Methods Using the national cohort study from the Korean Health Insurance Review and Assessment Service, patients with neck dissection for thyroid cancer (1,041) and control participants (4,164) were selected and matched 1:4 (age, gender, income, and region of residence). The Chi-square test, Fischer's exact test, and the Cox-proportional hazard model were used. The Cox-proportional analysis used a crude model and an adjusted model for age, gender, income, region of residence, hypertension, diabetes, dyslipidemia. Results None of the participants had suffered hemorrhagic stroke in the neck dissection group, while 0.3% (13/4,164) of participants had suffered hemorrhagic stroke in the control group (P = 0.085). In total, 0.8% (8/1,041) of participants had suffered an ischemic stroke in the neck dissection group, and 0.7% (31/4,133) of participants had suffered an ischemic stroke in the control group (P = 0.936). The adjusted hazard ratio for ischemic stroke after neck dissection was 1.06 (95% confidence interval [CI] = 0.49-2.31, P = 0.884). Conclusion The risk of hemorrhagic or ischemic stroke was not higher in thyroid cancer patients who underwent neck dissection than that in the matched control group.	[Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Min, Chanyang] Hallym Univ, Coll Med, Hallym Data Sci Lab, Anyang, South Korea	Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549				Chang CF, 2017, HEAD NECK-J SCI SPEC, V39, P63, DOI 10.1002/hed.24535; Chu CN, 2011, BRIT J CANCER, V105, P1419, DOI 10.1038/bjc.2011.361; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16; MacNeil SD, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001106; Mead GE, 1999, J NEUROL NEUROSUR PS, V66, P16, DOI 10.1136/jnnp.66.1.16; NOSAN DK, 1993, ANN OTO RHINOL LARYN, V102, P717, DOI 10.1177/000348949310200913; Rechtweg J, 1998, LARYNGOSCOPE, V108, P1150, DOI 10.1097/00005537-199808000-00009; Sawicka-Gutaj N, 2014, ENDOKRYNOL POL, V65, P54, DOI 10.5603/EP.2014.0008; Thompson SK, 2004, ANN SURG, V239, P428, DOI 10.1097/01.sla.0000114130.01282.26; Thompson SK, 2003, CAN J SURG, V46, P332; Wang XF, 2016, ONCOTARGET, V7, P55912, DOI 10.18632/oncotarget.10352	13	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195074	10.1371/journal.pone.0195074	http://dx.doi.org/10.1371/journal.pone.0195074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596481	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000075
J	Lu, GM; Pine, P; Leeds, JM; DeGuzman, F; Pratikhya, P; Lin, J; Malinowski, J; Hollenbach, SJ; Curnutte, JT; Conley, PB				Lu, Genmin; Pine, Polly; Leeds, Janet M.; DeGuzman, Francis; Pratikhya, Pratikhya; Lin, Joyce; Malinowski, John; Hollenbach, Stanley J.; Curnutte, John T.; Conley, Pamela B.			Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model	PLOS ONE			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; ANTAGONIST ORAL ANTICOAGULANTS; ACTIVATED FACTOR-VII; FACTOR-XA; ATRIAL-FIBRILLATION; RIVAROXABAN; MANAGEMENT; APIXABAN; WARFARIN; DABIGATRAN	Introduction Increasing use of factor Xa (FXa) inhibitors necessitates effective reversal agents to manage bleeding. Andexanet alfa, a novel modified recombinant human FXa, rapidly reverses the anticoagulation effects of direct and indirect FXa inhibitors. Objective To evaluate the ability of andexanet to reverse anticoagulation in vitro and reduce bleeding in rabbits administered edoxaban. Materials and methods In vitro studies characterized the interaction of andexanet with edoxaban and its ability to reverse edoxaban-mediated anti-FXa activity. In a rabbit model of surgically induced, acute hemorrhage, animals received edoxaban vehicle+andexanet vehicle (control), edoxaban (1 mg/kg)+andexanet vehicle, edoxaban+andexanet (75 mg, 5-minute infusion, 20 minutes after edoxaban), or edoxaban vehicle+andexanet prior to injury. Results Andexanet bound edoxaban with high affinity similar to FXa. Andexanet rapidly and dose dependently reversed the effects of edoxaban on FXa activity and coagulation pharmacodynamic parameters in vitro. In edoxaban-anticoagulated rabbits, andexanet reduced anti-FXa activity by 82% (from 548 +/- 87 to 100 +/- 41 ng/ml; P<0.0001), mean unbound edoxaban plasma concentration by similar to 80% (from 100 +/- 10 to 21 +/- 6 ng/ml; P<0.0001), and blood loss by 80% vs. vehicle (adjusted for control, 2.6 vs. 12.9 g; P= 0.003). The reduction in blood loss correlated with the decrease in anti-FXa activity (r = 0.6993, P<0.0001) and unbound edoxaban (r = 0.5951, P = 0.0035). Conclusion These data demonstrate that andexanet rapidly reversed the anticoagulant effects of edoxaban, suggesting it could be clinically valuable for the management of acute and surgery related bleeding. Correlation of blood loss with anti-FXa activity supports the use of anti-FXa activity as a biomarker for assessing anticoagulation reversal in clinical trials.	[Lu, Genmin; Pine, Polly; Leeds, Janet M.; DeGuzman, Francis; Pratikhya, Pratikhya; Lin, Joyce; Malinowski, John; Hollenbach, Stanley J.; Curnutte, John T.; Conley, Pamela B.] Portola Pharmaceut Inc, San Francisco, CA 94080 USA; [Lu, Genmin] Jazz Pharmaceut, Palo Alto, CA USA; [Hollenbach, Stanley J.] Novan Therapeut Inc, Durham, NC USA	Jazz Pharmaceuticals	Conley, PB (corresponding author), Portola Pharmaceut Inc, San Francisco, CA 94080 USA.	pconley@portola.com		DeGuzman, Francis/0000-0002-4479-1129	Portola Pharmaceuticals; Portola Pharmaceuticals, Inc.	Portola Pharmaceuticals; Portola Pharmaceuticals, Inc.	The study has been funded by Portola Pharmaceuticals. The study has been designed, performed, and analysed by all authors who were employees of Portola Pharmaceuticals and received salaries. Currently, all authors, besides PP and SJH, are employees of Portola. The authors have met the ICMJE criteria, participated in the development of the manuscript, agreed to the content, and approved its submission. No one other than the listed authors had control over the data, over how the data were analyzed or interpreted, or over the wording or conclusions used by the authors in the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Financial support for medical editorial assistance was provided by Portola Pharmaceuticals, Inc. The authors thank Tamalette Loh, PhD; Supriya Bavadekar, PhD; and William Sinkins, PhD; all of Accuverus, and Iwona Bucior of Portola Pharmaceuticals, Inc. for medical editorial assistance with this manuscript.	Barco S, 2016, BRIT J HAEMATOL, V172, P255, DOI 10.1111/bjh.13821; Brown KS, 2015, THROMB RES, V136, P825, DOI 10.1016/j.thromres.2015.07.012; Cheung YW, 2015, J THROMB HAEMOST, V13, P1799, DOI 10.1111/jth.13115; Chowdary P, 2015, J THROMB HAEMOST, V13, P743, DOI 10.1111/jth.12864; Conley PB, 2016, AM SOC HEM 58 ANN M; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Crowther M, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4269.4269; Desai NR, 2014, AM J MED, V127, P1075, DOI 10.1016/j.amjmed.2014.05.013; Dogliotti A, 2013, CLIN CARDIOL, V36, P61, DOI 10.1002/clc.22081; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Godier A, 2012, ANESTHESIOLOGY, V116, P94, DOI 10.1097/ALN.0b013e318238c036; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; HARA T, 1995, THROMB RES, V80, P99, DOI 10.1016/0049-3848(95)00155-K; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Herzog E, 2015, THROMB RES, V135, P554, DOI 10.1016/j.thromres.2015.01.007; Herzog E, 2015, ANESTHESIOLOGY, V122, P387, DOI 10.1097/ALN.0000000000000520; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Levi M, 2014, J THROMB HAEMOST, V12, P1428, DOI 10.1111/jth.12599; Levy JH, 2018, J THROMB HAEMOST, V16, P54, DOI 10.1111/jth.13894; Lip GYH, 2014, EUR HEART J, V35, P1844, DOI 10.1093/eurheartj/ehu181; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lu G, 2017, J THROMB HAEMOST, V15, P1747, DOI 10.1111/jth.13768; Lu G, 2015, INT SOC THROMB MAEM; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Majeed A, 2017, BLOOD, V130, P1706, DOI 10.1182/blood-2017-05-782060; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Martin AC, 2013, INT J CARDIOL, V168, P4228, DOI 10.1016/j.ijcard.2013.07.152; Nagalla S, 2016, CTS-CLIN TRANSL SCI, V9, P176, DOI 10.1111/cts.12398; Niessner A, 2017, EUR HEART J, V38, P1710, DOI 10.1093/eurheartj/ehv676; Oktay E., 2015, INT J CARDIOVAS ACAD, V1, P1; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Raval AN, 2017, CIRCULATION, V135, pE604, DOI 10.1161/CIR.0000000000000477; Ruff CT, 2016, CIRCULATION, V134, P248, DOI 10.1161/CIRCULATIONAHA.116.021831; Shatzel JJ, 2016, NEW ENGL J MED, V375, P2499, DOI 10.1056/NEJMc1613270; Siegal Deborah, 2017, Blood Adv, V1, P1827, DOI 10.1182/bloodadvances.2017007112; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; SKOGEN WF, 1984, J BIOL CHEM, V259, P2306; Slot KMHB, 2014, JAMA-J AM MED ASSOC, V311, P1150, DOI 10.1001/jama.2014.1403; Tomaselli GF, 2017, J AM COLL CARDIOL, V70, P3042, DOI 10.1016/j.jacc.2017.09.1085; US National Library of Medicine, STUD PAT AC MAJ BLEE; Zahir H, 2015, CIRCULATION, V131, P82, DOI 10.1161/CIRCULATIONAHA.114.013445	43	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195122	10.1371/journal.pone.0195122	http://dx.doi.org/10.1371/journal.pone.0195122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590221	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100105
J	Maia, LD; Peterle, GT; dos Santos, M; Trivilin, LO; Mendes, SO; de Oliveira, MM; dos Santos, JG; Stur, E; Agostini, LP; Couto, CVMD; Dalbo, J; de Assisi, ALEM; Archanjo, AB; Mercante, AMD; Lopez, RVM; Nunes, FD; de Carvalho, MB; Tajara, EH; Louro, LD; Alvares-da-Silva, AM				Maia, Lucas de Lima; Peterle, Gabriela Tonini; dos Santos, Marcelo; Trivilin, Leonardo Oliveira; Mendes, Suzanny Oliveira; de Oliveira, Mayara Mota; dos Santos, Joaquim Gasparini; Stur, Elaine; Agostini, Lidiane Pignaton; Monteiro da Silva Couto, Cinthia Vidal; Dalbo, Juliana; Evangelista Monteiro de Assisi, Aricia Leone; Archanjo, Anderson Barros; Da Cunha Mercante, Ana Maria; Mendoza Lopez, Rossana Veronica; Nunes, Fabio Daumas; de Carvalho, Marcos Brasilino; Tajara, Eloiza Helena; Louro, Luri Drumond; Alvares-da-Silva, Adriana Madeira			JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma	PLOS ONE			English	Article							HISTONE LYSINE DEMETHYLASES; HYPOXIA-INDUCED EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; EPIGENETIC REGULATION; TISSUE MICROARRAYS; NECK-CANCER; ADRENOMEDULLIN; SURVIVAL; TUMOR	Aims Jumonji Domain-Containing 1 A (JMJD1A) protein promotes demethylation of histones, especially at lysin-9 of di-methylated histone H3 (H3K9me2) or mono-methylated (H3K9me1). Increased levels of H3 histone methylation at lysin-9 (H3K9) is related to tumor suppressor gene silencing. JMJD1A gene target Adrenomeduline (ADM) has shown to promote cell growth and tumorigenesis. JMJD1A and ADM expression, as well as H3K9 methylation level have been related with development risk and prognosis of several tumor types. Methods and results We aimed to evaluate JMJD1A, ADM, H3K9me1 and H3K9me2expression in paraffin embedded tissue microarrays from 84 oral and oropharyngeal squamous cell carcinoma samples through immunohistochemistry analysis. Our results showed that nuclear JMJD1A expression was related to lymph node metastasis risk. In addition, JMJD1A cytoplasmic expression was an independent risk marker for advanced tumor stages. H3K9me1 cytoplasmic expression was associated with reduced disease-specific death risk. Furthermore, high H3K9me2 nuclear expression was associated with worse specific-disease and disease-free survival. Finally, high ADM cytoplasmic expression was an independent marker of lymph node metastasis risk. Conclusion JMJD1A, H3K9me1/2 and ADM expression may be predictor markers of progression and prognosis in oral and oropharynx cancer patients, as well as putative therapeutic targets.	[Maia, Lucas de Lima; Peterle, Gabriela Tonini; Trivilin, Leonardo Oliveira; Mendes, Suzanny Oliveira; de Oliveira, Mayara Mota; dos Santos, Joaquim Gasparini; Stur, Elaine; Agostini, Lidiane Pignaton; Monteiro da Silva Couto, Cinthia Vidal; Dalbo, Juliana; Evangelista Monteiro de Assisi, Aricia Leone; Archanjo, Anderson Barros; Louro, Luri Drumond; Alvares-da-Silva, Adriana Madeira] Univ Fed Espirito Santo, Programa Posgrad Biotecnol, Vitoria, ES, Brazil; [dos Santos, Marcelo] Univ Fed Rio Grande do Norte, Escola Multicampi Ciencias Med Rio Grande Norte, Caico, RN, Brazil; [Da Cunha Mercante, Ana Maria] Hosp Heliopolis, Dept Anat Patol, Sao Paulo, Brazil; [Mendoza Lopez, Rossana Veronica] Inst Canc Estado Sao Paulo, Ctr Invest Translac Oncol, Sao Paulo, Brazil; [Nunes, Fabio Daumas] Univ Sao Paulo, Dept Patol Bucal, Fac Odontol, Sao Paulo, Brazil; [de Carvalho, Marcos Brasilino] Hosp Heliopolis, Lab Biol Mol, Sao Paulo, Brazil; [Tajara, Eloiza Helena] Fac Med, Dept Biol Mol, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo	Maia, LD (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Biotecnol, Vitoria, ES, Brazil.	lucas_lmbio@hotmail.com	Tonini Peterle, Gabriela/GWU-6986-2022; Mendoza Lopez, Rossana Veronica/X-3968-2018; Álvares-da-Silva, Adriana M/J-2912-2018; Nunes, Fabio Daumas/B-4543-2011; Mendoza Lopez, Rossana Veronica/ABA-2587-2021; Archanjo, Anderson Barros/Q-5245-2017	Mendoza Lopez, Rossana Veronica/0000-0001-7993-767X; Álvares-da-Silva, Adriana M/0000-0002-8078-0304; Nunes, Fabio Daumas/0000-0002-7785-6785; Archanjo, Anderson Barros/0000-0002-9305-271X; STUR, ELAINE/0000-0001-5962-0050; Gasparini dos Santos, Joaquim/0000-0001-6096-116X; MOTA DE OLIVEIRA, MAYARA/0000-0003-2735-9788	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12054-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (http://www.fapesp.br/) grants 04/12054-9; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://cnpq.br/); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES) (https://fapes.es.gov.br/); and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://capes.gov.br/).	Amar A, 2013, BRAZ J OTORHINOLAR, V79, P734, DOI 10.5935/1808-8694.20130134; [Anonymous], 1978, PLOS ONE; Baranello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040678; Bauman JE, 2012, CURR OPIN ONCOL, V24, P235, DOI 10.1097/CCO.0b013e3283517920; Benard A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-531; Bono P, 2004, CLIN CANCER RES, V10, P7144, DOI 10.1158/1078-0432.CCR-03-0826; Bredell MG, 2016, ONCOTARGET, V7, P50781, DOI 10.18632/oncotarget.9549; Cajaiba MM, 2006, PEDIATR DEVEL PATHOL, V9, P196, DOI 10.2350/05-12-0002.1; Chakrabarti KR, 2015, ONCOTARGET, V6, P36292, DOI 10.18632/oncotarget.5345; Dambacher S, 2013, CELL CYCLE, V12, P2925, DOI 10.4161/cc.26179; dos Santos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045228; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Fan L, 2016, ONCOGENE, V35, P2441, DOI 10.1038/onc.2015.309; Galli P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-137; Gao YQ, 2016, ONCOTARGET, V7, P63374, DOI 10.18632/oncotarget.11463; Guo X, 2011, NEOPLASMA, V58, P153, DOI 10.4149/neo_2011_02_153; Harris AL, 2004, NAT REV CANCER, V2, P38; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Hsu FD, 2002, MODERN PATHOL, V15, P1374, DOI 10.1097/01.MP.0000039571.02827.CE; Karpinich NO, 2013, FASEB J, V27, P590, DOI 10.1096/fj.12-214080; Kasioulis I, 2014, MOL BIOL CELL, V25, P1216, DOI 10.1091/mbc.E13-08-0471; Kaukonen R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12237; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li MQ, 2015, ONCOL LETT, V10, P1003, DOI 10.3892/ol.2015.3278; Lim S, 2010, INT J CANCER, V127, P1991, DOI 10.1002/ijc.25538; Liu J, 2016, ONCOTARGET, V7, P85151, DOI 10.18632/oncotarget.13208; Muller-Tidow C, 2010, BLOOD, V116, P3564, DOI 10.1182/blood-2009-09-240978; OCHOACALLEJERO L, 2017, SMALL MOL REL ADR, V7, DOI DOI 10.1038/S41598-017-17573-X; Oehler MK, 2003, BRIT J CANCER, V89, P1927, DOI 10.1038/sj.bjc.6601397; Park SJ, 2013, BIOCHEM BIOPH RES CO, V434, P722, DOI 10.1016/j.bbrc.2013.03.091; Park YS, 2008, ANN SURG ONCOL, V15, P1968, DOI 10.1245/s10434-008-9927-9; Ponnaluri VKC, 2011, BIOCHEM BIOPH RES CO, V415, P373, DOI 10.1016/j.bbrc.2011.10.075; Puram SV, 2015, HEMATOL ONCOL CLIN N, V29, P971, DOI 10.1016/j.hoc.2015.07.003; Rimm DL, 2001, EXP MOL PATHOL, V70, P255, DOI 10.1006/exmp.2001.2363; Rogenhofer S, 2012, ANTICANCER RES, V32, P879; Sobin L, 2009, TNM CLASSIFICATION M; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Uemura M, 2010, CLIN CANCER RES, V16, P4636, DOI 10.1158/1078-0432.CCR-10-0407; Vavilala DT, 2012, BIOCHEM BIOPH RES CO, V422, P369, DOI 10.1016/j.bbrc.2012.04.143; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Xia RH, 2013, ARCH PATHOL LAB MED, V137, P1761, DOI 10.5858/arpa.2012-0704-OA; Yang HY, 2015, INT J CLIN EXP PATHO, V8, P11092; Yang J, 2009, ANN NY ACAD SCI, V1177, P185, DOI 10.1111/j.1749-6632.2009.05027.x; Zhang CJ, 2010, J HEPATOL, V53, P889, DOI 10.1016/j.jhep.2010.05.012	47	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194884	10.1371/journal.pone.0194884	http://dx.doi.org/10.1371/journal.pone.0194884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590186	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100084
J	Moreno, X; Albala, C; Lera, L; Leyton, B; Angel, B; Sanchez, H				Moreno, Ximena; Albala, Cecilia; Lera, Lydia; Leyton, Barbara; Angel, Barbara; Sanchez, Hugo			Gender, nutritional status and disability-free life expectancy among older people in Santiago, Chile	PLOS ONE			English	Article							MOBILITY DISABILITY; BODY-COMPOSITION; SAO-PAULO; OBESITY; ADULTS; HEALTH; OVERWEIGHT; WEIGHT; IMPACT; LIMITATIONS	Background This study was aimed to estimate life expectancy (LE), disability-free life expectancy (DFLE) and disabled life expectancy (DLE) among older adults from Santiago, Chile, and to determine the existence of differences by gender and by body mass index (BMI) categories in these indicators. Methods A sample of 1216 people aged 60 or more, from the Chilean cohort of the Study of Health, Ageing and Well-Being was recruited in 2000; two follow-up assessments were carried out in a 10-year period. Functional limitation was assessed through self-report of difficulties in activities of daily living, instrumental activities of daily living and mobility. BMI was determined with measured weight and height. Multistate life tables were employed to estimate LE and healthy life expectancy (HLE). Results At 60 years, women could expect to live on average an additional 20.4 years (95% CI 19.0-21.6), and men an additional 16.4 years (95% CI 14.9-17.7). Total LE was longer among women at all ages, but they had a higher proportion of disabled years to be lived compared to men, with a difference of 14% at 60 years, and 10% at 90 years. There were no significant differences in LE, DFLE and DLE between BMI categories. Discussion Despite a longer LE, Chilean older women expect to live a higher proportion of years with disabilities, compared to men. Public health programs should address factors affecting LE of older men, and those associated with disability among older women.	[Moreno, Ximena; Albala, Cecilia; Lera, Lydia; Leyton, Barbara; Angel, Barbara; Sanchez, Hugo] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile	Universidad de Chile	Albala, C (corresponding author), Univ Chile, Inst Nutr & Food Technol, Santiago, Chile.	calbala@uchile.cl	Lera, Lydia/A-8508-2015; Albala, Cecilia/A-7260-2015; Angel, Barbara B/A-8427-2015	Lera, Lydia/0000-0001-7470-2433; Angel, Barbara B/0000-0001-8773-5904; Moreno, Ximena/0000-0002-0586-4364	Chilean National Fund for Scientific and Technological Development [Fondecyt 1080589]	Chilean National Fund for Scientific and Technological Development	This study was supported by the Chilean National Fund for Scientific and Technological Development (project Fondecyt 1080589, main investigator: Cecilia Albala). This funding institution played no role in the design, execution, analysis and interpretation of the data, nor writing of the study.	Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; Albala C, 2004, GERONTOLOGIST, V44, P550; ALBALA C, 2010, ESTUDIO NACL DEPENDE; Albala C, 2011, REV MED CHILE, V139, P1276, DOI [10.4067/S0034-98872011001000005, /S0034-98872011001000005]; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Andrade FCD, 2010, J GERONTOL B-PSYCHOL, V65, P381, DOI 10.1093/geronb/gbp119; Apinonkul B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153763; Arroyo P, 2007, REV MED CHILE, V135, P846; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Belon AP, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-88; Beltran-Sanchez H, 2013, J AGING HEALTH, V25, P815, DOI 10.1177/0898264313491425; Chen HL, 2008, J AM GERIATR SOC, V56, P689, DOI 10.1111/j.1532-5415.2007.01624.x; Dhana K, 2016, INT J OBESITY, V40, P1535, DOI 10.1038/ijo.2016.94; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Drumond Andrade Flavia Cristina, 2013, J Aging Res, V2013, P905094, DOI 10.1155/2013/905094; Andrade FCD, 2011, WOMEN HEALTH ISS, V21, P64, DOI 10.1016/j.whi.2010.08.007; Fabbri E, 2015, J AM GERIATR SOC, V63, P1791, DOI 10.1111/jgs.13608; Freedman VA, 2016, AM J PUBLIC HEALTH, V106, P1079, DOI 10.2105/AJPH.2016.303089; Froehlich-Grobe K, 2011, AM J PREV MED, V41, P541, DOI 10.1016/j.amepre.2011.07.015; Hoogendijk E, 2008, INT J PUBLIC HEALTH, V53, P281, DOI 10.1007/s00038-008-8079-9; Hosseinpoor AR, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-52; Houston DK, 2009, AM J EPIDEMIOL, V169, P927, DOI 10.1093/aje/kwp007; Jackson C., 2016, MULTISTATE MODELLING; Jackson CH, 2011, J STAT SOFTW, V38, P1; Jagger C, 2016, LANCET, V387, P779, DOI 10.1016/S0140-6736(15)00947-2; Kingston A, 2015, ARCH GERONTOL GERIAT, V60, P405, DOI 10.1016/j.archger.2015.02.006; Leigh L, 2016, BRIT J NUTR, V116, P692, DOI 10.1017/S0007114516002403; Lera L, 2017, J FRALITY AGING, V6, P12, DOI 10.14283/jfa.2016.117; Leveille SG, 2005, PAIN, V116, P332, DOI 10.1016/j.pain.2005.05.002; Majer IM, 2011, OBESITY, V19, P1451, DOI 10.1038/oby.2011.46; Ministry of Health, 2010, ENC NAC SAL ENS CHIL; Morrison A, 2013, CLINICOECONOMIC OUTC, V5, P9, DOI 10.2147/CEOR.S38721; Murphy RA, 2014, J AM GERIATR SOC, V62, P1476, DOI 10.1111/jgs.12954; Murtagh KN, 2004, AM J PUBLIC HEALTH, V94, P1406, DOI 10.2105/AJPH.94.8.1406; Nusselder WJ, 2010, EUR J AGEING, V7, P219, DOI 10.1007/s10433-010-0169-x; Oksuzyan A, 2010, EUR J AGEING, V7, P213, DOI 10.1007/s10433-010-0170-4; Payne CF, 2015, J GERONTOL B; Pongiglione B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130747; Reuser M, 2009, OBESITY, V17, P783, DOI 10.1038/oby.2008.640; Reynolds SL, 2009, OBESITY, V17, P363, DOI 10.1038/oby.2008.534; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Camargos MCS, 2007, J BIOSOC SCI, V39, P455, DOI 10.1017/S0021932006001428; Santosa A, 2016, J EPIDEMIOL COMMUN H, V70, P855, DOI 10.1136/jech-2015-206640; Stenholm S, 2017, INT J OBESITY, V41, P769, DOI 10.1038/ijo.2017.29; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; UNFPA and HelpAge International, 2012, AG 21 CENT CEL CHALL; Van Oyen H, 2013, INT J PUBLIC HEALTH, V58, P143, DOI 10.1007/s00038-012-0361-1; Van Oyen H, 2010, EUR J AGEING, V7, P229, DOI 10.1007/s10433-010-0172-2; Campos ACV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1666-9; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2017, PREVALENCE OBESITY A	55	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194074	10.1371/journal.pone.0194074	http://dx.doi.org/10.1371/journal.pone.0194074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590148	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100048
J	Sorrentino, R; Bortolini, E; Lugli, F; Mancuso, G; Buti, L; Oxilia, G; Vazzana, A; Figus, C; Serrangeli, MC; Margherita, C; Penzo, A; Gruppioni, G; Gottarelli, A; Jochum, KP; Belcastro, MG; Cipriani, A; Feeney, RNM; Benazzi, S				Sorrentino, Rita; Bortolini, Eugenio; Lugli, Federico; Mancuso, Giuseppe; Buti, Laura; Oxilia, Gregorio; Vazzana, Antonino; Figus, Carla; Serrangeli, Maria Cristina; Margherita, Cristiana; Penzo, Annachiara; Gruppioni, Giorgio; Gottarelli, Antonio; Jochum, Klaus Peter; Belcastro, Maria Giovanna; Cipriani, Anna; Feeney, Robin N. M.; Benazzi, Stefano			Unravelling biocultural population structure in 4th/3rd century BC Monterenzio Vecchio (Bologna, Italy) through a comparative analysis of strontium isotopes, non-metric dental evidence, and funerary practices	PLOS ONE			English	Article							CASALECCHIO-DI-RENO; SKELETAL AGE; AFFINITIES; MIGRATION; SOUTHERN; MOBILITY; PACKAGE; PLEISTOCENE; EVOLUTION; DISTANCE	The 4th century BC marks the main entrance of Celtic populations in northern Italy. Their arrival has been suggested based on the presence of Celtic customs in Etruscan mortuary contexts, yet up to now few bioarchaeological data have been examined to support or reject the arrival of these newcomers. Here we use strontium isotopes, non-metric dental traits and funerary patterns to unravel the biocultural structure of the necropolis of Monterenzio Vecchio (Bologna, Italy). Subsamples of our total sample of 38 individuals were analyzed based on different criteria characterizing the following analyses: 1) strontium isotope analysis to investigate migratory patterns and provenance; 2) non-metric dental traits to establish biological relationships between Monterenzio Vecchio, 13 Italian Iron age necropolises and three continental and non-continental Celtic necropolises; 3) grave goods which were statistically explored to detect possible patterns of cultural variability. The strontium isotopes results indicate the presence of local and non-local individuals, with some revealing patterns of mobility. The dental morphology reveals an affinity between Monterenzio Vecchio and Iron Age Italian samples. However, when the Monterenzio Vecchio sample is separated by isotopic results into locals and non-locals, the latter share affinity with the sample of non continental Celts from Yorkshire (UK). Moreover, systematic analyses demonstrate that ethnic background does not retain measurable impact on the distribution of funerary elements. Our results confirm the migration of Celtic populations in Monterenzio as archaeologically hypothesized on the basis of the grave goods, followed by a high degree of cultural admixture between exogenous and endogenous traits. This contribution shows that combining different methods offers a more comprehensive perspective for the exploration of biocultural processes in past and present populations.	[Sorrentino, Rita; Belcastro, Maria Giovanna] Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Via Selmi 3, Bologna, Italy; [Sorrentino, Rita; Bortolini, Eugenio; Mancuso, Giuseppe; Buti, Laura; Oxilia, Gregorio; Vazzana, Antonino; Figus, Carla; Margherita, Cristiana; Gruppioni, Giorgio; Benazzi, Stefano] Univ Bologna, Dept Cultural Heritage, Via Ariani 1, Ravenna, Italy; [Bortolini, Eugenio] Univ Pompeu FabraRamon Trias Fargas, Complex & Socioecol Dynam Res Grp, Dept Humanities, Barcelona, Spain; [Lugli, Federico; Cipriani, Anna] Univ Modena & Reggio Emilia, Dept Chem & Geol Sci, Via Campi 103, Modena, Italy; [Oxilia, Gregorio] Univ Firenze, Dept Biol, Via Proconsolo, Florence, Italy; [Serrangeli, Maria Cristina; Feeney, Robin N. M.] Univ Coll Dublin Belfield, Hlth Sci Ctr, UCD Sch Med, Dublin, Ireland; [Penzo, Annachiara; Gottarelli, Antonio] Univ Bologna, Dept Hist & Cultures, Piazza San Giovanni Monte 2, Bologna, Italy; [Jochum, Klaus Peter] Max Planck Inst Chem, Biogeochem Dept, Mainz, Germany; [Jochum, Klaus Peter] Max Planck Inst Chem, Climate Geochem Dept, Mainz, Germany; [Cipriani, Anna] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Benazzi, Stefano] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, Leipzig, Germany	University of Bologna; University of Bologna; Universita di Modena e Reggio Emilia; University of Florence; University College Dublin; University of Bologna; Max Planck Society; Max Planck Society; Columbia University; Max Planck Society	Sorrentino, R (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Via Selmi 3, Bologna, Italy.; Sorrentino, R (corresponding author), Univ Bologna, Dept Cultural Heritage, Via Ariani 1, Ravenna, Italy.	rita.sorrentino2@unibo.it	Oxilia, Gregorio/AAY-2413-2020; Benazzi, Stefano/AAH-3923-2020; Sorrentino, Rita/C-9436-2018; Cipriani, Anna/A-2797-2012	Oxilia, Gregorio/0000-0001-5412-0997; Sorrentino, Rita/0000-0002-6529-7250; BORTOLINI, EUGENIO/0000-0001-6751-5680; BELCASTRO, MARIA GIOVANNA/0000-0002-8932-8509; Figus, Carla/0000-0001-7405-2573; Cipriani, Anna/0000-0001-8457-0147; Lugli, Federico/0000-0002-5642-2216	European Research Council (ERC) under the European Union [724046 SUCCESS]	European Research Council (ERC) under the European Union(European Research Council (ERC))	This project was funded by the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (http://www.erc-success.eu/) grant agreement No 724046 SUCCESS awarded to Prof. Stefano Benazzi, and Programma Giovani Ricercatori Rita Levi Montalcini (to AC).	Acsadi G., HIST HUMAN LIFE SPAN; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Anctil MJ, 2016, THESIS; [Anonymous], 2011, BIOINFORMATICS, P592; Bell AV, 2009, P NATL ACAD SCI USA, V106, P17671, DOI 10.1073/pnas.0903232106; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2013, J ANTHROPOL ARCHAEOL, V32, P303, DOI 10.1016/j.jaa.2012.01.009; BINFORD LR, 1965, AM ANTIQUITY, V31, P203, DOI 10.2307/2693985; Bondini A, 2004, STUDI SCAVI, V2004, P51; Boyd R., 1985, CULTURE EVOLUTIONARY; Brasili P, 1997, Anthropol Anz, V55, P247; Brasili P, 2000, HOMO, V51, P200; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brothwell D. R, 1981, DIGGING BONES, V3rd; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Buikstra Jane., 1994, STANDARDS DATA COLLE, V44, P209, DOI DOI 10.1002/AJHB.1310070519; Burnett SE, 2013, WEARS PROBLEM EXAMIN; Camporeale G., 2011, GLI ETRUSCHI STORIA; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; Charlier P, 2009, MELANGES ECOLE FRANC, V121, P269; Coppa A, 2007, AM J PHYS ANTHROPOL, V133, P918, DOI 10.1002/ajpa.20620; Coppa A, 1998, AM J PHYS ANTHROPOL, V107, P371, DOI 10.1002/(SICI)1096-8644(199812)107:4<371::AID-AJPA1>3.3.CO;2-0; Coppa A, 1997, ETRUSCAN STUD, V4, P87, DOI DOI 10.1515/ETST.1997.4.1.87; Creanza N, 2015, P NATL ACAD SCI USA, V112, P1265, DOI 10.1073/pnas.1424033112; Eerkens JW, 2005, J ANTHROPOL ARCHAEOL, V24, P316, DOI 10.1016/j.jaa.2005.08.001; Ehrlich S, 2004, CAN J ANAL SCI SPECT, V49, P136; EXCOFFIER L, 1992, GENETICS, V131, P479; Fort J, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0166; Giusberti G., 1981, MELANGES ECOLE FRANC, V93, P155; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GREEN RF, 1976, AM J PHYS ANTHROPOL, V45, P61, DOI 10.1002/ajpa.1330450108; Gruppioni G., 1980, ATTI SOC NATURALISTI, VIII, P1; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; HAEUSSLER AM, 1988, AM J PHYS ANTHROPOL, V75, P218; Hanihara T, 2008, AM J PHYS ANTHROPOL, V136, P169, DOI 10.1002/ajpa.20792; Harris EF, 2004, DENT ANTHR, V17, P8393; Herrera B, 2014, AM J PHYS ANTHROPOL, V154, P334, DOI 10.1002/ajpa.22513; HILLSON S, 1996, DENT ANTHR; Hubbard AR, 2015, AM J PHYS ANTHROPOL, V157, P295, DOI 10.1002/ajpa.22714; Irish JD, 2010, HOMO, V61, P81, DOI 10.1016/j.jchb.2010.02.001; Irish JD, 2006, AM J PHYS ANTHROPOL, V129, P529, DOI 10.1002/ajpa.20261; Irish JD, 2005, AM J PHYS ANTHROPOL, V128, P520, DOI 10.1002/ajpa.20109; Irish JD, 1997, AM J PHYS ANTHROPOL, V102, P455; Irish JD, 1998, J HUM EVOL, V34, P81, DOI 10.1006/jhev.1997.0191; Irish JD, 2014, AM J PHYS ANTHROPOL, V155, P33, DOI 10.1002/ajpa.22526; Irish JD, 2010, AM J HUM BIOL, V22, P378, DOI 10.1002/ajhb.21010; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [DOI 10.5169/SEALS-266450, 10.5169/seals-266450]; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7; Jean-Pierre B., 1977, B MEM SOC ANTHRO PAR, V6, P351; JOHNSON AL, 1994, AM J PHYS ANTHROPOL, V93, P427, DOI 10.1002/ajpa.1330930403; Kimmerle EH, 2008, J FORENSIC SCI, V53, P558, DOI 10.1111/j.1556-4029.2008.00711.x; Kruta V, 1999, I CELTI IN ITALIA; Kruta V., 2003, GRANDE STORIA CELTI; Kusaka S, 2012, J ANTHROPOL ARCHAEOL, V31, P551, DOI 10.1016/j.jaa.2012.05.004; Larsen CS, 1997, HUMAN BIOL; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lugli F, 2017, ARCHAEOMETRY, V59, P1119, DOI 10.1111/arcm.12295; Lugli F, 2017, INT J MASS SPECTROM, V412, P38, DOI 10.1016/j.ijms.2016.12.012; Mariotti V, 2005, INT J OSTEOARCHAEOL, V15, P311, DOI 10.1002/oa.775; Marker M., 2009, MAKING HIST INTERACT, P1, DOI DOI 10.1109/ICEMS.2009.5382736; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; McIlvaine BK, 2014, AM J PHYS ANTHROPOL, V153, P236, DOI 10.1002/ajpa.22425; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Nenadic O, 2007, CORRES ANAL R 2 3 DI; Novak M, 2012, HOMO, V63, P435, DOI 10.1016/j.jchb.2012.08.003; Ortalli J., 2008, TRA MONDO CELTICO MO, P299; Ortalli J., 1992, EUROPE CELTIQUE ILLE; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Penzo A., 2016, MONDO ETRUSCO MONDO, P221; Pinhasi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006747; Price TD, 2014, J ANTHROPOL ARCHAEOL, V36, P32, DOI 10.1016/j.jaa.2014.02.003; R Core Team, 2015, R LANGUAGE ENV STAT; Ricaut FX, 2010, AM J PHYS ANTHROPOL, V143, P355, DOI 10.1002/ajpa.21322; Ross RM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3065; Rzeszutek T, 2012, P ROY SOC B-BIOL SCI, V279, P1606, DOI 10.1098/rspb.2011.1750; Sarno S, 2016, EUR J HUM GENET, V24, P600, DOI 10.1038/ejhg.2015.138; Sassatelli G., 2010, ETRUSCHI CITTA FONTI, P204; Sassatelli G., 2003, OCNUS QUAD SC SPEC A, V11, P231; Sassatelli G., 2001, ETRUSCHI FUORI ETRUR, P168; Scheeres M, 2013, J ARCHAEOL SCI, V40, P3614, DOI 10.1016/j.jas.2013.05.003; Schmitt Aurore, 2000, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V12, P279; SCOTT GR, 1988, ANNU REV ANTHROPOL, V17, P99, DOI 10.1146/annurev.an.17.100188.000531; Scott GR, 2008, BIOL ANTHR HUMAN SKE, P265, DOI DOI 10.1002/9780470245842; Shaw B, 2011, J ANTHROPOL ARCHAEOL, V30, P344, DOI 10.1016/j.jaa.2011.05.004; Shennan SJ, 2015, EVOL HUM BEHAV, V36, P103, DOI 10.1016/j.evolhumbehav.2014.09.006; SJOVOLD T, 1973, HOMO, V24, P204; Steele J., 2009, INNOVATION DIFFUSION; Stojanowski CM, 2015, AM J PHYS ANTHROPOL, V156, P349, DOI 10.1002/ajpa.22653; Tafuri MA, 2006, J ANTHROPOL ARCHAEOL, V25, P390, DOI 10.1016/j.jaa.2006.01.002; Thompson AR, 2015, AM J PHYS ANTHROPOL, V158, P341, DOI 10.1002/ajpa.22791; TURNER CG, 1987, AM J PHYS ANTHROPOL, V73, P305, DOI 10.1002/ajpa.1330730304; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; Ubelaker D.H., 1989, HUMAN SKELETAL REMAI, V3rd; Ullinger JM, 2005, AM J PHYS ANTHROPOL, V128, P466, DOI 10.1002/ajpa.20074; Vital D, 2008, TLS-TIMES LIT SUPPL, P13; Vitali D., 1992, TOMBE NECROPOLI GALL; Vitali D., 2004, IBERES VENETES COLLE, V328, P277; Vitali D., 1983, MONTERENZIO VALLE ID; Vitali D., 1987, ATT C INT BOL 12 14; Vitali D, 2002, OCNUS QUAD SC SPEC A; Vitali D., 2003, NECROPOLI MONTE TAMB; Weber AW, 2013, J ANTHROPOL ARCHAEOL, V32, P330, DOI 10.1016/j.jaa.2012.01.006; Weber M, 2017, GEOSTAND GEOANALYTIC	104	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193796	10.1371/journal.pone.0193796	http://dx.doi.org/10.1371/journal.pone.0193796			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590155	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100032
J	Di Fede, M; Biagini, M; Cartocci, E; Parillo, C; Greco, A; Martinelli, M; Marchi, S; Pezzicoli, A; Delany, I; Paccani, SR				Di Fede, Martina; Biagini, Massimiliano; Cartocci, Elena; Parillo, Carlo; Greco, Alessandra; Martinelli, Manuele; Marchi, Sara; Pezzicoli, Alfredo; Delany, Isabel; Paccani, Silvia Rossi			Neisseria Heparin Binding Antigen is targeted by the human alternative pathway C3-convertase	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; TISSUE KALLIKREIN; MENINGOCOCCAL CARRIAGE; MENINGITIDIS; COMPLEMENT; ACTIVATION; EXPRESSION; CONVERTASE; PROTEINS; TRACHEA	Neisserial Heparin Binding Antigen (NHBA) is a surface-exposed lipoprotein specific for Neisseria and constitutes one of the three main protein antigens of the Bexsero vaccine. Meningococcal and human proteases, cleave NHBA protein upstream or downstream of a conserved Arg-rich region, respectively. The cleavage results in the release of the C-terminal portion of the protein. The C-terminal fragment originating from the processing of meningococcal proteases, referred to as C2 fragment, exerts a toxic effect on endothelial cells altering the endothelial permeability. In this work, we reported that recombinant C2 fragment has no influence on the integrity of human airway epithelial cell monolayers, consistent with previous findings showing that Neisseria meningitidis traverses the epithelial barrier without disrupting the junctional structures. We showed that epithelial cells constantly secrete proteases responsible for a rapid processing of C2 fragment, generating a new fragment that does not contain the Arg-rich region, a putative docking domain reported to be essential for C2-mediated toxic effect. Moreover, we found that the C3-convertase of the alternative complement pathway is one of the proteases responsible for this processing. Overall, our data provide new insights on the cleavage of NHBA protein during meningococcal infection. NHBA cleavage may occur at different stages of the infection, and it likely has a different role depending on the environment the bacterium is interacting with.	[Di Fede, Martina; Biagini, Massimiliano; Cartocci, Elena; Parillo, Carlo; Greco, Alessandra; Martinelli, Manuele; Marchi, Sara; Pezzicoli, Alfredo; Delany, Isabel; Paccani, Silvia Rossi] GSK, Siena, Italy; [Di Fede, Martina] Inst Virol & Med Biochem, Munster, Germany	GlaxoSmithKline	Paccani, SR (corresponding author), GSK, Siena, Italy.	silvia.x.rossi-paccani@gsk.com	Greco, Alessandra/AAB-9743-2019	Greco, Alessandra/0000-0002-3130-0079	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was sponsored and funded by GlaxoSmithKline Biologicals SA. GlaxoSmithKline Biologicals SA provided support in the form of salaries for MB, EC, CP, AG, SM, AP, ID, SRP. The specific roles of these authors are articulated in the author contributions section.	Alcorlo M, 2013, P NATL ACAD SCI USA, V110, P13504, DOI 10.1073/pnas.1309618110; Ali M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-4; Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Casellato A, 2014, CELL MICROBIOL, V16, P925, DOI 10.1111/cmi.12250; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; CHRISTIANSEN SC, 1987, J CLIN INVEST, V79, P188, DOI 10.1172/JCI112782; Crum-Cianflone N, 2016, INFECT DIS THER, V5, P89, DOI 10.1007/s40121-016-0107-0; Davis AS, 2015, J HISTOCHEM CYTOCHEM, V63, P312, DOI 10.1369/0022155415570968; DISCIPIO RG, 1982, IMMUNOLOGY, V45, P587; Forteza R, 1999, AM J RESP CELL MOL, V21, P666, DOI 10.1165/ajrcmb.21.6.3651; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; HIEMSTRA PS, 1985, THROMB RES, V38, P491, DOI 10.1016/0049-3848(85)90182-3; Keck T, 2000, LARYNGOSCOPE, V110, P651, DOI 10.1097/00005537-200004000-00021; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Lappann M, 2016, INFECT IMMUN, V84, P3484, DOI 10.1128/IAI.00584-16; Leu CH, 2015, ANTIMICROB AGENTS CH, V59, P5619, DOI 10.1128/AAC.00065-15; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Pantano E, NEIS SERIA HEPARIN B; PROUD D, 1993, AM J RESP CELL MOL, V8, P16, DOI 10.1165/ajrcmb/8.1.16; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Sim RJ, 2000, LANCET, V356, P1653, DOI 10.1016/S0140-6736(00)03162-7; STEPHENS DS, 1983, J INFECT DIS, V148, P369, DOI 10.1093/infdis/148.3.369; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; Vacca I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162878; Varsano S, 2000, THORAX, V55, P364, DOI 10.1136/thorax.55.5.364	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194662	10.1371/journal.pone.0194662	http://dx.doi.org/10.1371/journal.pone.0194662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579105	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800045
J	Geldenhuys, M; Mortlock, M; Weyer, J; Bezuidt, O; Seamark, ECJ; Kearney, T; Gleasner, C; Erkkila, TH; Cui, HL; Markotter, W				Geldenhuys, Marike; Mortlock, Marinda; Weyer, Jacqueline; Bezuidt, Oliver; Seamark, Ernest C. J.; Kearney, Teresa; Gleasner, Cheryl; Erkkila, Tracy H.; Cui, Helen; Markotter, Wanda			A metagenomic viral discovery approach identifies potential zoonotic and novel mammalian viruses in Neoromicia bats within South Africa	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MERS CORONAVIRUS; DROMEDARY CAMELS; GENETIC DIVERSITY; GENOME ANALYSIS; PREVALENCE; CHINA; ADENOVIRUSES; PARAMYXOVIRUSES; CLASSIFICATION	Species within the Neoromicia bat genus are abundant and widely distributed in Africa. It is common for these insectivorous bats to roost in anthropogenic structures in urban regions. Additionally, Neoromicia capensis have previously been identified as potential hosts for Middle East respiratory syndrome (MERS)-related coronaviruses. This study aimed to ascertain the gastrointestinal virome of these bats, as viruses excreted in fecal material or which may be replicating in rectal or intestinal tissues have the greatest opportunities of coming into contact with other hosts. Samples were collected in five regions of South Africa over eight years. Initial virome composition was determined by viral metagenomic sequencing by pooling samples and enriching for viral particles. Libraries were sequenced on the Illumine MiSeq and NextSeq500 platforms, producing a combined 37 million reads. Bioinformatics analysis of the high throughput sequencing data detected the full genome of a novel species of the Circoviridae family, and also identified sequence data from the Adenoviridae, Coronaviridae, Herpesviridae, Parvoviridae, Papillomaviridae, Phenuiviridae, and Picornaviridae families. Metagenomic sequencing data was insufficient to determine the viral diversity of certain families due to the fragmented coverage of genomes and lack of suitable sequencing depth, as some viruses were detected from the analysis of reads-data only. Follow up conventional PCR assays targeting conserved gene regions for the Adenoviridae, Coronaviridae, and Herpesviridae families were used to confirm metagenomic data and generate additional sequences to determine genetic diversity. The complete coding genome of a MERS-related coronavirus was recovered with additional amplicon sequencing on the MiSeq platform. The new genome shared 97.2% overall nucleotide identity to a previous Neoromicia-associated MERS-related virus, also from South Africa. Conventional PCR analysis detected diverse adenovirus and herpesvirus sequences that were widespread throughout Neoromicia populations in South Africa. Furthermore, similar adenovirus sequences were detected within these populations throughout several years. With the exception of the coronaviruses, the study represents the first report of sequence data from several viral families within a Southern African insectivorous bat genus; highlighting the need for continued investigations in this regard.	[Geldenhuys, Marike; Mortlock, Marinda; Markotter, Wanda] Univ Pretoria, Dept Med Virol, Ctr Viral Zoonoses, Pretoria, South Africa; [Weyer, Jacqueline] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Bezuidt, Oliver] Univ Pretoria, Ctr Microbial Ecol & Genom, Pretoria, South Africa; [Seamark, Ernest C. J.] AfricanBats NPC, Pretoria, South Africa; [Seamark, Ernest C. J.] Univ Pretoria, Mammal Res Inst, Eugene Marais Chair Wildlife Management, Pretoria, South Africa; [Kearney, Teresa] Ditsong Natl Museum Nat Hist, Pretoria, South Africa; [Kearney, Teresa] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Gleasner, Cheryl; Erkkila, Tracy H.; Cui, Helen] Los Alamos Natl Lab, Los Alamos, NM USA	University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; University of Pretoria; University of Witwatersrand; United States Department of Energy (DOE); Los Alamos National Laboratory	Markotter, W (corresponding author), Univ Pretoria, Dept Med Virol, Ctr Viral Zoonoses, Pretoria, South Africa.	wanda.markotter@up.ac.za	Geldenhuys, Marike/AAL-4868-2020	Geldenhuys, Marike/0000-0003-4005-118X; Kearney, Teresa/0000-0002-0050-4060; bezuidt, keoagile oliver/0000-0002-1690-9716; Markotter, Wanda/0000-0002-7550-0080; Mortlock, Marinda/0000-0001-9286-1040; Seamark, Ernest C. J./0000-0001-9741-9147	National Research Foundation (NRF) of South Africa: the South African Research Chair [98339, 92524, 85756, 91496]; Poliomyelitis Research Foundation [12/14]; Research Trust of the National Health Laboratory Service; Medical Research Council; Centers for Disease Control and Prevention [5 NU2GGH001874-02-00]; NRF's Innovation bursary award [UID: 79409]; University of Pretoria	National Research Foundation (NRF) of South Africa: the South African Research Chair; Poliomyelitis Research Foundation; Research Trust of the National Health Laboratory Service; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NRF's Innovation bursary award; University of Pretoria	This work was financially supported in part by the National Research Foundation (NRF) of South Africa: the South African Research Chair held by WM grant no. 98339, as well as grant numbers 92524, 85756, and 91496. The opinions, findings and conclusions expressed are those of the authors alone, and the NRF accepts no liability in this regard for research supported. Additional support was obtained by WM from the Poliomyelitis Research Foundation (grant number: 12/14). The Research Trust of the National Health Laboratory Service and the Medical Research Council was awarded to JW. This research was partially supported by the Grant or Cooperative Agreement Number [5 NU2GGH001874-02-00], funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. MG was supported by funding from the NRF's Innovation bursary award (grant UID: 79409), the Poliomyelitis Research Foundation (grant no. 13/48), and the postgraduate study abroad bursary program of the University of Pretoria, which funded a research visit to the Los Alamos National Laboratory in New Mexico.	Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]; Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Benko M, 2014, FUTURE MICROBIOL, V9, P269, DOI 10.2217/fmb.13.170; Chu DKW, 2014, EMERG INFECT DIS, V20, P1049, DOI 10.3201/eid2006.140299; Corman VM, 2014, EMERG INFECT DIS, V20, P1319, DOI 10.3201/eid2008.140596; Corman VM, 2014, J VIROL, V88, P11297, DOI 10.1128/JVI.01498-14; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Darriba D., 2015, NAT METHODS, V9, P6, DOI DOI 10.1038/NMETH.2109.JM0DELTEST; de Groot RJ, 2012, VIRUS TAXONOMY, P806, DOI DOI 10.1016/B978-0-12-384684-6.00068-9; Lima FED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118070; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013; Drexler JF, 2013, P NATL ACAD SCI USA, V110, P16151, DOI 10.1073/pnas.1308049110; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Escalera-Zamudio M, 2016, MBIO, V7, DOI [10.1128/mBio.01425-16, 10.1128/mbio.01425-16]; Faye B, 2015, EMIR J FOOD AGR, V27, P318, DOI 10.9755/ejfa.v27i4.19906; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Geldenhuys M, 2013, VECTOR-BORNE ZOONOT, V13, P516, DOI 10.1089/vbz.2012.1101; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Goodman SM, 2017, ZOOTAXA, V4236, P351, DOI 10.11646/zootaxa.4236.2.10; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P344, DOI 10.1111/tbed.12401; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huson DH, 2007, MEGAN ANAL METAGENOM, P377; Hutson AM, 2014, IUCN RED LIST THREAT; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jacobs D, 2014, IUCN RED LIST THREAT; Janoska M, 2011, VET J, V189, P118, DOI 10.1016/j.tvjl.2010.06.020; Kemenesi G, 2015, J GEN VIROL, V96, P815, DOI 10.1099/jgv.0.000028; Kohl C, 2015, EMERG INFECT DIS, V21, P48, DOI 10.3201/eid2101.140766; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Lukashev AN, 2017, J GEN VIROL, V98, P955, DOI 10.1099/jgv.0.000760; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Mortlock M, 2015, EMERG INFECT DIS, V21, P1840, DOI 10.3201/eid2110.140368; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026; Oude Munnink BBO, 2016, GENOME ANNOUNC, V4; Pankovics P, 2016, INFECT GENET EVOL, V37, P117, DOI 10.1016/j.meegid.2015.11.012; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Phillips S. B., 2006, International Journal of Global Environmental Issues, V6, P231, DOI 10.1504/IJGENVI.2006.010156; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Rahman MA, 2012, VECTOR-BORNE ZOONOT, V12, P65, DOI 10.1089/vbz.2011.0656; Reusken CBEM, 2013, LANCET, V3099, P1; Reusken CBEM, 2014, EMERG INFECT DIS, V20, P1370, DOI 10.3201/eid2008.140590; Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608; Sayre R, 2013, AFRICAN GEOGR REV, P1; Seamark ECJ, 2016, PRETORIA AFRICANBATS; Shabman RS, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00070-15; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Sumibcay L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-34; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Tao Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01953-16; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Vidovszky MZ, 2015, ACTA VET HUNG, V63, P508, DOI 10.1556/004.2015.047; Wang J, 2015, J GEN VIROL, V96, P2442, DOI 10.1099/vir.0.000158; Wang SL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-451; Wilson R. T., 2013, African Journal of Agricultural Research, V8, P3716; Wu Z, 2015, ISME J, V2015, P1, DOI DOI 10.1038/ISMEJ.2015.138; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Yuan LH, 2014, VIRUSES-BASEL, V6, P2138, DOI 10.3390/v6052138; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao GY, 2017, VIROLOGY, V503, P21, DOI 10.1016/j.virol.2017.01.005; Zheng XY, 2016, ARCH VIROL, V161, P135, DOI 10.1007/s00705-015-2614-9	82	48	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194527	10.1371/journal.pone.0194527	http://dx.doi.org/10.1371/journal.pone.0194527			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579103	Green Submitted, Green Published, gold			2022-12-27	WOS:000428351800035
J	Arnould, L; Binquet, C; Guenancia, C; Alassane, S; Kawasaki, R; Daien, V; Tzourie, C; Kawasaki, Y; Bourredjem, A; Bron, A; Creuzot-Garcher, C				Arnould, Louis; Binquet, Christine; Guenancia, Charles; Alassane, Seydou; Kawasaki, Ryo; Daien, Vincent; Tzourie, Christophe; Kawasaki, Yumiko; Bourredjem, Abderrahmane; Bron, Alain; Creuzot-Garcher, Catherine			Association between the retinal vascular network with Singapore "I" Vessel Assessment (SIVA) software, cardiovascular history and risk factors in the elderly: The Montrachet study, population-based study	PLOS ONE			English	Article							ATHEROSCLEROSIS RISK; BLOOD-PRESSURE; DIAMETERS; HYPERTENSION; DISEASE; CALIBER; COMMUNITIES; MORTALITY; NUMBER; SCREE	Purpose To identify patterns summarizing the retinal vascular network in the elderly and to investigate the relationship of these vascular patterns with cardiovascular history. Methods We conducted a population-based study, the Montrachet study (Maculopathy Optic Nerve nuTRition neurovAsCular and HEarT diseases), in participants older than 75 years. The history of cardiovascular disease and a score-based estimation of their 10-year risk of cardiovascular mortality (Heart SCORE) were collected. Retinal vascular network analysis was performed by means of Singapore "I" Vessel Assessment (SIVA) software. Principal component analysis was used to condense the information contained in the high number of variables provided and to identify independent retinal vascular patterns. Results Overall, 1069 photographs (1069 participants) were reviewed with SIVA software. The mean age was 80.0 +/- 3.8 years. We extracted three vascular patterns summarizing 41.3% of the vascular information. The most clinically relevant pattern, Sparse vascular network, accounted for 17.4% of the total variance. It corresponded to a lower density in the vascular network and higher variability in vessel width. Diabetic participants with hypoglycemic treatment had a sparser vascular network pattern than subjects without such treatment (odds ratio, [OR], 1.68; 95% CI, 1.04-2.72; P=0.04). Participants with no history of cardiovascular disease who had a sparser vascular network were associated with a higher Heart SCORE (OR, 1.76; 95% CI, 1.08-2.25; P=0.02). Conclusions Three vascular patterns were identified. The Sparse vascular network pattern was associated with having a higher risk profile for cardiovascular mortality risk at 10 years.	[Arnould, Louis; Bron, Alain; Creuzot-Garcher, Catherine] Univ Hosp, Dept Ophthalmol, Dijon, France; [Arnould, Louis; Binquet, Christine; Alassane, Seydou; Bourredjem, Abderrahmane] INSERM, CIC1432, Clin Epidemiol Unit, Dijon, France; [Arnould, Louis; Binquet, Christine; Alassane, Seydou; Bourredjem, Abderrahmane] Dijon Univ Hosp, Clin Invest Ctr, Clin Epidemiol Clin Trials Unit, Dijon, France; [Guenancia, Charles] Dijon Univ Hosp, Dept Cardiol, Dijon, France; [Guenancia, Charles] Dijon Univ Hosp, INSERM, UMR866, Lab Cardiometab Physiopathol & Pharmacol, Dijon, France; [Alassane, Seydou; Bron, Alain; Creuzot-Garcher, Catherine] INRA, UMR 1324, CSGA, Eye & Nutr Res Grp, Dijon, France; [Kawasaki, Ryo; Kawasaki, Yumiko] Yamagata Univ, Dept Publ Hlth, Grad Sch Med Sci, Yamagata, Japan; [Daien, Vincent] Univ Hosp, Dept Ophthalmol, Montpellier, France; [Tzourie, Christophe] Univ Hosp, U708, INSERM, Epidemiol, Bordeaux, France	CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Yamagata University; Universite de Montpellier; CHU de Montpellier; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Creuzot-Garcher, C (corresponding author), Univ Hosp, Dept Ophthalmol, Dijon, France.; Creuzot-Garcher, C (corresponding author), INRA, UMR 1324, CSGA, Eye & Nutr Res Grp, Dijon, France.	catherine.creuzot-garcher@chu-dijon.fr	Guenancia, Charles/M-5558-2013; Kawasaki, Ryo/H-9716-2019; Arnould, Louis/AAG-2207-2021; Binquet, Christine/E-8953-2018; Kawasaki, Ryo/B-7266-2009; Bron, Alain/AAP-8010-2020; DAIEN, Vincent/Z-5516-2019; Tzourio, christophe/B-4015-2009	Guenancia, Charles/0000-0002-3554-7714; Binquet, Christine/0000-0002-9417-5754; Kawasaki, Ryo/0000-0002-7492-6303; Bron, Alain/0000-0002-7265-931X; DAIEN, Vincent/0000-0001-5675-0861; Tzourio, christophe/0000-0002-6517-2984; Alassane, Seydou/0000-0001-8958-6834	Regional Council of Burgundy; Agence Nationale de la Recherche (FR)	Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Agence Nationale de la Recherche (FR)(French National Research Agency (ANR))	This work was supported by Regional Council of Burgundy (Pr Catherine Creuzot-Garcher) and Agence Nationale de la Recherche (FR) (Pr Catherine Creuzot-Garcher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Beltramo E, 2004, DIABETES-METAB RES, V20, P330, DOI 10.1002/dmrr.470; CATTELL RB, 1977, MULTIVAR BEHAV RES, V12, P289, DOI 10.1207/s15327906mbr1203_2; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Cheung CYL, 2010, MICROCIRCULATION, V17, P495, DOI 10.1111/j.1549-8719.2010.00048.x; Cheung N, 2007, HYPERTENSION, V50, P617, DOI 10.1161/HYPERTENSIONAHA.107.091926; Cheung N, 2007, J AM COLL CARDIOL, V50, P48, DOI 10.1016/j.jacc.2007.03.029; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Creuzot-Garcher C, 2016, ACTA OPHTHALMOL, V94, pE90, DOI 10.1111/aos.12842; Ding J, 2014, J HYPERTENS, V32, P207, DOI 10.1097/HJH.0b013e32836586f4; Feihl F, 2006, HYPERTENSION, V48, P1012, DOI 10.1161/01.HYP.0000249510.20326.72; Harman H. H., 1976, MODERN FACTOR ANAL; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Knudtson MD, 2004, BRIT J OPHTHALMOL, V88, P57, DOI 10.1136/bjo.88.1.57; Li HQ, 2005, IEEE T BIO-MED ENG, V52, P1352, DOI 10.1109/TBME.2005.847402; Liao DP, 2004, STROKE, V35, P837, DOI 10.1161/01.STR.0000120310.43457.AD; Liew G, 2008, OPHTHALMOLOGY, V115, P1951, DOI 10.1016/j.ophtha.2008.05.029; Liew G, 2011, EUR HEART J, V32, P422, DOI 10.1093/eurheartj/ehq431; Lim LS, 2011, INVEST OPHTH VIS SCI, V52, P669, DOI 10.1167/iovs.10-6184; Murray CD, 1926, J GEN PHYSIOL, V9, P835, DOI 10.1085/jgp.9.6.835; Puro DG, 2012, PROG RETIN EYE RES, V31, P258, DOI 10.1016/j.preteyeres.2012.01.001; Sasongko MB, 2012, OPHTHAL EPIDEMIOL, V19, P322, DOI 10.3109/09286586.2012.702258; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; Tuppin P, 2009, ARCH CARDIOVASC DIS, V102, P279, DOI 10.1016/j.acvd.2009.02.005; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; WHO, 2015, NONC DIS; Wilkinson-Berka JL, 2006, INT J BIOCHEM CELL B, V38, P752, DOI 10.1016/j.biocel.2005.08.002; World Health Organization, 2012, GLOB HLTH OBS DAT RE; Zhu PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106551	35	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194694	10.1371/journal.pone.0194694	http://dx.doi.org/10.1371/journal.pone.0194694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614075	Green Published, gold			2022-12-27	WOS:000429081600015
J	Brinkman, NE; Villegas, EN; Garland, JL; Keely, SP				Brinkman, Nichole E.; Villegas, Eric N.; Garland, Jay L.; Keely, Scott P.			Reducing inherent biases introduced during DNA viral metagenome analyses of municipal wastewater	PLOS ONE			English	Article							VIRUSES; AMPLIFICATION; AGGREGATION; SLUDGE; POLYOMAVIRUSES; IDENTIFICATION; GENERATION; DIVERSITY; DYNAMICS; QUALITY	Metagenomics is a powerful tool for characterizing viral composition within environmental samples, but sample and molecular processing steps can bias the estimation of viral community structure. The objective of this study is to understand the inherent variability introduced when conducting viral metagenomic analyses of wastewater and provide a bioinformatic strategy to accurately analyze sequences for viral community analyses. A standard approach using a combination of ultrafiltration, membrane filtration, and DNase treatment, and multiple displacement amplification (MDA) produced DNA preparations without any bacterial derived genes. Results showed recoveries in wastewater matrix ranged between 60-100%. A bias towards small single stranded DNA (ssDNA; polyomavirus) virus types vs larger double stranded DNA (dsDNA; adenovirus) viruses was also observed with a total estimated recovery of small circular viruses to be as much as 173-fold higher. Notably, ssDNA abundance decreased with sample dilution while large dsDNA genomes (e.g., Caudovirales) initially increased in abundance with dilution before gradually decreasing with further dilution in wastewater samples. The present study revealed the inherent biases associated with different components of viral metagenomic methods applied to wastewater. Overall, these results provide a well-characterized approach for effectively conducting viral metagenomics analysis of wastewater and reveal that dilution can effectively mitigate MDA bias.	[Brinkman, Nichole E.; Villegas, Eric N.; Garland, Jay L.; Keely, Scott P.] US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	United States Environmental Protection Agency	Keely, SP (corresponding author), US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA.	keely.scott@epa.gov	Keely, Scott/W-5761-2019	Keely, Scott/0000-0002-5343-3649				American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Aw TG, 2014, J VIROL METHODS, V210, P15, DOI 10.1016/j.jviromet.2014.09.017; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; Cashdollar JL, 2013, APPL ENVIRON MICROB, V79, P215, DOI 10.1128/AEM.02270-12; Colson P, 2013, INTERVIROLOGY, V56, P376, DOI 10.1159/000354558; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; FLOYD R, 1979, APPL ENVIRON MICROB, V38, P395, DOI 10.1128/AEM.38.3.395-401.1979; Gassilloud B, 2005, APPL ENVIRON MICROB, V71, P912, DOI 10.1128/AEM.71.2.912-920.2005; Gutierrez L, 2012, ENVIRON SCI TECHNOL, V46, P8705, DOI 10.1021/es301336u; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hammer O., 2011, PALAEONTOL ELECTRON, V4, P9; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Johne R, 2006, J VIROL, V80, P3523, DOI 10.1128/JVI.80.7.3523-3531.2006; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Kleiner M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1207-4; Leow A, 2017, ENVIRON SCI-WAT RES, V3, P224, DOI [10.1039/c6ew00226a, 10.1039/C6EW00226A]; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Marine R, 2011, APPL ENVIRON MICROB, V77, P8071, DOI 10.1128/AEM.05610-11; McCrady MH, 1915, J INFECT DIS, V17, P183, DOI 10.1093/infdis/17.1.183; McQuaig SM, 2009, APPL ENVIRON MICROB, V75, P3379, DOI 10.1128/AEM.02302-08; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Norman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104405; NRC, 2012, WAT REUS POT EXPL NA; Otawa K, 2007, MICROB ECOL, V53, P143, DOI 10.1007/s00248-006-9150-9; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P2673, DOI 10.1128/AEM.02520-09; R Development Core Team, 2009, R LANG ENV STAT COMP; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Roux S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76; Stachlert E, 2014, ENVIRON SCI TECH LET, V1, P405, DOI 10.1021/ez500266s; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Thatcher SA, 2015, CLIN CHEM, V61, P89, DOI 10.1373/clinchem.2014.221374; USEPA, 2010, 1615 USEPA; Vazquez-Castellanos JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-37; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P231; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	47	16	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195350	10.1371/journal.pone.0195350	http://dx.doi.org/10.1371/journal.pone.0195350			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614100	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600052
J	Berende, A; Nieuwenhuis, L; ter Hofstede, HJM; Vos, FJ; Vogelaar, ML; Tromp, M; van Middendorp, H; Donders, ART; Evers, AWM; Kullberg, BJ; Adang, EMM				Berende, Anneleen; Nieuwenhuis, Lisette; ter Hofstede, Hadewych J. M.; Vos, Fidel J.; Vogelaar, Michiel L.; Tromp, Mirjam; van Middendorp, Henriet; Donders, A. Rogier T.; Evers, Andrea W. M.; Kullberg, Bart Jan; Adang, Eddy M. M.			Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease	PLOS ONE			English	Article							HEALTH-CARE; BORRELIOSIS; MANAGEMENT; GUIDELINES; DIAGNOSIS; DURATION; THERAPY; DESIGN; TRIAL	Background The treatment of persistent symptoms attributed to Lyme disease remains controversial. Recently, the PLEASE study did not demonstrate any additional clinical benefit of longer term versus shorter-term antibiotic treatment. However, the economic impact of the antibiotic strategies has not been investigated. Methods This prospective economic evaluation, adhering a societal perspective, was performed alongside the PLEASE study, a multicenter, placebo-controlled, double-blind 1:1:1 randomized clinical trial in which all patients received open-label intravenous ceftriaxone for two weeks before the 12-week randomized blinded oral antibiotic regimen (doxycycline, clarithromycin plus hydroxychloroquine, or placebo). Between 2010 and 2013, patients (n = 271) with borreliosis-attributed persistent symptoms were enrolled and followed for one year. Main outcomes were costs, quality-adjusted life years, and incremental net monetary benefit of longer-term versus shorter-term antibiotic therapy. Results Mean quality-adjusted life years (95% CI) were not significantly different (p = 0.96): 0.82 (0.77-0.88) for ceftriaxone/doxycycline (n = 82), 0.81 (0.76-0.88) for ceftriaxone/clarithromycin-hydroxychloroquine (n = 93), and 0.81 (0.76-0.86) for ceftriaxone/placebo (n = 96). Total societal costs per patient (95% CI) were not significantly different either (p = 0.35): (sic)11,995 ((sic)8,823- 15,670) for ceftriaxone/doxycycline, (sic)12,202 ((sic)9,572- 15,253) for ceftriaxone/clarithromycin-hydroxychloroquine, and (sic)15,249 ((sic)11,294- 19,781) for ceftriaxone/ placebo. Incremental net monetary benefit (95% CI) for ceftriaxone/doxycycline compared to ceftriaxone/placebo varied from (sic)3,317 (-(sic) 2,199- 8,998) to (sic)4,285 (-(sic) 6,085-(sic)14,524) over the willingness-to-pay range, and that of ceftriaxone/clarithromycin-hydroxychloroquine compared to ceftriaxone/placebo from (sic)3,098 (-(sic)888-(sic)7,172) to (sic)3,710 (-(sic)4,254-(sic)11,651). For every willingness-to-pay threshold, the incremental net monetary benefits did not significantly differ from zero. Conclusion The longer-term treatments were similar with regard to costs, effectiveness and cost-effectiveness compared to shorter-term treatment in patients with borreliosis-attributed persistent symptoms after one year of follow-up. Given the results of this study, and taking into account the external costs associated with antibiotic resistance, the shorter-term treatment is the antibiotic regimen of first choice.	[Berende, Anneleen; ter Hofstede, Hadewych J. M.; Vos, Fidel J.; Vogelaar, Michiel L.; Tromp, Mirjam; Kullberg, Bart Jan] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Berende, Anneleen; ter Hofstede, Hadewych J. M.; Vos, Fidel J.; Vogelaar, Michiel L.; Tromp, Mirjam; Kullberg, Bart Jan] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Nieuwenhuis, Lisette; Donders, A. Rogier T.; Adang, Eddy M. M.] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands; [Nieuwenhuis, Lisette] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Vos, Fidel J.] Sint Maartensklin, Nijmegen, Netherlands; [Vogelaar, Michiel L.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, Nijmegen, Netherlands; [van Middendorp, Henriet; Evers, Andrea W. M.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [van Middendorp, Henriet; Evers, Andrea W. M.] Leiden Univ, Hlth Med & Neuropsychol Unit, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University; Sint Maartens Clinic; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Berende, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Berende, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.	Anneleen.Berende@radboudumc.nl	Kullberg, BJ/C-8520-2013; Evers, A.W.M./L-4299-2015; Hofstede, Hadewych ter/AAD-1118-2019; Evers, Andrea/GWV-9705-2022; A, Berende/G-3303-2016; Evers, Andrea/U-8983-2019; van Middendorp, Henriet/B-8300-2013; Adang, E.M.M./L-4169-2015; Donders, A.R.T./L-4277-2015	Kullberg, BJ/0000-0002-6813-8167; A, Berende/0000-0002-9079-9519; Evers, Andrea/0000-0002-0090-5091; Donders, A.R.T./0000-0002-0484-1419; van Middendorp, Henriet/0000-0003-4575-0895	Netherlands Organization for Health Research and Development (ZonMw) [171002304]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by a grant (171002304) from the Netherlands Organization for Health Research and Development (ZonMw). Authors who received the funding: HH, FV, BJK, AE, EA. https://www.zonmw.nl/nl/onderzoek-resultaten/doelmatigheidsonderzoek/programmas/ project-detail/doelmatigheidsonderzoek/efficiency efficacy-and-costs-of-guideline-based-therapeutic-strategies-for-patients-with-proven-or/. The funders had a role in study design, data collection and analysis, but no role in the decision to publish, or preparation of the manuscript.	Adrion ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116767; [Anonymous], 2006, ZINNIGE DUURZAME ZOR; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Berende A, 2016, NEW ENGL J MED, V374, P1209, DOI 10.1056/NEJMoa1505425; Berende A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0543-y; Bouwmans C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-217; Busschbach JJ, 2010, PAKKETPRINCIPE KOSTE; Byford S, 1998, BRIT MED J, V316, P1529, DOI 10.1136/bmj.316.7143.1529; Cameron DJ, 2014, EXPERT REV ANTI-INFE, V12, P1103, DOI 10.1586/14787210.2014.940900; DeLong AK, 2012, CONTEMP CLIN TRIALS, V33, P1132, DOI 10.1016/j.cct.2012.08.009; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond MF, 2015, METHODS EC EVALUATIO; Fallon Brian A, 2012, Open Neurol J, V6, P79, DOI 10.2174/1874205X01206010079; Hakkaart-van Roijen L, 2015, OPDRACHT ZORGINSTITU, P12; Klempner MS, 2013, AM J MED, V126, P665, DOI 10.1016/j.amjmed.2013.02.014; Kowalski TJ, 2010, CLIN INFECT DIS, V50, P512, DOI 10.1086/649920; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Laxminarayan R., 2015, WOUND HEAL S AFRICA; Lohr B, 2015, TICKS TICK-BORNE DIS, V6, P56, DOI 10.1016/j.ttbdis.2014.09.004; Mygland A, 2010, EUR J NEUROL, V17, P8, DOI 10.1111/j.1468-1331.2009.02862.x; Rizzoli A, 2011, EURO SURVEILL, V16; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; van den Wijngaard CC, 2015, EUR J PUBLIC HEALTH, V25, P1071, DOI 10.1093/eurpub/ckv091; vanRoijen L, 1996, INT J TECHNOL ASSESS, V12, P405, DOI 10.1017/S0266462300009764; World Health Organization, 2016, ANTIMICROBIAL RESIST; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005	28	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195260	10.1371/journal.pone.0195260	http://dx.doi.org/10.1371/journal.pone.0195260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608590	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800043
J	Choi, MG; Kim, MJ; Kim, DG; Yu, R; Jang, YN; Oh, WJ				Choi, Mal-Gi; Kim, Mi Jin; Kim, Do-Geun; Yu, Ri; Jang, You-Na; Oh, Won-Jong			Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODY; IN-VITRO; NACP/ALPHA-SYNUCLEIN; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; FIBRIL FORMATION; OLIGOMERS; MICE	alpha-Synuclein (alpha-syn) is a major component of Lewy bodies found in synucleinopathies including Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB). Under the pathological conditions, alpha-syn tends to generate a diverse form of aggregates showing toxicity to neuronal cells and able to transmit across cells. However, mechanisms by which alpha-syn aggregates affect cytotoxicity in neurons have not been fully elucidated. Here we report that alpha-syn aggregates preferentially sequester specific synaptic proteins such as vesicle-associated membrane protein 2 (VAMP2) and synaptosomal-associated protein 25 (SNAP25) through direct binding which is resistant to SDS. The sequestration effect of alpha-syn aggregates was shown in a cell-free system, cultured primary neurons, and PD mouse model. Furthermore, we identified a specific blocking peptide derived from VAMP2 which partially inhibited the sequestration by alpha-syn aggregates and contributed to reduced neurotoxicity. These results provide a mechanism of neurotoxicity mediated by alpha-syn aggregates and suggest that the blocking peptide interfering with the pathological role of alpha-syn aggregates could be useful for designing a potential therapeutic drug for the treatment of PD.	[Choi, Mal-Gi; Kim, Mi Jin; Kim, Do-Geun; Yu, Ri; Jang, You-Na; Oh, Won-Jong] Korea Brain Res Inst, Dept Struct & Funct Neural Network, Daegu, South Korea	Korea Brain Research Institute (KBRI)	Choi, MG; Oh, WJ (corresponding author), Korea Brain Res Inst, Dept Struct & Funct Neural Network, Daegu, South Korea.	choimg@kbri.re.kr; ohwj@kbri.re.kr	Kim, Mi Jin/GXH-9639-2022	Oh, Won-Jong/0000-0001-8867-7814	KBRI basic research program through Korea Brain Research Institute - Ministry of Science and ICT [17-BR-02]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A3012721]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, South Korea [H I14C1135]	KBRI basic research program through Korea Brain Research Institute - Ministry of Science and ICT; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, South Korea	This research was supported by KBRI basic research program through Korea Brain Research Institute funded by the Ministry of Science and ICT (17-BR-02), Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A3012721), and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare, South Korea (H I14C1135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Agarwal R, 2008, J BIOL CHEM, V283, P25944, DOI 10.1074/jbc.M803756200; Amaral E, 2011, METHODS MOL BIOL, V689, P137, DOI 10.1007/978-1-60761-950-5_8; Betzer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116473; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Fletcher PL, 2010, J BIOL CHEM, V285, P7405, DOI 10.1074/jbc.M109.028365; George S, 2015, J PARKINSON DIS, V5, P413, DOI 10.3233/JPD-150630; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Horvath I, 2012, J AM CHEM SOC, V134, P3439, DOI 10.1021/ja209829m; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwatsubo T, 2007, NEUROPATHOLOGY, V27, P474, DOI 10.1111/j.1440-1789.2007.00785.x; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim HY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9997; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kordower JH, 1998, MOVEMENT DISORD, V13, P88; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Mao X, 2016, SCIENCE, V353, P6307, DOI DOI 10.1126/SCIENCE.AAH3374; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Mor DE, 2017, NAT NEUROSCI, V20, P1560, DOI 10.1038/nn.4641; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nie Q, 2011, ACTA PHARMACOL SIN, V32, P545, DOI 10.1038/aps.2011.14; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Perni M, 2017, P NATL ACAD SCI USA, V114, pE1009, DOI 10.1073/pnas.1610586114; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Recasens A, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00128; Rekas A, 2010, EUR BIOPHYS J BIOPHY, V39, P1407, DOI 10.1007/s00249-010-0595-x; Relini A, 2010, BIOPHYS J, V98, P1277, DOI 10.1016/j.bpj.2009.11.052; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Shrivastava AN, 2015, EMBO J, V34, P2408, DOI 10.15252/embj.201591397; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Takeda A, 1998, AM J PATHOL, V152, P367; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; TRITSCHLER HJ, 1994, BIOCHEM MOL BIOL INT, V34, P169; Tsigelny IF, 2012, FEBS J, V279, P1000, DOI 10.1111/j.1742-4658.2012.08489.x; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195339	10.1371/journal.pone.0195339	http://dx.doi.org/10.1371/journal.pone.0195339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608598	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800046
J	Meehan, SA; Sloot, R; Draper, HR; Naidoo, P; Burger, R; Beyers, N				Meehan, Sue-Ann; Sloot, Rosa; Draper, Heather R.; Naidoo, Pren; Burger, Ronelle; Beyers, Nulda			Factors associated with linkage to HIV care and TB treatment at community-based HIV testing services in Cape Town, South Africa	PLOS ONE			English	Article							METAANALYSIS	Background Diagnosing HIV and/or TB is not sufficient; linkage to care and treatment is conditional to reduce the burden of disease. This study aimed to determine factors associated with linkage to HIV care and TB treatment at community-based services in Cape Town, South Africa. Methods This retrospective cohort study utilized routinely collected data from clients who utilized stand-alone (fixed site not attached to a health facility) and mobile HIV testing services in eight communities in the City of Cape Town Metropolitan district, between January 2008 and June 2012. Clients were included in the analysis if they were >12 years and had a known HIV status. Generalized estimating equations (GEE) logistic regression models were used to assess the association between determinants (sex, age, HIV testing service and co infection status) and self-reported linkage to HIV care and/or TB treatment. Results Linkage to HIV care was 3 738/5 929 (63.1%). Linkage to HIV care was associated with the type of HIV testing service. Clients diagnosed with HIV at mobile services had a significantly reduced odds of linking to HIV care (aOR 0.7 (CI 95%: 0.6-0.8), p<0.001. Linkage to TB treatment was 210/275 (76.4%). Linkage to TB treatment was not associated with sex and service type, but was associated with age. Clients in older age groups were less likely to link to TB treatment compared to clients in the age group 12-24 years (all, p-value<0.05). Conclusion A large proportion of clients diagnosed with HIV at mobile services did not link to care. Almost a quarter of clients diagnosed with TB did not link to treatment. Integrated community-based HIV and TB testing services are efficient in diagnosing HIV and TB, but strategies to improve linkage to care are required to control these epidemics.	[Meehan, Sue-Ann; Sloot, Rosa; Draper, Heather R.; Naidoo, Pren; Beyers, Nulda] Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa; [Sloot, Rosa] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Burger, Ronelle] Stellenbosch Univ, Dept Econ, Cape Town, South Africa	Stellenbosch University; Stellenbosch University	Meehan, SA (corresponding author), Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa.	sueannm@sun.ac.za	Burger, Ronelle/N-5203-2017	Burger, Ronelle/0000-0003-2463-5265; Meehan, Sue-Ann/0000-0002-0826-1833; Sloot, Rosa/0000-0001-7295-3247	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) [U2GPS000739]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC)	The community-based HIV testing modalities (stand-alone centres and mobile services) described in this study was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) under the terms of co-operative agreement number U2GPS000739. The content of this publication is solely the responsibility of the authors and do not necessarily represent the official views of PEPFAR or CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NAT TUBERC MAN GUID; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P603, DOI 10.5588/ijtld.12.0505; Daftary A, 2007, AIDS CARE, V19, P572, DOI 10.1080/09540120701203931; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Hood JE, 2012, AIDS BEHAV, V16, P1902, DOI 10.1007/s10461-012-0253-7; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2014, 90 90 90  AMB TREAT; Joint United Nations Programme on HIV/ AIDS (UNAIDS), AIDS INT; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Leon N, 2010, SAMJ S AFR MED J, V100, P220, DOI 10.7196/SAMJ.4043; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Mabuto T, 2014, PLOS MED, V9; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Meehan SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2173-8; Meehan SA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0658-2; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Nglazi M. D., 2012, JAIDS-J ACQ IMM DEF, V59, P9; Parker LA, 2015, TROP MED INT HEALTH, V20, P893, DOI 10.1111/tmi.12501; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Reddy P., 2014, S AFRICA NATL HLTH N; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Shisana O, 2014, S AFRICAN NATL HIV P; South African National Department of Health, 2010, S AFR ANT TREATM GUI; South African National Department of Health, 2016, NAT HIV TEST SERV PO; South African National Department of Health, 2017, LET OUR ACT COUNT S; South African National Department of Health, 2012, NAT STRAT PLAN HIV S; Statistics South Africa, 2011, INT DAT SUPERCROSS; Van Rooyen H, 2012, AIDS BEHAV; van Rooyen H, 2009, HIV/AIDS IN SOUTH AFRICA 25 YEARS ON: PSYCHOSOCIAL PERSPECTIVES, P165, DOI 10.1007/978-1-4419-0306-8_12; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Western Cape Government Department of Health, 2012, PROV STRAT PLAN HIV; Western Cape Government Department of Health, 2016, W CAP CONS GUID HIV; Western Cape Government Department of Health, 2004, ANT TREATM PROT VERS; WHO, 2011, RET HIV PROGR DEF CH; WHO, 2015, CONSOLIDATED GUIDELI; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, 2008, CAR TREATM PRIM HLTH; Wringe A, 2008, TROP MED INT HEALTH, V13, P319, DOI 10.1111/j.1365-3156.2008.02005.x	43	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195208	10.1371/journal.pone.0195208	http://dx.doi.org/10.1371/journal.pone.0195208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608616	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800037
J	Mihara, K; Ogawa, A; Matsubara, H; Terao, T; Ichikawa, Y				Mihara, Kazuko; Ogawa, Aiko; Matsubara, Hiromi; Terao, Takumi; Ichikawa, Yoshitaka			Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)-An open-label, single-arm study	PLOS ONE			English	Article							SURVIVAL; THERAPY; PROSTACYCLIN	Objective This study was conducted to evaluate the safety and efficacy of a new more thermostable Flolan (epoprostenol) solution prepared with the reformulated pH 12.0 diluent in Japanese patients with pulmonary arterial hypertension (PAH) receiving higher doses of Flolan than those typically administered in Western countries. Methods This open-label, single-arm study was conducted in 10 Japanese PAH patients. During the run-in period, patients were intravenously infused with Flolan (45 ng/kg/min or higher doses) solution prepared with the existing pH 10.5 diluent. The patients were then switched to a new more thermostable Flolan solution prepared with the reformulated pH 12.0 diluent and observed for a 4-week treatment period. As a primary endpoint, safety after switching to the new Flolan solution was evaluated. Secondary endpoints included hemodynamics and the necessity for dose adjustment of Flolan in these patients. Results All 10 patients completed the study period. Observed adverse events were nausea and hepatic function abnormal in 1 patient each, and both events were mild. No patients required dose adjustment due to the change from baseline in mean pulmonary artery pressure (mPAP) measured 3 hrs after switching to Flolan solution prepared with the reformulated diluent. No major changes from baseline in mPAP, pulmonary vascular resistance, or right atrial pressure were observed at 24 hrs and at 4 weeks after switching to the Flolan solution prepared with pH 12.0 diluent. Although some patients showed increases in cardiac output (CO) from baseline at 24 hrs and 4 weeks, no patients required dose reduction as a result of an increase in CO. Conclusion Neither safety/efficacy concerns nor any dose adjustments of Flolan after switching to a more thermostable Flolan solution prepared with the reformulated pH 12.0 diluent could be required in Japanese patients with PAH receiving higher doses of Flolan.	[Mihara, Kazuko] GlaxoSmithKline KK, Med Dev, Tokyo, Japan; [Ogawa, Aiko; Matsubara, Hiromi] Natl Hosp Org Okayama Med Ctr, Dept Clin Sci, Okayama, Japan; [Terao, Takumi] GlaxoSmithKline KK, Biomed Data Sci Dept, Tokyo, Japan; [Ichikawa, Yoshitaka] GlaxoSmithKline KK, Project Management Dept, Tokyo, Japan; [Ichikawa, Yoshitaka] SymBio Pharmaceut Ltd, Div Res & Dev, Clin Dev Grp, Tokyo, Japan	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Mihara, K (corresponding author), GlaxoSmithKline KK, Med Dev, Tokyo, Japan.	kazuko.2.mihara@gsk.com	Ogawa, Aiko/AAW-1518-2021	Ogawa, Aiko/0000-0003-2784-752X; Mihara, Kazuko/0000-0001-9083-3820	GlaxoSmithKline K.K; GlaxoSmithKline K.K., Tokyo, Japan by Honyaku Center Inc.	GlaxoSmithKline K.K(GlaxoSmithKline); GlaxoSmithKline K.K., Tokyo, Japan by Honyaku Center Inc.	The study was funded by GlaxoSmithKline K.K. The funder provided support in the form of salaries for authors (KM, TT, YI) and shares/stock options for author TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Medical writing assistance, supported financially by GlaxoSmithKline K.K., Tokyo, Japan, was provided by Honyaku Center Inc. during the preparation of this manuscript.	Akagi S, 2010, CIRC J, V74, P2200, DOI 10.1253/circj.CJ-10-0190; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; BARST RJ, 1994, ANN INTERN MED, V121, P409, DOI 10.7326/0003-4819-121-6-199409150-00003; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; ICH Steering Committee International Council for Harmonisation of Techinical Requirements for Pharmaceuticals for Human Use, 1996, ICH HARM TRIP GUID G; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Ogawa A, 2017, AM J CARDIOL, V119, P1479, DOI 10.1016/j.amjcard.2017.01.015; Ogawa A, 2014, LIFE SCI, V118, P414, DOI 10.1016/j.lfs.2014.01.077; Provencher S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120657; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; World Medical Association, 2013, WORLD MED ASS DECL H	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195195	10.1371/journal.pone.0195195	http://dx.doi.org/10.1371/journal.pone.0195195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608587	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800035
J	Buskermolen, ABC; Kurniawan, NA; Bouten, CVC				Buskermolen, Antonetta B. C.; Kurniawan, Nicholas A.; Bouten, Carlijn V. C.			An automated quantitative analysis of cell, nucleus and focal adhesion morphology	PLOS ONE			English	Article							IMAGE-ANALYSIS; STRESS FIBERS; ACTIN; DYNAMICS; FIBROBLASTS; MATURATION; MIGRATION; SOFTWARE; SURFACES; GUIDANCE	Adherent cells sense the physical properties of their environment via focal adhesions. Improved understanding of how cells sense and response to their physical surroundings is aided by quantitative evaluation of focal adhesion size, number, orientation, and distribution in conjunction with the morphology of single cells and the corresponding nuclei. We developed a fast, user-friendly and automated image analysis algorithm capable of capturing and characterizing these individual components with a high level of accuracy. We demonstrate the robustness and applicability of the algorithm by quantifying morphological changes in response to a variety of environmental changes as well as manipulations of cellular components of mechanotransductions. Finally, as a proof-of-concept we use our algorithm to quantify the effect of Rho-associated kinase inhibitor Y-27632 on focal adhesion maturation. We show that a decrease in cell contractility leads to a decrease in focal adhesion size and aspect ratio.	[Buskermolen, Antonetta B. C.; Kurniawan, Nicholas A.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Buskermolen, Antonetta B. C.; Kurniawan, Nicholas A.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology	Kurniawan, NA (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands.; Kurniawan, NA (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands.	n.a.kurniawan@tue.nl	Bouten, Carlijn/AAT-5187-2020	Bouten, Carlijn/0000-0003-1035-5094	Dutch Heart Foundation Antonetta B. C. Buskermolen [CVON 2012-01]; TU/e Impuls Antonetta B. C. Buskermolen	Dutch Heart Foundation Antonetta B. C. Buskermolen; TU/e Impuls Antonetta B. C. Buskermolen	This work was supported by CVON 2012-01 Dutch Heart Foundation Antonetta B. C. Buskermolen and TU/e Impuls Antonetta B. C. Buskermolen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Barry DJ, 2015, J CELL BIOL, V209, P163, DOI 10.1083/jcb.201501081; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; DUNN GA, 1986, J CELL SCI, V83, P313; Elosegui-Artola A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107393; Farrell DL, 2017, DEVELOPMENT, V144, P1725, DOI 10.1242/dev.146837; Gautrot JE, 2017, CELL SENSING PHYS PR; Geiger B., 2011, COLD SPRING HARBOR P, V3; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goetsch KP, 2014, J CELL BIOCHEM, V115, P1299, DOI 10.1002/jcb.24784; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kurniawan NA, 2016, J BIOMECH, V49, P1355, DOI 10.1016/j.jbiomech.2015.12.023; Mol A, 2006, CIRCULATION, V114, pI152, DOI 10.1161/CIRCULATIONAHA.105.001123; Munjal A, 2014, DEVELOPMENT, V141, P1789, DOI 10.1242/dev.091645; Myers G, 2012, NAT METHODS, V9, P659, DOI 10.1038/nmeth.2024; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Spanjaard E, 2015, EXP CELL RES, V330, P382, DOI 10.1016/j.yexcr.2014.10.012; Stricker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070652; Tamiello C, 2015, CELLULAR MOL BIOENGI; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478; Wiesmann V, 2015, J MICROSC-OXFORD, V257, P39, DOI 10.1111/jmi.12184; Wurflinger T, 2009, IEEE IMAGE PROC, P4209, DOI 10.1109/ICIP.2009.5413530; Yan PK, 2008, IEEE T INF TECHNOL B, V12, P109, DOI 10.1109/TITB.2007.898006; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189; Yang X, 2013, IEEE T CIRCUITS SYST, V53; Zamir E, 1999, J CELL SCI, V112, P1655	38	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195201	10.1371/journal.pone.0195201	http://dx.doi.org/10.1371/journal.pone.0195201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601604	Green Published, Green Submitted, gold			2022-12-27	WOS:000428845900023
J	Brabcova, D; Kohout, J; Potuzak, D; Benova, B; Krsek, P				Brabcova, Dana; Kohout, Jiri; Potuzak, Daniel; Benova, Barbora; Krsek, Pavel			Psychometric properties of the Czech version of the Stigma Scale of Epilepsy	PLOS ONE			English	Article							VALIDATION; CHILDREN	Although significant attention has been devoted to analyzing stigma associated with epilepsy, there is still a significant lack of valid and reliable instruments. We aimed to validate the 23-item Czech version of the Stigma Scale of Epilepsy (SSE; originally developed in Brazil), which has been used to evaluate epilepsy-related stigma in the general population. Verification of the SSE questionnaire was carried out in a group of 207 students aged 15-18 years of whom none had epilepsy. These students completed the SSE twice in a period of 3-6 months as part of standard test-retest evaluation practice. The instrument exhibits good psychometric properties including internal consistency higher than in the original version (Cronbach's alpha of 0.856 here compared with 0.81 reported in Brazil) and acceptable test-retest reliability. Using exploratory factor analysis (not provided for the original version), four factors were identified and corresponding subscales were described and interpreted. Two items did not fit into the structure and were eliminated. Confirmatory factor analysis was used to propose and verify the hierarchical 4-factor structure of the Czech version of SSE confirming the existence of a common factor corresponding to stigma. The results showed that the Czech version of SSE has good psychometric properties and can be used in further research and clinical practice.	[Brabcova, Dana; Potuzak, Daniel] Univ West Bohemia, Dept Psychol, Fac Educ, Plzen, Czech Republic; [Kohout, Jiri] Univ West Bohemia, Dept Phys, Fac Educ, Plzen, Czech Republic; [Benova, Barbora; Krsek, Pavel] Univ Hosp Motol, Dept Child Neurol, Fac Med 2, Prague, Czech Republic	University of West Bohemia Pilsen; University of West Bohemia Pilsen; Charles University Prague; Motol University Hospital	Kohout, J (corresponding author), Univ West Bohemia, Dept Phys, Fac Educ, Plzen, Czech Republic.	kohout.j2@seznam.cz	Kohout, Jiri/AGY-2275-2022; Kohout, Jiří/N-8106-2016; Brabcová, Dana Buršíková/AAD-1423-2020; Benova, Barbora/AAB-3423-2019	Kohout, Jiri/0000-0002-5614-2126; Kohout, Jiří/0000-0002-5614-2126; Brabcová, Dana Buršíková/0000-0003-4189-7347; Benova, Barbora/0000-0001-8448-2833; Krsek, Pavel/0000-0002-5740-3690				Akaike H., 2011, INT ENCY STAT SCI, P25, DOI DOI 10.1007/978-3-642-04898-2_110; Beavers AS, PRAC ASSES RES EVAL, V18, P1; Brabcova D, 2017, EPILEPSY BEHAV, V69, P12, DOI 10.1016/j.yebeh.2017.01.019; Brabcova D, 2014, PHD EXISTENCE 2014, P10; Brabcova D, 2014, EPILEPSY BEHAV, V33, P31, DOI 10.1016/j.yebeh.2014.02.013; Bruno E, 2012, EPILEPSY BEHAV, V25, P131, DOI 10.1016/j.yebeh.2012.07.011; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Elafros MA, 2015, QUAL LIFE RES, V24, P1483, DOI 10.1007/s11136-014-0868-4; Fernandes PT, 2007, ARQ NEURO-PSIQUIAT, V65, P35, DOI 10.1590/S0004-282X2007001000006; Fernandes PT, 2011, EPILEPSY BEHAV, V22, P55, DOI 10.1016/j.yebeh.2011.02.014; Fernandes PT, 2004, J EPILEPSY CLIN NEUR, V10, P213; Fiest KM, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0444-x; FISCHER RA, 1954, STAT METHODS RES WOR; Goffman E., 1968, STIGMA NOTES MANAGEM; Hermann B, 2009, EPILEPSY BEHAV, V15, pS11, DOI 10.1016/j.yebeh.2009.03.029; Herrmann LK, 2016, EPILEPSY BEHAV, V60, P165, DOI 10.1016/j.yebeh.2016.04.003; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.21427/D7CF7R, 10.21427/D79B73]; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Pahl K, 2005, ATL EP CAR WORLD, P72; Reis R, 2002, EPILEPSY BEHAV, V3, pS33; Reno BA, 2007, ARQ NEURO-PSIQUIAT, V65, P49, DOI 10.1590/S0004-282X2007001000008; Salgado PC, 2005, ARQ NEURO-PSIQUIAT, V63, P395, DOI 10.1590/S0004-282X2005000300005	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195225	10.1371/journal.pone.0195225	http://dx.doi.org/10.1371/journal.pone.0195225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596486	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000094
J	Patt, JM; Robbins, PS; Niedz, R; McCollum, G; Alessandro, R				Patt, Joseph M.; Robbins, Paul S.; Niedz, Randy; McCollum, Greg; Alessandro, Rocco			Exogenous application of the plant signalers methyl jasmonate and salicylic acid induces changes in volatile emissions from citrus foliage and influences the aggregation behavior of Asian citrus psyllid (Diaphorina citri), vector of Huanglongbing	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; TERPENOID ACCUMULATION; HEMIPTERA LIVIIDAE; INDUCED RESISTANCE; INSECT VECTOR; RESPONSES; DISEASE; TOMATO; PATTERNS; FLORIDA	Huanglongbing, also known as citrus greening, is a destructive disease that threatens citrus production worldwide. It is putatively caused by the phloem-limited bacterium Candidatus Liberibacter asiaticus (Las). Currently, the disease is untreatable and efforts focus on intensive insecticide use to control the vector, Asian citrus psyllid (Diaphorina citri). Emerging psyllid resistance to multiple insecticides has generated investigations into the use of exogenously applied signaling compounds to enhance citrus resistance to D. citri and Las. In the present study, we examined whether foliar applications of methyl jasmonate (MJ), a volatile signaling compound associated with the induced systemic resistance pathway, and salicylic acid, a constituent of the systemic acquired resistance pathway, would elicit the emission of defense-related volatiles in citrus foliage, and what effect this might have on the host-plant searching behavior of D. citri. Comparisons were made of volatiles emitted from growing shoots of uninfected and Las-infected 'Valencia' sweet orange (Citrus sinensis) trees over two consecutive sampling days. A settling behavioral assay was used to compare psyllid attraction to MJ-treated vs. Tween-treated citrus sprigs. All three main effects, Las infection status, plant signaler application, and sampling day, influenced the proportions of individual volatile compounds emitted in different treatment groups. MJ- and SA-treated trees had higher emission rates than Tween-treated trees. Methyl salicylate (MeSA) and beta-caryophyllene were present in higher proportions in the volatiles collected from Las-infected + trees. On the other hand, Las-infected + MJ-treated trees emitted lower proportions of MeSA than did Las-infected + Tween-treated trees. Because MeSA is a key D. citri attractant, this result suggests that MJ application could suppress MeSA emission from Las-infected trees, an approach that could be used to discourage psyllid colonization during shoot growth. MJ application enhanced emission of E-beta-ocimene, indole, volatiles attractive to many of the psyllid's natural enemies, indicating that MJ application could be used in an 'attract and reward' conservation biological control strategy. Volatile emissions in SA-treated trees were dominated by MeSA. MJ application elicited aggregation behavior in D. citri. Similar numbers of psyllids settled on MJ-treated versus Tween-treated sprigs, but a significantly greater percentage of the MJ-treated sprigs had aggregations of nine or more psyllids on them. Taken together, the results of this study indicate that exogenous applications of MJ or SA could be used to influence Asian citrus psyllid settling behavior and attract its natural enemies.	[Patt, Joseph M.; Robbins, Paul S.; Niedz, Randy; McCollum, Greg; Alessandro, Rocco] ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Patt, JM (corresponding author), ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA.	joseph.patt@ars.usda.gov	Patt, Joseph/V-1113-2018; Robbins, Paul/AAC-3180-2020	Patt, Joseph/0000-0001-9105-8520; 				Aksenov AA, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00078; Aksenov AA, 2014, ANAL CHEM, V86, P2481, DOI 10.1021/ac403469y; Albrecht U, 2014, HORTSCIENCE, V49, P367, DOI 10.21273/HORTSCI.49.3.367; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Boina DR, 2015, PEST MANAG SCI, V71, P808, DOI 10.1002/ps.3957; Bove JM, 2006, J PLANT PATHOL, V88, P7; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Chamberlain K, 2001, BIOCHEM SYST ECOL, V29, P1063, DOI 10.1016/S0305-1978(01)00050-3; Citrus Research and Education Center, 2015, GREEN HUANGL HLB WOR; Clarke KR, 2015, PRIMER V7 USER MANUA; Costa MG, 2010, SCI AGR, V67, P546, DOI 10.1590/S0103-90162010000500008; Davis TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049330; Dugo G., 2003, CITRUS GENUS CITRUS; Erb M, 2014, NATURE COMMUNICATION, P6; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Francis MI, 2009, EUR J PLANT PATHOL, V124, P283, DOI 10.1007/s10658-008-9415-x; Frey M, 2004, PHYTOCHEMISTRY, V65, P1047, DOI 10.1016/j.phytochem.2003.11.021; Frey M, 2000, P NATL ACAD SCI USA, V97, P14801, DOI 10.1073/pnas.260499897; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; Gomi K, 2003, PLANT MOL BIOL, V53, P189, DOI 10.1023/B:PLAN.0000009287.95682.24; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2016, J ECON ENTOMOL, V109, P558, DOI 10.1093/jee/tow009; Hall DG, 2015, J INSECT BEHAV, V28, P555, DOI 10.1007/s10905-015-9525-1; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hijaz F, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1138193; Hijaz F, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25677; Huang Z, 2015, J ELECTR COMPUT ENG, V2015, DOI 10.1155/2015/258343; Kawazu K, 2012, ARTHROPOD-PLANT INTE, V6, P221, DOI 10.1007/s11829-011-9174-z; Kesonja D, 2017, ANAL COURT PRACTICE; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kishimoto K, 2006, PHYTOCHEMISTRY, V67, P1520, DOI 10.1016/j.phytochem.2006.05.027; Krol P, 2015, J PLANT PHYSIOL, V179, P122, DOI 10.1016/j.jplph.2015.01.018; Lewis-Rosenblum H, 2015, J ECON ENTOMOL, V108, P3, DOI 10.1093/jee/tou008; Li JY, 2017, MOL PLANT MICROBE IN, V30, P620, DOI [10.1094/mpmi-12-16-0257-r, 10.1094/MPMI-12-16-0257-R]; Li JY, 2016, PHYTOPATHOLOGY, V106, P37, DOI 10.1094/PHYTO-08-15-0196-R; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Martini X, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00008; Martini X, 2016, J CHEM ECOL, V42, P357, DOI 10.1007/s10886-016-0695-x; Martini X, 2014, ARTHROPOD-PLANT INTE, V8, P453, DOI 10.1007/s11829-014-9326-z; Maserti BE, 2011, J PLANT PHYSIOL, V168, P392, DOI 10.1016/j.jplph.2010.07.026; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Mayer CJ, 2008, J CHEM ECOL, V34, P1045, DOI 10.1007/s10886-008-9516-1; Mayer CJ, 2011, AGR FOREST ENTOMOL, V13, P25, DOI 10.1111/j.1461-9563.2010.00495.x; McCormick AC, 2012, TRENDS PLANT SCI, V17, P303, DOI 10.1016/j.tplants.2012.03.012; Michaud JP, 2002, ENTOMOL NEWS, V113, P216; Michaud JP, 2001, FLA ENTOMOL, V84, P608, DOI 10.2307/3496392; Miresmailli S, 2010, PEST MANAG SCI, V66, P916, DOI 10.1002/ps.1967; Moss CB, EC COST HUANGLONGBIN; Niinemets U, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00262; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Patt Joseph M., 2014, Insects, V5, P921, DOI 10.3390/insects5040921; Pickett JA, 2003, BIOCHEM SOC T, V31, P123, DOI 10.1042/BST0310123; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Pluke RWH, 2005, FLA ENTOMOL, V88, P123, DOI 10.1653/0015-4040(2005)088[0123:PIOLBO]2.0.CO;2; Qureshi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112331; Qureshi JA, 2009, BIOL CONTROL, V50, P129, DOI 10.1016/j.biocontrol.2009.04.001; Rid M, 2016, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00152; Setamou M, 2008, J ECON ENTOMOL, V101, P1478, DOI 10.1603/0022-0493(2008)101[1478:DPASPF]2.0.CO;2; Setamou M, 2016, J ECON ENTOMOL, V109, P1973, DOI 10.1093/jee/tow171; Stockton DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149815; Stover E, 2011, HORTSCIENCE, V46, P1344, DOI 10.21273/HORTSCI.46.10.1344; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; THOMSON WW, 1976, BOT GAZ, V137, P330, DOI 10.1086/336880; Tiwari S, 2013, B ENTOMOL RES, V103, P592, DOI 10.1017/S0007485313000229; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; Veyrat N, 2016, J ECOL, V104, P591, DOI 10.1111/1365-2745.12526; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Yamasaki Yumiko, 2007, Journal of General Plant Pathology, V73, P168, DOI 10.1007/s10327-007-0013-0	79	20	28	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193724	10.1371/journal.pone.0193724	http://dx.doi.org/10.1371/journal.pone.0193724			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596451	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000012
J	Raciti, GA; Fiory, F; Campitelli, M; Desiderio, A; Spinelli, R; Longo, M; Nigro, C; Pepe, G; Sommella, E; Campiglia, P; Formisano, P; Beguinot, F; Miele, C				Raciti, Gregory Alexander; Fiory, Francesca; Campitelli, Michele; Desiderio, Antonella; Spinelli, Rosa; Longo, Michele; Nigro, Cecilia; Pepe, Giacomo; Sommella, Eduardo; Campiglia, Pietro; Formisano, Pietro; Beguinot, Francesco; Miele, Claudia			Citrus aurantium L. dry extracts promote C/ebp beta expression and improve adipocyte differentiation in 3T3-L1 cells	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; BINDING PROTEIN-BETA; WHITE ADIPOSE-TISSUE; GYMNEMA-SYLVESTRE; DIABETES-MELLITUS; TRANSCRIPTIONAL REGULATION; INSULIN-RESISTANCE; FENUGREEK SEEDS; IN-VIVO; OBESITY	Metabolic and/or endocrine dysfunction of the white adipose tissue (WAT) contribute to the development of metabolic disorders, such as Type 2 Diabetes (T2D). Therefore, the identification of products able to improve adipose tissue function represents a valuable strategy for the prevention and/or treatment of T2D. In the current study, we investigated the potential effects of dry extracts obtained from Citrus aurantium L. fruit juice (CAde) on the regulation of 3T3-L1 cells adipocyte differentiation and function in vitro. We found that CAde enhances terminal adipocyte differentiation of 3T3-L1 cells raising the expression of CCAAT/enhancer binding protein beta (C/Ebp beta), peroxisome proliferator activated receptor gamma (Ppar gamma), glucose transporter type 4 (Glut4) and fatty acid binding protein 4 (Fabp4). CAde improves insulin-induced glucose uptake of 3T3-L1 adipocytes, as well. A focused analysis of the phases occurring in the pre-adipocytes differentiation to mature adipocytes furthermore revealed that CAde promotes the early differentiation stage by up-regulating C/ebp beta expression at 2, 4 and 8 h post the adipogenic induction and anticipating the 3T3-L1 cell cycle entry and progression during mitotic clonal expansion (MCE). These findings provide evidence that the exposure to CAde enhances in vitro fat cell differentiation of pre-adipocytes and functional capacity of mature adipocytes, and pave the way to the development of products derived from Citrus aurantium L. fruit juice, which may improve WAT functional capacity and may be effective for the prevention and/or treatment of T2D.	[Raciti, Gregory Alexander; Fiory, Francesca; Campitelli, Michele; Desiderio, Antonella; Spinelli, Rosa; Longo, Michele; Nigro, Cecilia; Formisano, Pietro; Beguinot, Francesco; Miele, Claudia] CNR, URT Inst Expt Endocrinol & Oncol G Salvatore, Naples, Italy; [Raciti, Gregory Alexander; Fiory, Francesca; Campitelli, Michele; Desiderio, Antonella; Spinelli, Rosa; Longo, Michele; Nigro, Cecilia; Formisano, Pietro; Beguinot, Francesco; Miele, Claudia] Federico II Univ Naples, Dept Translat Med Sci, Naples, Italy; [Pepe, Giacomo; Sommella, Eduardo; Campiglia, Pietro] Univ Salerno, Dept Pharm, Sch Pharm, Fisciano, Italy; [Campiglia, Pietro] European Biomed Res Inst Salerno, Salerno, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Salerno	Raciti, GA; Miele, C (corresponding author), CNR, URT Inst Expt Endocrinol & Oncol G Salvatore, Naples, Italy.; Raciti, GA; Miele, C (corresponding author), Federico II Univ Naples, Dept Translat Med Sci, Naples, Italy.	gregoryraciti@gmail.com; c.miele@ieos.cnr.it	Campiglia, Pietro/J-5625-2018; Formisano, Pietro/J-4237-2018; LONGO, Michele/AAB-9188-2019; Longo, Michele/AAB-5972-2020; Campitelli, Michele/AAB-9734-2019; NIGRO, Cecilia/AAB-9189-2019; Nigro, Cecilia/K-7338-2016	LONGO, Michele/0000-0003-4798-0504; Campitelli, Michele/0000-0001-7592-5022; NIGRO, Cecilia/0000-0001-8924-9731; Desiderio, Antonella/0000-0002-3510-7663; RACITI, GREGORYALEXANDER/0000-0003-2742-5634; Formisano, Pietro/0000-0001-7020-6870; Sommella, Eduardo/0000-0001-8654-6431				Al-Romaiyan A, 2010, PHYTOTHER RES, V24, P1370, DOI 10.1002/ptr.3125; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ANDERSON JW, 2008, NUTRACEUTICALS GLYCE; Arbo MD, 2008, FOOD CHEM TOXICOL, V46, P2770, DOI 10.1016/j.fct.2008.04.037; Arias BA, 2005, J ETHNOPHARMACOL, V97, P89, DOI 10.1016/j.jep.2004.10.019; Armstrong WJ, 2001, J EXERC PHYSL, V4, P28; Basch Ethan, 2003, Altern Med Rev, V8, P20; Cassese A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060555; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Coelho M, 2013, ARCH MED SCI, V9, P191, DOI 10.5114/aoms.2013.33181; Dey Lucy, 2002, Altern Med Rev, V7, P45; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fiory F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113655; Fox KAA, 2009, EUR HEART J, V30, P3055, DOI 10.1093/eurheartj/ehp371; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Gupta A, 2001, J Assoc Physicians India, V49, P1057; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Karimi E, 2012, MOLECULES, V17, P1203, DOI 10.3390/molecules17021203; Karoui IJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/345415; Kassaian N, 2009, INT J VITAM NUTR RES, V79, P34, DOI 10.1024/0300-9831.79.1.34; Kim GS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-31; Kim HG, 2012, BIOMED CHROMATOGR, V26, P464, DOI 10.1002/bmc.1688; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Leach MJ, 2007, J ALTERN COMPLEM MED, V13, P977, DOI 10.1089/acm.2006.6387; Lee DH, 2012, EVID-BASED COMPL ALT, V2012; Leung L, 2009, BRIT J NUTR, V102, P1703, DOI 10.1017/S0007114509992054; Liu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038130; Longo M, 2016, BBA-MOL CELL RES, V1863, P1146, DOI 10.1016/j.bbamcr.2016.02.019; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Mattoli L, 2005, J AGR FOOD CHEM, V53, P9860, DOI 10.1021/jf051270+; Mecocci P, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00147; Nair HB, 2010, BIOCHEM PHARMACOL, V80, P1833, DOI 10.1016/j.bcp.2010.07.021; Nasri H, 2014, INT J PREVENTIVE MED, V5, P1487; Neelakantan N, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-7; Passaretti F, 2014, PLATELETS, V25, P252, DOI 10.3109/09537104.2013.809060; Pellati F, 2002, J PHARMACEUT BIOMED, V29, P1113, DOI 10.1016/S0731-7085(02)00153-X; Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4; Porchezhian E, 2003, PHARMAZIE, V58, P5; Raciti GA, 2010, DIABETOLOGIA, V53, P955, DOI 10.1007/s00125-010-1676-1; Raciti GA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43526; Ramaa CS, 2006, CURR PHARM BIOTECHNO, V7, P15, DOI 10.2174/138920106775789647; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shi Jun, 2008, V456, P307, DOI 10.1007/978-1-59745-245-8_23; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069925; Stohs SJ, 2012, INT J MED SCI, V9, P527, DOI 10.7150/ijms.4446; Summers SA, 2000, INT J OBESITY, V24, pS67, DOI 10.1038/sj.ijo.0801509; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Weisiger RA, 2002, MOL CELL BIOCHEM, V239, P35, DOI 10.1023/A:1020550405578; Wronkowitz N, 2014, FRONT HORM RES, V43, P79, DOI 10.1159/000360560; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	62	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193704	10.1371/journal.pone.0193704	http://dx.doi.org/10.1371/journal.pone.0193704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596447	gold, Green Published			2022-12-27	WOS:000428630000011
J	Shankles, PG; Millet, LJ; Aufrecht, JA; Retterer, ST				Shankles, Peter G.; Millet, Larry J.; Aufrecht, Jayde A.; Retterer, Scott T.			Accessing microfluidics through feature-based design software for 3D printing	PLOS ONE			English	Article							GRADIENT GENERATOR; BIOLOGICAL APPLICATIONS; DEVICES; FABRICATION; POLY(DIMETHYLSILOXANE); REACTIONWARE; SYSTEMS; PDMS	Additive manufacturing has been a cornerstone of the product development pipeline for decades, playing an essential role in the creation of both functional and cosmetic prototypes. In recent years, the prospects for distributed and open source manufacturing have grown tremendously. This growth has been enabled by an expanding library of printable materials, low-cost printers, and communities dedicated to platform development. The microfluidics community has embraced this opportunity to integrate 3D printing into the suite of manufacturing strategies used to create novel fluidic architectures. The rapid turnaround time and low cost to implement these strategies in the lab makes 3D printing an attractive alternative to conventional micro-and nanofabrication techniques. In this work, the production of multiple microfluidic architectures using a hybrid 3D printing-soft lithography approach is demonstrated and shown to enable rapid device fabrication with channel dimensions that take advantage of laminar flow characteristics. The fabrication process outlined here is underpinned by the implementation of custom design software with an integrated slicer program that replaces less intuitive computer aided design and slicer software tools. Devices are designed in the program by assembling parameterized microfluidic building blocks. The fabrication process and flow control within 3D printed devices were demonstrated with a gradient generator and two droplet generator designs. Precise control over the printing process allowed 3D microfluidics to be printed in a single step by extruding bridge structures to 'jump-over' channels in the same plane. This strategy was shown to integrate with conventional nanofabrication strategies to simplify the operation of a platform that incorporates both nanoscale features and 3D printed microfluidics.	[Shankles, Peter G.; Millet, Larry J.; Aufrecht, Jayde A.; Retterer, Scott T.] Univ Tennessee, Bredesen Ctr Interdisciplinary Res, Knoxville, TN 37996 USA; [Retterer, Scott T.] Oak Ridge Natl Lab, Div Mat Sci, Ctr Nanophase, Oak Ridge, TN 37830 USA; [Retterer, Scott T.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Retterer, ST (corresponding author), Univ Tennessee, Bredesen Ctr Interdisciplinary Res, Knoxville, TN 37996 USA.; Retterer, ST (corresponding author), Oak Ridge Natl Lab, Div Mat Sci, Ctr Nanophase, Oak Ridge, TN 37830 USA.; Retterer, ST (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.	rettererst@ornl.gov	Aufrecht, Jayde/HGT-9643-2022; Shankles, Peter/ABD-7498-2021; Retterer, Scott/A-5256-2011; Millet, Larry/F-3476-2012	Shankles, Peter/0000-0002-8692-8779; Aufrecht, Jayde/0000-0002-7102-980X; Retterer, Scott/0000-0001-8534-1979; Millet, Larry/0000-0001-6443-2505	NIDCR NIH HHS [R01 DE024463] Funding Source: Medline; NIH HHS [1R01DE024463-01] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Albaugh C., 2017, ADIDAS MAKES 1 3D SH; Anderson JR, 2000, ANAL CHEM, V72, P3158, DOI 10.1021/ac9912294; Anderson KB, 2013, ANAL CHEM, V85, P5622, DOI 10.1021/ac4009594; Atencia J, 2012, LAB CHIP, V12, P309, DOI 10.1039/c1lc20829b; Au AK, 2016, ANGEW CHEM INT EDIT, V55, P3862, DOI 10.1002/anie.201504382; Au AK, 2015, LAB CHIP, V15, P1934, DOI 10.1039/c5lc00126a; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Bonyar A, 2014, INT J MATER FORM, V7, P189, DOI 10.1007/s12289-012-1119-2; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Cao LR, 2010, ANAL BIOANAL CHEM, V398, P1985, DOI 10.1007/s00216-010-4168-8; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Garstecki P, 2006, LAB CHIP, V6, P693; Gong H, 2017, LAB CHIP, V17, P2899, DOI 10.1039/c7lc00644f; He Y., 2016, ELECTROANAL, P1; Ho CMB, 2015, LAB CHIP, V15, P3627, DOI 10.1039/c5lc00685f; Huang SH, 2013, INT J ADV MANUF TECH, V67, P1191, DOI 10.1007/s00170-012-4558-5; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Jung SY, 2010, LAB CHIP, V10, P2688, DOI [10.1039/c0lc00120a, 10.1039/c01c00120a]; Kim SH, 2007, ADV FUNCT MATER, V17, P3493, DOI 10.1002/adfm.200601203; Kitson PJ, 2013, CHEM SCI, V4, P3099, DOI 10.1039/c3sc51253c; Kitson PJ, 2012, LAB CHIP, V12, P3267, DOI 10.1039/c2lc40761b; Knowlton S, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/2/025019; Kontoudis GP, 2015, IEEE INT C INT ROBOT, P5857, DOI 10.1109/IROS.2015.7354209; Li ZA, 2017, RSC ADV, V7, P3313, DOI 10.1039/c6ra24884e; Matthew K., 2015, R SOC CHEM, P1736; McDonald JC, 2002, ANAL CHEM, V74, P1537, DOI 10.1021/ac010938q; Millet LJ, 2015, LAB CHIP, V15, P1799, DOI 10.1039/c5lc00094g; Morgan AJL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152023; Radis L., 2017, GE AVIATION GETS FAA; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shankles PG, 2015, J VAC SCI TECHNOL B, V33, DOI 10.1116/1.4932671; Sivashankar S, 2016, MICRO NANO LETT, V11, P654, DOI 10.1049/mnl.2016.0530; Tan YC, 2006, SENSOR ACTUAT B-CHEM, V114, P350, DOI 10.1016/j.snb.2005.06.008; Tothill AM, 2017, J MICROMECH MICROENG, V27, DOI 10.1088/1361-6439/aa5ae3; Vittayarukskul K, 2017, J MICROMECH MICROENG, V27, DOI 10.1088/1361-6439/aa53ed; Walsh D. I., 2017, TRENDS BIOTECHNOL, P1; Wang S, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4941339	38	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0192752	10.1371/journal.pone.0192752	http://dx.doi.org/10.1371/journal.pone.0192752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596418	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000003
J	Slater, K; Barrett, A; Brown, LR				Slater, Kerry; Barrett, Alan; Brown, Leslie R.			Home range utilization by chacma baboon (Papio ursinus) troops on Suikerbosrand Nature Reserve, South Africa	PLOS ONE			English	Article							HABITAT USE; MOUNTAIN BABOONS; DAY LENGTH; POPULATION-STRUCTURE; BEHAVIORAL ECOLOGY; HAMADRYAS-URSINUS; FOOD AVAILABILITY; CAPE PENINSULA; PREDATION RISK; GROUP-SIZE	Rapid urbanization coupled with decreasing areas of natural habitat are causing baboon populations to become scattered and isolated, often resulting in increased levels of human-baboon conflict. To implement baboon-human conflict management strategies, it is essential to formulate realistic conservation policies that deal with all stakeholder concerns and ensure the conservation of viable baboon populations. A study was initiated in response to complaints of perceived excessive baboon numbers and associated lack of food resources on Suikerbosrand Nature Reserve in South Africa. Data obtained from GPS tracking collars fitted to one baboon from each of 10 identified troops were analyzed to determine home range size and utilization. The spatial representation of home ranges generated from this study will allow reserve management to identify areas of potential high and low human-baboon conflict and will contribute to the development of a formal baboon management plan to reduce human-baboon conflict on and around the reserve. Home ranges were unevenly distributed and had a mean size of 26.72 km(2) +/- 13.91 SD in the cold/dry season and 26.54 km(2) +/- 12.76 SD in the warm/wet season. Troop home ranges overlapped to some degree and five troops utilized areas outside the reserve. Although no significant relationship between troop size and home range was found, there was a positive relationship between troop size and daily distance travelled. All troops had significantly longer mean daily distances during the warm/wet season than during the cold/dry season (P <= 0.02).	[Slater, Kerry; Barrett, Alan; Brown, Leslie R.] Univ South Africa, Appl Behav Ecol & Ecosyst Res Unit, Dept Environm Sci, Florida, South Africa	University of South Africa	Slater, K (corresponding author), Univ South Africa, Appl Behav Ecol & Ecosyst Res Unit, Dept Environm Sci, Florida, South Africa.	slatek@unisa.ac.za	Slater, Kerry/C-7406-2015; Brown, Leslie R/N-9762-2015	Slater, Kerry/0000-0001-6362-1064; Brown, Leslie R/0000-0002-1026-5438				ABRAMS PA, 1991, ECOLOGY, V72, P1242, DOI 10.2307/1941098; Altmann SA, 1970, BABOON ECOLOGY AFRIC; Anderson C.M., 1981, International Journal of Primatology, V2, P285, DOI 10.1007/BF02693480; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; Beamish EK, 2010, THESIS; Birss C, 2007, SUIKERBOSRAND NATURE; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; BYRNE RW, 1993, BEHAV ECOL SOCIOBIOL, V33, P233, DOI 10.1007/BF02027120; Chance MRA, 1970, SOCIAL GROUPS MONKEY; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; COLLINS DA, 1984, ANIM BEHAV, V32, P536, DOI 10.1016/S0003-3472(84)80292-4; Cowlishaw G, 1997, ANIM BEHAV, V54, P241, DOI 10.1006/anbe.1996.0466; Cowlishaw G, 1997, ANIM BEHAV, V53, P667, DOI 10.1006/anbe.1996.0298; DAVIDGE C, 1978, ZOOL AFR, V13, P329, DOI 10.1080/00445096.1978.11447633; Davidge C, 1976, THESIS; Dias LG, 2003, INT J PRIMATOL, V24, P209, DOI 10.1023/A:1023054513354; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; Erasmus D, 1993, THESIS; Gaynor D., 1994, THESIS; Gillespie TR, 2001, BEHAV ECOL SOCIOBIOL, V50, P329, DOI 10.1007/s002650100371; HAMILTON WJ, 1976, ECOLOGY, V57, P1264, DOI 10.2307/1935050; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Hennop JA, 2007, PROJECT REPORT COLLE; Henzi SP, 2011, INT J PRIMATOL, V32, P1020, DOI 10.1007/s10764-011-9519-6; Henzi SP, 1997, ANIM BEHAV, V53, P525, DOI 10.1006/anbe.1996.0302; HENZI SP, 1995, AM J PRIMATOL, V35, P155, DOI 10.1002/ajp.1350350208; Henzi SP, 1998, ANIM BEHAV, V55, P1421, DOI 10.1006/anbe.1997.0716; HENZI SP, 1992, INT J PRIMATOL, V13, P601, DOI 10.1007/BF02551256; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Hill RA, 2004, S AFR J WILDL RES, V34, P39; Hill RA, 2003, BEHAV ECOL SOCIOBIOL, V53, P278, DOI 10.1007/s00265-003-0590-7; Hill RA, 2002, EVOL ECOL, V16, P579, DOI 10.1023/A:1021625003597; Hoffman TS, 2012, AM J PRIMATOL, V74, P853, DOI 10.1002/ajp.22040; Hoffman TS, 2011, INT J PRIMATOL, V32, P308, DOI 10.1007/s10764-010-9467-6; Kansky R, 2000, BABOON MANAGEMENT ST; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Klaassen RHG, 2006, THEOR POPUL BIOL, V70, P452, DOI 10.1016/j.tpb.2006.04.002; Marais A. J., 2006, Koedoe, V49, P67; Marais AJ, 2005, THESIS; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Mucina L, 2006, VEGETATION MAP S AFR; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Noser R, 2007, ANIM BEHAV, V73, P257, DOI 10.1016/j.anbehav.2006.04.012; Oates J.F., 1987, P197; Pahad G, 2010, THESIS; Panagos MD, 1999, SCALE PHYTOPHYSIOGNO; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Segal C, 2008, THESIS; Skinner J. D., 2005, MAMMALS SO AFRICAN S; Stoltz L, 1977, THESIS; STOLTZ LP, 1973, J HUM EVOL, V2, P195, DOI 10.1016/0047-2484(73)90076-6; Stone OML, 2012, PRIMATES, V53, P337, DOI 10.1007/s10329-012-0303-9; STRUM SC, 1994, REV ECOL-TERRE VIE, V49, P295; Strum SC, 2010, INT J PRIMATOL, V31, P133, DOI 10.1007/s10764-009-9387-5; van Doorn AC, 2010, AM J PRIMATOL, V72, P104, DOI 10.1002/ajp.20759; WHITEN A, 1987, INT J PRIMATOL, V8, P367, DOI 10.1007/BF02737389	57	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194717	10.1371/journal.pone.0194717	http://dx.doi.org/10.1371/journal.pone.0194717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596482	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000038
J	Wai, PP; Shewade, HD; Kyaw, NTT; Thein, S; Thu, AS; Kyaw, KWY; Aye, NN; Phyo, AM; Maung, HMW; Soe, KT; Aung, ST				Wai, Pyae Phyo; Shewade, Hemant Deepak; Kyaw, Nang Thu Thu; Thein, Saw; Thu, Aung Si; Kyaw, Khine Wut Yee; Aye, Nyein Nyein; Phyo, Aye Mon; Maung, Htet Myet Win; Soe, Kyaw Thu; Aung, Si Thu			Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; OUTCOMES; INDIA; TIME	Background The Union in collaboration with national TB programme (NTP) started the community-based MDR-TB care (CBMDR-TBC) project in 33 townships of upper Myanmar to improve treatment initiation and treatment adherence. Patients with MDR-TB diagnosed/registered under NTP received support through the project staff, in addition to the routine domiciliary care provided by NTP staff. Each township had a project nurse exclusively for MDR-TB and 30 USD per month (max. for 4 months) were provided to the patient as a pre-treatment support. Objectives To assess whether CBMDR-TBC project's support improved treatment initiation. Methods In this cohort study (involving record review) of all diagnosed MDR-TB between January 2015 and June 2016 in project townships, CBMDR-TBC status was categorized as "receiving support" if date of project initiation in patient's township was before the date of diagnosis and "not receiving support", if otherwise. Cox proportional hazards regression (censored on 31 Dec 2016) was done to identify predictors of treatment initiation. Results Of 456 patients, 57% initiated treatment: 64% and 56% among patients "receiving support (n = 208)" and "not receiving support (n = 228)" respectively (CBMDR-TBC status was not known in 20 (4%) patients due to missing diagnosis dates). Among those initiated on treatment (n = 261), median (IQR) time to initiate treatment was 38 (20, 76) days: 31 (18, 50) among patients "receiving support" and 50 (26,101) among patients "not receiving support". After adjusting other potential confounders (age, sex, region, HIV, past history of TB treatment), patients "receiving support" had 80% higher chance of initiating treatment [aHR (0.95 CI): 1.8 (1.3, 2.3)] when compared to patients "not receiving support". In addition, age 15-54 years, previous history of TB and being HIV negative were independent predictors of treatment initiation. Conclusion Receiving support under CBMDR-TBC project improved treatment initiation: it not only improved the proportion initiated but also reduced time to treatment initiation. We also recommend improved tracking of all diagnosed patients as early as possible.	[Wai, Pyae Phyo; Kyaw, Nang Thu Thu; Thu, Aung Si; Kyaw, Khine Wut Yee; Aye, Nyein Nyein; Phyo, Aye Mon] Int Union TB & Lung Dis Union, Mandalay, Myanmar; [Shewade, Hemant Deepak] Int Union TB & Lung Dis Union, South East Asia Off, New Delhi, India; [Thein, Saw] Minist Hlth & Sports, Natl TB Programme, Mandalay, Myanmar; [Maung, Htet Myet Win; Aung, Si Thu] Minist Hlth & Sports, Natl TB Programme, Nay Pyi Daw, Myanmar; [Soe, Kyaw Thu] Minist Hlth & Sports, Dept Med Res, Pyin Oo Lwin Branch, Pyin Oo Lwin, Myanmar		Wai, PP (corresponding author), Int Union TB & Lung Dis Union, Mandalay, Myanmar.	dr.p.p.wai2012@gmail.com	Kyaw, Khine Wut Yee/K-4130-2019	Kyaw, Khine Wut Yee/0000-0003-0709-484X; SOE, KYAW THU/0000-0003-0969-8815				Cleves M., 2008, INTRO SURVIVAL ANAL; Cox H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002238; Ebonwu JI, 2013, INT J TUBERC LUNG D, V17, P1043, DOI 10.5588/ijtld.13.0071; Harris RC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1524-0; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Hossain ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129155; Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369; Ministry of Immigration and Population M, 2014, POP HOUS CENS MYANM; Naidoo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1145-0; Nair D, 2016, T ROY SOC TROP MED H, V110, P534, DOI 10.1093/trstmh/trw060; National TB Programme Myanmar, 2016, NAT STRAT PLAN TB 20; National Tuberculosis Programme (NTP), 2016, GUID MAN DR IB MYANM; National Tuberculosis Programme (NTP), 2015, NAT TUB PROGR MYANM; National Tuberculosis Programme (NTP), 2016, MYANM NAT STRAT PLAN, P126; Shewade HD, 2016, PUBLIC HEALTH ACTION, V6, P242, DOI 10.5588/pha.16.0075; Singla N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102989; Wai PP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187223; WHO, 2014, END TB STRAT; World Bank, 2015, WORLD BANK REP 2015; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Xu Z, 2017, PLOS ONE, V12	21	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194087	10.1371/journal.pone.0194087	http://dx.doi.org/10.1371/journal.pone.0194087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596434	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000016
J	Kahuthia-Gathu, R; Thungu, DK; Wangu, L; Kimani, R				Kahuthia-Gathu, Ruth; Thungu, Duncan Kirubi; Wangu, Lucy; Kimani, Rachael			Wood-boring beetles associated with Acacia xanthophloea in Nairobi and Machakos Counties, Kenya	PLOS ONE			English	Article							F-MUELL FORESTS; COLEOPTERA BOSTRICHIDAE; NUTRIENT BALANCE; DREPANOLOBIUM; BIOMASS; STRESS	Naivasha thorn tree, Acacia xanthophloea, is grown for foliage, timber, shade and rehabilitation of soils in areas with high water tables in Kenya. Its production is threatened by insect pests, which cause major losses. Very little is documented on wood-boring beetles which cause considerable economic damage to lumber used in a variety of applications, and little is known about their natural enemies in Kenya. We conducted the study to evaluate the occurrence of wood-boring beetles on A. xanthophloea in two different regions of Kenya. Infested wood samples of A. xanthophloea with fresh exit holes were collected from three sites in Kenyatta University (KU), Nairobi and Mitaboni in Machakos, Kenya. The samples were placed in clear plastic buckets and kept at ambient temperatures 23 +/- 2 degrees C, 65 +/- 10% relative humidity and 12L: 12D in a laboratory where they were observed daily for adult emergence. Adult beetles were collected every three days for identification and data recording. The experiment was replicated four times and data collected twice a week for 6 months. Data on abundance was subjected to analysis of variance using SAS software. A total of 5,850 and 4,691 beetles were collected where 2,187 and 3,097 were Bostrichidae, accounting for 37% and 66% in KU and Mitaboni, respectively. A total of 12 bostrichid species was identified, including Sinoxylon ruficorne, S. doliolum, Xylion adustus, Xyloperthodes nitidipennis, Xyloperthella picea, Xylopsocus castanoptera, Lyctus brunneus, Heterbostrychus brunneus, Xylopsocus sp., and Dinoderus gabonicus. The most abundant species in KU was Xylion adustus with 1,915 beetles accounting for 88.4%, and Sinoxylon ruficorne in Mitaboni with 1,050 beetles accounting for 33.9% of the total. Sinoxylon ruficorne was only recorded in Mitaboni while only 2 specimens of D. gabonicus were found in KU. The mean number of exit holes on A. xanthophloea differed significantly between sites, which corresponded approximately to the amount of economic damage caused by the beetles to the structural integrity of the lumber. In addition, a number of predators in the family Cerambycidae, Cleridae, Histeridae and parasitoids from Braconidae, lchneumonidae, and Chalcididae were recovered, suggesting a need to conduct further studies to document these species' diversity, parasitism rates and efficacy for possible biological control.	[Kahuthia-Gathu, Ruth; Thungu, Duncan Kirubi; Wangu, Lucy; Kimani, Rachael] Kenyatta Univ, Dept Agr Sci & Technol, Nairobi, Kenya	Kenyatta University	Kahuthia-Gathu, R (corresponding author), Kenyatta Univ, Dept Agr Sci & Technol, Nairobi, Kenya.	rkahuthia@gmail.com	Kahuthia, Ruth/AAZ-6285-2021	Kahuthia, Ruth/0000-0001-9621-5310				ADAMS MA, 1984, AUST J BOT, V32, P205, DOI 10.1071/BT9840205; ADAMS MA, 1984, AUST J BOT, V32, P217, DOI 10.1071/BT9840217; Akhter K, 2005, 36 ANN M BANG IND AP, P24; Allen DC, 2005, NEW YORK FOREST OWNE, V38, P1; Balasubramanya R. H., 1990, Journal of the Indian Society for Cotton Improvement, V15, P34; Beaver Roger A., 2011, Tropical Natural History, V11, P135; Bellamy C.L., WORLD JEWEL BEETLES; Binda F., 1991, Boletin de Entomologia Venezolana, V6, P83; Borgemeister C, 1999, ANN ENTOMOL SOC AM, V92, P766, DOI 10.1093/aesa/92.5.766; Borowski J., 2007, WORLD CATALOGUE BOST; Bushara M. G., 1981, Sudan Silva, V4, P25; Chase KD, 2012, FLA ENTOMOL, V95, P767, DOI 10.1653/024.095.0329; Chippendale GM, 1963, TOP FEED FODDER TREE; Cookson LJ, 2004, TREATMENT METHODS PR; Creffield JW, 1991, WOOD DESTROYING INSE; Dharani N, 2006, AFR J ECOL, V44, P523, DOI 10.1111/j.1365-2028.2006.00668.x; European Environment Agency [EEA], 2012, 16 EEA; Everist S.L., 1969, USE FODDER TREES SHR; Findlay WPK., 1985, PRESERVATION TIMBER, P273; FISHER WS, 1950, USDA MISCELLANEOUS P, V698, P1, DOI DOI 10.5962/BHL.TITLE.65663; Gathuru G., 2011, THESIS; Gerberg E. J., 1957, Technical Bulletin United States Department of Agriculture Washington, Vno. 1157, P1; Hagstrum D.W., 2009, STORED PRODUCT INSEC; Hakeem KR, 2012, OMICS, V16, P621, DOI 10.1089/omi.2012.0041; Halperin J, 1999, PHYTOPARASITICA, V27, P257, DOI 10.1007/BF02981481; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Herard F., 2009, Bulletin OEPP, V39, P146, DOI 10.1111/j.1365-2338.2009.02286.x; Ivie M. A., 2002, AM BEETLES, V2, P233; Kangkamanee T, 2011, J FOREST RES-JPN, V16, P302, DOI 10.1007/s10310-010-0224-7; Kuria SK, 2010, AFR ENTOMOL, V18, P87, DOI 10.4001/003.018.0109; Lawrence JF, 2010, HBK ZOOL, P209; Lek-Uthai P, 1982, WOOD PRODUCT SECTION, P1; Lesne P., 1924, ENCY ENTOMOLOGIQUE A, V3, P1; Liu Lan-Yu, 2008, Mitteilungen Muenchener Entomologischen Gesellschaft, V98, P91; Lopes-da-Silva M., 2014, Agricultural Sciences, V5, P634, DOI 10.4236/as.2014.57067; Lykidis Charalampos T., 2016, Fragmenta Entomologica, V48, P101, DOI 10.4081/fe.2016.171; Monks KA, 2000, EKOLOGI NUSA TENGGAR, P33; Nair KSS, 2007, NAIR KSS TROPICAL FO, P404; Okello BD, 2001, FOREST ECOL MANAG, V142, P143, DOI 10.1016/S0378-1127(00)00346-7; Orwa C., AGROFORESTREE DATABA; Filho OP, 2006, NEOTROP ENTOMOL, V35, P712, DOI 10.1590/S1519-566X2006000500023; Peters B. C., 2002, Australian Forestry, V65, P107; Price T, 2011, FLA ENTOMOL, V94, P354, DOI 10.1653/024.094.0235; Sakalian V, 2013, ACTA ZOOL BULGAR, V65, P457; SANDHU G S, 1975, Journal of Research Punjab Agricultural University, V12, P152; SAS Institute, 2001, STAT US GUID; Singh R. M. P., 1995, 70 INT CTR RES AGR N, P1; Sittichaya Wisut, 2009, Songklanakarin Journal of Science and Technology, V31, P381; Sittichaya W, 2009, ZOOKEYS, P33, DOI 10.3897/zookeys.26.88; Speight M.R., 2008, ECOLOGY INSECTS CONC, V2nd ed.; TEIXEIRA ÉDSON P., 2002, Neotrop. entomol., V31, P651, DOI 10.1590/S1519-566X2002000400021; Thomas FM, 2002, FOREST PATHOL, V32, P277, DOI 10.1046/j.1439-0329.2002.00291.x; Tomimura Y., 1993, B FOR FOR PROD RES I, V365, P33; Wargo PM, 1996, ANN SCI FOREST, V53, P359, DOI 10.1051/forest:19960218	54	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0188773	10.1371/journal.pone.0188773	http://dx.doi.org/10.1371/journal.pone.0188773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584732	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000001
J	Munster, A; Knipper, C; Oelze, VM; Nicklisch, N; Stecher, M; Schlenker, B; Ganslmeier, R; Fragata, M; Friederich, S; Dresely, V; Hubensack, V; Brandt, G; Dohle, HJ; Vach, W; Schwarz, R; Metzner-Nebelsick, C; Meller, H; Alt, KW				Muenster, Angelina; Knipper, Corina; Oelze, Vicky M.; Nicklisch, Nicole; Stecher, Marcus; Schlenker, Bjoern; Ganslmeier, Robert; Fragata, Matthias; Friederich, Susanne; Dresely, Veit; Hubensack, Vera; Brandt, Guido; Doehle, Hans-Juergen; Vach, Werner; Schwarz, Ralf; Metzner-Nebelsick, Carole; Meller, Harald; Alt, Kurt W.			4000 years of human dietary evolution in central Germany, from the first farmers to the first elites	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; BONE-COLLAGEN; NITROGEN ISOTOPES; FEEDING PRACTICES; TROPHIC LEVEL; CARBON; AGE; DELTA-N-15; RATIOS; MILK	Investigation of human diet during the Neolithic has often been limited to a few archaeological cultures or single sites. In order to provide insight into the development of human food consumption and husbandry strategies, our study explores bone collagen carbon and nitrogen isotope data from 466 human and 105 faunal individuals from 26 sites in central Germany. It is the most extensive data set to date from an enclosed geographic microregion, covering 4,000 years of agricultural history from the Early Neolithic to the Early Bronze Age. The animal data show that a variety of pastures and dietary resources were explored, but that these changed remarkably little over time. In the human delta N-15 however we found a significant increase with time across the different archaeological cultures. This trend could be observed in all time periods and archaeological cultures (Bell Beaker phenomenon excluded), even on continuously populated sites. Since there was no such trend in faunal isotope values, we were able largely to exclude manuring as the cause of this effect. Based on the rich interdisciplinary data from this region and archaeological period we can argue that meat consumption increased with the increasing duration of farming subsistence. In delta C-13, we could not observe any clear increasing or decreasing trends during the archaeological time periods, either for humans or for animals, which would have suggested significant changes in the environment and landscape use. We discovered sex-related dietary differences, with males of all archaeological periods having higher delta N-15 values than females, and an age-related increasing consumption of animal protein. An initial decrease of delta N-15-values at the age of 1-2 years reveals partial weaning, while complete weaning took place at the age of 3-4 years.	[Muenster, Angelina; Stecher, Marcus] Johannes Gutenberg Univ Mainz, Inst Anthropol, Mainz, Germany; [Knipper, Corina] Curt Engelhorn Ctr Archaeometry gGmbH, Mannheim, Germany; [Oelze, Vicky M.] Univ Calif Santa Cruz, Anthropol Dept, Santa Cruz, CA 95064 USA; [Nicklisch, Nicole; Alt, Kurt W.] DPU, Ctr Nat & Cultural Hist Man, Krems Stein, Austria; [Nicklisch, Nicole; Schlenker, Bjoern; Ganslmeier, Robert; Friederich, Susanne; Dresely, Veit; Doehle, Hans-Juergen; Schwarz, Ralf; Meller, Harald; Alt, Kurt W.] Saxony Anhalt State Museum Prehist, State Off Heritage Management & Archaeol, Halle, Germany; [Fragata, Matthias] Xylem Analyt Germany Sales GmbH & Co KG, Mainz, Germany; [Hubensack, Vera] State Off Heritage Management, Dresden, Germany; [Brandt, Guido] Max Planck Inst Sci Human Hist, Jena, Germany; [Vach, Werner] Univ Freiburg, Med Ctr, Ctr Med Biometry & Med Informat, Clin Epidemiol Grp, Freiburg, Germany; [Metzner-Nebelsick, Carole] Ludwig Maximilian Univ Munich, Inst Prehistor Archaeol & Prov Roman Archaeol, Munich, Germany; [Alt, Kurt W.] Basel Univ, Dept Biomed Engn & Integrat Prehist & Archaeol Sc, Basel, Switzerland	Johannes Gutenberg University of Mainz; University of California System; University of California Santa Cruz; University of Freiburg; University of Munich	Munster, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anthropol, Mainz, Germany.; Alt, KW (corresponding author), DPU, Ctr Nat & Cultural Hist Man, Krems Stein, Austria.; Alt, KW (corresponding author), Saxony Anhalt State Museum Prehist, State Off Heritage Management & Archaeol, Halle, Germany.; Alt, KW (corresponding author), Basel Univ, Dept Biomed Engn & Integrat Prehist & Archaeol Sc, Basel, Switzerland.	amuenster@uni-mainz.de; kurt.alt@dp-uni.ac.at	Vach, Werner/F-2512-2011	Vach, Werner/0000-0003-1865-8399; Nicklisch, Nicole/0000-0001-7423-8343; Munster, Angelina/0000-0002-1997-7933	German Research Foundation [39072354]	German Research Foundation(German Research Foundation (DFG))	This research was supported by the German Research Foundation (project number 39072354) and the Geocycles Research Centre at the University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimutis WR, 2004, J NUTR, V134, p989S, DOI 10.1093/jn/134.4.989S; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Ambrose S.H., 2000, BIOGEOCHEMICAL APPRO; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; Ambrose SH, 2003, J ANTHROPOL ARCHAEOL, V22, P217, DOI 10.1016/S0278-4165(03)00036-9; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; [Anonymous], 1980, J HUM EVOL, V9, P517; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Asam Tanja, 2006, Anthropologischer Anzeiger, V64, P1; Balasse M, 2002, J ARCHAEOL SCI, V29, P853, DOI 10.1006/jasc.2001.0725; Barrett J.H., 2004, EUR J ARCHAEOL, V7, P249, DOI [10.1177/1461957104056502, DOI 10.1177/1461957104056502]; Beier HJ, 1992, BEITRAGE UR FRUHGESC, V4; Bellwood P.S., 2007, 1 FARMERS ORIGINS AG; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bosl C, 2006, INT J OSTEOARCHAEOL, V16, P296, DOI 10.1002/oa.834; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; Bogaard A, P NATL ACAD SCI, V110, P12589; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; BOWEN WH, 1993, CARIES RES, V27, P461, DOI 10.1159/000261581; Brandt G, 2015, THESIS; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Britton K, 2008, J ARCHAEOL SCI, V35, P2111, DOI 10.1016/j.jas.2008.01.012; Britton K, 2017, ANTIQUITY, V91, P853, DOI 10.15184/aqy.2017.98; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Buikstra JE., 1994, ARKANSAS ARCHEOLOGIC, V44; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; CARLITHIELE P, 1996, SPUREN MANGELERKRANK; Caselitz P, 1998, DENTAL ANTHROPOLOGY, P203; Caselitz P, 1986, ERNAHRUNGSMOGLICHKEI; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Cerling TE, 1997, J HUM EVOL, V33, P635, DOI 10.1006/jhev.1997.0151; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Dohle, 1994, LINIENBANDKERAMISCHE; Dohle HJ., 1997, JAHRESSCHRIFT MITTEL, P111; Doppler T., 2015, QUATERNARY INT B, V436, P18; Drucker D, 2003, PALAEOGEOGR PALAEOCL, V195, P375, DOI 10.1016/S0031-0182(03)00366-3; Drucker DG, 2005, J HUM EVOL, V49, P19, DOI 10.1016/j.jhevol.2005.02.007; Drucker DG, 2008, PALAEOGEOGR PALAEOCL, V266, P69, DOI 10.1016/j.palaeo.2008.03.020; Dupras TL, 2007, AM J PHYS ANTHROPOL, V134, P63, DOI 10.1002/ajpa.20639; Eaton SB, 1997, WORLD REV NUTR DIET, V81, P26; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Evershed RP, 2007, ECOL METHOD CONCEPT, P480, DOI 10.1002/9780470691854.ch14; Fernandes R, 2015, AM J PHYS ANTHROPOL, V158, P325, DOI 10.1002/ajpa.22788; Fernandes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087436; Fogel ML, 1997, ORG GEOCHEM, V27, P275, DOI 10.1016/S0146-6380(97)00060-0; Fraser RA, 2013, WORLD ARCHAEOL, V45, P492, DOI 10.1080/00438243.2013.820649; Fraser RA, 2011, J ARCHAEOL SCI, V38, P2790, DOI 10.1016/j.jas.2011.06.024; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P45, DOI 10.1002/ajpa.20244; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gerbault P, 2013, IUBMB LIFE, V65, P983, DOI 10.1002/iub.1227; Greenfield HJ, 2010, WORLD ARCHAEOL, V42, P29, DOI 10.1080/00438240903429722; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hamilton J, 2009, ANTIQUITY, V83, P998, DOI 10.1017/S0003598X00099300; HEATON THE, 1986, NATURE, V322, P822, DOI 10.1038/322822a0; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Howcroft R., 2013, THESIS STOCKHOLM U; Howcroft R, 2014, J ANTHROPOL ARCHAEOL, V34, P42, DOI 10.1016/j.jaa.2014.01.001; Hublin J.-J., 2009, EVOLUTION HOMININ DI, V1st; Huelsemann F, 2013, AM J PHYS ANTHROPOL, V152, P58, DOI 10.1002/ajpa.22328; Jacomet S, 2008, OFFA BUCHER, P355; Jim S, 2006, BRIT J NUTR, V95, P1055, DOI 10.1079/BJN20051685; Katzenberg M. Anne, 1995, BODIES EVIDENCE RECO, P221; Katzenberg Mary Anne Saunders, 2000, BIOL ANTHR HUMAN SKE; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Knipper C., 2011, RAUMLICHE ORG LINEAR; Knipper C, 2016, AM J PHYS ANTHROPOL, V159, P496, DOI 10.1002/ajpa.22892; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Lee-Thorp Julia, 2007, P289, DOI 10.1007/978-3-540-33761-4_9; Lipson M, 2017, BIORXIV; Litt T., 1990, JAHRESSCHR MITTELDT, V73, P49; Litt T., 1992, EVALUATION LAND SURF, P83; Litt T., 1992, VEGETATION HIST ARCH, V1, P64; Lomer MCE, 2008, ALIMENT PHARM THER, V27, P93, DOI 10.1111/j.1365-2036.2007.03557.x; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Luning J., 1996, ERNEUTE GEDANKEN BEN, V74, P233; Mathieson I, 2015, BIORXIV; Meller H., 2013, 3300 BC MYSTENOSE ST; Mellinger N, 2003, URSPRUNG WANDEL LUST; Meyer C, 2008, TOTENHUTTE BENZINGER, P107; Minagawa M, 1992, MASS SPECTROSC, V40, P47; Morseburg A, 2015, J ANTHROPOL ARCHAEOL, V39, P210, DOI 10.1016/j.jaa.2015.04.001; Muller HH, 1964, HAUSTIERE MITTELDEUT; Muller HH, 1985, JAHRESSCHRIFT MITTEL, V68, P179; Nehlich O, 2011, GEOCHIM COSMOCHIM AC, V75, P4963, DOI 10.1016/j.gca.2011.06.009; Nehlich O, 2009, ARCHAEOL ANTHROP SCI, V1, P59, DOI 10.1007/s12520-009-0003-6; Nicklisch N., 2014, THESIS; Nicklisch N, 2016, ANN ANAT, V203, P90, DOI 10.1016/j.aanat.2015.02.001; Nitsch EK, 2010, J ARCHAEOL SCI, V37, P3191, DOI 10.1016/j.jas.2010.07.019; Nitsch EK, 2011, AM J PHYS ANTHROPOL, V146, P619, DOI 10.1002/ajpa.21623; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; Oelze VM, 2011, J ARCHAEOL SCI, V38, P270, DOI 10.1016/j.jas.2010.08.027; Ozdogan M., 2014, DOCUMENTA PRAEHISTOR, V41, P33, DOI DOI 10.4312/DP.41.2; Parkhomenko P., 2013, GAGARIN 1 SPACE; Paul D, 2007, RAPID COMMUN MASS SP, V21, P3006, DOI 10.1002/rcm.3185; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Preuss J., 1992, NEOLITHIKUM MITTELEU; Reitsema LJ, 2015, AM J PHYS ANTHROPOL, V157, P347, DOI 10.1002/ajpa.22713; REYNOLDS EC, 1982, CALCIFIED TISSUE INT, V34, pS52; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Roffet-Salque M, 2015, KOPYDLOWO STANOWISKO, P133; Rose JC, 1998, DENTAL ANTHROPOLOGY, P349; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Schnyder H, 2006, GLOBAL CHANGE BIOL, V12, P1315, DOI 10.1111/j.1365-2486.2006.01169.x; Schurr MR, 1997, J ARCHAEOL SCI, V24, P919, DOI 10.1006/jasc.1996.0171; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Sealy J., 2005, HDB ARCHAEOLOGICAL S, P269; Sealy J, 2014, J ARCHAEOL SCI, V47, P64, DOI 10.1016/j.jas.2014.04.011; SHERRATT A, 1983, WORLD ARCHAEOL, V15, P90, DOI 10.1080/00438243.1983.9979887; Sherratt A., 1988, PLOUGH PASTORALISM A; Simmons AH, 2007, NEOLITHIC REVOLUTION; Sjogren KG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155083; Spangenberg JE, 2006, J ARCHAEOL SCI, V33, P1, DOI 10.1016/j.jas.2005.05.013; Spangenberg JE, 2008, ISOT ENVIRON HEALT S, V44, P189, DOI 10.1080/10256010802066349; Stecher M., 2013, MESOLITHIC BURIALS R; Szecsenyi-Nagy A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0339; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; Tuross Noreen, 1994, SKELETAL BIOL GREAT, P283; VACCASMITH AM, 1994, ARCH ORAL BIOL, V39, P1063, DOI 10.1016/0003-9969(94)90059-0; Vaiglova P, 2014, J ARCHAEOL SCI, V42, P201, DOI 10.1016/j.jas.2013.10.023; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; van Klinken GJ, 2000, BIOGEOCHEMICAL APPRO, P39, DOI DOI 10.1007/0-306-47194-9_3; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; WALKER PL, 1990, AM ANTHROPOL, V92, P383, DOI 10.1525/aa.1990.92.2.02a00080; Webb EC, 2015, J ARCHAEOL SCI, V63, P104, DOI 10.1016/j.jas.2015.08.001; Werner F, 2012, COW BOVINE BIOGRAPHY; White T.D., 2000, HUMAN OSTEOLOGY; Zich B, 1992, STUDIEN REGIONALEN C	129	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194862	10.1371/journal.pone.0194862	http://dx.doi.org/10.1371/journal.pone.0194862			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584767	Green Published, gold, Green Accepted			2022-12-27	WOS:000428373000045
J	Davis, KAS; Bashford, O; Jewell, A; Shetty, H; Stewart, RJ; Sudlow, CLM; Hotopf, MH				Davis, Katrina Alice Southworth; Bashford, Oliver; Jewell, Amelia; Shetty, Hitesh; Stewart, Robert J.; Sudlow, Cathie L. M.; Hotopf, Matthew Hugo			Using data linkage to electronic patient records to assess the validity of selected mental health diagnoses in English Hospital Episode Statistics (HES)	PLOS ONE			English	Article							PSYCHIATRIC-DIAGNOSIS; ADMINISTRATIVE DATA; ILLNESS; CARE; POPULATION; PREVALENCE; DISORDERS; ACCURACY	Background Administrative data can be used to support research, such as in the UK Biobank. Hospital Episode Statistics (HES) are national data for England that include contain ICD-10 diagnoses for inpatient mental healthcare episodes, but the validity of these diagnoses for research purposes has not been assessed. Methods 250 peoples' HES records were selected based on a HES recorded inpatient stay at the South London and Maudsley NHS Foundation Trust with a diagnosis of schizophrenia, a wider schizophrenia spectrum disorder, bipolar affective disorder or unipolar depression. A gold-standard research diagnosis was made using Clinical Records Interactive Search pseudonymised electronic patient records using, and the OPCRIT+ algorithm. Results Positive predictive value at the level of lifetime psychiatric disorder was 100%, and at the level of lifetime diagnosis in the four categories of schizophrenia, wider schizophrenia spectrum, bipolar or unipolar depression was 73% (68-79). Agreement varied by diagnosis, with schizophrenia having the highest PPV at 90% (80-96). Each person had an average of five psychiatric HES records. An algorithm that looked at the last recorded psychiatric diagnosis led to greatest overall agreement with the research diagnosis. Discussion For people who have a HES record from a psychiatric admission with a diagnosis of schizophrenia spectrum disorder, bipolar affective disorder or unipolar depression, HES records appear to be a good indicator of a mental disorder, and can provide a diagnostic category with reasonable certainty. For these diagnoses, HES records can be an effective way of ascertaining psychiatric diagnosis.	[Davis, Katrina Alice Southworth; Stewart, Robert J.; Hotopf, Matthew Hugo] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England; [Davis, Katrina Alice Southworth; Bashford, Oliver; Jewell, Amelia; Shetty, Hitesh; Stewart, Robert J.; Hotopf, Matthew Hugo] South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, De Crespigny Pk,Denmark Hill, London, England; [Bashford, Oliver] Surrey & Borders Partnership NHS Fdn Trust, Leatherhead, Surrey, England; [Sudlow, Cathie L. M.] Univ Edinburgh, UK Biobank, Edinburgh, Midlothian, Scotland; [Sudlow, Cathie L. M.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	University of London; King's College London; University of Edinburgh; University of Edinburgh	Hotopf, MH (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.; Hotopf, MH (corresponding author), South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, De Crespigny Pk,Denmark Hill, London, England.	matthew.hotopf@kcl.ac.uk	Stewart, Robert/B-1667-2010; Hotopf, Matthew/E-4971-2010	Stewart, Robert/0000-0002-4435-6397; Sudlow, Cathie/0000-0002-7725-7520; Hotopf, Matthew/0000-0002-3980-4466; Davis, Katrina/0000-0001-5945-4646	UK Biobank; Scottish Funding Council; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust; King's College London; MRC [MC_PC_17214] Funding Source: UKRI	UK Biobank; Scottish Funding Council; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust; King's College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant from UK Biobank. Cathie Sudlow is supported by UK Biobank and the Scottish Funding Council. Matthew Hotopf, Rob Stewart, Hitesh Shetty, Amelia Jewell and Katrina Davis are funded by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allebeck P, 2009, ACTA PSYCHIAT SCAND, V120, P386, DOI 10.1111/j.1600-0447.2009.01474.x; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Capita Health and Wellbeing, 2014, QUAL CLIN COD NHS; Chubak J, 2012, J CLIN EPIDEMIOL, V65, P343, DOI 10.1016/j.jclinepi.2011.09.002; Crabbe T, 1999, J EPIDEMIOL COMMUN H, V53, P159, DOI 10.1136/jech.53.3.159; CRIS Network, 2017, GOV 2017; Davis KAS, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0963-x; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Fernandes AC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-71; First MB, 2005, PSYCHOPATHOLOGY, V38, P206, DOI 10.1159/000086093; Frayne SM, 2010, AM J MED QUAL, V25, P42, DOI 10.1177/1062860609346347; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Lobo SEM, 2015, INT J MED INFORM, V84, P675, DOI 10.1016/j.ijmedinf.2015.05.001; Munk-Jorgensen P, 2014, ACTA PSYCHIAT SCAND, V130, P87, DOI 10.1111/acps.12281; National Collaborating Centre for Mental Health, 2011, COMM MENT HLTH DIS I; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; NHS Digital, 2017, HOSP EP STAT NAT HLT; NHS Digital, 2016, US US HOSP EP STAT; Perera G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008721; RSA Open Public Services Network, 2015, EXPL AV NHS DAT CAN; Rucker J, 2011, BRIT J PSYCHIAT, V199, P151, DOI 10.1192/bjp.bp.110.082925; Sara G, 2014, SOC PSYCH PSYCH EPID, V49, P1729, DOI 10.1007/s00127-014-0881-5; SARTORIUS N, 1993, ARCH GEN PSYCHIAT, V50, P115; Sinha S, 2013, EUR J PUBLIC HEALTH, V23, P86, DOI 10.1093/eurpub/cks046; Spiranovic C, 2016, ADV MENT HEALTH, V14, P14, DOI 10.1080/18387357.2015.1063635; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; Stewart R, 2014, ACTA PSYCHIAT SCAND, V130, P83, DOI 10.1111/acps.12279; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; The Nuffield Council on Bioethics, 2015, COLL LINK US DAT BIO; Thompson A, 2004, BRIT J PSYCHIAT, V185, P334, DOI 10.1192/bjp.185.4.334; Vach W, 2005, J CLIN EPIDEMIOL, V58, P655, DOI 10.1016/j.jclinepi.2004.02.021; van Os J, 2016, WORLD PSYCHIATRY, V15, P118, DOI 10.1002/wps.20310; Vares M, 2006, PSYCHOPATHOLOGY, V39, P286, DOI 10.1159/000095733; Vuorilehto MS, 2007, PSYCHOL MED, V37, P893, DOI 10.1017/S0033291707000098; Zaiontz, REAL STAT RESOURCE P	36	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0195002	10.1371/journal.pone.0195002	http://dx.doi.org/10.1371/journal.pone.0195002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579109	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800076
J	Massad, E; dos Santos, PCC; da Rocha, AF; Stupple, EJN				Massad, Eduardo; Costa dos Santos, Paulo Cesar; da Rocha, Armando Freitas; Stupple, Edward J. N.			The Monty Hall problem revisited: Autonomic arousal in an inverted version of the game	PLOS ONE			English	Article							DECISION-MAKING; LOSS AVERSION; LOSSES; GAINS	The asymmetry of autonomic arousal for potential losses and gains was assessed by the galvanic skin response (GSR) of participants playing classic and inverted versions of the Monty Hall problem (MHP). In both versions, the prize remained the same (a pen valued at 10 pound for the right answer), but in the modified version, prizes were received prior to choosing the door. Both experimental groups showed increased levels of GSR while completing the task, demonstrating increased autonomic arousal during the game. However, a robust difference in GSR was detected between classic and inverted versions of the MHP, thus demonstrating the differing autonomic arousal involved in deciding between the alternatives presented by the game. Participants experienced a stronger autonomic response when they could lose the prize than when they could win the prize. This experiment presents the first demonstration of this effect on the MHP. The stronger autonomic arousal for the inverted task may indicate a stronger emotional reaction and/or greater attentional focus than for the standard version of the task. These data demonstrate that potential losses increase arousal in more complex tasks than is typically shown.	[Massad, Eduardo; Costa dos Santos, Paulo Cesar; da Rocha, Armando Freitas] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Massad, Eduardo] London Sch Hyg & Trop Med, London, England; [Massad, Eduardo; Stupple, Edward J. N.] Univ Derby, Coll Life & Nat Sci, Derby, England; [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil; [Costa dos Santos, Paulo Cesar] Univ Paulista, Sao Paulo, Brazil; [Costa dos Santos, Paulo Cesar] Univ Sao Paulo, Inst Adv Studies, Sao Paulo, Brazil	Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine; University of Derby; Escola de Pos-Graduacao em Economia (EPGE); Getulio Vargas Foundation; Universidade Paulista; Universidade de Sao Paulo	Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.; Massad, E (corresponding author), Univ Derby, Coll Life & Nat Sci, Derby, England.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.	edmassad@usp.br	Stupple, Edward J N/H-2925-2016; Massad, Eduardo/B-1169-2012	Stupple, Edward J N/0000-0001-8545-9504; Massad, Eduardo/0000-0002-7200-2916				Atkinson KE, 1989, INTRO NUMERICAL ANAL; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bland M., 2000, INTRO MED STAT, V3rd; Burns BD, 2004, J EXP PSYCHOL GEN, V133, P434, DOI 10.1037/0096-3445.133.3.434; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; De Martino B, 2008, J NEUROSCI, V28, P10746, DOI 10.1523/JNEUROSCI.2895-08.2008; Gardner M., 1959, SCI AM, V201, P174; Gokay R, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON MULTISENSOR FUSION AND INTEGRATION FOR INTELLIGENT SYSTEMS (MFI), P178, DOI 10.1109/MFI.2015.7295805; GRANBERG D, 1995, PERS SOC PSYCHOL B, V21, P711; Hochman G, 2014, J ECON BEHAV ORGAN, V107, P582, DOI 10.1016/j.jebo.2014.01.014; Hochman G, 2011, J BEHAV DECIS MAKING, V24, P140, DOI 10.1002/bdm.692; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193; Krauss S, 2003, J EXP PSYCHOL GEN, V132, P3, DOI 10.1037/0096-3445.132.1.3; LeDoux J.E., 2015, ANXIOUS MODERN MIND; Lejarraga T, 2017, PSYCHON B REV, V24, P708, DOI 10.3758/s13423-016-1158-7; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Oviatt S, 2006, P 14 ACM INT C MULTI, P871; Page SE, 1998, ECON LETT, V61, P175, DOI 10.1016/S0165-1765(98)00158-X; Piattelli-Palmarini M., 1991, PROBABILITY BLINDNES, P28; Rick S, 2011, J CONSUM PSYCHOL, V21, P453, DOI 10.1016/j.jcps.2010.04.004; Rosenhouse J., 2009, MONTY HALL PROBLEM; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Yechiam E, 2014, PSYCHOL SCI, V25, P494, DOI 10.1177/0956797613510725; Yechiam E, 2013, PSYCHOL BULL, V139, P497, DOI 10.1037/a0029383	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0192542	10.1371/journal.pone.0192542	http://dx.doi.org/10.1371/journal.pone.0192542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579122	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000428351800005
J	Xavier, MJ; Nixon, B; Roman, SD; Aitken, RJ				Xavier, Miguel J.; Nixon, Brett; Roman, Shaun D.; Aitken, Robert John			Improved methods of DNA extraction from human spermatozoa that mitigate experimentally-induced oxidative DNA damage	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CHROMATIN-STRUCTURE ASSAY; HUMAN SPERM; STRAND BREAKS; NUCLEOSOME OCCUPANCY; MAMMALIAN SPERM; TUNEL ASSAY; GERM-CELLS; INTEGRITY; MOUSE	Current approaches for DNA extraction and fragmentation from mammalian spermatozoa provide several challenges for the investigation of the oxidative stress burden carried in the genome of male gametes. Indeed, the potential introduction of oxidative DNA damage induced by reactive oxygen species, reducing agents (dithiothreitol or beta-mercaptoethanol), and DNA shearing techniques used in the preparation of samples for chromatin immunoprecipitation and next-generation sequencing serve to cofound the reliability and accuracy of the results obtained. Here we report optimised methodology that minimises, or completely eliminates, exposure to DNA damaging compounds during extraction and fragmentation procedures. Specifically, we show that Micrococcal nuclease (MNase) digestion prior to cellular lysis generates a greater DNA yield with minimal collateral oxidation while randomly fragmenting the entire paternal genome. This modified methodology represents a significant improvement over traditional fragmentation achieved via sonication in the preparation of genomic DNA from human spermatozoa for downstream applications, such as next-generation sequencing. We also present a redesigned bioinformatic pipeline framework adjusted to correctly analyse this form of data and detect statistically relevant targets of oxidation.	[Xavier, Miguel J.; Nixon, Brett; Roman, Shaun D.; Aitken, Robert John] Univ Newcastle, Reprod Sci Grp, Fac Sci, Callaghan, NSW, Australia; [Xavier, Miguel J.; Nixon, Brett; Roman, Shaun D.; Aitken, Robert John] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [Roman, Shaun D.] Univ Newcastle, Prior Res Ctr Chem Biol & Clin Pharm, Callaghan, NSW, Australia; [Aitken, Robert John] Univ Newcastle, Fac Hlth & Med, Callaghan, NSW, Australia	University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle	Xavier, MJ (corresponding author), Univ Newcastle, Reprod Sci Grp, Fac Sci, Callaghan, NSW, Australia.; Xavier, MJ (corresponding author), Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia.	migueljoao.xavier@uon.edu.au	Aitken, Robert John/AAY-8238-2020; Xavier, Miguel/AAD-4576-2022; Roman, Shaun/AFR-5087-2022; ROMAN, SHAUN/G-7047-2013; Nixon, Brett/B-5121-2012	Aitken, Robert John/0000-0002-9152-156X; Xavier, Miguel/0000-0003-0709-7223; ROMAN, SHAUN/0000-0002-7758-7757; Nixon, Brett/0000-0003-2745-8188	University of Newcastle's Priority Research Centre for Reproductive Sciences	University of Newcastle's Priority Research Centre for Reproductive Sciences	This work was supported by the University of Newcastle's Priority Research Centre for Reproductive Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727, DOI 10.1016/S1472-6483(10)60676-1; Aitken RJ, 2013, MOL HUM REPROD, V19, P475, DOI 10.1093/molehr/gat025; Aitken RJ, 2013, ANDROLOGY-US, V1, P192, DOI 10.1111/j.2047-2927.2012.00056.x; Aitken RJ, 2009, J CLIN INVEST, V119, P1849, DOI 10.1172/JCI39688; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Aitken RJ, 2004, J ANDROL, V25, P455; Aitken RJ, 1998, BIOL REPROD, V59, P1037, DOI 10.1095/biolreprod59.5.1037; Aravindan GR, 1997, EXP CELL RES, V236, P231, DOI 10.1006/excr.1997.3719; Arpanahi A, 2009, GENOME RES, V19, P1338, DOI 10.1101/gr.094953.109; BAHNAK BR, 1988, NUCLEIC ACIDS RES, V16, P1208, DOI 10.1093/nar/16.3.1208; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Chankitisakul V, 2013, J REPROD DEVELOP, V59, P66; Charrier JG, 2012, ATMOS CHEM PHYS, V12, P9321, DOI 10.5194/acp-12-9321-2012; Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Cui KR, 2012, METHODS MOL BIOL, V833, P413, DOI 10.1007/978-1-61779-477-3_24; De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446; De Iuliis GN, 2009, BIOL REPROD, V81, P517, DOI 10.1095/biolreprod.109.076836; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Fan XC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn535; FUCIARELLI AF, 1995, FREE RADICAL BIO MED, V18, P231, DOI 10.1016/0891-5849(94)00119-5; GATEWOOD JM, 1990, J BIOL CHEM, V265, P20662; Irvine DS, 2000, J ANDROL, V21, P33; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kocer A, 2015, FREE RADICAL BIO MED, V89, P993, DOI 10.1016/j.freeradbiomed.2015.10.419; Kumagai Y, 2002, CHEM RES TOXICOL, V15, P483, DOI 10.1021/tx0100993; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis SEM, 2008, MUTAGENESIS, V23, P163, DOI 10.1093/mutage/gem052; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Mieczkowski J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11485; Milowska K, 2007, BIOMOL ENG, V24, P263, DOI 10.1016/j.bioeng.2007.02.001; Mitchell LA, 2011, INT J ANDROL, V34, P2, DOI 10.1111/j.1365-2605.2009.01042.x; Noblanc A, 2013, FREE RADICAL BIO MED, V65, P719, DOI 10.1016/j.freeradbiomed.2013.07.044; Oger I, 2003, ZYGOTE, V11, P367, DOI 10.1017/S0967199403002442; Pan WW, 2013, GENE, V526, P287, DOI 10.1016/j.gene.2013.03.103; R Core Team, 2004, R LANG ENV STAT COMP; Ramos L, 2001, HUM REPROD, V16, P1703, DOI 10.1093/humrep/16.8.1703; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAILER BL, 1995, J ANDROL, V16, P80; Siegel S., 1988, NONPARAMETRIC STAT B; Simon L, 2011, REPROD BIOMED ONLINE, V23, P724, DOI 10.1016/j.rbmo.2011.08.010; Simon L, 2011, FERTIL STERIL, V95, P652, DOI 10.1016/j.fertnstert.2010.08.019; Smit AF., 2018, REPEATMASKER; Smith TB, 2013, J CELL SCI, V126, P1488, DOI 10.1242/jcs.121657; Spano M, 2005, CURR OPIN OBSTET GYN, V17, P255, DOI 10.1097/01.gco.0000169102.77504.66; Szczygiel MA, 2003, BIOL REPROD, V68, P1903, DOI 10.1095/biolreprod.102.012377; Szczygiel MA, 2002, BIOL REPROD, V67, P1532, DOI 10.1095/biolreprod.101.002667; Tolstorukov MY, 2010, EPIGENOMICS-UK, V2, P187, DOI 10.2217/EPI.09.48; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; van der Heijden GW, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-34; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Yamauchi Y, 2012, J ANDROL, V33, P229, DOI 10.2164/jandrol.111.013532; Zalenskaya IA, 2000, BIOCHEM BIOPH RES CO, V279, P213, DOI 10.1006/bbrc.2000.3917; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321	70	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0195003	10.1371/journal.pone.0195003	http://dx.doi.org/10.1371/journal.pone.0195003			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579126	Green Published, Green Submitted, gold			2022-12-27	WOS:000428351800077
J	Costa, ASH; Costa, P; Alves, SP; Alfaia, CM; Prates, JAM; Vleck, V; Cassar-Malek, I; Hocquette, JF; Bessa, RJB				Costa, Ana S. H.; Costa, Paulo; Alves, Susana P.; Alfaia, Cristina M.; Prates, Jose A. M.; Vleck, Veronica; Cassar-Malek, Isabelle; Hocquette, Jean-Francois; Bessa, Rui J. B.			Does growth path influence beef lipid deposition and fatty acid composition?	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; GENE-EXPRESSION DATA; COMPENSATORY GROWTH; SKELETAL-MUSCLE; BELGIAN BLUE; MEAT; CHAIN; BIOHYDROGENATION; STEERS; IDENTIFICATION	Despite the recent advances in transcriptomics, gene expression studies addressing cattle's skeletal muscle adaptations in response to compensatory growth are warranted, particularly regarding lipid metabolism due to its impact in meat sensory and nutritional traits. In the present study, in comparison to ad libitum feeding, a period of feed restriction was used in order to understand the changes in bull's lipid metabolism and gene expression of the adipogenic and lipogenic pathways after re-alimentation. Thus, 40 young Alentejana bulls were either fed ad libitum (CG group) from 9 to 18 months of age or subjected to food restriction from 9 to 15 months of age, and fed ad libitum until 24 months of age (DG group). The intramuscular fat (IMF) and total fatty acids (FA) contents were similar between groups. The major FA (>2%) contents were similar (16:0, 16:1c9, 18:1c9 and 18:2n-6) between treatments with the exception of 18:0 content that was 15% lower in DG than in CG and 20:4n-6 that tended to be greater on DG bulls. Regarding minor FA (<2%), the DG group presented greater proportions (P<0.01) of 17:1c9, 18:1t9, 18:1t10 (18:1c11), 18:1c13, 18:3n-6, 22:0, 22:4n-6 and 22:6n-3 and lower (P<0.05) proportions of 20:0, 18:1t16+c14, and branched chain FA (iso-15:0, anteiso-15:0, iso-16:0 and anteiso-17:0) than the CG group. Delta-9 desaturase activity indices were consistently greater (P<0.05) in DG, when compared to the CG group. Regarding microarray analysis, differentially expressed genes between CG and DG bulls were grouped in 5 main biological functions: lipid and nucleic acid metabolisms, small molecule biochemistry, molecular transport and translational modification. Discontinuous growth down-regulated the expression of ACACB (FC (fold-change) = 1.32), FABP3 (FC = 1.45), HADHA (FC = 1.41) and SLC37A4 (FC = 1.40) genes, when compared to the CG system (FDR<0.05). In contrast, in the CG bulls, the expression of ELOVL5 (FC = 1.58) and FASN (FC = 1.71) was down-regulated when compared to DG bulls. These results were confirmed to be significant (P<0.05) in the case of ELOVL5, FASN and SLC37A4, and almost significant for FABP3 by qRT-PCR analysis. The SCD1 and SCD5 gene expressions were not found to be affected by growth path. These results contribute to the still scarce knowledge about the mechanisms involved in fatty acid metabolism during compensatory growth which have decisive role on meat quality produced in Mediterranean areas.	[Costa, Ana S. H.; Costa, Paulo; Alves, Susana P.; Alfaia, Cristina M.; Prates, Jose A. M.; Bessa, Rui J. B.] Polo Univ Alto Ajuda, Univ Lisboa, Fac Med Vet, CIISA, Ave Univ Tecn, Lisbon, Portugal; [Vleck, Veronica] Univ Lisbon, Fac Motricidade Humana, CIPER, Estr Costa, Lisbon, Portugal; [Cassar-Malek, Isabelle; Hocquette, Jean-Francois] INRA, UR 1213, URH, St Genes Champanelle, France; [Cassar-Malek, Isabelle; Hocquette, Jean-Francois] Clermont Univ, VetAgro Sup, UMR1213, Clermont Ferrand, France; [Costa, Ana S. H.] Univ Cambridge, MRC Canc Unit, Hutch MRC Res Ctr, Cambridge Biomed Campus, Cambridge, England	Universidade de Lisboa; Universidade de Lisboa; INRAE; VetAgro Sup; University of Cambridge	Costa, P (corresponding author), Polo Univ Alto Ajuda, Univ Lisboa, Fac Med Vet, CIISA, Ave Univ Tecn, Lisbon, Portugal.	paulocosta@fmv.ulisboa.pt	Alves, Susana/Q-3889-2019; Prates, José A M/K-9934-2013; Costa, Ana SH/H-2852-2012; Costa, Ana/HDL-9297-2022; Hocquette, Jean-Francois/I-1034-2019; , Cassar-Malek/AAW-6386-2020; Bessa, Rui J. B./B-8006-2008; Alves, Susana P/C-1447-2008; Alfaia, Cristina/H-4874-2013; costa, paulo/A-2556-2010; Vleck, Veronica/H-6473-2011	Alves, Susana/0000-0002-3171-9566; Prates, José A M/0000-0003-1032-5987; Costa, Ana SH/0000-0001-8932-6370; Hocquette, Jean-Francois/0000-0003-2409-3881; , Cassar-Malek/0000-0001-7407-1408; Bessa, Rui J. B./0000-0003-4109-3488; Alves, Susana P/0000-0002-3171-9566; Alfaia, Cristina/0000-0001-8648-2204; costa, paulo/0000-0003-3791-2735; Vleck, Veronica/0000-0001-8168-8633	Fundacao para a Ciencia e a Tecnologia (FCT) through Centro de Investigacao Interdisciplinar em Sanidade Animal [UID/CVT/00276/2013, PTDC/CVT/65707/2006, PTDC/CVT/111744/2009, SFRH/BPD/76836/2011, SFRH/BPD/111051/2015, SFRH/BPD/104394/2014]	Fundacao para a Ciencia e a Tecnologia (FCT) through Centro de Investigacao Interdisciplinar em Sanidade Animal	This research was supported by the Fundacao para a Ciencia e a Tecnologia (FCT) through Centro de Investigacao Interdisciplinar em Sanidade Animal (UID/CVT/00276/2013) and from Project grants (PTDC/CVT/65707/2006 and PTDC/CVT/111744/2009) and individual fellowships to: A. S.C (SFRH/BPD/76836/2011), P. C. (SFRH/BPD/111051/2015), S.P.A. (SFRH/BPD/76836/2011) and V. V. (SFRH/BPD/104394/2014). All the funding sources are presented in this submission. There was no additional external funding received for this study.	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Allingham PG, 1998, MEAT SCI, V48, P65, DOI 10.1016/S0309-1740(97)00076-4; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Archibeque SL, 2005, J ANIM SCI, V83, P1153; BERGE P, 1991, LIVEST PROD SCI, V28, P203, DOI 10.1016/0301-6226(91)90143-E; Bernard C, 2009, MEAT SCI, V82, P205, DOI 10.1016/j.meatsci.2009.01.012; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; Bessa RJB, 2015, EUR J LIPID SCI TECH, V117, P1325, DOI 10.1002/ejlt.201400468; Burczynski FJ, 1999, CAN J PHYSIOL PHARM, V77, P896, DOI 10.1139/cjpp-77-11-896; Byrne KA, 2005, J ANIM SCI, V83, P1; Carolino NR, 1997, REV PORTUGUESA ZOOTE; CARSTENS GE, 1991, J ANIM SCI, V69, P3251; Cassar-Malek I, 2008, AUST J EXP AGR, V48, P701, DOI 10.1071/EA08018; Cassar-Malek I, 2004, ANIM SCI, V79, P49, DOI 10.1017/S1357729800054527; Cassar-Malek I, 2009, J PHYSIOL PHARMACOL, V60, P83; Costa P, 2017, ANIMAL, V11, P175, DOI 10.1017/S1751731116001373; Costa P, 2015, ANIMAL, V9, P1414, DOI 10.1017/S1751731115000427; Costa P, 2012, ANIMAL, V6, P1187, DOI 10.1017/S1751731111002722; Cuvelier C, 2006, ANIM SCI, V82, P125, DOI 10.1079/ASC20057; De Smet S, 2004, ANIM RES, V53, P81, DOI 10.1051/animres:2004003; Dutta-Roy AK, 2000, CELL MOL LIFE SCI, V57, P1360, DOI 10.1007/PL00000621; Griinari JM, 1999, ADVANCES IN CONJUGATED LINOLEIC ACID RESEARCH, VOL 1, P180; Guillemin N, 2011, ANIMAL, V5, P885, DOI 10.1017/S1751731110002612; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Hegarty RS, 2004, AUST J EXP AGR, V44, P458, DOI 10.1071/EA02148; Hiller B, 2012, BRIT J NUTR, V108, P858, DOI 10.1017/S0007114511006179; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hocquette JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-135; Hornick JL, 1998, J ANIM SCI, V76, P249; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; Jeronimo E, 2011, EUR J LIPID SCI TECH, V113, P924, DOI 10.1002/ejlt.201000398; Joseph SJ, 2010, BIOINFORM BIOL INSIG, V4, P19; Keogh K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149373; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Lehnert SA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-95; Lengi AJ, 2007, LIPIDS, V42, P499, DOI 10.1007/s11745-007-3056-2; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loor JJ, 2004, J DAIRY SCI, V87, P2472, DOI 10.3168/jds.S0022-0302(04)73372-X; Maeyashiki C, 2017, BIOCHEM BIOPH RES CO, V484, P636, DOI 10.1016/j.bbrc.2017.01.159; Matsumoto H, 2012, LIVEST SCI, V144, P281, DOI 10.1016/j.livsci.2011.12.003; McLachlan GJ, 2006, BIOINFORMATICS, V22, P1608, DOI 10.1093/bioinformatics/btl148; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Pan CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023157; Park S, 2013, J MOL RECOGNIT, V26, P679, DOI 10.1002/jmr.2313; Pfaffl M, 1998, EXP CLIN ENDOCR DIAB, V106, P514, DOI 10.1055/s-0029-1212026; Picard B, 2014, J AGR FOOD CHEM, V62, P9808, DOI 10.1021/jf501528s; Reverter A, 2003, J ANIM SCI, V81, P1900; Schmid A, 2006, MEAT SCI, V73, P29, DOI 10.1016/j.meatsci.2005.10.010; Scollan ND, 2014, MEAT SCI, V97, P384, DOI 10.1016/j.meatsci.2014.02.015; Shingfield KJ, 2007, EUR J LIPID SCI TECH, V109, P799, DOI 10.1002/ejlt.200700026; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viegas I, 2011, NEW MEDIT, V10, P17; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Zhu B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3847-7	59	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0193875	10.1371/journal.pone.0193875	http://dx.doi.org/10.1371/journal.pone.0193875			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614102	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600006
J	Liu, H; Xu, JW; Bi, Y				Liu, Hui; Xu, Jian-Wei; Bi, Yaw			Malaria burden and treatment targets in Kachin Special Region II, Myanmar from 2008 to 2016: A retrospective analysis	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; NORTHEASTERN MYANMAR; VIVAX MALARIA; BORDER; CHINA; EPIDEMIOLOGY; INFECTIONS	Although drug-based treatment is the primary intervention for malaria control and elimination, optimal use of targeted treatments remains unclear. From 2008 to 2016, three targeted programs on treatment were undertaken in Kachin Special Region II (KR2), Myanmar. Program I (2008-2011) treated all confirmed, clinical and suspected cases; program II (2012-2013) treated confirmed and clinical cases; and program III (2014-2016) targeted confirmed cases only. This study aims to evaluate the impacts of the three programs on malaria burden individually based on the annual parasite incidence (API), slide positivity rate (SPR) and their relative values. The API is calculated from original collected data and the incidence rate ratio (IRR) for each year is calculated by using the first-year API as a reference in each program phase across the KR2. Same method is applied to calculate SPR and risk ratio (RR) at the sentinel hospital too. During program I (2008-2011), malaria burden was reduced by 61% (95%CI: 58%-74%) and the actual API decreased from 9.8 (95%CI: 9.6-10.1) per 100 person-years in 2008 to 3.8 (3.6-4.1) per 100 person-years in 2011. Amid program II (2012-2013), the malaria burden increased by 33% (95%CI: 22%-46%) and the actual API increased from 2.1(95%CI: 2.0-2.3) per 100 person-years in 2012 to 2.8 (95%CI: 2.7-2.9) per 100 person-years in 2013. During program III (2014-2016) the malaria burden increased furtherly by 60% (95%CI: 51% - 69%) and the actual API increased from 3.2(95%CI: 3.0-3.3) per 100 person-years in 2014 to 5.1 (95%CI: 4.9-5.2) per 100 person-years in 2016. Results of the slide positivity of the sentinel hospital also confirm these results. Resurgence of malaria was mainly due to Plasmodium vivax during program II and III. This study indicates that strategy adopted in program I (2008-2011) should be more appropriate for the KR2. Quality-assured treatment of all confirmed, clinical and suspected malaria cases may be helpful for the reduction of malaria burden.	[Liu, Hui; Xu, Jian-Wei] Yunnan Prov Collaborat Innovat Ctr Publ Hlth & Di, Yunnan Prov Ctr Malaria Res, Yunnan Inst Parasit Dis, Yunnan Prov Key Lab Vector Borne Dis Control & Re, Puer City, Peoples R China; [Bi, Yaw] Laiza City Hosp, Laiza City, Kachin Special, Myanmar		Xu, JW (corresponding author), Yunnan Prov Collaborat Innovat Ctr Publ Hlth & Di, Yunnan Prov Ctr Malaria Res, Yunnan Inst Parasit Dis, Yunnan Prov Key Lab Vector Borne Dis Control & Re, Puer City, Peoples R China.	xjw426@163.com	Xu, Jian-wei/ABI-7923-2020	Xu, Jian-wei/0000-0003-2769-819X	National Natural Science Foundation of China [NSFC/81560543]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC/81560543) funded to collect and analyse the data. Dr Liu received the grant. Funder's website: https://isisn.nsfc.gov.cn/egrantweb/. The funders had no role role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000396; [Anonymous], 1980, ESSENTIAL MALARIOLOG; Baum E, 2015, MALARIA J, V15, P333; Baum E, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0611-9; Bjorkman A, 2017, CLIN INFECT DIS, V64, P1236, DOI 10.1093/cid/cix136; Chen J, 2016, LANCET, V388, P959, DOI 10.1016/S0140-6736(16)31490-8; Chen SB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3523-y; Cibulskis R, 2015, LANCET INFECT DIS, V15, P1127, DOI 10.1016/S1473-3099(15)00237-6; Deng ZS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177917; Hsiang MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-383; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Huang F, 2017, AM J TROP MED HYG, V97, P1524, DOI 10.4269/ajtmh.17-0167; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/s1473-3099(17)30048-8, 10.1016/S1473-3099(17)30048-8]; Li PP, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1605-y; Liu H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0727-y; Liu H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0584-8; Long SW, 1998, COMPREHENSIVE MED CH; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; ONORI E, 1972, B WORLD HEALTH ORGAN, V47, P543; Thein ST, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1793-0; Thein ST, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1761-8; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; White NJ, 2017, LANCET INFECT DIS, V17, pE15, DOI 10.1016/S1473-3099(16)30269-9; WHO, 2015, WORLD MAL REP 2015; WHO (World Health Organization), 2016, METH MAN LAB QUAL CO; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2015, STRAT MAL EL GREAT M; World Health Organization, 2015, CONTROL ELIMINATION; World Health Organization, 2015, GUID TREATM MAL, Vthird; Xu JW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1709-z; Xu JW, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0171-4; Xu JW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1413-4; Yang HL, 2015, YUNNAN MALARIA, P39; Yuan LL, 2013, ACTA TROP, V125, P53, DOI 10.1016/j.actatropica.2012.09.008; Zhang ZX., 2016, IMPLEMENTATION EFFEC; Zhao YH, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1813-0; Zhou GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1512-2	37	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195032	10.1371/journal.pone.0195032	http://dx.doi.org/10.1371/journal.pone.0195032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614088	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600026
J	Logviss, K; Krievins, D; Purvina, S				Logviss, Konstantins; Krievins, Dainis; Purvina, Santa			Characteristics of clinical trials in rare vs. common diseases: A register-based Latvian study	PLOS ONE			English	Article							ORPHAN DRUG DEVELOPMENT; ACCELERATED APPROVAL; END-POINTS; CANCER; CLINICALTRIALS.GOV; DISORDERS; MEDICINES; ACCESS; AGENCY	Background Conducting clinical studies in small populations may be very challenging; therefore quality of clinical evidence may differ between rare and non-rare disease therapies. Objective This register-based study aims to evaluate the characteristics of clinical trials in rare diseases conducted in Latvia and compare them with clinical trials in more common conditions. Methods The EU Clinical Trials Register (clinicaltrialsregister.eu) was used to identify interventional clinical trials related to rare diseases (n = 51) and to compose a control group of clinical trials in non-rare diseases (n = 102) for further comparison of the trial characteristics. Results We found no significant difference in the use of overall survival as a primary endpoint in clinical trials between rare and non-rare diseases (9.8% vs. 13.7%, respectively). However, clinical trials in rare diseases were less likely to be randomized controlled trials (62.7% vs. 83.3%). Rare and non-rare disease clinical trials varied in masking, with rare disease trials less likely to be double blind (45.1% vs. 63.7%). Active comparators were less frequently used in rare disease trials (36.4% vs. 58.8% of controlled trials). Clinical trials in rare diseases enrolled fewer participants than those in non-rare diseases: in Latvia (mean 18.3 vs. 40.2 subjects, respectively), in the European Economic Area (mean 181.0 vs. 626.9 subjects), and in the whole clinical trial (mean 335.8 vs. 1406.3 subjects). Although, we found no significant difference in trial duration between the groups (mean 38.3 vs. 36.4 months). Conclusions The current study confirms that clinical trials in rare diseases vary from those in non-rare conditions, with notable differences in enrollment, randomization, masking, and the use of active comparators. However, we found no significant difference in trial duration and the use of overall survival as a primary endpoint.	[Logviss, Konstantins; Purvina, Santa] Riga Stradins Univ, Dept Pharmacol, Riga, Latvia; [Krievins, Dainis] Pauls Stradins Clin Univ Hosp, Dept Educ & Sci, Riga, Latvia; [Krievins, Dainis] Univ Latvia, Riga, Latvia	Riga Stradins University; Pauls Stradins Clinical University Hospital; University of Latvia	Logviss, K (corresponding author), Riga Stradins Univ, Dept Pharmacol, Riga, Latvia.	konstantins.logviss@gmail.com		Logviss, Konstantins/0000-0002-4780-0852; Purvina, Santa/0000-0002-4934-3106				Abrahamyan L, 2014, J POPUL THER CLIN PH, V21, pE66; [Anonymous], 2016, TUB SURV MON EUR 201; [Anonymous], 2001, CHOIC CONTR GROUP CL; Bell SA, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0170-0; Buckley BM, 2008, LANCET, V371, P2051, DOI 10.1016/S0140-6736(08)60876-4; Committee for Medicinal Products for Human Use (CHMP), 2006, GUID CLIN TRIALS SMA; Dupont AG, 2011, BRIT J CLIN PHARMACO, V71, P488, DOI 10.1111/j.1365-2125.2010.03877.x; Gagne JJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6802; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Hee SW, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0597-1; Heemstra HE, 2011, DRUG DISCOV TODAY, V16, P73, DOI 10.1016/j.drudis.2010.11.006; Joppi R, 2013, EUR J CLIN PHARMACOL, V69, P1009, DOI 10.1007/s00228-012-1423-2; Joppi R, 2009, BRIT J CLIN PHARMACO, V67, P494, DOI 10.1111/j.1365-2125.2009.03369.x; Kakkis ED, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-014-0195-4; Kanters TA, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-124; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Logviss K, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0434-y; Logviss K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0147-z; Maeda H, 2015, ANN ONCOL, V26, P211, DOI 10.1093/annonc/mdu500; Mechler K, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0262-5; Meekings KN, 2012, DRUG DISCOV TODAY, V17, P660, DOI 10.1016/j.drudis.2012.02.005; Mitsumoto J, 2009, ANN NEUROL, V66, P184, DOI 10.1002/ana.21676; Miyamoto BE, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-49; Onakpoya IJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007199; Orfali M, 2012, CLIN PHARMACOL THER, V92, P262, DOI 10.1038/clpt.2012.87; Picavet E, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-164; Richey EA, 2009, J CLIN ONCOL, V27, P4398, DOI 10.1200/JCO.2008.21.1961; Spokiene I, 2008, MED LITH, V44, P571, DOI 10.3390/medicina44080074; Unkel S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0402-6; Winstone J, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0349-z	30	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194494	10.1371/journal.pone.0194494	http://dx.doi.org/10.1371/journal.pone.0194494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614103	gold, Green Submitted, Green Published			2022-12-27	WOS:000429081600011
J	Weiss, D; Rydland, HT; Oversveen, E; Jensen, MR; Solhaug, S; Krokstad, S				Weiss, Daniel; Rydland, Havard T.; Oversveen, Emil; Jensen, Magnus Rom; Solhaug, Solvor; Krokstad, Steinar			Innovative technologies and social inequalities in health: A scoping review of the literature	PLOS ONE			English	Review							FUNDAMENTAL CAUSE THEORY; POPULATION HEALTH; UNITED-STATES; SOCIOECONOMIC-STATUS; MEDICAL SOCIOLOGY; CHRONIC DISEASE; PUBLIC-HEALTH; DISPARITIES; PATIENT; DIFFUSION	The aim of this study was to systematically review the range, nature, and extent of current research activity exploring the influence of innovative health-related technologies on social inequalities in health, with specific focus on a deeper understanding of the variables used to measure this connection and the pathways leading to the (re)production of inequalities. A review process was conducted, based on scoping review techniques, searching literature published from January 1, 1996 to November 25, 2016 using MEDLINE, Scopus, and ISI web of science. Search, sorting, and data extraction processes were conducted by a team of researchers and experts using a dynamic, reflexive examination process. Of 4139 studies collected from the search process, a total of 33 were included in the final analysis. Results of this study include the classification of technologies based on how these technologies are accessed and used by end users. In addition to the factors and mechanisms that influence unequal access to technologies, the results of this study highlight the importance of variations in use that importantly shape social inequalities in health. Additionally, focus on health care services technologies must be accompanied by investigating emerging technologies influencing healthy lifestyle, genomics, and personalized devices in health. Findings also suggest that choosing one measure of social position over another has important implications for the interpretation of research results. Furthermore, understanding the pathways through which various innovative health technologies reduce or (re)produce social inequalities in health is context dependent. In order to better understand social inequalities in health, these contextual variations draw attention to the need for critical distinctions between technologies based on how these various technologies are accessed and used. The results of this study provide a comprehensive starting point for future research to further investigate how innovative technologies may influence the unequal distribution of health as a human right.	[Weiss, Daniel; Krokstad, Steinar] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway; [Weiss, Daniel; Krokstad, Steinar] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, HUNT Res Ctr, Levanger, Norway; [Rydland, Havard T.; Oversveen, Emil] Norwegian Univ Sci & Technol, Dept Sociol & Polit Sci, Trondheim, Norway; [Jensen, Magnus Rom; Solhaug, Solvor] Norwegian Univ Sci & Technol, Lib Sect Humanities Educ & Social Sci, Trondheim, Norway; [Krokstad, Steinar] Nord Trondelag Hosp Trust, Levanger Hosp, Levanger, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Weiss, D (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway.; Weiss, D (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, HUNT Res Ctr, Levanger, Norway.	daniel.weiss@ntnu.no		Krokstad, Steinar/0000-0002-2932-6675; Rydland, Havard/0000-0002-8039-3179	NTNU, Norwegian University of Science and Technology	NTNU, Norwegian University of Science and Technology	This research received funding from the strategic research area NTNU Health in 2016/17 at NTNU, Norwegian University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Armstrong R, 2011, J PUBLIC HEALTH-UK, V33, P147, DOI 10.1093/pubmed/fdr015; Barclay G, 2014, AM J PUBLIC HEALTH, V104, P2246, DOI 10.2105/AJPH.2014.302334; Baum F, 2014, HEALTH PROMOT INT, V29, P349, DOI 10.1093/heapro/das062; Beckfield J, 2015, SOC THEOR HEALTH, V13, P227, DOI 10.1057/sth.2015.19; Bekelis K, 2014, INT ANGIOL, V33, P446; Butler MJ, 2013, HEALTH INFORM J, V19, P91, DOI 10.1177/1460458212460846; Casper MJ, 2010, J HEALTH SOC BEHAV, V51, pS120, DOI 10.1177/0022146510383493; Chang VW, 2009, J HEALTH SOC BEHAV, V50, P245, DOI 10.1177/002214650905000301; Cheng EM, 2012, NEUROLOGY, V79, P138, DOI 10.1212/WNL.0b013e31825f04c5; Choi N.G., 2013, J MED INTERNET RES, V15, P16; Cockerham WC, 2005, J HEALTH SOC BEHAV, V46, P51, DOI 10.1177/002214650504600105; COTTERMAN WW, 1989, COMMUN ACM, V32, P1313, DOI 10.1145/68814.68816; Eddens KS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1163; Ferris TG, 2006, MED CARE, V44, P81, DOI 10.1097/01.mlr.0000188914.47033.cd; Fonga H, 2015, B WORLD HEALTH ORGAN, V93, P438, DOI 10.2471/BLT.15.155952; Freese J, 2011, HANDB SOCIOL SOC RES, P67, DOI 10.1007/978-1-4419-7261-3_4; Gibbons MC, 2011, J HEALTH COMMUN, V16, P77, DOI 10.1080/10810730.2011.596916; Glied S, 2008, DEMOGRAPHY, V45, P741; Goel MS, 2011, J GEN INTERN MED, V26, P1112, DOI 10.1007/s11606-011-1728-3; Goldman DP, 2005, CONTRIBUTIONS EC ANA, V4; Gonzales AL, 2016, NEW MEDIA SOC, V18, P1422, DOI 10.1177/1461444814558670; Groeneveld PW, 2005, MED CARE, V43, P320, DOI 10.1097/01.mlr.0000156849.15166.ec; Han JH, 2010, HEALTH INF MANAG J, V39, P30, DOI 10.1177/183335831003900205; He D, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-39; Horvitz-Lennon M, 2012, PSYCHIAT SERV, V63, P1171, DOI 10.1176/appi.ps.201100408; Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647; Kontos EZ, 2010, J HEALTH COMMUN, V15, P216, DOI 10.1080/10810730.2010.522689; Korda RJ, 2011, SOC SCI MED, V72, P224, DOI 10.1016/j.socscimed.2010.11.002; Lang A, 2011, TELEMED E-HEALTH, V17, P262, DOI 10.1089/tmj.2010.0174; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Link BG, 2008, J HEALTH SOC BEHAV, V49, P367, DOI 10.1177/002214650804900401; Loureiro S, 2007, EUR J DEV RES, V19, P66; Lupton D., 2016, THE QUANTIFIED SELF; Lupton D, 2015, HEALTH PROMOT INT, V30, P174, DOI 10.1093/heapro/dau091; Lupton D, 2013, SOC THEOR HEALTH, V11, P256, DOI 10.1057/sth.2013.10; Lutfey K, 2005, AM J SOCIOL, V110, P1326, DOI 10.1086/428914; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Marmot M., 2005, PUBLIC HEALTH; McGibbon E, 2008, QUAL INQ, V14, P1134, DOI 10.1177/1077800408322229; Newhouse N, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3700; Newman L, 2012, AUST HEALTH REV, V36, P125, DOI 10.1071/AH11042; Ohl M, 2013, AIDS BEHAV, V17, P250, DOI 10.1007/s10461-011-0107-8; Ohlsson H, 2009, EUR J CLIN PHARMACOL, V65, P141, DOI 10.1007/s00228-008-0569-4; Oversveen E, 2017, SCANDINAVIAN J PUBLI; Perez SL, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0344-x; Pham MT, 2014, RES SYNTH METHODS, V5, P371, DOI 10.1002/jrsm.1123; Phelan J.C., 2013, MED SOCIOLOGY MOVE, P105; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303; Piot P, 2012, GLOB PUBLIC HEALTH, V7, pS46, DOI 10.1080/17441692.2012.698294; Polonijo AN, 2013, SOC SCI MED, V82, P115, DOI 10.1016/j.socscimed.2012.12.020; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Rubin MS, 2010, AM J PUBLIC HEALTH, V100, P1053, DOI 10.2105/AJPH.2009.170241; Shankardass K, 2012, INT J PUBLIC HEALTH, V57, P25, DOI 10.1007/s00038-011-0302-4; Slade EP, 2001, HEALTH POLICY, V58, P1, DOI 10.1016/S0168-8510(01)00151-8; Stanley A, 2007, J NATL MED ASSOC, V99, P201; Swan M, 2009, INT J ENV RES PUB HE, V6, P492, DOI 10.3390/ijerph6020492; Thomson Patricia, 2014, P BOURDIEU KEY CONCE; Tuckson RV, 2013, JAMA-J AM MED ASSOC, V309, P1469, DOI 10.1001/jama.2013.1468; Wang PJ, 2010, INT J PUBLIC HEALTH, V55, P497, DOI 10.1007/s00038-010-0132-9; Williams DR, 1996, INT J HEALTH SERV, V26, P483, DOI 10.2190/U9QT-7B7Y-HQ15-JT14; Wise PH, 2012, FUTURE CHILD, V22, P169; Woolf SH, 2007, AM J PUBLIC HEALTH, V97, P679, DOI 10.2105/AJPH.2005.084848; Zibrik L, 2015, HEALTH POLICY TECHN, V4, P348, DOI 10.1016/j.hlpt.2015.08.002	65	77	78	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195447	10.1371/journal.pone.0195447	http://dx.doi.org/10.1371/journal.pone.0195447			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614114	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600059
J	Owen, B; Brown, AD; Kuhlberg, J; Millar, L; Nichols, M; Economos, C; Allender, S				Owen, Brynle; Brown, Andrew D.; Kuhlberg, Jill; Millar, Lynne; Nichols, Melanie; Economos, Christina; Allender, Steven			Understanding a successful obesity prevention initiative in children under 5 from a systems perspective	PLOS ONE			English	Article							INCREASING COMMUNITY CAPACITY; CHILDHOOD OBESITY; PUBLIC-HEALTH; INTERVENTION; PREVALENCE; OVERWEIGHT; DYNAMICS; SCIENCE; ROMP; IMPACT	Introduction/Background Systems thinking represents an innovative and logical approach to understanding complexity in community-based obesity prevention interventions. We report on an approach to apply systems thinking to understand the complexity of a successful obesity prevention intervention in early childhood (children aged up to 5 years) conducted in a regional city in Victoria, Australia. Methods A causal loop diagram (CLD) was developed to represent system elements related to a successful childhood obesity prevention intervention in early childhood. Key stakeholder interviews (n = 16) were examined retrospectively to generate purposive text data, create microstructures, and form a CLD. Results A CLD representing key stakeholder perceptions of a successful intervention comprised six key feedback loops explaining changes in project implementation over time. The loops described the dynamics of collaboration, network formation, community awareness, human resources, project clarity, and innovation. Conclusion The CLD developed provides a replicable means to capture, evaluate and disseminate a description of the dynamic elements of a successful obesity prevention intervention in early childhood.	[Owen, Brynle; Brown, Andrew D.; Nichols, Melanie; Allender, Steven] Deakin Univ, Sch Hlth & Social Dev, Fac Hlth, Ctr Populat Hlth Res,Global Obes Ctr GLOBE, Geelong, Vic, Australia; [Kuhlberg, Jill] North Carolina State Univ, Dept Agr & Human Sci, NC Cooperat Extens, Raleigh, NC 27695 USA; [Millar, Lynne] Victoria Univ, Australian Hlth Policy Collaborat, Melbourne, Vic, Australia; [Economos, Christina] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	Deakin University; University of North Carolina; North Carolina State University; Victoria University; Tufts University	Brown, AD (corresponding author), Deakin Univ, Sch Hlth & Social Dev, Fac Hlth, Ctr Populat Hlth Res,Global Obes Ctr GLOBE, Geelong, Vic, Australia.	andrew.brown@deakin.edu.au	Millar, Lynne/AAD-5983-2019; Millar, Lynne/AAS-4907-2020; Brown, Andrew/W-4026-2019; Allender, Steven/G-9881-2011	Brown, Andrew/0000-0002-6385-3225; Nichols, Melanie/0000-0002-7834-5899; Allender, Steven/0000-0002-4842-3294	NHLBI NIH HHS [R01 HL115485] Funding Source: Medline; NIH HHS [1R01HL115485-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allender S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129683; Borys JM, 2016, ANN NUTR METAB, V68, P35, DOI 10.1159/000446223; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Daw C, 2016, HEALTH PROMOT INT, V31, P375, DOI 10.1093/heapro/dau118; de Groot FP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-522; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; de Silva-Sanigorski A, 2011, CHILD CARE HLTH DEV, V37, P385, DOI 10.1111/j.1365-2214.2010.01205.x; de Silva-Sanigorski AM, 2012, CHILD OBES, V8, P205, DOI 10.1089/chi.2011.0118; de Silva-Sanigorski AM, 2010, AM J CLIN NUTR, V91, P831, DOI 10.3945/ajcn.2009.28826; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Finegood DT, 2010, OBESITY, V18, pS13, DOI 10.1038/oby.2009.426; Hammond RA, 2009, PREV CHRONIC DIS, V6; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Hovmand PS, 2014, COMMUNITY BASED SYST, DOI DOI 10.1007/978-1-4614-8763-0_2; Hunt H., 2011, LOND NATL I HLTH CAR; Kim H, 2012, SYST DYNAM REV, V28, P311, DOI 10.1002/sdr.1480; Lich KH, 2013, PREV SCI, V14, P279, DOI 10.1007/s11121-012-0285-2; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Mabry PL, 2013, HEALTH EDUC BEHAV, V40, p9S, DOI 10.1177/1090198113503469; McGlashan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165459; Meadows D., 1997, WHOLE EARTH REV, V91, P78; Millar L, 2011, OBES REV, V12; Millar L, 2013, PREV MED, V56, P379, DOI 10.1016/j.ypmed.2013.02.020; Power C, 1997, INT J OBESITY RELATE, V21; Sanigorski AM, 2008, INT J OBESITY, V32, P1060, DOI 10.1038/ijo.2008.79; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Strugnell C, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0127-y; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swinburn B, 2014, PEDIATR OBES, V9, P455, DOI 10.1111/j.2047-6310.2013.00201.x; Swinburn BA, 2011, OBES REV, V12, P3, DOI 10.1111/j.1467-789X.2011.00921.x; Swinburn B, 2015, LANCET, V386, P1716, DOI 10.1016/S0140-6736(15)00722-9; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Nguyen T, 2015, J EPIDEMIOL COMMUN H, V69, P693, DOI 10.1136/jech-2014-204523; Turner BL, 2013, SYST DYNAM REV, V29, P253, DOI 10.1002/sdr.1506; Van Koperen TM, 2013, OBES REV, V14, P162, DOI 10.1111/j.1467-789X.2012.01057.x; Vandenbroeck I.P., 2007, TACKLING OBESITIES F; Wake M, 2007, INT J OBESITY, V31, P1044, DOI 10.1038/sj.ijo.0803503; Wang Y, 2013, CHILDHOOD OBES PREVE; Wheaton N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006963	42	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195141	10.1371/journal.pone.0195141	http://dx.doi.org/10.1371/journal.pone.0195141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596488	Green Published, Green Accepted, gold			2022-12-27	WOS:000428630000085
J	Wastesson, JW; Minguez, AC; Fastbom, J; Maioli, S; Johnell, K				Wastesson, Jonas W.; Minguez, Angel Cedazo; Fastbom, Johan; Maioli, Silvia; Johnell, Kristina			The composition of polypharmacy: A register-based study of Swedes aged 75 years and older	PLOS ONE			English	Article							ITALIAN MEDICINES AGENCY; DRUG-USE; NATIONWIDE REPORT; CLINICAL-TRIALS; UNITED-STATES; PEOPLE; ADULTS; PRESCRIPTION; POPULATION; MEDICATION	Background Polypharmacy is common among older adults. However, little is known about the composition of polypharmacy: which are the most frequently used drugs, and how much do these drugs contribute to the overall prevalence of polypharmacy. Methods A total of 822,619 Swedes aged >= 75 years was identified from the Total Population Register. Through record-linkage with the Swedish Prescribed Drug Register and the Social Services Register we could analyze concurrent drug use in the entire population (both individuals living in the community and institution) on the 31 December 2013. Results The prevalence of polypharmacy (>= 5 drugs) was 45%. The most frequently used drugs were cardiovascular drugs, analgesics, and psychotropics. By excluding the ten most frequently used drug classes or compounds, the prevalence of polypharmacy was reduced by 69% and 51% respectively. The majority of the users of either one of the 10 most frequently used drugs concurrently used at least 4 other drug classes (66%-85%). Conclusion Almost half of the individuals aged >= 75 years are exposed to polypharmacy in Sweden. A handful of drugs make a large contribution to the overall prevalence of polypharmacy and the majority of drugs prescribed to persons aged >= 75 years are used in combination with other drugs. This highlights the high use of drugs, and the need to consider other concurrent drug treatments when prescribing for older adults.	[Wastesson, Jonas W.; Fastbom, Johan; Johnell, Kristina] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Wastesson, Jonas W.; Fastbom, Johan; Johnell, Kristina] Stockholm Univ, Stockholm, Sweden; [Minguez, Angel Cedazo; Maioli, Silvia] Karolinska Inst, Div Neurogeriatr, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Wastesson, JW (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden.; Wastesson, JW (corresponding author), Stockholm Univ, Stockholm, Sweden.	Jonas.wastesson@ki.se	Wastesson, Jonas/P-2845-2019; Maioli, Silvia/AAM-7312-2020; Cedazo-Minguez, Angel/C-6707-2012	Wastesson, Jonas/0000-0001-7601-4319; Cedazo-Minguez, Angel/0000-0003-4626-4864; Maioli, Silvia/0000-0002-9577-0803				Abolhassani N, 2017, EUR J CLIN PHARMACOL, V73, P1187, DOI 10.1007/s00228-017-2288-1; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; Cherubini A, 2010, J AM GERIATR SOC, V58, P1791, DOI 10.1111/j.1532-5415.2010.03032.x; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Garfinkel D, 2007, ISR MED ASSOC J, V9, P430; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Herr M, 2015, PHARMACOEPIDEM DR S, V24, P637, DOI 10.1002/pds.3772; Johansson T, 2016, BRIT J CLIN PHARMACO, V82, P532, DOI 10.1111/bcp.12959; Johnell K, 2012, DRUG AGING, V29, P751, DOI 10.1007/s40266-012-0002-7; Little MO, 2013, J AM MED DIR ASSOC, V14, P152, DOI 10.1016/j.jamda.2012.11.007; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Meloni E, 2015, ITAL J MED, V9, P212, DOI 10.4081/itjm.2015.539; Nordberg G, 2007, INT J GERIATR PSYCH, V22, P639, DOI 10.1002/gps.1724; Onder G, 2016, J AM MED DIR ASSOC, V17, P168, DOI 10.1016/j.jamda.2015.08.009; Onder G, 2014, J GERONTOL A-BIOL, V69, P430, DOI 10.1093/gerona/glt118; Qato DM, 2016, JAMA INTERN MED, V176, P473, DOI 10.1001/jamainternmed.2015.8581; Schon P, 2016, HEALTH SOC CARE COMM, V24, P631, DOI 10.1111/hsc.12237; Shi S, 2008, EUR J CLIN PHARMACOL, V64, P183, DOI 10.1007/s00228-007-0422-1; Socialstyrelsen (National Board of Health and Welfare), REG SOC TILL ALDR OC; Sonntag A, 2006, PHARMACOPSYCHIATRY, V39, P142, DOI 10.1055/s-2006-946704; Taipale H, 2016, AGE AGEING, V45, P900, DOI 10.1093/ageing/afw141; Tamura BK, 2011, J AM MED DIR ASSOC, V12, P326, DOI 10.1016/j.jamda.2010.08.013; Tinetti ME, 2014, JAMA INTERN MED, V174, P397, DOI 10.1001/jamainternmed.2013.13283; Wastesson JW, 2017, PHARMACOEPIDEM DR S, V26, P152, DOI 10.1002/pds.4120; Wastesson JW, 2012, AGE AGEING, V41, P218, DOI 10.1093/ageing/afr144; Witham MD, 2007, DRUG AGING, V24, P187, DOI 10.2165/00002512-200724030-00002	27	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194892	10.1371/journal.pone.0194892	http://dx.doi.org/10.1371/journal.pone.0194892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596512	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000046
J	Eduardo, AA; Martinez, PA; Gouveia, SF; Santos, FD; de Aragao, WS; Morales-Barbero, J; Kerber, L; Liparini, A				Eduardo, Anderson Aires; Martinez, Pablo Ariel; Gouveia, Sidney Feitosa; Santos, Franciely da Silva; de Aragao, Wilcilene Santos; Morales-Barbero, Jennifer; Kerber, Leonardo; Liparini, Alexandre			Extending the paleontology-biogeography reciprocity with SDMs: Exploring models and data in reducing fossil taxonomic uncertainty	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LATE PLEISTOCENE; PREDICTIONS; RODENTIA; PHYLOGEOGRAPHY; CHINCHILLIDAE; DISTRIBUTIONS; EQUILIBRIUM; EXTINCTION; RESPONSES	Historically, studies aimed at prospecting and analyzing paleontological and neontological data to investigate species distribution have developed separately. Research at the interface between paleontology and biogeography has shown a unidirectional bias, mostly focusing on how paleontological information can aid biogeography to understand species distribution through time. However, the modern suit of techniques of ecological biogeography, particularly species distribution models (SDM), can be instrumental for paleontologists as well, improving the biogeography-paleontology interchange. In this study, we explore how to use paleoclimatic data and SDMs to support paleontological investigation regarding reduction of taxonomic uncertainty. Employing current data from two neotropical species (Lagostomus maximus and Myocastor coipus), we implemented SDMs and performed model validation comparing hindcasts with dated fossil occurrences (similar to 14k and similar to 20k years back present, respectively). Finally, we employed the hindcasting process for two South American fossil records of a misidentified species of caiman (Caiman sp.) to show that C. latirostris is the most likely species identity of these fossils (among four candidate species: C. latirostris, C. yacare, C. crocodilus, and Melanosuchus niger). Possible limitations of the approach are discussed. With this strategy, we have shown that current developments in biogeography research can favour paleontology, extending the (biased) current interchange between these two scientific disciplines.	[Eduardo, Anderson Aires; Martinez, Pablo Ariel; Gouveia, Sidney Feitosa; Santos, Franciely da Silva; de Aragao, Wilcilene Santos; Liparini, Alexandre] Univ Fed Sergipe, PIBiLab Lab Pesquisa Integrat Biodiversid, Integrat Res Biodivers Lab, Aracaju, State Of Sergip, Brazil; [Eduardo, Anderson Aires; Martinez, Pablo Ariel; Liparini, Alexandre] Univ Fed Sergipe, Dept Biol, Aracaju, State Of Sergip, Brazil; [Gouveia, Sidney Feitosa] Univ Fed Sergipe, Dept Ecol, Aracaju, State Of Sergip, Brazil; [Morales-Barbero, Jennifer] Univ Salamanca, Fac Biol, Unit Ecol, Salamanca, CU Miguel De Un, Spain; [Kerber, Leonardo] Univ Fed Santa Maria, CAPPA Ctr Apoio Paleontol Quarta Colonia, Sao Joao Do Polesine, State Of Rio Gr, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe; University of Salamanca; Universidade Federal de Santa Maria (UFSM)	Eduardo, AA (corresponding author), Univ Fed Sergipe, PIBiLab Lab Pesquisa Integrat Biodiversid, Integrat Res Biodivers Lab, Aracaju, State Of Sergip, Brazil.; Eduardo, AA (corresponding author), Univ Fed Sergipe, Dept Biol, Aracaju, State Of Sergip, Brazil.	andersonaed@gmail.com	Kerber, Leonardo/M-3969-2019; Kerber, Leonardo/O-3980-2017; Morales-Barbero, Jennifer/AAF-1711-2021; Gouveia, Sidney F/G-6438-2013; Liparini, Alexandre/AAE-1477-2021; Martinez, Pablo Ariel/R-9374-2017; Eduardo, Anderson/J-2928-2015	Kerber, Leonardo/0000-0001-8139-1493; Kerber, Leonardo/0000-0001-8139-1493; Gouveia, Sidney F/0000-0003-4941-7440; Liparini, Alexandre/0000-0002-9967-2311; Martinez, Pablo Ariel/0000-0002-5583-3179; Eduardo, Anderson/0000-0001-8045-8043	Fundacao de Amparo a Pesquisa e a Inovacao Tecnologica do Estado do Sergipe [0.19.203.00428/2016-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [430807/2016-3, 402469/2016-0, 431463/2016-6]	Fundacao de Amparo a Pesquisa e a Inovacao Tecnologica do Estado do Sergipe; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa e a Inovacao Tecnologica do Estado do Sergipe - URL: http://fapitec.se.gov.br/, proc. 0.19.203.00428/2016-1 (authors who received the funding: AAE AL); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - URL: http://cnpq.br/, proc. 430807/2016-3 (author who received the funding: LK); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - URL: http://cnpq.br/, proc. 402469/2016-0, (author who received the funding: SFG); and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - URL: http://cnpq.br/, proc. 431463/2016-6 (author who received the funding: PAM).	Alba-Sanchez F, 2010, DIVERS DISTRIB, V16, P214, DOI 10.1111/j.1472-4642.2010.00636.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Behrensmeyer Anna K., 2012, P69; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Candela Adriana M., 2004, Instituto Superior de Correlacion Geologica (INSUGEO) Miscelanea, V12, P77; Carnaval AC, 2014, P R SOC B; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Castro MC, 2014, QUATERN INT, V352, P164, DOI 10.1016/j.quaint.2014.06.038; Chapman RE, 2007, PALAEOBIOLOGY, VII, P489; Collevatti RG, 2013, J BIOGEOGR, V40, P345, DOI 10.1111/jbi.12005; Crocodile Specialist Group, 1996, IUCN RED LIST THREAT; Diniz-Filho JAF, 2013, FRONT BIOGEOGR, V26, P217; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Elith J, 2002, ECOL MODEL, V157, P313, DOI 10.1016/S0304-3800(02)00202-8; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fortier DC, 2013, QUATERN INT, V305, P141, DOI 10.1016/j.quaint.2012.03.018; Franca LD, 2014, QUATERN INT, V352, P159, DOI 10.1016/j.quaint.2014.06.046; Fritz SA, 2013, TRENDS ECOL EVOL, V28, P509, DOI 10.1016/j.tree.2013.05.004; Hadler Patrica, 2008, REVISTA BRASILEIRA DE PALEONTOLOGIA, V11, P97; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2016, PACKAGE DISMO, P67; HOLZ M, 1994, PALAEOGEOGR PALAEOCL, V107, P179, DOI 10.1016/0031-0182(94)90170-8; Jackson John E., 1996, Mammalian Species, V543, P1; Kerber L, 2014, QUATERN INT, V352, P147, DOI 10.1016/j.quaint.2013.11.022; Kerber L, 2011, REV BRAS PALEONTOLOG, V14, P229, DOI 10.4072/rbp.2011.3.03; Langston W., 1965, FOSSIL CROCODILIANS; Liaw A., 2015, PACKAGE RANDOMFOREST; Lima-Ribeiro MS, 2012, NAT CONSERVACAO, V10, P145, DOI 10.4322/natcon.2012.022; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; MCCULLAGH P, 1984, EUR J OPER RES, V16, P285, DOI 10.1016/0377-2217(84)90282-0; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; McGuire JL, 2013, J BIOGEOGR, V40, P1490, DOI 10.1111/jbi.12106; Morales-Barbero J, 2017, ECOGRAPHY; Nogues-Bravo D, 2008, PLOS BIOL, V6, P685, DOI 10.1371/journal.pbio.0060079; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Ojeda R, 2013, IUCN RED LIST THREAT; Patton James L., 2015, P733; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson JE, 2014, PEERJ, V2, DOI 10.7717/peerj.347; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimiento C, 2016, J BIOGEOGR, V43, P1645, DOI 10.1111/jbi.12754; Ramirez-Barahona S, 2013, ECOL EVOL, V3, P725, DOI 10.1002/ece3.483; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Roach N., 2016, IUCN RED LIST THREAT; Ross J.P., 2000, IUCN RED LIST THREAT; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Stoklosa J, 2015, METHODS ECOL EVOL, V6, P412, DOI 10.1111/2041-210X.12217; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Thorbjarnarson J., 1992, CROCODILES ACTION PL; Ubilla M, 2016, ALCHERINGA, V40, P354, DOI 10.1080/03115518.2016.1145466; Varela S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129037; Varela S, 2014, ECOGRAPHY, V37, P1084, DOI 10.1111/j.1600-0587.2013.00441.x; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; Varela S, 2010, QUATERNARY SCI REV, V29, P2027, DOI 10.1016/j.quascirev.2010.04.017; Varela S, 2009, J BIOGEOGR, V36, P1645, DOI 10.1111/j.1365-2699.2009.02125.x; Venegas-Anaya M, 2008, J EXP ZOOL PART A, V309A, P614, DOI 10.1002/jez.502; Wilkinson David M., 2012, P9; Williams JW, 2013, GLOBAL ECOL BIOGEOGR, V22, P289, DOI 10.1111/j.1466-8238.2012.00760.x; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yannic G, 2012, BIOL J LINN SOC, V105, P864, DOI 10.1111/j.1095-8312.2011.01824.x	69	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194725	10.1371/journal.pone.0194725	http://dx.doi.org/10.1371/journal.pone.0194725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590174	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100072
J	Heerfordt, IM; Torsnes, LR; Philipsen, PA; Wulf, HC				Heerfordt, Ida M.; Torsnes, Linnea R.; Philipsen, Peter A.; Wulf, Hans Christian			Sunscreen use optimized by two consecutive applications	PLOS ONE			English	Article							SUN-PROTECTION FACTOR; SKIN; PHOTOPROTECTION; PREVENTION; THICKNESS; HOLIDAY; BEACH	Sunscreen users are often inadequately protected and become sunburned. This study aimed to investigate how much two consecutive sunscreen applications increased the quantity of sunscreen applied and decreased the skin area left without sunscreen (missed area) compared to a single application. Thirty-one healthy volunteers wearing swimwear were included and applied sunscreen two consecutive times in a laboratory environment. Participants had pictures taken in black light before and after each application. As sunscreens absorb black light, the darkness of the skin increased with increasing amounts of sunscreen applied. We conducted a standard curve establishing a link between change in picture darkness and quantity of sunscreen. The quantity of sunscreen at selected skin sites as well as the percentage of missed area was determined after each application. Participants had missed a median of 20% of their available body surface after a single application. After double application they had missed 9%. The decrease in missed areas was significant for the whole body surface and for each of the body regions separately. The median participant had applied between 13% and 100% more sunscreen at the selected skin sites after double application than after single application. We recommend double application, especially before intense sun exposure.	[Heerfordt, Ida M.; Torsnes, Linnea R.; Philipsen, Peter A.; Wulf, Hans Christian] Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Nv Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Heerfordt, IM (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Nv Copenhagen, Denmark.	ida.marie.heerfordt@regionh.dk	Heerfordt, Ida M./AAS-3890-2020	Heerfordt, Ida M./0000-0002-6130-875X; Philipsen, Peter Alshede/0000-0002-9656-733X	Bispebjerg Hospital	Bispebjerg Hospital	Galderma A/S provided sunscreen for the study but had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Except for this, the study was funded solely by Bispebjerg Hospital.	AUGUSTSSON A, 1992, ACTA DERM-VENEREOL, V72, P123; Azurdia RM, 1999, BRIT J DERMATOL, V140, P255; Bauer U, 2010, PHOTOCHEM PHOTOBIOL, V86, P1397, DOI 10.1111/j.1751-1097.2010.00816.x; BECHTHOMSEN N, 1993, PHOTODERMATOL PHOTO, V9, P242; Bodekaer M, 2008, PHOTODERMATOL PHOTO, V24, P296, DOI 10.1111/j.1600-0781.2008.00379.x; De Villa D, 2011, PHOTOCHEM PHOTOBIOL, V87, P457, DOI 10.1111/j.1751-1097.2010.00856.x; Faurschou A, 2007, BRIT J DERMATOL, V156, P716, DOI 10.1111/j.1365-2133.2006.07684.x; Gaughan MD, 1998, ARCH DERMATOL, V134, P515, DOI 10.1001/archderm.134.4.515; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Heerfordt IM, 2018, PUBLIC HEALTH, V155, P88, DOI 10.1016/j.puhe.2017.11.018; Heerfordt IM, 2018, PHOTODERMATOL PHOTO, V34, P117, DOI 10.1111/phpp.12373; Heerfordt IM, 2017, ACTA DERM-VENEREOL, V97, P1202, DOI 10.2340/00015555-2772; Jeanmougin M, 2014, PHOTODERMATOL PHOTO, V30, P323, DOI 10.1111/phpp.12138; Kim SM, 2010, J AM ACAD DERMATOL, V62, P218, DOI 10.1016/j.jaad.2009.06.047; Lademann J, 2004, J Cosmet Dermatol, V3, P62, DOI 10.1111/j.1473-2130.2004.00107.x; Lautenschlager S, 2007, LANCET, V370, P528, DOI 10.1016/S0140-6736(07)60638-2; LYNFIELD YL, 1984, J AM ACAD DERMATOL, V10, P56, DOI 10.1016/S0190-9622(84)80043-2; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; ODIO MR, 1994, PHOTODERMATOL PHOTO, V10, P118; Ouyang H, 2018, J DRUGS DERMATOL, V17, P116; Petersen B, 2014, PHOTODERMATOL PHOTO, V30, P96, DOI 10.1111/phpp.12099; Petersen B, 2013, PHOTODERMATOL PHOTO, V29, P221, DOI 10.1111/phpp.12048; Petersen B, 2013, PHOTOCH PHOTOBIO SCI, V12, P190, DOI 10.1039/c2pp25127b; Pruim B, 1999, Australas J Dermatol, V40, P14, DOI 10.1046/j.1440-0960.1999.00309.x; Rhodes LE, 1997, BRIT J DERMATOL, V136, P12, DOI 10.1046/j.1365-2133.1997.d01-1135.x; Teramura T, 2012, CLIN EXP DERMATOL, V37, P904, DOI 10.1111/j.1365-2230.2012.04388.x; Ulrich C, 2009, BRIT J DERMATOL, V161, P78, DOI 10.1111/j.1365-2133.2009.09453.x; Verheugen G., 2006, OFFICIAL J EUR UNION, V265, P39; Wulf HC, 1997, PHOTODERMATOL PHOTO, V13, P129, DOI 10.1111/j.1600-0781.1997.tb00215.x	29	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193916	10.1371/journal.pone.0193916	http://dx.doi.org/10.1371/journal.pone.0193916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590142	gold, Green Published			2022-12-27	WOS:000428603100037
J	Lindquist, C; Bjorndall, B; Rossmann, CR; Svardal, A; Hallstrom, S; Berge, RK				Lindquist, Carine; Bjorndall, Bodil; Rossmann, Christine Renate; Svardal, Asbjorn; Hallstroem, Seth; Berge, Rolf Kristian			A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis	PLOS ONE			English	Article							BUTYROBETAINE HYDROXYLASE INHIBITOR; METABOLIC SYNDROME; LIVER-DISEASE; CARDIOVASCULAR-DISEASE; EICOSAPENTAENOIC ACID; ENDOPLASMIC-RETICULUM; UNCOUPLING PROTEINS; BETA-OXIDATION; MALONYL-COA; MILDRONATE	L-carnitine is important for the catabolism of long-chain fatty acids in the mitochondria. We investigated how the triacylglycerol (TAG)-lowering drug 2-(tridec-12-yn-1-ylthio)acetic acid (1-triple TTA) influenced lipid metabolism in carnitine-depleted, 3-(2,2,2-trimethylhydrazinium)propionate dehydrate (Mildronate; meldonium)-treated male Wistar rats. As indicated, carnitine biosynthesis was impaired by Mildronate. However, TAG levels of both plasma and liver were decreased by 1-triple TTA in Mildronate-treated animals. This was accompanied by increased gene expression of proteins involved in mitochondrial activity and proliferation and reduced mRNA levels of Dgat2, ApoB and ApoCIII in liver. The hepatic energy state was reduced in the group of Mildronate and 1-triple TTA as reflected by increased AMP/ATP ratio, reduced energy charge and induced gene expression of uncoupling proteins 2 and 3. The increase in mitochondrial fatty acid oxidation was observed despite low plasma carnitine levels, and was linked to strongly induced gene expression of carnitine acetyltransferase, translocase and carnitine transporter, suggesting an efficient carnitine turnover. The present data suggest that the plasma TAG-lowering effect of 1-triple TTA in Mildronate-treated rats is not only due to increased mitochondrial fatty acid oxidation reflected by increased mitochondrial biogenesis, but also to changes in plasma clearance and reduced TAG biosynthesis.	[Lindquist, Carine; Bjorndall, Bodil; Svardal, Asbjorn; Berge, Rolf Kristian] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Lindquist, Carine; Berge, Rolf Kristian] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Rossmann, Christine Renate; Hallstroem, Seth] Med Univ Graz, Inst Physiol Chem, Graz, Austria	University of Bergen; University of Bergen; Haukeland University Hospital; Medical University of Graz	Lindquist, C; Berge, RK (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Lindquist, C; Berge, RK (corresponding author), Haukeland Hosp, Dept Heart Dis, Bergen, Norway.	carine.lindquist@uib.no; rolf.berge@uib.no		Rossmann, Christine/0000-0002-1791-1981	Bergen Research Foundation; Western Norway Regional Health Authority [911945]	Bergen Research Foundation; Western Norway Regional Health Authority	This work was financially supported by the Bergen Research Foundation and Western Norway Regional Health Authority (911945) to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELINI C, 1992, CRIT REV CL LAB SCI, V29, P217, DOI 10.3109/10408369209114601; BATES EJ, 1977, FEBS LETT, V84, P229, DOI 10.1016/0014-5793(77)80694-7; BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BREMER J, 1981, BIOCHIM BIOPHYS ACTA, V665, P628, DOI 10.1016/0005-2760(81)90282-4; Bruce Alberts A. J., 2007, MOL BIOL CELL; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; DAAE LNW, 1970, BIOCHIM BIOPHYS ACTA, V210, P92; Dambrova M, 2002, TRENDS CARDIOVAS MED, V12, P275, DOI 10.1016/S1050-1738(02)00175-5; Dambrova M, 2016, PHARMACOL RES, V113, P771, DOI 10.1016/j.phrs.2016.01.019; Del Ben M, 2012, INTERN EMERG MED, V7, pS291, DOI 10.1007/s11739-012-0819-4; Du ZY, 2013, BBA-MOL CELL BIOL L, V1831, P291, DOI 10.1016/j.bbalip.2012.10.002; Du ZY, 2010, BBA-MOL CELL BIOL L, V1801, P526, DOI 10.1016/j.bbalip.2010.01.002; El-Hattab AW, 2015, MOL GENET METAB, V116, P107, DOI 10.1016/j.ymgme.2015.09.004; Fisher RA, 1935, DESIGN EXPT, Vxi; FURST W, 1992, J CHROMATOGR-BIOMED, V578, P39, DOI 10.1016/0378-4347(92)80222-C; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Grigat S, 2009, DRUG METAB DISPOS, V37, P330, DOI 10.1124/dmd.108.023929; Grube M, 2011, AM J PATHOL, V178, P2547, DOI 10.1016/j.ajpath.2011.02.020; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hallstrom S, 2002, CIRCULATION, V105, P3032, DOI 10.1161/01.CIR.0000018745.11739.9B; Harchaoui KEL, 2009, CURR CARDIOL REV, V5, P216, DOI 10.2174/157340309788970315; Hayashi Y, 2000, BIOL PHARM BULL, V23, P770; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; KIM YS, 1978, ARCH BIOCHEM BIOPHYS, V190, P585, DOI 10.1016/0003-9861(78)90314-4; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kuka J, 2012, J CARDIOVASC PHARM T, V17, P215, DOI 10.1177/1074248411419502; LaBrecque DR, 2014, J CLIN GASTROENTEROL, V48, P467, DOI 10.1097/MCG.0000000000000116; Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y; Lindquist C, 2017, J LIPID RES, V58, P1362, DOI 10.1194/jlr.M074849; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Madsen L, 1998, J LIPID RES, V39, P583; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Oppedisano F, 2008, J BIOCHEM MOL TOXIC, V22, P8, DOI 10.1002/jbt.20208; Paschos P, 2009, HIPPOKRATIA, V13, P9; Pelzmann B, 2003, BRIT J PHARMACOL, V139, P749, DOI 10.1038/sj.bjp.0705300; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; PONS R, 1995, J CHILD NEUROL, V10, pS2, DOI 10.1177/0883073895010002S03; RAAKA BM, 1979, J BIOL CHEM, V254, P6755; REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Roncari D A, 1981, Methods Enzymol, V71 Pt C, P73; ROSEKAHN G, 1985, J BIOL CHEM, V260, P8411; SIMKHOVICH BZ, 1988, BIOCHEM PHARMACOL, V37, P195, DOI 10.1016/0006-2952(88)90717-4; Sjakste N, 2005, CNS DRUG REV, V11, P151; SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205; Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012; Spaniol M, 2001, EUR J BIOCHEM, V268, P1876, DOI 10.1046/j.1432-1327.2001.02065.x; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Stadlmann S, 2006, CELL BIOCHEM BIOPHYS, V44, P179, DOI 10.1385/CBB:44:2:179; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tanabe T, 1981, Methods Enzymol, V71 Pt C, P5; URBANIAK GC, 2013, RES RANDOMIZER; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Vernez L, 2004, RAPID COMMUN MASS SP, V18, P1233, DOI 10.1002/rcm.1470; Vigerust NF, 2012, FERTIL STERIL, V98, P1620, DOI 10.1016/j.fertnstert.2012.08.024; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; WILLUMSEN N, 1993, J LIPID RES, V34, P13	64	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194978	10.1371/journal.pone.0194978	http://dx.doi.org/10.1371/journal.pone.0194978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590220	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100093
J	Ortiz-Perea, N; Gander, R; Abbey, O; Callaghan, A				Ortiz-Perea, Natali; Gander, Rebecca; Abbey, Oliver; Callaghan, Amanda			The effect of pond dyes on oviposition and survival in wild UK Culex mosquitoes	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; WEST-NILE-VIRUS; CONTAINER SIZE; CULICIDAE; BEHAVIOR; COLOR; TRAP; CONSERVATION; TEMPERATURE; ALBOPICTUS	British Culex pipiens complex [Culex pipiens sensu lato) mosquito distribution, abundance, and potential for disease transmission are intimately linked to their environment. Pond and lake dyes that block light to restrict algal photosynthesis are a relatively new product assumed to be an environmentally friendly since they are based on food dyes. Their use in urban garden ponds raises questions linked to mosquito oviposition, since coloured water can be an attractant. Culex (mostly pipiens) is commonly found in UK gardens and is a potential vector of viruses including the West Nile Virus (WNV). Any factors that significantly change the distribution and population of Cx pipiens could impact future risks of disease transmission. A gravid trap was used to catch female Cx pipiens mosquitoes for use in oviposition choice tests in laboratory and semi-field conditions. Two types of pond dye, blue and shadow (which looks slightly red), were tested for their impact on oviposition and survival of wild caught Cx pipiens. There were no significant differences in the number of egg batches laid when gravid mosquitoes were given a choice between either blue dye and clear water or shadow dye and clear water indicating that these dyes are not attractants. Larvae hatched from egg batches laid by wild-caught gravid females were used to measure survival to adulthood with or without dye, in a habitat controlled to prevent further colonisation. The experiment was run twice, once in the summer and again in the autumn, whereas the dyes had no impact on emergence in the summer, there were highly significant reductions in emergence of adults in both dye treated habitats in the autumn. Containers with or without shadow dye were placed outside to colonise naturally and were sampled weekly for larvae and pupae over a 6 month period through summer and autumn. There was a significant negative effect of shadow dye on pupal abundance in a three week period over the summer, but otherwise there was no effect. It is likely that population abundance and food was a more powerful factor for mosquito survival than the dye.	[Ortiz-Perea, Natali; Gander, Rebecca; Abbey, Oliver; Callaghan, Amanda] Univ Reading, Sch Biol Sci, Ecol & Evolutionary Biol Sect, Reading, Berks, England	University of Reading	Callaghan, A (corresponding author), Univ Reading, Sch Biol Sci, Ecol & Evolutionary Biol Sect, Reading, Berks, England.	a.callaghan@reading.ac.uk			Colciencias: Department of Science, Technology and Innovation	Colciencias: Department of Science, Technology and Innovation	This research was funded by a scholarship to Natali Ortiz-Perea from Colciencias: Department of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dyofix provided the dyes but had no part in any aspect of the research design, aim, analysis or conclusion.	[Anonymous], 1992, BIOL MOSQUITOES DEV; Barbosa RMR, 2007, MEM I OSWALDO CRUZ, V102, P523, DOI 10.1590/S0074-02762007005000058; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Boyd C. E., 1982, N AM J FISH MANAGE, V2, P193; Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164; BUGLEWICZ E G, 1977, Transactions of the Nebraska Academy of Sciences, V4, P23; Collins LE, 2000, J VECTOR ECOL, V25, P127; Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Day JF, 2016, INSECTS, V7, DOI 10.3390/insects7040065; Dhileepan K, 1997, ENVIRON ENTOMOL, V26, P318, DOI 10.1093/ee/26.2.318; DyoFix, DYOFIX LAK PONDS COL; DyoFix, 2016, DYOFIX PROD FAQS 201; DyoFix, DYOFIX LAK POND COL; Hamer GL, 2011, J AM MOSQUITO CONTR, V27, P142, DOI 10.2987/10-6090.1; Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203; Hill MJ, 2014, FUND APPL LIMNOL, V185, P107, DOI 10.1127/fal/2014/0612; Hoel DF, 2011, J AM MOSQUITO CONTR, V27, P245, DOI 10.2987/11-6121.1; Huang J, 2007, PHYSIOL ENTOMOL, V32, P34, DOI 10.1111/j.1365-3032.2006.00538.x; Hunter MR, 2008, INSECT CONSERV DIVER, V1, P189, DOI 10.1111/j.1752-4598.2008.00024.x; KENNEDY JOHN S., 1942, BULL ENT RES, V32, P279, DOI 10.1017/S0007485300017235; Li J, 2009, J AGR URBAN ENTOMOL, V26, P23, DOI 10.3954/1523-5475-26.1.23; Marinho RA, 2016, J VECTOR ECOL, V41, P1, DOI 10.1111/jvec.12187; Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x; Oliva LO, 2014, J INSECT BEHAV, V27, P81, DOI 10.1007/s10905-013-9407-3; Panigrahi SK, 2014, J INSECTS; Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021; Perea NO, 2017, PEERJ, V5, DOI 10.7717/peerj.3361; R Development Core T, 2015, R 3 2 2 R PROJ STAT; Reiskind MH, 2012, J MED ENTOMOL, V49, P71, DOI 10.1603/ME10270; Reiter P, 2008, REV SCI TECH OIE, V27, P383, DOI 10.20506/rst.27.2.1804; REITER P, 1987, J AM MOSQUITO CONTR, V3, P325; Rizzoli A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0831-4; Snow Keith, 2006, European Mosquito Bulletin, V21, P1; SPENCER DF, 1984, J AQUAT PLANT MANAGE, V22, P80; Tew KS, 2003, IMPACTS ALGAL CONTRO; Torrisi GJ, 2013, NORTHEAST NAT, V20, P363, DOI 10.1656/045.020.0211; Townroe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095325; Vezzani D, 2005, ACTA TROP, V95, P123, DOI 10.1016/j.actatropica.2005.03.010; WILLIAMS RE, 1962, J PARASITOL, V48, P919, DOI 10.2307/3275123	40	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193847	10.1371/journal.pone.0193847	http://dx.doi.org/10.1371/journal.pone.0193847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590133	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100035
J	Weech, S; Moon, J; Troje, NF				Weech, Seamas; Moon, Jae; Troje, Nikolaus F.			Influence of bone-conducted vibration on simulator sickness in virtual reality	PLOS ONE			English	Article							GALVANIC VESTIBULAR STIMULATION; EVOKED MYOGENIC POTENTIALS; MOTION SICKNESS; POSTURAL INSTABILITY; DRIVING SIMULATOR; CYBERSICKNESS; ENVIRONMENTS; SENSITIVITY; RESPONSES; EXPOSURE	Use of virtual reality (VR) technology is often accompanied by a series of unwanted symptoms, including nausea and headache, which are characterised as 'simulator sickness'. Sensory mismatch has been thought to lie at the heart of the problem and recent studies have shown that reducing cue mismatch in VR can have a therapeutic effect. Specifically, electrical stimulation of vestibular afferent nerves (galvanic vestibular stimulation; GVS) can reduce simulator sickness in VR. However, GVS poses a risk to certain populations and can also result in negative symptoms in normal, healthy individuals. Here, we tested whether noisy vestibular stimulation through bone-vibration can also reduce symptoms of simulator sickness. We carried out two experiments in which participants performed a spatial navigation task in VR and completed the Simulator Sickness Questionnaire over a series of trials. Experiment 1 was conducted using a high-end projection-based VR display, whereas Experiment 2 involved the use of a consumer head mounted display. During each trial, vestibular stimulation was either: 1) absent; 2) coupled with large angular accelerations of the projection camera; or 3) applied randomly throughout each trial. In half of the trials, participants actively navigated using a motion controller, and in the other half they were moved passively through the environment along pre-recorded motion trajectories. In both experiments we obtained lower simulator sickness scores when vestibular stimulation was coupled with angular accelerations of the camera. This effect was obtained for both active and passive movement control conditions, which did not differ. The results suggest that noisy vestibular stimulation can reduce simulator sickness, and that this effect appears to generalize across VR conditions. We propose further examination of this stimulation technique.	[Weech, Seamas; Troje, Nikolaus F.] Queens Univ, Dept Psychol, Kingston, ON, Canada; [Moon, Jae; Troje, Nikolaus F.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Troje, Nikolaus F.] Queens Univ, Dept Biol, Kingston, ON, Canada; [Troje, Nikolaus F.] Queens Univ, Sch Comp, Kingston, ON, Canada; [Weech, Seamas] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Moon, Jae] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Waterloo; University of Toronto	Weech, S (corresponding author), Queens Univ, Dept Psychol, Kingston, ON, Canada.; Weech, S (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	sweech@uwaterloo.ca	Troje, Niko/F-1107-2010	Weech, Seamas/0000-0003-2333-3505; Troje, Niko/0000-0002-1533-2847	Natural Sciences and Engineering Research Council of Canada (NSERC) [298198-11-388699]; NSERC Collaborative Research and Training Experience Grant [575375]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Collaborative Research and Training Experience Grant	This work was funded by Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC, grant number 298198-11-388699, URL: http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) awarded to NFT, and an NSERC Collaborative Research and Training Experience Grant (grant number 575375, URL: www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/CREATE-FONCER_eng.asp) awarded to NFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykent B, 2014, P I MECH ENG D-J AUT, V228, P818, DOI 10.1177/0954407013516101; Bozgeyikli E, 2016, CHI PLAY 2016: PROCEEDINGS OF THE 2016 ANNUAL SYMPOSIUM ON COMPUTER-HUMAN INTERACTION IN PLAY, P205, DOI 10.1145/2967934.2968105; Cevette MJ, 2012, AVIAT SPACE ENVIR MD, V83, P549, DOI 10.3357/ASEM.3239.2012; Chara J., 2017, INTEGRATING LANDSCAP, V1st, P1; Curry R., 2002, P DRIV SIM C; Curthoys IS, 2012, ACTA OTORHINOLARYNGO, V32, P41; Curthoys IS, 2014, CLIN EXP PHARMACOL P, V41, P371, DOI 10.1111/1440-1681.12222; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; Dennison MS, 2017, APPL ERGON, V58, P215, DOI 10.1016/j.apergo.2016.06.014; Dong X, 2011, J EXP PSYCHOL-APPL, V17, P128, DOI 10.1037/a0024097; Dorado JL, 2014, 3D US INT 3DUI 2014; Duh HBL, 2004, HUM FACTORS, V46, P142, DOI 10.1518/hfes.46.1.142.30384; Dziuda L, 2014, APPL ERGON, V45, P406, DOI 10.1016/j.apergo.2013.05.003; Eisenman LM, 2009, MED HYPOTHESES, V73, P790, DOI 10.1016/j.mehy.2009.04.031; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Flanagan MB, 2004, J VESTIBUL RES-EQUIL, V14, P335; Galvez-Garcia G, 2015, HUM FACTORS, V57, P649, DOI 10.1177/0018720814554948; Gibson J.J., 1966, SENSES CONSIDERED PE; Gibson JJ, 1950, PERCEPTION VISUAL WO; Greenlee MW, 2016, MULTISENS RES, V29, P525, DOI 10.1163/22134808-00002527; Kennedy R.S., 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Kennedy RS, 2000, PRESENCE-TELEOP VIRT, V9, P463, DOI 10.1162/105474600566952; Keshavarz B, 2011, HUM FACTORS, V53, P415, DOI 10.1177/0018720811403736; Kluver M, 2016, TRANSPORT RES F-TRAF, V37, P78, DOI 10.1016/j.trf.2015.12.005; Kluver M, 2015, P DRIV SIM C; Kolasinski EM, 1995, 1027 ARI; La Viola J. J.  Jr., 2000, SIGCHI Bulletin, V32, P47, DOI 10.1145/333329.333344; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lawson BD, 2001, P 72 ANN M AER MED A; Lenggenhager B, 2008, EXP BRAIN RES, V184, P211, DOI 10.1007/s00221-007-1095-9; Lin JJW, 2002, P IEEE VIRT REAL ANN, P164, DOI 10.1109/VR.2002.996519; McCauley M., 2006, DO ARMY HELICOPTER T; Min BC, 2004, APPL ERGON, V35, P549, DOI 10.1016/j.apergo.2004.06.002; Money K. E., 1990, MOTION SPACE SICKNES, P1; Munafo J, 2017, EXP BRAIN RES, V235, P889, DOI 10.1007/s00221-016-4846-7; Park JR, 2008, INT J NEUROSCI, V118, P857, DOI 10.1080/00207450701239459; Reason JT., 1975, MOTION SICKNESS; Rebenitsch L, 2016, VIRTUAL REAL-LONDON, V20, P101, DOI 10.1007/s10055-016-0285-9; Reed-Jones RJ, 2007, P 4 INT DRIV S HUM F, P534, DOI [10.17077/drivingassessment.1288, DOI 10.17077/DRIVINGASSESSMENT.1288]; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Riecke B. E., 2006, 7 INT MULT RES FOR I; ROLNICK A, 1991, ERGONOMICS, V34, P867, DOI 10.1080/00140139108964831; Rosengren SM, 2005, CLIN NEUROPHYSIOL, V116, P1938, DOI 10.1016/j.clinph.2005.03.019; Roston GP, 1997, IEEE INT CONF ROBOT, P3006, DOI 10.1109/ROBOT.1997.606744; Sadiq O, 2017, BALANCE CONTROL MOTI; Sheykholeslami K, 2000, ACTA OTO-LARYNGOL, V120, P731; Sheykholeslami K, 2001, HEARING RES, V160, P58, DOI 10.1016/S0378-5955(01)00333-1; Stanney KM, 2009, HUM FACTORS ERGON, P293; Stanney KM, 1998, PRESENCE-TELEOP VIRT, V7, P447, DOI 10.1162/105474698565848; Stanney KM, 1997, PROCEEDINGS OF THE HUMAN FACTORS AND ERGONOMICS SOCIETY 41ST ANNUAL MEETING, 1997, VOLS 1 AND 2, P1138, DOI 10.1177/107118139704100292; Stanney KM, 1999, APPL ERGON, V30, P27, DOI 10.1016/S0003-6870(98)00039-8; Todd NPM, 2000, HEARING RES, V141, P180, DOI 10.1016/S0378-5955(99)00222-1; TREISMAN M, 1977, SCIENCE, V197, P493, DOI 10.1126/science.301659; Utz KS, 2011, BRAIN INJURY, V25, P1058, DOI 10.3109/02699052.2011.607789; Weech S, 2017, MULTISENS RES, V30, P65, DOI 10.1163/22134808-00002545; Zao JK, 2016, LECT NOTES ARTIF INT, V9743, P121, DOI 10.1007/978-3-319-39955-3_12	56	46	46	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194137	10.1371/journal.pone.0194137	http://dx.doi.org/10.1371/journal.pone.0194137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590147	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100049
J	Almeida, JFD; Conceicao, SV; Pinto, LR; de Camargo, RS; de Miranda, G				de Freitas Almeida, Joao Flavio; Conceicao, Samuel Vieira; Pinto, Luiz Ricardo; de Camargo, Ricardo Saraiva; de Miranda Junior, Gilberto			Flexibility evaluation of multiechelon supply chains	PLOS ONE			English	Article							ROBUST OPTIMIZATION; UNCERTAINTY	Multiechelon supply chains are complex logistics systems that require flexibility and coordination at a tactical level to cope with environmental uncertainties in an efficient and effective manner. To cope with these challenges, mathematical programming models are developed to evaluate supply chain flexibility. However, under uncertainty, supply chain models become complex and the scope of flexibility analysis is generally reduced. This paper presents a unified approach that can evaluate the flexibility of a four-echelon supply chain via a robust stochastic programming model. The model simultaneously considers the plans of multiple business divisions such as marketing, logistics, manufacturing, and procurement, whose goals are often conflicting. A numerical example with deterministic parameters is presented to introduce the analysis, and then, the model stochastic parameters are considered to evaluate flexibility. The results of the analysis on supply, manufacturing, and distribution flexibility are presented. Tradeoff analysis of demand variability and service levels is also carried out. The proposed approach facilitates the adoption of different management styles, thus improving supply chain resilience. The model can be extended to contexts pertaining to supply chain disruptions; for example, the model can be used to explore operation strategies when subtle events disrupt supply, manufacturing, or distribution.	[de Freitas Almeida, Joao Flavio; Conceicao, Samuel Vieira; Pinto, Luiz Ricardo; de Camargo, Ricardo Saraiva] Univ Fed Minas Gerais, Dept Ind Engn, Belo Horizonte, MG, Brazil; [de Miranda Junior, Gilberto] Univ Fed Espirito Santo, Dept Appl Math, Sao Mateus, ES, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Espirito Santo	Almeida, JFD (corresponding author), Univ Fed Minas Gerais, Dept Ind Engn, Belo Horizonte, MG, Brazil.	joao.flavio@dep.ufmg.br	Camargo, Ricardo Saraiva de/HCI-5010-2022; de Freitas Almeida, João Flávio/ABH-3357-2020; Miranda, Gilberto/R-8538-2019	de Freitas Almeida, João Flávio/0000-0002-3884-217X; Miranda, Gilberto/0000-0001-5552-0079	Pro-Rectory of Research of Universidade Federal de Minas Gerais; FAPEMIG, the Research Support Foundation of Minas Gerais	Pro-Rectory of Research of Universidade Federal de Minas Gerais; FAPEMIG, the Research Support Foundation of Minas Gerais	This work was supported by Pro-Rectory of Research of Universidade Federal de Minas Gerais, and FAPEMIG, the Research Support Foundation of Minas Gerais.	Alem D, 2013, OR SPECTRUM, V35, P773, DOI 10.1007/s00291-012-0312-5; Amin SH, 2017, EXPERT SYST APPL, V73, P82, DOI 10.1016/j.eswa.2016.12.024; Avci MG, 2017, EXPERT SYST APPL, V67, P95, DOI 10.1016/j.eswa.2016.09.034; Ben-Tal A, 1998, MATH OPER RES, V23, P769, DOI 10.1287/moor.23.4.769; Ben-Tal A., 2005, Manufacturing & Service Operations Management, V7, P248, DOI 10.1287/msom.1050.0081; Birge J. R., 1997, INFORMS Journal on Computing, V9, P111, DOI 10.1287/ijoc.9.2.111; Birge JR, 2011, SPRINGER SER OPER RE, P3, DOI 10.1007/978-1-4614-0237-4; BITRAN GR, 1982, MANAGE SCI, V28, P1174, DOI 10.1287/mnsc.28.10.1174; Chiu SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167511; Dantzig GB, 1955, MANAGE SCI, V1, P197, DOI 10.1287/mnsc.1.3-4.197; DeNeufville R, 2011, ENG SYST, P1; Dupacova J, 2000, ANN OPER RES, V100, P25, DOI 10.1023/A:1019206915174; Esmaeilikia M, 2016, ANN OPER RES, V244, P407, DOI 10.1007/s10479-014-1544-3; FALK JE, 1976, OPER RES, V24, P783, DOI 10.1287/opre.24.4.783; Gabrel V, 2014, EUR J OPER RES, V235, P471, DOI 10.1016/j.ejor.2013.09.036; Gunasekaran A, 2015, INT J PROD RES, V53, P6809, DOI 10.1080/00207543.2015.1093667; Gupta A, 2003, COMPUT CHEM ENG, V27, P1219, DOI 10.1016/S0098-1354(03)00048-6; Higle J.L., 2005, EMERGING THEORY METH, P30, DOI DOI 10.1287/EDUC.1053.0016; King A., 2012, MODELING STOCHASTIC; Kristianto Y, 2014, EXPERT SYST APPL, V41, P39, DOI 10.1016/j.eswa.2013.07.009; Lalmazloumian M, 2016, ANN OPER RES, V240, P435, DOI 10.1007/s10479-013-1421-5; Mula J, 2006, INT J PROD ECON, V103, P271, DOI 10.1016/j.ijpe.2005.09.001; MULVEY JM, 1995, OPER RES, V43, P264, DOI 10.1287/opre.43.2.264; Pedram A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174951; Pishvaee MS, 2011, APPL MATH MODEL, V35, P637, DOI 10.1016/j.apm.2010.07.013; Pochet Y, 2006, SPRING S OPERAT RES, DOI 10.1007/0-387-33477-7.; Sahinidis NV, 2004, COMPUT CHEM ENG, V28, P971, DOI 10.1016/j.compchemeng.2003.09.017; Sodhi MS, 2009, INT J PROD ECON, V121, P728, DOI 10.1016/j.ijpe.2009.02.009; SOYSTER AL, 1973, OPER RES, V21, P1154, DOI 10.1287/opre.21.5.1154; Wallace SW, 2000, OPER RES, V48, P20, DOI 10.1287/opre.48.1.20.12441; Yu CS, 2000, INT J PROD ECON, V64, P385, DOI 10.1016/S0925-5273(99)00074-2	31	6	6	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194050	10.1371/journal.pone.0194050	http://dx.doi.org/10.1371/journal.pone.0194050			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584755	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000012
J	Ma, J; Saghatelian, A; Shokhirev, MN				Ma, Jiao; Saghatelian, Alan; Shokhirev, Maxim Nikolaievich			The influence of transcript assembly on the proteogenomics discovery of microproteins	PLOS ONE			English	Article							RNA-SEQ; PEPTIDES; GENOME; RECONSTRUCTION; REVEALS; MUSCLE; CELLS	Proteogenomics methods have identified many non-annotated protein-coding genes in the human genome. Many of the newly discovered protein-coding genes encode peptides and small proteins, referred to collectively as microproteins. Microproteins are produced through ribosome translation of small open reading frames (smORFs). The discovery of many smORFs reveals a blind spot in traditional gene-finding algorithms for these genes. Biological studies have found roles for microproteins in cell biology and physiology, and the potential that there exists additional bioactive microproteins drives the interest in detection and discovery of these molecules. A key step in any proteogenomics workflow is the assembly of RNA-Seq data into likely mRNA transcripts that are then used to create a searchable protein database. Here we demonstrate that specific features of the assembled transcriptome impact microprotein detection by shotgun proteomics. By tailoring transcript assembly for downstream mass spectrometry searching, we show that we can detect more than double the number of high-quality microprotein candidates and introduce a novel open-source mRNA assembler for proteogenomics (MAPS) that incorporates all of these features. By integrating our specialized assembler, MAPS, and a popular generalized assembler into our proteogenomics pipeline, we detect 45 novel human microproteins from a high quality proteogenomics dataset of a human cell line. We then characterize the features of the novel microproteins, identifying two classes of microproteins. Our work highlights the importance of specialized transcriptome assembly upstream of proteomics validation when searching for short and potentially rare and poorly conserved proteins.	[Ma, Jiao; Saghatelian, Alan; Shokhirev, Maxim Nikolaievich] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Shokhirev, Maxim Nikolaievich] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Shokhirev, MN (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Shokhirev, MN (corresponding author), Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA.	mshokhirev@salk.edu			Razavi Newman Integrative Genomics and Bioinformatics Core and Next Generation Sequencing Core Facilities of the Salk Institute [NIH-NCICCSG:P30 014195]; Chapman Foundation; Helmsley Charitable Trust; Larry Hillblom Foundation; NIH [R01 GM102491]; NCI Cancer Center Support Grant P30 [CA014195 MASS core]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Mary K. Chapman Foundation; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102491] Funding Source: NIH RePORTER	Razavi Newman Integrative Genomics and Bioinformatics Core and Next Generation Sequencing Core Facilities of the Salk Institute; Chapman Foundation; Helmsley Charitable Trust; Larry Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant P30; Leona M. and Harry B. Helmsley Charitable Trust; Mary K. Chapman Foundation; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work and M. N. Shokhirev were supported by the Razavi Newman Integrative Genomics and Bioinformatics Core and Next Generation Sequencing Core Facilities of the Salk Institute with funding from NIH-NCICCSG:P30 014195, the Chapman Foundation and the Helmsley Charitable Trust. We thank M. Ku (Next Generation Sequencing Core) for performing RNA-Seq, J. K. Diedrich (Mass Spectrometry Core) for performing mass spectrometry, and Thomas Martinez, Arko Sen, and Hsiuyi Chen for helpful suggestions. J. Ma is supported by Larry Hillblom Foundation Fellowship Grant, A. Saghatelian is supported by NIH (R01 GM102491), the NCI Cancer Center Support Grant P30 (CA014195 MASS core), The Leona M. and Harry B. Helmsley Charitable Trust grant (#2012-PG-MED002), Mary K. Chapman Foundation, and Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; D'Lima NG, 2016, NATURE CHEM BIOL; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; Lin D, 2003, BBA-PROTEINS PROTEOM, V1646, P1, DOI 10.1016/S1570-9639(02)00546-0; Ma J, 2016, ANAL CHEM, V88, P3967, DOI 10.1021/acs.analchem.6b00191; Ma J, 2014, J PROTEOME RES, V13, P1757, DOI 10.1021/pr401280w; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pueyo JI, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002395; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Vanderperre B, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas025; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yates JR, 1996, J AM SOC MASS SPECTR, V7, P1089, DOI 10.1016/S1044-0305(96)00079-7	33	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194518	10.1371/journal.pone.0194518	http://dx.doi.org/10.1371/journal.pone.0194518			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584760	Green Submitted, gold, Green Published			2022-12-27	WOS:000428373000026
J	Droit-Volet, S; Monceau, S; Berthon, M; Trahanias, P; Maniadakis, M				Droit-Volet, Sylvie; Monceau, Sophie; Berthon, Mickael; Trahanias, Panos; Maniadakis, Michail			The explicit judgment of long durations of several minutes in everyday life: Conscious retrospective memory judgment and the role of affects?	PLOS ONE			English	Article							TIME PERCEPTION; INTERVAL; MODEL; DISCRIMINATION	In this study, individuals estimated interval times of several minutes (from 2 to 32 minutes) during their everyday lives using a cell phone they kept with them. Their emotional state, the difficulty of the activity performed during this interval, and the attention that it required were also assessed, together with their subjective experience of the passage of time. The results showed that the mean time estimates and their variability increased linearly with increasing interval duration, indicating that the fundamental scalar property of time found for short durations also applies to very long durations of several minutes. In addition, the emotional state and difficulty of the activity were significant predictors of the judgment of long durations. However, the awareness of the passage of time appeared to play a crucial role in the judgment of very long duration in humans. A theory on the emergence of the awareness of the passage of time and how it affects the judgment of interval durations lasting several minutes is therefore discussed.	[Droit-Volet, Sylvie; Monceau, Sophie; Berthon, Mickael] Univ Clermont Auvergne, CNRS, UMR 6324, Clermont Ferrand, France; [Trahanias, Panos; Maniadakis, Michail] Fdn Res & Technol FORTH, Hellas, Greece	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Droit-Volet, S (corresponding author), Univ Clermont Auvergne, CNRS, UMR 6324, Clermont Ferrand, France.	Sylvie.droit-volet@uca.fr		Droit-Volet, Sylvie/0000-0002-1523-952X; Maniadakis, Michail/0000-0002-5903-7778	H2020 European Research Council, Horizon research and innovation action, TIMESTORM	H2020 European Research Council, Horizon research and innovation action, TIMESTORM	The authors received funding for this work from H2020 European Research Council, Horizon 2020 research and innovation action, TIMESTORM, H2020-FETPROACT-2014.	Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Avni-Babad D, 2003, J EXP PSYCHOL GEN, V132, P543, DOI 10.1037/0096-3445.132.4.543; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Baddeley A.D., 2000, OXFORD HDB MEMORY, P77; BADDELEY AD, 1975, J VERB LEARN VERB BE, V14, P575, DOI 10.1016/S0022-5371(75)80045-4; Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; BLOCK RA, 1980, ACTA PSYCHOL, V46, P81, DOI 10.1016/0001-6918(80)90001-3; BLOCK RA, 1992, NATO ADV SCI INST SE, V66, P141; BROWN SW, 1988, PERCEPTION, V17, P297, DOI 10.1068/p170297; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; CHURCH RM, 1982, J EXP PSYCHOL ANIM B, V8, P165, DOI 10.1037/0097-7403.8.2.165; CHURCH RM, 1980, LEARN MOTIV, V11, P208, DOI 10.1016/0023-9690(80)90013-2; Droit-Volet S., 2016, HUMEUR NORMALE DEPRE, P167; Droit-Volet S., 2014, SUBJECTIVE TIME PHIL; Droit-Volet S., 2013, TIMING TIME PERCEPT, V1, P99, DOI DOI 10.1163/22134468-00002004; Droit-Volet S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00176; Droit-Volet S, 2017, ACTA PSYCHOL, V173, P116, DOI 10.1016/j.actpsy.2016.12.010; Droit-Volet S, 2019, TIME SOC, V28, P60, DOI 10.1177/0961463X16656852; Droit-Volet S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00176; Droit-Volet S, 2015, ACTA PSYCHOL, V156, P77, DOI 10.1016/j.actpsy.2015.01.006; Droit-Volet S, 2009, PHILOS T R SOC B, V364, P1943, DOI 10.1098/rstb.2009.0013; Fayolle S, 2015, BEHAV PROCESS, V120, P135, DOI 10.1016/j.beproc.2015.09.014; Fraisse P., 1967, PSYCHOL DU TEMPS; Frijda N.H., 2009, OXFORD COMPANION EMO, P258; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gil S, 2012, COGNITION EMOTION, V26, P847, DOI 10.1080/02699931.2011.625401; Grondin S, 2007, Q J EXP PSYCHOL, V60, P1303, DOI 10.1080/17470210600988976; Gu BM, 2011, LECT NOTES ARTIF INT, V6789, P67, DOI 10.1007/978-3-642-21478-3_6; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; Hollingworth H. L., 1910, J PHILOS PSYCHOL SCI, V7, P461, DOI [10.2307/2012819, DOI 10.2307/2012819]; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; Lake JI, 2016, CURR OPIN BEHAV SCI, V8, P214, DOI 10.1016/j.cobeha.2016.02.009; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; MCCLAIN L, 1983, PERCEPT PSYCHOPHYS, V34, P185, DOI 10.3758/BF03211347; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Mella N, 2011, BRAIN COGNITION, V75, P182, DOI 10.1016/j.bandc.2010.11.012; MILLER GW, 1978, ACTA PSYCHOL, V42, P173, DOI 10.1016/0001-6918(78)90026-4; Ornstein RE., 1969, EXPERIENCE TIME; Rammsayer TH, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01626; Rattat AC, 2012, BEHAV RES METHODS, V44, P67, DOI 10.3758/s13428-011-0135-3; Rau PLP, 2006, CYBERPSYCHOL BEHAV, V9, P396, DOI 10.1089/cpb.2006.9.396; SPETCH ML, 1983, J EXP PSYCHOL ANIM B, V9, P14, DOI 10.1037/0097-7403.9.1.14; Tobin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009271; Tobin S, 2009, COMPUT HUM BEHAV, V25, P554, DOI 10.1016/j.chb.2008.12.002; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; van Rijn H, 2014, ADV EXP MED BIOL, V829, P75, DOI 10.1007/978-1-4939-1782-2_5; Wearden J., 2016, PSYCHOL TIME PERCEPT; Wearden JH, 2008, Q J EXP PSYCHOL, V61, P569, DOI 10.1080/17470210701282576; Wearden J. H., 2015, TIMING TIME PERCEPT, V3, P223, DOI [10.1163/22134468-03002051, DOI 10.1163/22134468-03002051]; ZAKAY D, 1984, ACTA PSYCHOL, V57, P69, DOI 10.1016/0001-6918(84)90054-4; Zakay D., 1996, ADV PSYCHOL, V115, P143, DOI [10.1016/S0166-4115(96)80057-4, DOI 10.1016/S0166-4115(96)80057-4]	56	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195397	10.1371/journal.pone.0195357	http://dx.doi.org/10.1371/journal.pone.0195357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614116	gold, Green Published			2022-12-27	WOS:000429081600055
J	Kurvers, RHJM; de Zoete, A; Bachman, SL; Algra, PR; Ostelo, R				Kurvers, Ralf H. J. M.; de Zoete, Annemarie; Bachman, Shelby L.; Algra, Paul R.; Ostelo, Raymond			Combining independent decisions increases diagnostic accuracy of reading lumbosacral radiographs and magnetic resonance imaging	PLOS ONE			English	Article							LOW-BACK-PAIN; COLLECTIVE INTELLIGENCE; CHIROPRACTIC RADIOLOGISTS; GROUP-PERFORMANCE; 2 HEADS; RELIABILITY; EXPENDITURES; MAMMOGRAMS; PHYSICIANS; PATTERNS	Diagnosing the causes of low back pain is a challenging task, prone to errors. A novel approach to increase diagnostic accuracy in medical decision making is collective intelligence, which refers to the ability of groups to outperform individual decision makers in solving problems. We investigated whether combining the independent ratings of chiropractors, chiropractic radiologists and medical radiologists can improve diagnostic accuracy when interpreting diagnostic images of the lumbosacral spine. Evaluations were obtained from two previously published studies: study 1 consisted of 13 raters independently rating 300 lumbosacral radiographs; study 2 consisted of 14 raters independently rating 100 lumbosacral magnetic resonance images. In both studies, raters evaluated the presence of "abnormalities", which are indicators of a serious health risk and warrant immediate further examination. We combined independent decisions of raters using a majority rule which takes as final diagnosis the decision of the majority of the group. We compared the performance of the majority rule to the performance of single raters. Our results show that with increasing group size (i.e., increasing the number of independent decisions) both sensitivity and specificity increased in both data-sets, with groups consistently outperforming single raters. These results were found for radiographs and MR image reading alike. Our findings suggest that combining independent ratings can improve the accuracy of lumbosacral diagnostic image reading.	[Kurvers, Ralf H. J. M.; Bachman, Shelby L.] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany; [de Zoete, Annemarie; Ostelo, Raymond] Vrije Univ, Amsterdam Publ Hlth Res Inst, Dept Hlth Sci, Amsterdam, Netherlands; [Algra, Paul R.] Med Ctr Alkmaar, Dept Radiol, Alkmaar, Netherlands	Max Planck Society; Vrije Universiteit Amsterdam; Medical Center Of Alkmaar	Kurvers, RHJM (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany.	kurvers@mpib-berlin.mpg.de	de Zoete, Annemarie/J-3865-2014; Ostelo, Raymond/GSE-2602-2022	Bachman, Shelby/0000-0002-4460-4661; Ostelo, Raymond/0000-0001-7679-7210; de Zoete, Annemarie/0000-0002-1421-3862	Netherlands Organisation for Health Research and Development (ZonMW); Netherlands Organisation for Scientific Research (NWO); Scientific College of Physiotherapy (WCF); EUROSPINE	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Scientific College of Physiotherapy (WCF); EUROSPINE	R. Ostelo acknowledges funding of the Netherlands Organisation for Health Research and Development (ZonMW), the Netherlands Organisation for Scientific Research (NWO), the Scientific College of Physiotherapy (WCF) and EUROSPINE. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Bang D, 2014, CONSCIOUS COGN, V26, P13, DOI 10.1016/j.concog.2014.02.002; Baras JD, 2009, HEALTH AFFAIR, V28, pW1133, DOI 10.1377/hlthaff.28.6.w1133; Blass T, 1999, J APPL SOC PSYCHOL, V29, P955, DOI 10.1111/j.1559-1816.1999.tb00134.x; BOLAND PJ, 1989, STATISTICIAN, V38, P181, DOI 10.2307/2348873; Bonabeau E, 1999, SWARM INTELLIGENCE N, DOI DOI 10.1093/OSO/9780195131581.001.0001; Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2012, RADIOL CLIN N AM, V50, P569, DOI 10.1016/j.rcl.2012.04.005; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Clement RJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077943; de Zoete A, 2002, SPINE, V27, P1926, DOI 10.1097/00007632-200209010-00021; de Zoete A, 2015, SPINE, V40, pE653, DOI 10.1097/BRS.0000000000000896; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Deyo RA, 2016, NEW ENGL J MED, V374, P1763, DOI 10.1056/NEJMcp1512658; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Dinnes J, 2001, BREAST, V10, P455, DOI 10.1054/brst.2001.0350; GROFMAN B, 1983, THEOR DECIS, V15, P261, DOI 10.1007/BF00125672; Gromet M, 2008, AM J ROENTGENOL, V190, P854, DOI 10.2214/AJR.07.2812; Hackman J. R, 1975, ADV EXPT SOCIAL PSYC, P1, DOI DOI 10.1016/S0065-2601(08)60248-8; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Harvey SC, 2003, AM J ROENTGENOL, V180, P1461, DOI 10.2214/ajr.180.5.1801461; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Hilden J, 1996, STAT MED, V15, P969, DOI 10.1002/(SICI)1097-0258(19960530)15:10<969::AID-SIM211>3.0.CO;2-9; Kammer JE, 2017, MED DECIS MAKING, V37, P715, DOI 10.1177/0272989X17696998; Kattan MW, 2016, MED DECIS MAKING, V36, P536, DOI 10.1177/0272989X15581615; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; King AJ, 2013, CANCER EPIDEMIOL, V37, P979, DOI 10.1016/j.canep.2013.09.004; Klein N, 2015, P NATL ACAD SCI USA, V112, P7460, DOI 10.1073/pnas.1504048112; Koriat A, 2015, J EXP PSYCHOL GEN, V144, P934, DOI 10.1037/xge0000092; Koriat A, 2012, SCIENCE, V336, P360, DOI 10.1126/science.1216549; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Kurvers RHJM, 2016, P NATL ACAD SCI USA, V113, P8777, DOI 10.1073/pnas.1601827113; Kurvers RHJM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150222; Kurvers RHJM, 2015, JAMA DERMATOL, V151, P1346, DOI 10.1001/jamadermatol.2015.3149; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Lurie JD, 2008, SPINE, V33, P1605, DOI 10.1097/BRS.0b013e3181791af3; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; McGrath J. E., 1984, GROUPS INTERACTION P; Moussaid M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167223; Sorkin RD, 1998, PSYCHOL SCI, V9, P456, DOI 10.1111/1467-9280.00085; Surowiecki James, 2004, WISDOM CROWDS WHY MA; Tan AL, 2016, J GEN INTERN MED, V31, P156, DOI 10.1007/s11606-015-3475-3; Turner ME, 1998, ORGAN BEHAV HUM DEC, V73, P105, DOI 10.1006/obhd.1998.2756; Wassenaar M, 2012, EUR SPINE J, V21, P220, DOI 10.1007/s00586-011-2019-8; Wolf M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134269; Wolf M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2777; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194128	10.1371/journal.pone.0194128	http://dx.doi.org/10.1371/journal.pone.0194128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614070	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600008
J	Erices, R; Frewer, A; Gumz, A				Erices, Rainer; Frewer, Andreas; Gumz, Antje			The role of the State Security Service (Stasi) in the context of international clinical trials conducted by western pharmaceutical companies in Eastern Germany (1961-1990)	PLOS ONE			English	Article								Background After the building of the Berlin Wall in the 1960s, a number of international pharmaceutical manufacturers from the West had their drugs tested in Eastern Germany (GDR). So far, the extensive collection of documents on the subject stored in the archives of the GDR State Security Service (Stasi, MfS) has not been systematically analysed. Until now, the role of the Stasi with respect to the surveillance of the trials has been unclear. Methods A keyword search within the database of the Stasi files was conducted. All available files were screened in order to identify institutions, companies and personnel involved in the clinical trials. On this basis, further files were requested. A total of 259 files were available for analysis. Relevant data was derived from 160 of these files. A contextualised approach was applied, which critically explored the origin, content, and impact of the data. In addition, an approach guided by the central steps of document analysis was applied. Results At least 400 clinical trials were conducted during the GDR period. The exact number remains speculative. According to references found in the Stasi files, it might have been considerably higher. Initially, the main goal of the trials was for the GDR authorities to decide whether to import certain Western drugs. By 1983, this intention had changed. Now, the primary aim of the trials was the procurement of foreign currency. The Stasi feared that the pharmaceutical companies could have a significant influence on GDR Health System. Stasi spies were holding positions in the responsible medical committees, universities, and hospitals. Constant surveillance by the Stasi served the purpose of monitoring any contact between people from the West and the East. Unknowingly, representatives of Western companies were surveilled by the Stasi. The studied documents also point to the fact that a number of clinical trials conducted during the GDR period did not comply with GDR regulations, and were therefore deemed illegal by the Stasi. The Stasi was not particularly interested in medico-ethical questions. Conclusions Clinical trials conducted during the GDR period were surveilled by the Stasi. It was their aim to monitor all people involved in the trials, including their Western contacts. Relevant medico-ethical questions like patient consent and safety with respect to the clinical trials were not the focus. Considering the significant number of conducted trials, only limited evidence exists of doctors having discussed them critically. The public was not officially informed about the trials.	[Erices, Rainer; Frewer, Andreas] Univ Erlangen Nurnberg, Inst Hist Med & Med Eth, Erlangen, Germany; [Gumz, Antje] Berlin Univ Psychol PHB, Berlin, Germany; [Gumz, Antje] Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany; [Gumz, Antje] Schon Klin Hamburg Eilbek, Hamburg, Germany	University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Erices, R (corresponding author), Univ Erlangen Nurnberg, Inst Hist Med & Med Eth, Erlangen, Germany.	rainer@erices.de	Gumz, Antje/P-9045-2014; Erices, Rainer/AAN-1322-2021; Gumz, Antje/ABF-7163-2021	Gumz, Antje/0000-0002-2193-6540; Erices, Rainer/0000-0001-7050-5483; Gumz, Antje/0000-0002-2193-6540				[Anonymous], 1991, ARZNEIMITTELPRUFUNGE, V10, P7; Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027; Buthmann R., 2004, ARBEITSGRUPPE BEREIC; Erices, 2014, TOTALITARISMUS DEMOK, V11, P207; Erices R, 2014, GESUNDHEITSWESEN, V76, P73, DOI 10.1055/s-0033-1343443; Erices R., 2013, GERBERGASSE 18 FORUM, V66, P26; Erices R, 2014, ARBEITSKREIS MEDIZIN, V27, P87; Erices R, 2015, J MED ETHICS, V41, P529, DOI 10.1136/medethics-2013-101925; FREUDENSTEIN U, 1992, BRIT MED J, V304, P827, DOI 10.1136/bmj.304.6830.827; Frewer, 2015, MEDIZINETHIK DDR MOR; Haendcke-Hoppe-Arndt M, 1996, WIRTSCHAFTLICHE OKOL; Hansen Gerhard, 1973, ARZTLICHES HANDELN R; Henke K-D, 1995, AKTENLAGE; Henke K-D, 1993, VIERTELJAHRESHEFTE Z, V41, P14; Hess V., 2007, MEDIZINHISTORISCHES, V42, P23; HESS Volker, 2016, DDR ARZNEIMITTELSTUD; Hoffmann D., 2013, ULBNCHT HONECKER GES; Kerz-Ruhling I., 2004, VERRATER ODER VERFUH; Kowalczuk Ilko-Sascha, 2015, DDR ALLTAG MFS, P69; Meyer U, 2005, PHARMAZIE, V60, P468; Muller Klaus-Dieter, 1997, GESCH DTSCH ARZTESCH, P243; Pasternack P., 2011, WURZBURGER MEDIZINHI, V30, P39; Pence Kathereine, 2008, SOCIALIST MODERN E G; Quitz A., 2013, STAAT MACHT MORAL ME; Retzar A, 2014, GESCH PHARM, V66; Rice LP, 2005, QUALITATIVE RES METH; Roesler J., 1993, DEUTSCHLANDARCHIV, V26, P14; Roesler Jorg, 2002, WIRTSCHAFT DDR; Schlich T., 2002, INNOVATIONS HLTH MED, P106; Spaar Horst, 1996, DOKUMENTATION GESCH; Sperlich PW, 2006, OPPRESSION SCARCITY; Steinberg H, 2015, PSYCHIAT PRAX, V42, P3; Suss Sonja., 1998, POLITISCH MISSBRAUCH; Volze A., 1999, ENDZEIT DDR WIRTSCHA; Weil Francesca, 2008, ZIELGRUPPE ARZTESCHA; Wolle S., 2013, HEILE WELT DIKTATUR	36	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195017	10.1371/journal.pone.0195017	http://dx.doi.org/10.1371/journal.pone.0195017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608577	Green Submitted, Green Published, gold			2022-12-27	WOS:000428988800021
J	Lu, M; Cheng, XQ; Jiang, JZ; Lie, TT; Zhang, ZQ; Tsauo, CL; Liu, Y; Wang, ZG				Lu, Man; Cheng, Xueqing; Jiang, Jingzhen; Lie, TingTing; Zhang, Zhenqi; Tsauo, Chialing; Liu, Yin; Wang, Zhigang			Dual-modal photoacoustic and magnetic resonance tracking of tendon stem cells with PLGA/iron oxide microparticles in vitro	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; VIVO; NANOPARTICLES; MODEL; MRI	Reliable cell tracking is essential to understand the fate of stem cells following implantation, and thus promote the clinical application of stem cell therapy. Dual or multiple modal imaging modalities mediated by different types of multifunctional contrast agent are generally needed for efficient cell tracking. Here, we created a new contrast agent PLGA/iron oxide microparticles (PLGA/IO MPs) and characterized the morphology, structure and function of enhancing both photoacoustic (PA) and magnetic resonance imaging (MRI). Both PA and MRI signal increased with increased Fe concentration of PLGA/IO MPs. Fluorescent staining, Prussian blue staining and transmission electron microscope (TEM) certified that PLGA/IO MPs were successfully encapsulated in the labeled TSCs. The established PLGA/IO MPs demonstrated superior ability of dual-modal PA/MRI tracking of TSCs without cytotoxicity at relatively lower Fe concentrations (50, 100 and 200 mu g/mL). The optimal Fe concentration of PLGA/IO MPs was determined to be 100 mu g/mL, thus laying a foundation for the further study of dual-modal PA/MRI tracking of TSCs in vivo and promoting the repair of injured tendon.	[Lu, Man; Wang, Zhigang] Chongqing Med Univ, Affiliated Hosp 2, Chongqing Key Lab Ultrasound Mol Imaging, Chongqing, Peoples R China; [Lu, Man; Cheng, Xueqing; Jiang, Jingzhen; Lie, TingTing; Zhang, Zhenqi] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Sichuan Canc Hosp Inst,Ultrasound Med Ctr, Chengdu, Sichuan, Peoples R China; [Jiang, Jingzhen] North Sichuan Med Coll, Nanchong, Peoples R China; [Tsauo, Chialing; Liu, Yin] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Pharmacol, Chengdu, Sichuan, Peoples R China; [Liu, Yin] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China	Chongqing Medical University; University of Electronic Science & Technology of China; North Sichuan Medical University; Sichuan University; University of Electronic Science & Technology of China	Wang, ZG (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Chongqing Key Lab Ultrasound Mol Imaging, Chongqing, Peoples R China.	wzg62942443@163.com	zhang, zhenqi/GSN-1651-2022		National Natural Science Foundation of China [81571700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81571700) to ML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the National Natural Science Foundation of China (Grant No.81571700).	Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bossolasco P, 2012, INT J NANOMED, V7, P435, DOI 10.2147/IJN.S27537; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Castaneda RT, 2011, JOVE-J VIS EXP, DOI 10.3791/3482; Chen PJ, 2015, ADV MATER, V27, P6488, DOI 10.1002/adma.201502784; Cheng L, PEGYLATED WS 2 NANOS; Gao DY, 2017, INT J BIOL SCI, V13, P401, DOI 10.7150/ijbs.18750; Geburek F, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0281-8; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Ha SH, 2012, CYTOM PART A, V81A, P910, DOI 10.1002/cyto.a.22160; Huang GJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3643033; Im GI, 2017, EUR CELLS MATER, V33, P183, DOI 10.22203/eCM.v033a14; Josephson L, NEAR INFRARED FLUORE; Lai CW, 2008, SMALL, V4, P218, DOI 10.1002/smll.200700283; Laurent S, IRON OXIDE BASED MR; Lewin M, TAT PEPTIDE DERIVATI; Li JC, 2017, ADV COLLOID INTERFAC, V249, P374, DOI 10.1016/j.cis.2017.02.009; Liu G, 2011, J MATER SCI-MATER M, V22, P601, DOI 10.1007/s10856-010-4227-x; Mailander V, INTERACTION NANOPART; Matuszewski L, CELL TAGGING WITH CL; Mou J, 2015, BIOMATERIALS, V57, P12, DOI 10.1016/j.biomaterials.2015.04.020; Nam SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037267; Rodriguez-Porcel M, 2012, JACC-CARDIOVASC IMAG, V5, P559, DOI 10.1016/j.jcmg.2011.12.018; Scharf A, 2015, CONTRAST MEDIA MOL I, V10, P388, DOI 10.1002/cmmi.1642; Sivakumar B, 2017, BIOMATER SCI-UK, V5, P432, DOI 10.1039/c6bm00621c; Taylor A, 2012, CHEM SOC REV, V41, P2707, DOI 10.1039/c2cs35031a; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wu Y, IRON OXIDE NANOPARTI; Xu CJ, 2012, NANO LETT, V12, P4131, DOI 10.1021/nl301658q; Yang YF, 2013, ANN BIOMED ENG, V41, P2109, DOI 10.1007/s10439-013-0802-x; Zhang SJ, COMPARISON IMAGING T; Zhang YS, 2013, THERANOSTICS, V3, P532, DOI 10.7150/thno.5369	32	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193362	10.1371/journal.pone.0193362	http://dx.doi.org/10.1371/journal.pone.0193362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608568	gold, Green Published, Green Submitted			2022-12-27	WOS:000428988800003
J	Mahmoud, M; Zeng, Y; Shirali, M; Yin, T; Brugemann, K; Konig, S; Haley, C				Mahmoud, M.; Zeng, Y.; Shirali, M.; Yin, T.; Bruegemann, K.; Koenig, S.; Haley, C.			Genome-wide pleiotropy and shared biological pathways for resistance to bovine pathogens	PLOS ONE			English	Article							HOLSTEIN CATTLE; DAIRY-CATTLE; GASTROINTESTINAL NEMATODES; GENETIC SUSCEPTIBILITY; MASTITIS RESISTANCE; DISEASE RESISTANCE; ASSOCIATION; INFECTION; TRAITS; STRATIFICATION	Host genetic architecture is a major factor in resistance to pathogens and parasites. The collection and analysis of sufficient data on both disease resistance and host genetics has, however, been a major obstacle to dissection the genetics of resistance to single or multiple pathogens. A severe challenge in the estimation of heritabilities and genetic correlations from pedigree-based studies has been the confounding effects of the common environment shared among relatives which are difficult to model in pedigree analyses, especially for health traits with low incidence rates. To circumvent this problem we used genome-wide single-nucleotide polymorphism data and implemented the Genomic-Restricted Maximum Likelihood (G-REML) method to estimate the heritabilities and genetic correlations for resistance to 23 different infectious pathogens in calves and cows in populations undergoing natural pathogen challenge. Furthermore, we conducted gene-based analysis and generalized gene-set analysis to understand the biological background of resistance to infectious diseases. The results showed relatively higher heritabilities of resistance in calves than in cows and significant pleiotropy (both positive and negative) among some calf and cow resistance traits. We also found significant pleiotropy between resistance and performance in both calves and cows. Finally, we confirmed the role of the B-lymphocyte pathway as one of the most important biological pathways associated with resistance to all pathogens. These results both illustrate the potential power of these approaches to illuminate the genetics of pathogen resistance in cattle and provide foundational information for future genomic selection aimed at improving the overall production fitness of cattle.	[Mahmoud, M.; Yin, T.; Bruegemann, K.; Koenig, S.] Justus Liebig Univ Giessen, Inst Anim Breeding & Genet, Giessen, Germany; [Mahmoud, M.; Zeng, Y.; Haley, C.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Shirali, M.] Univ Edinburgh, Ctr Clin Brain Sci, Royal Edinburgh Hosp, Kennedy Tower, Edinburgh, Midlothian, Scotland; [Haley, C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Haley, C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	Justus Liebig University Giessen; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Konig, S (corresponding author), Justus Liebig Univ Giessen, Inst Anim Breeding & Genet, Giessen, Germany.; Haley, C (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.; Haley, C (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.; Haley, C (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	Sven.Koenig@agrar.uni-giessen.de; Chris.Haley@igmm.ed.ac.uk	Shirali, Masoud/AAZ-5633-2020; Shirali, Masoud/GYH-0339-2022	Shirali, Masoud/0000-0002-5401-0541; Shirali, Masoud/0000-0002-5401-0541	German Federal Ministry of Education and Research (BMBF); Forderverein Biookonomieforschung e.V. (FBV) / German Holstein Association (DHV) [031A416C]; Biotechnology and Biological Sciences Research Council in the UK [BB/P013759/1]; Medical Research Council in the UK [MC_PC_U127592696]; Biotechnology and Biological Sciences Research Council [BBS/E/D/30002275, BBS/E/D/20211554, BBS/E/D/20211553, BBS/E/D/20211550] Funding Source: researchfish; Medical Research Council [MC_PC_U127592696] Funding Source: researchfish; BBSRC [BBS/E/D/20211554, BBS/E/D/20211550, BBS/E/D/20211553] Funding Source: UKRI; MRC [MC_PC_U127592696] Funding Source: UKRI	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Forderverein Biookonomieforschung e.V. (FBV) / German Holstein Association (DHV); Biotechnology and Biological Sciences Research Council in the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council in the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research funded by the German Federal Ministry of Education and Research (BMBF), the Forderverein Biookonomieforschung e.V. (FBV) / German Holstein Association (DHV) and through the collaborative project "KMU-innovativ-10: Kuh-L - cow calibration groups for the implementation of selection strategies based on high-density genotyping in dairy cattle" (grant no. 031A416C). CSH was supported by the Biotechnology and Biological Sciences Research Council in the UK (Grant BB/P013759/1). CSH and YZ were supported by the Medical Research Council in the UK (Grant MC_PC_U127592696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the invaluable contributions of Pau Navarro, Carmen Amador and Charley Xia at the MRC Human Genetics Unit, University of Edinburgh and thank Andrea Wilson of The Roslin Institute, University of Edinburgh, for additional valuable comments on the manuscript. This research funded by the German Federal Ministry of Education and Research (BMBF), the Forderverein Biookonomieforschung e.V. (FBV) / German Holstein Association (DHV) and through the collaborative project "KMU-innovativ-10: Kuh-L-cow calibration groups for the implementation of selection strategies based on high-density genotyping in dairy cattle" (grant no. 031A416C).	Alberts B, 2002, INTRO PATHOGENS; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Alpay F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111704; [Anonymous], 2001, BERGEYS MANUAL SYSTE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Berry DP, 2011, IRISH VET J, V64, DOI 10.1186/2046-0481-64-5; Bishop SC, 2007, SMALL RUMINANT RES, V70, P48, DOI 10.1016/j.smallrumres.2007.01.006; Bishop SC, 2014, LIVEST SCI, V166, P190, DOI 10.1016/j.livsci.2014.04.034; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cad Leeuw, 2015, PLOS COMPUT BIOL, V11; Casas E, 2015, ANIM GENET, V46, P8, DOI 10.1111/age.12239; Chen GB, 2014, HUM MOL GENET, V23, P4710, DOI 10.1093/hmg/ddu174; Coppieters W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-96; DAVIS GP, 1993, AUST J AGR RES, V44, P179, DOI 10.1071/AR9930179; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Feucker W, ZENTRALER DIAGNOSESC; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; Gernand E, 2012, J DAIRY SCI, V95, P2144, DOI 10.3168/jds.2011-4812; Hamzic E, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0170-0; Heringstad B, 2008, J DAIRY SCI, V91, P367, DOI 10.3168/jds.2007-0365; Heringstad B, 2000, LIVEST PROD SCI, V64, P95, DOI 10.1016/S0301-6226(99)00128-1; Kiser JN, 2017, J ANIMAL SCI; Lee BY, 2015, ASIAN AUSTRAL J ANIM, V28, P166, DOI 10.5713/ajas.14.0383; Mahmoud M, 2017, J DAIRY SCI, V100, P2017, DOI 10.3168/jds.2016-11767; Pan Y, 2004, J DAIRY SCI, V87, P3967, DOI 10.3168/jds.S0022-0302(04)73537-7; Passafaro TL, 2015, VET PARASITOL, V210, P224, DOI 10.1016/j.vetpar.2015.03.017; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raszek MM, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00030; Richardson IW, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0197-x; Rupp R, 2009, J DAIRY SCI, V92, P1203, DOI 10.3168/jds.2008-1435; Segelke D, 2012, J DAIRY SCI, V95, P5403, DOI 10.3168/jds.2012-5466; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; STEAR MJ, 1994, VET PARASITOL, V54, P161, DOI 10.1016/0304-4017(94)90089-2; Stock K.F., 2013, ICAR TECHNICAL SERIE, V17, P75; Swalve HH, 2015, GERMAN PROJECTS GENO; Templeton J, 1990, P 4 WORLD C GEN APPL; Thompson-Crispi KA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-559; Tsairidou S, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0264-3; Tsairidou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096728; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zanella R, 2011, ANIM GENET, V42, P28, DOI 10.1111/j.1365-2052.2010.02076.x; Zare Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088380	50	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194374	10.1371/journal.pone.0194374	http://dx.doi.org/10.1371/journal.pone.0194374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608619	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800010
J	Moser, O; Eckstein, ML; McCarthy, O; Deere, R; Bain, SC; Haahr, HL; Zijlstra, E; Heise, T; Bracken, RM				Moser, Othmar; Eckstein, Max L.; McCarthy, Olivia; Deere, Rachel; Bain, Stephen C.; Haahr, Hanne L.; Zijlstra, Eric; Heise, Tim; Bracken, Richard M.			Heart rate dynamics during cardio-pulmonary exercise testing are associated with glycemic control in individuals with type 1 diabetes	PLOS ONE			English	Article							RATE PERFORMANCE CURVE; AEROBIC CAPACITY; ADOLESCENTS; THRESHOLD; MORTALITY; STATEMENT; POINT	Introduction This study investigated the degree and direction (k(HR)) of the heart rate to performance curve (HRPC) during cardio-pulmonary exercise (CPX) testing and explored the relationship with diabetes markers, anthropometry and exercise physiological markers in type 1 diabetes (T1DM). Material and methods Sixty-four people with T1DM (13 females; age: 34 +/- 8 years; HbA(1c): 7.8 +/- 1% (62 +/- 13 mmol.mol(-1)) performed a CPX test until maximum exhaustion. kHR was calculated by a second-degree polynomial representation between post-warm up and maximum power output. Adjusted stepwise linear regression analysis was performed to investigate k(HR) and its associations. Receiver operating characteristic (ROC) curve was performed based on k(HR) for groups k(HR) < 0.20 vs. > 0.20 in relation to HbA(1c). Results We found significant relationships between k(HR) and HbA(1c) (beta = -0.70, P < 0.0001), age beta = -0.23, P = 0.03) and duration of diabetes beta = 0.20, P = 0.04). Stepwise linear regression resulted in an overall adjusted R-2 of 0.57 (R = 0.79, P < 0.0001). Our data revealed also significant associations between k(HR) and percentage of heart rate at heart rate turn point from maximum heart rate beta = 0.43, P < 0.0001) and maximum power output relativized to body-weight beta = 0.44, P = 0.001) (overall adjusted R-2 of 0.44 (R = 0.53, P < 0.0001)). ROC curve analysis based on k(HR) resulted in a HbA(1c) threshold of 7.9% (62 mmol.mol(-1)). Conclusion Our data demonstrate atypical HRPC during CPX testing that were mainly related to glycemic control in people with T1DM.	[Moser, Othmar; Eckstein, Max L.; McCarthy, Olivia; Deere, Rachel; Bain, Stephen C.; Bracken, Richard M.] Swansea Univ, Med Sch, Diabet Res Grp, Swansea, W Glam, Wales; [Moser, Othmar; Eckstein, Max L.; McCarthy, Olivia; Deere, Rachel; Bracken, Richard M.] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Haahr, Hanne L.] Novo Nordisk AS, Soborg, Denmark; [Zijlstra, Eric; Heise, Tim] Profil, Neuss, Germany	Swansea University; Swansea University; Novo Nordisk; Profil	Moser, O (corresponding author), Swansea Univ, Med Sch, Diabet Res Grp, Swansea, W Glam, Wales.; Moser, O (corresponding author), Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales.	othmar.moser@swansea.ac.uk	Bracken, Rich/AAC-2586-2021	Bracken, Rich/0000-0002-6986-6449; McCarthy, Olivia/0000-0001-6971-611X; Deere, Rachel/0000-0001-6925-7865; Haahr, Hanne Lis/0000-0002-6980-8230	Novo Nordisk A/S [NN1250-3999]; Medtronic; Novo Nordisk A/S; Ser Cymru II COFUND fellowship/European Union; KESS2/European Social Fund scholarship; Abbott; Astra Zeneca; Boehringer Ingelheim; BMS; Diartis; Eli Lily and Company; GlaxoSmithKline; Johnson Johnson; Merck Sharp Dohme; Novartis; Novo Nordisk; Pfizer; Roche; Sanofi-Aventis; ScheringPlough; Servier; Takeda; Adocia; BD; Biocon; Dance Pharmaceuticals; Grunenthal; Sanofi; Senseonics; Mylan	Novo Nordisk A/S(Novo Nordisk); Medtronic(Medtronic); Novo Nordisk A/S(Novo Nordisk); Ser Cymru II COFUND fellowship/European Union; KESS2/European Social Fund scholarship; Abbott(Abbott Laboratories); Astra Zeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); BMS(Bristol-Myers Squibb); Diartis; Eli Lily and Company; GlaxoSmithKline(GlaxoSmithKline); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); ScheringPlough(Merck & CompanySchering Plough Corporation); Servier(Servier); Takeda(Takeda Pharmaceutical Company Ltd); Adocia; BD; Biocon(AblynxAkvaplan-nivaCentre National de la Recherche Scientifique (CNRS)); Dance Pharmaceuticals; Grunenthal(HAL Allergy Group); Sanofi; Senseonics; Mylan	This study was supported by Novo Nordisk A/S (NN1250-3999 to Tim Heise).; O. Moser has received lecture fees from Medtronic, a travel grant from Novo Nordisk A/S and research grants from Ser Cymru II COFUND fellowship/European Union and Novo Nordisk A/S. M. L. Eckstein has received a KESS2/European Social Fund scholarship. S. C. Bain reports having received honoraria, teaching and research grants from the Abbott, Astra Zeneca, Boehringer Ingelheim, BMS, Diartis, Eli Lily and Company, GlaxoSmithKline, Johnson & Johnson, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi-Aventis, ScheringPlough, Servier and Takeda. T. Heise reports having received research funds from Adocia, Astra Zeneca, BD, Biocon, Boehringer Ingelheim, Dance Pharmaceuticals, Grunenthal, Eli Lily and Company, Medtronic, Novo Nordisk, Novartis, Sanofi and Senseonics and having received speaker honoraria and travel grants from Eli Lily and Company, Mylan and Novo Nordisk. R. M. Bracken reports having received honoraria, travel and educational grant support from, Boehringer-Ingelheim, Eli Lily and Company, Novo Nordisk, Sanofi-Aventis. E. Zijlstra, R. Deere and O. McCarthy have no disclosures to report. H. L. Haahr is employee and shareholder in Novo Nordisk A/S. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; This study was funded by Novo Nordisk A/S. Data were extracted from a clinical trial (NCT01704417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Baldi JC, 2010, EXERC SPORT SCI REV, V38, P161, DOI 10.1097/JES.0b013e3181f4501e; Baldi JC, 2010, MED SCI SPORT EXER, V42, P1454, DOI 10.1249/MSS.0b013e3181d1fdb3; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Brahma MK, 2017, DIABETES METAB J, V41, P1, DOI 10.4093/dmj.2017.41.1.1; BUNC V, 1995, EUR J APPL PHYSIOL O, V70, P263, DOI 10.1007/BF00238574; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; COLUCCI WS, 1986, NEW ENGL J MED, V314, P349, DOI 10.1056/NEJM198602063140605; CONCONI F, 1982, J APPL PHYSIOL, V52, P869, DOI 10.1152/jappl.1982.52.4.869; Dresing TJ, 2000, AM J CARDIOL, V86, P602, DOI 10.1016/S0002-9149(00)01036-5; Gusso S, 2008, DIABETOLOGIA, V51, P1317, DOI 10.1007/s00125-008-1012-1; Heise T, 2016, DIABETES OBES METAB, V18, P196, DOI 10.1111/dom.12588; Heyman E, 2007, DIABETES METAB, V33, P422, DOI 10.1016/j.diabet.2007.10.003; Hofmann P, 2005, MED SCI SPORT EXER, V37, P1704, DOI 10.1249/01.mss.0000176308.70316.cc; Hofmann P, 1997, MED SCI SPORT EXER, V29, P762, DOI 10.1097/00005768-199706000-00005; HOFMANN P, 1994, EUR J APPL PHYSIOL O, V69, P132, DOI 10.1007/BF00609405; Hofmann P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/209302; Hofmann P, 2010, INT J SPORT PHYSIOL, V5, P437, DOI 10.1123/ijspp.5.4.437; Keytsman C, 2015, SPORTS MED, V45, P985, DOI 10.1007/s40279-015-0328-5; Kodama S, 2013, DIABETES CARE, V36, P471, DOI 10.2337/dc12-0783; Livingstone SJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001321; Lymperopoulos A, 2008, CIRC RES, V6, P2166; McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676; McNeilly AD, 2017, DIABETES, V66, P1696, DOI 10.2337/db16-1533; Moser O, 2017, ASIAN J SPORTS MED, P8; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Niranjan V, 1997, AM J MED, V103, P504, DOI 10.1016/S0002-9343(97)00251-9; Peltonen JE, 2012, RESP PHYSIOL NEUROBI, V181, P267, DOI 10.1016/j.resp.2012.04.002; RIBEIRO JP, 1985, INT J SPORTS MED, V6, P220, DOI 10.1055/s-2008-1025844; Sastre Julia, 2012, Endocrinol Nutr, V59, P539, DOI 10.1016/j.endonu.2012.07.003; Wallymahmed M., 2005, PRACTICAL DIABETES I, V22, P81; Wilson LC, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13248; Wonisch M, 2003, EUR J CARDIOV PREV R, V10, P296, DOI 10.1097/00149831-200308000-00013	33	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194750	10.1371/journal.pone.0194750	http://dx.doi.org/10.1371/journal.pone.0194750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608593	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800016
J	Bai, XM; Zhang, FL; Hou, J; Lee, I; Kong, XJ; Tolba, A; Xia, F				Bai, Xiaomei; Zhang, Fuli; Hou, Jie; Lee, Ivan; Kong, Xiangjie; Tolba, Amr; Xia, Feng			Quantifying the impact of scholarly papers based on higher-order weighted citations	PLOS ONE			English	Article							WEB	Quantifying the impact of a scholarly paper is of great significance, yet the effect of geographical distance of cited papers has not been explored. In this paper, we examine 30,596 papers published in Physical Review C, and identify the relationship between citations and geographical distances between author affiliations. Subsequently, a relative citation weight is applied to assess the impact of a scholarly paper. A higher-order weighted quantum PageRank algorithm is also developed to address the behavior of multiple step citation flow. Capturing the citation dynamics with higher-order dependencies reveals the actual impact of papers, including necessary self-citations that are sometimes excluded in prior studies. Quantum PageRank is utilized in this paper to help differentiating nodes whose PageRank values are identical.	[Bai, Xiaomei] Anshan Normal Univ, Ctr Comp, Anshan 114007, Peoples R China; [Bai, Xiaomei; Hou, Jie; Lee, Ivan; Kong, Xiangjie; Xia, Feng] Dalian Univ Technol, Key Lab Ubiquitous Network & Serv Software Liaoni, Sch Software, Dalian 116620, Peoples R China; [Zhang, Fuli] Anshan Normal Univ, Lib, Anshan 114007, Peoples R China; [Lee, Ivan] Univ South Australia, Sch ITMS, Mawson Lakes, SA 5095, Australia; [Tolba, Amr] King Saud Univ, Dept Comp Sci, Community Coll, Riyadh 11437, Saudi Arabia; [Tolba, Amr] Menoufia Univ, Dept Math, Fac Sci, Shibin Al Kawm 32511, Egypt	Anshan Normal University; Dalian University of Technology; Anshan Normal University; University of South Australia; King Saud University; Egyptian Knowledge Bank (EKB); Menofia University	Lee, I (corresponding author), Dalian Univ Technol, Key Lab Ubiquitous Network & Serv Software Liaoni, Sch Software, Dalian 116620, Peoples R China.; Lee, I (corresponding author), Univ South Australia, Sch ITMS, Mawson Lakes, SA 5095, Australia.	ivan.lee@unisa.edu.au	Kong, Xiangjie/B-8809-2016; Tolba, Amr/O-8464-2016; Xia, Feng/Y-2859-2019; Lee, Ivan/F-4131-2013	Kong, Xiangjie/0000-0003-2698-3319; Tolba, Amr/0000-0003-3439-6413; Xia, Feng/0000-0002-8324-1859; Lee, Ivan/0000-0002-2826-6367	International Scientific Partnership Program ISPP at King Saud University [ISPP0078]	International Scientific Partnership Program ISPP at King Saud University	The authors extend their appreciation to the International Scientific Partnership Program ISPP at King Saud University for funding this research work through ISPP#0078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinis H, 2012, ACAD MANAGE PERSPECT, V26, P105, DOI 10.5465/amp.2011.0088; Albarran P, 2015, J ASSOC INF SCI TECH, V66, P512, DOI 10.1002/asi.23219; Bai XM, 2017, WWW'17 COMPANION: PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P1243, DOI 10.1145/3041021.3053061; Bai XM, 2017, INFORMATION, V8, DOI 10.3390/info8030073; Bai XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162364; Bohlin L, 2015, J ASS INFORM SCI TE, V105, P443; Borner K, 2006, SCIENTOMETRICS, V68, P415, DOI 10.1007/s11192-006-0120-2; Box G.E.P., 2010, J TIME SER ANAL, V31, P303, DOI DOI 10.1111/J.1467-9892.2009.00643.X; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cawkell T, 1998, ASLIB PROC, V50, P27, DOI 10.1108/eb051479; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Chen YL, 2011, J INF SCI, V37, P254, DOI 10.1177/0165551511402421; Deshpande M., 2004, ACM T INTERNET TECHN, V4, P163, DOI DOI 10.1145/990301.990304; Diday E, 1980, CLUSTERING ANAL DIGI, P47; Dou R, 2016, PHYS REV PHYS EDUC R, V12, DOI 10.1103/PhysRevPhysEducRes.12.020124; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Gargouri Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013636; Gleich D. F., 2014, COMPUTER SCI, V57; Gleich DF, 2014, SIAM J MATRIX ANAL A, V36; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jing Z, 2016, CHIN CONTR CONF, P211, DOI 10.1109/ChiCC.2016.7553085; Kalavri V, 2016, PROC VLDB ENDOW, V9, P672; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00551; Paparo GD, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14150-y; Rosvall M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5630; Sayyadi H., 2009, SIAM INT C DAT MIN 2, P533; Schubert A, 2006, SCIENTOMETRICS, V69, P409, DOI 10.1007/s11192-006-0160-7; Shah N, 2015, S INDEX BETTER METRI; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Venkatramanan S, 2015, ENVIRON SCI POLLUT R, V22, P11209, DOI 10.1007/s11356-015-4290-4; Wang S., 2014, P 2014 SIAM INT C DA, P749, DOI DOI 10.1137/1.9781611973440.86; Wang Y., 2013, PROC AAAI C ARTIF IN, P933, DOI DOI 10.1609/AAAI.V27I1.8627; Wu J, 2013, GEOGRAPHICAL KNOWLED, P181; Xia F, 2017, IEEE T BIG DATA, V3, P18, DOI 10.1109/TBDATA.2016.2641460; Xia F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165997; Xie WL, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1325, DOI 10.1145/2783258.2783278; Xu J, 2015, SCI ADV, V2	42	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193192	10.1371/journal.pone.0193192	http://dx.doi.org/10.1371/journal.pone.0193192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596426	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000428630000005
J	Garelnabi, M; Taylor-Smith, LM; Bielska, E; Hall, RA; Stones, D; May, RC				Garelnabi, Mariam; Taylor-Smith, Leanne M.; Bielska, Ewa; Hall, Rebecca A.; Stones, Daniel; May, Robin C.			Quantifying donor-to-donor variation in macrophage responses to the human fungal pathogen Cryptococcus neoformans	PLOS ONE			English	Article							NERVOUS-SYSTEM CRYPTOCOCCOSIS; VAR. GRUBII; THERAPY; MENINGITIS	Cryptococcosis remains the leading cause of fungal meningitis worldwide, caused primarily by the pathogen Cryptococcus neoformans. Symptomatic cryptococcal infections typically affect immunocompromised patients. However, environmental exposure to cryptococcal spores is ubiquitous and most healthy individuals are thought to harbor infections from early childhood onwards that are either resolved, or become latent. Since macrophages are a key host cell for cryptococcal infection, we sought to quantify the extent of individual variation in this early phagocyte response within a small cohort of healthy volunteers with no reported immunocompromising conditions. We show that rates of both intracellular fungal proliferation and non-lytic expulsion (vomocytosis) are remarkably variable between individuals. However, we demonstrate that neither gender, in vitro host inflammatory cytokine profiles, nor polymorphisms in several key immune genes are responsible for this variation. Thus the data we present serve to quantify the natural variation in macrophage responses to this important human pathogen and will hopefully provide a useful "benchmark" for the research community.	[May, Robin C.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	May, RC (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.	r.c.may@bham.ac.uk	Bielska, Ewa/B-4936-2019; May, Robin Charles/ABA-9266-2021	Bielska, Ewa/0000-0002-3138-4719; May, Robin Charles/0000-0001-5364-1838; Hall, Rebecca/0000-0002-4908-8168; Taylor-Smith, Leanne/0000-0001-6217-6499; Stones, Daniel H./0000-0002-8981-7943	European Research Council [614562] Funding Source: Medline; Medical Research Council [MR/J008176/1, MR/L00903X/1, G0601171] Funding Source: Medline; MRC [G0601171, MR/J008176/1, MR/L00903X/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Biondo C, 2005, EUR J IMMUNOL, V35, P870, DOI 10.1002/eji.200425799; Brizendine KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060431; Chen M, 2016, MYCOSES, V59, P494, DOI 10.1111/myc.12497; Chen YC, 2012, MYCOPATHOLOGIA, V173, P329, DOI 10.1007/s11046-011-9471-1; Ecevit IZ, 2006, CLIN INFECT DIS, V42, P1443, DOI 10.1086/503570; Fischer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150632; George IA, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx004; Gilbert AS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700898; Gilbert AS, 2014, COLD SPRING HARB PER; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Jarvis JN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004754; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; McClelland EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063632; Mihara T, 2013, MED MYCOL, V51, P252, DOI 10.3109/13693786.2012.708883; Nguyen MH, 2010, J INFECTION, V61, P419, DOI 10.1016/j.jinf.2010.08.004; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pyrgos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056269; Qiu FM, 2013, MUTAGENESIS, V28, P561, DOI 10.1093/mutage/get033; Sabiiti W, 2012, FUTURE MICROBIOL, V7, P1297, DOI [10.2217/FMB.12.102, 10.2217/fmb.12.102]; Scriven JE, 2017, JAIDS-J ACQ IMM DEF, V75, P299, DOI [10.1097/QAI.0000000000001382, 10.1097/qai.0000000000001382]; Smith LM, 2014, CELLULAR MICROBIOLOG; Sorrell TC, 2016, MICROBES INFECT, V18, P57, DOI 10.1016/j.micinf.2015.08.017; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Tseng HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061921; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Voelz K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015968	32	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194615	10.1371/journal.pone.0194615	http://dx.doi.org/10.1371/journal.pone.0194615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596441	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000428630000034
J	Pfister, PB; de Bruin, ED; Sterkele, I; Maurer, B; de Bie, RA; Knols, RH				Pfister, Pierrette Baschung; de Bruin, Eling D.; Sterkele, Iris; Maurer, Britta; de Bie, Rob A.; Knols, Ruud H.			Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy: An intra- and interrater reliability and validity study	PLOS ONE			English	Article							INCLUSION-BODY MYOSITIS; REFERENCE VALUES; JUVENILE DERMATOMYOSITIS; INTERNATIONAL CONSENSUS; ISOKINETIC DYNAMOMETRY; NORMATIVE VALUES; KNEE EXTENSION; STRENGTH; POLYMYOSITIS; ADULT	Manual muscle testing (MMT) and hand-held dynamometry (HHD) are commonly used in people with inflammatory myopathy (IM), but their clinimetric properties have not yet been sufficiently studied. To evaluate the reliability and validity of MMT and HHD, maximum isometric strength was measured in eight muscle groups across three measurement events. To evaluate reliability of HHD, intra-class correlation coefficients (ICC), the standard error of measurements (SEM) and smallest detectable changes (SDC) were calculated. To measure reliability of MMT linear Cohen's Kappa was computed for single muscle groups and ICC for total score. Additionally, correlations between MMT8 and HHD were evaluated with Spearman Correlation Coefficients. Fifty people with myositis (56 +/- 14 years, 76% female) were included in the study. Intra-and interrater reliability of HHD yielded excellent ICCs (0.75-0.97) for all muscle groups, except for interrater reliability of ankle extension (0.61). The corresponding SEMs% ranged from 8 to 28% and the SDCs% from 23 to 65%. MMT8 total score revealed excellent intra-and interrater reliability (ICC>0.9). Intrarater reliability of single muscle groups was substantial for shoulder and hip abduction, elbow and neck flexion, and hip extension (0.64-0.69); moderate for wrist (0.53) and knee extension (0.49) and fair for ankle extension (0.35). Interrater reliability was moderate for neck flexion (0.54) and hip abduction (0.44); fair for shoulder abduction, elbow flexion, wrist and ankle extension (0.20-0.33); and slight for knee extension (0.08). Correlations between the two tests were low for wrist, knee, ankle, and hip extension; moderate for elbow flexion, neck flexion and hip abduction; and good for shoulder abduction. In conclusion, the MMT8 total score is a reliable assessment to consider general muscle weakness in people with myositis but not for single muscle groups. In contrast, our results confirm that HHD can be recommended to evaluate strength of single muscle groups.	[Pfister, Pierrette Baschung; Knols, Ruud H.] Univ Hosp Zurich, Physiotherapy Occupat Therapy Res Ctr, Directorate Res & Educ, Zurich, Switzerland; [Pfister, Pierrette Baschung] Zurich Univ Appl Sci, Inst Physiotherapy, Dept Hlth, Winterthur, Switzerland; [Pfister, Pierrette Baschung] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Functioning & Rehabil, NL-6200 MD Maastricht, Netherlands; [de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland; [de Bruin, Eling D.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, SE-14183 Huddinge, Sweden; [Sterkele, Iris] Univ Hosp Zurich, Physiotherapy Occupat Therapy, Nursing & Allied Hlth Profess Off, Zurich, Switzerland; [Maurer, Britta] Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland; [de Bie, Rob A.] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands	University of Zurich; University Zurich Hospital; Zurich University of Applied Sciences; Maastricht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Maastricht University	de Bruin, ED (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Dept Hlth Sci & Technol, Zurich, Switzerland.; de Bruin, ED (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, SE-14183 Huddinge, Sweden.	eling.debruin@hest.ethz.ch	de Bruin, Eling D./A-4751-2011	de Bruin, Eling D./0000-0002-6542-7385				AITKENS S, 1989, MUSCLE NERVE, V12, P173, DOI 10.1002/mus.880120302; Andersen H, 1997, EUR NEUROL, V37, P239, DOI 10.1159/000117450; Andrews AW, 1996, PHYS THER, V76, P248, DOI 10.1093/ptj/76.3.248; BACKMAN E, 1995, SCAND J REHABIL MED, V27, P109; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Bohannon RW, 2000, PERCEPT MOTOR SKILL, V90, P747, DOI 10.2466/PMS.90.3.747-750; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Bohannon RW, 2001, AM J PHYS MED REHAB, V80, P13, DOI 10.1097/00002060-200101000-00004; BOHANNON RW, 1993, J ORTHOP SPORT PHYS, V18, P564, DOI 10.2519/jospt.1993.18.4.564; DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; de Winter AF, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-18; Fleiss JL., 1999, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923, DOI 10.1002/9781118032923, DOI 10.1002/9781118032923.CHL]; Greenberg SA, 2008, SEMIN NEUROL, V28, P241, DOI 10.1055/s-2008-1062267; Harris-Love MO, 2009, RHEUMATOLOGY, V48, P134, DOI 10.1093/rheumatology/ken441; HAYES KW, 1992, J ORTHOP SPORT PHYS, V16, P145, DOI 10.2519/jospt.1992.16.3.145; Hengstman GJD, 2003, EUR NEUROL, V50, P10, DOI 10.1159/000070852; Isenberg DA, 2004, RHEUMATOLOGY, V43, P49, DOI 10.1093/rheumatology/keg427; Jain Minal, 2006, Phys Occup Ther Pediatr, V26, P5, DOI 10.1300/J006v26n03_02; Knols RH, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-31; Kolber MJ, 2005, PHYS THER REV, V10, P99, DOI 10.1179/108331905X55730; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mastaglia FL, 2002, RHEUM DIS CLIN N AM, V28, P723, DOI 10.1016/S0889-857X(02)00021-2; McKay MJ, 2017, NEUROLOGY, V88, P36, DOI 10.1212/WNL.0000000000003466; Meldrum D, 2007, AMYOTROPH LATERAL SC, V8, P47, DOI 10.1080/17482960601012491; Mentiplay BF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140822; Meyer A, 2015, RHEUMATOLOGY, V54, P50, DOI 10.1093/rheumatology/keu289; Noreau L, 1998, SPINAL CORD, V36, P716, DOI 10.1038/sj.sc.3100646; Pfister PB, 2015, RHEUMATOL INT, V35, P1641, DOI 10.1007/s00296-015-3343-9; Rider LG, 2004, ARTHRITIS RHEUM-US, V50, P2281, DOI 10.1002/art.20349; Rider LG, 2002, RHEUM DIS CLIN N AM, V28, P935, DOI 10.1016/S0889-857X(02)00027-3; Rider LG, 2011, ARTHRIT CARE RES, V63, pS118, DOI 10.1002/acr.20532; Rider Lisa G., 2003, Journal of Rheumatology, V30, P603; Rider LG, 2010, ARTHRIT CARE RES, V62, P465, DOI 10.1002/acr.20035; Scholtes VA, 2011, INJURY, V42, P236, DOI 10.1016/j.injury.2010.11.042; Siegel S., 1988, NONPARAMETRIC STAT B; Sole G, 2007, ARCH PHYS MED REHAB, V88, P626, DOI 10.1016/j.apmr.2007.02.006; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; STOLL T, 1995, J RHEUMATOL, V22, P473; Stoll T, 2000, CLIN RHEUMATOL, V19, P105, DOI 10.1007/s100670050026; Stone CA, 2011, J REHABIL MED, V43, P808, DOI 10.2340/16501977-0860; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Sultan Shabina M, 2003, Curr Rheumatol Rep, V5, P445, DOI 10.1007/s11926-003-0055-z; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; VANDERPLOEG RJO, 1991, J NEUROL NEUROSUR PS, V54, P244, DOI 10.1136/jnnp.54.3.244; Varju C, 2003, CLIN REHABIL, V17, P83, DOI 10.1191/0269215503cr572oa; Vet HCWd, 2011, MEASUREMENT MED PRAC, DOI 10.1017/CBO9780511996214	49	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194531	10.1371/journal.pone.0194531	http://dx.doi.org/10.1371/journal.pone.0194531			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596450	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000428630000028
J	Chow, NJ; Han, DJ; Lee, JH; Jang, SH; Kong, JS; Gill, HW; Park, S; Lee, EY				Chow, Nam-Jun; Han, Dong-Jae; Lee, Ji-Hye; Jang, Si-Hyong; Kong, Jeong Suk; Gill, Hyo-Wook; Park, Samel; Lee, Eun Young			Soluble klotho as a marker of renal fibrosis and podocyte injuries in human kidneys	PLOS ONE			English	Article							URINARY ANGIOTENSINOGEN; EXPRESSION; CONTRIBUTES; CLEAVAGE; RELEASE; STRESS; GENE	Klotho deficiency is relevant to renal fibrosis and podocyte injury in vivo and in vitro. We examined whether histological findings of renal biopsy specimens were associated with the levels of soluble klotho in humans. We investigated renal biopsy specimens of 67 patients and detailed microscopic findings were reviewed. Soluble serum/urinary klotho and urinary angiotensinogen were assessed by enzyme-linked immunosorbent assays, and tissue klotho expression was assessed by immunohistochemical staining. The median age of the study participants was 35.6 years. High serum klotho levels (>= 14 pg/mL) were associated with decreased odds ratios (ORs) of interstitial fibrosis (OR = 0.019, P= 0.003) and segmental sclerosis (OR = 0.190, P= 0.022) in multivariable logistic regression analysis. Patients with a lower urinary klotho-to-creatinine ratio (UKCR) were significantly more likely to have diffuse foot process effacement (OR = 0.450, P= 0.010). The area under the receiver-operating characteristic curve (AUC) of serum klotho for predicting interstitial fibrosis was 0.920 (95% CI, 0.844-0.996), and the best cut-off value of serum klotho was 138.1 pg/mL. The AUC of UKCR for predicting diffuse foot process effacement was 0.754 (95% CI, 0.636-0.872), and the best cut-off value of UKCR was 96.7 pg/mgCr. Urinary angiotensinogen-to-creatinine ratio was not associated with serum klotho, UKCR, or any pathological finding. Our data suggested that soluble serum and urinary klotho levels represent a potential biomarker to predict renal fibrosis and podocyte injury in humans.	[Chow, Nam-Jun; Han, Dong-Jae; Kong, Jeong Suk; Gill, Hyo-Wook; Park, Samel; Lee, Eun Young] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Lee, Ji-Hye; Jang, Si-Hyong] Soonchunhyang Univ, Cheonan Hosp, Dept Pathol, Cheonan, South Korea	Soonchunhyang University; Soonchunhyang University	Lee, EY (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	eylee@sch.ac.kr	Lee, Eun Young/Q-6592-2019	Lee, Eun Young/0000-0002-4513-9888	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A3B03027898]; Soonchunhyang University Research Fund	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Soonchunhyang University Research Fund	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A3B03027898) and Soonchunhyang University Research Fund.	Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155; An Y, 2015, NEPHROL DIAL TRANSPL, V30, P257, DOI 10.1093/ndt/gfu250; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2012, NAT REV NEPHROL, V8, P423, DOI 10.1038/nrneph.2012.92; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kim JH, 2017, J AM SOC NEPHROL, V28, P140, DOI 10.1681/ASN.2015080888; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lee EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102984; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim SC, 2014, J RENIN-ANGIO-ALDO S, V15, P487, DOI 10.1177/1470320313475905; Liu QF, 2015, IRAN J KIDNEY DIS, V9, P291; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; MCCARTY KS, 1986, CANCER RES, V46, P4244; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Rotondi S, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/872193; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Sugiura H, 2010, NEPHROL DIAL TRANSPL, V25, P60, DOI 10.1093/ndt/gfp451; Urushihara M, 2010, AM J NEPHROL, V31, P318, DOI 10.1159/000286037; Wu C, 2014, DIABETES RES CLIN PR, V106, P343, DOI 10.1016/j.diabres.2014.08.026; Wu YL, 2017, KIDNEY INT, V91, P830, DOI 10.1016/j.kint.2016.09.039; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P1558, DOI 10.1681/ASN.2006060554; Zhou LL, 2015, AM J PATHOL, V185, P3211, DOI 10.1016/j.ajpath.2015.08.004; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	34	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194617	10.1371/journal.pone.0194617	http://dx.doi.org/10.1371/journal.pone.0194617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590173	Green Submitted, gold, Green Published			2022-12-27	WOS:000428603100069
J	Lee, SW; Kulkarni, K; Annoni, EM; Libbus, I; KenKnight, BH; Tolkacheva, EG				Lee, Steven W.; Kulkarni, Kanchan; Annoni, Elizabeth M.; Libbus, Imad; KenKnight, Bruce H.; Tolkacheva, Elena G.			Stochastic vagus nerve stimulation affects acute heart rate dynamics in rats	PLOS ONE			English	Article							RATE-VARIABILITY; VAGAL-STIMULATION; REFRACTORY EPILEPSY; CARDIAC-FUNCTION; POINCARE PLOT; FAILURE; ISOFLURANE; MODEL	Vagus nerve stimulation (VNS) is an approved therapy for treatment of epilepsy and depression. While also shown to be promising in several preclinical and clinical studies to treat cardiovascular diseases, optimal therapeutic stimulation paradigms are still under investigation. Traditionally, parameters such as frequency, current, and duty cycle are used to adjust the efficacy of VNS therapy. This study explored the effect of novel stochastic VNS (S-VNS) on acute heart rate (HR) dynamics. The effect of S-VNS was evaluated in Sprague Dawley rats by comparing the acute HR and HR variability (HRV) responses to standard, periodic VNS (P-VNS) across different frequencies (FREQs, 10-30 Hz). Our results demonstrate that both S-VNS and P-VNS produced negative chronotropic effects in a FREQ-dependent manner with S-VNS inducing a significantly smaller drop in HR at 10 Hz and 20 Hz compared to P-VNS (p<0.05). S-VNS demonstrated a FREQ-dependent drop in the SD1/SD2 ratio, a measure of HRV, which was absent in P-VNS, suggesting that S-VNS may acutely modulate the nonlinear relationship between short- and long-term HRV. In conclusion, S-VNS is a novel stimulation procedure that may provide different physiological outcomes from standard P-VNS, as indicated by our analysis of HR dynamics. Our study provides a rationale for further detailed investigations into the therapeutic potential of S-VNS as a novel neuromodulation technique.	[Lee, Steven W.; Kulkarni, Kanchan; Annoni, Elizabeth M.; Tolkacheva, Elena G.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Libbus, Imad; KenKnight, Bruce H.] Cyberonics Inc, Livallova PLC, Houston, TX USA	University of Minnesota System; University of Minnesota Twin Cities	Tolkacheva, EG (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	talkacal@umn.edu	Kulkarni, Kanchan/AAZ-9557-2021	Kulkarni, Kanchan/0000-0002-3185-0484; Libbus, Imad/0000-0002-0675-8790	National Heart, Lung, and Blood Institute of the National Institutes of Health [F31HL129544, R21HL128790]; National Science Foundation CAREER [PHY-125541, DCSD 1662250]; LivaNova, PLC (Cyberonics, Inc); LivaNova, PLC	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation CAREER(National Science Foundation (NSF)); LivaNova, PLC (Cyberonics, Inc); LivaNova, PLC	This work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health F31HL129544 (to SWL), R21HL128790 (to EGT), and by National Science Foundation CAREER PHY-125541 (to EGT), DCSD 1662250 (to EGT), as well as support from LivaNova, PLC (Cyberonics, Inc). The funder LivaNova, PLC provided support in the form of salaries for authors (to IL, BHK, and EGT) and research materials (vagus nerve electrodes), but did not have any additional role in the study design, data collection and analysis, and decision to publish. The specific roles of these authors are articulated in the 'Author Contributions' section.	Abramovich-Sivan S, 1998, J THEOR BIOL, V192, P567, DOI 10.1006/jtbi.1998.0684; Annoni EM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12476; Ardell JL, 2015, AM J PHYSIOL-HEART C, V309, pH1740, DOI 10.1152/ajpheart.00557.2015; Azar T, 2011, J AM ASSOC LAB ANIM, V50, P175; Balasubramanian K, 2017, ANN INDIAN ACAD NEUR, V20, P403, DOI 10.4103/aian.AIAN_148_17; BERNTSON GG, 1992, J AUTONOM NERV SYST, V41, P221, DOI 10.1016/0165-1838(92)90062-L; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Buschman HP, 2006, NEUROMODULATION, V9, P214, DOI 10.1111/j.1525-1403.2006.00062.x; De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391; Dvir H, 2013, BIOPHYS J, V105, P533, DOI 10.1016/j.bpj.2013.06.012; Goel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136335; Gold MR, 2016, J AM COLL CARDIOL, V68, P149, DOI 10.1016/j.jacc.2016.03.525; Guzik P, 2007, J PHYSIOL SCI, V57, P63, DOI 10.2170/physiolsci.RP005506; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Hori M, 2012, J CARDIOL, V60, P86, DOI 10.1016/j.jjcc.2012.06.013; Kapa S, 2016, TRENDS CARDIOVAS MED, V26, P245, DOI 10.1016/j.tcm.2015.07.001; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Lee SW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12786; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Libbus I, 2017, J ELECTROCARDIOL; Libbus I, 2016, HEART RHYTHM, V13, P721, DOI 10.1016/j.hrthm.2015.11.030; Libbus Imad, 2002, Card Electrophysiol Rev, V6, P302, DOI 10.1023/A:1016349613464; Lund C, 2011, SEIZURE-EUR J EPILEP, V20, P34, DOI 10.1016/j.seizure.2010.10.002; Malik M., 1996, ANN NONINVAS ELECTRO, V1, P151, DOI DOI 10.1111/J.1542-474X.1996.TB00275.X; McIntyre SD, 2014, J THEOR BIOL, V350, P90, DOI 10.1016/j.jtbi.2014.02.015; Muppidi S, 2011, NEUROLOGY, V77, P1577, DOI 10.1212/WNL.0b013e318233b3a2; O'Reardon John P, 2006, Psychiatry (Edgmont), V3, P54; Olshansky B, 2016, J CARD FAIL, V22, P643, DOI 10.1016/j.cardfail.2016.05.005; PARKER P, 1984, J AUTONOM NERV SYST, V11, P226, DOI 10.1016/0165-1838(84)90080-8; Premchand RK, 2015, J CARD FAIL; Romero Ugalde HM, 2017, IEEE T BIOMED ENG, P1; Samniang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19749; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Stapelberg NJC, 2018, ANN NONINVAS ELECTRO, V23, DOI 10.1111/anec.12483; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Toader E, 2011, MINERVA ANESTESIOL, V77, P142; Tolkacheva EG, 2007, J BIOL PHYS, V33, P35, DOI 10.1007/s10867-007-9040-5; Ugalde HR, 2014, IEEE ENG MED BIO, P6262, DOI 10.1109/EMBC.2014.6945060; van der Groen O, 2017, BRAIN STIMUL, V10, pe4, DOI DOI 10.1016/J.BRS.2016.11.030; Xie XY, 2014, IEEE ENG MED BIO, P1575, DOI 10.1109/EMBC.2014.6943904; Yang CF, 2014, TZU CHI MED J, V26, P119, DOI 10.1016/j.tcmj.2014.07.005; YANG T, 1984, AM J PHYSIOL, V246, pH585, DOI 10.1152/ajpheart.1984.246.4.H585; Yoo PB, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12689; Yuan HK, 2016, HEADACHE, V56, P71, DOI 10.1111/head.12647; Zagon A, 2000, EPILEPSIA, V41, P1382, DOI 10.1111/j.1528-1157.2000.tb00113.x; Zannad F, 2015, EUR HEART J, V36, P425, DOI 10.1093/eurheartj/ehu345	47	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194910	10.1371/journal.pone.0194910	http://dx.doi.org/10.1371/journal.pone.0194910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590213	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100087
J	Stockbridge, EL; Miller, TL; Carlson, EK; Ho, C				Stockbridge, Erica L.; Miller, Thaddeus L.; Carlson, Erin K.; Ho, Christine			Private sector tuberculosis prevention in the US: Characteristics associated with interferon gamma release assay or tuberculin skin testing	PLOS ONE			English	Article							UNITED-STATES; INFECTION; DIAGNOSIS; SERVICES; ADULTS; COST	Objective To determine whether latent tuberculosis infection risk factors are associated with an increased likelihood of latent tuberculosis infection testing in the US private healthcare sector. Data source A national sample of medical and pharmacy claims representing services rendered January 2011 through December 2013 for 3,997,986 commercially insured individuals in the US who were 0 to 64 years of age. Study design We used multivariable logistic regression models to determine whether TB/LTBI risk factors were associated with an increased likelihood of Interferon-Gamma Release Assay (IGRA) or Tuberculin Skin Test (TST) testing in the private sector. Principal findings 4.31% (4.27-4.34%) received at least one TST/IGRA test between 2011 and 2013 while 1.69% (1.67-1.72%) received a TST/IGRA test in 2013. Clinical risk factors associated with a significantly increased likelihood of testing included HIV, immunosuppressive therapy, exposure to tuberculosis, a history of tuberculosis, diabetes, tobacco use, end stage renal disease, and alcohol use disorder. Other significant variables included gender, age, asthma, the state tuberculosis rate, population density, and percent of foreign born persons in a county. Conclusions Private sector TST/IGRA testing is not uncommon and testing varies with clinical risk indicators. Thus, the private sector can be a powerful resource in the fight against tuberculosis. Analyses of administrative data can inform how best to leverage private sector healthcare toward tuberculosis prevention activities.	[Stockbridge, Erica L.; Miller, Thaddeus L.] Univ North Texas, Sch Publ Hlth, Hlth Sci Ctr, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA; [Stockbridge, Erica L.] Magellan Hlth Inc, Dept Adv Hlth Analyt & Solut, Scottsdale, AZ 85251 USA; [Carlson, Erin K.] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76019 USA; [Ho, Christine] CDCP, Div TB Eliminat, Atlanta, GA USA	University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Arlington; Centers for Disease Control & Prevention - USA	Stockbridge, EL (corresponding author), Univ North Texas, Sch Publ Hlth, Hlth Sci Ctr, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA.; Stockbridge, EL (corresponding author), Magellan Hlth Inc, Dept Adv Hlth Analyt & Solut, Scottsdale, AZ 85251 USA.	Erica.Stockbridge@unthsc.edu			Magellan Health	Magellan Health	ELS is employed at a commercial company: Magellan Health, Inc. Magellan Health provided support in the form of salaries for author ELS and access to the data, but did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. No other authors have financial disclosures to report. The specific roles of all authors are articulated in the 'author contributions' section.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Alvarez F, 2012, UNIVERSAL TB TESTING; [Anonymous], 1990, MMWR Recomm Rep, V39, P1; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P962, DOI 10.1001/jama.2016.11046; Blumberg HM, 2016, JAMA-J AM MED ASSOC, V316, P931, DOI 10.1001/jama.2016.11021; Centers for Disease Control and Prevention, 2014, NCHS URB RUR CLASS S; Centers for Disease Control and Prevention, 2012, REP TUB US 2012; Centers for Disease Control and Prevention, 2015, DIV TUB EL STRAT PLA; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P269; Centers for Medicare & Medicaid Services, 2016, NAT MED PHYS FEE SCH; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Flaherman VJ, 2007, PEDIATRICS, V120, P90, DOI 10.1542/peds.2006-2168; Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116; Health Resources and Services Administration, 2016, SHORT DES; Hennessey KA, 1998, JAMA-J AM MED ASSOC, V280, P2008, DOI 10.1001/jama.280.23.2008; *I MED COMM EL TUB, 2000, END NEGL EL TUB US; Kahwati LC, 2016, AHRQ PUBLICATION, V14-05212-EF-1; Laurence YV, 2015, PHARMACOECONOMICS, V33, P939, DOI 10.1007/s40273-015-0279-6; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, P111, DOI 10.1093/cid/ciw778; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Mancuso JD, 2016, AM J RESP CRIT CARE, V194, P501, DOI 10.1164/rccm.201508-1683OC; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Miller TL, 2015, AM J PUBLIC HEALTH, V105, P930, DOI 10.2105/AJPH.2014.302431; Miller TL, 2010, ANN EPIDEMIOL, V20, P1, DOI 10.1016/j.annepidem.2009.09.004; Miller TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005080; Miramontes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140881; Optum, 2015, RETR DAT; Owusu-Edusei K, 2017, INT J TUBERC LUNG D, V21, P684, DOI 10.5588/ijtld.16.0617; Reves RR, 2012, AM J RESP CRIT CARE, V186, pI, DOI 10.1164/rccm.201206-1039ED; Salinas JL, 2016, MMWR-MORBID MORTAL W, V65, P273, DOI 10.15585/mmwr.mm6511a2; Schmit KM, 2017, MMWR-MORBID MORTAL W, V66, P289, DOI 10.15585/mmwr.mm6611a2; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; U. S. Department of Commerce, 2012, US SUMM 2010 POP HOU; Vozoris NT, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/1850879; WHO, 2017, GLOB TUB REP 2017; World Health Organisation, 2015, GUID MAN LAT TUB INF	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193432	10.1371/journal.pone.0193432	http://dx.doi.org/10.1371/journal.pone.0193432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590130	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100019
J	Yoon, J; Zame, WR; Banerjee, A; Cadeiras, M; Alaa, AM; van der Schaar, M				Yoon, Jinsung; Zame, William R.; Banerjee, Amitava; Cadeiras, Martin; Alaa, Ahmed M.; van der Schaar, Mihaela			Personalized survival predictions via Trees of Predictors: An application to cardiac transplantation	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; SHORT-TERM MORTALITY; HEART-TRANSPLANTATION; RECIPIENT RISK; WAITING-LIST; FAILURE; INDEX; DONOR	Background Risk prediction is crucial in many areas of medical practice, such as cardiac transplantation, but existing clinical risk-scoring methods have suboptimal performance. We develop a novel risk prediction algorithm and test its performance on the database of all patients who were registered for cardiac transplantation in the United States during 1985-2015. Methods and findings We develop a new, interpretable, methodology (ToPs: Trees of Predictors) built on the principle that specific predictive (survival) models should be used for specific clusters within the patient population. ToPs discovers these specific clusters and the specific predictive model that performs best for each cluster. In comparison with existing clinical risk scoring methods and state-of-the-art machine learning methods, our method provides significant improvements in survival predictions, both post-and pre-cardiac transplantation. For instance: in terms of 3-month survival post-transplantation, our method achieves AUC of 0.660; the best clinical risk scoring method (RSS) achieves 0.587. In terms of 3-year survival/mortality predictions post-transplantation (in comparison to RSS), holding specificity at 80.0%, our algorithm correctly predicts survival for 2,442 (14.0%) more patients (of 17,441 who actually survived); holding sensitivity at 80.0%, our algorithm correctly predicts mortality for 694 (13.0%) more patients (of 5,339 who did not survive). ToPs achieves similar improvements for other time horizons and for predictions pre-transplantation. ToPs discovers the most relevant features (covariates), uses available features to best advantage, and can adapt to changes in clinical practice. Conclusions We show that, in comparison with existing clinical risk-scoring methods and other machine learning methods, ToPs significantly improves survival predictions both post-and pre-cardiac transplantation. ToPs provides a more accurate, personalized approach to survival prediction that can benefit patients, clinicians, and policymakers in making clinical decisions and setting clinical policy. Because survival prediction is widely used in clinical decision making across diseases and clinical specialties, the implications of our methods are far reaching.	[Yoon, Jinsung; Zame, William R.; Cadeiras, Martin; Alaa, Ahmed M.; van der Schaar, Mihaela] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Banerjee, Amitava] UCL, Farr Inst Hlth Informat Res, London, England; [van der Schaar, Mihaela] Univ Oxford, Oxford, England; [van der Schaar, Mihaela] Alan Turing Inst, London, England	University of California System; University of California Los Angeles; University of London; University College London; University of Oxford	van der Schaar, M (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90024 USA.; van der Schaar, M (corresponding author), Univ Oxford, Oxford, England.; van der Schaar, M (corresponding author), Alan Turing Inst, London, England.	mihaela.vanderschaar@oxford-man.ox.ac.uk	; Banerjee, Amitava/D-4381-2014	van der schaar, Mihaela/0000-0003-3933-6049; Banerjee, Amitava/0000-0001-8741-3411	Office of Naval Research (ONR); National Science Foundation [ECCS1462245]; Alan Turing Institute [TU/B/000050] Funding Source: researchfish	Office of Naval Research (ONR)(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Alan Turing Institute	This work was supported by the Office of Naval Research (ONR) to Mihaela van der Schaar (https://www.onr.navy.mil/) and the National Science Foundation (Grant Number: ECCS1462245) to Mihaela van der Schaar (https://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Alan Agresti, 2003, CATEGORICAL DATA ANA, P482; Alan Agresti, 1996, INTRO CATEGORICAL DA, P135; Almond CSD, 2009, CIRCULATION, V119, P717, DOI 10.1161/CIRCULATIONAHA.108.815712; [Anonymous], 2016, AM HEART ASS NEWS; Arnaoutakis GJ, 2012, J THORAC CARDIOV SUR, V143, P157, DOI 10.1016/j.jtcvs.2011.09.040; BANKER RD, 1986, MANAGE SCI, V32, P1613, DOI 10.1287/mnsc.32.12.1613; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Buuren S., 2011, J STAT SOFTWARE, V45; Deng MC, 2000, BRIT MED J, V321, P540, DOI 10.1136/bmj.321.7260.540; Fang JC, 2013, MOVING BRIDGES; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Hardy Melissa A., 1993, REGRESSION DUMMY VAR, V93; Hong KN, 2011, ANN THORAC SURG, V92, P520, DOI 10.1016/j.athoracsur.2011.02.086; Klein JP, 2005, SURVIVAL ANAL TECHNI; Kleinbaum D.G., 2010, SURVIVAL ANAL, V3; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Mancini D, 2010, CIRCULATION, V122, P173, DOI 10.1161/CIRCULATIONAHA.109.858076; Maugh T.A., 2009, LOS ANGELES TIMES; Miller RG Jr, 2011, SURVIVAL ANAL, V66; Pagani FD, 2009, J AM COLL CARDIOL, V54, P312, DOI 10.1016/j.jacc.2009.03.055; Reynolds Henry T, 1984, ANAL NOMINAL DATA, V7; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Russo MJ, 2006, CIRCULATION, V114, P2280, DOI 10.1161/CIRCULATIONAHA.106.615708; Si XS, 2011, EUR J OPER RES, V213, P1, DOI 10.1016/j.ejor.2010.11.018; Singh T.P, 2012, CIRCULATION HEART FA; Weiss ES, 2012, J HEART LUNG TRANSPL, V31, P266, DOI 10.1016/j.healun.2011.10.004; Weiss ES, 2011, ANN THORAC SURG, V92, P914, DOI 10.1016/j.athoracsur.2011.04.030; Zannad F, 2012, EUR HEART J, V33, P1049, DOI 10.1093/eurheartj/ehr437	30	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194985	10.1371/journal.pone.0194985	http://dx.doi.org/10.1371/journal.pone.0194985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590219	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100094
J	Trosan, P; Smeringaiova, I; Brejchova, K; Bednar, J; Benada, O; Kofronova, O; Jirsova, K				Trosan, Peter; Smeringaiova, Ingrida; Brejchova, Kristyna; Bednar, Jan; Benada, Oldrich; Kofronova, Olga; Jirsova, Katerina			The enzymatic de-epithelialization technique determines denuded amniotic membrane integrity and viability of harvested epithelial cells	PLOS ONE			English	Article							EX-VIVO EXPANSION; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-I; HUMAN PLURIPOTENT; LIMBAL; DIFFERENTIATION; TRANSPLANTATION; SURFACE; PROLIFERATION; CULTURE	The human amniotic membrane (HAM) is widely used for its wound healing effect in clinical practice, as a feeder for the cell cultivation, or a source of cells to be used in cell therapy. The aim of this study was to find effective and safe enzymatic HAM de-epithelialization method leading to harvesting of both denuded undamaged HAM and viable human amniotic epithelial cells (hAECs). The efficiency of de-epithelialization using TrypLE Express, trypsin/ethylenediaminetetraacetic (EDTA), and thermolysin was monitored by hematoxylin and eosin staining and by the measurement of DNA concentration. The cell viability was determined by trypan blue staining. Scanning electron microscopy and immunodetection of collagen type IV and laminin alpha 5 chain were used to check the basement membrane integrity. De-epithelialized hAECs were cultured and their stemness properties and proliferation potential was assessed after each passage. The HAM was successfully de-epithelialized using all three types of reagents, but morphological changes in basement membrane and stroma were observed after the thermolysin application. About 60% of cells remained viable using trypsin/EDTA, approximately 6% using TrypLE Express, and all cells were lethally damaged after thermolysin application. The hAECs isolated using trypsin/EDTA were successfully cultured up to the 5th passage with increasing proliferation potential and decreased stem cell markers expression (NANOG, SOX2 in prolonged cell culture. Trypsin/EDTA technique was the most efficient for obtaining both undamaged denuded HAM and viable hAECs for consequent culture.	[Trosan, Peter; Smeringaiova, Ingrida; Brejchova, Kristyna; Bednar, Jan; Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Lab Biol & Pathol Eye, Prague, Czech Republic; [Trosan, Peter; Smeringaiova, Ingrida; Brejchova, Kristyna; Bednar, Jan; Jirsova, Katerina] Gen Univ Hosp, Prague, Czech Republic; [Trosan, Peter; Smeringaiova, Ingrida; Bednar, Jan; Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Prague, Czech Republic; [Benada, Oldrich; Kofronova, Olga] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Trosan, P (corresponding author), Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Lab Biol & Pathol Eye, Prague, Czech Republic.; Trosan, P (corresponding author), Gen Univ Hosp, Prague, Czech Republic.; Trosan, P (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Prague, Czech Republic.	peter.trosan@lf1.cuni.cz	Brejchova, Kristyna/H-5006-2017; Benada, Oldřich/H-2437-2014; Kofroňová, Olga/H-7239-2014; Smeringaiova, Ingrida/H-3625-2017	Brejchova, Kristyna/0000-0003-2839-6310; Benada, Oldřich/0000-0002-4592-6216; Kofroňová, Olga/0000-0002-5435-4088; Bednar, Jan/0000-0003-0879-6405; Smeringaiova, Ingrida/0000-0002-9254-5571	Norwegian Financial Mechanism; Ministry of Education, Youth and Sports [MSMT-28477/2014, 7F14156]; European Regional Development Fund [EF16_013/0001674]; SVV [260367/2017]; Ministry of Education, Youth and Sports of the Czech Republic [LO1509];  [Progres Q25/LF1];  [BBMRI_CZ LM2015089]	Norwegian Financial Mechanism; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission); SVV; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); ; 	This work was supported by the Norwegian Financial Mechanism 2009-2014 and the Ministry of Education, Youth and Sports under Project Contract no. MSMT-28477/2014, project 7F14156 (http://www.msmt.cz/vyzkum-a-vyvoj-2/ financial-andreporting-issues-in-the-czech-norwegian). This study was further supported by the Progres Q25/LF1 (http://www.cuni.cz/UK-7368. html), European Regional Development Fund, project EF16_013/0001674 (http://ec.europa.eu/ regional_policy/en/funding/erdf/) and by BBMRI_CZ LM2015089 (http://biobanka.lf1.cuni. cz/cz/) projects. PT was supported by SVV, project 260367/2017 (http://www.cuni.cz/UK-3362.html). The electron microscopy facility of IMIC was supported by the project LO1509 of the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/?lang=2).	Alcaraz A, 2013, CELL TRANSPLANT, V22, P1351, DOI 10.3727/096368912X657387; APLIN JD, 1985, J CELL SCI, V79, P119; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Avila-Gonzalez D, 2015, STEM CELL RES, V15, P322, DOI 10.1016/j.scr.2015.07.006; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Melo Gustavo Barreto de, 2007, Arq. Bras. Oftalmol., V70, P407, DOI 10.1590/S0004-27492007000300005; Diaz-Prado S, 2010, J CELL BIOCHEM, V111, P846, DOI 10.1002/jcb.22769; Dudakova L, 2012, EXP EYE RES, V104, P74, DOI 10.1016/j.exer.2012.09.005; Evron Ayelet, 2011, Int J Stem Cells, V4, P123; Fang CH, 2012, CELL TRANSPLANT, V21, P1687, DOI 10.3727/096368912X653039; Fatimah SS, 2012, J BIOSCI BIOENG, V114, P220, DOI 10.1016/j.jbiosc.2012.03.021; Fatimah SS, 2010, HUM CELL, V23, P141, DOI 10.1111/j.1749-0774.2010.00096.x; GERMAIN L, 1995, BURNS, V21, P175, DOI 10.1016/0305-4179(95)80004-8; Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664; Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Ito A, 2003, J BIOSCI BIOENG, V95, P589, DOI 10.1263/jbb.95.589; Izumi M, 2009, J REPROD IMMUNOL, V81, P39, DOI 10.1016/j.jri.2009.02.007; Jirsova K, 2017, CELL TISSUE BANK, V18, P193, DOI 10.1007/s10561-017-9618-5; Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013; Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3; Kolli S, 2008, REGEN MED, V3, P329, DOI 10.2217/17460751.3.3.329; Lai DM, 2009, CLONING STEM CELLS, V11, P331, DOI 10.1089/clo.2008.0047; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514; Garcia-Castro IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146082; Madhira SL, 2008, MOL VIS, V14, P189; Mahmood R, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/841062; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Modesti A, 1989, Prog Clin Biol Res, V296, P459; Mohan R, 2017, J INT SOC PREV COMMU, V7, P15, DOI 10.4103/jispcd.JISPCD_359_16; Nishishita N, 2015, AM J STEM CELLS, V4, P38; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NOGUCHI Y, 1995, BIOCHEM BIOPH RES CO, V210, P302, DOI 10.1006/bbrc.1995.1661; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136; Reboun M, 2016, FOLIA BIOL-PRAGUE, V62, P82; Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034; Roy R, 2016, J SURG RES, V200, P409, DOI 10.1016/j.jss.2015.08.022; Rutigliano L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt344; Saghizadeh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079632; Sangwan VS, 2003, BIOSCIENCE REP, V23, P169, DOI 10.1023/B:BIRE.0000007690.43273.73; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Shimazaki J, 1997, OPHTHALMOLOGY, V104, P2068, DOI 10.1016/S0161-6420(97)30057-8; Shortt AJ, 2008, OPHTHALMOLOGY, V115, P1989, DOI 10.1016/j.ophtha.2008.04.039; Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048; Simat S F, 2008, Med J Malaysia, V63 Suppl A, P53; Sudha B, 2008, INDIAN J MED RES, V128, P149; Tabatabaei Meraj, 2014, Avicenna Journal of Medical Biotechnology, V6, P10; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Tenenhaus M, 2017, ANN PLAS SURG, V78, pS11, DOI 10.1097/SAP.0000000000000983; Trosan P, 2016, STEM CELLS DEV, V25, P874, DOI 10.1089/scd.2016.0030; Trosan P, 2012, STEM CELLS DEV, V21, P3341, DOI 10.1089/scd.2012.0180; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9; VANHERENDAEL BJ, 1978, AM J OBSTET GYNECOL, V131, P872, DOI 10.1016/S0002-9378(16)33135-0; Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Zajicova A, 2010, CELL TRANSPLANT, V19, P1281, DOI 10.3727/096368910X509040; Zhang T, 2013, INVEST OPHTH VIS SCI, V54, P3072, DOI 10.1167/iovs.12-10805	64	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194820	10.1371/journal.pone.0194820	http://dx.doi.org/10.1371/journal.pone.0194820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584778	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000040
J	Wang, Y; Liu, HJ; Wu, FY; Yang, XD; Yue, MJ; Pang, YX; Lie, XX; Ma, J; Zhou, G; Gong, P; Liu, MT; Zhang, XM				Wang, Yun; Liu, Hongjian; Wu, Fangyuan; Yang, Xiaodi; Yue, Mengjia; Pang, Yingxin; Lie, Xuanxuan; Ma, Juan; Zhou, Ge; Gong, Ping; Liu, Meitian; Zhang, Xiumin			The association between BMI and body weight perception among children and adolescents in Jilin City, China	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; MASS INDEX; PSYCHOLOGICAL-FACTORS; MULTIETHNIC SAMPLE; CONTROL BEHAVIORS; PERCEIVED WEIGHT; HONG-KONG; OBESITY; OVERWEIGHT; HEALTH	Objectives We evaluated the association between BMI and body weight perception in a sample of children and adolescents. Methods A cross-sectional school-based study was conducted among 7-18 year-olds (N = 9727) from 4 districts in Jilin City, China. We calculated BMI from measured weight and height and assessed body weight perception using a single questionnaire item. We analyzed these data using SPSS version 20.0. Results Approximately 19.8% of these youth perceived themselves as underweight, 57.8% as normal weight, and 22.4% as overweight. In reality, 4.9% were underweight, 64.3% were normal weight, and 30.8% were overweight. Furthermore, approximately 66.4% of these Chinese youth correctly perceived their body image, 28.2% underestimated their true body image, and 5.4% overestimated their weight status. Girls were more likely than boys to overestimate their weight (chi(2) = 135.4, p < 0.05). Adolescents 13-18 years old were more likely than children 7-12 years old to overestimate their weight (chi(2) = 248.4, p < 0.05). Senior high school students were the most likely to overestimate their weight (chi(2) = 297.6, p < 0.05). Kappa tests revealed significant differences in consistency analysis of BMI and body weight perception (Kappa = 0.352, p < 0.05). Kappa < 0.4, the consistency of BMI and body weight perception was poor. Conclusions A mismatch existed between BMI and body weight perception among these children and adolescents. Thus, schools and parents should take steps to help them improve weight management and overall health awareness.	[Wang, Yun; Liu, Hongjian; Yang, Xiaodi; Yue, Mengjia; Pang, Yingxin; Zhou, Ge; Gong, Ping; Liu, Meitian] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China; [Wu, Fangyuan; Lie, Xuanxuan; Ma, Juan; Zhang, Xiumin] Jilin Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Zhang, XM (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changchun, Jilin, Peoples R China.	xiu_min@jlu.edu.cn	Zhang, Xiumin/J-8135-2018; Gong, Ping/J-8072-2018	Zhang, Xiumin/0000-0003-3286-8667; Gong, Ping/0000-0002-3783-2957	Health and Family Planning Commission of Jilin Province, China [2015R022]	Health and Family Planning Commission of Jilin Province, China	This study was supported by grant from the Health and Family Planning Commission of Jilin Province, China (Grant Number: 2015R022, http://wsjsw.jl.gov.cn/) to Xiumin Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2006, INT J PEDIATR OBES, V1, P239, DOI 10.1080/17477160600913552; Brener ND, 2004, OBES RES, V12, P1866, DOI 10.1038/oby.2004.232; Cheung Patrick C. H., 2007, Hong Kong Medical Journal, V13, P16; Chung AE, 2013, ACAD PEDIATR, V13, P371, DOI 10.1016/j.acap.2013.04.011; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Derenne JL, 2006, ACAD PSYCHIATR, V30, P257, DOI 10.1176/appi.ap.30.3.257; Deschamps V, 2015, PEDIATR OBES, V10, P15, DOI 10.1111/j.2047-6310.2013.00211.x; Dietz WH, 1998, PEDIATRICS, V101, P518; Falkner NH, 2001, OBES RES, V9, P32, DOI 10.1038/oby.2001.5; Felts WM, 1996, J ADOLESCENT HEALTH, V18, P20, DOI 10.1016/1054-139X(95)00046-U; Gurnani M, 2015, PEDIATR CLIN N AM, V62, P821, DOI 10.1016/j.pcl.2015.04.001; Heshmat R, 2015, QUAL LIFE RES, V24, P263, DOI 10.1007/s11136-014-0757-x; Hussin DK, 2011, ALEX J MED, V47, P365, DOI 10.1016/j.ajme.2011.07.013; Jansen W, 2008, J ADOLESCENT HEALTH, V42, P128, DOI 10.1016/j.jadohealth.2007.07.015; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; JI CY, 2006, WORLD J PEDIATR, V1, P29; Lee S, 2000, INT J EAT DISORDER, V27, P317, DOI 10.1002/(SICI)1098-108X(200004)27:3&lt;317::AID-EAT9&gt;3.0.CO;2-2; Monro F, 2005, INT J EAT DISORDER, V38, P85, DOI 10.1002/eat.20153; Neumark-Sztainer D, 2006, J ADOLESCENT HEALTH, V39, P244, DOI 10.1016/j.jadohealth.2005.12.001; Niu JJ, 2014, INT J BEHAV MED, V21, P691, DOI 10.1007/s12529-013-9332-z; Nye S., 2008, EAT DISORD, V17, P95, DOI [10.1080/10640260802570155, DOI 10.1080/10640260802570155]; O'Haver Judith, 2009, J Pediatr Nurs, V24, P474, DOI 10.1016/j.pedn.2008.06.011; Paeratakul S, 1998, INT J OBESITY, V22, P424, DOI 10.1038/sj.ijo.0800603; Pesa JA, 2000, J ADOLESCENT HEALTH, V26, P330, DOI 10.1016/S1054-139X(99)00118-4; Pritchard ME, 1997, ADOLESCENCE, V32, P863; Rierdan J, 1997, ADOLESCENCE, V32, P615; Shi ZM, 2007, PUBLIC HEALTH NUTR, V10, P298, DOI 10.1017/S1368980007352488; Standley R, 2009, BODY IMAGE, V6, P56, DOI 10.1016/j.bodyim.2008.08.004; Tatangelo GL, 2015, J HLTH PSYCHOL, DOI 10.1177/1359105315615409.; ter Bogt TFM, 2006, J ADOLESCENT HEALTH, V39, P27, DOI 10.1016/j.jadohealth.2005.09.007; Viner RM, 2006, INT J OBESITY, V30, P1514, DOI 10.1038/sj.ijo.0803352; Wang YF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-183; World Health Organization S-S, 2007, CHILD GROWTH STAND M; Xie B, 2006, PREV MED, V42, P229, DOI 10.1016/j.ypmed.2005.12.013; Xie B, 2006, AM J HEALTH BEHAV, V30, P115, DOI 10.5993/AJHB.30.2.1; Xie B, 2003, J ADOLESCENT HEALTH, V33, P202, DOI 10.1016/S1054-139X(03)00099-5; Yan AF, 2009, SOUTH MED J, V102, P354, DOI 10.1097/SMJ.0b013e318198720b	37	14	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194237	10.1371/journal.pone.0194237	http://dx.doi.org/10.1371/journal.pone.0194237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579108	gold, Green Published, Green Submitted			2022-12-27	WOS:000428351800023
J	Bai, G; Raat, H; Jaddoe, VWV; Mautner, E; Korfage, IJ				Bai, Guannan; Raat, Hein; Jaddoe, Vincent W. V.; Mautner, Eva; Korfage, Ida J.			Trajectories and predictors of women's health-related quality of life during pregnancy: A large longitudinal cohort study	PLOS ONE			English	Article							GENERATION-R; GROWTH; DELIVERY; CHILDREN; SMOKING; IMPACT; NAUSEA; SLEEP	The objective of this study was to identify distinct trajectories and their predictors of health related quality of life (HRQOL) of women during pregnancy in a prospective mother and child cohort. Analyses were based on 3936 Dutch pregnant women in Rotterdam area, the Netherlands. Information on potential predictors was collected in early pregnancy by questionnaire. Latent Class Mixture Modelling and Multinomial Logistic Regression were applied to assess the trajectory and predictors of HRQOL during pregnancy. HRQOL was measured by SF-12 in early, mid- and late pregnancy; physical and mental component summary (PCS-12/MCS-12) scores were calculated. Four physical HRQOL trajectories were identified: a healthy trajectory ('healthy) in 63.3%, consistently low (Vulnerable') in 10.8%; a small increase ('recovering') in 12.8% and a large decrease Cat risk') in 13.1%. Three mental HRQOL trajectories were identified: a healthy trajectory ('healthy') in 86.1%; a large increase ('recovering') in 7.5%; and a large decrease Cat risk') in 6.4%. Compared with healthy trajectories, the likelihood of following the 'vulnerable' physical HRQOL trajectory rather than a healthy trajectory was increased by daily fatigue(OR: 4.82[2.76, 8.40]), pelvic pain (OR:4.76[2.91, 7.78]) and back pain (OR:5.29[3.21, 8.70]); pregnancy-specific anxiety increased the likelihood of following the 'at risk' mental HRQOL trajectory (OR:7.95[4.84, 13.05]). Healthy physical and mental HRQOL trajectories during pregnancy were most common. Predictors indicative of poor HRQOL trajectories included pregnancy-related symptoms and anxiety.	[Bai, Guannan; Raat, Hein; Korfage, Ida J.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, South Holland, Netherlands; [Bai, Guannan; Jaddoe, Vincent W. V.] Erasmus MC, Univ Med Ctr Rotterdam, Generat R Grp, Rotterdam, South Holland, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, South Holland, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Paediat, Rotterdam, South Holland, Netherlands; [Mautner, Eva] Med Univ Graz, Dept Obstet & Gynaecol, Auenbruggerpl 14, Graz, Austria	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Medical University of Graz	Raat, H (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, South Holland, Netherlands.	h.raat@erasmusmc.nl			China Scholarship Council (CSC) [201406010271]	China Scholarship Council (CSC)(China Scholarship Council)	GB is supported by a China Scholarship Council (CSC) PhD Fellowship for her PhD study in Erasmus MC, Rotterdam, the Netherlands. The scholarship file number is 201406010271, CSC URL: [http://www.csc.edu.cn/]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2016, JCPSP-J COLL PHYSICI, V26, P507, DOI 2352; [Anonymous], 2008, DUTCH STAND CLASS ED; [Anonymous], 2016, MAT HLTH; Bai GN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166133; Calou C., 2014, HEALTH-LONDON, V6, P2375, DOI [10.4236/health.2014.618273, DOI 10.4236/HEALTH.2014.618273]; Chang SR, 2014, J ADV NURS, V70, P2245, DOI 10.1111/jan.12374; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Coban A, 2011, J PAK MED ASSOC, V61, P1122; Da Costa D, 2010, ARCH WOMEN MENT HLTH, V13, P249, DOI 10.1007/s00737-009-0104-3; Dalfra MG, 2012, QUAL LIFE RES, V21, P291, DOI 10.1007/s11136-011-9940-5; Effati-Daryani F, 2017, INT J NURS PRACT, V23, DOI 10.1111/ijn.12518; Emmanuel EN, 2014, J CLIN NURS, V23, P1611, DOI 10.1111/jocn.12265; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Guardino CM., 2014, ZERO 3, V34, P12; Haas JS, 2005, J GEN INTERN MED, V20, P45, DOI 10.1111/j.1525-1497.2004.40097.x; Henrichs J, 2009, INFANT CHILD DEV, V18, P556, DOI 10.1002/Icd.639; Hofman A, 2004, PAEDIATR PERINAT EP, V18, P61, DOI 10.1111/j.1365-3016.2003.00521.x; Holtrop JS, 2010, MATERN CHILD HLTH J, V14, P971, DOI 10.1007/s10995-009-0530-x; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Jomeen Julie, 2012, Pract Midwife, V15, P30; Kolu P, 2014, MATERN CHILD HLTH J, V18, P2098, DOI 10.1007/s10995-014-1457-4; Lacasse A, 2008, BJOG-INT J OBSTET GY, V115, P1484, DOI 10.1111/j.1471-0528.2008.01891.x; Lau Y, 2011, MIDWIFERY, V27, P668, DOI 10.1016/j.midw.2010.02.008; Magidson J, 2004, HDB QUANTITATIVE MET, P175, DOI DOI 10.4135/9781412986311.N19; Marchetti D, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/7058082; Munch S, 2011, J PERINATOL, V31, P10, DOI 10.1038/jp.2010.54; Nilsson C, 2012, WOMEN BIRTH, V25, P114, DOI 10.1016/j.wombi.2011.06.001; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Oskarsdottir GN, 2017, SCAND J PUBLIC HEALT, V45, P10, DOI 10.1177/1403494816676034; Ram N, 2009, INT J BEHAV DEV, V33, P565, DOI 10.1177/0165025409343765; Sahrakorpi N, 2016, ACTA OBSTET GYNECOLO; Schipper H., 1996, QUALITY LIFE PHARMAC, V2, P11; Setse R, 2009, MATERN CHILD HLTH J, V13, P577, DOI 10.1007/s10995-008-0392-7; Singh S, 2015, RELATIONSHIP PARITY; Tavoli Z, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0810-6; TRAUTMAN PD, 1995, PSYCHONEUROENDOCRINO, V20, P439, DOI 10.1016/0306-4530(94)00070-0; Tsai SY, 2016, INT J NURS STUD, V56, P45, DOI 10.1016/j.ijnurstu.2016.01.001; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE., 2002, SF 12 SCORE SF 12 PH, V4	41	25	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194999	10.1371/journal.pone.0194999	http://dx.doi.org/10.1371/journal.pone.0194999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614087	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600022
J	Kalokhe, AS; Iyer, SR; Kolhe, AR; Dhayarkar, S; Paranjape, A; del Rio, C; Stephenson, R; Sahay, S				Kalokhe, Ameeta S.; Iyer, Sandhya R.; Kolhe, Ambika R.; Dhayarkar, Sampada; Paranjape, Anuradha; del Rio, Carlos; Stephenson, Rob; Sahay, Seema			Correlates of domestic violence experience among recently-married women residing in slums in Pune, India	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; MENTAL-HEALTH; RISK-FACTORS; SOUTH-INDIA; PREVALENCE; PREVENTION; MORBIDITY; SYMPTOMS; MUMBAI	The high risk of experiencing domestic violence (DV) among married women in India who reside in slum communities underscores the need for effective, evidence-based, and culturally -tailored primary prevention. To inform such DV primary prevention strategies for this population, we herein aimed to identify correlates of DV experience in early marriage. Utilizing a cross-sectional design, potential correlates of DV experience were explored among a geographically-clustered random sample of 100 recently-married women residing in slums in Pune, India. In multivariable regression, DV experience was associated with less educational attainment by the participant's spouse (standardized beta=-0.281, p=0.004), less satisfaction of the spouse's family with the maanpaan (wedding-related gifts provided by the bride's family) they received at the time of marriage (standardized beta=-0.298, p<0.001), poorer conflict negotiation skills (standardized beta=-0.308, p<0.001), and greater acknowledgement of DV occurrence in family and friends (standardized beta=0.436, p<0.001). These correlates suggest strategies that could be incorporated into future DV primary prevention interventions for this vulnerable population (i.e. promoting completion of formal education of boys alongside girls, mitigating causes of familial dowry harassment, improving conflict negotiation skills, and challenging norms surrounding DV).	[Kalokhe, Ameeta S.; del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Kalokhe, Ameeta S.; del Rio, Carlos; Stephenson, Rob] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Iyer, Sandhya R.; Kolhe, Ambika R.; Sahay, Seema] Natl AIDS Res Inst, Dept Social & Behav Res, Pune, Maharashtra, India; [Dhayarkar, Sampada] Natl AIDS Res Inst, Dept Epidemiol & Biostat, Pune, Maharashtra, India; [Paranjape, Anuradha] Temple Univ, Lewis Katz Sch Med, Dept Med, Gen Internal Med, Philadelphia, PA 19122 USA; [Stephenson, Rob] Univ Michigan, Sch Nursing, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA	Emory University; Emory University; Rollins School Public Health; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Michigan System; University of Michigan	Kalokhe, AS (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.; Kalokhe, AS (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA.; Sahay, S (corresponding author), Natl AIDS Res Inst, Dept Social & Behav Res, Pune, Maharashtra, India.	akalokh@emory.edu; ssahay@nariindia.org	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517; Kalokhe, Ameeta/0000-0002-3556-1786	Indian Council of Medical Research; Fogarty International Center of the National Institutes of Health [K01TW009664]; FOGARTY INTERNATIONAL CENTER [K01TW009664] Funding Source: NIH RePORTER	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We express our most sincere gratitude to the participants for sharing their personal experiences with us. We greatly appreciate Suhas Shewale for her help conducting interviews and Nayana Yenbhar for her meticulous entry and management of the data. Additionally, we thank the staff of the many anganwadis, mitra mandals, and Teach for India for their assistance with recruitment. Lastly, we acknowledge the continued support of this work by NARI Director In-charge, Dr. Raman Gangakhedkar, and the Indian Council of Medical Research.; Research reported in this publication was funded by the Fogarty International Center of the National Institutes of Health under Award Number K01TW009664. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2011, PUNE CITY CENSUS 201; Begum S, 2015, INDIAN J MED RES, V141, P783, DOI 10.4103/0971-5916.160701; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Char A, 2010, REPROD HEALTH MATTER, V18, P154, DOI 10.1016/S0968-8080(10)35497-8; Fernandez M, 1997, J INTERPERS VIOLENCE, V12, P433, DOI 10.1177/088626097012003008; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Heise L., 2002, WORLD REPORT VIOLENC, V1, P87, DOI DOI 10.1503/CMAJ.1150071; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jejeebhoy SJ, 2013, GLOB PUBLIC HEALTH, V8, P1151, DOI 10.1080/17441692.2013.860466; Jejeebhoy SJ, 2013, ASIAN POPUL STUD, V9, P28, DOI 10.1080/17441730.2012.736699; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jeyaseelan V, 2015, J BIOSOC SCI, V47, P727, DOI 10.1017/S0021932014000571; Kalokhe AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148120; Kalokhe AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120909; Kamimura A, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-127; Krishnan S, 2010, SOC SCI MED, V70, P136, DOI 10.1016/j.socscimed.2009.09.026; Ministry of Human Resource Development Department of School Educaiton & Literacy, SEC ED NAT SCHEM INC; Orava TA, 1996, J FAM VIOLENCE, V11, P167, DOI 10.1007/BF02336668; Panchanadeswaran S, 2005, VIOLENCE AGAINST WOM, V11, P736, DOI 10.1177/1077801205276088; Pandey GK, 2009, J INTERPERS VIOLENCE, V24, P1175, DOI 10.1177/0886260508322186; Pandey S, 2013, MATERN CHILD HLTH J, V17, P1499, DOI 10.1007/s10995-012-1163-z; Patel V, 2005, BRIT MED J, V330, P1190, DOI 10.1136/bmj.38442.636181.E0; Pewa Preksha, 2015, J Contemp Dent Pract, V16, P227; Rocca CH, 2009, INT J EPIDEMIOL, V38, P577, DOI 10.1093/ije/dyn226; Ruikar Manisha M, 2008, Indian J Public Health, V52, P215; Shrivastava PS, 2013, INT J PREVENTIVE MED, V4, P27; Silverman JG, 2008, JAMA-J AM MED ASSOC, V300, P703, DOI 10.1001/jama.300.6.703; Silverman JG, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0223-z; Silverman JG, 2016, MATERN CHILD HLTH J, V20, P149, DOI 10.1007/s10995-015-1814-y; Solomon S, 2009, VIOLENCE AGAINST WOM, V15, P753, DOI 10.1177/1077801209334602; Sonpar S, 2005, CONTEMP FAM THER, V27, P301, DOI 10.1007/s10591-005-6211-z; Stephenson R, 2013, VIOLENCE AGAINST WOM, V19, P1133, DOI 10.1177/1077801213501898; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P569, DOI 10.1093/ije/dym007; Van Rompay KKA, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-6; Winter A, 2013, INT J GYNECOL OBSTET, V121, P218, DOI 10.1016/j.ijgo.2012.12.018; World Health Organization, 2001, WHOFCHGWH011; World Health Organization, 2021, GLOB REG EST VIOL WO	40	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195152	10.1371/journal.pone.0195152	http://dx.doi.org/10.1371/journal.pone.0195152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608581	Green Submitted, Green Published, gold			2022-12-27	WOS:000428988800028
J	Liu, TY; Yeh, SL; Hsiao, JH				Liu, Tianyin; Yeh, Su-Ling; Hsiao, Janet H.			Transfer of the left-side bias effect in perceptual expertise: The case of simplified and traditional Chinese character recognition	PLOS ONE			English	Article							VISUAL EXPERTISE; FACES; EXPERIENCE; ASYMMETRIES; BRAIN	The left-side bias (LSB) effect observed in face and expert Chinese character perception is suggested to be an expertise marker for visual object recognition. However, in character perception this effect is limited to characters printed in a familiar font (font-sensitive LSB effect). Here we investigated whether the LSB and font-sensitive LSB effects depend on participants' familiarity with global structure or local component information of the stimuli through examining their transfer effects across simplified and traditional Chinese scripts: the two Chinese scripts share similar overall structures but differ in the visual complexity of local components in general. We found that LSB in expert Chinese character processing could be transferred to the Chinese script that the readers are unfamiliar with. In contrast, the font sensitive LSB effect did not transfer, and was limited to characters with the visual complexity the readers were most familiar with. These effects suggest that the LSB effect may be generalized to another visual category with similar overall structures; in contrast, effects of within-category variations such as fonts may depend on familiarity with local component information of the stimuli, and thus may be limited to the exemplars of the category that experts are typically exposed to.	[Liu, Tianyin; Hsiao, Janet H.] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Yeh, Su-Ling] Natl Taiwan Univ, Dept Psychol, Taipei, Taiwan; [Liu, Tianyin] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; National Taiwan University; University of Hong Kong	Hsiao, JH (corresponding author), Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	jhsiao@hku.hk	; Hsiao, Janet Hui Wen/D-4916-2009	Liu, Tianyin/0000-0002-8194-5342; Hsiao, Janet Hui Wen/0000-0003-2271-8710	Research Grant Council of Hong Kong [HKU 758412H, 745210H, 758412H]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	We are grateful to the Research Grant Council of Hong Kong (project code HKU 758412H and 745210H to J.H. Hsiao).; This study is funded by the Research Grant Council of Hong Kong (http://www.ugc.edu.hk), project codes HKU 758412H and 745210H to J.H. Hsiao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady N, 2004, NEUROPSYCHOLOGIA, V42, P1156, DOI 10.1016/j.neuropsychologia.2004.02.007; Brady N., 2011, SPATIAL DIMENSION SO; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Chen K. M., 1999, CHINESE J PSYCHOL, V41, P65; Chen YP, 1996, Q J EXP PSYCHOL-A, V49, P1024, DOI 10.1080/713755668; CHRISTMAN SD, 1993, NEUROPSYCHOLOGIA, V31, P621, DOI 10.1016/0028-3932(93)90056-6; Galmar B, P 35 COGSCI 2013 BER; Gao DG, 2002, COGNITIVE NEUROSCIENCE STUDIES OF THE CHINESE LANGUAGE, P195; Gauthier I, 2006, PERCEPTION, V35, P541, DOI 10.1068/p5313; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Ho H, 1999, HONG KONG MAINLAND C; Hsiao JH, 2013, J COGNITIVE NEUROSCI, V25, P998, DOI 10.1162/jocn_a_00377; Hsiao JH, 2009, PSYCHOL SCI, V20, P455, DOI 10.1111/j.1467-9280.2009.02315.x; Huang S., 1996, FREQUENCY STROKE COU; Liu T, 2016, COGNITIVE SCI; McBride-Chang Catherine., 2005, READ WRIT, V18, P99, DOI [10.1007/s11145-004-7343-5, DOI 10.1007/S11145-004-7343-5]; McCleery JP, 2008, VISION RES, V48, P703, DOI 10.1016/j.visres.2007.11.025; McManus Ian Christopher., 2004, RIGHT HAND LEFT HAND; Megreya AM, 2011, LATERALITY, V16, P75, DOI 10.1080/13576500903213755; Meissner C. A., 2001, 30 YEARS INVESTIGATI; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Proietti V, 2015, LATERALITY, V20, P1, DOI 10.1080/1357650X.2014.912220; RHODES G, 1985, BRAIN COGNITION, V4, P197, DOI 10.1016/0278-2626(85)90070-3; SANOCKI T, 1987, J EXP PSYCHOL HUMAN, V13, P267, DOI 10.1037/0096-1523.13.2.267; SANOCKI T, 1988, J EXP PSYCHOL HUMAN, V14, P472; Taiwan Ministry of Education, 1997, INV REP COMM US WORD; Tan L. H., 1998, COGNITIVE PROCESSING, P11, DOI DOI 10.1007/978-94-015-9161-4_2; Tan LH, 2000, HUM BRAIN MAPP, V10, P16; Tso RVY, 2014, PSYCHOL SCI, V25, P1757, DOI 10.1177/0956797614541284; Wu CY, 2012, NEUROIMAGE, V63, P381, DOI 10.1016/j.neuroimage.2012.06.047; Yang M J, 1999, Laterality, V4, P149, DOI 10.1080/713754332; Yeh SL, 2003, VIS COGN, V10, P729, DOI 10.1080/13506280344000077; Zhou GM, 2012, PSYCHON B REV, V19, P157, DOI 10.3758/s13423-011-0174-x	35	6	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194405	10.1371/journal.pone.0194405	http://dx.doi.org/10.1371/journal.pone.0194405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608570	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800011
J	Makkar, P; Kang, HJ; Padalhin, AR; Park, I; Moon, BG; Lee, BT				Makkar, Preeti; Kang, Hoe Jin; Padalhin, Andrew R.; Park, Ihho; Moon, Byoung-Gi; Lee, Byong Taek			Development and properties of duplex MgF2/PCL coatings on biodegradable magnesium alloy for biomedical applications	PLOS ONE			English	Article							IN-VITRO DEGRADATION; POLYMER-COATED MAGNESIUM; CORROSION-RESISTANCE; CELL ATTACHMENT; MG; COMPOSITE; IMPLANTS; FILM; CYTOCOMPATIBILITY; PERFORMANCE	The present work addresses the performance of polycaprolactone (PCL) coating on fluoride treated (MgF2) biodegradable ZK60 magnesium alloy (Mg) for biomedical application. MgF2 conversion layer was first produced by immersing Mg alloy substrate in hydrofluoric acid solution. The outer PCL coating was then prepared using dip coating technique. Morphology, elements profile, phase structure, roughness, mechanical properties, invitro corrosion, and biocompatibility of duplex MgF2/PCL coating were then characterized and compared to those of fluoride coated and uncoated Mg samples. The invivo degradation behavior and biocompatibility of duplex MgF2/PCL coating with respect to ZK60 Mg alloy were also studied using rabbit model for 2 weeks. SEM and TEM analysis showed that the duplex coating was uniform and comprised of porous PCL film (similar to 3.3 mu m) as upper layer with compact MgF2 (similar to 2.2 mu m) as inner layer. No significant change in microhardness was found on duplex coating compared with uncoated ZK60 Mg alloy. The duplex coating showed improved invitro corrosion resistance than single layered MgF2 or uncoated alloy samples. The duplex coating also resulted in better cell viability, cell adhesion, and cell proliferation compared to fluoride coated or uncoated alloy. Preliminary invivo studies indicated that duplex MgF2/PCL coating reduced the degradation rate of ZK60 Mg alloy and exhibited good biocompatibility. These results suggested that duplex MgF2/PCL coating on magnesium alloy might have great potential for orthopedic applications.	[Makkar, Preeti; Padalhin, Andrew R.; Lee, Byong Taek] Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, Cheonan, South Korea; [Kang, Hoe Jin; Lee, Byong Taek] Soonchunhyang Univ, Coll Med, Dept Regenerat Med, Cheonan, South Korea; [Park, Ihho] Sk Innovat Global Technol, Daejeon, South Korea; [Moon, Byoung-Gi] Korea Inst Mat Sci, Adv Met Div, Chang Won, Gyeongnam, South Korea	Soonchunhyang University; Soonchunhyang University; SK Group; SK Innovation; Korea Institute of Materials Science (KIMS)	Lee, BT (corresponding author), Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, Cheonan, South Korea.; Lee, BT (corresponding author), Soonchunhyang Univ, Coll Med, Dept Regenerat Med, Cheonan, South Korea.	lbt@sch.ac.kr	Padalhin, Andrew/ABF-4523-2021	Padalhin, Andrew/0000-0002-3869-5720; Lee, Byong-Taek/0000-0001-9072-0033	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1A6A1A03032522]; Soonchunhyang University, South Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Soonchunhyang University, South Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2015R1A6A1A03032522) to Byong Taek Lee and partially supported by Soonchunhyang University, South Korea.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2015R1A6A1A03032522) and partially supported by Soonchunhyang University, South Korea. The authors extend their special thanks to Dr. Jhaleh Amirian for their support in conducting experiments.	Abdal-hay A, 2013, SOLID STATE SCI, V18, P131, DOI 10.1016/j.solidstatesciences.2012.11.017; Abdal-hay A, 2013, CERAM INT, V39, P183, DOI 10.1016/j.ceramint.2012.06.008; Abdal-Hay A, 2012, APPL SURF SCI, V261, P536, DOI 10.1016/j.apsusc.2012.08.051; Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790; [Anonymous], 2009, PREPARATION VITRO EV; Arafat MT, 2011, SOFT MATTER, V7, P8013, DOI 10.1039/c1sm05793f; Bakhsheshi-Rad HR, 2016, J MATER ENG PERFORM, V25, P3948, DOI 10.1007/s11665-016-2247-5; Bakhsheshi-Rad HR, 2014, VACUUM, V110, P127, DOI 10.1016/j.vacuum.2014.08.013; Bakhsheshi-Rad HR, 2013, SURF COAT TECH, V222, P79, DOI 10.1016/j.surfcoat.2013.02.007; Bakhsheshi-Rad HR, 2013, T NONFERR METAL SOC, V23, P699, DOI 10.1016/S1003-6326(13)62519-4; Budke E, 1999, SURF COAT TECH, V112, P108, DOI 10.1016/S0257-8972(98)00791-9; Carboneras M, 2010, J ALLOY COMPD, V496, P442, DOI 10.1016/j.jallcom.2010.02.043; Catauro M, 2014, MAT SCI ENG C-MATER, V39, P344, DOI 10.1016/j.msec.2014.03.025; Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035; Diba M, 2012, COMPOS SCI TECHNOL, V72, P716, DOI 10.1016/j.compscitech.2012.01.023; Gao JH, 2011, APPL SURF SCI, V257, P2231, DOI 10.1016/j.apsusc.2010.09.080; Herrasti P, 2011, ELECTROCHIM ACTA, V56, P1323, DOI 10.1016/j.electacta.2010.09.094; Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012; Huang LL, 2014, SURF COAT TECH, V258, P664, DOI 10.1016/j.surfcoat.2014.08.020; Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007; Kim BR, 2014, TISSUE ENG PT A, V20, P3279, DOI [10.1089/ten.TEA.2014.0081, 10.1089/ten.tea.2014.0081]; Li JN, 2010, J MATER SCI, V45, P6038, DOI 10.1007/s10853-010-4688-9; Li X, 2016, ACTA BIOMATER, V45, P2, DOI 10.1016/j.actbio.2016.09.005; Liu J, 2015, J MATER CHEM B, V3, P878, DOI 10.1039/c4tb01527d; Manivasagam Geetha, 2010, RECENT PATENTS CORRO; Meng EC, 2011, APPL SURF SCI, V257, P4811, DOI 10.1016/j.apsusc.2010.12.073; Neacsu P, 2017, MATERIALS, V10, DOI 10.3390/ma10070686; Ono S, 2001, MATER TRANS, V42, P1225, DOI 10.2320/matertrans.42.1225; Orchard A, 1977, HDB XRAY ULTRAVIOLET, P48; Ostrowski N, 2013, ACTA BIOMATER, V9, P8704, DOI 10.1016/j.actbio.2013.05.010; Pereda MD, 2010, ACTA BIOMATER, V6, P1772, DOI 10.1016/j.actbio.2009.11.004; Poinern G. Eddy Jai, 2013, AM J BIOMED ENG, V2, P218, DOI [10.5923/j.ajbe.20120206.02, DOI 10.5923/J.AJBE.20120206.02]; Seal C., 2009, IOP C SERIES MAT SCI; Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016; Supplit R, 2007, CORROS SCI, V49, P3015, DOI 10.1016/j.corsci.2007.02.006; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; Wang SR, 2010, T NONFERR METAL SOC, V20, P763, DOI [10.1016/S1003-6326(09)60211-9, 10.1016/S1003-6326(09)60211]; Wang YQ, 2005, MATER LETT, V59, P1727, DOI 10.1016/j.matlet.2005.01.050; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111; Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004; Xu LP, 2012, APPL SURF SCI, V258, P6353, DOI 10.1016/j.apsusc.2012.03.036; Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009	43	17	17	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193927	10.1371/journal.pone.0193927	http://dx.doi.org/10.1371/journal.pone.0193927			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608572	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800006
J	Wharton, TH; Nomie, KJ; Wharton, RP				Wharton, Tammy H.; Nomie, Krystle J.; Wharton, Robin P.			No significant regulation of bicoid mRNA by Pumilio or Nanos in the early Drosophila embryo	PLOS ONE			English	Article							GERMLINE STEM-CELLS; POSTERIOR DETERMINANT; BRAIN-TUMOR; TRANSLATIONAL REGULATOR; BINDING PROTEIN; BODY PATTERN; CYCLIN-B; GENE; DOMAIN; LOCALIZATION	Drosophila Pumilio (Pum) is a founding member of the conserved Puf domain class of RNA-binding translational regulators. Pum binds with high specificity, contacting eight nucleotides, one with each of the repeats in its RNA-binding domain. In general, Pum is thought to block translation in collaboration with Nanos (Nos), which exhibits no binding specificity in isolation but is recruited jointly to regulatory sequences containing a Pum binding site in the 3'-UTRs of target mRNAs. Unlike Pum, which is ubiquitous in the early embryo, Nos is tightly restricted to the posterior, ensuring that repression of its best-characterized target, maternal hunchback (hb) mRNA, takes place exclusively in the posterior. An exceptional case of Nos-independent regulation by Pum has been described-repression of maternal bicoid (bcd) mRNA at the anterior pole of the early embryo, dependent on both Pum and conserved Pum binding sites in the 3'-UTR of the mRNA. We have re-investigated regulation of bcd in the early embryo; our experiments reveal no evidence of a role for Pum or its conserved binding sites in regulation of the perdurance of bcd mRNA or protein. Instead, we find that Pum and Nos control the accumulation of bcd mRNA in testes.	[Wharton, Tammy H.; Wharton, Robin P.] Ohio State Univ, Dept Mol Genet, Ctr RNA Biol, Columbus, OH 43210 USA; [Wharton, Tammy H.; Wharton, Robin P.] Ohio State Univ, Dept Canc Biol & Genet, Ctr RNA Biol, Columbus, OH 43210 USA; [Nomie, Krystle J.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Holcombe Blvd, Houston, TX 77030 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Wharton, RP (corresponding author), Ohio State Univ, Dept Mol Genet, Ctr RNA Biol, Columbus, OH 43210 USA.; Wharton, RP (corresponding author), Ohio State Univ, Dept Canc Biol & Genet, Ctr RNA Biol, Columbus, OH 43210 USA.	wharton.88@osu.edu			NIGMS [GM084376]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIGMS grant GM084376 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT MK, 1991, GENETICS, V129, P783; Arrizabalaga G, 1999, GENETICS, V153, P1825; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bergsten SE, 1999, DEVELOPMENT, V126, P659; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bhogal B, 2016, DEVELOPMENT, V143, P2147, DOI 10.1242/dev.132415; Blewett NH, 2012, MOL CELL BIOL, V32, P4181, DOI 10.1128/MCB.00483-12; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Curtis D, 1997, EMBO J, V16, P834, DOI 10.1093/emboj/16.4.834; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Drocco JA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055004; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; Foe Victoria E., 1993, P149; Forbes A, 1998, DEVELOPMENT, V125, P679; Gamberi C, 2002, DEVELOPMENT, V129, P2699; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HULSKAMP M, 1989, NATURE, V338, P629, DOI 10.1038/338629a0; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kronja I, 2014, CELL REP, V7, P1495, DOI 10.1016/j.celrep.2014.05.002; Laver JD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0659-4; Lin HF, 1997, DEVELOPMENT, V124, P2463; Little SC, 2015, NAT CELL BIOL, V17, P558, DOI 10.1038/ncb3143; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Loedige I, 2015, CELL REP, V13, P1206, DOI 10.1016/j.celrep.2015.09.068; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Menon KP, 2009, J NEUROSCI, V29, P5558, DOI 10.1523/JNEUROSCI.0520-09.2009; Miles WO, 2014, EMBO J, V33, P2201, DOI 10.15252/embj.201488057; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Olesnicky EC, 2012, DEV BIOL, V365, P208, DOI 10.1016/j.ydbio.2012.02.028; Raisch T, 2016, EMBO J, V35, P974, DOI 10.15252/embj.201593634; Reveal B, 2011, RNA BIOL, V8, P1047, DOI 10.4161/rna.8.6.17542; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sato K, 2007, P NATL ACAD SCI USA, V104, P7455, DOI 10.1073/pnas.0610052104; Schroeder MD, 2011, DEVELOPMENT, V138, P3067, DOI 10.1242/dev.062141; Slaidina M, 2014, J CELL BIOL, V207, P13, DOI 10.1083/jcb.201407102; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; STRUHL G, 1989, NATURE, V338, P741, DOI 10.1038/338741a0; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Thomsen S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r93; Vardy L, 2007, DEV CELL, V12, P157, DOI 10.1016/j.devcel.2006.10.017; Vardy L, 2009, P NATL ACAD SCI USA, V106, P1838, DOI 10.1073/pnas.0813237106; Verrotti AC, 2000, DEVELOPMENT, V127, P5225; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Weidmann CA, 2016, ELIFE, V5, DOI 10.7554/eLife.17096; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Zamore PD, 1997, RNA, V3, P1421	63	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194865	10.1371/journal.pone.0194865	http://dx.doi.org/10.1371/journal.pone.0194865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601592	Green Published, Green Submitted, gold			2022-12-27	WOS:000428845900011
J	Cheong, SK; Strazzeri, JM; Williams, DR; Merigan, WH				Cheong, Soon Keen; Strazzeri, Jennifer M.; Williams, David R.; Merigan, William H.			All-optical recording and stimulation of retinal neurons in vivo in retinal degeneration mice	PLOS ONE			English	Article							IMAGING LIGHT RESPONSES; LIVING MOUSE EYE; GANGLION-CELLS; ADAPTIVE OPTICS; RETINITIS-PIGMENTOSA; VISUAL RESPONSES; NEURAL ACTIVITY; BIPOLAR CELLS; GENE-THERAPY; RD10 MICE	Here we demonstrate the application of a method that could accelerate the development of novel therapies by allowing direct and repeatable visualization of cellular function in the living eye, to study loss of vision in animal models of retinal disease, as well as evaluate the time course of retinal function following therapeutic intervention. We use high-resolution adaptive optics scanning light ophthalmoscopy to image fluorescence from the calcium sensor GCaMP6s. In mice with photoreceptor degeneration (rd10), we measured restored visual responses in ganglion cell layer neurons expressing the red-shifted channelrhodopsin ChrimsonR over a six-week period following significant loss of visual responses. Combining a fluorescent calcium sensor, a channelrhodopsin, and adaptive optics enables all-optical stimulation and recording of retinal neurons in the living eye. Because the retina is an accessible portal to the central nervous system, our method also provides a novel non-invasive method of dissecting neuronal processing in the brain.	[Cheong, Soon Keen; Strazzeri, Jennifer M.; Williams, David R.; Merigan, William H.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Strazzeri, Jennifer M.; Merigan, William H.] Univ Rochester, Flaum Eye Inst, Rochester, NY USA; [Williams, David R.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Cheong, Soon Keen] Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA	University of Rochester; University of Rochester; University of Rochester; Stanford University	Cheong, SK (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.; Cheong, SK (corresponding author), Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA.	skcheong@stanford.edu		Williams, David R/0000-0003-3227-8333	NATIONAL EYE INSTITUTE [R01EY021166, P30EY001319] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY021166, EY021166, P30 EY001319] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Bar-Noam AS, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.7; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; Bourne RRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162229; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chiu K, 2003, GLAUCOMA BASIC CLIN; Chiu K, 2012, AGE, V34, P633, DOI 10.1007/s11357-011-9260-2; Criscuolo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00053; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Dubra A, 2010, LECT NOTES COMPUT SC, V6204, P60, DOI 10.1007/978-3-642-14366-3_6; Fine I, 2015, VISION RES, V111, P115, DOI 10.1016/j.visres.2015.04.012; Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6; Garg SJ, 2013, CURR OPIN OPHTHALMOL, V24, P407, DOI 10.1097/ICU.0b013e328363829b; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Geng Y, 2012, BIOMED OPT EXPRESS, V3, P715, DOI 10.1364/BOE.3.000715; Goo YS, 2011, KOREAN J PHYSIOL PHA, V15, P415, DOI 10.4196/kjpp.2011.15.6.415; HAM WT, 1976, NATURE, V260, P153, DOI 10.1038/260153a0; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Johnson TV, 2010, BRAIN RES BULL, V81, P349, DOI 10.1016/j.brainresbull.2009.04.004; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Krieger B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180091; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LI ZY, 1995, J NEUROSCI, V15, P5429; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Mace E, 2015, MOL THER, V23, P7, DOI 10.1038/mt.2014.154; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Morgan JIW, 2008, INVEST OPHTH VIS SCI, V49, P3715, DOI 10.1167/iovs.07-1430; O'Brien EE, 2012, CLIN EXP OPTOM, V95, P473, DOI 10.1111/j.1444-0938.2012.00783.x; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Rosch S, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/874751; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Scholl HPN, 2014, LANCET, V383, P1105, DOI 10.1016/S0140-6736(14)60033-7; Sengupta A, 2016, EMBO MOL MED; Sharma R, 2013, BIOMED OPT EXPRESS, V4, P1285, DOI 10.1364/BOE.4.001285; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Stasheff SF, 2011, J NEUROPHYSIOL, V105, P3002, DOI 10.1152/jn.00704.2010; Theogarajan L, 2012, NEUROSCI LETT, V519, P129, DOI 10.1016/j.neulet.2012.02.001; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; THYLEFORS B, 1994, B WORLD HEALTH ORGAN, V72, P323; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Tsien RY, 2009, COLD SPRING HARB PRO, V2009; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Wang YV, 2011, J NEUROSCI, V31, P7670, DOI 10.1523/JNEUROSCI.0629-11.2011; Yin L, 2014, J NEUROSCI, V34, P6596, DOI 10.1523/JNEUROSCI.4438-13.2014; Yin L, 2013, J NEUROPHYSIOL, V109, P2415, DOI 10.1152/jn.01043.2012	63	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194947	10.1371/journal.pone.0194947	http://dx.doi.org/10.1371/journal.pone.0194947			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596518	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000055
J	Govani, SM; Higgins, PDR; Rubenstein, JH; Stidham, RW; Waljee, AK				Govani, Shail M.; Higgins, Peter D. R.; Rubenstein, Joel H.; Stidham, Ryan W.; Waljee, Akbar K.			CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital	PLOS ONE			English	Article							RADIATION-DOSE AWARENESS; COMPUTED-TOMOGRAPHY; CROHNS-DISEASE; EMERGENCY-DEPARTMENT; IONIZING-RADIATION; ULCERATIVE-COLITIS; EXPOSURE; ENTEROGRAPHY; PREVALENCE; CANCER	Objectives Patients with inflammatory bowel disease(IBD) are frequently exposed to computed tomography (CT). Each CT exposes patients to radiation that cumulatively could increase the risk of malignancy, particularly in younger patients. We aim to study the effect of age on CT use in IBD patients seen in the Emergency Department (ED) or the hospital. Methods We conducted a retrospective cohort study of IBD patients identified in Truven Health Marketscan databases between 2009-2013. The main outcome was use of CT during an ED or inpatient visit. Effect of age on CT use was characterized using logistic regression accounting for important covariables. Results There were 66,731 patients with IBD with 144,147 ED or inpatient visits in this cohort with a diagnosis code of IBD. At first visit, 5.8% percent were below age 18. CT was utilized in 26.6% of visits. In multivariable analysis, adjusting for medications, recent surgery, and gender, patients 18-35 were more likely to undergo CT (OR 2.35, 95% CI: 2.20-2.52) compared to those <18. Examining patients only between 16 and 19, the odds of an 18 or 19-year-old undergoing CT is significantly higher than a 16 or 17-year-old (OR 1.96, 95% CI: 1.71-2.24). Conclusions Patients with IBD undergo CT more than a quarter of the time in the ED or inpatient setting. Pediatric providers limit radiation exposure among those <18 while adult providers are not as cautious with radiation exposure for the young adult population. Increased awareness of the risks of cumulative radiation exposure in the young adult population is needed.	[Govani, Shail M.; Higgins, Peter D. R.; Rubenstein, Joel H.; Stidham, Ryan W.; Waljee, Akbar K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Govani, Shail M.; Rubenstein, Joel H.] South Texas Vet Healthcare Syst, San Antonio, TX 78228 USA; [Govani, Shail M.] UT Hlth San Antonio, San Antonio, TX 78229 USA; [Waljee, Akbar K.] VA Ann Arbor Hlth Care Syst, VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Govani, SM (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Govani, SM (corresponding author), UT Hlth San Antonio, San Antonio, TX 78229 USA.	shailgovani@gmail.com	Waljee, Akbar K/G-2067-2010	Waljee, Akbar K/0000-0003-1964-8790; Govani, Shail/0000-0002-5360-8576	NIDDK NIH HHS [K23 DK101687] Funding Source: Medline; HSRD VA [IK2 HX000775] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HSRD VA		[Anonymous], 2014, IM GENTL DEV PED CT; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bruining DH, 2008, INFLAMM BOWEL DIS, V14, P1701, DOI 10.1002/ibd.20529; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatu S, 2012, ALIMENT PHARM THER, V35, P529, DOI 10.1111/j.1365-2036.2011.04975.x; Desmond AN, 2008, GUT, V57, P1524, DOI 10.1136/gut.2008.151415; Dillman JR, 2015, RADIOGRAPHICS, V35, P835, DOI 10.1148/rg.2015140002; Gandhi NS, 2016, RADIOLOGY, V280, P436, DOI 10.1148/radiol.2016151281; Gashin L, 2015, INFLAMM BOWEL DIS, V21, P793, DOI 10.1097/MIB.0000000000000321; Goske MJ, 2008, PEDIATR RADIOL, V38, P265, DOI 10.1007/s00247-007-0743-3; Govani SM, 2014, CLIN GASTROENTEROL H, V12, P1702, DOI 10.1016/j.cgh.2014.02.036; Griffey RT, 2014, ACAD EMERG MED, V21, P768, DOI 10.1111/acem.12410; Guentner AS, GASTROENTEROLOGY, V144, pS403; Higgins PDR, 2007, INFLAMM BOWEL DIS, V13, P262, DOI 10.1002/ibd.20013; Kerner C, 2012, CLIN GASTROENTEROL H, V10, P52, DOI 10.1016/j.cgh.2011.09.005; Kroeker K, 2009, GASTROENTEROLOGY, V136, pA99; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Nguyen GC, 2017, INFLAMM BOWEL DIS, V23, P858, DOI 10.1097/MIB.0000000000001152; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Peloquin JM, 2008, AM J GASTROENTEROL, V103, P2015, DOI 10.1111/j.1572-0241.2008.01920.x; Smith-Bindman R, 2015, RADIOLOGY, V277, P134, DOI 10.1148/radiol.2015142728; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Thomas KE, 2006, PEDIATR RADIOL, V36, P823, DOI 10.1007/s00247-006-0170-x; Waljee AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158017; Yarur AJ, 2014, J CROHNS COLITIS, V8, P504, DOI 10.1016/j.crohns.2013.11.003	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195022	10.1371/journal.pone.0195022	http://dx.doi.org/10.1371/journal.pone.0195022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596461	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000068
J	Kamm, F; Strauch, U; Degenhardt, F; Lopez, R; Kunst, C; Rogler, G; Franke, A; Klebl, F; Rieders, F				Kamm, Florian; Strauch, Ulrike; Degenhardt, Frauke; Lopez, Rocio; Kunst, Claudia; Rogler, Gerhard; Franke, Andre; Klebl, Frank; Rieders, Florian			Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE ANTIBODIES; CROHNS-DISEASE; MANNAN ANTIBODIES; INTESTINAL PERMEABILITY; FAMILIAL EXPRESSION; SEROLOGICAL MARKERS; IBD; ASSOCIATION; DIAGNOSIS; FLAGELLIN	Background Serum anti-glycan antibodies are a promising tool for differential diagnosis, disease stratification and prediction of Crohn's disease (CD). To investigate possible heritability of the markers we assessed the presence of serum anti-glycan antibodies in affected and unaffected relatives of patients with CD. Methods Serum samples of 169 IBD patients of the German inflammatory bowel disease (IBD) network (140 CD & 29 Ulcerative colitis (UC)), 349 relatives of CD patients, 63 relatives of UC patients and 46 healthy controls were tested for the presence of anti-glycan antibodies by ELISA in a blinded fashion. Clinical data of the IBD patients and controls were available. Results A higher proportion of non-affected CD relatives was positive for anti-glycan antibodies compared to healthy subjects. No inheritance of a specific pattern of anti-glycan antibodies could be detected. No difference in marker expression depending on the degree of relationship in the non-affected relatives was noted and the presence of family history did not lead to a difference in marker levels in the affected CD subjects. Conclusions Non-affected CD relatives had a higher frequency of anti-glycan antibodies compared to healthy subjects. This difference was mild and was found to be true for the overall reactivity to glycan antigens, but not for specific patterns. This may indicate an inherited mechanism resulting in a non-specific increased reactivity to microbial antigens in IBD.	[Kamm, Florian; Strauch, Ulrike; Kunst, Claudia; Klebl, Frank; Rieders, Florian] Univ Regensburg, Dept Internal Med 1, Regensburg, Germany; [Degenhardt, Frauke; Franke, Andre] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lopez, Rocio] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Rogler, Gerhard] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Rogler, Gerhard] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Rieders, Florian] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA	University of Regensburg; University of Kiel; Cleveland Clinic Foundation; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Cleveland Clinic Foundation	Rieders, F (corresponding author), Univ Regensburg, Dept Internal Med 1, Regensburg, Germany.; Rieders, F (corresponding author), Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	riederf@ccf.org	Franke, Andre/B-2151-2010	Franke, Andre/0000-0003-1530-5811; Degenhardt, Frauke/0000-0001-7516-3179; Lopez, Ana Rocio/0000-0002-4319-420X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK110415] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK110415] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Annese V, 2001, AM J GASTROENTEROL, V96, P2407, DOI 10.1111/j.1572-0241.2001.04043.x; Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Crawford DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015088; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Ferrante M, 2007, INFLAMM BOWEL DIS, V13, P123, DOI 10.1002/ibd.20054; Folwaczny C, 1997, GASTROENTEROLOGY, V113, P101, DOI 10.1016/S0016-5085(97)70085-4; Glas J, 2002, DIGESTION, V66, P173, DOI 10.1159/000066760; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Hadrich I, 2007, SCAND J GASTROENTERO, V42, P717, DOI 10.1080/00365520601083625; Halme L, 2002, SCAND J GASTROENTERO, V37, P692, DOI 10.1080/00365520212511; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hugot JP, 2003, EUR J GASTROEN HEPAT, V15, P593, DOI 10.1097/00042737-200306000-00003; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Joossens M, 2010, INFLAMM BOWEL DIS, V16, P58, DOI 10.1002/ibd.20985; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Magro F, 2017, J CROHNS COLITIS; Mei L, 2006, GASTROENTEROLOGY, V130, P1078, DOI 10.1053/j.gastro.2006.02.013; Mow WS, 2004, DIGEST DIS SCI, V49, P1280, DOI 10.1023/B:DDAS.0000037824.66186.e2; Nores GA, 2008, BBA-GEN SUBJECTS, V1780, P538, DOI 10.1016/j.bbagen.2007.09.008; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Peeters M, 1997, GASTROENTEROLOGY, V113, P802, DOI 10.1016/S0016-5085(97)70174-4; Poulain D, 2000, GUT, V47, P870; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1367, DOI 10.1002/ibd.21179; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P263, DOI 10.1002/ibd.21046; Russell RK, 2004, BEST PRACT RES CL GA, V18, P525, DOI 10.1016/j.bpg.2003.12.006; Seibold F, 2001, SCAND J GASTROENTERO, V36, P196, DOI 10.1080/003655201750065960; SEIBOLD F, 1991, GUT, V32, P1192, DOI 10.1136/gut.32.10.1192; Sendid B, 1998, AM J GASTROENTEROL, V93, P1306, DOI 10.1111/j.1572-0241.1998.00415.x; Seow CH, 2009, AM J GASTROENTEROL, V104, P1426, DOI 10.1038/ajg.2009.79; Sutton CL, 2000, GUT, V46, P58, DOI 10.1136/gut.46.1.58; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Vermeire S, 2001, INFLAMM BOWEL DIS, V7, P8, DOI 10.1097/00054725-200102000-00002	36	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194222	10.1371/journal.pone.0194222	http://dx.doi.org/10.1371/journal.pone.0194222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596443	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000428630000020
J	Belluau, M; Shipley, B				Belluau, Michael; Shipley, Bill			Linking hard and soft traits: Physiology, morphology and anatomy interact to determine habitat affinities to soil water availability in herbaceous dicots	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; RELATIVE GROWTH-RATE; STOMATAL CONDUCTANCE; ASSIMILATION RATE; LEAF TRAITS; ECOLOGY; WORLDWIDE; STRESS; COMMUNITIES; RESPONSES	Background and aims Species' habitat affinities along environmental gradients should be determined by a combination of physiological (hard) and morpho-anatomical (soft) traits. Using a gradient of soil water availability, we address three questions: How well can we predict habitat affinities from hard traits, from soft traits, and from a combination of the two? How well can we predict species' physiological responses to drought (hard traits) from their soft traits? Can we model a causal sequence as soft traits -> hard traits -> species distributions? Methods We chose 25 species of herbaceous dicots whose affinities for soil moisture have already been linked to 5 physiological traits (stomatal conductance and net photosynthesis measured at soil field capacity, water use efficiency, stomatal conductance and soil water potential measured when leaves begin to wilt). Under controlled conditions in soils at field capacity, we measured five soft traits (leaf dry matter content, specific leaf area, leaf nitrogen content, stomatal area, specific root length). Key results Soft traits alone were poor predictors (R-2 = 0.129) while hard traits explained 48% of species habitat affinities. Moreover, hard traits were significantly related to combinations of soft traits. From a priori biological knowledge and hypothesized ecological links we built a path model showing a sequential pattern soft traits -> hard traits -> species distributions and accounting for 59.6% (p = 0.782) of habitat wetness. Conclusions Both direct and indirect causal relationships existed between soft traits, hard traits and species' habitat preferences. The poor predictive abilities of soft traits alone were due to the existence of antagonistic and synergistic direct and indirect effects of soft traits on habitat preferences mediated by the hard traits. To obtain a more realistic model applicable to a population level, it has to be tested in an experiment including species competition for water supply.	[Belluau, Michael; Shipley, Bill] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada	University of Sherbrooke	Belluau, M (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada.	Michael.Belluau@USherbrooke.ca	Shipley, Bill/A-4578-2011	Shipley, Bill/0000-0002-7026-3880; Belluau, Michael/0000-0001-6707-546X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (B. Shipley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameda D, 2012, ENVIRON EXP BOT, V79, P49, DOI 10.1016/j.envexpbot.2012.01.004; Araya YN, 2011, NEW PHYTOL, V189, P253, DOI 10.1111/j.1469-8137.2010.03475.x; Belluau M, 2017, ANN BOT-LONDON, V119, P1073, DOI 10.1093/aob/mcw267; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chaturvedi RK, 2014, J PLANT ECOL, V7, P544, DOI 10.1093/jpe/rtt053; Christensen RHB., 2015, ORDINAL REGRESSION M; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Galmes J, 2007, PLANT SOIL, V290, P139, DOI 10.1007/s11104-006-9148-6; Galmes J, 2013, PLANT CELL ENVIRON, V36, P920, DOI 10.1111/pce.12022; Garnier E., 2016, PLANT FUNCTIONAL DIV, V1st, DOI DOI 10.1093/ACPROF:OSO/9780198757368.001.0001; Grime J.P., 2007, COMP PLANT ECOLOGY F; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Juhrbandt J, 2004, FOREST ECOL MANAG, V202, P245, DOI 10.1016/j.foreco.2004.07.021; Krober W, 2014, TREES-STRUCT FUNCT, V28, P901, DOI 10.1007/s00468-014-1004-3; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; McFadden D., 1974, CONDITIONAL LOGIT AN, P105, DOI DOI 10.1108/EB028592; Mitchell PJ, 2008, PLANT CELL ENVIRON, V31, P1791, DOI 10.1111/j.1365-3040.2008.01882.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; R Core Team, 2015, R LANG ENV STAT COMP, V55, P275; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Romermann C, 2016, FOLIA GEOBOT, V51, P143, DOI 10.1007/s12224-016-9250-3; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sack L, 2010, FUNCT PLANT BIOL, V37, P687, DOI 10.1071/FP10097; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Shipley B., 2015, CAUSE CORRELATION BI; Shipley B, 2017, J VEG SCI, V28, P1082, DOI 10.1111/jvs.12554; Shipley B, 2016, OECOLOGIA, V180, P923, DOI 10.1007/s00442-016-3549-x; Silvertown J, 2015, J ECOL, V103, P93, DOI 10.1111/1365-2745.12332; Tyree M. T., 2007, FUNCTIONAL PLANT ECO, P175; Venables WN., 2002, MODERN APPL STAT S; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; WRIGHT SJ, 1992, OECOLOGIA, V89, P457, DOI 10.1007/BF00317149	38	23	25	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193130	10.1371/journal.pone.0193130	http://dx.doi.org/10.1371/journal.pone.0193130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590137	Green Submitted, gold, Green Published			2022-12-27	WOS:000428603100015
J	Borchardt, R; Moran, C; Cantrill, S; Chemjobber; Oho, SA; Hartings, MR				Borchardt, Rachel; Moran, Cullen; Cantrill, Stuart; Chemjobber; Oho, See Arr; Hartings, Matthew R.			Perception of the importance of chemistry research papers and comparison to citation rates	PLOS ONE			English	Article							H-INDEX; IMPACT	Chemistry researchers are frequently evaluated on the perceived significance of their work with the citation count as the most commonly-used metric for gauging this property. Recent studies have called for a broader evaluation of significance that includes more nuanced bibliometrics as well as altmetrics to more completely evaluate scientific research. To better understand the relationship between metrics and peer judgements of significance in chemistry, we have conducted a survey of chemists to investigate their perceptions of previously published research. Focusing on a specific issue of the Journal of the American Chemical Society published in 2003, respondents were asked to select which articles they thought best matched importance and significance given several contexts: highest number of citations, most significant (subjectively defined), most likely to share among chemists, and most likely to share with a broader audience. The answers to the survey can be summed up in several observations. The ability of respondents to predict the citation counts of established research is markedly lower than the ability of those counts to be predicted by the h-index of the corresponding author of each article. This observation is conserved even when only considering responses from chemists whose expertise falls within the subdiscipline that best describes the work performed in an article. Respondents view both cited papers and significant papers differently than papers that should be shared with chemists. We conclude from our results that peer judgements of importance and significance differ from metrics-based measurements, and that chemists should work with bibliometricians to develop metrics that better capture the nuance of opinions on the importance of a given piece of research.	[Borchardt, Rachel; Moran, Cullen; Hartings, Matthew R.] Amer Univ, Washington, DC 20016 USA; [Cantrill, Stuart] SpringerNature, Nat Chem, London, England; [Chemjobber] Chemjobber, Shell, WV USA; [Oho, See Arr] Just Cooking, Krypton, KY USA	American University; Royal Dutch Shell	Borchardt, R; Hartings, MR (corresponding author), Amer Univ, Washington, DC 20016 USA.	borchard@american.edu; hartings@american.edu		Borchardt, Rachel/0000-0002-8464-1045; Hartings, Matthew/0000-0003-0658-939X				[Anonymous], 2018, NATURE, V553, P5; Borchardt R, 2017, JACS CHALLENGE DATA, DOI [10.6084/m9.figshare.5187529, DOI 10.6084/M9.FIGSHARE.5187529]; Cameron BD, 2005, PORTAL-LIBR ACAD, V5, P105, DOI 10.1353/pla.2005.0003; Cantrill S., 2015, SCEPTICAL CHYMIST NA; Costas R, 2007, J INFORMETR, V1, P193, DOI 10.1016/j.joi.2007.02.001; Henning V, 2012, GUARDIAN; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Ke Q, 2015, P NATL ACAD SCI USA, V112, P7426, DOI 10.1073/pnas.1424329112; Kenna R, 2017, CONDENS MATTER PHYS, V20, DOI 10.5488/CMP.20.13803; Lariviere V., 2016, BIORXIV, DOI 10.1101/062109; Li X, 2012, P 17 INT C; Li XM, 2012, SCIENTOMETRICS, V91, P461, DOI 10.1007/s11192-011-0580-x; Lowe D., IN THE PIPELINE; Marchant S, 2013, SALARIES 2013 ANAL A; Mazloumian A., 2012, PLOS ONE, V7; Mohammadi E, 2015, J ASSOC INF SCI TECH, V66, P1832, DOI 10.1002/asi.23286; Ozanne JL, 2016, J PUBLIC POLICY MARK, V9156; Parra LC, AWARD REWARD WHICH C, DOI [10.1101/193755, DOI 10.1101/193755]; PETERS HPF, 1994, J AM SOC INFORM SCI, V45, P39, DOI 10.1002/(SICI)1097-4571(199401)45:1<39::AID-ASI5>3.0.CO;2-Q; Priem J, 2012, ALTMETRICS WILD USIN; Radicchi F, 2017, J INFORMETR, V11, P704, DOI 10.1016/j.joi.2017.05.010; Rezek I, 2011, ACAD RADIOL, V18, P1337, DOI 10.1016/j.acra.2011.06.017; Stephan P, 2017, NATURE, V544, P411, DOI 10.1038/544411a; von Bartheld CS, 2015, PEERJ, V3, DOI 10.7717/peerj.1262; Walters GD, 2006, SCIENTOMETRICS, V69, P499, DOI 10.1007/s11192-006-0166-1; Waltman L, 2014, J ASS; Wardle DA, 2010, IDEAS ECOL EVOL, V3, P11, DOI 10.4033/iee.2010.3.3.c; Whitesides GM, 2015, ANGEW CHEM INT EDIT, V54, P3196, DOI 10.1002/anie.201410884	28	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194903	10.1371/journal.pone.0194903	http://dx.doi.org/10.1371/journal.pone.0194903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590216	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100086
J	Dehghanizadeh, S; Khoddami, V; Mosbruger, TL; Hammoud, SS; Edes, K; Berry, TS; Done, M; Samowitz, WS; DiSarici, JA; Luba, DG; Burt, RW; Jones, DA				Dehghanizadeh, Somaye; Khoddami, Vahid; Mosbruger, Timothy L.; Hammoud, Sue S.; Edes, Kornelia; Berry, Therese S.; Done, Michelle; Samowitz, Wade S.; DiSarici, James A.; Luba, Daniel G.; Burt, Randall W.; Jones, David A.			Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile	PLOS ONE			English	Article							COLORECTAL-CANCER; BRAF MUTATION; MICROSATELLITE INSTABILITY; TUMOR PROGRESSION; THYROID-CANCER; PHENOTYPE; TUMORIGENESIS; SURVEILLANCE; SENESCENCE; CARCINOMA	Background Sessile serrated polyps (SSPs) have emerged as important precursors for a large number of sporadic colorectal cancers. They are difficult to detect during colonoscopy due to their flat shape and the excessive amounts of secreted mucin that cover the polyps. The underlying genetic and epigenetic basis for the emergence of SSPs is largely unknown with existing genetic studies confined to a limited number of oncogenes and tumor suppressors. A full characterization of the genetic and epigenetic landscape of SSPs would provide insight into their origin and potentially offer new biomarkers useful for detection of SSPs in stool samples. Methods We used a combination of genome-wide mutation detection, exome sequencing and DNA methylation profiling (via methyl-array and whole-genome bisulfite sequencing) to analyze multiple samples of sessile serrated polyps and compared these to familial adenomatous polyps. Results Our analysis revealed BRAF-V600E as the sole recurring somatic mutation in SSPs with no additional major genetic mutations detected. The occurrence of BRAF-V600E was coincident with a unique DNA methylation pattern revealing a set of DNA methylation markers showing significant (similar to 3 to 30 fold) increase in their methylation levels, exclusively in SSP samples. These methylation patterns effectively distinguished sessile serrated polys from adenomatous polyps and did so more effectively than parallel gene expression profiles. Conclusions This study provides an important example of a single oncogenic mutation leading to reproducible global DNA methylation changes. These methylated markers are specific to SSPs and could be of important clinical relevance for the early diagnosis of SSPs using non-invasive approaches such as fecal DNA testing.	[Dehghanizadeh, Somaye] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA; [Khoddami, Vahid] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Khoddami, Vahid; Mosbruger, Timothy L.] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran; [Hammoud, Sue S.; Edes, Kornelia; Berry, Therese S.; Done, Michelle; Burt, Randall W.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Hammoud, Sue S.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Samowitz, Wade S.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [DiSarici, James A.; Luba, Daniel G.] Monterey Bay Gastroenterol Res Inst, Monterey, CA USA; [Burt, Randall W.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Jones, David A.] Oklahoma Med Res Fdn, Funct & Chem Genom, 825 NE 13th St, Oklahoma City, OK 73104 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Academic Center for Education, Culture & Research (ACECR); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Oklahoma Medical Research Foundation	Jones, DA (corresponding author), Oklahoma Med Res Fdn, Funct & Chem Genom, 825 NE 13th St, Oklahoma City, OK 73104 USA.	David-Jones@omrf.org			National Cancer Institute of the National Institutes of Health [R01CA11648, PO1CA073992]; HHMI Med2Grad program; NATIONAL CANCER INSTITUTE [R01CA116468] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI Med2Grad program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers R01CA11648 and P01CA073992 and by HHMI Med2Grad program.; We are grateful to all the patients that donate their biopsies. We thank Drs. Alana Welm, Bryan Welm, Brad Cairns, Rodney Stewart, and Charles Murtaugh, for their helpful suggestions and comments. We thank Brian Dalley and Michael Klein at the sequencing core, and David Nix, Ying Sun, Brett Milash, Clint Mason, and Russell Bell for their help in data analysis. We also thank Ann Cline, and Paulette Bowman for their help in sample preparation and processing. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers R01CA11648 and PO1CA073992 and by HHMI Med2Grad program.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bosch LJW, 2011, CLIN COLORECTAL CANC, V10, P8, DOI 10.3816/CCC.2011.n.002; Brait M, 2012, EPIGENETICS-US, V7, P710, DOI 10.4161/epi.20524; Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099; Chang H, 2016, CYTOPATHOLOGY, V27, P122, DOI 10.1111/cyt.12248; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; Delker DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088367; Dhir M, 2011, INT J CANCER, V129, P1889, DOI 10.1002/ijc.25847; Ensari A, 2010, J CLIN PATHOL, V63, P665, DOI 10.1136/jcp.2010.077222; Ensari A, 2012, VIRCHOWS ARCH, V461, P495, DOI 10.1007/s00428-012-1319-7; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fernando WC, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/374926; Fu XS, 2014, INT J CLIN EXP PATHO, V7, P1275; Gaiser T, 2013, INT J CANCER, V132, P1800, DOI 10.1002/ijc.27869; Heigh RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085659; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lange CPE, 2013, EPIGENOMICS-UK, V5, P105, DOI [10.2217/EPI.13.4, 10.2217/epi.13.4]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nix DA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-455; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; O'Brien MJ, 2007, GASTROENTEROL CLIN N, V36, P947, DOI 10.1016/j.gtc.2007.08.007; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Rex DK, 2012, AM J GASTROENTEROLOG; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vedeld HM, 2017, INT J CANCER, V141, P967, DOI 10.1002/ijc.30796; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192499	10.1371/journal.pone.0192499	http://dx.doi.org/10.1371/journal.pone.0192499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590112	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100005
J	Ghosh, R; Roy, S; Franco, S				Ghosh, Rajib; Roy, Sanchita; Franco, Sonia			PARP1 depletion induces RIG-I-dependent signaling in human cancer cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE-1; ENDOGENOUS RETROELEMENTS; RNA; INTERFERON; RESPONSES; IMMUNITY; SYSTEM; STRESS	DNA Damage Response (DDR) and DNA repair pathways are emerging as potent, ubiquitous suppressors of innate immune signaling in human cells. Here, we show that human cells surviving depletion of the Single Strand Break (SSB) repair protein PARP1 undergo p21-dependent senescence or cell cycle checkpoint activation in the context of activation of innate immune signaling, or viral mimicry. Specifically, we observe induction of a large number of interferon-stimulated genes (ISGs) and multiple pattern recognition receptors (PRRs; including RIG-I, MDA-5, MAVS, TLR3 and STING) and increased nuclear IRF3 staining. Mechanistically, depletion of the double-stranded RNA (dsRNA) helicase RIG-I or its downstream effector MAVS specifically rescues ISG induction in PARP1-depleted cells, suggesting that the RIG-I/MAVS pathway is required for sustained ISG expression in this context. Experiments with conditioned media or a neutralizing antibody to the alpha/beta-IFN receptor revealed that persistent ISG expression additionally requires an autocrine/paracrine loop. Finally, loss of PARP1 and radiation-induced DNA damage strongly synergize in the induction of p21 and ISGs. Overall, these findings increase our understanding of how PARP1 may suppress deleterious phenotypes associated to aging, inflammation and cancer in humans.	[Ghosh, Rajib; Roy, Sanchita; Franco, Sonia] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Franco, S (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA.	sfranco2@jhmi.edu			National Cancer Institute [R21 CA181417-01A1]; Basser Center for BRCA Research; Allegheny Health Network-Johns Hopkins Cancer Fund	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Basser Center for BRCA Research; Allegheny Health Network-Johns Hopkins Cancer Fund	This study was supported by the National Cancer Institute (www.cancer.gov; grant R21 CA181417-01A1 to SF); the Basser Center for BRCA Research (www.basser.org; unnumbered Basser Innovation Award to SF) and the Allegheny Health Network-Johns Hopkins Cancer Fund (www.hopkinsinedicine.org; unnumbered Pilot Grant to SF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Beck C, 2014, EXP CELL RES, V329, P18, DOI 10.1016/j.yexcr.2014.07.003; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Chiang C, 2017, TRENDS IMMUNOL, V38, P39, DOI 10.1016/j.it.2016.10.008; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Ha HC, 2001, P NATL ACAD SCI USA, V98, P3364, DOI 10.1073/pnas.051633498; Hagan CR, 2003, NAT GENET, V35, P219, DOI 10.1038/ng1259; Hanzlikova H, 2016, NUCL ACIDS RES; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Holm CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10680; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; ISAACS A, 1963, LANCET, V2, P113; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jazaeri AA, 2002, JNCI-J NATL CANCER I, V94, P990, DOI 10.1093/jnci/94.13.990; Kassiotis G, 2016, NAT REV IMMUNOL, V16, P207, DOI 10.1038/nri.2016.27; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mangerich A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/321653; Minn AJ, 2015, TRENDS IMMUNOL, V36, P725, DOI 10.1016/j.it.2015.09.007; Mu X, 2016, ADV IMMUNOL, V132, P47, DOI 10.1016/bs.ai.2016.07.001; Nabet BY, 2017, CELL, V170, P352, DOI 10.1016/j.cell.2017.06.031; Orsburn B, 2010, MOL CELL BIOL, V30, P2341, DOI 10.1128/MCB.00091-10; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pommier Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9246; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rank L, 2016, NUCLEIC ACIDS RES, V44, P10386, DOI 10.1093/nar/gkw859; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Rudin CM, 2001, GENE CHROMOSOME CANC, V30, P64, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Suschak JJ, 2016, J IMMUNOL, V196, P310, DOI 10.4049/jimmunol.1501836; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Widau RC, 2014, P NATL ACAD SCI USA, V111, pE484, DOI 10.1073/pnas.1323253111; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Xu H, 2014, J PATHOL, V234, P386, DOI 10.1002/path.4404; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486; Zevini A, 2017, TRENDS IMMUNOL, V38, P194, DOI 10.1016/j.it.2016.12.004	63	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194611	10.1371/journal.pone.0194611	http://dx.doi.org/10.1371/journal.pone.0194611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590171	gold, Green Published, Green Submitted			2022-12-27	WOS:000428603100068
J	Marra, F; Motta, L; Brock, AL; Macri, P; Florindo, F; Sadori, L; Terrenato, N				Marra, Fabrizio; Motta, Laura; Brock, Andrea L.; Macri, Patrizia; Florindo, Fabio; Sadori, Laura; Terrenato, Nicola			Rome in its setting. Post-glacial aggradation history of the Tiber River alluvial deposits and tectonic origin of the Tiber Island	PLOS ONE			English	Article							COASTAL-PLAIN TUSCANY; LATE-HOLOCENE; CLIMATE CHANGES; SEA-LEVEL; EVOLUTION; SUCCESSIONS; STRATIGRAPHY; SEDIMENTARY; RECORD; AGE	The Tiber valley is a prominent feature in the landscape of ancient Rome and an important element for understanding its urban development. However, little is known about the city's original setting. Our research provides new data on the Holocene sedimentary history and human-environment interactions in the Forum Boarium, the location of the earliest harbor of the city. Since the Last Glacial Maximum, when the fluvial valley was incised to a depth of tens of meters below the present sea level, C-14 and ceramic ages coupled with paleomagnetic analysis show the occurrence of three distinct aggradational phases until the establishment of a relatively stable alluvial plain at 6-8 m a.s.l. during the late 3rd century BCE. Moreover, we report evidence of a sudden and anomalous increase in sedimentation rate around 2600 yr BP, leading to the deposition of a 4-6m thick package of alluvial deposits in approximately one century. We discuss this datum in the light of possible tectonic activity along a morpho-structural lineament, revealed by the digital elevation model of this area, crossing the Forum Boarium and aligned with the Tiber Island. We formulate the hypothesis that fault displacement along this structural lineament may be responsible for the sudden collapse of the investigated area, which provided new space for the observed unusually large accumulation of sediments. We also posit that, as a consequence of the diversion of the Tiber course and the loss in capacity of transport by the river, this faulting activity triggered the origin of the Tiber Island.	[Marra, Fabrizio; Macri, Patrizia; Florindo, Fabio] Ist Nazl Geofis & Vulcanol, Rome, Italy; [Motta, Laura] Univ Michigan, Kelsey Museum Archaeol, Ann Arbor, MI 48109 USA; [Brock, Andrea L.; Terrenato, Nicola] Univ Michigan, Dept Class Studies, Ann Arbor, MI 48109 USA; [Sadori, Laura] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy	Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sapienza University Rome	Marra, F (corresponding author), Ist Nazl Geofis & Vulcanol, Rome, Italy.	fabrizio.marra@ingv.it	Florindo, Fabio/F-4119-2010; MARRA, Fabrizio/AAB-9514-2019; Sadori, Laura/E-4774-2015; Florindo, Fabio/AAU-2548-2021; Terrenato, Nicola/AAZ-2008-2020; Florindo, Fabio/M-1459-2019; Macrì, Patrizia/ABD-2144-2021	Florindo, Fabio/0000-0002-6058-9748; MARRA, Fabrizio/0000-0002-4881-9563; Sadori, Laura/0000-0002-2774-6705; Terrenato, Nicola/0000-0002-1053-0094; Florindo, Fabio/0000-0002-6058-9748; Macrì, Patrizia/0000-0003-2287-4019; Brock, Andrea L./0000-0001-5390-7499; Motta, Laura/0000-0003-4136-3142	DTS-MIUR NextData project; University of Michigan; Etruscan Foundation; Fondazione Lemmermann; National Science Foundation [1259122]	DTS-MIUR NextData project; University of Michigan(University of Michigan System); Etruscan Foundation; Fondazione Lemmermann(Fondazione CarifeFondazione Caritro); National Science Foundation(National Science Foundation (NSF))	The Sant'Omobono Project is promoted by the Sovrintendenza ai Beni Culturali di Roma Capitale in collaboration with the University of Michigan and the Universita della Calabria. M. Ceci and G. Caruso supervise the work for the Sovraintendenza. Work in the field is conducted by P. Brocato and N. Terrenato. The borehole campaign was facilitated by M. Ceci and contracted to CONGEO snc (now CNG) under the supervision of M. Martinelli. Support for this work was provided by the DTS-MIUR NextData project, the University of Michigan, the Etruscan Foundation, and the Fondazione Lemmermann. This work includes data collected with funding from the National Science Foundation under Grant No. 1259122. Any opinions, findings, and conclusions expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.; Support for this work was provided by the DTS-MIUR NextData project, the University of Michigan, the Etruscan Foundation, and the Fondazione Lemmermann. This work includes data collected with funding from the National Science Foundation under Grant No. 1259122 (ALB). Any opinions, findings, and conclusions expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrete GS, 2007, FLOODS TIBER ANCIENT, Vxviii; AMMERMAN A. J., 1998, J ROMAN ARCHAEOL, V11, P213, DOI DOI 10.1017/S1047759400017268; Ammerman AJ, 2004, B COMUNALE, V99, P272; Ammerman Albert J., 2015, J ROMAN ARCHAEOL, V21, P7; Ammerman Albert J., 2000, SOC PREISTORIA PROTO, V8, P9; Amorosi A, 2013, QUATERN INT, V303, P93, DOI 10.1016/j.quaint.2013.03.030; Bellotti P, 2007, Z GEOMORPHOL, V51, P505, DOI 10.1127/0372-8854/2007/0051-0505; Belluomini G., 1986, GEOL ROMANA, V25, P213; Bencivenga M., 2001, PIENE TEVERE ROMA DA; Benito G, 2015, SCI REP-UK, V5, DOI 10.1038/srep16398; Benito G, 2015, CATENA, V130, P13, DOI 10.1016/j.catena.2014.11.014; Benvenuti M, 2006, HOLOCENE, V16, P863, DOI 10.1191/0959683606hl978rp; Bozzano F, 2008, J GEOPHYS RES SOLID, V113; Brocato P, 2016, RICERCHE NELL AREA T; Brocato P., 2017, AGE TARQUINIUS SUPER, P97; Brock AL, 2016, ANTIQUITY, V90, P654, DOI 10.15184/aqy.2016.65; Campo B, 2017, PALAEOGEOGR PALAEOCL, V466, P265, DOI 10.1016/j.palaeo.2016.11.016; Cinti FR, 2008, ANN GEOPHYS-ITALY, V51, P849; Ciotoli G, 2016, J GEOPHYS RES-SOL EA, V121, P48, DOI 10.1002/2015JB012557; Colini Antonio Maria, 1980, MAAR, V36, P43; Diffendale DP, 2016, J ROMAN ARCHAEOL, V29, P7, DOI 10.1017/S1047759400072032; Drescher-Schneider R, 2007, VEG HIST ARCHAEOBOT, V16, P279, DOI 10.1007/s00334-006-0089-z; Faccenna C, 1996, GEOPHYS J INT, V126, P781, DOI 10.1111/j.1365-246X.1996.tb04702.x; FOLLIERI M, 1988, Pollen et Spores, V30, P329; Frepoli A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006322; Fulminante F, 2014, URBANISATION ROME LA, Vxx; Giraudi C, 2011, HOLOCENE, V21, P105, DOI 10.1177/0959683610377529; Giraudi C, 2014, HOLOCENE, V24, P932, DOI 10.1177/0959683614534738; Goudeau MLS, 2015, PALAEOGEOGR PALAEOCL, V418, P304, DOI 10.1016/j.palaeo.2014.11.004; Guilizzoni P, 2002, QUATERN INT, V88, P57, DOI 10.1016/S1040-6182(01)00073-8; Hopkins JN, 2016, GENESIS ROMAN ARCHIT, Vxiv; Horden P, 2000, CORRUPTING SEA STUDY, Vxiii; Karner DB, 2001, EARTH PLANET SC LETT, V188, P135, DOI 10.1016/S0012-821X(01)00325-9; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Lambeck K, 2011, QUATERN INT, V232, P250, DOI 10.1016/j.quaint.2010.04.026; Luberti GM, 2017, QUATERN INT, V438, P40, DOI 10.1016/j.quaint.2017.01.044; Lurcock PC, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004098; Magny M, 2013, CLIM PAST, V9, P2043, DOI 10.5194/cp-9-2043-2013; Magny M, 2007, QUATERNARY SCI REV, V26, P1736, DOI 10.1016/j.quascirev.2007.04.014; Magri D, 1999, VEG HIST ARCHAEOBOT, V8, P247, DOI 10.1007/BF01291777; Marra F, 2016, EARTH PLANET SC LETT, V449, P105, DOI 10.1016/j.epsl.2016.05.037; Marra F, 2016, ARCHAEOMETRY, V58, P177, DOI 10.1111/arcm.12154; Marra F, 2004, J STRUCT GEOL, V26, P679, DOI 10.1016/j.jsg.2003.09.003; Marra F, 2013, GLOBAL PLANET CHANGE, V107, P157, DOI 10.1016/j.gloplacha.2013.05.002; Marra F, 2001, J STRUCT GEOL, V23, P127, DOI 10.1016/S0191-8141(00)00068-7; Marra F, 1999, GEOPHYS J INT, V138, P231, DOI 10.1046/j.1365-246x.1999.00866.x; Marra F, 2016, QUATERNARY SCI REV, V148, P85, DOI 10.1016/j.quascirev.2016.07.003; Marra F, 2015, QUATERNARY SCI REV, V129, P260, DOI 10.1016/j.quascirev.2015.10.027; Mensing SA, 2015, QUATERNARY SCI REV, V116, P72, DOI 10.1016/j.quascirev.2015.03.022; Mercuri AM, 2002, VEG HIST ARCHAEOBOT, V11, P263, DOI 10.1007/s003340200039; Mogetta M, 2015, J ROMAN STUD, V105, P1, DOI 10.1017/S007543581500043X; Molin D., 1989, TERREMOTI PRIMA MILL, P194; Peccerillo A., 2005, PLIO QUATERNARY VOLC, VXIV; Pepe C, 2016, J PALEOLIMNOL, V56, P173, DOI 10.1007/s10933-016-9903-5; Perkins P, 1999, ETRUSCAN SETTLEMENT; Peyron O, 2011, HOLOCENE, V21, P131, DOI 10.1177/0959683610384162; Ramrath A, 2000, HOLOCENE, V10, P87, DOI 10.1191/095968300669348734; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roberts N, 2011, HOLOCENE, V21, P3, DOI 10.1177/0959683610388058; Rossi V, 2012, GEOMORPHOLOGIE, P201; Sadori L, 2013, CLIM PAST, V9, P1969, DOI 10.5194/cp-9-1969-2013; Sadori L, 2016, HOLOCENE, V26, P1502, DOI 10.1177/0959683616640054; Sadori L, 2011, HOLOCENE, V21, P117, DOI 10.1177/0959683610377530; Salomon F, 2017, GEOARCHAEOLOGY, V32, P215, DOI 10.1002/gea.21589; Sarti G, 2015, PALAEOGEOGR PALAEOCL, V424, P183, DOI 10.1016/j.palaeo.2015.02.020; Stanford JD, 2011, GLOBAL PLANET CHANGE, V79, P193, DOI 10.1016/j.gloplacha.2010.11.002; Terrenato Nicola, 2006, CELTES GAULOIS ARCHE, P225; ZANCHETTA G, 2016, ALP MEDITERR QUAT, V29, P5	68	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194838	10.1371/journal.pone.0194838	http://dx.doi.org/10.1371/journal.pone.0194838			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590208	Green Published, gold			2022-12-27	WOS:000428603100077
J	McLaren, D; Fedje, D; Dyck, A; Mackie, Q; Gauvreau, A; Cohen, J				McLaren, Duncan; Fedje, Daryl; Dyck, Angela; Mackie, Quentin; Gauvreau, Alisha; Cohen, Jenny			Terminal Pleistocene epoch human footprints from the Pacific coast of Canada	PLOS ONE			English	Article							SEA-LEVEL CHANGE; BUENOS-AIRES PROVINCE; BRITISH-COLUMBIA; CONTINENTAL-SHELF; DEPOSITS; LAETOLI; CLOVIS; AGE; ENVIRONMENTS; MIGRATION	Little is known about the ice age human occupation of the Pacific Coast of Canada. Here we present the results of a targeted investigation of a late Pleistocene shoreline on Calvert Island, British Columbia. Drawing upon existing geomorphic information that sea level in the area was 2-3 m lower than present between 14,000 and 11,000 years ago, we began a systematic search for archaeological remains dating to this time period beneath intertidal beach sediments. During subsurface testing, we uncovered human footprints impressed into a 13,000-year-old paleosol beneath beach sands at archaeological site EjTa-4. To date, our investigations at this site have revealed a total of 29 footprints of at least three different sizes. The results presented here add to the growing body of information pertaining to the early deglaciation and associated human presence on the west coast of Canada at the end of the Last Glacial Maximum.	[McLaren, Duncan; Fedje, Daryl; Dyck, Angela; Gauvreau, Alisha] Hakai Inst, Calvert Island, BC, Canada; [McLaren, Duncan; Fedje, Daryl; Dyck, Angela; Mackie, Quentin; Gauvreau, Alisha; Cohen, Jenny] Univ Victoria, Victoria, BC, Canada	Hakai Institute; University of Victoria	McLaren, D (corresponding author), Hakai Inst, Calvert Island, BC, Canada.; McLaren, D (corresponding author), Univ Victoria, Victoria, BC, Canada.	dsmclaren@gmail.com			Tula Foundation, HALAP; Tula Foundation; Hakai Institute	Tula Foundation, HALAP; Tula Foundation; Hakai Institute	Funded by Tula Foundation, HALAP 2012-2017. https://tula.org/ to DM. The Tula Foundation provided funding for research expenses. The funders participated in meetings concerning the overall scope of this project. 'In kind' support was provided for transportation and accommodations while in the field. The funders encouraged us to pursue this line of investigation but had no role in the preparation of this manuscript.; Funding and in-kind support was provided by the Tula Foundation and Hakai Institute. We thank Christina Munck and Eric Peterson for their involvement, guidance and assistance in all aspects of this project. We are grateful to the staff at the Hakai Institute for providing meals and accommodations. Many thanks to Harvey Humchitt, Kelly Brown of the Heiltsuk Integrated Resource Management Department for their guidance and to Jennifer Carpenter for providing comments on an earlier version of this manuscript. We acknowledge Peter Johnson of the Wuikinuxv First Nation for his input and support. Thanks to the researchers that helped in the field or lab including: Maxwell Johnson Jr., John Maxwell, Jennifer Walkus, Joanne McSporran, Farid Rahemtulla, Andrea Walkus, Jim Stafford, Aurora Skala, Joshua Vickers, Jess Barton, Cecilia Porter, Johnny Johnson, Seonaid Duffield, Callum Abbott, Brittany Witherspoon, Carling Reid, Alex Nichini, Alex Lausanne, Grant Callegari, Meigan Henry and Iain McKechnie. Thanks to John Southon and the W.M. Keck Carbon Cycle Accelerator Mass Spectrometry Laboratory at the University of California, Irvine, for running all radiocarbon date samples. All work was conducted under BC Archaeology Branch permit #2011-171 and BC Park Use Permits #105588 and #105935. We acknowledge Steve Acheson and Vashti Thiesson who were the BC Archaeology Branch project officers for this work. A preliminary version of this paper was presented at the Prehistoric Human Tracks conference (May 11-13, 2017) at the University of Cologne and Neanderthal Museum in Germany, and we are grateful for the insights and feedback given by trackers, archaeologists and ethnographers who attended. Many thanks to Neil Roach, Jon Erlandson and two anonymous scholars for their time and effort in conducting peer reviews for this paper.	Ackerman R, 1996, EARLY HUMAN OCCUPATI, P123; Al-Suwaidi M, 2006, GEOARCHAEOLOGY, V21, P307, DOI 10.1002/gea.20106; Allen J, 2004, ARCHAEOLOGY SEVERN E, V14, P55; Aramayo SA, 2009, ICHNOS, V16, P25, DOI 10.1080/10420940802470714; Aramayo SA, 2009, ICHNOS, V16, P49, DOI 10.1080/10420940802470748; Ashton N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088329; Barrie JV, 2002, SEDIMENT GEOL, V150, P171, DOI 10.1016/S0037-0738(01)00274-3; Bayon C, 2011, EVOLUTION ED OUTREAC, V4, P205, DOI DOI 10.1007/S12052-011-0335-4; BEHRENSMEYER AK, 1981, NATURE, V289, P167, DOI 10.1038/289167a0; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berge C, 2006, CR PALEVOL, V5, P561, DOI 10.1016/j.crpv.2005.09.001; BLAISE B, 1990, QUATERNARY RES, V34, P282, DOI 10.1016/0033-5894(90)90041-I; Bohannon RW, 2007, PHYS THER, V87, P1642, DOI 10.2522/ptj.20060037; Bourgeon L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169486; Braadbaart F, 2009, J ARCHAEOL SCI, V36, P1672, DOI 10.1016/j.jas.2009.03.006; Braje T. J., 2017, PALEOAMERICA, V3, P200, DOI DOI 10.1080/20555563.2017.1348091; Braje TJ, 2017, SCIENCE, V358, P592, DOI 10.1126/science.aao5473; Brannock C, 1928, US Patent, Patent No. 1682366; Burns A, 2014, PREHISTORIC FOOTPRIN; Carlson R, 2008, PROJECTILE POINT SEQ, P353; Carlson R.L., 1996, EARLY HUMAN OCCUPATI, P83; CLAGUE J, 1982, CAN J EARTH SCI, V19, P597, DOI 10.1139/e82-048; Clague J, 2002, QUATERN INT, V68-71, P29; Clague J.J., 2004, ENTERING AM NE ASIA, P63; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; Dillehay T., 2000, SETTLEMENT AM NEW PR; Dillehay TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141923; Dixon J, 1999, BONES BOATS BISON AR; Eamer J, 2015, REPORT HAKAI ANCIENT; Eamer JBR, 2017, QUATERNARY RES, V87, P468, DOI 10.1017/qua.2017.16; Erlandson JM, 2015, J ISL COAST ARCHAEOL, V10, P392, DOI 10.1080/15564894.2014.1001923; Falkingham P, 2016, DINOSAUR TRACKS NEXT; Fedje D, 1996, EARLY HUMAN OCCUPATI, P35; Fedje D, 2011, QUATERN INT, V242, P452, DOI 10.1016/j.quaint.2011.03.042; Fedje DW, 2005, PACIF RIM ARCHAEOL, P21; Fedje DW, 1999, AM ANTIQUITY, V64, P635, DOI 10.2307/2694209; Fedje DW, 2000, GEOLOGY, V28, P99, DOI 10.1130/0091-7613(2000)28<99:DFAAOT>2.0.CO;2; Felstead NJ, 2014, J ARCHAEOL SCI, V42, P250, DOI 10.1016/j.jas.2013.11.010; Fladmark K, 1996, EARLY HUMAN OCCUPATI, P11; FLADMARK KR, 1979, AM ANTIQUITY, V44, P55, DOI 10.2307/279189; Friedman J, 1978, WOOD IDENTIFICATION; Gonzalez S, 2006, QUATERNARY SCI REV, V25, P201, DOI 10.1016/j.quascirev.2005.10.004; Halligan JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600375; Harman J, 2017, DSTRETCH WEBSITE DST; Hatala KG, 2017, J HUM EVOL, V112, P93, DOI 10.1016/j.jhevol.2017.08.013; Heaton TH, 2004, ICE AGE CAVE FAUNAS OF NORTH AMERICA, P17; Hetherington R, 2004, QUATERNARY SCI REV, V23, P295, DOI 10.1016/j.quascirev.2003.04.001; Hoadley B. R., 1990, IDENTIFYING WOOD ACC; Holen SR, 2017, NATURE, V544, P479, DOI 10.1038/nature22065; James T, 2002, GEOLOGICAL SURVEY CA, V16, P1; Jenkins DL, 2012, SCIENCE, V337, P223, DOI 10.1126/science.1218443; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; Letham B, 2016, QUATERNARY SCI REV, V153, P156, DOI 10.1016/j.quascirev.2016.10.004; Liebenberg L., 1990, ART TRACKING ORIGIN; Lockley MG, 2009, ICHNOS, V16, P55, DOI 10.1080/10420940802470755; Lucas S, 2017, PALEOAMERICA, V3, P97; Luebbers R, STUDIES BELLA BELLA; LUTERNAUER JL, 1989, GEOLOGY, V17, P357, DOI 10.1130/0091-7613(1989)017<0357:LPTDOT>2.3.CO;2; Marty D, 2009, ICHNOS, V16, P127, DOI 10.1080/10420940802471027; Masao FT, 2016, ELIFE, V5, DOI 10.7554/eLife.19568; McLaren D, 2001, CANADIAN J ARCHAEOLO, V35, P86; McLaren D., 2015, BC STUDIES, V187, P155, DOI DOI 10.14288/BCS.V0I187.186161; McLaren D, ARCHAEOLOGY LOWER FR; McLaren D., 2005, CANADIAN ZOOARCHAEOL, V22, P3; McLaren D, 2014, QUATERNARY SCI REV, V97, P148, DOI 10.1016/j.quascirev.2014.05.023; Morse S.A., 2014, HUMAN FOOTPRINTS FOS; Morse SA, 2013, AM J PHYS ANTHROPOL, V151, P265, DOI 10.1002/ajpa.22276; Morse SA, 2010, QUATERNARY SCI REV, V29, P2571, DOI 10.1016/j.quascirev.2010.03.012; Panshin AJ, 1970, TXB WOOD TECHNOLOGY; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Pruett C, 2017, CONDOR, V115, P725; Rahemtulla F, 2014, RES INVESTIGATIONS A; Rahemtulla F, 2006, THESIS; Rahemtulla F, 2014, ARCHAEOLOGICAL INVES; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Ramsey CL, 2004, QUATERNARY RES, V62, P105, DOI 10.1016/j.yqres.2004.05.003; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roach NT, 2016, SCI REP-UK, V6, DOI 10.1038/srep26374; Robbins L, 1985, FOOTPRINTS COLLECTIO; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sheldon I, 1971, ANIMAL TRACKS BRIT C; Shugar DH, 2014, QUATERNARY SCI REV, V97, P170, DOI 10.1016/j.quascirev.2014.05.022; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Waters MR, 2011, SCIENCE, V334, P351, DOI 10.1126/science.1207663; Willey P, 2009, ICHNOS, V16, P70, DOI 10.1080/10420940802470839	85	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193522	10.1371/journal.pone.0193522	http://dx.doi.org/10.1371/journal.pone.0193522			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590165	Green Published, gold			2022-12-27	WOS:000428603100023
J	Kobayashi, Y; Inagawa, H; Kohchi, C; Kazumura, K; Tsuchiya, H; Miwa, T; Okazaki, K; Soma, GI				Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Kazumura, Kimiko; Tsuchiya, Hiroshi; Miwa, Toshiyuki; Okazaki, Katsuichiro; Soma, Gen-Ichiro			Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses	PLOS ONE			English	Article							ACTIVATED MACROPHAGE; WHEAT-FLOUR; BIOLOGICAL-ACTIVITIES; POLLEN ALLERGY; MURINE MODEL; HOMEOSTASIS; EXTRACT; LPS; CHOLESTEROL; DISEASES	Pantoea agglomerans (P. agglomerans) is a Gram-negative bacterium that grows symbiotically with various edible plants, and the oral or sublingual administration of lipopolysaccharide derived from P. agglomerans (LPSp) have been suggested to contribute to prevention of immune-related diseases. Our previous study indicated that orally administered LPSp was shown to exhibit an LDL-lowering effect in hyperlipidemic volunteers; however, a preventive effect of LPSp on atherosclerosis is unclear. The present study attempted to evaluate the anti-atherosclerotic effect by LPSp in a mouse model of high-fat diet (HFD)-induced atherosclerosis. For 16 weeks, apoE-deficient mice were fed an HFD and received drinking water containing LPSp (0.3 or 1 mg/kg body weight/day). The results showed that the orally administered LPSp decreased body weight. A significant reduction in atherosclerotic plaque deposition was observed even with the lower dose of LPSp. The biochemical analyses showed that LPSp markedly improved glucose tolerance and reduced plasma LDL and oxidized LDL levels. In addition, LPSp significantly reduced the production of pro-inflammatory mediators including MCP-1 (in the plasma), TNF-alpha and IL-6 (in the colon), and decreased the oxidative burst activities in the peripheral blood sample. Taken together, these results suggest the possibility that oral administration of LPSp can effectively ameliorate HFD-induced hyperlipidemia and inflammatory/oxidative responses to prevent atherosclerosis and related metabolic disorders.	[Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro] Kagawa Univ, Fac Med, Dept Integrated Immunol, Takamatsu, Kagawa, Japan; [Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro] Kagawa Univ, Fac Med, Dept Holist Immunol, Takamatsu, Kagawa, Japan; [Inagawa, Hiroyuki; Soma, Gen-Ichiro] Control Innate Immun Technol Res Assoc, Takamatsu, Kagawa, Japan; [Inagawa, Hiroyuki; Soma, Gen-Ichiro] Niigata Univ Pharm & Appl Life Sci, Res Inst Hlth Living, Niigata, Japan; [Kohchi, Chie] Macrophi Inc, Takamatsu, Kagawa, Japan; [Kazumura, Kimiko; Tsuchiya, Hiroshi; Miwa, Toshiyuki] Hamamatsu Photon KK, Cent Res Lab, Shizuoka, Japan; [Okazaki, Katsuichiro] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Takamatsu, Kagawa, Japan	Kagawa University; Kagawa University; Niigata University; Hamamatsu Photonics; Kagawa University	Kobayashi, Y (corresponding author), Kagawa Univ, Fac Med, Dept Integrated Immunol, Takamatsu, Kagawa, Japan.; Kobayashi, Y (corresponding author), Kagawa Univ, Fac Med, Dept Holist Immunol, Takamatsu, Kagawa, Japan.	kobayashi@shizenmeneki.org		Kobayashi, Yutaro/0000-0003-0253-077X	Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP); Council for Science, Technology and Innovation (CSTI), 'Technologies for creating next generation agriculture, forestry and fisheries' (funding agency: Bio-oriented Technology Research Advancement Institution, NARO)	Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP); Council for Science, Technology and Innovation (CSTI), 'Technologies for creating next generation agriculture, forestry and fisheries' (funding agency: Bio-oriented Technology Research Advancement Institution, NARO)	This work was supported by the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP) and 'Technologies for creating next generation agriculture, forestry and fisheries' (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CK is employed by Macrophi Inc. The funder provided support in the form of salary for author CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KK, HT and TM are employed by Hamamatsu Photonics K.K. The funder provided support in the form of salaries for authors KK, HT and TM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Amano S, 2015, ANTICANCER RES, V35, P4509; Andoh Y, 2013, IMMUNOBIOLOGY, V218, P561, DOI 10.1016/j.imbio.2012.07.022; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan YK, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0883-4; Cole JE, 2013, TRENDS PHARMACOL SCI, V34, P629, DOI 10.1016/j.tips.2013.09.008; Cui GM, 2013, ACTA PHARMACOL SIN, V34, P231, DOI 10.1038/aps.2012.155; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fukasaka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126849; Grundtman C, 2015, ATHEROSCLEROSIS, V242, P303, DOI 10.1016/j.atherosclerosis.2015.06.044; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; IGUCHI M, 1992, CHEM PHARM BULL, V40, P1004, DOI 10.1248/cpb.40.1004; INAGAWA H, 1992, CHEM PHARM BULL, V40, P998, DOI 10.1248/cpb.40.998; INAGAWA H, 1992, CHEM PHARM BULL, V40, P994, DOI 10.1248/cpb.40.994; Inagawa H, 2016, IN VIVO, V30, P205; Inagawa H, 2011, ANTICANCER RES, V31, P2431; Andres-Manzano MJ, 2015, METHODS MOL BIOL, V1339, P85, DOI 10.1007/978-1-4939-2929-0_5; Kazumura K, 2016, J CLIN BIOCHEM NUTR, V59, P1, DOI 10.3164/jcbn.16-4; Komori T, 2015, ANTICANCER RES, V35, P4461; Lewkowicz N, 2016, MUCOSAL IMMUNOL, V9, P364, DOI 10.1038/mi.2015.66; Lim MK, 2015, EXP THER MED, V9, P1369, DOI 10.3892/etm.2015.2238; LINDH E, 1991, APMIS, V99, P347, DOI 10.1111/j.1699-0463.1991.tb05160.x; Lofgren L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27688; Matsushima Y, 1999, MAMM GENOME, V10, P352, DOI 10.1007/s003359901000; Matsuyama N, 2001, J MED MICROBIOL, V50, P865, DOI 10.1099/0022-1317-50-10-865; Miyake Y, 2016, FOOD SCI TECHNOL RES, V22, P713, DOI 10.3136/fstr.22.713; Montenegro D, 2015, BIOORG MED CHEM LETT, V25, P466, DOI 10.1016/j.bmcl.2014.12.036; Nakata K, 2011, NUTR RES PRACT, V5, P435, DOI 10.4162/nrp.2011.5.5.435; Ni JQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/476856; NISHIZAWA T, 1992, CHEM PHARM BULL, V40, P479, DOI 10.1248/cpb.40.479; Nunes C, 2001, INT J FOOD MICROBIOL, V70, P53, DOI 10.1016/S0168-1605(01)00523-2; OKUTOMI T, 1992, CHEM PHARM BULL, V40, P1268; Peluso Ilaria, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P351; Rabot S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32484; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rom O, 2017, ARCH TOXICOL, V91, P1709, DOI 10.1007/s00204-016-1859-8; Ryan PM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0246-x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SKARNES RC, 1966, ANN NY ACAD SCI, V133, P644, DOI 10.1111/j.1749-6632.1966.tb52395.x; Takahashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087279; Takehara M, 2017, BIOCHEM BIOPH RES CO, V487, P419, DOI 10.1016/j.bbrc.2017.04.077; Tamura Y, 2015, ANTICANCER RES, V35, P4467; Taniguchi Y, 2009, ANTICANCER RES, V29, P859; van Puijvelde HM, 2007, ARTERIOSCL THROM VAS, V27, P2677, DOI 10.1161/ATVBAHA.107.151274; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Vonghia L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/239623; Wakame K, 2015, ANTICANCER RES, V35, P4501; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yokota T, 2016, J NUTR BIOCHEM, V32, P46, DOI 10.1016/j.jnutbio.2016.01.011; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257; Zhao YT, 2015, J AGR FOOD CHEM, V63, P4843, DOI 10.1021/acs.jafc.5b01246	56	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195008	10.1371/journal.pone.0195008	http://dx.doi.org/10.1371/journal.pone.0195008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584779	Green Published, gold, Green Submitted			2022-12-27	WOS:000428373000055
J	Shin, H; Park, YH; Kim, YG; Lee, JY; Park, J				Shin, Hyunwoo; Park, Yong Hyun; Kim, Yong-Goo; Lee, Ji Youl; Park, Jaesung			Aqueous two-phase system to isolate extracellular vesicles from urine for prostate cancer diagnosis	PLOS ONE			English	Article							CELL-DERIVED EXOSOMES; BIOMARKERS; ANTIGEN; SEPARATION; PARTITION; LIQUID	Analyzing extracellular vesicles (EVs) is an attractive approach to diagnosis of prostate diagnosis. However, existing methods of EVs isolation have low efficiency, purity, and long process time, and therefore have low diagnostic ability. To solve these the problems, a two-phase system is adapted to isolate EVs from a patient's urine. Urine from 20 prostate cancer (PCA) patients and 10 benign prostate hyperplasia patients was used to quantify the EVs-isolation ability of an aqueous two-phase system (ATPS) and to compare the diagnostic ability of ATPS with that of the conventional diagnosis method. An optimized ATPS isolates EVs with similar to 100% efficiency within similar to 30 min, with 14 times as high as achieved by ultracentrifugation. Afterward, PCR and ELISA are used to detect EVs derived from PCA cells in urine. The results demonstrate that diagnostic ability based on ATPS is better than other conventional diagnostic methods. ATPS can obtain a high quality and quantity of EVs from patients' urine. EVs contain cancer-related protein and genes, so these abundant sources enable diagnosis with high specificity and sensitivity. Therefore, ATPS is a useful tool to increase the specificity and sensitivity of diagnosis.	[Shin, Hyunwoo; Park, Jaesung] POSTECH, Dept Mech Engn, Pohang, South Korea; [Park, Yong Hyun; Lee, Ji Youl] Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, Seoul, South Korea; [Kim, Yong-Goo] Catholic Univ Korea, Marys Hosp, Dept Lab Med, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Park, J (corresponding author), POSTECH, Dept Mech Engn, Pohang, South Korea.; Lee, JY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, Seoul, South Korea.	uroljy@catholic.ac.kr; jpark@postech.ac.kr			Korea Health Industry Development Institute grant (KHIDI) - Korea government [HI16C0665]	Korea Health Industry Development Institute grant (KHIDI) - Korea government	This work was supported by Korea Health Industry Development Institute grant (KHIDI) funded by the Korea government (No. HI16C0665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSSON PA, 1958, BIOCHIM BIOPHYS ACTA, V27, P378, DOI 10.1016/0006-3002(58)90345-7; Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; Coren LV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-64; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Davies RT, 2012, LAB CHIP, V12, P5202, DOI 10.1039/c2lc41006k; Coelho FF, 2015, GENET MOL RES, V14, P13519, DOI 10.4238/2015.October.28.13; Freedland SJ, 2005, J UROLOGY, V174, P1276, DOI 10.1097/01.ju.0000173907.84852.ec; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; He CY, 2005, J CHROMATOGR A, V1082, P143, DOI [10.1016/j.chroma.2005.05.065, 10.1016/j.chroma.2005.04.054]; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Hessels D, 2007, CLIN CANCER RES, V13, P5103, DOI 10.1158/1078-0432.CCR-07-0700; JOHANSSO.G, 1970, BIOCHIM BIOPHYS ACTA, V222, P381, DOI 10.1016/0304-4165(70)90127-3; Kim J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129760; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; LANTZ PG, 1994, APPL ENVIRON MICROB, V60, P3416, DOI 10.1128/AEM.60.9.3416-3418.1994; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Nawaz M, 2014, NAT REV UROL, V11, P688, DOI 10.1038/nrurol.2014.301; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Park YH, 2016, SCI REPORTS, P6; Rabesandratana H, 1998, BLOOD, V91, P2573, DOI 10.1182/blood.V91.7.2573.2573_2573_2580; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Ralib AM, 2011, J AM SOC NEPHROLOGY; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Shao HL, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150180; Shin H, 2015, SCI REPORTS, P5; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C., 2006, CURR PROTOC CELL BIO, V3, P1; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Viau C, 2004, INT ARCH OCC ENV HEA, V77, P177, DOI 10.1007/s00420-003-0495-9; WALTER H, 1976, BIOCHEMISTRY-US, V15, P2959, DOI 10.1021/bi00659a004; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	35	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194818	10.1371/journal.pone.0194818	http://dx.doi.org/10.1371/journal.pone.0194818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584777	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000039
J	Zhu, WB; Yan, J; Song, JR; You, P				Zhu, Wenbo; Yan, Jun; Song, Jingrui; You, Ping			The first mitochondrial genomes for Pyralinae (Pyralidae) and Glaphyriinae (Crambidae), with phylogenetic implications of Pyraloidea	PLOS ONE			English	Article							PRAYING-MANTISES DICTYOPTERA; LEPIDOPTERA; EVOLUTION	In the present study, we report five complete and one nearly complete mitochondrial genomes of the Pyraloidea including the first representatives from the Pyralinae (Pyralidae) and Glaphyriinae (Crambidae). We also conduct a comparative analysis of mitogenomic features of this group. Our results show that Pyraloidea mitogenomes evolved under a common trend found in lepidopteran mitogenomes and share several typical genomic characters. The extra conserved blocks are identified in the Pyraloidea control region, and diverse missing codons formed another unique trait within Pyraloidea mitogenome. Furthermore, we reconstruct the mitogenomic phylogeny of Pyraloidea and confirm the phylogenetic position of Pyralinae and Glaphyriinae within the Pyraloidea using BI and ML method based on multiple mitochondrial datasets.	[Zhu, Wenbo; Yan, Jun; Song, Jingrui; You, Ping] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China; [Zhu, Wenbo] Northwestern Polytech Univ, Res Ctr Ecoenvironm Sci, Xian, Shaanxi, Peoples R China	Shaanxi Normal University; Northwestern Polytechnical University	You, P (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China.	youping@snnu.edu.cn		You, Ping/0000-0002-2913-1544	National Natural Science Foundation of China [31372158]; Natural Science Foundation of Shaanxi Province [2017JM3014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This study was supported by grants from the National Natural Science Foundation of China (31372158) and the Natural Science Foundation of Shaanxi Province (2017JM3014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2011, BIOTROPICA, V43, P208, DOI 10.1111/j.1744-7429.2010.00689.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Gong YJ, 2012, MOL BIOL REP, V39, P2893, DOI 10.1007/s11033-011-1049-y; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li H., 2012, MICROLEPIDOPTERA QIN; Li Q, 2016, GENOME BIOL EVOL, V8, P2651, DOI 10.1093/gbe/evw184; Li XK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040773; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma HF, 2016, J ASIA-PAC ENTOMOL, V19, P697, DOI 10.1016/j.aspen.2016.05.011; Mitter C, 2017, ANNU REV ENTOMOL, V62, P265, DOI 10.1146/annurev-ento-031616-035125; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Shi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30660; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Solis M. Alma, 2002, Belgian Journal of Entomology, V4, P53; SOLIS MA, 1992, SYST ENTOMOL, V17, P79, DOI 10.1111/j.1365-3113.1992.tb00323.x; Staden R, 2000, Methods Mol Biol, V132, P115; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku917; Timmermans MJTN, 2014, MOL PHYLOGENET EVOL, V79, P169, DOI 10.1016/j.ympev.2014.05.031; Yang XS, 2015, MOL PHYLOGENET EVOL, V85, P230, DOI 10.1016/j.ympev.2015.02.005; Ye F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25634; Ye F, 2013, AQUAT INSECT, V35, P71, DOI 10.1080/01650424.2014.948456; Yong HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15155; You P, 2003, AQUAT INSECT, V25, P211, DOI 10.1076/aqin.25.3.211.15264; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhang HL, 2017, INT J BIOL SCI, V13, P367, DOI 10.7150/ijbs.17035; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhu WB, 2016, MITOCHONDRIAL DNA A, V27, P4528, DOI 10.3109/19401736.2015.1101547	35	7	8	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194672	10.1371/journal.pone.0194672	http://dx.doi.org/10.1371/journal.pone.0194672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584761	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000031
J	Gicevic, S; Gaskins, AJ; Fung, TT; Rosner, B; Tobias, DK; Isanaka, S; Willett, WC				Gicevic, Selma; Gaskins, Audrey J.; Fung, Teresa T.; Rosner, Bernard; Tobias, Deirdre K.; Isanaka, Sheila; Willett, Walter C.			Evaluating pre-pregnancy dietary diversity vs. dietary quality scores as predictors of gestational diabetes and hypertensive disorders of pregnancy	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; LOW-CARBOHYDRATE; WEIGHT-GAIN; LIFE-STYLE; RISK; MELLITUS; PREECLAMPSIA; PATTERNS; REPRODUCIBILITY; VALIDITY	Background Dietary diversity scores (DDS) are considered as metrics for monitoring the implementation of the UN's Sustainable Development Goals, but they need to be rigorously evaluated. Objective To examine two DDS, the Food Groups Index (FGI), and the Minimum Dietary Diversity Women (MDD-W), alongside two dietary quality scores, the Alternate Healthy Eating Index (AHEI-2010) and the Prime Diet Quality Score (PDQS), with risks of gestational diabetes mellitus (GDM) and hypertensive disorders of pregnancy (HDPs). Design The analysis included 21,312 (GDM) and 19,917 (HDPs) singleton births reported in the Nurses' Health Study II cohort (1991-2001), among women without major chronic disease or GDM/HDPs. Scores were derived using prepregnancy diet collected by a comprehensive food frequency questionnaire. Multivariable models were utilized to calculate relative risks (RR) and confidence intervals (95%CIs). Results Incident GDM (n = 916) and HDPs (n = 1,421) were reported. The MDD-W and FGI were not associated with risk of GDM or HDPs, but the AHEI-2010 and PDQS were associated with a lower risk of GDM and marginally lower risk of HDP. The RR's of GDM comparing the highest vs. lowest quintiles were 1.00 (95%CI: 0.79, 1.27; p-trend = 0.82) for MDD-W, 0.96 (95%CI: 0.76, 1.22; p-trend = 0.88) for FGI, 0.63 (95%CI: 0.50, 0.81; p-trend <0.0001) for the AHEI-2010 and 0.68 (95%CI: 0.54, 0.86; p-trend = 0.003) for the PDQS. Similarly, the RR's of HDPs were 0.92 (95%CI: 0.75, 1.12, p-trend = 0.94) for MDD-W, 0.97 (95%CI: 0.79, 1.17; p-trend = 0.83) for FGI, 0.84 (95%CI: 0.70, 1.02; p-trend = 0.07) for AHEI-2010 and 0.89 (95%CI: 0.74, 1.09; p-trend = 0.07) for PDQS. Conclusions MDD-W and FGI did not predict the risk of GDM and HDPs. These DDS should not be widely used as metrics for achieving dietary goals in their present form. The Prime Diet Quality Score warrants further testing as a promising measure of a sustainable and healthy diet on a global scale.	[Gicevic, Selma; Gaskins, Audrey J.; Fung, Teresa T.; Isanaka, Sheila; Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Gaskins, Audrey J.; Rosner, Bernard; Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Rosner, Bernard] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Tobias, Deirdre K.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Isanaka, Sheila] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Simmons University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Gicevic, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	selma.gicevic@mail.harvard.edu	Isanaka, Sheila/AAQ-9056-2020	Kronsteiner-Gicevic, Selma/0000-0002-5414-8671	National Institutes of Health [UM1 CA176726]; NIH National Institute of Environmental Health Sciences [K99ES026648]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [K01DK103720-01]; NATIONAL CANCER INSTITUTE [UM1CA176726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK103720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES026648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by UM1 CA176726 (National Institutes of Health, https://www.nih.gov/, NHSII cohort infrastructure grant); K99ES026648 (NIH National Institute of Environmental Health Sciences, https://www.niehs.nih.gov/, AJG); K01DK103720-01 (NIH National Institute of Diabetes and Digestive and Kidney Diseases, https://www.niddk.nih.gov/, DKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Fatima, 2014, J Ayub Med Coll Abbottabad, V26, P506; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Bao W, 2014, AM J CLIN NUTR, V99, P1378, DOI 10.3945/ajcn.113.082966; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; Bezerra IN, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-22; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; EATF, 2015, INT IND SUST FOOD SY; FANTA, 2006, 360 FANTA FHI; FANTA, 2015, 360FANTA FHI; FAO U, 2006, LIV LONG SHAD; Fung TT, 2017, AM J CLIN N IN PRESS; Garnett T., 2014, WHAT IS SUSTAINABLE, P31; Gruslin A, 2011, BEST PRACT RES CL OB, V25, P491, DOI 10.1016/j.bpobgyn.2011.02.004; IAEG, 2015, COMP MET REC IND GLO; IDF, 2016, GDM RES 2015; Intapad S, 2013, CURR CARDIOVASC RISK, V7, P183, DOI 10.1007/s12170-013-0303-3; International Council for Science and International Social Science Council (ICSU and ISSC), 2015, REV TARG SUST DEV GO; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Kernebeek H, 8 INT C LCA AGR SECT; Langer A, 2008, LANCET, V371, P705, DOI 10.1016/S0140-6736(08)60321-9; Macdiarmid JI, 2013, P NUTR SOC, V72, P13, DOI 10.1017/S0029665112002893; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Muti M, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0110-5; Oken E, 2007, ANN EPIDEMIOL, V17, P663, DOI 10.1016/j.annepidem.2007.03.003; Otto MCD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141341; Plagemann A, 2011, EARLY HUM DEV, V87, P743, DOI 10.1016/j.earlhumdev.2011.08.018; Rah JH, 2010, EUR J CLIN NUTR, V64, P1393, DOI 10.1038/ejcn.2010.171; Rifas-Shiman SL, 2001, PUBLIC HEALTH NUTR, V4, P249, DOI 10.1079/PHN200061; Salehi-Abargouei A, 2016, EUR J CLIN NUTR, V70, P1, DOI 10.1038/ejcn.2015.118; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schoenaker DAJM, 2016, DIABETES CARE, V39, P16, DOI 10.2337/dc15-0540; Schoenaker DAJM, 2015, AM J CLIN NUTR, V102, P94, DOI 10.3945/ajcn.114.102475; Schoenaker DAJM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0157-7; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Timmermans S, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.013; Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266; US. Department of Agriculture Agricultural Research Service, 2016, USDA NAT NUTR DAT ST; Vadiveloo M, 2014, BRIT J NUTR, V112, P1562, DOI 10.1017/S0007114514002049; WHO, 2013, COUNTD 2015 MAT NEWB; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wright MJ, 2015, PUBLIC HEALTH NUTR, V18, P1762, DOI 10.1017/S1368980015000427; Yuan CZ, 2017, AM J EPIDEMIOL, V185, P570, DOI 10.1093/aje/kww104; Zhang C, 2006, DIABETOLOGIA, V49, P2604, DOI 10.1007/s00125-006-0422-1; Zhang CL, 2006, DIABETES CARE, V29, P2223, DOI 10.2337/dc06-0266; Zhang CL, 2011, AM J CLIN NUTR, V94, p1975S, DOI 10.3945/ajcn.110.001032	54	37	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195103	10.1371/journal.pone.0195103	http://dx.doi.org/10.1371/journal.pone.0195103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614105	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600031
J	Liu, JL; Zhu, B; Mao, Y				Liu, Jinlin; Zhu, Bin; Mao, Ying			Association between rural clinical clerkship and medical students' intentions to choose rural medical work after graduation: A cross-sectional study in western China	PLOS ONE			English	Article							CAREER INTENTIONS; EDUCATION; PROGRAM; UNDERGRADUATE; PERSPECTIVES; RETENTION; PHARMACY; CHOICE; SCHOOL; IMPACT	Background A large number of programs have been implemented in many countries to increase the healthcare workforce recruitment in rural and remote areas. Rural early exposure programs for medical students have been shown to be effective strategies. However, no related studies have been reported before in China. This study was carried out to determine the association between medical students' participation in rural clinical clerkships and their intentions to choose rural medical work after graduation from western medical schools in China. Methods Based on a two-stage random sampling method, the cross-sectional survey was carried out in ten western provinces in China. A brief questionnaire filled in by medical students was used for data collection. A total of 4278 medical students participated in the study. The response rate was approximately 90.34%. Pearson's chi-squared tests and binary logistic regression analyses were performed for data analyses. Results Approximately 52.0% of medical students disclosed intentions to work in rural medical institutions after graduation. Only one in five participants had experience with a rural clinical clerkship. Rural clinical clerkships were significantly associated with medical students' intentions to work in rural medical institutions (OR: 1.24, 95%Cl: 1.05-1.46); further analyses indicated that such clerkships only had a significant impact among the medical students with an urban background (OR: 2.10, 95`)/X1: 1.48-2.97). In terms of the sociodemographic characteristics, younger age, low level of parental education, majoring in general practice, and studying in low-level medical schools increased the odds of having intentions to engage in rural medical work among medical students; however, rural origins was the only positive univariate predictor. In addition, the predictors of intentions to choose rural medical work were different between medical students with a rural background and those with an urban background. Conclusions Rural clinical clerkship is likely to increase the odds of having intentions to work in rural medical institutions after graduation among medical students in western China, especially for those with an urban background. Related policy makers could consider developing compulsory rural clerkship programs and implement them among medical students to increase early rural exposure.	[Liu, Jinlin; Zhu, Bin; Mao, Ying] Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China; [Zhu, Bin] City Univ Hong Kong, Dept Publ Policy, Hong Kong, Hong Kong, Peoples R China	Xi'an Jiaotong University; City University of Hong Kong	Mao, Y (corresponding author), Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China.	mao_ying@mail.xjtu.edu.cn	Liu, Jinlin/J-3794-2018	Liu, Jinlin/0000-0002-7655-8532; Zhu, Bin/0000-0002-0091-6356; Mao, Ying/0000-0002-8271-2524	China Medical Board [10-029]	China Medical Board	This study was funded by China Medical Board (grant number: 10-029; https:/www.chinamedicalboard.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the China Medical Board (10-029) and technically supported by experts from the WHO. We appreciate Dr. Fethiye Gulin Gedikg and Dr. Chunmei Wen from the WHO for the sufficient technical support for the questionnaire design. In addition, we also appreciate all the data collectors, medical school managers, and medical students for their cooperation and support.	Ahmed SMM, 2011, ADV MED EDUC PRACT, V2, P51, DOI 10.2147/AMEP.S13451; Andrew R, 2015, AFR J PRIM HEALTH CA, V7, P1, DOI DOI 10.4102/PHCFM.V7I1.739; Arscott-Mills T, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i1.1039; Bailey N, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-87; Barrett FA, 2011, ACAD MED, V86, P259, DOI 10.1097/ACM.0b013e3182046387; Borracci RA, 2015, RURAL REMOTE HEALTH, V15; Bowman RC, 2003, J RURAL HEALTH, V19, P214, DOI 10.1111/j.1748-0361.2003.tb00564.x; Budhathoki SS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013501; Burch V C, 2011, Educ Health (Abingdon), V24, P614; Capstick S, 2008, AUST J RURAL HEALTH, V16, P150, DOI 10.1111/j.1440-1584.2008.00965.x; Chuenkongkaew WL, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0719-9; Deressa W, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-68; Diwan V, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-127; Grobler L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005314.pub2; Halaas GW, 2008, J RURAL HEALTH, V24, P345, DOI 10.1111/j.1748-0361.2008.00180.x; Huntington I, 2012, HEALTH POLICY PLANN, V27, P417, DOI 10.1093/heapol/czr052; Ishimaru N, 2015, ASIA PACIFIC FAMILY, V14; Jones MP, 2014, MED EDUC, V48, P405, DOI 10.1111/medu.12399; Kirschbaum M, 2016, CURR PHARM TEACH LEA, V8, P615, DOI 10.1016/j.cptl.2016.06.002; Li X, 2012, HIGHER ED SOCIAL SCI, V3; National Bureau of Statistics of China, 2016, CHIN STAT YB 2016; National Health and Family Planning Commission of China, 2015, CHIN HLTH FAM PLANN; Playford D, 2017, MED J AUSTRALIA, V207, P154, DOI 10.5694/mja16.01322; Playford DE, 2014, MED J AUSTRALIA, V200, P104, DOI 10.5694/mja13.11082; Puddey IB, 2017, BMC MED EDUC, P17; Qing YB, 2015, J EDUC EVAL HEALTH P, V12, DOI 10.3352/jeehp.2015.12.40; Rabinowitz HK, 2005, ACAD MED, V80, P728, DOI 10.1097/00001888-200508000-00004; Roberts C, 2012, MED EDUC, V46, P179, DOI 10.1111/j.1365-2923.2011.04102.x; Sapkota BP, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0084-5; Sen Gupta T, 2014, RURAL REMOTE HEALTH, V14; Shamian Judith, 2016, Br J Nurs, V25, P54, DOI 10.12968/bjon.2016.25.1.54; Smucny J, 2005, ACAD MED, V80, P733, DOI 10.1097/00001888-200508000-00006; Somers GT, 2012, AUST J RURAL HEALTH, V20, P80, DOI 10.1111/j.1440-1584.2012.01258.x; Van Wyk JM, 2010, S AFR FAM PRACT, V52, P149, DOI 10.1080/20786204.2010.10873958; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; Wilkinson D, 2003, MED EDUC, V37, P809, DOI 10.1046/j.1365-2923.2003.01596.x; Winn CS, 2014, RURAL REMOTE HEALTH, V14; Zhang LL, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0472-5	38	11	11	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195266	10.1371/journal.pone.0195266	http://dx.doi.org/10.1371/journal.pone.0195266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608624	gold, Green Submitted, Green Published			2022-12-27	WOS:000428988800044
J	Zhang, LJ; Guo, CY; Jia, XD; Xu, HH; Pan, MZ; Xu, D; Shen, XB; Zhang, JH; Tan, JG; Qian, HL; Dong, CY; Shi, YW; Zhou, XD; Wu, C				Zhang, Lijun; Guo, Changyi; Jia, Xiaodong; Xu, Huihui; Pan, Meizhu; Xu, Dong; Shen, Xianbiao; Zhang, Jianghua; Tan, Jianguo; Qian, Hailei; Dong, Chunyang; Shi, Yewen; Zhou, Xiaodan; Wu, Chen			Personal exposure measurements of school-children to fine particulate matter (PM2.5) in winter of 2013, Shanghai, China	PLOS ONE			English	Article							YANGTZE-RIVER DELTA; SCHOOL CLASSROOMS; AIR-POLLUTION; GLOBAL BURDEN; CHILDREN; FILTRATION; OUTDOOR; DISEASE; QUALITY; RISKS	Objective The aim of this study was to perform an exposure assessment of PM2.5 (particulate matter less than 2.5 mu m in aerodynamic diameter) among children and to explore the potential sources of exposure from both indoor and outdoor environments. Methods In terms of real-time exposure measurements of PM2.5, we collected data from 57 children aged 8-12 years (9.64 +/- 0.93 years) in two schools in Shanghai, China. Simultaneously, questionnaire surveys and time-activity diaries were used to estimate the environment at home and daily time-activity patterns in order to estimate the exposure dose of PM2.5 in these children. Principle component regression analysis was used to explore the influence of potential sources of PM2.5 exposure. Results All the median personal exposure and microenvironment PM2.5 concentrations greatly exceeded the daily 24-h PM2.5 Ambient Air Quality Standards of China, the USA, and the World Health Organization (WHO). The median E-total (the sum of the PM2.5 exposure levels in different microenvironment and fractional time) of all students was 3014.13 (mu g.h)/m(3). The concentration of time-weighted average (TWA) exposure of all students was 137.01 mu g/m(3). The median TWA exposure level during the on-campus period (135.81 mu g/m(3)) was significantly higher than the off-campus period (115.50 mu g/m(3), P = 0.013 < 0.05). Besides ambient air pollution and meteorological conditions, storey height of the classroom and mode of transportation to school were significantly correlated with children's daily PM2.5 exposure. Conclusions Children in the two selected schools were exposed to high concentrations of PM2.5 in winter of 2013 in Shanghai. Their personal PM2.5 exposure was mainly associated with ambient air conditions, storey height of the classroom, and children's transportation mode to school.	[Zhang, Lijun; Xu, Huihui; Pan, Meizhu; Zhang, Jianghua; Qian, Hailei; Dong, Chunyang; Shi, Yewen; Zhou, Xiaodan; Wu, Chen] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai Inst Prevent Med, Div Heath Risk Factors Monitoring & Control, Environm Hlth Dept, Shanghai, Peoples R China; [Guo, Changyi] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai Inst Prevent Med, Gen Off, Shanghai, Peoples R China; [Jia, Xiaodong] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai Inst Prevent Med, Div Heath Risk Factors Monitoring & Control, Shanghai, Peoples R China; [Xu, Dong] Shanghai Xuhui Ctr Dis Control & Prevent, Environm Hlth Dept, Shanghai, Peoples R China; [Shen, Xianbiao] Shanghai Baoshan Ctr Dis Control & Prevent, Environm Hlth Dept, Shanghai, Peoples R China; [Tan, Jianguo] Shanghai Meteorol Serv, Shanghai Key Lab Meteorol & Hlth, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Xu, HH (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Shanghai Inst Prevent Med, Div Heath Risk Factors Monitoring & Control, Environm Hlth Dept, Shanghai, Peoples R China.	xuhuihui@scdc.sh.cn			Public Health Personnel Training Program of China; United States-Fogarty Foundation [TW005741-07]; Foundation of Shanghai Municipal Family Commission of Health and Family Planning [20134289]; Public Health Key Discipline Construction of Shanghai Municipal Family Commission of Health and Family Planning-Environmental and Occupational Health [15GWZK0201]	Public Health Personnel Training Program of China; United States-Fogarty Foundation; Foundation of Shanghai Municipal Family Commission of Health and Family Planning; Public Health Key Discipline Construction of Shanghai Municipal Family Commission of Health and Family Planning-Environmental and Occupational Health	This study was funded by Public Health Personnel Training Program of China and the United States-Fogarty Foundation and through a research grant (TW005741-07) (LZ); the Foundation of Shanghai Municipal Family Commission of Health and Family Planning [grant numbers] (Grant No. 20134289) (LZ); Public Health Key Discipline Construction of Shanghai Municipal Family Commission of Health and Family Planning-Environmental and Occupational Health (Grant No. 15GWZK0201) (XJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Oliveira BFA, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-64; Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Beko G, 2008, BUILD ENVIRON, V43, P1647, DOI 10.1016/j.buildenv.2007.10.006; Brown KW, 2008, J ENVIRON MONITOR, V10, P1041, DOI 10.1039/b805991h; Buonanno G, 2013, ATMOS ENVIRON, V79, P53, DOI 10.1016/j.atmosenv.2013.06.041; Buonanno G, 2012, SCI TOTAL ENVIRON, V438, P271, DOI 10.1016/j.scitotenv.2012.08.074; Buonanno G, 2012, ENVIRON POLLUT, V169, P183, DOI 10.1016/j.envpol.2012.03.002; Chan WR, 2016, INDOOR AIR, V26, P331, DOI 10.1111/ina.12189; Ferreira AMC, 2013, REV SAUDE PUBL, V47, P1059, DOI 10.1590/S0034-8910.2013047004810; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; EPA US, 2006, AIR QUAL CRIT PART M; Fromme H, 2008, ATMOS ENVIRON, V42, P6597, DOI 10.1016/j.atmosenv.2008.04.047; GOLDMAN LR, 1995, ENVIRON HEALTH PERSP, V103, P13, DOI 10.2307/3432338; Huang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141642; Huang J, 2012, SCI TOTAL ENVIRON, V425, P52, DOI 10.1016/j.scitotenv.2012.03.007; Huang LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138559; Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607; Jiang RT, 2011, J ENVIRON MONITOR, V13, P1695, DOI 10.1039/c0em00732c; Klepeis NE, 1999, ENVIRON HEALTH PERSP, V107, P365, DOI 10.2307/3434429; Kwon SB, 2015, J HAZARD MATER, V297, P295, DOI 10.1016/j.jhazmat.2015.05.015; Li MN, 2014, ENVIRON POLLUT, V189, P85, DOI 10.1016/j.envpol.2014.02.024; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu Q, 2017, SCI TOTAL ENVIRON, V574, P1502, DOI 10.1016/j.scitotenv.2016.08.152; MACINTOSH DL, 1995, J EXPO ANAL ENV EPID, V5, P375; MEP C, 2012, 30952012 MEPC GB; Ming LL, 2017, ENVIRON POLLUT, V223, P200, DOI 10.1016/j.envpol.2017.01.013; Montgomery JF, 2015, BUILD ENVIRON, V85, P17, DOI 10.1016/j.buildenv.2014.11.005; Morawska L, 2003, ATMOS ENVIRON, V37, P4195, DOI 10.1016/S1352-2310(03)00566-1; Osman LM, 2007, AM J RESP CRIT CARE, V176, P465, DOI 10.1164/rccm.200605-589OC; Pelucchi C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-453; ROGAN WJ, 1995, ENVIRON HEALTH PERSP, V103, P19, DOI 10.2307/3432339; Rovelli S, 2014, INT J ENV RES PUB HE, V11, P1398, DOI 10.3390/ijerph110201398; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Wang F, 2016, ENVIRON POLLUT, V215, P280, DOI 10.1016/j.envpol.2016.05.023; World Health Organization, 2006, WHO AIR QUAL GUID PA; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yanosky JD, 2002, ATMOS ENVIRON, V36, P107, DOI 10.1016/S1352-2310(01)00422-8; Zanobetti A, 2009, AM J CARDIOL, V104, P665, DOI 10.1016/j.amjcard.2009.04.046; Zuraimi MS, 2015, BUILD ENVIRON, V89, P336, DOI 10.1016/j.buildenv.2015.03.010	40	21	23	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193586	10.1371/journal.pone.0193586	http://dx.doi.org/10.1371/journal.pone.0193586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608594	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800004
J	Parizi, KB; Akin, D; Wong, HSP				Parizi, Kokab B.; Akin, Demir; Wong, H. -S. Philip			Internalization of subcellular-scale microfabricated chips by healthy and cancer cells	PLOS ONE			English	Article							SILICON CHIPS; LIVING CELLS; SIZE; NANOFABRICATION; PHAGOCYTOSIS; POLYSILICON; PARTICLES; BARCODES; TRACKING; SYSTEM	Continuous monitoring of physiological parameters inside a living cell will lead to major advances in our understanding of biology and complex diseases, such as cancer. It also enables the development of new medical diagnostics and therapeutics. Progress in nano-fabrication and wireless communication has opened up the potential of making a wireless chip small enough that it can be wholly inserted into a living cell. To investigate how such chips could be internalized into various types of living single cells and how this process might affect cells' physiology, we designed and fabricated a series of multilayered micron-scale tag structures with different sizes as potential RFID (Radio Frequency IDentification) cell trackers. While the present structures are test structures that do not resonate, the tags that do resonate have similar structure from device fabrication, material properties, and device size point of view. The structures are in four different sizes, the largest with the lateral dimension of 9 mu m x 21 mu m. The thickness for these structures is kept constant at 1.5 mu m. We demonstrate successful delivery of our fabricated chips into various types of living cells, such as melanoma skin cancer, breast cancer, colon cancer and healthy/normal fibroblast skin cells. To our surprise, we observed a remarkable internalization rate difference between each cell type; the uptake rate was faster for more aggressive cancer cells than the normal/healthy cells. Cell viability before and after tag cellular internalization and persistence of the internalized tags have also been recorded over the course of five days of incubation. These results establish the foundations of the possibility of long term, wireless, intracellular physiological signal monitoring.	[Parizi, Kokab B.; Wong, H. -S. Philip] Stanford Univ, Sch Engn, Dept Elect Engn, Stanford, CA 94305 USA; [Akin, Demir] Stanford Univ, Sch Med, Dept Radiol, Ctr Canc Nanotechnol Excellence, Stanford, CA 94305 USA	Stanford University; Stanford University	Parizi, KB (corresponding author), Stanford Univ, Sch Engn, Dept Elect Engn, Stanford, CA 94305 USA.	kokab@alumni.stanford.edu	Akin, Demir/D-3581-2012	Akin, Demir/0000-0002-2296-4674	Stanford Bio-X Seed Grant; Center for Cancer Nanotechnology Excellence at Stanford through National Cancer Institute (NCI) of the National Institutes of Health (NIH) [U54 CM 99075]; ARRA from the National Center for Research Resources (NCRR) [1S10RR026780-01]; NATIONAL CANCER INSTITUTE [U54CA199075] Funding Source: NIH RePORTER	Stanford Bio-X Seed Grant; Center for Cancer Nanotechnology Excellence at Stanford through National Cancer Institute (NCI) of the National Institutes of Health (NIH); ARRA from the National Center for Research Resources (NCRR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by Stanford Bio-X Seed Grant (there is no grant number). The website is: https://biox.stanford.edu/. It was also supported partially by the Center for Cancer Nanotechnology Excellence at Stanford through an award (U54 CM 99075) from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and finally it was supported in part by ARRA award number 1S10RR026780-01 from the National Center for Research Resources (NCRR). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancourt T, 2006, INT J NANOMED, V1, P483, DOI 10.2147/nano.2006.1.4.483; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Chen LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02295; Chen Y, 2001, ELECTROPHORESIS, V22, P187, DOI 10.1002/1522-2683(200101)22:2<187::AID-ELPS187>3.0.CO;2-0; Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702; Fernandez-Rosas E, 2010, BIOMED MICRODEVICES, V12, P371, DOI 10.1007/s10544-009-9393-6; Fernandez-Rosas E, 2009, SMALL, V5, P2433, DOI 10.1002/smll.200900733; French PJ, 2002, SENSOR ACTUAT A-PHYS, V99, P3, DOI 10.1016/S0924-4247(01)00876-7; Gomez-Martinez R, 2013, NAT NANOTECHNOL, V8, P517, DOI [10.1038/NNANO.2013.118, 10.1038/nnano.2013.118]; Gomez-Martinez R, 2010, SMALL, V6, P499, DOI 10.1002/smll.200901041; Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Ho JS, 2014, P NATL ACAD SCI USA, V111, P7974, DOI 10.1073/pnas.1403002111; Hu X, 2015, MICROTAS, P25; Hu XL, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.014031; McCarthy JR, 2006, SMALL, V2, P983, DOI 10.1002/smll.200600139; Molleman A., 2003, PATCH CLAMPING INTRO; Novo S, 2011, HUM REPROD, V26, P96, DOI 10.1093/humrep/deq309; Rogers WJ, 2006, NAT CLIN PRACT CARD, V3, P554, DOI 10.1038/ncpcardio0659; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Wightman RM, 2006, SCIENCE, V311, P1570, DOI 10.1126/science.1120027; Wilhelm C, 2008, BIOMATERIALS, V29, P3161, DOI 10.1016/j.biomaterials.2008.04.016	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194712	10.1371/journal.pone.0194712	http://dx.doi.org/10.1371/journal.pone.0194712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601607	gold, Green Published, Green Submitted			2022-12-27	WOS:000428845900009
J	De Francesco, D; Wit, FW; Cole, JH; Kootstra, NA; Winston, A; Sabin, CA; Underwood, J; van Zoest, RA; Schouten, J; Kooij, KW; Prins, M; Guaraldi, G; Caan, MWA; Burger, D; Franceschi, C; Libert, C; Burkie, A; Reiss, P				De Francesco, Davide; Wit, Ferdinand W.; Cole, James H.; Kootstra, Neeltje A.; Winston, Alan; Sabin, Caroline A.; Underwood, Jonathan; van Zoest, Rosan A.; Schouten, Judith; Kooij, Katherine W.; Prins, Maria; Guaraldi, Giovanni; Caan, Matthan W. A.; Burger, David; Franceschi, Claudio; Libert, Claude; Buerkie, Alexander; Reiss, Peter		COmorBidity Relation AIDS cobra	The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics	PLOS ONE			English	Article							LIFE EXPECTANCY; HIV-1 INFECTION; MORTALITY; PEOPLE; PREVENTION; MORBIDITY	Background Persons living with HIV on combination antiretroviral therapy (cART) may be at increased risk of the development of age-associated non-communicable comorbidities (AANCC) at relatively young age. It has therefore been hypothesised that such individuals, despite effective cART, may be prone to accelerated aging. Objective The COmorBidity in Relation to AIDS (COBRA) cohort study was designed to investigate the potential causal link between HIV and AANCC, amongst others, in a cohort of middle-aged individuals with HIV with sustained viral suppression on cART and otherwise comparable HIV-negative controls. Methods Longitudinal cohort study of HIV-positive subjects >= 45 years of age, with sustained HIV suppression on cART recruited from two large European HIV treatment centres and similarly-aged HIV-negative controls recruited from sexual health centres and targeted community groups. Both HIV-positive and HIV-negative subjects were assessed at study entry and again at follow-up after 2 years. Results Of the 134 HIV-positive individuals with a median (IQR) age of 56 (51, 62) years recruited, 93% were male, 88% of white ethnicity and 86% were men who have sex with men (MSM). Similarly, the 79 HIV-negative subjects had a median (IQR) age of 57 (52, 64) and 92% were male, 97% of white ethnicity and 80% were MSM. Conclusions The results from the COBRA study will be a significant resource to understand the link between HIV and AANCC and the pathogenic mechanisms underlying this link. COBRA will inform future development of novel prognostic tools for earlier diagnosis of AANCC and of novel interventions which, as an adjunct to cART, may prevent AANCC.	[De Francesco, Davide; Sabin, Caroline A.] UCL, London, England; [Wit, Ferdinand W.; Kootstra, Neeltje A.; van Zoest, Rosan A.; Schouten, Judith; Kooij, Katherine W.; Caan, Matthan W. A.; Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [Wit, Ferdinand W.] Stichting HIV Monitoring, Amsterdam, Netherlands; [Cole, James H.; Winston, Alan; Underwood, Jonathan] Imperial Coll London, London, England; [Prins, Maria] GGD Amsterdam, Publ Hlth Serv, Amsterdam, Netherlands; [Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Modena, Italy; [Burger, David] Stichting Katholieke Univ Nijmegen, Nijmegen, Netherlands; [Franceschi, Claudio] Alma Mater Studiorum Univ Bologna, Bologna, Italy; [Libert, Claude] Vlaams Inst Biotechnol, Ghent, Belgium; [Buerkie, Alexander] Univ Konstanz, Constance, Germany	University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Public Health Service Amsterdam; Universita di Modena e Reggio Emilia; University of Bologna; Flanders Institute for Biotechnology (VIB); University of Konstanz	De Francesco, D (corresponding author), UCL, London, England.	d.defrancesco@ucl.ac.uk	Guaraldi, Giovanni/J-9467-2018; Winston, Alan/AGZ-3015-2022; Cole, James H/I-5197-2019; Wit, Ferdinand/AAC-3803-2019; Kooij, Katherine/ABE-1415-2021	Winston, Alan/0000-0002-5847-8416; Cole, James H/0000-0003-1908-5588; Kootstra, Neeltje A./0000-0001-9429-7754; Caan, Matthan W.A./0000-0002-5162-8880; Underwood, Jonathan/0000-0001-6963-2821; De Francesco, Davide/0000-0002-6185-0514				Althoff KN, 2016, CURR OPIN HIV AIDS, V11, P527, DOI 10.1097/COH.0000000000000305; Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Booiman T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183357; Booiman T, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx108; Broom J, 2011, J INT ASS PHYS AIDS; Burkle A, 2015, MECH AGEING DEV, V151, P2, DOI 10.1016/j.mad.2015.03.006; Chiang MC, 2007, NEUROIMAGE, V34, P44, DOI 10.1016/j.neuroimage.2006.08.030; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cole JH, 2017, NEUROLOGY, V88, P1349, DOI [10.1212/WNL.0000000000003790, 10.1212/wnl.0000000000003790]; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; De Francesco D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1970-8; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; HIV Monitoring Foundation, 2015, HIV MON REP 2015; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; May Margaret, 2011, BMJ, V343, pd6016, DOI 10.1136/bmj.d6016; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schouten J, 2014, CLIN INFECT DIS; Schouten J, 2011, AIDS, V25, P561, DOI 10.1097/QAD.0b013e3283437f9a; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Underwood J, 2017, CLIN INFECT DIS OFFI; Van Zoest RA, 2017, J INFECT DIS; Wester CW, 2011, AIDS, V25, P1471, DOI 10.1097/QAD.0b013e328347f9d4; Winston A, 2013, NEUROCOGNITIVE FUNCT; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	32	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0191791	10.1371/journal.pone.0191791	http://dx.doi.org/10.1371/journal.pone.0191791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596425	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000002
J	Bagloee, SA; Sarvi, M				Bagloee, Saeed Asadi; Sarvi, Majid			An outer approximation method for the road network design problem	PLOS ONE			English	Article							GLOBAL OPTIMIZATION METHOD; BENDERS DECOMPOSITION; ALGORITHM; EQUILIBRIUM; MODELS; INFRASTRUCTURE; PROJECTS	Best investment in the road infrastructure or the network design is perceived as a fundamental and benchmark problem in transportation. Given a set of candidate road projects with associated costs, finding the best subset with respect to a limited budget is known as a bilevel Discrete Network Design Problem (DNDP) of NP-hard computationally complexity. We engage with the complexity with a hybrid exact-heuristic methodology based on a two-stage relaxation as follows: (i) the bilevel feature is relaxed to a single-level problem by taking the network performance function of the upper level into the user equilibrium traffic assignment problem (UE-TAP) in the lower level as a constraint. It results in a mixed-integer nonlinear programming (MINLP) problem which is then solved using the Outer Approximation (OA) algorithm (ii) we further relax the multi-commodity UE-TAP to a single-commodity MILP problem, that is, the multiple OD pairs are aggregated to a single OD pair. This methodology has two main advantages: (i) the method is proven to be highly efficient to solve the DNDP for a large-sized network of Winnipeg, Canada. The results suggest that within a limited number of iterations (as termination criterion), global optimum solutions are quickly reached in most of the cases; otherwise, good solutions (close to global optimum solutions) are found in early iterations. Comparative analysis of the networks of Gao and Sioux-Falls shows that for such a non-exact method the global optimum solutions are found in fewer iterations than those found in some analytically exact algorithms in the literature. (ii) Integration of the objective function among the constraints provides a commensurate capability to tackle the multi-objective (or multi-criteria) DNDP as well.	[Bagloee, Saeed Asadi; Sarvi, Majid] Univ Melbourne, Melbourne Sch Engn, Dept Infrastruct Engn, Smart Cities Transport Grp, Melbourne, Vic, Australia	University of Melbourne	Bagloee, SA (corresponding author), Univ Melbourne, Melbourne Sch Engn, Dept Infrastruct Engn, Smart Cities Transport Grp, Melbourne, Vic, Australia.	saeed.bagloee@unimelb.edu.au	sarvi, majid/A-2397-2009	Asadi Bagloee, Saeed/0000-0001-6078-6314				[Anonymous], 2017, WINNIPEG DATASET EMM; Bagloee Saeed Asadi, 2013, International Journal of Logistics Systems and Management, V16, P41; Bagloee Saeed A., 2012, International Journal of Logistics Systems and Management, V11, P114, DOI 10.1504/IJLSM.2012.044052; Bagloee SA, 2017, PUBLIC TRANSPORT, V9, P571, DOI 10.1007/s12469-017-0159-x; Bagloee SA, 2017, COMPUT-AIDED CIV INF, V32, P562, DOI 10.1111/mice.12261; Bagloee SA, 2017, COMPUT-AIDED CIV INF, V32, P319, DOI 10.1111/mice.12224; Bagloee SA, 2017, TRANSPORT PLAN TECHN, V40, P143, DOI 10.1080/03081060.2016.1266164; Bagloee SA, 2016, J MOD TRANSP, V24, P284, DOI 10.1007/s40534-016-0117-3; Bagloee SA, 2016, TRANSPORT RES A-POL, V94, P558, DOI 10.1016/j.tra.2016.10.019; Bagloee SA, 2016, TRANSPORT RES A-POL, V87, P102, DOI 10.1016/j.tra.2016.03.004; Bagloee SA, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/847324; Bagloee SA, 2015, TRANSPORT RES REC, P1, DOI 10.3141/2498-01; Bagloee SA, 2015, TRANSPORT RES A-POL, V75, P196, DOI 10.1016/j.tra.2015.03.016; Bagloee SA, 2014, TRANSPORTMETRICA A, V10, P437, DOI 10.1080/23249935.2013.787557; Bagloee SA, 2012, TRANSPORT RES REC, P1, DOI 10.3141/2319-01; BALAS E, 1972, SIAM J APPL MATH, V23, P61, DOI 10.1137/0123007; Bar-Gera H., 2016, TRANSPORTATION NETWO; Beckmann M.J., 1956, STUDIES EC TRANSPORT; BENAYED O, 1990, OPER RES, V38, P556, DOI 10.1287/opre.38.3.556; Bertsekas D., 1999, NONLINEAR PROGRAMMIN; Bertsekas D.P, 2010, CONVEX OPTIMIZATION; Borwein J., 2010, CONVEX ANAL NONLINEA; Cabanes G, 2015, BEHAV ECOL, V26, P223, DOI 10.1093/beheco/aru175; Chen XQ, 2015, TRANSPORT RES REC, P124, DOI 10.3141/2497-13; Colson B., 2005, 4OR-Q J OPER RES, V3, P87, DOI DOI 10.1007/S10288-005-0071-0; Dempe S, 2003, OPTIMIZATION, V52, P333, DOI 10.1080/0233193031000149894; DURAN MA, 1986, MATH PROGRAM, V36, P307, DOI 10.1007/BF02592064; Faivaresh H, 2011, TRANSPORT RES E-LOG, V47, P623, DOI 10.1016/j.tre.2011.02.001; Farahani RZ, 2013, EUR J OPER RES, V229, P281, DOI 10.1016/j.ejor.2013.01.001; Farvaresh H, 2013, NETW SPAT ECON, V13, P67, DOI 10.1007/s11067-012-9173-3; Floudas C. A, 1995, NONLINEAR MIXED INTE; Fontaine P, 2017, ANN OPER RES, V253, P757, DOI 10.1007/s10479-016-2171-y; Fontaine P, 2014, TRANSPORT RES B-METH, V70, P163, DOI 10.1016/j.trb.2014.09.007; Gao ZY, 2005, TRANSPORT RES B-METH, V39, P479, DOI 10.1016/j.trb.2004.06.004; Gonzalez AD, 2016, COMPUT-AIDED CIV INF, V31, P334, DOI 10.1111/mice.12171; Hosseininasab SM, 2015, EUR J OPER RES, V246, P762, DOI 10.1016/j.ejor.2015.05.039; INRO, 2009, EMME3 V 3 2 EMME3 US; Khooban Z, 2015, EUR J OPER RES, V247, P699, DOI 10.1016/j.ejor.2015.06.025; Larsson T, 1999, TRANSPORT RES B-METH, V33, P233, DOI 10.1016/S0191-2615(98)00024-1; Leblanc L. J., 1975, Transportation Science, V9, P183, DOI 10.1287/trsc.9.3.183; Li D., 2006, NONLINEAR INTEGER PR; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; Liu XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162618; Lu J, 2016, TRANSPORT RES REC, P31, DOI 10.3141/2550-05; Luathep P, 2011, TRANSPORT RES B-METH, V45, P808, DOI 10.1016/j.trb.2011.02.002; MAGNANTI TL, 1984, TRANSPORT SCI, V18, P1, DOI 10.1287/trsc.18.1.1; MathWorks, 2014, MATLAB STAT TOOLB RE; Miandoabchi E, 2015, J OPER RES SOC, V66, P894, DOI 10.1057/jors.2014.55; Miettinen K, 2012, NONLINEAR MULTIOBJEC, V12; Patriksson P., 1994, TRAFFIC ASSIGNMENT P; POORZAHEDY H, 1982, TRANSPORT RES B-METH, V16, P45, DOI 10.1016/0191-2615(82)90040-6; Poorzahedy H, 2007, EUR J OPER RES, V182, P578, DOI 10.1016/j.ejor.2006.07.038; Rockafellar R., 1970, CONVEX ANAL; Roughgarden T, 2002, J ACM, V49, P236, DOI 10.1145/506147.506153; Sarvi M, 2004, COMPUT-AIDED CIV INF, V19, P351, DOI 10.1111/j.1467-8667.2004.00362.x; Sarvi M, 2008, IEEE T INTELL TRANSP, V9, P580, DOI 10.1109/TITS.2008.2006812; Sheffi Y., 1985, URBAN TRANSPORTATION; Szeto WY, 2015, NETW SPAT ECON, V15, P791, DOI 10.1007/s11067-013-9191-9; Wang DZW, 2010, TRANSPORT RES B-METH, V44, P482, DOI 10.1016/j.trb.2009.10.003; Wang SA, 2013, TRANSPORT RES B-METH, V50, P42, DOI 10.1016/j.trb.2013.01.006; Wang X, 2017, J GLOBAL OPTIM, V67, P325, DOI 10.1007/s10898-015-0396-y; Wets RJB, 2010, VARIATIONAL ANAL; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016; Zhang HZ, 2009, J SYST SCI COMPLEX, V22, P446, DOI 10.1007/s11424-009-9177-3; Zhang X, 2015, J TRAFFIC LOGISTICS, V3; Zhang X, 2015, SCI REPORTS, V5	68	1	1	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192454	10.1371/journal.pone.0192454	http://dx.doi.org/10.1371/journal.pone.0192454			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590111	Green Published, gold			2022-12-27	WOS:000428603100004
J	Chang, AY; Nabbaale, J; Nalubwama, H; Okello, E; Ssinabulya, I; Longenecker, CT; Webel, AR				Chang, Andrew Y.; Nabbaale, Juliet; Nalubwama, Haddy; Okello, Emmy; Ssinabulya, Isaac; Longenecker, Christopher T.; Webel, Allison R.			Motivations of women in Uganda living with rheumatic heart disease: A mixed methods study of experiences in stigma, childbearing, anticoagulation, and contraception	PLOS ONE			English	Article							PREGNANCY OUTCOMES; DECISION-MAKING; AFRICA; FOCUS	Background Rheumatic heart disease (RHD) is a leading cause of premature mortality in low- and middle-income countries (LMICs). Women of reproductive age are a unique and vulnerable group of RHD patients, due to increased risk of cardiovascular complications and death during pregnancy. Yet, less than 5% of women of childbearing age with RHD in LMICs use contraceptives, and one in five pregnant women with RHD take warfarin despite known teratogenicity. It is unclear whether this suboptimal contraception and anticoagulant use during pregnancy is due to lack of health system resources, limited health literacy, or social pressure to bear children. Methods We conducted a mixed methods study of 75 women living with RHD in Uganda. Questionnaires were administered to 50 patients. Transcripts from three focus groups with 25 participants were analyzed using qualitative description methodology. Results Several themes emerged from the focus groups, including pregnancy as a calculated risk; misconceptions about side-effects of contraceptives and anticoagulation; reproductive decision -making control by male partners, in-laws, or physicians; abandonment of patients by male partners; and considerable stigma against heart disease patients for both their reproductive and financial limitations (often worse than that directed against HIV patients). All questionnaire respondents were told by physicians that their hearts were not strong enough to support a pregnancy. Only 14% used contraception while taking warfarin. All participants felt that society would look poorly on a woman who cannot have children due to a heart condition. Conclusions To our knowledge, this is the first qualitative study of female RHD patients and their attitudes toward cardiovascular disorders and reproduction. Our results suggest that health programs targeting heart disease in LMICs must pay special attention to the needs of women of childbearing age. There are opportunities for improved family/societal education programs and community engagement, leading to better outcomes and patient empowerment.	[Chang, Andrew Y.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Nabbaale, Juliet; Okello, Emmy; Ssinabulya, Isaac] Mulago Hosp, Uganda Heart Inst, Kampala, Uganda; [Nabbaale, Juliet; Longenecker, Christopher T.] Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Nalubwama, Haddy] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Webel, Allison R.] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA	Stanford University; Mulago National Referral Hospital; Case Western Reserve University; Makerere University; Case Western Reserve University	Webel, AR (corresponding author), Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA.	Allison.webel@case.edu	Webel, Allison R./ABA-1972-2020; Webel, Allison R./AFW-1806-2022	Chang, Andrew/0000-0002-3009-6678; Webel, Allison/0000-0002-7538-5780; Ssinabulya, Isaac/0000-0001-6521-7778	Medtronic Foundation [FY13-000406]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001084] Funding Source: NIH RePORTER	Medtronic Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Author C.L. has financial support from the Medtronic Foundation (Grant FY13-000406) for the submitted work. The funder provided support in the form of salary/research materials for author C.L., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors report no financial relationships with any other organizations that might have an interest in the submitted work; no other relationships or activities that could appear to have influenced or benefited from the submitted work. The specific roles of these authors are articulated in the 'author contributions' section.	Adongo PB, 1997, SOC SCI MED, V45, P1789, DOI 10.1016/S0277-9536(97)00110-X; Alshawabkeh L, 2016, J AM COLL CARDIOL, V68, P1804, DOI 10.1016/j.jacc.2016.06.076; Behboodi-Moghadam Zahra, 2016, J Int Assoc Provid AIDS Care, V15, P148, DOI 10.1177/2325957415593636; Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Bronfenbrenner U., 1993, INT ENCY ED, V3, P37; Carlsson-Lalloo E, 2016, AIDS PATIENT CARE ST, V30, P56, DOI 10.1089/apc.2015.0260; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Corney R, 2014, EUR J ONCOL NURS, V18, P17, DOI 10.1016/j.ejon.2013.10.003; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Diao M, 2011, ARCH CARDIOVASC DIS, V104, P370, DOI 10.1016/j.acvd.2011.04.001; Farmer DB, 2015, GLOB HEALTH, V3, P242, DOI 10.9745/GHSP-D-14-00198; Ginsberg JS, 2001, CHEST, V119, p122S, DOI 10.1378/chest.119.1_suppl.122S; Greutmann M, 2015, EUR HEART J, V36, P2491, DOI 10.1093/eurheartj/ehv288; Haththotuwa HR, 2009, INT J GYNECOL OBSTET, V104, P194, DOI 10.1016/j.ijgo.2008.10.031; Jeng JS, 2004, J NEUROL SCI, V221, P25, DOI 10.1016/j.jns.2004.03.006; Kane S, 2016, BMC PUBLIC HEALTH, P16; Kibira SPS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141998; Liu H, 2013, INT J GYNECOL OBSTET, V120, P245, DOI 10.1016/j.ijgo.2012.09.025; Liu H, 2010, CHINESE MED J-PEKING, V123, P2324, DOI 10.3760/cma.j.issn.0366-6999.2010.17.008; Mocumbi AO, 2012, HEART, V98, P450, DOI 10.1136/heartjnl-2011-301025; Moodley J, 2000, S AFR MED J, V90, P367; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Ochako R, 2015, BMC PUBLIC HEALTH, P15; Paar JA, 2010, AM J CARDIOL, V105, P1809, DOI 10.1016/j.amjcard.2010.01.364; Pattenden J, 2002, BMJ-BRIT MED J, V324, P1006, DOI 10.1136/bmj.324.7344.1006; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M., 2009, RES NURS HLTH; Siu SC, 2001, CIRCULATION, V104, P515, DOI 10.1161/hc3001.093437; Terreri MT, 2001, J RHEUMATOL, V28, P1394; Thorne S, 2006, HEART, V92, P1520, DOI 10.1136/hrt.2006.095240; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tong A, 2015, NEPHROL DIAL TRANSPL, V30, P652, DOI 10.1093/ndt/gfu378; Watkins DA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-23; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194030	10.1371/journal.pone.0194030	http://dx.doi.org/10.1371/journal.pone.0194030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590159	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100045
J	Dalgaard, F; Ruwald, MH; Lindhardt, TB; Gislason, GH; Torp-Pedersen, C; Pallisgaard, JL				Dalgaard, Frederik; Ruwald, Martin H.; Lindhardt, Tommi Bo; Gislason, Gunnar H.; Torp-Pedersen, Christian; Pallisgaard, Jannik L.			Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy	PLOS ONE			English	Article							HOSPITAL DISCHARGE; ELDERLY-PATIENTS; HEART-FAILURE; RISK; TRENDS; IMPLANTATION; PREVALENCE; MANAGEMENT; MORTALITY; DENMARK	Background The management of patients with non-valvular atrial fibrillation (NVAF) with rate-lowering or anti-arrhythmic drugs has markedly changed over the last decade, but it is unknown how these changes have affected patients with NVAF with a permanent pacemaker (PPM). Methods Through Danish nationwide registries, patients with NVAF and a PPM were identified from 2001 to 2012. Changes in concomitant pharmacotherapy and comorbidities were tested using the Cochran Armitage trend test and linear regression. Patients with NVAF were identified to calculate the proportional amount of PPM implants. Results A total of 12,231 NVAF patients with a PPM were included in the study, 55.6% of which were men. Median age was 78 years (interquartile range 70-84). From 2001 to 2012, the number of NVAF patients with a PPM increased from 850 to 1344, while the number of NVAF patients increased from 67,478 to 127,261. Thus, the proportional amount of NVAF patients with a PPM decreased from 1.3% to 1.1% (p = 0.015). Overall 45.9% had atrial fibrillation (AF) duration less than one year and the proportion declined from 55.5% to 42.4% (p <0.001). Diabetes mellitus increased from 7.2% to 16.8% (p <0.001). Heart failure (HF) decreased from 36.7% to 29.3% (p = 0.010) and ischemic heart disease (IHD) decreased from 32.4% to 26.1% (p <0.001). Beta-blocker use increased from 38.1% to 58.0% (p <0.001), while digoxin and anti-arrhythmic drug use decreased over time. Conclusion From 2001 to 2012, the absolute number of NVAF patients with a PPM increased while the proportional amount decreased. The number of NVAF patients receiving a PPM within one year of AF diagnosis decreased. The prevalence of DM increased, while the prevalence of HF and IHD was high but decreasing. The use of beta-blockers increased markedly, while use of digoxin and anti -arrhythmic drugs decreased over time.	[Dalgaard, Frederik; Ruwald, Martin H.; Lindhardt, Tommi Bo; Gislason, Gunnar H.; Torp-Pedersen, Christian; Pallisgaard, Jannik L.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Gislason, Gunnar H.] Danish Heart Fdn, Copenhagen, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; University of Southern Denmark; Aalborg University; Aalborg University Hospital	Dalgaard, F (corresponding author), Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	fdalgaard87@gmail.com	Dalgaard, Frederik/J-1878-2019; Gislason, Gunnar/B-7561-2009; Pallisgaard, Jannik Langtved/S-9546-2019	Dalgaard, Frederik/0000-0002-7287-4191; Gislason, Gunnar/0000-0002-0548-402X; Pallisgaard, Jannik Langtved/0000-0002-8072-3318	Danish Heart Foundation [16-R107-A6776-22972]; FUKAP; Department of Cardiology, Herlev & Gentofte Hospital	Danish Heart Foundation; FUKAP; Department of Cardiology, Herlev & Gentofte Hospital	This work has been supported by Danish Heart Foundation (www.hjerteforeningen.dk) [grant number: 16-R107-A6776-22972]; and FUKAP (www.fukap.dk), research fund of the Department of Cardiology, Herlev & Gentofte Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CIRCULATION, V104, P2118; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Barrett TW, 2012, AM J CARDIOL, V110, P1315, DOI 10.1016/j.amjcard.2012.06.037; Carlsson AC, 2013, EUR J CLIN PHARMACOL, V69, P245, DOI 10.1007/s00228-012-1322-6; Casale JC, 2013, ETHNIC DIS, V23, P275; Essebag V, 2003, J AM COLL CARDIOL, V41, P249, DOI 10.1016/S0735-1097(02)02709-2; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Green A, 2015, CLIN EPIDEMIOL, V7, P421, DOI 10.2147/CLEP.S88577; Guha A, 2017, J CARDIOVASC ELECTR, V28, P933, DOI 10.1111/jce.13248; Hansen ML, 2008, EUROPACE, V10, P395, DOI 10.1093/europace/eun011; Karasoy D, 2013, EUROPACE, V15, P669, DOI 10.1093/europace/eus418; Kirchhof P, 2016, EUR J CARDIOTHORAC S; Kralev S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024964; Lear JT, 1996, ACTA DIABETOL, V33, P169; Lee Jang Hoon, 2009, Korean Circ J, V39, P367, DOI 10.4070/kcj.2009.39.9.367; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Michniewicz E, 2018, ADV MED SCI-POLAND, V63, P30, DOI 10.1016/j.advms.2017.06.005; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Pallisgaard JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161768; Pallisgaard JL, 2015, EXPERT REV CARDIOVAS, V13, P643, DOI 10.1586/14779072.2015.1043892; Park S, 2013, J CARDIO VASC MED, V1; Ruwald MH, 2012, EUROPACE, V14, P1506, DOI 10.1093/europace/eus154; Schmidt M, 2016, HEAR RHYTHM, V12, P2018; Schmidt M, 2016, INT J CARDIOL, V225, P30, DOI 10.1016/j.ijcard.2016.09.071; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Vaughan-Sarrazin MS, 2014, AM HEART J, V168, P53, DOI 10.1016/j.ahj.2014.03.024; Wandell P, 2017, J CARDIOL; Wandell P, 2017, EUR J EPIDEMIOL, V32, P785, DOI 10.1007/s10654-017-0283-6; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zoni-Berisso M, 2014, CLIN EPIDEMIOL, V6, P213, DOI 10.2147/CLEP.S47385	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195175	10.1371/journal.pone.0195175	http://dx.doi.org/10.1371/journal.pone.0195175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590209	gold, Green Published, Green Submitted			2022-12-27	WOS:000428603100106
J	Insley, P; Shaham, S				Insley, Peter; Shaham, Shai			Automated C-elegans embryo alignments reveal brain neuropil position invariance despite lax cell body placement	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PLANE ILLUMINATION MICROSCOPY; IMAGE REGISTRATION; GENE-EXPRESSION; AXON GUIDANCE; NERVE RING; EMBRYOGENESIS; LINEAGE; SYSTEM; GROWTH	The Caenorhabditis elegans cell lineage is nearly invariant. Whether this stereotyped cell division pattern promotes reproducibility in cell shapes/positions is not generally known, as manual spatiotemporal cell-shape/position alignments are labor-intensive, and fully-automated methods are not described. Here, we report automated algorithms for spatiotemporal alignments of C. elegans embryos from pre-morphogenesis to motor-activity initiation. We use sparsely-labeled green-fluorescent nuclei and a pan-nuclear red-fluorescent reporter to register consecutive imaging time points and compare embryos. Using our method, we monitor early assembly of the nerve-ring (NR) brain neuropil. While NR pioneer neurons exhibit reproducible growth kinetics and axon positions, cell-body placements are variable. Thus, pioneer-neuron axon locations, but not cell-body positions, are under selection. We also show that anterior NR displacement in cam-1/ROR Wnt-receptor mutants is not an early NR assembly defect. Our results demonstrate the utility of automated spatiotemporal alignments of C. elegans embryos, and uncover key principles guiding nervous-system development in this animal.	[Insley, Peter; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10021 USA.	shaham@rockefeller.edu			NIH [NS064273, NS095795, NS081490, HD078703]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants NS064273, NS095795, NS081490, HD078703 to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZR, 2008, DEV BIOL, V318, P65, DOI 10.1016/j.ydbio.2008.02.054; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; BRENNER S, 1974, GENETICS, V77, P71; Christensen RP, 2015, ELIFE, V4, DOI 10.7554/eLife.10070; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Ho T. K., 1995, INT C, V1, P278, DOI DOI 10.1109/ICDAR.1995.598994; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kahaner D., 1989, NUMERICAL METHODS SO; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Kremser C, 1997, MAGN RESON IMAGING, V15, P579, DOI 10.1016/S0730-725X(97)00023-4; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Nath RD, 2016, CURRENT BIOL; Ooi SL, 2006, PLOS GENET, V2, P883, DOI 10.1371/journal.pgen.0020097; Peng HC, 2008, BIOINFORMATICS, V24, P234, DOI 10.1093/bioinformatics/btm569; Peng HC, 2011, NAT METHODS, V8, P493, DOI [10.1038/NMETH.1602, 10.1038/nmeth.1602]; Pujol N, 2000, DEVELOPMENT, V127, P3361; Rapti G, 2017, NAT NEUROSCI, V20, P1350, DOI 10.1038/nn.4630; Richards JL, 2013, DEV BIOL, V374, P12, DOI 10.1016/j.ydbio.2012.11.034; Sanders J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-156; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Singhal A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14100; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Strnad P, 2016, NAT METHODS, V13, P139, DOI [10.1038/NMETH.3690, 10.1038/nmeth.3690]; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Van Aelst S, 2009, WIRES COMPUT STAT, V1, DOI 10.1002/wics.19; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108; Zacharias AL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005585; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zhang YL, 2015, MICRON, V68, P122, DOI 10.1016/j.micron.2014.10.002; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194861	10.1371/journal.pone.0194861	http://dx.doi.org/10.1371/journal.pone.0194861			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590193	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100082
J	Lowe, NM; Kershaw, LE; Bernstein, JM; Withey, SB; Mais, K; Homer, JJ; Slevin, NJ; Bonington, SC; Carrington, BM; West, CM				Lowe, Natalie M.; Kershaw, Lucy E.; Bernstein, Jonathan M.; Withey, Stephanie B.; Mais, Kathleen; Homer, Jarrod J.; Slevin, Nicholas J.; Bonington, Suzanne C.; Carrington, Bernadette M.; West, Catharine M.			Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy	PLOS ONE			English	Article							LOCALLY ADVANCED HEAD; CONTRAST-ENHANCED MRI; INTRATUMOR HETEROGENEITY; COMPUTED-TOMOGRAPHY; CT PERFUSION; LOCOREGIONAL CONTROL; RADIATION-THERAPY; UNRESECTABLE HEAD; LUNG-CANCER; CHEMORADIOTHERAPY	Objectives Previously, we showed that pre-treatment tumour plasma perfusion (Fp) predicts RECIST response to induction chemotherapy (ICT) in locoregionally advanced head and neck squamous cell carcinoma (HNSCC). The aim here was to determine whether the pre-treatment tumour Fp estimate, changes in tumour Fp or RECIST response post 2 cycles of ICT were prognostic for long-term survival outcomes. Methods A prospective study enrolled patients with high stage HNSCC treated with docetaxel (T), cisplatin (P) and 5-fluorouracil (F) (ICT) followed by synchronous cisplatin and intensity modulated radiotherapy. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) before and after two cycles of ICT was used to measure Fp and RECIST response. Results Forty-two patients were recruited and 37 underwent two scans. The median follow-up was 36 (range 23-49) months. Pre-treatment tumour Fp (stratified by median) was not prognostic for overall survival (p = 0.42), disease specific survival (p = 0.20) and locoregional control (p = 0.64). Neither change in tumour Fp nor RECIST response post two cycles of ICT was prognostic for any outcome (p>0.21). Conclusion DCE-MRI parameters do not predict long-term survival outcomes following ICT and RECIST response to ICT may not be an appropriate endpoint to determine early efficacy of a treatment in HNSCC patients.	[Lowe, Natalie M.; Kershaw, Lucy E.; Bernstein, Jonathan M.; Homer, Jarrod J.; Slevin, Nicholas J.; West, Catharine M.] Univ Manchester, Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Canc Sci, Manchester, Lancs, England; [Kershaw, Lucy E.] Christie NHS Fdn Trust, Christie Med Phys & Engn, Manchester, Lancs, England; [Bernstein, Jonathan M.] Royal Marsden NHS Fdn Trust, Dept Otorhinolaryngol Head & Neck Surg, London, England; [Withey, Stephanie B.] Univ Hosp Birmingham, Med Phys, Birmingham, W Midlands, England; [Mais, Kathleen; Slevin, Nicholas J.] Christie NHS Fdn Trust, Head & Neck Clin Oncol, Manchester, Lancs, England; [Homer, Jarrod J.] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Univ Dept Otolaryngol Head & Neck Surg, Manchester, Lancs, England; [Bonington, Suzanne C.; Carrington, Bernadette M.] Christie NHS Fdn Trust, Dept Radiol, Manchester, Lancs, England; [West, Catharine M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	Christie NHS Foundation Trust; University of Manchester; Christie NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Birmingham; Christie NHS Foundation Trust; University of Manchester; Christie NHS Foundation Trust; University of Manchester	West, CM (corresponding author), Univ Manchester, Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Canc Sci, Manchester, Lancs, England.; West, CM (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England.	Catharine.West@manchester.ac.uk	; West, Catharine/J-4152-2012	Withey, Stephanie/0000-0003-4804-9033; West, Catharine/0000-0002-0839-3449; Lowe, Natalie/0000-0002-0348-5184	Christie Hospital Charitable Trust; Head and Neck Oncology Research Fund; Christie NHS Foundation Trust; Experimental Cancer Medicine Centre Network, UK	Christie Hospital Charitable Trust; Head and Neck Oncology Research Fund; Christie NHS Foundation Trust; Experimental Cancer Medicine Centre Network, UK	The authors thank Helen Valentine for help with p16 staining; Farag Shuweidi and Clare Hodgson for help with statistical analysis and Jason Kennedy for database management. The work was funded by the Christie Hospital Charitable Trust.; This study was funded by the Head and Neck Oncology Research Fund (Prof Nick J Slevin), The Christie NHS Foundation Trust and The Experimental Cancer Medicine Centre Network, UK.	Balluff B, 2015, J PATHOL, V235, P3, DOI 10.1002/path.4436; Bernstein JM, 2015, ORAL ONCOL, V51, P508, DOI 10.1016/j.oraloncology.2015.01.013; Bisdas S, 2010, AM J NEURORADIOL, V31, P576, DOI 10.3174/ajnr.A1852; Bisdas S, 2009, AM J NEURORADIOL, V30, P793, DOI 10.3174/ajnr.A1449; Blanchard P, 2011, J CLIN EPIDEMIOL, V64, P985, DOI 10.1016/j.jclinepi.2010.10.016; Bourhis J, 2012, LANCET ONCOL, V13, P145, DOI 10.1016/S1470-2045(11)70346-1; Brix G, 2004, MAGNET RESON MED, V52, P420, DOI 10.1002/mrm.20161; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; Brookes JA, 1999, JMRI-J MAGN RESON IM, V9, P163, DOI 10.1002/(SICI)1522-2586(199902)9:2<163::AID-JMRI3>3.0.CO;2-L; Buyse M, 2000, LANCET, V356, P373, DOI 10.1016/S0140-6736(00)02528-9; Cao Y, 2008, INT J RADIAT ONCOL, V72, P1287, DOI 10.1016/j.ijrobp.2008.08.024; Clinton B, 1996, REINVENTING REGULATI; Cohen EEW, 2014, J CLIN ONCOL, V32, P2735, DOI 10.1200/JCO.2013.54.6309; Cohen L, 2012, J CLIN ONCOL, V30; Donaldson SB, 2013, EUR J RADIOL, V82, P2161, DOI 10.1016/j.ejrad.2013.08.008; Edge SB, 2009, AJCC CANC STAGING MA, V7; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Maraghi RH, 2008, J CLIN ONCOL, V26, P1346, DOI 10.1200/JCO.2007.13.5913; Ferlay J, 2014, INT J CANC; Gandhi D, 2006, AM J NEURORADIOL, V27, P101; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghi M, 2017, ANN ONCOLOGY; Ghi MG, 2017, ANN ONCOL, V28, P2206, DOI 10.1093/annonc/mdx299; Goffin J, 2005, CLIN CANCER RES, V11, P5928, DOI 10.1158/1078-0432.CCR-05-0130; Hermans R, 2003, INT J RADIAT ONCOL, V57, P1351, DOI 10.1016/S0360-3016(03)00764-8; Hitt R, 2014, ANN ONCOL, V25, P216, DOI 10.1093/annonc/mdt461; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Ma J, 2012, ORAL ONCOL, V48, P1076, DOI 10.1016/j.oraloncology.2012.06.014; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Matoba M, 2015, J RADIAT RES, V56, P553, DOI 10.1093/jrr/rru123; Nguyen-Tan PF, 2014, J CLIN ONCOLOGY; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; O'Connor JPB, 2015, CLIN CANCER RES, V21, P249, DOI 10.1158/1078-0432.CCR-14-0990; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paesmans M, 1997, EUR J CANCER, V33, P2326, DOI 10.1016/S0959-8049(97)00325-0; Pascal J, 2013, P NATL ACAD SCI USA, V110, P14266, DOI 10.1073/pnas.1300619110; Passero VA, 2010, ANN ONCOL, V21, P2278, DOI 10.1093/annonc/mdq226; Patil V, 2013, ISRN Oncol, V2013, P259154, DOI 10.1155/2013/259154; Petralia G, 2009, J COMPUT ASSIST TOMO, V33, P552, DOI 10.1097/RCT.0b013e31818d446e; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Popovic KS, 2014, J BUON, V19, P937; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Sinek J, 2004, BIOMED MICRODEVICES, V6, P297, DOI 10.1023/B:BMMD.0000048562.29657.64; Stadler P, 1999, INT J RADIAT ONCOL, V44, P749, DOI 10.1016/S0360-3016(99)00115-7; Stokes WA, 2017, HEAD NECK-J SCI SPEC, V39, P1113, DOI 10.1002/hed.24739; Truong MT, 2011, AM J NEURORADIOL, V32, P1195, DOI 10.3174/ajnr.A2501; Urba S, 2006, J CLIN ONCOL, V24, P593, DOI 10.1200/JCO.2005.01.2047; Ursino S, 2017, EUR REV MED PHARMACO, V21, P4882; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Wang P, 2012, MED PHYS, V39, P5277, DOI 10.1118/1.4737022; Weber RS, 2003, ARCH OTOLARYNGOL, V129, P44, DOI 10.1001/archotol.129.1.44; William WN, 2013, J THORAC ONCOL, V8, P222, DOI 10.1097/JTO.0b013e3182774108; Zima A, 2007, AM J NEURORADIOL, V28, P328	54	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194841	10.1371/journal.pone.0194841	http://dx.doi.org/10.1371/journal.pone.0194841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590180	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100078
J	Pfeiffer, V; Gotz, R; Camarero, G; Heinsen, H; Blum, R; Rapp, UR				Pfeiffer, Verena; Goetz, Rudolf; Camarero, Guadelupe; Heinsen, Helmut; Blum, Robert; Rapp, Ulf Ruediger			Impaired neuronal maturation of hippocampal neural progenitor cells in mice lacking CRAF	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; ADULT NEUROGENESIS; DENTATE GYRUS; B-RAF; NOONAN-SYNDROME; STEM-CELLS; C-RAF; KNOCKOUT MICE; A-RAF	RAF kinases are major constituents of the mitogen activated signaling pathway, regulating cell proliferation, differentiation and cell survival of many cell types, including neurons. In mammals, the family of RAF proteins consists of three members, ARAF, BRAF, and CRAF. Ablation of CRAF kinase in inbred mouse strains causes major developmental defects during fetal growth and embryonic or perinatal lethality. Heterozygous germline mutations in CRAF result in Noonan syndrome, which is characterized by neurocognitive impairment that may involve hippocampal physiology. The role of CRAF signaling during hippocampal development and generation of new postnatal hippocampal granule neurons has not been examined and may provide novel insight into the cause of hippocampal dysfunction in Noonan syndrome. In this study, by crossing CRAF-deficiency to CD-1 outbred mice, a CRAF mouse model was established which enabled us to investigate the interplay of neural progenitor proliferation and postmitotic differentiation during adult neurogenesis in the hippo campus. Albeit the general morphology of the hippocampus was unchanged, CRAF-deficient mice displayed smaller granule cell layer (GCL) volume at postnatal day 30 (P30). In CRAF-deficient mice a substantial number of abnormal, chromophilic, fast dividing cells were found in the subgranular zone (SGZ) and hilus of the dentate gyrus (DG), indicating that CRAF signaling contributes to hippocampal neural progenitor proliferation. CRAF-deficient neural progenitor cells showed an increased cell death rate and reduced neuronal maturation. These results indicate that CRAF function affects postmitotic neural cell differentiation and points to a critical role of CRAF-dependent growth factor signaling pathway in the postmitotic development of adult-born neurons.	[Pfeiffer, Verena] Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, Wurzburg, Germany; [Pfeiffer, Verena; Goetz, Rudolf; Camarero, Guadelupe; Rapp, Ulf Ruediger] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Versbacher Str 5, Wurzburg, Germany; [Goetz, Rudolf; Blum, Robert] Univ Hosp Wurzburg, Inst Clin Neurobiol, Versbacher Str 5, Wurzburg, Germany; [Heinsen, Helmut] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Margarethe Hoppel Pl 1, Wurzburg, Germany; [Heinsen, Helmut] Univ Sao Paulo, Fac Med, Pathol LIM 44, Sao Paulo, SP, Brazil; [Rapp, Ulf Ruediger] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Pk Str 1, Bad Nauheim, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Universidade de Sao Paulo; Max Planck Society	Pfeiffer, V (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, Wurzburg, Germany.; Pfeiffer, V (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Versbacher Str 5, Wurzburg, Germany.	verena.pfeiffer@mail.uni-wuerzburg.de	Blum, Robert/E-8899-2013	Blum, Robert/0000-0002-5270-3854; Pfeiffer, Verena/0000-0001-5397-9564	Deutsche Forschungsgemeinschaft [1048]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft to the Graduate College 1048, University of Wurzburg. We are grateful to Doris Heim, Hilde Troll, Michaela Kessler and Daniel Pfeiffer for technical assistance. We also thank Prof. M. Sendtner and Prof E. Asan for their generous support.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; BAYER SA, 1990, EXP NEUROL, V107, P48, DOI 10.1016/0014-4886(90)90062-W; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Freeman Alyson K, 2013, Small GTPases, V4, P180, DOI 10.4161/sgtp.26117; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hindley A, 2002, J CELL SCI, V115, P1575; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; Jinno S, 2011, HIPPOCAMPUS, V21, P467, DOI 10.1002/hipo.20762; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KOZAK C, 1984, J VIROL, V49, P297, DOI 10.1128/JVI.49.1.297-299.1984; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Lutolf S, 2002, DEVELOPMENT, V129, P373; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pfeiffer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058259; Pierpont EI, 2009, GENES BRAIN BEHAV, V8, P275, DOI 10.1111/j.1601-183X.2008.00469.x; Pierpont EI, 2013, AM J MED GENET A, V161, P2250, DOI 10.1002/ajmg.a.36075; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vithayathil J, 2015, J NEUROSCI, V35, P6836, DOI 10.1523/JNEUROSCI.4196-14.2015; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Weber CK, 2001, CANCER RES, V61, P3595; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; Wu X, 2012, MOL CELL BIOL, V32, P3872, DOI 10.1128/MCB.00751-12; Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	66	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192067	10.1371/journal.pone.0192067	http://dx.doi.org/10.1371/journal.pone.0192067			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590115	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100002
J	Tanifuji, G; Takabayashi, S; Kume, K; Takagi, M; Nakayama, T; Kamikaw, R; Inagaki, Y; Hashimoto, T				Tanifuji, Goro; Takabayashi, Shun; Kume, Keitaro; Takagi, Mizue; Nakayama, Takuro; Kamikaw, Ryoma; Inagaki, Yuji; Hashimoto, Tetsuo			The draft genome of Kipferlia bialata reveals reductive genome evolution in fornicate parasites	PLOS ONE			English	Article							TRICHOMONAS-VAGINALIS; PROTEIN IMPORT; TARGETING SEQUENCES; GIARDIA-LAMBLIA; CLEAVAGE SITES; N. SP.; MITOCHONDRIAL; CARPEDIEMONAS; ULTRASTRUCTURE; CLASSIFICATION	The fornicata (fornicates) is a eukaryotic group known to consist of free-living and parasitic organisms. Genome datasets of two model fornicate parasites Giardia intestinalis and Spironucleus salmonicida are well annotated, so far. The nuclear genomes of G. intestinalis assemblages and S. salmonicida are small in terms of the genome size and simple in genome structure. However, an ancestral genomic structure and gene contents, from which genomes of the fornicate parasites have evolved, remains to be clarified. In order to understand genome evolution in fornicates, here, we present the draft genome sequence of a free-living fornicate, Kipferlia bialata, the divergence of which is earlier than those of the fornicate parasites, and compare it to the genomes of G. intestinalis and S. salmonicida. Our data show that the number of protein genes and introns in K. bialata genome are the most abundant in the genomes of three fornicates, reflecting an ancestral state of fornicate genome evolution. Evasion mechanisms of host immunity found in G. intestinalis and S. salmonicida are absent in the K. bialata genome, suggesting that the two parasites acquired the complex membrane surface proteins on the line leading to the common ancestor of G. intestinalis and S. salmonicida after the divergence from K. bialata. Furthermore, the mitochondrion related organelles (MROs) of K. bialata possess more complex suites of metabolic pathways than those in Giardia and in Spironucleus. In sum, our results unveil the process of reductive evolution which shaped the current genomes in two model fornicate parasites G. intestinalis and S. salmonicida.	[Tanifuji, Goro; Takabayashi, Shun; Kume, Keitaro; Takagi, Mizue; Inagaki, Yuji; Hashimoto, Tetsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tanifuji, Goro] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki, Japan; [Nakayama, Takuro; Inagaki, Yuji; Hashimoto, Tetsuo] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan; [Nakayama, Takuro] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Kamikaw, Ryoma] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Kyoto, Japan; [Kamikaw, Ryoma] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Kyoto, Japan	University of Tsukuba; National Museum of Nature and Science; University of Tsukuba; Tohoku University; Kyoto University; Kyoto University	Tanifuji, G; Hashimoto, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Tanifuji, G (corresponding author), Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki, Japan.; Hashimoto, T (corresponding author), Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan.	gorot@kahaku.go.jp; hashimoto.tetsuo.gm@u.tsukuba.ac.jp	NAKAYAMA, Takuro/AAT-9444-2020	NAKAYAMA, Takuro/0000-0001-5135-0156; Inagaki, Yuji/0000-0003-0101-8483	JSPS [23117005, 15H04406, 15H05231, 15K14591, 15H05606]; Grants-in-Aid for Scientific Research [16H04826] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	JSPS KAKENHI grant number 23117005, 15H04406, and 15H05231 to TH and 15K14591 and 15H05606 to RK.	Adam RD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-424; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garg S, 2015, GENOME BIOL EVOL, V7, P2716, DOI 10.1093/gbe/evv175; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hamann E, 2017, ISME J, V11, P1205, DOI 10.1038/ismej.2016.197; Hampl V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001383; Hirt RP, 2007, TRENDS PARASITOL, V23, P540, DOI 10.1016/j.pt.2007.08.020; Hirt RP, 2013, SEX TRANSM INFECT, V89, P439, DOI 10.1136/sextrans-2013-051105; Ishida K, 1999, MOL BIOL EVOL, V16, P321, DOI 10.1093/oxfordjournals.molbev.a026113; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kamikawa Ryoma, 2014, BMC Research Notes, V7, P413, DOI 10.1186/1756-0500-7-413; Karnkowska A, 2016, CURR BIOL, V26, P1274, DOI 10.1016/j.cub.2016.03.053; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koutsovoulos G, 2016, P NATL ACAD SCI USA, V113, P5053, DOI 10.1073/pnas.1600338113; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kusdian G, 2014, MOL BIOCHEM PARASIT, V198, P92, DOI 10.1016/j.molbiopara.2015.01.004; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leger MM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0092; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Makiuchi T, 2014, BIOCHIMIE, V100, P3, DOI 10.1016/j.biochi.2013.11.018; Maruyama Shinichiro, 2013, BMC Res Notes, V6, P145, DOI 10.1186/1756-0500-6-145; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; NASH TE, 1990, EXP PARASITOL, V71, P415, DOI 10.1016/0014-4894(90)90067-M; Park JS, 2010, J EUKARYOT MICROBIOL, V57, P520, DOI 10.1111/j.1550-7408.2010.00506.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Richards TA, 2016, P NATL ACAD SCI USA, V113, P4892, DOI 10.1073/pnas.1603862113; Roy SW, 2006, GENOME RES, V16, P750, DOI 10.1101/gr.4845406; Savojardo C, 2014, BIOINFORMATICS, V30, P2973, DOI 10.1093/bioinformatics/btu411; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simpson AGB, 1999, EUR J PROTISTOL, V35, P353, DOI 10.1016/S0932-4739(99)80044-3; Smith A, 2011, RES MICROBIOL, V162, P646, DOI 10.1016/j.resmic.2011.04.007; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stairs CW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0326; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Takishita K, 2012, PROTIST, V163, P344, DOI 10.1016/j.protis.2011.12.007; Waller RF, 2009, EUKARYOT CELL, V8, P19, DOI 10.1128/EC.00313-08; Wassmer SC, 2015, AM J TROP MED HYG, V93, P42, DOI 10.4269/ajtmh.14-0841; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xu FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004053; Yubuki N, 2007, J EUKARYOT MICROBIOL, V54, P191, DOI 10.1111/j.1550-7408.2007.00252.x; Yubuki N, 2013, PROTIST, V164, P423, DOI 10.1016/j.protis.2013.02.002	55	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194487	10.1371/journal.pone.0194487	http://dx.doi.org/10.1371/journal.pone.0194487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590215	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100062
J	Hodzic, A; Chayer, B; Wang, DY; Poree, J; Cloutier, G; Milliez, P; Normand, H; Garcia, D; Saloux, E; Tournoux, F				Hodzic, Amir; Chayer, Boris; Wang, Diya; Poree, Jonathan; Cloutier, Guy; Milliez, Paul; Normand, Herve; Garcia, Damien; Saloux, Eric; Tournoux, Francois			Accuracy of speckle tracking in the context of stress echocardiography in short axis view: An in vitro validation study	PLOS ONE			English	Article							DOBUTAMINE STRESS; 2-DIMENSIONAL STRAIN; MYOCARDIAL STRAIN; AGREEMENT; ROTATION; MODELS; MOUSE	Aim This study aimed to test the accuracy of a speckle tracking algorithm to assess myocardial deformation in a large range of heart rates and strain magnitudes compared to sonomicrometry. Methods and results Using a tissue-mimicking phantom with cyclic radial deformation, radial strain derived from speckle tracking (RS-SpT) of the upper segment was assessed in short axis view by conventional echocardiography (Vivid q, GE) and post-processed with clinical software (EchoPAC, GE). RS-SpT was compared with radial strain measured simultaneously by sonomicrometers (RS-SN). Radial strain was assessed with increasing deformation rates (60 to 160 beats/min) and increasing pulsed volumes (50 to 100 ml/beat) to simulate physiological changes occurring during stress echocardiography. There was a significant correlation (R-2 = 0.978, P <0.001) and a close agreement (bias +/- 2SD, 0.39 +/- 1.5%) between RS-SpT and RS-SN. For low strain values (<15%), speckle tracking showed a small but significant overestimation of radial strain compared to sonomicrometers. Two-way analysis of variance did not show any significant effect of the deformation rate. For RS-SpT, the feasibility was excellent and the intra- and inter-observer variability were low (the intraclass correlation coefficients were 0.96 and 0.97, respectively). Conclusions Speckle tracking demonstrated a good correlation with sonomicrometry for the assessment of radial strain independently of the heart rate and strain magnitude in a physiological range of values. Though speckle tracking seems to be a reliable and reproducible technique to assess myocardial deformation variations during stress echocardiography, further studies are mandated to analyze the impact of angulated and artefactual out-of-plane motions and inter-vendor variability.	[Hodzic, Amir; Garcia, Damien] Univ Montreal, Hosp Res Ctr, Res Unit Biomech & Imaging Cardiol, Montreal, PQ, Canada; [Hodzic, Amir; Milliez, Paul; Saloux, Eric] Univ Hosp Ctr, Dept Cardiol, Echocardiog Lab, Caen, France; [Hodzic, Amir; Normand, Herve] Univ Caen Normandy, Unicaen, Inserm Comete, Caen, France; [Chayer, Boris; Wang, Diya; Poree, Jonathan; Cloutier, Guy] Univ Montreal, Hosp Res Ctr, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Tournoux, Francois] Hosp Univ Montreal, Dept Cardiol, Echocardiog Lab, Montreal, PQ, Canada	Universite de Montreal; CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Universite de Montreal; Universite de Montreal	Tournoux, F (corresponding author), Hosp Univ Montreal, Dept Cardiol, Echocardiog Lab, Montreal, PQ, Canada.	francois.tournaux.chum@ssss.gouv.qc.ca	Tournoux, Francois/V-5621-2019; poree, jonathan jp/D-2101-2013; Hodzic, Amir/AAG-5977-2021; NORMAND, Hervé/N-8787-2015; Garcia, Damien/E-2206-2011	Garcia, Damien/0000-0002-8552-1475; HODZIC, AMIR/0000-0001-8099-0654				Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Castro PL, 2000, BIOMED SCI INSTRUM, V395, P197; D'hooge J, 2000, Eur J Echocardiogr, V1, P154, DOI 10.1053/euje.2000.0031; Delgado V, 2009, EUR HEART J, V30, P3037, DOI 10.1093/eurheartj/ehp351; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; Fromageau J, 2007, IEEE T ULTRASON FERR, V54, P498, DOI 10.1109/TUFFC.2007.273; Hanekom L, 2007, EUR HEART J, V28, P1765, DOI 10.1093/eurheartj/ehm188; Helle-Valle T, 2005, CIRCULATION, V112, P3149, DOI 10.1161/CIRCULATIONAHA.104.531558; Hoffmann R, 1996, J AM COLL CARDIOL, V27, P330, DOI 10.1016/0735-1097(95)00483-1; Ilardi F, 2016, INT J CARDIOL, V220, P357, DOI 10.1016/j.ijcard.2016.06.067; Joyce E, 2015, J AM SOC ECHOCARDIOG, V28, P1379, DOI 10.1016/j.echo.2015.07.023; Korinek J, 2005, J AM SOC ECHOCARDIOG, V18, P1247, DOI 10.1016/j.echo.2005.03.024; Kremer F, 2013, ULTRASOUND MED BIOL, V39, P1848, DOI 10.1016/j.ultrasmedbio.2013.04.004; Langeland S, 2004, IEEE T ULTRASON FERR, V51, P1537, DOI 10.1109/TUFFC.2004.1367495; Moonen M, 2009, ECHOCARDIOGR-J CARD, V26, P307, DOI 10.1111/j.1540-8175.2008.00864.x; Ng ACT, 2009, AM HEART J, V158, P836, DOI 10.1016/j.ahj.2009.09.010; Peng Y, 2009, AM J PHYSIOL-HEART C, V297, pH811, DOI 10.1152/ajpheart.00385.2009; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; PICANO E, 1991, J AM COLL CARDIOL, V17, P666, DOI 10.1016/S0735-1097(10)80182-2; Picano E, 2014, EUR HEART J, V35, P1033, DOI 10.1093/eurheartj/eht350; Picano E, 2009, J AM COLL CARDIOL, V54, P2251, DOI 10.1016/j.jacc.2009.07.046; Reant P, 2008, J AM COLL CARDIOL, V51, P149, DOI 10.1016/j.jacc.2007.07.088; Rosner A, 2015, EUR HEART J-CARD IMG, V16, P1137, DOI 10.1093/ehjci/jev058; Sicari R, 2008, EUR J ECHOCARDIOGR, V9, P415, DOI 10.1093/ejechocard/jen175; Ternacle J, 2013, EUR HEART J-CARD IMG, V14, P77, DOI 10.1093/ehjci/jes156; Teske Arco J, 2007, Cardiovasc Ultrasound, V5, P27; Tournoux F, 2008, J AM SOC ECHOCARDIOG, V21, P1168, DOI 10.1016/j.echo.2008.06.004; Urheim S, 2000, CIRCULATION, V102, P1158, DOI 10.1161/01.CIR.102.10.1158; Uusitalo V, 2016, J AM SOC ECHOCARDIOG; Voigt JU, 2003, CIRCULATION, V107, P2120, DOI 10.1161/01.CIR.0000065249.69988.AA; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193805	10.1371/journal.pone.0193805	http://dx.doi.org/10.1371/journal.pone.0193805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584751	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000008
J	Linde, LE; Rasmussen, S; Kessler, J; Ebbing, C				Linde, Lorentz Erland; Rasmussen, Svein; Kessler, Jorg; Ebbing, Cathrine			Extreme umbilical cord lengths, cord knot and entanglement: Risk factors and risk of adverse outcomes, a population-based study	PLOS ONE			English	Article							PRENATAL ULTRASONOGRAPHIC DIAGNOSIS; BLOOD-FLOW DISTRIBUTION; MEDICAL BIRTH REGISTRY; HUMAN FETAL; TRUE KNOT; VALIDATION; COMPRESSION; MOVEMENTS; DELIVERY; NORWAY	Objectives To determine risk factors for short and long umbilical cord, entanglement and knot. Explore their associated risks of adverse maternal and perinatal outcome, including risk of recurrence in a subsequent pregnancy. To provide population based gestational age and sex and parity specific reference ranges for cord length. Design Population based registry study. Setting Medical Birth Registry of Norway 1999-2013. Population All singleton births (gestational age>22weeks<45 weeks) (n = 856 300). Methods Descriptive statistics and odds ratios of risk factors for extreme cord length and adverse outcomes based on logistic regression adjusted for confounders. Main outcome measures Short or long cord (<10th or >90th percentile), cord knot and entanglement, adverse pregnancy outcomes including perinatal and intrauterine death. Results Increasing parity, maternal height and body mass index, and diabetes were associated with increased risk of a long cord. Large placental and birth weight, and fetal male sex were factors for a long cord, which again was associated with a doubled risk of intrauterine and perinatal death, and increased risk of adverse neonatal outcome. Anomalous cord insertion, female sex, and a small placenta were associated with a short cord, which was associated with increased risk of fetal malformations, placental complications, caesarean delivery, non cephalic presentation, perinatal and intrauterine death. At term, cord knot was associated with a quadrupled risk of perinatal death. The combination of a cord knot and entanglement had a more than additive effect to the association to perinatal death. There was a more than doubled risk of recurrence of a long or short cord, knot and entanglement in a subsequent pregnancy of the same woman. Conclusion Cord length is influenced both by maternal and fetal factors, and there is increased risk of recurrence. Extreme cord length, entanglement and cord knot are associated with increased risk of adverse outcomes including perinatal death. We provide population based reference ranges for umbilical cord length.	[Linde, Lorentz Erland; Rasmussen, Svein; Kessler, Jorg; Ebbing, Cathrine] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Rasmussen, Svein] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen	Ebbing, C (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway.	Cathrine.ebbing@helse-bergen.no	Ebbing, Cathrine/ABC-9123-2020	Ebbing, Cathrine/0000-0002-4331-1250; Linde, Lorentz Erland/0000-0001-5865-0581	Western Norway Regional Health Authority [911581]	Western Norway Regional Health Authority	Cathrine Ebbing was supported financially by the Western Norway Regional Health Authority (Post doctoral grant no 911581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas U, 2002, AM J PERINAT, V19, P127, DOI 10.1055/s-2002-25311; Almli CR, 2001, DEV PSYCHOBIOL, V38, P252, DOI 10.1002/dev.1019; Antoniou EE, 2011, BIOL REPROD, V85, P137, DOI 10.1095/biolreprod.110.088807; Baergen RN, 2001, PEDIATR DEVEL PATHOL, V4, P144, DOI 10.1007/s100240010135; Baghestan E, 2007, ACTA OBSTET GYN SCAN, V86, P205, DOI 10.1080/00016340601111364; Buss C, 2009, EARLY HUM DEV, V85, P633, DOI 10.1016/j.earlhumdev.2009.08.001; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Ebbing C., 2016, ACTA OBSTET GYNECOL; Ebbing C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070380; Engeland A, 2009, ACTA OBSTET GYN SCAN, V88, P1083, DOI 10.1080/00016340903128454; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gembruch U, 1996, ULTRASOUND OBST GYN, V8, P53, DOI 10.1046/j.1469-0705.1996.08010053.x; Georgiadis L, 2014, PLACENTA, V35, P275, DOI 10.1016/j.placenta.2014.02.001; Glynn LM, 2012, DEVELOPMENTAL SCI, V15, P601, DOI 10.1111/j.1467-7687.2012.01159.x; Guzikowski W, 2014, ARCH MED SCI, V10, P91, DOI 10.5114/aoms.2013.33068; Hepper PG, 2012, DEVELOPMENTAL SCI, V15, P373, DOI 10.1111/j.1467-7687.2011.01132.x; ITSKOVITZ J, 1987, AM J PHYSIOL, V252, pH100, DOI 10.1152/ajpheart.1987.252.1.H100; JENSEN A, 1991, J DEV PHYSIOL, V15, P309; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P126, DOI 10.1002/uog.2832; Koskinen A, 2015, PLACENTA, V36, P767, DOI 10.1016/j.placenta.2015.04.004; Krakowiak P, 2004, OBSTET GYNECOL, V103, P119, DOI 10.1097/01.AOG.0000102706.84063.C7; MILLER ME, 1982, J PEDIATR-US, V101, P844, DOI 10.1016/S0022-3476(82)80344-2; Olaya-C M, 2015, J Neonatal Perinatal Med, V8, P251, DOI 10.3233/NPM-15915056; Raisanen S, 2013, INT J GYNECOL OBSTET, V122, P18, DOI 10.1016/j.ijgo.2013.02.012; Rasmussen S, 2003, ACTA OBSTET GYN SCAN, V82, P109, DOI 10.1034/j.1600-0412.2003.00009.x; SALAFIA CM, 1990, AM J OBSTET GYNECOL, V163, P1282, DOI 10.1016/0002-9378(90)90708-F; SEPULVEDA W, 1995, ULTRASOUND OBST GYN, V5, P106; Sepulveda W, 2009, J ULTRAS MED, V28, P831, DOI 10.7863/jum.2009.28.6.831; Sherer DM, 1999, AM J PERINAT, V16, P445, DOI 10.1055/s-1999-6807; Skulstad SM, 2005, EARLY HUM DEV, V81, P325, DOI 10.1016/j.earlhumdev.2004.07.006; Sunde ID, ACTA OBSTET GYNECOLO; Taweevisit M, 2010, PEDIATR DEVEL PATHOL, V13, P112, DOI [10.2350/09-07-0680-CR.1, 10.2350/09-06-0669-CR.1]; Van der Meulen JA, 2008, DEV PSYCHOBIOL, V50, P530, DOI 10.1002/dev.20306; Verbruggen SW, 2016, BIOMECH MODEL MECHAN, V15, P995, DOI 10.1007/s10237-015-0738-1; Vintzileos AM, 1992, J MATERNAL FETAL MED, V1, P196; Vintzileos AM, 2015, AM J OBSTET GYNECOL, V213, pS70, DOI 10.1016/j.ajog.2015.05.059; Weiner E, 2015, J PERINATOL, V35, P919, DOI 10.1038/jp.2015.102	37	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194814	10.1371/journal.pone.0194814	http://dx.doi.org/10.1371/journal.pone.0194814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584790	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000038
J	Macias-Segura, N; Castaneda-Delgado, JE; Bastian, Y; Santiago-Algarra, D; Castillo-Ortiz, JD; Aleman-Navarro, AL; Jaime-Sanchez, E; Gomez-Moreno, M; Saucedo-Toral, CA; Lara-Ramirez, EE; Zapata-Zuniga, M; Enciso-Moreno, L; Gonzalez-Amaro, R; Ramos-Remus, C; Enciso-Moreno, JA				Macias-Segura, N.; Castaneda-Delgado, J. E.; Bastian, Y.; Santiago-Algarra, D.; Castillo-Ortiz, J. D.; Aleman-Navarro, A. L.; Jaime-Sanchez, E.; Gomez-Moreno, M.; Saucedo-Toral, C. A.; Lara-Ramirez, Edgar E.; Zapata-Zuniga, M.; Enciso-Moreno, L.; Gonzalez-Amaro, R.; Ramos-Remus, C.; Enciso-Moreno, J. A.			Transcriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; GENE-EXPRESSION; CYTOKINE PROFILE; SYNOVIAL-FLUIDS; BONE; ACTIVATION; COHORT; CELLS; AUTOANTIBODIES; FIBROBLASTS	Background Little is known regarding the mechanisms underlying the loss of tolerance in the early and preclinical stages of autoimmune diseases. The aim of this work was to identify the transcriptional profile and signaling pathways associated to non-treated early rheumatoid arthritis (RA) and subjects at high risk. Several biomarker candidates for early RA are proposed. Methods Whole blood total RNA was obtained from non-treated early RA patients with < 1 year of evolution as well as from healthy first-degree relatives of patients with RA (FDR) classified as ACCP+ and ACCP- according to their antibodies serum levels against cyclic citrullinated peptides. Complementary RNA (cRNA) was synthetized and hybridized to high-density microarrays. Data was analyzed in Genespring Software and functional categories were assigned to a specific transcriptome identified in subjects with RA and FDR ACCP positive. Specific signaling pathways for genes associated to RA were identified. Gene expression was evaluated by qPCR. Receiver operating characteristic (ROC) analysis was used to evaluate these genes as biomarkers. Results A characteristic transcriptome of 551 induced genes and 4,402 repressed genes were identified in early RA patients. Bioinformatics analysis of the data identified a specific transcriptome in RA patients. Moreover, some overlapped transcriptional profiles between patients with RA and ACCP+ were identified, suggesting an up-regulated distinctive transcriptome from the preclinical stages up to progression to an early RA state. A total of 203 pathways have up-regulated genes that are shared between RA and ACCP+. Some of these genes show potential to be used as progression biomarkers for early RA with area under the curve of ROC > 0.92. These genes come from several functional categories associated to inflammation, Wnt signaling and type I interferon pathways. Conclusion The presence of a specific transcriptome in whole blood of RA patients suggests the activation of a specific inflammatory transcriptional signature in early RA development. The set of overexpressed genes in early RA patients that are shared with ACCP+ subjects but not with ACCP- subjects, can represent a transcriptional signature involved with the transition of a preclinical to a clinical RA stage. Some of these particular up-regulated and down-regulated genes are related to inflammatory processes and could be considered as biomarker candidates for disease progression in subjects at risk to develop RA.	[Macias-Segura, N.; Santiago-Algarra, D.; Aleman-Navarro, A. L.; Jaime-Sanchez, E.; Gomez-Moreno, M.; Saucedo-Toral, C. A.; Lara-Ramirez, Edgar E.; Enciso-Moreno, L.; Enciso-Moreno, J. A.] IMSS, Unidad Invest Biomed Zacatecas, Zacatecas, Mexico; [Macias-Segura, N.; Aleman-Navarro, A. L.; Gomez-Moreno, M.; Gonzalez-Amaro, R.] Univ Autonoma San Luis Potosi, Fac Med, Dept Immunol, San Luis Potosi, Mexico; [Castaneda-Delgado, J. E.; Bastian, Y.] IMSS, Unidad Invest Biomed Zacatecas, Catedras CONACyT, Zacatecas, Mexico; [Santiago-Algarra, D.] Inst Potosino Invest Cient & Tecnol, San Luis Potosi, Mexico; [Castillo-Ortiz, J. D.; Ramos-Remus, C.] Unidad Invest Enfermedades Cron Degenerativas, Guadalajara, Jalisco, Mexico; [Zapata-Zuniga, M.] Univ Autonoma Zacatecas, Hosp Rural 51, IMSS, Fac Med Humana & Ciencias Salud, Villanueva, Zacatecas, Mexico; [Ramos-Remus, C.] Univ Autonoma Guadalajara, Guadalajara, Mexico; [Macias-Segura, N.] Univ Autonoma Aguascalientes, Dept Fisiol & Farmacol, Ctr Ciencias Basicas, Aguascalientes, Mexico	Universidad Autonoma de San Luis Potosi; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Autonoma de Zacatecas; Universidad Autonoma de Guadalajara; Universidad Autonoma de Aguascalientes	Enciso-Moreno, JA (corresponding author), IMSS, Unidad Invest Biomed Zacatecas, Zacatecas, Mexico.	enciso_2000@yahoo.com	Gonzalez-Amaro, Roberto/AAZ-1504-2020; Lara-Ramírez, Edgar E./A-6915-2018; Macias-Segura, Noe/AAK-5714-2020; Bastian, Yadira/AAH-5996-2020; Delgado, Julio Enrique Castañeda/AAL-1946-2020	Delgado, Julio Enrique Castañeda/0000-0003-2124-2036; bastian, yadira/0000-0002-2530-1040; Macias-Segura, Noe/0000-0002-6333-082X; Lara-Ramirez, Edgar E./0000-0001-7112-3233; Jaime-Sanchez, Elena/0000-0003-2090-5280; Ramos-Remus, Cesar/0000-0002-4898-4219	Financial Competition for the Development of Research Protocols and Technological Development on Priority Health Themes, Institute Mexicano del Seguro Social (IMSS), Summons [FIS/IMSS/PROT/PRIO/13/028]; CONACyT (Consejo Nacional de Ciencia y Tecnologia), Mexico [321165/CVU329223]; FIS-IMSS [FIS/IMSS/PROT/PRIO/13/028]	Financial Competition for the Development of Research Protocols and Technological Development on Priority Health Themes, Institute Mexicano del Seguro Social (IMSS), Summons; CONACyT (Consejo Nacional de Ciencia y Tecnologia), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FIS-IMSS	This project was financed with the support of the "Financial Competition for the Development of Research Protocols and Technological Development on Priority Health Themes, Institute Mexicano del Seguro Social (IMSS), 2013 Summons", with number: FIS/IMSS/PROT/PRIO/13/028. Macias-Segura N. was scholarship recipient of CONACyT (Consejo Nacional de Ciencia y Tecnologia), Mexico for the scholarship 321165/CVU329223. The research reported in this manuscript has been funded through FIS-IMSS FIS/IMSS/PROT/PRIO/13/028.	Aggarwal BB, 2006, E SCHERING RES FDN W, V56, P161; Ashino T, 2007, EUR J PHARMACOL, V558, P199, DOI 10.1016/j.ejphar.2006.11.072; Bax M, 2011, IMMUNOGENETICS, V63, P459, DOI 10.1007/s00251-011-0528-6; Boerckel JD, 2014, ARTERIOSCL THROM VAS, V34, P1020, DOI 10.1161/ATVBAHA.114.303403; Cantaert T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3150; Cantaert T, 2010, RHEUMATOLOGY, V49, P156, DOI 10.1093/rheumatology/kep345; Carmona L, 2010, BEST PRACT RES CL RH, V24, P733, DOI 10.1016/j.berh.2010.10.001; Castaneda-Delgado Julio E, 2017, Front Immunol, V8, P285, DOI 10.3389/fimmu.2017.00285; Chalan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26021; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; El-Gabalawy HS, 2012, ARTHRITIS RHEUM-US, V64, P1720, DOI 10.1002/art.34449; Faour WH, 2005, J BIOL CHEM, V280, P9536, DOI 10.1074/jbc.M414067200; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Foti DP, 2014, CLIN CHEM LAB MED, V52, P1729, DOI 10.1515/cclm-2014-0383; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; GLENNAS A, 1986, BIOCHEM PHARMACOL, V35, P2033, DOI 10.1016/0006-2952(86)90738-0; Grimbacher B, 1997, RHEUMATOL INT, V17, P109, DOI 10.1007/s002960050018; Hecht C, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2014-206631; Hendriks WJAJ, 2013, BBA-MOL BASIS DIS, V1832, P1673, DOI 10.1016/j.bbadis.2013.05.022; Hu MM, 2014, P NATL ACAD SCI USA, V111, P1509, DOI 10.1073/pnas.1318227111; Jorgensen KT, 2008, ANN RHEUM DIS, V67, P860, DOI 10.1136/ard.2007.073825; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; KEGG KEoGaG, 2011, RHEUM ARTHR PATHW 20; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Krause A, 2002, J IMMUNOL, V169, P6610, DOI 10.4049/jimmunol.169.11.6610; Lanfant-Weybel K, 2012, JOINT BONE SPINE, V79, P574, DOI 10.1016/j.jbspin.2011.11.006; Lifescience R, 2014, UN PROBELIBRARY 2014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Marti L, 2009, ANN NY ACAD SCI, V1173, P334, DOI 10.1111/j.1749-6632.2009.04740.x; Massardo L, 2009, JCR-J CLIN RHEUMATOL, V15, P203, DOI 10.1097/RHU.0b013e3181a90cd8; Miao CG, 2013, CELL SIGNAL, V25, P2069, DOI 10.1016/j.cellsig.2013.04.002; Mora C, 2009, BIOMEDICA, V29, P43; QIAGEN, 2014, QLAAMP RNA BLOOD MIN; Ramos-Remus C, 2015, ARTHRITIS RHEUMATOLO; Ramos-Remus C, 2015, ARTHRITIS RHEUMATOL, V67, P2837, DOI 10.1002/art.39297; Rockel JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2595; Salama A, 2014, CELL IMMUNOL, V290, P62, DOI 10.1016/j.cellimm.2014.05.003; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.0.CO;2-L; Sen M, 2002, ARTHRITIS RHEUM, V46, P2867, DOI 10.1002/art.10593; Sergienko E, 2012, ACS CHEM BIOL, V7, P366, DOI 10.1021/cb2004274; Seror R, 2016, SCI REP-UK, V6, DOI 10.1038/srep18421; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI200113568; Stock M, 2013, ARTHRITIS RHEUM-US, V65, P2310, DOI 10.1002/art.38054; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P694, DOI 10.1002/art.27294; van Roon JAG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2395; WANG F, 1995, J EXP MED, V182, P1825, DOI 10.1084/jem.182.6.1825; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yang CY, 2014, J IMMUNOL, V192, P1547, DOI 10.4049/jimmunol.1300989; Yu H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3457; Zhai Xin-Hui, 2004, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V12, P120	56	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194205	10.1371/journal.pone.0194205	http://dx.doi.org/10.1371/journal.pone.0194205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584756	gold, Green Published, Green Submitted			2022-12-27	WOS:000428373000018
J	Bromberg, SE; Moraes, PRAD; Ades, F				Bromberg, Silvio Eduardo; Moraes, Patricia Rodrigues Alves de Figueiredo; Ades, Felipe			Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery	PLOS ONE			English	Correction																		Bromberg SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191056	1	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0195130	10.1371/journal.pone.0195130	http://dx.doi.org/10.1371/journal.pone.0195130			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579107	gold, Green Submitted, Green Published			2022-12-27	WOS:000428351800079
J	Toosizadeh, N; Mohler, J; Marlinski, V				Toosizadeh, Nima; Mohler, Jane; Marlinski, Vladimir			Low intensity vibration of ankle muscles improves balance in elderly persons at high risk of falling	PLOS ONE			English	Article							POSTURAL SWAY; OLDER-ADULTS; BODY SWAY; AGE; RESPONSES; MOTONEURONS; THRESHOLDS; PERCEPTION; ADAPTATION; STANCE	In our study we examined postural performance of young healthy persons (HY), elderly healthy persons (HE), and elderly persons at high risk of falling (FR). Anterio-posterior (AP) and medio-lateral (ML) ankle and hip angular deviations, as well as linear displacements of the center of mass (COM) were assessed in persons standing with eyes either open or closed, while none, and 40 and 30 Hz vibrations were applied bilaterally to the ankle muscle gastrocnemius. During quiet standing with eyes open, balance parameters in FR group differed from those in healthy groups. ML ankle and hip angular deviations, as well as COM linear displacements were noticeably larger in FR group. During quiet standing with eyes closed, all balance parameters in participants of all groups had a clear trend to increase. During standing with eyes open, 40 Hz vibration increased all but one balance parameter within HY group, ankle angular deviations in HE group, but none in FR group. In response to 30 Hz vibration, only ankle angular deviations and COM linear displacements increased in HY group. There were no changes in both elderly groups. During standing with eyes closed, 40 and 30 Hz vibrations did not produce consistent changes in balance parameters in HY and HE groups. In FR persons, 40 Hz vibration did not change balance parameters. However, in FR groups, 30 Hz vibration decreased ankle and hip angular deviations, and COM linear displacements. The major result of the study is a finding that low intensity vibration of ankle muscles makes balance better in elderly persons at high risk of falling. This result is clinically relevant because it suggests that applying mild vibration to ankle muscles while standing and walking might benefit elderly persons, improving their postural performance and reducing a risk of unexpected falls.	[Toosizadeh, Nima; Mohler, Jane] Univ Arizona, Dept Med, Arizona Ctr Aging, Tucson, AZ USA; [Toosizadeh, Nima; Mohler, Jane] Univ Arizona, Dept Med, Div Geriatr Gen Internal Med & Palliat Med, Tucson, AZ USA; [Toosizadeh, Nima; Mohler, Jane] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA; [Marlinski, Vladimir] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	University of Arizona; University of Arizona; University of Arizona; Barrow Neurological Institute	Marlinski, V (corresponding author), Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA.	vladimir.marlinski@dignityhealth.org						Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Asslander L, 2015, HUM MOVEMENT SCI, V41, P147, DOI 10.1016/j.humov.2015.02.010; Bekkers EMJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00939; BERGIN PS, 1995, J NEUROL NEUROSUR PS, V58, P335, DOI 10.1136/jnnp.58.3.335; Brizzi L, 2002, J NEUROPHYSIOL, V88, P2207, DOI 10.1152/jn.01051.2001; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Cardinale M, 2003, J STRENGTH COND RES, V17, P621; Ceballos D, 1999, J ANAT, V195, P563, DOI 10.1046/j.1469-7580.1999.19540563.x; CHASE MH, 1985, EXP NEUROL, V90, P471, DOI 10.1016/0014-4886(85)90035-4; Cho CY, 1998, J AM GERIATR SOC, V46, P426, DOI 10.1111/j.1532-5415.1998.tb02461.x; COLLEDGE NR, 1994, GERONTOLOGY, V40, P273, DOI 10.1159/000213596; Daneault V, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0091-9; Deshpande N, 2008, NEUROBIOL AGING, V29, P765, DOI 10.1016/j.neurobiolaging.2006.12.002; Di Giminiani R, 2015, J ELECTROMYOGR KINES, V25, P853, DOI 10.1016/j.jelekin.2015.09.004; Dotson VM, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00250; Duchateau J, 2016, J EXP BIOL, V219, P197, DOI 10.1242/jeb.123158; Duclos NC, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-130; Eisen A, 1996, NEUROLOGY, V46, P1396, DOI 10.1212/WNL.46.5.1396; EKLUND G, 1972, UPSALA J MED SCI, V77, P112, DOI 10.1517/03009734000000016; ERA P, 1986, ACTA NEUROL SCAND, V74, P210, DOI 10.1111/j.1600-0404.1986.tb07857.x; Erim Z, 1999, J NEUROPHYSIOL, V82, P2081, DOI 10.1152/jn.1999.82.5.2081; Fallon JB, 2007, MUSCLE NERVE, V36, P21, DOI 10.1002/mus.20796; Farina D, 2010, CLIN NEUROPHYSIOL, V121, P1616, DOI 10.1016/j.clinph.2009.10.040; FERNIE GR, 1982, AGE AGEING, V11, P11, DOI 10.1093/ageing/11.1.11; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Fransson PA, 2004, EUR J APPL PHYSIOL, V91, P595, DOI 10.1007/s00421-003-1013-1; Goel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136335; Gomez S, 2009, GAIT POSTURE, V30, P93, DOI 10.1016/j.gaitpost.2009.03.009; Gravelle DC, 2002, NEUROREPORT, V13, P1853, DOI 10.1097/00001756-200210280-00004; Hay L, 1996, EXP BRAIN RES, V108, P129; HAYASHI R, 1981, EXP BRAIN RES, V43, P217; Hellebrandt FA, 1939, AM J PHYS ANTHROPOL, V24, P347, DOI 10.1002/ajpa.1330240318; Hilz MJ, 1998, J NEUROL SCI, V159, P219, DOI 10.1016/S0022-510X(98)00177-4; Howcroft J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172398; Kallio J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00773, 10.3389/fnhum.2014.00773]; Kamen G, 1995, J APPL PHYSIOL, V79, P1908, DOI 10.1152/jappl.1995.79.6.1908; Kararizou E, 2005, ANAL QUANT CYTOL, V27, P1; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; Kido A, 2004, CAN J PHYSIOL PHARM, V82, P238, DOI 10.1139/Y04-017; Kostyukov AI, 2005, EXP BRAIN RES, V163, P284, DOI 10.1007/s00221-004-2188-3; LACKNER JR, 1979, AVIAT SPACE ENVIR MD, V50, P346; Landers KA, 2001, J GERONTOL A-BIOL, V56, pB443, DOI 10.1093/gerona/56.10.B443; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Lin SI, 2002, J MOTOR BEHAV, V34, P37, DOI 10.1080/00222890209601929; Lipsitz LA, 2015, ARCH PHYS MED REHAB, V96, P432, DOI 10.1016/j.apmr.2014.10.004; Liu JX, 2005, J HISTOCHEM CYTOCHEM, V53, P445, DOI 10.1369/jhc.4A6257.2005; Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2; LORD SR, 1991, J GERONTOL, V46, pM69, DOI 10.1093/geronj/46.3.M69; Luft AR, 1999, CEREB CORTEX, V9, P712, DOI 10.1093/cercor/9.7.712; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; MANCHESTER D, 1989, J GERONTOL, V44, pM118; McNeil CJ, 2005, MUSCLE NERVE, V31, P461, DOI 10.1002/mus.20276; Melzer I, 2010, CLIN BIOMECH, V25, P984, DOI 10.1016/j.clinbiomech.2010.07.007; Mendez-Balbuena I, 2012, J NEUROSCI, V32, P12612, DOI 10.1523/JNEUROSCI.0680-12.2012; Metter EJ, 1997, J GERONTOL A-BIOL, V52, pB267, DOI 10.1093/gerona/52A.5.B267; Miwa T, 1995, NEUROSCI LETT, V201, P179, DOI 10.1016/0304-3940(95)12165-X; Najafi Bijan, 2010, J Diabetes Sci Technol, V4, P780; Naka M, 2015, PERCEPTION, V44, P39, DOI 10.1068/p7738; NARDONE A, 1995, ARCH PHYS MED REHAB, V76, P158, DOI 10.1016/S0003-9993(95)80025-5; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Piotrkiewicz M, 2007, J PHYSIOL-LONDON, V585, P483, DOI 10.1113/jphysiol.2007.142356; Polonyova A, 2001, PHYSIOL RES, V50, P405; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rivner MH, 2001, MUSCLE NERVE, V24, P1134, DOI 10.1002/mus.1124; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Rubenstein LZ, 2011, J SAFETY RES, V42, P493, DOI 10.1016/j.jsr.2011.08.006; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; Sozzi S, 2011, HUM MOVEMENT SCI, V30, P172, DOI 10.1016/j.humov.2010.06.002; Thelen DG, 1998, J GERONTOL A-BIOL, V53, pM33, DOI 10.1093/gerona/53A.1.M33; Tokuno CD, 2010, CLIN NEUROPHYSIOL, V121, P109, DOI 10.1016/j.clinph.2009.09.025; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Toosizadeh N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135255; Toosizadeh N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124763; Trevino M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00572; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Verschueren SMP, 2002, BEHAV BRAIN RES, V136, P593, DOI 10.1016/S0166-4328(02)00224-3; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Watanabe K, 2016, AGE, V38, DOI 10.1007/s11357-016-9915-0; Wierzbicka MM, 1998, J NEUROPHYSIOL, V79, P143, DOI 10.1152/jn.1998.79.1.143; Wiesmeier IK, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00097; Wingert JR, 2014, ARCH PHYS MED REHAB, V95, P253, DOI 10.1016/j.apmr.2013.08.012	87	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194720	10.1371/journal.pone.0194720	http://dx.doi.org/10.1371/journal.pone.0194720			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579098	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800050
J	van Oevelen, D; Mueller, CE; Lundalv, T; van Duyl, FC; de Goeij, JM; Middelburg, JJ				van Oevelen, Dick; Mueller, Christina E.; Lundalv, Tomas; van Duyl, Fleur C.; de Goeij, Jasper M.; Middelburg, Jack J.			Niche overlap between a cold-water coral and an associated sponge for isotopically-enriched particulate food sources	PLOS ONE			English	Article							ORGANIC-CARBON; LOPHELIA-PERTUSA; ROCKALL-BANK; NE ATLANTIC; DEEP; FLOW; COMMUNITY; REEFS; SIZE; SEA	The cold-water coral Lophelia pertusa is an ecosystem engineer that builds reef structures on the seafloor. The interaction of the reef topography with hydrodynamics is known to enhance the supply of suspended food sources to the reef communities. However, the reef framework is also a substrate for other organisms that may compete for the very same suspended food sources. Here, we used the passive suspension feeder Lophelia pertusa and the active suspension feeding sponge Hymedesmia coriacea as model organisms to study niche overlap using isotopically-enriched algae and bacteria as suspended food sources. The coral and the sponge were fed with a combination of C-13-enriched bacteria/N-15-enriched algae or N-15-enriched bacteria/C-13-enriched algae, which was subsequently traced into bulk tissue, coral skeleton and dissolved inorganic carbon (i.e. respiration). Both the coral and the sponge assimilated and respired the suspended bacteria and algae, indicating niche overlap between these species. The assimilation rates of C and N into bulk tissue of specimens incubated separately were not significantly different from assimilation rates during incubations with co-occurring corals and sponges. Hence, no evidence for exploitative resource competition was found, but this is likely due to the saturating experimental food concentration that was used. We do not rule out that exploitative competition occurs in nature during periods of low food concentrations. Food assimilation and respiration rates of the sponge were almost an order of magnitude higher than those of the cold water coral. We hypothesize that the active suspension feeding mode of the sponge explains the observed differences in resource uptake as opposed to the passive suspension feeding mode of the cold-water coral. These feeding mode differences may set constraints on suitable habitats for cold-water corals and sponges in their natural habitats.	[van Oevelen, Dick; Mueller, Christina E.] Royal Netherlands Inst Sea Res NIOZ Yerseke, Dept Estuarine & Delta Syst, Yerseke, Netherlands; [van Oevelen, Dick; Mueller, Christina E.] Univ Utrecht, Yerseke, Netherlands; [Lundalv, Tomas] Univ Gothenburg, Sven Loven Ctr Marine Sci, Stromstad, Sweden; [van Duyl, Fleur C.] Royal Netherlands Inst Sea Res NIOZ Texel, Dept Marine Microbiol & Biogeochem, Texel, Netherlands; [van Duyl, Fleur C.] Univ Utrecht, Texel, Netherlands; [de Goeij, Jasper M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Freshwater & Marine Ecol, Amsterdam, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Gothenburg; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Amsterdam; Utrecht University	van Oevelen, D (corresponding author), Royal Netherlands Inst Sea Res NIOZ Yerseke, Dept Estuarine & Delta Syst, Yerseke, Netherlands.; van Oevelen, D (corresponding author), Univ Utrecht, Yerseke, Netherlands.	Dick.van.Oevelen@nioz.nl	Middelburg, Jack/B-4951-2011; van Duyl, Fleur C./P-9711-2016; Lundälv, Tomas/O-7121-2019	Middelburg, Jack/0000-0003-3601-9072; van Duyl, Fleur C./0000-0002-8410-4151; 	CALMARO within the European Community's Seventh Framework Program; Netherlands Organisation for Scientific Research (VIDI grant) [864.13.007]; European Union's Horizon research and innovation programme [678760, 679849]	CALMARO within the European Community's Seventh Framework Program; Netherlands Organisation for Scientific Research (VIDI grant); European Union's Horizon research and innovation programme	This research was supported by the CALMARO project (FP7/2007-2013) within the European Communitys Seventh Framework Program (FP7/2007-2013), the Netherlands Organisation for Scientific Research (VIDI grant no. 864.13.007 to DvO) and has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreements No. 678760 (ATLAS) and No. 679849 (SponGES). This output reflects only the authors view and the European Union cannot be held responsible for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Cathalot C, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00037; Cyr F, 2016, GEOPHYS RES LETT, V43, P775, DOI 10.1002/2015GL067038; DAME R, 1991, ESTUARIES, V14, P130, DOI 10.2307/1351686; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; Dodds LA, 2007, J EXP MAR BIOL ECOL, V349, P205, DOI 10.1016/j.jembe.2007.05.013; Duineveld GCA, 2007, B MAR SCI, V81, P449; Duineveld GCA, 2012, MAR ECOL PROG SER, V444, P97, DOI 10.3354/meps09430; Findlay HS, 2013, GLOBAL CHANGE BIOL, V19, P2708, DOI 10.1111/gcb.12256; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gori A, 2014, DEEP-SEA RES PT II, V99, P42, DOI 10.1016/j.dsr2.2013.06.007; Guihen Damien, 2012, Marine Biodiversity Records, V5, P1; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; Johnsen E, FOOD SUPPLY ME UNPUB; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kiriakoulakis K, 2007, INT J EARTH SCI, V96, P159, DOI 10.1007/s00531-006-0078-6; Kiriakoulakis K, 2005, ERLANGEN EARTH C SER, P715, DOI 10.1007/3-540-27673-4_37; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LARSEN PS, 1994, J THEOR BIOL, V168, P53, DOI 10.1006/jtbi.1994.1087; Lavaleye M, 2009, OCEANOGRAPHY, V22, P76, DOI 10.5670/oceanog.2009.08; LESSER MP, 1994, BIOL BULL-US, V187, P319, DOI 10.2307/1542289; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Leys SP, LIMNOLOGY O IN PRESS; Long MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058581; Maier C, 2011, BIOGEOSCIENCES, V8, P2609, DOI 10.5194/bg-8-2609-2011; Middelburg JJ, 2015, SCI REPORTS, V5, P9; Mohn C, 2014, PROG OCEANOGR, V122, P92, DOI 10.1016/j.pocean.2013.12.003; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Mueller CE, 2014, BIOGEOSCIENCES, V11, P123, DOI 10.5194/bg-11-123-2014; Mueller CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058660; NIEUWENHUIZE J, 1994, MAR CHEM, V45, P217, DOI 10.1016/0304-4203(94)90005-1; Orejas C, 2016, J EXP MAR BIOL ECOL, V481, P34, DOI 10.1016/j.jembe.2016.04.002; Pile AJ, 1996, MAR ECOL PROG SER, V141, P95, DOI 10.3354/meps141095; Ribes M, 1998, MAR ECOL PROG SER, V175, P201, DOI 10.3354/meps175201; RIISGARD HU, 1995, BIOL REV, V70, P67, DOI 10.1111/j.1469-185X.1995.tb01440.x; Rix L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18715; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; SEBENS KP, 1984, P NATL ACAD SCI-BIOL, V81, P5473, DOI 10.1073/pnas.81.17.5473; Soetaert K, 2016, SCI REP-UK, V6, DOI 10.1038/srep35057; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Tanaka Y, 2007, LIMNOL OCEANOGR, V52, P1139, DOI 10.4319/lo.2007.52.3.1139; Tsounis G, 2010, MAR ECOL PROG SER, V398, P149, DOI 10.3354/meps08312; Turon X, 1997, J EXP ZOOL, V278, P22, DOI 10.1002/(SICI)1097-010X(19970501)278:1<22::AID-JEZ3>3.0.CO;2-8; van Duyl FC, 2008, MAR ECOL PROG SER, V358, P137, DOI 10.3354/meps07370; van Oevelen D, 2016, BIOGEOSCIENCES, V13, P5789, DOI 10.5194/bg-13-5789-2016; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; van Soest RWM, 2007, CONTRIB ZOOL, V76, P121, DOI 10.1163/18759866-07602005; Van Soest RWM, 2005, MAR BIOL RES, V1, P338, DOI 10.1080/17451000500380322; van Soest RWM, 2013, J MAR BIOL ASSOC UK, V95, P1461, DOI DOI 10.1017/S0025315413001410; van Weering TCE, 2003, MAR GEOL, V198, P67, DOI 10.1016/S0025-3227(03)00095-1; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Witte U, 1997, MAR ECOL PROG SER, V154, P241, DOI 10.3354/meps154241; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428; Zetsche EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146766	62	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194659	10.1371/journal.pone.0194659	http://dx.doi.org/10.1371/journal.pone.0194659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579118	Green Published, gold			2022-12-27	WOS:000428351800043
J	Ni, TT; Zhou, Y; Yong, AC; Wang, L; Zhou, QH				Ni, Ting-ting; Zhou, Ying; Yong, An-cui; Wang, Lu; Zhou, Qing-he			Intra-abdominal pressure, vertebral column length, and spread of spinal anesthesia in parturients undergoing cesarean section: An observational study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID DENSITY; PLAIN BUPIVACAINE; TERM PARTURIENT; 0.5-PERCENT BUPIVACAINE; ABDOMINAL GIRTH; PREGNANT-WOMEN; VENOUS PLEXUS; BODY-MASS; VOLUME; EXTENT	Background In parturients with increased physiologically intra-abdominal pressure (IAP) and a short stature, a greater cephalad spread of spinal anesthesia is often observed after a fixed amount of plain bupivacaine is administered. Therefore, we designed this prospective study to test whether IAP and vertebral column length (VCL) were predictors of spinal spread in parturients undergoing a cesarean section. Methods A total of 113 parturients, all undergoing elective cesarean sections with single-shot spinal anesthesia, were enrolled. The L3-L4 interspace was entered, and 2 mL of 0.5% plain bupivacaine was injected into the subarachnoid space. Upon loss of temperature sensation at the T4 level, IAP was measured through a bladder catheter while the patient was in the supine position with a 10 degrees left lateral tilt. Parturient demographic variables, including age, height, weight, IAP, and VCL were recorded. Linear regressions and multiple regressions were performed to analyze the relationships between parturient variables and the spread of spinal anesthesia. Results A total of 109 parturients were included in the analysis. Linear regression analysis showed a significant univariate correlation of height, weight, body mass index (BMI), IAP, and VCL with cephalad spread (all P < 0.004). Multiple linear regression analysis showed that IAP and VCL were the key determinants of spinal spread (both P < 0.0001), where as exclusion of age, weight, and height did not change the result (all P > 0.209). Conclusions Our data indicated that IAP and VCL were significant predictors of intrathecal spread of plain bupivacaine, and there was a positive association between IAP and abdominal girth in term parturients.	[Ni, Ting-ting; Zhou, Ying; Wang, Lu] Ningbo 7 Hosp, Dept Anesthesiol, Ningbo, Zhejiang, Peoples R China; [Yong, An-cui] Ningbo 7 Hosp, Dept Gynecol, Ningbo, Zhejiang, Peoples R China; [Zhou, Qing-he] Jiaxing Univ, Affiliated Hosp 2, Dept Anesthesiol, Jiaxing, Zhejiang, Peoples R China	Jiaxing University	Zhou, QH (corresponding author), Jiaxing Univ, Affiliated Hosp 2, Dept Anesthesiol, Jiaxing, Zhejiang, Peoples R China.	zqh@jxey.com	Zhou, Qing-he/GRS-0710-2022					Akamatsu T J, 1969, Clin Anesth, V3, P221; BARCLAY DL, 1968, AM J OBSTET GYNECOL, V101, P792, DOI 10.1016/0002-9378(68)90035-5; Carpenter RL, 1998, ANESTHESIOLOGY, V89, P24, DOI 10.1097/00000542-199807000-00007; Chun R, 2012, INT J OBSTET ANESTH, V21, P135, DOI 10.1016/j.ijoa.2011.10.010; Ekelof NP, 1997, ACTA ANAESTH SCAND, V41, P884, DOI 10.1111/j.1399-6576.1997.tb04804.x; Higuchi H, 2004, ANESTHESIOLOGY, V100, P106, DOI 10.1097/00000542-200401000-00019; Hirabayashi Y, 1997, BRIT J ANAESTH, V78, P317, DOI 10.1093/bja/78.3.317; Hogan QH, 1996, ANESTHESIOLOGY, V84, P1341, DOI 10.1097/00000542-199606000-00010; Igarashi T, 2000, ANESTHESIOLOGY, V92, P1631, DOI 10.1097/00000542-200006000-00021; Iwase K, 1994, HPB Surg, V8, P13; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Lee YH, 2014, J ANESTH, V28, P202, DOI 10.1007/s00540-013-1715-4; Leino KA, 2011, J ANESTH, V25, P213, DOI 10.1007/s00540-010-1082-3; LOGAN MR, 1986, BRIT J ANAESTH, V58, P292, DOI 10.1093/bja/58.3.292; Loubert C, 2011, ANESTH ANALG, V113, P811, DOI 10.1213/ANE.0b013e3182288bf2; Ngaka TC, 2016, ANESTH ANALG, V123, P1527, DOI 10.1213/ANE.0000000000001568; Pargger H, 1998, ACTA ANAESTH SCAND, V42, P430, DOI 10.1111/j.1399-6576.1998.tb05137.x; PITKANEN MT, 1987, ANESTH ANALG, V66, P127, DOI 10.1213/00000539-198702000-00005; RUSSELL IF, 1983, BRIT J ANAESTH, V55, P309, DOI 10.1093/bja/55.4.309; Schiffer E, 2002, ANESTHESIOLOGY, V96, P1325, DOI 10.1097/00000542-200206000-00010; Seyhan TO, 2015, INT J OBSTET ANESTH, V24, P35, DOI 10.1016/j.ijoa.2014.08.004; Sugerman H, 1997, J INTERN MED, V241, P71, DOI 10.1046/j.1365-2796.1997.89104000.x; TAIVAINEN T, 1990, BRIT J ANAESTH, V64, P542, DOI 10.1093/bja/64.5.542; Takiguchi T, 2006, ANESTHESIOLOGY, V105, P848, DOI 10.1097/00000542-200610000-00033; Wei CN, 2017, INT J OBSTET ANESTH, V31, P63, DOI 10.1016/j.ijoa.2017.02.002; Zhou QH, 2014, ANESTH ANALG, V119, P203, DOI 10.1213/ANE.0000000000000199	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195137	10.1371/journal.pone.0195137	http://dx.doi.org/10.1371/journal.pone.0195137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614090	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600035
J	Nitzschke, A; Bettenbrock, K				Nitzschke, Annika; Bettenbrock, Katja			All three quinone species play distinct roles in ensuring optimal growth under aerobic and fermentative conditions in E. coli K12	PLOS ONE			English	Article							ARCB SENSOR KINASE; SIGNAL-TRANSDUCTION SYSTEM; TRIMETHYLAMINE N-OXIDE; ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; REDOX STATE; IN-VITRO; DIHYDROOROTATE DEHYDROGENASE; TRANSCRIPTIONAL REGULATION; OXIDATIVE STRESS	The electron transport chain of E. coli contains three different quinone species, ubiquinone (UQ), menaquinone (MK) and demethylmenaquinone (DMK). The content and ratio of the different quinone species vary depending on the external conditions. To study the function of the different quinone species in more detail, strains with deletions preventing UQ synthesis, as well as MK and/or DMK synthesis were cultured under aerobic and anaerobic conditions. The strains were characterized with respect to growth and product synthesis. As quinones are also involved in the control of ArcB/A activity, we analyzed the phosphorylation state of the response regulator as well as the expression of selected genes. The data show reduced aerobic growth coupled to lactate production in the mutants defective in ubiquinone synthesis. This confirms the current assumption that ubiquinone is the main quinone under aerobic growth conditions. In the UQ mutant strains the amount of MK and DMK is significantly elevated. The strain synthesizing only DMK is less affected in growth than the strain synthesizing MK as well as DMK. An inhibitory effect of MK on aerobic growth due to increased oxidative stress is postulated. Under fermentative growth conditions the mutant synthesizing only UQ is severely impaired in growth. Obviously, UQ is not able to replace MK and DMK during anaerobic growth. Mutations affecting quinone synthesis have an impact on ArcA phosphorylation only under anaerobic conditions. ArcA phosphorylation is reduced in strains synthesizing only MK or MK plus DMK.	[Nitzschke, Annika; Bettenbrock, Katja] Max Planck Inst Dynam Complex Tech Syst, Sandtorstr, Magdeburg, Germany	Max Planck Society	Bettenbrock, K (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Sandtorstr, Magdeburg, Germany.	bettenbrock@mpi-magdeburg.mpg.de	Bettenbrock, Katja/AAN-5812-2020	Bettenbrock, Katja/0000-0002-2444-7777	German Federal Ministery of Education and Research [FKZ 031A127B]; German Federal Ministry of Education and Research (BMBF) [FKZ 031A127B]	German Federal Ministery of Education and Research; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Funded by German Federal Ministery of Education and Research FKZ 031A127B.; This work was supported by grant FKZ 031A127B of the German Federal Ministry of Education and Research (BMBF). We thank Prof. Hellingwerf (University of Amsterdam) for kindly supplying ArcA antiserum. We thank Andrea Schutze and Helga Tietgens for technical support.	Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; ANDREWS S, 1977, BIOCHIM BIOPHYS ACTA, V462, P153, DOI 10.1016/0005-2728(77)90197-9; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Bjornberg O, 1999, BIOCHEMISTRY-US, V38, P2899, DOI 10.1021/bi982352c; Brondijk THC, 2004, BIOCHEM J, V379, P47, DOI 10.1042/BJ20031115; CARTER K, 1985, J BIOL CHEM, V260, P986; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; COX GB, 1970, BIOCHEM J, V117, P551, DOI 10.1042/bj1170551; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; Evans C. G. T., 1970, METHODS MICROBIOLOGY, V2, DOI [10.1016/S0580-9517(08)70227-7, DOI 10.1016/S0580-9517(08)70227-7]; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; IUCHI S, 1993, J BIOL CHEM, V268, P23972; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; McBee ME, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00459; NEWTON NA, 1972, J BACTERIOL, V109, P69, DOI 10.1128/JB.109.1.69-73.1972; Palfey BA, 2001, BIOCHEMISTRY-US, V40, P4381, DOI 10.1021/bi0025666; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Pinske C, 2016, ECOSAL PLUS; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; SAUTER M, 1990, MOL MICROBIOL, V4, P355, DOI 10.1111/j.1365-2958.1990.tb00603.x; Sawers RG, 2004, ECOSAL PLUS; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Shalel-Levanon S, 2005, BIOTECHNOL BIOENG, V92, P147, DOI 10.1002/bit.20583; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; Sharma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075412; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; SPIRO S, 1991, TRENDS BIOCHEM SCI, V16, P310, DOI 10.1016/0968-0004(91)90125-F; Steinsiek S, 2011, J BIOTECHNOL, V154, P35, DOI 10.1016/j.jbiotec.2011.03.015; Steinsiek S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087307; Sutton VR, 2004, J BACTERIOL, V186, P8018, DOI 10.1128/JB.186.23.8018-8025.2004; Tyson K, 1997, ARCH MICROBIOL, V168, P403, DOI 10.1007/s002030050515; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Unden G., 2014, ECOSAL PLUS; Utrilla J, 2009, J IND MICROBIOL BIOT, V36, P1057, DOI 10.1007/s10295-009-0589-9; Valgepea K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-106; van Beilen JWA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01339; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Wang QZ, 2010, APPL ENVIRON MICROB, V76, P2107, DOI 10.1128/AEM.02545-09; WISSENBACH U, 1990, ARCH MICROBIOL, V154, P60; WISSENBACH U, 1992, ARCH MICROBIOL, V158, P68, DOI 10.1007/BF00249068; Zhou S, 2008, BIOTECHNOL LETT, V30, P335, DOI 10.1007/s10529-007-9544-x	60	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194699	10.1371/journal.pone.0194699	http://dx.doi.org/10.1371/journal.pone.0194699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614086	gold, Green Submitted, Green Published			2022-12-27	WOS:000429081600016
J	Mindus, S; Malinovschi, A; Ekerljung, L; Forsberg, B; Gislason, T; Jogi, R; Franklin, KA; Holm, M; Johannessen, A; Middelveld, R; Schlunssen, V; Svanes, C; Toren, K; Lindberg, E; Janson, C				Mindus, Stephanie; Malinovschi, Andrei; Ekerljung, Linda; Forsberg, Bertil; Gislason, Thorarinn; Jogi, Rain; Franklin, Karl A.; Holm, Mathias; Johannessen, Ane; Middelveld, Roelinde; Schlunssen, Vivi; Svanes, Cecilie; Toren, Kjell; Lindberg, Eva; Janson, Christer			Asthma and COPD overlap (ACO) is related to a high burden of sleep disturbance and respiratory symptoms: Results from the RHINE and Swedish GA(2)LEN surveys	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HEALTH SURVEY; PREVALENCE; INSOMNIA; ADULTS	Background The term Asthma and COPD Overlap (ACO) describes a condition where asthma and COPD overlap. We aimed to investigate associations between ACO and insomnia and respiratory symptoms, and to investigate the prevalence of ACO and the characteristics of subjects with ACO in two Northern European population studies. Methods The study comprised 25 429 subjects aged >40 years who participated in one of two Northern European general population surveys. Both surveys included questions on asthma, COPD, respiratory and sleep-related symptoms, including difficulty initiating sleep, difficulty maintaining sleep, early-morning awakening, and excessive daytime sleepiness. ACO was defined as having both self-reported asthma and COPD. Results The prevalence of ACO was 1.0%. The group with ACO had a higher prevalence of both insomnia and respiratory symptoms than subjects with only asthma or COPD. Having ACO was independently associated with a 2-3 times higher probability of having sleep-related symptoms as compared with the group without asthma or COPD, after adjustment for age, sex, BMI, smoking history and educational level (adjusted odds ratio 2.14-3.36, 95% CI). Conclusion Subjects with ACO have a high prevalence of insomnia and respiratory symptoms. To our knowledge, this is the first study to assess the association between sleep-related symptoms and ACO.	[Mindus, Stephanie; Lindberg, Eva; Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden; [Ekerljung, Linda] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Gislason, Thorarinn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jogi, Rain] Tartu Univ Clin, Lung Clin, Tartu, Estonia; [Franklin, Karl A.] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Holm, Mathias] Univ Gothenburg, Dept Occupat & Environm Med, Gothenburg, Sweden; [Johannessen, Ane] Haukeland Hosp, Clin Res Ctr, Bergen, Norway; [Middelveld, Roelinde] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Schlunssen, Vivi] Aarhus Univ, Dept Publ Hlth, Sect Environm Occupat & Hlth, Aarhus, Denmark; [Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Svanes, Cecilie] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Toren, Kjell] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden	Uppsala University; University of Gothenburg; Umea University; University of Iceland; University of Tartu; Umea University; University of Gothenburg; University of Bergen; Haukeland University Hospital; Karolinska Institutet; Aarhus University; University of Bergen; Haukeland University Hospital; University of Bergen; Sahlgrenska University Hospital	Janson, C (corresponding author), Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden.	christer.janson@medsci.uu.se	Svanes, Cecilie/N-7556-2017	Svanes, Cecilie/0000-0001-8512-5192; Franklin, Karl/0000-0002-5306-1697; Schlunssen, Vivi/0000-0003-4915-1734; Johannessen, Ane/0000-0003-3269-8354	EU Sixth Framework Programme for Research [FOOD-CT-2004-506378]; Swedish Heart and Lung Foundation; Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research; Swedish Association Against Asthma and Allergy; Swedish Association against Heart and Lung Disease; Swedish Council for Working Life and Social Research; Bror Hjerpstedt Foundation; Vardal Foundation for Health Care and Allergic Research; Faculty of. Health, Aarhus University, Denmark [240008]; Wood Dust Foundation [444508795]; Danish Lung Association; Norwegian Research Council [135773/330]; Norwegian Asthma and Allergy Association; Icelandic Research Council; Estonian Science Foundation [4350]	EU Sixth Framework Programme for Research(European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research; Swedish Association Against Asthma and Allergy; Swedish Association against Heart and Lung Disease; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Bror Hjerpstedt Foundation; Vardal Foundation for Health Care and Allergic Research; Faculty of. Health, Aarhus University, Denmark; Wood Dust Foundation; Danish Lung Association; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Asthma and Allergy Association; Icelandic Research Council; Estonian Science Foundation	The GA2LEN survey was financially supported by the EU Sixth Framework Programme for Research, contract no. FOOD-CT-2004-506378. The study was also financially supported by the Swedish Heart and Lung Foundation, the Swedish Asthma and Allergy Foundation and the Swedish Association against Heart and Lung Diseases. The Gothenburg part of the study was mainly funded by the VBG Group Centre for Asthma and Allergy Research. The RHINE study was funded by the Swedish Heart and Lung Foundation, the Swedish Association Against Asthma and Allergy, the Swedish Association against Heart and Lung Disease, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Vardal Foundation for Health Care and Allergic Research, the Faculty of. Health, Aarhus University, Denmark (Project No. 240008), the Wood Dust Foundation (Project No 444508795), the Danish Lung Association, the Norwegian Research Council (project 135773/330), the Norwegian Asthma and Allergy Association, the Icelandic Research Council and the Estonian Science Foundation (Grant No. 4350); The GA<SUP>2</SUP>LEN survey was financially supported by the EU Sixth Framework Programme for Research, contract no. FOOD-CT-2004-506378. The study was also financially supported by the Swedish Heart and Lung Foundation, the Swedish Asthma and Allergy Foundation and the Swedish Association against Heart and Lung Diseases. The Gothenburg part of the study was mainly funded by the VBG Group Centre for Asthma and Allergy Research.; The RHINE study was funded by the Swedish Heart and Lung Foundation, the Swedish Association Against Asthma and Allergy, the Swedish Association against Heart and Lung Disease, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Vardal Foundation for Health Care and Allergic Research, the Faculty of. Health, Aarhus University, Denmark (Project No. 240008), the Wood Dust Foundation (Project No 444508795), the Danish Lung Association, the Norwegian Research Council (project 135773/330), the Norwegian Asthma and Allergy Association, the Icelandic Research Council and the Estonian Science Foundation (Grant No. 4350).	[Anonymous], 2016, GLOBAL INITIATIVE AS; Bateman ED, 2015, LANCET RESP MED, V3, P719, DOI 10.1016/S2213-2600(15)00254-4; Burney P, 1996, EUR RESPIR J, V9, P687; Cosio BG, 2016, CHEST, V149, P45, DOI 10.1378/chest.15-1055; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; Diaz-Guzman E, 2011, COPD, V8, P400, DOI 10.3109/15412555.2011.611200; Gibson PG, 2015, THORAX, V70, P683, DOI 10.1136/thoraxjnl-2014-206740; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Janson C, 1996, EUR RESPIR J, V9, P2132, DOI 10.1183/09031936.96.09102132; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; Miravitlles M, 2013, RESP MED, V107, P1053, DOI 10.1016/j.rmed.2013.03.007; Rhee CK, 2014, COPD, V11, P163, DOI 10.3109/15412555.2013.831061; Stridsman C, 2013, COPD, V10, P125, DOI 10.3109/15412555.2012.728642; Sundbom F, 2013, ALLERGY, V68, P213, DOI 10.1111/all.12079; Sundbom F, 2016, J ASTHMA, V53, P398, DOI 10.3109/02770903.2015.1126846; Theorell-Haglow J, 2016, INT J CHRONIC OBSTR, V11, P151, DOI 10.2147/COPD.S94268	17	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195055	10.1371/journal.pone.0195055	http://dx.doi.org/10.1371/journal.pone.0195055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608582	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800023
J	Rosenberg, M; Pettifor, A; Duta, M; Demeyere, N; Wagner, RG; Selin, A; MacPhail, C; Laeyendecker, O; Hughes, JP; Stein, A; Tollman, S; Kahn, K				Rosenberg, Molly; Pettifor, Audrey; Duta, Mihaela; Demeyere, Nele; Wagner, Ryan G.; Selin, Amanda; MacPhail, Catherine; Laeyendecker, Oliver; Hughes, James P.; Stein, Alan; Tollman, Stephen; Kahn, Kathleen			Executive function associated with sexual risk in young South African women: Findings from the HPTN 068 cohort	PLOS ONE			English	Article							OF-THE-LITERATURE; DECISION-MAKING; WORKING-MEMORY; COGNITIVE PERFORMANCE; PHYSICAL-EDUCATION; TRANSACTIONAL SEX; ADOLESCENT BRAIN; HIV; HEALTH; PREVALENCE	Purpose Heightened sexual risk in adolescence and young adulthood may be partially explained by deficits in executive functioning, the set of cognitive processes used to make reasoned decisions. However, the association between executive function and sexual risk is understudied among adolescent girls and young women, particularly in low- and middle-income countries. Methods In a cohort of 853 young women age 18-25 in rural Mpumalanga province, South Africa, we evaluated executive function with three non-verbal cognitive tests: I. a rule-finding test, II. a trail-making test, and III. a figure drawing test. Using log-binomial regression models, we estimated the association between lower executive function test scores and indicators of sexual risk (unprotected sex acts, concurrent partnerships, transactional sex, and recent HSV-2 infection). Results In general, young women with lower executive function scores reported higher frequencies of sexual risk outcomes, though associations tended to be small with wide confidence intervals. Testing in the lowest quintile of Test I was associated with more unprotected sex [aPR (95% CI): 1.4 (1.0, 1.8)]. Testing in the lowest quintile of Test II was associated with more concurrent relationships and transactional sex [aPR (95% CI): 1.6 (1.1, 2.5) and 1.7 (1.3, 2.4), respectively], and testing in the lowest four quintiles of Test III was associated with more concurrent relationships [aPR (95% CI): 1.7 (1.0, 2.7)]. Conclusions These results demonstrate an association between low executive function and sexual risk in South African young women. Future work should seek to understand the nature of this association and whether there is promise in developing interventions to enhance executive function to reduce sexual risk.	[Rosenberg, Molly] Indiana Univ, Sch Publ Hlth Bloomington, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA; [Pettifor, Audrey] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Pettifor, Audrey; Selin, Amanda] Univ North Carolina Chapel Hill, Carolina Populat Ctr, Chapel Hill, NC USA; [Pettifor, Audrey; Wagner, Ryan G.; MacPhail, Catherine; Stein, Alan; Tollman, Stephen; Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Duta, Mihaela; Demeyere, Nele] Univ Oxford, Dept Expt Psychol, Oxford, England; [Wagner, Ryan G.; Tollman, Stephen; Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Wagner, Ryan G.; Tollman, Stephen; Kahn, Kathleen] Umea Univ, Umea Ctr Global Hlth Res, Div Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, Umea, Sweden; [MacPhail, Catherine] Univ Wollongong, Sch Hlth & Soc, Wollongong, NSW, Australia; [MacPhail, Catherine] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Laeyendecker, Oliver] NIAID, Immunoregulat Lab, NIH, Baltimore, MD USA; [Laeyendecker, Oliver] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Stein, Alan] Univ Oxford, Dept Psychiat, Oxford, England	Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Witwatersrand; University of Oxford; INDEPTH Network; Umea University; University of Wollongong; University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University; University of Washington; University of Washington Seattle; University of Oxford	Rosenberg, M (corresponding author), Indiana Univ, Sch Publ Hlth Bloomington, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA.	rosenmol@indiana.edu	Pettifor, Audrey/H-6793-2019; Duta, Mihaela/AAB-9598-2019; Wagner, Ryan G/AFK-7323-2022; MacPhail, Catherine/N-4234-2014; Demeyere, Nele/G-3974-2015	Pettifor, Audrey/0000-0002-3387-0817; Duta, Mihaela/0000-0002-0435-571X; Wagner, Ryan G/0000-0003-2741-3676; MacPhail, Catherine/0000-0002-0614-0157; Rosenberg, Molly/0000-0001-6679-6791; Laeyendecker, Oliver/0000-0002-6429-4760; Stein, Alan/0000-0001-8207-2822; Tollman, Stephen/0000-0003-0744-7588; Kahn, Kathleen/0000-0003-3339-3931; Demeyere, Nele/0000-0003-0416-5147	HIV Prevention Trials Network (HPTN) through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) [UM1AI068619, UM1AI068617, UM1AI068613]; Division of Intramural Research NIAID; Wellcome Trust [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z, 085477/B/08/Z]; University of the Witwatersrand; Medical Research Council, South Africa;  [5R01MH087118-02];  [R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, ZIAAI000361, UM1AI068613, UM1AI069423] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN) through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH); Division of Intramural Research NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); University of the Witwatersrand; Medical Research Council, South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the HPTN 068 study was provided by the HIV Prevention Trials Network (HPTN), funded through the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH) and the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under Award Numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). The study was also funded under Award Number 5R01MH087118-02 and R24 HD050924 to the Carolina Population Center. Additional funding was provided by the Division of Intramural Research NIAID. HPTN 068 is nested within the Agincourt Health and socio-Demographic Surveillance System, with funding from the Wellcome Trust (058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z), University of the Witwatersrand, and Medical Research Council, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio D, 2015, CONTEXT SPECIFIC ASS; Ardoy DN, 2014, SCAND J MED SCI SPOR, V24, pe52, DOI 10.1111/sms.12093; Bechara A, 2004, NEUROPSYCHOLOGY, V18, P152, DOI 10.1037/0894-4105.18.1.152; Bjork JM, 2015, DEV COGN NEUROS-NETH, V11, P56, DOI 10.1016/j.dcn.2014.07.008; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brown LK, 1997, J AM ACAD CHILD PSY, V36, P1609, DOI 10.1016/S0890-8567(09)66573-4; Burman CJ, 2015, AJAR-AFR J AIDS RES, V14, P75, DOI 10.2989/16085906.2015.1016983; Chambers Kathryn B, 2003, Issues Compr Pediatr Nurs, V26, P129, DOI 10.1080/01460860390223853; Clouston SAP, 2012, INT J EPIDEMIOL, V41, P1729, DOI 10.1093/ije/dys148; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Delany-Moretlwe S, 2010, SEX TRANSM INFECT, V86, P46, DOI 10.1136/sti.2009.036541; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Eilander A, 2010, AM J CLIN NUTR, V91, P115, DOI 10.3945/ajcn.2009.28376; Feldstein Ewing SW, 2015, AIDS BEHAV; Halpern CT, 2000, J ADOLESCENT HEALTH, V26, P213, DOI 10.1016/S1054-139X(99)00061-0; Hensel DJ, 2015, J ADOLESCENT HEALTH, V56, P389, DOI 10.1016/j.jadohealth.2014.11.004; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; House LD, 2010, J ADOLESCENT HEALTH, V46, pS7, DOI 10.1016/j.jadohealth.2009.12.003; Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175; Humphreys G, 2016, J GERONTOLOGY B; Iacono WG, 2008, ANNU REV CLIN PSYCHO, V4, P325, DOI 10.1146/annurev.clinpsy.4.022007.141157; Joint United Nations Programme on HIV/AIDS,, 2014, JOINT UN PROGR HIV A; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Karim QA, 2014, SEX TRANSM INFECT, V90, P620, DOI 10.1136/sextrans-2014-051548; Khurana A, 2015, CHILD DEV, V86, P1125, DOI 10.1111/cdev.12383; Khurana A, 2012, DEV PSYCHOL, V48, P1416, DOI 10.1037/a0027491; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Leonard AJ, 2014, NUTRIENTS, V6, P2419, DOI 10.3390/nu6062419; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI [10.2471/BLT.07.46128, DOI 10.2471/BLT.07.46128]; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Pettifor A, 2016, AIDS BEHAV, P1; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pettifor A, 2016, AIDS BEHAV, V20, P1863, DOI 10.1007/s10461-015-1270-0; Pettifor AE, 2011, J ADOLESCENT HEALTH, V49, P237, DOI 10.1016/j.jadohealth.2010.10.002; Rasberry CN, 2011, PREV MED, V52, pS10, DOI 10.1016/j.ypmed.2011.01.027; Robinson J, 2011, AM ECON J-APPL ECON, V3, P35, DOI 10.1257/app.3.1.35; Rosenberg M, 2015, INT J EPIDEMIOL; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Sherr L, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0883-z; Shisana O, 2014, S AFRICAN NATL HIV P; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Willoughby T, 2013, BRAIN COGNITION, V83, P315, DOI 10.1016/j.bandc.2013.09.008; WORTH D, 1989, STUD FAMILY PLANN, V20, P297, DOI 10.2307/1966433	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195217	10.1371/journal.pone.0195217	http://dx.doi.org/10.1371/journal.pone.0195217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608615	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800039
J	Sampat, BN; Shadlen, KC				Sampat, Bhaven N.; Shadlen, Kenneth C.			Indian pharmaceutical patent prosecution: The changing role of Section 3(d)	PLOS ONE			English	Article							TRIPS IMPLEMENTATION; DEVELOPING-COUNTRIES	India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of "secondary" pharmaceutical patents, i.e. patents on new forms of existing molecules and drugs. Previous research suggests the provision was rarely used against secondary applications in the years immediately following its enactment, and where it was, was redundant to other aspects of the patent law, raising concerns that 3(d) was being under-utilized by the Indian Patent Office. This paper uses a novel data source, the patent office's first examination reports, to examine changes in the use of the provision. We find a sharp increase over time in the use of Section 3(d), including on the main claims of patent applications, though it continues to be used in conjunction with other types of objections to patentability. More surprisingly, see a sharp increase in the use of the provision against primary patent applications, contrary to its intent, raising concerns about potential over-utilization.	[Sampat, Bhaven N.] Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY USA; [Sampat, Bhaven N.] NBER, Cambridge, MA 02138 USA; [Shadlen, Kenneth C.] London Sch Econ & Polit Sci, Dept Int Dev, London, England	Columbia University; National Bureau of Economic Research	Shadlen, KC (corresponding author), London Sch Econ & Polit Sci, Dept Int Dev, London, England.	k.shadlen@lse.ac.uk		Shadlen, Kenneth/0000-0003-4010-4835	Economic and Social Research Council [ES/K010999/1]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research was funded by the Economic and Social Research Council, Grant ES/K010999/1. We thank Jazmin Macias-Arteaga, Michael Novello, Antonio Postigo-Angon, Chetali Rao, Jennifer Reid, and Bhavish Vora for excellent research assistance.; The research was funded by the Economic and Social Research Council, Grant ES/K010999/1 (http://www.researchcatalogue.esrc.ac.uk/grants/ES.K010999.1/read) (KCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin TM, 2013, GLOBAL GOVERNANCE HI; [Anonymous], GUID EX; Basheer S., 2005, 1391562 ID SOC SCI R; Basheer S, 2008, EFFICACY INDIAN PATE; Berndt ER, 2014, HEALTH AFFAIR, V33, P1567, DOI 10.1377/hlthaff.2013.1307; Chaudhuri S., 2005, WTO INDIAS PHARM IND; Chaudhuri S, 2010, 5 YEARS PRODUCT PROD; Correa C, 2013, ECON POLIT WEEKLY, V48, P49; Das Sandip, 2015, EC TIMES; Drahos P, 2010, GLOBAL GOVERNANCE KN; Drahos P, 2008, AM J LAW MED, V34, P151, DOI 10.1177/009885880803400205; Du D., 2013, J INTELLECT PROP LAW, V2014, P223; Frakes MD, 2017, REV ECON STAT, V99, P550, DOI 10.1162/REST_a_00605; Gopakumar KM, 2013, EC POLIT WKLY, P48; Grover A., 2013, EC POLIT WKLY, V48, P46; Horner R, 2014, J ECON GEOGR, V14, P1117, DOI 10.1093/jeg/lbt022; James T. C., 2009, PATENT PROTECTION IN; Kapczynski A, 2009, CALIF LAW REV, V97, P1571; Lemley MA, 2012, REV ECON STAT, V94, P817, DOI 10.1162/REST_a_00194; Mashelkar R, 2009, REVISED REPORT TECHN; Matthews D., 2002, GLOBALISING INTELLEC; Mora Shalini, 2016, Journal of Intellectual Property Rights, V21, P16; MSF. Hands Off Our Medicines [Internet], HANDS OFF OUR MED; Pugatch Meir Perez, 2004, INT POLITICAL EC INT; Quinn G., 2014, UNDERSTANDING PATENT; Reddy P., 2017, CREATE COPY DISRUPT; Reichman Jerome H, 2009, Houst Law Rev, V46, P1115; Sampat BN, 2017, RES POLICY, V46, P693, DOI 10.1016/j.respol.2017.01.005; Sampat BN, 2015, NAT REV DRUG DISCOV, V14, P519, DOI 10.1038/nrd4681; Sampat BN, 2015, STUD COMP INT DEV, V50, P228, DOI 10.1007/s12116-015-9181-7; Sengupta, 2013, ECON POLIT WEEKLY, V48, P43; Shankar R., 2016, PHRMA CONCEMED SECT; Sinha Aseema, 2016, GLOBALIZING INDIA GL; TONG XS, 1994, RES POLICY, V23, P133, DOI 10.1016/0048-7333(94)90050-7; Turrill ZL, 2012, GEORGET J INT LAW, V2013, P1555; UNAIDS, 2011, DOHA 10 TRIPS FLEX A; USTR, SPEC 301 REP; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; Watal J., 2011, WIPO J, V3, P24; Yamauchi I, 2015, INT J IND ORGAN, V39, P19, DOI 10.1016/j.ijindorg.2015.01.003	41	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194714	10.1371/journal.pone.0194714	http://dx.doi.org/10.1371/journal.pone.0194714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608604	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000428988800015
J	Henneman, P; Bouman, A; Mul, A; Knegt, L; van der Kevie-Kersemaekers, AM; Zwaveling-Soonawala, N; Meijers-Heijboer, HEJ; van Trotsenburg, ASP; Mannens, MM				Henneman, Peter; Bouman, Arjan; Mul, Adri; Knegt, Lia; van der Kevie-Kersemaekers, Anne-Marie; Zwaveling-Soonawala, Nitash; Meijers-Heijboer, Hanne E. J.; van Trotsenburg, A. S. Paul; Mannens, Marcel M.			Widespread domain-like perturbations of DNA methylation in whole blood of Down syndrome neonates	PLOS ONE			English	Article							CHROMOSOME-21; PHENOTYPE; TRISOMY-21; IMBALANCE; PATTERNS; CHILDREN; GENOME; CELLS	Introduction Down syndrome (DS) is the most frequent genetic cause of intellectual disability. Despite the fact that more than 50 years have passed since the discovery of its genetic aberrations, the exact pathogenesis of the DS phenotype has remained largely unexplained. It was recently hypothesized that the DS pathogenesis involves complex (epi) genetic, molecular and cellular determinants. To date, many reports have addressed epigenetic aberrations associated with DS at different developmental stages/ages and tissue types, but to our best knowledge not in DS newborns. This study aimed to investigate genome-wide methylation patterns in DS newborns compared to non-trisomic newborns. Method We analyzed blood samples obtained from ten newborns with DS and five age-matched non-trisomic newborns. Epigenetic profiles were obtained from extracted DNA using the Illumina Infinium 450K array. Since aberrant blood cell distribution is known to be present in DS, we applied two distinct models: with and without correction for estimated blood cell distribution. Results Differentially methylated position (DMP) analysis of the uncorrected model detected 19525 significant hits (51,2% hypomethylated). In the corrected model, we found 121953 significant DMPs (49,8% hypomethylated). Independent of the used model we observed a chromosome 21 dosage effect. Moreover, we detected 46 and 145 differentially methylated regions in the uncorrected and corrected model respectively, both showing hypomethylation overrepresentation. Replication analyses of DMPs and DMRs found by Bacalini et al. (2015) showed a large overlap. Conclusion In this study, we found methylation profile differences between DS newborns and controls reflecting a systematically affected epigenetic profile. The observed chromosome 21 dosage effect suggests the involvement of affected essential regulatory factors/regions or altered expression of chromatin modeling enzymes located on chromosome 21. Additional research is necessary to substantiate these hypotheses.	[Henneman, Peter; Bouman, Arjan; Mul, Adri; Knegt, Lia; van der Kevie-Kersemaekers, Anne-Marie; Meijers-Heijboer, Hanne E. J.; Mannens, Marcel M.] Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Zwaveling-Soonawala, Nitash] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Endocrinol, Amsterdam, Netherlands; [van Trotsenburg, A. S. Paul] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat & Translat Genet, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Henneman, P (corresponding author), Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	p.henneman@amc.uva.nl	van Trotsenburg, Paul/ABC-2379-2020	van Trotsenburg, Paul/0000-0002-9677-7441; Zwaveling-Soonawala, Nitash/0000-0003-0318-5541				da Silva AFA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154108; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bacalini MG, 2015, AGING-US, V7, P82; BURGIO GR, 1978, CLIN EXP IMMUNOL, V33, P298; Carsetti R, 2015, EUR J IMMUNOL, V45, P903, DOI 10.1002/eji.201445049; Chango A, 2006, BIOCHEM BIOPH RES CO, V349, P492, DOI 10.1016/j.bbrc.2006.08.038; De Hingh YCM, 2005, J PEDIATR-US, V147, P744, DOI 10.1016/j.jpeds.2005.07.022; Eckmann-Scholz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039014; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hatt L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160319; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Inoshita M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0029-7; Jin SN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003515; Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Lu J, 2016, HUM MOL GENET, V25, P1714, DOI 10.1093/hmg/ddw043; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; Mendioroz M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0827-6; Newton RW PSaML, 2015, ADV MOL GENETICS SYN, P3; Patterson D, 2007, MENT RETARD DEV D R, V13, P199, DOI 10.1002/mrdd.20162; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Sailani MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135555; van Iterson M, 2014, BIOINFORMATICS, V30, P3435, DOI 10.1093/bioinformatics/btu566; Xia YY, 2014, MOL MED REP, V9, P1681, DOI 10.3892/mmr.2014.1985; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7	32	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194938	10.1371/journal.pone.0194938	http://dx.doi.org/10.1371/journal.pone.0194938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601581	Green Published, Green Submitted, gold			2022-12-27	WOS:000428845900013
J	Pimenta, NC; Antunes, AP; Barnett, AA; Macedo, VW; Shepard, GH				Pimenta, Natalia C.; Antunes, Andre P.; Barnett, Adrian A.; Macedo, Valencio W.; Shepard, Glenn H., Jr.			Differential resilience of Amazonian otters along the Rio Negro in the aftermath of the 20th century international fur trade	PLOS ONE			English	Article							MANU NATIONAL-PARK; PTERONURA-BRASILIENSIS; GIANT OTTERS; LONTRA-LONGICAUDIS; SUSTAINABILITY; CONSERVATION; MANAGEMENT; DISPERSAL; LANDSCAPE; COLLAPSE	Commercial hunting for the international trade in animal hides in the 20th century decimated many populations of aquatic wildlife in Amazonia. However, impacts varied significantly between different species and regions, depending upon hunting intensity, accessibility of habitat, and the inherent resilience of various species and their habitats. We investigated the differential responses of two Amazonian Mustelid species, the neotropical otter and giant otter, to commercial hunting pressure along the upper Rio Negro in Brazil, and examined historical factors that influenced spatial and temporal variation in commercial exploitation. We analyzed previously unanalyzed data from historical records of hide shipments to track changes in hide sales and prices for the two species in the late 20th century. We also gathered oral histories from older Baniwa people who had witnessed or participated in commercial otter hunting. These complimentary data sources reveal how intrinsic biological and social characteristics of the two otter species interacted with market forces and regional history. Whereas giant otter populations were driven to local or regional extinction during the late 20th century by commercial hunting, neotropical otters persisted. In recent decades, giant otter populations have returned to some parts of the upper Rio Negro, a development which local people welcome as part of a generalized recovery of the ecosystems in their territory as a result of the banning of animal pelt exports and indigenous land demarcation. This paper expands the scope of the field historical ecology and reflects on the role of local knowledge in biodiversity conservation.	[Pimenta, Natalia C.; Barnett, Adrian A.] Natl Inst Amazonian Res, Amazon Mammal Res Grp, Manaus, Amazonas, Brazil; [Pimenta, Natalia C.] Museu Paraense Emilio Goeldi, Inst Capac Bldg Program, Dept Anthropol, MCTIC, Belem, Para, Brazil; [Antunes, Andre P.] Natl Inst Amazonian Res, Dept Ecol, Manaus, Amazonas, Brazil; [Macedo, Valencio W.] Escola Indigena Baniwa & Coripaco Pamaali, Comunidade Urumutum Lago, Sao Gabriel Da Cachoeira, Amazonas, Brazil; [Shepard, Glenn H., Jr.] Museu Paraense Emilio Goeldi, Dept Anthropol, Belem, Para, Brazil	Institute Nacional de Pesquisas da Amazonia; Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC); Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; Museu Paraense Emilio Goeldi	Pimenta, NC (corresponding author), Natl Inst Amazonian Res, Amazon Mammal Res Grp, Manaus, Amazonas, Brazil.; Pimenta, NC (corresponding author), Museu Paraense Emilio Goeldi, Inst Capac Bldg Program, Dept Anthropol, MCTIC, Belem, Para, Brazil.	natalia.camps@gmail.com	Shepard, Glenn H./C-3667-2014; Antunes, André P/Q-3236-2018	Shepard, Glenn H./0000-0003-3195-8230; Antunes, André P/0000-0003-4404-3486; Barnett, Adrian Ashton/0000-0002-8829-2719; Pimenta, Natalia/0000-0003-4312-126X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through the Institutional Capacity Building Program of the Emilio Goeldi Museum [301089/2017-5]; Rufford Foundation [16845-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [140222/2011-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [14646/13-7]; Fundacao de Amparo a Pesquisa do Estado do Amazonas [062.00427/2013]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through the Institutional Capacity Building Program of the Emilio Goeldi Museum; Rufford Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Amazonas	NCP received Master scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br); scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through the Institutional Capacity Building Program of the Emilio Goeldi Museum (http://www.museu-goeldibr/), grant number: 301089/2017-5; financial support to field logistics from The Rufford Foundation (http://www.rufford.org), grant number: 16845-1; and equipment donation for field activities from Idea Wild (http://www.ideawild.org). APA received Doctoral scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br), grant number: 140222/2011-1, an exchange scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, grant number 14646/13-7 and financial support from Fundacao de Amparo a Pesquisa do Estado do Amazonas (http//www.fapeam.am.gov.br), grant number: 062.00427/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraao M. B., 2010, LANDSCAPE ETHNOECOLO, P83; Alexiades MN, 1986, SELECTED GUIDELINES, P53; Ames EP, 2004, FISHERIES, V29, P23; Antunes AP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600936; Antunes André Pinassi, 2014, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V9, P487, DOI 10.1590/1981-81222014000200013; Balee W, 2006, ANNU REV ANTHROPOL, V35, P75, DOI 10.1146/annurev.anthro.35.081705.123231; Bezerra BM, 2011, J ETHOL, V29, P169, DOI 10.1007/s10164-010-0218-0; Breheny P., 2017, PACKAGE VISREG VISUA; Cabalzar A., 2006, MAPA LIVRO POVOS IND; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; Conta M., 2016, BANDO PRESO COM SEIS, V1, P1; Damania R, 2005, P ROY SOC B-BIOL SCI, V272, P259, DOI 10.1098/rspb.2004.2945; de Oliveira GC, 2011, ANIM BIOL, V61, P175, DOI 10.1163/157075511X566506; Dean W., 1989, LUTA PELA BORRACHA B; deRodrigues L A, 2013, BIODIVERSIDADE BRAS, V3, P216; Diaz H. J., 2002, IUCN OTTER SPEC GROU, V19, P97; Duarte JCS, 1985, TRAFFIC B, V7, P1617; Duplaix N., 1980, REV ECOL, V34, P620; Duplaix Nicole, 2015, Latin American Journal of Aquatic Mammals, V10, P75; Eisenberg JF, 2000, MAMMALS NEOTROPICS, V3; Foster-Turley P, 1990, IUCN OTTER SPEC GR, V126; Groenendijk J, 2015, IUCN RED LIST THREAT, V8235; IBGE, 2015, SER HIST SEC 20; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOSHI NV, 1991, THEOR POPUL BIOL, V40, P211, DOI 10.1016/0040-5809(91)90053-I; Kruuk H., 2006, BEHAV CONSERVATION; Lanman RB, 2012, CALIF FISH GAME, V98, P65; Lariviere Serge, 1999, Mammalian Species, V608, P1, DOI 10.2307/3504420; Levi T, 2011, ECOL APPL, V21, P1802, DOI 10.1890/10-0375.1; Levi T, 2009, J APPL ECOL, V46, P804, DOI 10.1111/j.1365-2664.2009.01661.x; Lima Danielle dos Santos, 2014, Ambient. soc., V17, P127, DOI 10.1590/S1414-753X2014000200009; MacCreagh G., 1985, WHITE WATERS BLACK; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Navia R., 2018, FANG TRAFFICKING CHI; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Ohl-Schacherer J, 2007, CONSERV BIOL, V21, P1174, DOI 10.1111/j.1523-1739.2007.00759.x; Pamaali EIBC, KOPHENAI NAKO; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Peres CA, 2016, P NATL ACAD SCI USA, V113, P892, DOI 10.1073/pnas.1516525113; Pimenta N. C., 2016, THESIS; Read JM, 2010, J LAT AM GEOGR, V9, P213, DOI 10.1353/lag.2010.0030; Uscamaita MR, 2010, ORYX, V44, P83, DOI 10.1017/S0030605309990196; Reeves RR, 2004, MAR MAMMAL SCI, V20, P774, DOI 10.1111/j.1748-7692.2004.tb01192.x; Vieira MARD, 2015, CONSERV SOC, V13, P254, DOI 10.4103/0972-4923.170399; Rheingantz ML, 2015, IUCN RED LIST THREAT, V8235; Ribas C, 2012, STUD NEOTROP FAUNA E, V47, P19, DOI 10.1080/01650521.2012.662795; Ricardo CA, 2008, VISOES RIO NEGRO CON; Ripple WJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160498; Shepard GH, 2012, AM ANTHROPOL, V114, P652, DOI 10.1111/j.1548-1433.2012.01514.x; Shepard Glenn Harvey, 2004, TERRAS INDIGENAS UNI, P129; Silva RE, 2014, J NAT HIST, V48, P465, DOI 10.1080/00222933.2013.800607; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Smith N.J.H., 1976, Oryx, V13, P362; SMITH NJH, 1981, BIOL CONSERV, V19, P177, DOI 10.1016/0006-3207(81)90033-1; Szabo P, 2015, BIOL REV, V90, P997, DOI 10.1111/brv.12141; Szabo P, 2011, CONSERV BIOL, V25, P680, DOI 10.1111/j.1523-1739.2011.01710.x; Taylor MS, 2011, AM ECON REV, V101, P3162, DOI 10.1257/aer.101.7.3162; Tocantins L, 1983, LIVRARIA J OLYMPIO; Rosas FCW, 2009, BRAZ ARCH BIOL TECHN, V52, P587, DOI 10.1590/S1516-89132009000300010; Wood SN, 2006, GEN ADDITIVE MODELS; Wright Robin. M, 2005, HIST INDIGENA INDIGE	63	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0193984	10.1371/journal.pone.0193984	http://dx.doi.org/10.1371/journal.pone.0193984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB1XW	29601590	Green Submitted, Green Published, gold			2022-12-27	WOS:000428845900003
J	Farrell, LE; Levy, DM; Donovan, T; Mickey, R; Howard, A; Vashon, J; Freeman, M; Royer, K; Kilpatrick, CW				Farrell, Laura E.; Levy, Daniel M.; Donovan, Therese; Mickey, Ruth; Howard, Alan; Vashon, Jennifer; Freeman, Mark; Royer, Kim; Kilpatrick, C. William			Landscape connectivity for bobcat (Lynx rufus) and lynx (Lynx canadensis) in the Northeastern United States	PLOS ONE			English	Article							SOUTHERN RANGE PERIPHERY; CANADA LYNX; HABITAT-SELECTION; MULTIPLE SCALES; CLIMATE-CHANGE; SPACE USE; MAMMALIAN CARNIVORES; BEHAVIORAL-RESPONSES; CENTRAL MISSISSIPPI; HUMAN FOOTPRINT	Landscape connectivity is integral to the persistence of metapopulations of wide ranging carnivores and other terrestrial species. The objectives of this research were to investigate the landscape characteristics essential to use of areas by lynx and bobcats in northern New England, map a habitat availability model for each species, and explore connectivity across areas of the region likely to experience future development pressure. A Mahalanobis distance analysis was conducted on location data collected between 2005 and 2010 from 16 bobcats in western Vermont and 31 lynx in northern Maine to determine which variables were most consistent across all locations for each species using three scales based on average 1) local (15 minute) movement, 2) linear distance between daily locations, and 3) female home range size. The bobcat model providing the widest separation between used locations and random study area locations suggests that they cue into landscape features such as edge, availability of cover, and development density at different scales. The lynx model with the widest separation between random and used locations contained five variables including natural habitat, cover, and elevation all at different scales. Shrub scrub habitat where lynx's preferred prey is most abundant was represented at the daily distance moved scale. Cross validation indicated that outliers had little effect on models for either species. A habitat suitability value was calculated for each 30 m(2) pixel across Vermont, New Hampshire, and Maine for each species and used to map connectivity between conserved lands within selected areas across the region. Projections of future landscape change illustrated potential impacts of anthropogenic development on areas lynx and bobcat may use, and indicated where connectivity for bobcats and lynx may be lost. These projections provided a guide for conservation of landscape permeability for lynx, bobcat, and species relying on similar habitats in the region.	[Farrell, Laura E.; Kilpatrick, C. William] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Levy, Daniel M.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Donovan, Therese; Freeman, Mark] Univ Vermont, US Geol Survey, Vermont Cooperat Fish & Wildlife Res Unit, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Mickey, Ruth] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Howard, Alan] Univ Vermont, Stat Consulting Clin, Burlington, VT USA; [Vashon, Jennifer] Maine Dept Inland Fisheries & Wildlife, Bangor, ME USA; [Royer, Kim] Vermont Fish & Wildlife Dept Springfield, Springfield, VT USA; [Farrell, Laura E.] Otter Ridge Consulting LLC, Fukushima 96012, Japan; [Levy, Daniel M.] GIS Consultant, Waterbury, VT USA	University of Vermont; University of Vermont; United States Department of the Interior; United States Geological Survey; University of Vermont; University of Vermont; University of Vermont	Farrell, LE (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.; Farrell, LE (corresponding author), Otter Ridge Consulting LLC, Fukushima 96012, Japan.	lfarrel@gmail.com			US EPA STAR Fellowship [F5F21809]; Lindbergh Foundation; U.S. Geological Survey; University of Vermont; Vermont Department of Fish and Wildlife; Wildlife Management Institute	US EPA STAR Fellowship(United States Environmental Protection Agency); Lindbergh Foundation; U.S. Geological Survey(United States Geological Survey); University of Vermont; Vermont Department of Fish and Wildlife; Wildlife Management Institute	This work was supported by the US EPA STAR Fellowship (https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstractDetail/abstract/7582/report/0), F5F21809 to LF; and the Lindbergh Foundation (http://lindberghfoundation.org/) to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Walter Jakubas, of Maine Department of Inland Fisheries and Wildlife, for generously allowing the use of the lynx data in these analyses. The Vermont Advanced Computing Center and The Rubenstein School at University of Vermont provided computers. We thank Jennifer Morrow; Bob Devins; Christopher Hoving; Guoping Tang; T. Garin (Advanced Telemetry Systems); Tony Tur and Rachel Cliche of US Fish and Wildlife; Chris Bernier; wild-life agencies in Maine, New Hampshire and Vermont; and Joe Roman, for logistical support, assistance, and data sharing. Use of trade names or products does not constitute endorsement by the U.S. Government. The Vermont Cooperative Fish and Wildlife Research Unit is jointly supported by the U.S. Geological Survey, University of Vermont, Vermont Department of Fish and Wildlife, and Wildlife Management Institute.	Abouelezz HA, 2009, THESIS; Abrahms B, 2017, J APPL ECOL, V54, P412, DOI 10.1111/1365-2664.12714; Adams AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065763; Anderson EM, 2003, WILD MAMMALS N AM BI, P758; [Anonymous], 2007, DIFFERENCE CURRENT H; [Anonymous], 2013, FED REGISTER, V78, P187; BAILEY TN, 1974, J WILDLIFE MANAGE, V38, P435, DOI 10.2307/3800874; Ballinger N., 2004, PEOPLE AND EC; Bar Massada A, 2010, LANDSCAPE ECOL, V25, P711, DOI 10.1007/s10980-010-9452-7; Basille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065493; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Bernier CA, 2012, CANADA LYNX LYNX CAN; Burdett CL, 2007, J MAMMAL, V88, P457, DOI 10.1644/06-MAMM-A-181R.1; Buskirk Steven W., 2000, P83; Carroll C, 2007, CONSERV BIOL, V21, P1092, DOI 10.1111/j.1523-1739.2007.00719.x; Cejtin M., 2011, THESIS; Chamberlain M, 2003, AM MIDL NAT, V149, P395, DOI 10.1674/0003-0031(2003)149[0395:SUMAHS]2.0.CO;2; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; CLARK JD, 1993, J WILDLIFE MANAGE, V57, P519, DOI 10.2307/3809276; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Conservation Biology Institute, 2010, PADUS 1 1 NO REG PRO; Constible JM, 2006, AM MIDL NAT, V155, P352, DOI 10.1674/0003-0031(2006)155[352:RBLPAS]2.0.CO;2; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cushman SA, 2008, FRONT ECOL ENVIRON, V6, P13, DOI 10.1890/070039; Cushman SA, 2010, LANDSCAPE ECOL, V25, P967, DOI 10.1007/s10980-010-9467-0; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Donovan TM, 2011, BIOL CONSERV, V144, P2799, DOI 10.1016/j.biocon.2011.06.026; Duncan L, 2001, P SAS US GROUP INT 2; Eisenberg J.F., 1986, P293; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Farrell LE, 2012, THESIS; Foster D.R., 2010, WILDLANDS WOODLANDS; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Fuller AK, 2010, J MAMMAL, V91, P1269, DOI 10.1644/10-MAMM-A-005.1; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; HANSKI I, 1997, METAPOPULATION BIOL; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; HESS GR, 1994, CONSERV BIOL, V8, P256, DOI 10.1046/j.1523-1739.1994.08010256.x; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Hoving CL, 2005, J WILDLIFE MANAGE, V69, P739, DOI 10.2193/0022-541X(2005)069[0739:BPOCLO]2.0.CO;2; Kesterson MD, 1988, THESIS; KNICK ST, 1986, AM MIDL NAT, V116, P222, DOI 10.2307/2425959; Kolowski JM, 2002, J WILDLIFE MANAGE, V66, P822, DOI 10.2307/3803146; Kuehl AK, 2002, J WILDLIFE MANAGE, V66, P1224, DOI 10.2307/3802955; Lariviere Serge, 1997, Mammalian Species, V563, P1, DOI 10.2307/3504533; Lindenmayer DB, 2000, BIODIVERS CONSERV, V9, P15, DOI 10.1023/A:1008943713765; Linforth J, 2013, CANADA LYNX COMING B; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; Litvaitis JA, 2006, BIOL CONSERV, V128, P517, DOI 10.1016/j.biocon.2005.10.019; Lovallo MJ, 1996, AM MIDL NAT, V135, P241, DOI 10.2307/2426706; Lyra-Jorge MC, 2010, EUR J WILDLIFE RES, V56, P359, DOI 10.1007/s10344-009-0324-x; MacFaden SW, 2002, FOREST SCI, V48, P243; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; McRae B.H., 2011, LINKAGE MAPPER CONNE; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Millspaugh JJ, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P1; New Hampshire Fish and Game, 2011, CAN LYNX DOC NO NEW; Ng SJ, 2004, BIOL CONSERV, V115, P499, DOI 10.1016/S0006-3207(03)00166-6; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; Ohmark SM, 2015, CAN J ZOOL, V93, P391, DOI 10.1139/cjz-2014-0332; Parent J., 2009, LANDSCAPE FRAGMENTAT; Reed GC, 2017, ANIM CONSERV, V20, P308, DOI 10.1111/acv.12325; Rettie WJ, 1999, CAN J ZOOL, V77, P1175, DOI 10.1139/cjz-77-8-1175; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Robillard CM, 2015, CONSERV BIOL, V29, P1586, DOI 10.1111/cobi.12556; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; Rotenberry JT, 2006, ECOLOGY, V87, P1458, DOI 10.1890/0012-9658(2006)87[1458:GNMFMS]2.0.CO;2; Rotenberry JT, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P281; Rudnick D.A., 2012, ISSUES ECOL, V16, P1; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Seton ET, 1925, LIVES GAME ANIMALS C, V1; SINGLETON PH, 2002, PNWRP549 USDA FOR SE; Slough BG, 1996, J WILDLIFE MANAGE, V60, P946, DOI 10.2307/3802397; Sorenson E., 2014, VERMONT HABITAT BLOC; Spring D, 2010, CONSERV BIOL, V24, P691, DOI 10.1111/j.1523-1739.2009.01419.x; Squires JR, 2013, BIOL CONSERV, V157, P187, DOI 10.1016/j.biocon.2012.07.018; Squires JR, ECOLOGY CONSERVATION; Sunquist M.E., 1989, P283; Sunquist ME, 2002, WILD CATS WORLD; Swingland I. R., 1984, ECOLOGY ANIMAL MOVEM; Thatcher CA, 2009, J MAMMAL, V90, P918, DOI 10.1644/08-MAMM-A-219.1; Thompson CM, 2002, LANDSCAPE ECOL, V17, P569, DOI 10.1023/A:1021501231182; Thompson EH, 2005, WETLAND WOODLAND WIL; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Trombulak SC, 2008, NO APPALACHIAN ACAD; Van Rossum G, 2005, PYTHON 2 4 1; Vashon J.H., 2012, CANADA LYNX ASSESSME; Vashon JH, 2008, J WILDLIFE MANAGE, V72, P1479, DOI 10.2193/2007-462; Vashon JH, 2008, J WILDLIFE MANAGE, V72, P1488, DOI 10.2193/2007-475; VERBYLA DL, 1989, ENVIRON MANAGE, V13, P783, DOI 10.1007/BF01868317; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; WARD RMP, 1985, CAN J ZOOL, V63, P2817, DOI 10.1139/z85-421; WASSMER D A, 1988, Bulletin of the Florida State Museum Biological Sciences, V33, P159; Watrous KS, 2006, J WILDLIFE MANAGE, V70, P1228, DOI 10.2193/0022-541X(2006)70[1228:PMHCFT]2.0.CO;2; Weernetwerk, 2017, US CLIM DAT; Wiens JA, 1989, LANDSCAPE ECOL, V3, P87, DOI 10.1007/BF00131172; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x; Woolmer G, 2008, LANDSCAPE URBAN PLAN, V87, P42, DOI 10.1016/j.landurbplan.2008.04.005; Zeller KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179570	104	8	8	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194243	10.1371/journal.pone.0194243	http://dx.doi.org/10.1371/journal.pone.0194243			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590192	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100055
J	Nunez, FJ; Santalla, A; Carrasquila, I; Asian, JA; Reina, JI; Suarez-Arrones, LJ				Javier Nunez, Francisco; Santalla, Alfredo; Carrasquila, Irene; Antonio Asian, Jose; Ignacio Reina, Jose; Jesus Suarez-Arrones, Luis			The effects of unilateral and bilateral eccentric overload training on hypertrophy, muscle power and COD performance, and its determinants, in team sport players	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; SKELETAL-MUSCLE; SOCCER PLAYERS; RESISTANCE EXERCISE; NEURAL ACTIVATION; VASTUS LATERALIS; DIRECTION SPEED; EARLY-PHASE; LEG POWER; BED REST	The study aimed to compare the chronic eccentric-overload training effects of unilateral (lateral lunge) vs bilateral (half-squat) using an inertial device, on hypertrophy and physical performance. Twenty-seven young team sports male players performed a 4 sets of 7 repetitions of inertial eccentric overload training, biweekly for 6 weeks, distributed in unilateral lunge group (UG: age: 22.8 +/- 2.9 years; body mass: 75.3 +/- 8.8 kg; height: 177.3 +/- 3.7 cm) and bilateral squat group (BG: age: 22.6 +/- 2.7 years; body mass: 79.5 +/- 12.8 kg; height: 164.2 +/- 7 cm). Lower limb muscle volume, counter movement jump (CMJ), power with both (POWER), dominant (POWERd) and no-dominant leg (POWERnd), change of direction turn of 90 with dominant (COD90d) and no-dominant leg (COD90nd) and 180 degrees (COD180d and COD180nd), and 10m sprint time (T-10m) were measured pre and post-intervention. The UG obtained an increase of adductor major (+11.1%) and vastus medialis (+12.6%) higher than BG. The BG obtained an increase of vastus lateralis (+9.9%) and lateral gastrocnemius (+9.1%) higher than UG. Both groups improved CMJ, POWER, POWERd, POWERnd, COD90 and DEC-COD90, without changes in T-10m. The UG decrease DEC-COD90nd (-21.1%) and BG increase POWER (+38.6%) substantially more than the other group. Six-weeks of unilateral / bilateral EO training induce substantial improvements in lower limbs muscle volume and functional performance, although unilateral training seems to be more effective in improving COD90 performance.	[Javier Nunez, Francisco; Santalla, Alfredo; Carrasquila, Irene; Antonio Asian, Jose; Jesus Suarez-Arrones, Luis] Pablo de Olavide Univ Sevilla, Sport Fac, Dept Sports & Comp, Seville, Spain; [Santalla, Alfredo; Antonio Asian, Jose; Jesus Suarez-Arrones, Luis] Pablo de Olavide Univ Sevilla, Futbol, Seville, Spain; [Santalla, Alfredo] Hospiltal 12 Octubre I 12, Res Inst, Madrid, Spain; [Ignacio Reina, Jose] Dos Hermanas Radiol Ctr, Seville, Spain	Universidad Pablo de Olavide; Universidad Pablo de Olavide	Nunez, FJ (corresponding author), Pablo de Olavide Univ Sevilla, Sport Fac, Dept Sports & Comp, Seville, Spain.	fjnunsan@upo.es	Sánchez, Francisco Javier Núñez/F-4501-2016	Sánchez, Francisco Javier Núñez/0000-0002-4166-3877; Suarez Moreno-Arrones, Luis Jesus/0000-0002-5432-4786; Santalla Hernandez, Alfredo/0000-0001-9418-0564				Aagaard P, 2001, J PHYSIOL-LONDON, V534, P613, DOI 10.1111/j.1469-7793.2001.t01-1-00613.x; Alkner BA, 2004, EUR J APPL PHYSIOL, V93, P294, DOI 10.1007/s00421-004-1172-8; Alkner BA, 2004, ACTA PHYSIOL SCAND, V181, P345, DOI 10.1111/j.1365-201X.2004.01293.x; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P367, DOI 10.1123/ijspp.6.3.367; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Ben Abdelkrim N, 2010, J STRENGTH COND RES, V24, P1346, DOI 10.1519/JSC.0b013e3181cf7510; BERG HE, 1993, ACTA PHYSIOL SCAND, V148, P379, DOI 10.1111/j.1748-1716.1993.tb09573.x; BERG HE, 1994, AVIAT SPACE ENVIR MD, V65, P752; Berg HE, 1998, ACTA ASTRONAUT, V42, P219, DOI 10.1016/S0094-5765(98)00119-2; Brughelli M, 2008, SPORTS MED, V38, P1045, DOI 10.2165/00007256-200838120-00007; Castillo-Rodriguez A, 2012, J STRENGTH COND RES, V26, P725, DOI 10.1519/JSC.0b013e31822602db; Chelly MS, 2009, J STRENGTH COND RES, V23, P2241, DOI 10.1519/JSC.0b013e3181b86c40; COLLIANDER EB, 1990, ACTA PHYSIOL SCAND, V140, P31, DOI 10.1111/j.1748-1716.1990.tb08973.x; CRENSHAW AG, 1995, EUR J APPL PHYSIOL, V70, P13, DOI 10.1007/BF00601803; de Hoyo M, 2015, INT J SPORTS MED, V36, P308, DOI 10.1055/s-0034-1395521; de Hoyo M, 2015, J HUM KINET, V47, P155, DOI 10.1515/hukin-2015-0071; de Hoyo M, 2015, INT J SPORT PHYSIOL, V10, P46, DOI 10.1123/ijspp.2013-0547; Doan BK, 2002, J STRENGTH COND RES, V16, P9; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Fernandez-Gonzalo R, 2014, AVIAT SPACE ENVIR MD, V85, P694, DOI 10.3357/ASEM.3856.2014; Fernandez-Gonzalo R, 2014, EUR J APPL PHYSIOL, V114, P1075, DOI 10.1007/s00421-014-2836-7; Fisher J., 2014, J ATHL ENHANC, V3, DOI [10.4172/2324-9080.1000174, DOI 10.4172/2324-9080.1000174]; Gonzalo-Skok O, 2017, INT J SPORT PHYSIOL, V12, P951, DOI 10.1123/ijspp.2016-0251; Gonzalo-Skok O, 2017, INT J SPORT PHYSIOL, V12, P106, DOI 10.1123/ijspp.2015-0743; Gual G, 2016, J STRENGTH COND RES, V30, P1834, DOI 10.1519/JSC.0000000000001286; HATHER BM, 1991, ACTA PHYSIOL SCAND, V143, P177, DOI 10.1111/j.1748-1716.1991.tb09219.x; Higbie EJ, 1996, J APPL PHYSIOL, V81, P2173, DOI 10.1152/jappl.1996.81.5.2173; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hortobagyi T, 1996, J APPL PHYSIOL, V80, P765, DOI 10.1152/jappl.1996.80.3.765; Hortobagyi T, 2001, MED SCI SPORT EXER, V33, P1206; Irish SE, 2010, J STRENGTH COND RES, V24, P1256, DOI 10.1519/JSC.0b013e3181cf749f; JONES DA, 1987, J PHYSIOL-LONDON, V391, P1; Jones P, 2009, J SPORT MED PHYS FIT, V49, P97; Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756; KOMI PV, 1977, ACTA PHYSIOL SCAND, V100, P246, DOI 10.1111/j.1748-1716.1977.tb05943.x; Little T, 2005, J STRENGTH COND RES, V19, P76; MORITANI T, 1979, AM J PHYS MED REHAB, V58, P115; NARICI MV, 1989, EUR J APPL PHYSIOL O, V59, P310, DOI 10.1007/BF02388334; Norrbrand L, 2008, EUR J APPL PHYSIOL, V102, P271, DOI 10.1007/s00421-007-0583-8; Sanchez FJN, 2017, J STRENGTH COND RES, V31, P3177, DOI 10.1519/JSC.0000000000002095; Qian JG, 2014, J HUM KINET, V41, P59, DOI 10.2478/hukin-2014-0033; Schuenke MD, 2012, EUR J APPL PHYSIOL, V112, P3585, DOI 10.1007/s00421-012-2339-3; Seger JY, 1998, EUR J APPL PHYSIOL, V79, P49, DOI 10.1007/s004210050472; Seynnes OR, 2007, J APPL PHYSIOL, V102, P368, DOI 10.1152/japplphysiol.00789.2006; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Speirs DE, 2016, J STRENGTH COND RES, V30, P386, DOI 10.1519/JSC.0000000000001096; Spiteri T, 2014, J STRENGTH COND RES, V28, P2415, DOI 10.1519/JSC.0000000000000547; STARON RS, 1994, J APPL PHYSIOL, V76, P1247, DOI 10.1152/jappl.1994.76.3.1247; Tesch PA, 2004, ACTA PHYSIOL SCAND, V180, P89, DOI 10.1046/j.0001-6772.2003.01225.x; TESCH PA, 1990, ACTA PHYSIOL SCAND, V138, P263, DOI 10.1111/j.1748-1716.1990.tb08846.x; Tous-Fajardo J, 2016, INT J SPORT PHYSIOL, V11, P66, DOI 10.1123/ijspp.2015-0010; WESTING SH, 1989, INT J SPORTS MED, V10, P175, DOI 10.1055/s-2007-1024896; Young WB, 2002, J SPORT MED PHYS FIT, V42, P282	53	51	52	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193841	10.1371/journal.pone.0193841	http://dx.doi.org/10.1371/journal.pone.0193841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590139	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100034
J	Pound, P; Nicol, CJ				Pound, Pandora; Nicol, Christine J.			Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions	PLOS ONE			English	Article							FELASA WORKING GROUP; TRANSPARENCY	Background The harm benefit analysis (HBA) is the cornerstone of animal research regulation and is considered to be a key ethical safeguard for animals. The HBA involves weighing the anticipated benefits of animal research against its predicted harms to animals but there are doubts about how objective and accountable this process is. Objectives i. To explore the harms to animals involved in pre-clinical animal studies and to assess these against the benefits for humans accruing from these studies; ii. To test the feasibility of conducting this type of retrospective HBA. Methods Data on harms were systematically extracted from a sample of pre-clinical animal studies whose clinical relevance had already been investigated by comparing systematic reviews of the animal studies with systematic reviews of human studies for the same interventions (antifibrinolytics for haemorrhage, bisphosphonates for osteoporosis, corticosteroids for brain injury, Tirilazad for stroke, antenatal corticosteroids for neonatal respiratory distress and thrombolytics for stroke). Clinical relevance was also explored in terms of current clinical practice. Harms were categorised for severity using an expert panel. The quality of the research and its impact were considered. Bateson's Cube was used to conduct the HBA. Results The most common assessment of animal harms by the expert panel was 'severe'. Reported use of analgesia was rare and some animals (including most neonates) endured significant procedures with no, or only light, anaesthesia reported. Some animals suffered iatrogenic harms. Many were kept alive for long periods post-experimentally but only 1% of studies reported post-operative care. A third of studies reported that some animals died prior to endpoints. All the studies were of poor quality. Having weighed the actual harms to animals against the actual clinical benefits accruing from these studies, and taking into account the quality of the research and its impact, less than 7% of the studies were permissible according to Bateson's Cube: only the moderate bisphosphonate studies appeared to minimise harms to animals whilst being associated with benefit for humans. Conclusions This is the first time the accountability of the HBA has been systematically explored across a range of pre-clinical animal studies. The regulatory systems in place when these studies were conducted failed to safeguard animals from severe suffering or to ensure that only beneficial, scientifically rigorous research was conducted. Our findings indicate a pressing need to: i. review regulations, particularly those that permit animals to suffer severe harms; ii. reform the processes of prospectively assessing pre-clinical animal studies to make them fit for purpose; and iii. systematically evaluate the benefits of pre-clinical animal research to permit a more realistic assessment of its likely future benefits.	[Pound, Pandora] Univ Bristol, Populat Hlth Sci, Canynge Hall, Bristol, Avon, England; [Nicol, Christine J.] Univ Bristol, Sch Vet Sci, Langford House, Langford, England	University of Bristol; University of Bristol	Pound, P (corresponding author), Univ Bristol, Populat Hlth Sci, Canynge Hall, Bristol, Avon, England.	pandora.pound@bristol.ac.uk	Nicol, Christine J/B-4841-2011	Nicol, Christine J/0000-0001-6734-2177; Pound, Pandora/0000-0001-6885-6401				Alderson P, 2005, CORTICOSTEROIDS ACUT; Andrews NA, 2016, PAIN, V157, P901, DOI 10.1097/j.pain.0000000000000458; [Anonymous], 2012, ALT TREAT AC ISCH ST; [Anonymous], 2009, GUIDELINES ASSIGNING; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; BATESON P, 1986, NEW SCI, V109, P30; Bateson P., 2017, COMMUNICATION; Bronstad A, 2016, LAB ANIM-UK, V50, P1, DOI 10.1177/0023677216642398; Brown N., 2003, SCI TECHNOLOGY STUDI; Brown SGA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5215; Carbone L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155001; Cohen D., 2018, BMJ-BRIT MED J, P360; Comroe JH, 1978, BIOMEDICAL SCI PUBLI, P15; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Cressey D, 2015, NATURE, V523; Davies G., 2017, REV HARM BENEFIT ANA; Davies GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158791; De Cock Buning T., 1994, Animal Welfare, V3, P107; DeGrazia D, 2015, CAMB Q HEALTHC ETHIC, V24, P420, DOI 10.1017/S0963180115000080; European Commission, 2013, CAR AN AIM BETT SCI; European Commission, 2012, CAR AN AIM BETT SCI; European Union. European Union Directive, 2010, OFFICIAL J EUROPEAN, P276; Franco NH, 2012, ATLA-ALTERN LAB ANIM, V40, P271, DOI 10.1177/026119291204000506; Franco NH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047723; Grant J, 2000, BMJ-BRIT MED J, V320, P1107, DOI 10.1136/bmj.320.7242.1107; Greek R., 2011, J PHILOS SCI LAW, V11, P1, DOI [10.5840/jpsl20111133, DOI 10.5840/JPSL20111133]; Griffin G, 2014, REV SCI TECH OIE, V33, P265, DOI 10.20506/rst.33.1.2283; GRIMM H, 2015, ALTERN LAB ANIM, V43, P22; Gruber Franz P, 2004, ALTEX, V21 Suppl 1, P3; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hawkes Nigel, 2015, BMJ, V351, ph5453, DOI 10.1136/bmj.h5453; Henderson VC, 2015, ELIFE, V4, DOI 10.7554/eLife.08351; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Hirst JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098856; Holman C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002331; Home Office, NONT SUMM GRANT 2015; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hooijmans C. R, 2010, GOLD STANDARD PUBLIC; Ioannidis JPA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004631; Ipsos Mori, 2016, PUBLIC ATTITUDES ANI; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Laber K, 2016, LAB ANIM-UK, V50, P21, DOI 10.1177/0023677216642397; Lenzer J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3830; Macleod M., 2018, BMJ-BRIT MED J, P360; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Martic-Kehl MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137235; McGrath JC, 2015, BRIT J PHARMACOL, V172, P2671, DOI 10.1111/bph.12954; Mellor DJ, 2015, ANIM WELFARE, V24, P241, DOI 10.7120/09627286.24.3.241; *NAT I HLTH CLIN E, 2008, AL ET RIS RAL STRONT; NC3Rs, 2017, RESP US AN BIOSC RES; Percie du Sert N, 2017, J CEREBRAL BLOOD FLO; Perel P, 2006, TESTING TREATMENT AN; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Pollock N, 2010, SOC STUD SCI, V40, P525, DOI 10.1177/0306312710362275; PORTER DG, 1992, NATURE, V356, P101, DOI 10.1038/356101a0; Pound P, 2014, BMJ-BRIT MED J, V30, P348; Pound P, 2016, ATLA-ALTERN LAB ANIM, V44, P167, DOI 10.1177/026119291604400210; Rands SA, 2011, J AM ASSOC LAB ANIM, V50, P901; RCP. National Clinical Guideline for Stroke, 2016, NAT CLIN GUID STROK; Reichlin TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165999; REINES BP, 1991, J MED PHILOS, V16, P183, DOI 10.1093/jmp/16.2.183; Richardson CA, 2005, ANESTHESIA ANALGESIA, V1, P3; Ritskes-Hoitinga M, 2018, IMPROVING CONDUCT RE; Roberts D, 2017, COCHRANE DB SYST REV, V21, P3; Sandercock PAG, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0767-5; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Stafleu FR, 1999, LAB ANIM, V33, P295, DOI 10.1258/002367799780578255; Tirilazad International Steering Committee, 2001, COCHRANE DB SYST REV, P4; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Vogt L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000598; Walport M., 2016, COMMUNICATION; Wooding S, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-47	74	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193758	10.1371/journal.pone.0193758	http://dx.doi.org/10.1371/journal.pone.0193758			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590200	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000428603100030
J	Reynolds, LM; Howard, TD; Ruczinski, I; Kanchan, K; Seeds, MC; Mathias, RA; Chilton, FH				Reynolds, Lindsay M.; Howard, Timothy D.; Ruczinski, Ingo; Kanchan, Kanika; Seeds, Michael C.; Mathias, Rasika A.; Chilton, Floyd H.			Tissue-specific impact of FADS cluster variants on FADS1 and FADS2 gene expression	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; CORONARY-ARTERY-DISEASE; METABOLISM; HEALTH; POLYMORPHISMS; GENOME; ASSOCIATION; BLOOD; LIVER; PHOSPHOLIPIDS	Omega-6 (n-6) and omega-3 (n-3) long (>= 20 carbon) chain polyunsaturated fatty acids (LC-PUFAs) play a critical role in human health and disease. Biosynthesis of LC-PUFAs from dietary 18 carbon PUFAs in tissues such as the liver is highly associated with genetic variation within the fatty acid desaturase (FADS) gene cluster, containing FADS1 and FADS2 that encode the rate-limiting desaturation enzymes in the LC-PUFA biosynthesis pathway. However, the molecular mechanisms by which FADS genetic variants affect LCPUFA biosynthesis, and in which tissues, are unclear. The current study examined associations between common single nucleotide polymorphisms (SNPs) within the FADS gene cluster and FADS1 and FADS2 gene expression in 44 different human tissues (sample sizes ranging 70-361) from the Genotype-Tissue Expression (GTEx) Project. FADS1 and FADS2 expression were detected in all 44 tissues. Significant cis-eQTLs (within 1 mega base of each gene, False Discovery Rate, FDR<0.05, as defined by GTEx) were identified in 12 tissues for FADS1 gene expression and 23 tissues for FADS2 gene expression. Six tissues had significant (FDR<0.05) eQTLs associated with both FADS1 and FADS2 (including artery, esophagus, heart, muscle, nerve, and thyroid). Interestingly, the identified eQTLs were consistently found to be associated in opposite directions for FADS1 and FADS2 expression. Taken together, findings from this study suggest common SNPs within the FADS gene cluster impact the transcription of FADS1 and FADS2 in numerous tissues and raise important questions about how the inverse expression of these two genes impact intermediate molecular (such a LC-PUFA and LC-PUFA-containing glycero-lipid levels) and ultimately clinical phenotypes associated with inflammatory diseases and brain health.	[Reynolds, Lindsay M.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Howard, Timothy D.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Ruczinski, Ingo; Kanchan, Kanika; Mathias, Rasika A.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Seeds, Michael C.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC USA; [Chilton, Floyd H.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA	Wake Forest University; Wake Forest University; Johns Hopkins University; Wake Forest University; Wake Forest University	Chilton, FH (corresponding author), Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA.	schilton@wakehealth.edu		Reynolds, Lindsay/0000-0001-6157-0144	Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; National Institutes of Health [R01-AT008621]; National Institute on Aging of the National Institutes of Health [R03AG056959]; National Center for Complementary & Integrative Health [R01AT008621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG056959] Funding Source: NIH RePORTER	Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 12/02/16. The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. This work was supported by a grant (FHC) from the National Institutes of Health, R01-AT008621. Research reported in this publication was also supported by the National Institute on Aging of the National Institutes of Health under Award Number R03AG056959. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 12/02/16. The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.	BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buckley MT, 2017, MOL BIOL EVOL, V34, P1307, DOI 10.1093/molbev/msx103; Burr GO, 1930, J BIOL CHEM, V86, P0587; Burr GO, 1929, J BIOL CHEM, V82, P345; Chen YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S16; Chen YQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-519; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Cui T, 2016, PROSTATE, V76, P1182, DOI 10.1002/pros.23205; Del Gobbo LC, 2016, JAMA INTERN MED, V176, P1155, DOI 10.1001/jamainternmed.2016.2925; Dorajoo R, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0502-2; Draisma HHM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8208; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; ELBOUSTANI S, 1989, METABOLISM, V38, P315, DOI 10.1016/0026-0495(89)90117-0; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Hoile SP, 2013, J NUTR BIOCHEM, V24, P1213, DOI 10.1016/j.jnutbio.2012.09.005; Hong SH, 2013, CLIN INTERV AGING, V8, P585, DOI 10.2147/CIA.S42096; HORROBIN DF, 1993, AM J CLIN NUTR, V57, P732; Howard TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097510; Hu Y, 2016, HUM MOL GENET, V25, P1215, DOI 10.1093/hmg/ddw002; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2013, BRIT J NUTR, V109, P1196, DOI 10.1017/S0007114512003108; Lattka E, 2012, ANN NUTR METAB, V60, P8, DOI 10.1159/000337308; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; Lattka E, 2009, J NUTRIGENET NUTRIGE, V2, P119, DOI 10.1159/000235559; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mathias Rasika A, 2014, Curr Nutr Rep, V3, P139; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Mozaffarian D, 2015, AM J CLIN NUTR, V101, P398, DOI 10.3945/ajcn.114.094557; O'Neill CM, 2017, P NUTR SOC, V76, P64, DOI 10.1017/S0029665116000732; Pan G, 2017, NUCLEIC ACIDS RES, V45, P2408, DOI 10.1093/nar/gkw1186; Park HG, 2015, FASEB J, V29, P3911, DOI 10.1096/fj.15-271783; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; POISSON JP, 1993, BIOCHIM BIOPHYS ACTA, V1167, P109, DOI 10.1016/0005-2760(93)90149-4; Rahbar E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180903; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; Standl M, 2012, ALLERGY, V67, P83, DOI 10.1111/j.1398-9995.2011.02708.x; Standl M, 2011, CLIN EXP ALLERGY, V41, P1757, DOI 10.1111/j.1365-2222.2011.03833.x; Standl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037780; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang LB, 2015, HEPATOLOGY, V61, P119, DOI 10.1002/hep.27373; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Xie L, 2009, J NUTRIGENET NUTRIGE, V2, P243, DOI 10.1159/000255636; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	63	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194610	10.1371/journal.pone.0194610	http://dx.doi.org/10.1371/journal.pone.0194610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590160	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100067
J	Wade, TJ; Augustine, SAJ; Griffin, SM; Sams, EA; Oshima, KH; Egorov, AI; Simmons, KJ; Eason, TN; Dufour, AP				Wade, Timothy J.; Augustine, Swinburne A. J.; Griffin, Shannon M.; Sams, Elizabeth A.; Oshima, Kevin H.; Egorov, Andrey I.; Simmons, Kaneatra J.; Eason, Tarsha N.; Dufour, Alfred P.			Asymptomatic norovirus infection associated with swimming at a tropical beach: A prospective cohort study	PLOS ONE			English	Article							WATER-QUALITY; NORWALK VIRUS; GASTROENTERITIS; IMMUNOASSAY; DISEASE; ILLNESS	Background Swimming in fecally-contaminated waterbodies can result in gastrointestinal infections. However, the pathogenic microorganisms responsible are not well understood because sporadic cases of illness are not reported completely, exposure information is often not collected, and epidemiology studies rely on self-reported symptoms. Noroviruses are considered a likely cause because they are found in high densities in sewage, resistant to wastewater treatment and survive in the environment. In this study, saliva samples were collected from subjects at a beach in Puerto Rico and tested for evidence of norovirus-specific IgG responses as an indicator of incident norovirus infection. Methods Saliva samples were collected from 1298 participants using an oral swab. Samples were collected on the day of the beach visit (51); after 10-12 days (S2); and after three weeks (S3). Saliva was tested for IgG responses to GI.1 and GII.4 noroviruses using a microsphere based multiplex salivary immunoassay. Immunoconversion was defined as a four-fold increase in median fluorescence intensity (MFI) from 51 to S2 with the S3 sample at least three times above the 51 MFI. Results Thirty-four subjects (2.6%) immunoconverted to GI.1 or GII.4 norovirus. Swimmers who immersed their head in water had a higher rate of immunoconversion (3.4%), compared to either non-swimmers (0.0%, p = 0.003) or waders and non-swimmers combined (0.4%, Odds Ratio: 5.07, 95% Confidence Interval:1.48-17.00). Immunoconversion was not associated with gastrointestinal symptoms. Conclusions This is the first study to demonstrate an association between swimming at a beach impacted by fecal contamination and asymptomatic norovirus infection. The findings implicate recreational water as potentially important transmission pathway for norovirus infection.	[Wade, Timothy J.; Sams, Elizabeth A.; Egorov, Andrey I.; Eason, Tarsha N.] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Augustine, Swinburne A. J.; Griffin, Shannon M.; Oshima, Kevin H.; Dufour, Alfred P.] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Simmons, Kaneatra J.] Oconee Fall Line Tech Coll, Dublin, GA USA	United States Environmental Protection Agency; United States Environmental Protection Agency	Wade, TJ (corresponding author), US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	wade.tim@epa.gov	Augustine, Swinburne A J/U-9787-2019	Augustine, Swinburne A J/0000-0002-4948-884X; Eason, Tarsha/0000-0001-9881-3293	U.S. Environmental Protection Agency	U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the U.S. Environmental Protection Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Drew, 2003, Journal of Water and Health, V1, P85; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Augustine SAJ, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00084; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; Bartsch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151219; Currier RL, 2015, CLIN INFECT DIS, V60, P1631, DOI 10.1093/cid/civ165; Flannery J, 2012, APPL ENVIRON MICROB, V78, P3400, DOI 10.1128/AEM.07569-11; Frank E., 2010, REGRESSION MODELING; Gerba C. P., 2000, Quantitative Microbiology, V2, P55, DOI 10.1023/A:1010000230103; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Griffin SM, 2015, J IMMUNOL METHODS, V424, P53, DOI 10.1016/j.jim.2015.05.001; Griffin SM, 2011, J IMMUNOL METHODS, V364, P83, DOI 10.1016/j.jim.2010.11.005; KAY D, 1994, LANCET, V344, P905, DOI 10.1016/S0140-6736(94)92267-5; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Leon JS, 2011, APPL ENVIRON MICROB, V77, P5476, DOI 10.1128/AEM.02801-10; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; Lopman BA, 2015, J INFECT DIS, V211, P1813, DOI 10.1093/infdis/jiu672; Moe CL, 2004, CLIN DIAGN LAB IMMUN, V11, P1028, DOI 10.1128/CDLI.11.6.1028-1034.2004; POND K, 2005, WATER RECREATION DIS; Pringle K, 2015, FUTURE MICROBIOL, V10, P53, DOI 10.2217/fmb.14.102; Seitz SR, 2011, APPL ENVIRON MICROB, V77, P6884, DOI 10.1128/AEM.05806-11; Soller JA, 2016, MICROB RISK ANAL, V1, P2, DOI 10.1016/j.mran.2015.04.001; Soller JA, 2010, WATER RES, V44, P4736, DOI 10.1016/j.watres.2010.07.064; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Teunis PFM, 2015, EPIDEMIOL INFECT, V143, P1710, DOI 10.1017/S095026881400274X; USEPA, 1997, EPA821R97004; van Beek J, 2016, J GEN VIROL, V97, P2255, DOI 10.1099/jgv.0.000533; Wade TJ, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-67; Wade TJ, 2006, ENVIRON HEALTH PERSP, V114, P24, DOI 10.1289/ehp.8273; Wade TJ, 2003, ENVIRON HEALTH PERSP, V111, P1102, DOI 10.1289/ehp.6241; Wade TJ., 2010, REPORT 2009 NATL EPI; Zlot A, 2015, MMWR-MORBID MORTAL W, V64, P485	32	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195056	10.1371/journal.pone.0195056	http://dx.doi.org/10.1371/journal.pone.0195056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590196	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100100
J	Lindner, MD; Torralba, KD; Khan, NA				Lindner, Mark D.; Torralba, Karina D.; Khan, Nasim A.			Scientific productivity: An exploratory study of metrics and incentives	PLOS ONE			English	Article							CITATION BIAS; METHODOLOGICAL QUALITY; PUBLICATION TRENDS; TRIALS; EFFICACY; THERAPY; MODELS; DRUGS; CALL	Competitive pressure to maximize the current bibliometric measures of productivity is jeopardizing the integrity of the scientific literature. Efforts are underway to address the 'reproducibility crisis' by encouraging the use of more rigorous, confirmatory methods. However, as long as productivity continues to be defined by the number of discoveries scientists publish, the impact factor of the journals they publish in and the number of times their papers are cited, they will be reluctant to accept high quality methods and consistently conduct and publish confirmatory/replication studies. This exploratory study examined a sample of rigorous Phase II-IV clinical trials, including unpublished studies, to determine if more appropriate metrics and incentives can be developed. The results suggest that rigorous procedures will help reduce false positives, but to the extent that higher quality methods are accepted as the standard of practice, the current bibliometric incentives will discourage innovative studies and encourage scientists to shift their research to less informative studies of subjects that are already being more actively investigated. However, the results also suggest that it is possible to develop a more appropriate system of rewards. In contrast to the current bibliometric incentives, evaluations of the quality of the methods and reproducibility of the results, innovation and diversity of thought, and amount of information produced may serve as measures and incentives that maintain the integrity of the scientific literature and maximize scientific progress.	[Lindner, Mark D.] NIH, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA; [Torralba, Karina D.] Loma Linda Univ, Div Rheumatol, Loma Linda, CA 92350 USA; [Khan, Nasim A.] Univ Arkansas Med Sci, Dept Internal Med, Div Rheumatol, Little Rock, AR 72205 USA; [Khan, Nasim A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	National Institutes of Health (NIH) - USA; Loma Linda University; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Lindner, MD (corresponding author), NIH, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA.	Mark.Lindner@nih.gov		Lindner, Mark/0000-0002-8646-2980				ABEL EL, 1986, DRUG ALCOHOL DEPEN, V18, P107, DOI 10.1016/0376-8716(86)90119-5; Bacon F., 1620, NOVUM ORGANUM TRUE D; Baldi P, 2010, NEURAL NETWORKS, V23, P649, DOI 10.1016/j.neunet.2009.12.007; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bornmann L, 2017, J ASSOC INF SCI TECH, V68, P1064, DOI 10.1002/asi.23729; BROOKS TA, 1985, J AM SOC INFORM SCI, V36, P223, DOI 10.1002/asi.4630360402; BRUTON MN, 1991, ENVIRON BIOL FISH, V32, P403, DOI 10.1007/BF00007469; Button Katherine S, 2013, Nat Rev Neurosci, V14, P877, DOI 10.1038/nrn3475-c6; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chapman S, 2009, AUST NZ J PSYCHIAT, V43, P277, DOI 10.1080/00048670802653372; Collins Harry, 1992, CHANGING ORDER REPLI; Council of Canadian Academies, 2012, INF RES CHOIC IND JU; DeShazo JP, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-7; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Djulbegovic B, 2012, COCHRANE DATABASE SY, V10; Djulbegovic B, 2013, NATURE, V500, P395, DOI 10.1038/500395a; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fisher R., 1971, DESIGN EXPT; GARFIELD E, 1979, SCIENTOMETRICS, V1, P359, DOI 10.1007/BF02019306; GILBERT GN, 1977, SOC STUD SCI, V7, P113; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Greenberg SA, 2009, BMJ-BRIT MED J, V339, P210; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Higginson AD, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000995; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Hrobjartsson A, 2013, COCHRANE DATABASE SY, V4; Hutchins BI, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002541; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jannot AS, 2013, J CLIN EPIDEMIOL, V66, P296, DOI 10.1016/j.jclinepi.2012.09.015; Janssens ACJW, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002536; KERR S, 1975, ACAD MANAGE J, V18, P769, DOI 10.2307/255378; Khan NA, 2014, ARTHRITIS RHEUMATOL, V66, P2664, DOI 10.1002/art.38784; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kjaergard LL, 2002, J CLIN EPIDEMIOL, V55, P407, DOI 10.1016/S0895-4356(01)00513-3; Kontinen VK, 2003, PROG PAIN RES MANAG, V24, P489; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Larson RC, 2014, SYST RES BEHAV SCI, V31, P745, DOI 10.1002/sres.2210; Lindner MD, 2007, PHARMACOL THERAPEUT, V115, P148, DOI 10.1016/j.pharmthera.2007.05.002; Lucas C, 2002, LASER MED SCI, V17, P110, DOI 10.1007/s101030200018; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; MERTON RK, 1969, AM SCI, V57, P1; Mogil JS, 2017, NATURE, V542, P409, DOI 10.1038/542409a; NOBLE CE, 1965, PERCEPT MOTOR SKILL, V20, P959, DOI 10.2466/pms.1965.20.3.959; Philip M, 2009, STROKE, V40, P577, DOI 10.1161/STROKEAHA.108.524330; Popper K.R., 1968, CONJECTURES REFUTATI; Popper K. R., 1934, LOGIC SCI DISCOVERY; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Rice ASC, 2008, PAIN, V139, P243, DOI 10.1016/j.pain.2008.08.017; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; Rosenberg G., 2015, RES EXCELLENCE FRAME; Rzhetsky A, 2015, P NATL ACAD SCI USA, V112, P14569, DOI 10.1073/pnas.1509757112; Santangelo GM, 2017, MOL BIOL CELL, V28, P1401, DOI 10.1091/mbc.E16-01-0037; Schrag M, 2011, PROG NEUROBIOL, V94, P296, DOI 10.1016/j.pneurobio.2011.05.001; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Smaldino PE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160384; Thomas DW, 2016, CLIN DEV SUCCESS RAT, P2006; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van der Worp HB, 2005, J NEUROL, V252, P1108, DOI 10.1007/s00415-005-0802-3; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; Van Noorden R, 2014, NATURE, V514, P550, DOI 10.1038/514550a; Wang J, 2017, RES POLICY, V46, P1416, DOI 10.1016/j.respol.2017.06.006; Zyoud SH, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0335-z	66	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195321	10.1371/journal.pone.0195321	http://dx.doi.org/10.1371/journal.pone.0195321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614101	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600046
J	Ludecke, D; Bien, B; McKee, K; Krevers, B; Mestheneos, E; Di Rose, M; von dem Knesebeckl, O; Kofahl, C				Luedecke, Daniel; Bien, Barbara; McKee, Kevin; Krevers, Barbro; Mestheneos, Elizabeth; Di Rose, Mirko; von dem Knesebeckl, Olaf; Kofahl, Christopher			For better or worse: Factors predicting outcomes of family care of older people over a one-year period. A six-country European study	PLOS ONE			English	Article							CAREGIVER BURDEN; INFORMAL CAREGIVERS; SUPPORT SERVICES; ELDERLY PARENTS; HOME-CARE; DEMENTIA; QUALITY	Objectives Demographic change has led to an increase of older people in need of long-term care in nearly all European countries. Informal carers primarily provide the care and support needed by dependent people. The supply and willingness of individuals to act as carers are critical to sustain informal care resources as part of the home health care provision. This paper describes a longitudinal study of informal care in six European countries and reports analyses that determine those factors predicting the outcomes of family care over a one-year period. Methods Analyses are based on data from the EUROFAMCARE project, a longitudinal survey study of family carers of older people with baseline data collection in 2004 and follow-up data collection a year later in six European countries (Germany, Greece, Italy, Poland, Sweden, and the United Kingdom), N = 3,348. Descriptive statistics of the sample characteristics are reported. Binary logistic random-intercept regressions were computed, predicting the outcome of change of the care dyad's status at follow-up. Results Where care is provided by a more distant family member or by a friend or neighbour, the care-recipient is significantly more likely to be cared for by someone else (OR 1.62) or to be in residential care (OR 3.37) after one year. The same holds true if the care-recipient has memory problems with a dementia diagnosis (OR 1.79/OR 1.84). Higher dependency (OR 1.22) and behavioural problems (OR 1.76) in the care-recipient also lead to a change of care dyad status. Country of residence explained a relatively small amount of variance (8%) in whether a care-recipient was cared for by someone else after one year, but explained a substantial amount of variance (52%) in whether a care-recipient was in residential care. Particularly in Sweden, care-recipients are much more likely to be cared for by another family or professional carer or to be in residential care, whereas in Greece the status of the care dyad is much less likely to change. Discussion The majority of family carers continued to provide care to their respective older relatives over a one-year period, despite often high levels of functional, cognitive and behavioural problems in the care-recipient. Those family carers could benefit most from appropriate support. The carer/care-recipient relationship plays an important role in whether or not a family care dyad remains intact over a one-year period. The support of health and social care services should be particularly targeted toward those care dyads where there is no partner or spouse acting as carer, or no extended family network that might absorb the caring role when required. Distant relatives, friends or acquaintances who are acting as carers might need substantial intervention if their caregiving role is to be maintained.	[Luedecke, Daniel; von dem Knesebeckl, Olaf; Kofahl, Christopher] Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Martinistr, Hamburg, Germany; [Bien, Barbara] Med Univ Bialystok, Dept Geriatr, Bialystok, Poland; [McKee, Kevin] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [Krevers, Barbro] Linkoping Univ, Div Hlth Care Anal, Dept Med & Hlth Sci, Linkoping, Sweden; [Mestheneos, Elizabeth] 50 Hellas, Ammohostou 6, Halandri Attiki, Greece; [Di Rose, Mirko] Natl Inst Hlth & Sci Aging, Ancona, Italy	University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Bialystok; Dalarna University; Linkoping University	Ludecke, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Martinistr, Hamburg, Germany.	d.luedecke@uke.de	Kofahl, Christopher/AGZ-7071-2022; Di Rosa, Mirko/J-5974-2016	Di Rosa, Mirko/0000-0002-1862-4159; Bien, Barbara/0000-0002-2953-989X; Kofahl, Christopher/0000-0002-0503-3077; von dem Knesebeck, Olaf/0000-0001-6310-5879; Ludecke, Daniel/0000-0002-8895-3206	EU [QLK6-CT-2002-02647]	EU(European Commission)	The EUROFAMCARE project was funded by the EU (contract no.: QLK6-CT-2002-02647), FP5. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson M, 2016, HOUS THEORY SOC, V33, P217, DOI 10.1080/14036096.2015.1104385; Alber J, 2004, HLTH CARE ENLARGED E; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bien B, 2008, FAMILY CARERS OLDER, P233; Bien B, 2013, EUR J PUBLIC HEALTH, V23, P1032, DOI 10.1093/eurpub/cks190; Bonsang E, 2009, J HEALTH ECON, V28, P143, DOI 10.1016/j.jhealeco.2008.09.002; Bouget D, 2016, WORK LIFE BALANCE ME, P74; Brodaty H, 2014, J ALZHEIMERS DIS, V40, P221, DOI 10.3233/JAD-131850; Carretero S, 2009, ARCH GERONTOL GERIAT, V49, P74, DOI 10.1016/j.archger.2008.05.004; Chen QX, 2015, STAT MED, V34, P3637, DOI 10.1002/sim.6618; Chiao CY, 2015, INT NURS REV, V62, P340, DOI 10.1111/inr.12194; Crespo L, 2014, REV ECON STAT, V96, P693, DOI 10.1162/REST_a_00426; Delalibera M, 2015, CIENC SAUDE COLETIVA, V20, P2731, DOI 10.1590/1413-81232015209.09562014; Dilworth-Anderson P, 2007, J APPL GERONTOL, V26, P355, DOI 10.1177/0733464807302669; Epps F, 2015, J RELIG SPIRITUAL A, V27, P166, DOI 10.1080/15528030.2014.971141; Farre M, 2016, INT J NURS STUD, V55, P39, DOI 10.1016/j.ijnurstu.2015.10.012; Frericks P, 2014, J AGING STUD, V29, P66, DOI 10.1016/j.jaging.2013.12.002; Fulmer T, 2005, GERONTOLOGIST, V45, P525, DOI 10.1093/geront/45.4.525; Genet N, 2013, HEALTH POLICY, V110, P84, DOI 10.1016/j.healthpol.2013.01.009; Genet N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-207; Hajek A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148916; Hajek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144203; Hochgraeber I, 2015, DEMENTIA; Hodge DR, 2012, AGING MENT HEALTH, V16, P689, DOI 10.1080/13607863.2012.678481; Jeong YG, 2015, J PHYS THER SCI, V27, P1543, DOI 10.1589/jpts.27.1543; Kalwij A, 2014, REV ECON HOUSEHOLD, V12, P379, DOI 10.1007/s11150-012-9159-4; Keady J, 1996, J Psychiatr Ment Health Nurs, V3, P163, DOI 10.1111/j.1365-2850.1996.tb00083.x; Keating NC, 2014, J ECON AGEING, V3, P11, DOI 10.1016/j.jeoa.2014.03.002; Kehusmaa S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-317; Kofahl C, 2009, PFLEGE GESELLSCHAFT, V3, P236; Kofahl C., 2008, EUROPAISCHE PERSPEKT, P130; Kohler S, 2012, QUALITATIVE UNTERSUC, p293 ; Kommission Europaische, 2007, LIV COND EUR DAT 200; Lamura G, 2006, Z GERONTOL GERIATR, V39, P429, DOI 10.1007/s00391-006-0416-0; Lamura G, 2008, GERONTOLOGIST, V48, P752, DOI 10.1093/geront/48.6.752; Lamura Giovanni, 2008, FAMILY CARERS OLDER; Ldecke D., 2014, HLTH CARE UTILIZATIO, P171, DOI [10.1007/978-1-4614-9191-0_10, DOI 10.1007/978-1-4614-9191-0_10]; Conde-Sala JL, 2010, INT J NURS STUD, V47, P1262, DOI 10.1016/j.ijnurstu.2010.03.001; Ludecke D., 2018, SJPLOT DATA VISUALIZ; McKee K, 2008, FAMILY CARERS OLDER, P49; McKee KJ, 2003, AGING MENT HEALTH, V7, P39, DOI 10.1080/1360786021000006956; Mestheneos E, 2005, SUPPORTING FAMILY CA, V1; Mortazavi Hamed, 2015, Int J Community Based Nurs Midwifery, V3, P187; Oberg B, 2008, FAMILY CARERS OLDER, P75; Park M, 2015, INT PSYCHOGERIATR, V27, P1355, DOI 10.1017/S1041610215000460; R Development Core Team, 2009, R LANG ENV STAT COMP; Romero-Moreno R, 2011, INT PSYCHOGERIATR, V23, P573, DOI 10.1017/S1041610210001821; Shahly V., 2012, PSYCHOL MED, V9, P1; Stones D, 2016, AGEING SOC, V36, P449, DOI 10.1017/S0144686X14001214; Sutcliffe CL, 2015, INT J GERIATR PSYCHI; Wang YN, 2011, J ADV NURS, V67, P829, DOI 10.1111/j.1365-2648.2010.05505.x; Wu S, 2012, CONTEMP CLIN TRIALS, V33, P869, DOI 10.1016/j.cct.2012.05.004; Wun LM, 2007, STAT MED, V26, P1875, DOI 10.1002/sim.2809	53	17	17	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195294	10.1371/journal.pone.0195294	http://dx.doi.org/10.1371/journal.pone.0195294			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614108	Green Submitted, gold, Green Published			2022-12-27	WOS:000429081600041
J	Otim, MH; Tay, WT; Walsh, TK; Kanyesigye, D; Adumo, S; Abongosi, J; Ochen, S; Sserumaga, J; Alibu, S; Abalo, G; Asea, G; Agona, A				Otim, Michael H.; Tay, Wee Tek; Walsh, Thomas K.; Kanyesigye, Dalton; Adumo, Stella; Abongosi, Joseph; Ochen, Stephen; Sserumaga, Julius; Alibu, Simon; Abalo, Grace; Asea, Godfrey; Agona, Ambrose			Detection of sister-species in invasive populations of the fall armyworm Spodoptera frugiperda (Lepidoptera: Noctuidae) from Uganda	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; BT MAIZE; INSECTICIDE RESISTANCE; REPRODUCTIVE ISOLATION; HUBNER LEPIDOPTERA; HOST STRAINS; PEST; DNA; PATTERNS	The fall armyworm (FAW) Spodoptera frugiperda (J. E. Smith) is a species native to the Americas. This polyphagous lepidopteran pest was first reported in Nigeria and the Democratic Republic of Sao Tome and Principe in 2016, but its presence in eastern Africa has not been confirmed via molecular characterisation. In this study, FAW specimens from western and central Uganda were identified based on the partial mtDNA COI gene sequences, with mtDNA COI haplotypes matching those identified in Nigeria and Sao Tome. In this study, we sequence an additional partial mtDNA Cyt b gene and also the partial mtDNA COIII gene in Ugandan FAW samples. We detected identical mitochondrial DNA haplotypes for both the mtDNA Cyt b and COI partial genes, while combining the mtDNA COI/Cyt b haplotypes and mtDNA COIII haplotypes enabled a new maternal lineage in the Ugandan corn-preferred FAW samples to be identified. Our results suggested that the African incursions of S. frugiperda involved at least three maternal lineages. Recent full genome, phylogenetic and microsatellite analyses provided evidence to support S. frugiperda as likely consisted of two sympatric sister species known as the corn-preferred and rice-preferred strains. In our Ugandan FAW populations, we identified the presence of mtDNA haplotypes representative of both sister species. It is not known if both FAW sister species were originally introduced together or separately, and whether they have since spread as a single population. Further analyses of additional specimens originally collected from Sao Tome, Nigeria and throughout Africa would be required to clarify this issue. Importantly, our finding showed that the genetic diversity of the African corn-preferred FAW species is higher than previously reported. This potentially contributed to the success of FAW establishment in Africa. Furthermore, with the additional maternal lineages detected, there is likely an increase in paternal lineages, thereby increasing the diversity of the African FAW population. Knowledge of the FAW genetic diversity will be needed to assess the risks of introducing Bt-resistance traits and to understand the FAW incursion pathways into the Old World and its potential onward spread. The agricultural implications of the presence of two evolutionary divergent FAW lineages (the corn and the rice lineage) in the African continent are further considered and discussed.	[Otim, Michael H.; Kanyesigye, Dalton; Adumo, Stella; Abongosi, Joseph; Ochen, Stephen; Sserumaga, Julius; Alibu, Simon; Abalo, Grace; Asea, Godfrey] Natl Crops Resources Res Inst, Kampala, Uganda; [Tay, Wee Tek; Walsh, Thomas K.] CSIRO, Canberra, ACT, Australia; [Agona, Ambrose] Natl Agr Res Org, Entebbe, Uganda	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Otim, MH (corresponding author), Natl Crops Resources Res Inst, Kampala, Uganda.	motim9405@gmail.com	Walsh, Thomas K/C-1263-2009; Tay, Wee Tek/GPF-6142-2022; Sserumaga, Julius Pyton/AAN-7162-2020; Kanyesigye, Dalton/CAH-6903-2022; Otim, Michael/ABF-9389-2021; Tay, Wee Tek/C-1818-2008	Walsh, Thomas K/0000-0001-8425-0135; Tay, Wee Tek/0000-0002-8451-0811; Sserumaga, Julius Pyton/0000-0001-5152-2835; Otim, Michael/0000-0001-5406-012X; Tay, Wee Tek/0000-0002-8451-0811; Kanyesigye, Dalton/0000-0003-3035-2835; Alibu, Simon/0000-0003-2708-0293	Agricultural Technology and Agribusiness Advisory Services Project - World Bank [P109224]; CSIRO Health and Biosecurity [R-8681-1]; CSIRO Land and Water	Agricultural Technology and Agribusiness Advisory Services Project - World Bank; CSIRO Health and Biosecurity; CSIRO Land and Water(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	MHO acknowledges funding from the Agricultural Technology and Agribusiness Advisory Services Project (Project ID No.: P109224) funded by the World Bank. WTT and TKW acknowledged funding support from CSIRO Health and Biosecurity (R-8681-1) and CSIRO Land and Water.	Abo-Elghar GE, 2004, INSECT BIOCHEM MOLEC, V34, P743, DOI 10.1016/j.ibmb.2004.03.009; Adamczyk JJ, 1999, FLA ENTOMOL, V82, P230, DOI 10.2307/3496574; Anderson CJ, 2016, MOL ECOL, V25, P5296, DOI 10.1111/mec.13841; Arnemann JA, 2016, GENET MOL RES, V15; Arneodo JD, 2015, J ECON ENTOMOL, V108, P2505, DOI 10.1093/jee/tov254; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Bowden J., 1976, P97; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Chown SL, 2015, EVOL APPL, V8, P23, DOI 10.1111/eva.12234; Cock MJW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04238-y; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Diez-Rodriguez Gabriela I., 2001, Neotropical Entomology, V30, P311, DOI 10.1590/S1519-566X2001000200016; Downes S, 2016, CURR OPIN INSECT SCI, V15, P78, DOI 10.1016/j.cois.2016.04.002; Dumas P, 2015, GENETICA, V143, P305, DOI 10.1007/s10709-015-9829-2; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; European Union, 2017, EUR INT EUR UN NOT S; European Union, 2016, EUR INT EUR UN NOT S; European Union, 2016, EUR UN ANN REP 2015; European Union, 2015, EUR INT EUR UN NOT S; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRENCH RA, 1969, J ANIM ECOL, V38, P199, DOI 10.2307/2746; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Gouin A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10461-4; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harper GA, 2015, GLOB ECOL CONSERV, V3, P607, DOI 10.1016/j.gecco.2015.02.010; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayden J. E, 2015, FDACS02039 DIV PLANT; Hess Jon E., 2009, Aquatic Invasions, V4, P299, DOI 10.3391/ai.2009.4.2.1; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Jakka SRK, 2014, J INVERTEBR PATHOL, V122, P52, DOI 10.1016/j.jip.2014.08.009; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kergoat GJ, 2012, MOL PHYLOGENET EVOL, V65, P855, DOI 10.1016/j.ympev.2012.08.006; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ledezma LA, 2016, J ECON ENTOMOL, V109, P1957, DOI 10.1093/jee/tow111; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Liu QN, 2016, GENES GENOM, V38, P205, DOI 10.1007/s13258-015-0346-6; MARTIN JA, 1989, ANN ENTOMOL SOC AM, V82, P177, DOI 10.1093/aesa/82.2.177; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; MCCORD E, 1987, PESTIC BIOCHEM PHYS, V27, P114, DOI 10.1016/0048-3575(87)90103-9; Meagher RL, 2004, FLA ENTOMOL, V87, P454, DOI 10.1653/0015-4040(2004)087[0454:LDOFAL]2.0.CO;2; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181982; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171743; Niu Y., 2014, RESISTANCE FALL ARMY; OOI BG, 1988, VIROLOGY, V166, P515, DOI 10.1016/0042-6822(88)90522-3; Os JDR, 2011, J ECON ENTOMOL, V104, P1698; Paini DR, 2016, P NATL ACAD SCI USA, V113, P7575, DOI 10.1073/pnas.1602205113; PASHLEY DP, 1987, ANN ENTOMOL SOC AM, V80, P731, DOI 10.1093/aesa/80.6.731; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; PASHLEY DP, 1985, ANN ENTOMOL SOC AM, V78, P756, DOI 10.1093/aesa/78.6.756; Pea Abrahams, FALL ARMYWORM STATUS; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0413-3; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0402-6; PHA Ltd, 2007, IND BIOS PLAN VEG IN; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; QUISENBERRY SS, 1991, FLA ENTOMOL, V74, P194, DOI 10.2307/3495297; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Seymour PR, 1985, INSECTS OTHER INVERT; Sosa-Gomez DR, 2016, REV BRAS ENTOMOL, V60, P101, DOI 10.1016/j.rbe.2015.09.008; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Staden R, 2000, Methods Mol Biol, V132, P115; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tay WT, 2008, B ENTOMOL RES, V98, P509, DOI 10.1017/S000748530800583X; Tay WT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45302; Tay WT, 2016, PEST MANAG SCI, V72, P1250, DOI 10.1002/ps.3805; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; Vassal Jean-Michel, 2008, Commun Agric Appl Biol Sci, V73, P433; Velasquez-Velez MI, 2011, ANN ENTOMOL SOC AM, V104, P826, DOI 10.1603/AN10164; Venette R. C., 2003, MINIRISK ASSESSMENT; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wan XL, 2013, MOL BIOL REP, V40, P6333, DOI 10.1007/s11033-013-2748-3; Wild S, 2017, NATURE, V543, P13, DOI 10.1038/nature.2017.21527; Wu QL, 2013, MITOCHONDR DNA, V24, P31, DOI 10.3109/19401736.2012.716052; Yano E., 2016, SCIENCES, VX, P4; YOUNG JR, 1979, J ECON ENTOMOL, V72, P202, DOI 10.1093/jee/72.2.202; YU SJ, 1992, J ECON ENTOMOL, V85, P675, DOI 10.1093/jee/85.3.675; YU SJ, 1991, PESTIC BIOCHEM PHYS, V39, P84, DOI 10.1016/0048-3575(91)90216-9; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhu YC, 2015, PESTIC BIOCHEM PHYS, V122, P15, DOI 10.1016/j.pestbp.2015.01.007	91	44	50	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194571	10.1371/journal.pone.0194571	http://dx.doi.org/10.1371/journal.pone.0194571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614067	gold, Green Published, Green Submitted			2022-12-27	WOS:000429081600013
J	Pokholkova, GV; Demakov, SA; Andreenkov, OV; Andreenkova, NG; Volkova, EI; Belyaeva, ES; Zhimulev, IF				Pokholkova, Galina V.; Demakov, Sergei A.; Andreenkov, Oleg V.; Andreenkova, Natalia G.; Volkova, Elena I.; Belyaeva, Elena S.; Zhimulev, Igor F.			Tethering of CHROMATOR and dCTCF proteins results in decompaction of condensed bands in the Drosophila melanogaster polytene chromosomes but does not affect their transcription and replication timing	PLOS ONE			English	Article							INTERCALARY HETEROCHROMATIN; CHROMODOMAIN PROTEIN; INSULATOR PROTEINS; GENE-EXPRESSION; DNA-REPLICATION; GENOME; DOMAINS; UNDERREPLICATION; ORGANIZATION; DECONDENSATION	Instulator proteins are central to domain organization and gene regulation in the genome. We used ectopic tethering of CHROMATOR (CHRIZ/CHRO) and dCTCF to pre-defined regions of the genome to dissect the influence of these proteins on local chromatin organization, to analyze their interaction with other key chromatin proteins and to evaluate the effects on transcription and replication. Specifically, using UAS-GAL4DBD system, CHRO and dCTCF were artificially recruited into highly compacted polytene chromosome bands that share the features of silent chromatin type known as intercalary heterochromatin (IH). This led to local chromatin decondensation, formation of novel DHSes and recruitment of several "open chromatin" proteins. CHRO tethering resulted in the recruitment of CP190 and Z4 (PZG), whereas dCTCF tethering attracted CHRO, CP190, and Z4. Importantly, formation of a local stretch of open chromatin did not result in the reactivation of silent marker genes yellow and mini-white immediately adjacent to the targeting region (UAS), nor did RNA polll become recruited into this chromatin. The decompacted region retained late replicated, similarly to the wild-type untargeted region.	[Pokholkova, Galina V.; Demakov, Sergei A.; Andreenkov, Oleg V.; Andreenkova, Natalia G.; Volkova, Elena I.; Belyaeva, Elena S.; Zhimulev, Igor F.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Demakov, Sergei A.; Zhimulev, Igor F.] Novosibirsk State Univ, Novosibirsk, Russia	Russian Academy of Sciences; Novosibirsk State University	Zhimulev, IF (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia.; Zhimulev, IF (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Elena, Volkova/N-7468-2015; Demakov, Sergey A/N-6543-2015; Andreyenkova, Natalya G/N-4003-2015; Andreenkov, Oleg/N-4070-2015; Zhimulev, Igor F/N-7978-2015	Andreyenkova, Natalya G/0000-0002-5981-8857; Andreyenkov, Oleg/0000-0001-8231-8984; Zhimulev, Igor/0000-0002-6220-3028; Demakov, Sergey/0000-0002-5526-6784	Russian Science Foundation [14-14-00934]; Russian Foundation for Basic Research [15-04-03898]; program of support and development of bioresurce collections [0310-2016-0001];  [0310-2018-0010]; Russian Science Foundation [17-14-00038] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); program of support and development of bioresurce collections; ; Russian Science Foundation(Russian Science Foundation (RSF))	FISH experiments were supported by the Russian Science Foundation project 14-14-00934 IFZ; genetic analysis was supported by the Russian Foundation for Basic Research 15-04-03898 IFZ; budget grants 0310-2018-0010 IFZ; program of support and development of bioresurce collections ? 0310-2016-0001 SAD. The resources provided by the "Molecular and Cellular Biology core facility of the IMCB SB RAS, Sergei A. Demakov.; FISH experiments were supported by the Russian Science Foundation project 14-14-00934, genetic analysis was supported by the Russian Fund of Basic Research 15-04-03898, budget grants 0310-2018-0010 and program of support and development of bioresurce collections (No 0310-2016-0001). The authors are very grateful to colleagues supplying us with antibodies: I.V. Makunin, K. McKim, P.G. Georgiev, H. Saumweber, S. Elgin, A. Gorchakov as well as V. A. Khoroshko, T.Yu. Zykova, T.D. Kolesnikova and O.V. Antonenko for help in of the manuscript. We thank the Bloomington Drosophila Stock Center for kind providing the EY flystocks. The authors gratefully acknowledge the resources provided by the "Molecular and Cellular Biology" core facility of the IMCB SB RASpreparation	Ahanger SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep03917; Ali T, 2016, CURR OPIN GENET DEV, V37, P17, DOI 10.1016/j.gde.2015.11.009; Andreenkov O V, 2016, Tsitologiia, V58, P493; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Chesnokov IN, 2007, INT REV CYTOL, V256, P69, DOI 10.1016/S0074-7696(07)56003-1; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; Feng SH, 2014, MOL CELL, V55, P694, DOI 10.1016/j.molcel.2014.07.008; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Khoroshko VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157147; Kolesnikova TD, 2013, CHROMOSOMA, V122, P55, DOI 10.1007/s00412-012-0390-9; Kolesnikova TD, 2011, FLY, V5, P181, DOI 10.4161/fly.5.3.16729; Koryakov DE, 2012, CHROMOSOMA, V121, P573, DOI 10.1007/s00412-012-0382-9; Kwon SY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005969; Lubelsky Y, 2014, GENOME RES, V24, P1102, DOI 10.1101/gr.160010.113; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Maksimenko O, 2015, GENOME RES, V25, P89, DOI 10.1101/gr.174169.114; Makunin IV, 2002, GENETICS, V160, P1023; MEYEROWITZ EM, 1985, COLD SPRING HARB SYM, V50, P347, DOI 10.1101/SQB.1985.050.01.044; Milon B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-988; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Pokholkova GV, 2015, CHROMOSOMA, V124, P209, DOI 10.1007/s00412-014-0491-8; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; Regnard C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001327; Sambrook J., 2004, MOL CLONING LAB MANU; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Seum C, 2000, CHROMOSOMA, V109, P453, DOI 10.1007/s004120000101; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P185, DOI 10.1016/S0091-679X(08)60913-9; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Stadler MR, 2017, CHROMATIN EXTENSION; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; Van Bortle K, 2013, CURR OPIN GENET DEV, V23, P212, DOI 10.1016/j.gde.2012.11.003; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Wang C, 2011, J CELL SCI, V124, P4309, DOI 10.1242/jcs.092585; White R, 2012, BRIEF FUNCT GENOMICS, V11, P347, DOI 10.1093/bfgp/els020; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Yarosh W, 2014, GENE DEV, V28, P1840, DOI 10.1101/gad.245811.114; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X; Zhimolev IF, 1996, ADV GENET, V34, P1; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2003, J CELL SCI, V116, P169, DOI 10.1242/jcs.00196; Zhimulev IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101631	65	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0192634	10.1371/journal.pone.0192634	http://dx.doi.org/10.1371/journal.pone.0192634			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608600	Green Submitted, Green Published, gold			2022-12-27	WOS:000428988800001
J	Asaf, S; Khan, AL; Khan, MA; Shahzad, R; Lubna; Kang, SM; Al-Harrasi, A; Al-Rawahi, A; Lee, IJ				Asaf, Sajjad; Khan, Abdul Latif; Khan, Muhammad Aaqil; Shahzad, Raheem; Lubna; Kang, Sang Mo; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed; Lee, In-Jung			Complete chloroplast genome sequence and comparative analysis of loblolly pine (Pinus taeda L.) with related species	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INVERTED REPEAT COPIES; PATERNAL INHERITANCE; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; GENE ORGANIZATION; PHYSICAL MAP; SEED PLANTS; GLYCINE-MAX; RED PINE	Pinaceae, the largest family of conifers, has a diversified organization of chloroplast (cp) genomes with two typical highly reduced inverted repeats (IRs). In the current study, we determined the complete sequence of the cp genome of an economically and ecologically important conifer tree, the loblolly pine (Pinus taeda L.), using Illumina paired-end sequencing and compared the sequence with those of other pine species. The results revealed a genome size of 121,531 base pairs (bp) containing a pair of 830-bp IR regions, distinguished by a small single copy (42,258 bp) and large single copy (77,614 bp) region. The chloroplast genome of P. taeda encodes 120 genes, comprising 81 protein-coding genes, four ribosomal RNA genes, and 35 tRNA genes, with 151 randomly distributed microsatellites. Approximately 6 palindromic, 34 forward, and 22 tandem repeats were found in the P. taeda cp genome. Whole cp genome comparison with those of other Pinus species exhibited an overall high degree of sequence similarity, with some divergence in intergenic spacers. Higher and lower numbers of indels and single-nucleotide polymorphism substitutions were observed relative to P. contorta and P. monophylla, respectively. Phylogenomic analyses based on the complete genome sequence revealed that 60 shared genes generated trees with the same topologies, and P. taeda was closely related to P. contorta in the subgenus Pinus. Thus, the complete P. taeda genome provided valuable resources for population and evolutionary studies of gymnosperms and can be used to identify related species.	[Asaf, Sajjad; Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed] Univ Nizwa, Omans Med Plants & Marine Nat Prod, Nizwa, Oman; [Khan, Muhammad Aaqil; Shahzad, Raheem; Kang, Sang Mo; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Lubna] Abdul Wali Khan Univ Mardan, Dept Bot, Garden Campus, Mardan, Pakistan; [Lee, In-Jung] Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Daegu, South Korea	University of Nizwa; Kyungpook National University; Kyungpook National University	Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.; Lee, IJ (corresponding author), Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Daegu, South Korea.	ijlee@knu.ac.kr	Khan, Muhammad Aqil/ABB-9797-2021; Shahzad, Raheem/AAG-8370-2019; Lee, In-Jung/GLS-0432-2022; Asaf, Sajjad/ABA-3647-2021	Shahzad, Raheem/0000-0002-6594-8287; Lee, In-Jung/0000-0001-7154-4820; , Lubna/0000-0001-7869-7467; asaf, sajjad/0000-0001-8216-7549; Khan, Abdul Latif/0000-0001-9700-8903				Abe J, 1999, ECON BOT, V53, P285, DOI 10.1007/BF02866640; Akpinar BA, 2015, PLANT BIOTECHNOL J, V13, P740, DOI 10.1111/pbi.12302; Akpinar BA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10763; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Asaf S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00304; Asaf S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00843; Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1978, ANNU REV GENET, V12, P471, DOI 10.1146/annurev.ge.12.120178.002351; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Celinski K., 2016, CONSERV GENET, V9, P1; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Chen JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00447; CLARKE AK, 1994, PLANT MOL BIOL, V26, P851, DOI 10.1007/BF00028853; CLOSE PS, 1989, THEOR APPL GENET, V77, P768, DOI 10.1007/BF00268325; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; DONG JS, 1994, GENETICS, V136, P1187; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; DOYLE JJ, 1995, SYST BOT, V20, P272, DOI 10.2307/2419496; Duan RY, 2016, CONSERV GENET RESOUR, V8, P395, DOI 10.1007/s12686-016-0567-2; Echt CS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-17; Echt CS, 1998, MOL ECOL, V7, P307, DOI 10.1046/j.1365-294X.1998.00350.x; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Elsik CG, 2001, THEOR APPL GENET, V103, P1189, DOI 10.1007/s001220100725; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Fang MF, 2016, MITOCHONDRIAL DNA A, V27, P2732, DOI 10.3109/19401736.2015.1046169; FARJON A, 2001, WORLD CHECKLIST BIBL; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Frederick WJ, 2008, BIORESOURCE TECHNOL, V99, P5051, DOI 10.1016/j.biortech.2007.08.086; Gao C-W, 2016, CONSERV GENET, P1; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Hao ZD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161809; Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003; HILDEBRAND M, 1988, P NATL ACAD SCI USA, V85, P372, DOI 10.1073/pnas.85.2.372; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Hirata T, 1996, SOYBEAN GENETICS NEW; Do HDK, 2014, GENOME BIOL EVOL, V6, P1699, DOI 10.1093/gbe/evu138; Hohmann N, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0224-x; HONG YP, 1993, GENETICS, V135, P1187; Hu XS, 1997, HEREDITY, V79, P541, DOI 10.1038/hdy.1997.194; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jiao Y., 2017, NATURE; Johansson JT, 1999, PLANT SYST EVOL, V218, P133, DOI 10.1007/BF01087041; KANNO A, 1993, CURR GENET, V23, P166, DOI 10.1007/BF00352017; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; KOHCHI T, 1988, CURR GENET, V14, P147, DOI 10.1007/BF00569338; Kondo T, 1998, BREEDING SCI, V48, P177; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; Kraemer L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-41; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P716, DOI 10.1093/nar/gkg155; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; LAVIN M, 1990, EVOLUTION, V44, P390, DOI 10.1111/j.1558-5646.1990.tb05207.x; Leclercq S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-125; LEE DJ, 1992, THEOR APPL GENET, V85, P261, DOI 10.1007/BF00222868; Li XW, 2013, SCI CHINA LIFE SCI, V56, P189, DOI 10.1007/s11427-012-4430-8; Li ZH, 2016, MITOCHONDRIAL DNA A, V27, P2635, DOI 10.3109/19401736.2015.1041130; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIDHOLM J, 1991, CURR GENET, V20, P161, DOI 10.1007/BF00312780; LIDHOLM J, 1988, MOL GEN GENET, V212, P6, DOI 10.1007/BF00322438; Liston A., 1995, USE POLYMERASE CHAIN; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lopez GG, 2002, INT J PLANT SCI, V163, P737, DOI 10.1086/342213; Lucas SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1080; Mackay J, 2012, PLANT MOL BIOL, V80, P555, DOI 10.1007/s11103-012-9961-7; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; Millar Constance L., 1998, P69; Miller Jr CN, 1973, SILICIFIED CONES VEG; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Morton BR, 1998, J MOL EVOL, V46, P449, DOI 10.1007/PL00006325; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; NEALE DB, 1989, THEOR APPL GENET, V77, P212, DOI 10.1007/BF00266189; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; PALMER JD, 1981, P NATL ACAD SCI-BIOL, V78, P5533, DOI 10.1073/pnas.78.9.5533; PALMER JD, 1986, CURR GENET, V10, P823, DOI 10.1007/BF00418529; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Parkinson CL, 1999, CURR BIOL, V9, P1485, DOI 10.1016/S0960-9822(00)80119-0; Pauwels M, 2012, NEW PHYTOL, V193, P916, DOI 10.1111/j.1469-8137.2011.04003.x; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; POWELL W, 1995, CURR BIOL, V5, P1023, DOI 10.1016/S0960-9822(95)00206-5; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 1997, GENOME, V40, P104, DOI 10.1139/g97-014; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Qian J, 2013, PLOS ONE, V8; Raj M, 2005, SILVAE GENET, V54, P126, DOI 10.1515/sg-2005-0020; Raubeson L, 2005, CHLOROPLAST GENOMES, P45; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rose O, 1998, MOL BIOL EVOL, V15, P613, DOI 10.1093/oxfordjournals.molbev.a025964; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHIMADA H, 1991, NUCLEIC ACIDS RES, V19, P983, DOI 10.1093/nar/19.5.983; Shimamoto Y, 1992, SOYBEAN GENETICS NEW; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; SHOEMAKER RC, 1986, J HERED, V77, P26, DOI 10.1093/oxfordjournals.jhered.a110161; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Stewart JF, 2012, TREE GENET GENOMES, V8, P725, DOI 10.1007/s11295-011-0459-2; STRAUSS SH, 1988, P NATL ACAD SCI USA, V85, P3898, DOI 10.1073/pnas.85.11.3898; Sugiura C, 2004, PLANT J, V40, P314, DOI 10.1111/j.1365-313X.2004.02202.x; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; Syring J, 2005, AM J BOT, V92, P2086, DOI 10.3732/ajb.92.12.2086; SZMIDT AE, 1987, PLANT MOL BIOL, V9, P59, DOI 10.1007/BF00017987; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; TSUDZUKI J, 1992, MOL GEN GENET, V232, P206, DOI 10.1007/BF00279998; Tsuji S, 2007, J PLANT RES, V120, P281, DOI 10.1007/s10265-006-0055-y; TSUMURA Y, 1994, THEOR APPL GENET, V89, P922, DOI 10.1007/BF00224518; TSUMURA Y, 1993, THEOR APPL GENET, V86, P166, DOI 10.1007/BF00222075; UMESONO K, 1988, J MOL BIOL, V203, P299, DOI 10.1016/0022-2836(88)90002-2; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Vieira LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090618; WAGNER DB, 1987, P NATL ACAD SCI USA, V84, P2097, DOI 10.1073/pnas.84.7.2097; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; Wakasugi T, 1994, P NATL ACAD SCI USA, P91; Wambugu PW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13957; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; Wegrzyn JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072439; WHITE EE, 1990, THEOR APPL GENET, V79, P119, DOI 10.1007/BF00223797; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu CS, 2014, PLANT BIOTECHNOL J, V12, P344, DOI 10.1111/pbi.12141; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Wu CS, 2011, GENOME BIOL EVOL, V3, P309, DOI 10.1093/gbe/evr026; Wu ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yap JYS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128126; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042; Zheng WW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071084; Zonneveld BJM, 2012, NORD J BOT, V30, P490, DOI 10.1111/j.1756-1051.2012.01516.x	157	32	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0192966	10.1371/journal.pone.0192966	http://dx.doi.org/10.1371/journal.pone.0192966			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596414	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000004
J	Borgeat, K; Niessen, SJM; Wilkie, L; Harrington, N; Church, DB; Fuentes, VL; Connolly, DJ				Borgeat, Kieran; Niessen, Stijn J. M.; Wilkie, Lois; Harrington, Norelene; Church, David B.; Fuentes, Virginia Luis; Connolly, David J.			Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR RISK-FACTORS; GROWTH-HORMONE; DIABETIC CATS; ECHOCARDIOGRAPHIC FINDINGS; SYSTEMIC HYPERTENSION; DOMESTIC CATS; HEART-FAILURE; I LEVELS; HYPERTHYROIDISM	Background In humans, acromegaly due to a pituitary somatotrophic adenoma is a recognized cause of increased left ventricular (LV) mass. Acromegalic cardiomyopathy is incompletely understood, and represents a major cause of morbidity and mortality. We describe the clinical, echocardiographic and histopathologic features of naturally occurring feline acromegalic cardiomyopathy, an emerging disease among domestic cats. Methods Cats with confirmed hypersomatotropism (IGF-1>1000ng/ml and pituitary mass; n = 67) were prospectively recruited, as were two control groups: diabetics (IGF-1<800ng/ml; n = 24) and healthy cats without known endocrinopathy or cardiovascular disease (n = 16). Echocardiography was performed in all cases, including after hypersomatotropism treatment where applicable. Additionally, tissue samples from deceased cats with hypersomatotropism, hypertrophic cardiomyopathy and age-matched controls (n = 21 each) were collected and systematically histopathologically reviewed and compared. Results By echocardiography, cats with hypersomatotropism had a greater maximum LV wall thickness (6.5mm, 4.1-10.1mm) than diabetic (5.9mm, 4.2-9.1mm; Mann Whitney, p<0.001) or control cats (5.2mm, 4.1-6.5mm; Mann Whitney, p<0.001). Left atrial diameter was also greater in cats with hypersomatotropism (16.6mm, 13.0-29.5mm) than in diabetic (15.4mm, 11.2-20.3mm; Mann Whitney, p<0.001) and control cats (14.0mm, 12.6-17.4mm; Mann Whitney, p<0.001). After hypophysectomy and normalization of IGF-1 concentration (n = 20), echocardiographic changes proved mostly reversible. As in humans, histopathology of the feline acromegalic heart was dominated by myocyte hypertrophy with interstitial fibrosis and minimal myofiber disarray. Conclusions These results demonstrate cats could be considered a naturally occurring model of acromegalic cardiomyopathy, and as such help elucidate mechanisms driving cardiovascular remodeling in this disease.	[Borgeat, Kieran; Niessen, Stijn J. M.; Wilkie, Lois; Church, David B.; Fuentes, Virginia Luis; Connolly, David J.] Royal Vet Coll, Clin Sci & Serv, Hatfield, Herts, England; [Borgeat, Kieran] Univ Bristol, Langford Vet Serv, Bristol, Avon, England; [Harrington, Norelene] Royal Vet Coll, Pathol & Pathogen Biol, Hatfield, Herts, England	University of London; University of London Royal Veterinary College; University of Bristol; University of London; University of London Royal Veterinary College	Borgeat, K (corresponding author), Royal Vet Coll, Clin Sci & Serv, Hatfield, Herts, England.; Borgeat, K (corresponding author), Univ Bristol, Langford Vet Serv, Bristol, Avon, England.	k.borgeat@bristol.ac.uk	Harrington, Norelene/AAQ-4669-2020; Borgeat, Kieran/W-9342-2019	Borgeat, Kieran/0000-0001-9199-4941				Baldelli R, 2000, J CLIN ENDOCR METAB, V85, P4099, DOI 10.1210/jc.85.11.4099; BOND BR, 1988, J AM VET MED ASSOC, V192, P1546; Brown S, 2007, J VET INTERN MED, V21, P542, DOI 10.1892/0891-6640(2007)21[542:GFTIEA]2.0.CO;2; Colao A, 2000, J CLIN ENDOCR METAB, V85, P193, DOI 10.1210/jc.85.1.193; Colao A, 2000, J CLIN ENDOCR METAB, V85, P3132, DOI 10.1210/jc.85.9.3132; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Colao A, 2002, EUR J ENDOCRINOL, V146, P303, DOI 10.1530/eje.0.1460303; Colao A, 1999, J CLIN ENDOCR METAB, V84, P17, DOI 10.1210/jc.84.1.17; Colao A, 2001, J CLIN ENDOCR METAB, V86, P1551, DOI 10.1210/jc.86.4.1551; Colao A, 2011, EUR J ENDOCRINOL, V165, P713, DOI 10.1530/EJE-11-0408; Colao A, 2009, J CLIN ENDOCR METAB, V94, P3746, DOI 10.1210/jc.2009-0941; Connolly DJ, 2005, J FELINE MED SURG, V7, P289, DOI 10.1016/j.jfms.2005.01.002; Dal J, 2016, EUR J ENDOCRINOL, V175, P181, DOI 10.1530/EJE-16-0117; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; Dirtu AC, 2013, ENVIRON INT, V57-58, P60, DOI 10.1016/j.envint.2013.04.004; FAZIO S, 1993, EUR HEART J, V14, P26, DOI 10.1093/eurheartj/14.1.26; Fazio S, 1996, INTERNAL J ANGINA, V5, P55; Fazio S, J CLIN ENDOCRINOLOGY, V79, P441; Fieffe S, 2011, EUR J ENDOCRINOL, V164, P877, DOI 10.1530/EJE-10-1050; Fletcher JM, 2016, J VET INTERN MED, V30, P1216, DOI 10.1111/jvim.14360; Fox Philip R, 2003, J Vet Cardiol, V5, P39, DOI 10.1016/S1760-2734(06)70051-0; Fox PR, 2014, CARDIOVASC PATHOL, V23, P28, DOI 10.1016/j.carpath.2013.08.001; Fox PR, 2000, CIRCULATION, V102, P1863; FOX PR, 1995, CIRCULATION, V92, P2645, DOI 10.1161/01.CIR.92.9.2645; Fox PR, 1999, J AM ANIM HOSP ASSOC, V35, P27, DOI 10.5326/15473317-35-1-27; Fracassi F, 2016, J FELINE MED SURG OP; GALDERISI M, 1991, AM J CARDIOL, V68, P85, DOI 10.1016/0002-9149(91)90716-X; Gilbert J, 2003, Pituitary, V6, P11, DOI 10.1023/A:1026273509058; Gostelow R, 2017, J VET INTERN MED, V31, P355, DOI 10.1111/jvim.14662; JACOBS G, 1986, J AM VET MED ASSOC, V188, P52; Jaffrain-Rea ML, 2003, EUR J ENDOCRINOL, V148, P193, DOI 10.1530/eje.0.1480193; Kershaw O, 2012, J COMP PATHOL, V147, P73, DOI 10.1016/j.jcpa.2011.11.196; Keyte SV, 2016, J VET INTERN MED, V30, P973, DOI 10.1111/jvim.14373; Kittleson MD, 1999, CIRCULATION, V99, P3172, DOI 10.1161/01.CIR.99.24.3172; Lamb CR, 2014, J FELINE MED SURG, V16, P99, DOI 10.1177/1098612X13497212; LESSER M, 1992, J SMALL ANIM PRACT, V33, P55, DOI 10.1111/j.1748-5827.1992.tb01072.x; LIE JT, 1980, AM HEART J, V100, P41, DOI 10.1016/0002-8703(80)90277-X; Little CJL, 2008, J SMALL ANIM PRACT, V49, P17, DOI 10.1111/j.1748-5827.2007.00466.x; Liu CY, 2013, J AM COLL CARDIOL, V62, P1280, DOI 10.1016/j.jacc.2013.05.078; Liu S K, 1975, Recent Adv Stud Cardiac Struct Metab, V10, P627; LIU SK, 1984, J AM VET MED ASSOC, V185, P52; Lombardi G, 1996, METABOLISM, V45, P57, DOI 10.1016/S0026-0495(96)90083-9; Lombardi G, 2002, J ENDOCRINOL INVEST, V25, P971, DOI 10.1007/BF03344070; Maron BJ, 2015, J VET CARDIOL, V17, pS6, DOI 10.1016/j.jvc.2015.03.007; Maxie Grant M, 2007, PATHOLOGY DOMESTIC A, V3, P737; MCGUFFIN WL, 1974, ANN INTERN MED, V81, P11, DOI 10.7326/0003-4819-81-1-11; Meij BP, 2010, J FELINE MED SURG, V12, P406, DOI 10.1016/j.jfms.2010.03.014; Menaut P, 2012, J SMALL ANIM PRACT, V53, P673, DOI 10.1111/j.1748-5827.2012.01301.x; Mestron A, 2004, EUR J ENDOCRINOL, V151, P439, DOI 10.1530/eje.0.1510439; MOISE NS, 1986, AM J VET RES, V47, P1476; MOISE NS, 1986, AM J VET RES, V47, P1487; Murarka S, 2010, J CARD FAIL, V16, P971, DOI 10.1016/j.cardfail.2010.07.249; Myers JA, 2014, J VET INTERN MED, V28, P1235, DOI 10.1111/jvim.12386; Niessen SJM, 2007, J VET INTERN MED, V21, P899, DOI 10.1892/0891-6640(2007)21[899:FAAUE]2.0.CO;2; Niessen S, 2010, J FELINE MED SURG, V12, P15, DOI 10.1016/j.jfms.2009.12.003; Niessen SJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127794; Niessen SJM, 2013, VET CLIN N AM-SMALL, V43, P319, DOI 10.1016/j.cvsm.2012.12.004; Nishiki M, 1997, ENDOCR J, V44, P655, DOI 10.1507/endocrj.44.655; Paige CF, 2009, JAVMA-J AM VET MED A, V234, P1398, DOI 10.2460/javma.234.11.1398; Payne JR, 2015, J VET CARDIOL, V17, pS244, DOI 10.1016/j.jvc.2015.03.008; Pereira AM, 2004, J CLIN ENDOCR METAB, V89, P71, DOI 10.1210/jc.2003-030849; Pereira NJ, 2017, VET J, V225, P50, DOI 10.1016/j.tvjl.2017.04.017; PETERSON ME, 1990, J VET INTERN MED, V4, P192, DOI 10.1111/j.1939-1676.1990.tb00897.x; PETERSON ME, 1983, J AM VET MED ASSOC, V183, P103; PIOVESAN A, 1994, HORM METAB RES, V26, P234, DOI 10.1055/s-2007-1001672; Pivonello R, 2007, J CLIN ENDOCR METAB, V92, P476, DOI 10.1210/jc.2006-1587; Posch B, 2011, VET RADIOL ULTRASOUN, V52, P422, DOI 10.1111/j.1740-8261.2011.01821.x; Rosca M, 2014, J FELINE MED SURG, V16, P82, DOI 10.1177/1098612X13496246; Rosol T., 2016, PATHOLOGY DOMESTIC A, P271; Sangster JK, 2014, J VET INTERN MED, V28, P465, DOI 10.1111/jvim.12259; Wagner Tobias, 2010, J Vet Cardiol, V12, P171, DOI 10.1016/j.jvc.2010.05.003; Weichselbaum RC, 2005, VET RADIOL ULTRASOUN, V46, P506, DOI 10.1111/j.1740-8261.2005.00099.x; Wilkie LJ, 2015, J VET CARDIOL, V17, pS329, DOI 10.1016/j.jvc.2015.09.006	73	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194342	10.1371/journal.pone.0194342	http://dx.doi.org/10.1371/journal.pone.0194342			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596445	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000022
J	Dickter, CL; Burk, JA; Fleckenstein, K; Kozikowski, CT				Dickter, Cheryl L.; Burk, Joshua A.; Fleckenstein, Katarina; Kozikowski, C. Teal			Autistic traits and social anxiety predict differential performance on social cognitive tasks in typically developing young adults	PLOS ONE			English	Article							EMOTION RECOGNITION; VISUAL-SEARCH; SPECTRUM; CHILDREN; FACES; PHENOTYPE; GAZE; ADOLESCENTS; IMPAIRMENT; PERCEPTION	The current work examined the unique contribution that autistic traits and social anxiety have on tasks examining attention and emotion processing. In Study 1, 119 typically-developing college students completed a flanker task assessing the control of attention to target faces and away from distracting faces during emotion identification. In Study 2, 208 typically-developing college students performed a visual search task which required identification of whether a series of 8 or 16 emotional faces depicted the same or different emotions. Participants with more self-reported autistic traits performed more slowly on the flanker task in Study 1 than those with fewer autistic traits when stimuli depicted complex emotions. In Study 2, participants higher in social anxiety performed less accurately on trials showing all complex faces; participants with autistic traits showed no differences. These studies suggest that traits related to autism and to social anxiety differentially impact social cognitive processing.	[Dickter, Cheryl L.; Burk, Joshua A.; Fleckenstein, Katarina; Kozikowski, C. Teal] Coll William & Mary, Psychol Sci, Williamsburg, VA 23185 USA; [Kozikowski, C. Teal] Eastern Virginia Med Sch, Psychiat & Behav Sci, Norfolk, VA 23501 USA	William & Mary; Eastern Virginia Medical School	Dickter, CL (corresponding author), Coll William & Mary, Psychol Sci, Williamsburg, VA 23185 USA.	cldickter@wm.edu						Adams RB, 2006, MOTIV EMOTION, V30, P179, DOI 10.1007/s11031-006-9020-2; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Antshel KM, 2011, J DEV BEHAV PEDIATR, V32, P439, DOI 10.1097/DBP.0b013e318222355d; Ashwin C, 2006, SOC NEUROSCI-UK, V1, P349, DOI 10.1080/17470910601040772; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Banos RM, 2008, DEPRESS ANXIETY, V25, P55, DOI 10.1002/da.20269; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P1, DOI DOI 10.1023/A:1005653411471; BARONCOHEN S, 1993, COGNITION EMOTION, V7, P507, DOI 10.1080/02699939308409202; Bayliss AP, 2011, J EXP PSYCHOL HUMAN, V37, P634, DOI 10.1037/a0020559; Bayliss AP, 2005, BRIT J PSYCHOL, V96, P95, DOI 10.1348/000712604X15626; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; Bellini S, 2007, REM SPEC EDUC, V28, P153, DOI 10.1177/07419325070280030401; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Constantino JN, 2006, AM J PSYCHIAT, V163, P294, DOI 10.1176/appi.ajp.163.2.294; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Creed AT, 2008, PERS INDIV DIF, V25, P19; Dichter GS, 2007, NEUROIMAGE, V35, P1219, DOI 10.1016/j.neuroimage.2006.12.038; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fiske AP, 1996, CURR DIR PSYCHOL SCI, V5, P143, DOI 10.1111/1467-8721.ep11512349; Frith U., 1994, SOCIAL DEVELOP, V2, P108, DOI [DOI 10.1111/J.1467-9507.1994.TB00031.X, 10.1111/j.1467-9507.1994.tb00031.x]; Gross TF, 2004, J ABNORM CHILD PSYCH, V32, P469, DOI 10.1023/B:JACP.0000037777.17698.01; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; HOBSON RP, 1986, J CHILD PSYCHOL PSYC, V27, P321, DOI 10.1111/j.1469-7610.1986.tb01836.x; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Horlin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106552; Humphreys K, 2007, NEUROPSYCHOLOGIA, V45, P685, DOI 10.1016/j.neuropsychologia.2006.08.003; Jobe LE, 2007, PERS INDIV DIFFER, V42, P1479, DOI 10.1016/j.paid.2006.10.021; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; KASARI C, 1993, J CHILD PSYCHOL PSYC, V34, P353, DOI 10.1111/j.1469-7610.1993.tb00997.x; Keehn B, 2013, NEUROSCI BIOBEHAV R, V37, P164, DOI 10.1016/j.neubiorev.2012.11.014; Kemner C, 2008, J AUTISM DEV DISORD, V38, P553, DOI 10.1007/s10803-007-0406-0; Koegel R, 2013, J AUTISM DEV DISORD, V43, P2121, DOI 10.1007/s10803-013-1765-3; Krysko KM, 2009, BRAIN COGNITION, V69, P472, DOI 10.1016/j.bandc.2008.10.002; Kunihira Y, 2006, J AUTISM DEV DISORD, V36, P553, DOI 10.1007/s10803-006-0094-1; Kuusikko S, 2008, J AUTISM DEV DISORD, V38, P1697, DOI 10.1007/s10803-008-0555-9; Lacroix A, 2009, RES DEV DISABIL, V30, P976, DOI 10.1016/j.ridd.2009.02.002; LeSure-Lester G.E., 2001, COLL STUD J, V35, P317, DOI DOI 10.1089/CYBER.2019.0561; Lorenz T, 2016, PLOS ONE, V11; Loveland KA, 1997, DEV PSYCHOPATHOL, V9, P579, DOI 10.1017/S0954579497001351; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Miu AC, 2012, PSYCHIAT RES, V198, P489, DOI 10.1016/j.psychres.2012.01.024; Muth A, 2014, J AUTISM DEV DISORD, V44, P3245, DOI 10.1007/s10803-014-2188-5; Nummenmaa L, 2012, NEUROIMAGE, V59, P3356, DOI 10.1016/j.neuroimage.2011.10.075; O'Riordan M, 2001, Q J EXP PSYCHOL-A, V54, P961, DOI 10.1080/02724980042000543; O'Riordan MA, 2004, AUTISM, V8, P229, DOI 10.1177/1362361304045219; O'Toole MS, 2013, J ANXIETY DISORD, V27, P98, DOI 10.1016/j.janxdis.2012.09.005; OZONOFF S, 1990, J CHILD PSYCHOL PSYC, V31, P343, DOI 10.1111/j.1469-7610.1990.tb01574.x; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Richey JA, 2014, SOC COGN AFFECT NEUR, V9, P367, DOI 10.1093/scan/nss146; Roberson-Nay R, 2007, PSYCHOL ASSESSMENT, V19, P133, DOI 10.1037/1040-3590.19.1.133; Rump KM, 2009, CHILD DEV, V80, P1434, DOI 10.1111/j.1467-8624.2009.01343.x; Russell-Smith SN, 2013, J AUTISM DEV DISORD, V43, P695, DOI 10.1007/s10803-012-1614-9; Sasson NJ, 2013, AUTISM, V17, P655, DOI 10.1177/1362361312455704; Schry AR, 2012, PSYCHOL ASSESSMENT, V24, P846, DOI 10.1037/a0027398; Staugaard SR, 2010, CLIN PSYCHOL REV, V30, P669, DOI 10.1016/j.cpr.2010.05.001; Stewart ME, 2009, PERS INDIV DIFFER, V47, P224, DOI 10.1016/j.paid.2009.03.004; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; TANTAM D, 1989, J CHILD PSYCHOL PSYC, V30, P623, DOI 10.1111/j.1469-7610.1989.tb00274.x; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Uljarevic M, 2013, J AUTISM DEV DISORD, V43, P1517, DOI 10.1007/s10803-012-1695-5; Wainer AL, 2011, J PSYCHOPATHOL BEHAV, V33, P459, DOI 10.1007/s10862-011-9259-0; Webb SJ, 2012, SOC COGN AFFECT NEUR, V7, P578, DOI 10.1093/scan/nsp002; Wei X, 2013, J AUTISM DEV DISORD, V43, P1539, DOI 10.1007/s10803-012-1700-z; White SW, 2012, J AUTISM DEV DISORD, V42, P1138, DOI 10.1007/s10803-011-1353-3	71	13	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195239	10.1371/journal.pone.0195239	http://dx.doi.org/10.1371/journal.pone.0195239			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596523	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000098
J	Micha, R; Karageorgou, D; Bakogianni, I; Trichia, E; Whitsel, LP; Story, M; Penalvo, JL; Mozaffarian, D				Micha, Renata; Karageorgou, Dimitra; Bakogianni, Ioanna; Trichia, Eirini; Whitsel, Laurie P.; Story, Mary; Penalvo, Jose L.; Mozaffarian, Dariush			Effectiveness of school food environment policies on children's dietary behaviors: A systematic review and meta-analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; SUGAR-SWEETENED BEVERAGES; OBESITY PREVENTION; VEGETABLE CONSUMPTION; PHYSICAL-ACTIVITY; COMPETITIVE FOOD; NUTRIENT CONTENT; FRESH FRUIT; CHILDHOOD OBESITY; LUNCH PROGRAM	Background School food environment policies may be a critical tool to promote healthy diets in children, yet their effectiveness remains unclear. Objective To systematically review and quantify the impact of school food environment policies on dietary habits, adiposity, and metabolic risk in children. Methods We systematically searched online databases for randomized or quasi-experimental interventions assessing effects of school food environment policies on children's dietary habits, adiposity, or metabolic risk factors. Data were extracted independently and in duplicate, and pooled using inverse-variance random-effects meta-analysis. Habitual (within+outside school) dietary intakes were the primary outcome. Heterogeneity was explored using meta-regression and subgroup analysis. Funnel plots, Begg's and Egger's test evaluated potential publication bias. Results From 6,636 abstracts, 91 interventions (55 in US/Canada, 36 in Europe/New Zealand) were included, on direct provision of healthful foods/beverages (N = 39 studies), competitive food/beverage standards (N = 29), and school meal standards (N = 39) (some interventions assessed multiple policies). Direct provision policies, which largely targeted fruits and vegetables, increased consumption of fruits by 0.27 servings/d (n = 15 estimates (95% CI: 0.17, 0.36)) and combined fruits and vegetables by 0.28 servings/d (n = 16 (0.17, 0.40)); with a slight impact on vegetables (n = 11; 0.04 (0.01, 0.08)), and no effects on total calories (n = 6; -56 kcal/d (-174, 62)). In interventions targeting water, habitual intake was unchanged (n = 3; 0.33 glasses/d (-0.27, 0.93)). Competitive food/beverage standards reduced sugarsweetened beverage intake by 0.18 servings/d (n = 3 (-0.31, -0.05)); and unhealthy snacks by 0.17 servings/d (n = 2 (-0.22, -0.13)), without effects on total calories (n = 5; -79 kcal/d (-179, 21)). School meal standards (mainly lunch) increased fruit intake (n = 2; 0.76 servings/d (0.37, 1.16)) and reduced total fat (-1.49% energy; n = 6 (-2.42, -0.57)), saturated fat (n = 4; -0.93% energy (-1.15, -0.70)) and sodium (n = 4; -170 mg/d (-242, -98)); but not total calories (n = 8; -38 kcal/d (-137, 62)). In 17 studies evaluating adiposity, significant decreases were generally not identified; few studies assessed metabolic factors (blood lipids/glucose/pressure), with mixed findings. Significant sources of heterogeneity or publication bias were not identified. Conclusions Specific school food environment policies can improve targeted dietary behaviors; effects on adiposity and metabolic risk require further investigation. These findings inform ongoing policy discussions and debates on best practices to improve childhood dietary habits and health.	[Micha, Renata; Penalvo, Jose L.; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Karageorgou, Dimitra; Bakogianni, Ioanna; Trichia, Eirini] Agr Univ Athens, Dept Food Sci & Human Nutr, Athens, Greece; [Whitsel, Laurie P.] Amer Heart Assoc, Policy Res, Dallas, TX USA; [Story, Mary] Duke Univ, Global Hlth Inst, Durham, NC USA; [Story, Mary] Duke Univ, Community & Family Med, Durham, NC USA	Tufts University; Agricultural University of Athens; Duke University; Duke University	Micha, R (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	renata.micha@tufts.edu	Penalvo, Jose L./AAA-9210-2020; Mozaffarian, Dariush/ABC-2822-2020	Penalvo, Jose L./0000-0003-0096-6238; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115189] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amin SA, 2015, PUBLIC HEALTH REP, V130, P453, DOI 10.1177/003335491513000508; Anderson AS, 2005, PUBLIC HEALTH NUTR, V8, P650, DOI 10.1079/PHN2004721; Anderson LM, 2013, J SCH NURS, V29, P52, DOI 10.1177/1059840512453602; [Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19430; Ashfield-Watt PA, 2009, PILOT STUDY EFFECT P; Ask AS, 2010, PUBLIC HEALTH NUTR, V13, P238, DOI 10.1017/S1368980009990772; Bae Sang Geun, 2012, J Prev Med Public Health, V45, P47, DOI 10.3961/jpmph.2012.45.1.47; Baranowski T, 2010, NEW ENGL J MED, V363, P443, DOI 10.1056/NEJMoa1001933; Bartholomew JB, 2006, J AM DIET ASSOC, V106, P248, DOI 10.1016/j.jada.2005.10.030; Bartlett SOL., 2013, EVALUATION FRESH FRU; Bauhoff S, 2013, EC HUMAN BIOL; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bere E, 2005, PREV MED, V41, P463, DOI 10.1016/j.ypmed.2004.11.024; Bere E, 2006, FREE SCH FRUIT SUSTA, P268; Bere E, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-5; Bere E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0301-6; Bere E, 2010, BRIT J NUTR, V104, P589, DOI 10.1017/S0007114510000814; Bergman EA, 2014, J CHILD NUTR MANAG, V38; Birch LL, 1998, P NUTR SOC, V57, P617, DOI 10.1079/PNS19980090; Blum JEW, 2008, J NUTR EDUC BEHAV, V40, P341, DOI 10.1016/j.jneb.2007.12.004; Bogart LM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2493; Bonsergent E, 2013, AM J PREV MED, V44, P30, DOI 10.1016/j.amepre.2012.09.055; Burgess-Champoux TL, 2008, PUBLIC HEALTH NUTR, V11, P849, DOI 10.1017/S1368980007001346; Chriqui JF, 2014, JAMA PEDIATR, V168, P279, DOI 10.1001/jamapediatrics.2013.4457; Cohen JFW, 2014, AM J PREV MED, V46, P388, DOI 10.1016/j.amepre.2013.11.013; Cohen JFW, 2014, J ACAD NUTR DIET, V114, P48, DOI 10.1016/j.jand.2013.08.014; Cohen JFW, 2012, J ACAD NUTR DIET, V112, P927, DOI 10.1016/j.jand.2012.01.015; Coleman KJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-80; Coyle KK, 2009, PUBLIC HEALTH REP, V124, P660, DOI 10.1177/003335490912400508; Cradock AL, 2011, PREV CHRONIC DIS, V8; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Cullen KW, 2015, J ACAD NUTR DIET, V115, P743, DOI 10.1016/j.jand.2014.10.021; Cullen KW, 2008, AM J PUBLIC HEALTH, V98, P111, DOI 10.2105/AJPH.2007.111765; Cummings PL, 2014, PREV MED, V67, pS21, DOI 10.1016/j.ypmed.2014.03.004; Davis EM, 2009, J AM DIET ASSOC, V109, P1227, DOI 10.1016/j.jada.2009.04.017; de Sa J, 2008, EUR J PUBLIC HEALTH, V18, P558, DOI 10.1093/eurpub/ckn061; Delgado-Noguera M, 2011, PREV MED, V53, P3, DOI 10.1016/j.ypmed.2011.04.016; Driessen CE, 2014, OBES REV, V15, P968, DOI 10.1111/obr.12224; Dwyer J, 1996, IMPACT MODIFYING S S, V20, P21; Dwyer JT, 1996, PREV MED, V25, P413, DOI 10.1006/pmed.1996.0073; Eagle TF, 2013, AM J MED, V126, P903, DOI 10.1016/j.amjmed.2013.04.019; Elbel B, 2015, AM J PUBLIC HEALTH, V105, P365, DOI 10.2105/AJPH.2014.302221; Eriksen K, 2003, PUBLIC HEALTH NUTR, V6, P57, DOI 10.1079/PHN2002356; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; Fiske A, 2004, J AM DIET ASSOC, V104, P90, DOI 10.1016/j.jada.2003.10.011; Fogarty AW, 2007, INT J EPIDEMIOL, V36, P1080, DOI 10.1093/ije/dym133; Folta SC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-157; Foster GD, 2008, PEDIATRICS, V121, pE794, DOI 10.1542/peds.2007-1365; French SA, 2004, AM J PUBLIC HEALTH, V94, P1507, DOI 10.2105/AJPH.94.9.1507; Fung C, 2013, PREVENTIVE MED; Ganann Rebecca, 2014, BMC Res Notes, V7, P422, DOI 10.1186/1756-0500-7-422; Gartlehner G, 2008, METHODS GUIDE EFFECT; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Haroun D, 2011, PUBLIC HEALTH NUTR, V14, P209, DOI 10.1017/S1368980010002132; He MZ, 2009, PUBLIC HEALTH NUTR, V12, P2199, DOI 10.1017/S1368980009005801; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hollar Danielle, 2010, J Health Care Poor Underserved, V21, P93, DOI 10.1353/hpu.0.0304; Hoppu U, 2010, PUBLIC HEALTH NUTR, V13, P973, DOI 10.1017/S1368980010001163; Howerton MW, 2007, J NUTR EDUC BEHAV, V39, P186, DOI 10.1016/j.jneb.2007.01.010; Huehnergarth NF, 2016, FORBES; Jensen C. D., 2012, ICAN: Infant, Child & Adolescent Nutrition, V4, P276, DOI 10.1177/1941406412458314; Johnson DB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2015.3918; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Kaufman F., 2011, Childhood Obesity, V7, P291; Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x; Kim K, 2012, NUTR RES PRACT, V6, P138, DOI 10.4162/nrp.2012.6.2.138; Kocken PL, 2015, PUBLIC HEALTH NUTR, V18, P1545, DOI 10.1017/S1368980014002985; Kocken PL, 2012, J SCHOOL HEALTH, V82, P115, DOI 10.1111/j.1746-1561.2011.00674.x; Levy DT, 2011, ADV NUTR, V2, p182S, DOI 10.3945/an.111.000356; Loughridge JL, 2005, J HUM NUTR DIET, V18, P281, DOI 10.1111/j.1365-277X.2005.00622.x; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; Lytle LA, 2004, HEALTH EDUC BEHAV, V31, P270, DOI 10.1177/1090198103260635; Marcus C, 2009, INT J OBESITY, V33, P408, DOI 10.1038/ijo.2009.38; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Mobley CC, 2012, J SCHOOL HEALTH, V82, P82, DOI 10.1111/j.1746-1561.2011.00670.x; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moore L, 2008, J EPIDEMIOL COMMUN H, V62, P926, DOI 10.1136/jech.2007.070953; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Muckelbauer R, 2009, PEDIATRICS, V123, pE661, DOI 10.1542/peds.2008-2186; Mullally ML, 2010, CAN J PUBLIC HEALTH, V101, P40, DOI 10.1007/BF03405560; Murphy S, 2011, PUBLIC HEALTH NUTR, V14, P219, DOI 10.1017/S1368980010001886; Nelson M, 2011, NUTR BULL, V36, P381, DOI 10.1111/j.1467-3010.2011.01914.x; Nixon CA, 2012, OBES REV, V13, P106, DOI 10.1111/j.1467-789X.2011.00962.x; Olsho LEW, 2015, J ACAD NUTR DIET, V115, P1283, DOI 10.1016/j.jand.2014.12.026; Osganian SK, 2003, HEALTH EDUC BEHAV, V30, P418, DOI 10.1177/1090198103253509; Palakshappa D, 2016, PREV MED, V90, P107, DOI 10.1016/j.ypmed.2016.06.039; Perry CL, 2004, HEALTH EDUC BEHAV, V31, P65, DOI 10.1177/1090198103255530; Rahmani K, 2011, J RES MED SCI, V16, P469; Ransley JK, 2007, J EPIDEMIOL COMMUN H, V61, P699, DOI 10.1136/jech.2006.052696; Reinaerts E, 2008, HEALTH EDUC RES, V23, P987, DOI 10.1093/her/cyn027; Sanchez-Vaznaugh EV, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.0781; Sanchez-Vaznaugh EV, 2010, HEALTH AFFAIR, V29, P436, DOI 10.1377/hlthaff.2009.0745; Schwartz AE, 2016, JAMA PEDIATR, V170, P220, DOI 10.1001/jamapediatrics.2015.3778; Schwartz MB, 2015, CHILD OBES, V11, P242, DOI 10.1089/chi.2015.0019; Schwartz MB, 2009, HEALTH EDUC BEHAV, V36, P999, DOI 10.1177/1090198108329998; Simmonds M, 2016, OBES REV, V17, P95, DOI 10.1111/obr.12334; SIMONSMORTON BG, 1991, AM J PUBLIC HEALTH, V81, P986, DOI 10.2105/AJPH.81.8.986; Slusser WM, 2007, PUBLIC HEALTH NUTR, V10, P1490, DOI 10.1017/S1368980007000444; SNYDER MP, 1992, J AM DIET ASSOC, V92, P1087; Sobol-Goldberg S, 2013, OBESITY, V21, P2422, DOI 10.1002/oby.20515; Spence S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112648; Spence S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0128-6; Spence S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078298; Story M, 2003, PREV MED, V37, pS35, DOI 10.1016/j.ypmed.2003.08.009; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Taber DR, 2012, PEDIATRICS, V130, P437, DOI 10.1542/peds.2011-3353; Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P452, DOI 10.1001/archpediatrics.2011.1839; Tak NI, 2009, PUBLIC HEALTH NUTR, V12, P1213, DOI 10.1017/S1368980008003777; te Velde SJ, 2008, BRIT J NUTR, V99, P893, DOI 10.1017/S000711450782513X; U. S. Department of Agriculture Food and Nutrition Service, SCH MEALS HLTH HUNG; U. S. Department of Agriculture Food and Nutrition Service, NUTR STAND SCH MEALS; U. S. Department of Agriculture Food and Nutrition Service, FRESH FRUIT VEG PROG; U. S. Department of Agriculture Food and Nutrition Service, HLTH SCH DAY TOOLS S; Van Cauwenberghe E, 2010, BRIT J NUTR, V103, P781, DOI 10.1017/S0007114509993370; van de Gaar VMV, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0098-8; Vargas-Garcia EJ, 2017, OBES REV, V18, P1350, DOI 10.1111/obr.12580; Visscher TLS, 2010, OBESITY FACTS, V3, P109, DOI 10.1159/000300848; Wang Y., 2013, CHILDHOOD OBESITY PR; Welker E, 2016, CURR OBES REP, V5, P145, DOI 10.1007/s13679-016-0204-0; WHITAKER RC, 1993, PEDIATRICS, V91, P1107; Williams CL, 2002, J AM COLL NUTR, V21, P62, DOI 10.1080/07315724.2002.10719195; Williamson DA, 2007, OBESITY, V15, P906, DOI 10.1038/oby.2007.597; Williamson DA, 2012, OBESITY, V20, P1653, DOI 10.1038/oby.2012.60; Woodward-Lopez G, 2010, AM J PUBLIC HEALTH, V100, P2137, DOI 10.2105/AJPH.2010.193490; Wordell D, 2012, J ACAD NUTR DIET, V112, P137, DOI 10.1016/j.jada.2011.09.008	125	194	200	9	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194555	10.1371/journal.pone.0194555	http://dx.doi.org/10.1371/journal.pone.0194555			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596440	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000029
J	Sun, YJ; Rajput, IR; Ying, H; Fei, Y; Sanganyado, E; Ping, L; Wang, JZ; Liu, WH				Sun Yajing; Rajput, Imran Rashid; Ying, Huang; Fei, Yu; Sanganyado, Edmond; Ping, Li; Wang Jingzhen; Liu Wenhua			Establishment and characterization of pygmy killer whale (Feresa attenuata) dermal fibroblast cell line	PLOS ONE			English	Article							MOUSE FIBROBLASTS; TUMOR-ANTIGEN; TRANSFORMATION; SKIN; CONSERVATION; GENERATION; NEURONS	The pygmy killer whale (Feresa attenuata) (PKW) is a tropical and subtropical marine mammal commonly found in the Atlantic, Indian and Pacific oceans. Since the PKWs live in offshore protected territories, they are rarely seen onshore. Hence, PKW are one of the most poorly understood oceanic species of odontocetes. The dermal tissue comes primarily from stranding events that occur along the coast of the Shantou, Guangdong, China. The sampled tissues were immediately processed and attached on collagen-coated 6-well tissue culture plate. The complete medium (DMEM and Ham's F12, fetal bovine serum, antibiotic and essential amino acids) was added to the culture plates. The primary culture (PKW-LWH) cells were verified as fibroblast by vimentin and karyotype analyses, which revealed 42 autosomes and two sex chromosomes X and Y. Following transfection of PKW-LWH cells with a plasmid encoding, the SV40 large T-antigens and the transfected cells were isolated and expanded. Using RT-PCR, western blot, immunofluorescence analysis and SV40 large T-antigen stability was confirmed. The cell proliferation rate of the fibroblast cells, PKW-LWHT was faster than the primary cells PKW-LWH with the doubling time 68.9h and 14.4h, respectively. In this study, we established PKW dermal fibroblast cell line for the first time, providing a unique opportunity for in vitro studies on the effects of environmental pollutants and pathogens that could be determined in PKW and/or Cetaceans.	[Sun Yajing; Rajput, Imran Rashid; Ying, Huang; Fei, Yu; Sanganyado, Edmond; Ping, Li; Liu Wenhua] Shantou Univ, Marine Biol Inst, Coll Sci, Shantou, Guangdong, Peoples R China; [Rajput, Imran Rashid] Lasbela Univ Agr Water & Marine Sci, Fac Vet & Anim Sci, Uthal, Balochistan, Pakistan; [Wang Jingzhen] Qinzhou Univ, Ocean Coll, Qinzhou, Guangxi, Peoples R China	Shantou University; Lasbela University of Agricultural Water & Marine Science; Beibu Gulf University	Rajput, IR; Liu, WH (corresponding author), Shantou Univ, Marine Biol Inst, Coll Sci, Shantou, Guangdong, Peoples R China.; Rajput, IR (corresponding author), Lasbela Univ Agr Water & Marine Sci, Fac Vet & Anim Sci, Uthal, Balochistan, Pakistan.	drimranrajput@gmail.com; whliu@stu.edu.cn	Sanganyado, Edmond/B-8542-2013; Wang, Jingzhen/F-7816-2018	Sanganyado, Edmond/0000-0001-6244-3059; Wang, Jingzhen/0000-0002-1293-8368; RASHID, IMRAN/0000-0002-3172-4541; Sun, Yajing/0000-0002-7650-2205				Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1; Baird RW, 2011, MARINE MAMMAL SCI, V27; Burkard M, 2015, AQUAT TOXICOL, V167, P240, DOI 10.1016/j.aquatox.2015.08.005; Chen W, 2003, HISTOL HISTOPATHOL, V18, P541, DOI 10.14670/HH-18.541; Donahue MA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P938; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Heinzelmann L, 2009, J HERED, V100, P119, DOI 10.1093/jhered/esn064; Holt WV, 1999, REV REPROD, V4, P143, DOI 10.1530/revreprod/4.3.143; Huang SL, 2012, BIOL CONSERV, V147, P234, DOI 10.1016/j.biocon.2012.01.004; IUCN-UNEP-WWF, 1980, WORLD CONS STRAT LIV; Jin W, 2013, IN VITRO CELL DEV-AN, V49, P449, DOI 10.1007/s11626-013-9611-7; Leon-Quinto T, 2009, ANIM REPROD SCI, V112, P347, DOI 10.1016/j.anireprosci.2008.05.070; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; McSweeney DJ, 2009, MAR MAMMAL SCI, V25, P557, DOI 10.1111/j.1748-7692.2008.00267.x; Pennarossa G, 2014, STEM CELL REV REP, V10, P31, DOI 10.1007/s12015-013-9477-9; Pine M, 2004, AQUAT TOXICOL, V67, P195, DOI 10.1016/j.aquatox.2004.01.003; RICHARDS RG, 1995, BIOL REPROD, V52, P609, DOI 10.1095/biolreprod52.3.609; Rundell K, 2001, SEMIN CANCER BIOL, V11, P5, DOI 10.1006/scbi.2000.0341; Sakai D, 2004, SPINE, V29, P1515, DOI 10.1097/01.BRS.0000131419.25265.23; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Stacey GN, 2008, NAT PROTOC, V3, P1981, DOI 10.1038/nprot.2008.190; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Wade P.R., 1993, REPORTS INT WHALING, V43, P477; Wang JZ, 2011, IN VITRO CELL DEV-AN, V47, P618, DOI 10.1007/s11626-011-9448-x; Wang YX, 2017, STEM CELL REP, V8, P1587, DOI 10.1016/j.stemcr.2017.04.018; Wang YH, 2016, EXP CELL RES, V347, P283, DOI 10.1016/j.yexcr.2016.07.026; Whitworth DJ, 2012, STEM CELLS DEV, V21, P2288, DOI 10.1089/scd.2011.0608; Yi MS, 2010, NAT PROTOC, V5, P1418, DOI 10.1038/nprot.2010.104; Yu J, 2005, ANAT REC PART A, V287A, P1246, DOI 10.1002/ar.a.20266	30	15	16	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195128	10.1371/journal.pone.0195128	http://dx.doi.org/10.1371/journal.pone.0195128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596530	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000428630000081
J	Pasqualini, FS; Agarwal, A; O'Connor, BB; Liu, QH; Sheehy, SP; Parker, KK				Pasqualini, Francesco Silvio; Agarwal, Ashutosh; O'Connor, Blakely Bussie; Liu, Qihan; Sheehy, Sean P.; Parker, Kevin Kit			Traction force microscopy of engineered cardiac tissues	PLOS ONE			English	Article							ON-A-CHIP; STEM-CELL; EXTRACELLULAR-MATRIX; HEART; CARDIOMYOCYTES; ELASTICITY; HYDROGELS; STIFFNESS; FIBROSIS; DEVICES	Cardiac tissue development and pathology have been shown to depend sensitively on microenvironmental mechanical factors, such as extracellular matrix stiffness, in both in vivo and in vitro systems. We present a novel quantitative approach to assess cardiac structure and function by extending the classical traction force microscopy technique to tissue-level preparations. Using this system, we investigated the relationship between contractile proficiency and metabolism in neonate rat ventricular myocytes (NRVM) cultured on gels with stiffness mimicking soft immature (1 kPa), normal healthy (13 kPa), and stiff diseased (90 kPa) cardiac microenvironments. We found that tissues engineered on the softest gels generated the least amount of stress and had the smallest work output. Conversely, cardiomyocytes in tissues engineered on healthy- and disease-mimicking gels generated significantly higher stresses, with the maximal contractile work measured in NRVM engineered on gels of normal stiffness. Interestingly, although tissues on soft gels exhibited poor stress generation and work production, their basal metabolic respiration rate was significantly more elevated than in other groups, suggesting a highly ineffective coupling between energy production and contractile work output. Our novel platform can thus be utilized to quantitatively assess the mechanotransduction pathways that initiate tissue-level structural and functional remodeling in response to substrate stiffness.	[Pasqualini, Francesco Silvio; Agarwal, Ashutosh; O'Connor, Blakely Bussie; Liu, Qihan; Sheehy, Sean P.; Parker, Kevin Kit] Harvard Univ, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA; [Pasqualini, Francesco Silvio; Agarwal, Ashutosh; O'Connor, Blakely Bussie; Liu, Qihan; Sheehy, Sean P.; Parker, Kevin Kit] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Agarwal, Ashutosh] Univ Miami, Dept Biomed Engn, Miami, FL USA; [Agarwal, Ashutosh] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Agarwal, Ashutosh] Dr John T Macdonald Fdn, Biomed Nanotechnol Inst, Miami, FL USA	Harvard University; Harvard University; University of Miami; University of Miami	Parker, KK (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA.; Parker, KK (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	kkparker@seas.harvard.edu	Pasqualini, Francesco/AAQ-5928-2021; Liu, Qihan/F-9044-2010; Liu, Qihan/AAY-5040-2020	Pasqualini, Francesco/0000-0001-7038-3121; Liu, Qihan/0000-0002-0907-4773; Parker, Kevin Kit/0000-0002-5968-7535; O'Connor, Blakely/0000-0003-0636-9514	NIH NCATS UH2 award [TR000522]; NIH NCATS UH3 award [TR000522]; DARPA [BM-11-73]; NSF Materials Research Science and Engineering Center (MRSEC) [DMR-1420570]; NSF [ECS-0335765]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000522] Funding Source: NIH RePORTER	NIH NCATS UH2 award; NIH NCATS UH3 award; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors also acknowledge support from NIH NCATS UH2 and UH3 awards TR000522 "Human Cardiopulmonary System On-a-Chip" to KKP, DARPA BM-11-73 "Human Microphysiological Systems Program" to KKP, and NSF Materials Research Science and Engineering Center (MRSEC) grant DMR-1420570. This work was partially performed at the Harvard University Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by NSF award ECS-0335765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Prof. Megan McCain for valuable discussions and would like to thank Michael Rosnach for the figure illustrations. The authors also acknowledge support from NIH NCATS UH2 and UH3 awards TR000522 "Human Cardiopulmonary System-On-a-Chip," DARPA BAA-11- 73 "Human Microphysiological Systems Program," and NSF Materials Research Science and Engineering Center (MRSEC) grant DMR-1420570. Parts of this work were performed at the Harvard University Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by NSF award ECS-0335765. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2015, INTEGR BIOL-UK, V7, P383, DOI 10.1039/c4ib00292j; Agarwal A, 2013, LAB CHIP, V13, P3599, DOI 10.1039/c3lc50350j; Annoni G, 1998, MECH AGEING DEV, V101, P57, DOI 10.1016/S0047-6374(97)00165-6; Aratyn-Schaus Y, 2016, J CELL BIOL, V212, P389, DOI 10.1083/jcb.201508026; Ariyasinghe NR, 2017, INTEGR BIOL-UK, V9, P730, DOI 10.1039/c7ib00081b; Baillargeon B, 2014, EUR J MECH A-SOLID, V48, P38, DOI 10.1016/j.euromechsol.2014.04.001; Banerjee S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.108101; Broeckel U, 2016, CELL STEM CELL, V19, P282, DOI 10.1016/j.stem.2016.08.016; Chabiniok R, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0083; Chaudhuri O, 2017, BIOMATER SCI-UK, V5, P1480, DOI 10.1039/c7bm00261k; Dabiri GA, 1997, P NATL ACAD SCI USA, V94, P9493, DOI 10.1073/pnas.94.17.9493; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Genet M, 2016, ANN BIOMED ENG, V44, P112, DOI 10.1007/s10439-015-1351-2; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Grosberg A, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/2/026003; Grosberg A, 2009, J THEOR BIOL, V257, P359, DOI 10.1016/j.jtbi.2008.11.022; Grosberg A, 2009, MED BIOL ENG COMPUT, V47, P301, DOI 10.1007/s11517-008-0431-y; Han SJ, 2015, NAT METHODS, V12, P653, DOI [10.1038/NMETH.3430, 10.1038/nmeth.3430]; Hazeltine Laurie B, 2012, Int J Cell Biol, V2012, P508294, DOI 10.1155/2012/508294; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Jacot JG, 2010, ANN NY ACAD SCI, V1188, P121, DOI 10.1111/j.1749-6632.2009.05091.x; Lee LC, 2015, BIOMECH MODEL MECHAN, V14, P217, DOI 10.1007/s10237-014-0598-0; Lind JU, 2017, NAT MATER, V16, P303, DOI [10.1038/NMAT4782, 10.1038/nmat4782]; Lyra-Leite DM, 2017, AM J PHYSIOL-HEART C, V313, pH757, DOI 10.1152/ajpheart.00290.2017; Maass C, 2017, INTEGR BIOL-UK, V9, P290, DOI 10.1039/c6ib00243a; McCain ML, 2014, AM J PHYSIOL-HEART C, V306, pH1525, DOI 10.1152/ajpheart.00799.2013; McCain ML, 2014, BIOMATERIALS, V35, P5462, DOI 10.1016/j.biomaterials.2014.03.052; McCain ML, 2013, P NATL ACAD SCI USA, V110, P9770, DOI 10.1073/pnas.1304913110; McCain ML, 2012, P NATL ACAD SCI USA, V109, P9881, DOI 10.1073/pnas.1203007109; Merkel R, 2007, BIOPHYS J, V93, P3314, DOI 10.1529/biophysj.107.111328; Mertz AF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198101; Nam S, 2016, P NATL ACAD SCI USA, V113, P5492, DOI 10.1073/pnas.1523906113; Park SJ, 2016, SCIENCE, V353, P158, DOI 10.1126/science.aaf4292; Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114; Pasqualini FS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4081638; Pasqualini FS, 2015, STEM CELL REP, V4, P340, DOI 10.1016/j.stemcr.2015.01.020; Ribeiro AJS, 2016, METHODS, V94, P51, DOI 10.1016/j.ymeth.2015.08.005; Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112; Schoen I, 2010, NANO LETT, V10, P1823, DOI 10.1021/nl100533c; Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003; Sheehy SP, 2014, STEM CELL REP, V2, P282, DOI 10.1016/j.stemcr.2014.01.015; Sheehy SP, 2017, EXPT BIOL MED; Smith NP, 2005, PROG BIOPHYS MOL BIO, V88, P1, DOI 10.1016/j.pbiomolbio.2003.11.014; Stokes CL, 2015, CPT-PHARMACOMET SYST, V4, P559, DOI 10.1002/psp4.12042; Tang X, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003631; Tiburcy M, 2017, CIRCULATION; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; VILLARI B, 1993, J AM COLL CARDIOL, V22, P1477, DOI 10.1016/0735-1097(93)90560-N; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	52	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194706	10.1371/journal.pone.0194706	http://dx.doi.org/10.1371/journal.pone.0194706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590169	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100071
J	Peressotti, F; Scaltritti, M; Miozzo, M				Peressotti, Francesca; Scaltritti, Michele; Miozzo, Michele			Can sign language make you better at hand processing?	PLOS ONE			English	Article							SIMON; ATTENTION; GAZE; DEAF	The languages developed by deaf communities are unique for using visual signs produced by the hand. In the present study, we explored the cognitive effects of employing the hand as articulator. We focused on the arbitrariness of the form-meaning relationship a fundamental feature of natural languages and asked whether sign languages change the processing of arbitrary non-linguistic stimulus-response (S-R) associations involving the hand. This was tested using the Simon effect, which specifically requires such type of associations. Differences between signers and speakers (non-signers) only appeared in the Simon task when hand stimuli were shown. Response-time analyses revealed that the distinctiveness of signers' responses derived from an increased ability to process memory traces of arbitrary S-R pairs related to the hand. These results shed light on the interplay between language and cognition as well as on the effects of sign language acquisition.	[Peressotti, Francesca] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy; [Scaltritti, Michele] Univ Trento, Dipartimento Psicol & Sci Cognit, Rovereto, Italy; [Miozzo, Michele] New Sch Social Res, Dept Psychol, New York, NY 10011 USA	University of Padua; University of Trento; The New School	Peressotti, F (corresponding author), Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy.	francesca.peressani@unipd.it	Peressotti, Francesca/AAB-7795-2022	Peressotti, Francesca/0000-0002-2425-9231	University of Padua [CPDA143734/14]	University of Padua	This research was supported by a grant from the University of Padua (CPDA143734/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the personnel of the Istituto Magarotto, and particularly to Arianna Caccaro, for having facilitated the testing of the deaf participants. We also want to acknowledge the help of Anna Cacciavillani with data collection, and the comments received by Victoria Shuster and Carlo Umilta. This research was supported by a grant from the University of Padua (CPDA143734/14).	Ansorge U, 2003, VIS COGN, V10, P363, DOI 10.1080/13506280244000122; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bettger J, 1997, J Deaf Stud Deaf Educ, V2, P223; Dalmaso M, 2013, NEUROPSYCHOLOGY, V27, P608, DOI 10.1037/a0033518; De Saussure F., 2011, COURSE GEN LINGUISTI; Dye MWG, 2016, EXP BRAIN RES, V234, P1067, DOI 10.1007/s00221-015-4530-3; EMMOREY K, 1993, COGNITION, V46, P139, DOI 10.1016/0010-0277(93)90017-P; Fox J., 2019, R COMPANION APPL REG; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; MacSweeney M, 2004, NEUROIMAGE, V22, P1605, DOI 10.1016/j.neuroimage.2004.03.015; Masaki H, 2000, PSYCHOPHYSIOLOGY, V37, P464, DOI 10.1017/S0048577200981976; Masson MEJ, 2013, J EXP PSYCHOL LEARN, V39, P898, DOI 10.1037/a0029180; Miozzo M, 2016, COGNITION, V154, P69, DOI 10.1016/j.cognition.2016.05.008; Newman AJ, 2002, NAT NEUROSCI, V5, P76, DOI 10.1038/nn775; Nishimura A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00219; Praamstra P, 1999, NEUROREPORT, V10, P3671, DOI 10.1097/00001756-199911260-00038; R Development Core Team, 2009, R LANG ENV STAT COMP; Sakai KL, 2005, BRAIN, V128, P1407, DOI 10.1093/brain/awh465; Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Siple Patricia, 1990, THEORETICAL ISSUES S, V1, P191, DOI DOI 10.1007/978-94-011-3468-2; Stokoe WC, 2005, J DEAF STUD DEAF EDU, V10, P3, DOI 10.1093/deafed/eni001; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; UMILTA C, 1990, ADV PSYCHOL, V65, P89, DOI DOI 10.1016/S0166-4115(08)61; Zorzi M, 2003, PSYCHON B REV, V10, P423, DOI 10.3758/BF03196501	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194771	10.1371/journal.pone.0194771	http://dx.doi.org/10.1371/journal.pone.0194771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590204	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100073
J	Rahimi, F; Rasekh, HR; Abbasian, E; Peiravian, F; Etemadifar, M; Ashtari, F; Sabzghabaee, AM; Amirsadri, MR				Rahimi, Farimah; Rasekh, Hamid Reza; Abbasian, Ezatollah; Peiravian, Farzad; Etemadifar, Masoud; Ashtari, Fereshteh; Sabzghabaee, Ali Mohammad; Amirsadri, Mohammad Reza			Patient preferences for Interferon-beta in Iran: A discrete choice experiment	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; ECONOMIC-EVALUATION; CONJOINT-ANALYSIS; HEALTH; THERAPY	Multiple sclerosis is a chronic, progressive, and common disease affecting the central nervous system in young adults. Interferon-beta is one of the most widely used medicines to reduce the disease progression. Given the variety of drugs in this category, we aimed to identify the preferences of patients for IFN-beta that play an important role in policymaking in this area. Discrete choice experiment method was used in the present study to identify and prioritize those attributes that are of interest to MS patients and increases the utility of the use of IFN-beta in their treatment. Questionnaires were given to 358 patients in Isfahan-Iran, who were asked to choose between the two treatment choices in each scenario. The results of the logit model showed that the changes in the efficacy lead to the most changes in the patient utility. Changes in side effects and ease of injection have been placed in the next rankings. Considering the drug attributes considered more desirable by patients can lead to greater medication adherence and possibly better treatment outcomes. Also, pharmaceutical companies, the health ministry, the Food and Drug Administration, insurance organizations, and neurologists can benefit from this information in production and importation, policymaking, and prescription.	[Rahimi, Farimah] Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran; [Rahimi, Farimah; Rasekh, Hamid Reza; Peiravian, Farzad] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacoecon & Pharmaceut Management, Tehran, Iran; [Abbasian, Ezatollah] Bu Ali Sina Univ, Dept Econ, Hamadan, Iran; [Etemadifar, Masoud; Ashtari, Fereshteh] Isfahan Univ Med Sci, Med Sch, Dept Neurol, Esfahan, Iran; [Sabzghabaee, Ali Mohammad] Isfahan Univ Med Sci, Isfahan Clin Toxicol Res Ctr, Esfahan, Iran; [Amirsadri, Mohammad Reza] Isfahan Univ Med Sci, Sch Pharm & Pharmaceut & Hlth Management & Econ S, Dept Clin Pharm & Pharm Practice, Esfahan, Iran	Isfahan University Medical Science; Shahid Beheshti University Medical Sciences; Bu Ali Sina University; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science	Rahimi, F (corresponding author), Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran.; Rahimi, F (corresponding author), Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacoecon & Pharmaceut Management, Tehran, Iran.	Farimah.Rahimi@gmail.com	Sabzghabaee, Alimohammad/AAE-7584-2020; abbasian, ezatollah/X-6077-2019; Rahimi, Farimeh/V-7494-2018	abbasian, ezatollah/0000-0001-8364-6461; Rahimi, Farimeh/0000-0001-5745-1839				Alpizar F., 2003, EC ISSUES, V8, P83; Asgari A, 2015, BIOMEDICAL PHARM J M, V8, P105; Bridges JFP, 2005, PHARMACOECONOMICS, V23, P317, DOI 10.2165/00019053-200523040-00002; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Cary N, 2012, DESIGN EXPT GUIDE; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; de Vries ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139755; Ebrahimi HA, 2013, NEUROL ASIA, V18, P385; Eskandarieh S, PREVALENCE INCIDENCE; Etemadifar M, 2013, EUR NEUROL, V70, P356, DOI 10.1159/000355140; Gerard K, 2005, FAM PRACT, V22, P28, DOI 10.1093/fampra/cmh623; Goverover Y, 2017, CHANGES IN THE BRAIN, P145, DOI [10.1007/978-0-387-98188-8_7, DOI 10.1007/978-0-387-98188-8_7]; Gries KS, 2016, APPL HEALTH ECON HEA, P1; Helter TM, 2016, J SUBST USE, V21, P662, DOI 10.3109/14659891.2015.1118563; Lloyd A, 2011, CLIN THER, V33, P1258, DOI 10.1016/j.clinthera.2011.07.017; Mansfield C, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150433; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; Pinto SL, 2009, RES SOC ADMIN PHARM, V5, P253, DOI 10.1016/j.sapharm.2008.10.001; Poulos C, 2016, THERAPEUTIC ADV NEUR; Poulos C, 2016, PATIENT, V9, P171, DOI 10.1007/s40271-015-0136-x; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Ryan Mandy, 2003, Appl Health Econ Health Policy, V2, P55; Shah SA, 2016, J SOC OBSTET GYNAECO, V6, P106; Shingler S L, 2013, J Med Econ, V16, P1036, DOI 10.3111/13696998.2013.811079; Stewart KD, 2016, PATIENT PREFER ADHER, V10, P1385, DOI 10.2147/PPA.S101821; Utz KS, 2014, THER ADV NEUROL DISO, V7, P263, DOI 10.1177/1756285614555335; WHO. World Health Organization, 2013, MULT SCLER INT FED A; Wicks P, 2015, INTERACT J MED RES, V4, P3, DOI 10.2196/ijmr.3776; Wilson L, 2014, J NEUROL SCI, V344, P80, DOI 10.1016/j.jns.2014.06.030; Witney AG, 2006, RHEUMATOLOGY, V45, P975, DOI 10.1093/rheumatology/kel027; Zare N, 2013, J KOREAN MED SCI, V28, P1801, DOI 10.3346/jkms.2013.28.12.1801	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193090	10.1371/journal.pone.0193090	http://dx.doi.org/10.1371/journal.pone.0193090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590134	Green Published, gold			2022-12-27	WOS:000428603100013
J	Ahmadizadeh, S; Karoly, PJ; Nesic, D; Grayden, DB; Cook, MJ; Soudry, D; Freestone, DR				Ahmadizadeh, Saeed; Karoly, Philippa J.; Nesic, Dragan; Grayden, David B.; Cook, Mark J.; Soudry, Daniel; Freestone, Dean R.			Bifurcation analysis of two coupled Jansen-Rit neural mass models	PLOS ONE			English	Article							SYNCHRONIZATION; WILSON; EEG; GENERATION; EPILEPSY; NETWORK	We investigate how changes in network structure can lead to pathological oscillations similar to those observed in epileptic brain. Specifically, we conduct a bifurcation analysis of a network of two Jansen-Rit neural mass models, representing two cortical regions, to investigate different aspects of its behavior with respect to changes in the input and interconnection gains. The bifurcation diagrams, along with simulated EEG time series, exhibit diverse behaviors when varying the input, coupling strength, and network structure. We show that this simple network of neural mass models can generate various oscillatory activities, including delta wave activity, which has not been previously reported through analysis of a single Jansen-Rit neural mass model. Our analysis shows that spike-wave discharges can occur in a cortical region as a result of input changes in the other region, which may have important implications for epilepsy treatment. The bifurcation analysis is related to clinical data in two case studies.	[Ahmadizadeh, Saeed; Nesic, Dragan] Univ Melbourne, Dept Elect & Elect Engn, Melbourne, Vic, Australia; [Karoly, Philippa J.; Grayden, David B.] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia; [Grayden, David B.; Cook, Mark J.; Freestone, Dean R.] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Melbourne, Vic, Australia; [Soudry, Daniel; Freestone, Dean R.] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Columbia University; University of Melbourne	Freestone, DR (corresponding author), Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Melbourne, Vic, Australia.; Freestone, DR (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.	deanrf@unimelb.edu.au	Karoly, Philippa/ABC-9135-2021; Karoly, Philippa Jane/AAG-1544-2020; Grayden, David B/L-5782-2018; Cook, Mark/A-7096-2010	Karoly, Philippa/0000-0002-9879-5854; Karoly, Philippa Jane/0000-0002-9879-5854; Grayden, David B/0000-0002-5497-7234; Cook, Mark/0000-0002-8875-4135; Freestone, Dean/0000-0003-2411-5358				Ahmadizadeh S, 2017, LINEAR ALGEBRA APPL, V530, P541, DOI 10.1016/j.laa.2017.06.023; Ahmadizadeh S, 2017, LINEAR ALGEBRA APPL, V523, P281, DOI 10.1016/j.laa.2017.02.029; Ahmadizadeh S, 2016, AUTOMATICA, V71, P169, DOI 10.1016/j.automatica.2016.04.030; Ahmadizadeh S, 2015, IEEE DECIS CONTR P, P3104, DOI 10.1109/CDC.2015.7402686; Badawy RAB, 2012, NEUROSCIENCE, V222, P89, DOI 10.1016/j.neuroscience.2012.07.015; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; BEURLE RL, 1956, PHILOS T ROY SOC B, V240, P55, DOI 10.1098/rstb.1956.0012; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Campbell S, 1996, IEEE T NEURAL NETWOR, V7, P541, DOI 10.1109/72.501714; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; FitzHugh R., 1955, B MATH BIOPHYS, V17, P257, DOI [10.1007/BF02477753, DOI 10.1007/BF02477753, 10.1007/bf02477753]; Freestone DR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00383; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Geng S, 2014, BIOL CYBERN, P1; Genz A, 2004, STAT COMPUT, V14, P251, DOI 10.1023/B:STCO.0000035304.20635.31; Govaerts W, 2011, TECH REP; Grimbert F, 2006, NEURAL COMPUT, V18, P3052, DOI 10.1162/neco.2006.18.12.3052; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holliday Stephen L, 2003, Neurology, V60, pE3; Huang G, 2011, NEUROCOMPUTING, V74, P1026, DOI 10.1016/j.neucom.2010.11.019; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Jedynak M., 2017, COUPLING STOCHASTICI; Jedynak M, 2017, ARXIV170703812; Jirsa VK, 2014, BRAIN, V137, P2210, DOI 10.1093/brain/awu133; Julier S.J., 1997, P AEROSENSE 11 INT S; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lopes da Silva F H, 1976, Prog Brain Res, V45, P281; Merrison-Hort R, 2013, J MATH NEUROSCI, V3, DOI 10.1186/2190-8567-3-14; SHILNIKOV AL, 1993, PHYSICA D, V62, P338, DOI 10.1016/0167-2789(93)90292-9; Spiegler A, 2010, NEUROIMAGE, V52, P1041, DOI 10.1016/j.neuroimage.2009.12.081; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; Touboul J, 2011, NEURAL COMPUT, V23, P3232, DOI 10.1162/NECO_a_00206; Wendling F, 2000, BIOL CYBERN, V83, P367, DOI 10.1007/s004220000160; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	38	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0192842	10.1371/journal.pone.0192842	http://dx.doi.org/10.1371/journal.pone.0192842			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584728	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000003
J	Loas, G; Lefebvre, G; Rotsaert, M; Englert, Y				Loas, Gwenole; Lefebvre, Guillaume; Rotsaert, Marianne; Englert, Yvon			Relationships between anhedonia, suicidal ideation and suicide attempts in a large sample of physicians	PLOS ONE			English	Article							DEPRESSION; BEHAVIOR; SCHIZOPHRENIA; EXPERIENCES; VALIDATION; PSYCHOLOGY; PREDICTION; COMPONENTS; INPATIENTS; DISORDERS	Background The relationships between anhedonia and suicidal ideation or suicide attempts were explored in a large sample of physicians using the interpersonal psychological theory of suicide. We tested two hypotheses: firstly, that there is a significant relationship between anhedonia and suicidality and, secondly, that anhedonia could mediate the relationships between suicidal ideation or suicide attempts and thwarted belongingness or perceived burdensomeness. Methods In a cross-sectional study, 557 physicians filled out several questionnaires measuring suicide risk, depression, using the abridged version of the Beck Depression Inventory (BDI-13), and demographic and job-related information. Ratings of anhedonia, perceived burdensomeness and thwarted belongingness were then extracted from the BDI-13 and the other questionnaires. Results Significant relationships were found between anhedonia and suicidal ideation or suicide attempts, even when significant variables or covariates were taken into account and, in particular, depressive symptoms. Mediation analyses showed significant partial or complete mediations, where anhedonia mediated the relationships between suicidal ideation (lifetime or recent) and perceived burdensomeness or thwarted belongingness. For suicide attempts, complete mediation was found only between anhedonia and thwarted belongingness. When the different components of anhedonia were taken into account, dissatisfaction not the loss of interest or work inhibition had significant relationships with suicidal ideation, whereas work inhibition had significant relationships with suicide attempts. Conclusions Anhedonia and its component of dissatisfaction could be a risk factor for suicidal ideation and could mediate the relationship between suicidal ideation and perceived burdensomeness or thwarted belongingness in physicians. Dissatisfaction, in particular in the workplace, may be explored as a strong predictor of suicidal ideation in physicians.	[Loas, Gwenole] ULB, Dept Psychiat, Brussels, Belgium; ULB, Clin Univ Bruxelles, Lab Psychiat Res ULB 266, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Loas, G (corresponding author), ULB, Dept Psychiat, Brussels, Belgium.	Gwenole.Loas@erasme.ulb.ac.be		loas, gwenole/0000-0003-1719-916X				Auerbach RP, 2015, J AFFECT DISORDERS, V186, P127, DOI 10.1016/j.jad.2015.06.031; Ballard ED, 2016, BIPOLAR DISORD, V18, P363, DOI 10.1111/bdi.12397; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Carpenter LM, 1997, OCCUP ENVIRON MED, V54, P388, DOI 10.1136/oem.54.6.388; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; Cornette MM, 2009, ARCH SUICIDE RES, V13, P1, DOI 10.1080/13811110802571801; Ducasse D, 2017, DEPRESS ANXIETY, P1; EPSTEIN LC, 1973, J NERV MENT DIS, V156, P19, DOI 10.1097/00005053-197301000-00002; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; Fenton WS, 1997, AM J PSYCHIAT, V154, P199; Fink-Miller EL, 2015, PSYCHIAT RES, V229, P143, DOI 10.1016/j.psychres.2015.07.055; Fink-Miller EL, 2015, SUICIDE LIFE-THREAT, V45, P488, DOI 10.1111/sltb.12147; Frank E, 1999, AM J PSYCHIAT, V156, P1887; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gold KJ, 2013, GEN HOSP PSYCHIAT, V35, P45, DOI 10.1016/j.genhosppsych.2012.08.005; Golding S, 2015, J CLIN SLEEP MED, V11, P1385, DOI 10.5664/jcsm.5270; Hikiji W, 2014, J FORENSIC LEG MED, V22, P37, DOI 10.1016/j.jflm.2013.12.022; Joiner TE, 2005, ANNU REV PSYCHOL, V56, P287, DOI 10.1146/annurev.psych.56.091103.070320; Joiner TE, 2003, PSYCHIAT RES, V119, P243, DOI 10.1016/S0165-1781(03)00131-8; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kleiman EM, 2014, COMPR PSYCHIAT, V55, P431, DOI 10.1016/j.comppsych.2013.10.015; Lapyte A, 2015, ANN PSYCHIAT MENTAL, V3, P8; Leventhal AM, 2006, J CLIN PSYCHOL, V62, P1545, DOI 10.1002/jclp.20327; Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274; Loas G, 2000, COMPR PSYCHIAT, V41, P369, DOI 10.1053/comp.2000.9008; Loas G., 2014, ANHEDONIA SUICIDE BE, VVolume II; Loas G, 2007, PSYCHOL REP, V100, P183, DOI 10.2466/PR0.100.1.183-190; Loas G, 2016, PSYCHIAT RES, V246, P296, DOI 10.1016/j.psychres.2016.09.056; Lussier A, 2015, PSYCHOL REP, V116, P855, DOI 10.2466/09.02.PR0.116k27w2; Martin EA, 2016, J PERS DISORD, V30, P451, DOI 10.1521/pedi_2015_29_203; OLKINUORA M, 1990, SOC PSYCH PSYCH EPID, V25, P81; Pedrazza M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01238; PETERSON CA, 1983, J PERS ASSESS, V47, P539, DOI 10.1207/s15327752jpa4705_16; Rout U, 1999, PSYCHOL REP, V85, P981, DOI 10.2466/PR0.85.7.981-986; Ruitenburg MM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-292; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Spijker J, 2010, SOC PSYCH PSYCH EPID, V45, P513, DOI 10.1007/s00127-009-0093-6; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006598; Van Orden KA, 2012, PSYCHOL ASSESSMENT, V24, P197, DOI 10.1037/a0025358; Winer ES, 2016, J CLIN PSYCHOL, V72, P947, DOI 10.1002/jclp.22298; Winer ES, 2016, ARCH SUICIDE RES, V20, P265, DOI 10.1080/13811118.2015.1025119; Winer ES, 2014, PSYCHIAT RES, V218, P124, DOI 10.1016/j.psychres.2014.04.016; Winer ES, 2014, J AFFECT DISORDERS, V152, P193, DOI 10.1016/j.jad.2013.09.010; Wurm W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149913; Yaseen ZS, 2016, J AFFECT DISORDERS, V203, P77, DOI 10.1016/j.jad.2016.05.066	45	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193619	10.1371/journal.pone.0193619	http://dx.doi.org/10.1371/journal.pone.0193619			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584785	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000006
J	Wang, RR; Liu, JJ; Li, XY; Liang, AP; Bourgoin, T				Wang, Rong-Rong; Liu, Jia-Jia; Li, Xin-Yu; Liang, Ai-Ping; Bourgoin, Thierry			Relating antennal sensilla diversity and possible species behaviour in the planthopper pest Lycorma delicatula (Hemiptera: Fulgoromorpha: Fulgoridae)	PLOS ONE			English	Article							CLOTHING WAX CICADA; INSECTA HEMIPTERA; BROWN PLANTHOPPER; ORGANS; MORPHOLOGY; HOMOPTERA; RECORD; KOREA; OIL	Antennal sensory units in nymphs and adults of the spotted Lanternfly, Lycorma delicatula (White) (Hemiptera: Fulgoromorpha: Fulgoridae), an economically important plant pest, are studied with scanning electron microscopy. Sensilla trichodea / chaetica type recognition is based on their external morphology and ratio of their size to diameter. The flagellum Bourgoin's organ is a complex sensory unit with 2-3 internal sensilla coeloconica. During nymphal stages, the sensory surface available for a chemoreceptive function particularly increases with the number and size of sensilla placodea on the antennal pedicel. From first to fourth instar and to adult males and females, plate organ sensory surface is estimated to increase respectively by 33x, 68x and 125x (= 2.72 mm(2) and 5.02 mm(2) respectively for males and females). The most important increase (5x) occurs between second and third instar. In parallel, a distinctive pair of plate organs on the flagellum decreases in size from first to third instar, and disappears. Sexual dimorphism occurs in sensilla placodea in adults. Diversity, disparity and evolution of nymphal sensilla, and their sexual dimorphism in adults are discussed in the context of the species and planthopper behaviour.	[Wang, Rong-Rong; Liang, Ai-Ping] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Liu, Jia-Jia] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Li, Xin-Yu] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Bourgoin, Thierry] SorbonneUniversite, Inst Systemat Evolut Biodiversite ISYEB, UMR MNHN 7205, CNRS,EPHE,Museum Natl Hist Nat, CP50, Paris, France	Chinese Academy of Sciences; Institute of Zoology, CAS; Beihang University; Beijing Forestry University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.; Bourgoin, T (corresponding author), SorbonneUniversite, Inst Systemat Evolut Biodiversite ISYEB, UMR MNHN 7205, CNRS,EPHE,Museum Natl Hist Nat, CP50, Paris, France.	liangap@ioz.ac.cn; thierry.bourgoin@mnhn.fr	Bourgoin, Thierry/L-5146-2019	Bourgoin, Thierry/0000-0001-9277-2478; LI, XINYU/0000-0001-5136-0303	National Natural Science Foundation of China [31270043, 30900145]; Fundamental Research Funds for the Central Universities [XS201405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (Grant Nos. 31270043 and 30900145) awarded to RRW, and the Fundamental Research Funds for the Central Universities (No. XS201405) to JJL.; We are grateful to Ms. Jun-Na Shi (Beijing Forestry University), who gave us invaluable help with this study. This study was supported by the National Natural Science Foundation of China (Grant Nos. 31270043 and 30900145) awarded to RRW, and the Fundamental Research Funds for the Central Universities (No. XS201405) to JJL. Part of these results were also first lectured during the ICE Symposium 660: An invasive planthopper goes global: shedding light on the spotted lanternfly (Lycorma delicatula) [51].	ALJUNID SF, 1983, CELL TISSUE RES, V228, P313, DOI 10.1007/BF00204881; BACKUS EA, 1988, J INSECT PHYSIOL, V34, P151, DOI 10.1016/0022-1910(88)90045-5; BAKER GT, 1993, P ENTOMOL SOC WASH, V95, P245; Barringer LE, 2015, ENTOMOL NEWS, V125, P20, DOI 10.3157/021.125.0105; BOURGOIN T, 1985, Nouvelle Revue d'Entomologie, V2, P11; BOURGOIN T, 1994, INT J INSECT MORPHOL, V23, P159, DOI 10.1016/0020-7322(94)90008-6; Brozek J, 2013, ZOOMORPHOLOGY, V132, P33, DOI 10.1007/s00435-012-0174-z; Bugnion E, 1908, J PSYCHOL NEUROL, V13, P326; Chen XX, 2006, PARASITOIDS PREDATOR; Cheng Chiou-Ling, 1996, Chinese Journal of Entomology, V16, P187; Choi Man-Young, 2014, Korean Journal of Applied Entomology, V53, P135, DOI 10.5656/KSAE.2014.01.1.075; Cobben R.H., 1988, P81; Dara SK, 2015, J INTEGR PEST MANAG, V6, DOI 10.1093/jipm/pmv021; Denno RF, 1994, PLANTHOPPERS THEIR E, P599; Emelyanov A.F., 1987, Trudy Vsesoyuznogo Entomologicheskogo Obshchestva, V69, P19; Fennah RG, 1975, NZ J ZOOL, V2, P277; Fu BX, 2012, MICROSC RES TECHNIQ, V75, P1492, DOI 10.1002/jemt.22093; Hamilton K.G. Andrew, 2011, Cicadina, V12, P57; Han Jung Min, 2008, Entomological Research, V38, P281, DOI 10.1111/j.1748-5967.2008.00188.x; Jang Y, 2013, ENTOMOL RES, V43, P115, DOI 10.1111/1748-5967.12012; Jones McKee L., 2018, WINES VINES     1202; Jung M, 2016, FLA ENTOMOL, V99, P47, DOI 10.1653/024.099.0109; Kim JG, 2011, J INSECT BEHAV, V24, P423, DOI 10.1007/s10905-011-9266-8; Lee Jeong-Eun, 2009, Korean Journal of Applied Entomology, V48, P467; Lewis C. T, 1970, Tissue Cell, V2, P375, DOI 10.1016/S0040-8166(70)80038-6; Liang AP, 2001, RAFFLES B ZOOL, V49, P221; MARSHALL AT, 1973, TISSUE CELL, V5, P233, DOI 10.1016/S0040-8166(73)80019-9; MARSHALL AT, 1971, ZOOL J LINN SOC-LOND, V50, P181, DOI 10.1111/j.1096-3642.1971.tb00758.x; METCALF ZP, 1947, GEN CATALOGUE HOMOPT, P1; Moon SR, 2011, J KOREAN SOC APPL BI, V54, P558, DOI 10.3839/jksabc.2011.085; Nault LR, 1985, LEAFHOPPERS PLANTHOP, P1; Park Ji-Doo, 2009, Korean Journal of Applied Entomology, V48, P53; Park M, 2013, B ENTOMOL RES, V103, P414, DOI 10.1017/S0007485313000011; Pham H.T., 2011, P 3 NAT SCI C EC BIO, P317; Riolo P, 2012, J CHEM ECOL, V38, P1017, DOI 10.1007/s10886-012-0154-2; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Sforza R, 1999, EUR J ENTOMOL, V96, P409; Shields V.D.C., 2010, MICROSCOPY SCI TECHN, P321; Shih Hsien-Tzung, 1996, Chinese Journal of Entomology, V16, P279; Shih Hsien-Tzung, 1997, Chinese Journal of Entomology, V17, P33; Soulier-Perkins A, 2007, AUST J ENTOMOL, V46, P129, DOI 10.1111/j.1440-6055.2007.00566.x; Spichiger SE., 2016, 25 INT C ENT ORL FLO; Stroinski A, 2011, ZOOTAXA, P1; Wang RR, 2016, 25 INT C ENT ORL FLO; Xue G, 1996, Zhongguo Zhong Yao Za Zhi, V21, P554; Yang Chung-Tu, 1994, Chinese Journal of Entomology, V14, P529; Yoon C, 2011, J ASIA-PAC ENTOMOL, V14, P411, DOI 10.1016/j.aspen.2011.06.003; Youn YN, 2002, J ECON ENTOMOL, V95, P269, DOI 10.1603/0022-0493-95.2.269; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1991, ANNU REV ENTOMOL, V36, P331, DOI 10.1146/annurev.en.36.010191.001555	51	11	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194995	10.1371/journal.pone.0194995	http://dx.doi.org/10.1371/journal.pone.0194995			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584780	Green Submitted, gold, Green Published			2022-12-27	WOS:000428373000054
J	Thorpe, CJ; Lewis, TR; Kulkarni, S; Watve, A; Gaitonde, N; Pryce, D; Davies, L; Bilton, DT; Knight, ME				Thorpe, Christopher J.; Lewis, Todd R.; Kulkarni, Siddharth; Watve, Aparna; Gaitonde, Nikhil; Pryce, David; Davies, Lewis; Bilton, David T.; Knight, Mairi E.			Micro-habitat distribution drives patch quality for sub-tropical rocky plateau amphibians in the northern Western Ghats, India	PLOS ONE			English	Article							ANURA RHACOPHORIDAE; REPRODUCTIVE MODES; NATIONAL-PARK; HABITAT; FROG; CONSERVATION; ASSEMBLAGES; MAHARASHTRA; VEGETATION; DIVERSITY	The importance of patch quality for amphibians is frequently overlooked in distribution models. Here we demonstrate that it is highly important for the persistence of endemic and endangered amphibians found in the threatened and fragile ecosystems that are the rocky plateaus in Western Maharashtra, India. These plateaus are ferricretes of laterite and characterise the northern section of the Western Ghats/Sri Lanka Biodiversity Hotspot, the eighth most important global hotspot and one of the three most threatened by population growth. We present statistically supported habitat associations for endangered and data deficient Indian amphibians, demonstrating significant relationships between individual species and their microhabitats. Data were collected during early monsoon across two seasons. Twenty-one amphibian taxa were identified from 14 lateritic plateaus between 67 and 1179m above sea level. Twelve of the study taxa had significant associations with microhabitats using a stepwise analysis of the AICc subroutine (distLM, Primer-e, v7). Generalist taxa were associated with increased numbers of microhabitat types. Non-significant associations are reported for the remaining 9 taxa. Microhabitat distribution was spatially structured and driven by climate and human activity. Woody plants were associated with 44% of high-elevation taxa. Of the 8 low-elevation taxa 63% related to water bodies and 60% of those were associated with pools. Rock size and abundance were important for 33% of high elevation specialists. Three of the 4 caecilians were associated with rocks in addition to soil and stream presence. We conclude the plateaus are individualistic patches whose habitat quality is defined by their microhabitats within climatic zones.	[Thorpe, Christopher J.; Pryce, David; Davies, Lewis; Bilton, David T.; Knight, Mairi E.] Univ Plymouth, Sch Biol & Marine Sci, Ecol & Evolut Res Grp, Plymouth, Devon, England; [Lewis, Todd R.] Westfield, Wareham, Dorset, England; [Kulkarni, Siddharth] George Washington Univ, Washington, DC USA; [Watve, Aparna] Tata Inst Social Sci, Osmanabad, Maharashtra, India; [Gaitonde, Nikhil] Natl Ctr Biol Sci, Bengaluru, Karnataka, India	University of Plymouth; George Washington University; Tata Institute of Social Sciences; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Thorpe, CJ (corresponding author), Univ Plymouth, Sch Biol & Marine Sci, Ecol & Evolut Res Grp, Plymouth, Devon, England.; Lewis, TR (corresponding author), Westfield, Wareham, Dorset, England.	Christapher.tharpe@plymouth.ac.uk; ecolewis@gmail.com	Kulkarni, Siddharth/X-6449-2019; Lewis, Todd/E-2225-2019	Lewis, Todd/0000-0001-5433-8777	Royal Geographical Society; IBG; Monica Cole Award; Erasmus Darwin Barlow Expedition Fund; Zoological Society of London	Royal Geographical Society; IBG; Monica Cole Award; Erasmus Darwin Barlow Expedition Fund; Zoological Society of London	This work was supported by the following: CJT: The Royal Geographical Society with IBG (www.rgs.org) through Geographical Fieldwork Grants in 2013 and 2014 and the Monica Cole Award 2012. CJT: The Erasmus Darwin Barlow Expedition Fund, Zoological Society of London (https://www.zsl.org) grant in 2014. TRL: Percy Sladen Memorial Trust (https://www.linnean.org > The Society > Medals, Awards, Prizes and Grants) award in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, SELECTED PAPERS HIRO, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Amstrup S.C., 2010, HDB CAPTURE RECAPTUR; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], APPL HERPETOL, DOI DOI 10.1163/157075405774483094; Aravind N, 2011, THEME PAPER AM UNPUB, P20; Babbitt KJ, 2009, AMPHIBIAN ECOLOGY CO; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Balaji D, 2014, J NAT CONSERV, V22, P337, DOI 10.1016/j.jnc.2014.03.004; BELL EA, 1994, NEW ZEAL J ZOOL, V21, P437, DOI 10.1080/03014223.1994.9518014; Bharucha EK, 2010, CURRENT ECOLOGICAL S; Bhatta G, 1998, J BIOSCIENCE, V23, P73, DOI 10.1007/BF02728526; Biju SD, 2009, ZOOL J LINN SOC-LOND, V155, P374, DOI 10.1111/j.1096-3642.2008.00466.x; Biju S. D., 2001, OCCAS PUBL INDIAN SO, V1, P1; Biju Sd, 2009, BMC Res Notes, V2, P241, DOI 10.1186/1756-0500-2-241; Bossuyt F, 2002, J HERPETOL, V36, P656, DOI 10.2307/1565937; CEPF, 2016, AS PAC BIOD HOTSP CR; Chan LM, 2003, BIOL J LINN SOC, V78, P489, DOI 10.1046/j.0024-4066.2002.00157.x; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Clarke KR, 1994, CHANGE MARINE COMMUN; Clarke KR, 2015, PRIMER V7 USER MANUA; Cortes-Gomez AM, 2013, TROP CONSERV SCI, V6, P749, DOI 10.1177/194008291300600604; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; da Silva FR, 2012, J BIOGEOGR, V39, P1720, DOI 10.1111/j.1365-2699.2012.02726.x; Daniel, 2002, BOOK INDIAN REPTILES; DANIELS RJR, 1992, J BIOGEOGR, V19, P521, DOI 10.2307/2845771; Deans RA, 2016, OIKOS; Dinesh KP, 2017, CHECKLIST AMPHIBIANS; Dinesh KP., 2009, ANNOTATED CHECKLIST; Doan TM, 2003, J HERPETOL, V37, P72, DOI 10.1670/0022-1511(2003)037[0072:WMAMEF]2.0.CO;2; Dubois Alain, 2001, Alytes (Paris), V19, P53; DUELLMAN WE, 1988, ANN MO BOT GARD, V75, P79, DOI 10.2307/2399467; Ernst Raffael, 2006, Ecotropica-Bonn, V12, P113; FAUTH JE, 1989, BIOTROPICA, V21, P178, DOI 10.2307/2388708; Feeley KJ, 2016, DIVERS DISTRIB; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; FRIEND GR, 1990, J TROP ECOL, V6, P131, DOI 10.1017/S0266467400004235; Frishkoff LO, 2015, GLOBAL CHANGE BIOL, V21, P3901, DOI 10.1111/gcb.13016; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gaitonde N, 2016, J NAT HIST, V50, P2557, DOI 10.1080/00222933.2016.1200686; Gaitonde N, 2014, CURR SCI INDIA, V107, P109; GASCON C, 2007, AMPHIBIAN CONSERVATI; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Giri V, 2016, THREATENED AMPHIBIAN, P80; Giri Varad, 2003, Zootaxa, V351, P1; Gower DJ, 2011, MOL PHYLOGENET EVOL, V59, P698, DOI 10.1016/j.ympev.2011.03.002; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Gururaja K, 2013, RUSSIAN J HERPETOLOG, V10, P87; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hartel T, 2007, HYDROBIOLOGIA, V583, P173, DOI 10.1007/s10750-006-0490-8; Heard GW, 2017, CONSERV LETT, V12375, P1; Hillis DM, 2007, MOL PHYLOGENET EVOL, V42, P331, DOI 10.1016/j.ympev.2006.08.001; Hiragond NC, 2001, J HERPETOL, V35, P166, DOI 10.2307/1566044; Holdridge L. R., 1967, Life zone ecology.; Hopper SD, 2015, PLANT SOIL, P1; Humraskar D, 2007, NEED STUDIES AMPHIBI, P1032; Hussain Q. A., 2012, International Journal of Biodiversity and Conservation, V4, P348; IMD India Meteorological Department, 2016, ONS WITHDR SW MONS 2; India Go. Indiastat, 2017, IND MET DAT RAINF; Iskandar DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119988; IUCN, IUCN RED LIST THREAT; Jocque A M, 2010, FRESHWATER BIOL, V2010, P1; Jocque M, 2007, HYDROBIOLOGIA, V592, P271, DOI 10.1007/s10750-007-0766-7; Krishnamurthy SV, 2003, ENVIRON CONSERV, V30, P274, DOI 10.1017/S0376892903000274; Krishnamurthy SV, 2001, CURR SCI INDIA, V80, P887; Kumar A, 2001, CURR SCI INDIA, V80; Kupfer A, 2005, ACTA OECOL, V28, P95, DOI 10.1016/j.actao.2005.03.002; Kuramoto Mitsuru, 2007, Current Herpetology, V26, P81, DOI 10.3105/1881-1019(2007)26[81:TGFARI]2.0.CO;2; Kuramoto Mitsuru, 2003, Current Herpetology, V22, P51; Lad R. J., 2013, INT J RECENT SCI RES, V4, P1275; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Lee JC, 1993, GEOGRAPHIC VARIATION; Lekhak M. M., 2012, Rheedea, V22, P39; Lynch JDD, 1980, ELEUTHERODACTYLUS AM; Mahabal A, 2012, FAUNA OF MAHARASHTRA; Menin M, 2011, HERPETOL J, V21, P255; Molur S, 2015, DIS AQUAT ORGAN, V112, P251, DOI 10.3354/dao02804; Mortelliti A, 2010, OECOLOGIA, V163, P535, DOI 10.1007/s00442-010-1623-3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naniwadekar R, 2007, J BIOGEOGR, V34, P842, DOI 10.1111/j.1365-2699.2006.01648.x; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; Padhye A.D., 2002, Zoos' Print Journal, V17, P735; Padhye Anand D., 2013, Journal of Threatened Taxa, V5, P4913; Phillips J, 2012, ENVIRON EARTH SCI, V67, P1587, DOI 10.1007/s12665-012-1601-7; Pinder A. M., 2000, Journal of the Royal Society of Western Australia, V83, P149; Porembski S, 2005, PHYTOCOENOLOGIA, V35, P389, DOI 10.1127/0340-269X/2005/0035-0389; Porembski S, 2016, BIODIVERS CONSERV, V25, P2827, DOI 10.1007/s10531-016-1171-1; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Raj Prudhvi, 2011, Herpetology Notes, V4, P11; Ram MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142597; Ramesh V, 2017, BIOL CONSERV, V210, P205, DOI 10.1016/j.biocon.2017.03.019; Rittenhouse TAG, 2007, WETLANDS, V27, P153, DOI 10.1672/0277-5212(2007)27[153:DOAITH]2.0.CO;2; Robin VV, 2012, CURR SCI INDIA, V103, P1427; Santos-Barrera G, 2011, REV MEX BIODIVERS, V82, P679; Scheffer M, 2006, OIKOS, V112, P227, DOI 10.1111/j.0030-1299.2006.14145.x; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Schut AGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082778; Seshadri KS, 2015, BIOL J LINN SOC, V114, P1, DOI 10.1111/bij.12388; Seshadri KS, 2012, ZOOTAXA, P19; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; Smith GR, 1999, FRESHWATER BIOL, V41, P829, DOI 10.1046/j.1365-2427.1999.00445.x; Smith HM, 2006, HERPETOL CONSERV BIO, V1, P6; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thorpe C. J., 2016, J ECOL SOC, V29, P25; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; Van Bocxlaer I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-131; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Vonesh J. R., 1998, THESIS; Vonesh JR, 2001, BIOTROPICA, V33, P502, DOI 10.1111/j.1744-7429.2001.tb00204.x; Vonesh JR, 2010, AMPHIBIAN ECOLOGY CO, P263, DOI 10.1007/BF02728526; Watve A., 2010, ROCKY PLATEAUS SPECI; Watve Aparna, 2013, Journal of Threatened Taxa, V5, P3935, DOI 10.11609/JoTT.o3372.3935-62; Wells KD, 2007, SPR HDB AUD, V28, P44; Widdowson M, 1996, EARTH PLANET SC LETT, V137, P57, DOI 10.1016/0012-821X(95)00211-T; Widdowson M., 2007, GEOCHEMICAL SEDIMENT, P46; Williams SE, 2001, BIOL CONSERV, V98, P1, DOI 10.1016/S0006-3207(99)00093-2	118	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194810	10.1371/journal.pone.0194810	http://dx.doi.org/10.1371/journal.pone.0194810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579111	gold, Green Published			2022-12-27	WOS:000428351800057
J	Philbin, MM; Hirsch, JS; Wilson, PA; Ly, T; Giang, LM; Parker, RG				Philbin, Morgan M.; Hirsch, Jennifer S.; Wilson, Patrick A.; An Thanh Ly; Le Minh Giang; Parker, Richard G.			Structural barriers to HIV prevention among men who have sex with men (MSM) in Vietnam: Diversity, stigma, and healthcare access	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; TRANSGENDER WOMEN; YOUNG MEN; RISK BEHAVIORS; PACIFIC REGION; SUBSTANCE USE; BLACK-MEN; ASIA; INFECTION; THAILAND	Men who have sex with men (MSM) in Vietnam experience disproportionate rates of HIV infection. To advance understanding of how structural barriers may shape their engagement with HIV prevention services, we draw on 32 in-depth interviews and four focus groups (n = 31) conducted with MSM in Hanoi between October 2015-March 2016. Three primary factors emerged: (1) Diversity, both in relation to identity and income; Vietnamese MSM described themselves as segregated into Bong kin (hidden, often heterosexually-identified MSM) and Bong IO ('out,' transgender, or effeminate MSM). Lower-income, 'hidden' MSM from rural areas were reluctant to access MSM-targeted services; (2) Stigma: MSM reported being stigmatized by the healthcare system, family, and other MSM; and (3) Healthcare access: this was limited due to economic barriers and lack of MSM-friendly services. Our research suggests the need for multiple strategies to reach diverse types of MSM as well as to address barriers in access to health services such as stigma and costs. While a great deal has been written about the diversity of MSM in relation to gender performance and sexual identities, our research points to the substantial structural-level barriers that must be addressed in order to achieve meaningful and effective HIV prevention for MSM worldwide.	[Philbin, Morgan M.; Hirsch, Jennifer S.; Wilson, Patrick A.; Parker, Richard G.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA; [An Thanh Ly; Le Minh Giang] Hanoi Med Univ, Ctr Res & Training HIV AIDS CREATA, Hanoi, Vietnam	Columbia University; Hanoi Medical University	Philbin, MM (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA.	mp3243@columbia.edu	/AET-2949-2022; /AAF-4450-2021; Le, Giang/P-2309-2019	Giang, Le Minh/0000-0003-3370-4453	National Institute of Child Health and Human Development [R24 HD056691]; Department of Sociomedical Sciences; Center for the Study of Culture, Politics and Health; Columbia Population Research Center [P2-CHD058486]; NIDA [K01DA039804A]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD056691, P2CHD058486] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Sociomedical Sciences; Center for the Study of Culture, Politics and Health; Columbia Population Research Center; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a grant from the National Institute of Child Health and Human Development (R24 HD056691; PIs Hirsch and Parker). Support was also provided by the Department of Sociomedical Sciences and the Center for the Study of Culture, Politics and Health. Dr. Hirsch was partially supported by the Columbia Population Research Center (P2-CHD058486). Dr. Philbin is supported by a NIDA-funded K01 (K01DA039804A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMFAR, 2016, WILL IMP CUTS PEPFAR; [Anonymous], 2013, HEALTH; Ayala G, 2013, J SEXUALLY TRANSMITT, V2013; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Barlow J, 2010, J ROY SOC MED, V103, P51, DOI 10.1258/jrsm.2009.090296; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Berry MC, 2013, AIDS CARE, V25, P38, DOI 10.1080/09540121.2012.687808; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boellstorff T., 2005, GAY ARCHIPELAGO SEXU; Boellstorff T, 2011, CULT ANTHROPOL, V26, P287, DOI 10.1111/j.1548-1360.2011.01100.x; Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816; Center for Applied Research on Men and Community Health (CARMAH), 2015, STUD TRANSG WOM HLTH; Colby D, 2004, AIDS EDUC PREV, V16, P45, DOI 10.1521/aeap.16.1.45.27722; Colby D, 2016, AIDS BEHAV, V20, pS379, DOI 10.1007/s10461-016-1485-8; Dao A, 2013, GLOB PUBLIC HEALTH, V8, pS7, DOI 10.1080/17441692.2013.811532; de Loenzien Myriam, 2009, Sante, V19, P141, DOI 10.1684/san.2009.0169; de Oliveira DL, 2011, CIENC SAUDE COLETIVA, V16, P3093, DOI 10.1590/S1413-81232011000800030; Ekman B, 2008, HEALTH POLICY PLANN, V23, P252, DOI 10.1093/heapol/czn009; Epstein S., 1998, IMPURE SCI AIDS ACTI, V7; Gangcuangco Louie Mar A, 2013, Southeast Asian J Trop Med Public Health, V44, P810; Garcia J, 2016, GLOB PUBLIC HEALTH, P1; Garcia MC, 2014, GLOB PUBLIC HEALTH, V9, P1225, DOI 10.1080/17441692.2014.948481; Garcia Macarena C, 2012, BMJ Open, V2, DOI 10.1136/bmjopen-2012-001511; Golub SA, 2017, AIDS BEHAV, V21, P1229, DOI 10.1007/s10461-015-1129-4; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Hirsch JS, 2015, J HEALTH POLIT POLIC, V40, P13, DOI 10.1215/03616878-2854447; HIV pre-exposure prophylaxis and health and community systems in the Global South, 2015, J INT AIDS SOC; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Horton P, 2014, CULT HEALTH SEX, V16, P960, DOI 10.1080/13691058.2014.924556; Giang LM, 2013, J FOOD DRUG ANAL, V21, pS42, DOI 10.1016/j.jfda.2013.09.032; Giang LM, 2013, GLOB PUBLIC HEALTH, V8, pS1, DOI 10.1080/17441692.2013.797484; Lo Y-R, 2014, SEXUAL HLTH; Lo YR, 2014, SEX HEALTH, V11, P126, DOI 10.1071/SH13094; Logie CH, 2016, AIDS PATIENT CARE ST, V30, P92, DOI 10.1089/apc.2015.0197; Maher L, 2007, INT J DRUG POLICY, V18, P296, DOI 10.1016/j.drugpo.2006.12.006; Malebranche DJ, 2009, MEN MASC, V12, P90, DOI 10.1177/1097184X07309504; Ministry of Health (MOH) & Health Partnership Group (HPG), 2013, JOINT ANN HLTH REV 2; Newman P.A., 2017, NEW ERA FOCUS GROUP, P83; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; Ngo DA, 2009, AIDS EDUC PREV, V21, P251, DOI 10.1521/aeap.2009.21.3.251; Oldenburg CE, 2016, AIDS BEHAV, V20, pS365, DOI 10.1007/s10461-016-1483-x; Oosterhoff P, NEGOTIATING PUBLIC L; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Parker Richard G., 2000, GLOBAL HLTH POLICY L; Philbin MM, 2016, AIDS PATIENT CARE ST, V30, P282, DOI 10.1089/apc.2016.0037; Pham QD, 2015, SEX TRANSM INFECT, V91, P178, DOI 10.1136/sextrans-2014-051574; Ramesh M, 2008, PAC REV, V21, P171, DOI 10.1080/09512740801990238; Solomon SS, 2015, AIDS, V29, P723, DOI 10.1097/QAD.0000000000000602; Nguyen TV, 2016, AIDS BEHAV, V20, P2357, DOI 10.1007/s10461-015-1265-x; Underhill K, 2016, AIDS BEHAV, V20, P1514, DOI 10.1007/s10461-015-1088-9; Underhill K, 2015, J URBAN HEALTH, V92, P667, DOI 10.1007/s11524-015-9961-4; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Vietnam Authority of AIDS Control, 2016, RES HIV SENT SURV IN; Vietnam Authority of AIDS Control, 2012, VIETN HIV AIDS EST P; Vu BN, 2008, SEX HEALTH, V5, P83, DOI 10.1071/SH07064; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; Wilson P, CATEGORICAL IN PRESS; World Bank, 2006, VIETN DEV REP 2007 A; World Health Organization, 2009, ASS COMP TREATM PEOP; World Health Organization, 2012, HLTH SERV DEL PROF V; Zablotska I, 2016, J INT AIDS SOC, P19	62	30	31	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195000	10.1371/journal.pone.0195000	http://dx.doi.org/10.1371/journal.pone.0195000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614104	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600023
J	Meadows, KRT; Steinberg, MW; Clemons, B; Stokes, ME; Opiteck, GJ; Peach, R; Scott, FL				Meadows, Kristen R. Taylor; Steinberg, Marcos W.; Clemons, Bryan; Stokes, Matthew E.; Opiteck, Gregory J.; Peach, Robert; Scott, Fiona L.			Ozanimod (RPC1063), a selective S1P(R1) and S1P(R5) modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; LYMPHOID ORGANS; FTY720; S1P(1); PATHOGENESIS; FINGOLIMOD; INFECTION; NEPHRITIS; EFFICACY; UPDATE	Ozanimod (RPC1063) is a specific and potent small molecule modulator of the sphingosine 1-phosphate receptor 1 (S1PRi) and receptor 5 (S1PR5), which has shown therapeutic benefit in clinical trials of relapsing multiple sclerosis and ulcerative colitis. Ozanimod and its active metabolite, RP-101075, exhibit a similar specificity profile at the S1P receptor family in vitro and pharmacodynamic profile in vivo. The NZBWF1 mouse model was used in therapeutic dosing mode to assess the potential benefit of ozanimod and RP-101075 in an established animal model of systemic lupus erythematosus. Compared with vehicle-treated animals, ozanimod and RP-101075 reduced proteinuria over the duration of the study and serum blood urea nitrogen at termination. Additionally, ozanimod and RP-101075 reduced kidney disease in a dose-dependent manner, as measured by histological assessment of mesangial expansion, endo- and exo-capillary proliferation, interstitial infiltrates and fibrosis, glomerular deposits, and tubular atrophy. Further exploration into gene expression changes in the kidney demonstrate that RP-101075 also significantly reduced expression of fibrotic and immune-related genes in the kidneys. Of note, RP-101075 lowered the number of plasmacytoid dendritic cells, a major source of interferon alpha in lupus patients, and reduced all B and T cell subsets in the spleen. Given the efficacy demonstrated by ozanimod and its metabolite RP-101075 in the NZBWF1 preclinical animal model, ozanimod may warrant clinical evaluation as a potential treatment for systemic lupus erythematosus.	[Meadows, Kristen R. Taylor; Steinberg, Marcos W.; Clemons, Bryan; Opiteck, Gregory J.; Peach, Robert; Scott, Fiona L.] Receptos, San Diego, CA 92121 USA; [Stokes, Matthew E.] Celgene Corp, Seattle, WA USA	Bristol-Myers Squibb; Celgene Corporation	Meadows, KRT (corresponding author), Receptos, San Diego, CA 92121 USA.	krtaylor@celgene.com		Stokes, Matthew/0000-0002-1953-1616	Celgene Corporation	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	Celgene Corporation (http://www.celgene.com/) funded this study. The funder provided support in the form of salaries and research materials for authors KRTM, MWS, BC, MES, GJO, RP and FLS. KRTM, MWS, BC, MES, GJO, RP and FLS had additional roles in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Alperovich G, 2007, LUPUS, V16, P18, DOI 10.1177/0961203306073136; Ando S, 2010, BIOCHEM BIOPH RES CO, V394, P804, DOI 10.1016/j.bbrc.2010.03.078; Aoki M, 2016, MEDIAT INFLAMM, V2016, DOI [DOI 10.1155/2016/8606878, 10.1155/2016/8606878]; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Clark EA, 2005, ANN RHEUM DIS, V64, P77, DOI 10.1136/ard.2005.042507; Cohen JA, 2016, LANCET NEUROL, V15, P373, DOI 10.1016/S1474-4422(16)00018-1; Corsiero E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00430; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; HURD ER, 1975, ARTHRITIS RHEUM-US, V18, P67, DOI 10.1002/art.1780180113; Kappos L, 2016, JAMA NEUROL, V73, P1089, DOI 10.1001/jamaneurol.2016.1451; Khatri BO, 2016, THER ADV NEUROL DISO, V9, P130, DOI 10.1177/1756285616628766; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim SS, 2012, THER ADV CHRONIC DIS, V3, P11, DOI 10.1177/2040622311424806; Lech M, 2013, J AM SOC NEPHROL, V24, P1357, DOI 10.1681/ASN.2013010026; Marro BS, 2017, P NATL ACAD SCI USA, V114, P3708, DOI 10.1073/pnas.1700878114; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mehling M, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000028; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Noor S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-77; Okazaki H, 2002, J RHEUMATOL, V29, P707; Oldstone MBA, 2013, VIROLOGY, V435, P92, DOI 10.1016/j.virol.2012.09.039; Oon S, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.26; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Sandborn WJ, 2016, NEW ENGL J MED, V374, P1754, DOI 10.1056/NEJMoa1513248; SCHRIEBER L, 1986, RHEUMATOL INT, V6, P215, DOI 10.1007/BF00541370; Schurer SC, 2008, ACS CHEM BIOL, V3, P486, DOI 10.1021/cb800051m; Scott FL, 2016, BRIT J PHARMACOL, V173, P1778, DOI 10.1111/bph.13476; Sistigu A, 2011, SEMIN IMMUNOPATHOL, V33, P369, DOI 10.1007/s00281-011-0245-0; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Teijaro JR, 2016, P NATL ACAD SCI USA, V113, P1351, DOI 10.1073/pnas.1525356113; Tobon GJ, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/827254	36	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193236	10.1371/journal.pone.0193236	http://dx.doi.org/10.1371/journal.pone.0193236			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608575	Green Published, gold			2022-12-27	WOS:000428988800002
J	Patcharanarumol, W; Panichkriangkrai, W; Sommanuttaweechai, A; Hanson, K; Wanwong, Y; Tangcharoensathien, V				Patcharanarumol, Walaiporn; Panichkriangkrai, Warisa; Sommanuttaweechai, Angkana; Hanson, Kara; Wanwong, Yaowaluk; Tangcharoensathien, Viroj			Strategic purchasing and health system efficiency: A comparison of two financing schemes in Thailand	PLOS ONE			English	Article								Strategic purchasing is an essential health financing function. This paper compares the strategic purchasing practices of Thailand's two tax-financed health insurance schemes, the Universal Coverage Scheme (UCS) and the Civil Servant Medical Benefit Scheme (CSMBS), and identifies factors contributing to successful universal health coverage outcomes by analysing the relationships between the purchaser and government, providers and members. The study uses a cross-sectional mixed-methods design, including document review and interviews with 56 key informants. The Comptroller General Department (CGD) of Ministry of Finance manages CSMBS as one among civil servant welfare programmes. Their purchasing is passive. Fee for service payment for outpatient care has resulted in rapid cost escalation and overspending of their annual budget. In contrast, National Health Security Office (NHSO) manages purchasing for UCS, which undertakes a range of strategic purchasing actions, including applying closed ended provider payment, promoting primary healthcare's gate keeping functions, exercising collective purchasing power and engaging views of members in decision making process. This difference in purchasing arrangements resulted in expenditure per CSMBS member being 4 times higher than UCS in 2014. The governance of the purchaser organization, the design of the purchasing arrangements including incentives and use of information, and the institutional capacities to implement purchasing functions are essential for effective strategic purchasing which can improve health system efficiency as a whole.	[Patcharanarumol, Walaiporn; Panichkriangkrai, Warisa; Sommanuttaweechai, Angkana; Wanwong, Yaowaluk; Tangcharoensathien, Viroj] Minist Publ Hlth, IHPP, Nonthaburi, Thailand; [Hanson, Kara] London Sch Hyg & Trop Med, London, England	Ministry of Public Health - Thailand; University of London; London School of Hygiene & Tropical Medicine	Patcharanarumol, W (corresponding author), Minist Publ Hlth, IHPP, Nonthaburi, Thailand.	walaiporn@ihpp.thaigov.net		Patcharanarumol, Walaiporn/0000-0003-1798-8767; Lekagul, Angkana/0000-0002-7335-9028	UK Aid from the UK Department for International Development (DFID); Department for International Development (DFID) [201889] Funding Source: researchfish	UK Aid from the UK Department for International Development (DFID); Department for International Development (DFID)	Walaiporn Patcharanarumol, Warisa Panichkraingkrai, Angkana Sommanuttaweechai, Viroj Tangcharoensathien and Kara Hanson are members of the Consortium for Resilient and Responsive Health Systems (RESYST). This document is an output from a project funded by the UK Aid from the UK Department for International Development (DFID) for the benefit of developing countries. However, the views expressed and information contained in it are not necessarily those of or endorsed by DFID, which can accept no responsibility for such views or information or for any reliance placed on them.	[Anonymous], 2013, INVESTIGATING PURCHA; Chootipongchaivat S, 2015, POLICY BRIEF; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Fahamnuaypol P., 2015, KINGDOM THAILAND HLT; Figueras J., 2005, PURCHASING IMPROVE H; Government Pharmaceutical Organization, 2013, REP CENTR PROC E2 ME; Health Insurance System Research Office (HISRO), 2012, PROP CONT COST DRUGS; Jongudomsuk P., 2012, EC PUBLIC HLTH CARE, P307; Kasemsup V, 2006, J NEPHROL SOC THAI S, V12, P125; Kutzin J, 2001, HEALTH POLICY, V56, P171, DOI 10.1016/S0168-8510(00)00149-4; Mohara A, 2012, J COMP EFFECT RES, V1, P137, DOI [10.2217/CER.12.10, 10.2217/cer.12.10]; National Drug Commitee, 2008, NAT LIST ESS MED 200; National Health Security Office, 2015, NAT HLTH SEC OFF ANN; National Health Security Office, 2012, NAT HLTH SEC OFF ANN; National Statistical Office, 2015, REP HLTH WELF SURV; National Statistical Office, 2005, SURV POP CHANG; Patcharanarumol W, 2011, GOOD HLTH LOW COST 2, P193; Preker Alexander S, 2005, SPENDING WISELY BUYI; Saengpassa C., 2016, THE NATIONS     1213; Sruamsiri R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008671; Strategic Purchasing Factsheet, 2014, FINANCING RES THEME; Tangcharoensathien V, 2006, J NEPHROLOGY SOC S2, V12, P21; Tangcharoensathien V, 2005, UNIVERSAL ACCESS REN; Tantivess S, 2016, HEALTH SYST REFORM, V2, P106, DOI 10.1080/23288604.2016.1128514; Tantivess S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f462; Teerawattananon Y, Z EVIDENZ FORTBILDUN, V108, P397; World Health Organization, 2000, HLTH SYST IMPR PERF	28	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195179	10.1371/journal.pone.0195179	http://dx.doi.org/10.1371/journal.pone.0195179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608610	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800033
J	Ross, J; Edmonds, A; Hoover, DR; Shi, QH; Anastos, K; Lelo, P; Behets, F; Yotebieng, M				Ross, Jonathan; Edmonds, Andrew; Hoover, Donald R.; Shi, Qiuhu; Anastos, Kathryn; Lelo, Patricia; Behets, Frieda; Yotebieng, Marcel			Association between pregnancy at enrollment into HIV care and loss to care among women in the Democratic Republic of Congo, 2006-2013	PLOS ONE			English	Article							OPTION B PLUS; RANDOMIZED CONTROLLED-TRIAL; CONDITIONAL CASH TRANSFERS; TO-CHILD TRANSMISSION; FOLLOW-UP; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; RISK-FACTORS; RETROSPECTIVE COHORT; POSTPARTUM WOMEN	Background Loss to care is high among asymptomatic HIV-infected women initiated on antiretroviral therapy (ART) during pregnancy or in the postpartum period. However, whether pregnancy itself plays a role in the high loss to care rate is uncertain. We compared loss to care over seven years between pregnant and non-pregnant women at enrollment into HIV care in the Democratic Republic of Congo (DRC). Methods We conducted a retrospective analysis of all ART-naive women aged 15-45 initiating HIV care at two large clinics in Kinshasa, DRC, from 2007-2013. Pregnancy status was recorded at care enrollment. Patients were classified as having no follow-up if they did not return to care after the initial enrollment visit. Among those with at least one follow-up visit after enrollment, we classified patients as lost to care if more than 365 days had passed since their last clinic visit. We used logistic regression to model the association between pregnancy status and no follow-up, and Cox proportional hazards regression to model the association between pregnancy status and time to loss to care. Results Of 2175 women included in the analysis, 1497 (68.8%) were pregnant at enrollment. Compared to non-pregnant women, pregnant women were less likely to be over 35 years of age (19.1% vs. 31.9%, p<0.0001) and less likely to be in WHO stage III or IV (9.0% vs. 26.3%, p<0.0001). Among pregnant women, 106 (7.1%) were not seen after enrollment, versus 25 (3.7%) non-pregnant women (adjusted odds ratio 2.01, 95% CI 1.24-3.24). Of the 2,044 women with at least one follow-up visit, 46.5% of pregnant women and 46.7% of non-pregnant women were lost to care by 5 years; hazards of loss to care were similar for pregnant and non-pregnant women (adjusted hazard ratio 1.08, 95% CI 0.93-1.26). Conclusions In this large cohort of HIV-infected women, patients pregnant at care enrollment were more likely to never return for follow-up. Among those who attended at least one follow-up visit, loss to care was not different between pregnant and non-pregnant women, suggesting that pregnancy itself may not be the main driver of the high attrition observed in this cohort.	[Ross, Jonathan; Anastos, Kathryn] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, Bronx, NY 10467 USA; [Edmonds, Andrew; Behets, Frieda] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, New Brunswick, NJ USA; [Shi, Qiuhu] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA; [Lelo, Patricia] Kalembelembe Pediat Hosp, Kinshasa, DEM REP CONGO; [Yotebieng, Marcel] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Rutgers State University New Brunswick; New York Medical College; University System of Ohio; Ohio State University	Ross, J (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, Bronx, NY 10467 USA.	joross@montefiore.org	Ross, Jonathan/AAV-2402-2020; Yotebieng, Marcel/L-2083-2013	Ross, Jonathan/0000-0001-6126-3048; Yotebieng, Marcel/0000-0003-2110-2631; Edmonds, Andrew/0000-0001-6768-0096	National Institute of Allergy and Infectious Diseases [U01 AI096299]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD087993]; National Institute of Mental Health [K23 MH114752]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD087993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI096299, P30AI124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH114752] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was conducted as part of the Central Africa International Epidemiologic Databases to Evaluate AIDS (CA-IeDEA) consortium, which is funded by the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov, grant number U01 AI096299 to KA), and received additional support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov, grant number R01 HD087993) and National Institute of Mental Health grant K23 MH114752 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, GLOB PLAN COUNTR FAC; [Anonymous], 2013, CONSOLIDATED GUIDELI; [Anonymous], 2016, FAST TRACK AIDS FREE; Boyles TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019201; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Dzangare J, 2016, TROP MED INT HEALTH, V21, P202, DOI 10.1111/tmi.12637; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Edmonds A, 2009, INT J EPIDEMIOL, V38, P1612, DOI 10.1093/ije/dyp208; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Gwynn RC, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0898-9; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Joint United Nations Programmes on HIV/AIDS, 2011, COUNTD ZER GLOB PLAN; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kim MH, PLOS ONE, V11; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Landes M, 2016, BMC Public Health, V15, P713, DOI 10.1186/s12889-016-3380-7; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Ministere du Plan et Suivi de la Mise en oeuvre de la Re A volution de la Modernite A et Ministere de la Sante A Publique, 2014, MIN PLAN SUIV MIS OE; Mitiku I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20662; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; OKOBOI S, 2016, J INT AIDS SOC S4, V19; Pati R, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18490; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Rawizza HE, 2015, CURR HIV RES, V13, P201, DOI 10.2174/1570162X1303150506183256; Schnippel K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0778-2; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Sturt AS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008440; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Vuylsteke B, 2015, JAIDS-J ACQ IMM DEF, V68, pS99, DOI 10.1097/QAI.0000000000000442; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 2022, ANT DRUGS TREAT PREG; World Health Organization, 2021, ANT DRUGS TREAT PREG; Yotebieng M, 2017, JAIDS-J ACQ IMM DEF, V74, P150, DOI 10.1097/QAI.0000000000001219; Yotebieng M, 2016, LANCET HIV, V3, pE85, DOI 10.1016/S2352-3018(15)00247-7; Yotebieng M, 2015, LANCET GLOB HEALTH, V3, pE546, DOI 10.1016/S2214-109X(15)00012-1; Yotebieng M, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-11	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195231	10.1371/journal.pone.0195231	http://dx.doi.org/10.1371/journal.pone.0195231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608618	Green Published, gold			2022-12-27	WOS:000428988800040
J	Machingaidze, S; Grimmer, K; Louw, Q; Kredo, T; Young, T; Volmink, J				Machingaidze, Shingai; Grimmer, Karen; Louw, Quinette; Kredo, Tamara; Young, Taryn; Volmink, Jimmy			Next generation clinical guidance for primary care in South Africa - credible, consistent and pragmatic	PLOS ONE			English	Article							GUIDELINES EXCELLENCE SAGE; STANDARDS; QUALITY	Background Agreed international development standards underpin high quality de novo clinical practice guidelines (CPGs). There is however, no international consensus on how high quality CPGs should 'look'; or on whether high quality CPGs from one country can be viably implemented elsewhere. Writing de novo CPGs is generally resource-intensive and expensive, making this challenging in resource-poor environments. This paper proposes an alternative, efficient method of producing high quality CPGs in such circumstances, using existing CPGs layered by local knowledge, contexts and products. Methods We undertook a mixed methods case study in South African (SA) primary healthcare (PHC), building on findings from four independent studies. These comprised an overview of international CPG activities; a rapid literature review on international CPG development practices; critical appraisal of 16 purposively-sampled SA PHC CPGs; and additional interrogation of these CPGs regarding how, why and for whom, they had been produced, and how they 'looked'. Results Despite a common aim to improve SA PHC healthcare practices, the included CPGs had different, unclear and inconsistent production processes, terminology and evidence presentation styles. None aligned with international quality standards. However many included innovative succinct guidance for end-users (which we classified as evidence-based summary recommendations, patient management tools or protocols). We developed a three-tiered model, a checklist and a glossary of common terms, for more efficient future production of better quality, contextually-relevant, locally-implementable SA PHC CPGs. Tier 1involves transparent synthesis of existing high quality CPG recommendations; Tier 2 reflects local expertise to layer Tier 1 evidence with local contexts; and Tier 3 comprises tailored locally-relevant end-user guidance. Conclusion Our model could be relevant for any resource-poor environment. It should reduce effort and costs in finding and synthesising available research evidence, whilst efficiently focusing scant resources on contextually-relevant evidence-based guidance, and implementation.	[Machingaidze, Shingai; Louw, Quinette; Kredo, Tamara; Young, Taryn] Cochrane South Africa, South African Med Res Council, Cape Town, South Africa; [Machingaidze, Shingai] European & Developing Countries Clin Trial Partne, Cape Town, South Africa; [Grimmer, Karen; Louw, Quinette; Volmink, Jimmy] Stellenbosch Univ, Physiotherapy Dept, Fac Med & Hlth Sci, Cape Town, South Africa; [Grimmer, Karen; Louw, Quinette; Young, Taryn] Stellenbosch Univ, Ctr Evidence Based Hlth Care CEBHC, Cape Town, South Africa	South African Medical Research Council; Stellenbosch University; Stellenbosch University	Grimmer, K (corresponding author), Stellenbosch Univ, Physiotherapy Dept, Fac Med & Hlth Sci, Cape Town, South Africa.; Grimmer, K (corresponding author), Stellenbosch Univ, Ctr Evidence Based Hlth Care CEBHC, Cape Town, South Africa.	ubiquitous598@hotmail.com	; Grimmer, Karen/F-3984-2013	Kredo, Tamara/0000-0001-7115-9535; Grimmer, Karen/0000-0002-9540-458X; Young, Taryn/0000-0003-2406-081X	South African Medical Research Council Intramural Flagship [131122]	South African Medical Research Council Intramural Flagship	This work was supported by the South African Medical Research Council Intramural Flagship grant 131122 obtained in 2013 by the authorship team, principal investigator Dr Tamara Kredo (www.mrc.ac.za). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SAMJ S AFR MED J; Barnett KN, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0133-9; Bhatia M, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-13; Bramesfeld A., 2016, GUID INT NETW C PHIL; Brouwers MC, 2010, PREV MED, V51, P421, DOI 10.1016/j.ypmed.2010.08.005; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Creswell J. W., 2007, HDB MIXED METHODS SO, P209, DOI DOI 10.4135/9781506335193; Dizon Janine Margarita, 2016, BMC Res Notes, V9, P442, DOI 10.1186/s13104-016-2244-7; Dwyer T., 2013, ELECT J BUSINESS RES, V11, P55; Field MJ, 1990, CLIN PRACTICE GUIDEL, P38; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Johnson R. B., 2004, ED RES, V33, P14, DOI [10.3102/0013189X033007014, DOI 10.3102/0013189X033007014]; Kohn M., 2016, GUID INT NETW C PHIL; Kredo T, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-1; Kredo T, 2016, INT J QUAL HEALTH C, V28, P122, DOI 10.1093/intqhc/mzv115; Kredo T, 2016, SAMJ S AFR MED J, V106, P18, DOI [10.7196/SAMJ.2016.v106i1.10286, 10.7196/SAMJ.2016.V106I1.10286]; Lomazzi M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23695; Machingaidze S, 2017, J CLIN EPIDEMIOL, V83, P31, DOI 10.1016/j.jclinepi.2016.09.015; Machingaidze S, 2015, SAMJ S AFR MED J, V105, P743, DOI 10.7196/SAMJnew.7697; Dizon JM, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0145-9; Moosa S, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-125; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Schaay N, 2011, OVER HLTH SECT REF S; Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237; WHO and UNICEF, 1994, NAT HLTH PLAN S AFR; Yamaguchi N., 2016, GUID INT NETW C PHIL; 2011, CLIN PRACTICE GUIDEL, P1	27	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195025	10.1371/journal.pone.0195025	http://dx.doi.org/10.1371/journal.pone.0195025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601611	Green Submitted, Green Published, gold			2022-12-27	WOS:000428845900014
J	Coletta, NA; Mallette, MM; Gabriel, DA; Tyler, CJ; Cheung, SS				Coletta, Nico A.; Mallette, Matthew M.; Gabriel, David A.; Tyler, Christopher J.; Cheung, Stephen S.			Core and skin temperature influences on the surface electromyographic responses to an isometric force and position task	PLOS ONE			English	Article							PREDICTING BODY DENSITY; MOTOR UNIT RECRUITMENT; ELBOW FLEXOR MUSCLES; PASSIVE HYPERTHERMIA; FATIGUING CONTRACTIONS; NEUROMUSCULAR FUNCTION; GENERALIZED EQUATIONS; ACTIVATION; PERFORMANCE; EXERCISE	The large body of work demonstrating hyperthermic impairment of neuromuscular function has utilized maximal isometric contractions, but extrapolating these findings to whole-body exercise and submaximal, dynamic contractions may be problematic. We isolated and compared core and skin temperature influences on an isometric force task versus a position task requiring dynamic maintenance of joint angle. Surface electromyography (sEMG) was measured on the flexor carpi radialis at 60% of baseline maximal voluntary contraction while either pushing against a rigid restraint (force task) or while maintaining a constant wrist angle and supporting an equivalent inertial load (position task). Twenty participants performed each task at 0.5 degrees C rectal temperature (T-re) intervals while being passively heated from 37.1 +/- 0.3 degrees C to >= 1.5 degrees C T-re and then cooled to 37.8 +/- 0.3 degrees C, permitting separate analyses of core versus skin temperature influences. During a 3-s contraction, trend analysis revealed a quadratic trend that peaked during hyperthermia for root-mean-square (RMS) amplitude during the force task. In contrast, RMS amplitude during the position task remained stable with passive heating, then rapidly increased with the initial decrease in skin temperature at the onset of passive cooling (p = 0.010). Combined hot core and hot skin elicited shifts toward higher frequencies in the sEMG signal during the force task (p = 0.003), whereas inconsistent changes in the frequency spectra occurred for the position task. Based on the patterns of RMS amplitude in response to thermal stress, we conclude that core temperature was the primary thermal afferent influencing neuromuscular response during a submaximal force task, with minimal input from skin temperature. However, skin temperature was the primary thermal afferent during a position task with minimal core temperature influence. Therefore, temperature has a task-dependent impact on neuromuscular responses.	[Coletta, Nico A.; Mallette, Matthew M.; Gabriel, David A.; Cheung, Stephen S.] Brock Univ, Dept Kinesiol, St Catharines, ON, Canada; [Tyler, Christopher J.] Univ Roehampton, Dept Life Sci, London, England	Brock University; Roehampton University	Cheung, SS (corresponding author), Brock Univ, Dept Kinesiol, St Catharines, ON, Canada.	scheung@brocku.ca	Cheung, Stephen/HGU-6191-2022; Tyler, Chris/AAG-1087-2020; Cheung, Stephen/AAE-9136-2020	Cheung, Stephen/0000-0002-6149-4978; Mallette, Matthew/0000-0003-4582-2713; Tyler, Christopher/0000-0002-3233-0771				BELL DG, 1993, EUR J APPL PHYSIOL O, V67, P256, DOI 10.1007/BF00864225; Bigland-Ritchie B, 1981, Exerc Sport Sci Rev, V9, P75; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BUCHANAN TS, 1995, NEUROSCI LETT, V194, P61, DOI 10.1016/0304-3940(95)11727-E; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Cheung SS, 2004, EXERC SPORT SCI REV, V32, P100, DOI 10.1097/00003677-200407000-00005; Cheung SS, 2004, EUR J APPL PHYSIOL, V91, P723, DOI 10.1007/s00421-004-1062-0; Cheung SS, 2007, APPL PHYSIOL NUTR ME, V32, P808, DOI 10.1139/H07-043; Dimitrov GV, 2008, J ELECTROMYOGR KINES, V18, P35, DOI 10.1016/j.jelekin.2006.07.002; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Enoka RM, 2002, MUSCLE NERVE, V25, P763, DOI 10.1002/mus.10117; FALLENTIN N, 1993, EUR J APPL PHYSIOL O, V67, P335, DOI 10.1007/BF00357632; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Green LA, 2015, MUSCLE NERVE, V52, P818, DOI 10.1002/mus.24631; Green LA, 2014, APPL PHYSIOL NUTR ME, V39, P275, DOI 10.1139/apnm-2013-0253; Hakkinen K, 1994, Electromyogr Clin Neurophysiol, V34, P205; Hunter SK, 2016, J APPL PHYSIOL, V121, P982, DOI 10.1152/japplphysiol.00475.2016; Hunter SK, 2003, J APPL PHYSIOL, V94, P2439, DOI 10.1152/japplphysiol.01038.2002; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; Ivanova T, 1997, MUSCLE NERVE, V20, P867, DOI 10.1002/(SICI)1097-4598(199707)20:7<867::AID-MUS11>3.0.CO;2-P; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Kent-Braun JA, 2012, COMPR PHYSIOL, V2, P997, DOI 10.1002/cphy.c110029; Masuda K, 1999, J ELECTROMYOGR KINES, V9, P39, DOI 10.1016/S1050-6411(98)00021-2; Mero A., 1981, SCAND J SPORTS SCI, V3, P16; MORITANI T, 1987, EUR J APPL PHYSIOL, V56, P260, DOI 10.1007/BF00690890; Morrison S, 2004, EUR J APPL PHYSIOL, V91, P729, DOI 10.1007/s00421-004-1063-z; Morrison SA, 2006, MED SCI SPORT EXER, V38, P1754, DOI 10.1249/01.mss.0000230120.83641.98; Morrison SA, 2009, APPL PHYSIOL NUTR ME, V34, P66, DOI 10.1139/H08-139; MURPHY AJ, 1994, EUR J APPL PHYSIOL O, V69, P250, DOI 10.1007/BF01094797; Murphy AJ, 1996, EUR J APPL PHYSIOL O, V73, P353, DOI 10.1007/BF02425498; NAKAZAWA K, 1993, EUR J APPL PHYSIOL O, V66, P214, DOI 10.1007/BF00235096; NARDONE A, 1989, J PHYSIOL-LONDON, V409, P451, DOI 10.1113/jphysiol.1989.sp017507; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01204.x; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Roman-Liu D, 2016, INT J OCCUP SAF ERGO, V22, P77, DOI 10.1080/10803548.2015.1116817; Rutkove SB, 2001, MUSCLE NERVE, V24, P867, DOI 10.1002/mus.1084.abs; Rutkove SB, 1997, MUSCLE NERVE, V20, P431, DOI 10.1002/(SICI)1097-4598(199704)20:4<431::AID-MUS5>3.0.CO;2-B; Thomas MM, 2006, J APPL PHYSIOL, V100, P1361, DOI 10.1152/japplphysiol.00945.2005; Todd G, 2005, J PHYSIOL-LONDON, V563, P621, DOI 10.1113/jphysiol.2004.077115; Watanabe K, 2010, J ELECTROMYOGR KINES, V20, P661, DOI 10.1016/j.jelekin.2010.01.003; WINKEL J, 1991, EUR J APPL PHYSIOL O, V63, P345, DOI 10.1007/BF00364460	43	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195219	10.1371/journal.pone.0195219	http://dx.doi.org/10.1371/journal.pone.0195219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596491	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000092
J	Lee, MS; Hwang, JW; Lee, CS; Kim, JY; Lee, JH; Kim, E; Chang, HY; Bae, S; Park, JH; Bhang, SY				Lee, Mi-Sun; Hwang, Jun-Won; Lee, Cheol-Soon; Kim, Ji-Youn; Lee, Ju-Hyun; Kim, Eunji; Chang, Hyoung Yoon; Bae, SeungMin; Park, Jang-Ho; Bhang, Soo-Young			Development of post-disaster psychosocial evaluation and intervention for children: Results of a South Korean delphi panel survey	PLOS ONE			English	Article							MENTAL-HEALTH; RESEARCH PRIORITIES; HURRICANE KATRINA; GUIDELINES; TRAUMA; ADOLESCENTS; DISASTERS; SUPPORT; CARE	Objective This study aimed to administer a Delphi panel survey and provide evidence for the development of a psychological intervention protocol for use after disasters in South Korea. Method A three-round Delphi survey was conducted. In all rounds, respondents answered open-or closed-ended questions regarding their views on i) the concept of disaster, ii) evaluation, iii) intervention, and iv) considerations in a disaster. Data from Round 1 were subjected to content analysis. In Round 2, items with content validity ratios (CVRs) greater than 0.49 were included, and in Round 3, items with a CVR >= 0.38 were accepted. Results The response rates for the Delphi survey were high: 83% (n = 15, Round 1), 80% (n = 16, Round 2), and 86% (n = 24, Round 3). The data collected during this survey showed a need for a support system for children; for preventive strategies, including disaster readiness plans; for the protection of children's safety; and for the development of post-disaster psychosocial care. Conclusions The panel experts reached a consensus regarding the steps they considered critical in postdisaster evaluation and intervention. The findings suggest a unified model for advancing the development of the Korean version of an intervention protocol for children and adolescents exposed to traumatic events.	[Lee, Mi-Sun] Eulji Univ Hosp, Dept Psychiat, Seoul, South Korea; [Hwang, Jun-Won] Kangwon Natl Univ, Sch Med, Dept Psychiat, Chunchon, South Korea; [Lee, Cheol-Soon] Gyeongsang Natl Univ, Sch Med, Changwon Hosp, Dept Psychiat, Chang Won, South Korea; [Kim, Ji-Youn] Goodmind Psychiat Clin, Suwon, South Korea; [Lee, Ju-Hyun] Inarae Psychiat Clin, Seoul, South Korea; [Kim, Eunji] Todak Psychiat Clin, Ansan, South Korea; [Chang, Hyoung Yoon] Ajou Univ, Sch Med, Dept Psychiat, Suwon, South Korea; [Chang, Hyoung Yoon] Sunflower Ctr Southern Gyeonggi Women & Children, Suwon, South Korea; [Bae, SeungMin] Gachon Univ Gil Med Ctr, Dept Psychiat, Incheon, South Korea; [Park, Jang-Ho] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Psychiat, Ulsan, South Korea; [Bhang, Soo-Young] Eulji Univ, Sch Med, Eulji Univ Hosp, Dept Psychiat, Seoul, South Korea	Eulji University; Kangwon National University; Gyeongsang National University; Ajou University; Gachon University; University of Ulsan; Ulsan University Hospital; Eulji University	Bhang, SY (corresponding author), Eulji Univ, Sch Med, Eulji Univ Hosp, Dept Psychiat, Seoul, South Korea.	dresme@dreamwiz.com	Lee, Mi-Sun/P-4276-2019	Lee, Mi-Sun/0000-0003-2918-0546; Bhang, Soo-Young/0000-0001-5254-0314				Adams ZW, 2014, J CHILD PSYCHOL PSYC, V55, P1047, DOI 10.1111/jcpp.12220; Ager A, 2010, CHILD DEV, V81, P1271, DOI 10.1111/j.1467-8624.2010.01467.x; Aronson BD, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe767125; Association TKN, 2014, KOREAN NEUROPSYCHIAT, V54, P6; Ayub M, 2012, CHILD PSYCHIAT HUM D, V43, P323, DOI 10.1007/s10578-011-0267-9; Barrett T, 2011, INTERVENTION, V9, P159, DOI 10.1097/WTF.0b013e328348dfd2; Birko S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135162; Birko S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129706; Bolton D, 2000, J CHILD PSYCHOL PSYC, V41, P513, DOI 10.1111/1469-7610.00636; Cain D.S., 2010, J CHILD ADOLESCENT T, V3, P330, DOI [10.1080/19361521.2010.523063, DOI 10.1080/19361521.2010.523063, https://doi.org/10.1080/19361521.2010.523063]; Cohen JA, 1998, J AM ACAD CHILD PSY, V37, p4S, DOI 10.1097/00004583-199810001-00002; Cohen JA, 2009, CLIN CHILD FAM PSYCH, V12, P55, DOI 10.1007/s10567-009-0039-2; Colagiuri R, 2015, INT J ENV RES PUB HE, V12, P12941, DOI 10.3390/ijerph121012941; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Diab M, 2015, CHILD ABUSE NEGLECT, V40, P24, DOI 10.1016/j.chiabu.2014.12.002; Dimitry L, 2012, CHILD CARE HLTH DEV, V38, P153, DOI 10.1111/j.1365-2214.2011.01246.x; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Jackson KA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007609; Jangho Park，, 2016, [Korean Journal of Child & Adolescent Psychiatry, 소아 청소년 정신의학], V27, P164, DOI 10.5765/jkacap.2016.27.3.163; Jaycox Lisa H, 2009, School Ment Health, V1, P49; Jaycox LH, 2010, J TRAUMA STRESS, V23, P223, DOI 10.1002/jts.20518; Kong LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134125; La Greca AM, 2010, J CONSULT CLIN PSYCH, V78, P794, DOI 10.1037/a0020775; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Lucio R, 2016, J EVID-INFORM SOC WO, V13, P469, DOI 10.1080/23761407.2016.1166839; Maarsingh OR, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-12; Ohan JL, 2002, J AM ACAD CHILD PSY, V41, P1401, DOI 10.1097/00004583-200212000-00012; Ostad Taghizadeh A, 2013, Ann Burns Fire Disasters, V26, P44; Pfefferbaum B, 2014, PREHOSPITAL DISASTER, V29, P494, DOI 10.1017/S1049023X14000910; Pfefferbaum B, 2014, CHILD ADOL PSYCH CL, V23, P363, DOI 10.1016/j.chc.2013.12.006; Pfefferbaum B, 2012, PREHOSP DISASTER MED, V27, P567, DOI 10.1017/S1049023X12001343; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Saylor C., 2002, HELPING CHILDREN COP, P35; Schoenly L, 2015, J CORRECT HEALTH CAR, V21, P400, DOI 10.1177/1078345815600257; Taylor RM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011361; Twycross A, 2001, J ADV NURS, V34, P51, DOI 10.1046/j.1365-2648.2001.3411734.x; van de Glind I, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-015-0195-y; van Ommeren M, 2015, E MEDITERR HEALTH J, V21, P498; Wang HR, 2014, PSYCHIAT INVEST, V11, P1, DOI 10.4306/pi.2014.11.1.1; Wilson FR, 2012, MEAS EVAL COUNS DEV, V45, P197, DOI 10.1177/0748175612440286; Yoon MK, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0083-5	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195235	10.1371/journal.pone.0195235	http://dx.doi.org/10.1371/journal.pone.0195235			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596483	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000097
J	Liakoni, E; Gartwyl, F; Ricklin, M; Exadaktylos, AK; Krahenbuhl, S				Liakoni, Evangelia; Gartwyl, Fabienne; Ricklin, Meret; Exadaktylos, Aristomenis K.; Krahenbuhl, Stephan			Psychoactive substances and violent offences: A retrospective analysis of presentations to an urban emergency department in Switzerland	PLOS ONE			English	Article							ACUTE RECREATIONAL DRUG; CANNABIS USE; COCAINE; ALCOHOL; ABUSE; MARIJUANA; HOMICIDE; TOXICITY; INJURIES	Background Psychoactive substances are often regarded as causal factors contributing to violent injuries, sexual abuse and homicides. While these effects have been demonstrated for some substances (e.g. cocaine), current available data for others are more controversial (e.g. cannabis) or very limited (e.g. ecstasy). Aims of the study To collect data on the type and frequency of psychoactive substance use in cases of emergency department (ED) presentations related to interpersonal violence. Methods Retrospective study at the University Hospital of Bern, Switzerland, between May 2012 and June 2016. The study covered cases of violent crime associated with psychoactive substances. Cases of isolated ethanol intoxication, suicide attempts, and substance use for medical purposes were excluded. Results The study included 103 cases among the 164,846 ED attendances. In the majority of the cases, the type of violence was bodily force (52%) related to urban violence (83%). The mean patient age was 29 years and 79% were male. 63% of the patients reported use of more than one drug; alcohol co-use was reported in 60% of the cases. Besides alcohol, the substances most often reported were cannabis (50%) and cocaine (21%). Alcohol and cannabis was also the most commonly reported substance combination (36% of the total cases). Urine drug screening was performed in 34% of the cases and cannabis and cocaine were the most commonly detected substances (46% and 19%, respectively). There were no cases of novel substances. 23% of the patients were admitted to a hospital ward, 10% to a psychiatric clinic. Conclusion Cannabis and cocaine were, besides alcohol, the substances most often reported in ED presentations related to offences of violence. Because of the high prevalence of alcohol co-use, no final conclusions can be drawn on the contribution of single substances.	[Liakoni, Evangelia; Gartwyl, Fabienne; Krahenbuhl, Stephan] Univ Bern, Bern Univ Hosp, Inselspital, Clin Pharmacol & Toxicol,Dept Gen Internal Med, Bern, Switzerland; [Liakoni, Evangelia; Gartwyl, Fabienne] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Ricklin, Meret; Exadaktylos, Aristomenis K.] Univ Bern, Bern Univ Hosp, Emergency Dept, Inselspital, Bern, Switzerland; [Krahenbuhl, Stephan] Basel Univ Hosp, Div Clin Pharmacol & Toxicol, Basel, Switzerland; [Krahenbuhl, Stephan] Univ Basel, Basel, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Basel; University of Basel	Liakoni, E (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Clin Pharmacol & Toxicol,Dept Gen Internal Med, Bern, Switzerland.; Liakoni, E (corresponding author), Univ Bern, Inst Pharmacol, Bern, Switzerland.	Evangelia.liakoni@insel.ch	Krähenbühl, Stephan/Z-4744-2019; Ricklin, Meret Elisabeth/AAY-7948-2021	Ricklin, Meret Elisabeth/0000-0003-3047-9350				Aderjan R, 2011, RICHTLINIEN BESTIMMU; [Anonymous], 2013, TOX DRUG SCREEN PROD; [Anonymous], 2016, TRENDS DEV; Blondell RD, 2005, J TRAUMA, V58, P561, DOI 10.1097/01.TA.0000152638.54978.53; Boles SM, 2003, AGGRESS VIOLENT BEH, V8, P155, DOI 10.1016/S1359-1789(01)00057-X; Buchan BJ, 2002, ADDICTION, V97, P98, DOI 10.1046/j.1360-0443.97.s01.1.x; Capriola M, 2013, CLIN PHARMACOL-ADV A, V5, P109, DOI 10.2147/CPAA.S42832; Chermack ST, 2002, DRUG ALCOHOL DEPEN, V66, P29, DOI 10.1016/S0376-8716(01)00180-6; Cherpitel CJ, 2013, AM J ADDICTION, V22, P87, DOI 10.1111/j.1521-0391.2013.00316.x; Dines AM, 2015, J MED TOXICOL, V11, P415, DOI 10.1007/s13181-014-0460-x; Dines AM, 2015, CLIN TOXICOL, V53, P893, DOI 10.3109/15563650.2015.1088157; EMCDDA (European Drug Report), 2014, TRENDS DEV; Falck R S, 2001, Violence Vict, V16, P79; Franklin FA, 2010, WEST J EMERG MED, V11, P283; Freeman D, 2015, SCHIZOPHRENIA BULL, V41, P391, DOI 10.1093/schbul/sbu098; Friedman AS, 2001, J ADDICT DIS, V20, P49, DOI 10.1300/J069v20n01_06; Gmel G, 2014, SUCHTMONITORING SCHW; Gmel G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-40; Grisso JA, 1999, NEW ENGL J MED, V341, P1899, DOI 10.1056/NEJM199912163412506; Gunderson EW, 2014, SUBST ABUS, V35, P184, DOI 10.1080/08897077.2013.846288; HANZLICK R, 1991, JAMA-J AM MED ASSOC, V265, P760, DOI 10.1001/jama.265.6.760; HARRUFF RC, 1988, J FORENSIC SCI, V33, P1231; Hill SL, 2011, CLIN TOXICOL PHILA, V49; Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033; Kilpatrick DG, 1997, J CONSULT CLIN PSYCH, V65, P834, DOI 10.1037/0022-006X.65.5.834; Korcha RA, 2014, DRUG ALCOHOL REV, V33, P43, DOI 10.1111/dar.12087; Liakoni E, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0369-x; Liakoni E, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0068-7; Liakoni E, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14166; LICATA A, 1993, PHARMACOL BIOCHEM BE, V45, P549, DOI 10.1016/0091-3057(93)90504-M; Lupi M, 2017, EAT WEIGHT DISORD-ST, V22, P619, DOI 10.1007/s40519-017-0429-2; Lynd LD, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-5; Macdonald S, 2008, ADDICT BEHAV, V33, P201, DOI 10.1016/j.addbeh.2007.07.002; Martinotti G, 2017, CNS NEUROL DISORD-DR, V16, P567, DOI 10.2174/1871527316666170413101839; Martinotti G, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2586; Moore TM, 2005, AGGRESS VIOLENT BEH, V10, P171, DOI 10.1016/j.avb.2003.10.002; Shafi A, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2606; Tardiff K, 1997, AM J PSYCHIAT, V154, P88; Vaughn MG, 2010, AM J DRUG ALCOHOL AB, V36, P181, DOI 10.3109/00952990.2010.491877; Wood DM, 2014, CLIN TOXICOL, V52, P239, DOI 10.3109/15563650.2014.898771	40	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195234	10.1371/journal.pone.0195234	http://dx.doi.org/10.1371/journal.pone.0195234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596473	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000096
J	Sugiyama, M; Kikuchi, A; Misu, H; Igawa, H; Ashihara, M; Kushima, Y; Honda, K; Suzuki, Y; Kawabe, Y; Kaneko, S; Takamura, T				Sugiyama, Masakazu; Kikuchi, Akihiro; Misu, Hirofumi; Igawa, Hirobumi; Ashihara, Motooki; Kushima, Youichi; Honda, Kiyofumi; Suzuki, Yoshiyuki; Kawabe, Yoshiki; Kaneko, Shuichi; Takamura, Toshinari			Inhibin beta E (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; GROWTH-HORMONE; MUSCLE MASS; ACTIVIN; DISEASE; OBESITY; GLUCOSE; CLONING; MICE; SUBUNITS	The liver plays a major role in whole-body energy homeostasis by releasing secretory factors, termed hepatokines. To identify novel target genes associated with insulin resistance, we performed a comprehensive analysis of gene expression profiles using a DNA chip method in liver biopsy samples from humans with varying degrees of insulin resistance. Inhibin beta E (INHBE) was identified as a novel putative hepatokine with hepatic gene expression that positively correlated with insulin resistance and body mass index in humans. Quantitative real time-PCR analysis also showed an increase in INHBE gene expression in independent liver samples from insulin-resistant human subjects. Additionally, Inhbe gene expression increased in the livers of db/db mice, a rodent model of type 2 diabetes. To preliminarily screen the role of Inhbe in vivo in whole-body energy metabolic status, hepatic mRNA was knocked down with siRNA for Inhbe (siINHBE) in db/db mice. Treatment with siINHBE suppressed body weight gain during the two-week experimental period, which was attributable to diminished fat rather than lean mass. Additionally, treatment with siINHBE decreased the respiratory quotient and increased plasma total ketone bodies compared with treatment with non-targeting siRNA, both of which suggest enhanced whole-body fat utilization. Our study suggests that INHBE functions as a possible hepatokine to alter the whole-body metabolic status under obese insulin-resistant conditions.	[Sugiyama, Masakazu; Ashihara, Motooki; Kushima, Youichi; Honda, Kiyofumi; Suzuki, Yoshiyuki; Kawabe, Yoshiki] Chugai Pharmaceut Co Ltd, Res Div, Gotemba, Shizuoka, Japan; [Kikuchi, Akihiro; Misu, Hirofumi; Igawa, Hirobumi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Endocrinol & Metab, Kanazawa, Ishikawa, Japan; [Kikuchi, Akihiro; Igawa, Hirobumi; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Syst Biol, Kanazawa, Ishikawa, Japan; [Misu, Hirofumi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST)	Kikuchi, A; Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Endocrinol & Metab, Kanazawa, Ishikawa, Japan.; Kikuchi, A (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Syst Biol, Kanazawa, Ishikawa, Japan.	akikuchi@mail.kanazwa-u.ac.jp; ttakamura@med.kanazawa-u.ac.jp		Kawabe, Yoshiki/0000-0002-6465-7146; Suzuki, Yoshiyuki/0000-0002-0801-7793	Grants-in-Aid for Scientific Research [17K09822] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bramnert M, 2003, J CLIN ENDOCR METAB, V88, P1455, DOI 10.1210/jc.2002-020542; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Chabicovsky M, 2003, ENDOCRINOLOGY, V144, P3497, DOI 10.1210/en.2003-0388; Chen JJ, 2014, SCI WORLD J, DOI 10.1155/2014/416530; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cusi K, 2016, DIABETOLOGIA, V59, P1112, DOI 10.1007/s00125-016-3952-1; Fang JM, 1996, BIOCHEM BIOPH RES CO, V228, P669, DOI 10.1006/bbrc.1996.1715; Fang JM, 1997, BIOCHEM BIOPH RES CO, V231, P655, DOI 10.1006/bbrc.1997.6162; Hashimoto O, 2002, MOL CELL ENDOCRINOL, V194, P117, DOI 10.1016/S0303-7207(02)00157-0; Hashimoto O, 2006, BIOCHEM BIOPH RES CO, V341, P416, DOI 10.1016/j.bbrc.2005.12.205; Hashimoto O, 2011, VITAM HORM, V85, P217, DOI 10.1016/B978-0-12-385961-7.00011-1; Hashimoto O, 2009, LIFE SCI, V85, P534, DOI 10.1016/j.lfs.2009.08.007; Kang HP, 2012, DIABETOLOGIA, V55, P2205, DOI 10.1007/s00125-012-2568-3; Kubota N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12977; Kubota T, 2017, CELL METAB, V25, P797, DOI 10.1016/j.cmet.2017.03.004; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Lau AL, 2000, MOL CELL BIOL, V20, P6127, DOI 10.1128/MCB.20.16.6127-6137.2000; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Leslie RD, 2016, DIABETOLOGIA, V59, P13, DOI 10.1007/s00125-015-3789-z; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Magnusson B, 2010, BIOCHEM BIOPH RES CO, V395, P373, DOI 10.1016/j.bbrc.2010.04.022; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; O'Bryan MK, 2000, J MOL ENDOCRINOL, V24, P409, DOI 10.1677/jme.0.0240409; Otero YF, 2014, J BIOL CHEM, V289, P20462, DOI 10.1074/jbc.R114.576355; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Rodt T, 2011, ACTA RADIOL, V52, P75, DOI 10.1258/ar.2010.100059; Sekiyama K, 2009, BIOCHEM BIOPH RES CO, V385, P319, DOI 10.1016/j.bbrc.2009.05.054; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Takamura T, 2008, OBESITY, V16, P2601, DOI 10.1038/oby.2008.419; Vejda S, 2002, J MOL ENDOCRINOL, V28, P137, DOI 10.1677/jme.0.0280137; Vejda S, 2003, CARCINOGENESIS, V24, P1801, DOI 10.1093/carcin/bgg154; Wada W, 2005, ENDOCR J, V52, P169, DOI 10.1507/endocrj.52.169	37	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194798	10.1371/journal.pone.0194798	http://dx.doi.org/10.1371/journal.pone.0194798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596463	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000043
J	Turton, JL; Raab, R; Rooney, KB				Turton, Jessica L.; Raab, Ron; Rooney, Kieron B.			Low-carbohydrate diets for type 1 diabetes mellitus: A systematic review	PLOS ONE			English	Review							GLYCEMIC CONTROL; METABOLIC-CONTROL; INSULIN THERAPY; RISK; HYPERINSULINEMIA; COMPLICATIONS; MORTALITY; DISEASE; WEIGHT; ADULTS	Type 1 diabetes is an autoimmune condition characterised by pancreatic beta cell destruction and absolute insulin deficiency. The strongest predictor of diabetes complications is glycaemic control and achieving HbA1c <= 7.0% is the primary management target. However, standard treatment appears to be lacking and adjunctive strategies require consideration. A systematic review was conducted to examine the effect of low-carbohydrate diets on type 1 diabetes management. Four databases were searched from inception until 28 March 2017: MEDLINE; CINAHL; Cochrane Library; and EMBASE. All primary studies containing a methods section (excluding cross-sectional) were included. Reports had to quantitatively measure the effect(s) of a dietary intervention or observed intake over at least two weeks where carbohydrate is below 45% total energy in adults and/or children with type 1 diabetes. The primary outcome was HbA1c and secondary outcomes were severe hypoglycaemia, total daily insulin, BMI, quality of life and mean daily glucose. Seventy-nine full-text articles were assessed for eligibility and nine were included (two randomised controlled trials, four pre-post interventions, two case-series, one case-report). Eight studies reported a mean change in HbA1c with a low-carbohydrate diet. Of these, four reported a non-significant change (P >= 0.05) and three reported statistically significant reductions (P < 0.05). Two studies reported severe hypoglycaemia, five reported total insulin, three reported BMI, and one reported blood glucose. Due to the significant heterogeneity of included studies, an overall effect could not be determined. This review presents all available evidence on low-carbohydrate diets for type 1 diabetes and suggests an urgent need for more primary studies.	[Turton, Jessica L.] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Discipline Nutr & Dietet, Sydney, NSW, Australia; [Raab, Ron] Insulin Life Australia, Melbourne, Vic, Australia; [Rooney, Kieron B.] Univ Sydney, Charles Perkins Ctr, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney	Rooney, KB (corresponding author), Univ Sydney, Charles Perkins Ctr, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW, Australia.	kieron.rooney@sydney.edu.au	Rooney, Kieron/I-6252-2018	Rooney, Kieron/0000-0001-6563-7617; Turton, Jessica/0000-0003-2263-9350				ANDERSON JW, 1991, AM J CLIN NUTR, V54, P936, DOI 10.1093/ajcn/54.5.936; [Anonymous], 2006, NUTR REF VAL AUSTR N; BERNSTEIN RK, 1980, DIABETES CARE, V3, P140, DOI 10.2337/diacare.3.1.140; Bernstein RK, 2011, BERNSTEINS DIABETES; Buyken AE, 2000, DIABETIC MED, V17, P351, DOI 10.1046/j.1464-5491.2000.00283.x; CHANTELAU E, 1982, DIABETES CARE, V5, P612, DOI 10.2337/diacare.5.6.612; Chartres N, 2017, ASS IND SPONSORSHIP; Cheung NW, 2009, AUSTR DIABETES SOC P; Cochrane Collaboration, 2014, DAT COLL FORMS INT R; Cochrane Methods Bias Group, 2016, RISK BIAS NON RAND S; Craig M., 2011, NATL EVIDENCE BASED; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Feinman RD, 2015, NUTRITION, V31, P1, DOI 10.1016/j.nut.2014.06.011; Garcia-Romero G, 2006, CURR DIABETES REV, V2, P39, DOI 10.2174/157339906775473635; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; IRELAND P, 1992, DIABETES CARE, V15, P1499, DOI 10.2337/diacare.15.11.1499; Juutilainen A, 2008, DIABETES CARE, V31, P714, DOI 10.2337/dc07-2124; Knight BA, 2016, DIABETES RES CLIN PR, V116, P36, DOI 10.1016/j.diabres.2016.03.016; Krebs JD, 2016, ASIA PAC J CLIN NUTR, V25, P78, DOI 10.6133/apjcn.2016.25.1.11; Lawton J, 2011, DIABETES RES CLIN PR, V91, P87, DOI 10.1016/j.diabres.2010.11.007; Lehto S, 1999, ARTERIOSCL THROM VAS, V19, P1014, DOI 10.1161/01.ATV.19.4.1014; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676; Merlin T, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-34; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; National Institutes of Health, 2014, QUAL ASS TOOL PREP S; Nielsen JV, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-23; O' Neill Daniel F, 2003, Metab Syndr Relat Disord, V1, P291, DOI 10.1089/1540419031361345; Osler W, 1920, PRINCIPLES PRACTICE; Purnell JQ, 1998, JAMA-J AM MED ASSOC, V280, P140, DOI 10.1001/jama.280.2.140; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; The Joanna Briggs Institute, 2016, JOANN BRIGGS I REV M; Thorn LM, 2009, DIABETES CARE, V32, P950, DOI 10.2337/dc08-2022; Vernon MC, 2003, METAB SYNDR RELAT D, V1, P233, DOI 10.1089/154041903322716714; Wang MY, 2013, J DIABETES COMPLICAT, V27, P70, DOI 10.1016/j.jdiacomp.2012.08.008; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011	37	51	52	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194987	10.1371/journal.pone.0194987	http://dx.doi.org/10.1371/journal.pone.0194987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596460	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000061
J	Cheng, F; Zhang, M; Wang, Q; Xu, HJ; Dong, X; Gao, Z; Chen, JJ; Wei, YJ; Qin, F				Cheng, Fei; Zhang, Mi; Wang, Quan; Xu, Haijun; Dong, Xiao; Gao, Zhen; Chen, Jiajuan; Wei, Yunjie; Qin, Fen			Tooth loss and risk of cardiovascular disease and stroke: A dose-response meta analysis of prospective cohort studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERIODONTAL-DISEASE; STATISTICS-2012 UPDATE; ORAL-HEALTH; MORTALITY; TEETH; ASSOCIATIONS; INFLAMMATION; CANCER; MEN	Conflicting results identifying the association between tooth loss and cardiovascular disease and stroke have been reported. Therefore, a dose-response meta-analysis was performed to clarify and quantitatively assess the correlation between tooth loss and cardiovascular disease and stroke risk. Up to March 2017, seventeen cohort studies were included in current meta-analysis, involving a total of 879084 participants with 43750 incident cases. Our results showed statistically significant increment association between tooth loss and cardiovascular disease and stroke risk. Subgroups analysis indicated that tooth loss was associated with a significant risk of cardiovascular disease and stroke in Asia and Caucasian. Furthermore, tooth loss was associated with a significant risk of cardiovascular disease and stroke in fatal cases and nonfatal cases. Additionally, a significant dose-response relationship was observed between tooth loss and cardiovascular disease and stroke risk. Increasing per 2 of tooth loss was associated with a 3% increment of coronary heart disease risk; increasing per 2 of tooth loss was associated with a 3% increment of stroke risk. Subgroup meta-analyses in study design, study quality, number of participants and number of cases showed consistent findings. No publication bias was observed in this meta-analysis. Considering these promising results, tooth loss might provide harmful health benefits.	[Cheng, Fei; Zhang, Mi; Xu, Haijun; Dong, Xiao; Gao, Zhen; Chen, Jiajuan; Wei, Yunjie] Hubei Univ Med, Taihe Hosp, Dept Cardiol, Shiyan, Hubei, Peoples R China; [Wang, Quan] Hubei Univ Med, Taihe Hosp, Dept Stomatol, Shiyan, Hubei, Peoples R China; [Qin, Fen] Hubei Univ Med, Taihe Hosp, Dept Obstet & Gynecol, Shiyan, Hubei, Peoples R China	Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine	Qin, F (corresponding author), Hubei Univ Med, Taihe Hosp, Dept Obstet & Gynecol, Shiyan, Hubei, Peoples R China.	xuc859@sina.com						Abnet CC, 2005, INT J EPIDEMIOL, V34, P467, DOI 10.1093/ije/dyh375; Adegboye ARA, 2012, NUTRITION, V28, P779, DOI 10.1016/j.nut.2011.11.011; Awan Z, 2015, EUR J PREV CARDIOL, V22, P719, DOI 10.1177/2047487314529350; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Elter JR, 2004, J PERIODONTOL, V75, P782, DOI 10.1902/jop.2004.75.6.782; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Gerritsen AE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-126; He JZ, 2015, FOLIA MICROBIOL, V60, P69, DOI 10.1007/s12223-014-0342-2; Hiraki A, 2008, CANCER EPIDEM BIOMAR, V17, P1222, DOI 10.1158/1055-9965.EPI-07-2761; Holmlund A, 2010, J PERIODONTOL, V81, P870, DOI 10.1902/jop.2010.090680; Howell TH, 2001, J AM COLL CARDIOL, V37, P445, DOI 10.1016/S0735-1097(00)01130-X; Hujoel PP, 2001, JAMA-J AM MED ASSOC, V285, P40; Hung HC, 2004, J PUBLIC HEALTH DENT, V64, P209, DOI 10.1111/j.1752-7325.2004.tb02755.x; Joshipura KJ, 1996, J DENT RES, V75, P1631, DOI 10.1177/00220345960750090301; Joshy G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012386; Jung YS, 2014, J CLIN PERIODONTOL, V41, P262, DOI 10.1111/jcpe.12204; Liljestrand JM, 2015, J DENT RES, V94, P1055, DOI 10.1177/0022034515586352; Noguchi S, 2015, J PUBLIC HEALTH-UK, V37, P605, DOI 10.1093/pubmed/fdu076; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schwahn C, 2013, INT J CARDIOL, V167, P1430, DOI 10.1016/j.ijcard.2012.04.061; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tu YK, 2007, HEART, V93, P1098, DOI 10.1136/hrt.2006.097410; Tuominen R, 2003, J DENT RES, V82, P713, DOI 10.1177/154405910308200911; Vedin O, 2016, EUR J PREV CARDIOL, V23, P839, DOI 10.1177/2047487315621978; Watt RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030797; Xu C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000759; You ZY, 2009, ATHEROSCLEROSIS, V203, P615, DOI 10.1016/j.atherosclerosis.2008.07.037	34	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194563	10.1371/journal.pone.0194563	http://dx.doi.org/10.1371/journal.pone.0194563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590166	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100066
J	Shahid, MA; Marenda, MS; Markham, PF; Noormohammadi, AH				Shahid, Muhammad A.; Marenda, Marc S.; Markham, Philip F.; Noormohammadi, Amir H.			Complementation of the Mycoplasma synoviae MS-H vaccine strain with wild-type obg influencing its growth characteristics	PLOS ONE			English	Article							GTP-BINDING PROTEIN; 50S RIBOSOMAL-SUBUNIT; TEMPERATURE SHIFT EXPERIMENTS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PLASMID RK2; GENE; MUTANTS; GTPASES; DEGRADATION	The temperature-sensitive (ts(+)) Mycoplasma synoviae vaccine strain MS-H harbors a non-synonymous mutation which results in Glycine to Arginine substitution at position 123 in the highly conserved glycine-rich motif of Obg-fold in the GTP-binding protein Obg. In-silico analysis of the wild-type and mutant Obgs of M. synoviae has indicated that this amino acid substitution affects structure of the protein, potentially leading to abrogation of Obg function in vivo. Present study was conducted to develop the first expression vector for M. synoviae and to investigate the potential effect(s) of complementation of MS-H vaccine with the wild type obg from 86079/7NS, the parent strain of MS-H. An oriCvector, pKS-VOTL, harboring the 86079/7NS obg gene, downstream of the variable lipoprotein haemagglutinin (vIhA) gene promoter, also cloned from 86079/7NS, was used to transform MS-H. The plasmid was localised at the chromosomal oriC locus of MS-H without any detectable integration at the chromosomal obg locus. Analysis of the MS-H transformants revealed abundant obg transcripts as well as Obg protein, when compared to the MS-H transformed with a similar vector, pMAS-LoriC, lacking obg coding sequence. The MS-H transformants complemented with wild-type Obg maintained their original temperature-sensitivity phenotype (consistent with MS-H vaccine) but, when compared to the MS-H transformed with pMAS-LoriC, had significantly higher (p < 0.05) growth rate and viability at the permissive (33 degrees C) and non-permissive temperature (39.5 degrees C), respectively. Analysis of Obg expression in MS-H and its wild-type parent strain revealed comparatively lower levels of Obg in MS-H. These results indicate that not only the mutation in Obg, but also the level of Obg expression, can confer functional abnormalities in the bacterial host. Furthermore, with the construction of first expression vector for M. synoviae, this study has set foundation for the development of recombinant vaccine(s) based on MS-H.	[Shahid, Muhammad A.; Marenda, Marc S.; Noormohammadi, Amir H.] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia; [Markham, Philip F.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Shahid, Muhammad A.] Bahauddin Zakariya Univ, Dept Pathobiol, Fac Vet Sci, Multan, Punjab, Pakistan	University of Melbourne; University of Melbourne; Bahauddin Zakariya University	Shahid, MA (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia.; Shahid, MA (corresponding author), Bahauddin Zakariya Univ, Dept Pathobiol, Fac Vet Sci, Multan, Punjab, Pakistan.	drakbarshahid@gmail.com	Shahid, Muhammad Akbar/M-7608-2019	Shahid, Muhammad Akbar/0000-0003-2554-5990; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; MARENDA, MARC/0000-0001-6778-1110	University of Melbourne; Higher Education Commission of Pakistan	University of Melbourne(University of Melbourne); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Financial support to conduct this study was provided jointly by the University of Melbourne and the Higher Education Commission of Pakistan. The senior author was supported by the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 1997, J BACTERIOL, V179, P4277, DOI 10.1128/jb.179.13.4277-4284.1997; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; Cardin SE, 2017, METHODS MOL BIOL, V1617, P39, DOI 10.1007/978-1-4939-7046-9_3; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Czyz A, 2005, ACTA BIOCHIM POL, V52, P35; Datta K, 2004, MOL MICROBIOL, V54, P1379, DOI 10.1111/j.1365-2958.2004.04354.x; Dutkiewicz R, 2002, CURR MICROBIOL, V45, P440, DOI 10.1007/s00284-002-3713-x; Feng BY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001866; Foti JJ, 2007, MOL MICROBIOL, V65, P569, DOI 10.1111/j.1365-2958.2007.05811.x; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Fraser CM, 2000, EMERG INFECT DIS, V6, P505, DOI 10.3201/eid0605.000510; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; HAUGAN K, 1992, J BACTERIOL, V174, P7026, DOI 10.1128/JB.174.21.7026-7032.1992; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Karunakaran P, 1998, J BACTERIOL, V180, P3793, DOI 10.1128/JB.180.15.3793-3798.1998; Kint C, 2014, CRIT REV MICROBIOL, V40, P207, DOI 10.3109/1040841X.2013.776510; KIRSCHBAUM JB, 1975, P NATL ACAD SCI USA, V72, P2375, DOI 10.1073/pnas.72.6.2375; Kobayashi G, 2001, MOL MICROBIOL, V41, P1037, DOI 10.1046/j.1365-2958.2001.02574.x; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; Kuo S, 2008, J BACTERIOL, V190, P6625, DOI 10.1128/JB.00799-08; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; Lin B, 2001, FEBS LETT, V489, P107, DOI 10.1016/S0014-5793(00)02214-6; Meynell G.G., 1970, THEORY PRACTICE EXPT, Vsecond; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; MORROW CJ, 1990, AUST VET J, V67, P121, DOI 10.1111/j.1751-0813.1990.tb07726.x; Okamoto S, 1997, J BACTERIOL, V179, P170, DOI 10.1128/jb.179.1.170-179.1997; Okamoto S, 1998, MOL MICROBIOL, V30, P107, DOI 10.1046/j.1365-2958.1998.01042.x; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Polkinghorne A, 2011, MICROB PATHOGENESIS, V50, P200, DOI 10.1016/j.micpath.2010.12.005; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Roche, 2008, DIG APPL MANUAL FILT, P17; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Scott JM, 1999, J BACTERIOL, V181, P4653, DOI 10.1128/JB.181.15.4653-4660.1999; Shahid MA, 2014, J MICROBIOL METH, V103, P70, DOI 10.1016/j.mimet.2014.05.014; Shahid MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073954; Shahid MA, 2013, AVIAN PATHOL, V42, P185, DOI 10.1080/03079457.2013.779363; Sikora AE, 2006, J BACTERIOL, V188, P1205, DOI 10.1128/JB.188.3.1205-1210.2006; Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; VALLA S, 1991, PLASMID, V25, P131, DOI 10.1016/0147-619X(91)90025-R; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; VIDWANS SJ, 1995, J BACTERIOL, V177, P3308, DOI 10.1128/jb.177.11.3308-3311.1995; Waters P J, 2001, Curr Issues Mol Biol, V3, P57; Whithear K., 1993, AUSTR STANDARD DIAGN, P1; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194528	10.1371/journal.pone.0194528	http://dx.doi.org/10.1371/journal.pone.0194528			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590172	Green Published, gold			2022-12-27	WOS:000428603100065
J	Wang, CS; Lie, L; Liu, SY; Liao, GN; Li, L; Chen, YN; Cheng, J; Lu, Y; Li, JP				Wang, Chengshi; Lie, Ling; Liu, Shuyun; Liao, Guangneng; Li, Lan; Chen, Younan; Cheng, Jingqiu; Lu, Yanrong; Li, Jingping			GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BODY-MASS INDEX; DIABETIC-NEPHROPATHY; RENIN-ANGIOTENSIN; OXIDATIVE STRESS; PROTECTIVE ROLES; DISEASE; INFLAMMATION; INHIBITION; LIPOTOXICITY	Increasing evidence indicates that obesity is highly associated with chronic kidney disease (CKD). GLP-1 receptor (GLP-1R) agonist has shown benefits on kidney diseases, but its direct role on kidney metabolism in obesity is still not clear. This study aims to investigate the protection and metabolic modulation role of liraglutide (Lira) on kidney of obesity. Rats were induced obese by high-fat diet (HFD), and renal function and metabolism changes were evaluated by metabolomic, biological and histological methods. HFD rats exhibited systemic metabolic disorders such as obesity, hyperlipidemia and impaired glucose tolerance, as well as renal histological and function damages, while Lira significantly ameliorated these adverse effects in HFD rats. Metabolomic data showed that Lira directly reduced renal lipids including fatty acid residues, cholesterol, phospholipids and triglycerides, and improved mitochondria metabolites such as succinate, citrate, taurine, fumarate and nicotinamide adenine dinucleotide (NAD+) in the kidney of HFD rats. Furthermore, we revealed that Lira inhibited renal lipid accumulation by coordinating lipogenic and lipolytic signals, and partly rescued renal mitochondria function via Sirt1/AMPK/PGC1a pathways in HFD rats. This study suggested that Lira alleviated HFD-induced kidney injury at least partly via directly restoring renal metabolism, thus GLP-1R agonist is a promising therapy for obesity associated CKD.	[Wang, Chengshi; Liu, Shuyun; Liao, Guangneng; Li, Lan; Chen, Younan; Cheng, Jingqiu; Lu, Yanrong; Li, Jingping] Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Chengdu, Sichuan, Peoples R China; [Lie, Ling] Sichuan Univ, West China Hosp, Kidney Res Inst, Div Nephrol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Lu, Y; Li, JP (corresponding author), Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Chengdu, Sichuan, Peoples R China.	luyanrong@scu.edu.cn; liujingping@scu.edu.cn	Liu, Jingping/P-8908-2019; wang, chengshi/AAX-4864-2021	wang, chengshi/0000-0002-0650-4109; Liao, Guangneng/0000-0002-5753-827X	National Natural Science Foundation of China [31200754, 81571808]; China Postdoctoral Science Foundation [2012M511931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China, 31200754 (Dr. Jingping Liu); National Natural Science Foundation of China 81571808 (Dr. Jingping Liu); and China Postdoctoral Science Foundation, 2012M511931 (Dr. Jingping Liu).; This work was supported by grants from National Natural Science Foundation of China (31200754, 81571808) and China Postdoctoral Science Foundation (2012M511931).	Andersen K, 2017, J AM SOC NEPHROL, V28, P76, DOI 10.1681/ASN.2015111285; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Bolignano D, 2013, NEPHROL DIAL TRANSPL, V28, P82, DOI 10.1093/ndt/gft302; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cheng ZY, 2014, CELL CYCLE, V13, P890, DOI 10.4161/cc.28189; Chung HW, 2012, NEPHROL DIAL TRANSPL, V27, P2213, DOI 10.1093/ndt/gfr613; CONSOLI A, 1990, J CLIN INVEST, V86, P2038, DOI 10.1172/JCI114940; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Einbinder Y, 2016, DIABETES-METAB RES, V32, P805, DOI 10.1002/dmrr.2801; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Frederico MJS, 2011, SCAND J GASTROENTERO, V46, P1381, DOI 10.3109/00365521.2011.613945; Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Guillet C, 2012, OBES REV, V13, P51, DOI 10.1111/j.1467-789X.2012.01037.x; Han XB, 2012, AMINO ACIDS, V43, P2249, DOI 10.1007/s00726-012-1314-y; Hocher B, 2017, NAT REV NEPHROL, V13, P728, DOI 10.1038/nrneph.2017.140; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jelenik T, 2013, ANTIOXID REDOX SIGN, V19, P258, DOI 10.1089/ars.2012.4910; Katagiri D, 2013, J AM SOC NEPHROL, V24, P2034, DOI 10.1681/ASN.2013020134; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Liu JP, 2015, ANAL BIOANAL CHEM, V407, P2569, DOI 10.1007/s00216-015-8481-0; Liu SY, 2017, J CELL MOL MED, V21, P2553, DOI 10.1111/jcmm.13176; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824; Muenter K, 2001, HYPERTENSION, V37, pE13, DOI 10.1161/01.HYP.37.5.e13; Nosadini R, 2011, NUTR METAB CARDIOVAS, V21, P79, DOI 10.1016/j.numecd.2010.10.002; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Stenvinkel P, 2013, J AM SOC NEPHROL, V24, P1727, DOI 10.1681/ASN.2013040330; Takashima S, 2016, KIDNEY INT, V90, P783, DOI 10.1016/j.kint.2016.06.012; Thethi T, 2012, CURR HYPERTENS REP, V14, P160, DOI 10.1007/s11906-012-0245-z; Toblli JE, 2017, DRUG DES DEV THER, V11, P3401, DOI 10.2147/DDDT.S151162; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wang S.Q, 2013, 13 INT C FRACT, V9, P1, DOI DOI 10.1016/j.jnutbio.2013.09.001; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Xu F, 2014, DIABETES, V63, P3637, DOI 10.2337/db14-0263; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Yin QH, 2016, J BIOL CHEM, V291, P26487, DOI 10.1074/jbc.M116.730564; Zhong Z, 2003, CURR OPIN CLIN NUTR, V6, P229, DOI 10.1097/00075197-200303000-00013	45	53	55	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193473	10.1371/journal.pone.0193473	http://dx.doi.org/10.1371/journal.pone.0193473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590132	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100021
J	Williams, GP; Wu, B; Liu, YC; Teo, E; Nyein, CL; Peh, G; Tan, DT; Mehta, JS				Williams, Geraint P.; Wu, Benjamin; Liu, Yu Chi; Teo, Ericia; Nyein, Chan L.; Peh, Gary; Tan, Donald T.; Mehta, Jodhbir S.			Hyperopic refractive correction by LASIK, SMILE or lenticule reimplantation in a non-human primate model	PLOS ONE			English	Article							FEMTOSECOND LASER; EXTRACTION SMILE; EYE-DISEASE; CROSS-LINKING; MYOPIA; OUTCOMES; SURGERY; PREDICTABILITY; IMPLANTATION; ASTIGMATISM	Hyperopia is a common refractive error, apparent in 25% of Europeans. Treatments include spectacles, contact lenses, laser interventions and surgery including implantable contact lenses and lens extraction. Laser treatment offers an expedient and reliable means of correcting ametropia. LASIK is well-established however SMILE (small-incision lenticule extraction) or lenticule implantation (derived from myopic laser-correction) are newer options. In this study we compared the outcomes of hyperopic LASIK, SMILE and lenticule re-implantation in a primate model at +2D/+4D treatment. While re-implantation showed the greatest regression, broadly comparable refractive results were seen at 3-months with SMILE and LASIK (<1.4D of intended), but a greater tendency to regression in +2D lenticule reimplantation. Central corneal thickness showed greater variation at +2D treatment, but central thickening during lenticule reimplantation at +4D treatment was seen (-17 +/- 27 mu m LASIK,-45 +/- 18 mu m SMILE and 28 +/- 17 mu m Re-implantation; p <0.01) with expected paracentral thinning following SMILE. Although in vivo confocal microscopy appeared to show higher reflectivity in all +4D treatment groups, there were minimal and inconsistent changes in inflammatory responses between modalities. SMILE and lenticule re-implantation may represent a safe and viable method for treating hyperopia, but further optimization for lower hyperopic treatments is warranted.	[Williams, Geraint P.; Liu, Yu Chi; Teo, Ericia; Nyein, Chan L.; Peh, Gary; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Williams, Geraint P.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Wu, Benjamin; Tan, Donald T.; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore; [Tan, Donald T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore.	jodmehta@gmail.com	Liu, Yu Chi/AAM-7010-2020; Peh, Gary/A-8327-2010	Liu, Yu Chi/0000-0001-5408-0382; Peh, Gary/0000-0002-5387-4209	National Medical Research Council, Translational & Clinical Research (TCR) Flagship Programme, Singapore [NMRC/TCR/01020-SERI/2013]; Dowager Eleanor Peel Trust Travelling Grant; Royal College of Ophthalmologists/Pfizer Ophthalmic Fellowship	National Medical Research Council, Translational & Clinical Research (TCR) Flagship Programme, Singapore; Dowager Eleanor Peel Trust Travelling Grant; Royal College of Ophthalmologists/Pfizer Ophthalmic Fellowship	This study is supported by a National Medical Research Council, Translational & Clinical Research (TCR) Flagship Programme, Singapore Grant (NMRC/TCR/01020-SERI/2013). Geraint P Williams' SERI fellowship is supported by a Dowager Eleanor Peel Trust Travelling Grant and a Royal College of Ophthalmologists/Pfizer Ophthalmic Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2014, SURV OPHTHALMOL, V59, P579, DOI 10.1016/j.survophthal.2014.04.004; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P1414, DOI 10.1167/iovs.11-8808; Angunawela RI, 2012, INVEST OPHTH VIS SCI, V53, P4975, DOI 10.1167/iovs.12-10170; Aslanides IM, 2013, CLIN OPHTHALMOL, V7, P637, DOI 10.2147/OPTH.S39796; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Blum M, 2016, BRIT J OPHTHALMOL, V100, P1192, DOI 10.1136/bjophthalmol-2015-306822; Blum M, 2013, GRAEF ARCH CLIN EXP, V251, P349, DOI 10.1007/s00417-012-2064-y; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Borchert MS, 2011, OPHTHALMOLOGY, V118, P1966, DOI 10.1016/j.ophtha.2011.06.030; Chen SH, 2012, J REFRACT SURG, V28, P15, DOI 10.3928/1081597X-20111228-02; Denoyer A, 2015, OPHTHALMOLOGY, V122, P669, DOI 10.1016/j.ophtha.2014.10.004; Dong ZX, 2014, BRIT J OPHTHALMOL, V98, P263, DOI 10.1136/bjophthalmol-2013-303415; Ganesh S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/263412; Ganesh S, 2014, J REFRACT SURG, V30, P590, DOI 10.3928/1081597X-20140814-02; Gil-Cazorla R, 2011, AM J OPHTHALMOL, V152, P16, DOI 10.1016/j.ajo.2011.01.009; Hansen RS, 2016, GRAEF ARCH CLIN EXP, V254, P399, DOI 10.1007/s00417-015-3226-5; Kamiya K, 2014, AM J OPHTHALMOL, V157, P128, DOI 10.1016/j.ajo.2013.08.011; Kanellopoulos AJ, 2012, J REFRACT SURG, V28, pS837, DOI 10.3928/1081597X-20121005-05; Lee BS, 2014, CURR OPIN OPHTHALMOL, V25, P281, DOI 10.1097/ICU.0000000000000066; Li MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081435; Lim CHL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083046; Liu R, 2015, INVEST OPHTH VIS SCI, V56, P3715, DOI 10.1167/iovs.14-15296; Liu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29802; Liu YC, 2016, J REFRACT SURG, V32, P346, DOI 10.3928/1081597X-20160217-05; Mimouni M, 2016, CORNEA, V35, P607, DOI 10.1097/ICO.0000000000000795; Mohamed-Noriega K, 2014, INVEST OPHTH VIS SCI, V55, P1823, DOI 10.1167/iovs.13-13324; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; Pradhan KR, 2013, J REFRACT SURG, V29, P777, DOI 10.3928/1081597X-20131021-07; Reinstein DZ, 2017, J REFRACT SURG, V33, P370, DOI 10.3928/1081597X-20170331-01; Reinstein DZ, 2014, J REFRACT SURG, V30, P813, DOI 10.3928/1081597X-20141113-07; Riau AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067058; Santhiago MR, 2015, J REFRACT SURG, V31, P258, DOI 10.3928/1081597X-20150319-05; Santhiago MR, 2014, AM J OPHTHALMOL, V158, P87, DOI 10.1016/j.ajo.2014.04.002; Sekundo W, 2016, LASERS MED SCI; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Settas G, 2012, COCHRANE DB SYST REV, V6; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Shetty R, 2012, J REFRACT SURG, V28, pS815, DOI 10.3928/1081597X-20121005-01; Sun L, 2015, J REFRACT SURG, V31, P374, DOI 10.3928/1081597X-20150521-03; VANSETTEN GB, 1992, GRAEF ARCH CLIN EXP, V230, P178, DOI 10.1007/BF00164660; Vestergaard AH, 2014, ACTA OPHTHALMOL, V92, P492, DOI 10.1111/aos.12450; Wei SS, 2013, GRAEF ARCH CLIN EXP, V251, P1645, DOI 10.1007/s00417-013-2272-0; Wen G, 2013, OPHTHALMOLOGY, V120, P2109, DOI 10.1016/j.ophtha.2013.06.039; Williams KM, 2015, EUR J EPIDEMIOL, V30, P305, DOI 10.1007/s10654-015-0010-0	44	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194209	10.1371/journal.pone.0194209	http://dx.doi.org/10.1371/journal.pone.0194209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590157	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100052
J	Kou, N; Xue, M; Yang, L; Zang, MX; Qu, H; Wang, MM; Miao, Y; Yang, B; Shi, DZ				Kou, Na; Xue, Mei; Yang, Lin; Zang, Ming-Xuan; Qu, Hua; Wang, Ming-Ming; Miao, Yu; Yang, Bin; Shi, Da-Zhuo			Panax quinquefolius saponins combined with dual antiplatelet drug therapy alleviate gastric mucosal injury and thrombogenesis through the COX/PG pathway in a rat model of acute myocardial infarction	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INHIBITION; EXPRESSION; ASPIRIN; DAMAGE	Objectives Previous studies have found that Panax quinquefolius saponins (PQS) combined with dual antiplatelet therapy (DAPT) of aspirin and clopidogrel enhances antithrombotic effects while reducing gastric mucosal injury induced by DAPT. We investigated the effects of the combined drug therapy (PQS+DAPT) through the COX/PG pathways. Methods Acute myocardial infarction (AMI) was induced in Wistar rats by ligation of the left anterior descending (LAD) coronary artery, and the animals were randomly divided into Model, DAPT, and PQS+DAPT groups. Rats in the sham group did not undergo artery ligation. They were intragastrically treated for 14 days. Myocardial infarct size; myocardial pathology; platelet aggregation rate, CD62p activation, concentrations of thromboxane B-2 (TXB2), 6-keto-PGF1 alpha, tissue plasminogen activator (t-PA), and plasminogen activator inhibitor (PAI), the TXB2/6-keto-PGF1 alpha ratio were measured. The ultrastructure of the gastric mucosa was observed by scanning electron microscopy. The expression of PGE(2) and 6-keto-PGF1 alpha in gastric mucosa was measured by radio immunoassay, and levels of COX-1, COX-2, and VEGF in gastric mucosa were assessed using immunohistochemistry. Results The addition of Panax quinquefolius saponins (PQS+DAPT) to standard DAPT therapy significantly decreased the myocardial infarct area, degree of myocardial lesions, TXB2 and PAI levels, and the TXB2/6-keto-PGF1 alpha ratio, while increasing 6-keto-PGF1 alpha and t-PA levels and reducing the degree of gastric mucosal injury. Expression of PGE(2), 6-keto-PGF1 alpha, COX-2, and VEGF in the gastric mucosa was upregulated in the PQS+DAPT group compared with the standard DAPT group. Conclusion PQS increases the degree of DAPT inhibition of myocardial necrosis and antiplatelet effects in AMI rats, as well as reducing damage to the gastric mucosa caused by DAPT. The mechanism may be related to inhibition of TXB2 and PAI activity and elevation of 6-keto-PGF1 alpha and t-PA levels in blood, and may be associated with upregulated expression of COX-2, PGE(2), PGI(2), and VEGF in gastric tissue.	[Kou, Na; Xue, Mei; Yang, Lin; Zang, Ming-Xuan; Qu, Hua; Wang, Ming-Ming; Miao, Yu; Yang, Bin; Shi, Da-Zhuo] Xiyuan Hosp, China Acad Chinese Med Sci, Ctr Cardiol, Lab Cardiol, Beijing, Peoples R China; [Kou, Na; Qu, Hua; Shi, Da-Zhuo] Beijing Univ Chinese Med, Xiyuan Hosp, Clin Coll, Grad Sch, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; Beijing University of Chinese Medicine; Xiyuan Hospital, CACMS	Shi, DZ (corresponding author), Xiyuan Hosp, China Acad Chinese Med Sci, Ctr Cardiol, Lab Cardiol, Beijing, Peoples R China.; Shi, DZ (corresponding author), Beijing Univ Chinese Med, Xiyuan Hosp, Clin Coll, Grad Sch, Beijing, Peoples R China.	shidazhuo_11@163.com	Qu, Hua/AAN-9145-2021		National Natural Science Foundation of China [81273933, 81102722]; International Science and Technology Cooperation Program of China [2014DFG32700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China	This work was supported by the National Natural Science Foundation of China (81273933 and 81102722), and International Science and Technology Cooperation Program of China (2014DFG32700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Cattaneo M, 2011, HEMATOL-AM SOC HEMAT, P70, DOI 10.1182/asheducation-2011.1.70; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gladding P, 2008, AM HEART J, V155, P591, DOI 10.1016/j.ahj.2007.12.034; Gundamaraju R, 2014, PHARMACOGN MAG, V10, P557, DOI 10.4103/0973-1296.139782; Guo M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1531-x; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Kakeji Y, 2002, J EXP CLIN CANC RES, V21, P125; Lan Y, 2012, WORLD CHINESE J DIGE; Liu M, 2013, SHOCK, V40, P339, DOI 10.1097/SHK.0b013e3182a3f9e5; [刘蜜 Liu Mi], 2013, [中国病理生理杂志, Chinese Journal of Pathophysiology], V29, P796; Luo JC, 2016, J FORMOS MED ASSOC, V115, P764, DOI 10.1016/j.jfma.2015.07.022; Michelson AD, 2011, HEMATOL-AM SOC HEMAT, P62, DOI 10.1182/asheducation-2011.1.62; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Patrono C, 2015, J AM COLL CARDIOL, V66, P74, DOI 10.1016/j.jacc.2015.05.012; Ruschitzka FT, 1997, CARDIOLOGY, V88, P3, DOI 10.1159/000177500; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Takeuchi K, 2012, WORLD J GASTROENTERO, V18, P2147, DOI 10.3748/wjg.v18.i18.2147; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Wang BJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/932751; Wooten JG, 2008, AM J VET RES, V69, P457, DOI 10.2460/ajvr.69.4.457; Yang Lin, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P1942; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368; [张庆翔 Zhang Qingxiang], 2014, [科学通报, Chinese Science Bulletin], V59, P1133	26	7	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194082	10.1371/journal.pone.0194082	http://dx.doi.org/10.1371/journal.pone.0194082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584740	gold, Green Submitted, Green Published			2022-12-27	WOS:000428373000013
J	Wang, LY; Xing, HX; Yuan, YC; Wang, XL; Saeed, M; Tao, JC; Feng, W; Zhang, GH; Song, XL; Sun, XZ				Wang, Liyuan; Xing, Huixian; Yuan, Yanchao; Wang, Xianlin; Saeed, Muhammad; Tao, Jincai; Feng, Wei; Zhang, Guihua; Song, Xianliang; Sun, Xuezhen			Genome-wide analysis of codon usage bias in four sequenced cotton species	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM; CHLOROPLAST GENOME; PROVIDES INSIGHTS; BASE COMPOSITION; AMINO-ACID; GENE; EVOLUTION; PATTERN; SELECTION; RNA	Codon usage bias (CUB) is an important evolutionary feature in a genome which provides important information for studying organism evolution, gene function and exogenous gene expression. The CUB and its shaping factors in the nuclear genomes of four sequenced cotton species, G. arboreum (A(2)), G. raimondii (D-5), G. hirsutum (AD(1)) and G. barbadense (AD(2)) were analyzed in the present study. The effective number of codons (ENC) analysis showed the CUB was weak in these four species and the four subgenomes of the two tetraploids. Codon composition analysis revealed these four species preferred to use pyrimidinerich codons more frequently than purine-rich codons. Correlation analysis indicated that the base content at the third position of codons affect the degree of codon preference. PR2-bias plot and ENC-plot analyses revealed that the CUB patterns in these genomes and subgenomes were influenced by combined effects of translational selection, directional mutation and other factors. The translational selection (P2) analysis results, together with the non-significant correlation between GC12 and GC3, further revealed that translational selection played the dominant role over mutation pressure in the codon usage bias. Through relative synonymous codon usage (RSCU) analysis, we detected 25 high frequency codons preferred to end with T or A, and 31 low frequency codons inclined to end with C or G in these four species and four subgenomes. Finally, 19 to 26 optimal codons with 19 common ones were determined for each species and subgenomes, which preferred to end with A or T. We concluded that the codon usage bias was weak and the translation selection was the main shaping factor in nuclear genes of these four cotton genomes and four subgenomes.	[Wang, Liyuan; Xing, Huixian; Yuan, Yanchao; Wang, Xianlin; Tao, Jincai; Feng, Wei; Song, Xianliang; Sun, Xuezhen] Shandong Agr Univ, Agron Coll, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Saeed, Muhammad] Govt Coll Univ, Dept Bot, Faisalabad, Pakistan; [Zhang, Guihua] Heze Acad Agr Sci, Heze, Peoples R China	Shandong Agricultural University; Government College University Faisalabad	Song, XL; Sun, XZ (corresponding author), Shandong Agr Univ, Agron Coll, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	songx1999@163.com; sunxz@sdau.edu.cn	Saeed, Muhammad/O-3675-2019; Saeed, Muhammad/A-8562-2015; zhang, guihua/GVU-4494-2022	Saeed, Muhammad/0000-0002-7125-7394; Saeed, Muhammad/0000-0002-7125-7394; Wang, Liyuan/0000-0003-2975-4423	Major Projects for Transgenic Breeding of China [2017ZX08005-004-006]; System of Modern Agriculture Industrial Technology [SDAIT-03-03/05]; Natural Science foundation [ZR2017MC057]	Major Projects for Transgenic Breeding of China; System of Modern Agriculture Industrial Technology; Natural Science foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Projects for Transgenic Breeding of China (2017ZX08005-004-006); The System of Modern Agriculture Industrial Technology (SDAIT-03-03/05) and the Natural Science foundation (ZR2017MC057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baeza M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1493-5; Behura SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043111; Chakraborty S, 2017, GENE, V604, P48, DOI 10.1016/j.gene.2016.11.023; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Das S, 2006, VIRUS RES, V117, P227, DOI 10.1016/j.virusres.2005.10.007; Deb S, 2015, COMPUTATIONAL MOL BI; Dohra H, 2015, FEBS LETT, V589, P3113, DOI 10.1016/j.febslet.2015.08.033; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; GALAU GA, 1989, THEOR APPL GENET, V78, P23, DOI 10.1007/BF00299748; Gallagher JP, 2017, SYST BOT, V42, P115, DOI 10.1600/036364417X694593; Gatherer D, 1997, BIOCHEM MOL BIOL INT, V43, P107; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GROSJEAN H, 1978, J MOL EVOL, V12, P113, DOI 10.1007/BF01733262; Grover CE, 2012, PLANT SYST EVOL, V298, P1177, DOI 10.1007/s00606-012-0615-7; Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006; Guo H, 2014, GENETICS, V197, P1153, DOI 10.1534/genetics.114.166124; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Hiraoka Y, 2009, GENES CELLS, V14, P499, DOI 10.1111/j.1365-2443.2009.01284.x; Huang Y, 2009, NUCLEIC ACIDS RES, V37, P6799, DOI 10.1093/nar/gkp712; Hussain S, 2017, ACTA TROP, V173, P136, DOI 10.1016/j.actatropica.2017.06.006; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jiang Y, 2008, ARCH VIROL, V153, P2273, DOI 10.1007/s00705-008-0260-1; Kattoor JJ, 2015, INFECT GENET EVOL, V34, P17, DOI 10.1016/j.meegid.2015.06.018; Krapovickas A., 2008, BONPLANDIA, V17, P55, DOI [10.30972/bon.1711361, DOI 10.30972/BON.1711361]; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li N, 2016, J INTEGR AGR, V15, P983, DOI 10.1016/S2095-3119(16)61333-3; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Liu H, 2012, GENET MOL RES, V11, P4695, DOI 10.4238/2012.October.17.3; Liu HM, 2010, MOL BIOL REP, V37, P677, DOI 10.1007/s11033-009-9521-7; Liu QP, 2005, J GENET, V84, P55, DOI 10.1007/BF02715890; Liu X, 2015, SCI REP-UK, V5, DOI [10.1038/srep14139, 10.1038/srep10007]; Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68; Ma YP, 2014, ARCH VIROL, V159, P1841, DOI 10.1007/s00705-014-2000-z; Marais G, 2003, GENET RES, V81, P79, DOI 10.1017/S0016672302006079; McEwan NR, 1999, CAN J BOT, V77, P1287, DOI 10.1139/cjb-77-9-1287; 孙铮, 2009, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V39, P948; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Olejniczak M, 2006, BIOCHIMIE, V88, P943, DOI 10.1016/j.biochi.2006.06.005; Pandit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028889; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Prabha R, 2017, MAR GENOM, V32, P31, DOI 10.1016/j.margen.2016.10.001; Qiu S, 2011, GENOME BIOL EVOL, V3, P868, DOI 10.1093/gbe/evr085; Salim HMW, 2008, J BRAZIL CHEM SOC, V19, P257, DOI 10.1590/S0103-50532008000200008; Shang MingZhao, 2011, Scientia Agricultura Sinica, V44, P245; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; Subramanian S, 2008, GENETICS, V178, P2429, DOI 10.1534/genetics.107.086405; Sueoka N, 2001, J MOL EVOL, V53, P469, DOI 10.1007/s002390010237; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Suzuki H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154306; Tao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075323; Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z; Wang SF, 2016, J MICROBIOL IMMUNOL, V49, P477, DOI 10.1016/j.jmii.2014.08.011; Wei S, 2016, PLOS ONE, V11; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel JF, 2009, GENETICS GENOMICS CO, V3; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wu Xian-Ming, 2007, Yichuan, V29, P420, DOI 10.1360/yc-007-0420; Wu YX, 2013, CARYOLOGIA, V66, P368, DOI 10.1080/00087114.2013.857830; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zalucki YM, 2007, NUCLEIC ACIDS RES, V35, P5748, DOI 10.1093/nar/gkm577; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhao YC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3021-7	72	64	80	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194372	10.1371/journal.pone.0194372	http://dx.doi.org/10.1371/journal.pone.0194372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584741	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000021
J	Ribeiro, AF; Pellini, ACG; Kitagawa, BY; Marques, D; Madalosso, G; Fred, J; Albernaz, RKM; Carvalhanas, TRMP; Zanetta, DMT				Ribeiro, Ana Freitas; Guedes Pellini, Alessandra Cristina; Kitagawa, Beatriz Yuko; Marques, Daniel; Madalosso, Geraldine; Fred, Joao; Mangabeira Albernaz, Ricardo Kerti; Marques Pinto Carvalhanas, Telma Regina; Trevisan Zanetta, Dirce Maria			Severe influenza A(H1N1)pdm09 in pregnant women and neonatal outcomes, State of Sao Paulo, Brazil, 2009	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; A H1N1; UNITED-STATES; HOSPITALIZED-PATIENTS; POSTPARTUM WOMEN; INFECTION	To investigate the factors associated with death and describe the gestational outcomes in pregnant women with influenza A(H1N1)pdm09, we conducted a case-control study (deaths and recovered) in hospitalized pregnant women with laboratory-confirmed influenza A (H1N1)pdm09 with severe acute respiratory illness (SARI) in the state of Sao Paulo from June 9 to December 1, 2009. All cases were evaluated, and four controls that were matched by the epidemiological week of hospitalization of the case were randomly selected for each case. Cases and controls were selected from the National Disease Notification System-SINAN Influenza-web. The hospital records from 126 hospitals were evaluated, and home interviews were conducted using standardized forms. A total of 48 cases and 185 controls were investigated. Having had a previous health visit to a healthcare provider for an influenza episode before hospital admission was a risk factor for death (adjusted OR (ORadi)of 7.93, 95% CI 2.19-28.69). Although not significant in the multiple analysis (OR (adj) of 2.13, 95% CI 0.91-5.00), the 3rd trimester deserves attention, with an OR = 2.22, 95% CI 1.13-4.37 in the univariate analysis. Antiviral treatment was a protective factor when administered within 48 hours of symptom onset (ORadj= 0.16, 95% CI 0.05-0.50) and from 48 to 72 hours (ORadj= 0.09, 95% CI 0.01-0.87). There was a higher proportion of fetal deaths and preterm births among cases (p = 0.001) and live births with low weight (p = 0.019), compared to control subjects who gave birth during hospitalization. After discharge, control subjects had a favorable neonatal outcome. Early antiviral treatment during the presence of a flu-like illness is an important factor in reducing mortality from influenza in pregnant women and unfavorable neonatal outcomes. It is important to monitor pregnant women, particularly in the 3rd trimester of gestation, with influenza illness for diagnosis and early treatment.	[Ribeiro, Ana Freitas; Guedes Pellini, Alessandra Cristina; Kitagawa, Beatriz Yuko; Marques, Daniel; Madalosso, Geraldine; Fred, Joao; Mangabeira Albernaz, Ricardo Kerti; Marques Pinto Carvalhanas, Telma Regina] Sao Paulo State Secretary Hlth, Epidemiol Surveillance Ctr, Sao Paulo, SP, Brazil; [Trevisan Zanetta, Dirce Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, SP, Brazil; [Ribeiro, Ana Freitas] Emilio Ribas Inst Infectol, Sao Paulo, SP, Brazil; [Ribeiro, Ana Freitas] Univ Nove Julho, Hlth Adm Grad Dept, Sao Paulo, SP, Brazil; [Kitagawa, Beatriz Yuko] Municipal Hlth Dept Sao Paulo, Sao Paulo, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Nove de Julho	Ribeiro, AF (corresponding author), Sao Paulo State Secretary Hlth, Epidemiol Surveillance Ctr, Sao Paulo, SP, Brazil.; Ribeiro, AF (corresponding author), Emilio Ribas Inst Infectol, Sao Paulo, SP, Brazil.; Ribeiro, AF (corresponding author), Univ Nove Julho, Hlth Adm Grad Dept, Sao Paulo, SP, Brazil.	anafribeiro@uol.com.br	Alessandra, Pellini C. G./K-5156-2013; Zanetta, Dirce M T/G-4950-2013; Ribeiro, Ana Freitas/P-6862-2015	Alessandra, Pellini C. G./0000-0002-3799-9415; MARQUES, DANIEL/0000-0001-7281-3316; Madalosso, Geraldine/0000-0001-9501-6205; Zanetta, Dirce Maria/0000-0002-7273-5087	Sao Paulo State Secretary of Health	Sao Paulo State Secretary of Health	Sao Paulo State Secretary of Health financed the data collection. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Chowell G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-97; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Doyle TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079040; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Ellington SR, 2011, AM J OBSTET GYNECOL, V204, pS21, DOI 10.1016/j.ajog.2011.02.038; Fuhrman C, 2010, EUROSURVEILLANCE, V15, P17; Fukasawa L. O., 2010, Revista do Instituto Adolfo Lutz, V69, P131; Gonzalez-Velez AE, 2011, MED INTENSIVA, V35, P463, DOI 10.1016/j.medin.2011.03.007; GREENBERG M, 1958, AM J OBSTET GYNECOL, V76, P897, DOI 10.1016/0002-9378(58)90027-9; Hansen C, 2012, J INFECT DIS, V206, P1260, DOI 10.1093/infdis/jis488; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Lenzi L, 2012, CAD SAUDE PUBLICA, V28, P395, DOI 10.1590/S0102-311X2012000200018; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mertz D, 2013, BMJ-BRIT MED J, V347, P2; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Newsome Kimberly, 2011, Morbidity and Mortality Weekly Report, V60, P1193; Pan American Health Organization - World Health Organization, OP GUID INT NAT SARI; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Ribeiro AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118772; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Varner MW, 2011, OBSTET GYNECOL, V118, P593, DOI 10.1097/AOG.0b013e318229e484; WHO-World Health Organization, PAND H1N1 2009 WORLD; Zhang PJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-29	33	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194392	10.1371/journal.pone.0194392	http://dx.doi.org/10.1371/journal.pone.0194392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579099	Green Submitted, Green Published, gold			2022-12-27	WOS:000428351800028
J	Zhang, JY; Pan, DL; Jia, ZH; Wang, T; Wang, G; Guo, ZR				Zhang, Ji-Yu; Pan, De-Lin; Jia, Zhan-Hui; Wang, Tao; Wang, Gang; Guo, Zhong-Ren			Chlorophyll, carotenoid and vitamin C metabolism regulation in Actinidia chinensis 'Hongyang' outer pericarp during fruit development	PLOS ONE			English	Article							L-GALACTOSE GUANYLTRANSFERASE; HARVESTING-COMPLEX-II; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; CLEAVAGE DIOXYGENASE; OVER-EXPRESSION; BIOSYNTHESIS; DEGRADATION; KIWIFRUIT; YELLOW	Ascorbic acid (AsA), chlorophyll and carotenoid contents and their associated gene expression patterns were analysed in Actinidia chinensis 'Hongyang' outer pericarp. The results showed chlorophyll degradation during fruit development and softening, exposed the yellow carotenoid pigments. LHCB1 and CLS1 gene expressions were decreased, while PPH2 and PPH3 gene expressions were increased, indicating that downregulation of chlorophyll biosynthesis and upregulation of its degradation, caused chlorophyll degradation. A decrease in the expression of the late carotenoid biosynthesis and maintenance genes (LCYB1, LCYE1, CYP1, CYP2, ZEP1, VDE1, VDE2, and NCED2) and degradation gene (CCD1), showed biosynthesis and degradation of carotenoid could be regulatory factors involved in fruit development. Most genes expression data of L-galactose and recycling pathway were agreement with the AsA concentrations in the fruit, suggesting these are the predominant pathways of AsA biosynthesis. GMP1, GME1 and GGP1 were identified as the key genes controlling AsA biosynthesis in 'Hongyang' outer pericarp.	[Zhang, Ji-Yu; Pan, De-Lin; Jia, Zhan-Hui; Wang, Tao; Wang, Gang; Guo, Zhong-Ren] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, JY; Guo, ZR (corresponding author), Jiangsu Prov & Chinese Acad Sci, Inst Bot, Beijing, Peoples R China.	maxzhangjy@163.com; zhongrenguo@cnbg.net		Zhang, Ji-Yu/0000-0002-4075-5008	National Natural Science Foundation of China (NSFC) [31401854]; Natural Science Foundation of Jiangsu Province [BK20140760]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by grants from the National Natural Science Foundation of China (NSFC) (31401854) and the Natural Science Foundation of Jiangsu Province (grant no. BK20140760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3585; Alquezar B, 2008, PHYTOCHEMISTRY, V69, P1997, DOI 10.1016/j.phytochem.2008.04.020; Ampomah-Dwamena C, 2009, J EXP BOT, V60, P3765, DOI 10.1093/jxb/erp218; Annpomah-Dwamena C, 2012, J EXP BOT, V63, P4497, DOI 10.1093/jxb/ers134; Barry CS, 2009, PLANT SCI, V176, P325, DOI 10.1016/j.plantsci.2008.12.013; Beekwilder J, 2008, BIOFACTORS, V34, P57; Brandi F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-24; Bulley S, 2012, PLANT BIOTECHNOL J, V10, P390, DOI 10.1111/j.1467-7652.2011.00668.x; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Bulley SM, 2016, COMPEND PL GENOME, P163, DOI 10.1007/978-3-319-32274-2_13; Devitt LC, 2010, J EXP BOT, V61, P33, DOI 10.1093/jxb/erp284; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Falchi R, 2013, PLANT J, V76, P175, DOI 10.1111/tpj.12283; Ferguson AR, 2003, ACTA HORTIC, P131, DOI 10.17660/ActaHortic.2003.610.16; Garcia-Limones C, 2008, J AGR FOOD CHEM, V56, P9277, DOI 10.1021/jf801096t; Henare SJ, 2016, NUTRITIONAL COMPOSITION OF FRUIT CULTIVARS, P337, DOI 10.1016/B978-0-12-408117-8.00015-5; Huang HW, 2016, KIWIFRUIT: THE GENUS ACTINIDIA, P239, DOI 10.1016/B978-0-12-803066-0.00006-X; Jiang ZY, 2018, PLANT PHYSIOL BIOCH, V124, P20, DOI 10.1016/j.plaphy.2018.01.005; Jing GX, 2015, POSTHARVEST BIOL TEC, V109, P114, DOI 10.1016/j.postharvbio.2015.06.006; Karppinen K, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0785-5; Kita M, 2007, J AGR FOOD CHEM, V55, P3414, DOI 10.1021/jf063552v; Krupa T, 2011, SCI HORTIC-AMSTERDAM, V130, P410, DOI 10.1016/j.scienta.2011.06.044; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Li HS, 2000, PLANT PHYSL BIOCH EX; Li J, 2014, SCI HORTIC-AMSTERDAM, V169, P206, DOI 10.1016/j.scienta.2014.02.024; Li J, 2013, PLANTA, V238, P535, DOI 10.1007/s00425-013-1915-z; Li J, 2013, MOL BIOL REP, V40, P1473, DOI 10.1007/s11033-012-2190-y; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv P, 2015, FOOD CHEM, V174, P52, DOI 10.1016/j.foodchem.2014.11.022; McGhie TK, 2002, J AGR FOOD CHEM, V50, P117, DOI 10.1021/jf010677l; Montefiori M, 2009, SCI HORTIC-AMSTERDAM, V119, P377, DOI 10.1016/j.scienta.2008.08.022; Montefiori M, 2016, COMPEND PL GENOME, P149, DOI 10.1007/978-3-319-32274-2_12; Ohmiya A, 2013, ACS SYM SER, V1134, P21; Pilkington SM, 2012, PLANTA, V236, P1615, DOI 10.1007/s00425-012-1723-x; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Sha SF, 2011, AFR J AGR RES, V6, P3560; Tong ZG, 2012, MOL BIOTECHNOL, V50, P229, DOI 10.1007/s12033-011-9433-3; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034; Yin XR, 2012, POSTHARVEST BIOL TEC, V66, P1, DOI 10.1016/j.postharvbio.2011.11.009; Young PR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-243; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang B, 2015, NEW PHYTOL, V206, P1513, DOI 10.1111/nph.13335; Zhang JY, 2012, PLANT BIOLOGY, V14, P46, DOI 10.1111/j.1438-8677.2011.00483.x	46	13	13	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194835	10.1371/journal.pone.0194835	http://dx.doi.org/10.1371/journal.pone.0194835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579114	Green Published, Green Submitted, gold			2022-12-27	WOS:000428351800060
J	Han, XY; Appelbaum, RP				Han, Xueying; Appelbaum, Richard P.			China's science, technology, engineering, and mathematics (STEM) research environment: A snapshot	PLOS ONE			English	Article							NONRESPONSE BIAS; PUBLISH; PERISH; GUANXI	In keeping with China's President Xi Jinping's "Chinese Dream," China has set a goal of becoming a world-class innovator by 2050. China's higher education Science, Technology, Engineering, and Math (STEM) research environment will play a pivotal role in influencing whether China is successful in transitioning from a manufacturing-based economy to an innovation-driven, knowledge-based economy. Past studies on China's research environment have been primarily qualitative in nature or based on anecdotal evidence. In this study, we surveyed STEM faculty from China's top 25 universities to get a clearer understanding of how faculty members view China's overall research environment. We received 731 completed survey responses, 17% of which were from individuals who received terminal degrees from abroad and 83% of which were from individuals who received terminal degrees from domestic institutions of higher education. We present results on why returnees decided to study abroad, returnees' decisions to return to China, and differences in perceptions between returnees and domestic degree holders on the advantages of having a foreign degree. The top five challenges to China's research environment identified by survey respondents were: a promotion of short-term thinking and instant success (37% of all respondents); research funding (33%); too much bureaucratic or governmental intervention (31%); the evaluation system (27%); and a reliance on human relations (26%). Results indicated that while China has clearly made strides in its higher education system, there are numerous challenges that must be overcome before China can hope to effectively produce the kinds of innovative thinkers that are required if it is to achieve its ambitious goals. We also raise questions about the current direction of education and inquiry in China, particularly indications that government policy is turning inward, away from openness that is central to innovative thinking.	[Han, Xueying] Sci & Technol Policy Inst, Washington, DC 20515 USA; [Han, Xueying; Appelbaum, Richard P.] Univ Calif Santa Barbara, Ctr Nanotechnol Soc, Santa Barbara, CA 93106 USA; [Appelbaum, Richard P.] Univ Calif Santa Barbara, Dept Global Studies, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Han, XY (corresponding author), Sci & Technol Policy Inst, Washington, DC 20515 USA.; Han, XY (corresponding author), Univ Calif Santa Barbara, Ctr Nanotechnol Soc, Santa Barbara, CA 93106 USA.	xhan@ida.org		Han, Xueying/0000-0003-4643-2880	National Science Foundation [SES 0938099]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation (www.nsf.gov) under Grant No. SES 0938099 awarded to the Center for Nanotechnology in Society at the University of California, Santa Barbara (CNS-UCSB) to RPA. NSF and CNS-UCSB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, HIGH EDUC POLICY, DOI DOI 10.1057/PALGRAVE.HEP.8300076; [Anonymous], 2013, HANGZHOU WEEKLY 0107; Appelbaum R.P., 2018, INNOVATION CHINA CHA; Appelbaum RP, 2016, TECHNOL SOC, V46, P149, DOI 10.1016/j.techsoc.2016.03.004; ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783; Bai LM, 2006, CHINA QUART, P128, DOI 10.1017/S0305741006000087; Bonetta L., 2011, SCIENCE; Cao C, 2001, CHINA QUART, P960; Cao C., 2008, ASIAN POPUL STUD, V4, P331, DOI DOI 10.1080/17441730802496532; Cao C, 2006, PHYS TODAY, V59, P38, DOI 10.1063/1.2435680; Cao C, 2013, SCIENCE, V341, P460, DOI 10.1126/science.1234206; Cao C, 2009, INNOV-ORGAN MANAG, V11, P253, DOI 10.5172/impp.11.2.253; Carpenter CR, 2014, ACAD EMERG MED, V21, P1160, DOI 10.1111/acem.12482; Chen Q, 2016, GLOBALIZATION TRANSN; China Alumni Network, 2016, 2016 CHIN U RANK TOP; China Alumni Network, 2013, 2013 CHIN U RANK TOP; China STI, 2016, 13 5 YEAR NAT PLAN S; CSY. National Bureau of Statistics of China, 2015, CHIN STAT YB TABL 21; Ding YM, 2001, SCIENCE, V291, P1477; Gallup G. G., 2016, HIJACKED EXTERNAL FU; Groves R., 1999, 7 URB I; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Henry B, 2017, SCIENTIST, V31; Herve M., 2015, PACKAGE RVAIDEMEMOIR; Huang AS, 2010, SCIENCE, V329, P1471, DOI 10.1126/science.1190145; Huang F., 2017, 12 UCL I ED CTR GLOB; HUTCHISON J, 1987, RES HIGH EDUC, V26, P99, DOI 10.1007/BF00991936; Hvistendahl M, 2014, SCIENCE, V346, P411, DOI 10.1126/science.346.6208.411; Hvistendahl M, 2014, SCIENCE, V344, P953, DOI 10.1126/science.344.6187.953; Jia HP, 2006, NAT MED, V12, P867, DOI 10.1038/nm0806-867a; Johnson LC, 2000, INT J STRESS MANAGE, V7, P247, DOI 10.1023/A:1009589812697; Li M., 2017, J MEDIA CRITIQUES, V11, P21; Lim L., 2011, PLAGIARISM PLAGUE HI; Lindner J.R., 2001, J AGR ED, V42, P43, DOI [DOI 10.5032/JAE.2001.04043, https://doi.org/10.5032/jae.2001.04043]; Lixu Li, 2004, Asia Pacific Education Review, V5, P14; Luo YD, 2008, INT BUS REV, V17, P188, DOI 10.1016/j.ibusrev.2008.02.002; Min W. F., 2004, ASIAN U HIST PERSPEC; Normile D., 2017, SCIENCE; Qin Amy, 2017, NY TIMES; Radhakrishna R., 2008, J EXT, V46, P1; Rawat S, 2014, J RES MED SCI, V19, P87; Seife C., 2014, SCI AM; Shi T., 2017, BLOOMBERG LP    1017; Shi YG, 2014, NATL SCI REV, V1, P471, DOI 10.1093/nsr/nwu065; Shi YG, 2010, SCIENCE, V329, P1128, DOI 10.1126/science.1196916; Simon D. F., 2009, CHINA BUS REV, P34; Simon DF, 2013, MECH ENG, V135, P34; Simon DF, 2009, ISSUES SCI TECHNOL, V26, P29; SINA, 2013, WUSHULIAN 2013 CHIN; Smith TW, 1983, SURVEY RES METHODS R, P50; Statitsa, 2015, NUMB U CHIN 2005 201; STINCHCOMBE AL, 1981, PUBLIC OPIN QUART, V45, P359, DOI 10.1086/268670; U. S. Immigration and Customs Enforcement, 2012, STEM DES DEGR PROGR; Van Noorden R., 2016, NATURE, V534, P7608; Veugelers R., 2017, POLICY CONTRIBUTIONS, V19, P1; WEF, 2017, CONVERSATION    0413; Xiao-Ping Chen, 2004, Asia Pacific Journal of Management, V21, P305, DOI 10.1023/B:APJM.0000036465.19102.d5; Xin KR, 1996, ACAD MANAGE J, V39, P1641, DOI 10.2307/257072; Yang R., 2008, INT HIGHER ED, V39, P18; Yanjie Bian, 2002, SOCIAL CONNECTIONS C; Ye X., 2011, PEOPLES DAILY ONLINE; Yu JB, 2014, ISSUES SCI TECHNOL, V30, P58; Zweig D, 2014, INT STUD REV, V16, P252, DOI 10.1111/misr.12136	63	16	16	7	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195347	10.1371/journal.pone.0195347	http://dx.doi.org/10.1371/journal.pone.0195347			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614123	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600051
J	Zhang, XY; Matziari, M; Xie, YX; Fernig, D; Rong, R; Meng, J; Lu, ZL				Zhang, Xiaoyang; Matziari, Magdalini; Xie, Yixin; Fernig, David; Rong, Rong; Meng, Jia; Lu, Zhi-Liang			Functional examination of novel kisspeptin phosphinic peptides	PLOS ONE			English	Article							METASTASIS-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; HYPOGONADOTROPIC HYPOGONADISM; MATRIX METALLOPROTEINASES; POTENT INHIBITORS; HORMONE NEURONS; GPR54; KISS-1; EXPRESSION; CARCINOMA	Kisspeptins acting on their cognate G protein-coupled receptor, kisspeptin receptor, play important roles in the suppression of cancer cell metastasis and regulation of the reproductive system, and therefore are important for therapeutic intervention. All native functional human kisspeptins (kisspeptin-54, kisspsptin-14 and kisspeptin-13) share the 10 amino acids of kisspeptin-10 at their C-terminus (45-54). However, they are inactivated rapidly by matrix metalloproteinases (MMPs) through the cleavage of the peptide bond between glycine(51) and leucine(52), which limits their clinical applications. Development of MMP-resistant analogues of kisspeptins may provide better therapeutic outputs. In the present study, two kisspeptin phosphinic peptides were designed and synthesized, and their ability to induce phosphorylation of ERK1/2 through kisspeptin receptor and their inhibition on MMP-2 and MMP-9 whose activity correlates with cancer metastasis were assessed. The results showed that one analogue, phosphinic kisspeptin R isomer (PKPR), exhibited kisspeptin receptor-agonistic activity and also inhibitory activity on MMP-2, indicating that PKPR may serve as a lead for the further development of kisspeptin analogues for therapeutic purpose.	[Zhang, Xiaoyang; Rong, Rong; Meng, Jia; Lu, Zhi-Liang] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Jiangsu, Peoples R China; [Matziari, Magdalini; Xie, Yixin] Xian Jiaotong Liverpool Univ, Dept Chem, Suzhou, Jiangsu, Peoples R China; [Fernig, David] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool, Merseyside, England	Xi'an Jiaotong-Liverpool University; Xi'an Jiaotong-Liverpool University; University of Liverpool	Lu, ZL (corresponding author), Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Jiangsu, Peoples R China.	zhiliang.lu@xjtiu.edu.cn	Fernig, David G/A-3590-2008; Meng, Jia/H-8796-2019	Fernig, David G/0000-0003-4875-4293; Meng, Jia/0000-0003-3455-205X; Lu, Zhiliang/0000-0002-3442-1415; Xie, Yixin/0000-0002-7274-7731	National Natural Science Foundation of China [81373469]; Research Development Fund of Xi'an Jiaotong-Liverpool University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Development Fund of Xi'an Jiaotong-Liverpool University	This work was supported by the National Natural Science Foundation of China (81373469) (http://www.nsfc.gov.cn/) and the Research Development Fund of Xi'an Jiaotong-Liverpool University (http://www.xjtlu.edu.cn./en/) to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglund K, 2004, GYNECOL ONCOL, V94, P699, DOI 10.1016/j.ygyno.2004.06.028; Arttamangkul S, 2000, MOL PHARMACOL, V58, P1570, DOI 10.1124/mol.58.6.1570; Asami T, 2012, BIOORG MED CHEM LETT, V22, P6328, DOI 10.1016/j.bmcl.2012.08.087; Asami T, 2012, BIOORG MED CHEM LETT, V22, P6391, DOI 10.1016/j.bmcl.2012.08.069; Camerino MA, 2016, J PEPT SCI, V22, P406, DOI 10.1002/psc.2883; Chevrier L, 2013, MOL ENDOCRINOL, V27, P1004, DOI 10.1210/me.2012-1386; Daniel JA, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0021-4; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Desmeules P, 2015, HUM PATHOL, V46, P739, DOI 10.1016/j.humpath.2015.01.014; Dhillo WS, 2007, J CLIN ENDOCR METAB, V92, P3958, DOI 10.1210/jc.2007-1116; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Di Nezza LA, 2002, CANCER, V94, P1466, DOI 10.1002/cncr.10355; Dive V, 2004, CELL MOL LIFE SCI, V61, P2010, DOI 10.1007/s00018-004-4050-y; Georgiadis D, 2015, TOP CURR CHEM, V360, P1, DOI 10.1007/128_2014_571; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Jiang Y, 2005, CLIN EXP METASTAS, V22, P369, DOI 10.1007/s10585-005-8186-4; Kaneda M, 2014, BIOORGAN MED CHEM, V22, P3325, DOI 10.1016/j.bmc.2014.04.052; Kang HS, 2011, MOL CANCER THER, V10, P580, DOI 10.1158/1535-7163.MCT-10-0763; Kirby HR, 2010, PHARMACOL REV, V62, P565, DOI 10.1124/pr.110.002774; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li N, 2012, WORLD J GASTROENTERO, V18, P1827, DOI 10.3748/wjg.v18.i15.1827; Makaritis A, 2003, CHEM-EUR J, V9, P2079, DOI 10.1002/chem.200204456; Matziari M, 2005, ORG LETT, V7, P4049, DOI 10.1021/ol051622y; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Niida A, 2006, BIOORG MED CHEM LETT, V16, P134, DOI 10.1016/j.bmcl.2005.09.054; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pasquier J, 2014, J MOL ENDOCRINOL, V52, pT101, DOI 10.1530/JME-13-0224; Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Sullu Y, 2011, PATHOL RES PRACT, V207, P747, DOI 10.1016/j.prp.2011.09.010; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tan K, 2014, CURR MOL MED, V14, P652, DOI 10.2174/1566524014666140603115314; Tomita K, 2008, J MED CHEM, V51, P7645, DOI 10.1021/jm800930w; Vassiliou S, 1999, J MED CHEM, V42, P2610, DOI 10.1021/jm9900164; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Yiotakis A, 1996, J ORG CHEM, V61, P6601, DOI 10.1021/jo9603439; Ziegler E, 2013, ONCOL REP, V29, P549, DOI 10.3892/or.2012.2135	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195089	10.1371/journal.pone.0195089	http://dx.doi.org/10.1371/journal.pone.0195089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614094	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600029
J	Baquero, OS; Santana, LMR; Chiaravalloti-Neto, F				Baquero, Oswaldo Santos; Reis Santana, Lidia Maria; Chiaravalloti-Neto, Francisco			Dengue forecasting in Sao Paulo city with generalized additive models, artificial neural networks and seasonal autoregressive integrated moving average models	PLOS ONE			English	Article							RIO-DE-JANEIRO; BRAZIL	Globally, the number of dengue cases has been on the increase since 1990 and this trend has also been found in Brazil and its most populated city-Sao Paulo. Surveillance systems based on predictions allow for timely decision making processes, and in turn, timely and efficient interventions to reduce the burden of the disease. We conducted a comparative study of dengue predictions in Sao Paulo city to test the performance of trained seasonal autoregressive integrated moving average models, generalized additive models and artificial neural networks. We also used a naive model as a benchmark. A generalized additive model with lags of the number of cases and meteorological variables had the best performance, predicted epidemics of unprecedented magnitude and its performance was 3.16 times higher than the benchmark and 1.47 higher that the next best performing model. The predictive models captured the seasonal patterns but differed in their capacity to anticipate large epidemics and all outperformed the benchmark. In addition to be able to predict epidemics of unprecedented magnitude, the best model had computational advantages, since its training and tuning was straightforward and required seconds or at most few minutes. These are desired characteristics to provide timely results for decision makers. However, it should be noted that predictions are made just one month ahead and this is a limitation that future studies could try to reduce.	[Baquero, Oswaldo Santos] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Sch Vet Med, Sao Paulo, Brazil; [Baquero, Oswaldo Santos; Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Dept Epidemiol, Sch Publ Hlth, Sao Paulo, Brazil; [Reis Santana, Lidia Maria] Sao Paulo State, Epidemiol Surveillance Ctr, Dept Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Baquero, OS (corresponding author), Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Sch Vet Med, Sao Paulo, Brazil.; Baquero, OS (corresponding author), Univ Sao Paulo, Dept Epidemiol, Sch Publ Hlth, Sao Paulo, Brazil.	baquero@usp.br	Neto, Francisco Chiaravalloti/F-8006-2012; Baquero, Oswaldo/R-4265-2016	Neto, Francisco Chiaravalloti/0000-0003-2686-8740; Baquero, Oswaldo/0000-0003-2695-7946; , Lidia Maria/0000-0001-9993-8530	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1573079]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	OSB received funding from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, number: 1573079. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburas HM, 2010, EXPERT SYST APPL, V37, P4256, DOI 10.1016/j.eswa.2009.11.077; Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Centro de Vigilancia Epidemiologica do Estado de Sao Paulo. Dengue, 2015, DISTR CAS DENG NOT C; Chien LC, 2014, ENVIRON INT, V73, P46, DOI 10.1016/j.envint.2014.06.018; Gamboa JC., 2017, DEEP LEARNING TIME S; Glorot X., 2011, P 14 INT C ART INT S; Gomes AF, 2012, CAD SAUDE PUBLICA, V28, P2189, DOI 10.1590/S0102-311X2012001100018; Google.org, 2009, GOOGL FLU TRENDS; Greff K, 2017, IEEE T NEUR NET LEAR, V28, P2222, DOI 10.1109/TNNLS.2016.2582924; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hastie T., 2016, ELEMENTS STAT LEARNI; Hyndman RJ, 2014, FORECASTING PRINCIPL; Johansson MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33707; Kingma D. P., 2015, 3 INT C LEARNING REP; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285; Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9; Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Ministerio da Saudede Vigilancia em Saude, 2005, GUIA VIGILANCIA EPID; Morin CW, 2013, ENV HLTH PERSPECT; Pan American Health Organization, 2016, NUMB REP CAS DENG SE; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Ramadona AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152688; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Sousa LB, 2015, REGULARIZED LINEAR N, P121; Yuan QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064323	30	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195065	10.1371/journal.pone.0195065	http://dx.doi.org/10.1371/journal.pone.0195065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608586	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800024
J	Spaulding, AC; Drobeniuc, A; Frew, PM; Lemon, TL; Anderson, EJ; Cerwonka, C; Bowden, C; Freshley, J; del Rio, C				Spaulding, Anne C.; Drobeniuc, Ana; Frew, Paula M.; Lemon, Tiffany L.; Anderson, Emeli J.; Cerwonka, Colin; Bowden, Chava; Freshley, John; del Rio, Carlos			Jail, an unappreciated medical home: Assessing the feasibility of a strengths-based case management intervention to improve the care retention of HIV-infected persons once released from jail	PLOS ONE			English	Article							INCARCERATION; CONTINUUM; TRANSMISSION; HIV/AIDS	Background Linkage to and retention in care for US persons living with HIV (PLWH) after release from jail usually declines. We know of no rigorously evaluated behavioral interventions that can improve this. We hypothesized that a strengths-based case management intervention that we developed for PLWH leaving jail would increase linkage/retention in care (indicated by receipt of laboratory draws) and a suppressed HIV viral load (VL) in the year following release. Methods and findings We conducted a quasi-experimental feasibility study of our intervention for PLWH jailed in Atlanta. We recruited 113 PLWH in jail starting in 2014. "SUCCESS" (Sustained, Unbroken Connection to Care, Entry Services, and Suppression) began in jail and continued post-release. Subjects who started the intervention but subsequently began long-term incarcerations were excluded from further analysis. Persons who were retained in the intervention group were compared to contemporaneously incarcerated PLWH who did not receive the intervention. Identities were submitted to an enhanced HIV/AIDS reporting system (eHARS) at the state health department to capture all laboratories drawn. Both community engagement and care upon jail return were assessed equally. For 44 intervention participants released to Atlanta, 50% of care occurred on subsequent jail stays, as documented with EventFlow software. Forty-five receiving usual services only were recruited for comparison. By examining records of jail reentries, half of participants and 60% of controls recidivated (range: 1-8 returns). All but 6 participants in the intervention and 9 subjects in the comparison arm had >= 1 laboratory recorded in eHARS post-release. Among the intervention group, 52% were retained in care (i.e., had two laboratory studies, > = 3 months apart), versus 40% among the comparison group (OR = 1.60, 95% CI (0.71, 3.81)). Both arms showed improved viral load suppression. Conclusions There was a trend towards increased retention for PLWH released from jail after SUCCESS, compared to usual services. Measuring linkage at all venues, including jail-based clinics, fully captured engagement for this frequently recidivating population.	[Spaulding, Anne C.; Frew, Paula M.; del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Spaulding, Anne C.; Drobeniuc, Ana; Lemon, Tiffany L.; Anderson, Emeli J.; Cerwonka, Colin; Bowden, Chava; Freshley, John; del Rio, Carlos] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Frew, Paula M.] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Frew, Paula M.; del Rio, Carlos] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Spaulding, AC (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.; Spaulding, AC (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	aspauld@emory.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517; spaulding, anne/0000-0002-0281-0248	NIAID NIH HHS [P30 AI050409, T32 AI007535] Funding Source: Medline; NIDA NIH HHS [R34 DA035728] Funding Source: Medline; NIH HHS [DA035728] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Christopoulos KA, 2017, AIDS BEHAV, P1; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Colasanti J, 2016, CLIN INFECT DIS, V62, P648, DOI 10.1093/cid/civ941; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1046/j.1360-0443.1995.901013496.x; Davis T C, 1993, Fam Med, V25, P391; de Voux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037603; Drobeniuc AM, 2017, JAIDS-J ACQ IMM DEF, V76, pE22, DOI 10.1097/QAI.0000000000001465; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hammett TM, 2006, AM J PUBLIC HEALTH, V96, P974, DOI 10.2105/AJPH.2005.066993; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Iroh PA, 2015, AM J PUBLIC HEALTH, V105, pE5, DOI 10.2105/AJPH.2015.302635; Knight K, 2002, TREATMENT OF DRUG OFFENDERS: POLICIES AND ISSUES, P259; Lim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141912; Malik S, 2015, P 20 INT C INT US IN; Milloy MJ, 2014, CURR HIV-AIDS REP, V11, P308, DOI 10.1007/s11904-014-0214-z; Minton T., 2011, JAIL INMATES MIDYEAR; Monroe M, 2013, IEEE T VIS COMPUT GR, V19, P2227, DOI 10.1109/TVCG.2013.200; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; Spaulding AC, 2015, J PUBLIC HLTH MANAGE; Spaulding AC, 2013, AIDS BEHAV, V17, P220, DOI 10.1007/s10461-012-0353-4; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Westergaard RP, 2011, CLIN INFECT DIS, V53, P725, DOI 10.1093/cid/cir491; Whiteside YO, 2014, MMWR-MORBID MORTAL W, V63, P85; Wohl DA, 2011, AIDS BEHAV, V15, P356, DOI 10.1007/s10461-010-9843-4	27	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0191643	10.1371/journal.pone.0191643	http://dx.doi.org/10.1371/journal.pone.0191643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB1XW	29601591	Green Published, gold			2022-12-27	WOS:000428845900001
J	Akberdin, IR; Omelyanchuk, NA; Fadeev, SI; Leskova, NE; Oschepkova, EA; Kazantsev, FV; Matushkin, YG; Afonnikov, DA; Kolchanov, NA				Akberdin, Ilya R.; Omelyanchuk, Nadezda A.; Fadeev, Stanislav I.; Leskova, Natalya E.; Oschepkova, Evgeniya A.; Kazantsev, Fedor V.; Matushkin, Yury G.; Afonnikov, Dmitry A.; Kolchanov, Nikolay A.			Pluripotency gene network dynamics: System views from parametric analysis	PLOS ONE			English	Article							EMBRYONIC STEM-CELL; SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; NANOG AUTOREPRESSION; EXPRESSION; DIFFERENTIATION; HETEROGENEITY; STATE; FEEDBACK; OCT4	Multiple experimental data demonstrated that the core gene network orchestrating self-renewal and differentiation of mouse embryonic stem cells involves activity of Oct4, Sox2 and Nanog genes by means of a number of positive feedback loops among them. However, recent studies indicated that the architecture of the core gene network should also incorporate negative Nanog autoregulation and might not include positive feedbacks from Nanog to Oct4 and Sox2. Thorough parametric analysis of the mathematical model based on this revisited core regulatory circuit identified that there are substantial changes in model dynamics occurred depending on the strength of Oct4 and Sox2 activation and molecular complexity of Nanog autorepression. The analysis showed the existence of four dynamical domains with different numbers of stable and unstable steady states. We hypothesize that these domains can constitute the checkpoints in a developmental progression from naive to primed pluripotency and vice versa. During this transition, parametric conditions exist, which generate an oscillatory behavior of the system explaining heterogeneity in expression of pluripotent and differentiation factors in serum ESC cultures. Eventually, simulations showed that addition of positive feedbacks from Nanog to Oct4 and Sox2 leads mainly to increase of the parametric space for the naive ESC state, in which pluripotency factors are strongly expressed while differentiation ones are repressed.	[Akberdin, Ilya R.; Omelyanchuk, Nadezda A.; Leskova, Natalya E.; Oschepkova, Evgeniya A.; Kazantsev, Fedor V.; Matushkin, Yury G.; Afonnikov, Dmitry A.; Kolchanov, Nikolay A.] Fed Res Ctr Inst Cytol & Genet SB RAS, Novosibirsk, Russia; [Akberdin, Ilya R.; Omelyanchuk, Nadezda A.; Fadeev, Stanislav I.; Leskova, Natalya E.; Oschepkova, Evgeniya A.; Kazantsev, Fedor V.; Matushkin, Yury G.; Afonnikov, Dmitry A.; Kolchanov, Nikolay A.] Novosibirsk State Univ, Novosibirsk, Russia; [Akberdin, Ilya R.] San Diego State Univ, San Diego, CA 92182 USA; [Fadeev, Stanislav I.] Sobolev Inst Math SB RAS, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; California State University System; San Diego State University; Russian Academy of Sciences; Sobolev Institute of Mathematics	Akberdin, IR (corresponding author), Fed Res Ctr Inst Cytol & Genet SB RAS, Novosibirsk, Russia.; Akberdin, IR (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.; Akberdin, IR (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.	akberdin@bionet.nsc.ru	Oshchepkova, Evgeniya/AAT-3362-2021; Afonnikov, Dmitry/J-7806-2018; Akberdin, Ilya R/J-3172-2018; Kazantsev, Fedor V./AAC-8773-2020	Afonnikov, Dmitry/0000-0001-9738-1409; Akberdin, Ilya R/0000-0003-0010-8620; 				Abranches E, 2014, DEVELOPMENT, V141, P2770, DOI 10.1242/dev.108910; Abranches E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059928; Angarica VE, 2016, BIOESSAYS, V38, P758, DOI 10.1002/bies.201600103; Betschinger J., 2016, J MOL BIOL; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen CJ, 2017, SHOCK VIB, V2017, DOI 10.1155/2017/1427270; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-98; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; D'Aniello C, 2017, STEM CELL REP, V8, P1, DOI 10.1016/j.stemcr.2016.11.011; Fadeev S. I., 2004, INT J PURE APPL MATH, V14, P467; Fadeev S. I., 2006, P 6 INT C BIOINF GEN, V118, P120; Fernandes MG, 2016, STEM CELL REP, V6, P85, DOI 10.1016/j.stemcr.2015.11.012; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Filipczyk A, 2015, NAT CELL BIOL, V17, P1235, DOI 10.1038/ncb3237; Furusawa C, 2012, SCIENCE, V338, P215, DOI 10.1126/science.1224311; Furusawa T, 2006, BIOL REPROD, V75, P555, DOI 10.1095/biolreprod.105.049502; Galvin-Burgess KE, 2013, STEM CELLS, V31, P48, DOI 10.1002/stem.1252; Gingold JA, 2014, MOL CELL, V56, P140, DOI 10.1016/j.molcel.2014.08.014; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hahn S, 2014, J MOL MED, V92, P571, DOI 10.1007/s00109-014-1160-3; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Herberg M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0167; Herberg M, 2015, DEVELOPMENT, V142, P2250, DOI 10.1242/dev.116343; Herberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092496; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Ji PF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8415010; Kalkan T., 2017, DEVELOPMENT; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kholodniok M, 1991, METHODS ANAL NONLINE; Komatsu K, 2015, DEV GROWTH DIFFER, V57, P648, DOI 10.1111/dgd.12244; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lakatos D, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0112-4; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Li M., 2017, NATURE REV GENETICS; Likhoshvai V, 2007, J BIOINF COMPUT BIOL, V5, P521, DOI 10.1142/S0219720007002837; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Makarev E, 2015, ONCOTARGET, V6, P23204, DOI 10.18632/oncotarget.4673; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G., 2014, ANNU REV CELL DEV BI, P30; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyamoto T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004476; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Osorno R, 2011, PHILOS T R SOC B, V366, P2230, DOI 10.1098/rstb.2011.0043; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pigolotti S, 2007, P NATL ACAD SCI USA, V104, P6533, DOI 10.1073/pnas.0610759104; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smith A, 2017, DEVELOPMENT, V144, P365, DOI 10.1242/dev.142679; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen T. W., 2012, STEM CELLS CANC STEM, V6, P377; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van den Hurk M, 2016, EPIGENOMICS-UK, V8, P1131, DOI 10.2217/epi-2016-0032; Wang J, 2016, CELL DEATH DIFFER, V23, P393, DOI 10.1038/cdd.2015.106; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wray J., 2010, GROUND STATE PLURIPO; Wu QQ, 2015, INT J BIFURCAT CHAOS, V25, DOI 10.1142/S021812741540009X	89	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194464	10.1371/journal.pone.0194464	http://dx.doi.org/10.1371/journal.pone.0194464			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596533	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000026
J	Siegle, L; Schwab, JD; Kuhlwein, SD; Lausser, L; Tumpel, S; Pfister, AS; Kuhl, M; Kestler, HA				Siegle, Lea; Schwab, Julian D.; Kuehlwein, Silke D.; Lausser, Ludwig; Tuempel, Stefan; Pfister, Astrid S.; Kuehl, Michael; Kestler, Hans A.			A Boolean network of the crosstalk between IGF and Wnt signaling in aging satellite cells	PLOS ONE			English	Article							GENE REGULATORY NETWORK; INTESTINAL STEM-CELLS; RAPAMYCIN COMPLEX 2; FORKHEAD-BOX-O; BETA-CATENIN; OXIDATIVE STRESS; MAMMALIAN TARGET; PHOSPHOINOSITIDE 3-KINASE; INSULIN-RESISTANCE; KINASE KINASE	Aging is a complex biological process, which determines the life span of an organism. Insulin-like growth factor (IGF) and Wnt signaling pathways govern the process of aging. Both pathways share common downstream targets that allow competitive crosstalk between these branches. Of note, a shift from IGF to Wnt signaling has been observed during aging of satellite cells. Biological regulatory networks necessary to recreate aging have not yet been discovered. Here, we established a mathematical in silico model that robustly recapitulates the crosstalk between IGF and Wnt signaling. Strikingly, it predicts critical nodes following a shift from IGF to Wnt signaling. These findings indicate that this shift might cause age-related diseases.	[Siegle, Lea; Schwab, Julian D.; Kuehlwein, Silke D.; Lausser, Ludwig; Kestler, Hans A.] Ulm Univ, Inst Med Syst Biol, Ulm, Germany; [Siegle, Lea; Schwab, Julian D.; Kuehlwein, Silke D.] Ulm Univ, Int Grad Sch Mol Med, Ulm, Germany; [Tuempel, Stefan] Fritz Lipmann Inst, Leibniz Inst Aging, Jena, Germany; [Pfister, Astrid S.; Kuehl, Michael] Ulm Univ, Inst Biochem & Mol Biol, Ulm, Germany	Ulm University; Ulm University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Ulm University	Kestler, HA (corresponding author), Ulm Univ, Inst Med Syst Biol, Ulm, Germany.; Kuhl, M (corresponding author), Ulm Univ, Inst Biochem & Mol Biol, Ulm, Germany.	michael.kuehl@uni-ulm.de; hans.kestler@uni-ulm.de	Kestler, Hans A./D-5799-2012	Kestler, Hans A./0000-0002-4759-5254; Werle, Silke D./0000-0002-5153-0269				Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Avin KG, 2014, FRONT PHYSIOL, P5; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Boulter E, 2012, FASEB J, V26, P469, DOI 10.1096/fj.11-192252; Bracho-Valdes I, 2011, IUBMB LIFE, V63, P896, DOI 10.1002/iub.558; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brandt D, 2002, J BIOL CHEM, V277, P20903, DOI 10.1074/jbc.M200946200; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chiu TT, 2013, J BIOL CHEM, V288, P17520, DOI 10.1074/jbc.M113.467647; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dahlhaus M, 2016, CANCER LETT, V371, P79, DOI 10.1016/j.canlet.2015.11.025; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Famili F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.326; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Florian MC, 2010, STEM CELLS, V28, P1623, DOI 10.1002/stem.481; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; FRIEDMAN DB, 1988, GENETICS, V118, P75; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Ganguly G, 2017, DRUG DES DEVELOOPMEN, P11; Graudenzi A, 2011, J COMPUT BIOL, V18, P559, DOI 10.1089/cmb.2010.0224; Grieb M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131832; Gruber J, 2016, CANCERS, V8, DOI 10.3390/cancers8080073; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Herrmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046798; Hitomi H, 2011, AM J PHYSIOL-CELL PH, V301, pC1415, DOI 10.1152/ajpcell.00017.2011; Holmes WR, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/4/046001; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Hu ZY, 2014, AGING-US, V6, P160, DOI 10.18632/aging.100643; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kervizic G, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-99; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klipp Edda, 2009, SYSTEMS BIOL TXB; Lan T, 2012, ONCOL REP, V27, P2039, DOI 10.3892/or.2012.1726; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.519; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Lin AF, 2014, CANCER RES, V74, P1682, DOI 10.1158/0008-5472.CAN-13-1729; Lin GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086520; Liu AY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083736, 10.1371/journal.pone.0095291]; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Liu LY, 2014, INT J MOL MED, V33, P1089, DOI 10.3892/ijmm.2014.1701; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Marchand A, 2011, AGING CELL, V10, P220, DOI 10.1111/j.1474-9726.2010.00661.x; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; McCubrey JA, 2012, ONCOTARGET, V3, P954, DOI 10.18632/oncotarget.652; Miranti CK, 1999, J BIOL CHEM, V274, P10571, DOI 10.1074/jbc.274.15.10571; Mitchell L, 2013, ANTIOXID REDOX SIGN, V18, P250, DOI 10.1089/ars.2012.4687; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Naito AT, 2010, CIRC RES, V107, P1295, DOI 10.1161/CIRCRESAHA.110.223776; Nalapareddy K, 2017, CELL REP, V18, P2608, DOI 10.1016/j.celrep.2017.02.056; Naldi A, 2015, BIOINFORMATICS, V31, P1154, DOI 10.1093/bioinformatics/btv013; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richardson A, 2004, BEST PRACT RES CL EN, V18, P393, DOI 10.1016/j.beem.2004.02.002; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Saxena M, 2015, ONCOGENE, V34, P188, DOI 10.1038/onc.2013.549; Schlupf J, 2014, DIFFERENTIATION, V87, P209, DOI 10.1016/j.diff.2014.07.003; Schulte G, 2010, BRIT J PHARMACOL, V159, P1051, DOI 10.1111/j.1476-5381.2009.00466.x; Schwab J, 2017, BIOINFORMATICS, V33, P601, DOI 10.1093/bioinformatics/btw661; Selvaraj N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-61; Shah AV, 2017, EUR J PHARMACOL, V816, P82; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Smith GR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011092; Steed E, 2014, J CELL BIOL, V204, P821, DOI 10.1083/jcb.201304115; Strle K, 2006, ENDOCRINOLOGY, V147, P4363, DOI 10.1210/en.2005-1541; Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian H, 2015, CELL REP, V11, P33, DOI 10.1016/j.celrep.2015.03.007; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Watanabe S, 2015, FASEB J, V29, P1003, DOI 10.1096/fj.14-262154; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016; Xiao YF, 2009, CURR GENOMICS, V10, P511, DOI 10.2174/138920209789208237; Xie XD, 2011, CELL, V144, P640, DOI 10.1016/j.cell.2011.02.029; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Yin F, 2013, BIOCHEM SOC T, V41, P101, DOI 10.1042/BST20120260; Yokoyama N, 2009, J CELL SCI, V122, P4439, DOI 10.1242/jcs.051847; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhai GG, 2006, J NEURO-ONCOL, V76, P227, DOI 10.1007/s11060-005-6499-4; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhou D, 2011, REPOS U ULM, V25, P16; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823; Zielinski R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-88; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; ZSNAGY I, 1988, ANN NY ACAD SCI, V521, P215, DOI 10.1111/j.1749-6632.1988.tb35280.x	128	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195126	10.1371/journal.pone.0195126	http://dx.doi.org/10.1371/journal.pone.0195126			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596489	gold, Green Submitted, Green Published			2022-12-27	WOS:000428630000080
J	Tamez-Pena, JG; Rodriguez-Rojas, JA; Gomez-Rueda, H; Celaya-Padilla, JM; Rivera-Prieto, RA; Palacios-Corona, R; Garza-Montemayor, M; Cardona-Huerta, S; Trevino, V				Tamez-Pena, Jose-Gerardo; Rodriguez-Rojas, Juan-Andres; Gomez-Rueda, Hugo; Celaya-Padilla, Jose-Maria; Rivera-Prieto, Roxana-Alicia; Palacios-Corona, Rebeca; Garza-Montemayor, Margarita; Cardona-Huerta, Servando; Trevino, Victor			Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer	PLOS ONE			English	Article							RECURRENCE SCORE; IMAGING FEATURES; RISK PREDICTION; IN-SITU; RADIOMICS; CLASSIFICATION; MICROCALCIFICATIONS; HETEROGENEITY; SEGMENTATION; ASSOCIATIONS	In breast cancer, well-known gene expression subtypes have been related to a specific clinical outcome. However, their impact on the breast tissue phenotype has been poorly studied. Here, we investigate the association of imaging data of tumors to gene expression signatures from 71 patients with breast cancer that underwent pre-treatment digital mammograms and tumor biopsies. From digital mammograms, a semi-automated radiogenomics analysis generated 1,078 features describing the shape, signal distribution, and texture of tumors along their contralateral image used as control. From tumor biopsy, we estimated the OncotypeDX and PAM50 recurrence scores using gene expression microarrays. Then, we used multivariate analysis under stringent cross-validation to train models predicting recurrence scores. Few univariate features reached Spearman correlation coefficients above 0.4. Nevertheless, multivariate analysis yielded significantly correlated models for both signatures (correlation of OncotypeDX = 0.49 +/- 0.07 and PAM50 = 0.32 +/- 0.10 in stringent cross-validation and OncotypeDX = 0.83 and PAM50 = 0.78 for a unique model). Equivalent models trained from the unaffected contralateral breast were not correlated suggesting that the image signatures were tumor-specific and that overfitting was not a considerable issue. We also noted that models were improved by combining clinical information (triple negative status and progesterone receptor). The models used mostly wavelets and fractal features suggesting their importance to capture tumor information. Our results suggest that molecular-based recurrence risk and breast cancer subtypes have observable radiographic phenotypes. To our knowledge, this is the first study associating mammographic information to gene expression recurrence signatures.	[Tamez-Pena, Jose-Gerardo; Rodriguez-Rojas, Juan-Andres; Gomez-Rueda, Hugo; Celaya-Padilla, Jose-Maria; Rivera-Prieto, Roxana-Alicia; Trevino, Victor] Tecnol Monterrey, Escuela Med, Catedra Bioinformat, Ave Morones Prieto Pte 3000, Monterrey, NL, Mexico; [Celaya-Padilla, Jose-Maria] Univ Autonoma Zacatecas, Zacatecas, Zacatecas, Mexico; [Palacios-Corona, Rebeca] Inst Mexicano Seguro Social, Ctr Invest Biomed Noreste, Ave 2 Abril & San Luis Potosi S-N, Monterrey, NL, Mexico; [Garza-Montemayor, Margarita; Cardona-Huerta, Servando] Hosp Zambrano Hell, Ctr Canc Mama, Ave Col Real San Agustin, San Pedro Garza Garcia, Nuevo Leon, Mexico	Tecnologico de Monterrey; Universidad Autonoma de Zacatecas; Instituto Mexicano del Seguro Social	Trevino, V (corresponding author), Tecnol Monterrey, Escuela Med, Catedra Bioinformat, Ave Morones Prieto Pte 3000, Monterrey, NL, Mexico.	vtrevino@itesm.mx	Tamez-Pena, Jose/B-1845-2009; Trevino, Victor/C-9219-2009	Tamez-Pena, Jose/0000-0003-1361-5162; Trevino, Victor/0000-0002-7472-9844				Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Antonini M, 1992, IEEE T IMAGE PROCESS, V1, P205, DOI 10.1109/83.136597; Ashraf AB, 2013, IEEE T MED IMAGING, V32, P637, DOI 10.1109/TMI.2012.2219589; Ashraf AB, 2014, RADIOLOGY, V272, P374, DOI 10.1148/radiol.14131375; Axelrod DE, 2008, CANCER INFORM, V6, P99; Baish JW, 2000, CANCER RES, V60, P3683; Boisserie-Lacroix M, 2013, Diagn Interv Imaging, V94, P1069, DOI 10.1016/j.diii.2013.04.010; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Celaya-Padilla JM, 2015, BIOMED RES INT, V2015, P12; Celaya-Padilla JM, 2013, P SPIE INT SOC OPT E; Celaya-Padilla J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/231656; Cheng HD, 2006, PATTERN RECOGN, V39, P646, DOI 10.1016/j.patcog.2005.07.006; D'Orsi CJ., 2013, ACR BI RADS ATLAS BR; Dhahbi S, 2015, COMPUT BIOL MED, V64, P79, DOI 10.1016/j.compbiomed.2015.06.012; Drukker K, 2015, MED PHYS, V42, P3602, DOI 10.1118/1.4925588; Ergin S, 2014, COMPUT BIOL MED, V51, P171, DOI 10.1016/j.compbiomed.2014.05.008; Evans KK, 2016, P NATL ACAD SCI USA, V113, P10292, DOI 10.1073/pnas.1606187113; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Gevaert O, 2012, RADIOLOGY, V264, P387, DOI 10.1148/radiol.12111607; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Guo WT, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041007; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Haspinger ER, 2015, EUR J CANCER, V51, pS101, DOI 10.1016/S0959-8049(16)30301-X; Jain S, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0360-2; Karlo CA, 2014, RADIOLOGY, V270, P464, DOI 10.1148/radiol.13130663; Keller BM, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.2.024501; Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007; Kendall EJ, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-43; Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575; Kooi T, 2017, MED IMAGE ANAL, V35, P303, DOI 10.1016/j.media.2016.07.007; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Kuo MD, 2014, RADIOLOGY, V270, P320, DOI 10.1148/radiol.13132195; LAINE AF, 1994, IEEE T MED IMAGING, V13, P725, DOI 10.1109/42.363095; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Li H, 1997, IEEE T MED IMAGING, V16, P785, DOI 10.1109/42.650875; Li H, 2016, RADIOLOGY, V281, P382, DOI 10.1148/radiol.2016152110; Liu ZQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04002; Malkov S, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0778-1; Napel S, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041001; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Oh J, 2015, MED PHYS, V42, P3588, DOI 10.1118/1.4925514; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Petushi Sokol, 2006, BMC Med Imaging, V6, P14, DOI 10.1186/1471-2342-6-14; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rahbar H, 2016, ACAD RADIOL, V23, P768, DOI 10.1016/j.acra.2016.02.008; Rakha EA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1827; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Rodriguez-Rojas J, 2013, SPIE MED IMAGING; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Trop I, 2014, RADIOGRAPHICS, V34, P1178, DOI 10.1148/rg.345130049; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang TC, 1998, IEEE T MED IMAGING, V17, P498, DOI 10.1109/42.730395; Yamamoto S, 2012, AM J ROENTGENOL, V199, P654, DOI 10.2214/AJR.11.7824; Yepes MM, 2014, BREAST CANCER RES TR, V148, P117, DOI 10.1007/s10549-014-3143-z; Zheng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063332; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451	62	11	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193871	10.1371/journal.pone.0193871	http://dx.doi.org/10.1371/journal.pone.0193871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596496	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000014
J	Assuncao, N; Sudo, FK; Drummond, C; de Felice, FG; Mattos, P				Assuncao, Naima; Sudo, Felipe Kenji; Drummond, Claudia; de Felice, Fernanda Guarino; Mattos, Paulo			Metabolic Syndrome and cognitive decline in the elderly: A systematic review	PLOS ONE			English	Review							CLOCK-DRAWING TEST; BODY-MASS INDEX; INSULIN-RESISTANCE; LONGITUDINAL CHANGES; ALZHEIMERS-DISEASE; OLDEST-OLD; FOLLOW-UP; IMPAIRMENT; RISK; HYPERTENSION	Background Metabolic Syndrome (MetS) refers to a cluster of metabolic disturbances which is associated with increased risk for vascular and degenerative conditions in general population. Although the relationship between vascular risk factors and dementia is undisputable, additional hazard for cognitive decline in older population with concurrent metabolic disorders still waits to be demonstrated. The present review aims to analyze data on MetS and risk for cognitive decline in elderly persons. Methods Database searches were performed in Medline, ISI and Psycl NFO for articles assessing cognitive performances of older subjects with MetS. Results Of a total of 505 studies, 25 were selected for the review. Risk of selection biases was identified in all the studies. Although all articles followed recognized diagnostic recommendations for MetS, minor criteria modifications were detected in most of them. Hyperglycemia was consistently associated with impaired cognitive performances in older individuals, but the role of MetS for cognitive decline and for the onset of dementia showed heterogeneous results. Discussion Current available data in the literature concerning the impact of MetS on the cognition of older population is inconclusive and based on inconsistent evidence. Differential effects of individual MetS components and factors associated with the age of the sample may have accounted for divergent findings among articles, but larger and higher quality studies in this field are still needed.	[Assuncao, Naima; Sudo, Felipe Kenji; Drummond, Claudia; Mattos, Paulo] DOr Inst Res & Educ, Memory Clin, Rio De Janeiro, Brazil; [Assuncao, Naima; de Felice, Fernanda Guarino; Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Biomed Sci, Morphol Sci Program, Rio De Janeiro, Brazil; [Sudo, Felipe Kenji] Pontifical Catholic Univ Rio de Janeiro, Dept Psychol, Rio De Janeiro, Brazil; [Drummond, Claudia] Univ Fed Rio de Janeiro, Dept Speech & Hearing Pathol, Rio De Janeiro, Brazil; [de Felice, Fernanda Guarino] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil; [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Dept Psychiat & Forens Med, Rio De Janeiro, Brazil	IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Pontificia Universidade Catolica do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Sudo, FK (corresponding author), DOr Inst Res & Educ, Memory Clin, Rio De Janeiro, Brazil.; Sudo, FK (corresponding author), Pontifical Catholic Univ Rio de Janeiro, Dept Psychol, Rio De Janeiro, Brazil.	fksudo@gmail.com	De Felice, Fernanda G/M-1074-2017; Sudo, Felipe Kenji/P-3090-2016; de Mattos, Paulo Eduardo Luiz/D-2328-2014	Sudo, Felipe Kenji/0000-0003-4738-1368; de Mattos, Paulo Eduardo Luiz/0000-0003-0709-3783				Alberti K.G., 2016, DIABETIC MED, V23, P469; [Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794; [Anonymous], 2014, PLOS ONE, V11, DOI 10.1371/journal.pmed.1001711; Balkau B, 2002, DIABETES METAB, V28, P364; Berg E. van den, 2007, Neurology, V69, P979, DOI 10.1212/01.wnl.0000271381.30143.75; Booth ML, 2000, INT J OBESITY, V24, P1058, DOI 10.1038/sj.ijo.0801359; Coin A, 2012, J NUTR HEALTH AGING, V16, P553, DOI 10.1007/s12603-012-0052-x; Corrada MM, 2017, ALZHEIMERS DEMENT, V13, P103, DOI 10.1016/j.jalz.2016.09.007; Costa A, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0254-x; Daffner KR, 2015, NEUROLOGY, V85, P910, DOI 10.1212/WNL.0000000000001763; Danese Elisa, 2015, J Diabetes Sci Technol, V9, P169, DOI 10.1177/1932296814567227; Dasgupta K, 2014, CAN J CARDIOL, V30, P485, DOI 10.1016/j.cjca.2014.02.002; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; Del Brutto OH, 2016, AGING CLIN EXP RES, V28, P321, DOI 10.1007/s40520-015-0404-6; Denys K, 2009, ACTA CLIN BELG, V64, P23, DOI 10.1179/acb.2009.006; Dik MG, 2007, DIABETES CARE, V30, P2655, DOI 10.2337/dc06-1190; Doiron M, 2017, AGING MENT HEALTH, V21, P322, DOI 10.1080/13607863.2015.1090393; Ekblad LL, 2017, DIABETES CARE, V40, P751, DOI 10.2337/dc16-2001; Emamian F, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00078; Ghosh A, 2015, NEUROL INDIA, V63, P537, DOI 10.4103/0028-3886.162037; Greenberg MS, 2014, ALZHEIMERS DEMENT, V10, pS155, DOI 10.1016/j.jalz.2014.04.008; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HACHINSKI V, 1994, DEMENTIA, V5, P130, DOI 10.1159/000106709; Han BH, 2017, JAMA INTERN MED, V177, P955, DOI 10.1001/jamainternmed.2017.1442; Harrison SL, 2015, J AM GERIATR SOC, V63, P667, DOI 10.1111/jgs.13358; Hishikawa N, 2016, EUR J NEUROL, V23, P339, DOI 10.1111/ene.12845; Jellinger KA, 2007, ACTA NEUROPATHOL, V113, P349, DOI 10.1007/s00401-006-0185-2; Katsumata Y, 2012, J GERONTOL A-BIOL, V67, P126, DOI 10.1093/gerona/glr189; Ketema EB, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0088-6; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; Kjeldsen S, 2014, DRUGS, V74, P2033, DOI 10.1007/s40265-014-0306-5; Komulainen P, 2007, DEMENT GERIATR COGN, V23, P29, DOI 10.1159/000096636; Laudisio A, 2008, CLIN NUTR, V27, P747, DOI 10.1016/j.clnu.2008.07.001; Lee KS, 2010, ARCH GERONTOL GERIAT, V50, P69, DOI 10.1016/j.archger.2009.01.014; Leritz EC, 2011, CURR CARDIOVASC RISK, V5, P407, DOI 10.1007/s12170-011-0189-x; Liu CL, 2013, J NUTR HEALTH AGING, V17, P523, DOI 10.1007/s12603-013-0010-2; Liu M, 2015, CLIN ENDOCRINOL, V82, P844, DOI 10.1111/cen.12734; Lovden M, 2013, CURR OPIN PSYCHIATR, V26, P239, DOI 10.1097/YCO.0b013e32835f4135; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Masellis M, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt197; Mazza A, 2010, AGING HLTH, V6, P217, DOI [10.2217/ahe.10.9, DOI 10.2217/AHE.10.9]; National Institute for Health and Care Excellence, 2016, HYP CLIN MAN PRIM HY; Raffaitin C, 2011, NEUROLOGY, V76, P518, DOI 10.1212/WNL.0b013e31820b7656; Ravaglia G, 2006, DIABETES CARE, V29, P2471, DOI 10.2337/dc06-0282; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Roriz-Cruz M, 2007, NEUROBIOL AGING, V28, P1723, DOI 10.1016/j.neurobiolaging.2006.07.013; Rouch I, 2014, AM J GERIAT PSYCHIAT, V22, P1096, DOI 10.1016/j.jagp.2014.01.005; Sergi G, 2005, J GERONTOL A-BIOL, V60, P866, DOI 10.1093/gerona/60.7.866; Shigaeff Nadia, 2013, Dement. neuropsychol., V7, P206, DOI 10.1590/S1980-57642013DN70200011; Siervo M, 2014, J ALZHEIMERS DIS, V41, P151, DOI 10.3233/JAD-132279; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tortelli R, 2017, J ALZHEIMERS DIS, V59, P121, DOI [10.3233/JAD-170153, 10.3233/jad-170153]; Tsai CK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004791; Viscogliosi G, 2017, ARCH GERONTOL GERIAT, V70, P62, DOI 10.1016/j.archger.2016.12.008; Viscogliosi G, 2016, AM J GERIAT PSYCHIAT, V24, P359, DOI 10.1016/j.jagp.2015.09.001; Viscogliosi G, 2015, PSYCHIAT CLIN NEUROS, V69, P620, DOI 10.1111/pcn.12296; Viscogliosi G, 2012, METAB SYNDR RELAT D, V10, P358, DOI 10.1089/met.2012.0043; Viticchi G, 2015, INT J GERIATR PSYCH, V30, P1164, DOI 10.1002/gps.4269; Watts AS, 2013, J ALZHEIMERS DIS, V35, P253, DOI 10.3233/JAD-121168; Wells G, NEWCASTLE OTTAWA QUA; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; Yaffe K, 2007, J AM GERIATR SOC, V55, P758, DOI 10.1111/j.1532-5415.2007.01139.x	62	67	67	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194990	10.1371/journal.pone.0194990	http://dx.doi.org/10.1371/journal.pone.0194990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579115	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800072
J	Buchanan, B; Meng, Q; Poulin, MM; Zuccolo, J; Azike, CG; Gabriele, J; Baranowski, DC				Buchanan, Beth; Meng, Qingfang; Poulin, Mathieu-Marc; Zuccolo, Jonathan; Azike, Chike Godwin; Gabriele, Joseph; Baranowski, David Charles			Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine	PLOS ONE			English	Article							RAT PLASMA APPLICATION; UPLC-MS/MS METHOD; MASS-SPECTROMETRY; ACID; SIMVASTATIN; JATRORRHIZINE; COMBINATION; VALIDATION; HYDRASTINE; PALMATINE	The natural alkaloid berberine has been ascribed numerous health benefits including lipid and cholesterol reduction and improved insulin sensitivity in diabetics. However, oral (PO) administration of berberine is hindered by poor bioavailability and increasing dose often elicits gastro-intestinal side effects. To overcome the caveats associated with oral berberine, we developed transdermal (TD) formulations of berberine (BBR) and the berberine precursor dihydroberberine (DHB). These formulations were compared to oral BBR using pharmacokinetics, metabolism, and general safety studies in vivo. To complete this work, a sensitive quantitative LC-MS/MS method was developed and validated according the FDA guidelines for bioanalytical methods to simultaneously measure berberine, simvastatin, and simvastatin hydroxy acid with relative quantification used for the berberine metabolite demethylene berberine glucuronide (DBG). Acute pharmacokinetics in Sprague-Dawley rats demonstrated a statistically relevant ranking for berberine bioavailability based upon AUC(0-8) as DHB TD > BBR TD >> BBR PO with similar ranking for the metabolite DBG, indicating that transdermal administration achieves BBR levels well above oral administration. Similarly, chronic administration (14 days) resulted in significantly higher levels of circulating BBR and DBG in DHB TD treated animals. Chronically treated rats were given a single dose of simvastatin with no observed change in the drugs bioavailability compared with control, suggesting the increased presence of BBR had no effect on simvastatin metabolism. This observation was further supported by consistent CYP3A4 expression across all treatment groups. Moreover, no changes in kidney and liver biomarkers, including alanine aminotransferase and alkaline phosphatase, were observed between treatment formats, and confirming previous reports that BBR has no effect on HMG-CoA expression. This study supports the safe use of transdermal compositions that improve on the poor bioavailability of oral berberine and have the potential to be more efficacious in the treatment of dyslipidemia or hypercholesterolemia.	[Buchanan, Beth; Meng, Qingfang; Poulin, Mathieu-Marc; Zuccolo, Jonathan; Azike, Chike Godwin; Gabriele, Joseph; Baranowski, David Charles] Delivra Corp, Res & Dev, Charlottetown, PE, Canada		Baranowski, DC (corresponding author), Delivra Corp, Res & Dev, Charlottetown, PE, Canada.	dbaranowski@delivrainc.com		Baranowski, David/0000-0002-5372-7727	Innovation PEI [201606-33]; Atlantic Canada Opportunities Agency; National Research Council of Canada Industrial Research Assistance Program; Delivra Corp.	Innovation PEI; Atlantic Canada Opportunities Agency; National Research Council of Canada Industrial Research Assistance Program; Delivra Corp.	This work was partially supported by Innovation PEI through a post-doctoral award (201606-33 to BB), by the Atlantic Canada Opportunities Agency through equipment funding, and by the National Research Council of Canada Industrial Research Assistance Program through salary and consumables support. Delivra Corp., provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN AH, 1969, CAN J MICROBIOL, V15, P1067, DOI 10.1139/m69-190; BAHADUR S, 1983, J NAT PROD, V46, P454, DOI 10.1021/np50028a002; Car BD, 2006, AM COLL LAB, P127, DOI 10.1016/B978-012074903-4/50008-X; Chen W, 2011, AAPS PHARMSCITECH, V12, P705, DOI 10.1208/s12249-011-9632-z; Cicero AFG, 2017, ARCH MED SCI, V13, P965, DOI [10.1093/nutrit/nux047, 10.5114/aoms.2017.69326]; Cui HM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040464; Deng YT, 2008, J CHROMATOGR B, V863, P195, DOI 10.1016/j.jchromb.2007.12.028; Di Pierro F, 2013, CLIN PHARMACOL-ADV A, V5, P167, DOI 10.2147/CPAA.S54308; Dong H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591654; Feng RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10131; Gentry EJ, 1998, J NAT PROD, V61, P1187, DOI 10.1021/np9701889; Germoush MO, 2014, J CANCER RES CLIN, V140, P1103, DOI 10.1007/s00432-014-1665-8; Godugu Chandraiah, 2014, PLoS One, V9, pe89919, DOI 10.1371/journal.pone.0089919; Guo Y, 2012, EUR J CLIN PHARMACOL, V68, P213, DOI 10.1007/s00228-011-1108-2; Gupta PK, 2009, J PHARMACEUT BIOMED, V49, P1021, DOI 10.1016/j.jpba.2009.01.036; Han Zhong-Ze, 2010, Laboratory Animal Research, V26, P153; Kong W-J, 2017, METAB D CLIN EXP, V57, P1029; Kong WJ, 2008, METABOLISM, V57, P1029, DOI 10.1016/j.metabol.2008.01.037; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kurz A, 2009, INT J CLIN PRACT, V63, P799, DOI 10.1111/j.1742-1241.2009.02052.x; Li GF, 2016, BIOMED CHROMATOGR, V30, P1075, DOI 10.1002/bmc.3652; Li H, 2016, PHARM BIOL, V54, P2886, DOI 10.1080/13880209.2016.1190762; Li J, 2014, LIFE SCI, V98, P24, DOI 10.1016/j.lfs.2013.12.211; Liu M, 2015, J CHROMATOGR B, V1006, P8, DOI 10.1016/j.jchromb.2015.09.033; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Lv Z, 2015, ANTIMICROB AGENTS CH, V59, P3726, DOI 10.1128/AAC.04794-14; Markgraf CG, 2010, J PHARMACOL TOX MET, V62, P89, DOI 10.1016/j.vascn.2010.06.001; Mehrzadi S, 2018, BIOMED PHARMACOTHER, V97, P233, DOI 10.1016/j.biopha.2017.10.113; Moricz AM, 2015, CHROMATOGRAPHIA, V78, P707, DOI 10.1007/s10337-015-2870-6; Munaga SB, 2016, J CHROMATOGR SCI, V54, P985, DOI 10.1093/chromsci/bmw043; Pingali S, 2014, ACTA CRYSTALLOGR C, V70, P388, DOI 10.1107/S2053229614003751; Schulz E.R., 1926, J AM PHARM ASSOC, V15, P33, DOI [10.1002/jps.3080150109, DOI 10.1002/JPS.3080150109]; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; US Department of Health and Human Services FDA, 2013, GUID IND BIOAN METH; Wu N, 2011, AM J PHYSIOL-REG I, V300, pR635, DOI 10.1152/ajpregu.00441.2010; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Xin HW, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2013-z; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Yu F, 2017, DRUG DELIV, V24, P825, DOI 10.1080/10717544.2017.1321062; Yu S, 2007, INT J MASS SPECTROM, V268, P30, DOI 10.1016/j.ijms.2007.08.003; ZHANG MF, 1989, ACTA PHARM SINIC, V10, P174; Zhao JJ, 2002, J MASS SPECTROM, V37, P421, DOI 10.1002/jms.299; Zhou Y, 2017, DRUG DEV IND PHARM, V43, P1703, DOI 10.1080/03639045.2017.1339076; Zuo F, 2006, DRUG METAB DISPOS, V34, P2064, DOI 10.1124/dmd.106.011361	45	18	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194979	10.1371/journal.pone.0194979	http://dx.doi.org/10.1371/journal.pone.0194979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579096	Green Submitted, Green Published, gold			2022-12-27	WOS:000428351800070
J	Lin, J; Qin, Z; Qian, H; Li, YJ; Luo, NF; Du, L				Lin, Jing; Qin, Zhen; Qian, Hong; Li, Yajiao; Luo, Nanfu; Du, Lei			A novel catheter with retractable stent that can prevent aortic insufficiency during left ventricular assist	PLOS ONE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; CARDIOGENIC-SHOCK; DEVICE IMPLANTATION; DECOMPRESSION; EXPERIENCE; SECONDARY; PIGTAIL	Left ventricle (LV) assist, which refers to the use of a mini-pump or catheter implanted across the aortic valve connected to the pump, can promote myocardial recovery after left ventricle failure. However, conventional LV assist catheters compress the aortic valve, which can induce aortic insufficiency. Here we describe a novel LV assist catheter containing a retractable stent at its distal end that may prevent such insufficiency. The device was tested in six goats in which the coronary artery was ligated to induce acute LV failure, and then an LV assist was installed with a novel catheter in the left ventricle via the left subclavian artery. Inserting the catheter into the left ventricle caused mild to moderate aortic insufficiency. Releasing the stent maintained the catheter in the center of the three valve leaflets, which resolved the aortic insufficiency and, within a few minutes, led to significantly lower left ventricle end diastolic pressure (9.0 +/- 3.0 mmHg) than without stent release (17.6 +/- 5.0 mmHg, p = 0.012) as well as significantly higher left ventricle dP/dt(max), (614 +/- 299 mmHg/s) than without stent release (343 +/- 245 mmHg/s, p = 0.03). Our results indicate that this novel drainage catheter with retractable stent can effectively prevent aortic insufficiency by maintaining the catheter in the center of the aortic valve leaflets, thereby lowering left ventricular end diastolic pressure and improving systolic function.	[Lin, Jing; Qin, Zhen; Luo, Nanfu; Du, Lei] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Lin, Jing; Qin, Zhen; Luo, Nanfu; Du, Lei] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu, Sichuan, Peoples R China; [Qian, Hong] Sichuan Univ, West China Hosp, Dept Cardiovasc Surg, Chengdu, Sichuan, Peoples R China; [Li, Yajiao] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Du, L (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China.; Du, L (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu, Sichuan, Peoples R China.	dulei@scu.edu.cn			National Natural Science Foundation of China [81600394, 81270324]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grants No. 81600394, 81270324).; This work was supported by the National Natural Science Foundation of China (Grant Nos.: 81600394 and 81270324), https://isisn.nsfc.gov.cn/egrantweb/.	Alkhouli M, 2016, J CARDIAC SURG, V31, P177, DOI 10.1111/jocs.12696; Barbone A, 2011, INTERACT CARDIOV TH, V13, P293, DOI 10.1510/icvts.2011.269795; Cattermole GN, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13195; Chandola R, 2012, J CARDIAC SURG, V27, P400, DOI 10.1111/j.1540-8191.2012.01454.x; Dixon SR, 2009, JACC-CARDIOVASC INTE, V2, P91, DOI 10.1016/j.jcin.2008.11.005; Hong TH, 2016, ASAIO J, V62, P117, DOI 10.1097/MAT.0000000000000327; Jiang CL, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0611-8; Kim WH, 2017, ASAIO J, V63, P346, DOI 10.1097/MAT.0000000000000472; Lima B, 2016, AM J CARDIOL, V117, P1622, DOI 10.1016/j.amjcard.2016.02.038; Maini B, 2012, CATHETER CARDIO INTE, V80, P717, DOI 10.1002/ccd.23403; Pappalardo F, 2017, EUR J HEART FAIL, V19, P404, DOI 10.1002/ejhf.668; Rajagopal K, 2013, J THORAC CARDIOV SUR, V145, P1373, DOI 10.1016/j.jtcvs.2012.11.066; Schiller P, 2016, ASAIO J, V62, P518, DOI 10.1097/MAT.0000000000000392; Sharma S, 2014, INT J CARDIOL, V176, pE9, DOI 10.1016/j.ijcard.2014.06.057; Siegenthaler MP, 2004, J THORAC CARDIOV SUR, V127, P812, DOI 10.1016/j.jtcvs.2003.09.055; Soleimani B, 2012, PERFUSION-UK, V27, P326, DOI 10.1177/0267659112443722; Swartz MF, 2012, PEDIATR CARDIOL, V33, P185, DOI 10.1007/s00246-011-0113-7; Weymann A, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-60	18	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194658	10.1371/journal.pone.0194658	http://dx.doi.org/10.1371/journal.pone.0194658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608576	gold, Green Published, Green Submitted			2022-12-27	WOS:000428988800013
J	Abdulghani, HM; Haque, S; Almusalam, YA; Alanezi, SL; Alsulaiman, YA; Irshad, M; Shaik, SA; Khamis, N				Abdulghani, Hamza Mohammad; Haque, Shafiul; Almusalam, Yousef Abdullah; Alanezi, Saleh Lafi; Alsulaiman, Yazeed Abdulaziz; Irshad, Mohammad; Shaik, Shaffi Ahmed; Khamis, Nehal			Self-reported cheating among medical students: An alarming finding in a cross-sectional study from Saudi Arabia	PLOS ONE			English	Article							ACADEMIC DISHONESTY; PHARMACY STUDENTS; ATTITUDES; SCHOOL; MISCONDUCT; BEHAVIOR; PREVALENCE	Academic misconduct/dishonesty has become widespread behavior among many university students across the globe, and medical education is not an exception. Until recently, few efforts have been made to study the dishonest behavior in Middle-Eastern universities. This study examined the prevalence and predisposing factors of cheating among medical students in Saudi Arabia and suggests suitable preventive measures. A cross-sectional survey-based study was conducted at a government medical college during the 2014-2015 academic year. The response rate was 58.5% (421/720). The overall cheating behavior practiced by the participants was 29%, predominantly by male students. High GPA scoring students were the least likely to cheat. The participants living with their families were more likely to cheat compared to those who were living apart from their families. The reasons participants gave to justify their cheating behavior included getting better grades, passing the course, and lacking preparation while still recognizing that cheating is a 'mistake.' Overall, significant academic misconduct concerning cheating was found among the Saudi medical students; this misconduct is alarming in a reputable government institution. The implementation of strict punishments, requiring ethical courses and creating ethical awareness by exploiting the potential of Islamic religious belief might help to control this problem.	[Abdulghani, Hamza Mohammad; Almusalam, Yousef Abdullah; Alanezi, Saleh Lafi; Alsulaiman, Yazeed Abdulaziz; Irshad, Mohammad; Khamis, Nehal] King Saud Univ, Coll Med, Dept Med Educ, Riyadh, Saudi Arabia; [Haque, Shafiul] Jazan Univ, Coll Nursing & Allied Hlth Sci, Res & Sci Studies Unit, Jazan, Saudi Arabia; [Shaik, Shaffi Ahmed] King Saud Univ, Coll Med, Dept Family & Community Med, Riyadh, Saudi Arabia	King Saud University; College Nursing & Allied Health Science Saudi Arabia; Jazan University; King Saud University	Abdulghani, HM (corresponding author), King Saud Univ, Coll Med, Dept Med Educ, Riyadh, Saudi Arabia.	hamzaabg@gmail.com	Irshad, Mohammad/HCG-8571-2022; HAQUE, SHAFIUL/AAN-2946-2020	Irshad, Mohammad/0000-0002-7520-0221; HAQUE, SHAFIUL/0000-0002-2989-121X				Aggarwal R, 2002, PHARM J, V269, P529; Agud JL, 2014, REV CLIN ESP, V214, P410, DOI 10.1016/j.rce.2014.03.007; Al-Dwairi Ziad Nawaf, 2004, J Dent Educ, V68, P1192; Asokan S, 2013, J DENT EDUC, V77, P1379; Austin Z, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj700350; Bretag T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001574; Desalegn AA, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-89; Dogas V, 2014, BMC MED EDUC, V14, DOI 10.1186/s12909-014-0277-y; Ghias K, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-43; Hardigan PC, 2004, AM J PHARM EDUC, V68, DOI 10.5688/aj6805110; Hejri SM, 2013, MED EDUC, V47, P144, DOI 10.1111/medu.12085; Henning MA, 2013, MED TEACH, V35, pE1211, DOI 10.3109/0142159X.2012.737962; Hrabak M, 2004, MED EDUC, V38, P276, DOI 10.1111/j.1365-2923.2004.01766.x; Kim K-J, 2016, MED ED ONLINE, P21; Koletsi-Kounari H, 2011, J DENT EDUC, V75, P1383; Kusnoor AV, 2013, SOUTH MED J, V106, P479, DOI 10.1097/SMJ.0b013e3182a14388; McCabe DL, 2001, ETHICS BEHAV, V11, P219, DOI 10.1207/S15327019EB1103_2; McCabe DL, 2005, INT J EDUC INTEGR, V1; Mitchell MS, 2018, J APPL PSYCHOL, V103, P54, DOI 10.1037/apl0000254; Montuno E, 2012, PHYSIOTHER CAN, V64, P245, DOI 10.3138/ptc.2011-13; Muhney KA, 2008, J DENT EDUC, V72, P1247; Nonis S., 2001, J EDUC BUS, V77, P69, DOI [10.1080/08832320109599052, DOI 10.1080/08832320109599052]; Park EJ, 2014, NURS EDUC TODAY, V34, P1467, DOI 10.1016/j.nedt.2014.04.006; Pence PL, 2012, NURS EDUC, V37, P12, DOI 10.1097/NNE.0b013e3182383701; Rabi SM, 2006, AM J PHARM EDUC, V70, DOI 10.5688/aj700473; Rennie SC, 2003, J MED ETHICS, V29, P97, DOI 10.1136/jme.29.2.97; SPSS (Statistical Package for Social Sciences), PROGR VERS 21; Taradi SK, 2012, J MED ETHICS, V38, P376, DOI 10.1136/medethics-2011-100015; Tee S, 2018, NURS EDUC TODAY, V61, P153, DOI 10.1016/j.nedt.2017.11.030; Teplitsky Paul E, 2002, J Dent Educ, V66, P485; Tonkin AL, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4014	31	14	14	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194963	10.1371/journal.pone.0194963	http://dx.doi.org/10.1371/journal.pone.0194963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596538	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000058
J	Musa, S; Peek-Asa, C; Jovanovic, N; Selimovic, E				Musa, Sanjin; Peek-Asa, Corrine; Jovanovic, Nina; Selimovic, Edin			Association of adverse childhood experiences and health risk behaviors among young adults visiting a regional primary healthcare center, Federation of Bosnia and Herzegovina	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; ADOLESCENT GIRLS; FRAMEWORK; PATHWAYS; ABUSE	Background Many studies have linked adverse childhood experiences (ACEs) to long-term health outcomes, as well as health risk behaviors. In the post-war period in Bosnia and Herzegovina, many young people grew up in an environment of deteriorated living standards due to high unemployment and economic insecurity. The objectives of the study were to: 1) describe the health risk behaviors of young adults accessing primary healthcare; and 2) examine associations of these risk factors with adverse childhood experiences in this context. Methods This was a cross-sectional survey, conducted from April to October 2014. Participants were recruited from the Primary Healthcare Center Zenica. Patients between the ages of 18 and 24 were eligible for inclusion. The informed consent and self-administered questionnaire were offered to patients during clinic intake. The questionnaire contained questions on sexual and reproductive health, use of alcohol and drugs, dating violence, and adverse childhood experiences. Results During the study period 520 questionnaires were distributed, and 400 complete surveys were returned, for a response rate of 76.9%. Among the 400 respondents, 166 were males (41.5%) and 234 were females (58.5%). Our study showed that 48.7% of respondents had experienced some form of childhood adversity. Emotional neglect was the most common type of adverse childhood experience (25.6%) and was significantly more prevalent among females. Our study indicated that more than 15% of respondents had witnessed domestic violence. Overall, ACEs were associated with increased odds of early sex initiation, alcohol use, drug use, and dating violence, although some of these associations did not reach statistical significance. Emotional neglect was the exception, and reporting emotional neglect was associated with a significantly elevated odds ratio for all four of the health risk behaviors. Emotional abuse was associated with an increased odds of drug abuse (OR = 2.78; 95% CI = 1.31-5.90) and dating violence (OR = 2.31; 95% CI = 1.10-4.89). Sexual abuse was marginally associated with increased early sex initiation (OR = 3.2; 95% CI 0.93-10.8). Parental divorce was significantly associated with alcohol abuse. Conclusion The results of this study demonstrated associations between adverse experiences in childhood and the probability of engaging in health risk behavior which has implications for health outcomes in the long-term.	[Musa, Sanjin] Inst Publ Hlth Federat Bosnia & Herzegovina, Dept Epidemiol, Sarajevo, Bosnia & Herceg; [Peek-Asa, Corrine] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA; [Jovanovic, Nina] Cty Hosp Zenica, Dept Ophthalmol, Zenica, Bosnia & Herceg; [Selimovic, Edin] Healthcare Ctr Zen, Dept Dent, Zenica, Bosnia & Herceg	University of Iowa	Musa, S (corresponding author), Inst Publ Hlth Federat Bosnia & Herzegovina, Dept Epidemiol, Sarajevo, Bosnia & Herceg.	sanjinm@yahoo.com		Musa, Sanjin/0000-0001-7611-2162	FIC NIH HHS [D43 TW007261] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007261] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; Baban A., 2013, SURVEY ADVERSE CHILD; Babovic M., 2013, PREVALENCE CHARACTER; Bellis MA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-155; Bleil ME, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.029; Bonomi AE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-637; Bramsen RH, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.24533; Brown DW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-20; Brown MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065524; CDC, BEH RISK FACT SURV S; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Duke NN, 2010, PEDIATRICS, V125, pE778, DOI 10.1542/peds.2009-0597; Felitti Vincent J, 2002, Perm J, V6, P44; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2013, JAMA PEDIATR, V167, P70, DOI 10.1001/jamapediatrics.2013.420; Flaherty EG, 2013, JAMA PEDIATR, V167, P622, DOI 10.1001/jamapediatrics.2013.22; Foege WH, 1998, AM J PREV MED, V14, P354; Kabiru Caroline W, 2010, Child Adolesc Psychiatry Ment Health, V4, P17, DOI 10.1186/1753-2000-4-17; Kelly-Irving M, 2013, INT J PUBLIC HEALTH, V58, P3, DOI 10.1007/s00038-012-0370-0; Lanius RA, 2010, IMPACT EARLY LIFE TR, P163; Letic N, 2012, ISTRAZ IVANJE ISKUST; Levey EJ, 2017, CHILD ABUSE NEGLECT, V65, P48, DOI 10.1016/j.chiabu.2017.01.004; Lundgren R, 2015, J ADOLESCENT HEALTH, V56, pS42, DOI 10.1016/j.jadohealth.2014.08.012; Madkour AS, 2010, J ADOLESCENT HEALTH, V47, P389, DOI 10.1016/j.jadohealth.2010.02.008; Mair C, 2012, ANN EPIDEMIOL, V22, P832, DOI 10.1016/j.annepidem.2012.09.008; Miller E, 2011, J EPIDEMIOL COMMUN H, V65, P1006, DOI 10.1136/jech.2009.105429; Oral R, 2016, PEDIATR RES, V79, P227, DOI 10.1038/pr.2015.197; Pretty C, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-208; Qirjako G, 2013, COMMUNITY SURVEY PRE; Raleva M., 2013, SURVEY ADVERSE CHILD; Rossegger A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-81; Silverman JG, 2001, JAMA-J AM MED ASSOC, V286, P572, DOI 10.1001/jama.286.5.572; Silverman JG, 2004, PEDIATRICS, V114, P220, DOI 10.1542/peds.114.2.e220; Strine TW, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-30; Vesta, 2009, POJ RODN ZASN NAS AD; Weiss D, 2017, J CONTIN EDUC HEALTH, V37, P55, DOI 10.1097/CEH.0000000000000140; WHO, 2006, PREV CHILD MALTR GUI; Yount KM, 2017, SOC SCI MED, V192, P1, DOI 10.1016/j.socscimed.2017.08.038	38	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194439	10.1371/journal.pone.0194439	http://dx.doi.org/10.1371/journal.pone.0194439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596442	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000024
J	Treglown, L; Zivkov, K; Zarola, A; Furnham, A				Treglown, Luke; Zivkov, Katarina; Zarola, Anthony; Furnham, Adrian			Intention to quit and the role of dark personality and perceived organizational support: A moderation and mediation model	PLOS ONE			English	Article							EMPLOYEE TURNOVER; SIDE; TRAITS; IMPACT; BRIGHT; LEADERSHIP; RESOURCE; JUSTICE; STRESS; TRUST	This study investigated the role of individual differences (dark personality) and situational factors (perceived organisational support) in explaining intention to quit. Four hundred and fifty-one (50 of which females) ambulance personnel completed three questionnaires (Hogan Development Survey; Perceived Organisational Support Survey; and a single item Intention to Quit measure) as a part of a selection and development assessment. Employees high on Excitable, Sceptical, and Mischievous, but low on Colourful were found to have greater intentions to quit. Additionally, employees high on Excitable, Sceptical, Reserved, and Leisurely, but low on Dutiful and Diligent had lower perceptions of organisational support. Structural Equation Modelling revealed that perceived organisational support plays both a mediating and moderating role on dark personality and intention to quit. Theoretical implications of personality's role in perceived organisational support and intention to quit are discussed.	[Treglown, Luke; Zivkov, Katarina; Furnham, Adrian] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Zarola, Anthony] Zeal Solut, Nottingham, England; [Furnham, Adrian] Norwegian Business Sch BI, Oslo, Norway	University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.; Furnham, A (corresponding author), Norwegian Business Sch BI, Oslo, Norway.	a.furnham@ucl.ac.uk	Furnham, Adrian/ABB-2072-2020					Adriaenssens J, 2015, INT J NURS STUD, V52, P649, DOI 10.1016/j.ijnurstu.2014.11.004; Allen DG, 2013, J ORGAN BEHAV, V34, P350, DOI 10.1002/job.1805; Avey JB, 2009, HUM RESOUR MANAGE-US, V48, P677, DOI 10.1002/hrm.20294; Baron JN, 2001, AM J SOCIOL, V106, P960, DOI 10.1086/320296; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Brashear TG, 2005, J BUS RES, V58, P241, DOI 10.1016/S0148-2963(03)00134-6; Cascio W. F., 1991, COSTING HUMAN RESOUR; Cheung GW, 2007, ORG RES METH; Dawley D, 2010, J SOC PSYCHOL, V150, P238, DOI 10.1080/00224540903365463; DeConinck JB, 2011, J BUS RES, V64, P617, DOI 10.1016/j.jbusres.2010.06.014; Eisenberger R, 2001, J APPL PSYCHOL, V86, P42, DOI 10.1037//0021-9010.86.1.42; Eisenberger R., 2002, J APPL PSYCHOL, V87; Ettner SL, 2011, IND RELAT, V50, P149, DOI 10.1111/j.1468-232X.2010.00629.x; Furnham A, 2013, PERS INDIV DIFFER, V55, P952, DOI 10.1016/j.paid.2013.07.469; Furnham A, 2012, PERS INDIV DIFFER, V52, P908, DOI 10.1016/j.paid.2012.01.025; Glebbeek AC, 2004, ACAD MANAGE J, V47, P277, DOI 10.2307/20159578; Griffeth R.W., 2001, RETAINING VALUED EMP; Haar JM, 2004, INT J HUM RESOUR MAN, V15, P1040, DOI 10.1080/09585190410001677304; Harms PD, 2015, APPL PSYCHOL-INT REV, V64, P15, DOI 10.1111/apps.12042; Hogan R, 2005, REV GEN PSYCHOL, V9, P169, DOI 10.1037/1089-2680.9.2.169; Hogan R, 2001, INT J SELECT ASSESS, V9, P40, DOI 10.1111/1468-2389.00162; Hogan R., 1997, HOGAN DEV SURVEY MAN; Hom P.W., 1995, EMPLOYEE TURNOVER; Hooper D., 2008, ARTICLES, V2, DOI DOI 10.1080/10705519909540118; Horney K, COLLECTED WORKS K HO, VII; Hox J.J., 1999, FAMILY SCI REV, V11, P354, DOI DOI 10.1080/10705510903008345; Hu LT, EVALUATING MODEL FIT; HUSELID MA, 1995, ACAD MANAGE J, V38, P635, DOI 10.2307/256741; Jeswani S., 2012, MANAGEMENT LABOUR ST, V37, P253, DOI DOI 10.1177/0258042X13484837; Johnson A. A., 1995, J ACCOUNTANCY, V180, P53; Judeh M., 2012, INT BUSINESS RES, V5, P88; Kaiser RB, 2015, APPL PSYCHOL-INT REV, V64, P55, DOI 10.1111/apps.12024; Khoo HS, 2008, PERS INDIV DIFFER, V44, P86, DOI 10.1016/j.paid.2007.07.018; Kline RB., METHODOLOGY SOCIAL S; Koys DJ, 2001, PERS PSYCHOL, V54, P101, DOI 10.1111/j.1744-6570.2001.tb00087.x; LITTLE TD, 2007, MODELING CONTEXTUAL, P207, DOI DOI 10.1198/TECH.2006.S369; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Masterson SS, 2000, ACAD MANAGE J, V43, P738, DOI 10.2307/1556364; McCarthy Geraldine, 2007, J Nurs Manag, V15, P248, DOI 10.1111/j.1365-2834.2007.00648.x; Palaiou K, 2016, PERS INDIV DIFFER, V88, P12, DOI 10.1016/j.paid.2015.08.029; Park JH, 2016, INT J HUM RESOUR MAN, V27, P1173, DOI 10.1080/09585192.2015.1062038; Rhoades L, 2002, J APPL PSYCHOL, V87, P698, DOI 10.1037//0021-9010.87.4.698; Riggle RJ, 2009, J BUS RES, V62, P1027, DOI 10.1016/j.jbusres.2008.05.003; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Salgado JF, 2002, INT J SELECT ASSESS, V10, P117, DOI 10.1111/1468-2389.00198; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Sifuna Mayende T., 2014, INT J MANAGEMENT BUS, V4, P153; Singh A, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/306942; Stamper CL, 2003, J MANAGE, V29, P569, DOI 10.1016/S1049-2063(03)00025-4; Woo SE, 2016, J MANAGE, V42, P357, DOI 10.1177/0149206315622985; Woo SE, 2014, J BUS PSYCHOL, V29, P683, DOI 10.1007/s10869-013-9303-z; Woo SE, 2011, J VOCAT BEHAV, V79, P461, DOI 10.1016/j.jvb.2011.02.003; Zimmerman RD, 2008, PERS PSYCHOL, V61, P309, DOI 10.1111/j.1744-6570.2008.00115.x	53	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195155	10.1371/journal.pone.0195155	http://dx.doi.org/10.1371/journal.pone.0195155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596532	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000087
J	Kim, CR; Kim, EY; Kim, YS; Ahn, HK; Kim, KW; Jeong, YM; Kim, JH				Kim, Chang Rae; Kim, Eun Young; Kim, Young Saing; Ahn, Hee Kyung; Kim, Kun Woo; Jeong, Yu Mi; Kim, Jeong Ho			Histologic subtypes are not associated with the presence of sarcopenia in lung cancer	PLOS ONE			English	Article							SOLID TUMORS; OBESITY; PREVALENCE; CACHEXIA; CLASSIFICATION; ADULTS; HEALTH	Background Sarcopenia is prevalent and a known adverse prognostic effector in lung cancer (LCA). However, the relationship between sarcopenia and histology remains uncertain in LCA. Methods Consecutive patients with newly diagnosed LCA (n = 778) between June 2012 and February 2015 were retrospectively reviewed to identify factors associated with sarcopenia. Sarcopenia was defined as CT-determined L3 muscle index (muscle area at L3/height(2)) of < 55 cm(2)/m(2) for men and < 39 cm(2)/m(2) for women. Results Mean patient age was 67.7 +/- 10.8 years, and most (73.1%) were male. The most prevalent histology was adenocarcinoma (44.0%) and 71.6% of patients had stage III or IV disease. The overall prevalence of sarcopenia was 48.2% (60.3% in men, and 15.3% in women). Univariable analysis showed sarcopenia was significantly associated with male gender, age (> 65 years), smoking status, lower BMI (< 23 kg/m(2)), advanced stage (III and IV), and high comorbidity score (Charlson index > 3). Furthermore, the prevalence of sarcopenia was higher in squamous cell carcinoma (54.9%) and small cell LCA (56.4%) than in adenocarcinoma (39.8%). Multivariable analyses showed sarcopenia was independently associated with a male gender (odds ratio [OR], 11.13), elderly (OR, 2.02) and low BMI (OR, 6.28), stage IV (OR, 1.98), and high comorbidity (OR, 1.93). However, no significant association was found between histologic subtypes and sarcopenia. Conclusions Sarcopenia was found to be significantly associated with old age, male gender, an advanced stage, comorbidities, and low BMI in LCA. However, histology subtype was not an independent factor for the presence of sarcopenia.	[Kim, Chang Rae; Kim, Eun Young; Jeong, Yu Mi; Kim, Jeong Ho] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Kim, Young Saing; Ahn, Hee Kyung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Incheon, South Korea; [Kim, Kun Woo] Gachon Univ, Gil Med Ctr, Dept Thorac & Cardiovasc Surg, Incheon, South Korea	Gachon University; Gachon University; Gachon University	Kim, EY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea.	oneshot0229@gmail.com	Kim, Jeong Ho/AAA-7538-2022	Kim, Eun Young/0000-0002-2101-7982	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [HA17C0045]; Gachon University Gil Medical Center Research fund	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Gachon University Gil Medical Center Research fund	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (grant no. HA17C0045) (YSK), and was partially supported by a grant from Gachon University Gil Medical Center Research fund (EYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng HY, 2015, EXPERT OPIN EMERG DR, V20, P149, DOI 10.1517/14728214.2015.1001365; Collins J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003697; Edge SB, 2009, AJCC CANC STAGING MA, V7; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Kim YS, 2012, J GERONTOL A-BIOL, V67, P1107, DOI 10.1093/gerona/gls071; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prado CM, 2013, AM J CLIN NUTR, V98, P1012, DOI 10.3945/ajcn.113.060228; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Shachar SS, 2016, EUR J CANCER, V57, P58, DOI 10.1016/j.ejca.2015.12.030; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Travis WD, 2015, J THORAC ONCOL, V10, P1240, DOI 10.1097/JTO.0000000000000663; Yang CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132908; Zhang GX, 2016, ONCOL LETT, V11, P1230, DOI 10.3892/ol.2015.4019	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194626	10.1371/journal.pone.0194626	http://dx.doi.org/10.1371/journal.pone.0194626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590170	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100070
J	Nardin, C; Latarche, C; Soudant, M; Dahan, C; Michaud, M; Pittion-Vouyovitch, S; Guillemin, F; Debouverie, M; Mathey, G				Nardin, Clotilde; Latarche, Clotilde; Soudant, Marc; Dahan, Camille; Michaud, Maud; Pittion-Vouyovitch, Sophie; Guillemin, Francis; Debouverie, Marc; Mathey, Guillaume			Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; CAUCASIAN-AMERICANS; NATURAL-HISTORY; DISABILITY; PROGRESSION; EPIDEMIOLOGY; PREVALENCE; GUIDELINES; LORRAINE; RISK	Background The incidence of multiple sclerosis (MS) changes from generation to generation in ethnically different immigrants compared with native-born people. We aimed to determine whether there are generational changes in MS phenotypes among North African immigrants in France. Methods Cohort study with data from a population-based MS registry to compare the clinical characteristics of 80 first (NAG1) and 167 second (NAG2) generation North Africans with MS living in France with 5200 native-born Europeans. Adjusted Cox models were used to test the association between scores of 3 and 6 on the expanded disability status scale (EDSS) and the "origin/generation" variable. Results Cox models for EDSS scores 3 and 6 showed a higher risk of score 3 (hazard ratio = 1.738, 95% confidence interval 1.237 to 2.444; P = .002) and 6 (hazard ratio = 2.372, 95% confidence interval 1.626 to 3.462; P<.0001) for NAG1 than Europeans. Being NAG2 was not significantly associated with higher hazards of scores 3 and 6. Conclusions We found two different phenotypes among NAG1 and NAG2 MS patients in France. NAG1, but not NAG2, have a higher risk of disability than Europeans. This raises the question of environmental factors in MS expression, and advocates appropriate patient management according to generation in immigrants.	[Nardin, Clotilde; Dahan, Camille; Michaud, Maud; Pittion-Vouyovitch, Sophie; Debouverie, Marc; Mathey, Guillaume] Nancy Univ Hosp, Dept Neurol, Nancy, France; [Nardin, Clotilde] St Denis Hosp, Dept Neurol, St Denis, Reunion, France; [Latarche, Clotilde; Soudant, Marc; Guillemin, Francis] Univ Lorraine, Nancy Univ Hosp, INSERM, CIC Clin Epidemiol 1433, Nancy, France; [Mathey, Guillaume] Univ Lorraine, APEMAC, Nancy, France	CHU de Nancy; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine	Mathey, G (corresponding author), Nancy Univ Hosp, Dept Neurol, Nancy, France.; Mathey, G (corresponding author), Univ Lorraine, APEMAC, Nancy, France.	g.mathey@chru-nancy.fr		Soudant, Marc/0000-0001-5814-6924				Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Berg-Hansen P, 2015, MULT SCLER J, V21, P695, DOI 10.1177/1352458514554055; Brutel C, ETRE NE FRANCE PAREN; Cabre P, 2005, BRAIN, V128, P2899, DOI 10.1093/brain/awh624; Compston Alastair., 2005, MCALPINES MULTIPLE S, V4th; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; DEAN G, 1971, BMJ-BRIT MED J, V3, P725, DOI 10.1136/bmj.3.5777.725; Debouverie M, 2008, EUR J NEUROL, V15, P916, DOI 10.1111/j.1468-1331.2008.02241.x; Debouverie M, 2007, MULT SCLER J, V13, P962, DOI 10.1177/1352458507077938; Debouverie M, 2007, NEUROLOGY, V68, P29, DOI 10.1212/01.wnl.0000250347.51674.d7; El Adssi H, 2012, MULT SCLER J, V18, P1244, DOI 10.1177/1352458512437811; Ha-Vinh Philippe, 2016, Mult Scler J Exp Transl Clin, V2, p2055217316631762, DOI 10.1177/2055217316631762; Hirst CL, 2012, MULT SCLER J, V18, P1152, DOI 10.1177/1352458511433919; Howard J, 2016, NEUROL CLIN, V34, P919, DOI 10.1016/j.ncl.2016.06.016; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langer-Gould A, 2013, NEUROLOGY, V80, P1734, DOI 10.1212/WNL.0b013e3182918cc2; Lebrun C, 2008, MULT SCLER J, V14, P933, DOI 10.1177/1352458508091369; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Marrie RA, 2006, NEUROLOGY, V66, P1235, DOI 10.1212/01.wnl.0000208505.81912.82; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McKay KA, 2017, NEUROTOXICOLOGY, V61, P189, DOI 10.1016/j.neuro.2016.03.020; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Saeedi J, 2012, MULT SCLER J, V18, P1239, DOI 10.1177/1352458512436595; Sidhom Y, 2017, NEUROLOGY, V88, P1218, DOI 10.1212/WNL.0000000000003762; Tremlett H, 2010, NEUROLOGY, V74, P2004, DOI 10.1212/WNL.0b013e3181e3973f; Ventura RE, 2017, MULT SCLER J, V23, P1554, DOI 10.1177/1352458516679894; Wade BJ, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/124578	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194115	10.1371/journal.pone.0194115	http://dx.doi.org/10.1371/journal.pone.0194115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584762	Green Submitted, gold, Green Published			2022-12-27	WOS:000428373000016
J	Gotsman, I; Shauer, A; Elizur, Y; Zwas, DR; Lotan, C; Keren, A				Gotsman, Israel; Shauer, Ayelet; Elizur, Yair; Zwas, Donna R.; Lotan, Chaim; Keren, Andre			Temporal changes in electrocardiographic frontal QRS-T angle and survival in patients with heart failure	PLOS ONE			English	Article							GENERAL-POPULATION; CARDIAC DEATH; MORTALITY; ASSOCIATION; SOCIETY; DISEASE; HEALTH; RISK	Background Heart failure (HF) is associated with considerable mortality. The electrocardiographic frontal QRS-T angle is a simple parameter to measure, reflects changes in the direction of the repolarization sequence and predicts outcome in patients with HF. Data regarding temporal changes in the frontal QRS-T angle in patients with HF and its impact on outcome is limited. Aim To evaluate temporal changes in the frontal QRS-T angle and its effect on survival in patients with HF. Methods Baseline and follow-up QRS-T angle were calculated from the frontal QRS and T axis of the 12-lead surface electrocardiogram. Patients were followed for survival. Results 2,929 HF patients were evaluated. Median interval between baseline ECG and follow-up ECG was 895 days, median follow-up time was 1526 days. Overall, the QRS-T angle tended to be stable, with minor changes in the angle over time. The median QRS-T angle change was +3 degrees (IQR-19 degrees to +30 degrees). Overall survival during follow-up was 60%. Cox regression analysis after adjustment for significant predictors demonstrated that the QRS-T angle was an incremental predictor of increased mortality. A widening of the QRS-T angle during followup was independently associated with an increase in mortality, evident with an increase of the QRS-T angle difference above 0 degrees (P<0.0001 for the adjusted model). Conclusion QRS-T angle is relatively stable in patients with HF and is a powerful predictor of outcome. Widening of the QRS-T angle has predictive value and is an ominous sign.	[Gotsman, Israel; Shauer, Ayelet; Elizur, Yair; Zwas, Donna R.; Lotan, Chaim; Keren, Andre] Hadassah Univ Hosp, Heart Inst, Heart Failure Ctr, Jerusalem, Israel; [Gotsman, Israel; Zwas, Donna R.; Keren, Andre] Clalit Hlth Serv, Heart Failure Clin, Jerusalem, Israel	Hebrew University of Jerusalem; Clalit Health Services	Gotsman, I (corresponding author), Hadassah Univ Hosp, Heart Inst, Heart Failure Ctr, Jerusalem, Israel.; Gotsman, I (corresponding author), Clalit Hlth Serv, Heart Failure Clin, Jerusalem, Israel.	igotsman@bezeqint.net	Gotsman, Israel/AAH-8833-2021	Gotsman, Israel/0000-0001-9608-2298				Aro AL, 2012, EUROPACE, V14, P872, DOI 10.1093/europace/eur393; Borleffs CJW, 2009, CIRC-ARRHYTHMIA ELEC, V2, P548, DOI 10.1161/CIRCEP.109.859108; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Gotsman I, 2012, EUR J HEART FAIL; Gotsman I, 2013, AM J CARDIOL, V111, P1452, DOI 10.1016/j.amjcard.2013.01.294; Gotsman I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041022; Kardys I, 2003, EUR HEART J, V24, P1357, DOI 10.1016/S0195-668X(03)00203-3; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Pavri BB, 2008, CIRCULATION, V117, P3181, DOI 10.1161/CIRCULATIONAHA.107.733451; Rautaharju PM, 2006, CIRCULATION, V113, P473, DOI 10.1161/CIRCULATIONAHA.104.496091; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Selvaraj S, 2014, J AM SOC ECHOCARDIOG, V27, P74, DOI 10.1016/j.echo.2013.08.023; Whang W, 2012, AM J CARDIOL, V109, P981, DOI 10.1016/j.amjcard.2011.11.027; Zhang ZM, 2007, AM J CARDIOL, V100, P844, DOI 10.1016/j.amjcard.2007.03.104	14	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194520	10.1371/journal.pone.0194520	http://dx.doi.org/10.1371/journal.pone.0194520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579123	Green Submitted, gold, Green Published			2022-12-27	WOS:000428351800034
J	Kayadjanian, N; Schwartz, L; Farrar, E; Comtois, KA; Strong, TV				Kayadjanian, Nathalie; Schwartz, Lauren; Farrar, Evan; Comtois, Katherine Anne; Strong, Theresa V.			High levels of caregiver burden in Prader-Willi syndrome	PLOS ONE			English	Article							GROWTH-HORMONE THERAPY; QUALITY-OF-LIFE; MALADAPTIVE BEHAVIOR; FRAGILE-X; CHILDREN; PARENTS; DISABILITIES; INTERVIEW; METAANALYSIS; CHILDHOOD	Objectives Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder that is characterized by hyperphagia, developmental delay, incomplete sexual development, mild-to moderate intellectual disability, and a variety of challenging behavioral and psychiatric symptoms. The characteristics of PWS can be difficult for caregivers to cope with and are likely to cause significant and long-term caregiver burden. The current study examined burden in 142 caregivers of children and adults with PWS living in the US using the Zarit Burden Interview (ZBI). The study aimed to measure the level of burden in caregivers of individuals with PWS, to explore the impact of PWS on caregiver quality of life, and to assess ZBI as an indicator of that impact. Results Caregivers participating in this study were predominantly mothers, 30-59 years old, non Hispanic Whites, married or in a relationship, with an annual household income slightly distributed towards higher income. Nearly 90% of the caregiver's children with PWS lived at home. Caregivers experienced high caregiver burden with an average ZBI score of 44.4 15.4. ZBI scores were highest for caregivers of teenage and young adult individuals with PWS (49.2 +/- 14.6 and 49.2 +/- 14.1, respectively), while those caring for older adults (>30) and the youngest age group had lower scores (38.6 +/- 10.5 and 34.8 +/- 12.5, respectively). Caregivers reported that caring for a person with PWS negatively impacted their romantic relationship, ability to work, sleep, and mood. Whereas we did not find strong correlations between family income or level of help the caregiver receives and ZBI scores, the results showed significant correlations and a linear relationship between ZBI scores and caregiver depressed mood, feelings of anxiety, negative romantic relationship impact, as well as sleep and work disruption. Conclusions Our study reveals that PWS incurs high caregiver burden and impacts many aspects of the lives of caregiver. We identified the ZBI as a good predictor of that impact. Our findings draw attention to the critical unmet need for support for caregivers of individuals with PWS.	[Kayadjanian, Nathalie; Schwartz, Lauren; Strong, Theresa V.] Fdn Prader Willi Res, Walnut, CA 91789 USA; [Kayadjanian, Nathalie; Schwartz, Lauren; Farrar, Evan; Strong, Theresa V.] PWS Clin Trial Consortium, Walnut, CA 91789 USA; [Schwartz, Lauren] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Farrar, Evan] Prader Willi Syndrome Assoc USA, Sarasota, FL USA; [Comtois, Katherine Anne] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Strong, Theresa V.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Kayadjanian, N (corresponding author), Fdn Prader Willi Res, Walnut, CA 91789 USA.; Kayadjanian, N (corresponding author), PWS Clin Trial Consortium, Walnut, CA 91789 USA.	nathalie.kayadjanian@fpwr.org	Strong, Theresa/GSM-6652-2022	Strong, Theresa/0000-0001-6783-8703	PWS-Clinical Trial Consortium	PWS-Clinical Trial Consortium	The study was funded by the PWS-Clinical Trial Consortium (www.pwsctc.org) who provided support in the form of publication costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Beach SR, 2005, J AM GERIATR SOC, V53, P255, DOI 10.1111/j.1532-5415.2005.53111.x; Bello-Mojeed M.A., 2013, OA AUTISM, V1, P4; Boer H, 2002, LANCET, V359, P135, DOI 10.1016/S0140-6736(02)07340-3; Butler JV, 2010, DEV MED CHILD NEUROL, V52, pE88, DOI 10.1111/j.1469-8749.2009.03530.x; Cadman T, J AM ACAD CHILD ADOL, V51, P879; Clarke DJ, 1996, J INTELL DISABIL RES, V40, P159, DOI 10.1046/j.1365-2788.1996.743743.x; Deal CL, 2013, J CLIN ENDOCR METAB, V98, pE1072, DOI 10.1210/jc.2012-3888; Driscoll DJ, 1993, GENEREVIEWS R; Ducharme F, 2014, BMC NURS, V13, DOI 10.1186/s12912-014-0049-3; Dykens EM, 2007, OBESITY, V15, P1816, DOI 10.1038/oby.2007.216; DYKENS EM, 1992, J AM ACAD CHILD PSY, V31, P1131, DOI 10.1097/00004583-199211000-00023; Dykens EM, 1995, AM J MED GENET, V60, P546, DOI 10.1002/ajmg.1320600612; Einfeld SL, 2006, AM J MENT RETARD, V111, P193, DOI 10.1352/0895-8017(2006)111[193:MIPS]2.0.CO;2; Etnfeld S, 1999, J INTELLECT DEV DIS, V24, P349; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Hodapp RM, 1997, J AUTISM DEV DISORD, V27, P11, DOI 10.1023/A:1025865004299; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; Lanfranchi S, 2012, AJIDD-AM J INTELLECT, V117, P207, DOI 10.1352/1944-7558-117.3.207; Lingler JH, 2005, J AM GERIATR SOC, V53, P983, DOI 10.1111/j.1532-5415.2005.53313.x; Lopez-Bastida B, 2016, EUR J HEALTH ECON, V17, P99, DOI 10.1007/s10198-016-0788-z; Lopez-Wagner MC, 2008, J GENET PSYCHOL, V169, P245, DOI 10.3200/GNTP.169.3.245-260; Mazaheri MM, 2013, J INTELL DISABIL RES, V57, P861, DOI 10.1111/j.1365-2788.2012.01634.x; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Mohamed S, 2010, AM J GERIAT PSYCHIAT, V18, P917, DOI 10.1097/JGP.0b013e3181d5745d; Parish SL, 2004, MENT RETARD, V42, P413, DOI 10.1352/0047-6765(2004)42<413:EIOCAM>2.0.CO;2; Rice LJ, 2015, AM J MED GENET C, V169, P182, DOI 10.1002/ajmg.c.31442; Richdale AL, 1999, J INTELL DISABIL RES, V43, P380, DOI 10.1046/j.1365-2788.1999.043005380.x; Sanchez-Ortiga R, 2012, CLIN ENDOCRINOL, V77, P86, DOI 10.1111/j.1365-2265.2011.04303.x; Schoenmakers B, 2009, FAM PRACT, V26, P279, DOI 10.1093/fampra/cmp024; Schreiner AS, 2006, AGING MENT HEALTH, V10, P107, DOI 10.1080/13607860500312142; Schwartz L, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0504-1; Shearn J, 2000, J APPL RES INTELLECT, V13, P109, DOI 10.1046/j.1468-3148.2000.00021.x; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Sinnema M, 2011, RES DEV DISABIL, V32, P604, DOI 10.1016/j.ridd.2010.12.014; Skokauskas N, 2012, J CAN ACAD CHILD ADO, V21, P194; Stabile M, 2012, FUTURE CHILD, V22, P65; van den Borne HW, 1999, PATIENT EDUC COUNS, V38, P205, DOI 10.1016/S0738-3991(99)00004-X; WHITMAN BY, 1987, AM J MED GENET, V28, P897, DOI 10.1002/ajmg.1320280415; Williams VSL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-57; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072640; YOUNG RF, 1989, GERONTOLOGIST, V29, P660, DOI 10.1093/geront/29.5.660; Zammit GK, 1999, SLEEP, V22, pS379; Zarit S. H., 1990, MEMORY BEHAV PROBLEM; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	45	35	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194655	10.1371/journal.pone.0194655	http://dx.doi.org/10.1371/journal.pone.0194655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579119	Green Submitted, gold, Green Published			2022-12-27	WOS:000428351800042
J	Kawata, M; Sasabuchi, Y; Taketomi, S; Inui, H; Matsui, H; Fushimi, K; Chikuda, H; Yasunaga, H; Tanaka, S				Kawata, Manabu; Sasabuchi, Yusuke; Taketomi, Shuji; Inui, Hiroshi; Matsui, Hiroki; Fushimi, Kiyohide; Chikuda, Hirotaka; Yasunaga, Hideo; Tanaka, Sakae			Annual trends in arthroscopic meniscus surgery: Analysis of a national database in Japan	PLOS ONE			English	Article							PARTIAL MENISCECTOMY; AMERICAN BOARD; UNITED-STATES; REPAIR; TEARS; OSTEOARTHRITIS; DIAGNOSIS; KNEE; INCREASE; INJURY	Background The importance of meniscus preservation is widely recognized. There have been a few studies describing trends in meniscectomy and meniscus repair in the United States; however, they presented differing results. We reported annual trends in meniscus surgery, using a national database in Japan. Methods We interrogated the Diagnosis Procedure Combination database, which represents approximately half of all hospital admissions in Japan. We included the patients who underwent meniscectomy and meniscus repair between July 2007 and March 2015. The diagnosis, age and sex of each patient were recorded. Results We identified 83,105 patients: 69,310 underwent meniscectomy; 13,416 underwent meniscus repair and 379 underwent both in a single admission. The proportion of patients undergoing meniscus repair rose from 7.0% in 2007 to 25.9% in 2014 (p < 0.001), while the proportion undergoing meniscectomy fell from 92.8% in 2007 to 73.3% in 2014 (p < 0.001). Among patients under 30 years old, the proportions undergoing meniscus repair or meniscectomy in 2014 were 50.3% versus 48.3%, respectively. A bimodal age distribution was observed for meniscectomy, with peaks at 10-19 years of age and 60-69 years of age, whereas most patients undergoing meniscus repair were 10-19 years of age. Conclusions We found characteristic trends where the popularity of meniscus repair increased rapidly at the expense of meniscectomy in Japan during the study period. In the last survey year, the proportion of meniscus repair exceeded that of meniscectomy in those younger than 30 years. Meniscectomy was undertaken most often in adolescents and early old age, while meniscus repair was undertaken most often in adolescents.	[Kawata, Manabu; Taketomi, Shuji; Inui, Hiroshi; Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, Tokyo, Japan; [Sasabuchi, Yusuke; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Informat & Policy, Bunkyo Ku, Tokyo, Japan; [Chikuda, Hirotaka] Gunma Univ, Dept Orthopaed Surg, Grad Sch Med, Maebashi, Gunma, Japan	University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Gunma University	Taketomi, S (corresponding author), Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, Tokyo, Japan.	takeos-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414; Yasunaga, Hideo/0000-0002-6017-469X; Sasabuchi, Yusuke/0000-0001-7828-0549	Ministry of Health, Labour and Welfare, Japan [H29-Policy-Designated-009, H29-ICT-Genral-004]; Ministry of Education, Culture, Sports, Science and Technology, Japan [17H04141]; Japan Agency for Medical Research and Development (AMED)	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (H29-Policy-Designated-009 and H29-ICT-Genral-004); Ministry of Education, Culture, Sports, Science and Technology, Japan (17H04141); and the Japan Agency for Medical Research and Development (AMED). The sponsor had no role in the study design, data collection, data analysis, data interpretation or writing of the manuscript.	Abrams GD, 2013, AM J SPORT MED, V41, P2333, DOI 10.1177/0363546513495641; Akiyama T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002412; Andersson-Molina H, 2002, ARTHROSCOPY, V18, P183, DOI 10.1053/jars.2002.30435; Aune KT, 2014, AM J SPORT MED, V42, P1865, DOI 10.1177/0363546514535069; BAKER BE, 1985, AM J SPORT MED, V13, P1, DOI 10.1177/036354658501300101; Baratz ME, 1986, AM J SPORTS MED, V14; Bureau of Statistics Ministry of Internal Affairs and Communications of Japan, 2011, SUMM RES POP CENS JA; Campbell SE, 2001, AM J ROENTGENOL, V177, P409, DOI 10.2214/ajr.177.2.1770409; Chikuda H, 2014, SPINE J, V14, P2275, DOI 10.1016/j.spinee.2014.01.024; Chikuda H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-173; DICKASON JM, 1982, CLIN ORTHOP RELAT R, P75; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2012, NAT REV RHEUMATOL, V8, P412, DOI 10.1038/nrrheum.2012.69; Feeley BT, 2016, KNEE, V23, P674, DOI 10.1016/j.knee.2016.03.006; FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887; Garrett WE, 2006, J BONE JOINT SURG AM, V88A, P660, DOI 10.2106/JBJS.E.01208; Haas AL, 2005, ARTHROSCOPY, V21, P167, DOI 10.1016/j.arthro.2004.10.012; Hare KB, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-71; HEDE A, 1992, J BONE JOINT SURG BR, V74, P118, DOI 10.1302/0301-620X.74B1.1732238; HEDE A, 1992, INT ORTHOP, V16, P122, DOI 10.1007/BF00180200; Herrlin SV, 2013, KNEE SURG SPORT TR A, V21, P358, DOI 10.1007/s00167-012-1960-3; IKEUCHI H, 1982, CLIN ORTHOP RELAT R, P19; JACKSON R W, 1972, Journal of Bone and Joint Surgery British Volume, V54, P310; Jordan, 1996, J Am Acad Orthop Surg, V4, P191; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Kim S, 2011, J BONE JOINT SURG AM, V93A, P994, DOI 10.2106/JBJS.I.01618; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Koenig JH, 2009, ARTHROSCOPY, V25, P1025, DOI 10.1016/j.arthro.2009.03.015; Kramer DE, 2009, J AM ACAD ORTHOP SUR, V17, P698, DOI 10.5435/00124635-200911000-00004; Kurzweil PR, 2014, ARTHROSCOPY, V30, P1513, DOI 10.1016/j.arthro.2014.05.038; Lubowitz JH, 2011, ARTHROSCOPY, V27, P301, DOI 10.1016/j.arthro.2010.12.006; Maak TG, 2012, CLIN SPORT MED, V31, P1, DOI 10.1016/j.csm.2011.08.012; McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140; Montgomery SR, 2013, ORTHOPEDICS, V36, pE1007, DOI 10.3928/01477447-20130724-15; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Parker BR, 2016, AM J SPORT MED, V44, P1717, DOI 10.1177/0363546516638082; Paxton ES, 2011, ARTHROSCOPY, V27, P1275, DOI 10.1016/j.arthro.2011.03.088; Sgaglione NA, 2003, ARTHROSCOPY, V19, P161, DOI 10.1016/j.arthro.2003.10.032; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Stein T, 2010, AM J SPORT MED, V38, P1542, DOI 10.1177/0363546510364052; Thorlund JB, 2014, ACTA ORTHOP, V85, P287, DOI 10.3109/17453674.2014.919558; Vaquero J, 2016, MLTJ-MUSCLE LIGAMENT, V6, P71, DOI 10.11138/mltj/2016.6.1.071; Vidal Armando F, 2012, J Bone Joint Surg Am, V94, pe186, DOI 10.2106/JBJS.L.01243; VOLOSHIN AS, 1983, J BIOMED ENG, V5, P157, DOI 10.1016/0141-5425(83)90036-5; Xu CQ, 2015, KNEE SURG SPORT TR A, V23, P164, DOI 10.1007/s00167-013-2528-6; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8	46	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194854	10.1371/journal.pone.0194854	http://dx.doi.org/10.1371/journal.pone.0194854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614071	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600020
J	Kawata, T; Tokunaga, S; Murai, M; Masuda, N; Haruyama, W; Shoukei, Y; Hisada, Y; Yanagida, T; Miyazaki, H; Wada, M; Akizawa, T; Fukagawa, M				Kawata, Takehisa; Tokunaga, Shin; Murai, Miki; Masuda, Nami; Haruyama, Waka; Shoukei, Youji; Hisada, Yutaka; Yanagida, Tetsuya; Miyazaki, Hiroshi; Wada, Michihito; Akizawa, Tadao; Fukagawa, Masafumi			A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro	PLOS ONE			English	Article							PATIENTS RECEIVING HEMODIALYSIS; SECONDARY HYPERPARATHYROIDISM; CINACALCET HYDROCHLORIDE; CARDIOVASCULAR-DISEASE; PRACTICE PATTERNS; DIALYSIS PATIENTS; VITAMIN-D; CALCIUM; HCL; PTH	Cinacalcet hydrochloride (cinacalcet), an oral calcimimetic agent has been widely used for the management of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD). In sharp contrast to vitamin D receptor activators, cinacalcet suppresses SHPT without inducing hypercalcemia or hyperphosphatemia. Nevertheless, some patients remain refractory to SHPT with this agent, as the dose cannot be sufficiently increased due to gastrointestinal symptoms. In order to resolve this issue, we have developed a newly synthesized calcimimetic agent, evocalcet (MT-4580/KHK7580). In a rat model of CKD induced by 5/6 nephrectomy, oral administration of evocalcet efficiently suppressed the secretion of parathyroid hormone (PTH). With regard to the gastro-intestinal effects, cinacalcet induced a significant delay in gastric emptying in rats, while evocalcet did no marked effects on it. Evocalcet also demonstrated the less induction of emesis compared to cinacalcet in common marmosets. The pharmacological effects of evocalcet were observed at lower doses because of its higher bioavailability than cinacalcet, which may have contributed to the reduced GI tract symptoms. In addition, evocalcet showed no substantial direct inhibition of any CYP isozymes in in vitro liver microsome assay, suggesting a better profile in drug interactions than cinacalcet that inhibits cytochrome P450 (CYP) 2D6. These findings suggest that evocalcet can be a better alternative to cinacalcet, an oral calcimimetic agent, with a wider safety margin.	[Kawata, Takehisa; Tokunaga, Shin; Haruyama, Waka] Kyowa Hakko Kirin Co Ltd, R&D Div, Nephrol R&D Unit, Nephrol Res Labs, Shizuoka, Japan; [Murai, Miki; Shoukei, Youji] Kyowa Hakko Kirin Co Ltd, R&D Div, Res Core Funct Labs, Res Funct Unit, Shizuoka, Japan; [Masuda, Nami] Kyowa Hakko Kirin Co Ltd, Prod Div, Takasaki Plant, Gunma, Japan; [Hisada, Yutaka; Yanagida, Tetsuya; Miyazaki, Hiroshi] Mitsubishi Tanabe Pharma Corp, Res Unit, Innovat Res Div, Yokohama, Kanagawa, Japan; [Wada, Michihito] Kyowa Hakko Kirin Co Ltd, Med Affairs Dept, Tokyo, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Hiratsuka, Kanagawa, Japan	Kyowa Kirin Ltd; Kyowa Kirin Ltd; Kyowa Kirin Ltd; Mitsubishi Tanabe Pharma Corporation; Kyowa Kirin Ltd; Showa University; Tokai University	Fukagawa, M (corresponding author), Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Hiratsuka, Kanagawa, Japan.	fukagawa@tokai-u.jp		Fukagawa, Misato/0000-0003-1117-9213; Fukagawa, Masafumi/0000-0002-7832-2339	Mitsubishi Tanabe Pharma Corporation; Kyowa-Hakko Kirin Co., Ltd.; Kyowa Hakko Kirin Co., Ltd	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Kyowa-Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Kyowa Hakko Kirin Co., Ltd(Kyowa Kirin Ltd)	Mitsubishi Tanabe Pharma Corporation provided KHK7580 compound. The studies of rat PK study and CYP inhibition assay were performed and all the cost of these studies were supported by Mitsubishi Tanabe Pharma Corporation. Other studies were performed and the cost of them were supported by Kyowa-Hakko Kirin Co., Ltd. Takehisa Kawata, Shin Tokunaga, Miki Murai, Nami Masuda, Waka Haruyama, Youji Shoukei, and Michihito Wada are employees of Kyowa Hakko Kirin Co., Ltd. Kyowa Hakko Kirin Co., Ltd provided support in the form of salaries for authors, TK, ST, MM, NM, WH, YS and MW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This study was supported by Mitsubishi Tanabe Pharma Corporation under a collaboration agreement. We thank Ayako Kannami (Mitsubishi Tanabe Pharma Corporation) for providing data of PK and CYP studies, and Hikaru Yoneda (Mitsubishi Tanabe Pharma Corporation) for his helpful discussion and reviewing this manuscript. We also wish to thank Misaki Kobayashi, Eri Okita, Akiko Katsumata, Miho Araki, and Mika Kawai for their assistance in the in vivo studies.	Akizawa T, 2011, CLIN J AM SOC NEPHRO, V6, P2280, DOI 10.2215/CJN.11501210; Badary OA, 2006, WORLD J GASTROENTERO, V12, P5363, DOI 10.3748/wjg.v12.i33.5363; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Block GA, 2017, JAMA-J AM MED ASSOC, V317, P156, DOI 10.1001/jama.2016.19468; Boussios S, 2012, ANN GASTROENTEROL, V25, P106; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Fukagawa M, 2008, NEPHROL DIAL TRANSPL, V23, P328, DOI 10.1093/ndt/gfm534; Fukagawa M, 2012, CLIN J AM SOC NEPHRO, V7, P1473, DOI 10.2215/CJN.13081211; Fukuma S, 2013, KIDNEY INT SUPPL, V3, P436, DOI 10.1038/kisup.2013.91; Fukumoto K., 2010, J JPN SOC DIAL THER, V43, P309; Gincherman Y, 2010, HEMODIAL INT, V14, P68, DOI 10.1111/j.1542-4758.2009.00397.x; Hamano N, 2017, EXPERT OPIN PHARMACO, V18, P529, DOI 10.1080/14656566.2017.1303482; Harris RZ, 2007, CLIN PHARMACOKINET, V46, P495, DOI 10.2165/00003088-200746060-00003; Kawata T, 2006, J BONE MINER METAB, V24, P300, DOI 10.1007/s00774-006-0687-y; Kiefer L, 2011, EXPERT OPIN THER PAT, V21, P681, DOI 10.1517/13543776.2011.568479; Nagano N, 2006, PHARMACOL THERAPEUT, V109, P339, DOI 10.1016/j.pharmthera.2005.06.019; Nakashima D, 2007, J CLIN PHARMACOL, V47, P1311, DOI 10.1177/0091270007304103; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Padhi D, 2009, CLIN PHARMACOKINET, V48, P303, DOI 10.2165/00003088-200948050-00002; Palmer SC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001436; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Rutter AR, 2014, J PHARMACOL EXP THER, V350, P153, DOI 10.1124/jpet.114.214155; Sassi Graziella, 2005, J Oncol Pharm Pract, V11, P63, DOI 10.1191/1078155205jp154oa; Taniguchi M, 2013, THER APHER DIAL, V17, P221, DOI 10.1111/1744-9987.12030; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279; Tominaga Y, 2016, THER APHER DIAL, V20, P6, DOI 10.1111/1744-9987.12352; Wetmore JB, 2015, CLIN J AM SOC NEPHRO, V10, P1031, DOI 10.2215/CJN.07050714	31	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195316	10.1371/journal.pone.0195316	http://dx.doi.org/10.1371/journal.pone.0195316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614098	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600044
J	Cardillo, E; Acedo, A; Abad, E				Cardillo, Enrique; Acedo, Angel; Abad, Enrique			Topographic effects on dispersal patterns of Phytophthora cinnamomi at a stand scale in a Spanish heathland	PLOS ONE			English	Article							LANDSCAPE EPIDEMIOLOGY; SPATIAL-PATTERNS; OAK WOODLANDS; DISEASE; SOIL; PERSPECTIVES; INVOLVEMENT; VILLUERCAS; MORTALITY; PATHOGENS	Phytophthora cinnamomi is one of the most important plant pathogens in the world, causing root rot in more than a thousand plant species. This observational study was carried out on a P. cinnamomi infected heathland of Erica umbellata used as goat pasture. The patterns and shapes of disease foci and their distribution were described in a spatial and temporal context using an aerial photograph record. A set of topographic traits was selected on the basis of a disease dynamic hypothesis and their effects on observed spatial disease patterns were analyzed. Incipient infections situated in flat terrain expanded as compact circular front patterns with a low growth rate. On slopes, disease patches developed more rapidly down slope, forming parabolic shapes. The axis direction of the parabolas was highly correlated with terrain aspect, while the parabolic amplitude was associated with land curvature and slope. New secondary foci appeared over the years producing an accelerated increase of the affected surface. These new foci were observed in sites where disease density was higher or near sites more frequently visited by animals such as the stable or the forage crop. In contrast, a smaller number of disease foci occur in areas which animals are reluctant to visit, such as where they have a short range of vision. Our results suggest that 1) the growth of existing P. cinnamomi foci is controlled by a combination of root-to-root contact and water flows, 2) the increase in the diseased area arises mainly from the multiplication of patches, 3) the formation of new foci is mediated by long-distance transport due to the movement of animals and humans along certain preferential pathways, and 4) geomorphology and topography traits are associated with the epidemiology of this soil-borne pathogen.	[Cardillo, Enrique; Acedo, Angel] Ctr Invest Cient & Tecnol Extremadura CICYTEX, Inst Corcho Madera & Carbon Vegetal, Merida, Spain; [Abad, Enrique] Univ Extremadura, Dept Fis Aplicada, Merida, Spain; [Abad, Enrique] Univ Extremadura, Inst Computac Cient Avanzada ICCAEX, Merida, Spain	Universidad de Extremadura; Universidad de Extremadura	Cardillo, E (corresponding author), Ctr Invest Cient & Tecnol Extremadura CICYTEX, Inst Corcho Madera & Carbon Vegetal, Merida, Spain.	enrique.cardillo@juntaex.es	Abad, E/I-7242-2012	Abad, E/0000-0002-1765-409X; Cardillo, Enrique/0000-0002-9148-7090	local Goverment of Extremadura (Junta de Extremadura - Spain); MIMECO [FIS2016-76359-P]	local Goverment of Extremadura (Junta de Extremadura - Spain); MIMECO	This work was funding by the local Goverment of Extremadura (Junta de Extremadura - Spain) and by MIMECO Grant No FIS2016-76359-P to EA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo A., 2013, New Disease Reports, V28, P8, DOI 10.5197/j.2044-0588.2013.028.008; Baddeley A, 1997, ANN STAT, V25, P263; Bailey DW, 2008, RESOURCE ECOLOGY; Balci Y, 2003, FOREST PATHOL, V33, P157, DOI 10.1046/j.1439-0329.2003.00318.x; Balci Y, 2010, FOREST PATHOL, V40, P430, DOI 10.1111/j.1439-0329.2009.00617.x; Bates D., 1988, NONLINEAR REGRESSION; Bivand R, 2015, J STAT SOFTW, V63, P1; BRASIER CM, 1992, NATURE, V360, P539, DOI 10.1038/360539a0; Burgess TI, 2017, GLOBAL CHANGE BIOL, V23, P1661, DOI 10.1111/gcb.13492; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Costa A, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009097; Dillon WW, 2014, EUR J PLANT PATHOL, V138, P449, DOI 10.1007/s10658-013-0376-3; Ebdon D., 1985, A PRACTICAL APPROACH, V2nd; ESPEJO R, 1987, CATENA, V14, P399, DOI 10.1016/0341-8162(87)90012-9; ESRI, 2020, ARCGIS DESKT REL 10; Fox J., 2019, R COMPANION APPL REG, V.; Garbelotto M, 2006, PLANT DIS, V90, P685, DOI 10.1094/PD-90-0685C; Gaspar P, 2011, SMALL RUMINANT RES, V97, P1, DOI 10.1016/j.smallrumres.2011.03.001; Gomez-Aparicio L, 2012, NEW PHYTOL, V194, P1014, DOI 10.1111/j.1469-8137.2012.04108.x; CRANDALL B. S., 1950, Plant Disease Reporter, V34, P194; Hansen E., 2003, SUDD OAK DEATH ONL S, V4; Hengeveld R., 1989, DYNAMICS BIOL INVASI; HILL TCJ, 1994, AUST J BOT, V42, P725, DOI 10.1071/BT9940725; Holdenrieder O, 2004, TRENDS ECOL EVOL, V19, P446, DOI 10.1016/j.tree.2004.06.003; Hopewell L, 2005, BEHAV PROCESS, V70, P186, DOI 10.1016/j.beproc.2005.04.009; Huberli D, 2000, AUSTRALAS PLANT PATH, V29, P164, DOI 10.1071/AP00029; Jung T, 1996, EUR J FOREST PATHOL, V26, P253; Keith DA, 2012, P LINN SOC N S W, V134, pB147; Kelly M, 2002, PHOTOGRAMM ENG REM S, V68, P1001; KINAL J, 1993, PLANT DIS, V77, P1085, DOI 10.1094/PD-77-1085; KLIEJUNAS JT, 1976, PHYTOPATHOLOGY, V66, P457, DOI 10.1094/Phyto-66-457; Krull CR, 2013, AUSTRAL ECOL, V38, P534, DOI 10.1111/j.1442-9993.2012.02444.x; Lachica M, 1997, BRIT J NUTR, V77, P73, DOI 10.1017/S0007114500002890; Li AY, 2014, BIOL INVASIONS, V16, P765, DOI 10.1007/s10530-013-0535-7; Lopez-Herrera C.J., 1991, P 2 WORLD AVOCADO C, V1, P119; Lowe S, 2004, ENCY BIOL INVASIONS, P715; Madden LV, 2006, EUR J PLANT PATHOL, V115, P3, DOI 10.1007/s10658-005-1229-5; Mariscal-Sancho IL, 2008, THESIS; Meentemeyer RK, 2012, ANNU REV PHYTOPATHOL, V50, P379, DOI 10.1146/annurev-phyto-081211-172938; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Moreira AC, 2005, FOREST PATHOL, V35, P145, DOI 10.1111/j.1439-0329.2005.00397.x; Muller MM, 2016, BIOL INVASIONS, V18, P2841, DOI 10.1007/s10530-016-1174-6; Nagel JH, PHYTOPHTHORA GLOBAL; Okubo  A., 2013, DIFFUSION ECOLOGICAL, V14; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Plantegenest M, 2007, J R SOC INTERFACE, V4, P963, DOI 10.1098/rsif.2007.1114; R Core Team, 2014, R LANG ENV STAT COMP; RISENHOOVER KL, 1985, J WILDLIFE MANAGE, V49, P797, DOI 10.2307/3801714; Ristaino JB, 2000, ANNU REV PHYTOPATHOL, V38, P541, DOI 10.1146/annurev.phyto.38.1.541; Robin C, 1998, ANN SCI FOREST, P55; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodriguez-Molina MC, 2005, FOREST PATHOL, V35, P411, DOI 10.1111/j.1439-0329.2005.00423.x; SHEA SR, 1983, PLANT DIS, V67, P970, DOI 10.1094/PD-67-970; Shearer BL, 2014, AUSTRALAS PLANT PATH, V43, P327, DOI 10.1007/s13313-014-0274-y; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Silverman B., 1986, DENSITY ESTIMATION S, V175; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Swiecki TJ, 2002, P S CAL OAK WOODL 5, P789; Thompson S, 2013, AM NAT, V181, pE1, DOI 10.1086/668572; Thompson SE, 2014, GLOBAL CHANGE BIOL, V20, P1299, DOI 10.1111/gcb.12463; Vannini A, 2010, FOREST PATHOL, V40, P73, DOI 10.1111/j.1439-0329.2009.00609.x; Venables WN., 2002, MODERN APPL STAT S; Wilson BA, 2003, AUSTRAL ECOL, V28, P108, DOI 10.1046/j.1442-9993.2003.01253.x; Wilson BA, 2012, AUST J BOT, V60, P495, DOI 10.1071/BT11305; Yokoyama R, 2002, PHOTOGRAMM ENG REM S, V68, P257; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107	66	15	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195060	10.1371/journal.pone.0195060	http://dx.doi.org/10.1371/journal.pone.0195060			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601576	Green Published, gold, Green Submitted			2022-12-27	WOS:000428845900016
J	Rand, D				Rand, Debbie			Proprioception deficits in chronic stroke-Upper extremity function and daily living	PLOS ONE			English	Article							FUGL-MEYER ASSESSMENT; SENSORIMOTOR SYSTEM; POSITION SENSE; BLOCK TEST; RELIABILITY; RECOVERY; VALIDITY; PERFORMANCE; IMPAIRMENT; ARM	Background Proprioception deficits are common post-stroke and predict poor functional outcome. It is unknown if the presence of proprioception deficits is negatively associated with the motor and functional ability of the affected upper extremity and daily living at the chronic stage post-stroke. Aims 1) To describe proprioception deficits of individuals with chronic stroke, 2) to correlate the severity of proprioception deficits with the motor and functional ability of the upper extremity, and 3) to compare independence in basic and instrumental activities in daily living (BADL, IADL), upper extremity motor and functional abilities between individuals with and without proprioception deficits. Methods 102 adults aged 29-85 years with chronic stroke participated in this cross sectional study. The upper extremity was assessed for proprioception (Thumb localization Test), motor [Fugl-Meyer Motor Assessment (FMA)] and functional ability [Action Research Arm Test (ARAT), Box and Block Test (BBT)], grip strength and daily use [Motor Activity Log (MAL)]. Independence in BADL and IADL was also assessed. Results 71 participants had intact proprioception, 31 participants had mild-moderate proprioception deficits. Negative significant (p<.001) correlations were found between the severity of proprioception deficits to the motor ability (FMA) (r = -.41), functional ability (ARAT) (r = -.48), dexterity (BBT) (r = -.43), grip strength (r = -.41) and daily-use (MAL amount and quality) (r = -.55 and r = -.54, respectively) of the affected upper extremity. Significant between-group differences were found for BADL, IADL and upper extremity measures. Conclusion Proprioception deficits of individuals with chronic stroke are negatively associated with upper extremity motor and functional abilities and independence in daily living. Therefore, proprioception should be assessed at the chronic stage post-stroke.	[Rand, Debbie] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Rand, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, Tel Aviv, Israel.	drand@post.tau.ac.il		Rand, Debbie/0000-0001-6410-2389				Berthoz A., 2000, BRAINS SENSE MOVEMEN; Bohannon Richard W, 2005, J Hand Ther, V18, P426, DOI 10.1197/j.jht.2005.07.003; Carey L.M., 1995, CRIT REV PHYS REHABI, V7, P51, DOI [10.1615/CritRevPhysRehabilMed.v7.i1.40, DOI 10.1615/CRITREVPHYSREHABILMED.V7.I1.40]; Chalsen GG, 1987, J NEUROL REHABIL, V1, P137; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Cromwell FS, 1965, OCCUPATIONAL THERAPI, P29; Desrosiers J, 1996, STROKE, V27, P1564, DOI 10.1161/01.STR.27.9.1564; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; Fess EE, CLIN ASSESSMENT RECO, P41; Findlater SE, 2017, J MOTOR BEHAV, V49, P27, DOI 10.1080/00222895.2016.1219303; Findlater SE, 2016, CORTEX, V79, P42, DOI 10.1016/j.cortex.2016.03.008; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gottlieb D, 1997, J NEUROL REHABIL, V11, P239; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Haerer AF, 1997, DEJONGS NEUROLOGIC E; Harris JE, 2006, NEUROREHAB NEURAL RE, V20, P380, DOI 10.1177/1545968305284528; Hillier S, 2015, NEUROREHAB NEURAL RE, V29, P933, DOI 10.1177/1545968315573055; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Kenzie JM, 2014, J NEUROL SCI, V342, P52, DOI 10.1016/j.jns.2014.04.025; Kessner SS, 2016, TOP STROKE REHABIL, V23, P136, DOI 10.1080/10749357.2015.1116822; Kielhofner G., 2006, RES OCCUPATIONAL THE, P155, DOI DOI 10.1136/JNNP.73.2.188; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LAWTON MP, 1982, J GERONTOL, V37, P91, DOI 10.1093/geronj/37.1.91; Lephart SM, 2000, PROPRIOCEPTION AND NEUROMUSCULAR CONTROL IN JOINT STABILITY, pXVII; Lin JH, 2004, CLIN REHABIL, V18, P391, DOI 10.1191/0269215504cr737oa; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Masedo AI, 2005, AM J PHYS MED REHAB, V84, P167, DOI 10.1097/01.PHM.0000154898.25609.4A; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Niessen MHM, 2009, AM J PHYS MED REHAB, V88, P979, DOI 10.1097/PHM.0b013e3181c1eac1; Ogard WK, 2011, STRENGTH COND J, V33, P111, DOI 10.1519/SSC.0b013e31821bf3ae; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Portney L.G., 2000, FDN CLIN RES APPL PR, P560; PRESCOTT RJ, 1982, STROKE, V13, P641, DOI 10.1161/01.STR.13.5.641; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rand D, 1999, NEUROREHAB NEURAL RE, V13, P15, DOI 10.1177/154596839901300104; Rand D., 2001, PHYS OCCUPATIONAL TH, V18, P69, DOI DOI 10.1080/J148v18n03_05; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; REDING MJ, 1990, STROKE, V21, P35; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Semrau JA, 2013, STROKE, V44, P3414, DOI 10.1161/STROKEAHA.113.002058; SMITH DL, 1983, AGE AGEING, V12, P63, DOI 10.1093/ageing/12.1.63; Stern PH, 1971, STROKE, V2, P213, DOI 10.1161/01.STR.2.3.213; Sunderland A, 2000, STROKE, V31, P430, DOI 10.1161/01.STR.31.2.430; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; Wetter S, 2005, ARCH PHYS MED REHAB, V86, P776, DOI 10.1016/j.apmr.2004.08.009; Winward CE, 2002, CLIN REHABIL, V16, P523, DOI 10.1191/0269215502cr522oa; Ziegler DK, 1975, MAJORS PHYS DIAGNOSI, P118	56	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195043	10.1371/journal.pone.0195043	http://dx.doi.org/10.1371/journal.pone.0195043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB1XW	29601594	gold, Green Published, Green Submitted			2022-12-27	WOS:000428845900015
J	Joenvaara, S; Saraswat, M; Kuusela, P; Saraswat, S; Agarwal, R; Kaartinen, J; Jarvinen, A; Renkonen, R				Joenvaara, Sakari; Saraswat, Mayank; Kuusela, Pentti; Saraswat, Shruti; Agarwal, Rahul; Kaartinen, Johanna; Jarvinen, Asko; Renkonen, Risto			Quantitative N-glycoproteomics reveals altered glycosylation levels of various plasma proteins in bloodstream infected patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; ACUTE-PANCREATITIS; BACTEREMIA; SEPSIS; SERUM; PROCALCITONIN; MORTALITY; OUTCOMES; DISEASE	Bloodstream infections are associated with high morbidity and mortality with rates varying from 10-25% and higher. Appropriate and timely onset of antibiotic therapy influences the prognosis of these patients. It requires the diagnostic accuracy which is not afforded by current gold standards such as blood culture. Moreover, the time from blood sampling to blood culture results is a key determinant of reducing mortality. No established biomarkers exist which can differentiate bloodstream infections from other systemic inflammatory conditions. This calls for studies on biomarkers potential of molecular profiling of plasma as it is affected most by the molecular changes accompanying bloodstream infections. N-glycosylation is a post-translational modification which is very sensitive to changes in physiology. Here we have performed targeted quantitative N-glycoproteomics from plasma samples of patients with confirmed positive blood culture together with age and sex matched febrile controls with negative blood culture reports. Three hundred and sixty eight potential N-glycopeptides were quantified by mass spectrometry and 149 were further selected for identification. Twenty four N-glycopeptides were identified with high confidence together with elucidation of the peptide sequence, N-glycosylation site, glycan composition and proposed glycan structures. Principal component analysis, orthogonal projections to latent structures-discriminant analysis (S-Plot) and self-organizing maps clustering among other statistical methods were employed to analyze the data. These methods gave us clear separation of the two patient classes. We propose high-confidence N-glycopeptides which have the power to separate the bloodstream infections from blood culture negative febrile patients and shed light on host response during bacteremia. Data are available via ProteomeXchange with identifier PXD009048.	[Joenvaara, Sakari; Saraswat, Mayank; Saraswat, Shruti; Renkonen, Risto] Univ Helsinki, Transplantat Lab, Haartmaninkatu 3, Helsinki, Finland; [Joenvaara, Sakari; Saraswat, Mayank; Kuusela, Pentti; Jarvinen, Asko; Renkonen, Risto] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland; [Kuusela, Pentti] HUSLAB, Div Clin Microbiol, Helsinki, Finland; [Kuusela, Pentti] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Agarwal, Rahul] All India Inst Med Sci, Dept Reprod Biol, New Delhi, India; [Kaartinen, Johanna] Helsinki Univ Hosp, Emergency Med & Serv, Helsinki, Finland; [Jarvinen, Asko] Univ Helsinki, HUH Inflammat Ctr, Div Infect Dis, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Saraswat, M (corresponding author), Univ Helsinki, Transplantat Lab, Haartmaninkatu 3, Helsinki, Finland.; Saraswat, M (corresponding author), Helsinki Univ Hosp, HUSLAB, Helsinki, Finland.	sarawat.mk@gmail.com	Saraswat, Mayank/F-2985-2015	Saraswat, Mayank/0000-0002-5021-8150				ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Basset C, 2000, SCAND J IMMUNOL, V51, P300; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Brinkman-van der Linden ECM, 1998, GLYCOCONJUGATE J, V15, P177, DOI 10.1023/A:1006972307166; Chatterjee B. P., 2014, Proceedings of the Indian National Science Academy Part B Biological Sciences, V84, P865, DOI 10.1007/s40011-014-0331-x; DeCoux A, 2015, CRIT CARE MED, V43, P2049, DOI 10.1097/CCM.0000000000001134; Fumagalli O, 1997, INFECT IMMUN, V65, P4445, DOI 10.1128/IAI.65.11.4445-4451.1997; Geyer PE, 2016, CELL SYST, V2, P185, DOI 10.1016/j.cels.2016.02.015; Gornik O, 2007, GLYCOBIOLOGY, V17, P1321, DOI 10.1093/glycob/cwm106; HALL MM, 1976, J CLIN MICROBIOL, V3, P643; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Joenvaara S, 2008, GLYCOBIOLOGY, V18, P339, DOI 10.1093/glycob/cwn013; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kontro H, 2014, PROTEOMICS, V14, P1713, DOI 10.1002/pmic.201300270; Kreisman LSC, 2012, GLYCOBIOLOGY, V22, P1019, DOI 10.1093/glycob/cws070; Kuusela P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172987; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Nakamura A, 2009, SHOCK, V31, P586, DOI 10.1097/SHK.0b013e31819716fa; Nargis Waheeda, 2014, Int J Crit Illn Inj Sci, V4, P195, DOI 10.4103/2229-5151.141356; Nikfardjam M, 2000, J INTERN MED, V247, P341, DOI 10.1046/j.1365-2796.2000.00670.x; Povoa P, 2005, CLIN MICROBIOL INFEC, V11, P101, DOI 10.1111/j.1469-0691.2004.01044.x; Pritchett J W, 1996, Am J Orthop (Belle Mead NJ), V25, P759; Saraswat M, 2014, MOL CELLULAR PROTEOM; Saraswat M, 2016, J PROTEOME RES, V15, P991, DOI 10.1021/acs.jproteome.5b01069; Schwetz I, 2007, J CLIN MICROBIOL, V45, P2691, DOI 10.1128/JCM.00085-07; Shadick NA, 2006, ARCH INTERN MED, V166, P2490, DOI 10.1001/archinte.166.22.2490; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Skogberg K, 2012, CLIN MICROBIOL INFEC, V18, pE170, DOI 10.1111/j.1469-0691.2012.03845.x; TENNEY JH, 1982, J CLIN MICROBIOL, V15, P558, DOI 10.1128/JCM.15.4.558-561.1982; van Dijk W, 1994, GLYCOSYLATION DIS, V1, P5; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wines BD, 2011, J BIOL CHEM, V286, P33118, DOI 10.1074/jbc.M111.272252; Zarkesh Marjaneh, 2015, Acta Med Iran, V53, P408; Zhang Y, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-18	35	9	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195006	10.1371/journal.pone.0195006	http://dx.doi.org/10.1371/journal.pone.0195006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596458	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000065
J	Wang, KY; Yamada, S; Izumi, H; Tsukamoto, M; Nakashima, T; Tasaki, T; Guo, X; Uramoto, H; Sasaguri, Y; Kohno, K				Wang, Ke-Yong; Yamada, Sohsuke; Izumi, Hiroto; Tsukamoto, Manabu; Nakashima, Tamiji; Tasaki, Takashi; Guo, Xin; Uramoto, Hidetaka; Sasaguri, Yasuyuki; Kohno, Kimitoshi			Critical in vivo roles of WNT10A in wound healing by regulating collagen expression/synthesis in WNT10A-deficient mice	PLOS ONE			English	Article							NONALCOHOLIC-STEATOHEPATITIS; CELLS; APOPTOSIS; RECEPTORS; CANCER; ACTIVATION; FIBROSIS; DISEASE; PLAQUES; MODEL	Background We have reported that WNT10A plays a critical role in the growth of fibroblasts/myofibroblasts and microvascular endothelial cells, i.e.; wound healing/scarring. To ascertain the in vivo regulatory, central functions of WNT10A, we examined the net effects of WNT10A depletion using WNT10A-deficient mice (WNT10A(-/-)). Methods and results We generated WNT10A(-/-) mice, displaying a range of unique phenotypes of morpho/organogenetic failure, such as growth retardation, alopecia, kyphosis and infertility, and then focused on the functions of WNT10A in wound healing. We subjected C57BL/6J wild-type (WT) or WNT10A(-/-) mice to skin ulcer formation. The WNT10A(-/-) mice had significantly larger injured areas and delayed wound healing, which were associated with (a) a smaller number of fibroblasts/myofibroblasts and microvessels; and (b) more reduced expression and synthesis of collagen, compared with WT mice with intact WNT10A expression, especially in those with activated myofibroblasts. Conclusions These observations indicate that WNT10A signaling can play a pivotal in vivo role in wound healing by regulating the expression and synthesis of collagen, as one of fibrogenic factors, at least in part, and critical in vivo roles of WNT10A-mediated effective wound healing are extremely closely associated with collagen expression.	[Wang, Ke-Yong] Univ Occupat & Environm Hlth, Sch Med, Shared Use Res Ctr, Kitakyushu, Fukuoka, Japan; [Yamada, Sohsuke; Guo, Xin] Kanazawa Med Univ, Dept Pathol & Lab Med, Uchinada, Ishikawa, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Sch Med, Dept Occupat Pneumol, Kitakyushu, Fukuoka, Japan; [Tsukamoto, Manabu] Univ Occupat & Environm Hlth, Sch Med, Dept Orthopaed Surg, Kitakyushu, Fukuoka, Japan; [Nakashima, Tamiji] Univ Occupat & Environm Hlth, Dept Human Informat & Life Sci, Sch Med, Kitakyushu, Fukuoka, Japan; [Tasaki, Takashi; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka, Japan; [Uramoto, Hidetaka] Kanazawa Med Univ, Dept Thorac Surg, Uchinada, Ishikawa, Japan; [Sasaguri, Yasuyuki] Fukuoka Tokushukai Hosp, Lab Pathol, Fukuoka, Japan; [Kohno, Kimitoshi] Asahi Matsumoto Hosp, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; Kanazawa Medical University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Kanazawa Medical University	Yamada, S (corresponding author), Kanazawa Med Univ, Dept Pathol & Lab Med, Uchinada, Ishikawa, Japan.; Kohno, K (corresponding author), Asahi Matsumoto Hosp, Kitakyushu, Fukuoka, Japan.	sohsuke@kanazawa-med.ac.jp; kimitt2411@yahoo.co.jp	Tsukamoto, Manabu/AAJ-2632-2021	Tsukamoto, Manabu/0000-0003-4577-5072; wang, ke-yong/0000-0001-8295-1229	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UM1OD023221] Funding Source: NIH RePORTER; NIH HHS [UM1 OD023221] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Dunn L, 2013, JOVE-J VIS EXP, DOI 10.3791/50265; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Gallagher KA, 2015, DIABETES, V64, P1420, DOI 10.2337/db14-0872; Haddow A, 1972, Adv Cancer Res, V16, P181; Heise RL, 2011, J BIOL CHEM, V286, P17435, DOI 10.1074/jbc.M110.137273; Ji WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103224; Khosravi-Maharlooei M, 2016, IMMUNOLOGY, V148, P22, DOI 10.1111/imm.12584; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kina-Tanada M, 2017, DIABETOLOGIA, V60, P1138, DOI 10.1007/s00125-017-4259-6; Kirikoshi H, 2001, INT J ONCOL, V19, P533; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kuma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103240; Lan Y, 2014, SEMIN CELL DEV BIOL, V25, P61, DOI 10.1016/j.semcdb.2013.12.003; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Nawata A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152549; Noguchi H, 2014, AM J PATHOL, V184, P644, DOI 10.1016/j.ajpath.2013.11.030; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oda K, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0357-0; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Seong I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031477; Su JL, 2005, CARCINOGENESIS, V26, P1, DOI 10.1093/carcin/bgh220; Tasaki T, 2013, AM J PATHOL, V182, P597, DOI 10.1016/j.ajpath.2012.10.008; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Tsukamoto M, 2016, BONE, V85, P70, DOI 10.1016/j.bone.2016.01.025; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; Wang KY, 2010, AM J PATHOL, V177, P713, DOI 10.2353/ajpath.2010.091198; Xu MG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15397; Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Yamada S, 2011, ARTERIOSCL THROM VAS, V31, P1555, DOI 10.1161/ATVBAHA.111.227140; Yang J, 2015, MOL GENET GENOM MED, V3, P40, DOI 10.1002/mgg3.111; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Zhang JY, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040041	38	17	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195156	10.1371/journal.pone.0195156	http://dx.doi.org/10.1371/journal.pone.0195156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596490	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000088
J	Hamlington, KL; Bates, JHT; Roy, GS; Julianelle, AJ; Charlebois, C; Suki, B; Smith, BJ				Hamlington, Katharine L.; Bates, Jason H. T.; Roy, Gregory S.; Julianelle, Adele J.; Charlebois, Chantel; Suki, Bela; Smith, Bradford J.			Alveolar leak develops by a rich-get-richer process in ventilator-induced lung injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; EPITHELIAL-CELL DAMAGE; MECHANICAL VENTILATION; DEEP INFLATION; MODEL; PROGRESSION; DISRUPTION; PRESSURE; MICE; TRANSMIGRATION	Acute respiratory distress syndrome (ARDS) is a life-threatening condition for which there are currently no medical therapies other than supportive care involving the application of mechanical ventilation. However, mechanical ventilation itself can worsen ARDS by damaging the alveolocapillary barrier in the lungs. This allows plasma-derived fluid and proteins to leak into the airspaces of the lung where they interfere with the functioning of pulmonary surfactant, which increases the stresses of mechanical ventilation and worsens lung injury. Once such ventilator-induced lung injury (VILI) is underway, managing ARDS and saving the patient becomes increasingly problematic. Maintaining an intact alveolar barrier thus represents a crucial management goal, but the biophysical processes that perforate this barrier remain incompletely understood. To study the dynamics of barrier perforation, we subjected initially normal mice to an injurious ventilation regimen that imposed both volutrauma (overdistension injury) and atelectrauma (injury from repetitive reopening of closed airspaces) on the lung, and observed the rate at which macromolecules of various sizes leaked into the airspaces as a function of the degree of overall injury. Computational modeling applied to our findings suggests that perforations in the alveolocapillary barrier appear and progress according to a rich-get-richer mechanism in which the likelihood of a perforation getting larger increases with the size of the perforation. We suggest that atelectrauma causes the perforations after which volutrauma expands them. This mechanism explains why atelectrauma appears to be essential to the initiation of VILI in a normal lung, and why atelectrauma and volutrauma then act synergistically once VILI is underway.	[Hamlington, Katharine L.; Bates, Jason H. T.; Roy, Gregory S.; Julianelle, Adele J.; Charlebois, Chantel] Univ Vermont, Coll Med, Dept Med, Vermont Lung Ctr, Burlington, VT 05405 USA; [Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Smith, Bradford J.] Univ Colorado Denver, Dept Bioengn, Aurora, CO 80045 USA	University of Vermont; Boston University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, BJ (corresponding author), Univ Colorado Denver, Dept Bioengn, Aurora, CO 80045 USA.	bradford.smith@ucdenver.edu		Charlebois, Chantel/0000-0002-4139-3539; Hamlington, Katharine/0000-0002-5221-2123; Smith, Bradford/0000-0002-1583-6762	National Heart, Lung, and Blood Institute [R01 HL-124052, T32 HL-076122, R01 HL-111745, K99 HL-128944, R00 HL128944]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124052, T32HL076122, K99HL128944, R00HL128944, R01HL142702, R01HL111745] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/) grants R01 HL-124052 (JB), T32 HL-076122 (JB), R01 HL-111745 (BS), K99 HL-128944 (BJS), and R00 HL128944 (BJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2004, J APPL PHYSIOL, V96, P293, DOI 10.1152/japplphysiol.00270.2003; Allen G, 2002, J APPL PHYSIOL, V93, P1709, DOI 10.1152/japplphysiol.00473.2002; Allen GB, 2007, AM J PHYSIOL-LUNG C, V292, pL1580, DOI 10.1152/ajplung.00483.2006; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Bagrow JP, J PHYS A, V1008, P41; Bak P., 1996, NATURE WORKDS SCI SE; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bates JHT, 2007, ANN BIOMED ENG, V35, P1165, DOI 10.1007/s10439-007-9291-0; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Edens HA, 2000, ADV DRUG DELIVER REV, V41, P315, DOI 10.1016/S0169-409X(00)00049-1; Gajic O, 2003, AM J RESP CRIT CARE, V167, P1057, DOI 10.1164/rccm.200208-889OC; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; Hamlington KL, 2016, AM J RESP CRIT CARE, V193; Hamlington KL, 2016, CELL MOL BIOENG, V9, P151, DOI 10.1007/s12195-015-0426-3; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; HOLM BA, 1988, CHEM PHYS LIPIDS, V49, P49, DOI 10.1016/0009-3084(88)90063-1; Jain Sumeet V, 2016, Intensive Care Med Exp, V4, P11, DOI 10.1186/s40635-016-0085-2; Janda A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.248001; Kay SS, 2004, J APPL PHYSIOL, V97, P269, DOI 10.1152/japplphysiol.01288.2003; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Kollisch-Singule M, 2017, J PEDIATR SURG, V52, P50, DOI 10.1016/j.jpedsurg.2016.10.020; NASH S, 1988, LAB INVEST, V59, P531; Nusrat A, 1997, GASTROENTEROLOGY, V113, P1489, DOI 10.1053/gast.1997.v113.pm9352851; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Seah AS, 2011, ANN BIOMED ENG, V39, P1505, DOI 10.1007/s10439-010-0237-6; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Smith BJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00466; Smith BJ, 2015, J APPL PHYSIOL, V118, P932, DOI 10.1152/japplphysiol.00902.2014; Smith BJ, 2013, IEEE T BIO-MED ENG, V60, P3449, DOI 10.1109/TBME.2013.2267151; Smith BJ, 2013, ANN BIOMED ENG, V41, P527, DOI 10.1007/s10439-012-0693-2; Sutherasan Y, 2014, CRIT CARE, V18, DOI 10.1186/cc13778; Thammanomai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053934; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; WORTHEN GS, 1987, AM REV RESPIR DIS, V136, P19, DOI 10.1164/ajrccm/136.1.19; Yildiz C, 2015, ANESTHESIOLOGY, V122, P864, DOI 10.1097/ALN.0000000000000605; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR	45	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193934	10.1371/journal.pone.0193934	http://dx.doi.org/10.1371/journal.pone.0193934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590136	Green Submitted, gold, Green Published			2022-12-27	WOS:000428603100039
J	Lavictoire, L; Ramsey, AD; Moorkens, EA; Souch, G; Barnhart, MC				Lavictoire, Louise; Ramsey, Andrew D.; Moorkens, Evelyn A.; Souch, Graham; Barnhart, M. Christopher			Ontogeny of juvenile freshwater pearl mussels, Margaritifera margaritifera (Bivalvia: Margaritiferidae)	PLOS ONE			English	Article							LATERO-FRONTAL CIRRI; HYRIOPSIS LIMNOSCAPHA MYERSIANA; LABORATORY-CULTURED BACTERIA; CILIARY MECHANISMS; PARTICLE CAPTURE; MYTILUS-EDULIS; EVOLUTIONARY IMPLICATIONS; FUNCTIONAL-MORPHOLOGY; DREISSENA-POLYMORPHA; GILL DEVELOPMENT	The gills of juvenile freshwater bivalves undergo a complex morphogenesis that may correlate with changes in feeding ecology, but ontogenic studies on juvenile mussels are rare. Scanning electron microscopy was used to examine the ultrastructure and ontogeny of 117 juvenile freshwater pearl mussels (Margaritifera margaritifera) ranging in age from 1-44 months and length from 0.49-8.90 mm. Three stages of gill development are described. In Stage 1 (5-9 inner demibranch filaments), only unreflected inner demibranch filaments were present. In Stage 2 (9-17 inner demibranch filaments), inner demibranch filaments began to reflect when shell length exceeded 1.13 mm, at 13-16 months old. Reflection began in medial filaments and then proceeded anterior and posterior. In Stage 3 (28-94 inner demibranch filaments), outer demibranch filaments began developing at shell length > 3.1 mm and about 34 months of age. The oral groove on the inner demibranch was first observed in 34 month old specimens > 2.66 mm but was never observed on the outer demibranch. Shell length (R-2 = 0.99) was a better predictor of developmental stage compared to age (R-2 = 0.84). The full suite of gill ciliation was present on filaments in all stages. Interfilamentary distance averaged 31.3 mu m and did not change with age (4-44 months) or with size (0.75-8.9 mm). Distance between laterofrontal cirri couplets averaged 1.54 pm and did not change significantly with size or age. Labial palp primordia were present in even the youngest individuals but ciliature became more diverse in more developed individuals. Information presented here is valuable to captive rearing programmes as it provides insight in to when juveniles may be particularly vulnerable to stressors due to specific ontogenic changes. The data are compared with two other recent studies of Margaritifera development.	[Lavictoire, Louise] Freshwater Biol Assoc, Ambleside, Cumbria, England; [Lavictoire, Louise] Univ Cumbria, Ctr Wildlife Conservat, Ambleside, Cumbria, England; [Ramsey, Andrew D.; Souch, Graham] Univ Derby, Coll Life & Nat Sci, Derby, England; [Moorkens, Evelyn A.] Univ Dublin, Trinity Coll, Dublin, Ireland; [Barnhart, M. Christopher] Missouri State Univ, Dept Biol, Springfield, MO USA	Freshwater Biological Association (FBA); University of Cumbria; University of Derby; Trinity College Dublin; Missouri State University	Lavictoire, L (corresponding author), Freshwater Biol Assoc, Ambleside, Cumbria, England.; Lavictoire, L (corresponding author), Univ Cumbria, Ctr Wildlife Conservat, Ambleside, Cumbria, England.	louiselavictoire3@gmail.com	Moorkens, Evelyn/AAE-4609-2020	Ramsey, Andrew/0000-0002-6232-5869				ALDRIDGE DW, 1987, ENVIRON POLLUT, V45, P17, DOI 10.1016/0269-7491(87)90013-3; ANSELL AD, 1962, J MAR BIOL ASSOC UK, V42, P419, DOI 10.1017/S0025315400001405; Araujo R, 2018, J MORPHOL, V279, P4, DOI 10.1002/jmor.20748; Atkins D, 1938, Q J MICROSC SCI, V80, P345; Atkins D, 1937, Q J MICROSC SCI, V79, P375; Atkins D, 1937, Q J MICROSC SCI, V79, P339; Baker SM, 2003, HYDROBIOLOGIA, V505, P97, DOI 10.1023/B:HYDR.0000007298.52250.99; Barnhart MC., 2015, 2 INT REARING UNIONO; BENINGER PG, 1994, MAR BIOL, V119, P405, DOI 10.1007/BF00347537; Beninger PG, 1999, MAR ECOL PROG SER, V178, P259, DOI 10.3354/meps178259; Bogan AE, 2008, J N AM BENTHOL SOC, V27, P349, DOI 10.1899/07-069.1; BUDDENSIEK V, 1993, ARCH HYDROBIOL, V127, P151; Cannuel R, 2009, BIOL BULL-US, V217, P173, DOI 10.1086/BBLv217n2p173; Cannuel R, 2006, MAR BIOL, V149, P547, DOI 10.1007/s00227-005-0228-6; CUNJAK RA, 1991, CAN J ZOOL, V69, P353, DOI 10.1139/z91-055; Ellis MM, 1936, ECOLOGY, V17, P29, DOI 10.2307/1932951; Eybe T, 2013, AQUAT CONSERV, V23, P964, DOI 10.1002/aqc.2384; FITT WK, 1984, AQUACULTURE, V39, P181, DOI 10.1016/0044-8486(84)90265-5; Galbraith HS, 2009, J MOLLUS STUD, V75, P103, DOI 10.1093/mollus/eyn045; Gatenby CM, 1996, J N AM BENTHOL SOC, V15, P597, DOI 10.2307/1467810; Gatenby CM, 1997, AM MALACOL BULL, V14, P57; Graf DL, 2006, ZOOL J LINN SOC-LOND, V148, P343, DOI 10.1111/j.1096-3642.2006.00259.x; Gui Y, 2016, AQUACULTURE, V452, P120, DOI 10.1016/j.aquaculture.2015.07.035; Gum B, 2011, AQUAT CONSERV, V21, P743, DOI 10.1002/aqc.1222; Hanlon S. D, 2000, THESIS; Hastie LC, 2001, HYDROBIOLOGIA, V445, P109, DOI 10.1023/A:1017588222480; Henley WF, 2001, N AM J AQUACULT, V63, P144, DOI 10.1577/1548-8454(2001)063<0144:DAEORW>2.0.CO;2; Hruska Jaroslav, 1999, Heldia, V4, P69; Jones JW, 2005, N AM J AQUACULT, V67, P210, DOI 10.1577/A04-055.1; Jorgensen C.B., 1990, BIVALVE FILTER FEEDI; Jorgensen CB, 1996, MAR ECOL PROG SER, V142, P287, DOI 10.3354/meps142287; Kovitvadhi S, 2007, INVERTEBR REPROD DEV, V50, P207, DOI 10.1080/07924259.2007.9652248; Kovitvadhi S, 2006, INVERTEBR REPROD DEV, V49, P61, DOI 10.1080/07924259.2006.9652194; Lange M., 2005, P WORKSH PEARL MUSS, P47; Lasee BA, 1991, THESIS; Lavictoire L, 2017, THESIS, P115; Lavictoire L, 2016, HYDROBIOLOGIA, V766, P89, DOI 10.1007/s10750-015-2445-4; Lefevre G, 1910, J EXP ZOOL, V9, P79, DOI 10.1002/jez.1400090105; Lopes-Lima M, 2014, HYDROBIOLOGIA, V735, P1, DOI 10.1007/s10750-014-1902-9; Moorkens EA, 2011, IUCN RED LIST THREAT; Moorkens EA, 2014, AQUAT CONSERV, V24, P853, DOI 10.1002/aqc.2530; Moorkens EA, 2010, J CONCHOL, V40, P339; Murzina SA, 2017, BIOL BULL+, V44, P6, DOI 10.1134/S106235901701006X; Neumann D, 2003, BIOL BULL-US, V205, P73, DOI 10.2307/1543447; Ortmann A. E., 1911, Nautilus Boston Mass, V24; Ortmann A.E., 1911, MEM CARNEGIE MUS, V4, P279; Osterling ME, 2010, J APPL ECOL, V47, P759, DOI 10.1111/j.1365-2664.2010.01827.x; OWEN G, 1976, PROC R SOC SER B-BIO, V194, P527, DOI 10.1098/rspb.1976.0092; OWEN G, 1974, PROC R SOC SER B-BIO, V187, P83, DOI 10.1098/rspb.1974.0062; Passos FD, 2005, POLAR BIOL, V28, P372, DOI 10.1007/s00300-004-0702-5; Preston SJ, 2007, AQUAT CONSERV, V17, P539, DOI 10.1002/aqc.799; REID RGB, 1992, VELIGER, V35, P93; Riisgard HU, 2015, ACTA ZOOL-STOCKHOLM, V96, P273, DOI 10.1111/azo.12110; RIISGARD HU, 1988, MAR ECOL PROG SER, V45, P217, DOI 10.3354/meps045217; Riisgard HU, 2001, MAR ECOL PROG SER, V211, P275, DOI 10.3354/meps211275; Riisgard HU, 1996, MAR BIOL, V127, P259, DOI 10.1007/BF00942111; Santos RMB, 2015, SCI TOTAL ENVIRON, V511, P477, DOI 10.1016/j.scitotenv.2014.12.090; Schartum E, 2017, J MOLLUS STUD, V83, P36, DOI 10.1093/mollus/eyw037; Silverman H, 1997, CAN J ZOOL, V75, P1857, DOI 10.1139/z97-815; Silverman H, 1995, BIOL BULL-US, V189, P308, DOI 10.2307/1542148; Silverman H, 1996, BIOL BULL, V191, P42, DOI 10.2307/1543060; Skinner A, CONSERVING NATURA 20, V2; Sweeting RA, 2008, FRESHWATER PEARL MUS; Sweeting RA, 2010, FRESHWATER PEARL MUS; Tankersley RA, 1996, INVERTEBR BIOL, V115, P243, DOI 10.2307/3226934; Trump MP, 2010, THESIS; Veniot A, 2003, MAR BIOL, V142, P123, DOI 10.1007/s00227-002-0922-6; Ward JE, 2000, LIMNOL OCEANOGR, V45, P1203; Ward JE, 2004, J EXP MAR BIOL ECOL, V300, P83, DOI 10.1016/j.jembe.2004.03.002; WARD JE, 1993, LIMNOL OCEANOGR, V38, P265, DOI 10.4319/lo.1993.38.2.0265; YEAGER MM, 1994, J N AM BENTHOL SOC, V13, P217, DOI 10.2307/1467240; Yonge C. M., 1947, Philosophical Transactions London, V232B, P443, DOI 10.1098/rstb.1947.0003	72	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193637	10.1371/journal.pone.0193637	http://dx.doi.org/10.1371/journal.pone.0193637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590123	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000428603100026
J	Vagnoni, E; Lewis, J; Tajadura-Jimenez, A; Cardini, F				Vagnoni, Eleonora; Lewis, Jessica; Tajadura-Jimenez, Ana; Cardini, Flavia			Listening to a conversation with aggressive content expands the interpersonal space	PLOS ONE			English	Article							PERIPERSONAL SPACE; PERSONAL-SPACE; TOOL-USE; PERIARCUATE NEURONS; AFFERENT PROPERTIES; MACAQUE MONKEYS; BODY; PERCEPTION; HAND; SELF	The distance individuals maintain between themselves and others can be defined as 'interpersonal space'. This distance can be modulated both by situational factors and individual characteristics. Here we investigated the influence that the interpretation of other people interaction, in which one is not directly involved, may have on a person's interpersonal space. In the current study we measured, for the first time, whether the size of interpersonal space changes after listening to other people conversations with neutral or aggressive content. The results showed that the interpersonal space expands after listening to a conversation with aggressive content relative to a conversation with a neutral content. This finding suggests that participants tend to distance themselves from an aggressive confrontation even if they are not involved in it. These results are in line with the view of the interpersonal space as a safety zone surrounding one's body.	[Vagnoni, Eleonora] Ist Italiano Tecnol, Ctr Human Technol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Lewis, Jessica; Cardini, Flavia] Anglia Ruskin Univ, Dept Psychol, Cambridge, England; [Tajadura-Jimenez, Ana] Univ Carlos III Madrid, Interact Syst DEI Lab, Madrid, Spain; [Tajadura-Jimenez, Ana] UCL, UCLIC, London, England	Istituto Italiano di Tecnologia - IIT; University of Genoa; Anglia Ruskin University; Universidad Carlos III de Madrid; University of London; University College London	Cardini, F (corresponding author), Anglia Ruskin Univ, Dept Psychol, Cambridge, England.	flavia.cardini@anglia.ac.uk	Tajadura-Jimenez, Ana/O-2906-2019; Tajadura-Jimenez, Ana/B-2355-2015	Tajadura-Jimenez, Ana/0000-0003-3166-3512; Tajadura-Jimenez, Ana/0000-0003-3166-3512; Vagnoni, Eleonora/0000-0003-3773-4342; Cardini, Flavia/0000-0003-4301-611X	Ministerio de Economia, lndustria y Competitividad of Spain [RYC-2014-15421, PSI2016-79004-R]	Ministerio de Economia, lndustria y Competitividad of Spain	ATJ was supported by RYC-2014-15421 and PSI2016-79004-R ("MAGIC SHOES: Changing sedentary lifestyles by altering mental body representation using sensory feedback"; AEI/FEDER, UE), Ministerio de Economia, lndustria y Competitividad of Spain.	Aiello J. R., 1987, HDB ENV PSYCHOL, V1, P505; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brozzoli C, 2013, CURR BIOL, V23, P1764, DOI 10.1016/j.cub.2013.07.004; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Candini M, 2017, AUTISM RES, V10, P144, DOI 10.1002/aur.1637; Canzoneri E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02844; Canzoneri E, 2013, EXP BRAIN RES, V228, P25, DOI 10.1007/s00221-013-3532-2; Canzoneri E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044306; Cardini F, 2013, J EXP PSYCHOL HUMAN, V39, P630, DOI 10.1037/a0031049; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; Churchman A., 2002, HDB ENV PSYCHOL, P1; de Haan AM, 2016, EXP BRAIN RES, V234, P1875, DOI 10.1007/s00221-016-4571-2; de Vignemont F, 2015, NEUROPSYCHOLOGIA, V70, P327, DOI 10.1016/j.neuropsychologia.2014.11.018; Deus Valentina, 2006, Psychiatr Danub, V18, P150; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; EVANS GW, 1973, PSYCHOL BULL, V80, P334, DOI 10.1037/h0034946; Ferri F, 2015, NEUROPSYCHOLOGIA, V70, P468, DOI 10.1016/j.neuropsychologia.2015.03.001; Galli G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00639; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; Gessaroli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074959; GIFFORD R, 1993, CAN J BEHAV SCI, V25, P165, DOI 10.1037/h0078784; Graydon MM, 2012, COGNITION EMOTION, V26, P1301, DOI 10.1080/02699931.2012.667391; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Hunley SB, 2017, EXP PSYCHOL, V64, P49, DOI 10.1027/1618-3169/a000350; HYVARINEN J, 1974, BRAIN, V97, P673, DOI 10.1093/brain/97.1.673; Iachini T, 2015, ACTA PSYCHOL, V161, P131, DOI 10.1016/j.actpsy.2015.09.003; Iacoboni M, 2006, NEUROPSYCHOLOGIA, V44, P2691, DOI 10.1016/j.neuropsychologia.2006.04.029; Iriki A, 1996, NEUROREPORT, V7, P2325; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Kennedy DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103369; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Larsson P., 2005, THESIS; Larsson P, 2010, HUM-COMPUT INT-SPRIN, P143, DOI 10.1007/978-1-84882-733-2_8; Lieberz KA, 2017, AGGRESSIVE BEHAV, V43, P460, DOI 10.1002/ab.21704; Lloyd DM, 2008, NEUROPSYCHOLOGIA, V46, P95, DOI 10.1016/j.neuropsychologia.2007.08.007; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lourenco SF, 2011, COGNITION, V119, P448, DOI 10.1016/j.cognition.2011.02.009; Maister L, 2015, NEUROPSYCHOLOGIA, V70, P455, DOI 10.1016/j.neuropsychologia.2014.10.027; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; Noel JP, 2017, SCHIZOPHR RES, V179, P8, DOI 10.1016/j.schres.2016.09.021; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Parsons S, 2004, J AUTISM DEV DISORD, V34, P449, DOI 10.1023/B:JADD.0000037421.98517.8d; Patane I, 2017, COGNITION, V166, P13, DOI 10.1016/j.cognition.2017.04.013; Patane I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154247; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Ruggiero G., 2016, PSYCHOL RES-PSYCH FO, P1; Salomon R, 2017, COGNITION, V166, P174, DOI 10.1016/j.cognition.2017.05.028; Sambo CF, 2012, J NEUROSCI, V32, P12921, DOI 10.1523/JNEUROSCI.0607-12.2012; Sambo CF, 2012, J NEUROPHYSIOL, V107, P880, DOI 10.1152/jn.00731.2011; Sambo CF, 2013, J NEUROSCI, V33, P14225, DOI 10.1523/JNEUROSCI.0706-13.2013; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Serino A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18603; Serino A, 2011, J COGNITIVE NEUROSCI, V23, P2956, DOI 10.1162/jocn_a_00006; SOMMER R, 1959, SOCIOMETRY, V22, P247, DOI 10.2307/2785668; Taffou M, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00122; Tajadura-Jimenez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026083; Tajadura-Jimenez A, 2010, EMOTION, V10, P216, DOI 10.1037/a0018422; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Uzzell D, 2006, BRIT J SOC PSYCHOL, V45, P579, DOI 10.1348/014466605X58384; Vagnoni E, 2012, CURR BIOL, V22, pR826, DOI 10.1016/j.cub.2012.07.053	78	17	17	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192753	10.1371/journal.pone.0192753	http://dx.doi.org/10.1371/journal.pone.0192753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590110	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100010
J	Gonzales, PK; Roberts, CM; Fonte, V; Jacobsen, C; Stein, GH; Link, CD				Gonzales, Patrick K.; Roberts, Christine M.; Fonte, Virginia; Jacobsen, Connor; Stein, Gretchen H.; Link, Christopher D.			Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21	PLOS ONE			English	Article							DOWN-SYNDROME; BRAIN TRANSCRIPTOME; GENE-EXPRESSION; DOSAGE; CORTEX; MAPS; TAU	Trisomy of chromosome 21, the genetic cause of Down syndrome, has the potential to alter expression of genes on chromosome 21, as well as other locations throughout the genome. These transcriptome changes are likely to underlie the Down syndrome clinical phenotypes. We have employed RNA-seq to undertake an in-depth analysis of transcriptome changes resulting from trisomy of chromosome 21, using induced pluripotent stem cells (iPSCs) derived from a single individual with Down syndrome. These cells were originally derived by Li et al, who genetically targeted chromosome 21 in trisomic iPSCs, allowing selection of disomic sibling iPSC clones. Analyses were conducted on trisomic/disomic cell pairs maintained as iPSCs or differentiated into cortical neuronal cultures. In addition to characterization of gene expression levels, we have also investigated patterns of RNA adenosine-toinosine editing, alternative splicing, and repetitive element expression, aspects of the transcriptome that have not been significantly characterized in the context of Down syndrome. We identified significant changes in transcript accumulation associated with chromosome 21 trisomy, as well as changes in alternative splicing and repetitive element transcripts. Unexpectedly, the trisomic iPSCs we characterized expressed higher levels of neuronal transcripts than control disomic iPSCs, and readily differentiated into cortical neurons, in contrast to another reported study. Comparison of our transcriptome data with similar studies of trisomic iPSCs suggests that trisomy of chromosome 21 may not intrinsically limit neuronal differentiation, but instead may interfere with the maintenance of pluripotency.	[Gonzales, Patrick K.; Roberts, Christine M.; Fonte, Virginia; Stein, Gretchen H.; Link, Christopher D.] Univ Colorado, Linda Crnic Inst Syndrome, Aurora, CO 80045 USA; [Gonzales, Patrick K.; Roberts, Christine M.; Fonte, Virginia; Jacobsen, Connor; Link, Christopher D.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Stein, Gretchen H.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Link, CD (corresponding author), Univ Colorado, Linda Crnic Inst Syndrome, Aurora, CO 80045 USA.; Link, CD (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	linkc@colorado.edu		Link, Christopher D./0000-0003-2271-7697	Linda Crnic Institute for Down Syndrome	Linda Crnic Institute for Down Syndrome	This studywas funded by the Linda Crnic Institute for Down Syndrome http://www.ucdenver.edu/academics/colleges/medicalschool/institutes/lindacmic/Pages/lindacrnic.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M, 2013, NATURE, V501, P380, DOI 10.1038/nature12530; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Antonarakis SE, 2001, BRAIN RES REV, V36, P265, DOI 10.1016/S0165-0173(01)00103-5; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Costa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018493; Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Do Long H, 2015, F1000Res, V4, P269, DOI 10.12688/f1000research.6735.1; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Gardiner K, 2010, J NEUROSCI, V30, P14943, DOI 10.1523/JNEUROSCI.3728-10.2010; Gaspard N, 2009, CELL CYCLE, V8, P2491, DOI 10.4161/cc.8.16.9276; Guedj F, 2015, AM J MED GENET A, V167, P1993, DOI 10.1002/ajmg.a.37156; Hartley SW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw501; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lalioti MD, 1996, GENOMICS, V33, P298, DOI 10.1006/geno.1996.0196; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Ling KH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-624; Liu CH, 2011, DEV NEUROSCI-BASEL, V33, P404, DOI 10.1159/000329422; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mittaz L, 1997, GENOMICS, V41, P210, DOI 10.1006/geno.1997.4655; Olmos-Serrano JL, 2016, NEURON, V89, P1208, DOI 10.1016/j.neuron.2016.01.042; Potier MC, 2006, J NEUROCHEM, V97, P104, DOI 10.1111/j.1471-4159.2005.03624.x; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Roberts I, 2014, BRIT J HAEMATOL, V167, P587, DOI 10.1111/bjh.13096; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shi Y, 2012, NAT NEUROSCI, V15, pS1, DOI DOI 10.1038/NN.3041.; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sullivan KD, 2016, ELIFE, V5, DOI 10.7554/eLife.16220; Toiber D, 2010, NEUROBIOL DIS, V40, P348, DOI 10.1016/j.nbd.2010.06.011; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Zhang F, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1451-5	41	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194581	10.1371/journal.pone.0194581	http://dx.doi.org/10.1371/journal.pone.0194581			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584757	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000027
J	Morita, Y; Ito, H; Torii, M; Hanai, A; Furu, M; Hashimoto, M; Tanaka, M; Azukizawa, M; Arai, H; Mimori, T; Matsuda, S				Morita, Yugo; Ito, Hiromu; Torii, Mie; Hanai, Akiko; Furu, Moritoshi; Hashimoto, Motomu; Tanaka, Masao; Azukizawa, Masayuki; Arai, Hidenori; Mimori, Tsuneyo; Matsuda, Shuichi			Factors affecting walking ability in female patients with rheumatoid arthritis	PLOS ONE			English	Article							MINIMAL DISEASE-ACTIVITY; KNEE OSTEOARTHRITIS; PARKINSONS-DISEASE; JOINT DESTRUCTION; ACTIVITY SCORE; GAIT ANALYSIS; HEALTH; EPIDEMIOLOGY; METHOTREXATE; SATISFACTION	Objective To determine the factors associated with gait parameters in female patients with rheumatoid arthritis (RA). Methods The gait analysis was performed in a large cohort of RA patients, and three basic gait parameters (step length, cadence and gait speed) were calculated. Clinical and laboratory data were also collected. Factors associated with gait parameters were analyzed using multivariable linear regression in the three models with forced entry. Then, we divided those patients with Health Assessment Questionnaire disability index (HAQ) scores <= 0.5 into two groups according to their gait speed that were compared to identify the characteristics of patients with a good HAQ score but poor walking ability. Results A total of 318 female patients were analyzed. Knee extension strength had the strongest positive association with all three gait parameters (P < 0.0001), while methotrexate use was also positively associated with all three gait parameters (step length: P < 0.05, cadence: P < 0.05 in model 1 and 2; P < 0.01 in model 3, gait speed: P < 0.01). The disease activity score was negatively associated with step length and gait speed (step length, gait speed: P < 0.01 in model 1 and 2; P < 0.05 in model 3). 26% of patients with good HAQ scores showed slow gait speed. Patients with good HAQ scores and slow gait speed had higher disease activity scores (P < 0.05) and lower knee extension strength (P < 0.0001) than those with good HAQ scores and normal gait speed. Conclusions High knee extension strength, low disease activity and administration of methotrexate were strongly associated with good walking ability in female patients with RA. And, even if patients showed good HAQ scores, about quarter of those patients had poor walking ability, and they showed higher disease activity, lower knee extension strength, compared to the patients with normal gait speed.	[Morita, Yugo; Ito, Hiromu; Furu, Moritoshi; Azukizawa, Masayuki; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Torii, Mie; Hanai, Akiko] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Furu, Moritoshi; Hashimoto, Motomu; Tanaka, Masao] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan; [Arai, Hidenori] Natl Ctr Geriatr & Gerontol, Obu, Japan; [Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; National Center for Geriatrics & Gerontology; Kyoto University	Ito, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan.	hiromu@kuhp.kyoto-u.ac.jp	Arai, Hidenori/P-9816-2017	Arai, Hidenori/0000-0002-9000-6849; , Hiroyuki/0000-0001-7339-9030; Ito, Hiromu/0000-0002-1827-382X	Mitsubishi-Tanabe; Chugai; UCB Japan; city government (Nagahama city); Bristol-Myers; Astellas; Eli Lily; Ayumi	Mitsubishi-Tanabe(Mitsubishi Tanabe Pharma Corporation); Chugai; UCB Japan; city government (Nagahama city); Bristol-Myers(Bristol-Myers Squibb); Astellas(Astellas Pharmaceuticals); Eli Lily; Ayumi	M.H. and M.T. belong to a department that is financially supported by 4 pharmaceutical companies (Mitsubishi-Tanabe, Chugai, Ayumi, and UCB Japan) and a city government (Nagahama city). H.I. has received a research grant and/or speaker fee from Bristol-Myers, Astellas, and Eli Lily. Y.M., M.T., A.H., M.F., M.A., H.A., T.M., and S.M. declared no conflicts of interest. The sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication, and this commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The funder provided support in the form of salaries for authors (H.I., M.H. and M.T.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Amano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159172; Carmona L, 2002, RHEUMATOLOGY, V41, P88, DOI 10.1093/rheumatology/41.1.88; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Daniilidis K, 2017, ARCH ORTHOP TRAUM SU, V137, P499, DOI 10.1007/s00402-017-2652-8; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Furu M, 2016, J ORTHOP SCI, V21, P38, DOI 10.1016/j.jos.2015.10.002; Gabriel SE, 1999, ARTHRITIS RHEUM-US, V42, P415, DOI 10.1002/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z; Gaujoux-Viala C, 2012, JOINT BONE SPINE, V79, P149, DOI 10.1016/j.jbspin.2011.04.008; Ha Misook, 2017, J Phys Ther Sci, V29, P662, DOI 10.1589/jpts.29.662; Hamamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136611; Hatanaka N, 2016, EUR NEUROL, V75, P282, DOI 10.1159/000445111; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Ishikawa M, 2016, MOD RHEUMATOL, V26, P696, DOI 10.3109/14397595.2015.1128871; Iwata T, 2016, OSTEOPOROSIS INT, V27, P691, DOI 10.1007/s00198-015-3256-1; Juhl C, 2014, ARTHRITIS RHEUMATOL, V66, P622, DOI 10.1002/art.38290; Katoh M, 2009, J PHYS THER SCI, V21, P37, DOI 10.1589/jpts.21.37; KREMER JM, 1992, ARTHRITIS RHEUM, V35, P138, DOI 10.1002/art.1780350203; McMeeken J, 1999, Physiother Res Int, V4, P55; Miyata Ryuji, 2017, J Phys Ther Sci, V29, P874, DOI 10.1589/jpts.29.874; Ohira M, 2017, J DIABETES INVESTIG; Pietrapertosa D, 2009, RHEUMATOLOGY, V48, P1242, DOI 10.1093/rheumatology/kep217; PINCUS T, 1983, ARTHRITIS RHEUM-US, V26, P1346, DOI 10.1002/art.1780261107; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rubbert-Roth A, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2666; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; Sugihara T, 2015, RHEUMATOLOGY, V54, P798, DOI 10.1093/rheumatology/keu395; Turner DE, 2008, CLIN BIOMECH, V23, P93, DOI 10.1016/j.clinbiomech.2007.08.009; Uhlig T, 2008, ANN RHEUM DIS, V67, P1710, DOI 10.1136/ard.2007.084673; Wallaert B, 2013, CHEST, V144, P1652, DOI 10.1378/chest.13-0806; Weiss RJ, 2008, GAIT POSTURE, V28, P229, DOI 10.1016/j.gaitpost.2007.12.001; Wells GA, 2005, J RHEUMATOL, V32, P2016; Welsing PMJ, 2001, ARTHRITIS RHEUM, V44, P2009, DOI 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L; Wenham CYJ, 2013, RHEUMATOLOGY, V52, P888, DOI 10.1093/rheumatology/kes386; Yamada M, 2012, RHEUMATOL INT, V32, P3869, DOI 10.1007/s00296-011-2283-2; Yoneyama M, 2016, J MECH MED BIOL, V16, DOI 10.1142/S0219519416500299; Yoneyama M, 2014, IEEE T NEUR SYS REH, V22, P613, DOI 10.1109/TNSRE.2013.2260561	39	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195059	10.1371/journal.pone.0195059	http://dx.doi.org/10.1371/journal.pone.0195059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584787	gold, Green Submitted, Green Published			2022-12-27	WOS:000428373000059
J	Uttl, B; Whiten, CA; Cnudde, K; Grant, LM				Uttl, Bob; Whiten, Carmelo A.; Cnudde, Kelsey; Grant, Laura M.			Prospective memory, retrospective memory, and individual differences in cognitive abilities, personality, and psychopathology	PLOS ONE			English	Article							PERFORMANCE; IMPAIRMENT; AGE; ANXIETY; ADULTS; SCALE; TASKS; MIND	Although individual differences in processing speed, working memory, intelligence, and other cognitive functions were found to explain individual differences in retrospective memory (RetM), much less is known about their relationship with prospective memory (ProM). Moreover, the studies that investigated the relationship between ProM and cognitive functions arrived to contradictory conclusions. The relationship between ProM, personality, and psychopathology is similarly unsettled. Meta-analytic reviews of the relationships of ProM with aging and personality suggest that the contradictory findings may be due to widespread methodological problems plaguing ProM research including the prevalent use of inefficient, unreliable binary measures; widespread ceiling effects; failure to distinguish between various ProM subdomains (e.g., episodic ProM versus vigilance/monitoring); various confounds; and, importantly, small sample sizes, resulting in insufficient statistical power. Accordingly, in a large scale study with nearly 1,200 participants, we investigated the relationship between episodic event-cued ProM, episodic RetM, and fundamental cognitive functions including intelligence, personality, and psychopathology, using reliable continuous measures of episodic event-cued ProM. Our findings show that (a) continuous measures of episodic event-cued ProM were much more reliable than binary measures, (b) episodic event-cued ProM was associated with measures of processing speed, working memory, crystallized and fluid intelligence, as well as RetM, and that such associations were similar for ProM and RetM, (c) personality factors did not improve prediction of neither ProM nor RetM beyond the variance predicted by cognitive ability, (d) symptoms of psychopathology did not improve the prediction of ProM although they slightly improved the prediction of RetM, and (e) participants' sex was not associated with ProM but showed small correlations with RetM. In addition to advancing our theoretical understanding of ProM, our findings highlight the need to avoid common pitfalls plaguing ProM research.	[Uttl, Bob; Whiten, Carmelo A.; Cnudde, Kelsey; Grant, Laura M.] Mt Royal Univ, Psychol Dept, Calgary, AB, Canada; [Whiten, Carmelo A.] Univ British Columbia Okanagan, Dept Psychol, Kelowna, BC, Canada	Mount Royal University; University of British Columbia; University of British Columbia Okanagan	Uttl, B (corresponding author), Mt Royal Univ, Psychol Dept, Calgary, AB, Canada.	uttlbob@gmail.com			Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research was funded by the Discovery Grant to Bob Uttl from Natural Science and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Natural Science and Engineering Research Council of Canada Discovery Grant to Bob Uttl. We thank Amy L. Siegenthaler for careful reading and comments on the manuscript.	Alfaraj AMAI, 2009, J REPROD INFANT PSYC, V27, P54, DOI 10.1080/02646830701759678; Altgassen M, 2014, J EXP CHILD PSYCHOL, V127, P163, DOI 10.1016/j.jecp.2014.03.009; Arnold NR, 2015, MEMORY, V23, P1215, DOI 10.1080/09658211.2014.969276; Brandimonte MA, 1995, PROSPECTIVE MEMORY T; Brinthaupt TM, 2009, J PERS ASSESS, V91, P82, DOI 10.1080/00223890802484498; Brown JM, 1999, SELF REGULATION QUES; Cuttler C, 2008, J ANXIETY DISORD, V22, P642, DOI 10.1016/j.janxdis.2007.06.003; Cuttler C, 2007, SCAND J PSYCHOL, V48, P215, DOI 10.1111/j.1467-9450.2007.00570.x; Cuttler C, 2007, J ANXIETY DISORD, V21, P338, DOI 10.1016/j.janxdis.2006.06.001; Cuttler C, 2009, CLIN PSYCHOL REV, V29, P393, DOI 10.1016/j.cpr.2009.04.003; Cuttler C, 2009, J ANXIETY DISORD, V23, P813, DOI 10.1016/j.janxdis.2009.03.006; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90; Ford RM, 2012, J EXP CHILD PSYCHOL, V111, P468, DOI 10.1016/j.jecp.2011.10.006; Glass GV, 2008, STAT METHODS ED PSYC; Goldberg LR., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Graf P, 2002, LIFESPAN DEVELOPMENT OF HUMAN MEMORY, P257; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Graf P, 2012, CAN PSYCHOL, V53, P7, DOI 10.1037/a0026516; Harris LM, 2003, AUST J PSYCHOL, V55, P51, DOI 10.1080/00049530412331312874; Hertzog C, 2000, APPL COGNITIVE PSYCH, V14, P257, DOI 10.1002/(SICI)1099-0720(200005/06)14:3<257::AID-ACP651>3.0.CO;2-O; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Klix F, 1986, HUMAN MEMORY COGNITI; Livner A, 2008, J CLIN EXP NEUROPSYC, V30, P272, DOI 10.1080/13803390701380591; Maylor EA, 1998, AGING NEUROPSYCHOL C, V5, P107, DOI 10.1076/anec.5.2.107.599; MAYLOR EA, 1993, PSYCHOL AGING, V8, P420, DOI 10.1037/0882-7974.8.3.420; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McCarthy-Jones S, 2011, CONSCIOUS COGN, V20, P1586, DOI 10.1016/j.concog.2011.08.005; McDaniel MarkA., 2007, PROSPECTIVE MEMORY O, DOI [DOI 10.4135/9781452225913, 10.4135/9781452225913]; Raven J.C., 1958, GUIDE USING MILL HIL; Seo S, 2006, REV COMP METHODS DET; Shipley WC, 1940, J PSYCHOL, V9, P371, DOI 10.1080/00223980.1940.9917704; Strauss E, 2006, COMPENDIUM NEUROPSYC, P776; Tam JW, 2013, J CLIN EXP NEUROPSYC, V35, P279, DOI 10.1080/13803395.2013.770823; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Uttl B, 2006, AGING NEUROPSYCHOL C, V13, P141, DOI 10.1080/138255890969618; Uttl B, 2005, DYNAMIC COGNITIVE PROCESSES, P273, DOI 10.1007/4-431-27431-6_12; Uttl B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083443; Uttl B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00130; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; Uttl B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016618; Uttl B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001568; Wang Y, 2008, SCHIZOPHR RES, V105, P114, DOI 10.1016/j.schres.2008.07.002; Wechsler D, 2008, WAIS 4 WECHSLER ADUL; Wechsler D., 1981, WECHLER ADULT INTELL; [No title captured]	46	7	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193806	10.1371/journal.pone.0193806	http://dx.doi.org/10.1371/journal.pone.0193806			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584735	Green Published, gold, Green Submitted			2022-12-27	WOS:000428373000009
J	Zhang, SL; Han, Y				Zhang, Shuangling; Han, Yue			Preparation, characterisation and antioxidant activities of rutin-loaded zein-sodium caseinate nanoparticles	PLOS ONE			English	Article							COLLOIDAL PARTICLES; ENCAPSULATION; DELIVERY; ACID; DISPERSION; STABILITY; EMULSIONS; CURCUMIN; RELEASE; COMPLEX	Novel rutin-loaded zein-sodium caseinate nanoparticles (ZP) with antioxidant activity in aqueous medium were investigated. The results showed that the sodium caseinate concentrations, dosages of rutin and ethanol volume fractions significantly affected the zein nano particles' characteristics. Concerning the antioxidant properties, the highest values of rutin loaded ZP obtained using 2, 2-dipheny1-1-picrylhydrazyl scavenging and 2 and 2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) decolourisation assays were 52.7% and 71.2%, respectively, and the total antioxidant capacity was 0.40 nmol g(-1). The results suggest that zein-sodium caseinate nanoparticles can be used as a new nano carrier system for rutin or other water insoluble active ingredients.	[Zhang, Shuangling; Han, Yue] Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Shandong, Peoples R China	Qingdao Agricultural University	Zhang, SL (corresponding author), Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Shandong, Peoples R China.	zhshuanaalicia@hotmail.com		Zhang, Shuangling/0000-0001-5077-9532	Shandong Provincial Natural Science Foundation, China [ZR201709240233]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	Funded by Shandong Provincial Natural Science Foundation, China (ZR201709240233).	Chang C, 2017, INT J BIOL MACROMOL, V104, P117, DOI 10.1016/j.ijbiomac.2017.05.178; Chang C, 2017, FOOD HYDROCOLLOID, V70, P143, DOI 10.1016/j.foodhyd.2017.03.033; Chen FP, 2015, J AGR FOOD CHEM, V63, P3559, DOI 10.1021/acs.jafc.5b00448; Chen HQ, 2015, FOOD HYDROCOLLOID, V43, P593, DOI 10.1016/j.foodhyd.2014.07.018; Donsi F, 2017, FOOD HYDROCOLLOID, V63, P508, DOI 10.1016/j.foodhyd.2016.09.039; Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036; Garcia-Mateos R, 2013, NAT PROD RES, V27, P834, DOI 10.1080/14786419.2012.704370; Gorji Ghorbani, 2014, INT J BIOL MACROMOL, V151, P506; Guo M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/24/245101; Hu DD, 2012, J FOOD ENG, V109, P545, DOI 10.1016/j.jfoodeng.2011.10.025; Kandula S, 2014, J AM OIL CHEM SOC, V91, P1967, DOI 10.1007/s11746-014-2529-8; Kumari VS, 2012, POLYM BULL, V68, P1387, DOI 10.1007/s00289-011-0645-2; Lai LF, 2011, INT J PHARMACEUT, V404, P317, DOI 10.1016/j.ijpharm.2010.11.025; Li KK, 2014, J FOOD ENG, V127, P103, DOI 10.1016/j.jfoodeng.2013.12.001; Li KK, 2013, J FOOD ENG, V119, P343, DOI 10.1016/j.jfoodeng.2013.05.038; Lin Y, 2016, LWT-FOOD SCI TECHNOL, V72, P510, DOI 10.1016/j.lwt.2016.05.020; Liu F, 2013, J AGR FOOD CHEM, V61, P8888, DOI 10.1021/jf401859y; Luo YC, 2012, J AGR FOOD CHEM, V60, P836, DOI 10.1021/jf204194z; Mendes A. C., 2016, FOOD HYDROCOLLOIDS, V44, P10; Muthuselvi L, 2006, COLLOID SURFACE B, V51, P39, DOI 10.1016/j.colsurfb.2006.05.012; Natarajan V, 2011, J PHARM SCI-US, V100, P195, DOI 10.1002/jps.22266; Patel AR, 2012, FOOD CHEM, V133, P423, DOI 10.1016/j.foodchem.2012.01.054; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Surh J, 2005, J AGR FOOD CHEM, V53, P4236, DOI 10.1021/jf047944i; Teng Z, 2012, J AGR FOOD CHEM, V60, P2712, DOI 10.1021/jf205238x; Valentao P, 2002, J AGR FOOD CHEM, V50, P4989, DOI 10.1021/jf020225o; Wang L, 2016, J MICROENCAPSUL, V33, P43, DOI 10.3109/02652048.2015.1114042; Wu YP, 2012, LWT-FOOD SCI TECHNOL, V48, P283, DOI 10.1016/j.lwt.2012.03.027; Xiao D, 2011, J AGR FOOD CHEM, V59, P7393, DOI 10.1021/jf200774v; Zhang BC, 2011, FOOD CHEM, V124, P210, DOI 10.1016/j.foodchem.2010.06.019; Zhang SL, 2017, CARBOHYD POLYM, V169, P385, DOI 10.1016/j.carbpol.2017.04.044; Zhang YD, 2013, TRIBOL INT, V58, P7, DOI 10.1016/j.triboint.2012.09.004; Zhong QX, 2009, FOOD HYDROCOLLOID, V23, P2380, DOI 10.1016/j.foodhyd.2009.06.015	35	38	40	8	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194951	10.1371/journal.pone.0194951	http://dx.doi.org/10.1371/journal.pone.0194951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579133	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800069
J	Guan, Y; He, JM				Guan, Yuan; He, Jiamei			The effect of state self-control on the intertemporal decisions made by individuals with high and low trait self-control	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; NEUROVISCERAL INTEGRATION; EGO DEPLETION; DELAY; PREFERENCE; STRENGTH; CHOICE; MODEL; VALUATION; REWARDS	The present study aimed to explore how state self-control influences the intertemporal decisions made by individuals with high and low trait self-control. State self-control, represented by the degree of depletion, was manipulated by conducting Stroop tasks with different levels of difficulty, and the intertemporal decision task was used as a self-control task. Compared with participants with high trait self-control, the preferences of participants with low trait self-control for immediate rewards were more vulnerable to the difficulty of depletion tasks. Throughout the experimental stages, the heart rate variability (HRV) of participants with high trait self-control was significantly higher than that of participants with low trait self-control, indicating that individuals with high trait self-control may have stronger and more stable self-control abilities.	[Guan, Yuan; He, Jiamei] Liaoning Normal Univ, Dept Psychol, Dalian, Peoples R China; [Guan, Yuan; He, Jiamei] Collaborat Innovat Ctr Hlth Personal Assessment &, Dalian, Peoples R China	Liaoning Normal University	He, JM (corresponding author), Liaoning Normal Univ, Dept Psychol, Dalian, Peoples R China.; He, JM (corresponding author), Collaborat Innovat Ctr Hlth Personal Assessment &, Dalian, Peoples R China.	jiamei998@126.com			Department of Education of Liaoning Province of China [W201783656, L2013416]; School of Psychology, Liaoning Normal University	Department of Education of Liaoning Province of China; School of Psychology, Liaoning Normal University	This study was supported by the Department of Education of Liaoning Province of China (W201783656, L2013416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge support from the School of Psychology, Liaoning Normal University, and Cooperative Innovation Center of Healthy Personality Evaluation and Cultivation of Children and Adolescents in Liaoning Province for providing laboratory and data recoding equipment.	Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Aranovich GJ, 2016, NEUROIMAGE, V124, P733, DOI 10.1016/j.neuroimage.2015.09.027; Banich MT, 2013, PSYCHOL ADDICT BEHAV, V27, P416, DOI 10.1037/a0031991; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Blackburn M, 2012, COGNITION EMOTION, V26, P1459, DOI 10.1080/02699931.2012.673478; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Cherniawsky AS, 2013, COGN AFFECT BEHAV NE, V13, P36, DOI 10.3758/s13415-012-0122-x; Cooper N, 2013, J NEUROSCI, V33, P13150, DOI 10.1523/JNEUROSCI.0400-13.2013; Crescioni AW, 2011, J HEALTH PSYCHOL, V16, P750, DOI 10.1177/1359105310390247; [窦凯 Dou Kai], 2014, [心理学报, Acta Psychologica Sinica], V46, P1564; Dou ZN, 2017, ADV PSYCHOL SCI, V25, P860; Duan N., 2014, THESIS; Duschek S, 2009, BIOL PSYCHOL, V81, P110, DOI 10.1016/j.biopsycho.2009.03.003; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frazier TW, 2004, PSYCHOPHYSIOLOGY, V41, P75, DOI 10.1046/j.1469-8986.2003.00131.x; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Hansen AL, 2009, ANXIETY STRESS COPIN, V22, P77, DOI 10.1080/10615800802272251; Hare TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00050; [何贵兵 He Guibing], 2015, [心理科学, Journal of Psychological Science], V38, P1445; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Inzlicht M, 2014, TRENDS COGN SCI, V18, P127, DOI 10.1016/j.tics.2013.12.009; Karthikeyan P, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500383; Koffarnus MN, 2013, J EXP ANAL BEHAV, V99, P32, DOI 10.1002/jeab.2; Kotabe HP, 2015, PERSPECT PSYCHOL SCI, V10, P618, DOI 10.1177/1745691615593382; Krypotos AM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00278; Lerner JS, 2015, ANNU REV PSYCHOL, V66, P799, DOI 10.1146/annurev-psych-010213-115043; Li JB, 2013, INT J PSYCHOL, V48, P1303, DOI 10.1080/00207594.2012.762778; [黎建斌 Li Jianbin], 2013, [心理科学进展, Advances in Psychological Science], V21, P235; [梁竹苑 Liang Zhuyuan], 2011, [心理科学进展, Advances in Psychological Science], V19, P959; [刘雷 Liu Lei], 2014, [心理科学进展, Advances in Psychological Science], V22, P1047; Liu L, 2012, BEHAV BRAIN RES, V231, P40, DOI 10.1016/j.bbr.2012.02.045; Liu L, 2012, BRAIN RES, V1436, P92, DOI 10.1016/j.brainres.2011.12.018; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; Luo S, 2009, J NEUROSCI, V29, P14820, DOI 10.1523/JNEUROSCI.4261-09.2009; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Myrseth KOR, 2009, CURR DIR PSYCHOL SCI, V18, P247, DOI 10.1111/j.1467-8721.2009.01645.x; Ohira H, 2013, J NEUROIMMUNOL, V260, P28, DOI 10.1016/j.jneuroim.2013.04.011; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Pu J, 2010, BIOL PSYCHOL, V84, P531, DOI 10.1016/j.biopsycho.2009.07.006; [任天虹 Ren Tianhong], 2015, [心理科学进展, Advances in Psychological Science], V23, P303; Scherbaum S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00514; Schmidt B, 2017, PSYCHOPHYSIOLOGY, V54, P409, DOI 10.1111/psyp.12796; Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Suo T., 2012, THESIS; [谭树华 Tan Shuhua], 2012, [心理科学进展, Advances in Psychological Science], V20, P715; [谭树华 TAN Shuhua], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P468; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P723, DOI 10.1007/978-0-387-09488-5_47; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; van den Bos W, 2014, J NEUROSCI, V34, P10298, DOI 10.1523/JNEUROSCI.4105-13.2014; van den Bos W, 2013, J EXP ANAL BEHAV, V99, P58, DOI 10.1002/jeab.6; Volokhov RN, 2010, BRAIN COGNITION, V73, P1, DOI 10.1016/j.bandc.2009.10.015; Wagner DD, 2013, PSYCHOL SCI, V24, P2262, DOI 10.1177/0956797613492985; Wang XT, 2010, PSYCHOL SCI, V21, P183, DOI 10.1177/0956797609358096; Xin Y, 2015, THESIS; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; [于斌 Yu Bin], 2013, [心理科学进展, Advances in Psychological Science], V21, P1272; [袁冬华 Yuan Donghua], 2012, [心理科学, Journal of Psychological Science], V35, P608; Zahn D, 2016, BIOL PSYCHOL, V115, P9, DOI 10.1016/j.biopsycho.2015.12.007	63	5	5	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195333	10.1371/journal.pone.0195333	http://dx.doi.org/10.1371/journal.pone.0195333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614106	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600050
J	Honda, F; Hiramatsu, A; Hyogo, H; Aikata, H; Daijo, K; Teraoka, Y; Inagaki, Y; Morio, K; Kobayashi, T; Nakahara, T; Nagaoki, Y; Kawaoka, T; Yoneda, M; Tsuge, M; Imamura, M; Kawakami, Y; Ochi, H; Chayama, K				Honda, Fumi; Hiramatsu, Akira; Hyogo, Hideyuki; Aikata, Hiroshi; Daijo, Kana; Teraoka, Yuji; Inagaki, Yuki; Morio, Kei; Kobayashi, Tomoki; Nakahara, Takashi; Nagaoki, Yuko; Kawaoka, Tomokazu; Yoneda, Masayasu; Tsuge, Masataka; Imamura, Michio; Kawakami, Yoshiiku; Ochi, Hidenori; Chayama, Kazuaki			Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring	PLOS ONE			English	Article							HEPATIC CIRRHOSIS; HEMOGLOBIN; INSULIN; HYPERINSULINISM; DEGRADATION; RISK	Background and aims The feature of blood glucose dynamics in patients with chronic liver disease (CLD) is marked blood glucose fluctuations. However, the detail of blood glucose dynamics is not well known. The aim of the present study was to evaluate glycemic fluctuations by continuous glucose monitoring (CGM). Materials and methods A total of 105 CLD patients with type 2 diabetes mellitus (T2DM) were enrolled in this study. Various parameters of glycemic variability were evaluated. The association of these parameters with liver functional reserve was examined. The parameters were also evaluated according to glycated hemoglobin A1c (HbA1c) levels. Results and discussion Data of all patients showed that mean blood glucose (MBG) levels and the difference between highest and lowest blood glucose (Delta BG) increased significantly with worsening of liver functional reserve (P < 0.001 and P = 0.005, respectively). Although many of the cases were being treated for diabetes, postprandial hyperglycemia was seen in 92% of patients. Nocturnal hypoglycemia was seen in 22% of patients. In non-anemic patients with HbA1c levels of < 7.0%, the percentage of patients with mean amplitude of glycemic excursion (MAGE) of >= 77.4 mg/dL and that of MBG levels of > 145 mg/dL were higher in liver cirrhosis (LC) patients than in chronic hepatitis (CH) patients. In them, homeostasis model assessment for insulin resistance (HOMA-IR) of > 2.5 and LC were significantly associated with the increase in MAGE. LC was also significantly associated with increased MBG levels. Conclusion The CGM systems were useful in finding hidden abnormalities of blood glucose fluctuations in CLD patients with T2DM, especially in non-anemic CLD patients with HbA1c levels of <7.0%.	[Honda, Fumi; Hiramatsu, Akira; Aikata, Hiroshi; Daijo, Kana; Teraoka, Yuji; Inagaki, Yuki; Morio, Kei; Kobayashi, Tomoki; Nakahara, Takashi; Nagaoki, Yuko; Kawaoka, Tomokazu; Tsuge, Masataka; Imamura, Michio; Kawakami, Yoshiiku; Ochi, Hidenori; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan; [Hyogo, Hideyuki] JA Hiroshima Gen Hosp, Dept Gastroenterol & Hepatol, Hiroshima, Japan; [Yoneda, Masayasu] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Hiroshima, Japan	Hiroshima University; Hiroshima University	Hiramatsu, A (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan.	akirah@hiroshima-u.ac.jp	Tsuge, Masataka/G-5246-2019; chayama, Kazuaki/G-2917-2019; Nakahara, Takashi/H-2320-2019; Hiramatsu, Akira/G-9594-2019	Tsuge, Masataka/0000-0001-7591-8287; Chayama, Kazuaki/0000-0002-5530-5341				BALKAU B, 1991, J CLIN EPIDEMIOL, V44, P465, DOI 10.1016/0895-4356(91)90209-R; Bando Yukihiro, 1997, Journal of the Japan Diabetes Society, V40, P17; BIANCHI G, 1994, HEPATOLOGY, V20, P119, DOI 10.1016/0270-9139(94)90143-0; BOSCH J, 1984, AM J PHYSIOL, V247, pG206, DOI 10.1152/ajpgi.1984.247.3.G206; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; Chen T, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-38; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; Del Prato S, 2002, INT J OBESITY, V26, pS9, DOI 10.1038/sj.ijo.0802172; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; IWASAKI Y, 1978, J CLIN ENDOCR METAB, V47, P774, DOI 10.1210/jcem-47-4-774; JOHNSTON DG, 1977, LANCET, V1, P10; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Koga M, 2008, DIABETES RES CLIN PR, V81, P258, DOI 10.1016/j.diabres.2008.04.012; Koga M, 2010, ENDOCR J, V57, P751, DOI 10.1507/endocrj.K10E-138; Marling Cynthia R, 2011, J Diabetes Sci Technol, V5, P871; NOMURA Y, 1989, DIABETES RES CLIN EX, V11, P177; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; OWEN OE, 1983, J CLIN INVEST, V72, P1821, DOI 10.1172/JCI111142; PETRIDES AS, 1994, DIABETES REV, V2, P2; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; TRENTI T, 1990, RES CLIN LAB, V20, P261; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	24	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195028	10.1371/journal.pone.0195028	http://dx.doi.org/10.1371/journal.pone.0195028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614124	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600025
J	Picard-Jean, F; Brand, C; Tremblay-Letourneau, M; Allaire, A; Beaudoin, MC; Boudreault, S; Duval, C; Rainville-Sirois, J; Robert, F; Pelletier, J; Geiss, BJ; Bisaillon, M				Picard-Jean, Frederic; Brand, Carolin; Tremblay-Letourneau, Maude; Allaire, Andrea; Beaudoin, Maxime C.; Boudreault, Simon; Duval, Cyntia; Rainville-Sirois, Julien; Robert, Francis; Pelletier, Jerry; Geiss, Brian J.; Bisaillon, Martin			2 '-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; QUALITY-CONTROL MECHANISM; RIG-I; EXORIBONUCLEASE ACTIVITY; IDENTIFICATION; RECOGNITION; ENCODES; SELF	The 5' RNA cap structure ((m7)GpppRNA) is a key feature of eukaryotic mRNAs with important roles in stability, splicing, polyadenylation, mRNA export, and translation. Higher eukaryotes can further modify this minimal cap structure with the addition of a methyl group on the ribose 2'-O position of the first transcribed nucleotide ((m7)GpppN(m)pRNA) and sometimes on the adjoining nucleotide ((m7)GpppN(m)pN(m)pRNA). In higher eukaryotes, the DXO protein was previously shown to be responsible for both decapping and degradation of RNA transcripts harboring aberrant 5' ends such as pRNA, pppRNA, GpppRNA, and surprisingly, (m7)GpppRNA. It was proposed that the interaction of the cap binding complex with the methylated cap would prevent degradation of (m7)GpppRNAs by DXO. However, the critical role of the 2'-O-methylation found in higher eukaryotic cap structures was not previously addressed. In the present study, we demonstrate that DXO possesses both decapping and exoribonuclease activities toward incompletely capped RNAs, only sparing RNAs with a 2'O-methylated cap structure. Fluorescence spectroscopy assays also revealed that the presence of the 2'-O-methylation on the cap structure drastically reduces the affinity of DXO for RNA. Moreover, immunofluorescence and structure-function assays also revealed that a nuclear localisation signal is located in the amino-terminus region of DXO. Overall, these results are consistent with a quality control mechanism in which DXO degrades incompletely capped RNAs.	[Picard-Jean, Frederic; Brand, Carolin; Tremblay-Letourneau, Maude; Allaire, Andrea; Beaudoin, Maxime C.; Boudreault, Simon; Duval, Cyntia; Rainville-Sirois, Julien; Bisaillon, Martin] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ, Canada; [Robert, Francis; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Sherbrooke; McGill University; Colorado State University	Bisaillon, M (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ, Canada.	Martin.Bisaillon@USherbrooke.ca	Geiss, Brian/J-3021-2017; Duval, Cyntia/AAF-7468-2021	Geiss, Brian/0000-0001-8180-5772; 	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) (MB). M.B. is a Chercheur-boursier Senior from the Fonds de recherche du Quebec-Sante (FRQ-S). C.B. holds a graduate training award from the Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke. A.A. holds a graduate training award from the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JH, 2012, NAT STRUCT MOL BIOL, V19, P1011, DOI 10.1038/nsmb.2381; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P1904, DOI 10.1073/pnas.72.5.1904; Grudzien-Nogalska E., 2017, WILEY INTERDISCIP RE, V8; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Jiao XF, 2009, J NEUROSCI, V29, P12419, DOI 10.1523/JNEUROSCI.5954-08.2009; Jiao XF, 2006, MOL CELL, V24, P713, DOI 10.1016/j.molcel.2006.10.013; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Khanna R, 2004, EMBO J, V23, P1968, DOI 10.1038/sj.emboj.7600213; Nagarajan VK, 2013, BBA-GENE REGUL MECH, V1829, P590, DOI 10.1016/j.bbagrm.2013.03.005; Picard-Jean F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054621; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zheng DH, 2011, RNA, V17, P1619, DOI 10.1261/rna.2789611; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	23	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0193804	10.1371/journal.pone.0193804	http://dx.doi.org/10.1371/journal.pone.0193804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601584	Green Submitted, Green Published, gold			2022-12-27	WOS:000428845900002
J	Sanna, C; Scognamiglio, M; Fiorentino, A; Corona, A; Graziani, V; Caredda, A; Cortis, P; Montisci, M; Ceresola, ER; Canducci, F; Poli, F; Tramontano, E; Esposito, F				Sanna, Cinzia; Scognamiglio, Monica; Fiorentino, Antonio; Corona, Angela; Graziani, Vittoria; Caredda, Alessia; Cortis, Pierluigi; Montisci, Mariofilippo; Ceresola, Elisa Rita; Canducci, Filippo; Poli, Ferruccio; Tramontano, Enzo; Esposito, Francesca			Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication	PLOS ONE			English	Article							RIBONUCLEASE-H ACTIVITY; LA MADDALENA ARCHIPELAGO; DIKETO ACID-DERIVATIVES; REVERSE-TRANSCRIPTASE; RNASE-H; NATURAL-PRODUCTS; CHEMICAL-COMPOSITION; INTEGRASE INHIBITOR; BIOLOGICAL-ACTIVITY; ACTIVE-SITE	In a search for new potential multitarget anti-HIV compounds from natural products, we have identified in Hypericum scruglii, an endemic and exclusive species of Sardinia (Italy), a potent plant lead. The phytochemical study of the hydroalcoholic extract obtained from its leaves led to the isolation of its most abundant secondary metabolites, belonging to different chemical classes. In particular, three phloroglucinols derivatives were identified, confirming their significance as chemotaxonomic markers of the Hypericum genus. Among them, the 3-(13-hydroxygeranyl)-1-(2'-methylbutanoyl) phloroglucinol was reported here for the first time. All six isolated compounds have been evaluated firstly for the inhibition of both Human Immunodeficiency Virus type 1 (HIV-1) Reverse Transcriptase (RT)-associated DNA Polymerase (RDDP) and Ribonuclease H (RNase H) activities, for the inhibition of HIV-1 integrase (IN) in biochemical assays, and also for their effect on viral replication. Among the isolated metabolites, three phloroglucinol derivatives and quercitrin were effective on both RT-associated RDDP and RNase H activities in biochemical assays. The same active compounds affected also HIV-1 IN strand transfer function, suggesting the involvement of the RNase H active site. Furthermore, phloroglucinols compounds, included the newly identified compound, were able to inhibit the HIV-1 replication in cell based assays.	[Sanna, Cinzia; Corona, Angela; Caredda, Alessia; Cortis, Pierluigi; Montisci, Mariofilippo; Tramontano, Enzo; Esposito, Francesca] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Scognamiglio, Monica] Max Planck Inst Chem Ecol, Beutenberg Campus, Jena, Germany; [Fiorentino, Antonio; Graziani, Vittoria] Univ Campania, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Ceresola, Elisa Rita; Canducci, Filippo] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Canducci, Filippo] Osped San Raffaele, IRCCS, Microbiol Lab, Milan, Italy; [Poli, Ferruccio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy	University of Cagliari; Max Planck Society; Universita della Campania Vanvitelli; University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Bologna	Sanna, C (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	cinziasanna@unica.it	Corona, Angela/G-7327-2014; Scognamiglio, Monica/U-1116-2017; Graziani, Vittoria/AAO-2436-2020; Fiorentino, Antonio/W-3531-2018; Tramontano, Enzo/B-4919-2012	Corona, Angela/0000-0002-6630-8636; Graziani, Vittoria/0000-0002-8391-2763; Fiorentino, Antonio/0000-0002-9439-7074; SANNA, CINZIA/0000-0001-9797-2460; Scognamiglio, Monica/0000-0001-9614-0929; Tramontano, Enzo/0000-0002-4849-0980				Alcaro S, 2010, CURR MED CHEM, V17, P290, DOI 10.2174/092986710790192695; Appendino G, 2005, J NAT PROD, V68, P853, DOI 10.1021/np050120q; Artan M, 2008, BIOORGAN MED CHEM, V16, P7921, DOI 10.1016/j.bmc.2008.07.078; ARTS EJ, 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPERSPECT.A007161; Bacchetta G, 2010, NORD J BOT, V28, P469, DOI 10.1111/j.1756-1051.2009.00736.x; Bicchi C, 2009, PLANTA MED, V75, P1331, DOI 10.1055/s-0029-1185546; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Brolis M, 1998, J CHROMATOGR A, V825, P9, DOI 10.1016/S0021-9673(98)00697-9; Cagno V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172322; Cakir A, 2005, BIOCHEM SYST ECOL, V33, P245, DOI 10.1016/j.bse.2004.08.006; Camas N, 2014, PLANT SYST EVOL, V300, P953, DOI 10.1007/s00606-013-0934-3; Canducci F, 2011, J INFECT DIS, V204, P1811, DOI 10.1093/infdis/jir636; Canducci F, 2010, J ANTIMICROB CHEMOTH, V65, P425, DOI 10.1093/jac/dkp477; Cangelosi B, 2015, PHYTOCHEMISTRY, V115, P216, DOI 10.1016/j.phytochem.2015.02.008; Carcelli M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00440; Chauthe SK, 2010, BIOORGAN MED CHEM, V18, P2029, DOI 10.1016/j.bmc.2010.01.023; Chimenti F, 2006, J NAT PROD, V69, P945, DOI 10.1021/np060015w; Cirak C, 2006, BIOCHEM SYST ECOL, V34, P1, DOI 10.1016/j.bse.2005.06.004; Cirak C, 2016, S AFR J BOT, V104, P82, DOI 10.1016/j.sajb.2015.09.022; Cirak C, 2010, NAT PROD COMMUN, V5, P897; Cirak C, 2006, BIOCHEM SYST ECOL, V34, P897, DOI 10.1016/j.bse.2006.08.002; Cirak C, 2013, PHARM BIOL, V51, P391, DOI 10.3109/13880209.2012.733012; Conforti F, 2007, NAT PROD RES, V21, P42, DOI 10.1080/14786410500356243; Corona A, 2016, PLOS ONE, P11; Corona A, 2017, PATHOG DIS, P75; Corona A, 2016, ANTIVIR RES, V134, P236, DOI 10.1016/j.antiviral.2016.09.008; Corona A, 2014, ANTIMICROB AGENTS CH, V58, P6101, DOI 10.1128/AAC.03605-14; Corona A, 2014, FUTURE VIROL, V9, P445, DOI 10.2217/fvl.14.24; Corona A, 2014, ANTIMICROB AGENTS CH, V58, P4086, DOI 10.1128/AAC.00056-14; Corona A, 2013, FUTURE MED CHEM, V5, P2127, DOI 10.4155/fmc.13.178; Cos P, 2008, PLANTA MED, V74, P1323, DOI 10.1055/s-2008-1081314; Costi R, 2013, J MED CHEM, V56, P8588, DOI 10.1021/jm401040b; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; Crockett SL, 2008, PHYTOCHEM LETT, V1, P37, DOI 10.1016/j.phytol.2007.12.003; Crucitti GC, 2015, J MED CHEM, V58, P1915, DOI 10.1021/jm501799k; Distinto S, 2013, CURR PHARM DESIGN, V19, P1850, DOI 10.2174/1381612811319100009; Esposito F, 2016, PHYTOMEDICINE, V23, P1383, DOI 10.1016/j.phymed.2016.08.001; Esposito F, 2015, CHEMBIOCHEM, V16, P2507, DOI 10.1002/cbic.201500385; Esposito Francesca, 2014, Antiviral Chemistry & Chemotherapy, V23, P129, DOI 10.3851/IMP2690; Esposito F, 2013, PATHOG DIS, V68, P116, DOI 10.1111/2049-632X.12051; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; FESEN MR, 1993, P NATL ACAD SCI USA, V90, P2399, DOI 10.1073/pnas.90.6.2399; Fiebich BL, 2011, FITOTERAPIA, V82, P474, DOI 10.1016/j.fitote.2010.12.006; Fobofou SAT, 2015, BIOORGAN MED CHEM, V23, P6327, DOI 10.1016/j.bmc.2015.08.028; Gambari R, 2006, ADV PHYTOMED, V2, P299; Gibbons S, 2005, PHYTOCHEMISTRY, V66, P1472, DOI 10.1016/j.phytochem.2005.04.024; Guo ZR, 2017, ACTA PHARM SIN B, V7, P119, DOI 10.1016/j.apsb.2016.06.003; Gupta P, 2010, BIOORG MED CHEM LETT, V20, P4427, DOI 10.1016/j.bmcl.2010.06.057; Hicks C, 2009, CLIN INFECT DIS, V48, P931, DOI 10.1086/597290; Hillwig ML, 2008, J AGR FOOD CHEM, V56, P4359, DOI 10.1021/jf800411v; Hosseinzadeh H, 2005, J ETHNOPHARMACOL, V98, P207, DOI 10.1016/j.jep.2004.12.007; Jurgenliemk G, 2002, PLANTA MED, V68, P88, DOI 10.1055/s-2002-20053; Kawasuji T, 2013, J MED CHEM, V56, P1124, DOI 10.1021/jm301550c; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kharlamova T, 2009, MED CHEM, V5, P398, DOI 10.2174/157340609789117840; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Mandrone M, 2017, FITOTERAPIA, V120, P184, DOI 10.1016/j.fitote.2017.06.020; Mandrone M, 2015, IND CROP PROD, V76, P402, DOI 10.1016/j.indcrop.2015.07.012; Martini R, 2017, CHEMBIOCHEM, V18, P374, DOI 10.1002/cbic.201600592; Maxia A, 2015, IND CROP PROD, V65, P472, DOI 10.1016/j.indcrop.2014.10.039; Meleddu R, 2017, J ENZYM INHIB MED CH, V32, P264, DOI 10.1080/14756366.2016.1247061; Meleddu R, 2014, CHEMMEDCHEM, V9, P1869, DOI 10.1002/cmdc.201402015; Menendez-Arias L, 2013, ANTIVIR RES, V98, P93, DOI 10.1016/j.antiviral.2013.01.007; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; NAKANE H, 1991, FEBS LETT, V286, P83, DOI 10.1016/0014-5793(91)80946-Z; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; ONO K, 1990, EUR J BIOCHEM, V190, P469, DOI 10.1111/j.1432-1033.1990.tb15597.x; Ornano L, 2016, NAT PROD RES, V30, P1802, DOI 10.1080/14786419.2015.1079190; Ornano L, 2016, NAT PROD RES, V30, P920, DOI 10.1080/14786419.2015.1079189; Ornano L, 2015, J OLEO SCI, V64, P19, DOI 10.5650/jos.ess14171; Ozkan EE, 2018, S AFR J BOT, V114, P104, DOI 10.1016/j.sajb.2017.10.022; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Patridge E, 2016, DRUG DISCOV TODAY, V21, P204, DOI 10.1016/j.drudis.2015.01.009; Peruzzi L, 2014, PHYTOTAXA, V168, P1; Porzel A, 2014, METABOLOMICS, V10, P574, DOI 10.1007/s11306-013-0609-7; Salim A. A., 2008, P1, DOI 10.1007/978-3-540-74603-4_1; Sanchez-Mateo CC, 2002, J ETHNOPHARMACOL, V79, P119, DOI 10.1016/S0378-8741(01)00393-2; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; SCHATZ O, 1990, ADV AP BIOT, V7, P293; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Schneider A, 2016, NUCLEIC ACIDS RES, V44, P2310, DOI 10.1093/nar/gkw060; Shah S, 2013, NAT PROD RES, V27, P1502, DOI 10.1080/14786419.2012.724409; Shiu WKP, 2006, PHYTOCHEMISTRY, V67, P2568, DOI 10.1016/j.phytochem.2006.09.037; Smelcerovic A, 2008, BIOCHEM SYST ECOL, V36, P316, DOI 10.1016/j.bse.2007.09.002; sposito F, 2017, PATHOG DIS, P75; Stella-Ascariz N, 2017, J INFECT DIS, V216, pS847, DOI 10.1093/infdis/jix430; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tanaka T., 2011, Journal of Experimental and Clinical Medicine, V3, P27, DOI 10.1016/j.jecm.2010.12.005; Tiberi M, 2014, ANTIMICROB AGENTS CH, V58, P3043, DOI 10.1128/AAC.02739-13; Tintori C, 2015, BIOORG MED CHEM LETT, V25, P3013, DOI 10.1016/j.bmcl.2015.05.011; Tramontano E, 2005, ANTIVIR RES, V65, P117, DOI 10.1016/j.antiviral.2004.11.002; Tramontano E, 2006, MINI-REV MED CHEM, V6, P727, DOI 10.2174/138955706777435733; UNAIDS, 2017, GLOB HIV STAT JUL 20, P18; Vandegraaff N, 2001, ANTIMICROB AGENTS CH, V45, P2510, DOI 10.1128/AAC.45.9.2510-2516.2001; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Venditti A, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700072; Venditti A, 2016, NAT PROD RES, V30, P789, DOI 10.1080/14786419.2015.1067619; Vernekar SKV, 2017, J MED CHEM, V60, P5045, DOI 10.1021/acs.jmedchem.7b00440; Wang X, 2017, CURR MED CHEM, V24, P1; Xu LJ, 2015, J MICROBIOL, V53, P288, DOI 10.1007/s12275-015-4652-0; Yu DL, 2007, MED RES REV, V27, P108, DOI 10.1002/med.20075; Zhan P, 2016, J MED CHEM, V59, P2849, DOI 10.1021/acs.jmedchem.5b00497; Zorzetto C, 2015, FITOTERAPIA, V100, P95, DOI 10.1016/j.fitote.2014.11.013	104	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195168	10.1371/journal.pone.0195168	http://dx.doi.org/10.1371/journal.pone.0195168			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601601	Green Submitted, Green Published, gold			2022-12-27	WOS:000428845900021
J	He, P; Luo, YN; Hu, XY; Gong, R; Wen, X; Zheng, XY				He, Ping; Luo, Yanan; Hu, Xiangyang; Gong, Rui; Wen, Xu; Zheng, Xiaoying			Association of socioeconomic status with hearing loss in Chinese working-aged adults: A population-based study	PLOS ONE			English	Article							RISK-FACTORS; HEALTH RESEARCH; OLDER-ADULTS; IMPAIRMENT; PREVALENCE; EPIDEMIOLOGY; OCCUPATION; EDUCATION; POSITION; EXPOSURE	Hearing loss is the most common sensory impairment, but limited studies focused on the association of socioeconomic status (SES) with hearing loss among adults of working age. This paper aimed to fill this gap among Chinese adults. We obtained data from Ear and Hearing Disorder Survey conducted in four provinces of China in 2014-2015. The survey was based on WHO Ear and Hearing Disorders Survey Protocol and 25,860 adults aged 25 to 59 years were selected in this study. Trained local examiners performed pure tone audiometry to screen people with hearing loss, and those who were screened positively for hearing loss were referred to audiologists to make final diagnosis. SES was measured by occupation, education and income. Results show after adjusting for SES measures and covariates, in urban areas, compared with white-collar workers, blue-collar workers and the unemployed were more likely to have hearing loss, with an odds ratio of 1.2 (95% CI: 1.0, 1.3) and 1.2 (95% CI: 1.0, 1.4), respectively. Compared with people with education of senior high school or above, those with junior high school, primary school and illiteracy had 1.6 (95% CI: 1.4, 1.8), 2.1(95% CI: 1.7, 2.5) and 2.6 (95% CI: 1.9, 3.7) times as likely to have hearing loss, respectively. In rural areas, the unemployed had 1.5 (95% CI: 1.0, 2.3) times the risk of hearing loss compared with white-collar workers, and illiterates had 1.6 (95% CI: 1.6, 2.1) times the risk of hearing loss compared with people with education of senior high school or above, after SES variables and covariates were taken into considerations. Income was not significantly associated with hearing loss in urban and rural areas. In conclusion, SES, in the form of occupation and education, was associated with hearing loss among working-aged population, and further studies are needed to explore the mechanism of such association.	[He, Ping] Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China; [He, Ping; Luo, Yanan; Wen, Xu; Zheng, Xiaoying] Peking Univ, Inst Populat Res, Beijing, Peoples R China; [He, Ping] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hu, Xiangyang; Gong, Rui] China Rehabil Res Ctr Deaf Children, Beijing, Peoples R China; [Zheng, Xiaoying] Peking Univ, APEC Hlth Sci Acad HeSAY, Beijing, Peoples R China	Peking University; Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Peking University	Zheng, XY (corresponding author), Peking Univ, Inst Populat Res, Beijing, Peoples R China.; Zheng, XY (corresponding author), Peking Univ, APEC Hlth Sci Acad HeSAY, Beijing, Peoples R China.	xzheng@pku.edu.cn	Hu, Xiangyang/AAQ-3313-2021					Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Agrawal Y, 2009, OTOL NEUROTOL, V30, P139, DOI 10.1097/MAO.0b013e318192483c; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; [Anonymous], INFECT HEARING IMPAI; Bu X., 2011, AUDIOLOGICAL MED, V9, P141, DOI [10.3109/1651386X.2011.631285, DOI 10.3109/1651386X.2011.631285]; Bu X., 2003, INFORM CONSULTATION; Bu Xingkuan, 2005, J Am Acad Audiol, V16, P687, DOI 10.3766/jaaa.16.9.6; Chen ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132918; Cheng YJ, 2009, PREV MED, V49, P360, DOI 10.1016/j.ypmed.2009.07.021; Chou CF, 2015, AM J PUBLIC HEALTH, V105, P1262, DOI 10.2105/AJPH.2014.302475; Cruickshanks KJ, 2015, JAMA OTOLARYNGOL, V141, P641, DOI 10.1001/jamaoto.2015.0889; Cruickshanks KJ, 2010, HEARING RES, V264, P3, DOI 10.1016/j.heares.2009.10.008; Cubbin C, 2011, AM J PUBLIC HEALTH, V101, P939, DOI 10.2105/AJPH.2010.194175; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Emmett SD, 2015, OTOL NEUROTOL, V36, P545, DOI 10.1097/MAO.0000000000000562; Engdahl B, 2010, SCAND J WORK ENV HEA, V36, P250, DOI 10.5271/sjweh.2887; Feder K, 2015, HEALTH REP, V26, P18; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Guo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117354; Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430; Helvik AS, 2009, AM J PUBLIC HEALTH, V99, P1376, DOI 10.2105/AJPH.2007.133215; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Horner KC, 2003, NEUROSCI BIOBEHAV R, V27, P437, DOI 10.1016/S0149-7634(03)00071-X; Hu X Y, 2016, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V51, P819, DOI 10.3760/cma.j.issn.1673-0860.2016.11.004; Jarvelin MR, 1997, BRIT J AUDIOL, V31, P165, DOI 10.3109/03005364000000019; Lee JS, 2015, J KOREAN MED SCI, V30, P1175, DOI 10.3346/jkms.2015.30.8.1175; Looi LM, 2015, LANCET, V385, P943, DOI 10.1016/S0140-6736(15)60208-2; National Bureau of Statistics of China, 2010, 2010 POP CENS; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Power C, 2008, J EPIDEMIOL COMMUN H, V62, P1030, DOI 10.1136/jech.2007.068817; Stam M, 2013, WORK, V46, P207, DOI 10.3233/WOR-131747; Tak S, 2009, AM J IND MED, V52, P358, DOI 10.1002/ajim.20690; Uehata Tetsunojo, 1991, Journal of Human Ergology, V20, P147; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vyskocil A, 2012, TOXICOL IND HEALTH, V28, P796, DOI 10.1177/0748233711425067; Wang HX, 2014, ALCOHOL CLIN EXP RES, V38, P1035, DOI 10.1111/acer.12321; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; World Health Organization, 1999, WHO EAR HEAR DIS SUR; Zhan WH, 2011, PREV MED, V53, P338, DOI 10.1016/j.ypmed.2011.08.012	40	13	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195227	10.1371/journal.pone.0195227	http://dx.doi.org/10.1371/journal.pone.0195227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596478	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000095
J	Klingberg, K; Gadelhak, K; Jegerlehner, SN; Brown, AD; Exadaktylos, AK; Srivastava, DS				Klingberg, Karsten; Gadelhak, Khaled; Jegerlehner, Sabrina N.; Brown, Adam D.; Exadaktylos, Aristomenis K.; Srivastava, David S.			Bad manners in the Emergency Department: Incivility among doctors	PLOS ONE			English	Article							DISRUPTIVE BEHAVIORS; WORKPLACE INCIVILITY; PHYSICIAN; WORK; COMMUNICATION; MEDICINE; PERFORMANCE; DISTRESS; IMPACT; TEAMS	Introduction Negative workplace behaviour, especially negative communication is a recognised problem in many organisations and is known to have serious impact on workplace performance, productivity and personal wellbeing. Emergency Departments (ED) can be high stress environments in which communication and perceptions of respect between physicians and other staff may underlie individual functioning. We conducted a study to estimate the influence of incivility (ICV) among physicians in the ED. Methods We developed an online survey to assess workplace incivility in the ED. We focussed on frequency, origin, reasons and situations where ICV was reported. To measure the levels and the potential influence of ICV on psychological safety, social stress and personal wellbeing we correlated our questionnaire to standard psychological scales. Statistical analysis included Students t-test, chi squared distribution and Pearson correlation coefficient. Results We invited all seventy-seven ED physicians to participate in our survey. Among those that completed (n = 50, 65%) the survey, 9% of ED physicians reported frequent (1/week) and 38% occasional (1/month) incidents of ICV. 28% of physicians reported experiencing ICV once per quarter and 21% reported a frequency of only once per year, no physician reported ICV on a daily basis. Levels of ICV were significantly higher in interactions with specialists from outside then within the ED (p<0.01). ICV was perceived particularly during critical situations. Our findings showed a significant correlation between internal (within the ED team) ICV and psychological safety. To ED physicians internal ICV was associated with lower levels of psychological safety (p<0.01). ICV displayed from sources outside the ED team was not associated with psychological safety, but we found a significant influence of external ICV on personal irritability and reduced wellbeing (p<0.01). Discussion The incidence of incivility was high among the ED physicians. Although this was a small sample, the association between workplace ICV and psychological safety, personal irritation as well personal comfort suggests that ICV may be an important variable underlying ED team performance. These findings further underscore the need to foster a culture of respect and good communication between departments, as levels of ICV were highest with physicians from outside the ED. Future research would benefit from examining strategies to prevent and reduce ICV and identify reasons for personal variation in perception of ICV. During critical situations and in general collaboration with specialists, awareness of ICV and countermeasures are important to avoid decreased performance and negative impact on staff and patient.	[Klingberg, Karsten; Gadelhak, Khaled; Jegerlehner, Sabrina N.; Exadaktylos, Aristomenis K.; Srivastava, David S.] Bern Univ Hosp, Emergency Dept, Bern, Switzerland; [Klingberg, Karsten] St Vincents Univ Hosp, Emergency Dept, Dublin, Ireland; [Jegerlehner, Sabrina N.] Barts Hlth NHS Trust, Accid & Emergency, London, England; [Brown, Adam D.] Sarah Lawrence Coll, Dept Psychol, New York, NY USA; [Brown, Adam D.] NYU, Sch Med, Dept Psychiat, New York, NY USA	University of Bern; University Hospital of Bern; University College Dublin; Saint Vincent's University Hospital; Barts Health NHS Trust; Sarah Lawrence College; New York University	Srivastava, DS (corresponding author), Bern Univ Hosp, Emergency Dept, Bern, Switzerland.	david.srivastava@insel.ch		Klingberg, Karsten/0000-0002-2502-1428; Srivastava, David/0000-0002-4744-0463				Andersson LM, 1999, ACAD MANAGE REV, V24, P452, DOI 10.2307/259136; Baggs JG, 1999, CRIT CARE MED, V27, P1991, DOI 10.1097/00003246-199909000-00045; Bradley V, 2015, CLIN MED, V15, P541, DOI 10.7861/clinmedicine.15-6-541; Bragard I, 2015, EUR J EMERG MED, V22, P227, DOI 10.1097/MEJ.0000000000000194; Burnes B, 2007, INT J PUBLIC SECT MA, V20, P285, DOI 10.1108/09513550710750011; Cortina L M, 2001, J Occup Health Psychol, V6, P64, DOI 10.1037/1076-8998.6.1.64; Edmondson A, 1999, ADMIN SCI QUART, V44, P350, DOI 10.2307/2666999; Flin R, 2004, QUAL SAF HEALTH CARE, V13, pI80, DOI 10.1136/qshc.2004.009993; Goettler CE, 2011, AM SURGEON, V77, P1600; Hoel H, 2000, DESTRUCTIVE CONFLICT; Hughes KM, 2014, J AM COLL SURGEONS, V219, P545, DOI 10.1016/j.jamcollsurg.2014.03.049; Lepnurm R, 2009, CAN J PSYCHIAT, V54, P170, DOI 10.1177/070674370905400305; Lewis PS, 2011, J NURS ADMIN, V41, P41, DOI 10.1097/NNA.0b013e3182002a4c; Mohr G, 2005, Z ARB ORGAN, V49, P44, DOI 10.1026/0932-4089.49.1.44; Pearson CM, 2005, ACAD MANAGE EXEC, V19, P7, DOI 10.5465/AME.2005.15841946; Pentland A, 2012, HARVARD BUS REV, V90, P61; Porath C., 2016, HARVARD BUS REV, V94, P22; Porath C, 2013, HARVARD BUS REV, V91, P114; Porath CL, 2007, ACAD MANAGE J, V50, P1181, DOI 10.2307/20159919; Quine L, 2003, CAMB Q HEALTHC ETHIC, V12, P91, DOI 10.1017/S0963180103121111; Riskin A, 2015, PEDIATRICS, V136, P487, DOI 10.1542/peds.2015-1385; Roberts NK, 2014, MED TEACH, V36, P621, DOI 10.3109/0142159X.2014.899690; Rosenstein A, 2013, RISK MANAGEMENT, V60, P38; Rosenstein A.H., 2015, J PSYCHOL CLIN PSYCH, V3, P00136, DOI 10.15406/jpcpy.2015.03.00136; Rosenstein AH, 2015, WORLD J CLIN CASES, V3, P930, DOI 10.12998/wjcc.v3.i11.930; Rosenstein AH, 2012, J EMERG MED, V43, P139, DOI 10.1016/j.jemermed.2011.01.019; Rosenstein AH, 2008, JT COMM J QUAL PATIE, V34, P464, DOI 10.1016/S1553-7250(08)34058-6; Spencer R, 2004, ANN EMERG MED, V44, P268, DOI 10.1016/j.annemergmed.2004.04.006; Ummenhofer W, 2001, RESUSCITATION, V49, P39, DOI 10.1016/S0300-9572(00)00304-X; WHITEHEAD DC, 1992, ANN EMERG MED, V21, P1250, DOI 10.1016/S0196-0644(05)81758-5; Zapf D., 1991, PSYCHISCHER STRESS A, P168	31	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194933	10.1371/journal.pone.0194933	http://dx.doi.org/10.1371/journal.pone.0194933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596513	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000052
J	Syczylo, K; Platt-Samoraj, A; Bancerz-Kisiel, A; Szczerba-Turek, A; Pajdak-Czaus, J; Labuc, S; Procajlo, Z; Socha, P; Chuzhebayeva, G; Szweda, W				Syczylo, Kinga; Platt-Samoraj, Aleksandra; Bancerz-Kisiel, Agata; Szczerba-Turek, Anna; Pajdak-Czaus, Joanna; Labuc, Sebastian; Procajlo, Zbigniew; Socha, Piotr; Chuzhebayeva, Gulzhan; Szweda, Wojciech			The prevalence of Yersinia enterocolitica in game animals in Poland	PLOS ONE			English	Article							WILD BOARS; SUS-SCROFA; YSTB GENES; STRAINS; CARCASSES; AIL	Natural reservoirs of Yersinia (Y.) enterocolitica comprise different animal species, but little is known about the role of wild animals in the epidemiology of yersiniosis. The aim of the study was to evaluate the prevalence of Y. enterocolitica among game animals in Poland. The bio-serotypes and the pathogenicity markers of the analyzed isolates were determined. The experimental material comprised rectal swabs from 857 free-living animals hunter-harvested over a period of 2 years (2013-2014) in hunting districts across Poland. The isolates from bacteriological studies were confirmed by PCR and bio-serotyped based on the results of biochemical and agglutination tests. In the group of the 218 analyzed isolates of Y. enterocolitica, 133 were derived from wild boars, 70 from red deer, 11 from roe deer and 4 from fallow deer, and they accounted for 61.0%, 32.1%, 5.1% and 1.8% of all isolates, respectively. Bio-serotyping assays revealed that 91.7% of the examined isolates belonged to biotype 1A (200/218). The remaining 18 isolates belonged to bio-serotypes 1B/NI (3/218, 1.4%), 1B/O: 8 (1/218, 0.5%), 2/NI (6/218, 2.8%), 2/O: 27 (1/218, 0.5%), 2/O: 3 (1/218, 0.5%), 2/O: 9 (2/218, 0.9%), 3/NI (2/218, 0.9%), 4/O: 3 (1/218, 0.5%) and 4/O: 9 (1/218, 0.5%). The ail gene, a suggestive virulence gene for Y. enterocolitica, has been found in 30 isolates from 20 wild boars, in 6 isolates from red deer, and in 1 isolate from roe deer. Our study demonstrated that Y. enterocolitica is frequently isolated from game animals in Poland, which poses a risk of spreading these infectious agents to other animal species and humans.	[Syczylo, Kinga; Platt-Samoraj, Aleksandra; Bancerz-Kisiel, Agata; Szczerba-Turek, Anna; Pajdak-Czaus, Joanna; Labuc, Sebastian; Procajlo, Zbigniew; Szweda, Wojciech] Univ Warmia & Mazury, Dept Epizootiol, Fac Vet Med, Oczapowskiego 13, Olsztyn, Poland; [Socha, Piotr] Univ Warmia & Mazury, Dept Anim Reprod Clin, Fac Vet Med, Oczapowskiego 13, Olsztyn, Poland; [Chuzhebayeva, Gulzhan] Baitursynov Kostanay State Univ, Fac Vet & Livestock Technol, Dept Vet Publ Hlth, Baitursynov 47, Kostanay, Kazakhstan	University of Warmia & Mazury; University of Warmia & Mazury; Baitursynov Kostanay Regional University	Platt-Samoraj, A (corresponding author), Univ Warmia & Mazury, Dept Epizootiol, Fac Vet Med, Oczapowskiego 13, Olsztyn, Poland.	platt@uwm.edu.pl	Szczerba-Turek, Anna/F-8411-2011; Bancerz-Kisiel, Agata/AGN-6782-2022; Pajdak-Czaus, Joanna/R-6662-2018; Szczerba-Turek, Anna/AAY-6237-2020	Szczerba-Turek, Anna/0000-0002-7340-0991; Bancerz-Kisiel, Agata/0000-0003-0514-0363; Pajdak-Czaus, Joanna/0000-0003-2289-2241; Procajlo, Zbigniew/0000-0003-3377-6174; Labuc, Sebastian/0000-0001-9369-4395; Chuzhebayeva, Gulzhagan/0000-0002-0091-8888				Al Dahouk S, 2005, J VET MED B, V52, P444, DOI 10.1111/j.1439-0450.2005.00898.x; [Anonymous], 2005, 10273 PNEN ISO; Arrausi-Subiza M, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0184-9; Avagnina A, 2012, MEAT SCI, V91, P266, DOI 10.1016/j.meatsci.2012.01.025; Bancerz-Kisiel A, 2015, EPIDEMIOL INFECT, V143, P2758, DOI 10.1017/S0950268814003872; Bancerz-Kisiel A, 2014, POL J VET SCI, V17, P315, DOI 10.2478/pjvs-2014-0043; Bancerz-Kisiel A, 2012, POL J VET SCI, V15, P609, DOI 10.2478/v10181-012-0096-1; Bancerz-Kisiel A, 2016, VET J, V208, P102, DOI 10.1016/j.tvjl.2015.08.010; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bucher M, 2008, FOODBORNE PATHOG DIS, V5, P273, DOI 10.1089/fpd.2007.0076; EFSA, 2016, EFSA J, V14, DOI [10.2903/j.efsa.2016.4375, 10.2903/j.efsa.2016.4584]; Fredriksson-Ahomaa M, 2003, CLIN MICROBIOL REV, V16, P220, DOI 10.1128/CMR.16.2.220-229.2003; Fredriksson-Ahomaa M, 2006, FEMS IMMUNOL MED MIC, V47, P315, DOI 10.1111/j.1574-695X.2006.00095.x; Fredriksson-Ahomaa M, 2011, FOODBORNE PATHOG DIS, V8, P733, DOI 10.1089/fpd.2010.0711; Gurtler M, 2005, J FOOD PROTECT, V68, P850; HACKING M A, 1974, Journal of Wildlife Diseases, V10, P452; Harnett N, 1996, EPIDEMIOL INFECT, V117, P59, DOI 10.1017/S0950268800001138; Huovinen E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-122; Jakubczak Antoni, 1993, Medycyna Weterynaryjna, V49, P301; Nikolova S, 2001, J VET MED B, V48, P203, DOI 10.1046/j.1439-0450.2001.00448.x; Platt-Samoraj A, 2006, J VET MED B, V53, P341, DOI 10.1111/j.1439-0450.2006.00969.x; Platt-Samoraj A, 2017, VET J, V221, P11, DOI 10.1016/j.tvjl.2017.01.013; Platt-Samoraj A, 2015, POL J VET SCI, V18, P449, DOI 10.1515/pjvs-2015-0058; Przybylak R., 2016, CLIMATES REGIONAL LO; Ramamurthy T, 1997, MICROB PATHOGENESIS, V23, P189, DOI 10.1006/mpat.1997.0146; Rastawicki W, 2013, EPIDEMIOL INFECT, V141, P2039, DOI 10.1017/S0950268812002786; Riksson-Ahomaa MF, 2009, INT J FOOD MICROBIOL, V135, P199, DOI 10.1016/j.ijfoodmicro.2009.08.019; Sihvonen LM, 2011, FOODBORNE PATHOG DIS, V8, P455, DOI 10.1089/fpd.2010.0747; Stanisz A., 2007, PRZYSTEPNY KURS STAT, V1; Syczylo K, 2016, POL J VET SCI, V19, P221, DOI 10.1515/pjvs-2016-0027; Tennant SM, 2003, FEMS IMMUNOL MED MIC, V38, P127, DOI 10.1016/S0928-8244(03)00180-9; Tirziu E., 2011, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V44, P144; von Altrock A, 2015, APPL ENVIRON MICROB, V81, P4835, DOI 10.1128/AEM.00550-15; Wauters G, 1987, Contrib Microbiol Immunol, V9, P14; Wauters G., 1987, YERSINIA ENTERCOLITI, P41; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730	36	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195136	10.1371/journal.pone.0195136	http://dx.doi.org/10.1371/journal.pone.0195136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596492	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000083
J	Hume, JP; Martill, D; Hing, R				Hume, Julian P.; Martill, David; Hing, Richard			A terrestrial vertebrate palaeontological review of Aldabra Atoll, Aldabra Group, Seychelles	PLOS ONE			English	Review							WESTERN INDIAN-OCEAN; HIPPOSIDERIDAE; PLEISTOCENE; CHIROPTERA; PETROLOGY; EVOLUTION; LIZARDS	The Pleistocene vertebrate assemblage of Aldabra Atoll has been comparatively well studied. Three Upper Pleistocene fossil localities have been described yielding birds, reptiles and terrestrial molluscs. Those of Bassin Cabri and Bassin Lebine on Ile Picard are undated but must be in excess of 136,000 YBP, whereas Point Hodoul on Malabar Island is circa 100,000 YBP. Aldabra was seemingly completely submerged between deposition of the Ile Picard and Point Hodoul deposits, resulting in local faunal extinctions. Here we present the results of an ongoing study of fossil material collected on Ile Picard in 1987, which reveals a more diverse assemblage than previously realised. Notable discoveries are an Ardeola heron, three Procellariformes, tropic-bird Phaethon, gull Larus, rail Dryolimnas, harrier Circus and owl Tyto, plus evidence of recolonisation of the atoll by some seabirds, rail, harrier, owl, giant tortoises and lizards after the Ile Picard/Point Hodoul submergence event.	[Hume, Julian P.] Nat Hist Museum, Dept Life Sci, Bird Grp, Akeman St, Tring, Herts, England; [Martill, David; Hing, Richard] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England	Natural History Museum London; University of Portsmouth	Hume, JP (corresponding author), Nat Hist Museum, Dept Life Sci, Bird Grp, Akeman St, Tring, Herts, England.	j.hume@nhm.ac.uk		Martill, David/0000-0002-3208-5702	Percy Sladen Centenary Fund	Percy Sladen Centenary Fund	JPH received funding for fossil preparation from the Percy Sladen Centenary Fund. https://www.linnean.org/the.society/medals-awards-prizes-grants/percy-sladen memorial fund-grants. The other authors received no specific funding for this work.; We thank Robert Prys-Jones (NHMUK), Anthony Cheke, Steve Goodman and an anonymous reviewer for comments that helped improve this paper. We thank Storrs Olson, Helen James, Jennifer Strotman and Mark Florence (USNM) for the long term loan of the J. Becker Aldabra material. We thank Sandra Chapman and Lorna Steel (NHMUK) for access to material in their care; Harry Taylor (NHMUK) for photography, and Robert Loveridge for some fossil preparation. We especially thank the Percy Sladen Centenary Fund whose financial support made this research possible.	ARNOLD E.N., 1976, B BRIT MUSEUM NATURA, V29, P83; ARNOLD EN, 1979, PHILOS T ROY SOC B, V286, P127, DOI 10.1098/rstb.1979.0022; Batsch G.C., 1788, VERSUCH UNLEITUNG KE; Benda P, 2009, FOLIA ZOOL, V58, P1; BENSON CW, 1971, PHILOS T R SOC B, V260, P417, DOI 10.1098/rstb.1971.0021; BGde, 1799, TABL SOUS CLASS DIV; Billberg GJ, 1828, SYNOPSIS FAUNAE SCAN, V1; BLAISE B, 1990, QUATERNARY RES, V34, P282, DOI 10.1016/0033-5894(90)90041-I; Bloom AL, 1971, LATE CENOZOIC GLACIA, P355; Boddaert P., 1783, TABLE PLANCHEES ENLU; Boie F., 1822, UEBER CLASSICATION I; Bonaparte C. L, 1854, CONSPECTUS GENERUM A, V2; Bonaparte C. -L., 1856, CR HEBD ACAD SCI, V42, P764; Braithwaite C., 1984, BIOGEOGRAPHY ECOLOGY, P17; BRAITHWAITE CJ, 1973, PHILOS T R SOC B, V266, P307, DOI 10.1098/rstb.1973.0051; BRAITHWAITE CJR, 1975, PHILOS T ROY SOC B, V273, P1, DOI 10.1098/rstb.1975.0101; BRAITHWAITE CJR, 1980, PHILOS T ROY SOC B, V288, P511, DOI 10.1098/rstb.1980.0025; Brandt JF, 1840, MEM ACAD IMP SCI ST, V5, P239; Brisson MJ, 1760, ORNITHOLOGIA ORNITHO; Brochu CA, 2006, COPEIA, P149; Camoin GF, 2004, MAR GEOL, V206, P119, DOI 10.1016/j.margeo.2004.02.003; Camp CL, 1923, B AM MUS NAT HIST, V48, P289; Cheke A., 2008, LOST LAND DODO ECOLO; Cheke A.S., 1984, Monographiae Biologicae, V55, P331; Cheke Anthony, 2010, Phelsuma, V18, P38; Cheke Anthony S., 2014, P31; Cope ED., 1868, P ACAD NATURAL SCI, V1868, P242; FARROW GE, 1971, PHILOS T ROY SOC B, V260, P93, DOI 10.1098/rstb.1971.0008; Farrow GE., 1971, PHILOS T R SOC B, V260, P67; Fitzinger L., 1843, SYSTEMA REPTILIUM FA; Fitzinger L.J.F.J., 1826, NEUE CLASSIFICATION, DOI [10.5962/bhl.title.4683, DOI 10.5962/BHL.TITLE.4683]; Fosberg F.R, 1980, FLORA ALDABRA NEIGHB; FOSBERG FR, 1971, PHILOS T ROY SOC B, V260, P215, DOI 10.1098/rstb.1971.0011; Fuarbringer M., 1888, UNTERSUCHUNGEN MORPH, V15; Gerlach J., 2006, TERRESTRIAL FRESHWAT; Gerlach J, 2006, J NAT HIST, V40, P2403, DOI 10.1080/00222930601058290; Goodman SM, 2008, ZOOSYSTEMA, V30, P681; Gray J. E., 1831, ANIMAL KINGDOM ARRAN, P1, DOI [10.5962/bhl.title.45021, DOI 10.5962/BHL.TITLE.45021]; Gray J. E., 1825, ANN PHILOS, V10, P193; Gray JE., 1827, PHILOS MAG, V2, P54, DOI [10.1080/14786442708675620, DOI 10.1080/14786442708675620]; Gunther A., 1867, Annals & Magazine of Natural History, Vxx, P45; Gunther A.C.L.G, 1879, ANN MAG NAT HIST, V3, P164, DOI [10.1080/00222937908682495, DOI 10.1080/00222937908682495]; HARRISON CJO, 1978, J NAT HIST, V12, P7, DOI 10.1080/00222937800770021a; HNATIUK RJ, 1979, PHILOS T ROY SOC B, V286, P25, DOI 10.1098/rstb.1979.0013; Hume J.P., 2017, EXTINCT BIRDS; Hutson A.M., 2004, Phelsuma, V12, P126; Huxley Thomas H., 1867, Proceedings of the Zoological Society, P415; Leach W. E., 1820, SYNOPSIS CONTENTS BR, P65; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Loveridge A., 1957, B MUS COMP ZOOL HARV, V115, P161; MACNAE W, 1971, PHILOS T ROY SOC B, V260, P237, DOI 10.1098/rstb.1971.0013; Mathews GM, 1912, BIRDS AUSTR 2, V2; Olson SL, 2006, J HERPETOL, V40, P394, DOI 10.1670/0022-1511(2006)40[394:GCOEAS]2.0.CO;2; Oppel M., 1811, ORDNUNGEN FAMILIEN U; Plummer P.S., 1995, ALDABRA WORLD HERITA, P49; Rafinesque C. S., 1815, ANAL NATURE TABLEAU, DOI 10.5962/bhl.title.106607; Ridgway R, 1914, B US NATL MUS, V50, P1; Rocha Sara, 2009, Herpetological Bulletin, P20; Safford R, 2013, BIRDS OF AFRICA, VVIII; Scheyer TM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171800; Sharpe R. B, 1893, B BRIT ORNITHOLOGIST, V5, P26; Stoddart D.R., 1983, Nature and Resources, V19, P20; STODDART D. R., 1967, ATOLL RES BULL, V118/119, P11; STODDART DR, 1979, PHILOS T ROY SOC B, V286, P11, DOI 10.1098/rstb.1979.0012; STODDART DR, 1971, PHILOS T ROY SOC B, V260, P31, DOI 10.1098/rstb.1971.0006; Stoddart DR, 1984, BIOGEOGRAPHY ECOLOGY, P220; SUNDEVALL CJ, 1836, KUNGLIGA SVENSKA VET, V1836, P43; Swinhoe R., 1867, IBIS               2, V3, P226; Swinhoe R., 1867, IBIS, V385-413, P52; TAYLOR JD, 1979, PHILOS T ROY SOC B, V286, P47, DOI 10.1098/rstb.1979.0015; THOMSON J, 1972, NATURE, V240, P145, DOI 10.1038/240145a0; Titus TA, 1996, MOL PHYLOGENET EVOL, V6, P49, DOI 10.1006/mpev.1996.0057; Trudgill ST, 1981, ATOLL RES B, V255, P11; Vieillot LJP, 1816, NOUVEAU DICT HIST NA, V5; Wagler JG, 1830, BEITRAGE VERLEICHHEN; Walsh R.P.D., 1984, BIOGEOGRAPHY ECOLOGY, P39; [No title captured]	77	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192675	10.1371/journal.pone.0192675	http://dx.doi.org/10.1371/journal.pone.0192675			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590117	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100007
J	Jaffey, JA; Backus, RC; McDaniel, KM; DeClue, AE				Jaffey, Jared A.; Backus, Robert C.; McDaniel, Kaylyn M.; DeClue, Amy E.			Serum vitamin D concentrations in hospitalized critically ill dogs	PLOS ONE			English	Article							D DEFICIENCY; PULMONARY TUBERCULOSIS; INCREASED MORTALITY; SURGICAL-PATIENTS; SEVERE SEPSIS; D LEVEL; MACROPHAGES; OUTCOMES; CARE; EXPRESSION	Hypovitaminosis D has been extensively documented in critically ill humans. However, whether or not critically ill dogs have alterations in vitamin D concentrations remains unconfirmed. The primary aims of our study were to compare serum 25-hydroxycholecalciferol [25 (OH)D] concentrations in critically ill dogs with healthy control dogs, determine the prognostic utility of serum 25(OH)D concentration as a biomarker in critically ill dogs, and to assess if serum 25(OH)D concentrations in critically ill dogs are associated with length of stay in the intensive care unit or illness severity. Serum concentrations of 25(OH)D together with a range of other clinical, biochemical, and hematological parameters, were measured in 99 dogs within 24 hours of admission to the Intensive Care Unit (ICU). Critically ill dogs (P = 0.001) and dogs with sepsis (P = 0.002) had significantly lower serum 25(OH)D concentrations compared to healthy control dogs. In addition, serum 25(OH)D concentration was an independent predictor of in-hospital and 30 day survival. Using a cut-off of 33 ng/mL, serum 25(OH)D concentrations had excellent sensitivity (0.94; 95% CI, 0.71-1.00), but poor specificity (0.41; 95% CI, 0.31-0.53) for detection of survival. Serum 25(OH)D concentrations were inversely associated with acute patient physiologic and laboratory evaluation (APPLE) fast score but were not associated with ICU length of stay. Hospitalized dogs with critical illness have decreased serum 25(OH)D concentrations compared to healthy dogs and can be used to predict survival in this cohort.	[Jaffey, Jared A.; Backus, Robert C.; McDaniel, Kaylyn M.; DeClue, Amy E.] Univ Missouri, Dept Vet Med & Surg, Vet Hlth Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Jaffey, JA (corresponding author), Univ Missouri, Dept Vet Med & Surg, Vet Hlth Ctr, Columbia, MO 65211 USA.	jaffeyj@missouri.edu		Jaffey, Jared/0000-0002-0270-4728				Alizadeh N, 2015, J RES PHARM PRACT, V4, P193, DOI 10.4103/2279-042X.167051; Altieri B, 2017, REV ENDOCR METAB DIS, V18, P335, DOI 10.1007/s11154-016-9405-9; Amrein K, 2014, CRIT CARE, V18, DOI 10.1186/cc13790; Anwar E, 2017, NUTR CLIN PRACT, V32, P378, DOI 10.1177/0884533616671741; Arnson Y, 2012, QJM-INT J MED, V105, P633, DOI 10.1093/qjmed/hcs014; Atalan HK, 2017, TURK J ANAESTHESIOL, V45, P193, DOI 10.5152/TJAR.2017.60234; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Barnett N, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-5; Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Carnevale V, 2001, OSTEOPOROSIS INT, V12, P1026, DOI 10.1007/s001980170012; Chandra G, 2004, J CLIN IMMUNOL, V24, P249, DOI 10.1023/B:JOCI.0000025446.44146.52; Czarnik T, 2018, J CRIT CARE, V43, P294, DOI 10.1016/j.jcrc.2017.09.179; de Haan K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0660-4; De Pascale G, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.015; DeClue AE, 2011, J VET INTERN MED, V25, P453, DOI 10.1111/j.1939-1676.2011.0713.x; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Dickerson RN, 2016, BURNS TRAUMA, V4, DOI 10.1186/s41038-016-0054-8; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Grubczak K, 2015, INT ARCH ALLERGY IMM, V166, P170, DOI 10.1159/000380882; Guan J, 2016, J NEUROSURG; Harishankar M, 2014, INT IMMUNOPHARMACOL, V23, P148, DOI 10.1016/j.intimp.2014.08.021; Hayes G, 2010, J VET INTERN MED, V24, P1034, DOI 10.1111/j.1939-1676.2010.0552.x; Higgins DM, 2012, JPEN-PARENTER ENTER, V36, P713, DOI 10.1177/0148607112444449; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Jaffey J, 2017, J VET INTERN MED, V31, P775; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Klenk J, 2013, AGE AGEING, V42, P404, DOI 10.1093/ageing/aft042; Krishnan A, 2010, CRIT CARE, V14, DOI 10.1186/cc9341; Leaf DE, 2014, AM J RESP CRIT CARE, V190, P533, DOI 10.1164/rccm.201405-0988OC; Leary PF, 2017, J AM OSTEOPATH ASSOC, V117, P433, DOI 10.7556/jaoa.2017.089; Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Madden K, 2015, ANN AM THORAC SOC, V12, P1654, DOI 10.1513/AnnalsATS.201503-160OC; Matthews LR, 2012, AM J SURG, V204, P37, DOI 10.1016/j.amjsurg.2011.07.021; Moromizato T, 2014, CRIT CARE MED, V42, P97, DOI 10.1097/CCM.0b013e31829eb7af; Motlagh BM, 2015, IRAN J BASIC MED SCI, V18, P672; Neve A, 2014, CLIN EXP MED, V14, P275, DOI 10.1007/s10238-013-0249-2; Nye CJ, 2017, J VET EMERG CRIT CAR, V27, P66, DOI 10.1111/vec.12557; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Putzu A, 2017, J CRIT CARE, V38, P109, DOI 10.1016/j.jcrc.2016.10.029; Quraishi SA, 2014, CRIT CARE MED, V42, P1365, DOI 10.1097/CCM.0000000000000210; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Szymczak I, 2016, SCAND J IMMUNOL, V83, P83, DOI 10.1111/sji.12403; Tokuda N, 1996, P SOC EXP BIOL MED, V211, P244, DOI 10.3181/00379727-211-43967; Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585; Villaggio B, 2012, CLIN EXP RHEUMATOL, V30, P934; Vipul P, 2017, INDIAN J CRIT CARE M, V21, P199, DOI 10.4103/ijccm.IJCCM_192_16; Walsh JS, 2017, CURR OPIN ENDOCRINOL, V24, P389, DOI 10.1097/MED.0000000000000371; Young LR, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.23	53	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194062	10.1371/journal.pone.0194062	http://dx.doi.org/10.1371/journal.pone.0194062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590167	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100047
J	Kovacs, G; Sipeki, N; Suga, B; Tornai, T; Fechner, K; Norman, GL; Shums, Z; Antal-Szalmas, P; Papp, M				Kovacs, Gyorgy; Sipeki, Nora; Suga, Boglarka; Tornai, Tamas; Fechner, Kai; Norman, Gary L.; Shums, Zakera; Antal-Szalmas, Peter; Papp, Maria			Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; POPULATION-BASED COHORT; 2 CURRENT MANAGEMENT; CROHNS-DISEASE; PREDICTIVE-VALUE; RISK-FACTORS; EXTENT; PROGRESSION	Background & aims To determine the prognostic potential of classic and novel serologic antibodies regarding unfavorable disease course in a prospective ulcerative colitis (UC) patient cohort, since few and conflicting data are available in the literature regarding this matter. Methods 187 consecutive patients were studied prospectively (median follow-up: 135 months) from a single referral IBD center in Hungary. Sera were tested for different IgA/IgG type autoantibodies (anti-neutrophil cytoplasmic [ANCA], anti-DNA-bound-lactoferrin [anti-LFS], anti goblet cell [anti-GAB] and anti-pancreatic [PAB: anti-CUZD1 and anti-GP2)]) by indirect immunofluorescence technique and for anti-microbial (anti-Saccharomyces cerevisiae [ASCA] IgG/IgA and anti-OMP Plus TM IgA) antibodies by enzyme-linked immunosorbent assays. Results A total of 73.6%, 62.4% and 11.2% of UC patients were positive for IgA/IgG type of atypical perinuclear-ANCA, anti-LFS and anti-GAB, respectively. Occurrences of PABs were 9.6%, while ASCA IgA/IgG and anti-OMP IgA were 17.6% and 19.8%, respectively. Antibody status was stable over time. IgA type PABs were more prevalent in patients with primary sclerosing cholangitis (37.5% vs. 4.7% for anti-CUZD1 and 12.5% vs. 0% for anti-GP2, p<0.001 for both). IgA type ASCA and anti-CUZD1 antibodies were associated with higher risk of requirement for long-term immunosuppressant therapy in Kaplan-Meier analysis (pLogRank <0.01 for both). However, in multivariate Cox-regression analysis only ASCA IgA (HR: 2.74, 95`)/X1: 1.46-5.14, p<0.01) remained independent predictor. UC-related hospitalization due to disease activity was only associated with multiple antibody positivity (for 3 or more; HR 2.03 [95% CI: 1.16-3.56]; p = 0.013). None of the individual antibodies or their combination was associated with the risk of development of extensive disease or colectomy. Conclusion Even with low prevalence rates, present study gives further evidence to the role of certain antibodies as markers for distinct phenotype and disease outcome in UC. Considering the result of the multivariate analysis the novel antibodies investigated do not seem to be associated with poor clinical outcome in UC, only a classic antibody, IgA subtype ASCA remained an independent predictor of long-term immunosuppressive therapy.	[Kovacs, Gyorgy; Sipeki, Nora; Suga, Boglarka; Tornai, Tamas; Papp, Maria] Univ Debrecen, Fac Med, Dept Internal Med, Div Gastroenterol, Debrecen, Hungary; [Fechner, Kai] Euroimmun AG, Inst Expt Immunol, Lubeck, Germany; [Norman, Gary L.; Shums, Zakera] Inova Diagnost Inc, San Diego, CA USA; [Antal-Szalmas, Peter] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary	University of Debrecen; EUROIMMUN; Inova Diagnostics, Inc.; University of Debrecen	Papp, M (corresponding author), Univ Debrecen, Fac Med, Dept Internal Med, Div Gastroenterol, Debrecen, Hungary.	papp.maria@med.unideb.hu	Sipeki, Nóra/AAV-4567-2021	Sipeki, Nóra/0000-0002-6806-2991; Papp, Maria/0000-0003-3662-4010	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences [BO/00426/11]; Internal Research Grant of University of Debrecen [RH/885/2013]; Research Grant of University National, Research, Development and Innovation Office [K 115818, 2015/1]; IOIBD Research Grant; Inova Diagnostics, Inc.	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Internal Research Grant of University of Debrecen; Research Grant of University National, Research, Development and Innovation Office; IOIBD Research Grant; Inova Diagnostics, Inc.	Supported by Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (BO/00426/11), Internal Research Grant (RH/885/2013) of University of Debrecen and Research Grant of University National, Research, Development and Innovation Office (K 115818, 2015/1), IOIBD Research Grant (2012-2015). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They only provided financial support in the form of authors' salaries and/or research materials. Inova Diagnostics, Inc., as a funder provided support in the form of salaries for authors [GLN, ZS] and partially research material (QUANTA Lite (R) ELISA for the detection of ASCA IgG /IgA and anti-OMP PlusTM antibodies), but the commercial company itself did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript; only the co-authors (GLN, ZS) did.	Ayres RC, 1996, EUR J GASTROEN HEPAT, V8, P555, DOI 10.1097/00042737-199606000-00011; Bresci G, 1997, INT J CLIN PHARM RES, V17, P17; BROSTROM O, 1990, MED CLIN N AM, V74, P201, DOI 10.1016/S0025-7125(16)30596-X; Corrigendum, 2015, ALIMENT PHARM THER, V42, P1334; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Elkadri AA, 2013, INFLAMM BOWEL DIS, V19, P1499, DOI 10.1097/MIB.0b013e318281f2a1; Gower-Rousseau C, 2009, AM J GASTROENTEROL, V104, P2080, DOI 10.1038/ajg.2009.177; Harbord M, 2017, J CROHNS COLITIS, V11, P769, DOI 10.1093/ecco-jcc/jjx009; Hoie O, 2008, J CROHNS COLITIS, V2, P114, DOI 10.1016/j.crohns.2007.10.001; Etchevers MJ, 2009, INFLAMM BOWEL DIS, V15, P1320, DOI 10.1002/ibd.20897; Kevans D, 2015, J GASTROEN HEPATOL, V30, P64, DOI 10.1111/jgh.12661; Lakatos L, 2006, POSTGRAD MED J, V82, P270, DOI 10.1136/pgmj.2005.043901; Lakatos PL, 2015, J CROHNS COLITIS, V9, P891, DOI 10.1093/ecco-jcc/jjv127; Lakatos PL, 2011, AM J GASTROENTEROL, V106, P406, DOI 10.1038/ajg.2010.505; Langholz E, 1996, SCAND J GASTROENTERO, V31, P260, DOI 10.3109/00365529609004876; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Magro F, 2017, J CROHNS COLITIS, V11, P649, DOI 10.1093/ecco-jcc/jjx008; Michaels MA, 2015, INFLAMM BOWEL DIS, V21, P2864, DOI 10.1097/MIB.0000000000000564; Moum B, 1999, AM J GASTROENTEROL, V94, P1564; Navaneethan U, 2014, GASTROENTEROL REP, V2, P193, DOI 10.1093/gastro/gou036; NIV Y, 1987, AM J GASTROENTEROL, V82, P1046; Papp M, 2015, J CROHNS COLITIS, V9, P659, DOI 10.1093/ecco-jcc/jjv087; Papp M, 2014, CURR OPIN GASTROEN, V30, P359, DOI 10.1097/MOG.0000000000000076; Papp M, 2013, J HEPATOL, V59, P457, DOI 10.1016/j.jhep.2013.04.018; Papp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012957; Papp M, 2009, CLIN VACCINE IMMUNOL, V16, P464, DOI 10.1128/CVI.00002-09; Pavlidis P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/640835; Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903; Rieder F, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000342603; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1367, DOI 10.1002/ibd.21179; Riegler G, 1996, ITAL J GASTROENTEROL, V28, P211; Rinawi F, 2017, J CLIN GASTROENTEROL; Roggenbuck D, 2013, ADV CLIN CHEM, V60, P187, DOI 10.1016/B978-0-12-407681-5.00006-4; Safroneeva E, 2015, ALIMENT PHARM THER, V42, P540, DOI 10.1111/apt.13307; Sahami S, 2017, UNITED EUR GASTROENT, V5, P554, DOI 10.1177/2050640616679552; Sandborn WJ, 1996, MAYO CLIN PROC, V71, P431, DOI 10.4065/71.5.431; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Seow CH, 2010, GUT, V59, P49, DOI 10.1136/gut.2009.183095; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sipeki N, 2015, WORLD J GASTROENTERO, V21, P6952, DOI 10.3748/wjg.v21.i22.6952; Solberg IC, 2009, SCAND J GASTROENTERO, V44, P431, DOI 10.1080/00365520802600961; Solberg IC, 2009, INFLAMM BOWEL DIS, V15, P406, DOI 10.1002/ibd.20781; Terjung B, 2010, GUT, V59, P808, DOI 10.1136/gut.2008.157818; Van Assche G, 2013, J CROHNS COLITIS, V7, P1, DOI 10.1016/j.crohns.2012.09.005; Vecchi M, 1998, SCAND J GASTROENTERO, V33, P170, DOI 10.1080/00365529850166905; VECCHI M, 1994, DIGESTION, V55, P34, DOI 10.1159/000201120; Waterman M, 2015, INFLAMM BOWEL DIS, V21, P2097, DOI 10.1097/MIB.0000000000000466	49	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194166	10.1371/journal.pone.0194166	http://dx.doi.org/10.1371/journal.pone.0194166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590158	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100051
J	Porter, CK; Lynen, A; Riddle, MS; Talaat, K; Sack, D; Gutierrez, RL; McKenzie, R; DeNearing, B; Feijoo, B; Kaminski, RW; Taylor, DN; Kirkpatrick, BD; Bourgeois, AL				Porter, Chad K.; Lynen, Amanda; Riddle, Mark S.; Talaat, Kawsar; Sack, David; Gutierrez, Ramiro L.; McKenzie, Robin; DeNearing, Barbara; Feijoo, Brittany; Kaminski, Robert W.; Taylor, David N.; Kirkpatrick, Beth D.; Bourgeois, A. Louis			Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score	PLOS ONE			English	Article							TRAVELERS DIARRHEA; DEVELOPING-COUNTRIES; SONNEI VACCINE; GLOBAL BURDEN; ETIOLOGY; CONSEQUENCES; POPULATIONS; VOLUNTEERS; EXPERIENCE; CANDIDATE	Background Since 1946 the controlled human infection model (CHIM) for Shigella has been used to improve understanding of disease pathogenesis, describe clinical and immunologic responses to infection and as a tool for vaccine development. As the frequency and intent for use in vaccine comparisons increases, standardization of the primary endpoint definition is necessary. Methods Subject-level data were obtained from previously conducted experimental Shigella CHIM studies. Signs and symptoms severity were categorized consistently across all studies. Sign and symptom correlations were estimated and univariate models were utilized to describe the association between stool output and other Shigella-attributable signs and symptoms. Multiple correspondence and hierarchical clustering analyses were performed to describe the co-occurrence of signs and symptoms. A disease score is proposed based on the co-occurrence of these events. Results Data were obtained on 54 subjects receiving 800 to 2000 colony forming units (cfu) of S. flexneri. The median maximum 24 hour stool output was 514 ml (IQR: 300, 998 ml) with a median frequency of 6 (IQR: 4, 9). Subjects reported abdominal pain or cramps (81.5%), headache (66.7%) and anorexia (64.8%), 50.0% had a fever and 27.8% had gross blood in multiple loose stools. Multiple correspondence analyses highlighted co-occurrence of symptoms based on severity. A 3-parameter disease severity score predicted shigellosis endpoints and better differentiated disease spectrum. Conclusion Dichotomous endpoints for Shigella CHIM fail to fully account for disease variability. An ordinal disease score characterizing the breadth of disease severity may enable a better characterization of shigellosis and can decrease sample size requirements. Furthermore, the disease severity score may be a useful tool for portfolio management by enabling prioritization across vaccine candidates with comparable efficacy estimates using dichotomous endpoints.	[Porter, Chad K.; Lynen, Amanda; Riddle, Mark S.; Gutierrez, Ramiro L.] Naval Med Res Ctr, Enter Dis Dept, Infect Dis Directorate, Silver Spring, MD 20910 USA; [Talaat, Kawsar; Sack, David; DeNearing, Barbara; Feijoo, Brittany; Bourgeois, A. Louis] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [McKenzie, Robin] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Kaminski, Robert W.] Walter Reed Army Inst Res, Dept Enter Infect, Silver Spring, MD USA; [Taylor, David N.] PATH, Drug Dev Global Program, Seattle, WA USA; [Kirkpatrick, Beth D.] Univ Vermont, Coll Med, Vaccine Testing Ctr, Dept Med, Burlington, VT USA; [Bourgeois, A. Louis] PATH, Enter Vaccine Initiat, Washington, DC USA	Naval Medical Research Center (NMRC); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Vermont	Porter, CK (corresponding author), Naval Med Res Ctr, Enter Dis Dept, Infect Dis Directorate, Silver Spring, MD 20910 USA.	chad.k.porter2.civ@mail.mil	Riddle, Mark/R-8788-2019	Riddle, Mark/0000-0002-0607-7880; Porter, Chad/0000-0001-7258-1690; Kaminski, Robert/0000-0002-4015-5694	Military Infectious Disease Research Program	Military Infectious Disease Research Program	The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of the Army, Department of Defense, nor the U.S. Government. This is a US Government work. There are no restrictions on its use. There were no financial conflicts of interests among any of the authors. Funding for this study was provided by the Military Infectious Disease Research Program. Authors (CKP, MSR, RLG, RWK) are employees of the U.S. Government or military service members. This work was prepared as part of official duties. Title 17 U.S.C. 105 provides that 'Copyright protection under this title is not available for any work of the United States Government.' Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties.	Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S11; DUPONT HL, 1972, J INFECT DIS, V125, P12, DOI 10.1093/infdis/125.1.12; Durbin AP, 2001, INF DIS SOC AM 39 AN; Fedorov V, 2009, PHARM STAT, V8, P50, DOI 10.1002/pst.331; Feijoo B., 2017, VACCINES ENTERIC DIS; Frenck Jr RW, 2017, VACCINES ENTERIC DIS; Giersing BK, 2019, VACCINE, V37, P7315, DOI 10.1016/j.vaccine.2016.10.090; Greenacre Michael, 1984, THEORY APPL CORRES A; Harro C, 2009, 5 INT VACC ENT DIS C; HERRINGTON DA, 1990, VACCINE, V8, P353, DOI 10.1016/0264-410X(90)90094-3; Hosangadi D, 2019, VACCINE, V37, P7372, DOI 10.1016/j.vaccine.2017.09.083; Kahsay Atsebaha Gebrekidan, 2016, BMC Res Notes, V9, P422, DOI 10.1186/s13104-016-2236-7; KEAN BH, 1969, LANCET, V2, P583; Kotloff KL, 2017, VACCINE, V35, P6783, DOI 10.1016/j.vaccine.2017.07.036; KOTLOFF KL, 1995, VACCINE, V13, P495, DOI 10.1016/0264-410X(94)00011-B; KOTLOFF KL, 1995, VACCINE, V13, P1488, DOI 10.1016/0264-410X(95)00102-7; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Nataro JP, 2017, VACCINE, V35, P6807, DOI 10.1016/j.vaccine.2017.05.035; Pitisuttithum P, 2016, CLIN VACCINE IMMUNOL, V23, P564, DOI 10.1128/CVI.00665-15; Porter CK, 2013, EPIDEMIOL INFECT, V141, P223, DOI 10.1017/S0950268812001677; Porter CK, 2017, MIL MED, V182, P4, DOI 10.7205/MILMED-D-17-00064; Porter CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149358; Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891; Riddle MS, 2017, MIL MED, V182, P34, DOI 10.7205/MILMED-D-17-00077; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; SHAUGHNESSY HJ, 1946, JAMA-J AM MED ASSOC, V132, P362, DOI 10.1001/jama.1946.02870420002002; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; TACKET CO, 1992, AM J TROP MED HYG, V47, P276, DOI 10.4269/ajtmh.1992.47.276; Taylor DN, 2008, ANTIMICROB AGENTS CH, V52, P1179, DOI 10.1128/AAC.01108-07; Taylor DN, 2006, CLIN INFECT DIS, V42, P1283, DOI 10.1086/503039; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1	32	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194325	10.1371/journal.pone.0194325	http://dx.doi.org/10.1371/journal.pone.0194325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590182	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100057
J	Tomaszewska, E; Dobrowolski, P; Klebaniuk, R; Kwiecien, M; Tomczyk-Warunek, A; Szymanczyk, S; Kowalik, S; Milczarek, A; Blicharski, T; Muszynski, S				Tomaszewska, Ewa; Dobrowolski, Piotr; Klebaniuk, Renata; Kwiecien, Malgorzata; Tomczyk-Warunek, Agnieszka; Szymanczyk, Sylwia; Kowalik, Sylwester; Milczarek, Anna; Blicharski, Tomasz; Muszynski, Siemowit			Gut-bone axis response to dietary replacement of soybean meal with raw low-tannin faba bean seeds in broiler chickens	PLOS ONE			English	Article							2-OXOGLUTARIC ACID IMPROVES; ALBUS VAR. MULTITALIA; SORGHUM GRAIN DIETS; PEA PISUM-SATIVUM; VICIA-FABA; ALPHA-KETOGLUTARATE; INTESTINAL-TRACT; METABOLIZABLE ENERGY; JEJUNAL EPITHELIUM; GROWTH-PERFORMANCE	It seems that faba bean (FB) seeds could be a good protein-energy component in animal feed, but the presence of anti-nutritional substances limits their use as a substitute of soybean meal. The aim of the study was to examine the influence of different concentrations of raw, low-tannin, FB seeds on the gut-bone axis in Ross 308 broilers. One-day old chickens were randomly subjected to one of the 3 dietary treatments: the control group was fed standard diet based on soybean meal and without FB seeds, and two groups were fed 8%/15% and 16%/22% of raw low-tannin FB seeds in the starter and grower, respectively. On the 35(th) day, hematological and serum biochemical analyses as well histomorphometry of the small intestine and liver tissue and bone mechanical tests were performed. The diet type had no effect on the body weight gain and feed conversion ratio. However, the basal intestinal structures were significantly reduced in birds fed the lower concentration of FB. The enlargement of nerve plexuses was dependent on the concentration used in the diet and, additionally, on the kind of plexus and location in the intestinal tract. The liver was characterized by an increase in non-hepatocytes. There was no influence of the low-tannin FB seeds on most of the analyzed serum parameters in the 35-day-old broiler chickens, except the decreased concentration of total cholesterol and Ca in both experimental groups, triglycerides in group I, and P and uric acid in group II. Furthermore, the increasing concentration of the dietary low-tannin FB did not influence the activities of AspAT (except the group fed the higher amount of FB), ALAT, and LDH. The broiler chickens had no visible leg lesions and no problem in the locomotor function, but the tibiae were lighter mainly in birds fed the higher concentration of FB seeds. Geometric analysis revealed reduction of the cross section area and wall thickness, indicating a decline in the bone midshaft, which influenced the densitometric parameters and the results of mechanical tests. In conclusion, the dietary inclusion of raw low-tannin FB seeds had no negative effects on broiler growth, but disturbed the intestine structure and tibia characteristics. Therefore, all these negative effects necessitate additional examinations before inclusion of raw low-tannin FB seed into poultry diet.	[Tomaszewska, Ewa; Tomczyk-Warunek, Agnieszka; Szymanczyk, Sylwia; Kowalik, Sylwester] Univ Life Sci Lublin, Dept Anim Physiol, Lublin, Poland; [Dobrowolski, Piotr] Marie Curie Sklodowska Univ, Dept Comparat Anat & Anthropol, Lublin, Poland; [Klebaniuk, Renata; Kwiecien, Malgorzata] Univ Life Sci Lublin, Dept Bromatol & Food Physiol, Lublin, Poland; [Milczarek, Anna] Siedlce Univ Nat Sci & Humanities, Dept Anim Nutr & Feed Management, Siedlce, Poland; [Blicharski, Tomasz] Med Univ Lublin, Chair & Dept Rehabil & Orthopaed, Lublin, Poland; [Muszynski, Siemowit] Univ Life Sci, Dept Phys, Lublin, Poland	University of Life Sciences in Lublin; Maria Curie-Sklodowska University; University of Life Sciences in Lublin; Medical University of Lublin	Tomaszewska, E (corresponding author), Univ Life Sci Lublin, Dept Anim Physiol, Lublin, Poland.; Muszynski, S (corresponding author), Univ Life Sci, Dept Phys, Lublin, Poland.	ewaRST@interia.pl; siemowit.muszynski@up.lublin.pl	Milczarek, Anna/AAB-9644-2020; Kowalik, Sylwester/AAD-2296-2021; Milczarek, Anna/R-1798-2017; Tomaszewska, Ewa/U-5490-2018; Dobrowolski, Piotr Jerzy/R-7917-2019; Muszyński, Siemowit/U-4945-2018; Klebaniuk, Renata/V-2664-2018	Milczarek, Anna/0000-0002-2714-3533; Kowalik, Sylwester/0000-0002-0498-2924; Milczarek, Anna/0000-0002-2714-3533; Tomaszewska, Ewa/0000-0002-7574-2653; Dobrowolski, Piotr Jerzy/0000-0001-5873-9666; Muszyński, Siemowit/0000-0002-4118-6302; Klebaniuk, Renata/0000-0003-1700-3390; Blicharski, Tomasz/0000-0001-9747-8817; Szymanczyk, Sylwia/0000-0003-2469-6113; Tomczyk-Warunek, Agnieszka/0000-0002-5007-7327; Kwiecien, Malgorzata/0000-0002-8047-8682				Abbel-Monein Mamdouh Abbas, 2013, Journal of Agrobiology, V30, P43, DOI 10.2478/agro-2013-0005; AHMED AE, 1991, BRIT J NUTR, V65, P189, DOI 10.1079/BJN19910080; [Anonymous], 1990, ANN ANIM SCI; ARMSTRON.WD, 1973, POULTRY SCI, V52, P1592, DOI 10.3382/ps.0521592; Bederska-Lojewska D, 2017, ANN ANIM SCI, V17, P351, DOI 10.1515/aoas-2016-0090; Blicharski T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179693; Brevault N, 2003, JOURN RECH AV TOURS; BURR ML, 1985, NUTR RES, V5, P465, DOI 10.1016/S0271-5317(85)80156-1; Carew LB, 2003, TROPICAL SUBTROPICAL, V1, P267; Crepon K, 2010, FIELD CROP RES, V115, P329, DOI 10.1016/j.fcr.2009.09.016; Diaz D, 2006, ITAL J ANIM SCI, V5, P43; Dobrowolski P, 2012, NUTRITION, V28, P428, DOI 10.1016/j.nut.2011.10.002; Eder K, 1996, ARCH ANIM NUTR, V49, P221, DOI 10.1080/17450399609381883; ELKIN RG, 1978, POULTRY SCI, V57, P757, DOI 10.3382/ps.0570757; Emiola I. A., 2013, INT J API AGR RES, V9, P140; GATEL F, 1994, ANIM FEED SCI TECH, V45, P317, DOI 10.1016/0377-8401(94)90036-1; Gdala J, 1998, J ANIM FEED SCI, V7, P131; Hanczakowska E, 2014, ANN ANIM SCI, V14, P921, DOI 10.2478/aoas-2014-0068; Harr KE, 2002, VET CLIN PATH, V31, P140, DOI 10.1111/j.1939-165X.2002.tb00295.x; Hassan IAG, 2003, TROP ANIM HEALTH PRO, V35, P189, DOI 10.1023/A:1022833820757; Helsper JPFG, 1996, J AGR FOOD CHEM, V44, P1070, DOI 10.1021/jf950484w; HEVIA P, 1977, J NUTR, V107, P959, DOI 10.1093/jn/107.6.959; Horwitz W, 2011, OFFICIAL METHODS ANA; Houshmand M, 2015, BRAZ J POULTRY SCI, V17, P17, DOI 10.1590/1516-635x170117-24; JANSMAN AJM, 1993, ARCH GEFLUGELKD, V57, P220; Jimenez-Moreno E, 2009, POULTRY SCI, V88, P2562, DOI 10.3382/ps.2009-00179; KAKADE ML, 1974, CEREAL CHEM, V51, P376; KING TP, 1983, J SCI FOOD AGR, V34, P1404, DOI 10.1002/jsfa.2740341214; Kowalik S, 2005, B VET I PULAWY, V49, P343; Kumar V, 2007, BRIT POULTRY SCI, V48, P198, DOI 10.1080/00071660701251089; Lacassagne L, 2000, SCI TECHNIQUES AVICO, V32, P17; Laudadio V, 2011, J APPL POULTRY RES, V20, P12, DOI 10.3382/japr.2010-00173; LONGSTAFF M, 1991, BRIT J NUTR, V65, P199, DOI 10.1079/BJN19910081; Metayer JP, 2003, JOURN RECH AV TOURS; Mikulski D, 2017, ANIMAL IN PRESS; Moschini M, 2005, ITAL J ANIM SCI, V4, P59; Moundras C, 1997, J NUTR, V127, P1068, DOI 10.1093/jn/127.6.1068; Muszynski S, 2017, POULTRY SCI, V96, P491, DOI 10.3382/ps/pew301; Nalle CL, 2010, ANIM FEED SCI TECH, V156, P104, DOI 10.1016/j.anifeedsci.2010.01.010; OKUMURA JI, 1969, J NUTR, V97, P316, DOI 10.1093/jn/97.3.316; OLABORO G, 1981, J SCI FOOD AGR, V32, P1163, DOI 10.1002/jsfa.2740321205; Oomah BD, 2011, J AGR FOOD CHEM, V59, P3763, DOI 10.1021/jf200338b; ORTIZ LT, 1994, BRIT POULTRY SCI, V35, P743, DOI 10.1080/00071669408417739; Palander S, 2006, ANIM FEED SCI TECH, V127, P89, DOI 10.1016/j.anifeedsci.2005.07.003; Perez-Maldonado RA, 1999, BRIT POULTRY SCI, V40, P667, DOI 10.1080/00071669987061; Potokar M, 2016, ARCH ANIM NUTR, V70, P378; Przywitowski M, 2016, ANIM FEED SCI TECH, V221, P124, DOI 10.1016/j.anifeedsci.2016.08.027; RUBIO LA, 1989, BRIT POULTRY SCI, V30, P101, DOI 10.1080/00071668908417129; SALIH ME, 1991, ANIM FEED SCI TECH, V33, P139, DOI 10.1016/0377-8401(91)90052-T; SELL DR, 1985, NUTR REP INT, V31, P1369; Shargh MS, 2010, INDIAN J ANIM SCI, V80, P940; Silva PRL, 2007, BRAZ J POULTRY SCI, V9, P229, DOI 10.1590/S1516-635X2007000400004; Sliwa E, 2006, J MATERN-FETAL NEO M, V19, P489, DOI 10.1080/14767050600850381; Sliwa E, 2005, B VET I PULAWY, V49, P117; Sliwa E, 2009, J ANIM PHYSIOL AN N, V93, P192, DOI 10.1111/j.1439-0396.2007.00805.x; Smulikowska S., 2018, NUTR RECOMMENDATIONS, Vfourth; Suvara SK., 2013, BANCROFTS THEORY PRA, V7th ed; Tatara MR, 2006, BONE, V39, P100, DOI 10.1016/j.bone.2005.12.016; Tatara MR, 2005, POULTRY SCI, V84, P1604, DOI 10.1093/ps/84.10.1604; Tomaszewska E, 2018, ANIM PROD SCI, V58, P507, DOI 10.1071/AN16289; Tomaszewska E, 2014, J PHYSIOL PHARMACOL, V65, P107; Tomaszewska E, 2012, J PHYSIOL PHARMACOL, V63, P547; Tomaszewska E, 2017, ANN ANIM SCI, V17, P477, DOI 10.1515/aoas-2016-0056; Tomaszewska E, 2016, ANN ANIM SCI, V16, P507, DOI 10.1515/aoas-2015-0087; Tomaszewska E, 2016, J VET MED SCI, V78, P563, DOI 10.1292/jvms.15-0385; Tomaszewska E, 2015, B VET I PULAWY, V59, P563, DOI 10.1515/bvip-2015-0084; Tomaszewska E, 2015, ENVIRON TOXICOL PHAR, V40, P708, DOI 10.1016/j.etap.2015.09.002; Tomaszewska E, 2015, CONNECT TISSUE RES, V56, P483, DOI 10.3109/03008207.2015.1069822; Tomaszewska E, 2015, EXP TOXICOL PATHOL, V67, P331, DOI 10.1016/j.etp.2015.02.005; Tomaszewska E, 2012, NUTRITION, V28, P190, DOI 10.1016/j.nut.2011.05.010; Vilarino M, 2009, ANIM FEED SCI TECH, V150, P114, DOI 10.1016/j.anifeedsci.2008.08.001; VOHRA P, 1966, POULTRY SCI, V45, P135, DOI 10.3382/ps.0450135; Wiryawan KG, 1990, ANIM FEED SCI TECHNO, V76, P185; Zantop D. W., 1997, AVIAN MED PRINCIPLES, P115	74	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194969	10.1371/journal.pone.0194969	http://dx.doi.org/10.1371/journal.pone.0194969			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590191	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100092
J	Wu, TH; Shi, LF; Adrian, J; Shi, MY; Nair, RV; Snyder, MP; Kao, PN				Wu, Ting-Hsuan; Shi, Lingfang; Adrian, Jessika; Shi, Minyi; Nair, Ramesh V.; Snyder, Michael P.; Kao, Peter N.			NF90/ILF3 is a transcription factor that promotes proliferation over differentiation by hierarchical regulation in K562 erythroleukemia cells	PLOS ONE			English	Article							IL-2 MESSENGER-RNA; GENE-EXPRESSION; NUCLEAR FACTOR; NEGATIVE REGULATOR; PROTEOMIC ANALYSIS; CHROMATIN STATE; BIND DNA; IN-VIVO; NF90; NF45	NF90 and splice variant NF110 are DNA- and RNA-binding proteins encoded by the Interleukin enhancer-binding factor 3 (ILF3) gene that have been established to regulate RNA splicing, stabilization and export. The roles of NF90 and NF110 in regulating transcription as chromatin-interacting proteins have not been comprehensively characterized. Here, chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) identified 9,081 genomic sites specifically occupied by NF90/NF110 in K562 cells. One third of NF90/NF110 peaks occurred at promoters of annotated genes. NF90/NF110 occupancy colocalized with chromatin marks associated with active promoters and strong enhancers. Comparison with 150 ENCODE ChIP-seq experiments revealed that NF90/NF110 clustered with transcription factors exhibiting preference for promoters over enhancers (POLR2A, MYC, YY1). Differential gene expression analysis following shRNA knockdown of NF90/NF110 in K562 cells revealed that NF90/NF110 activates transcription factors that drive growth and proliferation (EGR1, MYC), while attenuating differentiation along the erythroid lineage (KLF1). NF90/NF110 associates with chromatin to hierarchically regulate transcription factors that promote proliferation and suppress differentiation.	[Wu, Ting-Hsuan; Shi, Lingfang; Kao, Peter N.] Stanford Univ, Sch Med, Pulm & Crit Care Med, Stanford, CA 94305 USA; [Wu, Ting-Hsuan] Stanford Univ, Sch Med, Biomed Informat, Stanford, CA 94305 USA; [Adrian, Jessika; Shi, Minyi; Snyder, Michael P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA; [Nair, Ramesh V.] Stanford Univ, Sch Med, Stanford Ctr Genom & Personalized Med, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University	Wu, TH; Kao, PN (corresponding author), Stanford Univ, Sch Med, Pulm & Crit Care Med, Stanford, CA 94305 USA.; Wu, TH (corresponding author), Stanford Univ, Sch Med, Biomed Informat, Stanford, CA 94305 USA.	thsuanwu@stanford.edu; peterkao@stanford.edu	Wu, Timothy Ting Hsuan/AAQ-8510-2020	Snyder, Michael/0000-0003-0784-7987; Wu, Timothy/0000-0002-6869-362X	National Institutes of Health [R01 AI39624, U54 HG006996]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health; R01 AI39624 provided support for PNK and LF; and U54 HG006996 provided support for JA, MS, RVN and MPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benayoun BA, 2009, TRENDS CELL BIOL, V19, P189, DOI 10.1016/j.tcb.2009.02.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512; Castella S, 2015, WIRES RNA, V6, P243, DOI 10.1002/wrna.1270; Cazanove O, 2008, BIOCHEMISTRY-US, V47, P8350, DOI 10.1021/bi7008486; Chaumet A, 2013, BIOCHIMIE, V95, P1146, DOI 10.1016/j.biochi.2013.01.004; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fung LF, 2000, LIFE SCI, V67, P923, DOI 10.1016/S0024-3205(00)00684-6; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Higuchi T, 2016, J BIOL CHEM, V291, P21074, DOI 10.1074/jbc.M116.748210; Huang Q, 2014, TUMOUR BIOL J INT SO; Hudson WH, 2014, NAT REV MOL CELL BIO, V15, P749, DOI 10.1038/nrm3884; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jiang W., 2015, CELL CYCLE HEPATOCEL, V34, P4460, DOI DOI 10.1038/onc.2014.373; Jiang ZY, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0853-2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAO PN, 1994, J BIOL CHEM, V269, P20691; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Kornberg RD, 1999, TRENDS BIOCHEM SCI, V24, pM46, DOI 10.1016/S0962-8924(99)01679-7; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li Y, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020047; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Masuda K, 2013, INT J MOL SCI, V14, P17111, DOI 10.3390/ijms140817111; Nadel J, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0040-6; Nakadai T, 2015, J BIOL CHEM, V290, P26832, DOI 10.1074/jbc.M115.688317; Ni TT, 2015, J MOL HISTOL, V46, P325, DOI 10.1007/s10735-015-9624-5; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Parrott AM, 2007, METHOD ENZYMOL, V429, P243, DOI 10.1016/S0076-6879(07)29012-3; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Reichman TW, 2003, RNA, V9, P543, DOI 10.1261/rna.2181103; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Ren B, 2010, NATURE, V465, P173, DOI 10.1038/465173a; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Saunders LR, 2001, GENOMICS, V71, P256, DOI 10.1006/geno.2000.6423; Shabman RS, 2011, J INFECT DIS, V204, pS911, DOI 10.1093/infdis/jir343; Shamanna RA, 2011, MOL CELL BIOL, V31, P4832, DOI 10.1128/MCB.05849-11; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Stark R., 2012, DIFFBIND DIFFERENTIA; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vinjamur DS, 2014, HAEMATOLOGICA, V99, P1565, DOI 10.3324/haematol.2014.104943; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Wolkowicz UM, 2012, NUCLEIC ACIDS RES, V40, P9356, DOI 10.1093/nar/gks696; Ye JL, 2017, RNA, V23, P1270, DOI 10.1261/rna.061499.117; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu P, 2010, J IMMUNOL, V185, P5140, DOI 10.4049/jimmunol.1000849	78	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193126	10.1371/journal.pone.0193126	http://dx.doi.org/10.1371/journal.pone.0193126			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590119	Green Submitted, gold, Green Published			2022-12-27	WOS:000428603100014
J	Li, QF; Alonge, O; Lawhorn, C; Ambaw, Y; Kumar, S; Jacobs, T; Hyder, AA				Li, Qingfeng; Alonge, Olakunle; Lawhorn, Collene; Ambaw, Yirga; Kumar, Smita; Jacobs, Troy; Hyder, Adnan A.			Child injuries in Ethiopia: A review of the current situation with projections	PLOS ONE			English	Review							INTIMATE PARTNER VIOLENCE; SEXUAL-ABUSE; PSYCHOSOCIAL CONSEQUENCES; SURVEILLANCE SYSTEM; RECALL BIAS; ADOLESCENTS; DEPRESSION; MORTALITY; RISK	Background Heavy burden of child injuries and lack of policy response in Ethiopia call for an improved understanding of the situation and development of action plans from multiple governmental agencies and stakeholders. Methods A consortium of international and Ethiopian researchers and stakeholders used extensive literature review and mixed analytical methods to estimate and project the burden of fatal and non-fatal child unintentional injuries in Ethiopia from 2015 to 2030. Estimates were derived for children aged 0-14 years. Data sources include a longitudinal study conducted by the Central Statistics Agency of Ethiopia and the World Bank as well as model-based estimates from World Health Organization 2017 and Global Burden of Disease 2016 project. Results Injuries caused about 25 thousand deaths among 0-14-year olds in Ethiopia in 2015. The leading cause of fatal child unintentional injuries in Ethiopia was road-traffic injuries, followed by fire, heat and hot substances and drowning. The death rate due to injuries among 0-14 years olds was about 50 percent higher in males than females. Rural children were exposed to a greater risk of injury than their urban peers. The longitudinal survey suggests that the incidence rate of child injuries increased during the period 2011-2014. The annual mortality caused by injuries is projected to increase from 10,697 in 2015 to 11,279 in 2020 and 11,989 in 2030 among children under 5 years, an increase of 12 percentage points in 15 years. The number of deaths among 0-14-year olds will be 26,463, 27,807, and 30,364 respectively in 2015, 2020, and 2030. Conclusions As the first multisectoral collaboration on child injuries in Ethiopia, this study identified gaps in understanding of the burden of child injuries in Ethiopia. In consultation with Ethiopian government and other stakeholders, we propose starting an injury surveillance system at health clinics and hospitals and building an intervention package based on existing platforms.	[Li, Qingfeng; Alonge, Olakunle; Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Johns Hopkins Int Injury Res Unit, Baltimore, MD 21205 USA; [Lawhorn, Collene; Jacobs, Troy] United States Agcy Int Dev, Off Hlth Infect Dis & Nutr, Bur Global Hlth, Washington, DC USA; [Ambaw, Yirga; Kumar, Smita] United States Agcy Int Dev, Off Hlth AIDS Populat & Nutr, Addis Ababa, Ethiopia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; United States Agency for International Development (USAID)	Li, QF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Johns Hopkins Int Injury Res Unit, Baltimore, MD 21205 USA.	qli28@jhu.edu	Hyder, Adnan/AAT-9503-2021; Li, Qingfeng/J-9520-2016	Hyder, Adnan/0000-0002-7292-577X; Li, Qingfeng/0000-0002-6390-6921; Alonge, Olakunle/0000-0001-7642-2806	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The study was funded by United States Agency for International Development (USAID). The sponsor of the study had no role in study design, data collection, data analysis, data inter preparation, or writing of the report.	Amouzou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126909; Branche C., 2008, WORLD REPORT CHILD I; Commission UCPS, 1997, NEISS NAT EL INJ SUR; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Deyessa N, 2010, ARCH DIS CHILD, V95, P771, DOI 10.1136/adc.2009.165571; Duan LL, 2015, INJURY, V46, P572, DOI 10.1016/j.injury.2014.12.013; G/Mariam Abebe, 2006, Ethiop Med J, V44, P339; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P1340, DOI 10.2105/AJPH.74.12.1340; Garoma S, 2012, J TROP PEDIATRICS, V58, P467, DOI 10.1093/tropej/fms018; Howe LD, 2006, TROP MED INT HEALTH, V11, P1557, DOI 10.1111/j.1365-3156.2006.01708.x; Jemal J, 2012, ETHIOP J HEALTH SCI, V22, P59; Kruijshaar ME, 2005, EUR J EPIDEMIOL, V20, P103, DOI 10.1007/s10654-004-1009-0; Lakew Z, 2001, East Afr Med J, V78, P80; Li Q, 2016, ARCH DIS CHILD; Linnan M, 2007, CHILD MORTALITY INJU; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Morrow V, 2014, HEALTH POLICY PLANN, V29, P67, DOI 10.1093/heapol/czs134; United Nations DoEaSA Population Division, 2017, ESAPWP248 UN DOEASA; WHO, GLOB HLTH EST 2014; Woldemichael K, 2011, ETHIOP J HEALTH SCI, V21, P155; Wondie Y, 2011, J INTERPERS VIOLENCE, V26, P2025, DOI 10.1177/0886260510372937; Wondie Y, 2011, J CHILD SEX ABUS, V20, P305, DOI 10.1080/10538712.2011.573458; Worku D, 2006, TROP DOCT, V36, P137, DOI 10.1258/004947506777978325	24	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194692	10.1371/journal.pone.0194692	http://dx.doi.org/10.1371/journal.pone.0194692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584763	Green Published, gold, Green Submitted			2022-12-27	WOS:000428373000032
J	Ortiz-Ortiz, KJ; Tortolero-Luna, G; Rios-Motta, R; Veintidos-Feli, A; Hunter-Mellado, R; Torres-Cintoon, CR; Suarez-Ramos, T; Magno, P				Ortiz-Ortiz, Karen J.; Tortolero-Luna, Guillermo; Rios-Motta, Ruth; Veintidos-Feli, Alejandro; Hunter-Mellado, Robert; Torres-Cintron, Carlos R.; Suarez-Ramos, Tonatiuh; Magno, Priscilla			Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study	PLOS ONE			English	Article							HEALTH-INSURANCE; SURVIVAL BENEFIT; MARITAL-STATUS; OXALIPLATIN; AGE; FLUOROURACIL; OUTCOMES; CARE; CAPECITABINE; LEUCOVORIN	Objective This study aims to examine factors associated with the use of adjuvant chemotherapy and the use of oxaliplatin after curative resection in stage III colon cancer patients and assesses the effect of their use in three-year survival. Methods This retrospective cohort study was conducted using Puerto Rico Central Cancer Registry Health Insurance Linkage Database. The study cohort consisted of stage III colon cancer patients with a curative surgery in the period 2008-2012. Multivariate logistic regression was used to estimate adjusted odds ratios. Kaplan-Meier methods and Cox proportional hazards models were used to assess the association between adjuvant chemotherapy and oxaliplatin use and overall survival and risk of death, respectively. Results Overall, 75% of the study population received adjuvant chemotherapy during the study period. Factors statistically associated with receiving adjuvant chemotherapy within four months after resection included being married (adjusted odds ratio [AOR] 1.64; 95% C11.18-2.28; p = 0.003), and being enrolled in Medicare (AOR 1.68; 95% CI: 1.03-2.75; p = 0.039) or Medicaid and Medicare dual eligible (AOR 1.66; 95% CI: 1.06-2.60; p = 0.028). However, patients aged >= 70 years were less likely to receive adjuvant chemotherapy (AOR 0.22; 95%Cl 0.14-0.36; p<0.001). Discussion We observed a significant reduction in mortality in adjuvant chemotherapy treated patients. Similarly, patients <70 years treated with oxaliplatin had significantly lower risk of death than those who did not, although for patients >= 70 years no statistical significance was achieved. Future studies should assess effective interventions to reduce barriers to access guideline based recommended colon cancer treatment.	[Ortiz-Ortiz, Karen J.; Tortolero-Luna, Guillermo] Univ Puerto Rico, Comprehens Canc Ctr, Canc Control & Populat Sci Program, San Juan, PR 00936 USA; [Ortiz-Ortiz, Karen J.; Rios-Motta, Ruth] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Hlth Serv Adm, Med Sci Campus, San Juan, PR 00936 USA; [Tortolero-Luna, Guillermo; Torres-Cintron, Carlos R.] Univ Puerto Rico, Comprehens Canc Ctr, Puerto Rico Cent Canc Registry, San Juan, PR 00936 USA; [Veintidos-Feli, Alejandro] San Juan Bautista Sch Med, Caguas, PR USA; [Hunter-Mellado, Robert; Magno, Priscilla] Univ Puerto Rico, Comprehens Canc Ctr, Div Canc Med, San Juan, PR 00936 USA; [Suarez-Ramos, Tonatiuh] Univ Puerto Rico, Coll Nat Sci, Rio Piedras Campus, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Rio Piedras	Ortiz-Ortiz, KJ (corresponding author), Univ Puerto Rico, Comprehens Canc Ctr, Canc Control & Populat Sci Program, San Juan, PR 00936 USA.; Ortiz-Ortiz, KJ (corresponding author), Univ Puerto Rico, Grad Sch Publ Hlth, Dept Hlth Serv Adm, Med Sci Campus, San Juan, PR 00936 USA.	karen.ortiz@upr.eciu		Ortiz-Ortiz, Karen/0000-0002-0134-9947; Torres Cintron, Carlos R/0000-0002-3614-7034	National Institute on Minority Health and Health Disparities of the National Institutes of Health [S21MD001830]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health [U54MD007587, 5UGICA189862-03]; National Program of Cancer Registries (NPCR) of the Centers of Disease Control and Prevention (CDC) by the Puerto Rico Central Cancer Registry [5U58-DP 003863-05]; National Institute on Minority Health and Health Disparities [U54MD007587] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Program of Cancer Registries (NPCR) of the Centers of Disease Control and Prevention (CDC) by the Puerto Rico Central Cancer Registry; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number S21MD001830, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (Award Number U54MD007587), and by Award Number 5UGICA189862-03 (PR NCI Oncology Research Program Minority / Underserved - Cancer Care Delivery Research). The collection of cancer incidence data was supported, in part, by the National Program of Cancer Registries (NPCR) of the Centers of Disease Control and Prevention (CDC) by the Puerto Rico Central Cancer Registry, Grant #5U58-DP 003863-05. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, NCI or PRCCR.	Abraham A, 2013, CANCER-AM CANCER SOC, V119, P395, DOI 10.1002/cncr.27755; Abrams TA, 2011, J CLIN ONCOL, V29, P3255, DOI 10.1200/JCO.2011.35.0058; Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Becerra AZ, 2015, SURGERY, V158, P692, DOI 10.1016/j.surg.2015.03.057; Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; Boland GM, 2013, CANCER-AM CANCER SOC, V119, P1593, DOI 10.1002/cncr.27935; Booth CM, 2016, J NATL COMPR CANC NE, V14, P47, DOI 10.6004/jnccn.2016.0006; Gray PJ, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.7_suppl.42; Ha GS, 2017, ANTICANCER RES, V37, P915, DOI 10.21873/anticanres.11399; Hanna NN, 2012, COLORECTAL DIS, V14, P48, DOI 10.1111/j.1463-1318.2011.02545.x; Hines RB, 2016, CANCER EPIDEMIOL, V44, P77, DOI 10.1016/j.canep.2016.08.004; Hsiao FY, 2011, J AM GERIATR SOC, V59, P1717, DOI 10.1111/j.1532-5415.2011.03501.x; Hsieh Mei-Chin, 2013, J Registry Manag, V40, P180; Inverso G, 2015, CANCER-AM CANCER SOC, V121, P1273, DOI 10.1002/cncr.29171; Jeong WK, 2015, ANN SURG TREAT RES, V89, P124, DOI 10.4174/astr.2015.89.3.124; Kaiser Family Foundation, 2016, 8 QUEST ANSW PUERT R; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lund JL, 2013, CANCER-AM CANCER SOC, V119, P2038, DOI 10.1002/cncr.27991; McCleary NJ, 2013, J CLIN ONCOL, V31, P2600, DOI 10.1200/JCO.2013.49.6638; McGory ML, 2006, DIS COLON RECTUM, V49, P319, DOI 10.1007/s10350-005-0283-6; Merchant SJ, 2017, CANCER-AM CANCER SOC, V123, P2840, DOI 10.1002/cncr.30691; Murphy CC, 2015, J CLIN ONCOL, V33, P2530, DOI 10.1200/JCO.2015.61.3026; Ortiz-Ortiz KJ, 2014, P R HEALTH SCI J, V33, P132; Ortiz-Ortiz KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096746; Ortiz-Ortiz KJ, 2014, PLOS ONE, V9; Panchal JM, 2013, CLIN COLORECTAL CANC, V12, P113, DOI 10.1016/j.clcc.2012.09.007; Portela M, 2015, MILBANK Q, V93, P584, DOI 10.1111/1468-0009.12138; POTOSKY AL, 1993, MED CARE, V31, P732; Rivera-Hernandez M, 2016, JAMA INTERN MED, V176, P787, DOI 10.1001/jamainternmed.2016.0267; Sanoff HK, 2012, J CLIN ONCOL, V30, P2624, DOI 10.1200/JCO.2011.41.1140; Sanoff HK, 2012, JNCI-J NATL CANCER I, V104, P211, DOI 10.1093/jnci/djr524; Santiago-Casas Y, 2013, CLIN RHEUMATOL, V32, P763, DOI 10.1007/s10067-013-2167-9; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Schmoll HJ, 2014, LANCET ONCOL, V15, P1481, DOI 10.1016/S1470-2045(14)70486-3; Upadhyay S, 2015, THER ADV MED ONCOL, V7, P244, DOI 10.1177/1758834015587867; US Census Bureau, 2016, 2011 2015 PUERT RIC; van Erning FN, 2017, INT J CANCER, V140, P224, DOI 10.1002/ijc.30423; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539; Zhang Q, 2017, ONCOTARGET; Zuckerman IH, 2009, J AM GERIATR SOC, V57, P1403, DOI 10.1111/j.1532-5415.2009.02355.x	42	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194415	10.1371/journal.pone.0194415	http://dx.doi.org/10.1371/journal.pone.0194415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584752	Green Published, gold			2022-12-27	WOS:000428373000023
J	Uwitonze, A; Huang, JQ; Ye, YQ; Cheng, WQ; Li, ZP				Uwitonze, Alfred; Huang, Jiaqing; Ye, Yuanqing; Cheng, Wenqing; Li, Zongpeng			Exact and heuristic algorithms for Space Information Flow	PLOS ONE			English	Article							STEINER MINIMAL-TREES; UNDIRECTED NETWORKS; MULTICAST	Space Information Flow (SIF) is a new promising research area that studies network coding in geometric space, such as Euclidean space. The design of algorithms that compute the optimal SIF solutions remains one of the key open problems in SIF. This work proposes the first exact SIF algorithm and a heuristic SIF algorithm that compute min-cost multicast network coding for N (N >= 3) given terminal nodes in 2-D Euclidean space. Furthermore, we find that the Butterfly network in Euclidean space is the second example besides the Pentagram network where SIF is strictly better than Euclidean Steiner minimal tree. The exact algorithm design is based on two key techniques: Delaunay triangulation and linear programming. Delaunay triangulation technique helps to find practically good candidate relay nodes, after which a min-cost multicast linear programming model is solved over the terminal nodes and the candidate relay nodes, to compute the optimal multicast network topology, including the optimal relay nodes selected by linear programming from all the candidate relay nodes and the flow rates on the connection links. The heuristic algorithm design is also based on Delaunay triangulation and linear programming techniques. The exact algorithm can achieve the optimal SIF solution with an exponential computational complexity, while the heuristic algorithm can achieve the sub-optimal SIF solution with a polynomial computational complexity. We prove the correctness of the exact SIF algorithm. The simulation results show the effectiveness of the heuristic SIF algorithm.	[Uwitonze, Alfred; Huang, Jiaqing; Cheng, Wenqing] Huazhong Univ Sci & Technol, Sch Elect Informat & Commun, Wuhan 430074, Hubei, Peoples R China; [Uwitonze, Alfred] Univ Rwanda, Coll Sci & Technol, POB 3900, Kigali, Rwanda; [Ye, Yuanqing] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Li, Zongpeng] Univ Calgary, Dept Comp Sci, Calgary, AB, Canada	Huazhong University of Science & Technology; University of Rwanda; Carnegie Mellon University; University of Calgary	Huang, JQ (corresponding author), Huazhong Univ Sci & Technol, Sch Elect Informat & Commun, Wuhan 430074, Hubei, Peoples R China.	jqhuang@mail.hust.edu.cn			National Natural Science Foundation of China [61271227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by No.61271227, National Natural Science Foundation of China, JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, 2004 IEEE INFORMATION THEORY WORKSHOP, PROCEEDINGS, P247; Ahlswede R, 2000, IEEE T INFORM THEORY, V46, P1204, DOI 10.1109/18.850663; Arora S, 1998, J ACM, V45, P753, DOI 10.1145/290179.290180; Barekatain B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069844; Fragouli C, 2006, IEEE T INFORM THEORY, V52, P829, DOI 10.1109/TIT.2005.864435; GILBERT EN, 1968, SIAM J APPL MATH, V16, P1, DOI 10.1137/0116001; Huang J., 2013, ADV MECH ENG, V2013, P1, DOI DOI 10.1038/NSMB; Huang Jun Z., 2016, 2016 74th Annual Device Research Conference (DRC), P1, DOI 10.1109/DRC.2016.7548456; Huang JQ, 2014, IEEE GLOB COMM CONF, P1460, DOI 10.1109/GLOCOM.2014.7037014; Leach G, 1992, 4 CAN C COMP GEOM, P340; Li Z., 2011, SPACE INFORM FLOW; Li ZP, 2007, IEEE INFOCOM SER, P231, DOI 10.1109/INFCOM.2007.35; Li ZP, 2006, IEEE T INFORM THEORY, V52, P2467, DOI 10.1109/TIT.2006.874515; Maheshwar S, 2012, IEEE T INFORM THEORY, V58, P570, DOI 10.1109/TIT.2011.2173720; Muhammad RB, 2008, ICWN, P229; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; SMITH JM, 1981, NETWORKS, V11, P23, DOI 10.1002/net.3230110104; Uwitonze A, 2016, 4 INT C GEO INF RES, P254; Uwitonze A, 2016, 11 INT C COMM NETW C, P475; Uwitonze A, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040902; Van Laarhoven J. W., 2010, THESIS; WAXMAN BM, 1988, IEEE J SEL AREA COMM, V6, P1617, DOI 10.1109/49.12889; WENG JF, 1995, DISCRETE MATH, V141, P259, DOI 10.1016/0012-365X(93)E0183-5; Winter P, 1997, NETWORKS, V30, P149, DOI 10.1002/(SICI)1097-0037(199710)30:3<149::AID-NET1>3.0.CO;2-L; Xiahou T, 2014, IEEE T INFORM THEORY, V60, P2884, DOI 10.1109/TIT.2014.2308998; Xunrui Yin, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, P1316, DOI 10.1109/ISIT.2012.6283071; Yue M, 1990, MINIMUM NETWORK STEI, V41, P1069; Zhang GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148725; Zongpeng Li, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, P1897, DOI 10.1109/ISIT.2012.6283627	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193350	10.1371/journal.pone.0193350	http://dx.doi.org/10.1371/journal.pone.0193350			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584729	gold, Green Published, Green Submitted			2022-12-27	WOS:000428373000005
J	Anutrakunchai, C; Bolscher, JGM; Krom, BP; Kanthawong, S; Chareonsudjai, S; Taweechaisupapong, S				Anutrakunchai, Chitchanok; Bolscher, Jan G. M.; Krom, Bastiaan P.; Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri; Taweechaisupapong, Suwimol			Impact of nutritional stress on drug susceptibility and biofilm structures of Burkholderia pseudomallei and Burkholderia thailandensis grown in static and microfluidic systems	PLOS ONE			English	Article							ACTIVE ATTACHMENT MODEL; LISTERIA-MONOCYTOGENES; STREPTOCOCCUS-MUTANS; SEVERE MELIOIDOSIS; IN-VITRO; IMIPENEM; ARCHITECTURE; ANTIBIOTICS; CEFTAZIDIME; DIVERSITY	Burkholderia pseudomallei is the causative agent of melioidosis and regarded as a bioterrorism threat. It can adapt to the nutrient-limited environment as the bacteria can survive in triple distilled water for 16 years. Moreover, B. pseudomallei exhibits intrinsic resistance to diverse groups of antibiotics in particular while growing in biofilms. Recently, nutrient-limited condition influenced both biofilm formation and ceftazidime (CAZ) tolerance of B. pseudomallei were found. However, there is no information about how nutrient-limitation together with antibiotics used in melioidosis treatment affects the structure of the biofilm produced by B. pseudomallei. Moreover, no comparative study to investigate the biofilm architectures of B. pseudomallei and the related B. thailandensis under different nutrient concentrations has been reported. Therefore, this study aims to provide new information on the effects of four antibiotics used in melioidosis treatment, viz. ceftazidime (CAZ), imipenem (IMI), meropenem (MEM) and doxycycline (DOX) on biofilm architecture of B. pseudomallei and B. thailandensis with different nutrient concentrations under static and flow conditions using confocal laser scanning microscopy. Impact of nutritional stress on drug susceptibility of B. pseudomallei and B. thailandensis grown planktonically or as biofilm was also evaluated. The findings of this study indicate that nutrient-limited environment enhanced survival of B. pseudomallei in biofilm after exposure to the tested antibiotics. The shedding planktonic B. pseudomallei and B. thailandensis were also found to have increased CAZ tolerance in nutrient-limited environment. However, killing activities of MEM and IMI were stronger than CAZ and DOX on B. pseudomallei and B. thailandensis both in planktonic cells and in 2-day old biofilm. In addition, MEM and IMI were able to inhibit B. pseudomallei and B. thailandensis biofilm formation to a larger extend compared to CAZ and DOX. Differences in biofilm architecture were observed for biofilms grown under static and flow conditions. Under static conditions, biofilms grown in full strength modified Vogel and Bonner's medium (MVBM) showed honeycomb-like architecture while a knitted-like structure was observed under limited nutrient condition (0.1xMVBM). Under flow conditions, biofilms grown in MVBM showed a multilayer structure while merely dispersed bacteria were found when grown in 0.1xMVBM. Altogether, this study provides more insight on the effect of four antibiotics against B. pseudomallei and B. thailandensis in biofilm under different nutrient and flow conditions. Since biofilm formation is believed to be involved in disease relapse, MEM and IMI may be better therapeutic options than CAZ for melioidosis treatment.	[Anutrakunchai, Chitchanok; Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri; Taweechaisupapong, Suwimol] Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand; [Anutrakunchai, Chitchanok; Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri; Taweechaisupapong, Suwimol] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Bolscher, Jan G. M.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, Amsterdam, Netherlands; [Bolscher, Jan G. M.; Krom, Bastiaan P.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Krom, Bastiaan P.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Khon Kaen University	Taweechaisupapong, S (corresponding author), Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand.; Taweechaisupapong, S (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.	suvi_taw@kku.ac.th	Krom, Bastiaan/ABC-7026-2020; Bolscher, Jan/ABF-6102-2021; Taweechaisupapong, suwimol/F-6759-2010; Chareonsudjai, Sorujsiri/AFM-5607-2022	Krom, Bastiaan/0000-0002-1497-1161; Bolscher, Jan/0000-0001-5669-6164; Chareonsudjai, Sorujsiri/0000-0001-7176-2924	Biofilm Research Group; Research Affairs and Graduate School, Khon Kaen University [58437]; Division for Earth and Life Sciences; Netherlands Organization for Scientific Research (NWO); University of Amsterdam	Biofilm Research Group; Research Affairs and Graduate School, Khon Kaen University; Division for Earth and Life Sciences; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); University of Amsterdam	This work was supported by Biofilm Research Group and the Post-doctoral Program from Research Affairs and Graduate School, Khon Kaen University [grant number 58437 to Chitchanok Anutrakunchai]. Purchase of the Bioflux Z1000 system was made possible by a grant to BPK from the Division for Earth and Life Sciences to Bastiaan P. Krom (ALW; http://www.nwo.nl/en) with financial aid from the Netherlands Organization for Scientific Research (NWO). Bastiaan P. Krom is supported by a grant from the University of Amsterdam for research into the focal point "Oral Infections and Inflammation".	Allegrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063914; Anutrakunchai C, 2016, TROP BIOMED, V33, P786; Anutrakunchai C, 2015, TROP BIOMED, V32, P300; Bachtiar EW, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00094; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Buijs J, 2008, CLIN MICROBIOL INFEC, V14, P344, DOI 10.1111/j.1469-0691.2007.01940.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chen K, 2005, ANTIMICROB AGENTS CH, V49, P1002, DOI 10.1128/AAC.49.3.1002-1009.2005; Chen P, 2014, ANTIMICROB AGENTS CH, V58, P1208, DOI 10.1128/AAC.01353-13; Cheng AC, 2010, CURR OPIN INFECT DIS, V23, P554, DOI 10.1097/QCO.0b013e32833fb88c; Cherifi T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00864; Clinical and Laboratory Standards Institute (CLSI), 2015, M07A10 CLIN LAB STAN, V10th; Combrouse T, 2013, J APPL MICROBIOL, V114, P1120, DOI 10.1111/jam.12127; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Dance D, 2014, INT J ANTIMICROB AG, V43, P310, DOI 10.1016/j.ijantimicag.2014.01.005; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; Guilbaud M, 2015, APPL ENVIRON MICROB, V81, P1804, DOI 10.1128/AEM.03173-14; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kadam SR, 2013, INT J FOOD MICROBIOL, V165, P259, DOI 10.1016/j.ijfoodmicro.2013.05.025; Kamjumphol W, 2013, SE ASIAN J TROP MED, V44, P72; Kanthawong S, 2012, INT J ANTIMICROB AG, V39, P39, DOI 10.1016/j.ijantimicag.2011.09.010; LAM J, 1980, INFECT IMMUN, V28, P546; Lee J, 2013, MACROMOL RAPID COMM, V34, P1351, DOI 10.1002/marc.201300444; Li XL, 2014, J BASIC MICROB, V54, P97, DOI 10.1002/jobm.201200457; Limmathurotsakul D, 2014, CLIN MICROBIOL INFEC, V20, pO854, DOI 10.1111/1469-0691.12614; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Majewski M., 2014, POL ANN MED, V21, P57, DOI [10.1016/j.poamed.2013.12.001, DOI 10.1016/J.POAMED.2013.12.001]; Pibalpakdee P, 2012, INT J ANTIMICROB AG, V39, P356, DOI 10.1016/j.ijantimicag.2011.12.010; Puknun A, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-1988-x; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schweizer HP, 2008, EMERG INFECT DIS, V14, P1689, DOI [10.3201/eid1411.080431, 10.3201/eid1407.071501]; Schweizer HP, 2012, FUTURE MICROBIOL, V7, P1389, DOI [10.2217/fmb.12.116, 10.2217/FMB.12.116]; Silva TC, 2012, J DENT, V40, P41, DOI 10.1016/j.jdent.2011.09.009; Simpson AJH, 2000, J INFECT DIS, V181, P1014, DOI 10.1086/315306; Simpson AJH, 1999, CLIN INFECT DIS, V29, P381, DOI 10.1086/520219; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Van Laar TA, 2015, ANTIMICROB AGENTS CH, V59, P1712, DOI 10.1128/AAC.04581-14; Vorachit M, 1995, J TROP MED HYG, V98, P379; Wang YC, 2016, ANTIMICROB AGENTS CH, V60, P4670, DOI 10.1128/AAC.00551-16; Wiersinga WJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.107; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445	49	10	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194946	10.1371/journal.pone.0194946	http://dx.doi.org/10.1371/journal.pone.0194946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579106	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800068
J	Arruda, AG; Vilalta, C; Puig, P; Perez, A; Alba, A				Arruda, Andreia Goncalves; Vilalta, Caries; Puig, Pere; Perez, Andres; Alba, Anna			Time-series analysis for porcine reproductive and respiratory syndrome in the United States	PLOS ONE			English	Article							SYNDROME VIRUS; TRANSMISSION; EPIDEMIOLOGY; TRANSPORT; VEHICLES; FOMITES; HERDS	Industry-driven voluntary disease control programs for swine diseases emerged in North America in the early 2000's, and, since then, those programs have been used for monitoring diseases of economic importance to swine producers. One example of such initiatives is Dr. Morrison's Swine Health Monitoring Project, a nation-wide monitoring program for swine diseases including the porcine reproductive and respiratory syndrome (PRRS). PRRS has been extensively reported as a seasonal disease in the U.S., with predictable peaks that start in fall and are extended through the winter season. However, formal time series analysis stratified by geographic region has never been conducted for this important disease across the U.S. The main objective of this study was to use approximately seven years of PRRS incidence data in breeding swine herds to conduct time-series analysis in order to describe the temporal patterns of PRRS outbreaks at the farm level for five major swine producing states across the U.S. including the states of Minnesota, Iowa, North Carolina, Nebraska and Illinois. Data was aggregated retrospectively at the week level for the number of herds containing animals actively shedding PRRS virus. Basic descriptive statistics were conducted followed by autoregressive integrated moving average (ARIMA) modelling, conducted separately for each of the above-mentioned states. Results showed that there was a difference in the nature of PRRS seasonality among states. Of note, when comparing states, the typical seasonal pattern previously described for PRRS could only be detected for farms located in the states of Minnesota, North Carolina and Nebraska. For the other two states, seasonal peaks every six months were detected within a year. In conclusion, we showed that epidemic patterns are not homogeneous across the U.S, with major peaks of disease occurring through the year. These findings highlight the importance of coordinating alternative control strategies in different regions considering the prevailing epidemiological patterns.	[Arruda, Andreia Goncalves] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Vilalta, Caries; Perez, Andres; Alba, Anna] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Puig, Pere] Autonomous Univ Barcelona, Dept Math, Barcelona, Spain	University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; Autonomous University of Barcelona	Arruda, AG (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.	goncalvesarruda.1@osu.edu	Puig, Pedro/K-4414-2014; Perez, Andres/HGD-8377-2022	Puig, Pedro/0000-0002-6607-9642; Arruda, Andreia/0000-0001-7040-9686; Vilalta, Carles/0000-0002-9220-8620	Swine Health Information Center; National Pork Board; MN Drive Program; Spanish Ministry of Economy and Competitiveness [MTM2015-69493-R, MDM-2014-0445]	Swine Health Information Center; National Pork Board; MN Drive Program; Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funding for the MSHMP and this study was provided by the Swine Health Information Center, the National Pork Board, and the MN Drive Program to AP. The third author (PP) was partially funded by the grant MTM2015-69493-R and by the "Maria de Maeztu" Programme for Units of Excellence in R&D (MDM-2014-0445) from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122547; Alkamis MA, 2017, SURVEILLANCE PORCINE; Anatia A, 2016, SORT-STAT OPER RES T, V40, P267; Arruda AG, 2016, PREV VET MED, V128, P41, DOI 10.1016/j.prevetmed.2016.03.010; Arruda AG, 2017, FRONT VET SCI; Arruda AG, 2015, CAN J VET RES, V79, P268; Arruda AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172638; Bowman AS, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.5; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Dee SA, 2004, CAN J VET RES, V68, P128; Dunsmuir WTM, 2015, J STAT SOFTW, V67, P1; Fernandez-Fontelo A, 2017, STAT MODEL, V17, P172, DOI 10.1177/1471082X16683113; Hermann J, 2007, VET RES, V38, P81, DOI 10.1051/vetres:2006044; Holtkamp DJ, 2011, J SWINE HEALTH PROD, V19, P44; National Pork Board, 2016, HOGSPIGS 06 24 2016; Otake S, 2002, J SWINE HEALTH PROD, V10, P59; Perez AM, FRONT VET SCI; Perez AM, 2015, JAVMA-J AM VET MED A, V246, P1304, DOI 10.2460/javma.246.12.1304; Pitkin A, 2009, CAN J VET RES, V73, P298; Tousignant SJP, 2015, CAN VET J, V56, P1087; Tousignant SJP, 2015, AM J VET RES, V76, P70, DOI 10.2460/ajvr.76.1.70; U. S. Department of Agriculture, 2015, OV US HOG IND; Valdes-Donoso P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149498	23	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195282	10.1371/journal.pone.0195282	http://dx.doi.org/10.1371/journal.pone.0195282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614099	Green Submitted, gold, Green Published			2022-12-27	WOS:000429081600040
J	Benadiba, J; Ansari, M; Krajinovic, M; Vachon, MF; Duval, M; Teira, P; Cellot, S; Bittencourt, H				Benadiba, Joy; Ansari, Marc; Krajinovic, Maja; Vachon, Marie-France; Duval, Michel; Teira, Pierre; Cellot, Sonia; Bittencourt, Henrique			Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; RECEIVING INTRAVENOUS BUSULFAN; BONE-MARROW-TRANSPLANTATION; VENOOCCLUSIVE DISEASE; PEDIATRIC-PATIENTS; GRAFT-REJECTION; ORAL BUSULFAN; HOST DISEASE; IV BUSULFAN; LEUKEMIA	Unrelated umbilical cord blood transplantation (UCBT) is an alternative to provide transplants in children with acute leukemia or myelodysplastic syndrome who lack a related donor. Intravenous Busulfan (Bu) combined with therapeutic drug monitoring-guided dosing has been increasingly used, with more predictable bioavailability and better outcomes comparing to oral Bu. There is still an important variation in Bu pharmacokinetic between patients that is associated with an increased risk of toxicity and graft failure. The objective of the study was to analyze the impact of first-dose pharmacokinetic adapted myeloablative conditioning regimen of intravenous Bu on the different outcomes after transplantation. Data of 36 children who underwent allogeneic HSCT with Bu plus a second alkylating agent at Sainte Justine Hospital in Montreal, Canada, between December 2000 and April 2012 were analyzed. For children with high risk myeloid malignancies receiving an UCBT, first dose Bu pharmacokinetic seems to be a significant prognostic factor, influencing neutrophil (100% vs 67.9%) and platelet recovery (95.5% vs 70.5%), non-relapse mortality (0% vs 18.6%), EFS (64% vs 28.6%) and OS (81.3% vs 37.5%) for a first-dose steady-state concentration (Css) <600ng/mL vs >600ng/mL, respectively. These data reinforce the importance of Busulfan therapeutic drug monitoring-guided dosing in pediatric HSCT patients, particularly in the context of UCBT.	[Benadiba, Joy] Nice Univ Hosp, Dept Hematooncol Pediat, Nice, France; [Ansari, Marc] Geneva Univ Hosp, Dept Pediat, Geneva, Switzerland; [Ansari, Marc] Geneva Univ Med Sch, Cansearch Res Lab, Geneva, Switzerland; [Krajinovic, Maja; Vachon, Marie-France; Duval, Michel; Teira, Pierre; Cellot, Sonia; Bittencourt, Henrique] Ste Justine Hosp, Ctr Cancerol Charles Bruneau, Hematol Oncol Div, Montreal, PQ, Canada; [Krajinovic, Maja] Ste Justine Hosp, Clin Pharmacol Unit, Montreal, PQ, Canada; [Krajinovic, Maja; Duval, Michel; Teira, Pierre; Cellot, Sonia; Bittencourt, Henrique] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada	CHU Nice; University of Geneva; Universite de Montreal; Universite de Montreal; Universite de Montreal	Benadiba, J (corresponding author), Nice Univ Hosp, Dept Hematooncol Pediat, Nice, France.	benadiba.j@chu-nice.fr		ansari, marc/0000-0002-9649-6498				Andersson BS, 2002, BIOL BLOOD MARROW TR, V8, P477, DOI 10.1053/bbmt.2002.v8.pm12374452; Ansari M, 2013, BONE MARROW TRANSPL, V48, P939, DOI 10.1038/bmt.2012.265; Ansari M, 2010, BONE MARROW TRANSPL, V45, P261, DOI 10.1038/bmt.2009.143; Ansari M, 2014, THER DRUG MONIT, V36, P93, DOI 10.1097/FTD.0b013e3182a04fc7; Ansari M, 2012, RAPID COMMUN MASS SP, V26, P1437, DOI 10.1002/rcm.6241; Baker KS, 2000, BONE MARROW TRANSPL, V26, P607, DOI 10.1038/sj.bmt.1702590; Bartelink IH, 2008, BIOL BLOOD MARROW TR, V14, P88, DOI 10.1016/j.bbmt.2007.09.015; Bartelink IH, 2009, BIOL BLOOD MARROW TR, V15, P231, DOI 10.1016/j.bbmt.2008.11.022; Bleyzac N, 2001, BONE MARROW TRANSPL, V28, P743, DOI 10.1038/sj.bmt.1703207; Copelan EA, 2001, BONE MARROW TRANSPL, V27, P1121, DOI 10.1038/sj.bmt.1703047; Dalle JH, 2003, BONE MARROW TRANSPL, V32, P647, DOI 10.1038/sj.bmt.1704209; Dix SP, 1996, BONE MARROW TRANSPL, V17, P225; Dupuis LL, 2008, BIOL BLOOD MARROW TR, V14, P576, DOI 10.1016/j.bbmt.2008.03.002; Gibbs JP, 1997, CANCER RES, V57, P5509; HASSAN M, 1994, BLOOD, V84, P2144; Huezo-Diaz P, 2014, CURR DRUG METAB, V15, P251, DOI 10.2174/1389200215666140202214012; Johnson L, 2008, J CLIN PHARMACOL, V48, P1052, DOI 10.1177/0091270008321940; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim I, 2007, CLIN TRANSPLANT, V21, P207, DOI 10.1111/j.1399-0012.2006.00624.x; Madureira ABM, 2011, LEUKEMIA, V25, P449, DOI 10.1038/leu.2010.285; McCune JS, 2007, BIOL BLOOD MARROW TR, V13, P853, DOI 10.1016/j.bbmt.2007.03.012; McCune JS, 2002, BONE MARROW TRANSPL, V30, P167, DOI 10.1038/sj.bmt.1703612; MCDONALD GB, 1993, ANN INTERN MED, V118, P255, DOI 10.7326/0003-4819-118-4-199302150-00003; Michel G, 2016, LEUKEMIA, V30, P1180, DOI 10.1038/leu.2015.243; Michel G, 2003, BLOOD, V102, P4290, DOI 10.1182/blood-2003-04-1288; Nguyen L, 2004, BONE MARROW TRANSPL, V33, P979, DOI 10.1038/sj.bmt.1704446; Paci A, 2012, THER DRUG MONIT, V34, P198, DOI 10.1097/FTD.0b013e31824c2f60; Perkins J, 2011, BONE MARROW TRANSPL, V46, P1418, DOI 10.1038/bmt.2010.315; Pidala J, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-36; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rifai N, 1997, THER DRUG MONIT, V19, P169, DOI 10.1097/00007691-199704000-00009; SANTOS GW, 1983, NEW ENGL J MED, V309, P1347, DOI 10.1056/NEJM198312013092202; Sisler IY, 2009, BIOL BLOOD MARROW TR, V15, P1620, DOI 10.1016/j.bbmt.2009.08.014; SLATTERY JT, 1995, BONE MARROW TRANSPL, V16, P31; Slattery JT, 1997, BLOOD, V89, P3055, DOI 10.1182/blood.V89.8.3055; Tse WT, 2009, BONE MARROW TRANSPL, V44, P145, DOI 10.1038/bmt.2008.437; Zwaveling J, 2005, BONE MARROW TRANSPL, V35, P17, DOI 10.1038/sj.bmt.1704707	37	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193862	10.1371/journal.pone.0193862	http://dx.doi.org/10.1371/journal.pone.0193862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608607	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800005
J	Lyu, AR; Kim, DH; Lee, SH; Shin, DS; Shin, SA; Park, YH				Lyu, Ah-Ra; Kim, Dong Hyun; Lee, Seung Hun; Shin, Dong-Sik; Shin, Sun-Ae; Park, Yong-Ho			Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: A comparison of administration routes	PLOS ONE			English	Article							GUINEA-PIG MODEL; ROUND WINDOW APPROACH; COCHLEAR IMPLANTATION; INNER-EAR; CISPLATIN OTOTOXICITY; ELECTRODE INSERTION; CONSERVES HEARING; ANIMAL-MODEL; PRESERVATION; DELIVERY	Preservation of residual hearing after cochlear implant is an important issue with regards to hearing performance. Various methods of steroid administration have been widely used in clinical practice to reduce inflammation and preserve residual hearing. Here we compare the effect of different routes of dexamethasone administration on intracochlear inflammation and residual hearing in guinea pig ears. Dexamethasone was delivered into the guinea pigs either through intracochlear, intratympanic or systemic route. The intracochlear concentration of dexamethasone, residual hearing, inflammatory cytokines and histopathologic changes were evaluated over time. A higher intracochlear dexamethasone concentration was observed after intracochlear administration than through the other routes. Residual hearing was better preserved with local dexamethasone administration as was supported by the reduced inflammatory cytokines, more hair cell survival and less severe intracochlear fibrosis and ossification concurrently seen in the local delivery group than in the systemic group. The results demonstrate that local dexamethasone delivery can reduce intracochlear inflammation and preserve residual hearing better than in systemically administered dexamethasone.	[Lyu, Ah-Ra; Kim, Dong Hyun; Lee, Seung Hun; Shin, Sun-Ae; Park, Yong-Ho] Chungnam Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea; [Lyu, Ah-Ra; Shin, Sun-Ae] Chungnam Natl Univ, Coll Med, Dept Med Sci, Daejeon, South Korea; [Shin, Dong-Sik] Chungnam Natl Univ Hosp, Biomed Convergence Res Ctr, Daejeon, South Korea; [Park, Yong-Ho] Chungnam Natl Univ, Coll Med, Brain Res Inst, Daejeon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University Hospital; Chungnam National University	Park, YH (corresponding author), Chungnam Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea.; Park, YH (corresponding author), Chungnam Natl Univ, Coll Med, Brain Res Inst, Daejeon, South Korea.	parkyh@cnu.ac.kr		Park, Yong-Ho/0000-0003-2106-3791	Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2015R1D1A3A01018881, NRF-2018R1A2B2005022]	Basic Science Research Program through the National Research Foundation of Korea (NRF)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) (NRF-2015R1D1A3A01018881 and NRF-2018R1A2B2005022 for Yong-Ho Park), https://ernd.nrf.re.kr/index.do.	Adunka OF, 2014, OTOL NEUROTOL, V35, P613, DOI 10.1097/MAO.0000000000000269; Backous Douglas D, 2014, Neurosurg Focus, V36, P1, DOI 10.3171/2014.V1.FOCUS13537; Balkany TJ, 2006, OTOL NEUROTOL, V27, P1083, DOI 10.1097/01.mao.0000244355.34577.85; Barbara M, 2003, J LARYNGOL OTOL, V117, P850, DOI 10.1258/002221503322542836; Bird PA, 2011, OTOL NEUROTOL, V32, P933, DOI 10.1097/MAO.0b013e3182255933; Bohl A, 2012, J MATER SCI-MATER M, V23, P2151, DOI 10.1007/s10856-012-4698-z; Chang MY, 2017, OTOL NEUROTOL, V38, P962, DOI 10.1097/MAO.0000000000001453; Cho HS, 2016, AUDIOL NEURO-OTOL, V21, P178, DOI 10.1159/000445099; Douchement D, 2015, Cochlear Implants Int, V16, P195, DOI 10.1179/1754762813Y.0000000053; Eastwood H, 2010, HEARING RES, V265, P25, DOI 10.1016/j.heares.2010.03.006; El Kechai N, 2016, J CONTROL RELEASE, V226, P248, DOI 10.1016/j.jconrel.2016.02.013; Erixon E, 2012, ACTA OTO-LARYNGOL, V132, P923, DOI 10.3109/00016489.2012.680198; Eshraghi AA, 2007, OTOL NEUROTOL, V28, P842, DOI 10.1097/MAO.0b013e31805778fc; Haake SM, 2009, HEARING RES, V255, P22, DOI 10.1016/j.heares.2009.05.003; Havenith S, 2013, OTOL NEUROTOL, V34, P667, DOI 10.1097/MAO.0b013e318288643e; Heinrich UR, 2015, LARYNGOSCOPE; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Jia H, 2013, ANN OTO RHINOL LARYN, V122, P33, DOI 10.1177/000348941312200107; Juhn S K, 2001, Int Tinnitus J, V7, P72; Juhn S K, 1989, Acta Otolaryngol Suppl, V457, P43; Kaur T, 2015, J NEUROSCI, V35, P15050, DOI 10.1523/JNEUROSCI.2325-15.2015; Keithley EM, 2008, OTOL NEUROTOL, V29, P854, DOI 10.1097/MAO.0b013e31818256a9; Kil SH, 2013, HEARING RES, V299, P63, DOI 10.1016/j.heares.2013.01.020; Kuthubutheen J, 2015, HEARING RES, V327, P257, DOI 10.1016/j.heares.2015.06.010; Lee J, 2013, AUDIOL NEURO-OTOL, V18, P392, DOI 10.1159/000353582; Liu Y, 2015, HEARING RES, V327, P89, DOI 10.1016/j.heares.2015.04.019; Fernandez MM, 2016, OTOLARYNG HEAD NECK, V155, P8, DOI 10.1177/0194599816644440; Metrailer AM, 2016, CURR OPIN OTOLARYNGO, V24, P403, DOI 10.1097/MOO.0000000000000287; Morawski K, 2009, OTOL NEUROTOL, V30, P851, DOI 10.1097/MAO.0b013e3181b12296; Murphy D, 2011, OTOLARYNG HEAD NECK, V145, P452, DOI 10.1177/0194599811406673; Nadol JB, 2001, ANN OTO RHINOL LARYN, V110, P883, DOI 10.1177/000348940111000914; O'Connell BP, 2016, CURR OPIN OTOLARYNGO, V24, P413, DOI 10.1097/MOO.0000000000000289; Plontke SK, 2008, OTOL NEUROTOL, V29, P401, DOI 10.1097/MAO.0b013e318161aaae; Rajan GP, 2012, LARYNGOSCOPE, V122, P190, DOI 10.1002/lary.22142; Ryu KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136617; Salehi P, 2014, OTOL NEUROTOL, V35, P1131, DOI 10.1097/MAO.0000000000000403; Salt AN, 2011, AUDIOL NEURO-OTOL, V16, P323, DOI 10.1159/000322504; Seyyedi M, 2014, OTOL NEUROTOL, V35, P1545, DOI 10.1097/MAO.0000000000000540; Skarzynski H, 2010, ACTA OTO-LARYNGOL, V130, P435, DOI 10.3109/00016480903283733; Stathopoulos Dimitra, 2014, Cochlear Implants Int, V15, P254, DOI 10.1179/1754762813Y.0000000054; Sun CL, 2016, NEUROSCI LETT, V619, P142, DOI 10.1016/j.neulet.2016.03.012; Takemura K, 2004, HEARING RES, V196, P58, DOI 10.1016/j.heares.2004.06.003; Takumi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110238; van de Water TR, 2010, ACTA OTO-LARYNGOL, V130, P308, DOI 10.3109/00016480903124655; Vivero RJ, 2008, LARYNGOSCOPE, V118, P2028, DOI 10.1097/MLG.0b013e31818173ec; Wilk M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147552; Woodson EA, 2010, ADV OTO-RHINO-LARYNG, V67, P125, DOI 10.1159/000262604; Zhang HZ, 2015, OTOL NEUROTOL, V36, P1157, DOI 10.1097/MAO.0000000000000787	48	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195230	10.1371/journal.pone.0195230	http://dx.doi.org/10.1371/journal.pone.0195230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601595	gold, Green Submitted, Green Published			2022-12-27	WOS:000428845900025
J	Chiu, SL; Gee, MJ; Muo, CH; Chu, CL; Lan, SJ; Chen, CL				Chiu, Shin-Lin; Gee, Mei-Jih; Muo, Chih-Hsin; Chu, Chiao-Lee; Lan, Shou-Jen; Chen, Chiu-Liang			The sociocultural effects on orthopedic surgeries in Taiwan	PLOS ONE			English	Article							GHOST MONTH; NATURAL EXPERIMENT; HEALTH; DEATH; SUPERSTITION; MORTALITY; CHINESE; FRIDAY; BELIEF; 13TH	Various sociocultural factors affect healthcare-seeking behaviors. In Taiwanese society, superstitions and lunar festivals play important roles in people's lives. We investigated the impact of "Ghost Month" (the 7th lunar month) and Chinese New Year (the 12th lunar month and the 1st lunar month of the following year) on the number of elective surgeries and emergent surgeries in Taiwan. The number of total knee replacement (TKR) surgeries and proximal femur fracture (PFF) surgeries in each lunar month from 2000 to 2011 were extracted from the Taiwan National Health Insurance Database, a computerized and population-based database. Patients were then sorted by location of residence or gender. The average number of TKR surgeries performed was significantly lower during the 1st, 7th, and 12th lunar months in urban areas, whereas in rural areas this trend was only evident in the 7th and 12th lunar months. There was however, no significant difference in the average number of PFF surgeries in each lunar month except for an increase seen in the 1st lunar month in rural patients (p<0.05). When sorted by gender, the average number of TKR surgeries was significantly decreased in the 7th and 12th lunar months in male patients, and decreased in the 1st, 7th, and 12th lunar months in female patients. In contrast, there was no difference in the average numbers of PFF surgeries in the 7th and 12th lunar months either in male or female patients. We proposed that the timing of elective surgeries such as TKR might be influenced by Ghost Month and Chinese New Year; however, emergent PFF surgeries were not significantly influenced by sociocultural beliefs and taboos in Taiwan.	[Chiu, Shin-Lin] Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chiu, Shin-Lin] Da Yeh Univ, Dept Optometry, Changhua, Taiwan; [Gee, Mei-Jih] Fong Chia Univ, Dept Stat, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chu, Chiao-Lee] Natl Quemoy Univ, Dept Long Term Care, Jinning, Quemoy County, Taiwan; [Lan, Shou-Jen] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Lan, Shou-Jen] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Chiu-Liang] Changhua Christian Hosp, Dept Orthoped, Changhua, Taiwan; [Chen, Chiu-Liang] Da Yeh Univ, Dept Nursing, Changhua, Taiwan	Changhua Christian Hospital; Da Yeh University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Changhua Christian Hospital; Da Yeh University	Chen, CL (corresponding author), Changhua Christian Hosp, Dept Orthoped, Changhua, Taiwan.; Chen, CL (corresponding author), Da Yeh Univ, Dept Nursing, Changhua, Taiwan.	111111@cch.org.tw						Anson J, 2001, SOC SCI MED, V52, P83, DOI 10.1016/S0277-9536(00)00125-8; BAILEY EJ, 1987, J NATL MED ASSOC, V79, P389; Bureau of National Health Insurance DoH, 2012, EX YUAN; Dodge B, 2005, AM J HEALTH BEHAV, V29, P172, DOI 10.5993/AJHB.29.2.8; Ficklscherer A, 2012, ARCH MED SCI, V8, P111, DOI 10.5114/aoms.2012.27290; Gupta Vidya Bhushan, 2010, J Cult Divers, V17, P13; Huang CY YM, 1997, J CHIN PUBLIC HLTH, V16, P10; Joswig H, 2016, ACTA NEUROCHIR, V158, P1095, DOI 10.1007/s00701-016-2802-8; Keane EM, 1997, IRISH MED J, V90, P28; Kim Jung Ran, 2004, J Transcult Nurs, V15, P147; Lai JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025183; Lin HC, 2006, J EPIDEMIOL COMMUN H, V60, P522, DOI 10.1136/jech.2005.041475; Mansson A, 2007, UROLOGY, V70, P1086, DOI 10.1016/j.urology.2007.07.071; Nayha S, 2002, AM J PSYCHIAT, V159, P2110, DOI 10.1176/appi.ajp.159.12.2110; O'Reilly D., 2000, Journal of Obstetrics and Gynaecology (Abingdon), V20, P139; Panesar NS, 2012, EMERG MED J, V29, P319, DOI 10.1136/emermed-2011-200015; Panesar NS, 2003, MED J AUSTRALIA, V179, P656, DOI 10.5694/j.1326-5377.2003.tb05741.x; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Phillips DP, 2001, BRIT MED J, V323, P1443, DOI 10.1136/bmj.323.7327.1443; Russell Kathleen M, 2003, Oncol Nurs Forum, V30, P633, DOI 10.1188/03.ONF.633-640; SCANLON TJ, 1993, BRIT MED J, V307, P1584, DOI 10.1136/bmj.307.6919.1584; Shen HN, 2012, DIABETES CARE, V35, P1061, DOI 10.2337/dc11-1925; Srikanthan A, 2008, J OBSTET GYNAECOL CA, V30, P129, DOI 10.1016/S1701-2163(16)32736-0; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315; Yang CH, 2008, SOC SCI MED, V66, P1990, DOI 10.1016/j.socscimed.2008.01.014	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195183	10.1371/journal.pone.0195183	http://dx.doi.org/10.1371/journal.pone.0195183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596539	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000090
J	Ferecatu, I; Canal, F; Fabbri, L; Mazure, NM; Bouton, C; Golinelli-Cohen, MP				Ferecatu, Ioana; Canal, Frederic; Fabbri, Lucilla; Mazure, Nathalie M.; Bouton, Cecile; Golinelli-Cohen, Marie-Pierre			Dysfunction in the mitochondrial Fe-S assembly machinery leads to formation of the chemoresistant truncated VDAC1 isoform without HIF-1 alpha activation	PLOS ONE			English	Article							IRON-SULFUR CLUSTER; NITRIC-OXIDE; ENDOPLASMIC-RETICULUM; REGULATORY PROTEIN-1; CYSTEINE RESIDUES; CA2+ HOMEOSTASIS; CANCER-CELLS; IN-VITRO; HYPOXIA; CHANNEL	Biogenesis of iron-sulfur clusters (ISC) is essential to almost all forms of life and involves complex protein machineries. This process is initiated within the mitochondrial matrix by the ISC assembly machinery. Cohort and case report studies have linked mutations in ISC assembly machinery to severe mitochondrial diseases. The voltage-dependent anion channel (VDAC) located within the mitochondrial outer membrane regulates both cell metabolism and apoptosis. Recently, the C-terminal truncation of the VDAC1 isoform, termed VDAC1-Delta C, has been observed in chemoresistant late-stage tumor cells grown under hypoxic conditions with activation of the hypoxia-response nuclear factor HIF-1 alpha. These cells harbored atypical enlarged mitochondria. Here, we show for the first time that depletion of several proteins of the mitochondrial ISC machinery in normoxia leads to a similar enlarged mitochondria phenotype associated with accumulation of VDAC1-Delta C. This truncated form of VDAC1 accumulates in the absence of HIF-1 alpha and HIF-2 alpha activations and confers cell resistance to drug-induced apoptosis. Furthermore, we show that when hypoxia and siRNA knock-down of the ISC machinery core components are coupled, the cell phenotype is further accentuated, with greater accumulation of VDAC1-Delta C. Interestingly, we show that hypoxia promotes the downregulation of several proteins (ISCU, NFS1, FXN) involved in the early steps of mitochondrial Fe-S cluster biogenesis. Finally, we have identified the mitochondria-associated membrane (MAM) localized Fe-S protein CISD2 as a link between ISC machinery downregulation and accumulation of anti-apoptotic VDAC1-Delta C. Our results are the first to associate dysfunction in Fe-S cluster biogenesis with cleavage of VDAC1, a form which has previously been shown to promote tumor resistance to chemotherapy, and raise new perspectives for targets in cancer therapy.	[Ferecatu, Ioana; Canal, Frederic; Bouton, Cecile; Golinelli-Cohen, Marie-Pierre] Univ Paris Saclay, Univ Paris Sud, CNRS, ICSN,UPR 2301, Gif Sur Yvette, France; [Fabbri, Lucilla; Mazure, Nathalie M.] Univ Nice Sophia Antipolis, CNRS, INSERM,U1081,UMR 7284, Inst Res Canc & Aging Nice,Ctr Antoine Lacassagne, Nice, France; [Ferecatu, Ioana] Univ Paris 05, Sorbonne Paris Cite, INSERM, Fac Sci Pharmaceut & Biol,UMR S1139, Paris, France; [Fabbri, Lucilla; Mazure, Nathalie M.] INSERM, U1065, C3M, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Bouton, C; Golinelli-Cohen, MP (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, ICSN,UPR 2301, Gif Sur Yvette, France.	cecile.bouton@cnrs.fr; marie-pierre.golinelli@cnrs.fr	Ferecatu, Ioana/AAW-5055-2021; Golinelli, Marie-Pierre/K-4287-2013	Ferecatu, Ioana/0000-0001-6842-9506; Golinelli, Marie-Pierre/0000-0002-6738-8631; Mazure, Nathalie/0000-0003-1350-7161				Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Allouche M, 2012, BIOCHEM BIOPH RES CO, V429, P12, DOI 10.1016/j.bbrc.2012.10.108; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Andreini C, 2016, J PROTEOME RES, V15, P1308, DOI 10.1021/acs.jproteome.6b00045; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Bouton Cecile, 2003, Sci STKE, V2003, ppe17, DOI 10.1126/stke.2003.182.pe17; Brahimi-Horn MC, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0133-5; Brahimi-Horn MC, 2015, MOL CELL BIOL, V35, P1491, DOI 10.1128/MCB.01402-14; Brahimi-Horn MC, 2012, CANCER RES, V72, P2140, DOI 10.1158/0008-5472.CAN-11-3940; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Canal F, 2007, ARCH BIOCHEM BIOPHYS, V465, P282, DOI 10.1016/j.abb.2007.06.003; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chang NC, 2012, HUM MOL GENET, V21, P2277, DOI 10.1093/hmg/dds048; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Chiche J, 2010, J CELL PHYSIOL, V222, P648, DOI 10.1002/jcp.21984; Ciesielski SJ, 2017, CURR GENET, V63, P51, DOI 10.1007/s00294-016-0618-y; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Corce V, 2016, BIOORG MED CHEM LETT, V26, P251, DOI 10.1016/j.bmcl.2015.11.094; Drapier JC, 1996, BIOESSAYS, V18, P549, DOI 10.1002/bies.950180706; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Golinelli-Cohen M.-P., 2017, CURR CHEM BIOL, V11, P70, DOI [10.2174/2212796811666170406163809, DOI 10.2174/2212796811666170406163809]; Guardiani C, 2016, BBA-BIOMEMBRANES, V1858, P813, DOI 10.1016/j.bbamem.2016.01.013; Guccini I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.5; Habener A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156054; Hagen T, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/436981; Holt SH, 2016, J CELL SCI, V129, P155, DOI 10.1242/jcs.178293; Karmi O., 2017, PLOS ONE, V12; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Maurya SR, 2015, J BIOL CHEM, V290, P30240, DOI 10.1074/jbc.M115.693978; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Mazure NM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00193; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Michieli P, 2009, CELL CYCLE, V8, P3291, DOI 10.4161/cc.8.20.9741; Mons C, 2017, METHOD ENZYMOL, V595, P83, DOI 10.1016/bs.mie.2017.07.010; Mylonis I, 2017, J CELL SCI, V130, P466, DOI 10.1242/jcs.195339; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Okazaki M, 2015, BBA-BIOMEMBRANES, V1848, P3188, DOI 10.1016/j.bbamem.2015.09.017; Reina S, 2016, ONCOTARGET, V7, P2249, DOI 10.18632/oncotarget.6850; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rouzier C, 2017, HUM MOL GENET, V26, P1599, DOI 10.1093/hmg/ddx060; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Shi Y, 2003, BIOCHEM BIOPH RES CO, V303, P475, DOI 10.1016/S0006-291X(03)00359-0; Shore GC, 2009, EMBO REP, V10, P1311, DOI 10.1038/embor.2009.249; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Ullmann P, 2016, ONCOTARGET, V7, P65454, DOI 10.18632/oncotarget.11772; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Wachnowsky C, 2017, METHOD ENZYMOL, V595, P55, DOI 10.1016/bs.mie.2017.06.045; Wang CH, 2014, HUM MOL GENET, V23, P4770, DOI 10.1093/hmg/ddu193; White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511; Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372; Yoshioka Y, 2012, J BIOL CHEM, V287, P34110, DOI 10.1074/jbc.M112.356717; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012; ZHOU G, 1992, J BIOL CHEM, V267, P7936	69	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194782	10.1371/journal.pone.0194782	http://dx.doi.org/10.1371/journal.pone.0194782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596470	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000042
J	Grzywocz, Z; Hoser, G; Sabalinska, S; Ladyzynski, P; Czubak, J; Dworczynska, M; Debski, R; Pius-Sadowska, E; Machalinski, B; Kawiak, J				Grzywocz, Zofia; Hoser, Grazyna; Sabalinska, Stanislawa; Ladyzynski, Piotr; Czubak, Jaroslaw; Dworczynska, Malgorzata; Debski, Romuald; Pius-Sadowska, Ewa; Machalinski, Boguslaw; Kawiak, Jerzy			Response of human normal and leukemia cells to factors released by amnion fragments in vitro	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MEMBRANE TRANSPLANTATION; ENDOTHELIAL-CELLS; SCATTER FACTOR; PROLIFERATION; EXPRESSION; RECEPTORS; PECAM-1; AXIS; BETA	Amnion is a membrane surrounding the embryo/fetus which determine growth factors and interleukins with angiogenic, immunogenic, and anti-inflammatory properties. The aim of the present study was to investigate the effects of conditioned culture medium from 24-h cultures of human amnion (hAM CCM) on migration and proliferation of human umbilical vein endothelial primary cells (HUVECs), freshly isolated bone marrow mononuclear cells (BM MNCs), and Jurkat leukemia cell line. Amnion membrane was freshly isolated from healthy placenta and its fragments cultured in vitro to produce hAM CCM. Members of the IGFBP protein family made up one third of all assayed proteins present in the hAM medium. The hAM CCM did not affect the proliferation rate of HUVECs or MNCs, but we observed more intensive migration of those cells, and lower expression of CD31 surface antigen on HUVECs as compared to control cultures. In contrast, Jurkat cells did not respond to hAM CCM treatment by proliferation or mobility change. The conditioned medium from 24-h cultures of human amnion is easy to obtain and is a convenient source of various growth and other factors that may be useful in practical medicine.	[Grzywocz, Zofia] Med Ctr Postgrad Educ, Dept Clin Cytophysiol, Warsaw, Poland; [Hoser, Grazyna; Kawiak, Jerzy] Med Ctr Postgrad Educ, Lab Flow Cytometry, Warsaw, Poland; [Sabalinska, Stanislawa; Ladyzynski, Piotr; Kawiak, Jerzy] Nalecz Inst Biocybernet & Biomed Engn PAS, Warsaw, Poland; [Czubak, Jaroslaw] Med Ctr Postgrad Educ, Clin Pediat Orthopedy & Traumatol, Warsaw, Poland; [Dworczynska, Malgorzata; Debski, Romuald] Bielanski Hosp, Obstet & Gynecol Clin, Warsaw, Poland; [Pius-Sadowska, Ewa; Machalinski, Boguslaw] Pomeranian Med Univ, Dept Gen Pathol, Szczecin, Poland	Centre of Postgraduate Medical Education - Poland; Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Centre of Postgraduate Medical Education - Poland; Pomeranian Medical University	Kawiak, J (corresponding author), Med Ctr Postgrad Educ, Lab Flow Cytometry, Warsaw, Poland.; Kawiak, J (corresponding author), Nalecz Inst Biocybernet & Biomed Engn PAS, Warsaw, Poland.	jkawiak@ibib.waw.pl	Ladyzynski, Piotr/U-2741-2019; Pius-Sadowska, Ewa/O-8254-2014	Ladyzynski, Piotr/0000-0003-3268-9896; Pius-Sadowska, Ewa/0000-0003-3106-8705; Machalinski, Boguslaw/0000-0002-6013-0419; Czubak, Jaroslaw/0000-0003-2358-8735; Hoser, Grazyna/0000-0002-0917-5611; Kawiak, Jerzy/0000-0002-3048-0653; Sabalinska, Stanislawa/0000-0001-5870-3647				Alio JL, 2005, EXPERT REV MED DEVIC, V2, P153, DOI 10.1586/17434440.2.2.153; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; COLOTTA F, 1993, EXP CELL RES, V206, P311, DOI 10.1006/excr.1993.1151; Duan-Arnold Y, 2015, ADV WOUND CARE, V4, P329, DOI 10.1089/wound.2015.0637; Duncan GS, 1999, J IMMUNOL, V162, P3022; GALIMI F, 1994, J CELL BIOL, V127, P1743, DOI 10.1083/jcb.127.6.1743; Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a; Grzywocz Z, 2012, ADV CELL BIOL, V39, P637; Grzywocz Z, 2014, FOLIA HISTOCHEM CYTO, V52, P163, DOI 10.5603/FHC.2014.0019; Jung HJ, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00472; Kasprzak A, 2017, MUTAT RES-REV MUTAT, V772, P78, DOI 10.1016/j.mrrev.2016.08.007; KOJIMA S, 1989, J CELL PHYSIOL, V138, P192, DOI 10.1002/jcp.1041380125; Koob TJ, 2013, INT WOUND J, V10, P493, DOI 10.1111/iwj.12140; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.x; MAKELA TP, 1987, MOL CELL BIOL, V7, P3656; Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Park S, 2015, CLIN SCI, V129, P217, DOI 10.1042/CS20140714; SORSBY A, 1947, BRIT J OPHTHALMOL, V31, P409, DOI 10.1136/bjo.31.7.409; Steinritz D, 2015, JOVE-J VIS EXP, DOI 10.3791/52768; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207; Zhao B, 2016, CELL TISSUE RES, V365, P85, DOI 10.1007/s00441-016-2366-1; Zloza A, 2011, CANCER IMMUNOL IMMUN, V60, P291, DOI 10.1007/s00262-010-0962-6	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195035	10.1371/journal.pone.0195035	http://dx.doi.org/10.1371/journal.pone.0195035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596519	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000069
J	Heo, JY; Seo, YB; Choi, WS; Lee, J; Yoon, JG; Lee, SN; Choi, MJ; Noh, JY; Ahn, JY; Jeong, HW; Cheong, HJ; Kim, WJ; Lee, HY; Song, JY				Heo, Jung Yeon; Seo, Yu Bin; Choi, Won Suk; Lee, Jacob; Yoon, Jin Gu; Lee, Saem Na; Choi, Min Joo; Noh, Ji Yun; Ahn, Jin-Young; Jeong, Hye Won; Cheong, Hee Jin; Kim, Woo Joo; Lee, Hee Young; Song, Joon Young			Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis	PLOS ONE			English	Article							CONJUGATE VACCINE; REQUIRING HOSPITALIZATION; COST-EFFECTIVENESS; ECONOMIC BURDEN; EPIDEMIOLOGY	Background Pneumonia is a leading infectious cause of morbidity and mortality among adults. Pneumococcal pneumonia (PP) is the most common vaccine-preventable bacterial etiology of pneumonia. In this study, we estimated the incidence of community-acquired pneumonia (CAP) and pneumococcal diseases among Korean adults. Methods Clinical and microbiological databases from three hospitals were retrospectively reviewed to determine the incidence and case fatality rates of CAP and pneumococcal diseases in Korean adults aged >= 19 years from 2011 to 2014. Incidence and case fatality rates of CAP, PP and invasive pneumococcal diseases (IPD) were evaluated based on the catchment population. Catchment population was calculated using national health insurance data, estimating the proportion of patients with pneumonia that were medically attended at each hospital. Results Among 5,783 patients with medically attended CAP, 833 (14.4%) had PP. For IPD, a total of 91 culture-confirmed cases were identified. The overall incidence of CAP was 307.7 cases per 100,000 persons per year with an in-hospital mortality rate of 6.2%. The estimated annual incidence of pneumococcal pneumonia was 42.2-49.4 cases per 100,000 persons per year, increasing with age to 280 per 100,000 persons per year in older patients over 70 years. The annual incidence of IPD had a range of 4.1-6.5 cases per 100,000 persons per year. The overall case fatality rate for invasive pneumococcal diseases was 30.8% with the highest rate of 66.7% in patients over 80 years. Conclusion Over the study period, incidences of CAP, PP and IPD were consistently high, particularly in older people. These results provide baseline data to establish healthcare strategies and estimate their impact among Korean adults.	[Heo, Jung Yeon] Ajou Univ, Dept Infect Dis, Sch Med, Suwon, South Korea; [Seo, Yu Bin; Lee, Jacob] Hallym Univ, Coll Med, Dept Internal Med, Div Infect Dis, Chunchon, South Korea; [Choi, Won Suk; Yoon, Jin Gu; Lee, Saem Na; Choi, Min Joo; Noh, Ji Yun; Cheong, Hee Jin; Kim, Woo Joo; Song, Joon Young] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Noh, Ji Yun; Cheong, Hee Jin; Kim, Woo Joo; Song, Joon Young] Korea Univ, Guro Hosp, APII, Seoul, South Korea; [Ahn, Jin-Young; Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea; [Ahn, Jin-Young] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Cheongju, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; [Lee, Hee Young] Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea	Ajou University; Hallym University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Chungbuk National University; Chungbuk National University; Chungbuk National University Hospital; Chungbuk National University; Chungbuk National University Hospital; Seoul National University (SNU)	Song, JY (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Song, JY (corresponding author), Korea Univ, Guro Hosp, APII, Seoul, South Korea.; Lee, HY (corresponding author), Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea.	wanderingstone@gmail.com; infection@korea.ac.kr	lee, hy/GRS-0797-2022; Choi, Won Suk/V-2730-2017	Heo, Jung Yeon/0000-0002-6548-1939; Cheong, Hee Jin/0000-0002-2532-1463; Choi, Won Suk/0000-0001-5874-4764; Song, Joon Young/0000-0002-0148-7194				Almirall J, 2000, EUR RESPIR J, V15, P757, DOI 10.1034/j.1399-3003.2000.15d21.x; BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; Bodi M, 2005, CLIN INFECT DIS, V41, P1709, DOI 10.1086/498119; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; CDC, 2016, ACT BACT COR SURV RE; Choi MJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008429; Choi MJ, 2015, J INFECT CHEMOTHER, V21, P672, DOI 10.1016/j.jiac.2015.06.003; Chowdhary S, 2008, B WHO, V86; Dirmesropian S, 2015, HUM VACC IMMUNOTHER, V11, P818, DOI 10.1080/21645515.2015.1011954; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Heo JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177342; Hoshi SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139140; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Kyaw MH, 2003, CLIN INFECT DIS, V37, P1283, DOI 10.1086/379016; Lee HY, 2017, J MICROBIOL IMMUNOL; Lee SG., 2013, KOREAN NATL IMMUNIZA; Marrie Thomas J, 2005, Can Respir J, V12, P139; MARRIE TJ, 1994, CLIN INFECT DIS, V18, P501, DOI 10.1093/clinids/18.4.501; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; Reinert RR, 2005, CLIN MICROBIOL INFEC, V11, P985, DOI 10.1111/j.1469-0691.2005.01282.x; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Schnoor M, 2007, J INFECTION, V55, P233, DOI 10.1016/j.jinf.2007.04.355; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Sohn JW, 2006, J KOREAN MED SCI, V21, P602, DOI 10.3346/jkms.2006.21.4.602; Song JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093477; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Song JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-202; Song JY, 2013, J KOREAN MED SCI, V28, P4, DOI 10.3346/jkms.2013.28.1.4; Statistics Korea, 2017, KOR STAT INF SERV; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; Takaki M, 2014, JPN J INFECT DIS, V67, P269, DOI 10.7883/yoken.67.269; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang TU, 2016, VACCINE, V34, P1623, DOI 10.1016/j.vaccine.2016.01.043; Yoo KH, 2013, J KOREAN MED SCI, V28, P888, DOI 10.3346/jkms.2013.28.6.888; Zar HJ, 2013, THORAX, V68, P1052, DOI 10.1136/thoraxjnl-2013-204247	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194598	10.1371/journal.pone.0194598	http://dx.doi.org/10.1371/journal.pone.0194598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596444	gold, Green Submitted, Green Published			2022-12-27	WOS:000428630000033
J	Jang, MH; Hwang, YS				Jang, Min-Hee; Hwang, Yu Sik			Effects of functionalized multi-walled carbon nanotubes on toxicity and bioaccumulation of lead in Daphnia magna	PLOS ONE			English	Article							HEAVY-METAL IONS; AQUEOUS-SOLUTION; ADSORPTION; CADMIUM; SURFACE; SINGLE; ACCUMULATION; EXPOSURE; SORPTION; REMOVAL	Increased production of carbon nanotubes (CNTs) and their widespread application in industrial and consumer products have led to a rise in the release of CNTs into the aquatic environment. CNTs have a very strong adsorption affinity for various environmental contaminants; therefore, they may also influence the toxic effects of other pollutants, such as toxic metals. In this study, the effect of two different functionalized carbon nanotubes, carboxylate and polyethyleneimine modified multi-walled carbon nanotubes (C-MWCNTs and N-MWCNT, respectively) on lead toxicity and bioaccumulation was investigated with a freshwater zooplankton Daphnia magna. The acute toxicity results indicate that the different surface properties of the two types of MWCNTs have different effects on lead toxicity to D. magna. The negatively charged C-MWCNT showed a notable decrease in lead toxicity (LC50 value increased from 0.15 mg L-1 to 1.08 mg L-1 in the presence of 10 mg L-1 C-MWCNT), whereas the positively charged N-MWCNT had only a slight effect on lead toxicity (LC50 value increased from 0.15 mg L-1 to 0.16 mg L-1 in the presence of 10 mg L-1 N-MWCNT). The decrease of lead toxicity was related with the reduced bioavailability of free metal form (Pb2+) caused by greater adsorption of lead onto the MWCNTs. The present study suggests that there is a need to consider carefully the complex interaction of CNTs with toxic metals in future ecotoxicological studies.	[Jang, Min-Hee; Hwang, Yu Sik] Korea Inst Toxicol, Future Environm Res Ctr, Jinju, Gyeongsangnam D, South Korea	Korea Institute of Toxicology	Hwang, YS (corresponding author), Korea Inst Toxicol, Future Environm Res Ctr, Jinju, Gyeongsangnam D, South Korea.	yshwang@kitox.re.kr						Altindag A, 2008, AFR J BIOTECHNOL, V7, P4298; [Anonymous], EURASIP J WIRELESS C, DOI DOI 10.11646/Z00TAXA.3989.1.1; Balasubramanian K, 2005, SMALL, V1, P180, DOI 10.1002/smll.200400118; Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k; Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x; Frolov AI, 2010, CHEMPHYSCHEM, V11, P2612, DOI 10.1002/cphc.201000231; Gao HJ, 2016, WATER SCI TECHNOL, V73, P1269, DOI 10.2166/wst.2015.601; Ihsanullah, 2016, SEP PURIF TECHNOL, V157, P141, DOI 10.1016/j.seppur.2015.11.039; Kim KT, 2009, ENVIRON SCI TECHNOL, V43, P8979, DOI 10.1021/es900647f; Kumar R, 2015, J WATER HEALTH, V13, P18, DOI 10.2166/wh.2014.024; Lee J, 2007, MEAS SCI TECHNOL, V18, P3707, DOI 10.1088/0957-0233/18/12/005; Li YH, 2003, CARBON, V41, P1057, DOI 10.1016/S0008-6223(02)00440-2; Li YH, 2005, WATER RES, V39, P605, DOI 10.1016/j.watres.2004.11.004; Liu J, 2015, ENVIRON TOXICOL CHEM, V34, P2824, DOI 10.1002/etc.3122; Moradi O, 2011, INT J NANO DIMENS, V1, P203, DOI 10.7508/ijnd.2010.03.004; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023; Pacurari M, 2008, ENVIRON HEALTH PERSP, V116, P1211, DOI 10.1289/ehp.10924; Park M, 2011, CARBON, V49, P811, DOI 10.1016/j.carbon.2010.10.019; Qin L, 2014, ENVIRON TOXICOL PHAR, V38, P199, DOI 10.1016/j.etap.2014.05.016; Qu RJ, 2014, J HAZARD MATER, V275, P89, DOI 10.1016/j.jhazmat.2014.04.051; Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7; Rao GP, 2007, SEP PURIF TECHNOL, V58, P224, DOI 10.1016/j.seppur.2006.12.006; Saleh NB, 2010, ENVIRON SCI TECHNOL, V44, P2412, DOI 10.1021/es903059t; Sayanty S., 2009, THESIS; Shooto N. D., 2015, CHEM SCI J, V6; Srivastava S., 2013, MATER LETT, V4, P2, DOI [DOI 10.5185/amlett.2013.icnano.110, 10.5185/amlett.2013.icnano.110, DOI 10.5185/AMLETT.2013.ICNANO.110]; Stafiej A, 2007, SEP PURIF TECHNOL, V58, P49, DOI 10.1016/j.seppur.2007.07.008; Tejral G, 2009, J APPL BIOMED, V7, P1; Tian XL, 2012, CHEMOSPHERE, V89, P1316, DOI 10.1016/j.chemosphere.2012.05.082; Tofighy MA, 2011, J HAZARD MATER, V185, P140, DOI 10.1016/j.jhazmat.2010.09.008; Uo M, 2011, DENT MATER J, V30, P245, DOI 10.4012/dmj.2010-039; Vukovic GD, 2011, CHEM ENG J, V173, P855, DOI 10.1016/j.cej.2011.08.036; Wang HJ, 2007, J COLLOID INTERF SCI, V316, P277, DOI 10.1016/j.jcis.2007.07.075; Wang XH, 2016, ENVIRON TOXICOL CHEM, V35, P1852, DOI 10.1002/etc.3340; Wang XH, 2016, ENVIRON POLLUT, V208, P732, DOI 10.1016/j.envpol.2015.10.053; World Health Organization, 2017, LEAD POIS HLTH; Xu D, 2008, J HAZARD MATER, V154, P407, DOI 10.1016/j.jhazmat.2007.10.059; Yu XL, 2013, J ENVIRON SCI, V25, P933, DOI 10.1016/S1001-0742(12)60145-4; Zhou Y, 2017, WATER SCI TECHNOL, V76, P302, DOI 10.2166/wst.2017.198	40	29	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194935	10.1371/journal.pone.0194935	http://dx.doi.org/10.1371/journal.pone.0194935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596457	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000053
J	Biscotti, MA; Barucca, M; Canapa, A				Biscotti, Maria Assunta; Barucca, Marco; Canapa, Adriana			New insights into the genome repetitive fraction of the Antarctic bivalve Adamussium colbecki	PLOS ONE			English	Article							MOLLUSK DONAX-TRUNCULUS; TRANSPOSABLE ELEMENTS MITES; SATELLITE DNA; PECTINIDAE MOLLUSCA; MOLECULAR PHYLOGENY; TANDEM REPEATS; TRNASCAN-SE; RNA GENES; EVOLUTION; FAMILY	Repetitive DNA represents the major component of the genome in both plant and animal species. It includes transposable elements (TEs), which are dispersed throughout the genome, and satellite DNAs (satDNAs), which are tandemly organized in long arrays. The study of the structure and organization of repetitive DNA contributes to our understanding of genome architecture and the mechanisms leading to its evolution. Molluscs represent one of the largest groups of invertebrates and include organisms with a wide variety of morphologies and lifestyles. To increase our knowledge of bivalves at the genome level, we analysed the Antarctic scallop Adamussium colbecki. The screening of the genomic library evidenced the presence of two novel satDNA elements and the CvA transposon. The interspecific investigation performed in this study demonstrated that one of the two satDNAs isolated in A. colbecki is widespread in polar molluscan species, indicating a possible link between repetitive DNA and abiotic factors. Moreover, the transcriptional activity of CvA and its presence in long-diverged bivalves suggests a possible role for this ancient element in shaping the genome architecture of this Glade.	[Biscotti, Maria Assunta; Barucca, Marco; Canapa, Adriana] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy	Marche Polytechnic University	Barucca, M (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	m.barucca@univpm.it			"Programma Nazionale di Ricerche in Antartide" (PNRA) [PdR 2009/A1.10]	"Programma Nazionale di Ricerche in Antartide" (PNRA)	This work was supported by a grant (PdR 2009/A1.10) from "Programma Nazionale di Ricerche in Antartide" (PNRA).	Albertin CB, 2015, NATURE, V524, P220, DOI 10.1038/nature14668; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barucca M, 2004, MOL PHYLOGENET EVOL, V31, P89, DOI 10.1016/j.ympev.2003.07.003; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Biscotti MA, 2007, GENE, V406, P91, DOI 10.1016/j.gene.2007.06.027; Biscotti MA, 2014, CYTOGENET GENOME RES, V144, P212, DOI 10.1159/000370054; Biscotti MA, 2008, CHROMOSOME RES, V16, P907, DOI 10.1007/s10577-008-1248-0; Biscotti MA, 2015, CHROMOSOME RES, V23, P415, DOI 10.1007/s10577-015-9499-z; Biscotti MA, 2015, CHROMOSOME RES, V23, P463, DOI 10.1007/s10577-015-9494-4; Canapa A, 2000, J MOL EVOL, V50, P93, DOI 10.1007/s002399910010; Canapa A, 2015, CYTOGENET GENOME RES, V147, P217, DOI 10.1159/000444429; Cheng ZJ, 2003, GENETICS, V164, P665; Clabby C, 1996, GENE, V168, P205, DOI 10.1016/0378-1119(95)00749-0; Emadzade K, 2014, ANN BOT-LONDON, V114, P1597, DOI 10.1093/aob/mcu178; Feliciello I, 2013, EPIGENETICS-US, V8, P534, DOI 10.4161/epi.24507; Ferreira D, 2015, CHROMOSOME RES, V23, P479, DOI 10.1007/s10577-015-9482-8; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Garrido-Ramos MA, 1998, CYTOGENET CELL GENET, V83, P3, DOI 10.1159/000015151; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hernandez-Ibarra NK, 2008, GENOME, V51, P570, DOI 10.1139/G08-041; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178; Kapitonov VV, 1998, MOL BIOL EVOL, V15, P611, DOI 10.1093/oxfordjournals.molbev.a025963; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; KNIGHT M, 1992, GENE, V118, P181, DOI 10.1016/0378-1119(92)90187-T; Koga A, 2014, DNA RES, V21, P407, DOI 10.1093/dnares/dsu005; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kourtidis A, 2006, GENOME, V49, P1451, DOI 10.1139/G06-111; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Levitsky VG, 2014, J BIOMOL STRUCT DYN, V32, P115, DOI 10.1080/07391102.2012.755796; Lopez-Flores I, 2004, GENE, V339, P181, DOI 10.1016/j.gene.2004.06.049; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Lopez-Flores I, 2010, GENETICA, V138, P1211, DOI 10.1007/s10709-010-9517-1; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Macas J, 2009, GENE, V448, P198, DOI 10.1016/j.gene.2009.06.014; Martinez-Lage A, 2005, GENOME, V48, P247, DOI 10.1139/G04-115; Martinez-Lage A, 2002, GENOME, V45, P922, DOI [10.1139/g02-056, 10.1139/G02-056]; Matveev V, 2009, GENE, V434, P16, DOI 10.1016/j.gene.2008.04.022; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; Mestrovic N, 2015, CHROMOSOME RES, V23, P583, DOI 10.1007/s10577-015-9483-7; Miller WJ, 2000, MOL BIOL EVOL, V17, P1597, DOI 10.1093/oxfordjournals.molbev.a026259; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mravinac B, 2005, J MOL EVOL, V61, P542, DOI 10.1007/s00239-004-0342-y; Mravinac B, 2010, MOL BIOL EVOL, V27, P1857, DOI 10.1093/molbev/msq068; Muchmore ME, 1998, MOL MAR BIOL BIOTECH, V7, P1; Nakanishi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043785; Nishihara H, 2016, GENOME BIOL EVOL, V8, P528, DOI 10.1093/gbe/evw029; Noma K, 2000, DNA RES, V7, P1, DOI 10.1093/dnares/7.1.1; Oki N, 2008, GENES GENET SYST, V83, P321, DOI 10.1266/ggs.83.321; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Panchin Y, 2008, BIOCHEM BIOPH RES CO, V369, P818, DOI 10.1016/j.bbrc.2008.02.097; Passamonti M, 1998, ZOOL SCI, V15, P599, DOI 10.2108/0289-0003(1998)15[599:COAHRD]2.0.CO;2; Pennisi E, 2010, SCIENCE, V330, P1614, DOI 10.1126/science.330.6011.1614; Petraccioli A, 2015, MOL GENET GENOMICS, V290, P1717, DOI 10.1007/s00438-015-1036-4; Petrovic V, 2005, GENE, V362, P37, DOI 10.1016/j.gene.2005.06.044; Petrovic V, 2009, CYTOGENET GENOME RES, V124, P63, DOI 10.1159/000200089; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Piacentini L, 2014, CHROMOSOMA, V123, P345, DOI 10.1007/s00412-014-0464-y; Plohl M, 1997, J MOL EVOL, V44, P189, DOI 10.1007/PL00006135; Plohl M, 2012, GENOME DYNAM, V7, P126, DOI 10.1159/000337122; Plohl M, 2010, HEREDITY, V104, P543, DOI 10.1038/hdy.2009.141; Plohl M, 1996, GENE, V169, P157, DOI 10.1016/0378-1119(95)00734-2; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Pontecorvo G, 2000, MOL BIOL REP, V27, P225, DOI 10.1023/A:1011003928698; RUIZLARA S, 1992, GENE, V117, P237; Satovic E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3347-1; Satovic E, 2013, GENOME BIOL EVOL, V5, P2549, DOI 10.1093/gbe/evt202; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Serb JM, 2017, J EVOLUTION BIOL, V30, P1736, DOI 10.1111/jeb.13137; Sharma A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-142; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Vera M, 2015, MAR GENOM, V24, P335, DOI 10.1016/j.margen.2015.08.006; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Vittorazzi SE, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0111-x; Wang S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0120; Warren IA, 2015, CHROMOSOME RES, V23, P505, DOI 10.1007/s10577-015-9493-5; Willard HF, 1998, CURR OPIN GENET DEV, V8, P219, DOI 10.1016/S0959-437X(98)80144-5; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	79	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194502	10.1371/journal.pone.0194502	http://dx.doi.org/10.1371/journal.pone.0194502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590185	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100063
J	Chen, T; Ren, CH; Jiang, X; Zhang, LP; Li, HM; Huang, W; Hu, CQ				Chen, Ting; Ren, Chunhua; Jiang, Xiao; Zhang, Lvping; Li, Hongmei; Huang, Wen; Hu, Chaoqun			Mechanisms for type-II vitellogenesis-inhibiting hormone suppression of vitellogenin transcription in shrimp hepatopancreas: Crosstalk of GC/cGMP pathway with different MAPK-dependent cascades	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; CRUSTACEAN HYPERGLYCEMIC HORMONE; PRAWN MARSUPENAEUS-JAPONICUS; LOBSTER HOMARUS-AMERICANUS; CDNA-ENCODING VITELLOGENIN; MESSENGER-RNA EXPRESSION; SYNDROME VIRUS-INFECTION; VTG GENE-EXPRESSION; GREEN SHORE CRAB; LITOPENAEUS-VANNAMEI	Vitellogenesis is the process of yolk formation via accumulating vitellin (Vn) with nutrients in the oocytes. Expression of vitellogenin (Vg), the precursor of Vn, is one of the indicators for the start of vitellogenesis. In Pacific white shrimp (Litopenaeus vannamel), the type-II vitellogenesis-inhibiting hormone (VIH-2) effectively suppresses hepatopancreatic Vg mRNA expression. In this study, we demonstrate the increasing transcript levels of hepatopancreatic Vg during L. vannamei ovarian development, suggesting that the hepatopancreas-derived Vg/Nn may also contribute to vitellogenesis in this species. Using a combination of in vivo injections and in vitro primary cell cultures, we provide evidences that the inhibition of VIH-2 on hepatopancreatic Vg gene expression is mediated through a functional coupling of the GC/cGMP pathway with different MAPK-dependent cascades in female shrimp. In VIH-2 signaling, the NO-independent GC/cGMP/PKG cascades were upstream of the MAPKs. Activations of the MAPK signal by VIH-2 include the phosphorylation of JNK and the mRNA/protein expression of P(38)MAPK. Additionally, the cAMP/PKA pathway is another positive intracellular signal for hepatopancreatic Vg mRNA expression but is independent of its VIH-2 regulation. Our findings establish a model for the signal transduction mechanism of Vg regulation by VIH and shed light on the biological functions and signaling of the CHH family in crustaceans.	[Chen, Ting; Ren, Chunhua; Jiang, Xiao; Zhang, Lvping; Li, Hongmei; Huang, Wen; Hu, Chaoqun] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangzhou, Guangdong, Peoples R China; [Chen, Ting; Ren, Chunhua; Jiang, Xiao; Zhang, Lvping; Li, Hongmei; Huang, Wen; Hu, Chaoqun] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Guangdong, Peoples R China; [Chen, Ting; Ren, Chunhua; Huang, Wen; Hu, Chaoqun] South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Li, Hongmei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Huang, W; Hu, CQ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangzhou, Guangdong, Peoples R China.; Huang, W; Hu, CQ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Guangdong, Peoples R China.; Huang, W; Hu, CQ (corresponding author), South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China.	huangwen@scsio.ac.cn; hucq@scsio.ac.cn	huang, wen/GXW-0661-2022	Chen, Ting/0000-0002-5777-909X	National Natural Science Foundation of China [31402287, 31602135]; Guangdong Province Program [2016A020210062, 2017B030314052, 2017A030310429, 2013B091300020, 2014B030301064, 2015B020231007, 2016A030310112]; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province [A201601A03]; National High Technology Research & Development Program of China (863 Program) [2012AA10A404-4]; Science and Technology Service Network Initiative of the Chinese Academy of Sciences [KFJ-SW-STS-146]; National Share & Service Platform Construction Program for Aquaculture Germplasm and Resources [2017DKA30470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Program; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province; National High Technology Research & Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science and Technology Service Network Initiative of the Chinese Academy of Sciences; National Share & Service Platform Construction Program for Aquaculture Germplasm and Resources	This work was supported by grants from the National Natural Science Foundation of China (31402287 to Dr. Ting Chen and 31602135 to Dr. Wen Huang), the Guangdong Province Program (2016A020210062 to Dr. Ting Chen, 2017B030314052 to Dr. Wen Huang, 2017A030310429 to Dr. Xiao Jiang, 2013B091300020 to Prof. Chaoqun Hu, 2014B030301064 to Prof. Chaoqun Hu, 2015B020231007 to Prof. Chaoqun Hu and 2016A030310112 to Prof. Chaoqun Hu), the Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province (A201601A03 to Prof. Chaoqun Hu), the National High Technology Research & Development Program of China (863 Program) (2012AA10A404-4 to Ms. Chunhua Ren), the Science and Technology Service Network Initiative of the Chinese Academy of Sciences (KFJ-SW-STS-146 to Prof. Chaoqun Hu) and the National Share & Service Platform Construction Program for Aquaculture Germplasm and Resources (2017DKA30470 to Dr. Lvping Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcos FG, 2011, AQUACULTURE, V316, P93, DOI 10.1016/j.aquaculture.2011.02.045; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; Azzouna A, 2003, GEN COMP ENDOCR, V131, P134, DOI 10.1016/S0016-6480(02)00645-7; Bae SH, 2017, GEN COMP ENDOCR, V246, P301, DOI 10.1016/j.ygcen.2017.01.006; Bae SH, 2013, FISHERIES SCI, V79, P895, DOI 10.1007/s12562-013-0652-3; Chan SM, 2003, GEN COMP ENDOCR, V134, P214, DOI 10.1016/S0016-6480(03)00263-6; Chen T, 2016, AQUACULTURE, V451, P405, DOI 10.1016/j.aquaculture.2015.10.005; Chen T, 2015, FISH SHELLFISH IMMUN, V42, P114, DOI 10.1016/j.fsi.2014.10.042; Chen T, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115030; Chung JS, 2006, GEN COMP ENDOCR, V147, P206, DOI 10.1016/j.ygcen.2006.01.002; Covi JA, 2009, COMP BIOCHEM PHYS A, V152, P470, DOI 10.1016/j.cbpa.2008.12.005; DEKLEIJN DPV, 1994, FEBS LETT, V353, P255, DOI 10.1016/0014-5793(94)01055-2; Feijo RG, 2016, MAR BIOTECHNOL, V18, P117, DOI 10.1007/s10126-015-9676-2; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Hopkins PM, 2012, GEN COMP ENDOCR, V175, P357, DOI 10.1016/j.ygcen.2011.12.002; Huang W, 2017, PLOS ONE, V12; Huang XS, 2017, GEN COMP ENDOCR, V250, P175, DOI 10.1016/j.ygcen.2017.06.013; Jasmani S, 2000, FISHERIES SCI, V66, P535, DOI 10.1046/j.1444-2906.2000.00084.x; Kang BJ, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112243; Kung SY, 2004, BIOL REPROD, V71, P863, DOI 10.1095/biolreprod.103.022905; Lee SG, 2007, J EXP BIOL, V210, P3245, DOI 10.1242/jeb.007740; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Li GL, 2015, GENET MOL RES, V14, P14056, DOI 10.4238/2015.October.29.25; Li GL, 2015, GENES GENOM, V37, P883, DOI 10.1007/s13258-015-0315-0; Li K, 2006, COMP BIOCHEM PHYS B, V143, P453, DOI 10.1016/j.cbpb.2005.12.019; Li R, 2016, J EXP BIOL, V219, P1259, DOI 10.1242/jeb.133181; Luo X, 2015, PEPTIDES, V68, P58, DOI 10.1016/j.peptides.2014.11.002; Mykles DL, 2010, PHYSIOL BIOCHEM ZOOL, V83, P836, DOI 10.1086/648470; Nagai C, 2014, J BIOL CHEM, V289, P32166, DOI 10.1074/jbc.M114.590646; Nagai C, 2009, ANN NY ACAD SCI, V1163, P478, DOI 10.1111/j.1749-6632.2009.04452.x; Ohira T, 2006, PEPTIDES, V27, P1251, DOI 10.1016/j.peptides.2005.10.019; Okumura T, 2007, COMP BIOCHEM PHYS A, V147, P1028, DOI 10.1016/j.cbpa.2007.03.011; Okumura T, 2007, ZOOL SCI, V24, P233, DOI 10.2108/zsj.24.233; Okumura T, 2006, GEN COMP ENDOCR, V148, P245, DOI 10.1016/j.ygcen.2006.03.005; Okuno A, 2002, J EXP ZOOL, V292, P417, DOI 10.1002/jez.10083; Pitts NL, 2017, COMP BIOCHEM PHYS A, V203, P328, DOI 10.1016/j.cbpa.2016.10.012; Qiao H, 2015, COMP BIOCHEM PHYS A, V185, P1, DOI [10.1016/j.cbpa.2015.03.005, 10.1016/j.hemonc.2014.09.004]; Quackenbush LS, 2001, AM ZOOL, V41, P458, DOI 10.1668/0003-1569(2001)041[0458:YSITMS]2.0.CO;2; Raviv S, 2006, GEN COMP ENDOCR, V145, P39, DOI 10.1016/j.ygcen.2005.06.009; Shi H, 2014, DEV COMP IMMUNOL, V44, P180, DOI 10.1016/j.dci.2013.12.005; Shi H, 2012, FISH SHELLFISH IMMUN, V33, P813, DOI 10.1016/j.fsi.2012.07.008; Shi H, 2012, DEV COMP IMMUNOL, V37, P421, DOI 10.1016/j.dci.2012.03.002; SOYEZ D, 1987, J EXP ZOOL, V244, P479, DOI 10.1002/jez.1402440314; Treerattrakool S, 2008, FEBS J, V275, P970, DOI 10.1111/j.1742-4658.2008.06266.x; Treerattrakool S, 2011, MAR BIOTECHNOL, V13, P163, DOI 10.1007/s10126-010-9276-0; Tsukimura B, 2001, AM ZOOL, V41, P465, DOI 10.1668/0003-1569(2001)041[0465:CVIRIO]2.0.CO;2; Tsutsui N, 2000, ZOOL SCI, V17, P651, DOI 10.2108/zsj.15.651; Tsutsui N, 2004, J EXP ZOOL PART A, V301A, P802, DOI 10.1002/jez.a.53; Tsutsui N, 2007, MAR BIOTECHNOL, V9, P360, DOI 10.1007/s10126-006-6151-0; Tsutsui N, 2013, FISHERIES SCI, V79, P357, DOI 10.1007/s12562-013-0603-z; Ventura-Lopez C, 2017, GEN COMP ENDOCR, V246, P164, DOI 10.1016/j.ygcen.2016.12.005; Vrinda S, 2017, COMP BIOCHEM PHYS A, V203, P167, DOI 10.1016/j.cbpa.2016.09.007; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wongprasert K, 2006, AQUACULTURE, V261, P1447, DOI 10.1016/j.aquaculture.2006.08.044; Wu LT, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104752; Xu DD, 2014, DEV COMP IMMUNOL, V47, P287, DOI 10.1016/j.dci.2014.08.004; Yamano K, 2004, BIOL REPROD, V70, P1670, DOI 10.1095/biolreprod.103.025379; Yan AF, 2016, INT J BIOL SCI, V12, P1544, DOI 10.7150/ijbs.16612; Yao DF, 2015, DEV COMP IMMUNOL, V49, P282, DOI 10.1016/j.dci.2014.12.012; Zheng J, 2008, GEN COMP ENDOCR, V155, P780, DOI 10.1016/j.ygcen.2007.10.009; Zmora Nilli, 2009, Saline Syst, V5, P6, DOI 10.1186/1746-1448-5-6	62	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194459	10.1371/journal.pone.0194459	http://dx.doi.org/10.1371/journal.pone.0194459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590153	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100060
J	Nguenha, N; Tivane, A; Pale, M; Machalele, L; Nacoto, A; Pires, G; Mationane, E; Salencia, J; Gundane, F; Muteto, D; Chilundo, J; Mavale, S; Adamo, N; Sema-Baltazar, C; Augusto, O; Gudo, E; Mussa, T				Nguenha, Neuza; Tivane, Almiro; Pale, Mirela; Machalele, Loira; Nacoto, Afonso; Pires, Germano; Mationane, Edirsse; Salencia, Judite; Gundane, Felix; Muteto, Delcio; Chilundo, Josina; Mavale, Sandra; Adamo, Noorbebi; Sema-Baltazar, Cynthia; Augusto, Orvalho; Gudo, Eduardo; Mussa, Tufaria			Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014-2016	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HOSPITALIZED CHILDREN; GLOBAL BURDEN; SOUTH-AFRICA; SEASONAL INFLUENZA; HIGH-PREVALENCE; RISK-FACTORS; ILLNESS; COUNTRIES; ETIOLOGY	In Sub-Saharan Africa, where burden, impact, and incidence of acute respiratory infections (ARI) are the highest in the world, conversely, the epidemiology of influenza-associated severe acute respiratory infections (SARI) is incompletely known. The aim of this study was to describe the clinical and epidemiological features of influenza-associated SARI in hospitalized children in Maputo city, Mozambique. Nasopharyngeal and oropharyngeal swabs were collected from children aged 0-14 years old who met the case definition for SARI in two hospitals in Maputo city after their parents or legal representative consented to participate. A structured questionnaire was used to collect clinical and demographic data. Typing and subtyping of influenza were performed by real-time PCR. From January 2014 to December 2016, a total of 2,007 eligible children were recruited, of whom 1,997 (99.5%) were screened for influenza by real-time PCR. The median age of participants was 16.9 months (IQR: 7.0-38.9 months) and 53.9% (1076/1991) were male. A total of 77 were positive for influenza, yielding a frequency of 3.9% (77/1,991), with the highest frequency being reported in the age group 1-5 years old. Cases of influenza peaked twice each year, during which, its frequency reached up to 60%-80%. Among all influenza confirmed cases, 33.7% (26/77), 35.1% (27/77) and 28.6% (22/77) were typed as influenza A/H3N2, A/H1N1pdm09, and B, respectively. This represents the first report of influenza in urban/sub urban setting in Mozambique and the first evidence of distribution of strains of influenza in the country. Our data showed that frequency of influenza was lower than reported in a rural setting in Mozambique and the frequency of seasonal (A/H1N1pdm09) and (A/H3N2) subtypes were similar in children with SARI.	[Nguenha, Neuza; Tivane, Almiro; Pale, Mirela; Machalele, Loira; Nacoto, Afonso; Pires, Germano; Mationane, Edirsse; Salencia, Judite; Gundane, Felix; Adamo, Noorbebi; Sema-Baltazar, Cynthia; Gudo, Eduardo; Mussa, Tufaria] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Salencia, Judite; Gundane, Felix] Hosp Geral de Mavalane, Pediat Dept, Maputo, Mozambique; [Muteto, Delcio; Chilundo, Josina; Mavale, Sandra] Hosp Cent Maputo, Pediat Dept, Maputo, Mozambique; [Augusto, Orvalho; Mussa, Tufaria] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique	Eduardo Mondlane University	Nguenha, N (corresponding author), Minist Hlth, Natl Inst Hlth, Maputo, Mozambique.	neusaguenha@gmail.com	Augusto, Orvalho/J-8767-2019	Augusto, Orvalho/0000-0002-0005-3968; Mussa, Tufaria/0000-0002-9635-3585	Centers for Diseases Control and Prevention [1U51IP000825-01]; World Health Organization	Centers for Diseases Control and Prevention; World Health Organization(World Health Organization)	This work was supported by the Centers for Diseases Control and Prevention (Grant #1U51IP000825-01) http://www.cdc.gov and the World Health Organization, www.who.int The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2015, INFLUENZA OTHER RESP, V9, P101, DOI 10.1111/irv.12308; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cummings MJ, 2016, ANN AM THORAC SOC, V13, P2159, DOI 10.1513/AnnalsATS.201607-561OC; Cunguara B FG, 2012, J AFRICAN DEV 2012 J, V14; El Kholy AA, 2014, J INFECT DEV COUNTR, V8, P1285, DOI 10.3855/jidc.4682; Emukule GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138708; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Heraud JM, 2012, J INFECT DIS, V206, pS5, DOI 10.1093/infdis/jis541; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Ho A, 2017, CLIN INFECT DIS; Huai Y, 2017, INFLUENZA OTHER RESP, V11, P148, DOI 10.1111/irv.12419; INE, 2007, ANUARIO ESTATSTICO R; Iuliano A. D., 2017, LANCET; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Ma HY, 2016, J MICROBIOL IMMUNOL, V49, P387, DOI 10.1016/j.jmii.2015.05.015; Mainassara HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133178; McMorrow ML, 2015, J INFECT DIS, V212, P853, DOI 10.1093/infdis/jiv100; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Mulholland K, 2003, PEDIATR PULM, V36, P469, DOI 10.1002/ppul.10344; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; O'Callaghan-Gordo C, 2011, TROP MED INT HEALTH, V16, P1054, DOI 10.1111/j.1365-3156.2011.02811.x; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Peterson I, 2016, J INFECT DIS, V214, P1700, DOI 10.1093/infdis/jiw426; Pretorius MA, 2016, J CLIN VIROL, V75, P21, DOI 10.1016/j.jcv.2015.12.004; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; SaUde INd Estatistica INd Macro I., 2010, INQ NAC PREV RISC CO; Simusika P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0779-1; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Theo A, 2012, J INFECT DIS, V206, pS173, DOI 10.1093/infdis/jis599; UNAIDS, 2015, AIDSINFO 2015; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Vasileiou E, 2017, CLIN INFECT DIS, V65, P1388, DOI 10.1093/cid/cix524; Wabwire-Mangen F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164861; Walaza S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx116; WHO, 2016, INFL SEAS 2016; WHO, 2017, WHO SURV CAS DEF ILI; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	43	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194138	10.1371/journal.pone.0194138	http://dx.doi.org/10.1371/journal.pone.0194138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590162	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100050
J	Pandey, PR; Sarwade, RD; Khalique, A; Seshadri, V				Pandey, Poonam R.; Sarwade, Rucha D.; Khalique, Abdul; Seshadri, Vasudevan			Interaction of HuDA and PABP at 5'UTR of mouse insulin2 regulates insulin biosynthesis	PLOS ONE			English	Article							BINDING PROTEIN HUD; PRE-MESSENGER-RNA; TRANSLATIONAL CONTROL; 5'-UNTRANSLATED REGION; GLUCOSE REGULATION; GENE-EXPRESSION; POLY(A); ELAV; TRANSCRIPTION; ELEMENTS	Understanding the regulation of insulin biosynthesis is important as it plays a central role in glucose metabolism. The mouse insulin gene2 (Ins2) has two splice variants; long (Ins2L) and short (Ins2S), that differ only in their 5'UTR sequence and Ins2S is the major transcript which translate more efficiently as compared to Ins2L. Here, we show that cellular factors bind preferentially to the Ins2L 5'UTR, and that PABP and HuD can bind to Ins2 splice variants and regulate its translation. In vitro binding assay with insulin 5'UTR and different HuD isoforms indicate that the 'N' terminal region of HuD is important for RNA binding and insulin translation repression. Using reporter assay we showed that specifically full-length HuD A isoform represses translation of reporter containing insulin 5'UTR. We further show that PABP and HuD interact with each other in RNA-dependent manner and this interaction is affected by glucose and PDI (5'UTR associated translation activator). These results suggest that PABP interacts with HuD in basal glucose conditions making translation inhibitory complex, however upon glucose stimulation this association is affected and PABP is acted upon by PDI resulting in stimulation of insulin translation. Together, our findings snapshot the mechanism of post-transcriptional regulation of insulin biosynthesis.	[Pandey, Poonam R.; Sarwade, Rucha D.; Khalique, Abdul; Seshadri, Vasudevan] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Pandey, Poonam R.; Sarwade, Rucha D.; Khalique, Abdul] Savitribai Phule Pune Univ, Dept Biotechnol, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Seshadri, V (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	seshadriv@nces.res.in	PANDEY, POONAM/AAV-5030-2020; Khalique, Abdul/AAJ-8079-2020	Khalique, Abdul/0000-0003-0499-1115; Seshadri, Vasudevan/0000-0002-1603-2969	Department of Biotechnology, Government of India [BT/PR14109/BRB/10/812/2010]; National Centre for Cell Science (NCCS), Pune, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Centre for Cell Science (NCCS), Pune, India	This work is supported by grant from Department of Biotechnology, Government of India (BT/PR14109/BRB/10/812/2010) and intramural funds from National Centre for Cell Science (NCCS), Pune, India. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Bronicki LM, 2013, EMERGING COMPLEXITY, P1019; Bronicki LM, 2012, J NEUROSCI, V32, P11164, DOI 10.1523/JNEUROSCI.2247-12.2012; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Fred RG, 2009, MOL CELL ENDOCRINOL, V297, P28, DOI 10.1016/j.mce.2008.06.007; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Hayashi S, 2015, ALTERNATIVE ROLE HUD, V409, P399; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; Kini HK, 2015, CYTOPLASMIC POLY A B, P1; Kulkarni SD, 2011, J BIOL CHEM, V286, P14146, DOI 10.1074/jbc.M110.190553; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Lisbin MJ, 2000, GENETICS, V155, P1789; LOMEDICO P, 1979, CELL, V18, P545, DOI 10.1016/0092-8674(79)90071-0; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Melo EO, 2003, FEBS LETT, V546, P329, DOI 10.1016/S0014-5793(03)00620-3; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Muralidharan B, 2007, FEBS LETT, V581, P4103, DOI 10.1016/j.febslet.2007.07.050; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Panda AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101084; Panda AC, 2010, FEBS LETT, V584, P1169, DOI 10.1016/j.febslet.2010.02.020; Park-Lee S, 2003, J BIOL CHEM, V278, P39801, DOI 10.1074/jbc.M307105200; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Perrone-Bizzozero Nora, 2013, Front Biosci (Schol Ed), V5, P554; Safaee N, 2012, MOL CELL, V48, P375, DOI 10.1016/j.molcel.2012.09.001; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Steller U, 1996, MOL BRAIN RES, V35, P285, DOI 10.1016/0169-328X(95)00231-G; Svitkin YV, 2006, MOL BIOL+, V40, P684; Tabassum R, 2012, PLOS ONE, V7; Wang HW, 2010, NUCLEIC ACIDS RES, V38, P3760, DOI 10.1093/nar/gkq028; Wang ZH, 2011, NEUROCHEM RES, V36, P1027, DOI 10.1007/s11064-011-0443-0; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Wicksteed B, 2007, CELL METAB, V5, P221, DOI 10.1016/j.cmet.2007.02.007; Yannoni YM, 1999, J CELL SCI, V112, P4501; Yoo YM, 2013, J PINEAL RES, V55, P207, DOI 10.1111/jpi.12064; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194482	10.1371/journal.pone.0194482	http://dx.doi.org/10.1371/journal.pone.0194482			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590218	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100061
J	Pittermann, J; Cowan, J; Kaufman, N; Baer, A; Zhang, E; Kuty, D				Pittermann, Jarmila; Cowan, Joshua; Kaufman, Nathan; Baer, Alex; Zhang, Elaine; Kuty, David			The water relations and xylem attributes of albino redwood shoots (Sequioa sempervirens (D. Don.) Endl.)	PLOS ONE			English	Article							HYDRAULIC EFFICIENCY; CAVITATION RESISTANCE; STOMATAL CONDUCTANCE; CLIMATE-CHANGE; CONIFER XYLEM; WOODY-PLANTS; CUPRESSACEAE; ANGIOSPERMS; PRESSURE; DROUGHT	Plants that lack chlorophyll are rare and typically restricted to holoparasites that obtain their carbon, water and mineral resources from a host plant. Although not parasites in the traditional sense, albino foliage, such as the sprouts that sometimes develop from redwood tree trunks, are comparable in function. They occur sporadically, and can reach the size of shrubs and in rare cases, trees. Albino redwoods are interesting because in addition to their reduced carbon resources, the absence of chloroplasts may impede proper stomatal function, and both aspects may have upstream consequences on water transport and xylem quality. We examined the water relations, water transport and xylem anatomical attributes of albino redwoods and show that similar to achlorophyllous and parasitic plants, albino redwoods have notably higher stomatal conductance than green sprouts. Given that stem xylem tracheid size as well as water transport efficiency are nearly equivalent in both albino and green individuals, we attribute the increased leaf water loss in albino sprouts to lower leaf to xylem area ratios, which favour improved hydration relative to green sprouts. The stems of albino redwoods were more vulnerable to drought-induced embolism than green stems, and this was consistent with the albino's weaker tracheids, as characterized by wall thickness to lumen diameter measures. Our results are both complementary and consistent with previous research on achlorophyllous plants, and suggest that the loss of stomatal control and photosynthetic capacity results in substantial vascular and anatomical adjustments.	[Pittermann, Jarmila; Cowan, Joshua] Univ Calif Berkeley, Dept Ecol & Evolutionary Biol, Berkeley, CA 94720 USA; [Kaufman, Nathan] Urban Adamah, Berkeley, CA USA; [Baer, Alex] Calif State Univ Fullerton, Dept Biol, Fullerton, CA 92634 USA; [Zhang, Elaine] Univ San Francisco, Coll Arts & Sci, San Francisco, CA 94117 USA; [Kuty, David] Henry Cowell Redwoods State Pk, Felton, CA USA	University of California System; University of California Berkeley; California State University System; California State University Fullerton; University of San Francisco	Pittermann, J (corresponding author), Univ Calif Berkeley, Dept Ecol & Evolutionary Biol, Berkeley, CA 94720 USA.	jpitterm@ucsc.edu			Faculty Research Grant from the University of California, Santa Cruz	Faculty Research Grant from the University of California, Santa Cruz	This work was supported by Faculty Research Grant, University of California, Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Joshua Cowan, a former undergraduate at UC Santa Cruz, could not be reached regarding co-authorship on this paper, but his interest and contributions to data collection underpin the study. Christine Manuck, Lindsey Roark and Sherwin Bastami were helpful and fun assistants in the field and lab. We thank the staff at Henry Cowell State Park, the Santa Cruz District of California State Parks and the Fernwood Resort at Big Sur for allowing us to work on their redwood trees. This work was supported in part by a Faculty Research Grant from the University of California, Santa Cruz.	Alder NN, 1997, J EXP BOT, V48, P665, DOI 10.1093/jxb/48.3.665; Assmann SM, 2016, CURR OPIN PLANT BIOL, V33, P157, DOI 10.1016/j.pbi.2016.07.003; Baer A, 2016, NEW PHYTOL, V210, P122, DOI 10.1111/nph.13770; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; Dawson TE, 2007, TREE PHYSIOL, V27, P561, DOI 10.1093/treephys/27.4.561; Delzon S, 2010, PLANT CELL ENVIRON, V33, P2101, DOI 10.1111/j.1365-3040.2010.02208.x; Drake PL, 2013, J EXP BOT, V64, P495, DOI 10.1093/jxb/ers347; Ehleringer J. R., 1995, P125; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1316, DOI 10.1111/j.1365-3040.2005.01378.x; Gitelson AA, 1999, REMOTE SENS ENVIRON, V69, P296, DOI 10.1016/S0034-4257(99)00023-1; Gleason SM, 2016, NEW PHYTOL, V209, P123, DOI 10.1111/nph.13646; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Jacobsen AL, 2005, PLANT PHYSIOL, V139, P546, DOI 10.1104/pp.104.058404; Jansen S, 2012, PLANT CELL ENVIRON, V35, P1109, DOI 10.1111/j.1365-3040.2011.02476.x; Jaret P., 2014, NATL GEOGRAPHIC NEWS; Kolb KJ, 1999, ECOLOGY, V80, P2373, DOI 10.1890/0012-9658(1999)080[2373:DIDABS]2.0.CO;2; Lawson T, 2009, NEW PHYTOL, V181, P13, DOI 10.1111/j.1469-8137.2008.02685.x; Lo Gullo MA, 2012, ANN BOT-LONDON, V109, P1101, DOI 10.1093/aob/mcs033; Lo Gullo MA, 2007, TREE PHYSIOL, V27, P209, DOI 10.1093/treephys/27.2.209; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; Murray F., 1967, J APPL METEOROL CLIM, V6, P203, DOI [10.1175/1520-0450(1967)0062.0.CO;2, DOI 10.1175/1520-0450(1967)0062.0.CO;2]; NEUFELD HS, 1992, PLANT PHYSIOL, V100, P1020, DOI 10.1104/pp.100.2.1020; Pittermann J, 2006, PLANT CELL ENVIRON, V29, P1618, DOI 10.1111/j.1365-3040.2006.01539.x; Pittermann J, 2012, P NATL ACAD SCI USA, V109, P9647, DOI 10.1073/pnas.1114378109; Pittermann J, 2010, PLANT PHYSIOL, V153, P1919, DOI 10.1104/pp.110.158824; POCKMAN WT, 1995, NATURE, V378, P715, DOI 10.1038/378715a0; PRESS MC, 1991, FUNCT ECOL, V5, P278, DOI 10.2307/2389265; Rasband W., 2006, IMAGEJ; Rico C, 2013, NEW PHYTOL, V199, P956, DOI 10.1111/nph.12339; Scott AD, 2016, NEW PHYTOL, V211, P186, DOI 10.1111/nph.13930; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Sperry J., 1993, P86, DOI 10.1017/CBO9780511753305.009; STEWART GR, 1990, ANNU REV PLANT PHYS, V41, P127, DOI 10.1146/annurev.pp.41.060190.001015; Stockel M, 2011, NEW PHYTOL, V189, P790, DOI 10.1111/j.1469-8137.2010.03510.x; Team RC., 2013, R LANG ENV STAT COMP; WONG SC, 1979, NATURE, V282, P424, DOI 10.1038/282424a0	37	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0191836	10.1371/journal.pone.0191836	http://dx.doi.org/10.1371/journal.pone.0191836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590113	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100001
J	Tsang, S; Duncan, GE; Dinescu, D; Turkheimer, E				Tsang, Siny; Duncan, Glen E.; Dinescu, Diana; Turkheimer, Eric			Differential models of twin correlations in skew for body-mass index (BMI)	PLOS ONE			English	Article							ADOLESCENT HEALTH; POOLED ANALYSIS; GENETICS; AGE; EMERGENESIS; ADULTHOOD; ZYGOSITY; CLUSTERS; REGISTRY; COHORTS	Background Body Mass Index (BMI), like most human phenotypes, is substantially heritable. However, BMI is not normally distributed; the skew appears to be structural, and increases as a function of age. Moreover, twin correlations for BMI commonly violate the assumptions of the most common variety of the classical twin model, with the MZ twin correlation greater than twice the DZ correlation. This study aimed to decompose twin correlations for BMI using more general skew-t distributions. Methods Same sex MZ and DZ twin pairs (N= 7,086) from the community-based Washington State Twin Registry were included. We used latent profile analysis (LPA) to decompose twin correlations for BMI into multiple mixture distributions. LPA was performed using the default normal mixture distribution and the skew-t mixture distribution. Similar analyses were performed for height as a comparison. Our analyses are then replicated in an independent dataset. Results A two-class solution under the skew-t mixture distribution fits the BMI distribution for both genders. The first class consists of a relatively normally distributed, highly heritable BMI with a mean in the normal range. The second class is a positively skewed BMI in the overweight and obese range, with lower twin correlations. In contrast, height is normally distributed, highly heritable, and is well-fit by a single latent class. Results in the replication dataset were highly similar. Conclusions Our findings suggest that two distinct processes underlie the skew of the BMI distribution. The contrast between height and weight is in accord with subjective psychological experience: both are under obvious genetic influence, but BMI is also subject to behavioral control, whereas height is not.	[Tsang, Siny] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA; [Duncan, Glen E.] Washington State Univ, Hlth Sci, Dept Nutr & Exercise Physiol, Spokane, WA USA; [Dinescu, Diana] Kennedy Krieger Inst, Baltimore, MD USA; [Dinescu, Diana] Johns Hopkins Sch Med, Baltimore, MD USA; [Turkheimer, Eric] Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA	Columbia University; Washington State University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Virginia	Tsang, S (corresponding author), Columbia Univ, Dept Epidemiol, New York, NY 10027 USA.	st2989@cumc.columbia.ed			National Institute of Mental Health [5-T32-MH 13043]; National Institute on Aging [R56AG042176]; John Templeton Foundation; Genetics and Human Agency; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH013043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG042176] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John Templeton Foundation; Genetics and Human Agency; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Siny Tsang is supported by the research training grant 5-T32-MH 13043 from the National Institute of Mental Health. Glen E. Duncan is supported by R56AG042176 (PI: G Duncan) from the National Institute on Aging. Eric Turkheimer is supported by the John Templeton Foundation, "Genetics and Human Agency."	Afari N, 2006, TWIN RES HUM GENET, V9, P1023, DOI 10.1375/183242706779462543; Beam CR, 2013, DEV PSYCHOPATHOL, V25, P7, DOI 10.1017/S0954579412000867; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Dinescu D, 2016, HEALTH PSYCHOL, V35, P157, DOI 10.1037/hea0000255; Duncan G., 2017, SUBJECTIVE OBJECTIVE; EISEN S, 1989, CLIN GENET, V35, P423, DOI 10.1111/j.1399-0004.1989.tb02967.x; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Fran CE, 2007, TWIN RES HUM GENET, V10, P537, DOI 10.1375/twin.10.4.537; Gatz M, 1958, NATL ACAD SCI NATL R; Gordon-Larsen P, 2004, AM J CLIN NUTR, V80, P569; Hayes A, 2015, INT J OBESITY, V39, P1209, DOI 10.1038/ijo.2015.50; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P391; Lee S, 2014, STAT COMPUT, V24, P181, DOI 10.1007/s11222-012-9362-4; Lin TI, 2010, STAT COMPUT, V20, P343, DOI 10.1007/s11222-009-9128-9; Lykken DT, 2006, GENES BRAIN BEHAV, V5, P306, DOI 10.1111/j.1601-183X.2006.00233.x; LYKKEN DT, 1992, AM PSYCHOL, V47, P1565, DOI 10.1037/0003-066X.47.12.1565; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Muthen B, 2015, STAT MED, V34, P1041, DOI 10.1002/sim.6388; Muthen L.K., 2012, MPLUS STAT ANAL LATE; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Rushton JL, 2002, J AM ACAD CHILD PSY, V41, P199, DOI 10.1097/00004583-200202000-00014; Scherrer JF, 2015, JAMA PSYCHIAT, V72, P342, DOI 10.1001/jamapsychiatry.2014.2497; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silventoinen K, 2017, AM J CLIN NUTR, V106, P457, DOI 10.3945/ajcn.117.153643; Silventoinen K, 2016, AM J CLIN NUTR, V104, P371, DOI 10.3945/ajcn.116.130252; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; TORGERSEN S, 1979, ACTA GENET MED GEMEL, V28, P225, DOI 10.1017/S0001566000009077; Turkheimer E, 2011, PSYCHOL BULL, V137, P825, DOI 10.1037/a0024306	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194968	10.1371/journal.pone.0194968	http://dx.doi.org/10.1371/journal.pone.0194968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590176	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100091
J	Xu, XJ; Liu, XY; Zhang, Y				Xu, Xiaojun; Liu, Xiaoyuan; Zhang, Yan			Osthole inhibits gastric cancer cell proliferation through regulation of PI3K/AKT	PLOS ONE			English	Article							CYCLE ARREST; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; A549 CELLS; APOPTOSIS; ACTIVATION	Osthole is an active compound isolated from Chinese herb Cnidium monnieri (L.) Cusson, and had been reported to possess antitumor effect. However, the effect of osthole on the gastric cancer cells has not been investigated. In this study, the effects of osthole on the proliferation of human gastric cancer cells were tested. The data showed that osthole treatment significantly inhibited the proliferation of gastric cancer cells and resulted in the cell cycle arrest at G2/M phase in a dose-dependent manner. Western-blot study showed that the expression of cyclin B1 and cdc2 was markedly reduced by osthole. Moreover, expression of P13K and pAKT was also significantly suppressed, and the results indicated that the inhibition of pAKT, cyclin B1, and cdc2 levels by osthole was notably enhanced by a P13K inhibitor. These results demonstrate that osthole could inhibit gastric cancer cells proliferation via induction of cell cycle arrest at G2/M phase by the reduction of PI3K/AKT.	[Xu, Xiaojun] Second Peoples Hosp Wuxi, Dept Pharm, Wuxi, Peoples R China; [Liu, Xiaoyuan] Forth Peoples Hosp Wuxi, Dept Pharm, Wuxi, Peoples R China; [Zhang, Yan] Wuxi M & Child Hlth Hosp, Dept Pharm, Wuxi, Peoples R China	Jiangnan University	Zhang, Y (corresponding author), Wuxi M & Child Hlth Hosp, Dept Pharm, Wuxi, Peoples R China.	2004zhangshanshi@163.com			National Natural Science Foundation of China [81401222, 81671489]; Youth project of Wuxi Health Bureau [2014Z02]; Youth Medicine project of Jiangsu province [QNRC2016166]; Doctor Fund of Wuxi Health Bureau [2014BS01]; Wuxi City Hospital Management Center Pharmacy Program [YGZXY1303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth project of Wuxi Health Bureau; Youth Medicine project of Jiangsu province; Doctor Fund of Wuxi Health Bureau; Wuxi City Hospital Management Center Pharmacy Program	This work was supported by grants from the National Natural Science Foundation of China under Grant #81401222 and #81671489, Youth project of Wuxi Health Bureau under Grant 2014Z02, Youth Medicine project of Jiangsu province under Grant QNRC2016166 and Doctor Fund of Wuxi Health Bureau under Grant 2014BS01 and Wuxi City Hospital Management Center Pharmacy Program (YGZXY1303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China under Grant #81401222 and #81671489, Youth project of Wuxi Health Bureau under Grant 2014Z02, Youth Medicine project of Jiangsu province under Grant QNRC2016166 and Doctor Fund of Wuxi Health Bureau under Grant 2014BS01.	Chen R, 2013, J PHARM PHARM SCI, V16, P732, DOI 10.18433/J3HK5C; Ding DF, 2013, CELL PHYSIOL BIOCHEM, V32, P1751, DOI 10.1159/000356609; Feng HT, 2017, CELL ADHES MIGR, V11, P464, DOI 10.1080/19336918.2016.1259058; Gao P, 2017, MINERVA MED, V108, P74, DOI 10.23736/S0026-4806.16.04628-0; Jiang GQ, 2016, J ETHNOPHARMACOL, V193, P368, DOI 10.1016/j.jep.2016.08.045; Kaya DM, 2017, EXPERT REV CLIN PHAR, V10, P263, DOI 10.1080/17512433.2017.1279969; Li K, 2016, BIOL PHARM BULL, V39, P336, DOI 10.1248/bpb.b15-00699; Li LW, 2011, EUR J PHARMACOL, V670, P13, DOI 10.1016/j.ejphar.2011.08.054; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Muller S, 2017, NAT REV GENET, V18, P192, DOI 10.1038/nrg.2016.157; Venerito M, 2016, HELICOBACTER, V21, P39, DOI 10.1111/hel.12339; Wang H, 2016, ONCOL REP, V35, P3659, DOI 10.3892/or.2016.4730; Wang LT, 2015, J BIOMED RES, V29, P132, DOI 10.7555/JBR.27.20120115; Wang L, 2016, CELL PHYSIOL BIOCHEM, V38, P2173, DOI 10.1159/000445573; Xu XM, 2016, ONCOL LETT, V12, P3779, DOI 10.3892/ol.2016.5170; Xu XM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-33; Yan YH, 2017, NEUROCHEM RES, V42, P398, DOI 10.1007/s11064-016-2082-y; Yang SM, 2014, FREE RADICAL BIO MED, V73, P260, DOI 10.1016/j.freeradbiomed.2014.05.009; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Yuan L, 2015, MOL MED REP, V11, P2459, DOI 10.3892/mmr.2014.3100; Zhai YK, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/921954; Zhang LR, 2015, IMMUNOPHARM IMMUNOT, V37, P301, DOI 10.3109/08923973.2015.1035391; Zhang ZR, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/919616; Zhao L, 2016, MOL CARCINOGEN, V55, P778, DOI 10.1002/mc.22321	24	29	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193449	10.1371/journal.pone.0193449	http://dx.doi.org/10.1371/journal.pone.0193449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590128	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100020
J	Zhong, L; Liu, EX; Yang, CZ; Diao, Y; Harijati, N; Liu, JD; Hu, ZL; Jin, SR				Zhong, Lin; Liu, Erxi; Yang, Chaozhu; Diao, Ying; Harijati, Nunung; Liu, Jiangdong; Hu, Zhongli; Jin, Surong			Gene cloning of a neutral ceramidase from the sphingolipid metabolic pathway based on transcriptome analysis of Amorphophallus muelleri	PLOS ONE			English	Article							MOLECULAR-CLONING; PURIFICATION; SPHINGOSINE	Amorphophallus is a perennial herbaceous plant species mainly distributed in the tropics or subtropics of Asia and Africa. It has been used as a traditional medicine for a long time and now is utilized for the pharmaceutical, chemical and agriculture industries as a valued economic crop. Recently, Amorphophallus has attracted tremendous interest because of its high ceramide content. However, the breeding and genome studies are severely limited by the arduous whole genome sequencing of Amorphophallus. In this study, the transcriptome data of A. muelleri was obtained by utilizing the high-throughput Illumina sequencing platform. Based on this information, the majority of the significant genes involved in the proposed sphingolipid metabolic pathway were identified. Then, the full-length neutral ceramidase cDNA was obtained with the help of its candidate transcripts, which were acquired from the transcriptome data. Furthermore, we demonstrated that this neutral ceramidase was a real ceramidase by eukaryotic expression in the yeast double knockout mutant Delta ypc1 Delta ydc1, which lacks the ceramidases-dihydroCDase (YDC1p), phytoCDase (YPC1p). In addition, the biochemical characterization of purified A. muelleri ceramidase (AmCDase) exhibited classical Michaelis-Menten kinetics with an optimal activity ranging from pH 6.5 to 8.0. Based on our knowledge, this study is the first to report the related information of the neutral ceramidase in Amorphophallus. All datasets can provide significant information for related studies, such as gene expression, genetic improvement and application on breeding in Amorphophallus.	[Zhong, Lin; Hu, Zhongli] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China; [Liu, Erxi; Yang, Chaozhu] Enshi Acad Agr Sci, Inst Konjac, Enshi, Hubei, Peoples R China; [Diao, Ying] Wuhan Univ, Coll Life Sci, Lotus Engn Res Ctr Hubei Prov, Wuhan, Hubei, Peoples R China; [Harijati, Nunung] Brawijaya Univ, Dept Biol, Fac Math & Nat Sci, Jl Vet, Malang, Indonesia; [Liu, Jiangdong] Wuhan Univ, Coll Life Sci, Dept Biol, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Jin, Surong] Wuhan Univ Technol, Inst Chem & Life Sci, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Brawijaya University; Wuhan University; Wuhan University of Technology	Hu, ZL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China.; Jin, SR (corresponding author), Wuhan Univ Technol, Inst Chem & Life Sci, Wuhan, Hubei, Peoples R China.	huzhongli@whu.edu.cn; rsjin@whut.edu.cn			National Science and Technology Supporting Program [2011BAD33B03]; National Natural Science Foundation of China [30971829]; Philanthropic Project of Scientific Research of Hubei [2012DBA11001]	National Science and Technology Supporting Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Philanthropic Project of Scientific Research of Hubei	This study was supported by grants from the National Science and Technology Supporting Program (No. 2011BAD33B03), the National Natural Science Foundation of China (No. 30971829) and Philanthropic Project of Scientific Research of Hubei (No. 2012DBA11001). The funders had a role in study design, decision to publish of the manuscript.	Chen M, 2009, ADV PHOTOSYNTH RESP, V30, P77; [寸湘琴 CUN Xiang-qin], 2009, [云南农业大学学报, Journal of Yunnan Agricultural University], V24, P764; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Diao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095428; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Galadari S, 2006, BIOCHEM J, V393, P687, DOI 10.1042/BJ20050682; GATT S, 1963, J BIOL CHEM, V238, P3131; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hetterscheid W., 1996, AROIDEANA, V19, P7; Hua Zhang Dong, 2010, RESOURCE DEV MARKET; Liu H, 2015, S AFR J BOT, V97, P101, DOI 10.1016/j.sajb.2014.11.008; Liu Ren-ping, 2011, NATURAL PRODUCT RES, V23; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Monjusho H, 2003, BIOCHEM J, V376, P473, DOI 10.1042/BJ20030652; Okino N, 2010, BIOSCI BIOTECH BIOCH, V74, P316, DOI 10.1271/bbb.90645; Pata MO, 2008, PLANT J, V55, P1000, DOI 10.1111/j.1365-313X.2008.03569.x; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Santosa E, 2007, MOL ECOL NOTES, V7, P814, DOI 10.1111/j.1471-8286.2007.01713.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462; Wu JX, 2015, PLANT J, V81, P767, DOI 10.1111/tpj.12769; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Yoshimura Y, 2002, J BIOCHEM, V132, P229, DOI 10.1093/oxfordjournals.jbchem.a003215; Yu XM, 2011, MOL BIOL REP, V38, P3447, DOI 10.1007/s11033-010-0454-y; Zhong L, 2017, OPEN LIFE SCI, V12, P34, DOI 10.1515/biol-2017-0004; Zhou H., 2013, CHEM BIOENGINEERING, V4	29	1	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194863	10.1371/journal.pone.0194863	http://dx.doi.org/10.1371/journal.pone.0194863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590184	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100083
J	Binder, K; Krauss, S; Bruckmaier, G; Marienhagen, J				Binder, Karin; Krauss, Stefan; Bruckmaier, Georg; Marienhagen, Joerg			Visualizing the Bayesian 2-test case: The effect of tree diagrams on medical decision making	PLOS ONE			English	Article							NATURAL FREQUENCIES; ECOLOGICAL RATIONALITY; INDIVIDUAL-DIFFERENCES; DIAGNOSTIC INFERENCES; CONJUNCTION FALLACY; REPRESENTATION; PROBABILITY; NUMBERS; TELL; HIV	In medicine, diagnoses based on medical test results are probabilistic by nature. Unfortunately, cognitive illusions regarding the statistical meaning of test results are well documented among patients, medical students, and even physicians. There are two effective strategies that can foster insight into what is known as Bayesian reasoning situations: (1) translating the statistical information on the prevalence of a disease and the sensitivity and the false-alarm rate of a specific test for that disease from probabilities into natural frequencies, and (2) illustrating the statistical information with tree diagrams, for instance, or with other pictorial representation. So far, such strategies have only been empirically tested in combination for "1-test cases", where one binary hypothesis ("disease" vs. "no disease") has to be diagnosed based on one binary test result ("positive" vs. "negative"). However, in reality, often more than one medical test is conducted to derive a diagnosis. In two studies, we examined a total of 388 medical students from the University of Regensburg (Germany) with medical "2-test scenarios". Each student had to work on two problems: diagnosing breast cancer with mammography and sonography test results, and diagnosing HIV infection with the ELISA and Western Blot tests. In Study 1 (N = 190 participants), we systematically varied the presentation of statistical information ("only textual information" vs. "only tree diagram" vs. "text and tree diagram in combination"), whereas in Study 2 (N = 198 participants), we varied the kinds of tree diagrams ("complete tree" vs. "highlighted tree" vs. "pruned tree"). All versions were implemented in probability format (including probability trees) and in natural frequency format (including frequency trees). We found that natural frequency trees, especially when the question-related branches were highlighted, improved performance, but that none of the corresponding probabilistic visualizations did.	[Binder, Karin; Krauss, Stefan] Univ Regensburg, Fac Math, Math Educ, Regensburg, Germany; [Bruckmaier, Georg] FHNW Univ Appl Sci & Arts Northwestern Switzerlan, Sch Educ, Inst Primary Educ, Liestal, Switzerland; [Marienhagen, Joerg] Univ Hosp Regensburg, Regensburg, Germany	University of Regensburg; University of Regensburg	Binder, K (corresponding author), Univ Regensburg, Fac Math, Math Educ, Regensburg, Germany.	Karin.Binder@ur.de	Binder, Karin/GZM-4431-2022	Binder, Karin/0000-0003-0416-3029; Krauss, Stefan/0000-0002-7440-9154	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the funding program Open Access Publishing.; The authors would like to thank all participating students for their contribution, Robert DeHaney and Francis Lorie for editing the manuscript, Sven Hilbert for his statistical advice and Editor (Gerd Gigerenzer), Ulrich Hoffrage and an anonymous reviewer for their helpful comments. This publication was supported by the German Research Foundation (DFG) within the funding program Open Access Publishing.	[Anonymous], 2016, JAHR EV 2013; Barbey AK, 2007, BEHAV BRAIN SCI, V30, P241, DOI 10.1017/S0140525X07001653; Bhattacharya R, 2008, AIDS CARE, V20, P560, DOI 10.1080/09540120701867206; Binder K, GEN BAYESIAN R UNPUB; Binder K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01186; Bocherer-Linder K, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02026; Brase GL, 2014, J COGN PSYCHOL, V26, P81, DOI 10.1080/20445911.2013.861840; Brase GL, 2009, APPL COGNITIVE PSYCH, V23, P369, DOI 10.1002/acp.1460; Budgett S., 2016, ANN PERSPECTIVES MAT, P37; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8; Eddy DM, 1982, JUDGMENT UNCERTAINTY, P249; Ellis KM, 2015, CURR HIV RES, V13, P381, DOI 10.2174/1570162X13666150511125629; ELLIS KM, 2014, P HUM FACT ERGON SOC, V58, P1323, DOI DOI 10.1177/1541931214581276; Friederichs H, 2014, MED DECIS MAKING, V34, P253, DOI 10.1177/0272989X13504499; Garcia-Retamero R, 2007, Q J EXP PSYCHOL, V60, P1197, DOI 10.1080/17470210600937528; Garcia-Retamero R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00932; Garcia-Retamero R, 2013, SOC SCI MED, V83, P27, DOI 10.1016/j.socscimed.2013.01.034; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G, 1998, AIDS CARE, V10, P197, DOI 10.1080/09540129850124451; Gigerenzer G, 2011, STRUNGMANN FORUM REP, P3; Hertwig R, 1999, J BEHAV DECIS MAKING, V12, P275, DOI 10.1002/(SICI)1099-0771(199912)12:4<275::AID-BDM323>3.0.CO;2-M; Hoffrage U, 1998, ACAD MED, V73, P538, DOI 10.1097/00001888-199805000-00024; Hoffrage U, 2000, SCIENCE, V290, P2261, DOI 10.1126/science.290.5500.2261; Hoffrage U, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01473; Hoffrage U, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00642; Johnson ED, 2013, LEARN INDIVID DIFFER, V28, P34, DOI 10.1016/j.lindif.2013.09.004; JORGENSEN KJ, 2009, BMJ, V339; Khan A. U., 2015, QUAL QUANT, V2015, P1, DOI DOI 10.1016/J.IJHCS.2015.07.001; Krauss S, 2003, J EXP PSYCHOL GEN, V132, P3, DOI 10.1037/0096-3445.132.1.3; Krauss S, 1999, MODEL-BASED REASONING IN SCIENTIFIC DISCOVERY, P165; Mandel DR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01872; Martignon L., 2003, THINKING PSYCHOL PER; Mautone PD, 2001, J EDUC PSYCHOL, V93, P377, DOI 10.1037/0022-0663.93.2.377; Mayer RE, 2005, CAMBRIDGE HDB MULTIM, P31; Mayer RE, 2008, AM PSYCHOL, V63, P760, DOI 10.1037/0003-066X.63.8.760; McDowell M, 2017, METAANALYSIS EFFECT; McDowell M, 2017, PSYCHOL BULL, V143, P1273, DOI 10.1037/bul0000126; McGee S., 2012, EVIDENCE BASED PHYS, V3rd; Micallef L, 2012, IEEE T VIS COMPUT GR, V18, P2536, DOI 10.1109/TVCG.2012.199; Oldford RW, PICTURING PROBABILIT; Operskalski JT, 2016, SCIENCE, V352, P413, DOI 10.1126/science.aaf7966; Pfannkuch M, 2016, INT J RES UNDERGRAD; Pighin S, 2016, MED DECIS MAKING, V36, P686, DOI 10.1177/0272989X16640785; Prinz R, 2015, CURR HIV RES, V13, P369, DOI 10.2174/1570162X13666150511125200; Reimer L, 1997, CLIN INFECT DIS, V25, P98, DOI 10.1086/514491; Rey GD, 2011, J EXP PSYCHOL-APPL, V17, P33, DOI 10.1037/a0022243; Sedlmeier P, 2001, J EXP PSYCHOL GEN, V130, P380, DOI 10.1037//0096-3445.130.3.380; Siegrist M, 2011, J RISK RES, V14, P1039, DOI 10.1080/13669877.2011.571786; Sirota M, 2015, PSYCHON B REV; Sirota M, 2014, PSYCHON B REV, V21, P198, DOI 10.3758/s13423-013-0464-6; Sloman SA, 2003, ORGAN BEHAV HUM DEC, V91, P296, DOI 10.1016/S0749-5978(03)00021-9; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Steckelberg Anke, 2004, BMC Med Educ, V4, P13, DOI 10.1186/1472-6920-4-13; Stine GJ., 1996, ACQUIRED IMMUNE DEFI; Sweller J, 2003, PSYCHOL LEARN MOTIV, V43, P215, DOI 10.1016/S0079-7421(03)01015-6; Sweller J., 2005, CAMBRIDGE HDB MULTIM, P159, DOI DOI 10.1017/CB09780511816819.011; Talboy AN, 2017, J BEHAV DECIS MAKING, V30, P373, DOI 10.1002/bdm.1949; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; Wegwarth O, 2013, JAMA INTERN MED, V173, P2086, DOI 10.1001/jamainternmed.2013.10363; Woike J., 2017, INTEGRATING TESTING; Wu CM, 2017, J EXP PSYCHOL LEARN, V43, P1274, DOI 10.1037/xlm0000374; Yamagishi K, 2003, EXP PSYCHOL, V50, P97, DOI 10.1026//1618-3169.50.2.97; Zhu LQ, 2006, COGNITION, V98, P287, DOI 10.1016/j.cognition.2004.12.003; Zikmund-Fisher BJ, 2014, MED DECIS MAKING, V34, P443, DOI 10.1177/0272989X13511706	65	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195029	10.1371/journal.pone.0195029	http://dx.doi.org/10.1371/journal.pone.0195029			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584770	Green Published, gold, Green Submitted			2022-12-27	WOS:000428373000057
J	Brunell, AB; Robison, J; Deems, NP; Okdie, BM				Brunell, Amy B.; Robison, Joshua; Deems, Nicholas P.; Okdie, Bradley M.			Are narcissists more attracted to people in relationships than to people not in relationships?	PLOS ONE			English	Article							PERSONALITY; SEX	Does grandiose narcissism predict greater attraction for others in relationships? We examined this question by replicating previous work implicating grandiose narcissists as mate poachers (Studies 1 and 2). We then used an experimental paradigm (Studies 3 and 4) to assess the extent to which grandiose narcissists indicate a greater interest in someone who is already in a relationship compared to someone who is single. Results suggest that although grandiose narcissism related to reports of more frequent mate poaching attempts, grandiose narcissists did not appear to be more interested in taking someone away from an existing relationship. Instead, participants took their own relationship status into consideration (rather than the relationship status of a target) when evaluating their interest in a target for a short-term fling or a long-term relationship. Thus, although grandiose narcissists report more frequent mate poaching attempts, they do not appear to be more interested in people in relationships compared to those who are single.	[Brunell, Amy B.; Robison, Joshua; Deems, Nicholas P.; Okdie, Bradley M.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Brunell, AB (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	brunell.2@osu.edu						Aubrey JS, 2004, SEX ROLES, V50, P505, DOI 10.1023/B:SERS.0000023070.87195.07; Bleske-Rechek A, 2008, PERS INDIV DIFFER, V45, P420, DOI 10.1016/j.paid.2008.05.018; Brunell A.B., 2011, HDB NARCISSISM NARCI, P344, DOI DOI 10.1002/9781118093108.CH30; Brunell AB, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00299; Brunell AB, 2011, PERS INDIV DIFFER, V50, P323, DOI 10.1016/j.paid.2010.10.006; Brunell AB, 2008, PERS SOC PSYCHOL B, V34, P1663, DOI 10.1177/0146167208324101; BUSS DM, 1991, J PERS, V59, P179, DOI 10.1111/j.1467-6494.1991.tb00773.x; Buss DM, 1997, J RES PERS, V31, P193, DOI 10.1006/jrpe.1997.2175; Campbell W.K., 2011, HDB NARCISSISM NARCI; Campbell WK, 2002, PERS SOC PSYCHOL B, V28, P484, DOI 10.1177/0146167202287006; Campbell WK, 2002, J PERS SOC PSYCHOL, V83, P340, DOI 10.1037//0022-3514.83.2.340; Daddis C, 2015, J RES PERS, V58, P115, DOI 10.1016/j.jrp.2015.07.007; Davies APC, 2007, ARCH SEX BEHAV, V36, P702, DOI 10.1007/s10508-006-9158-8; Dufner M, 2013, PERS SOC PSYCHOL B, V39, P870, DOI 10.1177/0146167213483580; EYSENCK HJ, 1972, J PSYCHOSOM RES, V16, P141, DOI 10.1016/0022-3999(72)90037-2; Foster JD, 2006, J SOC PERS RELAT, V23, P367, DOI 10.1177/0265407506064204; Holtzman NS, 2017, PERS INDIV DIFFER, V114, P187, DOI 10.1016/j.paid.2017.04.013; Holtzman NS, 2010, J RES PERS, V44, P478, DOI 10.1016/j.jrp.2010.06.001; Holtzman NS, 2010, J RES PERS, V44, P133, DOI 10.1016/j.jrp.2009.10.004; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Johnson SL, 2012, PSYCHOL BULL, V138, P692, DOI 10.1037/a0027503; Jonason PK, 2010, PERS INDIV DIFFER, V48, P373, DOI 10.1016/j.paid.2009.11.003; Jonason PK, 2009, EUR J PERSONALITY, V23, P5, DOI 10.1002/per.698; Kardum I, 2015, PERS INDIV DIFFER, V75, P7, DOI 10.1016/j.paid.2014.10.048; Kaspar K, 2016, PERS INDIV DIFFER, V92, P74, DOI 10.1016/j.paid.2015.12.013; Miller JD, 2008, J PERS, V76, P449, DOI 10.1111/j.1467-6494.2008.00492.x; Miller JD, 2011, J PERS, V79, P1013, DOI 10.1111/j.1467-6494.2010.00711.x; Parker J, 2009, J EXP SOC PSYCHOL, V45, P1016, DOI 10.1016/j.jesp.2009.04.022; Peplau LA, 2007, ANNU REV PSYCHOL, V58, P405, DOI 10.1146/annurev.psych.58.110405.085701; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; Reise SP, 1996, J RES PERS, V30, P128, DOI 10.1006/jrpe.1996.0009; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; Ryan KM, 2008, SEX ROLES, V58, P802, DOI 10.1007/s11199-008-9403-9; Schmitt DP, 2004, J PERS SOC PSYCHOL, V86, P560, DOI 10.1037/0022-3514.86.4.560; Schmitt DP, 2001, J PERS SOC PSYCHOL, V80, P894, DOI 10.1037/0022-3514.80.6.894; Schroder-Abe M, 2016, EUR J PERSONALITY, V30, P12, DOI 10.1002/per.2029; SEAL DW, 1994, SEX ROLES, V31, P1, DOI 10.1007/BF01560274; Widman L., 2011, HDB NARCISSISM NARCI; Yorzinski J.L., 2010, PLOS ONE, V5, pe911, DOI [10.1371/journatpone.0009115, DOI 10.1371/JOURNATPONE.0009115]	39	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194106	10.1371/journal.pone.0194106	http://dx.doi.org/10.1371/journal.pone.0194106			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584747	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000015
J	Peng, W; Berry, EM				Peng, Wen; Berry, Elliot M.			Global nutrition 1990-2015: A shrinking hungry, and expanding fat world	PLOS ONE			English	Article							STRATEGIES; POLICY; INDEX	Objectives Following its publication in 2008, the Global Nutritional Index (GNI) which captures the triple burden of malnutrition, has been updated to assess the overall nutritional status and nutritional trends of countries, regions and the world, including both under-nutrition and over-nutrition. Methods The GNI was modeled on the Human Development Index, using geometric means of three normalized indicators: protein-energy malnutrition (PEM, measured by Disability-Adjusted Life Years (DALYs) from PEM), micronutrient deficiency (MID, measured by DALYs from MID), and penalizing obesity (percent female obesity). GNI (range 0-1) was calculated from 1990-2015 for 186 countries, in seven World Bank income and WHO region groupings. Results World GNI increased from 0.433 to 0.473 as decreased deficits overcompensated for the rise in obesity. GNI for African low- and middle-income countries (LMIC) (median 0.301 to 0.392) and South-East Asian LMIC (0.456 to 0.564) improved significantly (P<0.001), while for high-income countries (0.657 to 0.611) worsened significantly (P<0.001). GNI for American LMIC (0.459 to 0.457), European LMIC (0.571 to 0.575), Eastern Mediterranean LMIC (0.484 to 0.483) and Western Pacific LMIC (0.433 to 0.494) were unchanged. The disaggregation of the GNI showed that in nearly all the seven country groups there was a significant decrease in both PEM and MID (all P<0.01) (except in HIC where only PEM dropped), and a significant increase in obesity (all P<0.001). Conclusion These trends are the result of the reciprocal changes between decreased under-nutrition and increased over-nutrition, which has become a major cause of malnutrition worldwide. We suggest, therefore, that future Sustainable Development Goals should include alongside "zero hunger"-"reduce obesity".	[Peng, Wen] Qinghai Univ, Sch Med, Dept Publ Hlth Nutr, Xining, Qinghai, Peoples R China; [Peng, Wen] Amity Fdn, Res Ctr, Nanjing, Jiangsu, Peoples R China; [Berry, Elliot M.] Hebrew Univ Jerusalem, Hadassah Med Sch, Braun Sch Publ Hlth, Dept Human Nutr & Metab, Jerusalem, Israel	Qinghai University; Hebrew University of Jerusalem	Berry, EM (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Braun Sch Publ Hlth, Dept Human Nutr & Metab, Jerusalem, Israel.	elliotb@ekmd.huji.ac.il						[Anonymous], 2016, LANCET, V388, P1447, DOI 10.1016/S0140-6736(16)31790-1; [Anonymous], 2015, AFSUN FOOD SECURITY; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berrocal E, 2015, PUBLIC HEALTH NUTR, P1; Black R, 2003, B WORLD HEALTH ORGAN, V81, P79; Global Burden of Disease Collaborative Network, 2021, GLOBAL BURDEN DIS ST; Gould J, 2017, NATURE, V544, pS6, DOI 10.1038/544S6a; International Food Policy Research Institue (IFPRI), 2016, GLOB HUNG IND GETT Z; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Miller DD, 2013, FOOD POLICY, V42, P115, DOI 10.1016/j.foodpol.2013.06.008; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pinstrup-Andersen P, 2007, AGR ECON-BLACKWELL, V37, P187, DOI 10.1111/j.1574-0862.2007.00244.x; Rosenbloom JI, 2008, FOOD NUTR BULL, V29, P266, DOI 10.1177/156482650802900403; United Nations Development Programme, 2020, HUMAN DEV REPORTS; WHO, 2017, ALPH LIST WHO MEMB S; World Bank, 2016, DAT WORLD BANK COUNT; World Health Organization, 2017, DEF REG GROUP; World Health Organization, 2017, OB BOD MASS IND 30 A; World Health Organization, 2018, OB OV FACT SHEET 311	19	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194821	10.1371/journal.pone.0194821	http://dx.doi.org/10.1371/journal.pone.0194821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584768	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000041
J	Ramirez-Olvera, SM; Trejo-Tellez, LI; Garcia-Morales, S; Perez-Sato, JA; Gomez-Merino, FC				Monzerrat Ramirez-Olvera, Sara; Iris Trejo-Tellez, Libia; Garcia-Morales, Soledad; Antonio Perez-Sato, Juan; Carlos Gomez-Merino, Fernando			Cerium enhances germination and shoot growth, and alters mineral nutrient concentration in rice	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; BIOCHEMICAL-CONSTITUENTS; OXIDE NANOPARTICLES; LANTHANUM; TOXICITY; SEEDLINGS; ARABIDOPSIS; NUTRITION; CADMIUM; NITRATE	Cerium (Ce) belongs to the rare earth elements (REEs), and although it is not essential for plants, it can stimulate growth and other physiological processes. The objective of this research was to evaluate the effect of Ce on seed germination, initial seedling growth, and vegetative growth in rice (Oryza sativa L.) cv. Morelos A-98. During the germination process, the seeds were treated with Ce concentrations of 0, 4, 8, and 12 mu M; after 5 d, germination percentage was recorded and after 10 d seedling growth was measured. For vegetative growth, a hydroponic system was established where 14-d-old plants without previous Ce treatment were transferred into nutrient solution. After two weeks of acclimatizing, 0, 25, 50, and 100 mu M Ce were added to the nutrient solution for 28 d. Ce significantly increased germination and the initial growth variables of the seedlings. During vegetative growth, Ce increased plant height, number of tillers, root volume, and shoot fresh and dry biomass, without affecting root biomass weight. With low Ce concentrations (25 and 50 mu M), the concentrations of chlorophylls and amino acids in the shoots were similar to those in the control, like amino acid concentration in the roots at a concentration of 25 mu M Ce. Conversely, the concentration of total sugars increased in the shoot with the application of 25, 50, and 100 mu M Ce, and in the roots with the application of 50 mu M Ce. Also, Ce did not affect the concentration of macro or micronutrients in the shoots. However, in the roots, the high Ce concentration decreased the concentrations of Ca, Fe, Mn, and Zn, while the Mg concentration increased. Our results indicate that Ce, at the right concentrations, can function as a biostimulant in rice germination and growth.	[Monzerrat Ramirez-Olvera, Sara; Antonio Perez-Sato, Juan; Carlos Gomez-Merino, Fernando] Colegio Postgrad, Dept Biotechnol, Campus Cordoba, Amatlan De Los Reyes, Veracruz, Mexico; [Iris Trejo-Tellez, Libia] Colegio Postgrad, Lab Plant Nutr, Dept Soil Sci, Campus Montecillo, Texcoco, State Of Mexico, Mexico; [Garcia-Morales, Soledad] Ctr Invest & Asistencia Tecnol & Diserio Estado J, CONACYT Ctr Res & Assistance Technol & Design Sta, Dept Plant Biotechnol, Zapopan, Jalisco, Mexico	Colegio de Postgraduados - Mexico; Colegio de Postgraduados - Mexico	Gomez-Merino, FC (corresponding author), Colegio Postgrad, Dept Biotechnol, Campus Cordoba, Amatlan De Los Reyes, Veracruz, Mexico.	fernandg@colpos.mx	LIBIA, TREJO-TÉLLEZ/AAV-8118-2021; Gómez-Merino, Fernando Carlos/D-2224-2014; Sato, Juan Antonio Perez/AAC-7562-2019; Gomez-Merino, Fernando Carlos/B-2423-2015	Sato, Juan Antonio Perez/0000-0002-8842-6262; RAMIREZ-OLVERA, SARA MONZERRAT/0000-0002-4652-8906; Gomez-Merino, Fernando Carlos/0000-0001-8496-2095; Garcia-Morales, Soledad/0000-0002-2551-2518	Mexico's National Science and Technology Council (CONACYT-Mexico); Colegio de Postgraduados Campus Cordoba and Campus Montecillo	Mexico's National Science and Technology Council (CONACYT-Mexico); Colegio de Postgraduados Campus Cordoba and Campus Montecillo	The authors are grateful to Mexico's National Science and Technology Council (CONACYT-Mexico) for the M. Sc. scholarship awarded to SMRO, and for the infrastructure and financial support provided by Colegio de Postgraduados Campus Cordoba and Campus Montecillo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aery NC, 1997, COMMUN SOIL SCI PLAN, V28, P949, DOI 10.1080/00103629709369845; Alcantar G.G., 1999, HDB CHEM ANAL PLANT, V1st; [Anonymous], 2011, STAT AN SYST VERS 9; Arsovski AA, 2015, PLANT PHYSIOL, V169, P2982, DOI 10.1104/pp.15.00717; BAILEY RW, 1958, BIOCHEM J, V68, P669, DOI 10.1042/bj0680669; Busoms S, 2015, PLANT PHYSIOL, V168, P915, DOI 10.1104/pp.15.00427; Calabrese EJ, 2014, MICROB CELL, V1, P145, DOI 10.15698/mic2014.05.145; Chen Y, 2015, PLANT CELL TISS ORG, V123, P283, DOI 10.1007/s11240-015-0831-2; d'Aquino L, 2009, CHEMOSPHERE, V75, P900, DOI 10.1016/j.chemosphere.2009.01.026; Diatloff E, 2008, ANN BOT-LONDON, V101, P971, DOI 10.1093/aob/mcn021; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; FAO, FAO CER SUPPL DEM BR; Fashui H, 2002, BIOL TRACE ELEM RES, V87, P191, DOI 10.1385/BTER:87:1-3:191; GABBRIELLI R, 1990, PLANT SOIL, V122, P271, DOI 10.1007/BF02851985; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Gong XL, 2011, BIOL TRACE ELEM RES, V141, P305, DOI 10.1007/s12011-010-8716-z; Espindola MCG, 2013, BIOSCI J, V29, P1501; He YW, 2000, PLANT SCI, V159, P117, DOI 10.1016/S0168-9452(00)00338-1; Hong FS, 2017, J AGR FOOD CHEM, V65, P9022, DOI 10.1021/acs.jafc.7b03398; Hong FS, 2002, SCI CHINA SER C, V45, P166, DOI 10.1360/02yc9019; Hong FS, 2002, BIOL TRACE ELEM RES, V89, P263, DOI 10.1385/BTER:89:3:263; Hu X, 2002, CHEMOSPHERE, V48, P621, DOI 10.1016/S0045-6535(02)00109-1; Hu YF, 2015, FRESEN ENVIRON BULL, V24, P4173; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Liu D, 2013, PLANT SOIL ENVIRON, V59, P196, DOI 10.17221/760/2012-PSE; Liu DW, 2012, ENVIRON SCI POLLUT R, V19, P3282, DOI 10.1007/s11356-012-0844-x; Liu DW, 2012, PROTEIN PEPTIDE LETT, V19, P198, DOI 10.2174/092986612799080121; Ma JJ, 2014, BIOL TRACE ELEM RES, V160, P427, DOI 10.1007/s12011-014-0062-0; Mali M, 2009, COMMUN SOIL SCI PLAN, V40, P1041, DOI 10.1080/00103620902753590; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; MOORE S, 1954, J BIOL CHEM, V211, P907; Moreno-Alvarado M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00073; Moyer M., 2010, SCI AM ENV, V2010, P74; PANDOLFINI T, 1992, PLANT CELL ENVIRON, V15, P719, DOI 10.1111/j.1365-3040.1992.tb01014.x; Paoli L, 2014, ECOTOX ENVIRON SAFE, V104, P379, DOI 10.1016/j.ecoenv.2014.02.028; Barbieri Ana Paula Piccinin, 2013, Pesqui. Agropecu. Trop., V43, P104, DOI 10.1590/S1983-40632013000100013; Poscic F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060577; Ramos SJ, 2016, CURR POLLUT REP, V2, P28, DOI 10.1007/s40726-016-0026-4; Rico CM, 2014, J AGR FOOD CHEM, V62, P9669, DOI 10.1021/jf503526r; Rico CM, 2013, J AGR FOOD CHEM, V61, P11278, DOI 10.1021/jf404046v; Shan XQ, 2003, PLANT SCI, V165, P1343, DOI 10.1016/S0168-9452(03)00361-3; Shi XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1954; Shtangeeva I, 2007, ENVIRON EXP BOT, V59, P49, DOI 10.1016/j.envexpbot.2005.10.011; Shtangeeva I, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1964-3; Shyam R, 2012, J SOIL SCI PLANT NUT, V12, P1, DOI 10.4067/S0718-95162012000100001; SOMASHEKARAIAH BV, 1992, PHYSIOL PLANTARUM, V85, P85, DOI 10.1111/j.1399-3054.1992.tb05267.x; Suryawanshi V, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3319-5; Thomas PJ, 2014, CHEMOSPHERE, V96, P57, DOI 10.1016/j.chemosphere.2013.07.020; Velasco J. R., 1979, Philippine Journal of Coconut Studies, V4, P1; [王建安 Wang Jian'an], 2010, [南京师大学报. 自然科学版, Journal of Nanjing Normal University. Natural Science], V33, P94; Wang X, 2007, RUSS J PLANT PHYSL+, V54, P693, DOI 10.1134/S1021443707050184; Wang X, 2012, J RARE EARTH, V30, P579, DOI 10.1016/S1002-0721(12)60094-5; Wu M, 2014, PLANT GROWTH REGUL, V74, P251, DOI 10.1007/s10725-014-9916-x; Xie YF, 2015, J RARE EARTH, V33, P898, DOI 10.1016/S1002-0721(14)60502-0; Yin ST, 2009, BIOL TRACE ELEM RES, V132, P247, DOI 10.1007/s12011-009-8392-z; Zhang CH, 2013, ACTA PHARM SIN B, V3, P20, DOI 10.1016/j.apsb.2012.12.005; Zhao HQ, 2012, BIOL TRACE ELEM RES, V148, P102, DOI 10.1007/s12011-012-9340-x; Zhou M, 2011, BIOL TRACE ELEM RES, V142, P760, DOI 10.1007/s12011-010-8769-z	58	31	32	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194691	10.1371/journal.pone.0194691	http://dx.doi.org/10.1371/journal.pone.0194691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579100	Green Published, Green Submitted, gold			2022-12-27	WOS:000428351800046
J	Shaw, T; Tellapragada, C; Vandana, KE; AuCoin, DP; Mukhopadhyayl, C				Shaw, Tushar; Tellapragada, Chaitanya; Vandana, K. E.; AuCoin, David P.; Mukhopadhyayl, Chiranjay			Performance evaluation of Active Melioidosis Detect-Lateral Flow Assay (AMD-LFA) for diagnosis of melioidosis in endemic settings with limited resources	PLOS ONE			English	Article							BURKHOLDERIA-PSEUDOMALLEI; RAPID DIAGNOSIS	Melioidosis is a fatal infection caused by the soil saprophyte Burkholderia pseudomallei. Early diagnosis and befitting medical management can significantly influence the clinical outcomes among patients with melioidosis. Witnessing an annual increment in the number of melioidosis cases, over the past few years, mainly from the developing tropical nations, the present study was undertaken to evaluate the diagnostic utility of Active Melioidosis Detect (TM) LateralFlow Assay (AMD-LFA), in comparison with enrichment culture and PCR. A total of 206clinical specimens obtained from 175 patients with clinical suspicion of melioidosis were considered for the evaluation. Positivity for B.pseudomallei using enrichment culture, PCR and AMD-LFA were observed among 63 (30.5%), 55 (26.6%) and 63 (30.5%) specimens respectively. The AMD-LFA failed to detect melioidosis from 9 culture-confirmed cases (6 whole blood specimens, 2 pus samples, and one synovial fluid). Further the test gave faint bands from 9 urine samples which were negative by culture and PCR. AMD-LFA demonstrated a sensitivity, specificity, of 85.71%(CI:74.61% to 93.25%) and 93.62% (Cl:88.23% to 97.04%), with positive predictive value of 85.71% (CI: 75.98% to 91.92%) and negative predictive value of 93.62% (Cl:88.89% to 96.42%). The test needs further evaluation in view of the faint bands from negative urine samples, for incorporating the test as a point of care assay. In view of its rapidity and ease of testing AMD-LFA might be useful in early diagnosis of melioidosis at resource constraint settings.	[Shaw, Tushar; Vandana, K. E.; Mukhopadhyayl, Chiranjay] Manipal Univ, Kasturba Med Coll, Dept Microbiol, Manipal, Karnataka, India; [Tellapragada, Chaitanya] Manipal Univ, Manipal Ctr Virus Res, Manipal, Karnataka, India; [AuCoin, David P.] Univ Nevada, Dept Mol Microbiol & Immunol, Reno, NV 89557 USA	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Nevada System of Higher Education (NSHE); University of Nevada Reno	Mukhopadhyayl, C (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Microbiol, Manipal, Karnataka, India.	chiranjay@gmail.com	Tellapragada, Chaitanya/AAS-1232-2021; Mukhopadhyay, Chiranjay/GLU-2887-2022; Shaw, Tushar/AAP-7846-2020	Mukhopadhyay, Chiranjay/0000-0003-0402-1143; Tellapragada, chaitanya/0000-0002-0117-5369				Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Hoffmaster Alex R, 2015, Emerg Infect Dis, V21, DOI 10.3201/eid2102.141045; Houghton RL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002727; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Mukhopadhyay Chiranjay, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS12, DOI 10.1016/S0035-9203(08)70005-1; O'Brien M, 2004, J CLIN MICROBIOL, V42, P2239, DOI 10.1128/JCM.42.5.2239-2240.2004; Robertson G, 2015, J MED MICROBIOL, V64, P845, DOI 10.1099/jmm.0.000098; Supaprom C, 2007, J CLIN MICROBIOL, V45, P2894, DOI 10.1128/JCM.00291-07; Tellapragada C, 2017, TROPICAL MED INT HLT; Vidyalakshmi K, 2012, INT J INFECT DIS, V16, pE491, DOI 10.1016/j.ijid.2012.02.012; WALSH AL, 1994, J CLIN PATHOL, V47, P377, DOI 10.1136/jcp.47.4.377; Winstanley C, 2000, J CLIN MICROBIOL, V38, P883, DOI 10.1128/JCM.38.2.883-885.2000	13	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194595	10.1371/journal.pone.0194595	http://dx.doi.org/10.1371/journal.pone.0194595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579128	Green Published, Green Submitted, gold			2022-12-27	WOS:000428351800037
J	Graves, GR; Newsome, SD; Fogel, ML				Graves, Gary R.; Newsome, Seth D.; Fogel, Marilyn L.			Stable hydrogen isotope variability within and among plumage tracts (delta H-2(F)) of a migratory wood warbler	PLOS ONE			English	Article							THROATED BLUE WARBLERS; NEOTROPICAL MIGRANT; DELTA-D; NONEXCHANGEABLE HYDROGEN; BREEDING POPULATIONS; WINTERING GROUNDS; DRINKING-WATER; RATIOS; DISPERSAL; BIRDS	Hydrogen isotope analysis of feather keratin (delta H-2(F)) has become an essential tool for tracking movements between breeding and wintering populations of migratory birds. In particular, delta H-2(F) has been used to create delta H-2(F) isoscapes that can be used to assign the geographic origins of molt. The majority of past studies have sampled a portion of a single feather as an isotopic proxy for the entire plumage although surprisingly little is known about variation of stable isotopes within and between feather tracts of individuals in local populations. Here we examine delta H-2(F) variation in 24 pterylographic variables (9 primaries, 6 secondaries, 6 rectrices, and 3 patches of ventral contour feathers) in individual specimens of black-throated blue warbler (Setophaga caerulescens) breeding in the Big Santeetlah Creek watershed (5350 ha), southern Appalachian Mountains. By restricting our study to territorial ASY males (after second year) inhabiting a small watershed, we could focus on delta H-2(F) variation generated during the complete prebasic annual molt in a circumscribed population while factoring out age and sexual differences in foraging behavior, isotopic incorporation, and post-breeding dispersal. Summed within-individual variation (delta H-2(F)) across 24 pterylographic variables ranged from 12 to 60 parts per thousand (= 21.8 9.4 parts per thousand), with 81% of the individuals exhibiting variation >= 16 parts per thousand (reproducibility of analyses was <= 4 parts per thousand). Adjacent feathers in feather tracts tend to have more similar delta H-2(F) values than feathers grown weeks apart, consistent with the stepwise replacement of flight feathers. The pooled population sample exhibited significant delta H-2(F) variation in primaries (-78 to-21 parts per thousand), secondaries (-80 to-17 parts per thousand), rectrices (-78 to-23 parts per thousand), and ventral contour feathers (-92 to-32 parts per thousand). Strong year effects in delta H-2(F) variation were observed in each of the 24 pterylographic variables. Altitudinal effects were observed only in ventral contour feathers. The current findings demonstrate that within-individual variation (delta H-2(F)) may be much greater than previously thought in migratory species that molt on or near breeding territories. Our study also highlights the need for greater pterylographic precision in research design of isotope-based studies of avian movement. Within-individual and within-population delta H-2(F) variation should be incorporated in geographic assignment models. In a broader context, the staggered Staffelmauser pattern of molt in wood warblers provides an exceptional view of the seasonal variation of hydrogen isotopes circulating in blood plasma during the six-week period of annual molt.	[Graves, Gary R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, MRC-116, Washington, DC 20560 USA; [Graves, Gary R.] Univ Copenhagen, Natl Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Newsome, Seth D.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Fogel, Marilyn L.] Univ Calif Riverside, Environm Dynam & Geoecol Inst, Riverside, CA 92521 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Copenhagen; University of New Mexico; University of California System; University of California Riverside	Graves, GR (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, MRC-116, Washington, DC 20560 USA.; Graves, GR (corresponding author), Univ Copenhagen, Natl Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.	gravesg@si.edu	Graves, Gary R/P-1003-2017	Graves, Gary R/0000-0003-1406-5246	Alexander Wetmore Fund; Smithsonian Institution; Smoketree Trust; National Science Foundation (NSF) [DEB-1343015, DEB-1437845]	Alexander Wetmore Fund; Smithsonian Institution(Smithsonian Institution); Smoketree Trust; National Science Foundation (NSF)(National Science Foundation (NSF))	This study was supported by Alexander Wetmore Fund, Smithsonian Institution, to GRG; Smoketree Trust (private financial support), to GRG; National Science Foundation (NSF) grant DEB-1343015, to SDN; National Science Foundation (NSF) grant DEB-1437845, to MLF.	Bent A. C., 1953, Bulletin United States National Museum, VNo. 203, P1; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; Biasiolli TG, 2008, THESIS; Blum JD, 2001, OECOLOGIA, V126, P569, DOI 10.1007/s004420000550; Boulet Marylene, 2006, Ornithological Monographs, V61, P29, DOI 10.1642/0078-6594(2006)61[29:IAOGSI]2.0.CO;2; Bowen GJ, 2005, RAPID COMMUN MASS SP, V19, P2371, DOI 10.1002/rcm.2069; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Clegg SM, 2003, MOL ECOL, V12, P819, DOI 10.1046/j.1365-294X.2003.01757.x; Dugger KM, 2004, CONDOR, V106, P744, DOI 10.1650/7632; ESTEP MF, 1980, SCIENCE, V209, P1537, DOI 10.1126/science.209.4464.1537; Fallon SM, 2006, BIOL LETTERS, V2, P213, DOI 10.1098/rsbl.2005.0429; Farmer A, 2008, OECOLOGIA, V158, P183, DOI 10.1007/s00442-008-1143-6; Graves GR, 2009, ECOL APPL, V19, P1264, DOI 10.1890/08-0934.1; Graves GR, 2004, AUK, V121, P473, DOI 10.1642/0004-8038(2004)121[0473:TVAAAA]2.0.CO;2; Graves GR, 2002, P NATL ACAD SCI USA, V99, P8096, DOI 10.1073/pnas.082240899; Graves GR, 1997, J FIELD ORNITHOL, V68, P443; Graves GR, 1997, ECOLOGY, V78, P2524; Grus WE, 2009, AUK, V126, P198, DOI 10.1525/auk.2009.07159; Hache S, 2012, CANADIAN J ZOOLOGY; Haney JC, 2001, CONDOR, V103, P268, DOI 10.1650/0010-5422(2001)103[0268:AHCCOB]2.0.CO;2; Hobson KA, 2004, CONDOR, V106, P732, DOI 10.1650/7631; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Hobson KA, 2015, AVIAN CONSERV ECOL, V10, DOI 10.5751/ACE-00719-100103; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Holberton RL, 2015, J FIELD ORNITHOL, V86, P213, DOI 10.1111/jofo.12112; HOLMES RT, 2005, BLACK THROATED BLUE; Jr Dwight J, 1900, ANN NEW YORK ACAD SC, V13, P73; Kelly JF, 2008, ECOL APPL, V18, P568, DOI 10.1890/07-0027.1; Kelly JF, 2006, AUK, V123, P431, DOI 10.1642/0004-8038(2006)123[431:SIELBG]2.0.CO;2; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; LORIMER CG, 1980, ECOLOGY, V61, P1169, DOI 10.2307/1936836; Meehan TD, 2003, CONDOR, V105, P567, DOI 10.1650/7283; Meehan TD, 2001, CONDOR, V103, P11, DOI 10.1650/0010-5422(2001)103[0011:UHIGTE]2.0.CO;2; Nolan V., 1978, ORNITHOL MONOGR, V26, P1; Nordell CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163957; Norris DR, 2004, SCIENCE, V306, P2249, DOI 10.1126/science.1103542; Paxton KL, 2007, AUK, V124, P162, DOI 10.1642/0004-8038(2007)124[162:SATMPO]2.0.CO;2; Perez GE, 2006, CONDOR, V108, P877, DOI 10.1650/0010-5422(2006)108[877:IEOIMI]2.0.CO;2; Poage MA, 2001, AM J SCI, V301, P1, DOI 10.2475/ajs.301.1.1; Podlesak DW, 2005, OECOLOGIA, V142, P501, DOI 10.1007/s00442-004-1737-6; Pyle P, 1997, IDENTIFICATION GUIDE; Reudink MW, 2008, AUK, V125, P742; Royle JA, 2004, ECOL APPL, V14, P1780; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Sauer PE, 2009, RAPID COMMUN MASS SP, V23, P949, DOI 10.1002/rcm.3954; Sellick MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004735; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; STRESEMANN ERWIN, 1966, J ORNITHOL, V107, P1; Studds CE, 2008, P NATL ACAD SCI USA, V105, P2929, DOI 10.1073/pnas.0710732105; van Dijk JGB, 2014, J AVIAN BIOL, V45, P103, DOI 10.1111/j.1600-048X.2013.00232.x; Van Wilgenburg Steven L., 2012, Endangered Species Research, V16, P17, DOI 10.3354/esr00383; Wassenaar LI, 2006, RAPID COMMUN MASS SP, V20, P2505, DOI 10.1002/rcm.2626; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3; Wetmore A., 1936, Auk, V53, P159; WILCOVE DS, 1988, WILSON BULL, V100, P256; Wiley AE, 2010, CONDOR, V112, P337, DOI 10.1525/cond.2010.090186; Wolf BO, 2000, OECOLOGIA, V124, P536, DOI 10.1007/s004420000406; Wolf N, 2012, J EXP BIOL, V215, P1915, DOI 10.1242/jeb.065219; Wolf N, 2011, J EXP BIOL, V214, P98, DOI 10.1242/jeb.050211; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1	69	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0193486	10.1371/journal.pone.0193486	http://dx.doi.org/10.1371/journal.pone.0193486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614120	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600004
J	Tzotzos, G; Iley, JN; Moore, EA				Tzotzos, George; Iley, Jim N.; Moore, Elaine A.			New insights on repellent recognition by Anopheles gambiae odorant-binding protein 1	PLOS ONE			English	Article							PHEROMONE-SENSITIVE NEURONS; BOLTZMANN SURFACE-AREA; LIGAND-BINDING; CONFORMATIONAL-CHANGES; MOLECULAR-DYNAMICS; LYMANTRIA-DISPAR; FORCE-FIELD; GYPSY-MOTH; RAS-RAF; MECHANISM	It is generally recognized that insect odorant binding proteins (OBPs) mediate the solubilisation and transport of hydrophobic odorant molecules and contribute to the sensitivity of the insect olfactory system. However, the exact mechanism by which OBPs deliver odorants to olfactory receptors and their role, if any, as selectivity filters for specific odorants, are still a matter of debate. In the case of Anopheles gambiae, recent studies indicate that ligand discrimination is effected through the formation of heterodimers such as AgamOBP1 and AgamOBP4 (odorant binding proteins 1 and 4 from Anopheles gambiae). Furthermore, AgamOBPs have been reported to be promiscuous in binding more than one ligand simultaneously and repellents such as DEET (N,N-diethyl-3-toluamide) and 6-MH (6-methyl-5-hepten-2-one) interact directly with mosquito OBPs and/or compete for the binding of attractive odorants thus disrupting OBP heterodimerisation. In this paper, we propose mechanisms of action of DEET and 6-MH. We also predict that ligand binding can occur in several locations of AgamOBP1 with partial occupancies and propose structural features appropriate for repellent pharmacophores.	[Tzotzos, George] Ferrogasse, Vienna, Austria; [Iley, Jim N.; Moore, Elaine A.] Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England	Open University - UK	Tzotzos, G (corresponding author), Ferrogasse, Vienna, Austria.	gtzotzos@me.com		Tzotzos, George/0000-0001-9258-4338; Moore, Elaine/0000-0003-4418-0536				Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Anjana R, 2012, BIOINFORMATION, V8, P1220, DOI 10.6026/97320630081220; [Anonymous], HYDR BONDS PI PI STA; [Anonymous], LANCET, V386, P31; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Cao LH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01185-0; Case D. A., 2010, AMBER 11 AMBERTOOLS; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; Drakou CE, 2017, CELL MOL LIFE SCI, V74, P319, DOI 10.1007/s00018-016-2335-6; Fuglebakk E, 2012, BIOINFORMATICS, V28, P2431, DOI 10.1093/bioinformatics/bts445; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Guimaraes Affonso RdS, 2013, J BRAZILIAN CHEM SOC, V24; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Manoharan M, 2014, J BIOMOL STRUCT DYN, V32, P1742, DOI 10.1080/07391102.2013.834118; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murphy EJ, 2013, J BIOL CHEM, V288, P4475, DOI 10.1074/jbc.M112.436386; Oliferenko PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064547; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 1996, J NEUROBIOL, V30, P3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Rusconi B, 2012, BBA-PROTEINS PROTEOM, V1824, P947, DOI 10.1016/j.bbapap.2012.04.011; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Tzotzos G., 2012, STRUCTURE FUNCTION P; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084795; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yin J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00056; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179	59	6	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194724	10.1371/journal.pone.0194724	http://dx.doi.org/10.1371/journal.pone.0194724			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614080	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600017
J	Lewien, MJ; Murray, TD; Jernigan, KL; Garland-Campbell, KA; Carter, AH				Lewien, Megan J.; Murray, Timothy D.; Jernigan, Kendra L.; Garland-Campbell, Kimberly A.; Carter, Arron H.			Genome-wide association mapping for eyespot disease in US Pacific Northwest winter wheat	PLOS ONE			English	Article							HERPOTRICHOIDES FRON DEIGHTON; PSEUDOCERCOSPORELLA-HERPOTRICHOIDES; OCULIMACULA-YALLUNDAE; TAPESIA-YALLUNDAE; CEREAL EYESPOT; RESISTANCE; REGISTRATION; GENE; IDENTIFICATION; POPULATIONS	Eyespot, caused by the soil-borne necrotrophic fungi Oculimacula yallundae and O. acuformis, is a disease of major economic significance for wheat, barley and rye. Pacific Northwest (PNW) winter wheat (Triticum aestivum L.) grown in areas of high rainfall and moderate winters is most vulnerable to infection. The objective of this research was to identify novel genomic regions associated with eyespot resistance in winter wheat adapted to the PNW. Two winter wheat panels of 469 and 399 lines were compiled for one of the first genome-wide association studies (GWAS) of eyespot resistance in US winter wheat germplasm. These panels were genotyped with the Infinium 9K and 90K iSelect SNP arrays. Both panels were phenotyped for disease resistance in a two-year field study and in replicated growth chamber trials. Growth chamber trials were used to evaluate the genetic resistance of O. acuformis and O. yallundae species separately. Best linear unbiased predictors (BLUPs) were calculated across all field and growth chamber environments. A total of 73 marker-trait associations (MTAs) were detected on nine different chromosomes (1A, 2A, 2B, 4A, 5A, 5B, 7A, 7B and 7D) that were significantly associated (p-value <0.001) with eyespot resistance in Panel A, and 19 MTAs on nine different chromosomes (1A, 1B, 2A, 2D, 3B, 5A, 5B, 7A, and 7B) in Panel B. The most significant SNPs were associated with Pch1 and Pch2 resistance genes on the long arms of chromosome 7D and 7A. Most of the novel MTAs appeared to have a minor effect on reducing eyespot disease. Nevertheless, eyespot disease scores decreased as the number of resistance alleles increased. Seven SNP markers, significantly associated with reducing eyespot disease across environments and in the absence and presence of Pch1 were identified. These markers were located on chromosomes 2A (IWB8331), 5A (IWB73709), 5B (IWB47298), 7AS (IWB47160), 7B (IWB45005) and two SNPs (Ex_c44379_2509 and IAAV4340) had unknown map positions. The additive effect of the MTAs explained most of the remaining phenotypic variation not accounted for by Pch1 or Pch2. This study provides breeders with adapted germplasm and novel sources of eyespot resistance to be used in the development of superior cultivars with increased eyespot resistance.	[Lewien, Megan J.; Jernigan, Kendra L.; Carter, Arron H.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Murray, Timothy D.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Garland-Campbell, Kimberly A.] Washington State Univ, USDA ARS, Wheat Hlth Genet & Qual Unit, Pullman, WA 99164 USA; [Jernigan, Kendra L.] Univ Mt Olive, Sch Arts & Sci, Mt Olive, NC USA	Washington State University; Washington State University; United States Department of Agriculture (USDA); Washington State University	Carter, AH (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ahcarter@wsu.edu	Murray, Timothy D/A-9771-2016; Carter, Arron/E-9631-2019	Murray, Timothy D/0000-0002-6772-202X; Carter, Arron/0000-0002-8019-6554	National Institute of Food and Agriculture, U.S. Department of Agriculture [2016-68004-24770]; Washington State University [3019-0232]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Washington State University	We would like to thank the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2016-68004-24770 to Arron H Carter and Washington State University (3019-0232) to Arron H Carter, for providing funding to support this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN RE, 1989, CROP SCI, V29, P1575, DOI 10.2135/cropsci1989.0011183X002900060068x; Bajgain P, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0628-9; Bates D., 2011, WELCOME LME4 MIXED E; Borner A, 2006, GENET RESOUR CROP EV, V53, P453, DOI 10.1007/s10722-004-1158-8; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burt C, 2011, THEOR APPL GENET, V122, P119, DOI 10.1007/s00122-010-1427-1; Burt C, 2010, PLANT PATHOL, V59, P819, DOI 10.1111/j.1365-3059.2010.02307.x; Cadle MM, 1997, PLANT DIS, V81, P1181, DOI 10.1094/PDIS.1997.81.10.1181; Carter AH, 2017, J PLANT REGIST, V11, P263, DOI 10.3198/jpr2016.09.0051crc; Carter AH, 2014, J PLANT REGIST, V8, P273, DOI 10.3198/jpr2013.12.0074crc; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; delaPena RC, 1997, GENOME, V40, P249, DOI 10.1139/g97-035; DOUSSINAULT G, 1983, NATURE, V303, P698, DOI 10.1038/303698a0; DOUSSINAULT G, 1977, Z PFLANZENZUCHT, V79, P122; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Garland-Campbell K, 2017, J PLANT REGIST, V11, P152, DOI 10.3198/jpr2016.04.0018crc; Garland-Campbell K, 2013, J PLANT REGIST, V7, P81, DOI 10.3198/jpr2012.01.0005crc; HOLLINS TW, 1988, PLANT PATHOL, V37, P251, DOI 10.1111/j.1365-3059.1988.tb02070.x; Leonard JM, 2008, THEOR APPL GENET, V116, P261, DOI 10.1007/s00122-007-0664-4; Li HJ, 2005, THEOR APPL GENET, V111, P932, DOI 10.1007/s00122-005-0025-0; Li HJ, 2004, PHYTOPATHOLOGY, V94, P932, DOI 10.1094/PHYTO.2004.94.9.932; Lind V, 1999, PLANT BREEDING, V118, P281, DOI 10.1046/j.1439-0523.1999.00388.x; LIND V, 1992, PLANT BREEDING, V108, P202, DOI 10.1111/j.1439-0523.1992.tb00121.x; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu W, 2017, PLANT GEN, V11; Morrill W., 2010, COMPENDIUM WHEAT DIS, P32; Murray TD, 1996, PLANT DIS, V80, P19, DOI 10.1094/PD-80-0019; MURRAY TD, 1994, PLANT BREEDING, V113, P281, DOI 10.1111/j.1439-0523.1994.tb00737.x; Naruoka Y, 2015, THEOR APPL GENET, V128, P1083, DOI 10.1007/s00122-015-2492-2; Parnell S, 2008, PLANT PATHOL, V57, P509, DOI 10.1111/j.1365-3059.2007.01786.x; PETERSON CJ, 1991, CROP SCI, V31, P1704; R Core Team, 2015, R LANGUAGE ENV STAT; Sheng H, 2013, PLANT DIS, V97, P346, DOI 10.1094/PDIS-12-11-1048-RE; STRAUSBAUGH CA, 1989, PHYTOPATHOLOGY, V79, P1048, DOI 10.1094/Phyto-79-1048; Summers RW, 2013, PLANT PATHOL, V62, P115, DOI 10.1111/ppa.12165; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wetzel HC, 2011, PLANT DIS MANAG REP, V5; Wetzel HC, 2010, PLANT DIS MANAGE REP, V4; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; WORLAND AJ, 1988, PLANT BREEDING, V101, P43, DOI 10.1111/j.1439-0523.1988.tb00265.x; Yildirim A, 2000, PLANT DIS, V84, P40, DOI 10.1094/PDIS.2000.84.1.40; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanke CD, 2016, THEOR APPL GENET, V3, P505; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	46	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194698	10.1371/journal.pone.0194698	http://dx.doi.org/10.1371/journal.pone.0194698			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608579	gold, Green Submitted, Green Published			2022-12-27	WOS:000428988800014
J	Oryan, A; Alidadi, S; Bigham-Sadegh, A; Moshiri, A				Oryan, Ahmad; Alidadi, Soodeh; Bigham-Sadegh, Amin; Moshiri, Ali			Healing potentials of polymethylmethacrylate bone cement combined with platelet gel in the critical-sized radial bone defect of rats	PLOS ONE			English	Article							RICH PLASMA; POLYMETHYL METHACRYLATE; COMPOSITE SCAFFOLD; CANCELLOUS BONE; IN-VIVO; REGENERATION; MODEL; AUGMENTATION; RABBIT; PHOSPHATE	Polymethylmethacrylate (PMMA) is the most commonly used filler material that lacks biological properties and osteoconductivity or osteoinductivity. Platelet gel (PG) is a typical source of growth factors, cytokines and molecules efficient for bone formation and remodeling. The aim of this study was to evaluate bone healing and regeneration of bone defect in rat model by combining PMMA with PG. A total of 50 defects were created in the diaphysis of the radii of 25 male Sprague-Dawley rats. These defects were randomly divided into five groups (n = 10 defects for each group) and treated by autograft, plain PMMA, PG and PMMA-PG or left untreated. The rats were examined clinically and radiologically during the experiment and also after euthanasia at the 8th post-operative week, the healed defects were evaluated by gross morphology, histopathology, histomorphometry, computed tomography, scanning electron microscopy and biomechanical testing. PG could function as efficiently as autograft in promoting bone healing of the radial bones. Additionally, bone formation, and densities of cartilaginous and osseous tissues in the defects treated with autograft, PG and PMMA-PG were more satisfactory than the untreated and PMMA treated defects. Compared with the PMMA-PG implant, more PMMA residuals remained in the defect area and induced more intense inflammatory reaction. In conclusion, addition of PG could improve the bone regenerative properties of PMMA bone cement compared with PMMA alone in vivo. Therefore, the PG-PMMA can be proposed as a promising option to increase regenerative potential of PMMA, particularly when it is used as fixator, filler or adhesive in the dentistry, neurosurgery and bone tissue engineering applications.	[Oryan, Ahmad; Alidadi, Soodeh] Shiraz Univ, Sch Vet Med, Dept Pathol, Shiraz, Iran; [Bigham-Sadegh, Amin] Shahrekord Univ, Sch Vet Med, Dept Clin Sci, Shahrekord, Iran; [Moshiri, Ali] AJA Univ Med Sci, Dept Orthoped Surg, Fac Med, Tehran, Iran	Shiraz University; Shahrekord University	Bigham-Sadegh, A (corresponding author), Shahrekord Univ, Sch Vet Med, Dept Clin Sci, Shahrekord, Iran.	dr.bigham@gmail.com	Alidadi, Soodeh/M-4690-2017; Moshiri, Ali/H-1851-2013; Oryan, Ahmad/J-6539-2014	Alidadi, Soodeh/0000-0003-2341-8533; Moshiri, Ali/0000-0003-3967-7468; Oryan, Ahmad/0000-0003-1697-2376				Aghyarian S, 2014, J BIOMATER APPL, V29, P688, DOI 10.1177/0885328214544770; Arabmotlagh M, 2014, J BIOMED MATER RES B, V102, P1613, DOI 10.1002/jbm.b.33140; Arora M, 2013, WORLD J ORTHOP, V4, P67, DOI 10.5312/wjo.v4.i2.67; Betoni W, 2013, J ORAL IMPLANTOL, V39, P14, DOI 10.1563/AAID-JOI-D-10-00043; Dalby MJ, 2002, BIOMATERIALS, V23, P569, DOI 10.1016/S0142-9612(01)00139-9; Fini M, 2002, BIOMATERIALS, V23, P4523, DOI 10.1016/S0142-9612(02)00196-5; Hatten HP, 2012, INTERV NEURORADIOL, V18, P105, DOI 10.1177/159101991201800114; Hautaamaki MP, 2008, ACTA ORTHOP, V79, P555, DOI 10.1080/17453670710015571; He FP, 2015, J BIOMED MATER RES A, V103, P1312, DOI 10.1002/jbm.a.35248; Jager M, 2003, J BIOMAT SCI-POLYM E, V14, P1283, DOI 10.1163/156856203322553491; Khairy NM, 2013, INT J ORAL MAX SURG, V42, P249, DOI 10.1016/j.ijom.2012.09.009; Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022; LANE JM, 1987, ORTHOP CLIN N AM, V18, P213; Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z; Lye KW, 2013, CLIN ORAL IMPLAN RES, V24, P100, DOI 10.1111/j.1600-0501.2011.02388.x; Magnan B, 2013, Musculoskelet Surg, V97, P93, DOI 10.1007/s12306-013-0293-9; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Mooren RECM, 2010, INT J ORAL MAX SURG, V39, P371, DOI 10.1016/j.ijom.2009.12.019; Moshiri A, 2015, J CELL MOL MED, V19, P1308, DOI 10.1111/jcmm.12511; Moshiri A, 2014, EXPERT OPIN BIOL TH, V14, P1065, DOI 10.1517/14712598.2014.915305; Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Ogundipe OK, 2011, J ORAL MAXIL SURG, V69, P2305, DOI 10.1016/j.joms.2011.02.014; Oryan A, 2012, CELL TISSUE BANK, V13, P639, DOI 10.1007/s10561-011-9285-x; Oryan A, 2017, CALCIFIED TISSUE INT; Oryan A, 2017, J CONTROL RELEASE, V254, P65, DOI 10.1016/j.jconrel.2017.03.040; Oryan A, 2016, EXPERT OPIN BIOL TH, V16, P213, DOI 10.1517/14712598.2016.1118458; Oryan A, 2015, EXP BIOL MED, V240, P194, DOI 10.1177/1535370214554532; Oryan A, 2014, BIODRUGS, V28, P537, DOI 10.1007/s40259-014-0107-0; Parizi AM, 2012, J MATER SCI-MATER M, V23, P473, DOI 10.1007/s10856-011-4478-1; Peng W, 2016, MAXILLOFAC PLAST REC, V38, P1; Plachokova AS, 2009, INT J ORAL MAX SURG, V38, P861, DOI 10.1016/j.ijom.2009.04.009; Rodriguez IA, 2014, BIOMED RES INT, V2014; Tajima S, 2015, TISSUE ENG PT A, V21, P895, DOI [10.1089/ten.tea.2014.0336, 10.1089/ten.TEA.2014.0336]; van Bergen CJA, 2013, OSTEOARTHR CARTILAGE, V21, P1746, DOI 10.1016/j.joca.2013.07.014; Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010; Wildemann B, 2005, BIOMATERIALS, V26, P4035, DOI 10.1016/j.biomaterials.2004.10.004; Wolf-Brandstetter C, 2013, J BIOMED MATER RES B, V101B, P599, DOI 10.1002/jbm.b.32862; Xing ZC, 2013, J BIOMAT SCI-POLYM E, V24, P61, DOI 10.1163/156856212X623526; Yang J, 2015, MED SCI MONITOR, V21, P1162, DOI 10.12659/MSM.893845; Zhang ZY, 2013, CELL TRANSPLANT, V22, P175, DOI 10.3727/096368912X653183; Zhu TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03207-9	42	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194751	10.1371/journal.pone.0194751	http://dx.doi.org/10.1371/journal.pone.0194751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608574	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800017
J	Barengolts, E; Green, SJ; Eisenberg, Y; Akbar, A; Reddivari, B; Layden, BT; Dugas, L; Chlipala, G				Barengolts, Elena; Green, Stefan J.; Eisenberg, Yuval; Akbar, Arfana; Reddivari, Bharathi; Layden, Brian T.; Dugas, Lara; Chlipala, George			Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease	PLOS ONE			English	Article							CATION TRANSPORTER 1; INTESTINAL MICROBIOTA; BETA-GLUCURONIDASES; METFORMIN; LACTOBACILLUS; ASSOCIATION; OBESITY; STRESS; EXPRESSION; PROBIOTICS	Objective The gut microbiota is known to be related to type 2 diabetes (T2D), psychiatric conditions, and opioid use. In this study, we tested the hypothesis that variability in gut microbiota in T2D is associated with psycho-metabolic health. Methods A cross-sectional study was conducted among African American men (AAM) (n = 99) that were outpatients at a Chicago VA Medical Center. The main outcome measures included fecal microbiota ecology (by 16S rRNA gene sequencing), psychiatric disorders including opioid use, and circulating leptin and oxytocin as representative hormone biomarkers for obesity and psychological pro-social behavior. Results The study subjects had prevalent overweight/obesity (78%), T2D (50%) and co-morbid psychiatric (65%) and opioid use (45%) disorders. In the analysis of microbiota, the data showed interactions of opioids, T2D and metformin with Bifidobacterium and Prevotella genera. The differential analysis of Bifidobacterium stratified by opioids, T2D and metformin, showed significant interactions among these factors indicating that the effect of one factor was changed by the other (FDR-adjusted p [q] < 0.01). In addition, the pair-wise comparison showed that participants with T2D not taking metformin had a significant 6.74 log2 fold increase in Bifidobacterium in opioid users as compared to non-users (q = 2.2 x 10(-8)). Since metformin was not included in this pair-wise comparison, the significant 'q' suggested association of opioid use with Bifidobacterium abundance. The differences in Bifidobacterium abundance could possibly be explained by opioids acting as organic cation transporter 1 (OCT1) inhibitors. Analysis stratified by lower and higher leptin and oxytocin (divided by the 50th percentile) in the subgroup without T2D showed lower Dialister in High-Leptin vs. Low-Leptin (p = 0.03). Contrary, the opposite was shown for oxytocin, higher Dialister in High-Oxytocin vs. Low-Oxytocin (p = 0.04). Conclusions The study demonstrated for the first time that Bifidobacterium and Prevotella abundance was affected by interactions of T2D, metformin and opioid use. Also, in subjects without T2D Dialister abundance varied according to circulating leptin and oxytocin.	[Barengolts, Elena; Eisenberg, Yuval; Akbar, Arfana; Reddivari, Bharathi; Layden, Brian T.] Univ Illinois, Med Ctr, Dept Med, Chicago, IL 60607 USA; [Barengolts, Elena; Layden, Brian T.] Jesse Brown VA Med Ctr, Dept Med, Chicago, IL 60612 USA; [Green, Stefan J.] Univ Illinois, DNA Serv Facil, Res Resources Ctr, Chicago, IL USA; [Akbar, Arfana; Reddivari, Bharathi] Jesse Brown VA Med Ctr, Div Res & Dev, Chicago, IL USA; [Dugas, Lara] Loyola Univ, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Chlipala, George] Univ Illinois, Core Res Informat, Res Resources Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Barengolts, E (corresponding author), Univ Illinois, Med Ctr, Dept Med, Chicago, IL 60607 USA.; Barengolts, E (corresponding author), Jesse Brown VA Med Ctr, Dept Med, Chicago, IL 60612 USA.	eibareng@uic.edu		Dugas, Lara/0000-0002-0692-8585; Chlipala, George/0000-0003-0203-3191	NIDDK NIH HHS [R01 DK104927] Funding Source: Medline; NIH HHS [R01DK104927-01A1] Funding Source: Medline; BLRD VA [IK2 BX001587] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BLRD VA		Aguilera M, 2013, MICROB ECOL, V66, P232, DOI 10.1007/s00248-013-0241-0; Altirriba J, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00119; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Bandelow B, 2017, WORLD J BIOL PSYCHIA, V18, P162, DOI 10.1080/15622975.2016.1190867; Banerjee S, 2016, MUCOSAL IMMUNOL, V9, P1418, DOI 10.1038/mi.2016.9; Barengolts E, 2016, ENDOCR PRACT, V22, P1224, DOI 10.4158/EP151157.RA; Barengolts E, 2016, ENDOCR PRACT, V22, P885, DOI 10.4158/EP151192.RA; Barengolts E, 2015, ENDOCR PRACT, V21, P604, DOI 10.4158/EP14548.OR; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Christensen MMH, 2011, PHARMACOGENET GENOM, V21, P837, DOI 10.1097/FPC.0b013e32834c0010; Christian LM, 2015, BRAIN BEHAV IMMUN, V45, P118, DOI 10.1016/j.bbi.2014.10.018; Ciubotaru I, 2015, TRANSL RES, V166, P401, DOI 10.1016/j.trsl.2015.06.015; de la Cuesta-Zuluaga J, 2017, DIABETES CARE, V40, P54, DOI 10.2337/dc16-1324; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Dujic T, 2016, DIABETIC MED, V33, P511, DOI 10.1111/dme.13040; Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388; Ejtahed HS, 2012, NUTRITION, V28, P539, DOI 10.1016/j.nut.2011.08.013; Erdman SE, 2016, AGING-US, V8, P3157, DOI 10.18632/aging.101154; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Gu YY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01682-2; Kiraly DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35455; Kleiman SC, 2015, PSYCHOSOM MED, V77, P969, DOI 10.1097/PSY.0000000000000247; Labad J, 2012, PSYCHOSOM MED, V74, P39, DOI 10.1097/PSY.0b013e31823ba8af; Leclercq S, 2016, CAN J PSYCHIAT, V61, P204, DOI 10.1177/0706743716635535; Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973; Martinotti G, 2013, CURR PHARM DESIGN, V19, P6367; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Moroti C, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-29; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Nakayama J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00197; Pinto -Sanchez MI., 2017, GASTROENTEROLOGY; Pollet RM, 2017, STRUCTURE, V25, P967, DOI 10.1016/j.str.2017.05.003; Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078898; REDDY BS, 1974, SCIENCE, V183, P416, DOI 10.1126/science.183.4123.416; Seltzer LJ, 2014, CHILD DEV, V85, P501, DOI 10.1111/cdev.12136; Semenkovich CF, 2015, DIABETES, V64, P3967, DOI 10.2337/db15-0597; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; Stage TB, 2016, BASIC CLIN PHARMACOL, V118, P487, DOI 10.1111/bcpt.12579; Tajabadi-Ebrahimi M, 2017, EXP CLIN ENDOCR DIAB, V125, P21, DOI 10.1055/s-0042-105441; Tonucci LB, 2017, CLIN NUTR, V36, P85, DOI 10.1016/j.clnu.2015.11.011; Valerio F, 2010, J CLIN GASTROENTEROL, V44, pS49, DOI 10.1097/MCG.0b013e3181d2dca4; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wan Y, 2015, DIABET METAB SYND OB, V8, P79, DOI 10.2147/DMSO.S50642; Wang FY, 2017, TOXICOL PATHOL, V45, P150, DOI 10.1177/0192623316679898; Wang G, 2017, FOOD FUNCT, V8, P3155, DOI 10.1039/c7fo00593h; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yamaguchi Y, 2016, DIGESTION, V94, P66, DOI 10.1159/000447690; Yunes RA, 2016, ANAEROBE, V42, P197, DOI 10.1016/j.anaerobe.2016.10.011; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	52	51	54	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194171	10.1371/journal.pone.0194171	http://dx.doi.org/10.1371/journal.pone.0194171			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596446	gold, Green Submitted, Green Published			2022-12-27	WOS:000428630000018
J	Ford, E; Greenslade, N; Paudyal, P; Bremner, S; Smith, HE; Banerjee, S; Sadhwani, S; Rooney, P; Oliver, S; Cassell, J				Ford, Elizabeth; Greenslade, Nicholas; Paudyal, Priya; Bremner, Stephen; Smith, Helen E.; Banerjee, Sube; Sadhwani, Shanu; Rooney, Philip; Oliver, Seb; Cassell, Jackie			Predicting dementia from primary care records: A systematic review and meta-analysis	PLOS ONE			English	Review							ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; RISK-FACTORS; GENERAL-PRACTICE; EARLY-DIAGNOSIS; DEPRESSION; THERAPY; ANXIETY; PREVALENCE; SEIZURES	Introduction Possible dementia is usually identified in primary care by general practitioners (GPs) who refer to specialists for diagnosis. Only two-thirds of dementia cases are currently recorded in primary care, so increasing the proportion of cases diagnosed is a strategic priority for the UK and internationally. Variables in the primary care record may indicate risk of developing dementia, and could be combined in a predictive model to help find patients who are missing a diagnosis. We conducted a meta-analysis to identify clinical entities with potential for use in such a predictive model for dementia in primary care. Methods and findings We conducted a systematic search in PubMed, Web of Science and primary care database bibliographies. We included cohort or case-control studies which used routinely collected primary care data, to measure the association between any clinical entity and dementia. Meta-analyses were performed to pool odds ratios. A sensitivity analysis assessed the impact of non-independence of cases between studies. From a sift of 3836 papers, 20 studies, all European, were eligible for inclusion, comprising >1 million patients. 75 clinical entities were assessed as risk factors for all cause dementia, Alzheimer's (AD) and Vascular dementia (VaD). Data included were unexpectedly heterogeneous, and assumptions were made about definitions of clinical entities and timing as these were not all well described. Meta-analysis showed that neuropsychiatric symptoms including depression, anxiety, and seizures, cognitive symptoms, and history of stroke, were positively associated with dementia. Cardiovascular risk factors such as hypertension, heart disease, dyslipidaemia and diabetes were positively associated with VaD and negatively with AD. Sensitivity analyses showed similar results. Conclusions These findings are of potential value in guiding feature selection for a risk prediction tool for dementia in primary care. Limitations include findings being UK-focussed. Further predictive entities ascertainable from primary care data, such as changes in consulting patterns, were absent from the literature and should also be explored in future studies.	[Ford, Elizabeth; Greenslade, Nicholas; Paudyal, Priya; Bremner, Stephen; Sadhwani, Shanu; Cassell, Jackie] Brighton & Sussex Med Sch, Dept Primary Care & Publ Hlth, Brighton, E Sussex, England; [Smith, Helen E.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Banerjee, Sube] Brighton & Sussex Med Sch, Ctr Dementia Studies, Brighton, E Sussex, England; [Rooney, Philip; Oliver, Seb] Univ Sussex, Dept Phys & Astron, Brighton, E Sussex, England	University of Brighton; University of Sussex; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Brighton; University of Sussex; University of Sussex	Ford, E (corresponding author), Brighton & Sussex Med Sch, Dept Primary Care & Publ Hlth, Brighton, E Sussex, England.	e.m.ford@bsms.ac.uk	Bremner, Stephen/R-4038-2016; Smith, Helen/M-2449-2016	Bremner, Stephen/0000-0003-0790-7070; Sadhwani, Shanu/0000-0002-7714-4841; Smith, Helen/0000-0003-1883-6124; Ford, Elizabeth/0000-0001-5613-8509; Banerjee, Sube/0000-0002-8083-7649; Paudyal, Priyamvada/0000-0002-6209-575X				Ballard C, 2000, J AFFECT DISORDERS, V59, P97, DOI 10.1016/S0165-0327(99)00057-9; Banerjee S, 2012, ARCH MED RES, V43, P705, DOI 10.1016/j.arcmed.2012.10.006; Banerjee S, 2009, INT J GERIATR PSYCH, V24, P748, DOI 10.1002/gps.2191; Barrett EB, 2014, DEMENTIA REVEALED WH; Beeri MS, 2005, J GERONTOL A-BIOL, V60, P471, DOI 10.1093/gerona/60.4.471; Booker A, 2016, INT PSYCHOGERIATR, V28, P1059, DOI 10.1017/S1041610215002082; Booth N, 1994, Health Libr Rev, V11, P177; Buntinx F, 1996, AGE AGEING, V25, P231, DOI 10.1093/ageing/25.3.231; Burton C, 2012, FAM PRACT, V30, P25; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Cui XJ, 2007, AM J PSYCHIAT, V164, P1221, DOI 10.1176/appi.ajp.2007.06040690; Davies NM, 2011, J ALZHEIMERS DIS, V26, P699, DOI 10.3233/JAD-2011-110347; Department of Health, 2012, PRIM MIN CHALL DEM D; Department of Health, 2009, LIVING WELL DEMENTIA; Dregan A, 2015, EUR J NEUROL, V22, P1421, DOI 10.1111/ene.12774; Dregan A, 2015, J ALZHEIMERS DIS, V46, P1039, DOI 10.3233/JAD-150171; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P91, DOI 10.1097/01.wad.0000165511.52746.1f; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P20, DOI 10.1097/01.wad.0000155068.23937.9b; Ferretti L, 2001, J GERIATR PSYCH NEUR, V14, P52, DOI 10.1177/089198870101400111; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; Iliffe S, 2003, FAM PRACT, V20, P376, DOI 10.1093/fampra/cmg407; Imfeld P, 2015, DRUG SAFETY; Imfeld P, 2016, BRAIN BEHAV IMMUN, V57, P187, DOI 10.1016/j.bbi.2016.03.014; Imfeld P, 2013, J ALZHEIMERS DIS, V35, P565, DOI 10.3233/JAD-121819; Imfeld P, 2013, EPILEPSIA, V54, P700, DOI 10.1111/epi.12045; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; Jammeh E, 2015, J NEUROL NEUROSUR PS, V86, DOI 10.1136/jnnp-2015-312379.44; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kessing LV, 2008, ARCH GEN PSYCHIAT, V65, P1331, DOI 10.1001/archpsyc.65.11.1331; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kohler S, 2015, J AM GERIATR SOC, V63, P692, DOI 10.1111/jgs.13357; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; NHS England, 2014, ENH SERV SPEC DEM ID; Park J., 2011, 19 COCHRANE C, P19; Pentzek M, 2009, AM J GERIAT PSYCHIAT, V17, P965, DOI 10.1097/JGP.0b013e3181b2075e; Prince M., 2015, WORLD ALZHEIMER REPO, DOI DOI 10.1111/j.0963-7214.2004.00293.x; Prince M, 2011, WORLD ALZHEIMER REPO; Ramakers IHGB, 2007, DEMENT GERIATR COGN, V24, P300, DOI 10.1159/000107594; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x; Seignourel PJ, 2008, CLIN PSYCHOL REV, V28, P1071, DOI 10.1016/j.cpr.2008.02.008; Seshadri S, 2001, ARCH NEUROL-CHICAGO, V58, P435, DOI 10.1001/archneur.58.3.435; Sherzai D, 2014, EPILEPSY BEHAV, V36, P53, DOI 10.1016/j.yebeh.2014.04.015; SPECK CE, 1995, EPIDEMIOLOGY, V6, P366, DOI 10.1097/00001648-199507000-00006; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stephan BC, 2010, NAT REV NEUROL, V6; Stephan BC, 2014, J ALZHEIMERS DIS, V42; Stephan BCM, 2016, CURR OPIN PSYCHIATR, V29, P174, DOI 10.1097/YCO.0000000000000235; Wagner G, 2012, INT J CLIN PHARM TH, V50, P195, DOI 10.5414/CP201284; Walters K, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0549-y	53	50	50	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194735	10.1371/journal.pone.0194735	http://dx.doi.org/10.1371/journal.pone.0194735			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596471	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000428630000039
J	Germino, EA; Miller, JP; Diehl, L; Swanson, CJ; Durinck, S; Modrusan, Z; Miner, JH; Shaw, AS				Germino, Elizabeth A.; Miller, Joseph P.; Diehl, Lauri; Swanson, Carter J.; Durinck, Steffen; Modrusan, Zora; Miner, Jeffrey H.; Shaw, Andrey S.			Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer	PLOS ONE			English	Article							KINASE SUPPRESSOR; SIGNAL-TRANSDUCTION; DUCTAL ADENOCARCINOMA; GENE ENCODES; C-ELEGANS; PROTEIN; SCAFFOLD; MICE; MEK; IDENTIFICATION	Given the frequency with which MAP kinase signaling is dysregulated in cancer, much effort has been focused on inhibiting RAS signaling for therapeutic benefit. KSR1, a pseudokinase that interacts with RAF, is a potential target; it was originally cloned in screens for suppressors of constitutively active RAS, and its deletion prevents RAS-mediated transformation of mouse embryonic fibroblasts. In this work, we used a genetically engineered mouse model of pancreatic cancer to assess whether KSR1 deletion would influence tumor development in the setting of oncogenic RAS. We found that Ksr1(-/-) mice on this background had a modest but significant improvement in all-cause morbidity compared to Ksr1(+/+) and Ksr1(+/-) cohorts. Ksr1(-/-) mice, however, still developed tumors, and precursor pancreatic intraepithelial neoplastic (PanIN) lesions were detected within a similar timeframe compared to Ksr1(+/+) mice. No significant differences in pERK expression or in proliferation were noted. RNA sequencing also did not reveal any unique genetic signature in Ksr1(-/-) tumors. Further studies will be needed to determine whether and in what settings KSR inhibition may be clinically useful.	[Germino, Elizabeth A.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Germino, Elizabeth A.; Swanson, Carter J.; Shaw, Andrey S.] Genentech Inc, Dept Biol Res, San Francisco, CA 94080 USA; [Miller, Joseph P.; Miner, Jeffrey H.] Washington Univ, Sch Med, Div Nephrol, St Louis, MO USA; [Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA USA; [Durinck, Steffen] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Durinck, Steffen; Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA USA	Washington University (WUSTL); Roche Holding; Genentech; Washington University (WUSTL); Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Shaw, AS (corresponding author), Genentech Inc, Dept Biol Res, San Francisco, CA 94080 USA.	shaw.andrey@gene.com		Shaw, Andrey/0000-0001-5685-0272	NIDDK NIH HHS [R01 DK058366] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058366] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Dhawan NS, 2016, NATURE, V537, P112, DOI 10.1038/nature19327; Evans RA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88328; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Kortum RL, 2006, MOL CELL BIOL, V26, P2202, DOI 10.1128/MCB.26.6.2202-2214.2006; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lozano J, 2003, CANCER RES, V63, P4232; Marino S, 2000, GENE DEV, V14, P994; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Stebbing J, 2015, ONCOGENE, V34, P2103, DOI 10.1038/onc.2014.129; Stewart S, 1999, MOL CELL BIOL, V19, P5523; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xing HR, 2003, NAT MED, V9, P1266, DOI 10.1038/nm927; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zhang JJ, 2008, CANCER BIOL THER, V7, P1492, DOI 10.4161/cbt.7.9.6472	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194998	10.1371/journal.pone.0194998	http://dx.doi.org/10.1371/journal.pone.0194998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596465	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000063
J	Konstantinou, D; Gerovasileiou, V; Voultsiadou, E; Gkelis, S				Konstantinou, Despoina; Gerovasileiou, Vasilis; Voultsiadou, Eleni; Gkelis, Spyros			Sponges-Cyanobacteria associations: Global diversity overview and new data from the Eastern Mediterranean	PLOS ONE			English	Article							BARRIER-REEF SPONGE; OSCILLATORIA-SPONGELIAE; BACTERIAL COMMUNITIES; MICROBIAL COMMUNITY; MARINE SPONGES; CHLOROPHYLL-A; AEGEAN SEA; SYMBIONTS; PHYLOGENY; AUSTRALIA	Sponge-cyanobacteria associations have attracted research interest from an ecological, evolutionary and biotechnological perspective. Current knowledge is, in its majority, "hidden" in metagenomics research studying the entire microbial communities of sponges, while knowledge on these associations is totally missing for certain geographic areas. In this study, we (a) investigated the occurrence of cyanobacteria in 18 sponge species, several of which are studied for the first time for their cyanobionts, from a previously unexplored eastern Mediterranean ecoregion, the Aegean Sea, (b) isolated sponge-associated cyanobacteria, and characterized them based on a polyphasic (morphological-morphometric and molecular phylogenetic analysis) approach, and (c) conducted a meta-analysis on the global diversity of sponge species hosting cyanobacteria, as well as the diversity of cyanobacterial symbionts. Our research provided new records for nine sponge species, previously unknown for this association, while the isolated cyanobacteria were found to form novel clades within Synechococcus, Leptolyngbyaceae, Pseudanabaenaceae, and Schizotrichaceae, whose taxonomic status requires further investigation; this is the first report of a Schizotrichaceae cyanobacterium associated with sponges. The extensive evaluation of the literature along with the new data from the Aegean Sea raised the number of sponge species known for hosting cyanobacteria to 320 and showed that the cyanobacterial diversity reported from sponges is yet underestimated.	[Konstantinou, Despoina; Gkelis, Spyros] Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, Thessaloniki, Greece; [Konstantinou, Despoina; Voultsiadou, Eleni] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, Thessaloniki, Greece; [Gerovasileiou, Vasilis] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Crete, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Hellenic Centre for Marine Research	Gkelis, S (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, Thessaloniki, Greece.	sgkelis@bio.auth.gr	Gkelis, Spyros/N-3484-2015; Gerovasileiou, Vasilis/H-6376-2019	Gkelis, Spyros/0000-0002-7746-3199; Gerovasileiou, Vasilis/0000-0002-9143-7480; Voultsiadou, Eleni/0000-0003-3429-6754				Alex A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051834; Antoniadou C, 2006, BELG J ZOOL, V136, P69; ARILLO A, 1993, MAR BIOL, V117, P159, DOI 10.1007/BF00346438; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Atashpaz S, 2010, MICROBIOLOGY+, V79, P538, DOI 10.1134/S0026261710040168; Bayer K, 2014, FEMS MICROBIOL ECOL, V89, P679, DOI 10.1111/1574-6941.12369; BERGQUIST P R, 1978, P268; Bergquist PR, 1980, SYSTEMA PORIFERA GUI, P1094; Betti F, 2012, MAR ECOL-EVOL PERSP, V33, P49, DOI [10.1111/j.1439-0485.2012.00525.x, 10.1111/j.1439-0485.2011.00456.x]; Burgsdorf I, 2015, MBIO, V6, DOI 10.1128/mBio.00391-15; Burgsdorf I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00529; Burja AM, 2001, HYDROBIOLOGIA, V461, P41, DOI 10.1023/A:1012713130404; Caroppo C, 2012, FOTTEA, V12, P315, DOI 10.5507/fot.2012.022; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; COX GC, 1985, MAR BIOL, V89, P149, DOI 10.1007/BF00392886; Diaz Maria Cristina, 2007, V28, P31; Dittmann E, 2015, TRENDS MICROBIOL, V23, P642, DOI 10.1016/j.tim.2015.07.008; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; Erwin PM, 2012, MICROB ECOL, V64, P771, DOI 10.1007/s00248-012-0047-5; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Fromont J, 2016, J MAR BIOL ASSOC UK, V96, P541, DOI 10.1017/S0025315415000491; Gao ZM, 2014, MBIO, V5, DOI 10.1128/mBio.00079-14; Gerovasileiou V, 2016, J MAR BIOL ASSOC UK, V96, P407, DOI 10.1017/S0025315415000697; Gerovasileiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039873; Gkelis S, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e7965; Guiry MD, 2017, ALGAEBASE; Hardoim CCP, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00611; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; HINDE R, 1994, MAR BIOL, V119, P99, DOI 10.1007/BF00350111; Hooper JN, 2002, GUIDE CLASSIFICATION; Horton T., 2018, WORLD REGISTER MARIN; Isaacs LT, 2009, MAR BIOTECHNOL, V11, P758, DOI 10.1007/s10126-009-9192-3; Komarek J, 1999, SUSSWASSERFLORA MITT, V19; Komarek J., 2005, SUSSWASSERFLORA MITT, V19/2, P759; Luo CW, 2015, NAT BIOTECHNOL, V33, P1045, DOI 10.1038/nbt.3319; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morrow C, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0099-8; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Olson JB, 2014, FEMS MICROBIOL ECOL, V87, P268, DOI 10.1111/1574-6941.12222; Pagliara P, 2011, TOXICON, V57, P889, DOI 10.1016/j.toxicon.2011.03.006; Pfannkuchen M, 2010, J EXP MAR BIOL ECOL, V390, P169, DOI 10.1016/j.jembe.2010.04.038; Pita L, 2013, FEMS MICROBIOL ECOL, V86, P268, DOI 10.1111/1574-6941.12159; Ramos V, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.54; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Ridley CP, 2005, APPL ENVIRON MICROB, V71, P7366, DOI 10.1128/AEM.71.11.7366-7375.2005; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Roling WF, MOL MICROBIAL ECOLOG, P177; SARA M, 1971, MAR BIOL, V11, P214, DOI 10.1007/BF00401270; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Slaby BM, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00268-17; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Steinert G, 2016, PEERJ, V4, DOI 10.7717/peerj.1936; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thacker RW, 2012, ADV MAR BIOL, V62, P57, DOI 10.1016/B978-0-12-394283-8.00002-3; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Thomas T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11870; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URIZ MJ, 1992, PSZNI MAR ECOL, V13, P101; Usher KM, 2008, MAR ECOL-EVOL PERSP, V29, P178, DOI 10.1111/j.1439-0485.2008.00245.x; Usher KM, 2004, MICROB ECOL, V48, P167, DOI 10.1007/s00248-003-1062-3; Usher KM, 2004, SYMBIOSIS, V36, P183; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Van Soest R.W.M, 2017, WORLD PORIFERA DATAB; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; VANSOEST RWM, 1994, SPONGES IN TIME AND SPACE, P213; Voigt O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033417; Voultsiadou E, 2005, ITAL J ZOOL, V72, P53, DOI 10.1080/11250000509356653; Voultsiadou E, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e7984; Voultsiadou E, 2009, HYDROBIOLOGIA, V628, P1, DOI 10.1007/s10750-009-9725-9; Wang GY, 2009, ISME J, V3, P374, DOI 10.1038/ismej.2008.107; WATERBURY JB, 1978, MICROBIOL REV, V42, P2, DOI 10.1128/MMBR.42.1.2-44.1978; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Wilkinson C.R., 1979, Colloques Internationaux du Centre National de la Recherche Scientifique, P373; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; Worheide G, 2012, ADV MAR BIOL; Zhang F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00561	83	22	24	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195001	10.1371/journal.pone.0195001	http://dx.doi.org/10.1371/journal.pone.0195001			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596453	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000064
J	Hague, E; Banik, U; Monwar, T; Anthony, L; Adhikary, AK				Hague, Ezazul; Banik, Urmila; Monwar, Tahmina; Anthony, Leela; Adhikary, Arun Kumar			Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon	PLOS ONE			English	Article							CONSECUTIVE YEARS 1991-2007; KOREAN CHILDREN; MOLECULAR EPIDEMIOLOGY; TRACT INFECTIONS; YOUNG-ADULTS; SEROTYPES 4; OUTBREAK; IDENTIFICATION; PNEUMONIA; STRAINS	Human adenovirus type 3 (HAdV-3) respiratory infections occurs worldwide in both children and adults, leading to severe morbidity and mortality, particularly in the paediatric age group and especially in neonates. During HAdV infection, neutralizing antibodies are formed against the epitopes located in the hyper variable regions (HVRs) of the hexon protein. These neutralizing antibodies provide protection against reinfection by viruses of the same type. Therefore it is reasonable to speculate that variations of HAdV-3 in the HVRs could impair the immunity acquired by previous infection with a different strain with variation in its HVRs. HAdV-3 has recently become the major agent of acute respiratory infection worldwide, being responsible for 15% to 87% of all adenoviral respiratory infections. However, despite the increased prevalence of HAdV-3 as respiratory pathogen, the diversity of hexon proteins in circulating strains remains unexplored. This study was designed to explore the variation in HVRs of hexon among globally distributed strains of HAdV-3 as well as to discover possible relationship among them, thus possibly shedding light on the cause for the increased prevalence of HAdV-3. In this study, for the first time we analysed the hexon proteins of all 248 available strains of HAdV-3 from the NCBI database and compared them with those of the HAdV-3 prototype (GB stain). We found that the HVRs of HAdV-3 strains circulating worldwide were highly heterogeneous and have been mutating continuously since-their original isolation. Based on their immense heterogeneity, the strains can be categorized into 25 hexon variants (3Hv-1 to 3Hv-25), 4 of which (3Hv-1 to 3Hv-4) comprises 80% of the strains. This heterogeneity may explain why HAdV-3 has become the most prevalent HAdVs type worldwide. The heterogeneity of hexon proteins also shows that the development of a vaccine against HAdV-3 might be challenging. The data on hexon variants provided here may be useful for the future epidemiological study of HAdV-3 infection.	[Hague, Ezazul; Monwar, Tahmina; Adhikary, Arun Kumar] AIMST Univ, Unit Microbiol, Fac Med, Jalan Bedong Semeling, Bedong, Kedah, Malaysia; [Banik, Urmila] AIMST Univ, Unit Pathol, Fac Med, Jalan Bedong Semeling, Bedong, Kedah, Malaysia; [Anthony, Leela] AIMST Univ, Unit Community Med, Fac Med, Jalan Bedong Semeling, Bedong, Kedah, Malaysia	AIMST University; AIMST University; AIMST University	Adhikary, AK (corresponding author), AIMST Univ, Unit Microbiol, Fac Med, Jalan Bedong Semeling, Bedong, Kedah, Malaysia.	arun_adhikary@msn.com	Monowar, Tahmina/P-2915-2019	Monowar, Tahmina/0000-0002-6885-9562; Banik, Urmila/0000-0003-2578-0288; Adhikary, Arun Kumar/0000-0002-6009-1608				Adhikary AK, 2017, J MED MICROBIOL, V66, P1616, DOI 10.1099/jmm.0.000625; Adhikary AK, 2014, J CLIN VIROL, V61, P477, DOI 10.1016/j.jcv.2014.10.015; Banik U, 2005, J CLIN MICROBIOL, V43, P1064, DOI 10.1128/JCM.43.3.1064-1068.2005; Barker JH, 2003, CLIN INFECT DIS, V37, pE142, DOI 10.1086/379127; Blasiole DA, 2004, J CLIN MICROBIOL, V42, P1686, DOI 10.1128/JCM.42.4.1686-1693.2004; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121375; Chen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155412; Choi EH, 2006, J MED VIROL, V78, P379, DOI 10.1002/jmv.20550; Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550; Crawford-Miksza LK, 1999, J CLIN MICROBIOL, V37, P1107, DOI 10.1128/JCM.37.4.1107-1112.1999; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; Demian PN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-50; Fujimoto T, 2008, JPN J INFECT DIS, V61, P143; Girouard G, 2011, CAN J INFECT DIS MED, V22, pE4, DOI 10.1155/2011/575476; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Harley D, 2001, Commun Dis Intell, V25, P9; HERBERT FA, 1977, CAN MED ASSOC J, V116, P274; HILLEMAN MR, 1958, ARCH INTERN MED, V102, P428, DOI 10.1001/archinte.1958.00030010428013; HILLEMAN MR, 1958, J IMMUNOL, V80, P299; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; HUEBNER RJ, 1954, NEW ENGL J MED, V251, P1077, DOI 10.1056/NEJM195412302512701; Hung K-H, 2015, MEDICINE, P94; James L, 2007, CLIN INFECT DIS, V45, P416, DOI 10.1086/519938; Jin Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-271; Kajon AE, 1996, J MED VIROL, V48, P151, DOI 10.1002/(SICI)1096-9071(199602)48:2&lt;151::AID-JMV6&gt;3.0.CO;2-8; Kim YJ, 2003, J CLIN MICROBIOL, V41, P4594, DOI 10.1128/JCM.41.10.4594-4599.2003; Lai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053614; Landry ML, 2009, J MED VIROL, V81, P1380, DOI 10.1002/jmv.21539; Lebeck MG, 2009, J CLIN VIROL, V46, P331, DOI 10.1016/j.jcv.2009.09.023; Lee J, 2010, J CLIN VIROL, V49, P115, DOI 10.1016/j.jcv.2010.07.007; Lee J, 2010, J MED VIROL, V82, P624, DOI 10.1002/jmv.21701; LI QG, 1988, J CLIN MICROBIOL, V26, P1009, DOI 10.1128/JCM.26.5.1009-1015.1988; Lin YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137890; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; Lynch JP, 2016, SEMIN RESP CRIT CARE, V37, P586, DOI 10.1055/s-0036-1584923; Mizuta K, 2009, VIRUS RES, V140, P32, DOI 10.1016/j.virusres.2008.10.014; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; Rebelo-De-Andrade H, 2010, J CLIN MICROBIOL, V48, P1391, DOI 10.1128/JCM.02019-09; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; Rojas LJ, 2012, EPIDEMIOL INFECT, V140, P818, DOI 10.1017/S0950268811001269; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Ryan MAK, 2002, CLIN INFECT DIS, V34, P577, DOI 10.1086/338471; SCHMITZ H, 1983, AM J EPIDEMIOL, V117, P455, DOI 10.1093/oxfordjournals.aje.a113563; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; Takeuchi S, 1999, J CLIN MICROBIOL, V37, P1839, DOI 10.1128/JCM.37.6.1839-1845.1999; Wang YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003577; Yeung R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-11; Zhang QW, 2006, J GEN VIROL, V87, P1531, DOI 10.1099/vir.0.81515-0; Zou LR, 2012, APMIS, V120, P683, DOI 10.1111/j.1600-0463.2012.02890.x	52	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194516	10.1371/journal.pone.0194516	http://dx.doi.org/10.1371/journal.pone.0194516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590206	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100064
J	Nozaki, S; Katoh, Y; Kobayashi, T; Nakayama, K				Nozaki, Shohei; Katoh, Yohei; Kobayashi, Takuya; Nakayama, Kazuhisa			BBS1 is involved in retrograde trafficking of ciliary GPCRs in the context of the BBSome complex	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; INTRAFLAGELLAR TRANSPORT; B COMPLEX; IFT; CILIOGENESIS; RECOGNITION; BINDING; MOTIFS; ROLES; ENTRY	Protein trafficking within cilia is mediated by the intraflagellar transport (IFT) machinery composed of large protein complexes. The BBSome consists of eight BBS proteins encoded by causative genes of Bardet-Biedl syndrome (BBS), and has been implicated in the trafficking of ciliary membrane proteins, including G protein-coupled receptors (GPCRs), by connecting the IFT machinery to cargo GPCRs. Membrane recruitment of the BBSome to promote cargo trafficking has been proposed to be regulated by the Arf-like small GTPase ARL6/BBS3, through its interaction with the BBS1 subunit of the BBSome. We here investigated how the BBSome core subcomplex composed of BBS1, BBS2, BBS7, and BBS9 assembles and interacts with ARL6, and found that the ARL6 BBS1 interaction is reinforced by BBS9. BBS1-knockout (KO) cells showed defects in the ciliary entry of other BBSome subunits and ARL6, and in ciliary retrograde trafficking and the export of the GPCRs, Smoothened and GPR161. The trafficking defect of these GPCRs was rescued by the exogenous expression of wild-type BBS1, but not by its mutant lacking BBS9-binding ability. Our data thus indicate that the intact BBSome is required for retrograde trafficking of GPCRs out of cilia.	[Nozaki, Shohei; Katoh, Yohei; Kobayashi, Takuya; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan	Kyoto University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Katoh, Yohei/AAA-3378-2020; Nakayama, Kazuhisa/ABF-2924-2020	Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology, Japan [15H01211]; Japan Society for the Promotion of Science (JSPS) [15H04370, 15K07929, 16J03865]; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Uehara Memorial Foundation; JSPS Research Fellowship; Grants-in-Aid for Scientific Research [15H04370, 16J03865] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); JSPS Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas "Cilia and Centrosome" from the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant number 15H01211 to K.N.); grants from the Japan Society for the Promotion of Science (JSPS) (grant numbers 15H04370 to K.N., 15K07929 to Y.K., and 16J03865 to S.N.); and grants from the Astellas Foundation for Research on Metabolic Disorders to K.N., and from the Takeda Science Foundation and the Uehara Memorial Foundation to Y.K. S.N. was supported by a JSPS Research Fellowship.	Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Funabashi T, 2017, MOL BIOL CELL, V28, P624, DOI 10.1091/mbc.E16-09-0648; Hirano T, 2017, MOL BIOL CELL, V28, P429, DOI 10.1091/mbc.E16-11-0813; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Katoh Y, 2017, MOL BIOL CELL, V28, P898, DOI 10.1091/mbc.E17-01-0051; Katoh Y, 2016, J BIOL CHEM, V291, P10962, DOI 10.1074/jbc.M116.713883; Katoh Y, 2015, J CELL SCI, V128, P2351, DOI 10.1242/jcs.168740; Klink BU, 2017, ELIFE, V6, DOI 10.7554/eLife.27434; Knockenhauer KE, 2015, J BIOL CHEM, V290, P19569, DOI 10.1074/jbc.M115.649202; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Madhivanan K, 2014, TRAFFIC, V15, P1031, DOI 10.1111/tra.12195; Mourao A, 2014, NAT STRUCT MOL BIOL, V21, P1035, DOI 10.1038/nsmb.2920; Mukhopadhyay S, 2014, SEMIN CELL DEV BIOL, V33, P63, DOI 10.1016/j.semcdb.2014.05.002; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakayama K, 2003, CELL STRUCT FUNCT, V28, P431, DOI 10.1247/csf.28.431; Nakayama K, 2018, J BIOCHEM, V163, P155, DOI 10.1093/jb/mvx087; Nishijima Y, 2017, MOL BIOL CELL, V28, P1652, DOI 10.1091/mbc.E17-01-0017; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Verhey KJ, 2016, CURR OPIN CELL BIOL, V41, P109, DOI 10.1016/j.ceb.2016.05.004; Wei Q, 2015, CURR OPIN CELL BIOL, V35, P98, DOI 10.1016/j.ceb.2015.04.015; Williams CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6813; Woodsmith J, 2017, NAT METHODS, V14, P1213, DOI [10.1038/NMETH.4464, 10.1038/nmeth.4464]; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108	38	31	32	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195005	10.1371/journal.pone.0195005	http://dx.doi.org/10.1371/journal.pone.0195005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590217	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100096
J	Maximiano, C; Lopez, I; Martin, C; Zugazabeitia, L; Marti-Ciriquian, JL; Nunez, MA; Contreras, J; Herdman, M; Traseira, S; Provencio, M				Maximiano, Constanza; Lopez, Iker; Martin, Cristina; Zugazabeitia, Luis; Marti-Ciriquian, Juan L.; Nunez, Miguel A.; Contreras, Jorge; Herdman, Michael; Traseira, Susana; Provencio, Mariano			An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement	PLOS ONE			English	Article							HEAD; PREVALENCE; RADIOTHERAPY	Background There have been few large-scale, real world studies in Spain to assess change in pain and quality of life (QOL) outcomes in cancer patients with moderate to severe pain. This study aimed to assess changes on both outcomes after 3 months of usual care and to investigate factors associated with change in QoL. Patients and methods Large, multi-centre, observational study in patients with lung, head and neck, colorectal or breast cancer experiencing a first episode of moderate to severe pain while attending one of the participating centres. QoL was assessed using the EuroQol-5D questionnaire and pain using the Brief Pain Inventory (BPI). Instruments were administered at baseline and after 3 months of follow up. Multivariate analyses were used to assess the impact of treatment factors, demographic and clinical variables, pain and other symptoms on QoL scores. Results 1711 patients were included for analysis. After 3 months of usual care, a significant improvement was observed in pain and QoL in all four cancer groups (p<0.001). Effect sizes were medium to large on the BPI and EQ-5D Index and Visual Analogue Scale (VAS). Improvements were seen on the majority of EQ-5D dimensions in all patient groups, though breast cancer patients showed the largest gains. Poorer baseline performance status (ECOG) and the presence of anxiety/depression were associated with significantly poorer QOL outcomes. Improvements in BPI pain scores were associated with improved QoL. Conclusion In the four cancer types studied, pain and QoL outcomes improved considerably after 3 months of usual care. Improvements in pain made a substantial contribution to QoL gains whilst the presence of anxiety and depression and poor baseline performance status significantly constrained improvement.	[Maximiano, Constanza; Provencio, Mariano] Hosp Puerta Hierro Majadahonda, Med Oncol, Madrid, Spain; [Lopez, Iker] Hosp Univ Virgen Rode, Med Oncol, Seville, Spain; [Martin, Cristina] Hosp Santa Creu & Sant Pau, Med Oncol, Barcelona, Spain; [Zugazabeitia, Luis] Hosp Povisa, Radiat Oncol, Pontevedra, Spain; [Marti-Ciriquian, Juan L.] Univ Alicante, Hosp Gen, Med Oncol, Alicante, Spain; [Nunez, Miguel A.] Hosp Santa Maria Nai, Med Oncol, Orense, Spain; [Contreras, Jorge] Complejo Hosp Reg Carlos Haya, Radiat Oncol, Malaga, Spain; [Herdman, Michael] Insight Consulting & Res, Barcelona, Spain; [Traseira, Susana] Mundipharma Pharmaceut SL, Med Dept, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Hospital of Santa Creu i Sant Pau; General University Hospital of Alicante; Universitat d'Alacant	Provencio, M (corresponding author), Hosp Puerta Hierro Majadahonda, Med Oncol, Madrid, Spain.	mprovenciop@gmail.com	Alonso, Constanza Maximiano/AAE-9102-2021; Provencio, Mariano/ABE-8586-2020	Alonso, Constanza Maximiano/0000-0002-4051-3965; Provencio, Mariano/0000-0001-9053-9197; Provencio Pulla, Mariano/0000-0001-6315-7919	Mundipharma Pharmaceuticals S.L.	Mundipharma Pharmaceuticals S.L.	Financial support for this research was provided by Mundipharma Pharmaceuticals S.L. The funder contracted Insight Consulting and Research for support with interpretation of results and manuscript organisation and development. The funder had limited input into study design, but no role in data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support for the study through unrestricted grants to the participating centres but did not pay a salary to any of the authors. The specific roles of the authors are articulated in the 'author contributions' section.	Bradley N, 2005, J PAIN SYMPTOM MANAG, V30, P123, DOI 10.1016/j.jpainsymman.2005.02.015; Breivik H, 2009, ANN ONCOL, V20, P1420, DOI 10.1093/annonc/mdp001; Bruera E, 1991, J Palliat Care, V7, P6; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cramarossa G, 2013, SUPPORT CARE CANCER, V21, P1709, DOI 10.1007/s00520-013-1717-7; Dawson J, 2010, BMJ-BRIT MED J, V340, pc186, DOI DOI 10.1136/BMJ.C186; de Andres Ares J, 2014, PAIN PRACT; Deandrea S, 2008, ANN ONCOL, V19, P1985, DOI 10.1093/annonc/mdn419; Epstein JB, 2010, SUPPORT CARE CANCER, V18, P1023, DOI 10.1007/s00520-010-0897-7; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Herdman M, 2001, Aten Primaria, V28, P425; Hird AE, 2008, J PALLIAT MED, V11, P1156, DOI 10.1089/jpm.2008.9846; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jordhoy MS, 2001, BRIT J CANCER, V85, P1478, DOI 10.1054/bjoc.2001.2116; Jost L, 2010, ANN ONCOL, V21, pv257, DOI 10.1093/annonc/mdq224; National Comprehensive Cancer Network (NCCN), 2010, NCCN CLIN PRACT GUID, V2; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Rathkopf DE, 2014, EUR UROL, V66, P815, DOI 10.1016/j.eururo.2014.02.056; Rentz A M, 2009, J Med Econ, V12, P371, DOI 10.3111/13696990903430481; Ripamonti CI, 2012, ANN ONCOL, V23, P139, DOI 10.1093/annonc/mds233; Romanus D, 2012, J PAIN SYMPTOM MANAG, V43, P205, DOI 10.1016/j.jpainsymman.2011.09.001; Ronis DL, 2008, ARCH OTOLARYNGOL, V134, P241, DOI 10.1001/archoto.2007.43; Shuman AG, 2012, ARCH OTOLARYNGOL, V138, P1147, DOI 10.1001/jamaoto.2013.853; Terrell JE, 2004, ARCH OTOLARYNGOL, V130, P401, DOI 10.1001/archotol.130.4.401; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Velazquez Rivera I, PAIN PRACTI IN PRESS; Whynes DK, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-155; Whynes DK, 2009, J EVAL CLIN PRACT, V15, P820, DOI 10.1111/j.1365-2753.2008.01102.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zimmermann C, 2011, SUPPORT CARE CANCER, V19, P621, DOI 10.1007/s00520-010-0866-1	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0193233	10.1371/journal.pone.0193233	http://dx.doi.org/10.1371/journal.pone.0193233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614068	gold, Green Submitted, Green Published			2022-12-27	WOS:000429081600003
J	Walston, LJ; Hartmann, HM				Walston, Leroy J.; Hartmann, Heidi M.			Development of a landscape integrity model framework to support regional conservation planning	PLOS ONE			English	Article							HUMAN FOOTPRINT; UNITED-STATES; ECOLOGICAL INTEGRITY; BIODIVERSITY; ELK; CLIMATE; SCALE; ROADS	Land managers increasingly rely upon landscape assessments to understand the status of natural resources and identify conservation priorities. Many of these landscape planning efforts rely on geospatial models that characterize the ecological integrity of the landscape. These general models utilize measures of habitat disturbance and human activity to map indices of ecological integrity. We built upon these modeling frameworks by developing a Landscape Integrity Index (LII) model using geospatial datasets of the human footprint, as well as incorporation of other indicators of ecological integrity such as biodiversity and vegetation departure. Our LII model serves as a general indicator of ecological integrity in a regional context of human activity, biodiversity, and change in habitat composition. We also discuss the application of the LII framework in two related coarse-filter landscape conservation approaches to expand the size and connectedness of protected areas as regional mitigation for anticipated land-use changes.	[Walston, Leroy J.; Hartmann, Heidi M.] Argonne Natl Lab, Environm Sci Div, Lemont, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Walston, LJ (corresponding author), Argonne Natl Lab, Environm Sci Div, Lemont, IL 60439 USA.	lwalston@anl.gov	Hartmann, Heidi/AAT-6481-2021	Walston, Leroy/0000-0002-6569-1223	U.S. Department of the Interior, Bureau of Land Management	U.S. Department of the Interior, Bureau of Land Management	Funding was provided by the U.S. Department of the Interior, Bureau of Land Management.	[Anonymous], 2017, PARTN; Auguie B, 2017, GRIDEXTRA MISCELLANE; Belote RT, 2017, BIOSCIENCE, V67, P494, DOI 10.1093/biosci/bix028; Belote RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154223; BLM, 2016, REG MIT STRAT AR SOL; BLM, 2014, 444 BLM SO NEV DISTR; BLM and Argonne National Laboratory, 2017, REG MIT STRAT COL SO; Bryce S., 2012, COLORADO PLATEAU RAP; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Bureau of Land Management (BLM), 2016, 2017021 BLM; Burgi M, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9081371; Carr NB, 2015, 20151155 US GEOL SUR; Carter S. K., 2017, 20161207 US GEOL SUR; Decker KL, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1775; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Freeman OE, 2015, ECOL SOC, V20, DOI 10.5751/ES-07175-200124; Hak JC, 2017, ECOL INDIC, V82, P206, DOI 10.1016/j.ecolind.2017.06.049; Hann W., 2004, INTERAGENCY FIRE REG; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; Krosby M, 2015, LANDSCAPE ECOL, V30, P2121, DOI 10.1007/s10980-015-0235-z; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Montgomery RA, 2013, J WILDLIFE MANAGE, V77, P313, DOI 10.1002/jwmg.462; National Park Service (NPS), 2014, SCAL UP COLL APPR LA; Naylor LM, 2009, J WILDLIFE MANAGE, V73, P328, DOI 10.2193/2008-102; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; NOSS RF, 1995, 28 NAT BIOL SERV; Nunez TA, 2013, CONSERV BIOL, V27, P407, DOI 10.1111/cobi.12014; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Rowland MM, 2000, J WILDLIFE MANAGE, V64, P672, DOI 10.2307/3802737; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8349, DOI 10.1073/pnas.1210595110; Scott JH, 2014, RMRSRN71 USDA FOR SE; Theobald DM, 2013, LANDSCAPE ECOL, V28, P1859, DOI 10.1007/s10980-013-9941-6; Theobald DM, 2012, CONSERV LETT, V5, P123, DOI 10.1111/j.1755-263X.2011.00218.x; Theobald DM, 2004, FRONT ECOL ENVIRON, V2, P139, DOI 10.1890/1540-9295(2004)002[0139:PELCIA]2.0.CO;2; Torres A, 2016, P NATL ACAD SCI USA, V113, P8472, DOI 10.1073/pnas.1522488113; U. S. Geological Survey (USGS), 2007, SW REG GAP AN PROJ F; USGS, 2016, LANDFIRE V 1 1 VEG D; USGS, 2016, GAP AN PROGR GAP PRO; USGS, 2010, LANDFIRE BIOPH SETT; Vimal R, 2012, J ENVIRON MANAGE, V95, P9, DOI 10.1016/j.jenvman.2011.09.018; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Woolmer G, 2008, LANDSCAPE URBAN PLAN, V87, P42, DOI 10.1016/j.landurbplan.2008.04.005; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; Wurtzebach Z, 2016, BIOSCIENCE, V66, P446, DOI 10.1093/biosci/biw037	47	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195115	10.1371/journal.pone.0195115	http://dx.doi.org/10.1371/journal.pone.0195115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614093	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600033
J	Huvanandana, J; Carberry, AE; Turner, RM; Bek, EJ; Raynes-Greenow, CH; McEwan, AL; Jeffery, HE				Huvanandana, Jacqueline; Carberry, Angela E.; Turner, Robin M.; Bek, Emily J.; Raynes-Greenow, Camille H.; McEwan, Alistair L.; Jeffery, Heather E.			An anthropometric approach to characterising neonatal morbidity and body composition, using air displacement plethysmography as a criterion method	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; BIRTH-WEIGHT; DEVELOPING-COUNTRIES; HEAD CIRCUMFERENCE; FAT PERCENTAGE; INFANTS; VALIDATION; NEWBORNS; BRAIN; AGE	Background With the greatest burden of infant undernutrition and morbidity in low and middle income countries (LMICs), there is a need for suitable approaches to monitor infants in a simple, low-cost and effective manner. Anthropometry continues to play a major role in characterising growth and nutritional status. Methods We developed a range of models to aid in identifying neonates at risk of malnutrition. We first adopted a logistic regression approach to screen for a composite neonatal morbidity, low and high body fat (BF%) infants. We then developed linear regression models for the estimation of neonatal fat mass as an assessment of body composition and nutritional status. Results We fitted logistic regression models combining up to four anthropometric variables to predict composite morbidity and low and high BF% neonates. The greatest area under receiver-operator characteristic curves (AUC with 95% confidence intervals (CI)) for identifying composite morbidity was 0.740 (0.63, 0.85), resulting from the combination of birthweight, length, chest and mid-thigh circumferences. The AUCs (95% CI) for identifying low and high BF% were 0.827 (0.78, 0.88) and 0.834 (0.79, 0.88), respectively. For identifying composite morbidity, BF% as measured via air displacement plethysmography showed strong predictive ability (AUC 0.786 (0.70, 0.88)), while birthweight percentiles had a lower AUC (0.695 (0.57, 0.82)). Birthweight percentiles could also identify low and high BF% neonates with AUCs of 0.792 (0.74, 0.85) and 0.834 (0.79, 0.88). We applied a sex-specific approach to anthropometric estimation of neonatal fat mass, demonstrating the influence of the testing sample size on the final model performance. Conclusions These models display potential for further development and evaluation in LMICs to detect infants in need of further nutritional management, especially where traditional methods of risk management such as birthweight for gestational age percentiles may be variable or non-existent, or unable to detect appropriately grown, low fat newborns.	[Huvanandana, Jacqueline; Carberry, Angela E.; McEwan, Alistair L.; Jeffery, Heather E.] Univ Sydney, Sch Elect & Informat Engn, Sydney, NSW, Australia; [Turner, Robin M.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Bek, Emily J.; Jeffery, Heather E.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Raynes-Greenow, Camille H.; Jeffery, Heather E.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Huvanandana, J (corresponding author), Univ Sydney, Sch Elect & Informat Engn, Sydney, NSW, Australia.	j.huvanandana@gmail.com	McEwan, Alistair L/W-6552-2019	McEwan, Alistair L/0000-0001-7597-6372				[Anonymous], 2010, WORLD HLTH STAT 2010; Aris IM, 2013, EUR J CLIN NUTR, V67, P922, DOI 10.1038/ejcn.2013.69; Carberry AE, 2013, PEDIATR RES, V74, P730, DOI 10.1038/pr.2013.156; CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3; Cauble JS, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0844-6; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; Deierlein AL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-21; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Donnelly JM, 2015, PEDIATR OBES, V10, P52, DOI 10.1111/j.2047-6310.2013.00216.x; Ellis KJ, 2007, AM J CLIN NUTR, V85, P90, DOI 10.1093/ajcn/85.1.90; Ellis KJ, 2007, SEMINARS FETAL NEONA; Flynn M, 1999, REPORT BRIT NUTR FDN, P45; Fonseca MJ, 2015, ACTA PAEDIATR, V104, P1028, DOI 10.1111/apa.12894; Goto E, 2011, J EPIDEMIOL, V21, P354, DOI 10.2188/jea.JE20100182; Thi HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142420; Hawkes CP, 2011, PEDIATRICS, V128, pE645, DOI 10.1542/peds.2010-3856; Jeffery HE, 1996, MED EDUC, V30, P440, DOI 10.1111/j.1365-2923.1996.tb00865.x; Koo WWK, 2004, PEDIATR RES, V56, P694, DOI 10.1203/01.PDR.0000142587.59238.BD; Lawoyin T., 1997, AFRICAN J MED MED SC, V27, P143; LEVITSKY DA, 1995, J NUTR, V125, pS2212, DOI 10.1093/jn/125.suppl_8.2212S; Lingwood BE, 2012, BRIT J NUTR, V107, P1545, DOI 10.1017/S0007114511004624; Ma GS, 2004, AM J CLIN NUTR, V79, P653; Mwangome MK, 2012, B WORLD HEALTH ORGAN, V90, P887, DOI 10.2471/BLT.12.109009; OCONNELL EJ, 1965, PEDIATRICS, V36, P62; Paley C, 2015, PEDIAT OBESITY; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; R Core Team, 2013, LANG ENV STAT COMP; Regnault N, 2011, ARCH DIS CHILD-FETAL, V96, pF217, DOI 10.1136/adc.2010.185546; Rodriguez G, 2004, EUR J PEDIATR, V163, P457, DOI 10.1007/s00431-004-1468-z; Roggero P, 2010, NEONATOLOGY, V97, P139, DOI 10.1159/000239767; Sauder KA, 2017, J PEDIATR-US, V183, P94, DOI 10.1016/j.jpeds.2017.01.014; Schmelzle HR, 2002, AM J CLIN NUTR, V76, P1096, DOI 10.1093/ajcn/76.5.1096; Singh KA, 2010, OBSTET GYNECOL, V115, P998, DOI 10.1097/AOG.0b013e3181da901a; United Nations Children's Fund (UNICEF), 2010, FACTS LIF, VFourth; West J, 2011, PAEDIATR PERINAT EP, V25, P164, DOI 10.1111/j.1365-3016.2010.01181.x; Wood AJ, 2013, J PAEDIATR CHILD H, V49, P199, DOI 10.1111/jpc.12119; Wrottesley SV, 2016, EUR J CLIN NUTR, V70, P1254, DOI 10.1038/ejcn.2016.91; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	40	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195193	10.1371/journal.pone.0195193	http://dx.doi.org/10.1371/journal.pone.0195193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601596	Green Published, Green Submitted, gold			2022-12-27	WOS:000428845900022
J	Patry, C; Remme, C; Betzen, C; Tonshoff, B; Yard, BA; Beck, G; Rafat, N				Patry, Christian; Remme, Christoph; Betzen, Christian; Toenshoff, Burkhard; Yard, Benito A.; Beck, Grietje; Rafat, Neysan			VCAM-1 expression is upregulated by CD34(+)/CD133(+)-stem cells derived from septic patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; INTERCELLULAR-ADHESION MOLECULE-1; ACUTE LUNG INJURY; GROWTH-FACTOR; ORGAN FAILURE; SEVERE SEPSIS; MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; STEM-CELLS; RECRUITMENT	CD34(+)/CD133(+)-cells are a bone marrow derived stem cell population, which presumably contain vascular progenitor cells and are associated with improved vascular repair. In this study, we investigated whether the adhesion molecules ICAM-1 (intercellular adhesion molecule-1), VCAM-1 (vascular adhesion molecule-1), E-selectin und L-selectin, which are involved in homing of vascular stem cells, are upregulated by CD34(+)/CD133(+)-stem cells from septic patients and would be associated with improved clinical outcome. Peripheral blood mononuclear cells from intensive care unit (ICU) patients with (n = 30) and without sepsis (n = 10), and healthy volunteers (n = 15) were isolated using Ficoll density gradient centrifugation. The expression of VCAM-1, ICAM-1, E-selectin and L-selectin was detected on CD34(+)/CD133(+)-stem cells by flow cytometry. The severity of disease was assessed by the Simplified Acute Physiology Score (SAPS) II. Serum concentrations of vascular endothelial growth factor (VEGF) and angiopoietin (Ang)-2 were determined by Enzyme-linked immunosorbent assay. The expression of VCAM-1, ICAM-1, E-selectin and L-selectin by CD34(+)/CD133(+)-stem cells was significantly upregulated in septic patients, and correlated with sepsis severity. Furthermore, high expression of VCAM-1 by CD34(+)/CD133(+)-stem cells revealed a positive association with mortalitiy (p<0.05). Furthermore, significantly higher serum concentrations of VEGF and Ang-2 were found in septic patients, however none showed a strong association with survival. Our data suggest, that VCAM-1 upregulation on CD34(+)/CD133(+)-stem cells could play a crucial role in their homing in the course of sepsis. An increase in sepsis severity resulted in both and increase in CD34(+)/CD133(+)-stem cells and VCAM-1-expression by those cells, which might reflect an increase in need for vascular repair.	[Patry, Christian; Betzen, Christian; Toenshoff, Burkhard; Rafat, Neysan] Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany; [Patry, Christian] Heidelberg Univ, Div Cardiovasc Physiol, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Remme, Christoph] Univ Med Ctr Mannheim, Dept Anaesthesiol & Crit Care Med, Mannheim, Germany; [Betzen, Christian] German Canc Res Ctr, Div Funct Genome Anal, Heidelberg, Germany; [Yard, Benito A.] Univ Med Ctr Mannheim, Dept Med 5, Mannheim, Germany; [Beck, Grietje] HELIOS Dr Horst Schmidt Kliniken, Dept Anaesthesiol & Crit Care Med, Wiesbaden, Germany; [Rafat, Neysan] Bahai Inst Higher Educ BIHE, Dept Pharmaceut Sci, Tehran, Iran	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Rafat, N (corresponding author), Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany.; Rafat, N (corresponding author), Bahai Inst Higher Educ BIHE, Dept Pharmaceut Sci, Tehran, Iran.	Neysan.Rafat@med.uni-heidelberg.de		Patry, Christian/0000-0002-1270-6508	University of Heidelberg	University of Heidelberg	Christian Patry and Neysan Rafat have been granted a 2 year research scholarship by the University of Heidelberg (physician scientist program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Becchi C, 2008, INT J IMMUNOPATH PH, V21, P697, DOI 10.1177/039463200802100324; Besnier E, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1734-x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Burnham EL, 2010, AM J RESP CELL MOL, V43, P326, DOI 10.1165/rcmb.2009-0015OC; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cribbs SK, 2012, INTENS CARE MED, V38, P429, DOI 10.1007/s00134-012-2480-9; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Gill KA, 2005, BIOCHEM BIOPH RES CO, V336, P392, DOI 10.1016/j.bbrc.2005.08.097; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Herrmann M, 2014, STEM CELL RES, V13, P465, DOI 10.1016/j.scr.2014.10.005; Karlsson S, 2008, ANESTH ANALG, V106, P1820, DOI 10.1213/ane.0b013e31816a643f; Kung CT, 2016, CLIN CHIM ACTA, V455, P1, DOI 10.1016/j.cca.2016.01.015; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Liu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34416; Luo TH, 2009, CRIT CARE, V13, DOI 10.1186/cc7968; Mackie AR, 2012, CIRC RES, V111, P312, DOI 10.1161/CIRCRESAHA.112.266015; Mackie AR, 2011, TEX HEART I J, V38, P474; Mutunga M, 2001, AM J RESP CRIT CARE, V163, P195, DOI 10.1164/ajrccm.163.1.9912036; Nolte D, 2004, EUR SURG RES, V36, P331, DOI 10.1159/000081641; Sosa-Bustamante GP, 2011, REV INVEST CLIN, V63, P601; Rafat N, 2014, J PULM RESP MED, V4; Rafat N, 2007, CRIT CARE MED, V35, P1677, DOI 10.1097/01.CCM.0000269034.86817.59; Rafat Neysan, 2014, BMC Res Notes, V7, P613, DOI 10.1186/1756-0500-7-613; Rafat N, 2013, AM J RESP CELL MOL, V48, P399, DOI 10.1165/rcmb.2011-0132TR; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Silverman MD, 2007, ARTHRITIS RHEUM-US, V56, P1817, DOI 10.1002/art.22706; Siner JM, 2009, SHOCK, V31, P348, DOI 10.1097/SHK.0b013e318188bd06; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Thum T, 2005, J AM COLL CARDIOL, V46, P1693, DOI 10.1016/j.jacc.2005.04.066; Tilling L, 2009, BRIT J CLIN PHARMACO, V68, P484, DOI 10.1111/j.1365-2125.2009.03486.x; Vajkoczy P, 2003, J EXP MED, V197, P1755, DOI 10.1084/jem.20021659; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; Verma I, 2017, INT J ANGIOL, V26, P36, DOI 10.1055/s-0036-1593445; Whalen MJ, 2000, CRIT CARE MED, V28, P2600, DOI 10.1097/00003246-200007000-00070; Yan R, 2017, J INNATE IMMUN, V9, P546, DOI 10.1159/000477211; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Yoon CH, 2006, ARTERIOSCL THROM VAS, V26, P1066, DOI 10.1161/01.ATV.0000215001.92941.6c; Zahran AM, 2016, PEDIATR EMERG CARE, V32, P163, DOI 10.1097/PEC.0000000000000727; Zhang YM, 2009, AM J PHYSIOL-HEART C, V296, pH1675, DOI 10.1152/ajpheart.00665.2008	45	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195064	10.1371/journal.pone.0195064	http://dx.doi.org/10.1371/journal.pone.0195064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601599	Green Published, gold, Green Submitted			2022-12-27	WOS:000428845900017
J	Aryal, B; Rao, VA				Aryal, Baikuntha; Rao, V. Ashutosh			Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASES; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; ANTIOXIDANT STATUS; HSP90 CHAPERONE; MICROENVIRONMENT; EXPRESSION; CARCINOMA; CATALASE	Protein carbonylation is an irreversible post-translational modification induced by severe oxidative stress. Reactive oxygen species (ROS) are constantly produced in cells and play important roles in both cancer progression and cancer suppression. ROS levels can be higher in tumor compared to surrounding healthy tissue but ROS-induced specific protein carbonylation and its unique role in cancer progression or suppression is poorly understood. In this study, we utilized previously validated ELISA and western blot methods to analyze the total and specific protein carbonylation in flash-frozen human breast cancer and matched adjacent healthy tissue to compare relative total, and specific protein carbonylation. Mass spectrometry, two-color western, and immunoprecipitation methods were used to identify and confirm the specifically carbonylated proteins in breast tumor tissue. Super-oxide dismutase (SOD) activity was measured as an indicator of antioxidant activity, and LC3-II protein level was analyzed for autophagy by western blot. Findings were further confirmed using the immortalized MDA-MB-231 and MDA-MB-468 breast cancer and MCF-12A noncancerous human epithelial breast cell lines. Our results indicate that tumor tissue has greater total protein carbonylation, lower SOD1 and SOD2 protein levels, lower total SOD activity, and higher LC3-II levels compared to adjacent healthy tissue. We identified and confirmed three specific proteins of interest; filamin A, heat shock protein 90 beta (HSP90 beta), and bifunctional glutamate/proline-tRNA ligase (EPRS), that were selectively carbonylated in tumor tissue compared to matched adjacent healthy tissue. Correspondingly, compared to noncancerous MCF-12A epithelial cells, MDA-MB-231 cancer cells exhibited an increase in filamin A and EPRS protein carbonylation, decreased total SOD activity, and increased autophagy, but not increased HSP90 beta protein carbonylation. Identification of selectively carbonylated proteins and defining their roles in cancer progression may promote the development of targeted therapeutic approaches toward mitigating oxidative damage of these proteins.	[Aryal, Baikuntha; Rao, V. Ashutosh] US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	ashutosh.rao@fda.hhs.gov	Rao, V Ashutosh/A-3569-2013	Rao, V Ashutosh/0000-0001-6817-8049				Alper O, 2009, CANCER SCI, V100, P1748, DOI 10.1111/j.1349-7006.2009.01244.x; Aryal B, 2014, P NATL ACAD SCI USA, V111, P2011, DOI 10.1073/pnas.1321783111; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; De Palma G, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/147528; Gopcevic KR, 2013, DIGEST DIS SCI, V58, P2646, DOI 10.1007/s10620-013-2681-2; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guner G, 1996, CANCER LETT, V103, P233, DOI 10.1016/0304-3835(96)04226-7; Hasan HR, 2012, ASIAN PAC J CANCER P, V13, P2571, DOI 10.7314/APJCP.2012.13.6.2571; Jezierska-Drutel A, 2013, ADV CANCER RES, V119, P107, DOI 10.1016/B978-0-12-407190-2.00003-4; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kocot J, 2013, ADV CLIN EXP MED, V22, P431; Kryndushkin D, 2017, PHARM RES-DORDR, V34, P765, DOI 10.1007/s11095-017-2103-9; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Mahajan M, 2013, INDIAN J CLIN BIOCHE, V28, P51, DOI 10.1007/s12291-012-0244-5; Maisonneuve E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007269; Malaviya R, 2014, TOXICOL APPL PHARM, V275, P145, DOI 10.1016/j.taap.2013.12.022; Mannello F, 2009, CELL ONCOL, V31, P383, DOI 10.3233/CLO-2009-0483; MARKLUND SL, 1982, CANCER RES, V42, P1955; Mehrabi S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/585083; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Narain NR, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2016-0065; Nathan FM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-382; Panis C, 2012, BREAST CANCER RES TR, V133, P881, DOI 10.1007/s10549-011-1851-1; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Subapriya R, 2002, CLIN BIOCHEM, V35, P489, DOI 10.1016/S0009-9120(02)00340-5; Thanan R, 2012, FREE RADICAL BIO MED, V52, P1465, DOI 10.1016/j.freeradbiomed.2012.01.018; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; Uehara H, 2015, PHARM RES-DORDR, V32, P691, DOI 10.1007/s11095-014-1496-y; Visconti R, 2009, IDRUGS, V12, P240; Wu ZL, 2011, PARASITOL RES, V109, P657, DOI 10.1007/s00436-011-2298-3; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yue JY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-7	41	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194164	10.1371/journal.pone.0194164	http://dx.doi.org/10.1371/journal.pone.0194164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596499	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000017
J	Burkholder, GA; Tamhane, AR; Safford, MM; Muntner, PM; Willig, AL; Willig, JH; Raper, JL; Saag, MS; Mugavero, MJ				Burkholder, Greer A.; Tamhane, Ashutosh R.; Safford, Monika M.; Muntner, Paul M.; Willig, Amanda L.; Willig, James H.; Raper, James L.; Saag, Michael S.; Mugavero, Michael J.			Racial disparities in the prevalence and control of hypertension among a cohort of HIV-infected patients in the southeastern United States	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; ACUTE MYOCARDIAL-INFARCTION; AFRICAN-ORIGIN; RISK; HEALTH; CARE; ATHEROSCLEROSIS; RACE/ETHNICITY; METAANALYSIS; POPULATIONS	Background African Americans are disproportionately affected by both HIV and hypertension. Failure to modify risk factors for cardiovascular disease and chronic kidney disease such as hypertension among HIV-infected patients may attenuate the benefits conferred by combination anti-retroviral therapy. In the general population, African Americans with hypertension are less likely to have controlled blood pressure than whites. However, racial differences in blood pressure control among HIV-infected patients are not well studied. Methods We conducted a cross-sectional study evaluating racial differences in hypertension prevalence, treatment, and control among 1,664 patients attending the University of Alabama at Birmingham HIV Clinic in 2013. Multivariable analyses were performed to calculate prevalence ratios (PR) with 95% confidence intervals (CI) as the measure of association between race and hypertension prevalence and control while adjusting for other covariates. Results The mean age of patients was 47 years, 77% were male and 54% African-American. The prevalence of hypertension was higher among African Americans compared with whites (49% vs. 43%; p = 0.02). Among those with hypertension, 91% of African Americans and 93% of whites were treated (p = 0.43). Among those treated, 50% of African Americans versus 60% of whites had controlled blood pressure (systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg) (p = 0.007). After multivariable adjustment for potential confounders, prevalence of hypertension was higher among African Americans compared to whites (PR 1.25; 95% CI 1.12-1.39) and prevalence of BP control was lower (PR 0.80; 95% CI 0.69-0.93). Conclusions Despite comparable levels of hypertension treatment, African Americans in our HIV cohort were less likely to achieve blood pressure control. This may place them at increased risk for adverse outcomes that disproportionately impact HIV-infected patients, such as cardiovascular disease and chronic kidney disease, and thus attenuate the benefits conferred by combination antiretroviral therapy.	[Burkholder, Greer A.; Tamhane, Ashutosh R.; Willig, Amanda L.; Willig, James H.; Raper, James L.; Saag, Michael S.; Mugavero, Michael J.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA; [Tamhane, Ashutosh R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Safford, Monika M.] Weill Cornell Med Coll, Div Gen Internal Med, New York, NY USA; [Muntner, Paul M.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University; University of Alabama System; University of Alabama Birmingham	Burkholder, GA (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA.	gburkholder@uabmc.edu		Burkholder, Greer/0000-0001-7185-3025; Willig, Amanda/0000-0001-8802-4311	NHLBI NIH HHS [K23 HL126570] Funding Source: Medline; NIAID NIH HHS [R24 AI067039, P30 AI027767] Funding Source: Medline; NIH HHS [P30-AI27767, 1R24 AI067039-1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL126570] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akgun KM, 2013, JAIDS-J ACQ IMM DEF, V62, P52, DOI 10.1097/QAI.0b013e318278f3fa; Allison Paul D., 2003, LOGISTIC REGRESSION; Armah KA, 2014, CLIN INFECT DIS, V58, P121, DOI 10.1093/cid/cit652; Bartley K, 2014, ETHNIC DIS, V24, P175; Bosworth HB, 2008, J GEN INTERN MED, V23, P692, DOI 10.1007/s11606-008-0547-7; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Chu C, 2011, J URBAN HEALTH, V88, P507, DOI 10.1007/s11524-010-9540-7; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-2; Cooper RS, 2015, J HYPERTENS, V33, P473, DOI 10.1097/HJH.0000000000000429; Crane HM, 2009, HIV MED, V10, P496, DOI 10.1111/j.1468-1293.2009.00720.x; D'Ascenzo F, 2014, J CARDIOVASC MED HAG; De Socio GV, 2014, AM J HYPERTENS, V27, P222, DOI 10.1093/ajh/hpt182; Farahani M, 2017, INT J STD AIDS, V28, P636, DOI 10.1177/0956462416632428; Florkowski Christopher M, 2011, Clin Biochem Rev, V32, P75; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Fuchs FD, 2011, HYPERTENSION, V57, P379, DOI 10.1161/HYPERTENSIONAHA.110.163196; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Howard G, 2006, STROKE, V37, P1171, DOI 10.1161/01.STR.0000217222.09978.ce; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Kozak MS, 2012, CLIN INFECT DIS, V54, P141, DOI 10.1093/cid/cir727; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Krauskopf Katherine, 2013, J Int Assoc Provid AIDS Care, V12, P325, DOI 10.1177/2325957413491432; Kressin NR, 2010, CIRC-CARDIOVASC QUAL, V3, P173, DOI 10.1161/CIRCOUTCOMES.109.860841; Lackland DT, 2014, AM J MED SCI, V348, P135, DOI 10.1097/MAJ.0000000000000308; Langness J, 2014, J MANAG CARE SPEC PH, V20, P809, DOI 10.18553/jmcp.2014.20.8.809; Lesko CR, 2015, CLIN INFECT DIS, V60, P1700, DOI 10.1093/cid/civ183; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; McNaughton CD, 2014, MED CARE, V52, P346, DOI 10.1097/MLR.0000000000000101; Medina-Torne Sheila, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P20, DOI 10.1177/1545109711418361; Morlat P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066223; Mujahid MS, 2011, AM J HYPERTENS, V24, P187, DOI 10.1038/ajh.2010.200; Mujib M, 2011, AM J CARDIOL, V107, P935, DOI 10.1016/j.amjcard.2010.11.012; Myerson M, 2014, JAIDS-J ACQ IMM DEF, V66, P370, DOI 10.1097/QAI.0000000000000168; Nuesch R, 2013, JAIDS-J ACQ IMM DEF, V62, P396, DOI 10.1097/QAI.0b013e3182847cd0; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Plantinga L, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-17; Prejean J, 2013, J COMMUN HEALTH, V38, P414, DOI 10.1007/s10900-012-9633-1; Richardson KK, 2016, J NATL MED ASSOC, V108, P201, DOI 10.1016/j.jnma.2016.08.001; Safford MM, 2007, ETHNIC DIS, V17, P421; Sampson UKA, 2014, CIRC-CARDIOVASC QUAL, V7, P33, DOI 10.1161/CIRCOUTCOMES.113.000155; Spruill TM, 2010, CURR HYPERTENS REP, V12, P10, DOI 10.1007/s11906-009-0084-8; Wiernik E, 2014, J HYPERTENS, V32, P1979, DOI 10.1097/HJH.0000000000000288; Williams SF, 2014, WORLD J CARDIOL, V6, P878, DOI 10.4330/wjc.v6.i9.878; Willig AL, 2015, AIDS RES HUM RETROV, V31, P898, DOI [10.1089/aid.2015.0062, 10.1089/AID.2015.0062]; Willig JH, 2008, CLIN INFECT DIS, V46, P1315, DOI 10.1086/533466; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194940	10.1371/journal.pone.0194940	http://dx.doi.org/10.1371/journal.pone.0194940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596462	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000054
J	Duan, WX; Wang, QM; Zhang, HY; Xie, BT; Li, AX; Hou, FY; Dong, SX; Wang, BQ; Qin, Z; Zhang, LM				Duan, Wenxue; Wang, Qingmei; Zhang, Haiyan; Xie, Beitao; Li, Aixian; Hou, Fuyun; Dong, Shunxu; Wang, Baoqing; Qin, Zhen; Zhang, Liming			Differences between nitrogen-tolerant and nitrogen-susceptible sweetpotato cultivars in photosynthate distribution and transport under different nitrogen conditions	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; IPOMOEA-BATATAS; PHLOEM; YIELD; GROWTH; POTASSIUM; STORAGE; EXPORT; ROOT; ASSIMILATION	To characterize the differences in photosynthate distribution and transport between nitrogen (N)-tolerant and N-susceptible sweetpotato cultivars under different N conditions, three N levels, including 0 (N0), 120 (N120), and 240 kg ha(-1) (N240), were used in field experiments with the Jishu26 (J26) and Xushu32 (X32) cultivars in 2015 and 2016. The results from both years revealed that high N application reduced the tuberous root yield, the tuber/vine rate of carbon-13 (C-13), and top-to-base (three equal segments of stem divided from the fifth opened leaf of the shoot tip to the main stem, defined as the top, middle, and base parts, respectively) gradients such as sucrose, ammonia N and potassium along the stem. 'J26' showed a higher yield than 'X32' under N0 but lower yield than 'X32' under N120 and N240. It also exhibited a higher C-13 distribution to tuberous roots compared with that of (')X32' under N0, and the opposite trend was observed under N120 and N240. Under N0, 'J26' showed a steep top-to-base amino acid gradient and a significantly lower top-to-base sucrose increase along the stem in the late growth stage. Under N120 and N240, 'X32' exhibited a greater top-to-base decrease in the ammonia N along the stem during the main growth stages, a steep top-to-base sucrose gradient along the stem in the early growth stage, and a lower top-to-base sucrose increase along the stem in the middle and late growth stages. The formation of a reasonable photosynthate distribution structure attributed to high yield was related to a desirable sucrose, ammonia N or K+ gradient downward along the stem. These results might help provide farmers with sweetpotato cultivars using less or no N fertilizer in soils of different fertility and enhance the knowledge of yield-related physiology.	[Duan, Wenxue; Wang, Qingmei; Zhang, Haiyan; Xie, Beitao; Li, Aixian; Hou, Fuyun; Dong, Shunxu; Wang, Baoqing; Qin, Zhen] Shandong Acad Agr Sci, Crop Res Inst, Jinan, Shandong, Peoples R China; [Duan, Wenxue; Wang, Qingmei; Zhang, Haiyan; Xie, Beitao; Li, Aixian; Hou, Fuyun; Dong, Shunxu; Wang, Baoqing; Qin, Zhen; Zhang, Liming] Sci Observat & Expt Stn Tuber & Root Crops Huang, Jinan, Shandong, Peoples R China; [Zhang, Liming] Shandong Acad Agr Sci, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Zhang, LM (corresponding author), Sci Observat & Expt Stn Tuber & Root Crops Huang, Jinan, Shandong, Peoples R China.; Zhang, LM (corresponding author), Shandong Acad Agr Sci, Jinan, Shandong, Peoples R China.	zhanglm11@sina.com						Alvim PDT, 1977, ROOT CROPS, P187; Bel AJEV, 1992, CROP PHOTOSYNTHESIS, P177; BOURKE RM, 1985, FIELD CROP RES, V12, P363, DOI 10.1016/0378-4290(85)90081-4; CHEN XK, 1982, J SHANDONG AGR U, V13, P79; Chen YC, 1961, SCI AGR SIN, V2, P25; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Eckardt NA, 2001, PLANT CELL, V13, P989; Ehlers K, 2000, PROTOPLASMA, V214, P80, DOI 10.1007/BF02524265; FADER GM, 1983, PLANT PHYSIOL, V73, P297, DOI 10.1104/pp.73.2.297; Gould N, 2004, FUNCT PLANT BIOL, V31, P987, DOI 10.1071/FP04058; Grodzinski B, 1998, PLANT PHYSIOL, V117, P207, DOI 10.1104/pp.117.1.207; Hartemink AE, 2000, AGR ECOSYST ENVIRON, V79, P271, DOI 10.1016/S0167-8809(00)00138-9; HILL WA, 1990, AGRON J, V82, P1120, DOI 10.2134/agronj1990.00021962008200060019x; Jonik C, 2012, PLANT BIOTECHNOL J, V10, P1088, DOI 10.1111/j.1467-7652.2012.00736.x; Kaupa P, 2014, FIELD CROP RES, V168, P48, DOI 10.1016/j.fcr.2014.08.011; Kaur G, 2015, INT J AGRIC BIOL, V17, P531, DOI 10.17957/IJAB/17.3.14.539; Kelm M., 2000, PLANT PRODUCTIVITY W, P273; Kockenberger W, 1997, PLANTA, V201, P53, DOI 10.1007/BF01258680; Komor E, 1996, J EXP BOT, V47, P1155, DOI 10.1093/jxb/47.Special_Issue.1155; Komor E, 2000, AUST J PLANT PHYSIOL, V27, P497; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Li RongLin, 2013, Food and Nutrition Sciences, V4, P1102; Liu CW, 2014, INT J ENV RES PUB HE, V11, P4427, DOI 10.3390/ijerph110404427; Liu HJ, 2015, PHOTOSYNTHETICA, V53, P378, DOI 10.1007/s11099-015-0121-6; Loewe A, 2010, NEW PHYTOL, V145, P565; Luo XingLu, 2011, Journal of Agricultural Science (Toronto), V3, P64; Ma DaiFu, 2012, Jiangsu Journal of Agricultural Sciences, V28, P969; MINCHIN PEH, 1984, J EXP BOT, V35, P538, DOI 10.1093/jxb/35.4.538; Nedunchezhiyan M., 2012, ISRN AGRON, V2012, P1, DOI [10.5402/2012/291285, DOI 10.5402/2012/291285]; Ning YunWang, 2015, Acta Agronomica Sinica, V41, P432; Njiti VN, 2013, HORTSCIENCE, V48, P73, DOI 10.21273/HORTSCI.48.1.73; Onunka NA, 2011, AGRO SCI, V10, P22; Patrick JW, 2001, AUST J PLANT PHYSIOL, V28, P695, DOI 10.1071/PP01023; Phillips SB, 2005, HORTSCIENCE, V40, P214, DOI 10.21273/HORTSCI.40.1.214; Ravi V., 2009, J ROOT CROPS, V35, P1; Satapathy M. R., 2007, Indian Journal of Agricultural Research, V41, P195; Sebastiani SK, 2006, ACTA HORTIC, P219, DOI 10.17660/ActaHortic.2006.703.27; Shedge M, 2013, ROLE PREHARVEST SPRA; Tekalign T, 2005, SCI HORTIC-AMSTERDAM, V105, P29, DOI 10.1016/j.scienta.2005.01.021; Uwah D. F., 2013, Journal of Agricultural Science (Toronto), V5, P61; Villagarcia MR, 1998, J AM SOC HORTIC SCI, V123, P814, DOI 10.21273/JASHS.123.5.814; Villordon A, 2010, HORTSCIENCE, V45, P1167, DOI 10.21273/HORTSCI.45.8.1167; Villordon AQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107384; Viola R, 2001, PLANT CELL, V13, P385, DOI 10.1105/tpc.13.2.385; VREUGDENHIL D, 1989, PHYSIOL PLANTARUM, V77, P385, DOI 10.1111/j.1399-3054.1989.tb05657.x; WALKER DW, 1987, COMMUN SOIL SCI PLAN, V18, P529, DOI 10.1080/00103628709367839; Wu ChunHong, 2016, Acta Agronomica Sinica, V42, P113; [徐聪 Xu Cong], 2014, [水土保持学报, Journal of Soil and Water Conservation], V28, P149; Yang ChangQin, 2014, Acta Agronomica Sinica, V40, P908; Zhang L., 2009, P325, DOI 10.1007/978-1-4020-9475-0_15	50	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194570	10.1371/journal.pone.0194570	http://dx.doi.org/10.1371/journal.pone.0194570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596436	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000031
J	Malagnino, V; Salpini, R; Maffongelli, G; Battisti, A; Fabeni, L; Piermatteo, L; Colagrossi, L; Fini, V; Ricciardi, A; Sarrecchia, C; Perno, CF; Andreoni, M; Svicher, V; Sarmati, L				Malagnino, Vincenzo; Salpini, Romina; Maffongelli, Gaetano; Battisti, Arianna; Fabeni, Lavinia; Piermatteo, Lorenzo; Colagrossi, Luna; Fini, Vanessa; Ricciardi, Alessandra; Sarrecchia, Cesare; Perno, Carlo Federico; Andreoni, Massimo; Svicher, Valentina; Sarmati, Loredana			High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; COST-EFFECTIVENESS; HEPATOCELLULAR-CARCINOMA; PHYLOGENETIC RELATEDNESS; GENETIC DIVERSITY; SURFACE-ANTIGEN; EPIDEMIOLOGY; STRAINS; HBSAG; DNA	Hepatitis B virus (HBV) genotype E almost exclusively occurs in African people, and its presence is more commonly associated with the development of chronic HBV (CHB) infection. Moreover, an epidemiological link has been found between the distribution of HBV genotype E infection and African countries with high incidences of hepatocellular carcinoma. As part of a programme for the health assessment of migrants, we evaluated 358 young African subjects for HBV infection; 58.1% (208/358) were positive for an HBV marker, and 54 (25.5%) had CHB. Eighty-one percent of the CHB subjects were infected with HBV genotype E, with a median serum HBV-DNA of 3.2 (IQR: 2.7-3.6) logIU/ml. All patients had high serum HBsAg titres (10,899 [range 5,359-20,272] IU/ml), and no correlation was found between HBsAg titres and HBV-DNA plasma levels. RT sequence analysis showed the presence of a number of immune escape mutations: strains from all of the patients had a serine at HBsAg position 140; 3 also had T116N, Y100C, and P142L + S143L substitutions; and 1 had a G112R substitution. Six (18%) patients had stop-codons at position 216. In 5 of the 9 (26.5%) CHB patients, ultrasound liver biopsy, quantification of total intrahepatic HBV-DNA and cccDNA, and RT/HBsAg sequencing were performed. The median (IQR) total intrahepatic HBV-DNA was 766 (753-1139) copies/1000 cells, and the median (IQR) cccDNA was 17 (10- 27) copies/1000 cells. Correlations were observed for both total intra-hepatic HBV-DNA and cccDNA with serum HBV-DNA, while no correlation was found for the HBsAg titres. A difference of 2.5/1,000 nucleotides was found in the HBsAg sequences obtained from plasma and from liver tissue, with 3 cases of possible viral anatomical compartmentalization. In conclusion, a high rate of CHB infection due to the E genotype was demonstrated in a group of immigrants from Western Africa. An analysis of the viral strains obtained showed the virological characteristics of immune escape, which may be the cause of viral replication persistence. Moreover, a fair percentage of stop codon mutations were found. The lack of correlation between HBsAg titres and plasma or intrahepatic HBV-DNA found in these subjects suggests a pathway of virus production that is not linked to HBsAg secretion. Studies with a larger number of patients with CHB due to the E genotype are advisable to corroborate these observations.	[Malagnino, Vincenzo; Maffongelli, Gaetano; Ricciardi, Alessandra; Sarrecchia, Cesare; Andreoni, Massimo; Sarmati, Loredana] Tor Vergata Univ, Dept Syst Med, Clin Infect Dis, Rome, Italy; [Salpini, Romina; Battisti, Arianna; Fabeni, Lavinia; Piermatteo, Lorenzo; Colagrossi, Luna; Fini, Vanessa; Perno, Carlo Federico; Svicher, Valentina] Tor Vergata Univ, Dept Expt Med & Surg, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Sarmati, L (corresponding author), Tor Vergata Univ, Dept Syst Med, Clin Infect Dis, Rome, Italy.	sarmati@med.uniroma2.it	Piermatteo, Lorenzo/J-5796-2018; Maffongelli, Gaetano/AAB-8651-2022; FABENI, LAVINIA/J-6626-2016; Andreoni, Masimo/AAL-2214-2020; Salpini, Romina/ABE-4828-2021; Salpini, Romina/K-2170-2016; Fini, Vanessa/AAL-3672-2021	Piermatteo, Lorenzo/0000-0002-3500-0858; FABENI, LAVINIA/0000-0002-2975-8611; Salpini, Romina/0000-0002-2488-2082; Salpini, Romina/0000-0002-2488-2082; Malagnino, Vincenzo/0000-0002-6561-5298; Fini, Vanessa/0000-0002-4489-8137; MAFFONGELLI, GAETANO/0000-0001-7784-2511; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Battisti, Arianna/0000-0001-6831-9227; SVICHER, VALENTINA/0000-0002-2377-504X; Colagrossi, Luna/0000-0001-5618-1523; sarmati, loredana/0000-0003-1452-0333				Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Bjornsdottir TB, 2005, J MED VIROL, V77, P481, DOI 10.1002/jmv.20480; Boglione L, 2014, J INFECTION, V69, P81, DOI 10.1016/j.jinf.2014.02.018; Coppola N, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES.2015.20.35.30009; Echevarria JM, 2006, J MED VIROL, V78, pS36, DOI 10.1002/jmv.20605; Eckman MH, 2011, CLIN INFECT DIS, V52, P1294, DOI 10.1093/cid/cir199; Erhardt A, 2009, J MED VIROL, V81, P1716, DOI 10.1002/jmv.21588; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Ganne-Carrie N, 2006, J MED VIROL, V78, P335, DOI 10.1002/jmv.20545; Hayashi PH, 2005, MED CLIN N AM, V89, P371, DOI 10.1016/j.mcna.2004.08.014; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Karra VK, 2016, J CLIN EXP HEPATOL, V6, P209, DOI 10.1016/j.jceh.2016.07.002; Kato H, 2004, J MED VIROL, V73, P516, DOI 10.1002/jmv.20120; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Mendy M, 2008, J MED VIROL, V80, P1537, DOI 10.1002/jmv.21221; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1992, J GEN VIROL, V73, P1201, DOI 10.1099/0022-1317-73-5-1201; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; Palumbo Emilio, 2007, Arq. Gastroenterol., V44, P54, DOI 10.1590/S0004-28032007000100012; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salpini R, 2015, HEPATOLOGY, V61, P823, DOI 10.1002/hep.27604; Shimakawa Y, 2016, GUT, V65, P2007, DOI 10.1136/gutjnl-2015-309892; Suzuki S, 2003, J MED VIROL, V69, P459, DOI 10.1002/jmv.10331; Svicher V, 2009, J HEPATOL, V50, P461, DOI 10.1016/j.jhep.2008.07.038; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wong WWL, 2011, LIVER INT, V31, P1179, DOI 10.1111/j.1478-3231.2011.02559.x; Wooddell CI, 2015, HEPATOLOGY, V62, p222A; World Health Organization, 2017, WHO GUID HEP B C TES	35	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195045	10.1371/journal.pone.0195045	http://dx.doi.org/10.1371/journal.pone.0195045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596494	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000071
J	Sanin, KI; Islam, MM; Mahfuz, M; Ahmed, AMS; Mondal, D; Haque, R; Ahmed, T				Sanin, Kazi Istiaque; Islam, M. Munirul; Mahfuz, Mustafa; Ahmed, A. M. Shamsir; Mondal, Dinesh; Haque, Rashidul; Ahmed, Tahmeed			Micronutrient adequacy is poor, but not associated with stunting between 12-24 months of age: A cohort study findings from a slum area of Bangladesh	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; CHILD NUTRITIONAL-STATUS; LOW-BIRTH-WEIGHT; YOUNG-CHILDREN; DIETARY-INTAKE; INFANT GROWTH; LOW-INCOME; DETERMINANTS; OVERWEIGHT; SETTLEMENT	The prevalence of stunting among children below 5 years of age is higher in the slum-dwelling population of Bangladesh compared to that in both urban and rural areas. Studies have reported that several factors such as inadequate nutrition, low socio-economic status, poor hygiene and sanitation and lack of maternal education are the substantial predictors of childhood stunting. Almost all these factors are universally present in the slum-dwelling population of Bangladesh. However, few studies have prospectively examined such determinants of stunting among slum populations. In this paper, we reveal the findings of a cohort study with an aim to explore the status of micronutrient adequacy among such vulnerable children and establish its association with stunting along with other determinants. Two-hundredsixty- five children were enrolled and followed since birth until 24 months of age. We collected anthropometric, morbidity and dietary intake data monthly. We used the 24-hour multiple-pass recall approach to collect dietary intake data from the age of 9 months onward. Micronutrient adequacy of the diet was determined by the mean adequacy ratio (MAR) which was constructed from the average intake of 9 vitamins and 4 minerals considered for the analysis. We used generalized estimating equation (GEE) regression models to establish the determinants of stunting between 12-24 months of age in our study population. The prevalence of low-birth-weight (LBW) was about 28.7% and approximately half of the children were stunted by the age of 24 months. The average micronutrient intake was considerably lower than the recommended dietary allowance and the MAR was only 0.48 at 24 months of age compared to the optimum value of 1. However, the MAR was not associated with stunting between 12-24 months of age. Rather, LBW was the significant determinant (AOR = 3.03, 95% CI: 1.69-5.44) after adjusting for other factors such as age (AOR = 2.12, 95% CI: 1.45-3.11 at 24 months and AOR = 1.97, 95% CI: 1.49-2.59 at 18 months, ref: 12 months) and sex (AOR = 1.98, 95% CI: 1.17-3.33, ref: female). Improving the nutritional quality of complementary food in terms of adequacy of micronutrients is imperative for optimum growth but may not be adequate to mitigate under-nutrition in this setting. Further research should focus on identifying multiple strategies that can work synergistically to diminish the burden of stunting in resource-poor settings.	[Sanin, Kazi Istiaque; Islam, M. Munirul; Mahfuz, Mustafa; Mondal, Dinesh; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Ahmed, A. M. Shamsir] Menzies Sch Hlth Res, Renal Unit, Darwin, NT, Australia; [Haque, Rashidul] Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Charles Darwin University; Menzies School of Health Research; International Centre for Diarrhoeal Disease Research (ICDDR)	Islam, MM (corresponding author), Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh.	mislam@icddrb.org	Mahfuz, Mustafa/H-5923-2017	Mahfuz, Mustafa/0000-0002-4090-785X				Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Ahmed T, 2014, CLIN INFECT DIS, V59, pS280, DOI 10.1093/cid/ciu458; Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; Ahsan KZ, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0176-x; Arifeen SE, 2000, AM J CLIN NUTR, V72, P1010; Arifeen SE, 2001, EUR J CLIN NUTR, V55, P167, DOI 10.1038/sj.ejcn.1601141; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Arsenault JE, 2013, J NUTR, V112; Bangladesh Bureau of Statistics, 2015, CENS SLUM AR FLOAT P; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Beaton GH, 1979, AM J CLIN NUTR US; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown KH, 2001, FOOD NUTR BULL, V22, P113, DOI DOI 10.1177/156482650102200201; BROWN KH, 1998, COMPLEMENTARY FEEDIN; Caulfield LE, 2014, CLIN INFECT DIS, V59, pS248, DOI 10.1093/cid/ciu421; Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dewey KG, 2013, J NUTR, V143, P2050, DOI 10.3945/jn.113.182527; Dewey KG, 2009, FOOD NUTR BULL, V30, pS187, DOI 10.1177/15648265090302S201; Espo M, 2002, ACTA PAEDIATR, V91, P1364, DOI 10.1111/j.1651-2227.2002.tb02835.x; Fenske N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078692; Ferland S, 2003, J REPROD MED, V48, P86; FITZHARD.PM, 1972, PEDIATRICS, V49, P671; FITZHARDINGE PM, 1989, ACTA PAEDIATR SCAND, P27; Ghosh Shanti, 2004, Indian Pediatr, V41, P682; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; GUTHRIE HA, 1981, J AM DIET ASSOC, V78, P240; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; Hautvast JLA, 1999, EUR J CLIN NUTR, V53, P50, DOI 10.1038/sj.ejcn.1600676; Hossain M, BANGLADESH ACHIEVES; Hossain MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164447; icddr b UNICEF/Bangladesh GAIN IPHN, 2013, BANGL NAT MICR SURV; Institute of Medicine, 2002, DIET REF INT APPL DI; Jang DG, 2011, ARCH GYNECOL OBSTET, V284, P73, DOI 10.1007/s00404-010-1597-8; Kant AK, 1996, J AM DIET ASSOC, V96, P785, DOI 10.1016/S0002-8223(96)00217-9; Keller HH, 1996, CANADIAN J PUBLIC HL, V88, P305; Kimmons JE, 2005, J NUTR, V135, P444, DOI 10.1093/jn/135.3.444; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lutter CK, 2003, J NUTR, V133, p2941S, DOI 10.1093/jn/133.9.2941S; MADDEN JP, 1976, J AM DIET ASSOC, V68, P143; Maillot M, 2007, AM J CLIN NUTR, V86, P690; MARR JW, 1986, HUM NUTR-APPL NUTR, V40A, P347; Martorell R, 1998, EUR J CLIN NUTR, V52, pS43; Martorell R, 1998, EUR J CLIN NUTR S1, V52; Moshfegh A, 2001, RES RESULTS USING NE, pA278; National Institute of Population Research and Training Mitra and Associates ICF International, 2015, BANGL DEM HLTH SURV; Olack B, 2011, J HEALTH POPUL NUTR, V29, P357, DOI 10.3329/jhpn.v29i4.8451; Owais A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165128; Rahman MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157814; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Rivera JA, 2003, J NUTR, V133, p4010S, DOI 10.1093/jn/133.11.4010S; Ruz M, 1998, PROCEEDINGS OF THE 16TH INTERNATIONAL CONGRESS OF NUTRITION - NUTRITION MONTREAL 97, P203; Salam A, 2004, NATL LOW BIRTH WEIGH; Sempos CT, 1999, AM J CLIN NUTR, V69, p1330S; Suri D, 2014, FASEB J S, V28, P620; TENOVUO A, 1987, ACTA PAEDIATR SCAND, V76, P636, DOI 10.1111/j.1651-2227.1987.tb10534.x; Theron M, 2007, PUBLIC HEALTH NUTR, V10, P379, DOI 10.1017/S1368980007246579; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; UN, 2015, MILLENNIUM DEV GOALS; UNICEF, 2016, CHILD WELL BEING SUR; UNICEF, 2016, MATER LETT, DOI DOI 10.1016/0167-577X(84)90080-6; USAID, 2015, BANGL PROF PRET LOW; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Wamani H, 2006, PUBLIC HEALTH NUTR, V9, P320, DOI 10.1079/PHN2006854	68	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195072	10.1371/journal.pone.0195072	http://dx.doi.org/10.1371/journal.pone.0195072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596493	Green Published, gold			2022-12-27	WOS:000428630000074
J	van Oers, AM; Mutsaerts, MAQ; Burggraaff, JM; Kuchenbecker, WKH; Perquin, DAM; Koks, CAM; van Golde, R; Kaaijk, EM; Broekmans, FJ; de Bruin, JP; van der Veen, F; Nap, AW; Gondrie, ETCM; Mol, BWJ; Groen, H; Hoek, A				van Oers, Anne M.; Mutsaerts, Meike A. Q.; Burggraaff, Jan M.; Kuchenbecker, Walter K. H.; Perquin, Denise A. M.; Koks, Carolien A. M.; van Golde, Ron; Kaaijk, Eugenie M.; Broekmans, Frank J.; de Bruin, Jan Peter; van der Veen, Fulco; Nap, Annemiek W.; Gondrie, Ed T. C. M.; Mol, Ben W. J.; Groen, Henk; Hoek, Annemieke		LIFEstyle study Grp	Association between periconceptional weight loss and maternal and neonatal outcomes in obese infertile women	PLOS ONE			English	Article							BODY-MASS INDEX; MECHANISMS LINKING OBESITY; LIFE-STYLE; PREGNANCY; RISK; OVERWEIGHT; COMPLICATIONS; INTERVENTION; MANAGEMENT; HEALTH	Background Obesity in women of reproductive age has deleterious effects on reproductive and offspring health. In this study, we aimed to evaluate the association between the magnitude of periconceptional body-mass index (BMI) change and maternal and neonatal outcomes in obese infertile women who participated in the LIFEstyle study. The LIFEstyle study was a randomized controlled trial, evaluating if a six-month lifestyle intervention program prior to infertility treatment in obese infertile women improved birth rates, compared to prompt infertility treatment. Methods and findings This is an exploratory post hoc analysis of the LIFEstyle study. We recorded periconceptional BMI change in women with an ongoing pregnancy, pooling data of all women, regardless of randomization arm. Periconceptional BMI change was calculated using weight at randomization and the periconceptional weight (measured in kilograms 12 weeks before or after conception and expressed as BMI change in units BMI (kg/m(2))). Subsequently, women were categorized into quartiles according to the magnitude of their periconceptional change in BMI. The odds of maternal and neonatal outcomes were calculated using logistic regression analysis, comparing women in each of the first three weight change quartiles separately, and combined, to women in the fourth quartile. The fourth quartile was chosen as reference group, since these women had the least weight loss. We adjusted for periconceptional BMI, nulliparity and smoking status. In addition, we performed a subgroup analysis for singleton pregnancies. In the LIFEstyle study, 321 obese infertile women achieved an ongoing pregnancy which was conceived within 24 months after randomization. Periconceptional BMI change was available in 244 of these women (76%). Median BMI at randomization was 35.9 kg/m(2). Women in the first quartile (Q1) had a periconceptional BMI change of <-2.1 kg/m(2), women in the second quartile (Q2)-2.1 to-0.9 kg/m(2), women in the third quartile (Q3)-0.9 to 0.1 kg/m2 and women in the fourth quartile (Q4) gained >= 0.1 kg/m(2). There were no significant differences between women in the quartiles regarding rates of excessive gestational weight gain (in term pregnancies), gestational diabetes, preterm birth, induction of labor, spontaneous vaginal birth and Caesarean section. Compared to women in Q4, the adjusted odds ratios, aOR, and 95% confidence interval for a hypertensive complication were; 0.55 (0.22-1.42) for women in Q1, 0.30 (0.12-0.78) for women in Q2, 0.39 (0.16-0.96) for women in Q3 and 0.39 (0.19-0.82) for women in Q1 to Q3 combined. In the subgroup analysis, investigating singleton pregnancies only, the statistically significant decreased rate of a hypertensive complication remained in women in Q2 (aOR 0.27, 95% CI 0.10-0.72) and Q3 (aOR 0.39, 95%Cl 0.16-0.98) and when comparing women in Q1 to Q3 together to women in Q4 (aOR 0.38, 95%Cl 0.18-0.80). Furthermore, there was a significantly decreased aOR (95%C1) of preterm birth in women in Q2 (0.24, 0.06-0.98) and when combining women in Q1 to Q3 (0.37, 0.14-0.97) compared to women in Q4. Conclusions These results suggest that a periconceptional decrease in BMI in obese infertile women could lead to a decrease of the rates of hypertensive pregnancy complications and preterm birth. The results are limited by the exploratory nature of the analyses and further evidence is necessary to provide more definitive conclusions.	[van Oers, Anne M.; Mutsaerts, Meike A. Q.; Hoek, Annemieke] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Mutsaerts, Meike A. Q.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Gen Practice, Utrecht, Netherlands; [Burggraaff, Jan M.] Scheper Hosp, Dept Obstet & Gynecol, Emmen, Netherlands; [Kuchenbecker, Walter K. H.] Isala, Dept Obstet & Gynecol, Zwolle, Netherlands; [Perquin, Denise A. M.] Med Ctr Leeuwarden, Dept Obstet & Gynecol, Leeuwarden, Netherlands; [Koks, Carolien A. M.] Maxima Med Ctr, Dept Obstet & Gynecol, Veldhoven, Netherlands; [van Golde, Ron] Univ Maastricht, Maastricht Univ Med Ctr, Dept Obstet & Gynecol, Maastricht, Netherlands; [Kaaijk, Eugenie M.] OLVG, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Broekmans, Frank J.] Univ Utrecht, Univ Med Ctr Utrecht, Div Female & Baby, Dept Reprod Med, Utrecht, Netherlands; [de Bruin, Jan Peter] Jeroen Bosch Hosp, Dept Obstet & Gynecol, Shertogenbosch, Netherlands; [van der Veen, Fulco] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Amsterdam, Netherlands; [Nap, Annemiek W.] Rijnstate, Dept Obstet & Gynecol, Arnhem, Netherlands; [Gondrie, Ed T. C. M.] Zuyderland MC, Dept Obstet & Gynecol, Sittard, Netherlands; [Mol, Ben W. J.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Oers, Anne M.] Med Spectrum Twente, Dept Obstet & Gynecol, Enschede, Netherlands	University of Groningen; Utrecht University; Utrecht University Medical Center; Medical Center Leeuwarden; Maxima Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); Utrecht University; Utrecht University Medical Center; Jeroen Bosch Ziekenhuis; University of Amsterdam; Academic Medical Center Amsterdam; Rijnstate Hospital; Robinson Research Institute; University of Adelaide; University of Groningen; Medical Spectrum Twente	van Oers, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands.; van Oers, AM (corresponding author), Med Spectrum Twente, Dept Obstet & Gynecol, Enschede, Netherlands.	a.m.van.oers@umcg.nl	NAP, Annemiek/ABE-1897-2021; Groen, Henk/B-2163-2013	Groen, Henk/0000-0002-6629-318X	ZonMw, the Dutch Organisation for Health Research and Development [50-50110-96-518]; ZonMw	ZonMw, the Dutch Organisation for Health Research and Development; ZonMw(Netherlands Organization for Health Research and Development)	The study was supported by a grant from ZonMw (www.zonmw.nl), the Dutch Organisation for Health Research and Development (50-50110-96-518). AH was project leader and received the funding. ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Catalano PM, 2015, OBSTET GYNECOL, V126, pe112, DOI 10.1097/AOG.0000000000001211; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Denison FC, 2014, BJOG-INT J OBSTET GY, V121, P72, DOI 10.1111/1471-0528.12443; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Eriksson JG, 2015, ANN MED, V47, P94, DOI 10.3109/07853890.2015.1004360; Forsythe LKS, 2008, NUTR RES REV, V21, P117, DOI 10.1017/S0954422408138732; Gademan MGJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094594; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Institute of Medicine and National Research Council, 2009, WEIGHT GAIN PREGNANC; Jain AP, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.018; Johansson K, 2015, NEW ENGL J MED, V372, P814, DOI 10.1056/NEJMoa1405789; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Koivusalo SB, 2016, DIABETES CARE, V39, P24, DOI 10.2337/dc15-0511; Liu P, 2016, OBES REV, V17, P1091, DOI 10.1111/obr.12455; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mostello D, 2010, OBSTET GYNECOL, V116, P667, DOI 10.1097/AOG.0b013e3181ed74ea; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Mutsaerts MAQ, 2016, NEW ENGL J MED, V374, P1942, DOI 10.1056/NEJMoa1505297; Mutsaerts MAQ, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-22; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; NVOG Dutch Society for Obstetrics and Gynaecology, GUID SUBF; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Rydhstroem H, 2001, Twin Res, V4, P227, DOI 10.1375/twin.4.4.227; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Walsh SW, 2007, TRENDS ENDOCRIN MET, V18, P365, DOI 10.1016/j.tem.2007.09.003; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Yi XY, 2015, INT J GYNECOL OBSTET, V130, P3, DOI 10.1016/j.ijgo.2015.01.011; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627	40	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192670	10.1371/journal.pone.0192670	http://dx.doi.org/10.1371/journal.pone.0192670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590118	Green Published, gold			2022-12-27	WOS:000428603100006
J	Garber, DA; Mitchell, J; Adams, D; Guenthner, P; Deyounks, F; Ellis, S; Kelley, K; Johnson, R; Dobard, C; Heneine, W; McNicholl, J				Garber, David A.; Mitchell, James; Adams, Debra; Guenthner, Patricia; Deyounks, Frank; Ellis, Shanon; Kelley, Kristen; Johnson, Ryan; Dobard, Charles; Heneine, Walid; McNicholl, Janet			Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; RHESUS MACAQUES; CHLAMYDIA-TRACHOMATIS; MUCOSAL TRANSMISSION; NONHUMAN-PRIMATES; MALE CIRCUMCISION; ANIMAL-MODELS; VACCINE; TRIAL; SHIVSF162P3	Penile acquisition of HIV infection contributes substantially to the global epidemic. Our goal was to establish a preclinical macaque model of penile HIV infection for evaluating the efficacy of new HIV prevention modalities. Rhesus macaques were challenged once or twice weekly with consistent doses of SHIV(sf)162P3 (a chimeric simian-human immunodeficiency virus containing HIV env) ranging from 4-600 TCID50 (50% tissue culture infective dose), via two penile routes, until systemic SHIV infection was confirmed. One route exposed the inner foreskin, glans and urethral os to virus following deposition into the prepuce (foreskin) pouch. The second route introduced the virus non-traumatically into the distal urethra only. Single-route challenges resulted in dose-dependent rates of SHIV acquisition informing selection of optimal SHIV dosing. Concurrent SHIV challenges via the prepuce pouch (200 TCID50) and urethra (16 TCID50) resulted in infection of 100% (10/10) animals following a median of 2.5 virus exposures (range, 1-12). We describe the first rhesus macaque repeat-exposure SHIV challenge model of penile HIV acquisition. Utilization of the model should further our understanding of penile HIV infection and facilitate the development of new HIV prevention strategies for men.	[Garber, David A.; Mitchell, James; Adams, Debra; Guenthner, Patricia; Deyounks, Frank; Ellis, Shanon; Kelley, Kristen; Johnson, Ryan; Dobard, Charles; Heneine, Walid; McNicholl, Janet] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Lab Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Garber, DA (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Lab Branch, Atlanta, GA 30333 USA.	david.garber@cdc.hhs.gov			Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by Centers for Disease Control and Prevention (CDC), intramural funding (DAG, JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2011, AM J REPROD IMMUNOL, V65, P220, DOI 10.1111/j.1600-0897.2010.00941.x; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Butler K, 2013, AIDS RES HUM RETROV, V29, P1091, DOI [10.1089/AID.2012.0383, 10.1089/aid.2012.0383]; Del Prete GQ, 2016, CURR OPIN HIV AIDS, V11, P546, DOI 10.1097/COH.0000000000000311; Dinh MH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004729; Fischetti L, 2009, AIDS, V23, P319, DOI 10.1097/QAD.0b013e328321b778; Ganor Y, 2013, MUCOSAL IMMUNOL, V6, P776, DOI 10.1038/mi.2012.116; Garcia-Lerma JG, 2012, CURR OPIN HIV AIDS, V7, P505, DOI 10.1097/COH.0b013e328358e484; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Henning TR, 2017, J MED PRIMATOL, V46, P218, DOI 10.1111/jmp.12272; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Ma ZM, 2016, J VIROL, V90, P4093, DOI 10.1128/JVI.02947-15; Makarova N, 2017, AIDS, V31, P745, DOI 10.1097/QAD.0000000000001389; McChesney MB, 2013, CURR OPIN HIV AIDS, V8, P376, DOI 10.1097/COH.0b013e328363d3a2; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; McDermott AB, 2004, J VIROL, V78, P3140, DOI 10.1128/JVI.78.6.3140-3144.2004; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Otten RA, 2005, J INFECT DIS, V191, P164, DOI 10.1086/426452; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Radzio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050632; Regoes RR, 2005, PLOS MED, V2, P798, DOI 10.1371/journal.pmed.0020249; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; UNAIDS, GLOB SUMM AIDS EP; Yeh WW, 2011, J VIROL, V85, P10389, DOI 10.1128/JVI.00854-11	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194837	10.1371/journal.pone.0194837	http://dx.doi.org/10.1371/journal.pone.0194837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584769	gold, Green Submitted, Green Published			2022-12-27	WOS:000428373000042
J	Grobe, H; Wustenhagen, A; Baarlink, C; Grosse, R; Grikscheit, K				Grobe, Hanna; Wuestenhagen, Andrea; Baarlink, Christian; Grosse, Robert; Grikscheit, Katharina			A Rac1-FMNL2 signaling module affects cell-cell contact formation independent of Cdc42 and membrane protrusions	PLOS ONE			English	Article							ARP2/3 COMPLEX; ACTIN POLYMERIZATION; MOTILITY DOWNSTREAM; FILOPODIA FORMATION; ADHERENS JUNCTIONS; IMAGE-ANALYSIS; E-CADHERIN; FORMINS; DYNAMICS; ADHESION	De novo formation of epithelial cell-cell contacts relies on actin-based protrusions as well as tightly controlled turnover of junctional actin once cells encounter each other and adhesion complexes assemble. The specific contributions of individual actin regulators on either protrusion formation or junctional actin turnover remain largely unexplored. Based on our previous findings of Formin-like 2 (FMNL2)-mediated control of junctional actin dynamics, we investigated its potential role in membrane protrusions and impact on newly forming epithelial contacts. CRISPR/Cas9-mediated loss of FMNL2 in human MCF10A cells combined with optogenetic control of Rac1 activity confirmed its critical function in the establishment of intercellular contacts. While lamellipodial protrusion rates remained unaffected, FMNL2 knockout cells were characterized by impaired filopodia formation similar to depletion of the Rho GTPase Cdc42. Silencing of Cdc42, however, failed to affect FMNL2-mediated contact formation. Hence, we propose a cell-cell contact-specific and Rac1-mediated function of FMNL2 entirely independent of Cdc42. Consistent with this, direct visualizations of native epithelial junction formation revealed a striking and specifically Rac1- and not Cdc42-dependent recruitment of FMNL2 to newly forming junctions as well as established cell-cell contacts within epithelial sheets.	[Grobe, Hanna; Wuestenhagen, Andrea; Baarlink, Christian; Grosse, Robert; Grikscheit, Katharina] Philipps Univ Marburg, Inst Pharmacol, Biochem Pharmacol Ctr, Marburg, Germany; [Grikscheit, Katharina] Philipps Univ Marburg, Inst Virol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Grikscheit, K (corresponding author), Philipps Univ Marburg, Inst Pharmacol, Biochem Pharmacol Ctr, Marburg, Germany.; Grikscheit, K (corresponding author), Philipps Univ Marburg, Inst Virol, Marburg, Germany.	katharina.grikscheit@staff.uni-marburg.de			DFG [SPP-1782]	DFG(German Research Foundation (DFG))	This work was supported by DFG SPP-1782 (RG).	Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Baarlink C, 2010, CELL, V142, DOI 10.1016/j.cell.2010.06.030; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gardberg M, 2016, J PATHOL CLIN RES, V2, P41, DOI 10.1002/cjp2.34; Gauvin TJ, 2015, MOL BIOL CELL, V26, P467, DOI 10.1091/mbc.E14-07-1247; Grikscheit K, 2016, TRENDS BIOCHEM SCI, V41, P148, DOI 10.1016/j.tibs.2015.12.002; Grikscheit K, 2015, J CELL BIOL, V209, P367, DOI 10.1083/jcb.201412015; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Guo ZH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005473; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Henson JH, 2015, MOL BIOL CELL, V26, P887, DOI 10.1091/mbc.E14-07-1244; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Kage F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14832; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kuhn S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8088; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Moriya K, 2012, BIOSCI BIOTECH BIOCH, V76, P1201, DOI 10.1271/bbb.120069; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Peladeau C, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0110-z; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao MV, 2016, MOL BIOL CELL, V27, P2844, DOI 10.1091/mbc.E16-06-0429; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wang Y, 2015, DEV CELL, V34, P475, DOI 10.1016/j.devcel.2015.06.015; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Young LE, 2015, MOL BIOL CELL, V26, P4646, DOI 10.1091/mbc.E15-09-0626	47	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194716	10.1371/journal.pone.0194716	http://dx.doi.org/10.1371/journal.pone.0194716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579104	Green Submitted, Green Published, gold			2022-12-27	WOS:000428351800048
J	Hortsch, SK; Kremling, A				Hortsch, Sayuri Katharina; Kremling, Andreas			Characterization of noise in multistable genetic circuits reveals ways to modulate heterogeneity	PLOS ONE			English	Article							POSITIVE FEEDBACK; EXPRESSION; STOCHASTICITY; TRANSCRIPTION; COMPETENCE; INITIATION; NETWORKS	Random fluctuations in the amount of cellular components like mRNA and protein molecules are inevitable due to the stochastic and discrete nature of biochemical reactions. If large enough, this so-called "cellular noise" can lead to random transitions between the expression states of a multistable genetic circuit. That way, heterogeneity within isogenic populations is created. Our aim is to understand which dynamical features of a simple auto regulatory system determine its intrinsic noise level, and how they can be modified in order to regulate state-transitions. To that end, novel mathematical methods for the state-dependent characterization and prediction of noise in multistable systems are developed. First, we introduce the hybrid LNA, a modified version of the Linear Noise Approximation. It yields good predictions on variances of mRNA and protein fluctuations, even for reaction systems comprising low-copy-number components (e.g. mRNA) and highly nonlinear reaction rates. Furthermore, the temporal structure of fluctuations and the skewness of the protein distribution are characterized via state-dependent protein burst sizes and burst frequencies. Based on this mathematical framework, we develop graphical methods which support the intuitive design of regulatory circuits with a desired noise pattern. The methods are then used to predict how overall noise in the system can be adapted, and how state-specific noise modifications are possible that allow, e.g., the generation of unidirectional transitions. Our considerations are validated by stochastic simulations. This way, a design of genetic circuits is possible that takes population heterogeneity into account and is valuable in applications of synthetic biology and biotechnology. Moreover, natural phenomena like the bimodal development of genetic competence can be studied.	[Hortsch, Sayuri Katharina; Kremling, Andreas] Tech Univ Munich, Fac Mech Engn, Syst Biotechnol, Garching, Germany	Technical University of Munich	Hortsch, SK (corresponding author), Tech Univ Munich, Fac Mech Engn, Syst Biotechnol, Garching, Germany.	sayuri.Hortsch@tum.de			German Ministry of Education and Research (BMBF) through the e:bio initiative [031A299C]	German Ministry of Education and Research (BMBF) through the e:bio initiative(Federal Ministry of Education & Research (BMBF))	SKH was funded by the German Ministry of Education and Research (BMBF) through the e:bio initiative (grant number: 031A299C).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chen M, 2013, ACS SYNTH BIOL, V2, P587, DOI 10.1021/sb400044g; Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; Guisoni N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151086; Gutierrez PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044812; Hahl SK, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00157; Hasenauer J, 2014, J MATH BIOL, V69, P687, DOI 10.1007/s00285-013-0711-5; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Jahnke T, 2011, MULTISCALE MODEL SIM, V9, P1646, DOI 10.1137/110821500; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kierzek AM, 2001, J BIOL CHEM, V276, P8165, DOI 10.1074/jbc.M006264200; Leisner M, 2008, CURR OPIN MICROBIOL, V11, P553, DOI 10.1016/j.mib.2008.09.020; Lin YK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/234245; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Reck M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005353; Singh A, 2011, IEEE T NANOBIOSCI, V10, P194, DOI 10.1109/TNB.2011.2168826; Son MJ, 2012, MOL MICROBIOL, V86, P258, DOI 10.1111/j.1365-2958.2012.08187.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas P, 2012, COMPUTATION BIOCH PA; Thomas P, 2014, P NATL ACAD SCI USA, V111, P6994, DOI 10.1073/pnas.1400049111; Tomioka R, 2004, J THEOR BIOL, V229, P501, DOI 10.1016/j.jtbi.2004.04.034; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wang LM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000764	39	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194779	10.1371/journal.pone.0194779	http://dx.doi.org/10.1371/journal.pone.0194779			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579101	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800053
J	Araujo, IJD; de Paula, AB; Alonso, RCB; Taparelli, JR; Mei, LHI; Stipp, RN; Puppin-Rontani, RM				de Souza Araujo, Isaac Jordao; de Paula, Andreia Bolzan; Bruschi Alonso, Roberta Caroline; Taparelli, Jesus Roberto; Innocentini Mei, Lucia Helena; Stipp, Rafael Nobrega; Puppin-Rontani, Regina Maria			A novel Triclosan Methacrylate-based composite reduces the virulence of Streptococcus mutans biofilm	PLOS ONE			English	Article							DENTAL RESTORATIVE MATERIALS; MOLECULAR-GENETICS; CALCIUM-PHOSPHATE; EXPRESSION; BIODEGRADATION; ANTIBACTERIAL; CHLORHEXIDINE; COMPONENTS; RESINS; GLUCOSYLTRANSFERASE	The use of antimicrobial monomers, linked to the polymer chain of resin composites, is an interesting approach to circumvent the effects of bacteria on the dental and material surfaces. In addition, it can likely reduce the incidence of recurrent caries lesions. The aim of this study was to evaluate the effects of a novel Triclosan Methacrylate (TM) monomer, which was developed and incorporated into an experimental resin composite, on Streptococcus mutans (S. mutans) biofilms, focusing on the analyses of vicR, gtfD, gtfC, covR, and gbpB gene expression, cell viability and biofilm characteristics. The contact time between TM-composite and S. mutans down-regulated the gbpB and covR and up-regulated the gtfC gene expression, reduced cell viability and significantly decreased parameters of the structure and characteristics of S. mutans biofilm virulence. The presence of Triclosan Methacrylate monomer causes harmful effects at molecular and cellular levels in S. mutans, implying a reduction in the virulence of those microorganisms.	[de Souza Araujo, Isaac Jordao; de Paula, Andreia Bolzan] Univ Estadual Campinas, Piracicaba Dent Sch, Dent Mat Div, Operat Dent Dept, Piracicaba, SP, Brazil; [Bruschi Alonso, Roberta Caroline] Metropolitan Univ Santos UNIMES, Sch Dent, Dept Dent, Santos, SP, Brazil; [Bruschi Alonso, Roberta Caroline] Univ Mogi das Cruzes, Sch Dent, Technol Res Ctr, Mogi das Cruzes, Brazil; [Taparelli, Jesus Roberto; Innocentini Mei, Lucia Helena] Univ Estadual Campinas, Chem Engn Sch, Dept Mat Engn & Bioproc, Campinas, SP, Brazil; [Stipp, Rafael Nobrega] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Oral Diag, Piracicaba, SP, Brazil; [Puppin-Rontani, Regina Maria] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Pediat Dent, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Mogi das Cruzes; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Puppin-Rontani, RM (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Pediat Dent, Sao Paulo, Brazil.	rmpuppin@fop.unicamp.br	PUPPIN-RONTANI, regina/AAM-9962-2020; Stipp, Rafael Nobrega/D-4518-2011; PUPPIN-RONTANI, REGINA/GVS-2045-2022; PUPPIN-RONTANI, regina/C-3994-2012; de Souza Araújo, Isaac Jordao/P-6068-2017	PUPPIN-RONTANI, regina/0000-0002-1218-5159; Stipp, Rafael Nobrega/0000-0001-5305-1299; PUPPIN-RONTANI, regina/0000-0002-1218-5159; de Souza Araújo, Isaac Jordao/0000-0002-1795-8640	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [AUXPE/CAPES/PROEX - 1777/2014]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/10750-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors received funding only for research project development from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (AUXPE/CAPES/PROEX - 1777/2014) and from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - (#2012/10750-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.capes.gov.br/. http://www.fapesp.br/; Authors thank FAPESP (#2012/10750-4) and CAPES/PROEX/AUXPE-1777/2014 for financial support, and also thank Jeremy Matis for language revision and editing.	Anusavice KJ, 2006, J DENT RES, V85, P950, DOI 10.1177/154405910608501016; Anusavice KJ, 2005, J DENT RES, V84, P440, DOI 10.1177/154405910508400508; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Cheng L, 2012, DENT MATER, V28, P853, DOI 10.1016/j.dental.2012.04.024; Cheng L, 2012, DENT MATER, V28, P573, DOI 10.1016/j.dental.2012.01.006; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Rodolpho PAD, 2011, DENT MATER, V27, P955, DOI 10.1016/j.dental.2011.06.001; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Eick S, 2004, J ORAL REHABIL, V31, P278, DOI 10.1046/j.0305-182X.2003.01233.x; Gharechahi M., 2012, J BIOMATER NANOBIOTE, V03, P541, DOI DOI 10.4236/JBNB.2012.324056; Imazato S, 2014, DENT MATER, V30, P97, DOI 10.1016/j.dental.2013.06.003; Junker LM, 2004, J ANTIMICROB CHEMOTH, V53, P989, DOI 10.1093/jac/dkh196; Kawai K, 2001, OPER DENT, V26, P396; Kawai K, 2000, J BIOMED MATER RES, V51, P123, DOI 10.1002/(SICI)1097-4636(200007)51:1<123::AID-JBM16>3.0.CO;2-7; Khalichi P, 2004, BIOMATERIALS, V25, P5467, DOI 10.1016/j.biomaterials.2003.12.056; Khalichi P, 2009, BIOMATERIALS, V30, P452, DOI 10.1016/j.biomaterials.2008.09.053; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; Meereis CTW, 2014, DENT MATER, V30, P945, DOI 10.1016/j.dental.2014.05.020; Mjor IA, 2000, INT DENT J, V50, P361; Opdam NJM, 2010, J DENT RES, V89, P1063, DOI 10.1177/0022034510376071; Padovani GC, 2014, OPER DENT, V39, P349, DOI 10.2341/13-089-C; Padovani GC, 2015, AM J DENT, V28, P3; Petersen RC, 2016, AIMS MOL SCI, V3, P88, DOI 10.3934/molsci.2016.1.88; Phan TN, 2006, CAN J MICROBIOL, V52, P977, DOI 10.1139/W06-055; Polydorou O, 2007, DENT MATER, V23, P1535, DOI 10.1016/j.dental.2006.12.011; de Fucio SBP, 2009, AM J DENT, V22, P131; Santerre JP, 1999, J DENT RES, V78, P1459, DOI 10.1177/00220345990780081201; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Singh J, 2009, J BIOMED MATER RES A, V88A, P551, DOI 10.1002/jbm.a.31879; Song F, 2015, J DENT RES, V94, P1027, DOI 10.1177/0022034515587690; Spencer Paulette, 2012, Braz Dent Sci, V15, P4; Steinberg D, 2002, J DENT, V30, P47, DOI 10.1016/S0300-5712(01)00058-6; Stipp RN, 2013, PLOS ONE, P8; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; Whillerhausen B, 1999, INT DENT J, P231; Zhang JF, 2014, J DENT RES, V93, P1283, DOI 10.1177/0022034514555143	39	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195244	10.1371/journal.pone.0195244	http://dx.doi.org/10.1371/journal.pone.0195244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608622	Green Submitted, Green Published, gold			2022-12-27	WOS:000428988800042
J	Li, LH; Yu, NH; Chan, CY; Lee, WB				Li, L. H.; Yu, N. H.; Chan, C. Y.; Lee, W. B.			Al6061 surface roughness and optical reflectance when machined by single point diamond turning at a low feed rate	PLOS ONE			English	Article								Ultra-precision face turning of Al6061 mirrors using single point diamond turning (SPDT) was undertaken to investigate the correlation between the surface roughness and reflectance. By reducing the feed rate, the optimal feed rate when the chip formation became unstable was studied. Most importantly, the impact on the roughness and reflectance was examined when the chip formation ceased to be continuous. It was determined that for a feed rate below 3 mm/min, the surface roughness always improved as the feed rate decreased, at the cost of a reduction of the normalized reflectance. The reduction of reflectance was determined to be the result of the lower material removal rates that led to a discontinuous chip formation.	[Li, L. H.; Yu, N. H.; Chan, C. Y.; Lee, W. B.] Hong Kong Polytech Univ, State Key Lab Ultraprecis Machining Technol, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China; [Li, L. H.; Yu, N. H.; Chan, C. Y.; Lee, W. B.] Hong Kong Polytech Univ, Shenzhen Res Inst, Shenzhen Branch, State Key Lab Ultra Precis Machining Technol, Shenzhen, Peoples R China	Hong Kong Polytechnic University; China Construction Bank; Hong Kong Polytechnic University	Yu, NH (corresponding author), Hong Kong Polytech Univ, State Key Lab Ultraprecis Machining Technol, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.; Yu, NH (corresponding author), Hong Kong Polytech Univ, Shenzhen Res Inst, Shenzhen Branch, State Key Lab Ultra Precis Machining Technol, Shenzhen, Peoples R China.	yudadashi@gmail.com		ninghui, yu/0000-0002-0832-921X	RTRB from The Hong Kong Polytechnic University; Shenzhen Fundamental Research fund [JCYJ20160331185006518]	RTRB from The Hong Kong Polytechnic University; Shenzhen Fundamental Research fund	This study was supported by grant number RTRB from The Hong Kong Polytechnic University to N.H. Yu (https://www.polyu.edu.hk/web/en/home/index.html), and this work is partially supported by Shenzhen Fundamental Research fund (JCYJ20160331185006518). I accept to publish this information with my article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2017, PRECIS ENG, V47, P397, DOI 10.1016/j.precisioneng.2016.09.013; [Anonymous], 2010, ASIAN J SCI RES; BENNETT HE, 1961, J OPT SOC AM, V51, P123, DOI 10.1364/JOSA.51.000123; Childs THC, 2015, PROC CIRP, V31, P270, DOI 10.1016/j.procir.2015.03.077; GINDELE K, 1985, APPL OPTICS, V24, P1757, DOI 10.1364/AO.24.001757; Hashmi S, 2014, COMPREHENSIVE MATERIALS PROCESSING, VOL 1: ASSESSING PROPERTIES OF CONVENTIONAL AND SPECIALIZED MATERIALS, pXXVII; Huang B., 2016, INT S OPT TECHN APPL; Jeon MW, 2016, INT J PRECIS ENG MAN, V17, P685, DOI 10.1007/s12541-016-0084-y; Ji SJ, 2016, STROJ VESTN-J MECH E, V62, P213, DOI 10.5545/sv-jme.2015.2528; Li L, 2010, J MANUF SCI E-T ASME, V132, DOI 10.1115/1.4001037; Mandal S, 2013, INT J OPTOMECHATRONI, V7, P244, DOI 10.1080/15599612.2013.879499; PEIPONEN KE, 1990, OPT LASER TECHNOL, V22, P127, DOI 10.1016/0030-3992(90)90022-V; Rahman MA, 2017, PRECIS ENG, V50, P393, DOI 10.1016/j.precisioneng.2017.06.014; Whitehouse D.J., 1994, HDB SURFACE METROLOG; WHITLEY JQ, 1987, OPT LASER TECHNOL, V19, P189, DOI 10.1016/0030-3992(87)90065-X; Yen YC, 2004, THESIS; Yonehara M, 2004, MATER TRANS, V45, P1027, DOI 10.2320/matertrans.45.1027; Zhang JB, 2017, CURR OPT PHOTONICS, V1, P364, DOI 10.3807/COPP.2017.1.4.364	18	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195083	10.1371/journal.pone.0195083	http://dx.doi.org/10.1371/journal.pone.0195083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608580	Green Submitted, gold, Green Published			2022-12-27	WOS:000428988800025
J	Menotta, M; Orazi, S; Gioacchini, AM; Spapperi, C; Ricci, A; Chessa, L; Magnani, M				Menotta, Michele; Orazi, Sara; Gioacchini, Anna Maria; Spapperi, Chiara; Ricci, Anastasia; Chessa, Luciana; Magnani, Mauro			Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; GENE-EXPRESSION; DNA-DAMAGE; NEUROLOGICAL SYMPTOMS; IONIZING-RADIATION; SIGNALING PATHWAYS; ATM PROTEIN; MUTATED ATM; SURVIVAL; AKT	Ataxia telangiectasia (A-T) is an incurable and rare hereditary syndrome. In recent times, treatment with glucocorticoid analogues has been shown to improve the neurological symptoms that characterize this condition, but the molecular mechanism of action of these analogues remains unknown. Hence, the aim of this study was to gain insight into the molecular mechanism of action of glucocorticoid analogues in the treatment of A-T by investigating the role of Dexamethasone (Dexa) in A-T lymphoblastoid cell lines. We used 2DE and tandem MS to identify proteins that were influenced by the drug in A-T cells but not in healthy cells. Thirty-four proteins were defined out of a total of 746 63. Transcriptome analysis was performed by microarray and showed the differential expression of 599 A-T and 362 wild type (WT) genes and a healthy un-matching between protein abundance and the corresponding gene expression variation. The proteomic and transcriptomic profiles allowed the network pathway analysis to pinpoint the biological and molecular functions affected by Dexamethasone in Dexa-treated cells. The present integrated study provides evidence of the molecular mechanism of action of Dexamethasone in an A-T cellular model but also the broader effects of the drug in other tested cell lines.	[Menotta, Michele; Orazi, Sara; Gioacchini, Anna Maria; Spapperi, Chiara; Ricci, Anastasia; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Chessa, Luciana] Sapienza Univ, Dept Clin & Mol Med, Rome, Italy	University of Urbino; Sapienza University Rome	Menotta, M (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.	michele.menotta@uniurb.it	Magnani, Mauro/A-1919-2008	Magnani, Mauro/0000-0001-6456-6626; Menotta, Michele/0000-0001-5206-6296	Sparks, A-T Society; Action for A-T [14SAP01]	Sparks, A-T Society; Action for A-T	This study was supported by Sparks, A-T Society and Action for A-T (grant ref. 14SAP01), https://www.sparks.org.uk/.; The study was supported by Sparks, A-T Society and Action for A-T (Grant ref. 14SAP01).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Biagiotti S, 2016, FEBS J, V283, P3962, DOI 10.1111/febs.13901; Biagiotti S, 2014, MOL CELL BIOCHEM, V392, P13, DOI 10.1007/s11010-014-2013-7; Boehrs JK, 2007, J NEUROCHEM, V100, P337, DOI 10.1111/j.1471-4159.2006.04254.x; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Broccoletti T, 2008, EUR J NEUROL, V15, P223, DOI 10.1111/j.1468-1331.2008.02060.x; Buoni S, 2006, ARCH NEUROL-CHICAGO, V63, P1479, DOI 10.1001/archneur.63.10.1479; Burns K, 1994, Trends Cell Biol, V4, P152; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Chaudhary MW, 2014, APPL CLIN GENET, V7, P159, DOI 10.2147/TACG.S35759; Cheema AK, 2013, RADIAT RES, V179, P674, DOI 10.1667/RR3198.1; Cheema AK, 2011, J PROTEOME RES, V10, P2651, DOI 10.1021/pr101243j; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chessa L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-5; Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015; D'Assante R, 2017, CLIN IMMUNOL, V175, P16, DOI 10.1016/j.clim.2016.11.015; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Fraser M, 2011, CELL CYCLE, V10, P2218, DOI 10.4161/cc.10.13.16305; Galat A, 2014, BIOCHEM BIOPH RES CO, V450, P1255, DOI 10.1016/j.bbrc.2014.06.105; Gudavicius G, 2013, BIOCHEM SOC T, V41, P761, DOI 10.1042/BST20130013; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35671; Koike M, 2015, J VET MED SCI, V77, P1137, DOI 10.1292/jvms.14-0651; Leuzzi V, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000098; Li Y, 2012, CHIN J CANCER, V31, P364, DOI 10.5732/cjc.012.10086; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Menotta M, 2018, MOL CELL BIOCHEM, V438, P153, DOI 10.1007/s11010-017-3122-x; Menotta M, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0669-2; Menotta M, 2017, CELL BIOCHEM BIOPHYS, V75, P95, DOI 10.1007/s12013-016-0775-0; Menotta M, 2012, J BIOL CHEM, V287, P41352, DOI 10.1074/jbc.M112.344473; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Tomimatsu N, 2007, J BIOL CHEM, V282, P10138, DOI 10.1074/jbc.M611880200; Toulany M, 2012, MOL CANCER RES, V10, P945, DOI 10.1158/1541-7786.MCR-11-0592; Toulany M, 2011, RADIOTHER ONCOL, V101, P140, DOI 10.1016/j.radonc.2011.06.004; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Wang ZY, 2013, AUTOPHAGY, V9, P925, DOI 10.4161/auto.24229; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zannolli R, 2012, MOVEMENT DISORD, V27, P1312, DOI 10.1002/mds.25126; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	54	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195388	10.1371/journal.pone.0195388	http://dx.doi.org/10.1371/journal.pone.0195388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608596	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800049
J	Zeng, JM; Jin, Y; Liu, ZC				Zeng, Jumei; Jin, Yun; Liu, Zhongchuan			Solution scattering study of the Bacillus subtilis PgdS enzyme involved in poly-gamma-glutamic acids degradation	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; SEQUENCE ALIGNMENT; POLYGLUTAMIC ACID; PROTEIN; RECOGNITION; PRODUCT; GENE; LYTF	The PgdS enzyme is a poly-gamma-glutamic (gamma-PGA) hydrolase, which has potential application for a controllable degradation of gamma-PGA by enzymatic depolymerization; however, the structure of PgdS is still unknown. Here, to study in detail the full-length PgdS structure, we analyze the low-resolution architecture of PgdS hydrolase from Bacillus subtilis in solution using small angle X-ray scattering (SAXS) method. Combining with other methods, like dynamic light scattering and mutagenesis analyses, a model for the full length structure and the possible substrate delivery route of PgdS are proposed. The results will provide useful hints for future investigations into the mechanisms of gamma-PGA degradation by the PgdS hydrolase and may provide valuable practical information.	[Zeng, Jumei; Jin, Yun; Liu, Zhongchuan] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Environm & Appl Microbiol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Liu, ZC (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Environm & Appl Microbiol, Chengdu, Sichuan, Peoples R China.	liuzhangch07@mails.ucas.ac.cn	jin, yun/GQZ-6618-2022	Liu, Zhongchuan/0000-0003-0806-4319	National Natural Science Foundation of China (NSFC) [31400040, 31700664]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Grants from National Natural Science Foundation of China (NSFC) (NO.31400040, NO.31700664). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Arai R, 2012, J BIOL CHEM, V287, P44736, DOI 10.1074/jbc.M112.414763; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Bajaj I, 2011, BIORESOURCE TECHNOL, V102, P5551, DOI 10.1016/j.biortech.2011.02.047; Bhat AR, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-36; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cao MF, 2011, BIORESOURCE TECHNOL, V102, P4251, DOI 10.1016/j.biortech.2010.12.065; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fujimoto Z, 2012, PROTEINS, V80, P722, DOI 10.1002/prot.23229; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Huang J, 2011, ENG LIFE SCI, V11, P291, DOI 10.1002/elsc.201000133; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levy-Assaraf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056138; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Li N, 2016, J APPL CRYSTALLOGR, V49, P1428, DOI 10.1107/S160057671601195X; Peng YY, 2015, PROCESS BIOCHEM, V50, P329, DOI 10.1016/j.procbio.2014.12.024; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; Tanimoto H, 2007, J AM COLL NUTR, V26, P645, DOI 10.1080/07315724.2007.10719642; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wong JEMM, 2015, ACTA CRYSTALLOGR D, V71, P592, DOI 10.1107/S139900471402793X; Xu QP, 2014, J MOL BIOL, V426, P169, DOI 10.1016/j.jmb.2013.09.011; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yamamoto H, 2003, J BACTERIOL, V185, P6666, DOI 10.1128/JB.185.22.6666-6677.2003; Yan S, 2015, BIOTECHNOL PROGR, V31, P1287, DOI 10.1002/btpr.2118; Yao J, 2009, J MOL CATAL B-ENZYM, V56, P158, DOI 10.1016/j.molcatb.2007.12.027; Yu YY, 2016, FRONT MICROBIOL, V7; Zhao CF, 2013, APPL BIOCHEM BIOTECH, V170, P562, DOI 10.1007/s12010-013-0214-2	40	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e195355	10.1371/journal.pone.0195355	http://dx.doi.org/10.1371/journal.pone.0195355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608608	Green Submitted, Green Published, gold			2022-12-27	WOS:000428988800048
J	Amiri, E; Kryger, P; Meixner, MD; Strand, MK; Tarpy, DR; Rueppell, O				Amiri, Esmaeil; Kryger, Per; Meixner, Marina D.; Strand, Micheline K.; Tarpy, David R.; Rueppell, Olav			Quantitative patterns of vertical transmission of deformed wing virus in honey bees	PLOS ONE			English	Article							APIS-MELLIFERA; PARALYSIS VIRUS; SACBROOD VIRUS; VIRAL LOAD; ASSAY; INFECTION; IMMUNITY; ROUTES; HOST	Deformed wing virus (DWV) is an important pathogen in a broad range of insects, including honey bees. Concordant with the spread of Varroa, DWV is present in the majority of honey bee colonies and can result in either low-level infections with asymptomatic bees that nonetheless exhibit increased colony loss under stress, or high-level infections with acute effects on bee health and viability. DWV can be transmitted vertically or horizontally and evidence suggests that horizontal transmission via Varroa is associated with acute symptomatic infections. Vertical transmission also occurs and is presumably important for the maintenance of DWV in honey bee populations. To further our understanding the vertical transmission of DWV through queens, we performed three experiments: we studied the quantitative effectiveness of vertical transmission, surveyed the prevalence of successful egg infection under commercial conditions, and distinguished among three possible mechanisms of transmission. We find that queen-infection level predicts the DWV titers in their eggs, although the transmission is not very efficient. Our quantitative assessment of DWV demonstrates that eggs in 1/3 of the colonies are infected with DWV and highly infected eggs are rare in newly-installed spring colonies. Additionally, our results indicate that DWV transmission occurs predominantly by virus adhering to the surface of eggs (transovum) rather than intracellularly. Our combined results suggest that the queens' DWV vectoring capacity in practice is not as high as its theoretical potential. Thus, DWV transmission by honey bee queens is part of the DWV epidemic with relevant practical implications, which should be further studied.	[Amiri, Esmaeil; Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Amiri, Esmaeil; Kryger, Per] Aarhus Univ, Dept Agroecol, Slagelse, Denmark; [Amiri, Esmaeil; Tarpy, David R.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Meixner, Marina D.] Landesbetrieb Landwirtschaft Hessen, Bieneninst Kirchhain, Kirchhain, Germany; [Strand, Micheline K.] US Army, Res Off, Life Sci Div, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Greensboro; Aarhus University; University of North Carolina; North Carolina State University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Amiri, E (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.; Amiri, E (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.; Amiri, E (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.	e.amiri79@gmail.com	Meixner, Marina/ABD-6400-2021; Kryger, Per/H-4600-2019; Rueppell, Olav/G-2679-2010	Meixner, Marina/0000-0002-7785-4894; Kryger, Per/0000-0001-5306-3230; Rueppell, Olav/0000-0001-5370-4229; Tarpy, David/0000-0001-8601-6094; Amiri, Esmaeil/0000-0001-8536-5815				Amiri E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33065; Amiri E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140272; Benaets K, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2149; Blanchard P, 2007, J VIROL METHODS, V141, P7, DOI 10.1016/j.jviromet.2006.11.021; Blanchard P, 2014, J VIROL METHODS, V197, P7, DOI 10.1016/j.jviromet.2013.09.012; Boncristiani HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073429; Brosi BJ, 2017, NAT ECOL EVOL, V1, P1250, DOI 10.1038/s41559-017-0246-z; Buchler R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.07; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen YP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004261; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Delaplane KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142985; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Fievet J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-16; Forsgren E, 2009, EXP APPL ACAROL, V47, P87, DOI 10.1007/s10493-008-9204-4; Forzan M, 2017, B INSECTOL, V70, P261; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Francis RM, 2013, J GEN VIROL, V94, P668, DOI 10.1099/vir.0.047019-0; Francis RM, 2012, J APIC SCI, V56, P137, DOI 10.2478/v10289-012-0014-x; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Glenny William, 2017, PLoS One, V12, pe0182814, DOI 10.1371/journal.pone.0182814; Kevill JL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110314; Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; McMahon DP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0811; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; McMenamin AJ, 2015, CURR OPIN INSECT SCI, V8, P121, DOI 10.1016/j.cois.2015.01.015; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Oldroyd BP, 2008, TRENDS ECOL EVOL, V23, P59, DOI 10.1016/j.tree.2007.10.012; Ravoet J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0386-9; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sebastien A, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0610; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Simone-Finstrom M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1007; Tarpy DR, 2013, NATURWISSENSCHAFTEN, V100, P723, DOI 10.1007/s00114-013-1065-y; Tentcheva D, 2006, APIDOLOGIE, V37, P41, DOI 10.1051/apido:2005057; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Yanez O, 2012, APIDOLOGIE, V43, P17, DOI 10.1007/s13592-011-0088-7; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zhang X, 2012, J INVERTEBR PATHOL, V109, P156, DOI 10.1016/j.jip.2011.09.010	55	25	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195283	10.1371/journal.pone.0195283	http://dx.doi.org/10.1371/journal.pone.0195283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596509	gold, Green Submitted, Green Published			2022-12-27	WOS:000428630000103
J	Bastien, R; Guayasamin, O; Douady, S; Moulia, B				Bastien, Renaud; Guayasamin, Olivia; Douady, Stephane; Moulia, Bruno			Coupled ultradian growth and curvature oscillations during gravitropic movement in disturbed wheat coleoptiles	PLOS ONE			English	Article							STIMULATION ANGLE; INDOLEACETIC-ACID; CORN COLEOPTILES; POSTURE CONTROL; AUXIN; PLANTS; QUANTIFICATION; ARABIDOPSIS; HYPOCOTYLS; DEPENDENCE	To grow straight and upright, plants need to regulate actively their posture. Gravitropic movement, which occurs when plants modify their growth and curvature to orient their aerial organ against the force of gravity, is a major feature of this postural control. A recent model has shown that graviception and proprioception are sufficient to account for the gravitropic movement and subsequent organ posture demonstrated by a range of species. However, some plants, including wheat coleoptiles, exhibit a stronger regulation of posture than predicted by the model. Here, we performed an extensive kinematics study on wheat coleoptiles during a gravitropic perturbation (tilting) experiment in order to better understand this unexpectedly strong regulation. Close temporal observations of the data revealed that both perturbed and unperturbed coleoptiles showed oscillatory pulses of elongation and curvature variation that propagated from the apex to the base of their aerial organs. In perturbed coleoptiles, we discovered a non-trivial coupling between the oscillatory dynamics of curvature and elongation. The relationship between those oscillations and the postural control of the organ remains unclear, but indicates the presence of a mechanism that is capable of affecting the relationship between elongation rate, differential growth, and curvature.	[Bastien, Renaud; Guayasamin, Olivia] Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany; [Bastien, Renaud; Guayasamin, Olivia] Univ Konstanz, Dept Biol, Constance, Germany; [Guayasamin, Olivia] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Douady, Stephane] Univ Paris Diderot, Matiere & Syst Complexes, F-75205 Paris 13, France; [Moulia, Bruno] UCA, INRA, UMR PIAF, F-63000 Clermont Ferrand, France	Max Planck Society; University of Konstanz; Princeton University; UDICE-French Research Universities; Universite Paris Cite; INRAE	Bastien, R (corresponding author), Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany.; Bastien, R (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	rbastien@orn.mpg.de	DOUADY, Stephane/C-4498-2018	DOUADY, Stephane/0000-0002-3416-886X				Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Baskin TI, 2006, RYTHMS IN PLANTS, P3; Bastien R, 2017, GROWTH WHEAT COLEOPT; Bastien R, 2017, GRAVITROPISM WHEAT C; Bastien R, 2017, OSCILLATORY MOVEMENT; Bastien R, 2016, PLOS COMPUTATIONAL B, V12, P1, DOI DOI 10.1371/J0URNAL.PCBI.1005238); Bastien R, 2016, PLANT J, V88, P468, DOI 10.1111/tpj.13255; Bastien R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004037; Bastien R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00136; Bastien R, 2013, P NATL ACAD SCI USA, V110, P755, DOI 10.1073/pnas.1214301109; Basu P, 2007, PLANT PHYSIOL, V145, P305, DOI 10.1104/pp.107.103226; BERG AR, 1992, AM J BOT, V79, P77, DOI 10.2307/2445200; Chavarria-Krauser A, 2008, NEW PHYTOL, V177, P811, DOI 10.1111/j.1469-8137.2007.02299.x; COSGROVE DJ, 1990, PLANT CELL ENVIRON, V13, P227, DOI 10.1111/j.1365-3040.1990.tb01307.x; Galland P, 2002, PLANTA, V215, P779, DOI 10.1007/s00425-002-0813-6; GOLDSMITH MH, 1967, PLANT PHYSIOL, V42, P258, DOI 10.1104/pp.42.2.258; Hamant O, 2016, NEW PHYTOLOGIST; Iino M, 1996, PLANT CELL ENVIRON, V19, P1160, DOI 10.1111/j.1365-3040.1996.tb00431.x; Kramer EM, 2011, TRENDS PLANT SCI, V16, P461, DOI 10.1016/j.tplants.2011.05.003; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Moulia B, 2006, AM J BOT, V93, P1477, DOI 10.3732/ajb.93.10.1477; Moulia B, 2009, J EXP BOT, V60, P461, DOI 10.1093/jxb/ern341; Nick P, 2010, PLANT SIGNAL BEHAV, V5, P94, DOI 10.4161/psb.5.2.10337; Philippar K, 1999, P NATL ACAD SCI USA, V96, P12186, DOI 10.1073/pnas.96.21.12186; SHENMILLER J, 1973, PLANT PHYSIOL, V51, P615, DOI 10.1104/pp.51.4.615; SHENMILLER J, 1973, PLANT PHYSIOL, V52, P166, DOI 10.1104/pp.52.2.166; SILK WK, 1984, ANNU REV PLANT PHYS, V35, P479, DOI 10.1146/annurev.pp.35.060184.002403; Tarui Y, 1997, PLANT CELL PHYSIOL, V38, P1346, DOI 10.1093/oxfordjournals.pcp.a029128; Walter A, 2002, J EXP BOT, V53, P689, DOI 10.1093/jexbot/53.369.689	31	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194893	10.1371/journal.pone.0194893	http://dx.doi.org/10.1371/journal.pone.0194893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596500	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000047
J	Ling, L; Jiang, Y; Meng, JJ; Cai, LM; Cao, GC				Ling, Lin; Jiang, Yang; Meng, Jiao Jing; Cai, Li Ming; Cao, Gui Cou			Phloem transport capacity of transgenic rice T1c-19 (Cry1C*) under several potassium fertilizer levels	PLOS ONE			English	Article							DIFFERENTIAL RESPONSES; VASCULAR BUNDLE; HIGHER-PLANTS; QTL ANALYSIS; YIELD; PANICLE; COTTON; LINES; CULTIVAR; GROWTH	Genetic modification of Cry-proteins from Bacillus thuringiensis (Bt) is a common practice in economically important crops to improve insecticide resistance and reduce the use of pesticides. However, introduction of these genes can have unintended side effects, which should be closely monitored for effective breeding and crop management. To determine the potential cause of these negative effects, we explored assimilate partitioning in the transgenic Bt rice line T1c-19 (Cry1C*), which was compared with that of its wild-type counterpart Minghui 63 (MH63) under different potassium fertilization application treatment conditions. In a pot experiment, 0, 0.4, and 0.6 g K2O was applied per kg of dry soil to determine the phloem transport characteristics of the two rice lines. We used a variety of assessment indicators ranging from morphological to physiological aspects, including the number of large and small vascular bundles in the neck internode at the heading stage, the diameter and bleeding intensity of the neck internode at the filling stage, and the content and apparent ratio of transferred non-structural carbohydrates (NSC) in the culm and sheath from the heading to maturing stages. The K utilization and grain yield at the maturing stage were also concerned. Results presented that the mean setting rate and grain yield of T1c-19 (Cry1C*) decreased by 22.3% and 26.2% compared to those in MH63, respectively. Compared to MH63, the K concentration and accumulation were significantly higher in the culms and leaves, but significantly lower in grain of T1c-19 (Cry1C*). T1c-19 (Cry1C*) had less apparent NSC efflux in the culm and sheath, fewer small vascular bundles, and a smaller diameter and bleeding intensity of the neck internode than MH63. In addition, linear correlation analysis indicated that there were positive correlations among grain yield, setting rate, the apparent NSC efflux in the culm and sheath, number of small vascular bundles, and the neck internode diameter and bleeding intensity. These unintended effects may directly or indirectly be caused by insertion of exogenous Bt (Cry1C*) gene, which should be further considered in the future breeding of transgenic crops.	[Ling, Lin; Jiang, Yang; Meng, Jiao Jing; Cai, Li Ming; Cao, Gui Cou] Huazhong Agr Univ, Minist Agr, Key Lab Crop Physiol Ecol & Cultivat Middle Reach, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Jiang, Y (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Crop Physiol Ecol & Cultivat Middle Reach, Wuhan, Hubei, Peoples R China.	jiangyang@webmail.hzau.edu.cn						Ansari TH, 2004, SOIL SCI PLANT NUTR, V50, P57, DOI 10.1080/00380768.2004.10408452; Chen LY, 2006, AM J BOT, V93, P94, DOI 10.3732/ajb.93.1.94; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Cowling WA, 2007, FIELD CROP RES, V104, P103, DOI 10.1016/j.fcr.2006.12.014; Coz I, 2008, J ENVIRON QUAL, V37, P647, DOI 10.2134/jeq2007.0352; Dingkuhn M, 2015, FIELD CROP RES, V182, P43, DOI 10.1016/j.fcr.2015.05.025; Guo RQ, 2011, PHOTOSYNTHETICA, V49, P507, DOI 10.1007/s11099-011-0060-9; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Jia Q, 2005, SCI AGR SINICA, V38, P73; Jia Q, 2004, ACTA AGR ZHEJIANGENS, V17, P39; Jiang Y, 2013, FIELD CROP RES, V151, P101, DOI 10.1016/j.fcr.2013.06.017; Kasturikasen Beura, 2013, Open Journal of Ecology, V3, P505, DOI 10.4236/oje.2013.38059; Kato T, 2004, J AGR SCI, V142, P177, DOI 10.1017/S0021859604004265; Kato T, 1996, CROP SCI, V36, P1135, DOI 10.2135/cropsci1996.0011183X003600050011x; LEIGH RA, 1984, NEW PHYTOL, V97, P1, DOI 10.1111/j.1469-8137.1984.tb04103.x; Liu GL, 2008, PLANT SCI, V174, P71, DOI 10.1016/j.plantsci.2007.09.011; Liu W, 2004, PESTICIDES; Lundegardh H., 1995, MECH ABSORPTION TRAN, V6, P1; LYNCH PT, 1995, EUPHYTICA, V85, P395, DOI 10.1007/BF00023972; Morita S, 2011, CROP SCI, V51, P818, DOI 10.2135/cropsci2010.06.0373; OPARKA KJ, 1981, PLANTA, V151, P561, DOI 10.1007/BF00387436; Pan JF, 2011, PHYSIOL PLANTARUM, V141, P321, DOI 10.1111/j.1399-3054.2010.01441.x; RAVEN JA, 1976, NEW PHYTOL, V76, P415, DOI 10.1111/j.1469-8137.1976.tb01477.x; Sanvido O, 2007, ADV BIOCHEM ENG BIOT, V107, P235, DOI 10.1007/10_2007_048; Shu QY, 2002, EUPHYTICA, V127, P345, DOI 10.1023/A:1020358617257; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Teng S, 2002, ACTA BOT SIN, V44, P301; Terai K., 2008, Japanese Journal of Crop Science, V77, P191, DOI 10.1626/jcs.77.191; Wang F, 2012, FIELD CROP RES, V126, P8, DOI 10.1016/j.fcr.2011.09.017; Wang M, 2013, INT J MOL SCI, V14, P7390; Wang Y., 2003, PRACTICAL HDB REFERE, P16; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; WARD G. M., 1960, Canadian Journal of Plant Science, V40, P729; Wu LL, 2011, AUST J CROP SCI, V5, P1356; Xia H, 2010, FIELD CROP RES, V118, P215, DOI 10.1016/j.fcr.2010.05.008; Xu Z, 1998, ACTA AGRONOMICA SINI, V1; Xu ZhengJin, 1996, Acta Agronomica Sinica, V22, P167; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; YUKUI R, 2009, PLANT BIOSYST, V143, P137, DOI DOI 10.1080/11263500802709731; Zhang BL, 2010, PLANT PROD SCI, V13, P279, DOI 10.1626/pps.13.279; Zhang ZY, 2007, J PLANT NUTR, V30, P659, DOI 10.1080/01904160701289206; Zhao Q., 1999, SCI AGR SINICA; [左开井 Zuo Kaijing], 2003, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University], V32, P409	44	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195058	10.1371/journal.pone.0195058	http://dx.doi.org/10.1371/journal.pone.0195058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596474	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000073
J	Blanco-Gandia, MC; Minarro, J; Aguilar, MA; Rodriguez-Arias, M				Carmen Blanco-Gandia, M.; Minarro, Jose; Asuncion Aguilar, Maria; Rodriguez-Arias, Marta			Increased ethanol consumption after interruption of fat bingeing	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; EATING-DISORDERS; GENE-EXPRESSION; NEUROBIOLOGICAL MECHANISMS; NATIONAL COMORBIDITY; INTERMITTENT ACCESS; SEEKING BEHAVIOR; REWARD; DIET; RAT	There is a marked comorbidity between alcohol abuse and eating disorders, especially in the young population. We have previously reported that bingeing on fat during adolescence increases the rewarding effects of ethanol (EtOH). The aim of the present work was to study if vulnerability to EtOH persists after cessation of binge eating. OF1 mice binged on fat (HFB: high-fat binge) during adolescence (PND 25-43) and were tested for 15 days after the last access to HFB (on PND 59) using the self-administration paradigm, the conditioned place preference (CPP) and locomotor sensitization to ethanol. Our results showed that after 15 days of cessation of fat ingestion, mice increased their consumption of ethanol and showed greater motivation to obtain ethanol. On the other hand, no effects were observed in the CPP, while an increased locomotor response to ethanol was detected. The present results confirm and extend our previous study demonstrating that the compulsive intake of fat induces long-lasting effects on the reward system that lead to an increased consumption of EtOH.	[Carmen Blanco-Gandia, M.; Minarro, Jose; Asuncion Aguilar, Maria; Rodriguez-Arias, Marta] Univ Valencia, Fac Psicol, Dept Psicobiol, Unidad Invest Psicobiol Drogodependenc, Valencia, Spain	University of Valencia	Rodriguez-Arias, M (corresponding author), Univ Valencia, Fac Psicol, Dept Psicobiol, Unidad Invest Psicobiol Drogodependenc, Valencia, Spain.	marta.rodriguez@uv.es	Rodriguez-Arias, Marta/B-5163-2011; Minarro, Jose/B-4414-2011; Blanco-Gandia, M.Carmen/M-1538-2014	Minarro, Jose/0000-0002-5731-7821; Rodriguez-Arias, Marta/0000-0002-1121-8879; Blanco-Gandia, M.Carmen/0000-0001-5990-1266	Ministerio de Sanidad, Servicios Sociales e Igualdad; Delegacion del Gobierno para el Plan Nacional Sobre Drogas, Proyectos de Investigacion sobre Drogodependencias [2014I007]; Generalitat Valenciana [PROMETEOII/2014/063]; Ministerio de Economia y Competitividad (MINECO), Institute de Salud Carlos III, Red de Trastornos Adictivos (RTA) [RD12/0028/0005, RD16/0017/0007]; Union Europea; Fondos FEDER "una manera de hacer Europa";  [PSI2014-51847-R]	Ministerio de Sanidad, Servicios Sociales e Igualdad(Spanish Government); Delegacion del Gobierno para el Plan Nacional Sobre Drogas, Proyectos de Investigacion sobre Drogodependencias; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Economia y Competitividad (MINECO), Institute de Salud Carlos III, Red de Trastornos Adictivos (RTA); Union Europea; Fondos FEDER "una manera de hacer Europa"; 	This work was supported by the Ministerio de Sanidad, Servicios Sociales e Igualdad. Delegacion del Gobierno para el Plan Nacional Sobre Drogas, Proyectos de Investigacion sobre Drogodependencias, 2014I007; Generalitat Valenciana, PROMETEOII/2014/063; Ministerio de Economia y Competitividad (MINECO), Institute de Salud Carlos III, Red de Trastornos Adictivos (RTA) RD12/0028/0005 y RD16/0017/0007 and Union Europea, Fondos FEDER "una manera de hacer Europa", and PSI2014-51847-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger H, 2013, PEDIATR REV, V34, P103, DOI 10.1542/pir.34-3-103; Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; Avena NA, 2004, ALCOHOL, V34, P203, DOI 10.1016/j.alcohol.2004.09.006; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2007, EXP CLIN PSYCHOPHARM, V15, P481, DOI 10.1037/1064-1297.15.5.481; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Baladi MG, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv024; Baladi MG, 2012, NEUROPHARMACOLOGY, V63, P76, DOI 10.1016/j.neuropharm.2012.02.005; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Bekker L, 2014, BEHAV BRAIN RES, V270, P108, DOI 10.1016/j.bbr.2014.04.050; Bello NT, 2003, AM J PHYSIOL-REG I, V284, pR1260, DOI 10.1152/ajpregu.00716.2002; Brown SA, 2008, PEDIATRICS, V121, pS290, DOI 10.1542/peds.2007-2243D; Carlin JL, 2016, NEUROSCIENCE, V326, P170, DOI 10.1016/j.neuroscience.2016.04.002; Ledesma JC, 2013, PSYCHOPHARMACOLOGY, V226, P673, DOI 10.1007/s00213-012-2831-9; Blanco-Gandia MC, 2017, PSYCHOPHARMACOLOGY, V234, P2337, DOI 10.1007/s00213-017-4630-9; Blanco-Gandia MC, 2017, NEUROPHARMACOLOGY, V121, P219, DOI 10.1016/j.neuropharm.2017.04.040; Blanco-Gandia MC, 2017, NEUROPHARMACOLOGY, V113, P31, DOI 10.1016/j.neuropharm.2016.09.020; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Corwin R. L., 2006, CURRENT PROTOCOLS NE, V36, P1, DOI [10.1002/0471142301.ns0923bs36, DOI 10.1002/0471142301.NS0923BS36]; Corwin RL, 1998, PHYSIOL BEHAV, V65, P545, DOI 10.1016/S0031-9384(98)00201-7; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Cottone P, 2008, AM J PHYSIOL-REG I, V295, pR1066, DOI 10.1152/ajpregu.90309.2008; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; Cruz JAA, 2000, EUR J CLIN NUTR, V54, pS29, DOI 10.1038/sj.ejcn.1600981; Davis C, 2009, APPETITE, V53, P1, DOI 10.1016/j.appet.2009.05.018; Daws LC, 2011, NEUROPHARMACOLOGY, V61, P1123, DOI 10.1016/j.neuropharm.2011.02.028; Degenhardt L, 2009, PSYCHOL MED, V39, P157, DOI 10.1017/S0033291708003425; Didone V, 2016, ADDICT BIOL, V21, P387, DOI 10.1111/adb.12216; Ganji V, 1995, EUR J CLIN NUTR, V49, P915; Gold MS, 2011, PHYSIOL BEHAV, V104, P157, DOI 10.1016/j.physbeh.2011.04.027; Gold MS, 2003, PSYCHIAT ANN, V33, P117, DOI 10.3928/0048-5713-20030201-08; Gosnell BA, 2005, BRAIN RES, V1031, P194, DOI 10.1016/j.brainres.2004.10.037; Groblewski PA, 2008, PSYCHOPHARMACOLOGY, V201, P97, DOI 10.1007/s00213-008-1251-3; Guerri C, 2002, NEUROTOX RES, V4, P327, DOI 10.1080/1029842021000010884; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Herpertz-Dahlmann B, 2015, CHILD ADOL PSYCH CL, V24, P177, DOI 10.1016/j.chc.2014.08.003; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Jonsson S, 2014, ALCOHOL CLIN EXP RES, V38, P722, DOI 10.1111/acer.12307; Klump KL, 2013, HORM BEHAV, V64, P399, DOI 10.1016/j.yhbeh.2013.02.019; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Martire SI, 2014, BEHAV BRAIN RES, V265, P132, DOI 10.1016/j.bbr.2014.02.027; Matson LM, 2013, ADDICT BIOL, V18, P921, DOI 10.1111/j.1369-1600.2011.00412.x; Miquel M, 2003, EUR J NEUROSCI, V17, P2163, DOI 10.1046/j.1460-9568.2003.02646.x; Morales-Mulia M, 2012, BEHAV BRAIN RES, V235, P189, DOI 10.1016/j.bbr.2012.07.036; Murray S, 2014, NAT REV ENDOCRINOL, V10, P540, DOI 10.1038/nrendo.2014.91; NANCE DM, 1983, NEUROSCI BIOBEHAV R, V7, P189, DOI 10.1016/0149-7634(83)90015-5; Nasrallah NA, 2009, P NATL ACAD SCI USA, V106, P17600, DOI 10.1073/pnas.0906629106; Navarrete F, 2014, ADDICT BIOL, V19, P862, DOI 10.1111/adb.12058; Navarrete F, 2012, BRIT J PHARMACOL, V165, P260, DOI 10.1111/j.1476-5381.2011.01542.x; Oliva JM, 2008, EUR NEUROPSYCHOPHARM, V18, P373, DOI 10.1016/j.euroneuro.2007.09.001; Ortiz S, 2004, ALCOHOL ALCOHOLISM, V39, P88, DOI 10.1093/alcalc/agh036; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Pina MM, 2015, NEUROPHARMACOLOGY, V99, P627, DOI 10.1016/j.neuropharm.2015.08.033; Puhl MD, 2011, BEHAV NEUROSCI, V125, P930, DOI 10.1037/a0025759; Roberts AJ, 1998, ALCOHOL CLIN EXP RES, V22, P1564, DOI 10.1111/j.1530-0277.1998.tb03950.x; Roberts AJ, 2001, ALCOHOL CLIN EXP RES, V25, P1249, DOI 10.1111/j.1530-0277.2001.tb02344.x; SAMSON HH, 1986, ALCOHOL CLIN EXP RES, V10, P436, DOI 10.1111/j.1530-0277.1986.tb05120.x; Schneider M, 2008, ADDICT BIOL, V13, P253, DOI 10.1111/j.1369-1600.2008.00110.x; Sharma S, 2013, INT J OBESITY, V37, P1183, DOI 10.1038/ijo.2012.197; Sirohi S, 2017, PHARMACOL BIOCHEM BE, V153, P105, DOI 10.1016/j.pbb.2016.12.009; Spear LP, 2000, CURR DIR PSYCHOL SCI, V9, P111, DOI 10.1111/1467-8721.00072; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Sturman DA, 2011, J NEUROSCI, V31, P1471, DOI 10.1523/JNEUROSCI.4210-10.2011; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; Wojnicki FHE, 2007, PHYSIOL BEHAV, V92, P566, DOI 10.1016/j.physbeh.2007.05.002; Zghoul T, 2007, PSYCHOPHARMACOLOGY, V190, P13, DOI 10.1007/s00213-006-0592-z	72	4	4	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194431	10.1371/journal.pone.0194431	http://dx.doi.org/10.1371/journal.pone.0194431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590149	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100058
J	Kinoshita, A; Nara, K; Sasaki, H; Feng, B; Obase, K; Yang, ZL; Yamanaka, T				Kinoshita, Akihiko; Nara, Kazuhide; Sasaki, Hiromi; Feng, Bang; Obase, Keisuke; Yang, Zhu L.; Yamanaka, Takashi			Using mating-type loci to improve taxonomy of the Tuber indicum complex, and discovery of a new species, T. longispinosum	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; DISTANCE ANALYSIS; CHINESE TRUFFLES; TAIWAN; GENES; SEQUENCES; PSEUDOEXCAVATUM; RECOGNITION; MYCORRHIZAE; PERFORMANCE	Black truffles that morphologically resemble Tuber indicum have been known to occur in Japan since 1979. Our previous studies showed that there are two phylotypes of these truffles, both of which fell into the T. indicum complex (hereinafter "Tubersp. 6" and "Tuber sp. 7"). However, their taxonomic treatment is still unclear. In this study, we conducted morphological and phylogenetic analyses for a total of 52 specimens from Japan (16 Tuber sp. 6 and 13 Tubersp. 7), China (10 T. himalayense and 8 T. indicum), and Taiwan (5 T. formosanum). We compared ascospore ornamentation, size, distribution of asci with average number of spores per ascus, spine size and shape of the Japanese specimens with their allied taxa. For phylogenetic analysis, we sequenced two mating loci (MAT1-1-1 and MAT-12-1) and three commonly used loci (ITS, beta-tubulin, and TEF1-alpha). Three distinct lineages were recognized by phylogenetic analyses based on the sequences of the two mating related loci and three independent loci. The Tubersp. 6 sequences clustered with those of T. himalayense and T. formosanum, and there was no clear difference in morphology among them. Tubersp. 7 formed a distinct lineage in each phylogram. The specimens tended to have five-spored asci more frequently than other allied species and could be characterized as having ascospore ornamentation with longer spines and narrower spine bases. We therefore described Tubersp. 7 as a new species (T. longispinosum), and treat Tuber sp. 6 and T. formosanum as synonyms of T. himalayense.	[Kinoshita, Akihiko] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto, Kumamoto, Japan; [Nara, Kazuhide] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Sasaki, Hiromi] Mycologist Circle Japan, Fujisawa, Kanagawa, Japan; [Feng, Bang; Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Obase, Keisuke; Yamanaka, Takashi] Forestry & Forest Prod Res Inst, Dept Mushroom Sci & Forest Microbiol, Tsukuba, Ibaraki, Japan	Forestry & Forest Products Research Institute - Japan; University of Tokyo; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Forestry & Forest Products Research Institute - Japan	Kinoshita, A (corresponding author), Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto, Kumamoto, Japan.	akinoshita@affrc.go.jp		Obase, Keisuke/0000-0002-1893-1001	JSPS [24710271, 21658054, 22380083, 15H02449]; Ministry of Agriculture, Forestry and Fisheries of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by JSPS KAKENHI Grants to AK (24710271) and KN (21658054, 22380083, 15H02449), and also by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan, entitled "Technology development for the optimal use of forest resources."	Aoki M, 2008, ILLUSTRATIONS JAPANE, VVI, P137; Belfiori B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082353; Bonito G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052765; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen J, 2012, NAN FANG YI KE DA XU, V32, DOI DOI 10.7872/CRYM.V32.ISS1.2012.083; Chen J, 2016, SOIL BIOL, V47, P19, DOI 10.1007/978-3-319-31436-5_2; Chen JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014625; Du MZ, 2005, MYCOLOGIA, V97, P641, DOI 10.3852/mycologia.97.3.641; Feng B, 2017, MYCORRHIZA, V27, P261, DOI 10.1007/s00572-016-0751-y; Feng B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21811; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geng Y, 2014, MYCOLOGIA, V106, P649, DOI 10.3852/13-383; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gyganskyi AP, 2010, PLOS ONE, V5; Hall I. R., 2012, EDIBLE ECTOMYCORRHIZ, P191; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hu H, 1992, J EXP FOR NATL TAIWA, V6, P79; Huang JY, 2009, FEMS MICROBIOL LETT, V294, P157, DOI 10.1111/j.1574-6968.2009.01571.x; Huang SSF, 2002, MOL ECOL, V11, P2349, DOI 10.1046/j.1365-294X.2002.01624.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kinoshita A, 2016, MYCOSCIENCE, V57, P366, DOI 10.1016/j.myc.2016.06.006; Kinoshita A, 2011, MYCOLOGIA, V103, P779, DOI 10.3852/10-138; Kizaki K., 1977, MARINE SCI MONTHLY, V9, P542; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee YJ, 2006, J HERED, V97, P261, DOI 10.1093/jhered/esj030; Lefevre C., 2012, EDIBLE ECTOMYCORRHIZ, P209, DOI [10.1007/978-3-642-33823-6_12, DOI 10.1007/978-3-642-33823-6_12]; Lin TP, 2003, MOL ECOL, V12, P2661, DOI 10.1046/j.1365-294X.2003.01912.x; Lopes A, 2017, FUNGAL BIOL-UK, V121, P394, DOI 10.1016/j.funbio.2016.08.011; Manjon JL, 2009, MYCOTAXON, V110, P399, DOI 10.5248/110.399; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martin SH, 2013, FUNGAL DIVERS, V58, P1, DOI 10.1007/s13225-012-0217-2; Merenyi Z, 2017, MYCOLOGICAL IN PRESS; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; Paolocci F, 1997, FEMS MICROBIOL LETT, V153, P255, DOI 10.1111/j.1574-6968.1997.tb12582.x; Qiao P, 2013, MYCOTAXON, V123, P293, DOI 10.5248/123.293; Rambaut A., 2014, FIGTREE VERSION 1 4; Rambaut A, 2014, TRACER VERSION 1 6 S; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roux C, 1999, FEMS MICROBIOL LETT, V180, P147, DOI 10.1111/j.1574-6968.1999.tb08789.x; Rubini A, 1998, FEMS MICROBIOL LETT, V164, P7, DOI 10.1016/S0378-1097(98)00183-9; Rubini A, 2011, NEW PHYTOL, V189, P710, DOI 10.1111/j.1469-8137.2010.03492.x; Sibuet JC, 2004, TECTONOPHYSICS, V379, P159, DOI 10.1016/j.tecto.2003.10.022; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Wang YJ, 2006, MYCOL RES, V110, P1034, DOI 10.1016/j.mycres.2006.06.013; Wang YJ, 2006, FEMS MICROBIOL LETT, V259, P269, DOI 10.1111/j.1574-6968.2006.00283.x; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wiens JJ, 1998, SYST BIOL, V47, P568, DOI 10.1080/106351598260581; Xu J, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0805-2; Zhang BC, 1988, T BRIT MYCOLOGICAL S, V91, P593; Zhang LF, 2005, FEMS MICROBIOL LETT, V245, P85, DOI 10.1016/j.femsle.2005.02.028; Zhang XW, 2015, BIOCHEM SYST ECOL, V63, P190, DOI 10.1016/j.bse.2015.10.010	54	12	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193745	10.1371/journal.pone.0193745	http://dx.doi.org/10.1371/journal.pone.0193745			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590201	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100029
J	Kondoh, Y; Taniguchi, H; Kataokal, K; Furukawa, T; Shintani, A; Fujisawa, T; Suda, T; Arita, M; Baba, T; Ichikado, K; Inoue, Y; Kishi, K; Kishaba, T; Nishiyama, O; Ogura, T; Tomii, K; Homma, S				Kondoh, Yasuhiro; Taniguchi, Hiroyuki; Kataokal, Kensuke; Furukawa, Taiki; Shintani, Ayumi; Fujisawa, Tomoyuki; Suda, Takafumi; Arita, Machiko; Baba, Tomohisa; Ichikado, Kazuya; Inoue, Yoshikazu; Kishi, Kazuma; Kishaba, Tomoo; Nishiyama, Osamu; Ogura, Takashi; Tomii, Keisuke; Homma, Sakae			Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; CONTROLLED-TRIAL; DIAGNOSIS; PIRFENIDONE; DISEASE; PREDICTORS; EFFICACY; UPDATE	Background Few studies have reported the diagnostic variability in patients with a possible usual interstitial pneumonia (UIP) pattern on high-resolution CT (HRCT) who underwent surgical lung biopsy (SLB), and the prognostic factors for these patients have not been fully evaluated. We retrospectively investigated the frequency of idiopathic pulmonary fibrosis (IPF) and prognostic factors in patients with possible UIP pattern on HRCT. Methods Consecutive patients who had a possible UIP pattern on HRCT, underwent SLB, and had a diagnosis of IIPs before SLB were retrospectively recruited from 10 hospitals. Diagnoses were made based on multidisciplinary discussion using the criteria for current IPF guidelines and multidisciplinary classification for IIPs in each hospital. Results 179 patients who underwent SLB were enrolled. The diagnoses were IPF in 91 patients (51%), unclassifiable IIPs in 47 (26%), idiopathic NSIP in 18 (10%), and chronic hypersensitivity pneumonia in 17 (9%). One-year FVC changes showed significant differences between IPF and non-IPF (-138.6 mL versus 18.2 mL, p = 0.014). Patients with IPF had a worse mortality than those with non-IPF (Logrank test, p = 0.025). Multivariable Cox regression analysis demonstrated that diagnoses of IPF (HR, 2.961; 95% CI, 1.183-7.410; p = 0.02), high modified MRC score (HR, 1.587; 95% CI, 1.003-2.510; p = 0.049), and low %FVC (HR, 0.972; 95% CI, 0.953-0.992; p = 0.005). Conclusions About a half of patients with a possible UIP pattern on HRCT had diagnoses other than IPF, and patients with IPF had a worse mortality than those with an alternative diagnosis. We reaffirmed that multidisciplinary discussion is crucial in patients with possible UIP pattern on HRCT.	[Kondoh, Yasuhiro; Taniguchi, Hiroyuki; Kataokal, Kensuke] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Japan; [Furukawa, Taiki] Nagoya Univ, Dept Resp Med, Grad Sch Med, Showa Ku, Nagoya, Aichi, Japan; [Shintani, Ayumi] Osaka City Univ, Dept Med Stat, Grad Sch Med, Osaka, Japan; [Fujisawa, Tomoyuki; Suda, Takafumi] Hamamatsu Univ Sch Med, Div 2, Dept Internal Med, Hamamatsu, Shizuoka, Japan; [Arita, Machiko] Kurashiki Cent Hosp, Dept Resp Med, Okayama, Japan; [Baba, Tomohisa; Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan; [Ichikado, Kazuya] Saiseikai Kumamoto Hosp, Div Resp Med, Kumamoto, Japan; [Inoue, Yoshikazu] Natl Hosp Org Kinki Chuo Chest Med Ctr, Clin Res Ctr, Osaka, Japan; [Kishi, Kazuma] Toranomon Gen Hosp, Dept Resp Med, Resp Ctr, Tokyo, Japan; [Kishaba, Tomoo] Okinawa Chubu Hosp, Dept Resp Med, Okinawa, Japan; [Nishiyama, Osamu] Kindai Univ, Dept Resp Med & Allergol, Fac Med, Osaka, Japan; [Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Homma, Sakae] Toho Univ, Dept Resp Med, Omori Med Ctr, Tokyo, Japan	Tosei General Hospital; Nagoya University; Osaka Metropolitan University; Hamamatsu University School of Medicine; Kurashiki Central Hospital; Kanagawa Cardiovascular & Respiratory Center; Saiseikai Kumamoto Hospital; Toranomon Hospital; Okinawa Chubu Central Hospital; Kindai University (Kinki University); Kobe City Medical Center General Hospital; Toho University	Kondoh, Y (corresponding author), Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Japan.	konyasu2003@yahoo.co.jp	Kondo, Yasuhiro/AAP-3658-2020; Inoue, Yoshikazu/ABE-9772-2020	Furukawa, Taiki/0000-0002-3522-1845; Nishiyama, Osamu/0000-0002-9163-9605				Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Brownell R, 2017, THORAX, V72, P424, DOI 10.1136/thoraxjnl-2016-209671; du Bois RM, 2012, EUR RESPIR REV, V21, P141, DOI 10.1183/09059180.00000812; Fell CD, 2010, AM J RESP CRIT CARE, V181, P832, DOI 10.1164/rccm.200906-0959OC; Johannson KA, 2014, LANCET RESP MED, V2, pE5, DOI 10.1016/S2213-2600(14)70075-X; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2014, LANCET RESP MED, V2, P277, DOI 10.1016/S2213-2600(14)70011-6; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Ryerson CJ, 2017, AM J RESP CRIT CARE, V196, P1249, DOI 10.1164/rccm.201702-0400PP; Ryerson CJ, 2013, EUR RESPIR J, V42, P750, DOI 10.1183/09031936.00131912; Salisbury ML, 2016, RESP MED, V118, P88, DOI 10.1016/j.rmed.2016.07.016; Skolnik K, 2016, RESPIROLOGY, V21, P51, DOI 10.1111/resp.12568; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Walsh SLF, 2016, LANCET RESP MED, V4, P557, DOI 10.1016/S2213-2600(16)30033-9; Yagihashi K, 2016, EUR RESPIR J, V47, P1189, DOI 10.1183/13993003.01680-2015	22	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193608	10.1371/journal.pone.0193608	http://dx.doi.org/10.1371/journal.pone.0193608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590152	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100025
J	Malhi, SK; Buchanan, L				Malhi, Simritpal Kaur; Buchanan, Lori			A test of the symbol interdependency hypothesis with both concrete and abstract stimuli	PLOS ONE			English	Article							DUAL CODING THEORY; CONTEXT-AVAILABILITY; METAPHOR COMPREHENSION; IMAGEABILITY RATINGS; DEEP DYSPHASIA; MENTAL-IMAGERY; BRAIN SYSTEMS; MOTOR; WORDS; LANGUAGE	In Experiment 1, the symbol interdependency hypothesis was tested with both concrete and abstract stimuli. Symbolic (i.e., semantic neighbourhood distance) and embodied (i.e., iconicity) factors were manipulated in two tasks one that tapped symbolic relations (i.e., semantic relatedness judgment) and another that tapped embodied relations (i.e., iconicity judgment). Results supported the symbol interdependency hypothesis in that the symbolic factor was recruited for the semantic relatedness task and the embodied factor was recruited for the iconicity task. Across tasks, and especially in the iconicity task, abstract stimuli resulted in shorter RTs. This finding was in contrast to the concreteness effect where concrete words result in shorter RTs. Experiment 2 followed up on this finding by replicating the iconicity task from Experiment 1 in an ERP paradigm. Behavioural results continued to show a reverse concreteness effect with shorter RTs for abstract stimuli. However, ERP results paralleled the N400 and anterior N700 concreteness effects found in the literature, with more negative amplitudes for concrete stimuli.	[Malhi, Simritpal Kaur; Buchanan, Lori] Univ Windsor, Dept Psychol, Windsor, ON, Canada	University of Windsor	Buchanan, L (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.	buchanan@uwindsor.ca		Malhi, Simritpal/0000-0002-5257-8790	Social Sciences and Humanities Research Council scholarship [767-2016-1440]; Social Sciences and Humanities Research Council Partnership grant [895-2016-1008]	Social Sciences and Humanities Research Council scholarship(Social Sciences and Humanities Research Council of Canada (SSHRC)); Social Sciences and Humanities Research Council Partnership grant	This research was supported by a Social Sciences and Humanities Research Council scholarship (767-2016-1440) awarded to SKM and a Social Sciences and Humanities Research Council Partnership grant (Words in the World 895-2016-1008), http://www.sshrc-crsh.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarriba J, 1999, BEHAV RES METH INS C, V31, P578, DOI 10.3758/BF03200738; Andrews M, 2014, TOP COGN SCI, V6, P359, DOI 10.1111/tops.12096; [Anonymous], 2021, LANG ENV STAT COMP; Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barber HA, 2013, BRAIN LANG, V125, P47, DOI 10.1016/j.bandl.2013.01.005; Barsalou L., 2008, SYMBOLS EMBODIMENT D, P245, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0013, 10.1093/acprof:oso/9780199217274.003.0013, DOI 10.1093/ACPROF:OSO/9780199217274.003]; Barsalou L., 1999, BRAIN BEHAV SCI, V22; Bennett SDR, 2011, BEHAV RES METHODS, V43, P1100, DOI 10.3758/s13428-011-0117-5; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; Binkofski F, 2000, HUM BRAIN MAPP, V11, P273, DOI 10.1002/1097-0193(200012)11:4<273::AID-HBM40>3.0.CO;2-0; Bird H, 2001, BEHAV RES METH INS C, V33, P73, DOI 10.3758/BF03195349; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Buchanan L, 2001, PSYCHON B REV, V8, P531, DOI 10.3758/BF03196189; Burgess C, 1997, LANG COGNITIVE PROC, V12, P177, DOI 10.1080/016909697386844; Burgess C, 1998, BRAIN COGNITION, V40, P67; Chasteen AL, 2010, NEUROPSYCHOLOGIA, V48, P627, DOI 10.1016/j.neuropsychologia.2009.09.029; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Coltheart M, 1980, DEEP DYSLEXIA; Danguecan AN, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01034; Dhond RP, 2007, HUM BRAIN MAPP, V28, P355, DOI 10.1002/hbm.20282; Dove G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00242; Dove G, 2009, COGNITION, V110, P412, DOI 10.1016/j.cognition.2008.11.016; Durda K., 2006, WORDMINE2; Durda K, 2008, BEHAV RES METHODS, V40, P705, DOI 10.3758/BRM.40.3.705; ERNEST CH, 1971, CAN J PSYCHOLOGY, V25, P83, DOI 10.1037/h0082371; Esopenko C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00084; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Foltz PW, 1998, DISCOURSE PROCESS, V25, P285, DOI 10.1080/01638539809545029; Fowler Harold N., 1921, PLATO 12 VOLUMES, V12; FRANKLIN S, 1995, COGNITIVE NEUROPSYCH, V12, P549, DOI 10.1080/02643299508252007; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 1999, DISCOURSE PROCESS, V28, P1, DOI 10.1080/01638539909545067; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Goodhew SC, 2014, PSYCHON B REV, V21, P1287, DOI 10.3758/s13423-014-0593-6; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Guan CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075183; Gullick MM, 2013, PSYCHOPHYSIOLOGY, V50, P431, DOI 10.1111/psyp.12033; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hinton G., 1986, EXPLORATIONS MICROST, V1, P77, DOI [10.1146/ANNUREV-PSYCH-120710-100344., DOI 10.1146/ANNUREV-PSYCH-120710-100344]; Holcomb PJ, 1999, J EXP PSYCHOL LEARN, V25, P721, DOI 10.1037/0278-7393.25.3.721; Huang HW, 2015, LANG LINGUIST-TAIWAN, V16, P503, DOI 10.1177/1606822X15583233; Huang HW, 2010, NEUROIMAGE, V49, P1116, DOI 10.1016/j.neuroimage.2009.07.031; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jarvis B. G., 2012, DIRECTRT COMPUTER SO; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jirak D, 2010, CONSCIOUS COGN, V19, P711, DOI 10.1016/j.concog.2010.06.020; Jones MN, 2007, PSYCHOL REV, V114, P1, DOI 10.1037/0033-295X.114.1.1; KATZ RB, 1990, BRAIN LANG, V39, P153, DOI 10.1016/0093-934X(90)90009-6; Kintsch W, 2000, PSYCHON B REV, V7, P257, DOI 10.3758/BF03212981; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; KROLL JF, 1986, J EXP PSYCHOL LEARN, V12, P92, DOI 10.1037/0278-7393.12.1.92; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; Kuznetsova A, 2013, IMERTEST TESTS RANDO, V2; Lakoff G., 1980, METAPHORS WE LIVE; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Laszlo S, 2011, PSYCHOPHYSIOLOGY, V48, P176, DOI 10.1111/j.1469-8986.2010.01058.x; Lee CL, 2008, BRAIN LANG, V104, P145, DOI 10.1016/j.bandl.2007.06.002; Lenth R., 2016, R PACKAGE VERSION, V2; LEVINE SC, 1982, BRAIN LANG, V17, P34, DOI 10.1016/0093-934X(82)90003-7; Louwerse M, 2010, COGNITIVE SCI, V35, P381; Louwerse M.M., 2007, HDB LATENT SEMANTIC, P107; Louwerse M, 2006, INT J ARTIF INTELL T, V15, P1021, DOI 10.1142/S0218213006003090; Louwerse M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00385; Louwerse MM, 2011, TOP COGN SCI, V3, P273, DOI 10.1111/j.1756-8765.2010.01106.x; Louwerse MM, 2010, COGNITION, V114, P96, DOI 10.1016/j.cognition.2009.09.002; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Lugli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064500; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Markman AB, 2000, TRENDS COGN SCI, V4, P470, DOI 10.1016/S1364-6613(00)01559-X; MARTIN N, 1992, BRAIN LANG, V43, P240, DOI 10.1016/0093-934X(92)90130-7; McRae K, 2004, PSYCHOL LEARN MOTIV, V45, P41, DOI 10.1016/S0079-7421(03)45002-0; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Nittono H, 2002, INT J PSYCHOPHYSIOL, V44, P219, DOI 10.1016/S0167-8760(02)00002-8; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; Paivio A, 1971, IMAGERY VERBAL PROCE; Paivio A, 2013, J EXP PSYCHOL GEN, V142, P282, DOI 10.1037/a0027004; Pexman PM, 2007, J COGNITIVE NEUROSCI, V19, P1407, DOI 10.1162/jocn.2007.19.8.1407; Santana E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00090; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; SCHWANENFLUGEL PJ, 1989, READ RES QUART, V24, P114, DOI 10.2307/748013; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; SCHWANENFLUGEL PJ, 1988, J MEM LANG, V27, P499, DOI 10.1016/0749-596X(88)90022-8; Segalowitz S.J., 1999, ERPSCORE PROGRAM PEA; Setic M, 2007, LANG COGNITIVE PROC, V22, P297, DOI 10.1080/01690960600732430; Shaoul C, 2010, BEHAV RES METHODS, V42, P393, DOI 10.3758/BRM.42.2.393; Shen ZY, 2015, LANG LINGUIST-TAIWAN, V16, P615, DOI 10.1177/1606822X15583241; Shibahara N, 2002, PERCEPT MOTOR SKILL, V94, P1292; Siakaluk PD, 2008, COGNITION, V106, P433, DOI 10.1016/j.cognition.2006.12.011; Siakaluk PD, 2003, MEM COGNITION, V31, P100, DOI 10.3758/BF03196086; Simmons WK, 2008, J PHYSIOL-PARIS, V102, P106, DOI 10.1016/j.jphysparis.2008.03.014; Stadthagen-Gonzalez H, 2006, BEHAV RES METHODS, V38, P598, DOI 10.3758/BF03193891; Sysoeva OV, 2007, INT J PSYCHOPHYSIOL, V65, P272, DOI 10.1016/j.ijpsycho.2007.05.003; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tremblay A, 2015, LMERCONVENIENCEFUNCT, V2; van Schie HT, 2005, COGN NEUROPSYCHOL, V22, P364, DOI 10.1080/02643290442000338; Vigliocco G, 2009, LANG COGN, V1, P219, DOI 10.1515/LANGCOG.2009.011; Wang J, 2010, HUM BRAIN MAPP, V31, P1459, DOI 10.1002/hbm.20950; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; Weiskopf DA, 2010, STUD HIST PHILOS SCI, V41, P294, DOI 10.1016/j.shpsa.2010.07.005; Welcome SE, 2011, EXP BRAIN RES, V212, P347, DOI 10.1007/s00221-011-2734-8; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Wiemer-Hastings K, 2005, COGNITIVE SCI, V29, P719, DOI 10.1207/s15516709cog0000_33; Wilson NL, 2007, COGNITIVE SCI, V31, P721, DOI 10.1080/15326900701399962; Zhang Y, 2015, J COGN PSYCHOL, V27, P218, DOI 10.1080/20445911.2014.995667; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1; Zwaan RA, 2003, PSYCHON B REV, V10, P954, DOI 10.3758/BF03196557	116	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192719	10.1371/journal.pone.0192719	http://dx.doi.org/10.1371/journal.pone.0192719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590121	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100009
J	Sanchez-Montoya, MM; von Schiller, D; Barbera, GG; Diaz, AM; Arce, MI; del Campo, R; Tockner, K				Mar Sanchez-Montoya, Maria; von Schiller, Daniel; Barbera, Gonzalo G.; Diaz, Angela M.; Arce, Maria Isabel; del Campo, Ruben; Tockner, Klement			Understanding the effects of predictability, duration, and spatial pattern of drying on benthic invertebrate assemblages in two contrasting intermittent streams	PLOS ONE			English	Article							MACROINVERTEBRATE ASSEMBLAGES; COMMUNITY STRUCTURE; TEMPORARY STREAMS; BIOLOGICAL TRAITS; RIVER; DROUGHT; RESPONSES; HABITAT; RESILIENCE; RESISTANCE	In the present study, we examined the effects of different drying conditions on the composition, structure and function of benthic invertebrate assemblages. We approached this objective by comparing invertebrate assemblages in perennial and intermittent sites along two intermittent Mediterranean streams with contrasting predictability, duration, and spatial patterns of drying: Fuirosos (high predictability, short duration, downstream drying pattern) and Rogativa (low predictability, long duration, patchy drying pattern). Specifically, we quantified the contribution of individual taxa to those differences, the degree of nestedness, and shifts in the composition, structure and function of benthic invertebrate assemblages along flow intermittence gradients. We observed greater effects of drying on the benthic invertebrate composition in Fuirosos than in Rogativa, resulting in a higher dissimilarity of assemblages between perennial and intermittent sites, as well as a lower degree of nestedness. Furthermore, a higher number of biotic metrics related to richness, abundance and biological traits were significantly different between perennial and intermittent sites in Fuirosos, despite a shorter dry period compared to Rogativa. At the same time, slightly different responses were detected during post-drying (autumn) than pre-drying (spring) conditions in this stream. In Rogativa, shifts in benthic invertebrate assemblages along increasing gradients of flow intermittence were found for three metrics (Ephemeroptera, Plecoptera and Trichoptera (EPT) and Odonata, Coleoptera and Heteroptera (OCH) abundances and aerial active dispersal. Furthermore, we demonstrated that combined gradients of dry period duration and distance to nearest perennial reach can generate complex, and different, responses of benthic invertebrate assemblages, depending on the flow intermittence metric. Our study advances the notion that special attention should be paid to the predictability, duration and spatial patterns of drying in intermittent streams in order to disentangle the effects of drying on benthic invertebrate assemblages, in particular in areas subject to high spatial heterogeneity and temporal variability in drying conditions.	[Mar Sanchez-Montoya, Maria; Diaz, Angela M.; Arce, Maria Isabel; Tockner, Klement] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany; [Mar Sanchez-Montoya, Maria; del Campo, Ruben] Univ Murcia, Dept Ecol & Hydrol, Reg Campus Int Excellence Campus Mare Nostrum, Campus Espinardo, Murcia, Spain; [von Schiller, Daniel] Univ Basque Country UPV EHU, Dept Plant Biol & Ecol, Fac Sci & Technol, Bilbao, Spain; [Barbera, Gonzalo G.] CEBAS, CSIC, Dept Soil & Water Conservat, Campus Univ Espinardo, Murcia, Spain; [Tockner, Klement] Free Univ Berlin, Inst Biol, Berlin, Germany; [Tockner, Klement] Austrian Sci Fund, Vienna, Austria	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Murcia; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia; Free University of Berlin	Sanchez-Montoya, MM (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany.; Sanchez-Montoya, MM (corresponding author), Univ Murcia, Dept Ecol & Hydrol, Reg Campus Int Excellence Campus Mare Nostrum, Campus Espinardo, Murcia, Spain.	marsanch@um.es	von Schiller, Daniel/C-1384-2009; del Campo, Rubén/Q-4365-2019; Sanchez-Montoya, Maria Mar/K-4387-2016; arce, maria isabel/L-2678-2014; Gonzalez Barbera, Gonzalo/D-8386-2011	von Schiller, Daniel/0000-0002-9493-3244; del Campo, Rubén/0000-0002-0560-831X; Sanchez-Montoya, Maria Mar/0000-0001-8179-7805; arce, maria isabel/0000-0001-7407-3884; Gonzalez Barbera, Gonzalo/0000-0003-2166-0633	CLITEMP Project [330466]; Marie-Curie postdoctoral fellowship; University of Murcia [FPU R-269/2014]; Alexander von Humboldt foundation [1162886]; Open Access Fund of the Leibniz Association	CLITEMP Project; Marie-Curie postdoctoral fellowship(European Commission); University of Murcia; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Open Access Fund of the Leibniz Association	This study was funded by the CLITEMP Project (330466 to M.M. Sanchez-Montoya; MC-IEF; FP7-people-2012-IEF). M. M. Sanchez-Montoya was financially supported by a Marie-Curie postdoctoral fellowship, R. del Campo by a PhD contract (FPU R-269/2014) from the University of Murcia, and M.I. Arce by a postdoc fellowship from the Alexander von Humboldt foundation (1162886). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna V, 2005, J N AM BENTHOL SOC, V24, P919, DOI 10.1899/04-078.1; ADAMS A, 1983, ANTENNA, V8, P58; Amalfitano S, 2008, MICROB ECOL, V55, P270, DOI 10.1007/s00248-007-9274-6; Armitage P., 1995, THE CHIRONOMIDAE, VXII, P572, DOI 10.1007/978-94-011-0715-0; Arscott DB, 2010, J N AM BENTHOL SOC, V29, P530, DOI 10.1899/08-124.1; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Barthes A, 2015, RIVER RES APPL, V31, P993, DOI 10.1002/rra.2793; Bergaya F, 2017, DEV CLAY SCI, V8, P1, DOI 10.1016/B978-0-08-100355-8.00001-1; Bernal S, 2013, HYDROBIOLOGIA, V719, P31, DOI 10.1007/s10750-012-1246-2; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Boersma KS, 2014, FRESHWATER BIOL, V59, P491, DOI 10.1111/fwb.12280; Bogan MT, 2015, FRESHWATER BIOL, V60, P2547, DOI 10.1111/fwb.12522; Bogan MT, 2013, FRESHWATER BIOL, V58, P1016, DOI 10.1111/fwb.12105; Bogan MT, 2001, FRESH WATER BIOL, V56, P2070; Boix-Fayos C, 2007, GEOMORPHOLOGY, V91, P103, DOI 10.1016/j.geomorph.2007.02.003; Bonada N, 2011, LIMNETICA, V30, P129; Bonada N, 2007, HYDROBIOLOGIA, V589, P91, DOI 10.1007/s10750-007-0723-5; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Bonada N, 2013, HYDROBIOLOGIA, V719, P1, DOI 10.1007/s10750-013-1634-2; BOULTON AJ, 1992, FRESHWATER BIOL, V27, P123, DOI 10.1111/j.1365-2427.1992.tb00528.x; Bunn SE, 2006, RIVER RES APPL, V22, P179, DOI 10.1002/rra.904; Canedo-Arguelles M, 2015, J BIOGEOGR, V42, P778, DOI 10.1111/jbi.12457; Canedo-Arguelles M, 2016, ECOL INDIC, V71, P155, DOI 10.1016/j.ecolind.2016.07.002; Crosskey RW, 2004, REVISED TAXONOMIC GE, V8, P78; Datry T, 2014, ECOGRAPHY, V37, P94, DOI 10.1111/j.1600-0587.2013.00287.x; Datry T, 2016, OIKOS, V125, P149, DOI 10.1111/oik.02922; Datry T, 2014, BIOSCIENCE, V64, P229, DOI 10.1093/biosci/bit027; Datry T, 2012, FRESHWATER BIOL, V57, P563, DOI 10.1111/j.1365-2427.2011.02725.x; Datry T, 2011, AQUAT SCI, V73, P453, DOI 10.1007/s00027-011-0236-1; Davey AJH, 2007, FRESHWATER BIOL, V52, P1719, DOI 10.1111/j.1365-2427.2007.01800.x; Doll P, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014037; Finn MA, 2009, FUND APPL LIMNOL, V175, P231, DOI 10.1127/1863-9135/2009/0175-0231; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; Fritz KM, 2005, MAR FRESHWATER RES, V56, P13, DOI 10.1071/MF04244; Gallart F, 2012, HYDROL EARTH SYST SC, V16, P3165, DOI 10.5194/hess-16-3165-2012; Garcia-Roger EM, 2011, AQUAT SCI, V73, P567, DOI 10.1007/s00027-011-0218-3; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Gorley C.K., 2006, GETTING STARTED PRIM; Gungle B, 2006, TIMING DURATION FLOW; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Leigh C, 2016, ECOGRAPHY, V39, P1; Leigh C, 2016, AQUAT SCI, V78, P291, DOI 10.1007/s00027-015-0427-2; Lopez-Rodriguez MJ, 2008, HYDROBIOLOGIA, V610, P277, DOI 10.1007/s10750-008-9444-7; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Matthews WJ, 2003, FRESHWATER BIOL, V48, P1232, DOI 10.1046/j.1365-2427.2003.01087.x; Diaz AM, 2008, FRESHWATER BIOL, V53, P1, DOI 10.1111/j.1365-2427.2007.01854.x; Morais M, 2004, HYDROBIOLOGIA, V516, P229, DOI 10.1023/B:HYDR.0000025268.66163.32; Navarro-Martinez Daniel, 2007, Illiesia, V3, P65; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Picazo F, 2012, FRESHWATER BIOL, V57, P2192, DOI 10.1111/j.1365-2427.2012.02859.x; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Rosset E, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1809; Sabater S, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00014; Sanchez-Montoya MM, 2010, ECOL INDIC, V10, P896, DOI 10.1016/j.ecolind.2010.01.008; Sanchez-Montoya MM, 2009, HYDROBIOLOGIA, V619, P39, DOI 10.1007/s10750-008-9580-0; Sanchez-Montoya MD, 2007, FRESHWATER BIOL, V52, P2240, DOI 10.1111/j.1365-2427.2007.01826.x; Sanchez-Montoya MM, 2016, ECOHYDROLOGY; SAS Institute, 2013, SAS STAT 13 1 US GUI; Stanley EH, 2004, AQUAT SCI, V66, P130, DOI 10.1007/s00027-003-0646-9; Steinman Alan D., 2007, P357, DOI 10.1016/B978-012332908-0.50024-3; Steward AL, 2011, AQUAT SCI, V73, P551, DOI 10.1007/s00027-011-0217-4; Strachan SR., 2015, SPRINGER SCI REV, V3, P57, DOI [10.1007/s40362-015-0031-9, DOI 10.1007/S40362-015-0031-9]; Stubbington R, 2017, INTERMITTENT RIVERS AND EPHEMERAL STREAMS: ECOLOGY AND MANAGEMENT, P217, DOI 10.1016/B978-0-12-803835-2.00007-3; Stubbington R, 2015, FRESHW SCI, V34, P344, DOI 10.1086/679467; Suarez ML, 2016, AQUAT SCI; Suemoto T, 2004, HYDROBIOLOGIA, V515, P107, DOI 10.1023/B:HYDR.0000027322.11005.20; Tachet H., 2010, INVERTEBRES EAU DOUC, V15; Team Core Writing, 2014, CLIMATE CHANGE SYNTH; Timoner X, 2014, AQUAT SCI, V76, P565, DOI 10.1007/s00027-014-0355-6; Tockner K, 2009, RIVERS OF EUROPE, 1ST EDITION, P1, DOI 10.1016/B978-0-12-369449-2.00001-1; Tornes E, 2010, MAR FRESHWATER RES, V61, P441, DOI 10.1071/MF09095; Vardakas L, 2015, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2015026; Vazquez E., 2013, BODENKULTUR, V64, P13; Velasco J, 1998, SOUTHWEST NAT, V43, P80; Vorste RV, 2016, FRESHW SCI, V35, P164, DOI 10.1086/683274; Westwood CG, 2006, RIVER RES APPL, V22, P703, DOI 10.1002/rra.934	78	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193933	10.1371/journal.pone.0193933	http://dx.doi.org/10.1371/journal.pone.0193933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590140	Green Published, gold			2022-12-27	WOS:000428603100038
J	Green, DB; Shackleton, TM; Grimsley, JMS; Zobay, O; Palmer, AR; Wallace, MN				Green, David B.; Shackleton, Trevor M.; Grimsley, Jasmine M. S.; Zobay, Oliver; Palmer, Alan R.; Wallace, Mark N.			Communication calls produced by electrical stimulation of four structures in the guinea pig brain	PLOS ONE			English	Article							PERIAQUEDUCTAL GRAY; ULTRASONIC VOCALIZATIONS; CHOLINERGIC STIMULATION; STRIA TERMINALIS; BED NUCLEUS; EXPRESSION; FOREBRAIN; INJECTION; RESPONSES; AMYGDALA	One of the main central processes affecting the cortical representation of conspecific vocalizations is the collateral output from the extended motor system for call generation. Before starting to study this interaction we sought to compare the characteristics of calls produced by stimulating four different parts of the brain in guinea pigs (Cavia porcellus). By using anaesthetised animals we were able to reposition electrodes without distressing the animals. Trains of 100 electrical pulses were used to stimulate the midbrain periaqueductal grey (PAG), hypothalamus, amygdala, and anterior cingulate cortex (ACC). Each structure produced a similar range of calls, but in significantly different proportions. Two of the spontaneous calls (chirrup and purr) were never produced by electrical stimulation and although we identified versions of chutter, durr and tooth chatter, they differed significantly from our natural call templates. However, we were routinely able to elicit seven other identifiable calls. All seven calls were produced both during the 1.6 s period of stimulation and subsequently in a period which could last for more than a minute. A single stimulation site could produce four or five different calls, but the amygdala was much less likely to produce a scream, whistle or rising whistle than any of the other structures. These three high-frequency calls were more likely to be produced by females than males. There were also differences in the timing of the call production with the amygdala primarily producing calls during the electrical stimulation and the hypothalamus mainly producing calls after the electrical stimulation. For all four structures a significantly higher stimulation current was required in males than females. We conclude that all four structures can be stimulated to produce fictive vocalizations that should be useful in studying the relationship between the vocal motor system and cortical sensory representation.	[Green, David B.; Shackleton, Trevor M.; Zobay, Oliver; Palmer, Alan R.; Wallace, Mark N.] Univ Nottingham, Sch Med, Med Res Council, Inst Hearing Res, Nottingham, England; [Grimsley, Jasmine M. S.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Nottingham; Northeast Ohio Medical University (NEOMED)	Wallace, MN (corresponding author), Univ Nottingham, Sch Med, Med Res Council, Inst Hearing Res, Nottingham, England.	Mark.Wallace@nottingham.ac.uk	Wallace, Mark/ABC-1573-2020	Wallace, Mark/0000-0001-6894-4903; Grimsley, Jasmine/0000-0002-7993-9699; Zobay, Oliver/0000-0002-0229-0668	Medical Research Council [MC_U135097126]; MRC [MC_UU_00010/5, MC_U135097126] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was wholly funded by the Medical Research Council (GB) as part of a core intramural grant to ARP (MC_U135097126). The MRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch-Tirado E, 2000, J SPEECH LANG HEAR R, V43, P432, DOI 10.1044/jslhr.4302.432; ARVOLA A, 1974, Annales Zoologici Fennici, V11, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERRYMAN JC, 1976, Z TIERPSYCHOL, V41, P80; Borszcz GS, 2006, PAIN, V123, P155, DOI 10.1016/j.pain.2006.02.026; Boyce S, 2001, NEUROPHARMACOLOGY, V41, P130, DOI 10.1016/S0028-3908(01)00051-X; BRUDZYNSKI SM, 1990, NEUROSCI LETT, V109, P222, DOI 10.1016/0304-3940(90)90567-S; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Burnstein D. D., 1967, PSYCHON SCI, V8, P39; Coulon J, 1973, REV COMPORT ANIM, V7, P123; Dujardin E, 2006, BEHAV BRAIN RES, V168, P23, DOI 10.1016/j.bbr.2005.10.006; Eisenberg J. F., 1974, Symposia of the Zoological Society of London, P211; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; EPPLE G, 1968, FOLIA PRIMATOL, V8, P1, DOI 10.1159/000155129; FEDIGAN L M, 1984, Primates, V25, P279, DOI 10.1007/BF02382267; Fischer J, 2016, NEUROSCI BIOBEHAV RE; Gibbs EL, 1936, J COMP NEUROL, V64, P209, DOI 10.1002/cne.900640203; Grimsley JMS, 2011, HEARING RES, V277, P134, DOI 10.1016/j.heares.2011.01.018; Grimsley JMS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051646; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Groenink L, 2015, EUR J PHARMACOL, V753, P191, DOI 10.1016/j.ejphar.2014.10.062; Hennessy MB, 2005, DEV PSYCHOBIOL, V46, P86, DOI 10.1002/dev.20045; HERMAN BH, 1981, SCIENCE, V211, P1060, DOI 10.1126/science.7466377; HINES M, 1985, J NEUROSCI, V5, P40; HINES M, 1992, BRAIN RES, V579, P321, DOI 10.1016/0006-8993(92)90068-K; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; Jurgens U, 1998, NATURWISSENSCHAFTEN, V85, P376, DOI 10.1007/s001140050519; JURGENS U, 1986, BRAIN RES, V373, P349, DOI 10.1016/0006-8993(86)90349-5; JURGENS U, 1994, BEHAV BRAIN RES, V62, P107, DOI 10.1016/0166-4328(94)90017-5; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; JURGENS U, 1967, EXP BRAIN RES, V4, P114; KIRZINGER A, 1991, EXP BRAIN RES, V84, P545; KUNKEL P., 1964, Zeitschrift fur Tierpsychologie, V21, P602; Kyuhou S, 1999, NEUROSCI LETT, V260, P113, DOI 10.1016/S0304-3940(98)00956-2; Kyuhou S, 1998, NEUROREPORT, V9, P1607, DOI 10.1097/00001756-199805110-00064; Leite-Panissi CRA, 2003, BRAIN RES BULL, V60, P167, DOI 10.1016/S0361-9230(03)00031-5; Lenell C, 2017, LARYNGOSCOPE, V127, pE270, DOI 10.1002/lary.26561; LU CL, 1993, BRAIN RES BULL, V32, P143, DOI 10.1016/0361-9230(93)90068-M; Ma J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00055; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Manteuffel G, 2007, BEHAV BRAIN RES, V178, P177, DOI 10.1016/j.bbr.2006.12.007; MARTIN JR, 1976, J COMP PHYSIOL PSYCH, V90, P1011, DOI 10.1037/h0078658; Michelsson K, 2002, FOLIA PHONIATR LOGO, V54, P190, DOI 10.1159/000063190; Monticelli PE, 2004, AN ACAD BRAS CIENC, V76, P368, DOI 10.1590/S0001-37652004000200027; Panksepp J., 1988, PHYSL CONTROL MAMMAL, P263, DOI 10.1007/978-1-4613-1051-8_15; PHILLIPS RE, 1972, ANIM BEHAV, V20, P689, DOI 10.1016/S0003-3472(72)80141-6; Rapisarda C, 1977, Arch Sci Biol (Bologna), V61, P1; ROBINSON BW, 1967, PHYSIOL BEHAV, V2, P345, DOI 10.1016/0031-9384(67)90050-9; Rood J.P., 1972, Animal Behav Monogr, V5, P1; Scheiner E, 2004, FOLIA PHONIATR LOGO, V56, P27, DOI 10.1159/000075326; Scheiner E, 2002, J VOICE, V16, P509, DOI 10.1016/S0892-1997(02)00127-3; Scheiner E, 2006, J VOICE, V20, P585, DOI 10.1016/j.jvoice.2005.09.001; SMITH WK, 1945, J NEUROPHYSIOL, V8, P241, DOI 10.1152/jn.1945.8.4.241; Sugiyama Y, 2014, NEUROSCI RES, V80, P17, DOI 10.1016/j.neures.2013.12.004; Sugiyama Y, 2010, NEUROSCI RES, V66, P359, DOI 10.1016/j.neures.2009.12.006; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tomaszycki ML, 2001, HORM BEHAV, V39, P267, DOI 10.1006/hbeh.2001.1659; Van Daele DJ, 2009, NEUROSCIENCE, V162, P501, DOI 10.1016/j.neuroscience.2009.05.005; Varty GB, 2005, PSYCHOPHARMACOLOGY, V182, P132, DOI 10.1007/s00213-005-0041-4; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; Zugaib J, 2017, BRAIN RES, V1671, P131, DOI 10.1016/j.brainres.2017.07.013; Zugaib J, 2014, PHYSIOL BEHAV, V126, P8, DOI 10.1016/j.physbeh.2013.12.004	63	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194091	10.1371/journal.pone.0194091	http://dx.doi.org/10.1371/journal.pone.0194091			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584746	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000428373000014
J	Hausmann, J; Deiner, C; Patra, AK; Immig, I; Starke, A; Aschenbach, JR				Hausmann, Janis; Deiner, Carolin; Patra, Amlan K.; Immig, Irmgard; Starke, Alexander; Aschenbach, Joerg R.			Effects of a combination of plant bioactive lipid compounds and biotin compared with monensin on body condition, energy metabolism and milk performance in transition dairy cows	PLOS ONE			English	Article							NONESTERIFIED FATTY-ACIDS; EARLY-LACTATION; ESSENTIAL OILS; RUMINAL FERMENTATION; SUBCLINICAL KETOSIS; DIETARY BIOTIN; HOLSTEIN COWS; REPRODUCTIVE-PERFORMANCE; BETA-HYDROXYBUTYRATE; PROPYLENE-GLYCOL	The aim of this study was to test whether a combination of plant bioactive lipid compounds (also termed 'essential oils') and biotin (PBLC+B) could decrease the mobilization of body reserves and ketosis incidence in postpartum dairy cows. We compared non-supplemented control (CON) cows with cows receiving monensin (MON) as a controlled-release capsule at d -21, and with cows receiving PBLC+B from day (d) -21 before calving until calving (Phase 1) and further until d 37 after calving (Phase 2), followed by PBLC+B discontinuation from d 38 to d 58 (Phase 3). The PBLC+B cows had higher body weight and higher back fat thickness than CON cows and lesser body weight change than MON and CON cows in Phase 3. Body condition score was not different among groups. Milk protein concentration tended to be higher on the first herd test day in PBLC+B vs. CON cows. Milk fat concentration tended to be highest in PBLC+B cows throughout Phases 2 and 3, with significantly higher values in PBLC+B vs. MON cows on the second herd test day. Yields of energy-corrected milk were higher in PBLC+B vs. CON and MON cows in Phase 2 and higher in PBLC+B and MON cows vs. CON cows in Phase 3. The incidence of subclinical ketosis was 83%, 61% and 50% in CON, PBLC+B and MON cows, respectively, with lower mean beta-hydroxybutyrate values in MON than in PBLC+B cows in Phase 1 prepartum. The serum triglyceride concentration was higher in PBLC+B vs. CON cows on d 37. No differences were observed in serum glucose, urea, non-esterified fatty acids, cholesterol and bilirubin concentrations. Aspartate transaminase and y-glutamyltranspeptidase but not glutamate dehydrogenase activities tended to be highest in MON and lowest in PBLC+B in Phase 2. We conclude that PBLC+B prevent body weight loss after parturition and are associated with similar ketosis incidence and partly higher yields of energy-corrected milk compared to MON supplementation of dairy cows.	[Hausmann, Janis; Deiner, Carolin; Patra, Amlan K.; Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Berlin, Oertzenweg, Germany; [Patra, Amlan K.] West Bengal Univ Anim & Fishery Sci, Dept Anim Nutr, Kolkata, India; [Immig, Irmgard] DSM Nutr Prod Ltd, Kaiseraugst, Wurmisweg, Switzerland; [Starke, Alexander] Univ Leipzig, Clin Ruminants & Swine, Leipzig, Germany	Free University of Berlin; West Bengal University of Animal & Fishery Sciences; DSM NV; Leipzig University	Aschenbach, JR (corresponding author), Free Univ Berlin, Inst Vet Physiol, Berlin, Oertzenweg, Germany.	joerg.achenbach@fu-berin.de	Aschenbach, Joerg R/R-7572-2016; Patra, Amlan K./U-7781-2019	Aschenbach, Joerg R/0000-0001-5080-1007; Patra, Amlan/0000-0003-1410-0902	DSM Nutritional Products Ltd.	DSM Nutritional Products Ltd.	This study was supported by DSM Nutritional Products Ltd. Coauthor II is an employee of DSM Nutritional Products Ltd and contributed to the study design and preparation of the manuscript. Data collection, data analysis and the decision to publish were independent of the sponsor.	Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Benchaar C, 2006, J DAIRY SCI, V89, P4352, DOI 10.3168/jds.S0022-0302(06)72482-1; Bradford BJ, 2005, J NUTR, V135, P2206, DOI 10.1093/jn/135.9.2206; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chen B, 2011, J DAIRY SCI, V94, P3537, DOI 10.3168/jds.2010-3764; Chen B, 2012, LIVEST SCI, V148, P168, DOI 10.1016/j.livsci.2012.06.002; Chibisa GE, 2008, J DAIRY SCI, V91, P3512, DOI 10.3168/jds.2007-0920; Compton CWR, 2015, NEW ZEAL VET J, V63, P249, DOI 10.1080/00480169.2014.999842; DeFrain JM, 2004, J DAIRY SCI, V87, P4195, DOI 10.3168/jds.S0022-0302(04)73564-X; Drackley JK, 2014, ANIMAL, V8, P5, DOI 10.1017/S1751731114000731; Drackley JK, 2001, J DAIRY SCI, V84, P1231, DOI 10.3168/jds.S0022-0302(01)74584-5; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Drong C, 2017, J ANIM PHYSIOL AN N, V101, P791, DOI 10.1111/jpn.12494; Drong C, 2016, J ANIM PHYSIOL AN N, V100, P537, DOI 10.1111/jpn.12401; Duffield T, 2002, J DAIRY SCI, V85, P397, DOI 10.3168/jds.S0022-0302(02)74087-3; Duffield TF, 2008, J DAIRY SCI, V91, P2328, DOI 10.3168/jds.2007-0801; Duffield TF, 2008, J DAIRY SCI, V91, P1347, DOI 10.3168/jds.2007-0608; Duffield TF, 2008, J DAIRY SCI, V91, P1334, DOI 10.3168/jds.2007-0607; Duffield TF, 2003, J DAIRY SCI, V86, P1171, DOI 10.3168/jds.S0022-0302(03)73700-X; Duffield TF, 1998, J DAIRY SCI, V81, P2866, DOI 10.3168/jds.S0022-0302(98)75846-1; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Emmerich IU, 2013, TIERAERZTL PRAX G N, V41, P247; Ferreira G, 2015, J DAIRY SCI, V98, P6449, DOI 10.3168/jds.2015-9620; FOSTER LA, 1988, VET CLIN N AM-FOOD A, V4, P253, DOI 10.1016/S0749-0720(15)31047-1; FOX FH, 1971, J DAIRY SCI, V54, P974, DOI 10.3168/jds.S0022-0302(71)85953-2; GfE (Gesellschaft fur Ernahrungsphysiologie), 2001, EMPF EN NAHRST MILCH; Gohary K, 2016, CAN VET J, V57, P733; Grummer RR, 2007, THERIOGENOLOGY, V68, pS281, DOI 10.1016/j.theriogenology.2007.04.031; Grummer RR, 2008, VET J, V176, P10, DOI 10.1016/j.tvjl.2007.12.033; GRUMMER RR, 1993, J DAIRY SCI, V76, P3882, DOI 10.3168/jds.S0022-0302(93)77729-2; Guo J, 2008, J DAIRY SCI, V91, P4293, DOI 10.3168/jds.2007-0962; Hammer KA, 1999, J APPL MICROBIOL, V86, P985, DOI 10.1046/j.1365-2672.1999.00780.x; Hausmann J, 2017, ANIM FEED SCI TECH, V225, P27, DOI 10.1016/j.anifeedsci.2017.01.009; Hayirli A, 2002, J DAIRY SCI, V85, P3430, DOI 10.3168/jds.S0022-0302(02)74431-7; Herdt TH, 2000, VET CLIN N AM-FOOD A, V16, P215, DOI 10.1016/S0749-0720(15)30102-X; Hinde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086169; Jain Sushil K, 2006, Pathophysiology, V13, P163, DOI 10.1016/j.pathophys.2006.05.005; Khiaosa-ard R, 2013, J ANIM SCI, V91, P1819, DOI 10.2527/jas.2012-5691; Kung L, 2008, J DAIRY SCI, V91, P4793, DOI 10.3168/jds.2008-1402; Larsen M, 2012, J DAIRY SCI, V95, P5946, DOI 10.3168/jds.2012-5458; Lean IJ, 2011, J DAIRY SCI, V94, P1465, DOI 10.3168/jds.2010-3682; Leroy JLMR, 2008, REPROD DOMEST ANIM, V43, P96, DOI 10.1111/j.1439-0531.2008.01148.x; Lischer CJ, 2002, VET J, V163, P51, DOI 10.1053/tvjl.2001.0627; McArt JAA, 2015, J DAIRY SCI, V98, P2043, DOI 10.3168/jds.2014-8740; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; McCarthy MM, 2015, J DAIRY SCI, V98, P3351, DOI 10.3168/jds.2014-8821; McIntosh FM, 2003, APPL ENVIRON MICROB, V69, P5011, DOI 10.1128/AEM.69.8.5011-5014.2003; Mirzaei-Alamouti H, 2016, ANIM FEED SCI TECH, V219, P132, DOI 10.1016/j.anifeedsci.2016.06.009; Naumann C, 2004, CHEM UNTERSUCHUNG FU, V3; Offer N. W., 2005, Proceedings of the British Society of Animal Science annual conference 2005, York, UK. 4th-6th April, 2005, P188; Ospina PA, 2010, J DAIRY SCI, V93, P1596, DOI 10.3168/jds.2009-2852; Rehage J., 2014, DTSCH TIERARZTEBL, V2014, P494; Rosendo O, 2004, J DAIRY SCI, V87, P2535, DOI 10.3168/jds.S0022-0302(04)73378-0; Ruoff J, 2017, J DAIRY SCI, V100, P5462, DOI 10.3168/jds.2016-12237; Shi XX, 2015, J STEROID BIOCHEM, V145, P103, DOI 10.1016/j.jsbmb.2014.10.014; Shingfield KJ, 2010, ANIMAL, V4, P1140, DOI 10.1017/S1751731110000510; Stangaferro ML, 2016, J DAIRY SCI, V99, P7395, DOI 10.3168/jds.2016-10907; Staufenbiel R, 1997, PRAKT TIERARZT, V78, P87; Waldrop GL, 2012, PROTEIN SCI, V21, P1597, DOI 10.1002/pro.2156; White HM, 2016, J DAIRY SCI, V99, P812, DOI 10.3168/jds.2015-9953; Wood KM, 2016, J ANIM SCI, V94, P2471, DOI 10.2527/jas.2016-0356; Wright TC, 2006, J DAIRY SCI, V89, P2552, DOI 10.3168/jds.S0022-0302(06)72331-1; Yousefi AR, 2016, THERIOGENOLOGY, V85, P1540, DOI 10.1016/j.theriogenology.2016.01.015; Zebeli Q, 2015, RES VET SCI, V103, P126, DOI 10.1016/j.rvsc.2015.09.020; Zimmerly CA, 2001, J DAIRY SCI, V84, P498, DOI 10.3168/jds.S0022-0302(01)74500-6	66	10	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193685	10.1371/journal.pone.0193685	http://dx.doi.org/10.1371/journal.pone.0193685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584764	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000007
J	Luchsinger, C; Aguilar, M; Burgos, PV; Ehrenfeld, P; Mardones, GA				Luchsinger, Charlotte; Aguilar, Marcelo; Burgos, Patricia V.; Ehrenfeld, Pamela; Mardones, Gonzalo A.			Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR-1; NUCLEOTIDE EXCHANGE FACTOR; BREFELDIN-A; GUANINE-NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOPLASMIC-RETICULUM; SULFIDE DERIVATIVES; PRODRUG CANDIDATES; TYROSINE KINASE; LACTAM ANALOG	Increasing evidence indicates that the Golgi apparatus plays active roles in cancer, but a comprehensive understanding of its functions in the oncogenic transformation has not yet emerged. At the same time, the Golgi is becoming well recognized as a hub that integrates its functions of protein and lipid biosynthesis to signal transduction for cell proliferation and migration in cancer cells. Nevertheless, the active function of the Golgi apparatus in cancer cells has not been fully evaluated as a target for combined treatment. Here, we analyzed the effect of perturbing the Golgi apparatus on the sensitivity of the MDA-MB-231 breast cancer cell line to the drugs Actinomycin D and Vinblastine. We disrupted the function of ARF1, a protein necessary for the homeostasis of the Golgi apparatus. We found that the expression of the ARF1-Q71L mutant increased the sensitivity of MDA-MB-231 cells to both Actinomycin D and Vinblastine, resulting in decreased cell proliferation and cell migration, as well as in increased apoptosis. Likewise, the combined treatment of cells with Actinomycin D or Vinblastine and Brefeldin A or Golgicide A, two disrupting agents of the ARF1 function, resulted in similar effects on cell proliferation, cell migration and apoptosis. Interestingly, each combined treatment had distinct effects on ERK1/2 and AKT signaling, as indicated by the decreased levels of either phospho-ERK1/2 or phospho-AKT. Our results suggest that disruption of Golgi function could be used as a strategy for the sensitization of cancer cells to chemotherapy.	[Luchsinger, Charlotte; Aguilar, Marcelo; Burgos, Patricia V.; Mardones, Gonzalo A.] Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile; [Luchsinger, Charlotte; Aguilar, Marcelo; Burgos, Patricia V.; Ehrenfeld, Pamela; Mardones, Gonzalo A.] Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile; [Burgos, Patricia V.; Mardones, Gonzalo A.] Univ San Sebastian, Sch Med & Sci, Ctr Cell Biol & Biomed CEBICEM, Santiago, Chile; [Burgos, Patricia V.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Aging & Regenerat CARE, Santiago, Chile; [Ehrenfeld, Pamela] Univ Austral Chile, Sch Med, Dept Anat Histol & Pathol, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Universidad San Sebastian; Pontificia Universidad Catolica de Chile; Universidad Austral de Chile	Mardones, GA (corresponding author), Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile.; Mardones, GA (corresponding author), Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile.; Mardones, GA (corresponding author), Univ San Sebastian, Sch Med & Sci, Ctr Cell Biol & Biomed CEBICEM, Santiago, Chile.	gonzalo.mardones@uach.cl	Luchsinger, Charlotte/AAZ-6028-2021	EHRENFELD, INGRID/0000-0002-2519-7570	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [1130710, 1161252, 1171649]; Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT); Comision Nacional de Investigacion Cientifica y Tecnologica [PFB12/2007, AFB1700005]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT); Comision Nacional de Investigacion Cientifica y Tecnologica	This work was funded by grants 1130710, 1161252 (G.A.M.) and 1171649 (P.V.B.) from Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT; http://www.conicyt.cl/fondecyt), and from Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh; http://investigacion.uach.cl) (G.A.M. and P.V.B.). C.L. is supported by a fellowship from Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT; http://www.conicyt.cl). Comision Nacional de Investigacion Cientifica y Tecnologica PFB12/2007 to Patricia V. Burgos, Comision Nacional de Investigacion Cientifica y Tecnologica AFB1700005 to Patricia V. Burgos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyaneh HS, 2017, CANCERS, V9, DOI 10.3390/cancers9100137; Anadu NO, 2006, J MED CHEM, V49, P3897, DOI 10.1021/jm0602817; Archambaud S, 2005, SYNLETT, P139, DOI 10.1055/s-2004-835669; Argade AB, 1998, J ORG CHEM, V63, P273, DOI 10.1021/jo971292y; Argade AB, 1998, J MED CHEM, V41, P3337, DOI 10.1021/jm970746g; Ayala I, 2017, BIOL CELL, V109, P364, DOI 10.1111/boc.201700032; Bates D, 2017, BRIT J CLIN PHARMACO, V83, P255, DOI 10.1111/bcp.13126; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; BERNHARDT G, 1992, J CANCER RES CLIN, V118, P35, DOI 10.1007/BF01192309; Bloom GS, 1998, J CELL BIOL, V140, P1277, DOI 10.1083/jcb.140.6.1277; Boal F, 2010, TRAFFIC, V11, P1537, DOI 10.1111/j.1600-0854.2010.01122.x; BONADONNA G, 1978, ANNU REV MED, V29, P149, DOI 10.1146/annurev.me.29.020178.001053; Borchmann S, 2016, CURR OPIN ONCOL, V28, P377, DOI 10.1097/CCO.0000000000000314; Boulay PL, 2011, ONCOGENE, V30, P3846, DOI 10.1038/onc.2011.100; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Braga S, 2016, METHODS MOL BIOL, V1395, P105, DOI 10.1007/978-1-4939-3347-1_8; Cancino J, 2013, TRAFFIC, V14, P121, DOI 10.1111/tra.12022; Casalou Cristina, 2016, Small GTPases, V7, P270; Chalakur-Ramireddy NKR, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171357; Charest A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/pnas.242741799; Chen FM, 2003, BIOPHYS J, V84, P432, DOI 10.1016/S0006-3495(03)74863-2; CIOCCA DR, 1992, CANCER RES, V52, P3648; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Davis JE, 2016, ONCOTARGET, V7, P39834, DOI 10.18632/oncotarget.9405; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Elyaman W, 2002, J NEUROCHEM, V81, P870, DOI 10.1046/j.1471-4159.2002.00838.x; Forster S, 2008, SYNLETT, P831, DOI 10.1055/s-2008-1042899; Forster S, 2011, EUR J ORG CHEM, V2011, P878, DOI 10.1002/ejoc.201001297; Fox BM, 2001, J MED CHEM, V44, P3915, DOI 10.1021/jm010054z; Gao J, 2008, TETRAHEDRON, V64, P11105, DOI 10.1016/j.tet.2008.09.065; Gendarme M, 2017, MOL BIOL CELL, V28, P3756, DOI 10.1091/mbc.E17-03-0176; Goldstein DP, 2015, EXPERT REV ANTICANC, V15, P1293, DOI 10.1586/14737140.2015.1088786; Gu GF, 2017, ONCOL REP, V37, P1511, DOI 10.3892/or.2017.5388; Haines E, 2015, CANCER BIOL THER, V16, P1535, DOI 10.1080/15384047.2015.1071737; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Ho CY, 2008, J CELL BIOCHEM, V105, P835, DOI 10.1002/jcb.21879; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hosoi H, 2016, PEDIATR INT, V58, P81, DOI 10.1111/ped.12867; Hubscher T, 2006, SYNLETT, P1323, DOI 10.1055/s-2006-941575; Ignashkova TI, 2017, TRAFFIC, V18, P530, DOI 10.1111/tra.12493; ISHII S, 1989, J ANTIBIOT, V42, P1877, DOI 10.7164/antibiotics.42.1877; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaczmarek B, 2017, BIOL CELL, V109, P391, DOI 10.1111/boc.201700042; Kandula Mahesh, 2013, World J Oncol, V4, P137, DOI 10.4021/wjon681e; Kang HJ, 2009, BIOCHEMISTRY-US, V48, P7392, DOI 10.1021/bi9006836; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kawanishi Shosuke, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P415, DOI 10.2174/1568011043352867; Kim MJ, 2015, INT J MOL SCI, V16, P29305, DOI 10.3390/ijms161226168; LADINSKY MS, 1992, EUR J CELL BIOL, V59, P92; Lang LW, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0583-4; Lewis-Saravalli S, 2013, CELL SIGNAL, V25, P1813, DOI 10.1016/j.cellsig.2013.05.011; Linardou H, 2015, ANTICANCER RES, V35, P1105; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lowe M, 2011, CURR OPIN CELL BIOL, V23, P85, DOI 10.1016/j.ceb.2010.10.004; Makowski SL, 2017, CURR OPIN CELL BIOL, V45, P17, DOI 10.1016/j.ceb.2017.01.004; Mamdani H, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0364-2; Mao LN, 2013, J CELL SCI, V126, P1498, DOI 10.1242/jcs.121954; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; Migita T, 2012, INT J BIOCHEM CELL B, V44, P1872, DOI 10.1016/j.biocel.2012.06.004; Morohashi Y, 2010, BIOCHEM J, V427, P401, DOI 10.1042/BJ20091681; Nam YJ, 2016, N-S ARCH PHARMACOL, V389, P951, DOI 10.1007/s00210-016-1242-6; Nan XL, 2017, ONCOTARGET, V8, P75712, DOI 10.18632/oncotarget.20095; Ohashi Y, 2016, CANCER RES, V76, P3895, DOI 10.1158/0008-5472.CAN-15-2220; Ohashi Y, 2012, J BIOL CHEM, V287, P3885, DOI 10.1074/jbc.M111.316125; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Oualla K, 2017, THER ADV MED ONCOL, V9, P493, DOI 10.1177/1758834017711380; Paek SM, 2007, HETEROCYCLES, V71, P1059; Paramanathan T, 2012, NUCLEIC ACIDS RES, V40, P4925, DOI 10.1093/nar/gks069; PHILLIPS LR, 1993, ANAL BIOCHEM, V211, P16, DOI 10.1006/abio.1993.1225; Ramos MC, 2017, EXPERT OPIN THER PAT, V27, P1251, DOI 10.1080/13543776.2017.1349106; Ross BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087357; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sakhrani NM, 2013, DRUG DES DEV THER, V7, P585, DOI 10.2147/DDDT.S45614; Samadi N, 2014, J CANCER RES THER, V10, P715, DOI 10.4103/0973-1482.139152; Schlienger S, 2015, CELL SIGNAL, V27, P403, DOI 10.1016/j.cellsig.2014.11.032; Seehafer K, 2013, J MED CHEM, V56, P5872, DOI 10.1021/jm400615g; Shao FY, 2017, ONCOTARGET, V8, P73329, DOI 10.18632/oncotarget.20274; Shao RG, 1996, EXP CELL RES, V227, P190, DOI 10.1006/excr.1996.0266; Shtutman M, 2011, P NATL ACAD SCI USA, V108, P12449, DOI 10.1073/pnas.1103842108; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; So B, 2017, CRIT REV ONCOL HEMAT, V113, P135, DOI 10.1016/j.critrevonc.2017.03.004; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Sonpavde G, 2016, J CLIN ONCOL, V34, P780, DOI 10.1200/JCO.2015.65.4442; Sotiropoulou PA, 2014, DRUG DISCOV TODAY, V19, P1547, DOI 10.1016/j.drudis.2014.05.002; TAMURA G, 1968, J ANTIBIOT, V21, P160, DOI 10.7164/antibiotics.21.160; Tenorio MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154719; Tenorio MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135260; THYBERG J, 1978, CELL TISSUE RES, V193, P247; THYBERG J, 1985, EXP CELL RES, V159, P1, DOI 10.1016/S0014-4827(85)80032-X; Tsai MM, 2012, CANCER SCI, V103, P1136, DOI 10.1111/j.1349-7006.2012.02243.x; Tseng CN, 2014, MOLECULES, V19, P17464, DOI 10.3390/molecules191117464; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; VIRTANEN I, 1986, EUR J CELL BIOL, V42, P281; Weaver MS, 2015, J PEDIAT HEMATOL ONC, V37, P237, DOI 10.1097/MPH.0000000000000286; WEHLAND J, 1983, P NATL ACAD SCI-BIOL, V80, P4286, DOI 10.1073/pnas.80.14.4286; Wilson C, 2011, BIOCHEM J, V433, P1, DOI 10.1042/BJ20101058; Wlodkowic D, 2009, LEUKEMIA RES, V33, P1440, DOI 10.1016/j.leukres.2009.05.025; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Wyrozumska P., 2014, CELL LOGIST, V4, P27732; Xie XY, 2016, ONCOTARGET, V7, P58111, DOI 10.18632/oncotarget.11185; Xu XH, 2017, ANN HEMATOL, V96, P847, DOI 10.1007/s00277-017-2949-2; Zeghouf M, 2005, BIOCHEM SOC T, V33, P1265, DOI 10.1042/BST0331265; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; Zhang MH, 2014, TARGET ONCOL, V9, P349, DOI 10.1007/s11523-013-0300-y; Zhou C, 2013, NEUROSCIENCE, V254, P361, DOI 10.1016/j.neuroscience.2013.09.045; Zhou H, 2016, CELL DEATH DIFFER, V23, P2031, DOI 10.1038/cdd.2016.86; Zhu CF, 2011, J CANCER RES CLIN, V137, P1587, DOI 10.1007/s00432-011-1049-2	115	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195401	10.1371/journal.pone.0195401	http://dx.doi.org/10.1371/journal.pone.0195401			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614107	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600056
J	Ogawa, K; Aoki, M; Kadono, S; Odani, A				Ogawa, Kazuma; Aoki, Miho; Kadono, Sumi; Odani, Akira			Complexes of myo-inositol-hexakisphosphate (InsP6) with zinc or lanthanum to enhance excretion of radioactive strontium from the body	PLOS ONE			English	Article							CHERNOBYL; CALCIUM	Sr-90, which was released into the atmosphere and the ocean following the Chernobyl and Fukushima Daiichi nuclear power plant disasters, is an important nuclear fission element. Compounds that inhibit the absorption of Sr-90 into the bloodstream and enhance its elimination can be beneficial in decreasing the absorbed radiation dose in people exposed to Sr-90. Recently, we prepared complexes of myo-inositol-hexakisphosphate (InsP6) with zinc or lanthanum as decorporation agents. These complexes, called Zn-InsP6 and La-InsP6 respectively, are insoluble in water and can potentially chelate additional metal cations. Hypothesizing that these complexes can assist the excretion of Sr-90 from the body, we evaluated them using Sr-85 instead of Sr-90. In in vitro binding experiments, Zn-InsP6 showed higher strontium adsorption capacity than La-InsP6. We then performed in vivo biodistribution experiments of Zn-InsP6 in mice after oral administration of (SrCl2)-Sr-85. Mice treated with Zn-InsP6 showed significantly lower bone accumulation of radioactivity than mice in a non treatment control group. Zn-InsP6 adsorbed radiostrontium in the gastrointestinal tract, inhibited this ion's absorption into the bloodstream, and enhanced its excretion in the feces. Therefore, Zn-InsP6 appears to be a promising Sr-90 "decorporation" agent.	[Ogawa, Kazuma] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan; [Aoki, Miho; Kadono, Sumi; Odani, Akira] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Ogawa, K (corresponding author), Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan.	kogawa@p.kanazawa-u.ac.jp	ODANI, Akira/B-3043-2011; Ogawa, Kazuma/D-8406-2015	ODANI, Akira/0000-0003-3786-6740; Ogawa, Kazuma/0000-0002-1691-7302				BARNES DWH, 1970, INT J RADIAT BIOL RE, V18, P531, DOI 10.1080/09553007014551461; Brumfiel G, 2011, NATURE, V474, P135, DOI 10.1038/474135a; Davis J, 2000, J NUCL MED, V41, P183; DUNGWORTH DL, 1969, BLOOD-J HEMATOL, V34, P610, DOI 10.1182/blood.V34.5.610.610; Evangeliou N, 2014, ENVIRON INT, V64, P17, DOI 10.1016/j.envint.2013.11.020; GRAF E, 1990, FREE RADICAL BIO MED, V8, P61, DOI 10.1016/0891-5849(90)90146-A; Graf E., 1983, Journal of the American Oil Chemists' Society, V60, P1861; Haratake M, 2012, CHEM PHARM BULL, V60, P1258, DOI 10.1248/cpb.c12-00430; HARRISON JE, 1966, CAN MED ASSOC J, V94, P1092; Kanai Y, 2012, J ENVIRON RADIOACTIV, V111, P33, DOI 10.1016/j.jenvrad.2011.10.011; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Liepe K, 2003, J NUCL MED, V44, P953; Ogawa K, 2012, CURR MED CHEM, V19, P3290, DOI 10.2174/092986712801215865; OGAWA K, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148080; Ogawa K, 2017, CHEM PHARM BULL, V65, P261, DOI 10.1248/cpb.c16-00792; Ogawa K, 2009, NUCL MED BIOL, V36, P129, DOI 10.1016/j.nucmedbio.2008.11.007; SIMPSON CJ, 1990, BRIT J NUTR, V64, P225, DOI 10.1079/BJN19900024; Stabin MG, 2005, J NUCL MED, V46, P1023; SUTTON A, 1967, NATURE, V216, P1005, DOI 10.1038/2161005a0; Szkudelski T, 2005, J ANIM PHYSIOL AN N, V89, P397, DOI 10.1111/j.1439-0396.2005.00532.x; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P5, DOI [10.1111/j.1749-6632.2009.04821.x, 10.1111/j.1749-6632.2009.04820.x]	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195067	10.1371/journal.pone.0195067	http://dx.doi.org/10.1371/journal.pone.0195067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614122	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600028
J	Perez-Rueda, E; Hernandez-Guerrero, R; Martinez-Nunez, MA; Armenta-Medina, D; Sanchez, I; Ibarra, JA				Perez-Rueda, Ernesto; Hernandez-Guerrero, Rafael; Martinez-Nunez, Mario Alberto; Armenta-Medina, Dagoberto; Sanchez, Israel; Ibarra, J. Antonio			Abundance, diversity and domain architecture variability in prokaryotic DNA-binding transcription factors	PLOS ONE			English	Article							ARAC/XYLS FAMILY; GENOME SIZE; REGULATORS; DATABASE; INFORMATION; REPERTOIRE; EVOLUTION; PROTEINS; BACTERIA; MOTIF	Gene regulation at the transcriptional level is a central process in all organisms, and DNA binding transcription factors, known as TFs, play a fundamental role. This class of proteins usually binds at specific DNA sequences, activating or repressing gene expression. In general, TFs are composed of two domains: the DNA-binding domain (DBD) and an extra domain, which in this work we have named "companion domain" (CD). This latter could be involved in one or more functions such as ligand binding, protein-protein interactions or even with enzymatic activity. In contrast to DBDs, which have been widely characterized both experimentally and bioinformatically, information on the abundance, distribution, variability and possible role of the CDs is scarce. Here, we investigated these issues associated with the domain architectures of TFs in prokaryotic genomes. To this end, 19 families of TFs in 761 non-redundant bacterial and archaeal genomes were evaluated. In this regard we found four main groups based on the abundance and distribution in the analyzed genomes: i) LysR and TetR/AcrR; ii) AraC/XyIS, SinR, and others; iii) Lrp, Fis, ArsR, and others; and iv) a group that included only two families, ArgR and BirA. Based on a classification of the organisms according to the life-styles, a major abundance of regulatory families in free-living organisms, in contrast with pathogenic, extremophilic or intracellular organisms, was identified. Finally, the protein architecture diversity associated to the 19 families considering a weight score for domain promiscuity evidenced which regulatory families were characterized by either a large diversity of CDs, here named as "promiscuous" families given the elevated number of variable domains found in those TFs, or a low diversity of CDs. Altogether this information helped us to understand the diversity and distribution of the 19 Prokaryotes TF families. Moreover, initial steps were taken to comprehend the variability of the extra domain in those TFs, which eventually might assist in evolutionary and functional studies.	[Perez-Rueda, Ernesto; Hernandez-Guerrero, Rafael; Sanchez, Israel] Univ Nacl Autonoma Mexico, Unidad Acad Yucatan, Inst Invest Matemat Aplicadas & Sistemas, Merida, Yucatan, Mexico; [Perez-Rueda, Ernesto] UNAM, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca, Morelos, Mexico; [Martinez-Nunez, Mario Alberto] UNAM, Fac Ciencias, Lab Ecogen, Unidad Acad Ciencias & Tecnol Yucatan, Merida, Yucatan, Mexico; [Armenta-Medina, Dagoberto] Infotec, Aguascalientes, Aguascalientes, Mexico; [Ibarra, J. Antonio] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Lab Genet Microbiana, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; INFOTEC - Centro de Investigacion e Innovacion en Tecnologias de la Informacion y Comunicacion; Instituto Politecnico Nacional - Mexico	Perez-Rueda, E (corresponding author), Univ Nacl Autonoma Mexico, Unidad Acad Yucatan, Inst Invest Matemat Aplicadas & Sistemas, Merida, Yucatan, Mexico.; Perez-Rueda, E (corresponding author), UNAM, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca, Morelos, Mexico.; Ibarra, JA (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Lab Genet Microbiana, Ciudad De Mexico, Mexico.	ernesto.perez@iimas.unam.mx; jaig19@gmail.com	Ibarra, J. Antonio/R-2030-2018; Martinez-Nuñez, Mario Alberto/AAH-6079-2019; Perez-Rueda, Ernesto/D-7468-2016	Ibarra, J. Antonio/0000-0002-5016-0622; Martinez-Nuñez, Mario Alberto/0000-0001-8907-2542; Perez-Rueda, Ernesto/0000-0002-6879-0673; Hernandez Guerrero, Rafael/0000-0003-1096-5968	Secretaria de Investigacion y Posgrado from Instituto Politecnico Nacional [20180647]; DGAPA-Universidad Nacional Autonoma de Mexico [IN-201117, IA-205417]	Secretaria de Investigacion y Posgrado from Instituto Politecnico Nacional; DGAPA-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	JAI was supported by grant 20180647 from Secretaria de Investigacion y Posgrado from Instituto Politecnico Nacional; EP-R and MAM-N were funded by DGAPA-Universidad Nacional Autonoma de Mexico (IN-201117 and IA-205417, respectively). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Nunez MA, 2015, PROTEINS, V83, P1625, DOI 10.1002/prot.24847; Martinez-Nunez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069707; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Chakravartty V, 2013, J BIOL CHEM, V288, P36029, DOI 10.1074/jbc.M113.525618; Charlier D, 2004, BIOCHEM SOC T, V32, P310, DOI 10.1042/BST0320310; Engstrom MD, 2017, SYN SYST BIOTECHNO, V2, P176, DOI 10.1016/j.synbio.2017.09.003; Fernandez-Lopez R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00648; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; GALLEGOS MT, 1993, NUCLEIC ACIDS RES, V21, P807, DOI 10.1093/nar/21.4.807; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Ibarra JA, 2008, GENETICA, V133, P65, DOI 10.1007/s10709-007-9185-y; Balderas-Martinez YI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065723; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Lee B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S5; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Pareja E, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-29; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; Perez-Rueda Ernesto, 2012, Science Progress, V95, P315, DOI 10.3184/003685012X13420097673409; Perez-Rueda E, 2009, MOL BIOSYST, V5, P1494, DOI 10.1039/b907384a; R-Programming Development Core Team, 2011, R LANG ENV STAT COMP; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Ranea JAG, 2005, TRENDS GENET, V21, P21, DOI 10.1016/j.tig.2004.11.014; Ranea JAG, 2004, J MOL BIOL, V336, P871, DOI 10.1016/j.jmb.2003.12.044; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Stothard P, 2005, NUCLEIC ACIDS RES, V33, pD317, DOI 10.1093/nar/gki075; Suvorova IA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132618; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001	34	29	31	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195332	10.1371/journal.pone.0195332	http://dx.doi.org/10.1371/journal.pone.0195332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614096	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600049
J	Bibi, N; Farwa, S; Muhammad, N; Jahngir, A; Usman, M				Bibi, Nargis; Farwa, Shabieh; Muhammad, Nazeer; Jahngir, Adnan; Usman, Muhammad			A novel encryption scheme for high-contrast image data in the Fresnelet domain	PLOS ONE			English	Article								In this paper, a unique and more distinctive encryption algorithm is proposed. This is based on the complexity of highly nonlinear S box in Flesnelet domain. The nonlinear pattern is transformed further to enhance the confusion in the dummy data using Fresnelet technique. The security level of the encrypted image boosts using the algebra of Galois field in Fresnelet domain. At first level, the Fresnelet transform is used to propagate the given information with desired wavelength at specified distance. It decomposes given secret data into four complex subbands. These complex sub-bands are separated into two components of real subband data and imaginary subband data. At second level, the net subband data, produced at the first level, is deteriorated to non-linear diffused pattern using the unique S box defined on the Galois field I. In the diffusion process, the permuted image is substituted via dynamic algebraic S-box substitution. We prove through various analysis techniques that the proposed scheme enhances the cipher security level, extensively.	[Bibi, Nargis] COMSATS Inst Informat Technol, Dept Math, Wah Cantt, Pakistan; [Farwa, Shabieh; Muhammad, Nazeer; Jahngir, Adnan] Fatima Jinnah Women Univ, Dept Comp Sci, Rawalpindi, Pakistan; [Usman, Muhammad] Ghulam Ishaq Khan Inst Engn Sci & Technol, Dept Engn Sci, Sawabi 23640, Pakistan	COMSATS University Islamabad (CUI); GIK Institute Engineering Science & Technology	Muhammad, N (corresponding author), Fatima Jinnah Women Univ, Dept Comp Sci, Rawalpindi, Pakistan.	nazeer@hanyang.ac.kr	Bibi, Nargis/ABE-6506-2021; Usman, Muhammad/N-2627-2015; Muhammad, Nazeer/M-5653-2018	Usman, Muhammad/0000-0003-3728-082X; Muhammad, Nazeer/0000-0002-4056-9854				Ahmad J, 2017, NEURAL COMPUT APPL, P111; Ahmed N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00645; Bashir Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22060867; Bibi N., 2018, CIRCUITS SYSTEMS SIG, V37; Bibi N, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2413-0; Biham E., 1991, Journal of Cryptology, V4, P3, DOI 10.1007/BF00630563; Carlet C, 2007, FINITE FIELDS TH APP, V13; Farwa S, 2017, INT J ADV COMPUTER S, V8; Farwa S, 2017, 3D RES, V8, DOI 10.1007/s13319-017-0135-x; Farwa S, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3298-7; Hussain I, 2012, Z NATURFORSCH A, V67; Hussain I, 2012, Z NATURFORSCH A, V67; Hussain I, 2013, NEURAL COMPUT APPL, V23, P97104; Hussain I, 2011, P PAK ACAD SCI, V48; Jamal SS, 2017, WIREL NETW, P113; Khan MA, 2018, PATTERN ANAL APPL; Kim J, 2009, CRYPTOLOGIA, V33, P246, DOI 10.1080/01611190802653228; Liu HJ, 2012, APPL SOFT COMPUT, V12, P1457, DOI 10.1016/j.asoc.2012.01.016; Liu HJ, 2011, OPT COMMUN, V284, P3895, DOI 10.1016/j.optcom.2011.04.001; Liu HJ, 2010, COMPUT MATH APPL, V59, P3320, DOI 10.1016/j.camwa.2010.03.017; Mahmood Z, 2017, KSII TRANSACTIONS ON, V11; Mahmood Z, 2017, FRACTALS, V25, DOI 10.1142/S0218348X17500256; Matsui M., WORKSH THEOR APPL CR; Mughal B., 2017, BIOMEDICAL RES, V28; Mughal B., 2018, MICROSC RES TECHNIQ, V81; Mughal B, 2017, EUR PHYS J PLUS, V132, DOI 10.1140/epjp/i2017-11523-8; Muhammad N, 2015, IET IMAGE PROCESS, V9; Muhammad N, 2017, PATTERN ANAL APPL, P110; Muhammad N., 2017, COMPUTERS ELECT ENG; Muhammad N, 2017, PATTERN ANAL APPL, P116; Muhammad N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176979; Muhammad N, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1534-1; Rehman AU, 2016, 3D RES, V7, DOI 10.1007/s13319-016-0084-9; Shannon C. E., 1949, BELL SYST TECH J, V28; Venkatachalam S, EL INF ENG ICEIE 201, V1; Wang XY, 2015, OPT LASER ENG, V73, P53, DOI 10.1016/j.optlaseng.2015.03.022; Wang XY, 2010, NONLINEAR DYNAM, V62, P615, DOI 10.1007/s11071-010-9749-8; Wang XY, 2015, OPT LASER ENG, V66, P10, DOI 10.1016/j.optlaseng.2014.08.005; Wang XY, 2014, NONLINEAR DYNAM, V75, P567, DOI 10.1007/s11071-013-1086-2; Wang XY, 2012, SIGNAL PROCESS, V92, P1101, DOI 10.1016/j.sigpro.2011.10.023; Xian ZH, 2011, ADVANCED MATERIALS R, V171; Zeghid M, 2007, WORLD ACAD SCI ENG T, V27; Zhang YQ, 2015, APPL SOFT COMPUT, V26, P10, DOI 10.1016/j.asoc.2014.09.039; Zhang YQ, 2014, INFORM SCIENCES, V273, P329, DOI 10.1016/j.ins.2014.02.156	44	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194343	10.1371/journal.pone.0194343	http://dx.doi.org/10.1371/journal.pone.0194343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608609	Green Published, gold			2022-12-27	WOS:000428988800008
J	Craft, CL; Moore, BD; Ran, Y; Chakrabarty, P; Levites, Y; Golde, TE; Giasson, BI				Craft, Cara L.; Moore, Brenda D.; Ran, Yong; Chakrabarty, Paramita; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.			Novel monoclonal antibodies targeting the microtubule-binding domain of human tau	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; CORTICOBASAL DEGENERATION; PICKS-DISEASE; MOUSE MODEL; PROTEIN-TAU; HUMAN-BRAIN; ISOFORMS	Tauopathies including Alzheimer's disease and Progressive Supranuclear Palsy are a diverse group of progressive neurodegenerative disorders pathologically defined by inclusions containing aberrantly aggregated, post-translationally modified tau. The tau pathology burden correlates with neurodegeneration and dementia observed in these diseases. The microtubule binding domain of tau is essential for its physiological functions in promoting neuronal cytoskeletal stability, however it is also required for tau to assemble into an amyloid structure that comprises pathological inclusions. A series of novel monoclonal antibodies were generated which recognize the second and fourth microtubule-binding repeat domain of tau, thus enabling the identification specifically of 4-repeat tau versus 3-/4-repeat tau, respectively. These antibodies are highly specific for tau and recognize pathological tau inclusions in human tauopathies including Alzheimer's disease and Progressive Supranuclear Palsy and in transgenic mouse models of tauopathies. These new antibodies will be useful for identifying and characterizing different tauopathies and as tools to target tau pathology in these diseases.	[Craft, Cara L.; Moore, Brenda D.; Ran, Yong; Chakrabarty, Paramita; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Craft, Cara L.; Moore, Brenda D.; Ran, Yong; Chakrabarty, Paramita; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Chakrabarty, Paramita; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.; Giasson, BI (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.; Giasson, BI (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32611 USA.	bgiasson@ufl.edu		Moore, Brenda/0000-0002-9685-6561; Croft, Cara Louise/0000-0001-7969-5084	National Institute of Neurological Disorders and Stroke [NS089622]; National Institute on Aging [AG047266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089622] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS089622) (https://www.ninds.nih.gov/) to BIG and the National Institute on Aging (AG047266) (https://www.nia.nih.gov/) to TEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS089622) to Benoit I. Giasson and the National Institute on Aging (AG047266) to Todd E. Golde.	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Avale ME, 2013, HUM MOL GENET, V22, P2603, DOI 10.1093/hmg/ddt108; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRANDT R, 1994, CELL MOTIL CYTOSKEL, V28, P143, DOI 10.1002/cm.970280206; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Buee L, 1999, BRAIN PATHOL, V9, P681; Coughlin D, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0779-1; Croft CL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.97; Dawson HN, 2001, J CELL SCI, V114, P1179; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0298-7; Golde TE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt233; Golde TE, 2013, NEURON, V80, P254, DOI 10.1016/j.neuron.2013.10.009; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hasegawa M, 2014, ACTA NEUROPATHOL, V127, P303, DOI 10.1007/s00401-013-1191-9; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; Hong M, 1998, SCIENCE, P282; Komori T, 1999, BRAIN PATHOL, V9, P663; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2016, ACTA NEUROPATHOL, V131, P27, DOI 10.1007/s00401-015-1507-z; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; Peck A, 2011, CYTOSKELETON, V68, P44, DOI 10.1002/cm.20494; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Pooler AM, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt214; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	46	8	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195211	10.1371/journal.pone.0195211	http://dx.doi.org/10.1371/journal.pone.0195211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608591	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800038
J	Kim, E; Wu, HG; Park, JM; Kim, JI; Kim, HJ; Kang, HC				Kim, Eunji; Wu, Hong-Gyun; Park, Jong Min; Kim, Jung-in; Kim, Hak Jae; Kang, Hyun-Cheol			Lung density change after SABR: A comparative study between tri-Co-60 magnetic resonance-guided system and linear accelerator	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; RADIATION-THERAPY SYSTEM; ABLATIVE RADIOTHERAPY; INOPERABLE PATIENTS; PULMONARY-FUNCTION; CANCER PATIENTS; POOLED ANALYSIS; INJURY; PNEUMONITIS; CT	Radiation-induced lung damage is an important treatment-related toxicity after lung stereo tactic ablative radiotherapy (SABR). After implementing a tri-Co-60 magnetic-resonance image guided system, ViewRay (TM), we compared the associated early radiological lung density changes to those associated with a linear accelerator (LINAC). Eight patients treated with the tri-Co-60 system were matched 1:1 with patients treated with LINAC. Prescription doses were 52 Gy or 60 Gy in four fractions, and lung dose-volumetric parameters were calculated from each planning system. The first two follow-up computed tomography (CT) were co-registered with the planning CT through deformable registration software, and lung density was measured by isodose levels. Tumor size was matched between the two groups, but the planning target volume of LINAC was larger than that of the tri-Co-60 system (p = 0.036). With regard to clinically relevant dose-volumetric parameters in the lungs, the ipsilateral lung mean dose, V-10Gy and V-20Gy were significantly poorer in tri-Co-60 plans compared to LINAC plans (p= 0.012, 0.036, and 0.017, respectively). Increased lung density was not observed in the first follow-up scan compared to the planning scan. A significant change of lung density was shown in the second follow-up scan and there was no meaningful difference between the tri-Co-60 system and LINAC for all dose regions. In addition, no patient developed clinical radiation pneumonitis until the second follow-up scan. Therefore, there was no significant difference in the early radiological lung damage between the tri-Co-60 system and LINAC for lung SABR despite of the inferior plan quality of the tri-Co-60 system compared to that of LINAC. Further studies with a longer follow-up period are needed to confirm our findings.	[Kim, Eunji; Wu, Hong-Gyun; Park, Jong Min; Kim, Jung-in; Kim, Hak Jae; Kang, Hyun-Cheol] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Wu, Hong-Gyun; Park, Jong Min; Kim, Jung-in; Kim, Hak Jae; Kang, Hyun-Cheol] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Wu, Hong-Gyun; Park, Jong Min; Kim, Jung-in; Kim, Hak Jae; Kang, Hyun-Cheol] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, HC (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea.; Kang, HC (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.; Kang, HC (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	hermes-shule@hanmail.net			National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [1631200]	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (grant No. 1631200). The funding source had no role in the design of this study, in data collection and interpretation, in deciding to publish, or in writing the manuscript.	Allibhai Z, 2013, INT J RADIAT ONCOL, V87, P1064, DOI 10.1016/j.ijrobp.2013.08.020; [Anonymous], 0813 RTOG; [Anonymous], 0915 RTOG; Chang JY, 2015, LANCET ONCOL, V16, P630, DOI 10.1016/S1470-2045(15)70168-3; Chang JY, 2015, J THORAC ONCOL, V10, P577, DOI 10.1097/JTO.0000000000000453; Chen HB, 2017, INT J RADIAT ONCOL, V98, P622, DOI 10.1016/j.ijrobp.2017.03.010; Choi YW, 2004, RADIOGRAPHICS, V24, P985, DOI 10.1148/rg.244035160; Crabtree T, 2013, J THORAC CARDIOV SUR, V145, P692, DOI 10.1016/j.jtcvs.2012.10.038; DAVIS SD, 1992, AM J ROENTGENOL, V159, P1157, DOI 10.2214/ajr.159.6.1442375; Fujino M, 2006, CANCER J, V12, P41, DOI 10.1097/00130404-200601000-00008; Guckenberger M, 2007, RADIOTHER ONCOL, V85, P435, DOI 10.1016/j.radonc.2007.10.044; Jenkins P, 2011, INT J RADIAT ONCOL, V81, P97, DOI 10.1016/j.ijrobp.2010.05.017; Kahan Z, 2007, INT J RADIAT ONCOL, V68, P673, DOI 10.1016/j.ijrobp.2006.12.016; Kishan AU, 2015, TECHNOL CANCER RES T, V14, P411, DOI 10.1177/1533034614551476; Koenig TR, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781383; LIBSHITZ HI, 1973, CANCER, V32, P206, DOI 10.1002/1097-0142(197307)32:1<206::AID-CNCR2820320131>3.0.CO;2-9; Ma JL, 2010, INT J RADIAT ONCOL, V76, P116, DOI 10.1016/j.ijrobp.2009.01.025; MAH K, 1988, RADIOTHER ONCOL, V11, P169, DOI 10.1016/0167-8140(88)90253-8; Mehta V, 2005, INT J RADIAT ONCOL, V63, P5, DOI 10.1016/j.ijrobp.2005.03.047; Min Park Jong, 2015, [PROGRESS in MEDICAL PHYSICS, 의학물리], V26, P193; Mutic S, 2014, SEMIN RADIAT ONCOL, V24, P196, DOI 10.1016/j.semradonc.2014.02.008; Palma DA, 2011, INT J RADIAT ONCOL, V81, P974, DOI 10.1016/j.ijrobp.2010.07.025; Park JM, 2016, RADIOTHER ONCOL, V120, P279, DOI 10.1016/j.radonc.2016.06.013; Park KJ, 2000, RADIOGRAPHICS, V20, P83, DOI 10.1148/radiographics.20.1.g00ja0483; Phernambucq ECJ, 2011, LUNG CANCER, V74, P451, DOI 10.1016/j.lungcan.2011.05.010; Ricardi U, 2015, RADIAT ONCOL J, V33, P57, DOI 10.3857/roj.2015.33.2.57; ROACH M, 1995, J CLIN ONCOL, V13, P2606, DOI 10.1200/JCO.1995.13.10.2606; Rosner B., 1995, FUNDAMENTALS BIOSTAT, P221; Sharifi H, 2016, ACTA ONCOL, V55, P156, DOI 10.3109/0284186X.2015.1080856; Stephans KL, 2009, J THORAC ONCOL, V4, P838, DOI 10.1097/JTO.0b013e3181a99ff6; Takeda A, 2008, INT J RADIAT ONCOL, V70, P1057, DOI 10.1016/j.ijrobp.2007.07.2383; Takeda A, 2010, INT J RADIAT ONCOL, V77, P685, DOI 10.1016/j.ijrobp.2009.06.001; Takeda T, 2004, AM J ROENTGENOL, V182, P1123, DOI 10.2214/ajr.182.5.1821123; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Wooten HO, 2015, INT J RADIAT ONCOL, V92, P771, DOI 10.1016/j.ijrobp.2015.02.057; Wooten HO, 2015, RADIOTHER ONCOL, V114, P402, DOI 10.1016/j.radonc.2015.01.015; Zhao J, 2016, INT J RADIAT ONCOL, V95, P1357, DOI 10.1016/j.ijrobp.2016.03.024	37	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195196	10.1371/journal.pone.0195196	http://dx.doi.org/10.1371/journal.pone.0195196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608606	Green Published, gold			2022-12-27	WOS:000428988800036
J	Skjaervold, NK; Knai, K; Elvemo, N				Skjaervold, Nils Kristian; Knai, Kathrine; Elvemo, Nicolas			Some oscillatory phenomena of blood glucose regulation: An exploratory pilot study in pigs	PLOS ONE			English	Article							PULSATILE INSULIN-SECRETION; GLYCEMIC PROFILE; COMPLEXITY; ROUTE	It is well-known that blood glucose oscillates with a period of approximately 15 min (900 s) and exhibits an overall complex behaviour in intact organisms. This complexity is not thoroughly studied, and thus, we aimed to decipher the frequency bands entailed in blood glucose regulation. We explored high-resolution blood glucose time-series sampled using a novel continuous intravascular sensor in four pigs under general anaesthesia for almost 24 hours. In all time series, we found several interesting oscillatory components, especially in the 5000-10000 s, 500-1000 s, and 50-100 s regions (0.0002-0.0001 Hz, 0.002-0.001 Hz, and 0.02-0.01 Hz). The presence of these oscillations is not permanent, as they come and go. This is the first report of glucose oscillations in the 50-100 s range. The origin of these oscillations and their role in overall blood glucose regulation is unknown. Although the sample size is small, we believe this finding is important for our understanding of glucose regulation and perhaps for our understanding of general homeostatic regulation in intact organisms.	[Skjaervold, Nils Kristian; Knai, Kathrine] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Skjaervold, Nils Kristian] Trondheim Reg & Univ Hosp, Dept Cardiothorac Anaesthesia & Intens Care Med, Trondheim, Norway; [Elvemo, Nicolas] Glucoset AS, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Skjaervold, NK (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway.; Skjaervold, NK (corresponding author), Trondheim Reg & Univ Hosp, Dept Cardiothorac Anaesthesia & Intens Care Med, Trondheim, Norway.	nils.k.skjaervold@ntnu.no		Elvemo, Nicolas-Andreas/0000-0002-5527-7985; Skjaervold, Nils Kristian/0000-0002-0085-7042	Norwegian University of Science and Technology	Norwegian University of Science and Technology	The cost of the animal experiments and the salaries of NKS and KK were provided by Norwegian University of Science and Technology. The glucose sensors used were fabricated and provided by GlucoSet AS who provided support in the form of salaries for author NE who, as CEO and shareholder of GlucoSetAS, was involved in study design, analysis and interpretation of data and writing of the paper. GlucoSet AS did not have any additional role in the data collection or decision to publish. The specific role of NE is articulated in the 'author contributions' section.	ANDREWS RJ, 1994, NEUROSURGERY, V34, P466, DOI 10.1227/00006123-199403000-00012; [Anonymous], 2021, LANG ENV STAT COMP; Brunner R, 2012, CRIT CARE, V16, DOI 10.1186/cc11657; Churruca J, 2008, DIABETES METAB SYNDR, V1, P3; Fugal DL, 2009, CONC WAV DIG SIGN PR; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Hellman B, 2009, UPSALA J MED SCI, V114, P193, DOI 10.3109/03009730903366075; Holt TA, 2002, DIABETIC MED, V19, P274, DOI 10.1046/j.1464-5491.2002.00662.x; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kroll MH, 1999, BIOSYSTEMS, V50, P189, DOI 10.1016/S0303-2647(99)00007-6; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Langeland H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13216; Lundelin K, 2010, CRIT CARE MED, V38, P849, DOI 10.1097/CCM.0b013e3181ce49cf; Matveyenko AV, 2008, AM J PHYSIOL-ENDOC M, V295, pE569, DOI 10.1152/ajpendo.90335.2008; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Signal Matthew, 2013, J Diabetes Sci Technol, V7, P1492; Skjaervold NK, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/245152; Skjaervold NK, 2012, DIABETES TECHNOL THE, V14, P23, DOI 10.1089/dia.2011.0118; Skjaervold NK, 2011, ANESTHESIOLOGY, V114, P120, DOI 10.1097/ALN.0b013e3181ff4187; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1; Varela M, 2010, PERSPECT BIOL MED, V53, P584, DOI 10.1353/pbm.2010.0003	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194826	10.1371/journal.pone.0194826	http://dx.doi.org/10.1371/journal.pone.0194826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608585	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800018
J	Wise, MG; Estabrook, MA; Sahm, DF; Stone, GG; Kazmierczak, KM				Wise, Mark G.; Estabrook, Mark A.; Sahm, Daniel F.; Stone, Gregory G.; Kazmierczak, Krystyna M.			Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program	PLOS ONE			English	Article							PLASMID-MEDIATED MCR-1; ESCHERICHIA-COLI; CARBAPENEM-RESISTANT; EXTENDED-SPECTRUM; INFECTIONS; EMERGENCE; STRAIN; SUSCEPTIBILITY; BLA(CTX-M-15); HOSPITALS	A set of 908 clinically derived colistin-resistant Enterobacteriaeae isolates collected worldwide in 2014-2016 were screened for the presence of the plasmid-borne mcr-1, mcr-2, mcr3, mcr-4 and mcr-5 genes. In total 3.2% (29/908) of the collection were positive for mcr, including 27 Escherichia coli, 1 Klebsiella pneumoniae and 1 Enterobacter cloacae. Twenty-four isolates possessed genes from the mcr-1 family, including the original mcr-1 (n = 22), as well as mcr-1.2 (n =1) and mcr-1.5 (n = 1), which each differ from mcr-1 by encoding single amino acid variations. Genes from the mcr-3 family were found in isolates from Thailand, including mcr-3.1 (n = 3) and mcr-3.2 (n = 1). An E. coli isolated from a patient with a urinary tract infection in Colombia contained the recently discovered mcr-5. The full colistin-resistant collection was tested against a panel of antimicrobial agents with ceftazidime-avibactam and tigecycline exhibiting the highest activity.	[Wise, Mark G.; Estabrook, Mark A.; Sahm, Daniel F.; Kazmierczak, Krystyna M.] Int Hlth Management Associates, Schaumburg, IL 60173 USA; [Stone, Gregory G.] AstraZeneca, Waltham, MA USA; [Stone, Gregory G.] Pfizer Inc, Groton, CT 06340 USA	AstraZeneca; Pfizer	Wise, MG (corresponding author), Int Hlth Management Associates, Schaumburg, IL 60173 USA.	mwise@ihma.com		Wise, Mark/0000-0001-7356-1851	AstraZeneca Pharmaceuticals, LP	AstraZeneca Pharmaceuticals, LP(AstraZeneca)	All work was performed at IHMA and sponsored by AstraZeneca Pharmaceuticals, LP, which also included compensation fees for manuscript preparation. AstraZeneca's rights to ceftazidime-avibactam were acquired by Pfizer in December 2016.	Al-Tawfiq JA, 2017, INT J INFECT DIS, V54, P77, DOI 10.1016/j.ijid.2016.11.415; Baron S, 2017, J GLOB ANTIMICROB RE, V10, P35, DOI 10.1016/j.jgar.2017.05.004; Borowiak M, 2017, J ANTIMICROB CHEMOTH; Carattoli A, 2017, EURO SURVEILL, V22; Castanheira M, 2016, ANTIMICROB AGENTS CH, V60, P5623, DOI 10.1128/AAC.01267-16; Clinical and laboratory standard institute, 2016, M100S26 CLSI; Clinical and Laboratory Standards Institute, 2015, M07 A10 METHODS DILU, V10th; Di Pilato V, 2016, ANTIMICROB AGENTS CH, V60, P5612, DOI 10.1128/AAC.01075-16; Du H, 2016, LANCET INFECT DIS, V16, P287, DOI 10.1016/S1473-3099(16)00056-6; EUCAST, 2016, CLIN BREAKP; Falagas ME, 2009, CLIN INFECT DIS, V48, P1729, DOI 10.1086/599226; Falgenhauer L, 2016, EMERG INFECT DIS, V22, P1689, DOI 10.3201/eid2209.160692; Forest Pharmaceuticals Inc, 2014, AV CEFT AV PRESCR IN; Fukuda A, 2017, INT J ANTIMICROB AGE; Haenni M, 2018, J ANTIMICROB CHEMOTH, V73, P533, DOI 10.1093/jac/dkx418; He QW, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0207-z; Izadpanah M, 2015, J RES PHARM PRACT, V4, P105, DOI 10.4103/2279-042X.162360; Karlowsky JA, 2016, ANTIMICROB AGENTS CH, V60, P2849, DOI 10.1128/AAC.02286-15; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lob SH, 2015, ANTIMICROB AGENTS CH, V59, P3606, DOI 10.1128/AAC.05186-14; Mediavilla JR, 2016, MBIO, V7, DOI 10.1128/mBio.01191-16; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Pulss S, 2017, INT J ANTIMICROB AG, V50, P232, DOI 10.1016/j.ijantimicag.2017.03.014; Rocha IV, 2017, INT J ANTIMICROB AG, V49, P655, DOI 10.1016/j.ijantimicag.2017.03.001; Ronco T, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3415-6; Rossi F, 2017, CLINICS, V72, P642, DOI 10.6061/clinics/2017(10)09; Sanchez-Benito R, 2017, INT J ANTIMICROB AG, V50, P285, DOI 10.1016/j.ijantimicag.2017.05.005; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Tacao M, 2017, EMERG INFECT DIS, V23, P1419, DOI 10.3201/eid2308.170162; Teo JQM, 2016, ANTIMICROB AGENTS CH, V60, P6435, DOI 10.1128/AAC.00804-16; Terveer EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178598; Tygacil&REG;, 2010, TYG TIG FDA PRESCR I; Wong SCY, 2016, EMERG INFECT DIS, V22, P1667, DOI 10.3201/eid2209.160091; Xavier B. B., 2016, EURO SURVEILL, V21; Yang RS, 2016, ANTIMICROB AGENTS CH, V60, P6899, DOI 10.1128/AAC.01365-16; Yang YQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01204-16, 10.1128/AAC.01204-16]; Yao X, 2016, LANCET INFECT DIS, V16, P288, DOI 10.1016/S1473-3099(16)00057-8; Yin W, 2017, MBIO, V8; Yu H, 2016, ANTIMICROB AGENTS CH, V60, P5033, DOI 10.1128/AAC.00440-16; Zeng KJ, 2016, ANTIMICROB AGENTS CH, V60, P3862, DOI 10.1128/AAC.00345-16; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0; Zhang YW, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00242; Zhao FF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02094; Zhong LL, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01962-16; Zurfluh K, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0250-8	47	54	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195281	10.1371/journal.pone.0195281	http://dx.doi.org/10.1371/journal.pone.0195281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608599	gold, Green Published, Green Submitted			2022-12-27	WOS:000428988800045
J	Caselle, JE; Hamilton, SL; Davis, K; Thompson, CDH; Turchik, A; Jenkinson, R; Simpson, D; Sala, E				Caselle, Jennifer E.; Hamilton, Scott L.; Davis, Kathryn; Thompson, Christopher D. H.; Turchik, Alan; Jenkinson, Ryan; Simpson, Doug; Sala, Enric			First quantification of subtidal community structure at Tristan da Cunha Islands in the remote South Atlantic: From kelp forests to the deep sea	PLOS ONE			English	Article							GIANT-KELP; MACROCYSTIS-PYRIFERA; GLOBAL PATTERNS; BASE-LINES; PREDATOR DIVERSITY; MARINE RESERVES; FRONTAL ZONES; TOP-DOWN; BIOMASS; TRAJECTORIES	Tristan da Cunha Islands, an archipelago of four rocky volcanic islands situated in the South Atlantic Ocean and part of the United Kingdom Overseas Territories (UKOTs), present a rare example of a relatively unimpacted temperate marine ecosystem. We conducted the first quantitative surveys of nearshore kelp forests, offshore pelagic waters and deep sea habitats. Kelp forests had very low biodiversity and species richness, but high biomass and abundance of those species present. Spatial variation in assemblage structure for both nearshore fish and invertebrates/algae was greatest between the three northern islands and the southern island of Gough, where sea temperatures were on average 3-4 degrees colder. Despite a lobster fishery that provides the bulk of the income to the Tristan islands, lobster abundance and biomass are comparable to or greater than many Marine Protected Areas in other parts of the world. Pelagic camera surveys documented a rich biodiversity offshore, including large numbers of juvenile blue sharks, Prionace glauca. Species richness and abundance in the deep sea is positively related to hard rocky substrate and biogenic habitats such as sea pens, crinoids, whip corals, and gorgonians were present at 40% of the deep camera deployments. We observed distinct differences in the deep fish community above and below similar to 750 m depth. Concurrent oceanographic sampling showed a discontinuity in temperature and salinity at this depth. While currently healthy, Tristan's marine ecosystem is not without potential threats: shipping traffic leading to wrecks and species introductions, pressure to increase fishing effort beyond sustainable levels and the impacts of climate change all could potentially increase in the coming years. The United Kingdom has committed to protection of marine environments across the UKOTs, including Tristan da Cunha and these results can be used to inform future management decisions as well as provide a baseline against which future monitoring can be based.	[Caselle, Jennifer E.; Davis, Kathryn; Jenkinson, Ryan] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Hamilton, Scott L.] Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA; [Thompson, Christopher D. H.] Univ Western Australia, Ctr Marine Futures, M092, Crawley, WA USA; [Turchik, Alan; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Simpson, Doug] Univ Montana, Sch Journalism, Missoula, MT 59812 USA	University of California System; University of California Santa Barbara; Moss Landing Marine Laboratories; University of Western Australia; National Geographic Society; University of Montana System; University of Montana	Caselle, JE (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	Caselle@ucsb.edu		Thompson, Christopher/0000-0001-8202-0221				Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Andrew T.G., 1995, Ichthyological Bulletin of the J. L. B. Smith Institute of Ichthyology, V63, P1; Andrew T. G., 1992, South African Journal of Antarctic Research, V22, P41; Babcock RC, 2007, MAR FRESHWATER RES, V58, P286, DOI 10.1071/MF06204; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Barrientos CA, 2006, FISH B-NOAA, V104, P489; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Baxter J. L., 1960, Fishery Bulletin Sacramento, VNo. 110, P1; Bell TW, 2015, J BIOGEOGR, V42, P2010, DOI 10.1111/jbi.12550; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Borrvall C, 2000, ECOL LETT, V3, P131, DOI 10.1046/j.1461-0248.2000.00130.x; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; BREEN PA, 1976, MAR BIOL, V34, P137, DOI 10.1007/BF00390755; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; Caselle JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14102; Chernova NV, 2014, PEERJ, V2, DOI 10.7717/peerj.692; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1994, AM ZOOL, V34, P90; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Deacon G., 1933, DISCOVERY REP, V7; DEACON GER, 1982, DEEP-SEA RES, V29, P1, DOI 10.1016/0198-0149(82)90058-9; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Doolittle DF, 2008, NOVA HEDWIGIA, P147; Dubiaski-Silva J, 2006, J COASTAL RES, P1190; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; EBERT DA, 1991, S AFR J MARINE SCI, V11, P565, DOI 10.2989/025776191784287547; Eklof A, 2006, J ANIM ECOL, V75, P239, DOI 10.1111/j.1365-2656.2006.01041.x; Etnoyer Peter, 2004, Oceanography, V17, P90; Freeman DT, 2012, ENVIRON CONSERV, V39, P295, DOI 10.1017/S037689291200015X; Friedlander AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145059; Friedlander AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100142; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Froese R., 2011, WORLD WIDE WEB ELECT; Glass JP, 2014, THESIS; Guggenheim DE, 2014, INT OIL SPILL C P; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Heydorn AEF, 1969, S ATLANTIC ROCK LOBS; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; JACKSON GA, 1987, MAR BIOL, V95, P611, DOI 10.1007/BF00393105; Jackson GA, 1977, OCEANOGRAPHY, V22; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Jordan F, 2002, J THEOR BIOL, V215, P441, DOI 10.1006/jtbi.2001.2523; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; LAUBSCHER RK, 1993, POLAR BIOL, V13, P471; Letessier T.B., 2013, METHODS OCEANOGR, V8, P41, DOI [10.1016/j.mio.2013.11.003, DOI 10.1016/J.MIO.2013.11.003]; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lutjeharms J. R. E., 1985, ANTARCTIC NUTR CYCLE, P11; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Nonato EF, 2000, POLAR BIOL, V23, P580, DOI 10.1007/s003000000129; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; POLLOCK DE, 1991, S AFR J MARINE SCI, V10, P1; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Queiroz N, 2016, P NATL ACAD SCI USA, V113, P1582, DOI 10.1073/pnas.1510090113; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Reed D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13757; Reed D, 2009, MAR BIOL, V156, P2077, DOI 10.1007/s00227-009-1238-6; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; Robinson PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036728; Rodriguez GE, 2013, ECOLOGY, V94, P1848, DOI 10.1890/12-1340.1; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scales KL, 2014, J APPL ECOL, V51, P1575, DOI 10.1111/1365-2664.12330; Scott S., 2016, BIOPHYSICAL PROFILE; SEYMOUR RJ, 1989, ESTUAR COAST SHELF S, V28, P277, DOI 10.1016/0272-7714(89)90018-8; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Smith CD, 2003, MAR BIOL, V143, P1127, DOI 10.1007/s00227-003-1144-2; Tegner MJ, 1997, MAR ECOL PROG SER, V146, P117, DOI 10.3354/meps146117; Utter BD, 1996, J EXP BIOL, V199, P2645; VANTUSSENBROEK BI, 1993, EUR J PHYCOL, V28, P161, DOI 10.1080/09670269300650251; Vroom PS, 2010, BIODIVERS CONSERV, V19, P797, DOI 10.1007/s10531-009-9735-y; Wanless RM, 2010, BIOL INVASIONS, V12, P2573, DOI 10.1007/s10530-009-9666-2; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	88	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195167	10.1371/journal.pone.0195167	http://dx.doi.org/10.1371/journal.pone.0195167			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596484	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000089
J	Coughlan, MR; Nelson, DR				Coughlan, Michael R.; Nelson, Donald R.			Influences of Native American land use on the Colonial Euro-American settlement of the South Carolina Piedmont	PLOS ONE			English	Article							EASTERN NORTH-AMERICA; SOUTHEASTERN UNITED-STATES; HUMAN NICHE CONSTRUCTION; HISTORICAL ECOLOGY; USE LEGACIES; APPALACHIAN LANDSCAPES; CULTURAL LANDSCAPES; FRENCH PYRENEES; RIVER VALLEY; LONG-TERM	We test the hypothesis that prehistoric Native American land use influenced the Euro-American settlement process in a South Carolina Piedmont landscape. Long term ecological studies demonstrate that land use legacies influence processes and trajectories in complex, coupled social and ecological systems. Native American land use likely altered the ecological and evolutionary feedback and trajectories of many North American landscapes. Yet, considerable debate revolves around the scale and extent of land use legacies of prehistoric Native Americans. At the core of this debate is the question of whether or not European colonists settled a mostly "wild" landscape or an already "humanized" landscape. We use statistical event analysis to model the effects of prehistoric Native American settlement on the rate of Colonial land grants (1749-1775). Our results reveal how abandoned Native American settlements were among the first areas claimed and homesteaded by Euro-Americans. We suggest that prehistoric land use legacies served as key focal nodes in the Colonial era settlement process. As a consequence, localized prehistoric land use legacies likely helped structure the long term, landscape-to regional-level ecological inheritances that resulted from Euro-American settlement.	[Coughlan, Michael R.; Nelson, Donald R.] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Coughlan, MR (corresponding author), Univ Georgia, Dept Anthropol, Athens, GA 30602 USA.	coughlan@uga.edu	coughlan, michael/X-7634-2019; Nelson, Donald R/C-3225-2014	coughlan, michael/0000-0001-6071-1873; Nelson, Donald R/0000-0002-7878-2853				Abrams MD, 2008, HOLOCENE, V18, P1123, DOI 10.1177/0959683608095581; Allison P.D., 1984, EVENT HIST ANAL REGR; Bain DJ, 2012, BIOSCIENCE, V62, P575, DOI 10.1525/bio.2012.62.6.8; Bain DJ, 2004, LANDSCAPE ECOL, V19, P843, DOI 10.1007/s10980-004-0167-5; Bass RD, 1989, 96 STRUGGLE S CAROLI; Bennett J. W., 1969, NO PLAINSMEN ADAPTIV; Benson R. W, 2006, CULTURAL RESOURCES O; Bird RB, 2013, P R SOC B; Black BA, 2006, CAN J FOREST RES, V36, P1266, DOI 10.1139/X06-027; Blossfeld H-P., 2012, EVENT HIST ANAL STAT; Bolstad PV, 2007, J ARCHAEOLOGICAL SCI, V10; Brantley CG, 2001, WILDLIFE SOC B, V29, P1175; Brook BW, 2004, J BIOGEOGR, V31, P517, DOI 10.1046/j.1365-2699.2003.01028.x; Charles Allen D., 1987, NARRATIVE HIST UNION; Chisholm M., 2017, RURAL SETTLEMENT LAN; Christensen N. L., 1989, Journal of Forest History, V33, P116, DOI 10.2307/4005121; CLARK JS, 1995, HOLOCENE, V5, P1, DOI 10.1177/095968369500500101; CORE EARL L., 1949, JOUR ELISHA MITCHELL SCI SOC, V65, P306; Coughlan MR, 2017, LAND-BASEL, V6, DOI 10.3390/land6020032; Coughlan MR, 2016, HUM ECOL, V44, P65, DOI 10.1007/s10745-016-9808-y; Coughlan MR, 2014, FOREST ECOL MANAG, V312, P55, DOI 10.1016/j.foreco.2013.10.021; Cousins SAO, 2001, LANDSCAPE ECOL, V16, P41, DOI 10.1023/A:1008108704358; COX DR, 1972, J R STAT SOC B, V34, P187; Cronon W., 1983, CHANGES LAND INDIANS; Delcourt HR, 1997, CONSERV BIOL, V11, P1010, DOI 10.1046/j.1523-1739.1997.96338.x; Delcourt PA, 1998, AM ANTIQUITY, V63, P263, DOI 10.2307/2694697; DELCOURT PA, 1986, QUATERNARY RES, V25, P330, DOI 10.1016/0033-5894(86)90005-0; Delcourt Paul A., 1998, Castanea, V63, P337; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Donahue Brian., 2004, GREAT MEADOW FARMERS; Dotterweich M, 2014, ANTHROPOCENE, V8, P6, DOI 10.1016/j.ancene.2015.05.003; Duilts TE, 2015, TOPOGRAPHY TOOLS ARC; Dyer JM, 2010, APPL VEG SCI, V13, P195, DOI 10.1111/j.1654-109X.2009.01061.x; Erickson CL, 2006, HIST ECOL SER, P187; Ethridge R, 2004, CREEK COUNTRY CREEK; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; FOSTER DR, 1992, J ECOL, V80, P753, DOI 10.2307/2260864; Foster HT, 2007, AM ANTIQUITY, V72, P35, DOI 10.2307/40035297; Foster HT, 2004, HUM ECOL, V32, P27, DOI 10.1023/B:HUEC.0000015211.98991.9c; Foundation UCH, 1995, LAND GRANT MAPS; Fowler C, 2007, HUM ECOL REV, V14, P165; Gagnon PR, 2009, WETLANDS, V29, P520, DOI 10.1672/08-50.1; Garnett A, 1935, GEOGR REV, V25, P601, DOI 10.2307/209399; Gragson T. L, 2008, AGRARIAN LANDSCAPES, P89; Gragson TL, 2015, CAPITAL CULT, P565; Gragson TL, 2006, SOC NATUR RESOUR, V19, P175, DOI 10.1080/08941920500394857; Green W, 2003, SE ARCH C CHARL N CA; Heckenberger MJ, 2007, PHILOS T R SOC B, V362, P197, DOI 10.1098/rstb.2006.1979; HILLIARD SB, 1982, GEOGR REV, V72, P416, DOI 10.2307/214594; HUDSON C, 1976, SE INDIANS; Hudson Charles, 1984, SE ARCHAEOLOGY, V3, P65; Ivers LE, 1970, COLONIAL FORTS S CAR; Jogiste K, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1706; Jones EE, 2017, J ARCHAEOL SCI, V84, P54, DOI 10.1016/j.jas.2017.05.009; Jones EE, 2012, J ARCHAEOL SCI, V39, P2593, DOI 10.1016/j.jas.2012.04.019; Jones Eric E., 2016, SE ARCHAEOLOGY, V35, P85; Kendal J, 2011, PHILOS T R SOC B, V366, P785, DOI 10.1098/rstb.2010.0306; Klein Rachel N., 2012, UNIFICATION SLAVE ST; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lehmann J, 2007, AMAZONIAN DARK EARTH; Leigh D, 2015, QUATERNARY INT; Leigh DS, 2013, J ARCHAEOL SCI, V40, P4107, DOI 10.1016/j.jas.2013.05.009; LEWIS HT, 1988, HUM ECOL, V16, P57, DOI 10.1007/BF01262026; Logan J.H., 1859, HIST UPPER COUNTRY S; Lunt ID, 2005, J BIOGEOGR, V32, P1859, DOI 10.1111/j.1365-2699.2005.01296.x; Martin P.S., 1984, P354; Mensing SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20286-4; Meriwether Robert L., 1940, EXPANSION S CAROLINA; Minnis P, 2001, BIODIVERSITY NATIVE; Morgan C, 2008, J ARCHAEOL SCI, V35, P247, DOI 10.1016/j.jas.2007.02.025; Munoz SE, 2014, J BIOGEOGR, V41, P2195, DOI 10.1111/jbi.12386; Munoz SE, 2010, HOLOCENE, V20, P967, DOI 10.1177/0959683610362815; Nigh R, 2013, FRONT ECOL ENVIRON, V11, pE45, DOI 10.1890/120344; Odling-Smee John, 2011, Biological Theory, V6, P220, DOI 10.1007/s13752-012-0030-x; Pettus L., 1995, BACKSIGHTS MAGAZINE; Platt Steven G., 1997, Castanea, V62, P8; Plieninger T, 2011, REG ENVIRON CHANGE, V11, P603, DOI 10.1007/s10113-010-0192-7; Pope TH, 1973, HIST NEWBERRY COUNTY; Prunty MC, 1965, P 4 ANN TALL TIMB FI; Richter D. D., 2001, UNDERSTANDING SOIL C, P272; RUSSELL EWB, 1983, ECOLOGY, V64, P78, DOI 10.2307/1937331; Silver T., 1990, NEW FACE COUNTRYSIDE, Vxii; Smith BD, 2015, J ARCHAEOL RES, V23, P215, DOI 10.1007/s10814-015-9081-4; Smith Bruce D., 2011, Biology Theory, V6, P260, DOI 10.1007/s13752-012-0028-4; Smith BD, 2011, CURR ANTHROPOL, V52, pS471, DOI 10.1086/659645; Smith BD, 2011, PHILOS T R SOC B, V366, P836, DOI 10.1098/rstb.2010.0253; Smith BD, 2009, J ETHNOBIOL, V29, P167, DOI 10.2993/0278-0771-29.2.167; Smith BD, 2009, P NATL ACAD SCI USA, V106, P6561, DOI 10.1073/pnas.0901846106; STEPONAITIS VP, 1986, ANNU REV ANTHROPOL, V15, P363, DOI 10.1146/annurev.an.15.100186.002051; Stewart Omer C., 2002, FORGOTTEN FIRES NATI; Stone G.D., 1996, SETTLEMENT ECOLOGY S; Sylvester K.M., 2008, AGRARIAN LANDSCAPES, P16; Turner F.J, 2010, FRONTIER AM HIST; Vale T.R., 2002, FIRE NATIVE PEOPLES; Vale TR, 1998, NAT AREA J, V18, P231; Warren RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150707; Waselkov Gregory A., 1997, STUDIES PALEOETHNOBO, P179; Wear DN, 1998, ECOSYSTEMS, V1, P575, DOI 10.1007/s100219900052; Whitlock C, 2017, CONSERVATION BIOL; WILHELM G, 1978, APPALACHIAN J, V5, P204; Williams G. W., 2005, REFERENCES AM INDIAN; Wood PH, 1989, CHANGING POPULATION; Zeder MA, 2012, J ANTHROPOL ARCHAEOL, V31, P241, DOI 10.1016/j.jaa.2012.03.003	103	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195036	10.1371/journal.pone.0195036	http://dx.doi.org/10.1371/journal.pone.0195036			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596504	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000070
J	Smug, D; Ashwin, P; Sornette, D				Smug, Damian; Ashwin, Peter; Sornette, Didier			Predicting financial market crashes using ghost singularities	PLOS ONE			English	Article							HERD BEHAVIOR; BUBBLES; POPULATION; MODEL; EXPECTATIONS; DYNAMICS	We analyse the behaviour of a non-linear model of coupled stock and bond prices exhibiting periodically collapsing bubbles. By using the formalism of dynamical system theory, we explain what drives the bubbles and how foreshocks or aftershocks are generated. A dynamical phase space representation of that system coupled with standard multiplicative noise rationalises the log-periodic power law singularity pattern documented in many historical financial bubbles. The notion of 'ghosts of finite-time singularities' is introduced and used to estimate the end of an evolving bubble, using finite-time singularities of an approximate normal form near the bifurcation point. We test the forecasting skill of this method on different stochastic price realisations and compare with Monte Carlo simulations of the full system. Remarkably, the approximate normal form is significantly more precise and less biased. Moreover, the method of ghosts of singularities is less sensitive to the noise realisation, thus providing more robust forecasts.	[Smug, Damian; Ashwin, Peter] Univ Exeter, Ctr Syst Dynam & Control, Dept Math, Harrison Bldg, Exeter EX4 4QF, Devon, England; [Sornette, Didier] ETH, Dept Management Technol & Econ, Scheuchzerstr 7, CH-8092 Zurich, Switzerland; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, 40 Blvd Pont Darve, CH-1211 Geneva 4, Switzerland	University of Exeter; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Smug, D; Ashwin, P (corresponding author), Univ Exeter, Ctr Syst Dynam & Control, Dept Math, Harrison Bldg, Exeter EX4 4QF, Devon, England.	d.smug@exeter.ac.uk; p.ashwin@exeter.ac.uk						Bartolozzi M, 2005, INT J MOD PHYS C, V16, P1347, DOI 10.1142/S0129183105007972; BENDER C. M., 1999, ADV MATH METHODS SCI, DOI DOI 10.1007/978-1-4757-3069-2; Berglund N., 2006, PROB APPL S, DOI 10.1007/1-84628-186-5; Bischi GI, 2006, MACROECON DYN, V10, P502, DOI 10.1017/S136510050605036X; Brock W.A., 2001, HDB ECONOMETRICS, V5, P3297, DOI DOI 10.1016/S1573-4412(01)05007-3; Brock W.A., 1991, NONLINEAR DYNAMICS C; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Brock WA, 2005, J MATH ECON, V41, P7, DOI 10.1016/j.jmateco.2004.02.002; Brock WA, 1998, J ECON DYN CONTROL, V22, P1235, DOI 10.1016/S0165-1889(98)00011-6; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; Cheriyan V, 2016, QUANT FINANC, V16, P309, DOI 10.1080/14697688.2015.1119009; Corcos A., 2002, Quantitative Finance, V2, P264, DOI 10.1088/1469-7688/2/4/303; Edlund E, 2010, J STAT PHYS, V139, P972, DOI 10.1007/s10955-010-9974-z; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Gaspard P., 1990, J PHYS CHEM, V94; Guo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022794; Husler A, 2013, J ECON BEHAV ORGAN, V92, P304, DOI 10.1016/j.jebo.2013.06.005; Ide K, 2002, PHYSICA A, V307, P63, DOI 10.1016/S0378-4371(01)00585-4; Israeli N, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026203; Israeli N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074105; Johansen A, 2001, PHYSICA A, V294, P465, DOI 10.1016/S0378-4371(01)00105-4; Johansen A., 2000, INT J THEOR APPL FIN, V2, P219, DOI [DOI 10.1142/S0219024900000115, 10.1142/S0219024900000115]; Johansen A, 2001, J RISK, V4, P69, DOI DOI 10.21314/JOR.2002.058; Johansen A, 1998, EUR PHYS J B, V143, P8; Johansen A., 1999, J RISK, V1, P5, DOI DOI 10.21314/JOR.1999.014; Kaizoji T, 2008, MARKET BUBBLES CRASH; Krishnan CNV, 2009, J EMPIR FINANC, V16, P353, DOI 10.1016/j.jempfin.2008.10.005; Kuzntesov YA, 2004, ELEMENTS APPL BIFURC; Leiss M, 2015, J ECON DYN CONTROL, V55, P1, DOI 10.1016/j.jedc.2015.03.005; Lin L, 2014, INT REV FINANC ANAL, V33, P210, DOI 10.1016/j.irfa.2014.02.012; Lin L, 2013, EUR J FINANC, V19, P344, DOI 10.1080/1351847X.2011.607004; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; Meng H, 2017, QUANT FINANC, V17, P959, DOI 10.1080/14697688.2016.1241424; Omurtag A, 2006, J ECON BEHAV ORGAN, V61, P562, DOI 10.1016/j.jebo.2004.07.016; SHILLER RJ, 1992, J MONETARY ECON, V30, P25, DOI 10.1016/0304-3932(92)90042-Z; Sornette D, 2003, WHY STOCK MARKETS CRASH: CRITICAL EVENTS IN COMPLEX FINANCIAL SYSTEMS, P1; Sornette D, 2002, INT J MOD PHYS C, V13, P171, DOI 10.1142/S0129183102003085; Sornette D., 2001, Quantitative Finance, V1, P452, DOI 10.1088/1469-7688/1/4/305; Sornette D, 2002, P NATL ACAD SCI USA, V99, P2522, DOI 10.1073/pnas.022581999; Sornette D., 2010, BRUSSELS EC REV CAHI, V53, P201; Sornette D, 2015, REV BEHAV ECON, V2, P279, DOI 10.1561/105.00000035; Sornette D, 2013, PHYSICA A, V392, P4417, DOI 10.1016/j.physa.2013.05.011; Strogatz S., 2000, NONLINEAR DYNAMICS C; Tramontana F, 2010, J ECON BEHAV ORGAN, V74, P187, DOI 10.1016/j.jebo.2010.02.008; Yukalov VI, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60313-1; Yukalov VI, 2009, J ECON BEHAV ORGAN, V70, P206, DOI 10.1016/j.jebo.2008.12.004; Zhou WX, 2003, INT J MOD PHYS C, V14, P1107, DOI 10.1142/S0129183103005212	48	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195265	10.1371/journal.pone.0195265	http://dx.doi.org/10.1371/journal.pone.0195265			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596485	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000100
J	Yu, M; Wei, CH; Niu, LL; Li, SH; Yu, YJ				Yu, Miao; Wei, Chenhui; Niu, Leilei; Li, Shaohua; Yu, Yongjun			Calculation for tensile strength and fracture toughness of granite with three kinds of grain sizes using three-point-bending test	PLOS ONE			English	Article							MODE-I FRACTURE; PROCESS ZONE; ACOUSTIC-EMISSION; CONCRETE; ROCKS; SPECIMENS; ENERGY	Tensile strength and fracture toughness, important parameters of the rock for engineering applications are difficult to measure. Thus this paper selected three kinds of granite samples (grain sizes = 1.01mm, 2.12mm and 3mm), used the combined experiments of physical and numerical simulation (RFPA-DIP version) to conduct three-point-bending (3-p-b) tests with different notches and introduced the acoustic emission monitor system to analyze the fracture mechanism around the notch tips. To study the effects of grain size on the tensile strength and toughness of rock samples, a modified fracture model was established linking fictitious crack to the grain size so that the microstructure of the specimens and fictitious crack growth can be considered together. The fractal method was introduced to represent microstructure of three kinds of granites and used to determine the length of fictitious crack. It is a simple and novel method to calculate the tensile strength and fracture toughness directly. Finally, the theoretical model was verified by the comparison to the numerical experiments by calculating the nominal strength sigma(n) and maximum loads P-max.	[Yu, Miao; Wei, Chenhui; Niu, Leilei; Li, Shaohua; Yu, Yongjun] Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Liaoning, Peoples R China	Northeastern University - China	Yu, M (corresponding author), Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Liaoning, Peoples R China.	741975392@qq.com						Aliha MRM, 2012, INT J ROCK MECH MIN, V51, P128, DOI 10.1016/j.ijrmms.2012.01.017; [Anonymous], 1988, INT J ROCK MECH MIN, V25, P71; Astm, 1996, E39990 ASTM; Bazant ZP, 1983, MATERIALS STRUCTURES, V16, P155, DOI DOI 10.1007/BF02486267; Bearman RA, 1999, INT J ROCK MECH MIN, V36, P257, DOI 10.1016/S0148-9062(99)00015-7; CEDOLIN L, 1983, CEMENT CONCRETE RES, V13, P557, DOI 10.1016/0008-8846(83)90015-7; Chalivendra VB, 2009, INT J IMPACT ENG, V36, P888, DOI 10.1016/j.ijimpeng.2008.11.009; CHONG KP, 1988, ENG FRACT MECH, V30, P701, DOI 10.1016/0013-7944(88)90160-9; Dai F, 2015, COMPUT GEOTECH, V69, P424, DOI 10.1016/j.compgeo.2015.06.011; FOWELL RJ, 1995, INT J ROCK MECH MIN, V32, P57, DOI 10.1016/0148-9062(94)00015-U; Guinea GV, 2000, ENG FRACT MECH, V65, P189, DOI 10.1016/S0013-7944(99)00115-0; HASHIDA T, 1993, INT J ROCK MECH MIN, V30, P47, DOI 10.1016/0148-9062(93)90175-D; HILLERBORG A, 1991, INT J FRACTURE, V51, P95; Hillerborg A., 1976, CEMENT CONCRETE RES, V6, P773, DOI [10.1016/0008-8846(76)90007-7, DOI 10.1016/0008-8846(76)90007-7]; Hoover CG, 2013, ENG FRACT MECH, V110, P281, DOI 10.1016/j.engfracmech.2013.08.008; Hu XZ, 2007, ENG FRACT MECH, V74, P1093, DOI 10.1016/j.engfracmech.2006.12.009; Hu XZ, 2008, INT J FRACTURE, V154, P3, DOI 10.1007/s10704-008-9290-7; Hu XZ, 2004, CEMENT CONCRETE RES, V34, P1321, DOI 10.1016/j.cemconres.2003.12.027; Iqbal MJ, 2007, ROCK MECH ROCK ENG, V40, P453, DOI 10.1007/s00603-006-0107-6; JANACH W, 1977, INT J ROCK MECH MIN, V14, P209, DOI 10.1016/0148-9062(77)90950-0; KRANZ RL, 1979, INT J ROCK MECH MIN, V16, P23, DOI 10.1016/0148-9062(79)90772-1; Mavko G., 1998, ROCK PHYS HDB TOOLS; Muralidhara S, 2010, CONSTR BUILD MATER, V24, P479, DOI 10.1016/j.conbuildmat.2009.10.014; Nasseri MHB, 2008, INT J ROCK MECH MIN, V45, P167, DOI 10.1016/j.ijrmms.2007.04.005; Nasseri MHB, 2005, INT J ROCK MECH MIN, V42, P450, DOI 10.1016/j.ijrmms.2004.11.007; Ohno K, 2014, CONSTR BUILD MATER, V67, P139, DOI 10.1016/j.conbuildmat.2014.05.012; Ouchterlony F, 1981, FRACTURE MECH METHOD, P237, DOI DOI 10.1520/STP28309S; ROSSMANITH HP, 1983, ENG FRACT MECH, V17, P509, DOI 10.1016/0013-7944(83)90112-1; Tang TX, 1996, ENG FRACT MECH, V55, P383, DOI 10.1016/0013-7944(96)00030-6; TAPPONNIER P, 1976, INT J ROCK MECH MIN, V13, P103, DOI 10.1016/0148-9062(76)91937-9; Tutluoglu L, 2011, INT J ROCK MECH MIN, V48, P1248, DOI 10.1016/j.ijrmms.2011.09.019; Wang YS, 2016, ROCK MECH ROCK ENG, V10, P48; Wei MD, 2016, ENG FRACT MECH, V154, P43, DOI 10.1016/j.engfracmech.2016.01.002; Yao SF, 2016, ROCK SOIL MECH, V37, P2341, DOI 10.16285/j.rsm.2016.08.028; Yin TB, 2015, ROCK MECH ROCK ENG, V48, P2213, DOI 10.1007/s00603-015-0712-3; Zhang ZX, 2002, INT J ROCK MECH MIN, V39, P401, DOI 10.1016/S1365-1609(02)00032-1	36	13	13	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0180880	10.1371/journal.pone.0180880	http://dx.doi.org/10.1371/journal.pone.0180880			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596422	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000001
J	Atinga, RA; Yarney, L; Gavu, NM				Atinga, Roger A.; Yarney, Lily; Gavu, Narissa Minta			Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: A qualitative investigation	PLOS ONE			English	Article							HEALTH-CARE; ADHERENCE; PREVALENCE; MEDICINES; AWARENESS; THERAPY; HEALERS; ADULTS	Background Evidence remains limited on why diabetes and hypertensive patients admitted to long-term drug therapy miss doses or discontinue medication taking. We examined this phenomenon from the perspective of diabetes and hypertension patients at a Ghanaian teaching hospital. Methods Between July and December 2015, we conducted a qualitative study targeting caregivers and their patients with chronic diabetes and hypertensive on re-admission at the Korle Bu Teaching Hospital due to non-adherence to prescribed medication. Participants were sampled purposefully and taking through in-depth interviews using an interview guide. Notes and audio recordings of interviews were transcribed, managed and coded for themes guided by the thematic network analysis recommended by Attride-Stirling. Results Non-adherence was the result of perceptions that the medications are not effective for managing the conditions. Patients with these perceptions rejected the medications and turned to herbal medicines and spiritual healing as therapeutic alternatives, because of their easy accessibility, perceived efficacy and affordability. Other factors identified to influence non-adherence included polypharmacy practice; tight work schedules; social norms; poor prescription instruction by health providers; and knowledge and experience of medication. Conclusion Findings suggests the need for health providers to adopt therapeutic approaches that take into account patients' beliefs, values and norms in administering medications. Sensitisation of patients and caregivers during admission on the implication of non-adherence, as well as interventions that monitor and provide feedback mechanisms on patients' medication taking behaviour holds promise for maximising diabetes and hypertensive medication adherence.	[Atinga, Roger A.; Yarney, Lily] Univ Ghana, Business Sch, Dept Publ Adm & Hlth Serv Management, Legon, Accra, Ghana; [Gavu, Narissa Minta] Korle Bu Teaching Hosp, Med Dept, Accra, Ghana	University of Ghana	Atinga, RA (corresponding author), Univ Ghana, Business Sch, Dept Publ Adm & Hlth Serv Management, Legon, Accra, Ghana.	ayimbillah@yahoo.com		Yarney, Lily/0000-0003-3423-326X	University of Ghana Business School Faculty support	University of Ghana Business School Faculty support	This research received support from the University of Ghana Business School Faculty support.	Ae-Ngibise K, 2010, INT REV PSYCHIATR, V22, P558, DOI 10.3109/09540261.2010.536149; Aikins Ad-G, 2005, BMJ, V33; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; [Anonymous], 2013, ANN REP KORL BU TEAC; Attride-Stirling J., 2001, QUAL RES, V1, P385, DOI [DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Berkowitz AD, 2002, SOCIAL NORMS APPROAC; Beune EJAJ, 2008, J HYPERTENS, V26, P648, DOI 10.1097/HJH.0b013e3282f4d20b; Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Bruce Suliasnaia P, 2015, Pharm Pract (Granada), V13, P533; Calys-Tagoe Benedict N L, 2014, BMC Res Notes, V7, P577, DOI 10.1186/1756-0500-7-577; Chatio S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116856; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Dako-Gyeke P, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-211; Dakubo J, 2014, POSTGRADUATE MED J G, V3, P15; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Farnes C, 2011, INT NURS REV, V58, P491, DOI 10.1111/j.1466-7657.2011.00917.x; Ghana Health Service, 2015, ANN REP GHAN HLTH SE; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Ho SC, 2016, J AFFECT DISORDERS, V193, P1, DOI 10.1016/j.jad.2015.12.029; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Laryeh JG, 2013, FACTORS INFLUENCING; Lehane E, 2007, INT J NURS STUD, V44, P1468, DOI 10.1016/j.ijnurstu.2006.07.010; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Luppa M, 2007, J AFFECT DISORDERS, V98, P29, DOI 10.1016/j.jad.2006.07.017; Mattke S., 2011, IMPROVING ACCESS MED; McMullen CK, 2015, PATIENT EDUC COUNS, V98, P102, DOI 10.1016/j.pec.2014.09.015; Mills E, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-19; Mohan V, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/409083; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Ofosu-Amaah S., 1996, HOSP AUTONOMY GHANA; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Read UM, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-13; Sabate AL, 2003, ADHERENCE LONG TERM; Sackey MB., 2002, I AFRICAN STUDIES RE, V18, P5; Saha S, 2008, J NATL MED ASSOC, V100, P1275, DOI 10.1016/S0027-9684(15)31505-4; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Sato A, 2012, HLTH POLICY PLANNING, V2013, P1; Schiffrin EL, 2012, LANCET, V380, P539, DOI 10.1016/S0140-6736(12)61219-7; Skinner M, 2015, GERIATR NURS, V36, P367, DOI 10.1016/j.gerinurse.2015.05.003; Tabi MM, 2006, INT NURS REV, V53, P52, DOI 10.1111/j.1466-7657.2006.00444.x; Ventana Systems Inc., 2014, VENS PLE SOFTW; Vervoort SCJM, 2007, AIDS, V21, P271, DOI 10.1097/QAD.0b013e328011cb20; Vlasnik Jon J, 2005, Case Manager, V16, P47; Voorham J, 2011, CLIN THER, V33, P121, DOI 10.1016/j.clinthera.2011.01.024; Wolf MS, 2011, MED CARE, V49, P96, DOI 10.1097/MLR.0b013e3181f38174; World Health Organization, 2014, FACT SHEET; Zarowitz BJ, 2005, PHARMACOTHERAPY, V25, P1636, DOI 10.1592/phco.2005.25.11.1636	51	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193995	10.1371/journal.pone.0193995	http://dx.doi.org/10.1371/journal.pone.0193995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590156	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100044
J	Zhen, XM; Li, YY; Chen, YX; Dong, P; Liu, S; Dong, HJ				Zhen, Xuemei; Li, Yuanyuan; Chen, Yixi; Dong, Peng; Liu, Stephanie; Dong, Hengjin			Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; CLINICAL CHARACTERISTICS; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; IMPACT; MANAGEMENT; ORGANISMS; BACTERIA; OUTCOMES	Background Multiple drug resistant (MDR) intra-abdominal infections (IAls) are associated with notable direct and societal costs. As previous studies have not considered the impact of MDR on the total medical costs (TMCs) of lAls, the present one examines this, as well as further estimates the additional costs at a national level. Methods This is a retrospective study. Firstly, we randomly selected a sample of 40% of all inpatients discharged between 2014 and 2015 from a teaching hospital, due to limits in budget and the large number of patients. Then, we manually selected 254 patients with lAls according to the International Classification of Disease, 10th revision, using electronic medical records. Eventually, 101 patients with lAls (64 MDR patients and 37 non-MDR patients) were included after excluding cases without laboratory test results, any pathogens detected, or antimicrobial resistant pathogens. Univariate analysis and a generalized linear model were applied to assess the parameters associated with TMCs. Results Compared to non-MDR patients, those with MDR pathogens were significantly associated with higher TMCs, higher antimicrobial costs, higher antimicrobial usage, larger number of pathogens, and longer length of stay and were more likely to have insurance and combination antimicrobial therapy. In addition, the average TMC among patients with MDR pathogens was 131801, which is 90201 higher than those without MDR pathogens. If our results are applied to the whole country, the sum of all attributable TMCs was 37 billion. The societal costs, furthermore, were Y111 billion in 2015. Conclusion Our results provide information that should lead to increased efforts to reduce inappropriate antimicrobial therapy, in order to decrease the emergence of MDR pathogens and to reduce their economic burden.	[Zhen, Xuemei; Li, Yuanyuan; Liu, Stephanie; Dong, Hengjin] Zhejiang Univ, Sch Med, Sch Publ Hlth, Ctr Hlth Policy Studies, Hangzhou, Zhejiang, Peoples R China; [Chen, Yixi; Dong, Peng] Pfizer Investment Co Ltd, Beijing, Peoples R China	Zhejiang University; Pfizer	Dong, HJ (corresponding author), Zhejiang Univ, Sch Med, Sch Publ Hlth, Ctr Hlth Policy Studies, Hangzhou, Zhejiang, Peoples R China.	donghj@zju.edu.cn		Dong, Hengjin/0000-0002-5064-7297	Pfizer Investment Co. Ltd.; Pfizer Investment Co. Ltd., Beijing China	Pfizer Investment Co. Ltd.; Pfizer Investment Co. Ltd., Beijing China	This study was supported by Pfizer Investment Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; It is acknowledged that in the data collection we obtained valuable help from the Center for Health Policy Studies, Zhejiang University School of Medicine. This study was funded by Pfizer Investment Co. Ltd., Beijing China. The views expressed in this paper are those of the authors and not the Pfizer Investment Co. Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Blot S, 2002, CLIN INFECT DIS, V34, P1600, DOI 10.1086/340616; Burns A. S., 2017, J NEUROTRAUMA; Carson JG, 2008, SURG INFECT, V9, P15, DOI 10.1089/sur.2006.081; Chong YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119956; Chusri S, 2015, J INFECT CHEMOTHER, V21, P90, DOI 10.1016/j.jiac.2014.10.002; Geue C, 2016, AGE AGEING, V45, P376, DOI 10.1093/ageing/afw040; Grau S, 2015, APPL HEALTH ECON HEA, V13, P369, DOI 10.1007/s40258-015-0162-9; Hsueh PR, 2010, INT J ANTIMICROB AG, V35, P94, DOI 10.1016/j.ijantimicag.2009.09.004; Hu BJ, 2010, CURR MED RES OPIN, V26, P1443, DOI 10.1185/03007991003769068; Hu FP, 2016, CLIN MICROBIOL INFEC, V22, pS9, DOI 10.1016/j.cmi.2016.01.001; Jean SS, 2014, INT J ANTIMICROB AG, V44, P222, DOI 10.1016/j.ijantimicag.2014.05.018; Jiao Y, 2015, PATHOG GLOB HEALTH, V109, P68, DOI 10.1179/2047773215Y.0000000004; Judd WR, 2016, AM J INFECT CONTROL, V44, P1275, DOI 10.1016/j.ajic.2016.04.218; Lee YR, 2015, DRUGS, V75, P2097, DOI 10.1007/s40265-015-0506-7; MAULDIN PD, 1994, AM J CARDIOL, V74, P772, DOI 10.1016/0002-9149(94)90432-4; Menichetti F, 2013, J CHEMOTHERAPY, V21, P3; Mutters NT, 2016, J HOSP INFECT, V93, P191, DOI 10.1016/j.jhin.2016.02.013; National Health and Family Planning Commission of the People's Republic of China, 2016, STAT B DEV HLTH FAM; ONeill Jim, 2015, INT EC J ONEILL VISI; Ouyang WW, 2016, INT J ANTIMICROB AG, V47, P210, DOI 10.1016/j.ijantimicag.2015.12.019; Paterson DL, 2001, J CLIN MICROBIOL, V39, P2206, DOI 10.1128/JCM.39.6.2206-2212.2001; Pogue JM, 2015, CLIN MICROBIOL INFEC, V21, P302, DOI 10.1016/j.cmi.2014.12.025; Sartelli M, 2015, SURG INFECT, V16, P213, DOI 10.1089/sur.2013.262; Sartelli M, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-37; Sartelli M, 2012, WORLD J GASTROENTERO, V18, P865, DOI 10.3748/wjg.v18.i9.865; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246; Syue LS, 2016, INT J ANTIMICROB AG, V47, P250, DOI 10.1016/j.ijantimicag.2015.12.021; Tan X, 2016, J CLIN PHARM THER, V41, P524, DOI 10.1111/jcpt.12430; Tansarli GS, 2013, EXPERT REV ANTI-INFE, V11, P321, DOI [10.1586/eri.13.4, 10.1586/ERI.13.4]; World Health Organisation, 2009, MED US PRIM HLTH CAR; World Health Organization, 2014, WHAT IS ANT RES; World Health Organization, 2014, ANT RES; World Health Organization (WHO), 2014, WHOS 1 GLOB REP ANT; Wu DD, 2011, SOUTH MED J, V104, P106, DOI 10.1097/SMJ.0b013e318206063d; Zhang H, 2016, ANTIMICROB AGENTS CH, V60, P245, DOI 10.1128/AAC.00956-15	36	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193977	10.1371/journal.pone.0193977	http://dx.doi.org/10.1371/journal.pone.0193977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590138	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100042
J	Detroux, T; Noel, JP; Virgin, LN; Kerschen, G				Detroux, Thibaut; Noel, Jean-Philippe; Virgin, Lawrence N.; Kerschen, Gaetan			Experimental study of isolas in nonlinear systems featuring modal interactions	PLOS ONE			English	Article							BIFURCATION-ANALYSIS; FREQUENCY-RESPONSE; NORMAL-MODES; CURVES; OSCILLATOR	The objective of the present paper is to provide experimental evidence of isolated resonances in the frequency response of nonlinear mechanical systems. More specifically, this work explores the presence of isolas, which are periodic solutions detached from the main frequency response, in the case of a nonlinear set-up consisting of two masses sliding on a horizontal guide. A careful experimental investigation of isolas is carried out using responses to swept-sine and stepped-sine excitations. The experimental findings are validated with advanced numerical simulations combining nonlinear modal analysis and bifurcation monitoring. In particular, the interactions between two nonlinear normal modes are shown to be responsible for the creation of the isolas.	[Detroux, Thibaut; Noel, Jean-Philippe; Kerschen, Gaetan] Univ Liege, Aerosp & Mech Engn Dept, Space Struct & Syst Lab, Liege, Belgium; [Virgin, Lawrence N.] Duke Univ, Pratt Sch Engn, Nonlinear Dynam Grp, Durham, NC USA	University of Liege; Duke University	Detroux, T (corresponding author), Univ Liege, Aerosp & Mech Engn Dept, Space Struct & Syst Lab, Liege, Belgium.	thetraux@uliege.be		Detroux, Thibaut/0000-0003-0647-1842	European Union through the ERC [NoVib 307265]; Erasmus+ Programme	European Union through the ERC; Erasmus+ Programme	The authors T. Detroux and J.P. Noel are Postdoctoral Researchers of the Fonds de la Recherche Scientifique - FNRS (URL: http://www.fnrs.be), which is gratefully acknowledged. The authors would also like to acknowledge the financial support of the European Union, through the ERC Starting Grant (URL: https://erc.europa.eu/funding/starting-grants) NoVib 307265 and the Erasmus+ Programme (URL: https://eacea.ec.europa.eu/erasmus-plus_en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NA, 2009, J SOUND VIB, V319, P445, DOI 10.1016/j.jsv.2008.05.018; Antonio D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1813; Avramov KV, 2013, APPL MECH REV, V65, DOI 10.1115/1.4023533; Barton DAW, 2012, J VIB CONTROL, V18, P509, DOI 10.1177/1077546310384004; Detroux T, 2015, COMPUT METHOD APPL M, V296, P18, DOI 10.1016/j.cma.2015.07.017; Duan CW, 2008, J SOUND VIB, V314, P12, DOI 10.1016/j.jsv.2007.12.040; G?radin M., 2014, MECH VIBRATIONS THEO; Gatti G, 2017, J SOUND VIB, V396, P246, DOI 10.1016/j.jsv.2017.02.008; Gatti G, 2010, PHYSICA D, V239, P591, DOI 10.1016/j.physd.2010.01.006; George C, 2016, INT J NONLIN MECH, V81, P55, DOI 10.1016/j.ijnonlinmec.2015.12.006; Gourc E, 2014, J VIB ACOUST, V136, DOI 10.1115/1.4026432; Hill TL, 2016, J SOUND VIB, V379, P150, DOI 10.1016/j.jsv.2016.05.030; Hill TL, 2015, J SOUND VIB, V349, P276, DOI 10.1016/j.jsv.2015.03.030; Kerschen G, 2009, MECH SYST SIGNAL PR, V23, P170, DOI 10.1016/j.ymssp.2008.04.002; KOENIGSBERG WD, 1975, IEEE T AUTOMAT CONTR, VAC20, P208, DOI 10.1109/TAC.1975.1100914; Kuether R, 2015, J SOUND VIB, V351, P299, DOI 10.1016/j.jsv.2015.04.035; Lossouarn B, 2015, SMART MATER STRUCT, V24, DOI 10.1088/0964-1726/24/11/115037; Mangussi F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162365; Mehrabi MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176480; Nayfeh AH, 2008, NONLINEAR OSCILLATIO; Rosenberg R. M, 1966, ADV APPL MECH, V9, P6; Sarrouy E, 2011, INT J NONLIN MECH, V46, P727, DOI 10.1016/j.ijnonlinmec.2011.02.005; Seydel R., 2010, PRACTICAL BIFURCATIO, P483, DOI 10.1007/978-1-4419-1740-9; Shaw AD, 2016, MECH SYST SIGNAL PR, V81, P19, DOI 10.1016/j.ymssp.2016.03.008; Sieber J, 2008, NONLINEAR DYNAM, V51, P365, DOI 10.1007/s11071-007-9217-2; Starosvetsky Y, 2009, J SOUND VIB, V324, P916, DOI 10.1016/j.jsv.2009.02.052; Takacs D, 2008, NONLINEAR DYNAM, V52, P27, DOI 10.1007/s11071-007-9253-y; Vakakis A.F., 2008, NORMAL MODES LOCALIZ; Virgin L. N, 2000, INTRO EXPT NONLINEAR	29	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194452	10.1371/journal.pone.0194452	http://dx.doi.org/10.1371/journal.pone.0194452			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584758	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000025
J	Huo, Y; Zhang, YH; Guo, HF; Liu, YJ; Fang, Q; Zhang, JX				Huo, Ying; Zhang, Yaohua; Guo, Huifen; Liu, Yingjuan; Fang, Qi; Zhang, Jianxu			Tph2(-/-) female mice restore socio-sexual recognition through upregulating ER alpha and OTR genes in the amygdala (vol 13, e0193395, 2018)	PLOS ONE			English	Correction																		Huo Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193395	1	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195245	10.1371/journal.pone0195245	http://dx.doi.org/10.1371/journal.pone0195245			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584766				2022-12-27	WOS:000428373000061
J	Zhou, Q; Guo, L				Zhou, Qi; Guo, Lei			Empirical approach to threshold determination for the delineation of built-up areas with road network data	PLOS ONE			English	Article							VOLUNTEERED GEOGRAPHIC INFORMATION; POPULATION-GROWTH; URBAN; PERSPECTIVE; CITY; REPRESENTATION; BOUNDARIES; DATABASES; IMAGERY; CITIES	Various approaches have been proposed to address the delineation of built-up areas for a wide range of applications. Recently developed approaches are based on the increasing availability of road network data. However, most approaches have employed one or more parameters to divide built-up from non-built-up areas. Very few studies have discussed how to determine appropriate thresholds for such parameters. This study employed an empirical approach for threshold determination, and validated that the approach is applicable for the delineation of built-up areas using road network data. A series of experiments were designed to investigate the most-appropriate thresholds (determined using a similarity measure) for multiple parameters of three existing approaches (street blocks, grid-based, and kernel density) with regard to different administrative regions and cities/towns. The results show that in most cases, the most-appropriate thresholds or ranges for different subdivisions are either identical or overlap thus validating the use of the most-appropriate thresholds to delineate built-up areas for one or multiple small subdivisions and, by inference, for a much larger region.	[Zhou, Qi; Guo, Lei] China Univ Geosci, Sch Informat Engn, Wuhan, Hubei, Peoples R China; [Zhou, Qi] Beijing Key Lab Urban Spatial Informat Engn, Beijing, Peoples R China	China University of Geosciences	Zhou, Q (corresponding author), China Univ Geosci, Sch Informat Engn, Wuhan, Hubei, Peoples R China.; Zhou, Q (corresponding author), Beijing Key Lab Urban Spatial Informat Engn, Beijing, Peoples R China.	sevenlaand@hotmail.com		ZHOU, Qi/0000-0001-7177-1820	National Natural Science Foundation of China [41771428]; Fundamental Research Funds for the Central Universities; China University of Geosciences (Wuhan) [G1323541711]; Beijing Key Laboratory of Urban Spatial Information Engineering [2017213]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China University of Geosciences (Wuhan); Beijing Key Laboratory of Urban Spatial Information Engineering	The project was supported by National Natural Science Foundation of China (No. 41771428 to QZ), Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) (G1323541711 to QZ), and Beijing Key Laboratory of Urban Spatial Information Engineering (2017213 to QZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsanjani JJ, 2013, INT J GEOGR INF SCI, V27, P2264, DOI 10.1080/13658816.2013.800871; BORRUSO G., 2003, T GIS, V7, P177, DOI DOI 10.1111/1467-9671.00139; Chaudhry O, 2008, COMPUT ENVIRON URBAN, V32, P95, DOI 10.1016/j.compenvurbsys.2007.09.001; Cheng HQ, 2003, LANDSCAPE URBAN PLAN, V62, P199; GONG P, 1990, PHOTOGRAMM ENG REM S, V56, P67; Griffiths P, 2010, REMOTE SENS ENVIRON, V114, P426, DOI 10.1016/j.rse.2009.09.012; Holmes TJ, 2009, EC AGGLOMERATIONS, P105; Ji W, 2006, COMPUT ENVIRON URBAN, V30, P861, DOI 10.1016/j.compenvurbsys.2005.09.002; Jia T, 2011, MEASURING URBAN SPRA; Jiang B, 2014, ANN ASSOC AM GEOGR, V104, P530, DOI 10.1080/00045608.2013.834239; Jiang B, 2012, INT J GEOGR INF SCI, V26, P215, DOI 10.1080/13658816.2011.575074; Jiang B, 2011, INT J GEOGR INF SCI, V25, P1269, DOI 10.1080/13658816.2010.510801; Li X, 2006, INT J GEOGR INF SCI, V20, P1109, DOI 10.1080/13658810600816870; Li ZL, 2012, INT J GEOGR INF SCI, V26, P855, DOI 10.1080/13658816.2011.616861; Luscher P, 2013, COMPUT ENVIRON URBAN, V37, P18, DOI 10.1016/j.compenvurbsys.2012.07.001; Qiu F, 2003, PHOTOGRAMM ENG REM S, V69, P1031, DOI 10.14358/PERS.69.9.1031; Rozenfeld HD, 2011, AM ECON REV, V101, P2205, DOI 10.1257/aer.101.5.2205; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Saravanan P., 2010, International Journal of Geomatics and Geosciences, V1, P141; Sudhira H. S., 2004, INT J APPL EARTH OBS, V5, P29, DOI [10.1016/j.jag.2003.08.002, DOI 10.1016/J.JAG.2003.08.002]; Sutton PC, 2003, REMOTE SENS ENVIRON, V86, P353, DOI 10.1016/S0034-4257(03)00078-6; Tannier C, 2011, GEOGR ANAL, V43, P211, DOI 10.1111/j.1538-4632.2011.00814.x; Terando AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102261; Thurstain-Goodwin M., 2000, T GIS, V4, P305, DOI [10.1111/1467-9671.00058, DOI 10.1111/1467-9671.00058]; Zhen F, 2017, CITIES, V60, P180, DOI 10.1016/j.cities.2016.08.014; Zhou Q, 2015, T GIS, V19, P848, DOI 10.1111/tgis.12135; Zhou Q, 2016, INT J GEOGR INF SCI, V30, P263, DOI 10.1080/13658816.2015.1085538	27	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194806	10.1371/journal.pone.0194806	http://dx.doi.org/10.1371/journal.pone.0194806			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584753	Green Published, gold, Green Submitted			2022-12-27	WOS:000428373000037
J	Masumoto, H; Matsuyama, S				Masumoto, Hiroshi; Matsuyama, Shigeru			The combination of NAD(+)-dependent deacetylase gene deletion and the interruption of gluconeogenesis causes increased glucose metabolism in budding yeast	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; FLUX ANALYSIS; TCA CYCLE; ACETYLATION; GENOME; FAMILY	Metabolic engineering focuses on rewriting the metabolism of cells to enhance native products or endow cells with the ability to produce new products. This engineering has the potential for wide-range application, including the production of fuels, chemicals, foods and pharmaceuticals. Glycolysis manages the levels of various secondary metabolites by controlling the supply of glycolytic metabolites. Metabolic reprogramming of glycolysis is expected to cause an increase in the secondary metabolites of interest. In this study, we constructed a budding yeast strain harboring the combination of triple sirtuin gene deletion (hst3 Delta, hst4 Delta sir2 Delta) and interruption of gluconeogenesis by the deletion of the FBP1 gene encoding fructose-1,6-bisphosphatase (fbp1 Delta). hst3 Delta hst4 Delta sir2 Delta fbp1 Delta cells harbored active glycolysis with high glucose consumption and active ethanol productivity. Using capillary electrophoresis time-of-flight mass spectrometry (CE TOF/MS) analysis, hst3 Delta hst4 Delta sir2 Delta fbp1 Delta cells accumulated not only glycolytic metabolites but also secondary metabolites, including nucleotides that were synthesized throughout the pentose phosphate (PP) pathway, although various amino acids remained at low levels. Using the stable isotope labeling assay for metabolites, we confirmed that hst3 Delta hst4 Delta sir2 Delta fbp1 Delta cells directed the metabolic fluxes of glycolytic metabolites into the PP pathway. Thus, the deletion of three sirtuin genes (HST3, HST4 and SIR2) and the FBP1 gene can allow metabolic reprogramming to increase glycolytic metabolites and several secondary metabolites except for several amino acids.	[Masumoto, Hiroshi] Natl Inst Genet, Transdisciplinary Res Integrat Ctr, 1111 Yata, Mishima, Shizuoka, Japan; [Matsuyama, Shigeru] Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tsukuba	Masumoto, H (corresponding author), Natl Inst Genet, Transdisciplinary Res Integrat Ctr, 1111 Yata, Mishima, Shizuoka, Japan.	himasumo@nagasaki-u.ac.jp	Matsuyama, Shigeru/AAC-1955-2020	Matsuyama, Shigeru/0000-0003-2673-5673	NIG Collaborative Research Program [2016-A1-2]; Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government	NIG Collaborative Research Program; Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government	This work was supported by NIG Collaborative Research Program (2016-A1-2) and Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government.	Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blank LM, 2004, MICROBIOL-SGM, V150, P1085, DOI 10.1099/mic.0.26845-0; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Brown G.W., 2015, METHODS YEAST GENETI; Buijs NA, 2013, CURR OPIN CHEM BIOL, V17, P480, DOI 10.1016/j.cbpa.2013.03.036; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Coyle WT., 2010, NEXT GENERATION BIOF; Devantier R, 2005, BIOTECHNOL BIOENG, V90, P703, DOI 10.1002/bit.20457; Devic S, 2016, J CANCER, V7, P817, DOI 10.7150/jca.14274; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fraenkel D. G., 2011, YEAST INTERMEDIARY M; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hachinohe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054011; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Lee CS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0013-2014; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Noronha SB, 2000, BIOTECHNOL BIOENG, V68, P316, DOI 10.1002/(SICI)1097-0290(20000505)68:3<316::AID-BIT10>3.0.CO;2-2; Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094; Salway J.G., 2017, METABOLISM GLANCE; Sauer U, 2004, CURR OPIN BIOTECH, V15, P58, DOI 10.1016/j.copbio.2003.11.001; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226; Zamboni N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-209; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	36	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194942	10.1371/journal.pone.0194942	http://dx.doi.org/10.1371/journal.pone.0194942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579121	gold, Green Published, Green Submitted			2022-12-27	WOS:000428351800067
J	Horibata, S; Rice, EJ; Zheng, H; Mukai, C; Chu, TY; Marks, BA; Coonrod, SA; Danko, CG				Horibata, Sachi; Rice, Edward J.; Zheng, Hui; Mukai, Chinatsu; Chu, Tinyi; Marks, Brooke A.; Coonrod, Scott A.; Danko, Charles G.			A bi-stable feedback loop between GDNF, EGR1, and ER alpha contribute to endocrine resistant breast cancer	PLOS ONE			English	Article							CELL VARIABILITY; TRANSCRIPTION; RET; INITIATION; REVEALS; KINASE; MECHANISMS; EXPRESSION; ENHANCERS; GROWTH	Discovering regulatory interactions between genes that specify the behavioral properties of cells remains an important challenge. We used the dynamics of transcriptional changes resolved by PRO-seq to identify a regulatory network responsible for endocrine resistance in breast cancer. We show that GDNF leads to endocrine resistance by switching the active state in a bi-stable feedback loop between GDNF, EGR1, and the master transcription factor ER alpha. GDNF stimulates MAP kinase, activating the transcription factors SRF and AP-1. SRF initiates an immediate transcriptional response, activating EGR1 and suppressing ER alpha. Newly translated EGR1 protein activates endogenous GDNF, leading to constitutive GDNF and EGR1 up-regulation, and the sustained down-regulation of ER alpha. Endocrine resistant MCF-7 cells are constitutively in the GDNF-high/ER alpha-low state, suggesting that the state in the bi-stable feedback loop may provide a 'memory' of endocrine resistance. Thus, we identified a regulatory network switch that contributes to drug resistance in breast cancer.	[Horibata, Sachi; Rice, Edward J.; Zheng, Hui; Mukai, Chinatsu; Chu, Tinyi; Marks, Brooke A.; Coonrod, Scott A.; Danko, Charles G.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Horibata, Sachi] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Chu, Tinyi] Cornell Univ, Grad Field Computat Biol, Ithaca, NY USA; [Coonrod, Scott A.; Danko, Charles G.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Coonrod, SA; Danko, CG (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.; Coonrod, SA; Danko, CG (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	sac269@cornell.edu; dankoc@gmail.com	Horibata, Sachi/AAC-3204-2020	Horibata, Sachi/0000-0002-2629-7821	NIH [R01 HG009309-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by the NIH grants R01 HG009309-01 to C.G.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andreucci E, 2016, ONCOTARGET, V7, P80543, DOI 10.18632/oncotarget.11826; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Chu T, 2017, CHROMATIN RUN ON REV; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Core LJ, 2014, NAT GENET; Danko CG, 2015, NAT METHODS, V12, P433, DOI [10.1038/NMETH.3329, 10.1038/nmeth.3329]; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Duarte FM, 2016, GENE DEV, V30, P1731, DOI 10.1101/gad.284430.116; Fang FQ, 2016, CELL REP, V14, P1218, DOI 10.1016/j.celrep.2016.01.002; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hah N, 2013, GENOME RES; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Horibata S, 2017, ER POSITIVE BREAST C; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; KIM TK, 2010, ALL RIGHTS RESERVED, V465, P182; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma CX, 2009, ONCOLOGY-NY, V23, P133; Magnani L, 2013, P NATL ACAD SCI USA, V110, pE1490, DOI 10.1073/pnas.1219992110; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Miller WR, 2012, PHARMACOGENOMICS J, V12, P10, DOI 10.1038/tpj.2010.67; Morandi A, 2010, RET BREAST CANC FUNC; Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Pisco AO, 2016, CONCEPTUAL CONFUSION; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; Schwalb B, 2016, SCIENCE, V352, P1225, DOI 10.1126/science.aad9841; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Thomas C, 2015, TRENDS ENDOCRIN MET, V26, P467, DOI 10.1016/j.tem.2015.06.007; Waddington C. H., 1939, INTRO MODERN GENETIC; WADDINGTON CH, 1968, NATURE, V218, P525, DOI 10.1038/218525a0; Wang Z, 2016, BIOINFORMATICS	46	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194522	10.1371/journal.pone.0194522	http://dx.doi.org/10.1371/journal.pone.0194522			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614078	Green Submitted, gold, Green Published			2022-12-27	WOS:000429081600012
J	Liu, HB; Zhu, BH; Qiu, SF; Xia, YD; Liang, BB; Yang, CJ; Dong, NA; Li, YR; Xiang, Y; Wang, S; Xie, J; Mahe, M; Sun, YS; Song, HB				Liu, Hongbo; Zhu, Binghua; Qiu, Shaofu; Xia, Yidan; Liang, Beibei; Yang, Chaojie; Dong, Nian; Li, Yongrui; Xiang, Ying; Wang, Shan; Xie, Jing; Mahe, Muti; Sun, Yansong; Song, Hongbin			Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, China	PLOS ONE			English	Article							EMPIRIC ANTIBIOTIC-THERAPY; INTENSIVE-CARE-UNIT; GENETIC-CHARACTERIZATION; MULTIDRUG-RESISTANCE; 2 INTEGRONS; SONNEI; FLEXNERI; ENTEROBACTERIACEAE; MUTATIONS; PATTERNS	Shigella represents one of the major diarrhea-inducing pathogens threatening public health, but its prevalence and antimicrobial resistance profile in Xinjiang Uygur Autonomous region, China, remains unclear. We conducted comprehensive investigation of Shigella serotype distribution and antimicrobial resistance pattern in Xinjiang, identifying 458 Shigella isolates between 2008 to 2014. Shigella flexneri was identified as predominant species, and several S. flexneri serotypes were isolated, including atypical serotypes 1 c, 2c, and 4s. Dominant S. flexneri serotypes were 2a, 1b, 2b, and Xv, different from those generally dominant in China. A hybrid serotype pattern was observed, which included the major Chinese serotypes (2a, Xv) and those predominant in Pakistan (1 b, 2b). Shigella sonnei was shown to have a lower frequency compared with that generally observed in China, but an increasing trend of infections associated with this pathogen was observed. Furthermore, a high frequency of drug resistance and different Shigella antimicrobial resistance patterns were demonstrated as well, including very severe resistance phenotypes, such as multidrug resistance and resistance to frontline antibiotics. Seventy-five cephalosporin-resistant Shigella isolates were frequently identified with the resistance determinants that can undergo horizontal transfer, such as bla(OXA), bla(TEM), bla(CTX-M), and integrons, facilitating the development of cephalosporin resistance among Shigella subtypes. Additionally, genetic analyses demonstrated that all 86 quinolone-resistant S. flexneri isolates possess 3-4 mutation sites in quinolone resistance-determining regions, primarily contributing to their resistance to quinolone. However, S. sonnei isolates were not shown to be quinolone resistant. Co-resistance to cephalosporins and quinolones was detected in 17 S. flexneri isolates, and these isolates were additionally multi drug resistant and carried beta-lactamase genes and quinolone-resistance determinants. As is demonstrated in this study, dominant serotypes of Shigella were distributed in unique trend with dangerous drug resistance patterns. Novel strategies are urgently required to prevent the development of drug resistance among diarrhea-inducing pathogens.	[Liu, Hongbo; Zhu, Binghua; Liang, Beibei; Dong, Nian; Xiang, Ying; Wang, Shan; Sun, Yansong] Acad Mil Med Sci, Acad Mil Med Sci, Beijing, Peoples R China; [Liu, Hongbo; Zhu, Binghua; Qiu, Shaofu; Liang, Beibei; Yang, Chaojie; Dong, Nian; Li, Yongrui; Xiang, Ying; Wang, Shan; Xie, Jing; Song, Hongbin] PLA, Inst Dis Control & Prevent, Beijing, Peoples R China; [Xia, Yidan; Mahe, Muti] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi, Peoples R China	Academy of Military Medical Sciences - China	Sun, YS (corresponding author), Acad Mil Med Sci, Acad Mil Med Sci, Beijing, Peoples R China.; Song, HB (corresponding author), PLA, Inst Dis Control & Prevent, Beijing, Peoples R China.; Mahe, M (corresponding author), Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi, Peoples R China.	mahefyk@163.com; sunys1964@hotmail.com; hongbinsong@263.net	Qiu, Shaofu/CAJ-0602-2022		National Key R&D Program of China [2017YFC1600105]; National Nature Science Foundation of China [81673237, 81473023]	National Key R&D Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key R&D Program of China (no. 2017YFC1600105) and the National Nature Science Foundation of China (nos. 81673237 and 81473023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2006, J MED MICROBIOL, V55, P1685, DOI 10.1099/jmm.0.46725-0; Ahmed SF, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-9; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Anderson M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00045; AOKI YOSHIO, 1968, ARCH IMMUNOL THER EXP, V16, P303; Bhattacharya D, 2015, EPIDEMIOL INFECT, V143, P470, DOI 10.1017/S0950268814000958; Bodhidatta L, 2012, VACCINE, V30, P7040, DOI 10.1016/j.vaccine.2012.09.061; Chung H., 2016, PLOS MED, V13; Collatz E, 2008, CLIN MICROBIOL INFEC, V14, P1, DOI 10.1111/j.1469-0691.2008.02127.x; Cristea Daniela, 2009, Roum Arch Microbiol Immunol, V68, P44; Cui XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129009; Cui XY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00435; English BK, 2010, ADV EXP MED BIOL, V659, P73, DOI 10.1007/978-1-4419-0981-7_6; Flores-Carrero A, 2016, J GLOB ANTIMICROB RE, V7, P114, DOI 10.1016/j.jgar.2016.08.006; Folster JP, 2011, ANTIMICROB AGENTS CH, V55, P1758, DOI 10.1128/AAC.01463-10; Galani I, 2010, INT J ANTIMICROB AG, V36, P252, DOI 10.1016/j.ijantimicag.2010.05.004; Gassama-Sow A, 2010, J INFECT DEV COUNTR, V4, P207, DOI 10.3855/jidc.583; Gu B, 2017, J GLOB ANTIMICROB RE, V10, P29, DOI 10.1016/j.jgar.2017.03.009; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, pS81, DOI 10.1097/MPG.0b013e31816f7b16; Hoffmann C, 2013, INFECTION, V41, P999, DOI 10.1007/s15010-013-0501-4; Hu LF, 2007, J MICROBIOL, V45, P168; Institute. CaLS, 2018, M100 CLSI I CALS; Kahsay Atsebaha Gebrekidan, 2016, BMC Res Notes, V9, P422, DOI 10.1186/s13104-016-2236-7; Ke X, 2011, ARCH MICROBIOL, V193, P767, DOI 10.1007/s00203-011-0744-3; Klontz KC, 2015, EXPERT REV ANTI-INFE, V13, P69, DOI 10.1586/14787210.2015.983902; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kuo HW, 2009, WIEN KLIN WOCHENSCHR, V121, P157, DOI 10.1007/s00508-008-1141-7; Li RC, 2017, J ANTIMICROB CHEMOTH, V72, P696, DOI 10.1093/jac/dkw509; Lindsey RL, 2017, GENOME ANNOUNCEMENTS, V5; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; Madiyarov RS, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-18; Mahemuti Wupuer, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P447; Matar GM, 2007, ANN TROP MED PARASIT, V101, P511, DOI 10.1179/136485907X193860; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; MITSUHASHI S, 1961, JPN J EXP MED, V31, P47; Moore John E, 2010, Ulster Med J, V79, P85; Nandy S, 2011, EMERG INFECT DIS, V17, P2072, DOI 10.3201/eid1711.110403; Nguyen TKN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000702; Oduro-Mensah D, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0144-2; Pan JC, 2006, J ANTIMICROB CHEMOTH, V58, P288, DOI 10.1093/jac/dkl228; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Pazhani GP, 2005, EPIDEMIOL INFECT, V133, P1089, DOI 10.1017/S0950268805004498; Pouwels KB, 2017, J HOSP INFECT, V96, P23, DOI 10.1016/j.jhin.2017.03.016; Puzari M, 2017, J INFECT PUBLIC HLTH; Qin T, 2016, EUR J CLIN MICROBIOL, V35, P2037, DOI 10.1007/s10096-016-2761-2; Qiu S, 2015, CLIN MICROBIOL INFEC, V21, P252; Qiu SF, 2013, EMERG INFECT DIS, V19, P1147, DOI 10.3201/eid1907.111221; Qiu SF, 2011, J CLIN MICROBIOL, V49, P1148, DOI 10.1128/JCM.01946-10; Qu F, 2012, DIAGN MICR INFEC DIS, V74, P166, DOI 10.1016/j.diagmicrobio.2012.06.026; Smet A, 2009, J ANTIMICROB CHEMOTH, V63, P1286, DOI 10.1093/jac/dkp101; Solgi H, 2018, J ANTIMICROBIAL CHEM; Tariq A, 2012, CAN J MICROBIOL, V58, P1047, DOI [10.1139/w2012-085, 10.1139/W2012-085]; Tatay-Dualde J, 2017, VET MICROBIOL, V207, P63, DOI 10.1016/j.vetmic.2017.06.003; Tong PP, 2015, FOODBORNE PATHOG DIS, V12, P345, DOI 10.1089/fpd.2014.1857; Ud-Din AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082601; Wang J, 2015, DIAGN MICR INFEC DIS, V83, P338, DOI 10.1016/j.diagmicrobio.2015.08.010; Wang X, 2015, BIOESSAYS, V37, P1045, DOI 10.1002/bies.201500071; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Wang Z, 2017, INFECT CONT HOSP EP, V38, P758, DOI 10.1017/ice.2017.60; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09; Zafar A, 2009, INT J INFECT DIS, V13, P668, DOI 10.1016/j.ijid.2008.10.005; Zhang CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-260; Zhang J, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1526, DOI 10.3760/cma.j.issn.0254-6450.2016.11.018; Zhu JY, 2011, CURR MICROBIOL, V62, P802, DOI 10.1007/s00284-010-9790-3	64	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195259	10.1371/journal.pone.0195259	http://dx.doi.org/10.1371/journal.pone.0195259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614121	gold, Green Published, Green Submitted			2022-12-27	WOS:000429081600039
J	Novakova, L; Axelsson, M; Malmestrom, C; Imberg, H; Elias, O; Zetterberg, H; Nerman, O; Lycke, J				Novakova, Lenka; Axelsson, Markus; Malmestrom, Clas; Imberg, Henrik; Elias, Olle; Zetterberg, Henrik; Nerman, Olle; Lycke, Jan			Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; BRAIN PARENCHYMAL FRACTION; NERVE-FIBER LAYER; CEREBROSPINAL-FLUID; DISABILITY PROGRESSION; OLIGOCLONAL BANDS; MATTER ATROPHY; NEUROFILAMENT; SEGMENTATION; GUIDELINES	Background Neurodegeneration occurs during the early stages of multiple sclerosis. It is an essential, devastating part of the pathophysiology. Tools for measuring the degree of neurodegeneration could improve diagnostics and patient characterization. Objective This study aimed to determine the diagnostic value of biomarkers of degeneration in patients with recent clinical onset of suspected multiple sclerosis, and to evaluate these biomarkers for characterizing disease course. Methods This cross-sectional study included 271 patients with clinical features of suspected multiple sclerosis onset and was the baseline of a prospective study. After diagnostic investigations, the patients were classified into the following disease groups: patients with clinically isolated syndrome (n = 4) or early relapsing remitting multiple sclerosis (early RRMS; n = 93); patients with relapsing remitting multiple sclerosis with disease durations >= 2 years (established RRMS; n = 39); patients without multiple sclerosis, but showing symptoms (symptomatic controls; n = 89); and patients diagnosed with other diseases (n = 46). In addition, we included healthy controls (n = 51) and patients with progressive multiple sclerosis (n = 23). We analyzed six biomarkers of neurodegeneration: cerebrospinal fluid neurofilament light chain levels; cerebral spinal fluid glial fibrillary acidic protein; cerebral spinal fluid tau; retinal nerve fiber layer thickness; macula volume; and the brain parenchymal fraction. Results Except for increased cerebral spinal fluid neurofilament light chain levels, median 670 ng/L (IQR 400-2110), we could not find signs of early degeneration in the early disease group with recent clinical onset. However, the intrathecal immunoglobin G production and cerebral spinal fluid neurofilament light chain levels showed diagnostic value. Moreover, elevated levels of cerebral spinal fluid glial fibrillary acidic protein, thin retinal nerve fiber layers, and low brain parenchymal fractions were associated with progressive disease, but not with the other phenotypes. Thin retinal nerve fiber layers and low brain parenchymal fractions, which indicated neurodegeneration, were associated with longer disease duration. Conclusions In clinically suspected multiple sclerosis, intrathecal immunoglobin G production and neurofilament light chain levels had diagnostic value. Therefore, these biomarkers could be included in diagnostic work-ups for multiple sclerosis. We found that the thickness of the retinal nerve fiber layer and the brain parenchymal fraction were not different between individuals that were healthy, symptomatic, or newly diagnosed with multiple sclerosis. This finding suggested that neurodegeneration had not reached a significant magnitude in patients with a recent clinical onset of multiple sclerosis.	[Novakova, Lenka; Axelsson, Markus; Malmestrom, Clas; Lycke, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Imberg, Henrik; Elias, Olle; Nerman, Olle] Chalmers Univ Technol, Math Sci, Gothenburg, Sweden; [Imberg, Henrik; Elias, Olle; Nerman, Olle] Univ Gothenburg, Gothenburg, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England	University of Gothenburg; Chalmers University of Technology; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London	Novakova, L (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden.	lenka.novakova@vgregion.se	Malmeström, Clas/A-8749-2012; Novakova, Lenka/ABF-5492-2020; Imberg, Henrik/ABC-5503-2021	Malmeström, Clas/0000-0003-2477-0088; Novakova, Lenka/0000-0001-7899-6395; Imberg, Henrik/0000-0001-9447-663X; Hallqvist Elias, Olof/0000-0002-4998-8561	Swedish Research Council; European Research Council; Swedish State Support for Clinical Research (ALFGBG); Knut and Alice Wallenberg Foundation; Frimurarestiftelsen; NEURO Sweden; Research Foundation of the Multiple Sclerosis Society of Gothenburg; Edith Jacobsons Foundation; Helena Ahlin's Foundation; Novartis; Biogen; TEVA	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish State Support for Clinical Research (ALFGBG); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Frimurarestiftelsen; NEURO Sweden; Research Foundation of the Multiple Sclerosis Society of Gothenburg; Edith Jacobsons Foundation; Helena Ahlin's Foundation; Novartis(Novartis); Biogen(Biogen); TEVA(Teva Pharmaceutical Industries)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was supported by grants from the Swedish and European Research Councils (HZ), Swedish State Support for Clinical Research (ALFGBG; HZ, JL), the Knut and Alice Wallenberg Foundation (HZ), Frimurarestiftelsen (HZ), NEURO Sweden (LN, JL), the Research Foundation of the Multiple Sclerosis Society of Gothenburg (LN, JL), the Edith Jacobsons Foundation (LN, JL), Helena Ahlin's Foundation (LN), Novartis (JL), Biogen and TEVA (unconditional grants) (LN, JL).	[Anonymous], 2017, R LANG ENV STAT COMP; Axelsson M, 2011, J NEUROL, V258, P882, DOI 10.1007/s00415-010-5863-2; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Behbehani R, 2015, J NEUROL SCI, V359, P305, DOI 10.1016/j.jns.2015.11.017; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Charil A, 2007, J NEUROL SCI, V259, P7, DOI 10.1016/j.jns.2006.08.017; Coles AJ, 2017, NEUROLOGY, V89, P1117, DOI 10.1212/WNL.0000000000004354; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Giovannoni G, 2015, MULT SCLER RELAT DIS, V4, P329, DOI 10.1016/j.msard.2015.04.006; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Granberg T, 2016, AM J NEURORADIOL, V37, P1023, DOI 10.3174/ajnr.A4665; Havrdova E, 2017, NEUROLOGY, V89, P1107, DOI 10.1212/WNL.0000000000004313; Henry RG, 2008, J NEUROL NEUROSUR PS, V79, P1236, DOI 10.1136/jnnp.2007.134825; Jacobsen C, 2014, J NEUROL NEUROSUR PS, V85, P1109, DOI 10.1136/jnnp-2013-306906; Kalincik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050101; Kuhle J, 2017, NEUROLOGY, V88, P826, DOI 10.1212/WNL.0000000000003653; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Lourenco P, 2013, MULT SCLER J, V19, P577, DOI 10.1177/1352458512459684; Martinez MAM, 2015, MULT SCLER J, V21, P550, DOI 10.1177/1352458514549397; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Paolillo A, 2000, J NEUROL SCI, V174, P85, DOI 10.1016/S0022-510X(00)00259-8; Perez-Miralles F, 2013, MULT SCLER J, V19, P1878, DOI 10.1177/1352458513488231; Petzold A, 2017, LANCET NEUROL, V16, P797, DOI 10.1016/S1474-4422(17)30278-8; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Pietroboni AM, 2019, MULT SCLER J, V25, P31, DOI 10.1177/1352458517740214; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu Bogdan F Gh, 2013, Continuum (Minneap Minn), V19, P901, DOI 10.1212/01.CON.0000433291.23091.65; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Therneau Terry., 2017, RPART RECURSIVE PART; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Vagberg M, 2017, ACTA NEUROL SCAND, V135, P17, DOI 10.1111/ane.12667; Vagberg M, 2013, AM J NEURORADIOL, V34, P498, DOI 10.3174/ajnr.A3262; Vagberg M, 2016, J NEURORADIOLOGY, V43, P384, DOI 10.1016/j.neurad.2016.08.002; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844; Zivadinov R, 2013, AM J NEURORADIOL, V34, P1931, DOI 10.3174/ajnr.A3503	40	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194828	10.1371/journal.pone.0194828	http://dx.doi.org/10.1371/journal.pone.0194828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614113	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600019
J	Golizeh, M; Melendez-Pena, CE; Ward, BJ; Saeed, S; Santamaria, C; Conway, B; Cooper, C; Klein, MB; Ndao, M				Golizeh, Makan; Melendez-Pena, Carlos E.; Ward, Brian J.; Saeed, Sahar; Santamaria, Cynthia; Conway, Brian; Cooper, Curtis; Klein, Marina B.; Ndao, Momar		Canadian Co-Infection Cohort	Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging	PLOS ONE			English	Article							HEPATITIS-C VIRUS; LIVER FIBROSIS; BIOCHEMICAL MARKERS; HEPATOCELLULAR-CARCINOMA; ANTIRETROVIRAL THERAPY; PROSTATE-CANCER; INFECTION; DISEASE; PROTEIN; PROGRESSION	Background Hepatic complications of hepatitis C virus (HCV), including fibrosis and cirrhosis are accelerated in human immunodeficiency virus (HIV)-infected individuals. Although, liver biopsy remains the gold standard for staging HCV-associated liver disease, this test can result in serious complications and is subject to sampling errors. These challenges have prompted a search for non-invasive methods for liver fibrosis staging. To this end, we compared serum proteome profiles at different stages of fibrosis in HIV/HCV co- and HCV mono-infected patients using surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS). Methods Sera from 83 HIV/HCV co- and 68 HCV mono-infected subjects in 4 stages of fibrosis were tested. Sera were fractionated, randomly applied to protein chip arrays (IMAC, CM10 and H50) and spectra were generated at low and high laser intensities. Results Sixteen biomarkers achieved a p value < 0.01 (ROC values > 0.75 or < 0.25) predictive of fibrosis status in co-infected individuals and 14 in mono infected subjects. Five of these candidate biomarkers contributed to both mono- and co-infected subjects. Candidate diagnostic algorithms were created to distinguish between non-fibrotic and fibrotic individuals using a panel of 4 biomarker peaks. Conclusion These data suggest that SELDI MS profiling can identify diagnostic serum biomarkers for fibrosis that are both common and distinct in HIV/HCV co-infected and HCV mono-infected individuals.	[Golizeh, Makan; Ward, Brian J.; Saeed, Sahar; Santamaria, Cynthia; Klein, Marina B.; Ndao, Momar] McGill Univ, Ctr Hlth, Res Inst, Program Infect Dis & Immun Global Hlth, Montreal, PQ, Canada; [Melendez-Pena, Carlos E.; Ward, Brian J.; Ndao, Momar] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Saeed, Sahar; Klein, Marina B.] McGill Univ, Ctr Hlth, Div Infect Dis, Montreal, PQ, Canada; [Saeed, Sahar; Klein, Marina B.] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada; [Conway, Brian] Vancouver Infect Dis Ctr, Vancouver, BC, Canada; [Cooper, Curtis] Ottawa Hosp Gen Campus, Ottawa, ON, Canada; [Ndao, Momar] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Ndao, Momar] McGill Univ, Ctr Hlth, Res Inst, Natl Reference Ctr Parasitol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; University of Ottawa; Ottawa Hospital Research Institute; McGill University; McGill University	Ndao, M (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Program Infect Dis & Immun Global Hlth, Montreal, PQ, Canada.; Ndao, M (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ, Canada.; Ndao, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Ndao, M (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Natl Reference Ctr Parasitol, Montreal, PQ, Canada.	momar.ndao@mcgill.ca	Cooper, Curtis/M-9320-2019; Golizeh, Makan/AAE-6063-2022	Golizeh, Makan/0000-0001-7746-5533; Klein, Marina/0000-0002-3063-8430; Saeed, Sahar/0000-0002-0224-379X; Ndao, Momar/0000-0002-9012-4212	Public Health Agency of Canada/National Microbiology Laboratory; Foundation of the Montreal General Hospital; Foundation of the McGill University Health Centre; Research Institute of the McGill University Health Centre; Area of Biomedical/Clinical HIV/AIDS; Canadian Institute of Health Research [HOP-90182]	Public Health Agency of Canada/National Microbiology Laboratory; Foundation of the Montreal General Hospital; Foundation of the McGill University Health Centre; Research Institute of the McGill University Health Centre; Area of Biomedical/Clinical HIV/AIDS; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank participants of the study and their treating physicians. The Canadian Co-Infection Cohort investigators (CTN222) are: Drs. Lisa Barrett, QEII Health Science Center for Clinical Research, Halifax, NS; Jeff Cohen, Windsor Regional Hospital Metropolitan Campus, Windsor, ON; Brian Conway, Vancouver Infectious Diseases Research and Care Centre, Vancouver, BC; Curtis Cooper, The Ottawa Hospital Research Institute, Ottawa ON; Pierre Cote, Clinique du Quartier Latin, Montreal, QC; Joseph Cox, MUHC IDTC-Montreal General Hospital, Montreal, QC; John Gill, Southern Alberta HIV Clinic, Calgary, AB; Shariq Haider, McMaster University, Hamilton, ON; Mark Hull, BC Centre for Excellence in HIV/AIDS, Vancouver, BC; Marina Klein, McGill University Health Centre, Division of Infectious Diseases and Chronic Viral Illness Service, Montreal, QC (Principal Investigator, marina.klein@mcgill.ca); Erica Moodie, McGill University, Montreal, QC; Neora Pick, Oak Tree Clinic, Children's and Women's Health Centre of British Columbia, University of British Columbia, Vancouver, BC; Anita Rachlis, Sunnybrook & Women's College Health Sciences Centre, Toronto, ON; Danielle Rouleau, Centre Hospitalier de l'Universite A de Montreal, Montreal, QC; Aida Sadr, St. Paul's Hospital, Vancouver, BC; Roger Sandre, HAVEN Program, Sudbury, ON; Mark Tyndall, BC Centre for Excellence in HIV/AIDS, Vancouver, BC; Steve Sanche, SHARE University of Saskatchewan, Saskatoon, SK; Marie-Louise Vachon, Centre Hospitalier Universitaire de Quebec, Quebec, QC; Sharon Walmsley, University Health Network, Toronto, ON; and Alex Wong, Regina Qu'Appelle Health Region, Regina General Hospital, Regina, SK. We thank all study coordinators and nurses for their assistance with study coordination, participant recruitment and care. The National Reference Centre for Parasitology is supported by Public Health Agency of Canada/National Microbiology Laboratory, the Foundation of the Montreal General Hospital, The Foundation of the McGill University Health Centre and the Research Institute of the McGill University Health Centre. We also thank Maxime Lemieux, graduate student of experimental medicine at McGill University, Montreal, QC for his kind assistance with data recovery and analysis. C.E.M.P. is a recipient of Doctoral Research Award in the Area of Biomedical/Clinical HIV/AIDS.; This study was funded by the Canadian Institute of Health Research (HOP-90182 to MBK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Afdhal Nezam H, 2012, Gastroenterol Hepatol (N Y), V8, P605; Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Al-Mohri H, 2007, JAIDS-J ACQ IMM DEF, V44, P463, DOI 10.1097/QAI.0b013e318030ff8e; Brebner Judith A, 2013, F1000 Med Rep, V5, P4, DOI 10.3410/M5-4; Comunale MA, 2004, PROTEOMICS, V4, P826, DOI 10.1002/pmic.200300625; [Draft Guidance for Industry Services UDoHaH], 2013, GUID IND CH IN PRESS; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Gonzalez SA, 2003, SEMIN LIVER DIS, V23, P149; Gouthamchandra K, 2014, J GEN VIROL, V95, P1654, DOI 10.1099/vir.0.062430-0; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kim J, 2002, ELECTROPHORESIS, V23, P4142, DOI 10.1002/elps.200290032; Klein MB, 2010, INT J EPIDEMIOL, V39, P1162, DOI 10.1093/ije/dyp297; Landgren O, 2010, J CLIN ONCOL, V28, P773, DOI 10.1200/JCO.2009.25.1322; Lu M, 2016, CLIN GASTROENTEROL H, V14, P1044, DOI 10.1016/j.cgh.2016.01.009; MAHARAJ B, 1986, LANCET, V1, P523; McLerran D, 2008, CLIN CHEM, V54, P44, DOI 10.1373/clinchem.2007.091470; Moodie EEM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004517; Ndao M, 2012, METHODS MOL BIOL, V818, P67, DOI 10.1007/978-1-61779-418-6_5; Ndao M, 2010, J CLIN MICROBIOL, V48, P1139, DOI 10.1128/JCM.02207-09; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; Pascual-Pareja JF, 2009, AIDS, V23, P971, DOI 10.1097/QAD.0b013e328329f994; Patel K, 2014, CLIN GASTROENTEROL H, V12, P2113, DOI 10.1016/j.cgh.2014.04.037; Poon TCW, 2003, CLIN CHEM, V49, P752, DOI 10.1373/49.5.752; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Ratziu V, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-6; Sarvari J, 2014, HEPAT MON, V14, P13103, DOI [10.5812/hep-atmon.13103, DOI 10.5812/HEP-ATMON.13103]; Sarvari J, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8351; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schwegler EE, 2005, HEPATOLOGY, V41, P634, DOI 10.1002/hep.20577; Shetty V, 2011, OMICS, V15, P705, DOI 10.1089/omi.2011.0004; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith JO, 2009, ALIMENT PHARM THER, V30, P557, DOI 10.1111/j.1365-2036.2009.04062.x; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Terrier B, 2009, ANN RHEUM DIS, V68, P89, DOI 10.1136/ard.2007.086488; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Xiao Z, 2005, MOL CELL ENDOCRINOL, V230, P95, DOI 10.1016/j.mce.2004.10.010; Yang LB, 2011, DIGEST DIS SCI, V56, P3305, DOI 10.1007/s10620-011-1745-4; Yip TTC, 2005, CLIN CHEM, V51, P47, DOI 10.1373/clinchem.2004.031229	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195148	10.1371/journal.pone.0195148	http://dx.doi.org/10.1371/journal.pone.0195148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608613	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800027
J	Kaplan, Z; Fehrer, J; Bambasova, V; Hellquist, CB				Kaplan, Zdenek; Fehrer, Judith; Bambasova, Veronika; Hellquist, C. Barre			The endangered Florida pondweed (Potamogeton floridanus) is a hybrid: Why we need to understand biodiversity thoroughly	PLOS ONE			English	Article							X-P.-NATANS; ISOZYME EVIDENCE; SEQUENCE DATA; PHYLOGENETIC-RELATIONSHIPS; BRITISH POPULATIONS; MOLECULAR ANALYSIS; BARCODING MARKERS; HYBRIDIZATION; TAXONOMY; EUROPE	Thorough understanding of biodiversity is a fundamental prerequisite for biological research. A lack of taxonomic knowledge and species misidentifications are particularly critical for conservation. Here we present an example of Potamogeton floridanus, the Florida Pond weed, an endangered taxon endemic to a small area in the Florida panhandle, whose taxonomic status remained controversial for more than a century, and all previous attempts to elucidate its identity have failed. We applied molecular approaches to tackle the origin of the mysterious taxon and supplemented them with morphological and anatomical investigations of both historical herbarium collections and plants recently collected in the type area for a comprehensive taxonomic reassessment. Sequencing of two nuclear ribosomal markers and one chloroplast non-coding spacer resulted in the surprising discovery that P. floridanus is a hybrid of P. pulcherand P. oakesianus, with the former being the maternal parent. The hybrid colony is currently geographically isolated from the distribution range of P. oakesianus. We show that previous molecular analyses have failed to reveal its hybrid identity due to inadequate nuclear DNA sequence editing. This is an example how the uncritical use of automized sequence reads can hamper molecular species identifications and also affect phylogenetic tree construction and interpretation. This unique hybrid taxon, P. xfloridanus, adds another case study to the debate on hybrid protection; consequences for its conservation are discussed.	[Kaplan, Zdenek; Fehrer, Judith; Bambasova, Veronika] Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Kaplan, Zdenek] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Hellquist, C. Barre] Massachusetts Coll Liberal Arts, Dept Biol, North Adams, MA USA	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Massachusetts System of Public Higher Education; Massachusetts College Liberal Arts	Kaplan, Z (corresponding author), Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic.; Kaplan, Z (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.	kaplan@ibot.cas.cz	Kaplan, Zdenek/A-3751-2012; Fehrer, Judith/B-9296-2013	Kaplan, Zdenek/0000-0003-1707-7461; Fehrer, Judith/0000-0002-0337-5444	Czech Science Foundation [17-06825S]; Czech Academy of Sciences [RVO 67985939]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences)	The research was supported by grant no. 17-06825S from the Czech Science Foundation and by the long-term research development project no. RVO 67985939 from The Czech Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2013, AN JARDIN BOT MADRID, V70, P72, DOI 10.3989/ajbm.2326; Becker M, 2013, NAT CLIM CHANGE, V3, P1039, DOI 10.1038/NCLIMATE2027; Bennett A, 1887, J BOT LONDON, V25, P177; Bennett A., 1903, J LINN SOC BOT, V36, P193; Bennett A., 1907, J BOT LONDON, V45, P373; Bennett A., 1914, PHILIPP J SCI C, V9, P339; Bennett A., 1896, B HERB BOISSIER, V4, P545; Bobrov AA, 2013, PHYTOTAXA, V149, P31, DOI 10.11646/phytotaxa.149.1.5; BORCHSENIUS F, 2009, FASTGAP 1 2; Borsch T, 2015, PERSPECT PLANT ECOL, V17, P284, DOI 10.1016/j.ppees.2015.05.003; Brochet AL, 2010, FRESHWATER BIOL, V55, P1262, DOI 10.1111/j.1365-2427.2009.02350.x; Brochet AL, 2009, ECOGRAPHY, V32, P919, DOI 10.1111/j.1600-0587.2009.05757.x; Chrtek J, 2009, ANN BOT-LONDON, V104, P161, DOI 10.1093/aob/mcp107; Clausen P, 2002, ACTA OECOL, V23, P191, DOI 10.1016/S1146-609X(02)01150-5; DANDY JE, 1975, HYBRIDIZATION FLORA, P444; DANDY JE, 1980, FLORA EUROPAEA, V5, P7; Du ZY, 2011, J SYST EVOL, V49, P246, DOI 10.1111/j.1759-6831.2011.00131.x; Du ZY, 2010, PLANT SYST EVOL, V287, P57, DOI 10.1007/s00606-010-0289-y; Ennos RA, 2005, TRENDS ECOL EVOL, V20, P164, DOI 10.1016/j.tree.2005.01.012; Fant JB, 2004, BOT J LINN SOC, V144, P99, DOI 10.1111/j.0024-4074.2004.00236.x; Fehrer J, 2008, CLADISTICS, V24, P443, DOI 10.1111/j.1096-0031.2008.00216.x; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Fehrer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-239; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Figuerola J, 2002, ARCH HYDROBIOL, V155, P557; Figuerola J, 2002, J ECOL, V90, P989, DOI 10.1046/j.1365-2745.2002.00734.x; FISCHER G, 1907, BER BAYER BOT GES, V11, P20; Fish US and Service Wildlife, 2013, FED THREAT END OTH S; Florida Natural Areas Inventory, 2014, FNAI EL TRACK SUMM; Gonzalez MEG, 2011, ACTA BOT GALLICA, V158, P577, DOI 10.1080/12538078.2011.10516296; Graebner P., 1907, PFLANZENREICH REGNI, P39; Green AJ, 2002, ACTA OECOL, V23, P177, DOI 10.1016/S1146-609X(02)01149-9; Guo Y.H., 2010, FLORA CHINA, P108; Hagstrom JO, 1906, KUNGL SVENSKA VETENS, V55, P1; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Haynes R.R., 2000, FLORA N AM N MEXICO, V22, P47; Haynes R.R, 2003, FLORA NEOTROPICA MON, V85, P1; Hettiarachchi P., 1991, OPERA BOT BELG, V4, P87; HOLLINGSWORTH PM, 1995, PLANT SYST EVOL, V197, P71, DOI 10.1007/BF00984633; Hollingsworth PM, 1996, PLANT SYST EVOL, V202, P219, DOI 10.1007/BF00983384; Hollingsworth PM, 1998, AQUAT BOT, V60, P433, DOI 10.1016/S0304-3770(97)00063-6; HOLLINGSWORTH PM, 1995, BOT J LINN SOC, V117, P59, DOI 10.1006/bojl.1995.0006; Iida S, 2004, AQUAT BOT, V80, P115, DOI 10.1016/j.aquabot.2004.08.005; Ito Yu, 2016, Bulletin of the National Museum of Nature and Science Series B-Botany, V42, P131; Kaplan Z, 2007, PLANT BIOSYST, V141, P344, DOI 10.1080/11263500701626408; Kaplan Z, 2005, PRESLIA, V77, P419; Kaplan Z, 2005, TAXON, V54, P822, DOI 10.2307/25065445; Kaplan Z, 2005, BOT J LINN SOC, V148, P329, DOI 10.1111/j.1095-8339.2005.00410.x; Kaplan Z, 2004, TAXON, V53, P1033, DOI 10.2307/4135570; Kaplan Z, 2004, FOLIA GEOBOT, V39, P431, DOI 10.1007/BF02803212; Kaplan Z, 2004, PRESLIA, V76, P141; Kaplan Z, 2003, PLANT SYST EVOL, V239, P95, DOI 10.1007/s00606-002-0252-7; Kaplan Z, 2002, FOLIA GEOBOT, V37, P141, DOI 10.1007/BF02804229; Kaplan Z., 1995, SIBERIANT NAT, V1, P73; Kaplan Z, 2007, ANN BOT-LONDON, V99, P1213, DOI 10.1093/aob/mcm072; Kaplan Zdenek, 2002, Preslia (Prague), V74, P187; Kaplan Z, 2006, PRESLIA, V78, P303; Kaplan Z, 2014, AQUAT BOT, V119, P91, DOI 10.1016/j.aquabot.2014.08.005; Kaplan Z, 2013, PRESLIA, V85, P421; Kaplan Z, 2013, BRITTONIA, V65, P452, DOI 10.1007/s12228-012-9299-0; Kaplan Z, 2013, AQUAT BOT, V105, P34, DOI 10.1016/j.aquabot.2012.11.002; Kaplan Z, 2012, BOT J LINN SOC, V170, P112, DOI 10.1111/j.1095-8339.2012.01270.x; Kaplan Z, 2011, NORD J BOT, V29, P477, DOI 10.1111/j.1756-1051.2011.01240.x; Kaplan Z, 2011, TAXON, V60, P758, DOI 10.1002/tax.603011; Kaplan Z, 2011, TELOPEA, V13, P245; Kaplan Z, 2010, ANN BOT FENN, V47, P373, DOI 10.5735/085.047.0508; Kaplan Z, 2010, PRESLIA, V82, P261; Kaplan Z, 2009, PRESLIA, V81, P387; Kaplan Z, 2009, SYST BOT, V34, P625, DOI 10.1600/036364409790139745; Kaplan Zdenek, 2001, Preslia (Prague), V73, P333; Kashina LI, 2000, FLORA SIBERIA, V1, P85; Kirschner J, 2002, TAXON, V51, P155, DOI 10.2307/1554973; Kolar F, 2015, PRESLIA, V87, P363; Les DH, 2009, SYST BOT, V34, P643, DOI 10.1600/036364409790139727; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Lindqvist C, 2006, CLADISTICS, V22, P568, DOI 10.1111/j.1096-0031.2006.00124.x; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Morong T., 1886, B TORREY BOT CLUB, V13, P145; Oakley CG, 2015, INT J PLANT SCI, V176, P11, DOI 10.1086/677946; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Ogden E., 1943, RHODORA, V45, P171; Ogden E.C., 1943, RHODORA, V45, P119; OGDEN EC, 1943, RHODORA, V45, P57; Papassotiriou S.E., 2011, FLORA OF AUSTR, V39, P84; Piett S, 2015, BIODIVERS CONSERV, V24, P1931, DOI 10.1007/s10531-015-0919-3; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Preston C. D., 1998, Watsonia, V22, P61; Preston C. D., 2015, HYBRID FLORA BRIT IS, P319; Preston CD., 1995, PONDWEEDS GREAT BRIT; Raduski AR, 2010, INT J MOL SCI, V11, P492, DOI 10.3390/ijms11020492; RAUNKIAER C, 1903, BOT TIDSSKR, V25, P253; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santamaria L, 2002, ARCH HYDROBIOL, V156, P11, DOI 10.1127/0003-9136/2002/0156-0011; Sedlacek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047415; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Small J. K., 1903, FLORA SE US; Smith GF, 2008, S AFR J SCI, V104, P254; Soltis DE, 2008, SYST BOT, V33, P7, DOI 10.1600/036364408783887401; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; SYMOENS JJ, 1979, B SOC ROY BOT BELG, V112, P79; Taylor N, 1909, N AM FLORA, V17, P13; USDI-FWS, 1993, FED REGISTER, V58, P51144; von Staden L, 2013, S AFR J SCI, V109, P48, DOI 10.1590/sajs.2013/1182; vonHoldt BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501714; Walter KS, 1998, 1997 IUCN RED LIST T; Wang B, 2016, ORYX, V50, P446, DOI 10.1017/S0030605315000435; Wang QD, 2007, PLANT SYST EVOL, V267, P65, DOI 10.1007/s00606-006-0499-5; Wiegleb G, 1998, FOLIA GEOBOT, V33, P241, DOI 10.1007/BF03216205; WIEGLEB G, 1990, PLANT SYST EVOL, V169, P245, DOI 10.1007/BF00937678; WIEGLEB G, 1990, FLORA, V184, P197; WIEGLEB G, 1990, PLANT SYST EVOL, V170, P53, DOI 10.1007/BF00937849; Wiegleb G, 2002, FLORA MALESIANA 1, V16, P174; Wiegleb G., 1988, REPERTORIUM SPECIERU, V99, P249; WILHELM G S, 1986, SIDA Contributions to Botany, V11, P340; Yang T, 2017, AQUAT BOT, V137, P56, DOI 10.1016/j.aquabot.2016.11.009; Zalewska-Galosz J, 2011, PRESLIA, V83, P259; Zalewska-Galosz J, 2010, TAXON, V59, P559, DOI 10.1002/tax.592020; Zalewska-Galosz J, 2009, PRESLIA, V81, P281; Zaya DN, 2017, CONSERV GENET, V18, P171, DOI 10.1007/s10592-016-0891-9; Zhang T, 2008, AQUAT BOT, V89, P34, DOI 10.1016/j.aquabot.2008.02.002	122	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195241	10.1371/journal.pone.0195241	http://dx.doi.org/10.1371/journal.pone.0195241			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608584	Green Submitted, Green Published, gold			2022-12-27	WOS:000428988800041
J	Gietel-Basten, S; Verropoulou, G				Gietel-Basten, Stuart; Verropoulou, Georgia			The changing relationship between marriage and childbearing in Hong Kong	PLOS ONE			English	Article							BELOW-REPLACEMENT FERTILITY; FAMILY; JAPAN; SAR; PATTERNS; POLICY	Births outside marriage (BoM) account for around 15% of all births globally. However, the distribution around the world is very uneven, as are cultural and political attitudes towards them. Studies from East Asia have shown that the percentage of such births is very low, with only modest increases in recent years. The orthodox demographic view holds that the maintenance of conservative views around the relationship between marriage and childbearing can play a role in keeping fertility low. Prenuptial pregnancies (PNP) (where births occur within eight months of marriage) have been identified as a growing phenomenon in Japan, possibly being an 'alternative' Asian pathway to family formation. As yet, no comprehensive statistical analysis of the trends of BoM or PNP has been performed for Hong Kong. Using a comprehensive microdata set of birth registration in Hong Kong from 1984-2015 (N = 1,680,831) we provide evidence of recent trends in such 'alternative pathways' to family formation and examine predictors through regression analysis. Our results indicate, in common with elsewhere in East Asia, low overall period rates of either BoM or PNP (although the latter has risen notably in recent years). While more recent birth cohorts exhibit higher prevalence of such births, their incomplete nature and higher expected propensity suggests that the figures are exaggerated. In our regression analysis, we find that lower educational attainment is a strong predictor of both BoM and PNP, suggesting that a bifurcation of experience may be occurring. This adds further evidence to the theory that the maintenance of traditional family formation systems in the context of revolutionised educational and work opportunities for women mean that the opportunity costs of the 'marriage package' become too high. Current disparities in rights and privileges between married and unmarried parents-and especially their children-means that targeted family planning services and support for vulnerable families are policy priorities.	[Gietel-Basten, Stuart] Hong Kong Univ Sci & Technol, Div Social Sci, Kowloon, Hong Kong, Peoples R China; [Gietel-Basten, Stuart] Hong Kong Univ Sci & Technol, Div Publ Policy, Kowloon, Hong Kong, Peoples R China; [Verropoulou, Georgia] Univ Piraeus, Dept Stat & Insurance Sci, Piraeus, Greece	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Piraeus	Gietel-Basten, S (corresponding author), Hong Kong Univ Sci & Technol, Div Social Sci, Kowloon, Hong Kong, Peoples R China.; Gietel-Basten, S (corresponding author), Hong Kong Univ Sci & Technol, Div Publ Policy, Kowloon, Hong Kong, Peoples R China.	sgb@ust.hk		Verropoulou, Georgia/0000-0001-6544-2086				[Anonymous], 2017, OECD FAM DAT; Basten S, 2014, SOCIOECONOMIC IMPACT, P1; Basten S., 2014, WORLD POPULATION HUM, P39, DOI DOI 10.1093/ACPROF:OSO/9780198703167.003.0003; Basten S, 2013, POP STUD-J DEMOG, V67, P323, DOI 10.1080/00324728.2013.826372; Beck U., 2002, INDIVIDUALIZATION; Bumpass L. L., 2009, Asian Population Studies, V5, P215, DOI 10.1080/17441730903351479; Cai Y, 2010, POPUL DEV REV, V36, P419, DOI 10.1111/j.1728-4457.2010.00341.x; Chan RKH, 2009, J ASIAN PUBLIC POLIC, V2, P354, DOI 10.1080/17516230903204943; Chang K. S., 2003, J POPULATION SOCIAL, V1, P596; Choe, 2015, LOW LOWER FERTILITY, P63, DOI 10.1007/978-3-319-21482-5; Community Legal Information Centre (Hong Kong), 2017, FAMILYCLIC; Davey M., 2014, GUARDIAN; Esping-Andersen G., 2009, INCOMPLETE REVOLUTIO; Frejka T, 2010, POPUL DEV REV, V36, P579, DOI 10.1111/j.1728-4457.2010.00347.x; Gershon S, 2015, S CHINA MORNING POST; Hamilton BE, 2015, NAT VITAL STAT REP, V64, P12; Haub C., 2013, POPULATION REFERENCE; Hertog E, 2011, J FAM ISSUES, V32, P1674, DOI 10.1177/0192513X11409333; Hertog Ekaterina, 2009, TOUGH CHOICES BEARIN; HKCSD, 2015, MARR DIV TRENDS HONG; HKFPA, 2007, REP SURV FAM PLANN K; HKFPA, 2012, HONG KONG YOUTH SEX; Home Affairs Bureau, 2012, FAM SURV 2011; Ivanova K, 2014, ADV LIFE COURSE RES, V21, P101, DOI 10.1016/j.alcr.2013.08.003; Koo AC., 2009, SOCIAL TRANSFORMATIO, P17, DOI DOI 10.1163/EJ.9789004175679.I-303.10; Lesthaeghe R., 1995, GENDER FAMILY CHANGE, P17; Lin Y, 2014, POP ASS AM ANN M BOS; Lu J.H., 2014, ANALYSING CHINAS POP, P37; McDonald P, 2013, DEMOGR RES, V28, P981, DOI 10.4054/DemRes.2013.28.34; McDonald Peter, 2000, J POPULATION RES, V17, P1, DOI DOI 10.1007/BF03029445; Nakano L, 2016, ASIAN J SOC SCI, V44, P363, DOI 10.1163/15685314-04403005; NIPSSR, 2011, ATT MARR FAM JAP SIN; Park C., 1997, J FAM ECON ISS, V18, P191; Raymo JM, 2008, J MARRIAGE FAM, V70, P847, DOI 10.1111/j.1741-3737.2008.00531.x; Raymo JM, 2015, ANNU REV SOCIOL, V41, P471, DOI 10.1146/annurev-soc-073014-112428; RINDFUSS RR, 1990, POPUL DEV REV, V16, P703, DOI 10.2307/1972963; Rindfuss RR, 2004, AM SOCIOL REV, V69, P838, DOI 10.1177/000312240406900605; Shieh W-Y, 2006, CHINESE J GUIDANCE C, V20, P51; SONG YJ, 2013, INTER ASIA CULT STUD, V14, P481; Thornton A, 2007, MARRIAGE COHABITATIO; Thornton A, 2009, EUR J POPUL, V25, P123, DOI 10.1007/s10680-009-9181-2; Wong OMH, 2003, J COMP FAM STUD, V34, P531, DOI 10.3138/jcfs.34.4.531; World Bank Group, 2020, WORLD DEV IND; YaleGlobal Online, 2017, OUT OF WEDL BIRTHS R; Yip PSF, 2002, SOC SCI MED, V55, P2159, DOI 10.1016/S0277-9536(01)00359-8; Yip PSF, 2001, SOC SCI MED, V53, P1003, DOI 10.1016/S0277-9536(00)00395-6; Yip PSF, 2006, ANAL LOWEST LOW TOTA; Young, 1995, UNDERSTANDING MARRIA; Zaidi B, 2017, ANNU REV SOCIOL, V43, P473, DOI 10.1146/annurev-soc-060116-053442	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194948	10.1371/journal.pone.0194948	http://dx.doi.org/10.1371/journal.pone.0194948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596466	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000056
J	Usama, M; Zakaria, N				Usama, Muhammad; Zakaria, Nordin			Chaos-Based Simultaneous Compression and Encryption for Hadoop (vol 12, e0168207, 2017)	PLOS ONE			English	Correction																		Usama M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168207	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195420	10.1371/journal.pone.0195420	http://dx.doi.org/10.1371/journal.pone.0195420			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596506	Green Published, gold			2022-12-27	WOS:000428630000112
J	Charlton, B; Adeboyeje, G; Barron, JJ; Grady, D; Shin, J; Redberg, RF				Charlton, Blake; Adeboyeje, Gboyega; Barron, John J.; Grady, Deborah; Shin, Jaekyu; Redberg, Rita F.			Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; PROPENSITY SCORE; MANAGEMENT; HEMORRHAGE; APIXABAN; OUTCOMES; THERAPY; EVENTS; DEATH	Background Different outcomes among patients hospitalized for bleeding after starting anticoagulation could influence choice of anticoagulant. We compared length of hospitalization, proportion of Intensive Care Unit (ICU) admissions, ICU length of stay, and 30- and 90-day mortality for adults with atrial fibrillation hospitalized for bleeding after starting warfarin, dabigatran, or rivaroxaban. Methods An US commercial database of 38 million members from 1 November 2010 to 31 March 2014 was used to examine adults with atrial fibrillation hospitalized for bleeding after starting warfarin (2,446), dabigatran (442), or rivaroxaban (256). Outcomes included difference in mean total length of hospitalization, proportion of ICU admissions, mean length of ICU stay, and all-cause 30- and 90-day mortality. Results Warfarin users were older and had more comorbidities. Multivariable regression modeling with propensity score weighting showed warfarin users were hospitalized 2.0 days longer (95% CI 1.8-2.3; p < 0.001) than dabigatran users and 2.6 days longer (95% CI 2.4-2.9; p < 0.001) than rivaroxaban users. Dabigatran users were hospitalized 0.6 days longer (95% CI 0.2-1.0; p = 0.001) than rivaroxaban users. There were no differences in the proportion of ICU admissions. Among ICU admissions, warfarin users stayed 3.0 days (95% CI 1.9-3.9; p < 0.001) longer than dabigatran users and 2.4 days longer (95% CI 0.9-3.7; p = 0.003) than rivaroxaban users. There was no difference in ICU stay between dabigatran and rivaroxaban users. There were no differences in 30- and 90-day all-cause mortality. Conclusions Rivaroxaban and dabigatran were associated with shorter hospitalizations; however, there were no differences in 30- and 90-day mortality. These findings suggest bleeding associated with the newer agents is not more dangerous than bleeding associated with warfarin.	[Charlton, Blake; Grady, Deborah; Redberg, Rita F.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Adeboyeje, Gboyega; Barron, John J.] HealthCore Inc, Wilmington, DE USA; [Shin, Jaekyu] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; HealthCore, Inc; University of California System; University of California San Francisco	Charlton, B (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	blake.charlton@ucsf.edu		Adeboyeje, Gboyega/0000-0002-1088-751X	Clinical & Translational Science Institute, University of California San Francisco; HealthCore	Clinical & Translational Science Institute, University of California San Francisco; HealthCore	Blake Charlton was supported by the Outstanding Resident Research Award, Resident ResearchFunding Grant, and Resident Research Travel Grant all from the Clinical & Translational Science Institute, University of California San Francisco. These awards and grants provided funding for statistical consultation and travel to the American Heart Association's 2015 conference, where this project was presented as a scientific poster. Gboyega Adeboyeje and John J Barron were employed by HealthCore, a wholly-owned and independently operated subsidiary of Anthem, Inc. HealthCore provided support in the form of salaries for the Gboyega Adeboyeje and John J Barron but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anthem has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Ashburner JM, 2015, AM J CARDIOL, V115, P40, DOI 10.1016/j.amjcard.2014.10.006; Beyer-Westendorf J, 2014, BLOOD, V124, P955, DOI 10.1182/blood-2014-03-563577; Cadarette SM, 2008, ANN INTERN MED, V148, P637, DOI 10.7326/0003-4819-148-9-200805060-00003; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; da Graca B, 2013, CIRC-CARDIOVASC QUAL, V6, P124, DOI 10.1161/CIRCOUTCOMES.112.968826; Dahl OE, 2012, INT ORTHOP, V36, P741, DOI 10.1007/s00264-011-1393-5; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; Halbritter K, 2013, J THROMB HAEMOST, V11, P651, DOI 10.1111/jth.12148; Held C, 2015, EUR HEART J, V36, P1264, DOI 10.1093/eurheartj/ehu463; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Majeed A, 2013, CIRCULATION, V128, P2325, DOI 10.1161/CIRCULATIONAHA.113.002332; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2014, EUR HEART J, V35, P1873, DOI 10.1093/eurheartj/ehu083; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Saji N, 2015, CIRC J, V79, P1018, DOI 10.1253/circj.CJ-14-1209; Sherwood MW, 2015, J AM COLL CARDIOL, V66, P2271, DOI 10.1016/j.jacc.2015.09.024; Siegal DM, 2015, N ENGL J MED; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000250; Skaistis J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137444; Spreeuwenberg MD, 2010, MED CARE, V48, P166, DOI 10.1097/MLR.0b013e3181c1328f; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924	31	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193912	10.1371/journal.pone.0193912	http://dx.doi.org/10.1371/journal.pone.0193912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590141	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100036
J	Hagenaars, TJ; Melchior, MB; Windig, JJ; Bossers, A; Davidse, A; van Zijderveld, FG				Hagenaars, Thomas J.; Melchior, Marielle B.; Windig, Jack J.; Bossers, Alex; Davidse, Aart; van Zijderveld, Fred G.			Modelling of strategies for genetic control of scrapie in sheep: The importance of population structure	PLOS ONE			English	Article							PROGRAM	Scrapie is a transmissible spongiform encephalopathy in sheep and an example of a disease that may be controlled through breeding for disease resistance. Member states of the European Union have introduced strategies for breeding against scrapie based on the selection of genetically resistant breeding rams. An ambitious strategy adopted in The Netherlands consisted of selecting resistant rams for breeding throughout both breeding and production sectors. Mathematical modelling of the effect of a breeding program on the spreading capacity of scrapie in a national flock is needed for making assessments on how long a breeding strategy needs to be maintained to achieve disease control. Here we describe such a model applied to the Dutch situation, with the use of data on the genetic content of the Dutch sheep population as well as on scrapie occurrence in this population. We show that the time needed for obtaining scrapie control depends crucially on two parameters measuring sheep population structure: the between-flock heterogeneity in genotype frequencies, and the heterogeneity of mixing (contact rates) between sheep flocks. Estimating the first parameter from Dutch genetic survey data and assuming scenario values for the second one, enables model prediction of the time needed to achieve scrapie control in The Netherlands.	[Hagenaars, Thomas J.; Melchior, Marielle B.; Bossers, Alex; Davidse, Aart; van Zijderveld, Fred G.] Wageningen Biovet Res, Lelystad, Netherlands; [Windig, Jack J.] Wageningen Livestock Res, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Hagenaars, TJ (corresponding author), Wageningen Biovet Res, Lelystad, Netherlands.	thomas.hagenaars@wur.nl	Bossers, Alex/AAA-6025-2021; Bossers, Alex/F-7757-2019	Bossers, Alex/0000-0002-6586-717X; Bossers, Alex/0000-0002-6586-717X	Dutch Ministry of Agriculture, Nature and Food Quality [WOT-01-002-01.06, WOT-01-002-001.01]	Dutch Ministry of Agriculture, Nature and Food Quality	This work was supported by the Dutch Ministry of Agriculture, Nature and Food Quality, research project codes WOT-01-002-01.06 and WOT-01-002-001.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Arnold M, 2002, PREV VET MED, V56, P227, DOI 10.1016/S0167-5877(02)00159-9; Bozzetta E, 2011, J VIROL METHODS, V173, P161, DOI 10.1016/j.jviromet.2011.01.008; Diekmann O., 2012, MATH TOOLS UNDERSTAN; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Gubbins S, 2005, PREV VET MED, V69, P175, DOI 10.1016/j.prevetmed.2004.12.009; Gubbins S, 2010, VET RES, V41, DOI 10.1051/vetres/2010014; Hagenaars TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139436; Hagenaars TJ, 2006, EPIDEMIOL INFECT, V134, P359, DOI 10.1017/S0950268805004966; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hagenaars TJ, 2010, BMC VET RES, V6; Kao RR, 2001, MATH BIOSCI, V174, P61, DOI 10.1016/S0025-5564(01)00082-7; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Lokhorst C, 2007, REPORTS ASG LIVESTOC, V50; Melchior MB, 2011, TIJDSCHR DIERGENEESK, V136, P84; Melchior MB, 2010, BMC VET RES, V6; Moreno CR, 2008, GENETICS, V179, P723, DOI 10.1534/genetics.108.088146; Nodelijk G, 2011, VET RES, V42; Ortiz-Pelaez A, 2014, VET REC, V174, P530, DOI 10.1136/vr.102255; Ortiz-Pelaez A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-31; Vaccari G, 2009, VET RES, V40; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061	22	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195009	10.1371/journal.pone.0195009	http://dx.doi.org/10.1371/journal.pone.0195009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584772	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000056
J	Hsu, NC; Huang, CC; Shu, CC; Yang, MC				Hsu, Nin-Chieh; Huang, Chun-Che; Shu, Chin-Chung; Yang, Ming-Chin			Implementation of a seven-day hospitalist program to improve the outcomes of the weekend admission: A retrospective before after study in Taiwan	PLOS ONE			English	Article							CARE; MEDICINE; MORTALITY; SERVICE; ASSOCIATION; EFFICIENCY; STROKE; SYSTEM; IMPACT	Objective Patients admitted during weekends may have worse outcomes than those during weekdays. Adjusting the practice of senior physicians over weekends may reduce the weekend effect. Design A controlled before-after study, with propensity score matching (PSM) for potential confounding variables, to compare outcomes between weekday and weekend admissions. Setting A 2000-bed medical centre in Taiwan Participants Hospitalised general medicine patients cared for by traditional internal medicine teams (pre-intervention cohort) and those cared for by hospitalists after introducing a seven-day hospitalist program in the first six-month (post-intervention cohort) and following three-year periods. Main outcome measures Proportion of intensive care unit (ICU) admissions, cardiopulmonary resuscitation (CPR) events, and in-hospital mortality. Results The pre-intervention cohort included 982 patients. Significantly higher mortality rates (11.3% vs. 6.2%, p = 0.032) were recorded in the case of weekend admissions, with similar proportions of ICU admission and CPR events. The post-intervention cohort included 601 patients. No significant difference was recorded in any of the main outcomes between weekday and weekend admissions. PSM for pre-intervention and post-intervention cohort showed shorter LOS after intervention, with no difference in ICU admission, CPR, and morality for the weekday and weekend admissions, respectively. The three-year cohort that followed, consisting of 3315 patients, showed no difference of outcomes between weekday and weekend admissions. After PSM, there were no significant differences in ICU admission rates (1.0% vs. 1.8%), CPR (0.3% vs. 0.2%) events and hospital mortality rates (8.1% vs. 8.5%), when weekday and weekend admissions were compared. Conclusions The seven-day hospitalist program shows potential in providing equally safe care for both weekday and weekend general medicine admissions with sustainable development.	[Hsu, Nin-Chieh; Shu, Chin-Chung] Natl Taiwan Univ Hosp, Div Hosp Med, Dept Traumatol, Taipei, Taiwan; [Hsu, Nin-Chieh; Shu, Chin-Chung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Huang, Chun-Che] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Yang, Ming-Chin] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University	Hsu, NC (corresponding author), Natl Taiwan Univ Hosp, Div Hosp Med, Dept Traumatol, Taipei, Taiwan.; Hsu, NC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.	chesthsu@gmail.com		SHU, CHIN-CHUNG/0000-0003-0311-5148; HSU, NIN-CHIEH/0000-0002-4997-1081; YANG, MING-CHIN/0000-0001-7326-8671				Aldridge C, 2016, LANCET, V388, P178, DOI 10.1016/S0140-6736(16)30442-1; Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Auerbach AD, 2016, J HOSP MED, V11, P892, DOI 10.1002/jhm.2631; Auerbach AD, 2010, ARCH INTERN MED, V170, P2004, DOI 10.1001/archinternmed.2010.432; Barba R, 2006, EUR J INTERN MED, V17, P322, DOI 10.1016/j.ejim.2006.01.003; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bellet PS, 2000, PEDIATRICS, V105, P478, DOI 10.1542/peds.105.3.478; Bray BD, 2017, BMJ QUAL SAF, V26, P607, DOI 10.1136/bmjqs-2016-005793; Burton MC, 2010, J HOSP MED, V5, P547, DOI 10.1002/jhm.808; Cohen ME, 2000, ARCH PHYS MED REHAB, V81, pS21, DOI 10.1053/apmr.2000.20620; Concha OP, 2014, BMJ QUAL SAF, V23, P215, DOI 10.1136/bmjqs-2013-002218; Deeny SR, 2015, BMJ QUAL SAF, V24, P505, DOI 10.1136/bmjqs-2015-004278; Deshmukh A, 2012, AM J CARDIOL, V110, P208, DOI 10.1016/j.amjcard.2012.03.011; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Friedman SM, 2009, ARCH INTERN MED, V169, P1712, DOI 10.1001/archinternmed.2009.321; Horwich TB, 2009, AM HEART J, V158, P451, DOI 10.1016/j.ahj.2009.06.025; Howrey BT, 2011, MED CARE, V49, P701, DOI 10.1097/MLR.0b013e3182166cb6; Huang CC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002643; Jamal A, 2012, BMJ QUAL SAF, V21, P171, DOI 10.1136/bmjqs-2011-000056; Kreckler S, 2013, BMJ QUAL SAF, V22, P916, DOI 10.1136/bmjqs-2013-001855; Landefeld CS, 2006, J HOSP MED, V1, P42, DOI 10.1002/jhm.11; Li LX, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2648; Lilford RJ, 2015, BMJ QUAL SAF, V24, P480, DOI 10.1136/bmjqs-2015-004360; McQuillan A, 2014, BMJ QUAL SAF, V23, P465, DOI 10.1136/bmjqs-2013-002146; Meacock R, 2017, J HEALTH SERV RES PO, V22, P12, DOI 10.1177/1355819616649630; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Mikulich O, 2011, Acute Med, V10, P182; Ruiz M, 2015, BMJ QUAL SAF, V24, P492, DOI 10.1136/bmjqs-2014-003467; Shu CC, 2011, J HOSP MED, V6, P378, DOI [10.1002/Thm.896, 10.1002/jhm.896]; Wachter RM, 1999, ANN INTERN MED, V130, P338, DOI 10.7326/0003-4819-130-4-199902161-00002; Wachter RM, 2015, J HOSP MED, V10, P830, DOI 10.1002/jhm.2398; Wachter RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e652; Whelan CT, 2010, J HOSP MED, V5, pS1, DOI 10.1002/jhm.828; White HL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-58; Wong HJ, 2011, J GEN INTERN MED, V26, P1050, DOI 10.1007/s11606-011-1715-8	35	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194833	10.1371/journal.pone.0194833	http://dx.doi.org/10.1371/journal.pone.0194833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579132	Green Submitted, Green Published, gold			2022-12-27	WOS:000428351800059
J	Lee, SY; Lee, SC; Shin, SD; Song, KJ; Ro, YS; Park, JH; Kong, SY				Lee, Sun Young; Lee, Seung Chul; Shin, Sang Do; Song, Kyoung Jun; Ro, Young Sun; Park, Jeong Ho; Kong, So Yeon			Epidemiology and outcomes of anaphylaxis-associated out-of-hospital cardiac arrest	PLOS ONE			English	Article							BYSTANDER CARDIOPULMONARY-RESUSCITATION; UNITED-STATES; EUROPEAN RESUSCITATION; IMMUNOLOGY; GUIDELINES; FATALITIES; COUNCIL; ALLERGY; UPDATE; ASTHMA	Background Understanding the epidemiological characteristics of anaphylaxis-associated out-of-hospital cardiac arrest (OHCA) is the first step toward developing preventative strategies and optimizing care systems. We aimed to describe and compare epidemiological features and clinical outcomes among patients with anaphylaxis-associated OHCAs according to causative agent groups. Methods We identified emergency medical service (EMS)-treated anaphylaxis-associated OHCA patients from a nationwide OHCA registry between 2008 and 2015. We compared epidemiological characteristics and outcomes according to causal agents (a natural agents group and an iatrogenic agents group) and evaluated temporal variability in incidence. Multivariate logistic regression analysis was performed to compare survival to discharge between causative agent groups. Results During the study period (8 years), the total number of anaphylaxis-associated OHCAs was 233. A total of 224 eligible cases were included in the analysis. There were 192 patients (85.6%) in the natural agents group and 32 patients (14.3%) in the iatrogenic agents group. There was significant diurnal and seasonal variability in the frequency of anaphylaxis-associated OHCAs (p values<0.01 for both), with the highest incidences occurring during the day (7:01 am to 3 pm; 64.6%) and in summer (June to August, 48.7%). Compared with the natural agents group, the adjusted odds ratio (AOR) for survival to discharge in the iatrogenic agents group was statistically insignificant (AOR 3.61, 95% CI 0.86 to 15.06). Conclusion The incidence of anaphylaxis-associated OHCA is considerably low, and significant temporal variability, with a peak during the day and in summer, is evident. Anaphylaxis-associated OHCA is more common by natural agents than by iatrogenic agents, but no difference in the survival-to-discharge rate is evident.	[Lee, Sun Young; Shin, Sang Do; Song, Kyoung Jun; Ro, Young Sun; Park, Jeong Ho; Kong, So Yeon] Seoul Natl Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Lee, Sun Young; Lee, Seung Chul; Shin, Sang Do; Song, Kyoung Jun; Ro, Young Sun; Park, Jeong Ho; Kong, So Yeon] Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul, South Korea; [Lee, Seung Chul] Dongguk Univ, Dept Emergency Med, Ilsan Hosp, Goyang Si, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Dongguk University; NHIS Ilsan Hospital	Lee, SC (corresponding author), Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul, South Korea.; Lee, SC (corresponding author), Dongguk Univ, Dept Emergency Med, Ilsan Hosp, Goyang Si, South Korea.	edlee@dumc.or.kr	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085; Lee, Sun Young/0000-0002-1626-2721	Research Program - Korea Centers for Disease Control and Prevention [2009-E00543-00, 2010-E33022-00, 2011-E33004-00, 2012-E33010-00, 2013-E33015-00, 2014-E33011-00]; Dongguk University	Research Program - Korea Centers for Disease Control and Prevention; Dongguk University	This study was financially supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (Grant No.:2009-E00543-00, 2010-E33022-00, 2011-E33004-00, 2012-E33010-00, 2013-E33015-00, 2014-E33011-00)(Sang Do Shin). This work was supported by the Dongguk University Research Fund of 2017(Seung Chul Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KO, 2011, RESUSCITATION, V82, P270, DOI 10.1016/j.resuscitation.2010.10.023; Bagai A, 2013, CIRCULATION, V128, P2595, DOI 10.1161/CIRCULATIONAHA.113.004164; Ben-Shoshan M, 2011, ALLERGY, V66, P1, DOI 10.1111/j.1398-9995.2010.02422.x; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Herlitz J, 2002, RESUSCITATION, V54, P133, DOI 10.1016/S0300-9572(02)00097-7; Jacobsen RC, 2011, PREHOSP EMERG CARE, V15, P570, DOI 10.3109/10903127.2011.598619; Jerschow E, 2014, J ALLERGY CLIN IMMUN, V134, P1318, DOI 10.1016/j.jaci.2014.08.018; Kounis NG, 2013, CLIN THER, V35, P563, DOI 10.1016/j.clinthera.2013.02.022; Lee SY, 2016, RESUSCITATION, V99, P84, DOI 10.1016/j.resuscitation.2015.11.027; Lieberman P, 2006, ANN ALLERG ASTHMA IM, V97, P596, DOI 10.1016/S1081-1206(10)61086-1; Lieberman P, 2015, ANN ALLERG ASTHMA IM, V115, P341, DOI 10.1016/j.anai.2015.07.019; Ma L, 2014, J ALLERGY CLIN IMMUN, V133, P1075, DOI 10.1016/j.jaci.2013.10.029; Moneret-Vautrin DA, 2005, ALLERGY, V60, P443, DOI 10.1111/j.1398-9995.2005.00785.x; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15; Nieto-Nieto A, 2017, J INVEST ALLERG CLIN, V27, P111, DOI 10.18176/jiaci.0146; Park HK, 2017, ALLERGOL INT, V66, P557, DOI 10.1016/j.alit.2017.02.008; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Pumphrey Richard S H, 2004, Novartis Found Symp, V257, P116; Sampson HA, 2003, PEDIATRICS, V111, P1601; Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1; Smit DV, 2005, J EMERG MED, V28, P381, DOI 10.1016/j.jemermed.2004.11.028; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Song KJ, 2014, RESUSCITATION, V85, P34, DOI 10.1016/j.resuscitation.2013.06.004; Turner PJ, 2015, J ALLERGY CLIN IMMUN, V135, P956, DOI 10.1016/j.jaci.2014.10.021; Yang MS, 2008, ANN ALLERG ASTHMA IM, V100, P31, DOI 10.1016/S1081-1206(10)60401-2; Yang MS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005750	27	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194921	10.1371/journal.pone.0194921	http://dx.doi.org/10.1371/journal.pone.0194921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579130	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800066
J	Kleyheeg, E; Claessens, M; Soons, MB				Kleyheeg, Erik; Claessens, Mascha; Soons, Merel B.			Interactions between seed traits and digestive processes determine the germinability of bird-dispersed seeds	PLOS ONE			English	Article							DABBLING DUCKS; DIETARY FIBER; GUT PASSAGE; ANAS; GERMINATION; MALLARDS; PLANTS; MORPHOLOGY; SUCCESS; SIZE	Waterbirds disperse a wide range of plant seeds via their guts, promoting biotic connectivity between isolated habitat patches. However, the intensity of digestive forces encountered by seeds, and therefore their potential to survive digestive tract passage, varies within and between waterbird species. Here, we investigate under controlled conditions how the interaction between seed traits and digestive strategies affect the germinability of seeds following waterbird-mediated dispersal. We exposed seeds of 30 wetland plant species to the main digestive processes in the dabbling duck digestive system: mechanical, chemical and intestinal digestion. These were simulated by 1) a pressure test and scarification treatment, 2) incubation in simulated gastric juice, and 3) incubation in intestinal contents of culled mallards (Anas platyrhynchos). We evaluated their separate and combined effects on seed germination, and identified the role of seed size and seed coat traits in resisting the digestive forces. Seeds were generally resistant to separate digestive processes, but highly sensitive to a combination. Resistance to mechanical break-down was reduced by up to 80% by chemical pre-treatment, especially for seeds with permeable coats. Scarified seeds were 12-17% more vulnerable to chemical and intestinal digestive processes than undamaged seeds. Large seeds and seeds with thin, permeable coats were particularly sensitive to chemical and intestinal digestion. These results indicate that efficient digestion of seeds requires multiple digestive processes. The gizzard, responsible for mechanical digestion, plays a key role in seed survival. Omnivorous birds, which have relatively light gizzards compared to pure herbivores or granivores, are thus most likely to disperse seeds successfully. Regardless of digestive strategy, small seeds with tough seed coats are most resistant to digestion and may be adapted to endozoochorous dispersal by waterbirds.	[Kleyheeg, Erik; Claessens, Mascha; Soons, Merel B.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands; [Soons, Merel B.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Kleyheeg, Erik] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Max Planck Society	Kleyheeg, E (corresponding author), Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands.; Kleyheeg, E (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	erikkleyheeg@gmail.com	KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research [VIDI 864.10.006]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was funded by the Netherlands Organization for Scientific Research (https://www.nwo.nl/); grant number VIDI 864.10.006 to Merel B. Soons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMI M, 1986, OECOLOGIA, V68, P473, DOI 10.1007/BF01036757; Albert A, 2015, ECOGRAPHY, V38, P440, DOI 10.1111/ecog.00709; BARNES EM, 1972, AM J CLIN NUTR, V25, P1475; BARNES GG, 1987, CAN J ZOOL, V65, P1812, DOI 10.1139/z87-274; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brochet AL, 2012, J ZOOL, V286, P171, DOI 10.1111/j.1469-7998.2011.00870.x; Brochet AL, 2010, FRESHWATER BIOL, V55, P1262, DOI 10.1111/j.1365-2427.2009.02350.x; Brochet AL, 2010, AQUAT BOT, V93, P99, DOI 10.1016/j.aquabot.2010.04.001; Brochet AL, 2009, ECOGRAPHY, V32, P919, DOI 10.1111/j.1600-0587.2009.05757.x; Charalambidou I, 2005, FUNCT ECOL, V19, P513, DOI 10.1111/j.1365-2435.2005.00998.x; Clench MH, 1999, J EXP ZOOL, V283, P441, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;441::AID-JEZ13&gt;3.0.CO;2-8; Dawson W.R., 2000, P343, DOI 10.1016/B978-012747605-6/50015-8; Farner DS, 1960, BIOLOGY COMPARATIVE, P411; Figuerola J, 2010, NATURWISSENSCHAFTEN, V97, P555, DOI 10.1007/s00114-010-0671-1; Green AJ, 2002, ACTA OECOL, V23, P177, DOI 10.1016/S1146-609X(02)01149-9; Green AJ, 2014, BIOL REV, V89, P105, DOI 10.1111/brv.12045; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jozefiak D, 2004, ANIM FEED SCI TECH, V113, P1, DOI 10.1016/j.anifeedsci.2003.09.007; KEHOE FP, 1988, CAN J ZOOL, V66, P1597, DOI 10.1139/z88-233; Kleyheeg E., 2015, THESIS; Kleyheeg E, 2017, J ECOL, V105, P1279, DOI 10.1111/1365-2745.12738; Kleyheeg E, 2016, FRESHWATER BIOL, V61, P1746, DOI 10.1111/fwb.12814; Kleyheeg E, 2015, OIKOS, V124, P899, DOI 10.1111/oik.01894; Meyer GA, 1998, AM MIDL NAT, V140, P129, DOI 10.1674/0003-0031(1998)140[0129:IOSPBF]2.0.CO;2; MILLER MR, 1975, J WILDLIFE MANAGE, V39, P168, DOI 10.2307/3800481; Milotic T, 2016, BASIC APPL ECOL, V17, P165, DOI 10.1016/j.baae.2015.09.007; Mouissie AM, 2005, FUNCT ECOL, V19, P284, DOI 10.1111/j.0269-8463.2005.00955.x; Mueller MH, 2002, WETLANDS, V22, P170, DOI 10.1672/0277-5212(2002)022[0170:TPRODI]2.0.CO;2; Pakeman RJ, 2002, FUNCT ECOL, V16, P296, DOI 10.1046/j.1365-2435.2002.00625.x; PIERSMA T, 1993, AUK, V110, P552, DOI 10.2307/4088419; Pollux BJA, 2005, FRESHWATER BIOL, V50, P232, DOI 10.1111/j.1365-2427.2004.01314.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Reynolds C, 2016, FRESHWATER BIOL, V61, P1157, DOI 10.1111/fwb.12776; Reynolds C, 2016, FRESHWATER BIOL, V61, P349, DOI 10.1111/fwb.12709; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Santamaria L, 2002, ARCH HYDROBIOL, V156, P11, DOI 10.1127/0003-9136/2002/0156-0011; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; Soons MB, 2008, J ECOL, V96, P619, DOI 10.1111/j.1365-2745.2008.01372.x; Soons MB, 2016, J ECOL, V104, P443, DOI 10.1111/1365-2745.12531; Starck JM, 1999, J EXP BIOL, V202, P3171; Traveset A., 2007, Seed dispersal: theory and its application in a changing world, P78, DOI 10.1079/9781845931650.0078; van Leeuwen CHA, 2012, J BIOGEOGR, V39, P2031, DOI 10.1111/jbi.12004; Whittow G.C., 2000, STURKEYS AVIAN PHYSL, V299, P325, DOI DOI 10.1016/C2012-0-02488-X; Wongsriphuek C, 2008, WETLANDS, V28, P290, DOI 10.1672/07-101.1; Ziswiler V., 1972, P343	47	19	19	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195026	10.1371/journal.pone.0195026	http://dx.doi.org/10.1371/journal.pone.0195026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614085	Green Published, gold			2022-12-27	WOS:000429081600024
J	Powers, KA; Price, MA; Karita, E; Kamali, A; Kilembe, W; Allen, S; Hunter, E; Bekker, LG; Lakhi, S; Inambao, M; Anzala, O; Latka, MH; Fast, PE; Gilmour, J; Sanders, EJ				Powers, Kimberly A.; Price, Matthew A.; Karita, Etienne; Kamali, Anatoli; Kilembe, William; Allen, Susan; Hunter, Eric; Bekker, Linda-Gail; Lakhi, Shabir; Inambao, Mubiana; Anzala, Omu; Latka, Mary H.; Fast, Patricia E.; Gilmour, Jill; Sanders, Eduard J.			Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa	PLOS ONE			English	Article							ACUTE RETROVIRAL SYNDROME; PRIMARY HIV-1 INFECTION; ANTIRETROVIRAL THERAPY; VIRAL LOAD; RNA LEVELS; SUBTYPE C; SET-POINT; PROGRESSION; SEROCONVERSION; SCORE	Objective Prompt identification of newly HIV-infected persons, particularly those who are most at risk of extended high viremia (EHV), allows important clinical and transmission prevention benefits. We sought to determine whether EHV could be predicted during early HIV infection (EHI) from clinical, demographic, and laboratory indicators in a large HIV-1 incidence study in Africa. Design Adults acquiring HIV-1 infection were enrolled in an EHI study assessing acute retroviral syndrome (ARS) symptoms and viral dynamics. Methods Estimated date of infection (EDI) was based on a positive plasma viral load or p24 antigen test prior to seroconversion, or the mid-point between negative and positive serological tests. EHV was defined as mean untreated viral load >= 5 log(10) copies/ml 130-330 days post-EDI. We used logistic regression to develop risk score algorithms for predicting EHV based on sex, age, number of ARS symptoms, and CD4 and viral load at diagnosis. Results Models based on the full set of five predictors had excellent performance both in the full population (c-statistic = 0.80) and when confined to persons with each of three HIV-1 subtypes (c-statistic = 0.80-0.83 within subtypes A, C, and D). Reduced models containing only 2-4 predictors performed similarly. In a risk score algorithm based on the final full-population model, predictor scores were one for male sex and enrollment CD4<350 cells/mm(3), and two for having enrollment viral load >4.9 log(10) copies/ml. With a risk score cut-point of two, this algorithm was 85% sensitive (95% CI: 76%-91%) and 61% specific (55%-68%) in predicting EHV. Conclusions Simple risk score algorithms can reliably identify persons with EHI in sub-Saharan Africa who are likely to sustain high viral loads if treatment is delayed. These algorithms may be useful for prioritizing intensified efforts around care linkage and retention, treatment initiation, adherence support, and partner services to optimize clinical and prevention outcomes.	[Powers, Kimberly A.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Price, Matthew A.; Kamali, Anatoli; Fast, Patricia E.; Gilmour, Jill] Int AIDS Vaccine Initiat, New York, NY USA; [Price, Matthew A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Karita, Etienne] Project San Francisco, Kigali, Rwanda; [Kamali, Anatoli] Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Kilembe, William; Lakhi, Shabir; Inambao, Mubiana] Zambia Emory Res Project, Lusaka, Zambia; [Kilembe, William; Lakhi, Shabir; Inambao, Mubiana] Zambia Emory Res Project, Copperbelt, Zambia; [Allen, Susan; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Anzala, Omu] Univ Nairobi, KAVI ICR, Nairobi, Kenya; [Latka, Mary H.] Aurum Inst, Johannesburg, South Africa; [Gilmour, Jill] Imperial Coll Sci Technol & Med, London, England; [Sanders, Eduard J.] Kenya Govt Med Res Ctr, Kilifi, Kenya; [Sanders, Eduard J.] Univ Oxford, Headington, England; [Sanders, Eduard J.] Univ Amsterdam, Amsterdam, Netherlands	University of North Carolina; University of North Carolina Chapel Hill; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; Uganda Virus Research Institute; Emory University; University of Cape Town; University of Nairobi; Imperial College London; Kenya Medical Research Institute; University of Oxford; University of Amsterdam	Powers, KA (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	powersk@email.unc.edu	Bekker, Linda-Gail/AAZ-8929-2020; Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; , Mubiana/0000-0002-1474-652X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	IAVI by the American people through the United States Agency for International Development (USAID); Wellcome Trust [077092, 107752/Z/15/Z]; Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064060] Funding Source: NIH RePORTER	IAVI by the American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Wellcome Trust(Wellcome TrustEuropean Commission); Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible in part by the generous support of IAVI by the American people through the United States Agency for International Development (USAID). A full list of IAVI donors is available at www.iavi.org. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The KEMRI-Wellcome Trust Research Programme at the Centre for Geographical Medicine Research-Kilifi is supported by core funding from the Wellcome Trust [grant number 077092]. This work was also supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant # DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant # 107752/Z/15/Z] and the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioum A, 1998, EPIDEMIOLOGY, V9, P605, DOI 10.1097/00001648-199811000-00007; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Braun DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114111; Campbell MS, 2013, J INFECT DIS, V207, P1166, DOI 10.1093/infdis/jit015; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Donnelly CA, 2005, HIV MED, V6, P170, DOI 10.1111/j.1468-1293.2005.00285.x; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; HOENIGL M, 2017, JAIDS-J ACQ IMM DEF, V74, pE114; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kamali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116100; Kaufmann GR, 1999, J ACQ IMMUN DEF SYND, V22, P437; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lindback S, 2000, AIDS, V14, P2283, DOI 10.1097/00002030-200010200-00009; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Novitsky V, 2011, AIDS, V25, P1515, DOI 10.1097/QAD.0b013e3283471eb2; Pedersen C, 1997, J ACQ IMMUN DEF SYND, V16, P93, DOI 10.1097/00042560-199710010-00004; Pezzotti P, 1996, BRIT MED J, V313, P583; Plazy M, 2014, TROP MED INT HEALTH, V19, P680, DOI 10.1111/tmi.12301; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sanders EJ, 2017, AIDS, V31, P2541, DOI 10.1097/QAD.0000000000001659; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Sullivan PS, 2012, AIDS, V26, P175, DOI 10.1097/QAD.0b013e32834ed8c8; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Wahome E, 2013, AIDS, V27, P2163, DOI 10.1097/QAD.0b013e3283629095; WHO (World Health Organization), 2017, TREAT ALL POL AD IMP; World Health Organization, 2015, GUID START ANT THER	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0192785	10.1371/journal.pone.0192785	http://dx.doi.org/10.1371/journal.pone.0192785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614069	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600002
J	Gonzalez-Dominguez, J; Exposit, RR				Gonzalez-Dominguez, Jorge; Exposit, Roberto R.			ParBiBit: Parallel tool for binary biclustering on modern distributed-memory systems	PLOS ONE			English	Article							GENE-EXPRESSION DATA; ALGORITHM	Biclustering techniques are gaining attention in the analysis of large-scale datasets as they identify two-dimensional submatrices where both rows and columns are correlated. In this work we present ParBiBit, a parallel tool to accelerate the search of interesting biclusters on binary datasets, which are very popular on different fields such as genetics, marketing or text mining. It is based on the state-of-the-art sequential Java tool BiBit, which has been proved accurate by several studies, especially on scenarios that result on many large biclusters. ParBiBit uses the same methodology as BiBit (grouping the binary information into patterns) and provides the same results. Nevertheless, our tool significantly improves performance thanks to an efficient implementation based on C++11 that includes support for threads and MPI processes in order to exploit the compute capabilities of modern distributed -memory systems, which provide several multicore CPU nodes interconnected through a network. Our performance evaluation with 18 representative input datasets on two different eight-node systems shows that our tool is significantly faster than the original BiBit. Source code in C++ and MPI running on Linux systems as well as a reference manual are available at https//sourceforge.net/projects/parbibt/.	[Gonzalez-Dominguez, Jorge; Exposit, Roberto R.] Univ A Coruna, Grp Arquitectura Comp, La Coruna, Spain	Universidade da Coruna	Gonzalez-Dominguez, J (corresponding author), Univ A Coruna, Grp Arquitectura Comp, La Coruna, Spain.	jgonzalezd@udc.es	Gonzalez-Dominguez, Jorge/H-7371-2016	Gonzalez-Dominguez, Jorge/0000-0002-2602-4874	Ministry of Economy, Industry and Competitiveness of Spain; FEDER funds of the European Union [TIN2016-75845-P]; Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation) [EDG431G/01]	Ministry of Economy, Industry and Competitiveness of Spain; FEDER funds of the European Union(European Commission); Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation)	This work was supported by the Ministry of Economy, Industry and Competitiveness of Spain and FEDER funds of the European Union (grant TIN2016-75845-P [AEI/FEDER/UE]), as well as by Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation 2016-2019, ref. EDG431G/01).	Bhatnagar, 2009, P SIAM INT C DAT MIN, P1050; Bhatnagar R, 2015, PROCEEDINGS 2015 IEEE INTERNATIONAL CONFERENCE ON BIG DATA, P1519, DOI 10.1109/BigData.2015.7363915; Bhattacharya A, 2017, SCI REPORTS, V7; Bozdag D, 2010, 1 ACM INT C BIOINFOR, P265, DOI [DOI 10.1145/1854776.1854814, 10.1145/1854776.1854814]; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Chen H, 2013, PLOS ONE, V8; Chorley MJ, 2010, J COMPUT SCI-NETH, V1, P168, DOI 10.1016/j.jocs.2010.05.001; Coulaud O, 2007, 6 INT S PAR DISTR CO; Dhillon I-S, 2003, P 9 ACM SIGKDD INT C, P89, DOI DOI 10.1145/956750.956764; Eren K, 2013, BRIEF BIOINFORM, V14, P279, DOI 10.1093/bib/bbs032; Gomez-Pulido JA, 2013, BMC BIOINFORMATICS, V17, P2540; Gonzalez-Dominguez J, 2016, BIOINFORMATICS, V32, P3826, DOI 10.1093/bioinformatics/btw558; Hoefler T., 2015, ACM T PARALLEL COMPU, V2; Kumar S, 2014, 21 EUR MPI US GROUP; Lee S, 2014, STAT COMPUT, V24, P429, DOI 10.1007/s11222-013-9379-3; Liu B, 2013, IEEE T PARALL DISTR, V25, P2540; Liu BB, 2014, NEUROCOMPUTING, V134, P239, DOI 10.1016/j.neucom.2013.06.049; Liu J.J., 2015, 11 INT C COMP INT SE; Liu JZ, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P187; Liu W, 2008, J COMPUT, V3, P71; Mamidala AR, 2008, IEEE ACM INT SYMP, P130, DOI 10.1109/CCGRID.2008.87; MIMAROGLU S, 2007, ICDMW, P51; Nichols B., 1996, PTHREADS PROGRAMMING; Orzechowski P, 2015, BIO-ALGORITHMS MED-S, V11, P243, DOI 10.1515/bams-2015-0033; Padilha VA, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1487-1; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pontes B, 2015, J BIOMED INFORM, V57, P163, DOI 10.1016/j.jbi.2015.06.028; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Reinders J., 2007, INTEL THREADING BUIL; Rodriguez-Baena DS, 2011, BIOINFORMATICS, V27, P2738, DOI 10.1093/bioinformatics/btr464; Saber HB, 2015, J PROTEOMICS BIOINFO, V8; Sarazin Tugdual, 2014, 2014 IEEE International Conference on Big Data (Big Data), P58, DOI 10.1109/BigData.2014.7004493; The MPI Forum, 1993, MPI MESS PASS INT; Tu BB, 2012, J SUPERCOMPUT, V60, P141, DOI 10.1007/s11227-009-0296-3; Wang H, 2002, 2002 ACM SIGMOD INT, P304; Yablonsky B., 2013, C 11 STANDARD LIB US	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194361	10.1371/journal.pone.0194361	http://dx.doi.org/10.1371/journal.pone.0194361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608567	gold, Green Published, Green Submitted			2022-12-27	WOS:000428988800009
J	Kang, J; Lee, SH; Son, JH; Lee, JW; Choi, YH; Choi, JH; Paik, WH; Ryu, JK; Kim, YT				Kang, Jinwoo; Lee, Sang Hyub; Son, Jun Hyuk; Lee, Jae Woo; Choi, Young Hoon; Choi, Jin Ho; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae			Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients	PLOS ONE			English	Article							ADVANCED PANCREATIC-CANCER; PROGNOSTIC-FACTOR; OBESITY PARADOX; OVERWEIGHT; SARCOPENIA; CHOLANGIOCARCINOMA; IMPACT; METAANALYSIS; MANAGEMENT; MORTALITY	Background The impact of obesity on survival is known to vary in different cancers. Advanced biliary tract cancer was rarely analyzed about the relationship between obesity and prognosis. We performed this study to evaluate the BMI and body weight change as prognostic factors for advanced biliary tract cancer patients with palliative chemotherapy. Methods Between January 2005 and December 2016, two hundred and seventy-six patients who underwent chemotherapy for biliary tract cancer were retrospectively analyzed. The relationship between BMI (kg/m(2)) and clinical outcomes including overall and progression-free survival was assessed. Additionally the relationship between change in body composition and overall survival was evaluated. Results Median overall survival was 9.7 months for underweight patients, 10.1 months for normal patients, 15.8 months for overweight group, 13.1 months for obese patients, respectively. (p = 0.047) Univariate analysis showed that BMI, stage III, age less than 64 year-old, gallbladder cancer, operation, radiotherapy and ECOG performance were significantly associated with better survival. Compared with normal patients, overweight patients (BMI 23-24.9kg/m(2)) had a reduced risk of mortality in multivariate analysis (HR 0.632; 95% CI 0.436-0.918, p = 0.016). In the additional analysis for the effect of changes in body weight and BMI to the overall survival, decrease in body weight and BMI (HR 1.410, 95% CI 1.168-1.986, p = 0.046) was associated with a shorter in overall survival. Conclusion Overweight status and the maintenance of body weight during the initial period of chemotherapy are important and independent predictors of better overall survival in advanced biliary tract cancer patients.	[Kang, Jinwoo; Lee, Sang Hyub; Son, Jun Hyuk; Lee, Jae Woo; Choi, Young Hoon; Choi, Jin Ho; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Jinwoo; Lee, Sang Hyub; Son, Jun Hyuk; Lee, Jae Woo; Choi, Young Hoon; Choi, Jin Ho; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kang, Jinwoo; Lee, Sang Hyub; Son, Jun Hyuk; Lee, Jae Woo; Choi, Young Hoon; Choi, Jin Ho; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kang, Jinwoo] SMG SNU Boramae Med Ctr, Dept Gastroenterolgy & Hepatol, Seoul, South Korea; [Son, Jun Hyuk] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea; [Lee, Jae Woo] Mediplex Sejong Hosp, Incheon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Inje University	Lee, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Lee, SH (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.; Lee, SH (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	gidoctor@snuh.org		Choi, Jin Ho/0000-0003-2758-1370; Lee, Sang Hyub/0000-0003-2174-9726				Arnold M, 2016, CANCER EPIDEMIOL, V41, P8, DOI 10.1016/j.canep.2016.01.003; Banack HR, 2015, EUR J EPIDEMIOL, V30, P1111, DOI 10.1007/s10654-015-0069-7; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2; Bouillanne O, 2009, AM J CLIN NUTR, V90, P505, DOI 10.3945/ajcn.2009.27819; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; Esnaola NF, 2016, CANCER-AM CANCER SOC, V122, P1349, DOI 10.1002/cncr.29692; Farhat MH, 2008, WORLD J GASTROENTERO, V14, P3224, DOI 10.3748/wjg.14.3224; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Gonzalez MC, 2014, AM J CLIN NUTR, V99, P999, DOI 10.3945/ajcn.113.071399; Hines RB, 2009, CANCER-AM CANCER SOC, V115, P5798, DOI 10.1002/cncr.24598; Horowitz NS, 2015, GYNECOL ONCOL, V138, P201, DOI 10.1016/j.ygyno.2015.04.002; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kaneko M, 2016, MOL CLIN ONCOL, V5, P289, DOI 10.3892/mco.2016.964; Kasenda B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-728; Kim MK, 2014, ENDOCRINOL METAB, V29, P405, DOI 10.3803/EnM.2014.29.4.405; Lanic H, 2014, LEUKEMIA LYMPHOMA, V55, P817, DOI 10.3109/10428194.2013.816421; Lennon H, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0539-4; Li JS, 2014, TUMOR BIOL, V35, P6831, DOI 10.1007/s13277-014-1939-4; Li Z, 2016, ONCOTARGET; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Murphy RA, 2010, CLIN NUTR, V29, P482, DOI 10.1016/j.clnu.2009.11.006; Myers J, 2011, AM J MED, V124, P924, DOI 10.1016/j.amjmed.2011.04.018; Rutten IJG, 2017, J CACHEXIA SARCOPENI, V8, P630, DOI 10.1002/jcsm.12180; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Shachar SS, 2017, CLIN CANCER RES, V23, P658, DOI 10.1158/1078-0432.CCR-16-0940; Tan WB, 2015, NUTRIENTS, V7, P8321, DOI 10.3390/nu7105387; Tsang NM, 2016, CANCER MED-US, V5, P665, DOI 10.1002/cam4.634; Wigmore SJ, 2000, BRIT J SURG, V87, P53, DOI 10.1046/j.1365-2168.2000.01317.x; Yildirim BA, 2016, PANCREATOLOGY, V16, P599, DOI 10.1016/j.pan.2016.03.006	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195118	10.1371/journal.pone.0195118	http://dx.doi.org/10.1371/journal.pone.0195118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608578	gold, Green Published, Green Submitted			2022-12-27	WOS:000428988800026
J	Pauciullo, A; Ogah, DM; Lannaccone, M; Erhardt, G; Di Stasio, L; Cosenza, G				Pauciullo, Alfredo; Ogah, Danlami Moses; Lannaccone, Marco; Erhardt, Georg; Di Stasio, Liliana; Cosenza, Gianfranco			Genetic characterization of the oxytocin-neurophysin I gene (OXT) and its regulatory regions analysis in domestic Old and New World camelids	PLOS ONE			English	Article							MEDITERRANEAN RIVER BUFFALO; LAMA-GLAMA MILK; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; PROMOTER ANALYSIS; DROMEDARIUS MILK; RESPONSE ELEMENT; VARIABILITY; RECEPTOR; LLAMA	Oxytocin is a neurohypophysial peptide linked to a wide range of biological functions, including milk ejection, temperament and reproduction. Aims of the present study were a) the characterization of the OXT(Oxytocin-neurophysin I) gene and its regulatory regions in Old and New world camelids; b) the investigation of the genetic diversity and the discovery of markers potentially affecting the gene regulation. On average, the gene extends over 814 bp, ranging between 825 bp in dromedary, 811 bp in Bactrian and 810 bp in llama and alpaca. Such difference in size is due to a duplication event of 21 bp in dromedary. The main regulatory elements, including the composite hormone response elements (CHREs), were identified in the promoter, whereas the presence of mature microRNAs binding sequences in the 3'UTR improves the knowledge on the factors putatively involved in the OXTgene regulation, although their specific biological effect needs to be still elucidated. The sequencing of genomic DNA allowed the identification of 17 intraspecific polymorphisms and 69 nucleotide differences among the four species. One of these (MF464535:g.622C>G) is responsible, in alpaca, for the loss of a consensus sequence for the transcription factor SP1. Furthermore, the same SNP falls within a CpG island and it creates a new methylation site, thus opening future possibilities of investigation to verify the influence of the novel allelic variant in the OXTgene regulation. A PCR-RFLP method was setup for the genotyping and the frequency of the allele C was 0.93 in a population of 71 alpacas. The obtained data clarify the structure of OXTgene in domestic camelids and add knowledge to the genetic variability of a genomic region, which has received little investigation so far. These findings open the opportunity for new investigations, including association studies with productive and reproductive traits.	[Pauciullo, Alfredo; Di Stasio, Liliana] Univ Torino, Dept Agr Forest & Food Sci, Grugliasco, TO, Italy; [Ogah, Danlami Moses] Nasarawa State Univ, Dept Anim Sci, Keffi, Shabu Lafia, Nigeria; [Lannaccone, Marco; Cosenza, Gianfranco] Univ Naples Federico II, Dept Agr Sci, Portici, NA, Italy; [Erhardt, Georg] Justus Liebig Univ Giessen, Dept Anim Breeding & Genet, Giessen, Germany	University of Turin; University of Naples Federico II; Justus Liebig University Giessen	Pauciullo, A (corresponding author), Univ Torino, Dept Agr Forest & Food Sci, Grugliasco, TO, Italy.	alfredo.pauciullo@unito.it	Pauciullo, Alfredo/AAF-7713-2020; IANNACCONE, Marco/K-7559-2016	Pauciullo, Alfredo/0000-0002-3140-9373; IANNACCONE, Marco/0000-0002-2283-6613	ProBufaLat Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy) [PAUA_RIL0_17_01]	ProBufaLat Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy)	This research was financially supported by ProBufaLat Project (PAUA_RIL0_17_01), Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN RAH, 1993, MOL ENDOCRINOL, V7, P47, DOI 10.1210/me.7.1.47; ADAN RAH, 1992, J BIOL CHEM, V267, P3771; ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; ANG HL, 1994, J ENDOCRINOL, V140, P53, DOI 10.1677/joe.0.1400053; Balmus G, 2007, CHROMOSOME RES, V15, P499, DOI 10.1007/s10577-007-1154-x; Bell CJ, 2006, J PSYCHOPHARMACOL, V20, P656, DOI 10.1177/0269881106060512; BURBACH JPH, 1994, J BIOL CHEM, V269, P15046; Burger PA, 2016, TROP ANIM HEALTH PRO, V48, P905, DOI 10.1007/s11250-016-1032-7; Cannell IG, 2008, DO MICRORNAS REGULAT; Choi JW, 2013, J NEUROCHEM, V126, P331, DOI 10.1111/jnc.12308; Cosenza G, 2007, ITAL J ANIM SCI, V6, P303; Cosenza G, 2017, J DAIRY RES, V84, P165, DOI 10.1017/S0022029917000097; Erhardt G., 2017, GENE, P36; Erhardt G, 2016, TROP ANIM HEALTH PRO, V48, P879, DOI 10.1007/s11250-016-0997-6; FAO, 2014, STAT LIV AN; Fitak RR, 2016, MOL ECOL RESOUR, V16, P314, DOI 10.1111/1755-0998.12443; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Haas BW, 2016, P NATL ACAD SCI USA, V113, pE3816, DOI 10.1073/pnas.1602809113; IVELL R, 1984, EMBO J, V3, P2351, DOI 10.1002/j.1460-2075.1984.tb02139.x; Jirimutu, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2192; Kadwell M, 2001, P ROY SOC B-BIOL SCI, V268, P2575, DOI 10.1098/rspb.2001.1774; Kappeler S, 1998, J DAIRY RES, V65, P209, DOI 10.1017/S0022029997002847; Kimura T, 2003, J MOL ENDOCRINOL, V30, P109, DOI 10.1677/jme.0.0300109; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lollivier V, 2002, REPROD NUTR DEV, V42, P173, DOI 10.1051/rnd:2002016; Pauciullo A, 2017, J DAIRY SCI, V100, P1282, DOI 10.3168/jds.2016-11918; Pauciullo A, 2014, GENE, V547, P159, DOI 10.1016/j.gene.2014.06.055; Pauciullo A, 2013, GENE, V513, P22, DOI 10.1016/j.gene.2012.10.083; Pauciullo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34781; Pauciullo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124963; Pauciullo A, 2012, J DAIRY RES, V79, P150, DOI 10.1017/S0022029911000914; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; RICHARD S, 1991, J BIOL CHEM, V266, P21428; RICHARD S, 1990, J BIOL CHEM, V265, P6098; Riek A, 2006, J DAIRY SCI, V89, P3484, DOI 10.3168/jds.S0022-0302(06)72387-6; RUPPERT S, 1984, NATURE, V308, P554, DOI 10.1038/308554a0; Saadaoui B, 2014, ELECTROPHORESIS, V35, P1406, DOI 10.1002/elps.201300383; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Sambrook J., 2001, MOL CLONING LAB MANU; Shuiep ES, 2013, INT DAIRY J, V28, P88, DOI 10.1016/j.idairyj.2012.09.002; Striepens N, 2011, FRONT NEUROENDOCRIN, V32, P426, DOI 10.1016/j.yfrne.2011.07.001; Volpato G, 2014, PASTORALISM, V4, DOI 10.1186/s13570-014-0007-4; Wardeh M, 1993, IMPORTANCE DROMEDARY; Wheeler J. C., 2012, Journal of Camelid Science, V5, P1; Wu HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6188	48	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195407	10.1371/journal.pone.0195407	http://dx.doi.org/10.1371/journal.pone.0195407			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608621	Green Submitted, gold, Green Published			2022-12-27	WOS:000428988800051
J	Chang, CH; Sakaguchi, M; Weil, J; Verstraeten, T				Chang, Chia-Hsien; Sakaguchi, Motonobu; Weil, John; Verstraeten, Thomas			The incidence of medically-attended norovirus gastro-enteritis in Japan: Modelling using a medical care insurance claims database	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; ENTERIC VIRUSES; MOLECULAR EPIDEMIOLOGY; GENOTYPE DISTRIBUTION; SPORADIC NOROVIRUSES; NARA PREFECTURE; OSAKA CITY; CHILDREN; INFANTS; INFECTION	Background The burden of medically-attended acute gastro-enteritis (MA-AGE) that can be attributed to norovirus is not well established in Japan. Using a nationwide database of medical care insurance claims, we estimated the incidence of medically-attended norovirus-attributable gastroenteritis (MA-NGE) in Japan. Methods The incidences of MA-NGE outpatient consultations or hospitalization in Japan were modelled on seasonal patterns of MA-AGE for unspecified causes derived from the Japan Medical Data Center (JMDC) database for the period July 2007 to June 2015. Results Mean age-adjusted annual incidence rates (per 10,000 person-years) of MA-NGE associated with outpatient care or hospitalization were 389 (95% CI 269-558) and 13 (95% CI 9-20), respectively. Highest rates were in children under 5 years of age: 1,569 (95% CI 1,325-1,792) for outpatient consultations and 48 (95% CI 39-56) for hospitalizations. Of all gastroenteritis episodes associated with outpatient care or hospitalization, 29% and 31% were attributed to norovirus, respectively. Norovirus was estimated to be responsible for 4,964,000 outpatient visits (95% CI 3,435,000-7,123,000) and 171,000 hospitalizations (95% CI 110,000-251,000) per year across Japan. Conclusions Incidence rates of MA-AGE are high in Japan, and norovirus-attributable disease is at least as high as in some other developed countries.	[Chang, Chia-Hsien; Sakaguchi, Motonobu] Takeda Pharmaceut Co Ltd, Global Patient Safety Evaluat Japan, Takeda Dev Ctr Japan, Osaka, Japan; [Weil, John] Takeda Pharmaceut Int AG, Zurich, Switzerland; [Verstraeten, Thomas] P95 Pharmacovigilance & Epidemiol, Heverlee, Belgium	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Chang, CH (corresponding author), Takeda Pharmaceut Co Ltd, Global Patient Safety Evaluat Japan, Takeda Dev Ctr Japan, Osaka, Japan.	chia-hsien.chang@takeda.com		Chang, Chia-Hsien/0000-0002-6988-7944	Takeda, Japan	Takeda, Japan	The funder (Takeda, Japan) provided support in the form of salaries for authors (CHC, MS) and research materials only, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; [Anonymous], 2011, NOR FOOD POIS JAP 20; [Anonymous], 2013, DET GASTR VIR JAP 20; Chan-It W, 2011, CLIN LAB, V57, P213; Dey SK, 2011, CLIN LAB, V57, P193; Dey SK, 2010, PEDIATR INFECT DIS J, V29, pE32, DOI 10.1097/INF.0b013e3181d742bf; Fujita M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151690; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Grytdal SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148395; Harada S, 2009, J MED VIROL, V81, P1117, DOI 10.1002/jmv.21454; Iritani N, 2014, J MED VIROL, V86, P2019, DOI 10.1002/jmv.23883; Ishida Y, 2012, PEDIATRICS, V129, pE113, DOI 10.1542/peds.2011-1321; Kawada JI, 2012, MICROBIOL IMMUNOL, V56, P756, DOI 10.1111/j.1348-0421.2012.00498.x; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Kitahori Y, 2008, JPN J INFECT DIS, V61, P89; Kitahori Y, 2009, JPN J INFECT DIS, V62, P82; Kumazaki M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1999-8; Lopman BA, 2004, CLIN INFECT DIS, V39, P318, DOI 10.1086/421948; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999; Minister for the Environment, 2016, NOR Q A MAN CAS NOR, P5; Mori K, 2017, JPN J INFECT DIS, V70, P143, DOI 10.7883/yoken.JJID.2015.456; Morton VK, 2015, EPIDEMIOL INFECT, V143, P3528, DOI 10.1017/S0950268815000734; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Nakamura N, 2016, J MED VIROL, V88, P1180, DOI 10.1002/jmv.24445; Nakanishi K, 2009, J CLIN VIROL, V46, P94, DOI 10.1016/j.jcv.2009.06.014; National Institute of Infectious Diseases N, 2017, DET GASTR VIR JAP; Okame M, 2006, J MED VIROL, V78, P1318, DOI 10.1002/jmv.20696; Onishi N, 2008, PEDIATR INT, V50, P65, DOI 10.1111/j.1442-200X.2007.02529.x; Phan TG, 2006, J MED VIROL, V78, P839, DOI 10.1002/jmv.20632; Phan TG, 2005, ARCH VIROL, V150, P1415, DOI 10.1007/s00705-005-0514-0; Phan TG, 2004, J MED VIROL, V74, P173, DOI 10.1002/jmv.20162; Phan TG, 2007, CLIN LAB, V53, P567; Phan TG, 2007, J MED VIROL, V79, P1388, DOI 10.1002/jmv.20924; Phan TG, 2006, CLIN LAB, V52, P519; Phan TG, 2006, J MED VIROL, V78, P971, DOI 10.1002/jmv.20649; Rha B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148505; Sakon N, 2015, J INFECT DIS, V211, P879, DOI 10.1093/infdis/jiu496; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3; Thongprachum A, 2016, J MED VIROL, V88, P551, DOI 10.1002/jmv.24387; Thongprachum A, 2015, J MED VIROL, V87, P1141, DOI 10.1002/jmv.24155; Trivedi TK, 2012, JAMA-J AM MED ASSOC, V308, P1668, DOI 10.1001/jama.2012.14023; Ushijima H, 2014, JPN J INFECT DIS, V67, P374, DOI 10.7883/yoken.67.374; Van Cauteren D, 2017, EMERG INFECT DIS, V23, P1486, DOI 10.3201/eid2309.170081; Verstraeten T, 2017, J INFECT DIS, V216, P957, DOI 10.1093/infdis/jix410; Yoneda M, 2014, INTERVIROLOGY, V57, P31, DOI 10.1159/000353852	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195164	10.1371/journal.pone.0195164	http://dx.doi.org/10.1371/journal.pone.0195164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601600	Green Submitted, gold, Green Published			2022-12-27	WOS:000428845900020
J	Adams, GG; Meal, A; Morgan, PS; Alzahrani, QE; Zobel, H; Lithgo, R; Kok, MS; Besong, DTM; Jiwani, SI; Ballance, S; Harding, SE; Chayen, N; Gillis, RB				Adams, Gary G.; Meal, Andrew; Morgan, Paul S.; Alzahrani, Qushmua E.; Zobel, Hanne; Lithgo, Ryan; Kok, M. Samil; Besong, David T. M.; Jiwani, Shahwar I.; Ballance, Simon; Harding, Stephen E.; Chayen, Naomi; Gillis, Richard B.			Characterisation of insulin analogues therapeutically available to patients	PLOS ONE			English	Article							CHEMICAL-STABILITY; MOLECULAR-WEIGHT; SELF-ASSOCIATION; BOVINE INSULIN; EQUILIBRIUM ULTRACENTRIFUGE; PHARMACEUTICAL-PREPARATIONS; SEDIMENTATION EQUILIBRIUM; NEUTRAL PH; FORMULATION; ZINC	The structure and function of clinical dosage insulin and its analogues were assessed. This included 'native insulins' (human recombinant, bovine, porcine), 'fast-acting analogues' (aspart, glulisine, lispro) and 'slow-acting analogues' (glargine, detemir, degludec). Analytical ultracentrifugation, both sedimentation velocity and equilibrium experiments, were employed to yield distributions of both molar mass and sedimentation coefficient of all nine insulins. Size exclusion chromatography, coupled to multi-angle light scattering, was also used to explore the function of these analogues. On ultracentrifugation analysis, the insulins under investigation were found to be in numerous conformational states, however the majority of insulins were present in a primarily hexameric conformation. This was true for all native insulins and two fast-acting analogues. However, glargine was present as a dimer, detemir was a multi-hexameric system, degludec was a dodecamer (di-hexamer) and glulisine was present as a dimer-hexamer-dihexamer system. However, size-exclusion chromatography showed that the two hexameric fast-acting analogues (aspart and lispro) dissociated into monomers and dimers due to the lack of zinc in the mobile phase. This comprehensive study is the first time all nine insulins have been characterised in this way, the first time that insulin detemir have been studied using analytical ultracentrifugation and the first time that insulins aspart and glulisine have been studied using sedimentation equilibrium. The structure and function of these clinically administered insulins is of critical importance and this research adds novel data to an otherwise complex functional physiological protein.	[Adams, Gary G.; Meal, Andrew; Morgan, Paul S.; Alzahrani, Qushmua E.; Kok, M. Samil; Jiwani, Shahwar I.; Gillis, Richard B.] Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2UH, England; [Adams, Gary G.; Alzahrani, Qushmua E.; Lithgo, Ryan; Jiwani, Shahwar I.; Harding, Stephen E.; Gillis, Richard B.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, England; [Alzahrani, Qushmua E.] Taif Univ, Fac Sci, At Taif, Saudi Arabia; [Zobel, Hanne; Ballance, Simon] Nofima AS, Osloveien 1, As, Norway; [Kok, M. Samil] Abant Izzet Baysal Univ, Dept Food Engn, Bolu, Turkey; [Besong, David T. M.] KAUST, Funct Nanomat Lab, Thuwal, Saudi Arabia; [Chayen, Naomi] Imperial Coll London, Fac Med, Dept Surg & Canc, Computat & Syst Med, London SW7 2AZ, England	University of Nottingham; University of Nottingham; Taif University; Nofima; Abant Izzet Baysal University; King Abdullah University of Science & Technology; Imperial College London	Adams, GG; Gillis, RB (corresponding author), Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2UH, England.; Adams, GG; Gillis, RB (corresponding author), Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, England.	gary.adams@nottingham.ac.uk; richard.gillis@nottingham.ac.uk	Adams, Gary/ABG-2959-2020	Adams, Gary/0000-0002-0335-2162; Alzahrani, Qushmua/0000-0001-5305-799X; Morgan, Paul/0000-0002-5870-1446; Harding, Stephen E./0000-0002-7798-9692; Lithgo, Ryan/0000-0002-4706-9916; Chayen, Naomi/0000-0003-2861-2458				Adams GG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06642-w; Aizen D, 2015, MOL CELL ENDOCRINOL, V406, P27, DOI 10.1016/j.mce.2015.02.011; Ang S, 2010, MACROMOL BIOSCI, V10, P798, DOI 10.1002/mabi.201000065; Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215; Birkeland KI, 2011, DIABETES CARE, V34, P661, DOI 10.2337/dc10-1925; BRANGE J, 1992, PHARMACEUT RES, V9, P727, DOI 10.1023/A:1015887001987; BRANGE J, 1992, ACTA PHARM NORDICA, V4, P149; BRANGE J, 1992, PHARMACEUT RES, V9, P715, DOI 10.1023/A:1015835017916; BRANGE J, 1992, ACTA PHARM NORDICA, V4, P223; BRANGE J, 1992, ACTA PHARM NORDICA, V4, P209; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; Coppolino R, 2006, J PHARM SCI-US, V95, P1029, DOI 10.1002/jps.20609; FREDERICQ E, 1956, ARCH BIOCHEM BIOPHYS, V65, P218, DOI 10.1016/0003-9861(56)90189-8; Gast K, 2017, PHARM RES-DORDR, V34, P2270, DOI 10.1007/s11095-017-2233-0; Gillis RB, 2013, EUR BIOPHYS J BIOPHY, V42, P777, DOI 10.1007/s00249-013-0924-y; GOLDMAN J, 1974, BIOCHEMISTRY-US, V13, P4566, DOI 10.1021/bi00719a015; GRANT PT, 1972, BIOCHEM J, V126, P433, DOI 10.1042/bj1260433; GUTFREUND H, 1948, BIOCHEM J, V42, P544, DOI 10.1042/bj0420544; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Hayes D. B., 1995, SEDNTERP; Hinds K, 2000, BIOCONJUGATE CHEM, V11, P195, DOI 10.1021/bc9901189; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; HOLLADAY LA, 1977, BIOCHIM BIOPHYS ACTA, V494, P245, DOI 10.1016/0005-2795(77)90152-0; Home PD, 2015, DIABETES OBES METAB, V17, P1011, DOI 10.1111/dom.12501; Jacober SJ, 2014, DIABETES OBES METAB, V16, P351, DOI 10.1111/dom.12223; JEFFREY PD, 1966, BIOCHEMISTRY-US, V5, P489, DOI 10.1021/bi00866a014; JEFFREY PD, 1965, BIOCHIM BIOPHYS ACTA, V109, P551, DOI 10.1016/0926-6585(65)90181-0; JEFFREY PD, 1966, BIOCHEMISTRY-US, V5, P3820, DOI 10.1021/bi00876a012; JEFFREY PD, 1976, BIOCHEMISTRY-US, V15, P4660, DOI 10.1021/bi00666a018; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Miller GL, 1942, J BIOL CHEM, V144, P459; Nakazawa S, 2012, ANAL BIOCHEM, V420, P61, DOI 10.1016/j.ab.2011.09.002; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; Provencher SW, 1992, LASER LIGHT SCATTERI; Richards JP, 1998, PHARMACEUT RES, V15, P1434, DOI 10.1023/A:1011961923870; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2014, ANALYST, V139, P79, DOI 10.1039/c3an01507f; Sjogren B, 1931, J AM CHEM SOC, V53, P2657, DOI 10.1021/ja01358a029; Steensgaard DB, 2013, BIOCHEMISTRY-US, V52, P295, DOI 10.1021/bi3008609; Teska BM, 2014, J PHARM SCI-US, V103, P2255, DOI 10.1002/jps.24039; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wyatt P. J., 1992, LASER LIGHT SCATTERI; Zemler RS, 2015, ARCH PHYSIOL BIOCHEM, V121, P32, DOI 10.3109/13813455.2014.1001856	43	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195010	10.1371/journal.pone.0195010	http://dx.doi.org/10.1371/journal.pone.0195010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596514	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000428630000066
J	Hachiya, M; Miyano, S; Mori, Y; Vynnycky, E; Keungsaneth, P; Vongphrachanh, P; Xeuatvongsa, A; Sisouk, T; Som-Oulay, V; Khamphaphongphane, B; Sengkeopaseuth, B; Pathammavong, C; Phounphenghak, K; Kitamura, T; Takeda, M; Komase, K				Hachiya, Masahiko; Miyano, Shinsuke; Mori, Yoshio; Vynnycky, Emilia; Keungsaneth, Phath; Vongphrachanh, Phengta; Xeuatvongsa, Anonh; Sisouk, Thongchanh; Som-Oulay, Vilasak; Khamphaphongphane, Bouaphan; Sengkeopaseuth, Bounthanom; Pathammavong, Chansay; Phounphenghak, Kongxay; Kitamura, Tomomi; Takeda, Makoto; Komase, Katsuhiro			Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine	PLOS ONE			English	Article							DRIED BLOOD SPOTS; PREGNANT-WOMEN; SYNDROME CRS; ELIMINATION; INFECTION; IMMUNITY; PROGRESS; IMPACT; AGE	Background Measles outbreaks have occurred in some countries despite supplementary immunization activities (SIA) using measles-containing vaccine with high vaccination coverage. We conducted a cross-sectional seroprevalence survey to estimate population immunity in Lao People's Democratic Republic where repeated mass immunization has failed to eliminate measles. Methods and findings In this nationwide multistage cluster sampling survey conducted in 2014 based on probability proportionate to size sampling, blood samples were collected from 2,135 children and adults living in 52 randomly selected villages. Anti-measles and anti-rubella IgG were measured, and IgG prevalence was calculated. We applied mathematical modelling to estimate the number of cases of congenital rubella syndrome (CRS) in 2013 that were averted by the 2011 SIA. A stability testing was applied to the MR vaccine at 4 degrees C, 25 degrees C, and 35 degrees C to examine stability differences between measles and rubella vaccine components. Measles IgG prevalence was significantly lower in the target age groups (5-21 years) of the 2011 SIA using a combination vaccine for measles and rubella vaccine (MR vaccine) than in young adults (22-39 years) (86.8% [95% CI: 83.0-90.6] vs. 99.0% [98.3-99.8]; p<0.001), whereas rubella IgG prevalence was significantly higher (88.2% [84.5-91.8] vs. 74.6% [70.7-78.5]; p<0.001). In the SIA target age groups, prevalence of measles IgG, but not rubella IgG, increased with age. CRS cases prevented in 2013 ranged from 16 [0-50] to 92 [32-180] if the force of infection had remained unchanged or had been reduced by 75%, respectively. In freeze-dried conditions, the measles vaccine component was more heat sensitive than the rubella component. Conclusions Inconsistent IgG prevalence between measles and rubella in Lao PDR can be partly explained by different stability of the measles and rubella vaccine components under heat exposure. Suboptimal vaccine handling may cause insufficient immunogenicity for measles, which subsequently leads to an outbreak despite high SIA coverage, while direct evidence is lacking. Temperature monitoring of the vaccine should be conducted.	[Hachiya, Masahiko; Miyano, Shinsuke; Kitamura, Tomomi] Natl Ctr Global Hlth & Med, Bur Int Hlth Cooperat, Shinjuku Ku, Tokyo, Japan; [Mori, Yoshio; Takeda, Makoto; Komase, Katsuhiro] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Vynnycky, Emilia] Publ Hlth England, Modelling & Econ Unit, London, England; [Vynnycky, Emilia] London Sch Hyg & Trop Med, TB Modelling Grp, London, England; [Vynnycky, Emilia] London Sch Hyg & Trop Med, TB Ctr, London, England; [Vynnycky, Emilia] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Keungsaneth, Phath] Minist Hlth, Dept Hyg & Hlth Promot, Vientiane Capital, Laos; [Vongphrachanh, Phengta; Sisouk, Thongchanh; Som-Oulay, Vilasak; Khamphaphongphane, Bouaphan; Sengkeopaseuth, Bounthanom] Minist Hlth, Natl Ctr Lab & Epidemiol, Vientiane Capital, Laos; [Xeuatvongsa, Anonh; Pathammavong, Chansay; Phounphenghak, Kongxay] Minist Hlth, Natl Immunizat Program, Vientiane Capital, Laos	National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Public Health England; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Hachiya, M (corresponding author), Natl Ctr Global Hlth & Med, Bur Int Hlth Cooperat, Shinjuku Ku, Tokyo, Japan.	m-hachiya@it.ncgm.go.jp	Hachiya, Masahiko/ABF-8472-2021	Hachiya, Masahiko/0000-0002-8720-5097; Kitamura, Tomomi/0000-0002-7956-4751				Alleman MM, 2016, VACCINE, V34, P6502, DOI 10.1016/j.vaccine.2016.10.059; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P374; Cutts FT, 2016, TROP MED INT HEALTH, V21, P1086, DOI 10.1111/tmi.12737; Cutts FT, 2013, EXPERT REV VACCINES, V12, P917, DOI 10.1586/14760584.2013.814847; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; Fitter DL, 2013, VACCINE, V32, P69, DOI 10.1016/j.vaccine.2013.10.071; Goodson JL, 2012, VACCINE, V30, P4709, DOI 10.1016/j.vaccine.2012.04.058; Komada K, 2015, INT J INFECT DIS, V36, P21, DOI 10.1016/j.ijid.2015.04.020; Mao B, 2015, EPIDEMIOL INFECT, V143, P1858, DOI 10.1017/S0950268814002817; Ministry of Health and Lao Statistics Bureau, 2012, LAO SOC IND SURV 201; Miyakawa M, 2014, VACCINE, V32, P1192, DOI 10.1016/j.vaccine.2013.08.076; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P1034; Plans-Rubio P, 2014, EXPERT REV ANTI-INFE, V12, P723, DOI 10.1586/14787210.2014.917047; Plotkin S.A., 2013, VACCINES-BASEL, P688; Rentsen T, 2007, JPN J INFECT DIS, V60, P198; Riddell MA, 2003, B WORLD HEALTH ORGAN, V81, P701; Robertson SE, 1997, B WORLD HEALTH ORGAN, V75, P69; Sakata M, 2009, VACCINE, V27, P234, DOI 10.1016/j.vaccine.2008.10.049; Shkedy Z, 2006, STAT MED, V25, P1577, DOI 10.1002/sim.2291; Strebel P, 2013, VACCINES, P352; Toda K, 2015, VACCINE, V33, P3673, DOI 10.1016/j.vaccine.2015.06.035; Uzicanin A, 2011, J INFECT DIS, V204, pS564, DOI 10.1093/infdis/jir088; Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160; Vynnycky E, 2016, HUM VACC IMMUNOTHER, V12, P150, DOI 10.1080/21645515.2015.1060380; *WHO, 2009, IMM BAS IMM SER; WHO, 2013, GUID COND SER SUPP M; World Health Organization, 2008, WKLY EPIDEMIOL REC, V83, P393; World Health Organization, 2008, IMM BAS IMM MOD 11 R; World Health Organization, 2009, MEAS VACC WHO POS PA, V84, P349; Xeuatvongsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088829	31	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194931	10.1371/journal.pone.0194931	http://dx.doi.org/10.1371/journal.pone.0194931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596472	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000428630000051
J	McKenna, S; Lee, E; Klik, KA; Markus, A; Hewstone, M; Reynolds, KJ				McKenna, Sarah; Lee, Eunro; Klik, Kathleen A.; Markus, Andrew; Hewstone, Miles; Reynolds, Katherine J.			Are diverse societies less cohesive? Testing contact and mediated contact theories	PLOS ONE			English	Article							NEIGHBORHOOD DIVERSITY; INTERGROUP CONTACT; ETHNIC DIVERSITY; SOCIAL COHESION; INTERETHNIC CONTACT; NEGATIVE CONTACT; TRUST; PREJUDICE; CONFLICT; US	Previous research has demonstrated that there is a negative relationship between ethnic diversity in a local community and social cohesion. Often the way social cohesion is assessed, though, varies across studies and only some aspects of the construct are included (e.g., trust). The current research explores the relationship between diversity and social cohesion across a number of indicators of social cohesion including neighbourhood social capital, safety, belonging, generalized trust, and volunteering. Furthermore, social psychological theories concerning the role of positive contact and its impact on feelings of threat are investigated. Using a sample of 1070 third generation 'majority' Australians and structural equation modelling (SEM), findings suggest ethnic diversity is related to positive intergroup contact, and that contact showed beneficial impacts for some indicators of social cohesion both directly and indirectly through reducing perceived threat. When interethnic contact and perceived threat are included in the model there is no direct negative effect between diversity and social cohesion. The theoretical implications of these findings are outlined including the importance of facilitating opportunities for positive contact in diverse communities.	[McKenna, Sarah; Klik, Kathleen A.; Reynolds, Katherine J.] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Lee, Eunro] Charles Darwin Univ, Sch Psychol & Clin Sci, Casuarina, NT, Australia; [Markus, Andrew] Monash Univ, Sch Philosoph Hist & Int Studies, Caulfield, Vic, Australia; [Hewstone, Miles] Univ Oxford, Oxford Ctr Study Intergrp Conflict, Dept Expt Psychol, Oxford, Oxon, England	Australian National University; Charles Darwin University; Monash University; University of Oxford	Reynolds, KJ (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.	katherine.reynolds@anu.edu.au	Klik, Kathleen/ABB-5547-2021; Reynolds, Katherine/GRR-4312-2022; Lee, Eunro/J-6373-2017	Lee, Eunro/0000-0002-0830-9083; Klik, Kathleen/0000-0001-7242-1726; McKenna, Sarah/0000-0002-8560-6399				Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Anderson Benedict, 2004, IMAGINED COMMUNITIES; Australian Bureau of Statistics, 2012, ABS PUBL, V1001. 0; Barlow FK, 2012, PERS SOC PSYCHOL B, V38, P1629, DOI 10.1177/0146167212457953; Baugh J., 2016, OXFORD HDB LANGUAGE, P349; Chan J, 2006, SOC INDIC RES, V75, P273, DOI 10.1007/s11205-005-2118-1; Cui T., ANZAPS 2012, P22; Dandy J, 2010, INT J INTERCULT REL, V34, P34, DOI 10.1016/j.ijintrel.2009.10.003; Department of Immigration and Border Protection, 2014, PEOPL AUSTR STAT 201; Dinesen PT, 2011, SOC SCI RES, V40, P572, DOI 10.1016/j.ssresearch.2010.12.002; Dixon J, 2005, AM PSYCHOL, V60, P697, DOI 10.1037/0003-066X.60.7.697; Edgar B, 2014, J ETHN MIGR STUD, V40, P363, DOI 10.1080/1369183X.2013.830890; Fearon JD, 2003, J ECON GROWTH, V8, P195, DOI 10.1023/A:1024419522867; Fieldhouse E, 2010, CAN J POLIT SCI, V43, P289, DOI 10.1017/S0008423910000065; Gesthuizen M., 2002, SCANDINAVIAN POLITIC, V32, P121; Gijsberts M, 2012, EUR SOCIOL REV, V28, P527, DOI 10.1093/esr/jcr022; Gundelach B, 2014, URBAN STUD, V51, P1236, DOI 10.1177/0042098013495578; Hayward LE, 2017, PERS SOC PSYCHOL B, V43, P347, DOI 10.1177/0146167216685291; Healy E., 2007, PEOPLE PLACE, V15, P49, DOI [10.3316/informit.158970231797993, DOI 10.3316/INFORMIT.158970231797993]; Hewstone M, 2015, J SOC ISSUES, V71, P417, DOI 10.1111/josi.12120; Hua-yong L. I., 2013, J CHONGQING TECHNOLO, V6; Kesler C, 2010, CAN J POLIT SCI, V43, P319, DOI 10.1017/S0008423910000077; Khoo S.E., 2002, PEOPLE PLACE, V10, P30; Koopmans R, 2014, SOC SCI RES, V47, P91, DOI 10.1016/j.ssresearch.2014.03.014; Leigh A, 2006, ECON REC, V82, P268, DOI 10.1111/j.1475-4932.2006.00339.x; Letki N, 2008, POLIT STUD-LONDON, V56, P99, DOI 10.1111/j.1467-9248.2007.00692.x; Markus A., 2014, MAPPING SOCIAL COHES; Meuleman B, 2009, SOC SCI RES, V38, P352, DOI 10.1016/j.ssresearch.2008.09.006; Muthen L. K., 2012, MPLUS; Paolini S, 2010, PERS SOC PSYCHOL B, V36, P1723, DOI 10.1177/0146167210388667; Pettigrew TF, 2011, INT J INTERCULT REL, V35, P271, DOI 10.1016/j.ijintrel.2011.03.001; Pettigrew TF, 2010, J ETHN MIGR STUD, V36, P635, DOI 10.1080/13691830903516034; Pink B., 2011, 2033055001 AUSTR BUR; Purnell T, 1999, J LANG SOC PSYCHOL, V18, P10, DOI 10.1177/0261927X99018001002; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; Raubenheimer J., 2004, SA J IND PSYCHOL, V30, P59, DOI [10.10520/EJC89023, DOI 10.4102/SAJIP.V30I4.168, 10.4102/sajip.v30i4.168]; Rothwell JT, 2012, URBAN STUD, V49, P2109, DOI 10.1177/0042098011428180; Savelkoul M, 2015, SOC SCI RES, V52, P236, DOI 10.1016/j.ssresearch.2015.01.013; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schiefer D., 2016, SOCIAL INDICATORS RE, V127, P1; Schmid K., 2014, PSYCHOL SCI, V46, P897; Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003; Sherif M., 1966, COMMON PREDICAMENT S; Stephan W. G., 1999, J APPL SOC PSYCHOL, V29, P559, DOI [DOI 10.1111/J.1559-1816.1999.TB00107.X, 10.1111/j.1559-1816.1999.tb00107.x]; Stolle D, 2008, POLIT STUD-LONDON, V56, P57, DOI 10.1111/j.1467-9248.2007.00717.x; Stolle D, 2013, POLIT STUD-LONDON, V61, P42, DOI 10.1111/j.1467-9248.2012.00969.x; Tabachnick B. G., 2013, USING MULTIVARIATE S; UN- Department of Economic and Social Affairs/ Organisation for Economic Cooperation and Development, 2013, WORLD MIGR FIG; Uslaner EM, 2011, COMP SOCIOL, V10, P221, DOI 10.1163/156913311X566571; van der Meer T, 2016, SOC SCI RES, V55, P63, DOI 10.1016/j.ssresearch.2015.09.005; van der Meer T, 2014, ANNU REV SOCIOL, V40, P459, DOI 10.1146/annurev-soc-071913-043309; Wickes R, 2014, J URBAN AFF, V36, P51, DOI 10.1111/juaf.12015; Wirth RJ, 2007, PSYCHOL METHODS, V12, P58, DOI 10.1037/1082-989X.12.1.58; Wlodarczyk A, 2014, REV PSICOL SOC, V29, P60, DOI 10.1080/02134748.2013.878574	54	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193337	10.1371/journal.pone.0193337	http://dx.doi.org/10.1371/journal.pone.0193337			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596501	Green Published, gold			2022-12-27	WOS:000428630000008
J	Nilsen, EB; Strand, O				Nilsen, Erlend B.; Strand, Olav			Integrating data from multiple sources for insights into demographic processes: Simulation studies and proof of concept for hierarchical change-in-ratio models	PLOS ONE			English	Article							AGE-SPECIFIC SURVIVAL; POPULATION-DYNAMICS; TEMPORAL VARIATION; LARGE HERBIVORES; RED DEER; ROE DEER; LIFE; MANAGEMENT; DENSITY; CONSEQUENCES	We developed a model for estimating demographic rates and population abundance based on multiple data sets revealing information about population age- and sex structure. Such models have previously been described in the literature as change-in-ratio models, but we extend the applicability of the models by i) using time series data allowing the full temporal dynamics to be modelled, by ii) casting the model in an explicit hierarchical modelling framework, and by iii) estimating parameters based on Bayesian inference. Based on sensitivity analyses we conclude that the approach developed here is able to obtain estimates of demographic rate with high precision whenever unbiased data of population structure are available. Our simulations revealed that this was true also when data on population abundance are not available or not included in the modelling framework. Nevertheless, when data on population structure are biased due to different observability of different age-and sex categories this will affect estimates of all demographic rates. Estimates of population size is particularly sensitive to such biases, whereas demographic rates can be relatively precisely estimated even with biased observation data as long as the bias is not severe. We then use the models to estimate demographic rates and population abundance for two Norwegian reindeer (Rangifer tarandus) populations where age-sex data were available for all harvested animals, and where population structure surveys were carried out in early summer (after calving) and late fall (after hunting season), and population size is counted in winter. We found that demographic rates were similar regardless whether we include population count data in the modelling, but that the estimated population size is affected by this decision. This suggest that monitoring programs that focus on population age- and sex structure will benefit from collecting additional data that allow estimation of observability for different age- and sex classes. In addition, our sensitivity analysis suggests that focusing monitoring towards changes in demographic rates might be more feasible than monitoring abundance in many situations where data on population age-and sex structure can be collected.	[Nilsen, Erlend B.; Strand, Olav] Norwegian Inst Nat Res, Trondheim, Norway	Norwegian Institute Nature Research	Nilsen, EB (corresponding author), Norwegian Inst Nat Res, Trondheim, Norway.	erlend.nilsen@nina.no	Nilsen, Erlend B./G-3134-2017	Nilsen, Erlend B./0000-0002-5119-8331				Andersen R, 2000, J WILDLIFE MANAGE, V64, P698, DOI 10.2307/3802739; Arnold TW, 2018, J WILDLIFE MANAGE, V82, P266, DOI 10.1002/jwmg.21404; Bled F, 2017, ECOL EVOL, V7, P9531, DOI 10.1002/ece3.3469; Bonenfant C, 2004, P ROY SOC B-BIOL SCI, V271, P883, DOI 10.1098/rspb.2003.2661; Broms K, 2010, J WILDLIFE MANAGE, V74, P310, DOI 10.2193/2008-469; Caswell, 2000, MATRIX POPULATION MO; Chandler RB, 2014, METHODS ECOL EVOL, V5, P1351, DOI 10.1111/2041-210X.12153; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; De Barba M, 2010, J APPL ECOL, V47, P172, DOI 10.1111/j.1365-2664.2009.01752.x; Delgiudice GD, 2006, J WILDLIFE MANAGE, V70, P1556, DOI 10.2193/0022-541X(2006)70[1556:ALASAO]2.0.CO;2; Engen S, 2007, J THEOR BIOL, V244, P308, DOI 10.1016/j.jtbi.2006.08.009; Fieberg JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012114; Gaillard JM, 2003, POPUL DEV REV, V29, P39; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gaillard JM, 2005, AM NAT, V166, P119, DOI 10.1086/430330; Gaillard JM, 2003, J WILDLIFE MANAGE, V67, P767, DOI 10.2307/3802684; Gervasi V, 2016, WILDLIFE BIOL, V22, P95, DOI 10.2981/wlb.00142; Gervasi V, 2014, ECOL EVOL, V4, P4637, DOI 10.1002/ece3.1258; Gervasi V, 2012, J ANIM ECOL, V81, P443, DOI 10.1111/j.1365-2656.2011.01928.x; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.2307/177239; Melis C, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00099.1; Nilsen EB, 2017, POPULASJONSDYNAMISKE; Nilsen EB, 2009, J ANIM ECOL, V78, P585, DOI 10.1111/j.1365-2656.2009.01523.x; O'Brien S, 2005, J APPL ECOL, V42, P1096, DOI 10.1111/j.1365-2664.2005.01084.x; Panzacchi M, 2015, ECOGRAPHY, V38, P659, DOI 10.1111/ecog.01075; Panzacchi M, 2013, LANDSCAPE ECOL, V28, P847, DOI 10.1007/s10980-012-9793-5; Popescu VD, 2016, J APPL ECOL, V53, P1248, DOI 10.1111/1365-2664.12660; Robinson RA, 2014, METHODS ECOL EVOL, V5, P1361, DOI 10.1111/2041-210X.12204; Saether BE, 1998, OIKOS, V83, P344; Schaub M, 2007, CONSERV BIOL, V21, P945, DOI 10.1111/j.1523-1739.2007.00743.x; Schaub M, 2011, J ORNITHOL, V152, P227, DOI 10.1007/s10336-010-0632-7; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Solberg EJ, 2017, OPPSUMMERINGSRAPPORT; Strand O, 2012, CAN J ZOOL, V90, P163, DOI 10.1139/Z11-123; Su Y-S, R PACKAGE VERSION 0; Testa JW, 2004, ECOLOGY, V85, P1439, DOI 10.1890/02-0671; Thomas L, 2005, AUST NZ J STAT, V47, P19, DOI 10.1111/j.1467-842X.2005.00369.x; UDEVITZ MS, 1992, WILDLIFE 2001 : POPULATIONS, P90; White GC, 1996, J WILDLIFE MANAGE, V60, P37, DOI 10.2307/3802037; Yamamura K, 2008, POPUL ECOL, V50, P131, DOI 10.1007/s10144-007-0069-x; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	49	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194566	10.1371/journal.pone.0194566	http://dx.doi.org/10.1371/journal.pone.0194566			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596430	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000030
J	Ong, SE; Koh, JJK; Toh, SAES; Chia, KS; Balabanova, D; McKee, M; Perel, P; Legido-Quigley, H				Ong, Suan Ee; Koh, Joel Jun Kai; Toh, Sue-Anne Ee Shiow; Chia, Kee Seng; Balabanova, Dina; McKee, Martin; Perel, Pablo; Legido-Quigley, Helena			Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: A systematic review	PLOS ONE			English	Review							BLOOD-PRESSURE CONTROL; DISEASE RISK-FACTORS; CHRONIC CARE MODEL; GLYCEMIC CONTROL; GENERAL-PRACTICE; FOLLOW-UP; SELF-CARE; IMPROVING OUTCOMES; MANAGEMENT PROGRAM; CLINICAL SERVICES	Background Type 2 Diabetes Mellitus (T2DM) is reported to affect one in 11 adults worldwide, with over 80% of T2DM patients residing in low-to-middle-income countries. Health systems play an integral role in responding to this increasing global prevalence, and are key to ensuring effective diabetes management. We conducted a systematic review to examine the health system-level factors influencing T2DM awareness, treatment, adherence, and control. Methods and findings A protocol for this study was published on the PROSPERO international prospective register of systematic reviews (PROSPERO 2016: CRD42016048185). Studies included in this review reported the effects of health systems factors, interventions, policies, or programmes on T2DM control, awareness, treatment, and adherence. The following databases were searched on 22 February 2017: Medline, Embase, Global health, LILACS, Africa-Wide, IMSEAR, IMEMR, and WPRIM. There were no restrictions on date, language, or study designs. Two reviewers independently screened studies for eligibility, extracted the data, and screened for risk of bias. Thereafter, we performed a narrative synthesis. A meta-analysis was not conducted due to methodological heterogeneity across different aspects of included studies. 93 studies were included for qualitative synthesis; 7 were conducted in LMICs. Through this review, we found two key health system barriers to effective T2DM care and management: financial constraints faced by the patient and limited access to health services and medication. We also found three health system factors that facilitate effective T2DM care and management: the use of innovative care models, increased pharmacist involvement in care delivery, and education programmes led by healthcare professionals. Conclusions This review points to the importance of reducing, or possibly eliminating, out-of-pocket costs for diabetes medication and self-monitoring supplies. It also points to the potential of adopting more innovative and integrated models of care, and the value of task-sharing of care with pharmacists. More studies which identify the effect of health system arrangements on various outcomes, particularly awareness, are needed.	[Ong, Suan Ee; Koh, Joel Jun Kai; Chia, Kee Seng; Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Toh, Sue-Anne Ee Shiow] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Toh, Sue-Anne Ee Shiow] Natl Univ Hlth Syst, Dept Med, Div Endocrinol, Singapore, Singapore; [Balabanova, Dina; McKee, Martin; Perel, Pablo; Legido-Quigley, Helena] London Sch Hyg & Trop Med, London, England; [Perel, Pablo] World Heart Federat, Geneva, Switzerland	National University of Singapore; National University of Singapore; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine	Ong, SE (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.	suaneeong@u.nus.edu	McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Ong, Suan Ee/0000-0001-7365-9015; McKee, Martin/0000-0002-0121-9683; /0000-0002-2342-301X				Abuyassin B, 2016, WORLD J DIABETES, V7, P165, DOI 10.4239/wjd.v7.i8.165; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Alberti H, 2007, BMC FAMILY PRACTICE, P8; Ali SM, 2016, INT J MED INFORM, V87, P91, DOI 10.1016/j.ijmedinf.2015.12.017; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Atun R, 2012, HEALTH POLICY PLANN, V27, P4, DOI 10.1093/heapol/czs088; Babamoto KS, 2009, HEALTH EDUC BEHAV, V36, P113, DOI 10.1177/1090198108325911; Baker MK, 2011, DIABETES RES CLIN PR, V91, P1, DOI 10.1016/j.diabres.2010.06.030; Balabanova D, 2009, HEALTH POLICY PLANN, V24, P46, DOI 10.1093/heapol/czn041; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Bello Shakirat I, 2012, Nig Q J Hosp Med, V22, P245; Berdine HJ, 2012, J AM PHARM ASSOC, V52, P661, DOI 10.1331/JAPhA.2012.10206; Bhojani U, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.22258; Bowker SL, 2004, CAN MED ASSOC J, V171, P39, DOI 10.1503/cmaj.1031830; Browning C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009319; Bunting BA, 2011, AM HEALTH DRUG BENEF, V4, P343; Burge MR, 2000, DIABETES OBES METAB, V2, P351, DOI 10.1046/j.1463-1326.2000.00105.x; Chalermsri Chalobol, 2014, Journal of the Medical Association of Thailand, V97, pS197; Chao JQ, 2015, ARCH GERONTOL GERIAT, V60, P82, DOI 10.1016/j.archger.2014.10.006; Chen L, 2015, METABOLISM, V64, P338, DOI 10.1016/j.metabol.2014.10.018; Chew B H, 2013, Med J Malaysia, V68, P397; Coast-Senior EA, 1998, ANN PHARMACOTHER, V32, P636, DOI 10.1345/aph.17095; Cohen LB, 2011, DIABETES EDUCATOR, V37, P801, DOI 10.1177/0145721711423980; Coleman K, 2007, J HEALTH CARE POOR U, V18, P966; Collinsworth AW, 2013, DIABETES EDUCATOR, V39, P792, DOI 10.1177/0145721713504470; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; deSonnaville JJJ, 1997, DIABETOLOGIA, V40, P1334, DOI 10.1007/s001250050829; Drivsholm T, 2006, FAM PRACT, V23, P192, DOI 10.1093/fampra/cmi123; Edelman D, 2015, J GEN INTERN MED, V30, P626, DOI 10.1007/s11606-014-3154-9; Elliott DJ, 2013, POPUL HEALTH MANAG, V16, P99, DOI 10.1089/pop.2012.0031; Gazmararian JA, 2009, DIABETES EDUCATOR, V35, P778, DOI 10.1177/0145721709338527; Gibson TB, 2010, AM J MANAG CARE, V16, P589; Gilson L., 2012, Health policy and systems research: a methodology reader; Gilson L, 2017, INT J EQUITY HLTH, V16; Groeneveld Y, 2001, SCAND J PRIM HEALTH, V19, P25, DOI 10.1080/028134301300034585; Grogan M, 2010, DIABETES EDUCATOR, V36, P774, DOI 10.1177/0145721710374653; Gu QA, 2010, AM J MANAG CARE, V16, P911; Harden A, 2001, YOUNG PEOPLE MENTAL; Heisler M, 2012, CIRCULATION, V125, P2863, DOI 10.1161/CIRCULATIONAHA.111.089169; Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007; Hopkinson B, 2004, INT J HEALTH PLAN M, V19, P43, DOI 10.1002/hpm.745; Houweling ST, 2009, NETH J MED, V67, P279; Houweling ST, 2011, J CLIN NURS, V20, P1264, DOI 10.1111/j.1365-2702.2010.03562.x; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hueston WJ, 2010, J AM BOARD FAM MED, V23, P424, DOI 10.3122/jabfm.2010.03.100048; Hull S, 2014, BMJ QUAL SAF, V23, P171, DOI 10.1136/bmjqs-2013-002008; Hunt Jacquelyn, 2009, Manag Care, V18, P47; International Diabetes Federation, 2015, IDF DIAB ATL, V7; Jacobs M, 2012, J AM PHARM ASSOC, V52, P613, DOI 10.1331/JAPhA.2012.10183; Jeffery R, 2013, DIABETIC MED, V30, P739, DOI 10.1111/dme.12087; Jeragh-Alhaddad FB, 2015, PATIENT PREFER ADHER, V9, P1491, DOI 10.2147/PPA.S86719; Johnson JA, 2006, DIABETIC MED, V23, P1247, DOI 10.1111/j.1464-5491.2006.01973.x; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Juul L, 2012, PRIM CARE DIABETES, V6, P221, DOI 10.1016/j.pcd.2012.04.001; KAMIEN M, 1994, DIABETES RES CLIN PR, V26, P197, DOI 10.1016/0168-8227(94)90061-2; Katz I, 2009, PRIM CARE DIABETES, V3, P157, DOI 10.1016/j.pcd.2009.06.007; Kengne AP, 2009, PRIM CARE DIABETES, V3, P181, DOI 10.1016/j.pcd.2009.08.005; Kiblinger L, 2007, INSULIN, V2, P24; King AB, 2009, J AM ACAD NURSE PRAC, V21, P24, DOI 10.1111/j.1745-7599.2008.00370.x; Ko IS, 2011, PUBLIC HEALTH NURS, V28, P429, DOI 10.1111/j.1525-1446.2011.00941.x; Ko JJ, 2016, J MANAG CARE SPEC PH, V22, P32, DOI 10.18553/jmcp.2016.22.1.32; Kocarnik BM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-391; Kodner Dennis L, 2002, Int J Integr Care, V2, pe12; Kodner Dennis L, 2009, Healthc Q, V13 Spec No, P6; Krass I, 2007, DIABETIC MED, V24, P677, DOI 10.1111/j.1464-5491.2007.02143.x; Krass I, 2015, DIABETIC MED, V32, P725, DOI 10.1111/dme.12651; Lewis CP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-737; Littenberg B, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-198; Loskutova NY, 2016, J AM BOARD FAM MED, V29, P78, DOI 10.3122/jabfm.2016.01.150048; Machado M, 2007, ANN PHARMACOTHER, V41, P1569, DOI 10.1345/aph.1K151; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Manders IG, 2016, DIABETIC MED, V33, P761, DOI 10.1111/dme.12899; Salinas-Martinez AM, 2009, REV MED CHILE, V137, P1323, DOI /S0034-98872009001000007; Maschak- Carey BJ, 1999, DIS MANAGE, V2, p43 ; McDermott RA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0695-5; Mendenhall E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2615-3; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Monte SV, 2009, J AM PHARM ASSOC, V49, P200, DOI 10.1331/JAPhA.2009.08160; Mshelia D. S., 2007, SMJ Singapore Medical Journal, V48, P74; Musacchio N, 2010, GIORNALE ITALIANO DI, V30, p49 ; Ngo-Metzger Q, 2012, J GEN INTERN MED, V27, P432, DOI 10.1007/s11606-011-1910-7; Nielsen ABS, 2006, DIABETES CARE, V29, P963, DOI 10.2337/dc05-1807; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Odegard PS, 2005, ANN PHARMACOTHER, V39, P433, DOI 10.1345/aph.1E438; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Oyetayo OO, 2011, J AM PHARM ASSOC, V51, P623, DOI 10.1331/JAPhA.2011.09229; Panarotto D, 2009, ARQ BRAS ENDOCRINOL, V53; Parchman ML, 2007, DIABETES CARE, V30, P2849, DOI 10.2337/dc06-2516; Patel AA, 2006, FORMULARY, V41, P518; Pawaskar M, 2010, POPUL HEALTH MANAG, V13, P209, DOI 10.1089/pop.2009.0046; Piette JD, 2005, ARCH INTERN MED, V165, P1749, DOI 10.1001/archinte.165.15.1749; Piette JD, 2004, DIABETES CARE, V27, P384, DOI 10.2337/diacare.27.2.384; Pilleron S, 2014, DIABETES RES CLIN PR, V104, P189, DOI 10.1016/j.diabres.2014.01.026; Pinsky B, 2011, AM HLTH DRUG BENEFIT, V4; Pladevall M, 2015, DIABETES EDUCATOR, V41, P136, DOI 10.1177/0145721714561031; Pyone T, 2017, HEALTH POLICY PLANN, V32, P710, DOI 10.1093/heapol/czx007; Quinones ME, 2016, AM J MANAG CARE, V22, pE147; Rachmani R, 2005, J AM SOC NEPHROL, V16, pS22, DOI 10.1681/ASN.2004110965; Reed R L, 2001, Arch Physiol Biochem, V109, P272; Rees R, 2001, YOUNG PEOPLE PHYS AC; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rhee MK, 2005, J HEALTH CARE POOR U, V16, P734; Richardson Gail Carr, 2014, Perm J, V18, pe134, DOI 10.7812/TPP/13-108; Ridgeway NA, 1999, SOUTHERN MED J, V92, P667, DOI 10.1097/00007611-199907000-00004; Russell AW, 2013, DIABETIC MED, V30, P1112, DOI 10.1111/dme.12251; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Santschi V, 2011, ARCH INTERN MED, V171, P1441, DOI 10.1001/archinternmed.2011.399; Schiel R, 2006, EXP CLIN ENDOCR DIAB, V114, P18, DOI 10.1055/s-2005-873079; Schmittdiel JA, 2009, J WOMENS HEALTH, V18, P2065, DOI 10.1089/jwh.2009.1406; Sheikh K, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-19; Simpson SH, 2011, DIABETES CARE, V34, P20, DOI 10.2337/dc10-1294; Smith S M, 2011, BMJ, V342, pd715, DOI 10.1136/bmj.d715; Sosa-Rubi SG, 2009, B WORLD HEALTH ORGAN, V87, P512, DOI 10.2471/BLT.08.053256; Soumerai SB, 2004, ARCH INTERN MED, V164, P645, DOI 10.1001/archinte.164.6.645; Spence MM, 2014, J MANAG CARE SPEC PH, V20, P1036, DOI 10.18553/jmcp.2014.20.10.1036; Spigt M, 2009, SCAND J PRIM HEALTH, V27, P232, DOI 10.3109/02813430903226480; Tai TY, 2006, J FORMOS MED ASSOC, V105, P105, DOI 10.1016/S0929-6646(09)60331-4; Tan E, 2015, J MANAG CARE SPEC PH, V21, P1195, DOI 10.18553/jmcp.2015.21.12.1195; Taylor CT, 2003, AM J HEALTH-SYST PH, V60, P1123, DOI 10.1093/ajhp/60.11.1123; Tranchie S, 2005, KIDNEY INT, V67, pS55, DOI 10.1111/j.1523-1755.2005.09313.x; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; Vella J, 2013, J EUROMED PHARM, P21; World Health Organization, 2016, FACT SHEET DIAB; World Health Organization, 2017, HLTH SYSTEMS; World Health Organization Regional Office for Europe, 2016, INT CAR MOD OV WORK; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; Wulsin LR, 2006, MED CLIN N AM, V90, P647, DOI 10.1016/j.mcna.2006.05.005; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yuan XD, 2016, PATIENT EDUC COUNS, V99, P1382, DOI 10.1016/j.pec.2016.03.010; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Ziemer DC, 2005, DIABETES EDUCATOR, V31, P564, DOI 10.1177/0145721705279050	134	33	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195086	10.1371/journal.pone.0195086	http://dx.doi.org/10.1371/journal.pone.0195086			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596495	Green Published, Green Accepted, gold			2022-12-27	WOS:000428630000076
J	Walker, M; Schonborn, S; Greifeneder, R; Vetter, T				Walker, Mirella; Schonborn, Sandro; Greifeneder, Rainer; Vetter, Thomas			The Basel Face Database: A validated set of photographs reflecting systematic differences in Big Two and Big Five personality dimensions	PLOS ONE			English	Article							SOCIAL-PERCEPTION; 1ST IMPRESSIONS; JUDGMENTS; DECISIONS; TRUSTWORTHINESS; STEREOTYPES; COMPETENCE; WARMTH; IMAGES	Upon a first encounter, individuals spontaneously associate faces with certain personality dimensions. Such first impressions can strongly impact judgments and decisions and may prove highly consequential. Researchers investigating the impact of facial information often rely on (a) real photographs that have been selected to vary on the dimension of interest, (b) morphed photographs, or (c) computer-generated faces (avatars). All three approaches have distinct advantages. Here we present the Basel Face Database, which combines these advantages. In particular, the Basel Face Database consists of real photographs that are subtly, but systematically manipulated to show variations in the perception of the Big Two and the Big Five personality dimensions. To this end, the information specific to each psychological dimension is isolated and modeled in new photographs. Two studies serve as systematic validation of the Basel Face Database. The Basel Face Database opens a new pathway for researchers across psychological disciplines to investigate effects of perceived personality.	[Walker, Mirella; Greifeneder, Rainer] Univ Basel, Dept Psychol, Basel, Switzerland; [Schonborn, Sandro; Vetter, Thomas] Univ Basel, Dept Math & Comp Sci, Basel, Switzerland	University of Basel; University of Basel	Walker, M (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	mirella.walker@unibas.ch	Walker, Mirella/Q-4374-2019	Walker, Mirella/0000-0002-1827-0733; Greifeneder, Rainer/0000-0002-0725-5626; Schonborn, Sandro/0000-0003-4316-8519	Swiss National Science Foundation [100014_135213, PZ00P1_168070]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Swiss National Science Foundation (http://www.snf.ch) under grant no. 100014_135213 (Recipients: MW, RG, TV) and grand no. PZ00P1_168070 (Recipient: MW).; We would like to thank Konstantin Escher and Anja Schenk for their help developing the database, Matthias Keller, Michael Lambertus, and Fatima Pigat for their assistance running and analyzing the validation studies, and to Leonie Reutner for discussing the project. This research was supported by the Swiss National Science Foundation under grant no. 100014_135213 and grant no. PZ00P1_168070.	Abele AE, 2008, EUR J SOC PSYCHOL, V38, P1202, DOI 10.1002/ejsp.575; [Anonymous], 2014, R LANG ENV STAT COMP; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; Crookes K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141353; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Fincher KM, 2016, J EXP PSYCHOL GEN, V145, P131, DOI 10.1037/xge0000132; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Gebauer JE, 2012, PERS SOC PSYCHOL B, V38, P1579, DOI 10.1177/0146167212456300; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; Miller SL, 2012, PERS SOC PSYCHOL B, V38, P1358, DOI 10.1177/0146167212450516; Moore D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-182; Mulyanegara R.C., 2007, J BRAND MANAG, V16, P234; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Paysan P, 2009, AVSS: 2009 6TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P296, DOI 10.1109/AVSS.2009.58; Penton-Voak IS, 2006, SOC COGNITION, V24, P607, DOI 10.1521/soco.2006.24.5.607; Porter S, 2010, PSYCHOL CRIME LAW, V16, P477, DOI 10.1080/10683160902926141; Prinzie P, 2009, J PERS SOC PSYCHOL, V97, P351, DOI 10.1037/a0015823; Rammstedt B, 2005, DIAGNOSTICA, V51, P195, DOI 10.1026/0012-1924.51.4.195; Rauschenbach C, 2012, EDUC GERONTOL, V38, P511, DOI 10.1080/03601277.2011.567187; Re D. E., 2013, EVOL PSYCHIATR, V11, p147470491301100109; Rudert SC, J EXP SOC PSYCHOL; RUNGE TE, 1981, J CROSS CULT PSYCHOL, V12, P142, DOI 10.1177/0022022181122002; Sutherland CAM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01616; Todorov A, 2016, 25 MAXIMALLY DISTINC; Todorov A, 2013, EMOTION, V13, P724, DOI 10.1037/a0032335; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Vetter T, 2016, MORPHFACE; Walker M, 2016, J PERS SOC PSYCHOL, V110, P609, DOI 10.1037/pspp0000064; Walker M, 2011, SOC PSYCHOL PERS SCI, V2, P609, DOI 10.1177/1948550611402519; Walker M, 2009, J VISION, V9, DOI 10.1167/9.11.12; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Westfall J., 2015, PANGEA POWER ANAL GE, DOI [DOI 10.1002/CNM, 10.1002/cnm]; Wiggins J.S., 1991, THINKING CLEARLY PSY, P89; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Zebrowitz L.A., 2011, OXFORD HDB FACE PERC, P31, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0003; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x	45	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193190	10.1371/journal.pone.0193190	http://dx.doi.org/10.1371/journal.pone.0193190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590124	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100016
J	Chae, JJ; Shin, YJ; Lee, JD; Seo, K; Elisseeff, JH				Chae, J. Jeremy; Shin, Yu Jung; Lee, Justin D.; Seo, Kangmoon; Elisseeff, Jennifer H.			Nictitating membrane fixation improves stability of the contact lens on the animal corneal surface	PLOS ONE			English	Article							EYELID CLOSURE; DOGS; PLACEMENT; REMOVAL; HYPOXIA; GLAND; CELLS; WEAR	We evaluated the feasibility and safety of nictitating membrane fixation to address reduced contact lens stability by the nictitating membrane in a rabbit model. Under general anesthesia, twelve animals received a horizontal mattress suture between the nictitating membrane and the upper eyelid of one eye. To assess the effects of this technique and secondary side effects, contact lens stability test, Schirmer tear test, tear break-up time measurement, eye tissue pathology and morphology were evaluated. Contact lens stability was increased after nictitating membrane fixation. The percentage of contact lens retention in the nictitating membrane fixed rabbit after 4 hours was 90% whereas that in the untreated rabbit was 42.5%. In addition, there were no significant differences in tear quantity and quality between the fixed and untreated eyes. Furthermore, no remarkable pathological lesions were found in gross observation during the 1-month time period or the following pathological examination. In this study, we demonstrated that nictitating membrane fixation increases contact lens stability without specific side effects using a rabbit model. This minimally invasive procedure could be useful when designing animal models for testing new contact lenses and has potential to apply to other biomaterial research on the ocular surface.	[Chae, J. Jeremy; Shin, Yu Jung; Lee, Justin D.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA; [Chae, J. Jeremy; Shin, Yu Jung; Lee, Justin D.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Chae, J. Jeremy; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21218 USA; [Seo, Kangmoon] Seoul Natl Univ, Coll Vet Med, Dept Vet Clin, Seoul, South Korea; [Chae, J. Jeremy] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Lee, Justin D.] Univ Calif Los Angeles, David Geffen Sch Med, Med Scientist Training Program, Los Angeles, CA 90095 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Seoul National University (SNU); University System of Georgia; Georgia Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA.; Elisseeff, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.; Elisseeff, JH (corresponding author), Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21218 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010	Elisseeff, Jennifer/0000-0002-5066-1996	Congressionally Directed Medical Research Program under the U.S. Army Medical Research and Materiel Command at Ft. Detrick, MD [W81XWH-09-2-0173]; Jules Stein Professorship from Research to Prevent Blindness; Morton Goldberg Chair; National Eye Institute - the Animal Module of the Wilmer Core Grant [EY001765]	Congressionally Directed Medical Research Program under the U.S. Army Medical Research and Materiel Command at Ft. Detrick, MD; Jules Stein Professorship from Research to Prevent Blindness; Morton Goldberg Chair; National Eye Institute - the Animal Module of the Wilmer Core Grant	This study was funded by the Congressionally Directed Medical Research Program under the U.S. Army Medical Research and Materiel Command at Ft. Detrick, MD (Contract No W81XWH-09-2-0173, Program Manager Dr. Dwayne Taliaferro) (http://cdmrp.army.mil/) to JHE, the Jules Stein Professorship from Research to Prevent Blindness (https://www.rpbusa.org/) to JHE, the Morton Goldberg Chair to JHE, and the National Eye Institute - the Animal Module of the Wilmer Core Grant, EY001765 (https://nei.nih.gov/ ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Carvalho IM, 2015, J CONTROL RELEASE, V202, P76, DOI 10.1016/j.jconrel.2015.01.023; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; EFRON N, 1979, INVEST OPHTH VIS SCI, V18, P93; Grinninger P, 2015, J SMALL ANIM PRACT, V56, P446, DOI 10.1111/jsap.12360; HELPER LC, 1974, J AM VET MED ASSOC, V165, P172; Hendrix DVH, 2007, VET OPHTHALMOL CANIN, P675; Ioannidis JPA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004631; Ladage PM, 2003, INVEST OPHTH VIS SCI, V44, P1843, DOI 10.1167/iovs.02-0897; Li Ling, 2002, CLAO Journal, V28, P48; Maitchouk DY, 2000, ARCH OPHTHALMOL-CHIC, V118, P246; McCanna DJ, 2008, EYE CONTACT LENS, V34, P160, DOI 10.1097/ICL.0b013e31815788d7; MCLAUGHLIN SA, 1988, J AM VET MED ASSOC, V193, P820; Park SA, 2009, J AM ANIM HOSP ASSOC, V45, P164, DOI 10.5326/0450164; Robertson DM, 2012, EYE CONTACT LENS, V38, P214, DOI 10.1097/ICL.0b013e3182482948; Sapienza JS, 2014, VET OPHTHALMOL, V17, P81, DOI 10.1111/vop.12073; Umeda Y, 2010, EXP EYE RES, V91, P721, DOI 10.1016/j.exer.2010.08.020; Yamamoto K, 2002, CORNEA, V21, P85, DOI 10.1097/00003226-200201000-00018	18	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194795	10.1371/journal.pone.0194795	http://dx.doi.org/10.1371/journal.pone.0194795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584737	gold, Green Published, Green Submitted			2022-12-27	WOS:000428373000036
J	Schay, G; Kaposi, AD; Smeller, L; Szigeti, K; Fidy, J; Herenyi, L				Schay, Gusztav; Kaposi, Andras D.; Smeller, Laszlo; Szigeti, Krisztian; Fidy, Judit; Herenyi, Levente			Dissimilar flexibility of alpha and beta subunits of human adult hemoglobin influences the protein dynamics and its alteration induced by allosteric effectors	PLOS ONE			English	Article							CYTOCHROME-C; R-STATE; HETEROTROPIC EFFECTORS; ANGSTROM RESOLUTION; T-STATE; PRESSURE; SIMULATIONS; SPECTRA; MODEL; COMPRESSIBILITY	The general question by what mechanism an "effector" molecule and the hemes of hemoglobin interact over widely separated intramolecular distances to change the oxygen affinity has been extensively investigated, and still has remained of central interest. In the present work we were interested in clarifying the general role of the protein matrix and its dynamics in the regulation of human adult hemoglobin (HbA). We used a spectroscopy approach that yields the compressibility (K) of the protein matrix around the hemes of the subunits in HbA and studied how the binding of heterotropic allosteric effectors modify this parameter. K is directly related to the variance of volume fluctuation, therefore it characterizes the molecular dynamics of the protein structure. For the experiments the heme groups either in the alpha or in the beta subunits of HbA were replaced by fluorescent Zn-protoporphyrinlX, and series of fluorescence line narrowed spectra were measured at varied pressures. The evaluation of the spectra yielded the compressibility that showed significant dynamic asymmetry between the subunits: K of the alpha subunit was 0.17 +/- 0.05/GPa, while for the beta subunit it was much higher, 0.36 +/- 0.07/GPa. The heterotropic effectors, chloride ions, inositol hexaphosphate and bezafibrate did not cause significant changes in roof the a subunits, while in the beta subunits the effectors lead to a significant reduction down to 0.15 +/- 0.04/GPa. We relate our results to structural data, to results of recent functional studies and to those of molecular dynamics simulations, and find good agreements. The observed asymmetry in the flexibility suggests a distinct role of the subunits in the regulation of Hb that results in the observed changes of the oxygen binding capability.	[Schay, Gusztav; Kaposi, Andras D.; Smeller, Laszlo; Szigeti, Krisztian; Fidy, Judit; Herenyi, Levente] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary	Semmelweis University	Herenyi, L (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary.	herenyi.levente@med.semmelweis-univ.hu	Kaposi, Andras/P-8355-2019	Kaposi, Andras/0000-0002-0913-3622	Semmelweis Egyetem [VKSZ_14-1-2015-0052]	Semmelweis Egyetem	This work was supported by VKSZ_14-1-2015-0052, Semmelweis Egyetem, http://nkfih.gov.hu/palyazatok/ktia/tamogatott-projektek/2015/vksz-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers GK, 2006, J BIOL CHEM, V281, P11441, DOI 10.1074/jbc.R500019200; ANGIOLILLO PJ, 1982, PHOTOCHEM PHOTOBIOL, V36, P133, DOI 10.1111/j.1751-1097.1982.tb04354.x; AVARMAA RA, 1985, SPECTROCHIM ACTA A, V41, P1365, DOI 10.1016/0584-8539(85)80189-6; Changeux JP, 2011, PROTEIN SCI, V20, P1119, DOI 10.1002/pro.658; Chao HL, 2014, SCI WORLD J, DOI 10.1155/2014/535308; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; FIDY J, 1992, BIOPHYS J, V63, P1605, DOI 10.1016/S0006-3495(92)81749-6; FORMAN RA, 1972, SCIENCE, V176, P284, DOI 10.1126/science.176.4032.284; FRIEDRICH J, 1994, P NATL ACAD SCI USA, V91, P1029, DOI 10.1073/pnas.91.3.1029; GEKKO K, 1986, BIOCHEMISTRY-US, V25, P6563, DOI 10.1021/bi00369a034; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Herenyi L, 1998, J PHYS CHEM B, V102, P5932, DOI 10.1021/jp981176e; Hub JS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000774; Imai K., 1982, ALLOSTERIC EFFECTS H; Jones EM, 2014, J AM CHEM SOC, V136, P10325, DOI 10.1021/ja503328a; Kharakoz DP, 2000, BIOPHYS J, V79, P511, DOI 10.1016/S0006-3495(00)76313-2; KOLOCZEK H, 1987, J CHEM PHYS, V87, P4388, DOI 10.1063/1.452899; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kovesi I, 2006, BBA-PROTEINS PROTEOM, V1764, P516, DOI 10.1016/j.bbapap.2005.12.002; Laberge M, 2005, FEBS LETT, V579, P627, DOI 10.1016/j.febslet.2004.12.033; LAIRD BB, 1989, J CHEM PHYS, V90, P3274, DOI 10.1063/1.455881; Landau L.D., 1980, COURSE THEORETICAL P, V5; Lesch H, 2004, BIOPHYS J, V86, P467, DOI 10.1016/S0006-3495(04)74124-7; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; Marechal JD, 2006, J COMPUT CHEM, V27, P1446, DOI 10.1002/jcc.20427; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mouawad L, 2005, BBA-GEN SUBJECTS, V1724, P385, DOI 10.1016/j.bbagen.2005.05.014; Mouawad L, 2002, BIOPHYS J, V82, P3224, DOI 10.1016/S0006-3495(02)75665-8; Nagatomo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135080; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Personov R. I., 1983, SPECTROSCOPY EXCITAT; PERSONOV RI, 1992, J PHOTOCH PHOTOBIO A, V62, P321, DOI 10.1016/1010-6030(92)85062-Y; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1994, J MOL BIOL, V239, P555, DOI 10.1006/jmbi.1994.1394; POYART C, 1994, METHOD ENZYMOL, V232, P496; Ribeiro AAST, 2016, CHEM REV, V116, P6488, DOI 10.1021/acs.chemrev.5b00543; RICHARD V, 1993, J MOL BIOL, V233, P270, DOI 10.1006/jmbi.1993.1505; Ronda L, 2013, BBA-PROTEINS PROTEOM, V1834, P1860, DOI 10.1016/j.bbapap.2013.03.013; Safo MK, 2011, BBA-PROTEINS PROTEOM, V1814, P797, DOI 10.1016/j.bbapap.2011.02.013; Scharnagl C, 2005, BIOPHYS J, V89, P64, DOI 10.1529/biophysj.104.057265; Schay G, 2006, J BIOL CHEM, V281, P25972, DOI 10.1074/jbc.M604216200; Shibayama N, 2014, J AM CHEM SOC, V136, P5097, DOI 10.1021/ja500380e; Smeller L, 2002, BIOPHYS J, V82, P426, DOI 10.1016/S0006-3495(02)75407-6; Sun DZP, 1997, BIOCHEMISTRY-US, V36, P6663, DOI 10.1021/bi963121d; Takayanagi M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04601; Tsuneshige A, 2002, BIOPHYS CHEM, V98, P49, DOI 10.1016/S0301-4622(02)00084-4; Vesper MD, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003232; Viappiani C, 2014, P NATL ACAD SCI USA, V111, P12758, DOI 10.1073/pnas.1413566111; Yonetani T, 2002, J BIOL CHEM, V277, P34508, DOI 10.1074/jbc.M203135200; Yonetani T, 2013, BBA-PROTEINS PROTEOM, V1834, P1873, DOI 10.1016/j.bbapap.2013.04.026; ZOLLFRANK J, 1991, J CHEM PHYS, V94, P8600, DOI 10.1063/1.460042; ZOLLFRANK J, 1992, BIOPHYS J, V61, P716, DOI 10.1016/S0006-3495(92)81876-3	54	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194994	10.1371/journal.pone.0194994	http://dx.doi.org/10.1371/journal.pone.0194994			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584765	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000053
J	Shellnutt, JG				Shellnutt, J. Gregory			Derivation of intermediate to silicic magma from the basalt analyzed at the Vega 2 landing site, Venus	PLOS ONE			English	Article							EASTERN APHRODITE TERRA; LARGE IGNEOUS PROVINCE; THERMAL EVOLUTION; CONTINENTAL-CRUST; VOLCANIC-ROCKS; MELT GENERATION; ALPHA REGIO; SW CHINA; PERALKALINE; ERUPTION	Geochemical modeling using the basalt composition analyzed at the Vega 2 landing site indicates that intermediate to silicic liquids can be generated by fractional crystallization and equilibrium partial melting. Fractional crystallization modeling using variable pressures (0.01 GPa to 0.5 GPa) and relative oxidation states (FMQ 0 and FMQ-1) of either a wet (H2O = 0.5 wt%) or dry (H2O = 0 wt%) parental magma can yield silicic (SiO2 > 60 wt%) compositions that are similar to terrestrial ferroan rhyolite. Hydrous (H2O = 0.5 wt%) partial melting can yield intermediate (trachyandesite to andesite) to silicic (trachydacite) compositions at all pressures but requires relatively high temperatures (>= 950 degrees C) to generate the initial melt at intermediate to low pressure whereas at high pressure (0.5 GPa) the first melts will be generated at much lower temperatures (< 800 degrees C). Anhydrous partial melt modeling yielded mafic (basaltic andesite) and alkaline compositions (trachybasalt) but the temperature required to produce the first liquid is very high (>= 1130 degrees C). Consequently, anhydrous partial melting is an unlikely process to generate derivative liquids. The modeling results indicate that, under certain conditions, the Vega 2 composition can generate silicic liquids that produce granitic and rhyolitic rocks. The implication is that silicic igneous rocks may form a small but important component of the northeast Aphrodite Terra.	[Shellnutt, J. Gregory] Natl Taiwan Normal Univ, Dept Earth Sci, Taipei, Taiwan	National Taiwan Normal University	Shellnutt, JG (corresponding author), Natl Taiwan Normal Univ, Dept Earth Sci, Taipei, Taiwan.	jgshelln@ntnu.edu.tw	Shellnutt, Greg/H-7554-2019	Shellnutt, Greg/0000-0003-2289-2903	Ministry of Science and Technology of Taiwan [106-2116-M-003-007]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (Grant No. 106-2116-M-003-007).	Abdrakhimov AM, 2002, SOLAR SYST RES+, V36, P136, DOI 10.1023/A:1015222316518; Airey MW, 2015, PLANET SPACE SCI, V113, P33, DOI 10.1016/j.pss.2015.01.009; Annen C, 2002, EARTH PLANET SC LETT, V203, P937, DOI 10.1016/S0012-821X(02)00929-9; Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; Annen C, 2015, LITHOS, V230, P206, DOI 10.1016/j.lithos.2015.05.008; [Anonymous], 1977, P 8 LUN SCI C HOUS T; Ansan V, 1996, PLANET SPACE SCI, V44, P833, DOI 10.1016/0032-0633(96)00011-6; Armann M, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004231; ATHERTON MP, 1993, J GEOL SOC LONDON, V150, P1009, DOI 10.1144/gsjgs.150.6.1009; Bachmann O, 2008, ELEMENTS, V4, P17, DOI 10.2113/GSELEMENTS.4.1.17; Bachmann O, 2016, AM MINERAL, V101, P2377, DOI 10.2138/am-2016-5675; Bachmann O, 2008, J PETROL, V49, P2277, DOI 10.1093/petrology/egn068; BAKER VR, 1992, J GEOPHYS RES-PLANET, V97, P13421, DOI 10.1029/92JE00927; BALLHAUS C, 1993, CONTRIB MINERAL PETR, V114, P331, DOI 10.1007/BF01046536; Basaltic Volcanism Study Project, 1981, BASALTIC VOLCANISM T; Basilevsky AT, 2012, ICARUS, V217, P434, DOI 10.1016/j.icarus.2011.11.003; BASILEVSKY AT, 1988, ANNU REV EARTH PL SC, V16, P295; Befus KS, 2014, B VOLCANOL, V76, DOI 10.1007/s00445-014-0808-8; BERGANTZ GW, 1989, SCIENCE, V245, P1093, DOI 10.1126/science.245.4922.1093; BINDSCHADLER DL, 1992, J GEOPHYS RES-PLANET, V97, P13563, DOI 10.1029/92JE01332; BINDSCHADLER DL, 1991, J GEOPHYS RES-SOLID, V96, P5889, DOI 10.1029/90JB02742; Bohrson WA, 1997, J PETROL, V38, P1137, DOI 10.1093/petrology/38.9.1137; Bonin B, 2004, LITHOS, V78, P1, DOI 10.1016/j.lithos.2004.04.042; Bonin B, 2012, LITHOS, V153, P3, DOI 10.1016/j.lithos.2012.04.007; Brooks CK., 1976, B GEOL SOC DENMARK, V25, P117; Brown CD, 1999, ICARUS, V139, P40, DOI 10.1006/icar.1999.6083; Budd DA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40624; BUDDINGTON AF, 1964, J PETROL, V5, P310, DOI 10.1093/petrology/5.2.310; CAMPBELL BA, 1992, J GEOPHYS RES-PLANET, V97, P16293, DOI 10.1029/92JE01558; CAMPBELL IH, 1983, GEOPHYS RES LETT, V10, P1061, DOI 10.1029/GL010i011p01061; Cashman KV, 2014, J VOLCANOL GEOTH RES, V288, P28, DOI 10.1016/j.jvolgeores.2014.09.007; Cawood PA, 2013, GEOL SOC AM BULL, V125, P14, DOI 10.1130/B30722.1; Charreteur G, 2013, CONTRIB MINERAL PETR, V166, P471, DOI 10.1007/s00410-013-0886-1; Chassefiere E, 2012, PLANET SPACE SCI, V63-64, P15, DOI 10.1016/j.pss.2011.04.007; Christiansen EH, 2008, B VOLCANOL, V70, P251, DOI 10.1007/s00445-007-0138-1; CRUMPLER LS, 1990, EARTH MOON PLANETS, V50-1, P343, DOI 10.1007/BF00142399; DONAHUE TM, 1982, SCIENCE, V216, P630, DOI 10.1126/science.216.4546.630; Dostal J, 2017, LITHOS, V292, P146, DOI 10.1016/j.lithos.2017.09.005; Ducea MN, 2017, GEOLOGY, V45, P235, DOI 10.1130/G38726.1; Ducea MN, 2010, TECTONICS, V29, DOI 10.1029/2009TC002615; EICHELBERGER JC, 1986, NATURE, V323, P598, DOI 10.1038/323598a0; Ernst RE., 2014, LARGE IGNEOUS PROVIN; Fegley Jr B, 2014, TREATISE GEOCHEMISTR, V2, P127, DOI DOI 10.1016/13978-0-08-095975-7.00122-4; Filiberto J, 2014, ICARUS, V231, P131, DOI 10.1016/j.icarus.2013.12.003; FINK JH, 1993, GEOPHYS RES LETT, V20, P261, DOI 10.1029/92GL03010; Frost CD, 2011, J PETROL, V52, P39, DOI 10.1093/petrology/egq070; Gale A, 2013, GEOCHEM GEOPHY GEOSY, P14; Gerya TV, 2007, PHYS EARTH PLANET IN, V160, P124, DOI 10.1016/j.pepi.2006.10.004; Ghail RC, 2015, GEOL SOC SPEC PUBL, V401, P97, DOI 10.1144/SP401.1; Gillmann C, 2014, J GEOPHYS RES-PLANET, V119, P1189, DOI 10.1002/2013JE004505; Gilmore MS, 2015, ICARUS, V254, P350, DOI 10.1016/j.icarus.2015.04.008; Gilmore MS, 2000, METEORIT PLANET SCI, V35, P667, DOI 10.1111/j.1945-5100.2000.tb01451.x; GRINSPOON DH, 1993, NATURE, V363, P428, DOI 10.1038/363428a0; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; Hansen VL, 2010, GEOLOGY, V38, P311, DOI 10.1130/G30587.1; Hansen VL, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002714; Hansen VL, 2007, DEV PREC G, V15, P987, DOI 10.1016/S0166-2635(07)15081-7; HANSEN VL, 1993, SCIENCE, V260, P526, DOI 10.1126/science.260.5107.526; Hansen VL, 1999, GEOLOGY, V27, P1071, DOI 10.1130/0091-7613(1999)027<1071:TTACPV>2.3.CO;2; Harris LB, 2014, MOD APPR SOL EARTH S, V7, P215, DOI 10.1007/978-94-007-7615-9_9; Hashimoto GL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003134; Hauri E, 2002, CHEM GEOL, V183, P115, DOI 10.1016/S0009-2541(01)00374-6; Hawkesworth CJ, 2010, J GEOL SOC LONDON, V167, P229, DOI 10.1144/0016-76492009-072; HEAD JW, 1992, J GEOPHYS RES-PLANET, V97, P13153, DOI 10.1029/92JE01273; Herzberg C, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002057; Herzberg C, 2015, GEOCHEM GEOPHY GEOSY, V16, P536; HESS PC, 1990, EARTH MOON PLANETS, V50-1, P57, DOI 10.1007/BF00142389; Houghton BF, 2010, J VOLCANOL GEOTH RES, V195, P31, DOI 10.1016/j.jvolgeores.2010.06.002; Huang HH, 2015, SCIENCE, V348, P773, DOI 10.1126/science.aaa5648; HUPPERT HE, 1988, J PETROL, V29, P599, DOI 10.1093/petrology/29.3.599; Jaxybulatov K, 2014, SCIENCE, V346, P617, DOI 10.1126/science.1258582; KARGEL JS, 1993, ICARUS, V103, P253, DOI 10.1006/icar.1993.1069; LEBAS MJ, 1986, J PETROL, V27, P745, DOI 10.1093/petrology/27.3.745; Lee CTA, 2010, NATURE, V463, P930, DOI 10.1038/nature08824; Lee CTA, 2009, EARTH PLANET SC LETT, V279, P20, DOI 10.1016/j.epsl.2008.12.020; Marshall AS, 1998, MINERAL MAG, V62, P477, DOI 10.1180/002646198547855; MCKENZIE D, 1992, J GEOPHYS RES-PLANET, V97, P13533, DOI 10.1029/92JE01350; Nathues A, 2015, NATURE, V528, P237, DOI 10.1038/nature15754; NIKOLAYEVA OV, 1990, EARTH MOON PLANETS, V50-1, P329, DOI 10.1007/BF00142398; Nimmo F, 1998, ANNU REV EARTH PL SC, V26, P23, DOI 10.1146/annurev.earth.26.1.23; O'Rourke JG, 2015, ICARUS, V260, P128, DOI 10.1016/j.icarus.2015.07.009; Owen-Smith TM, 2013, LITHOS, V182, P33, DOI 10.1016/j.lithos2013.09.011; PAVRI B, 1992, J GEOPHYS RES-PLANET, V97, P13445, DOI 10.1029/92JE01162; Petford N, 2000, T ROY SOC EDIN-EARTH, V91, P87, DOI 10.1017/S0263593300007318; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Sandor BJ, 2005, ICARUS, V177, P129, DOI 10.1016/j.icarus.2005.03.020; SAUNDERS RS, 1991, SCIENCE, V252, P249, DOI 10.1126/science.252.5003.249; Scaillet B, 1998, J GEOPHYS RES-SOL EA, V103, P27257, DOI 10.1029/98JB02469; Shellnutt JG, 2010, EARTH PLANET SC LETT, V289, P509, DOI 10.1016/j.epsl.2009.11.044; Shellnutt JG, 2007, CHEM GEOL, V243, P286, DOI 10.1016/j.chemgeo.2007.05.022; Shellnutt JG, 2016, ICARUS, V277, P98, DOI 10.1016/j.icarus.2016.05.014; Shellnutt JG, 2013, J GEOPHYS RES-PLANET, V118, P1350, DOI 10.1002/jgre.20094; Shellnutt JG, 2011, AM J SCI, V311, P773, DOI 10.2475/09.2011.02; Shellnutt JG, 2011, EUR J MINERAL, V23, P45, DOI 10.1127/0935-1221/2010/0022-2073; Sliwinski JT, 2015, J PETROL, V56, P2173, DOI 10.1093/petrology/egv068; Smrekar SE, 2007, GEOPHYS MONOGR SER, V176, P45, DOI 10.1029/176GM05; SPULBER SD, 1983, J PETROL, V24, P1; Stofan ER, 2016, ICARUS, V271, P375, DOI 10.1016/j.icarus.2016.01.034; SURKOV YA, 1986, J GEOPHYS RES-SOLID, V91, pE215, DOI 10.1029/JB091iB13p0E215; Surkov Yu. A., 1984, Journal of Geophysical Research, V89, P393, DOI 10.1029/JB089iS02p0B393; Takeuchi S, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008243; Treiman AH, 2007, GEOPHYS MONOGR SER, V176, P7, DOI 10.1029/176GM03; Van der Pluijm B.A., 2004, EARTH STRUCTURE; Vaniman DT, 2004, NATURE, V431, P663, DOI 10.1038/nature02973; Walker G.P.L, 1965, B VOLCANOL, V29, P375, DOI DOI 10.1007/BF02597164; Wanless VD, 2010, J PETROL, V51, P2377, DOI 10.1093/petrology/egq056; Way MJ, 2016, GEOPHYS RES LETT, V43, P8376, DOI 10.1002/2016GL069790; Weller M., 2015, LUNAR PLANET SCI C A, V46, P2749; Wiebe RA, 1996, T ROY SOC EDIN-EARTH, V87, P233, DOI 10.1017/S0263593300006647; Williams-Jones G, 1998, J GEOPHYS RES-PLANET, V103, P8545, DOI 10.1029/98JE00243; WILSON M, 1993, J GEOL SOC LONDON, V150, P611, DOI 10.1144/gsjgs.150.4.0611	112	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194155	10.1371/journal.pone.0194155	http://dx.doi.org/10.1371/journal.pone.0194155			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584745	gold, Green Published, Green Submitted			2022-12-27	WOS:000428373000017
J	Tiemensma, J; Depaoli, S; Winter, SD; Felt, JM; Rus, HM; Arroyo, AC				Tiemensma, Jitske; Depaoli, Sarah; Winter, Sonja D.; Felt, John M.; Rus, Holly M.; Arroyo, Amber C.			The performance of the IES-R for Latinos and non-Latinos: Assessing measurement invariance	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EMOTION REGULATION DIFFICULTIES; EVENT SCALE; PSYCHOMETRIC PROPERTIES; TRAUMATIC EVENTS; NONCLINICAL SAMPLE; IMPACT; SYMPTOMS; PREVALENCE; PTSD	Violent acts on university campuses are becoming more frequent. Enrollment rates of Latinos at universities is increasing. Research has indicated that youths are more susceptible to trauma, particularly Latinos. Thus, it is imperative to evaluate the validity of commonly used posttraumatic stress measures among Latino college students. The Impact of Event Scale Revised (IES-R) is one of the most commonly used metrics of posttraumatic stress disorder symptomatology. However, it is largely unknown if the IES-R is measuring the same construct across different sub-samples (e.g. Latino versus non-Latino). The current study aimed to assess measurement invariance for the IES-R between Latino and non-Latino participants. A total of 545 participants completed the IES-R. One- and three-factor scoring solutions were compared using confirmatory factor analyses. Measurement invariance was then evaluated by estimating several multiple-group confirmatory factor analytic models. Four models with an increasing degree of invariance across groups were compared. A significant chi(2) difference test was used to indicate a significant change in model fit between nested models within the measurement invariance testing process. The three-factor scoring solution could not be used for the measurement invariance process because the subscale correlations were too high for estimation (rs 0.92-1.00). Therefore, the one-factor model was used for the invariance testing process. Invariance was met for each level of invariance: configural, metric, scalar, and strict. All measurement invariance testing results indicated that the one-factor solution for the IES-R was equivalent for the Latino and non-Latino participants.	[Tiemensma, Jitske; Depaoli, Sarah; Winter, Sonja D.; Felt, John M.; Rus, Holly M.; Arroyo, Amber C.] Univ Calif Merced, Psychol Sci, Merced, CA 95340 USA	University of California System; University of California Merced	Depaoli, S (corresponding author), Univ Calif Merced, Psychol Sci, Merced, CA 95340 USA.	sdepaoli@ucmerced.edu	Winter, Sonja D/H-3292-2017; Felt, John M/B-6286-2015	Winter, Sonja D/0000-0002-2203-002X; Felt, John M/0000-0002-7334-6489; Depaoli, Sarah/0000-0002-1277-0462				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armour C, 2016, CLIN PSYCHOL REV, V44, P60, DOI 10.1016/j.cpr.2015.12.003; Arnberg FK, 2014, J ANXIETY DISORD, V28, P402, DOI 10.1016/j.janxdis.2014.02.005; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bardeen JR, 2013, J ANXIETY DISORD, V27, P188, DOI 10.1016/j.janxdis.2013.01.003; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Boals A, 2015, J SOC CLIN PSYCHOL, V34, P476, DOI 10.1521/jscp.2015.34.6.476; Callahan K. L., 2005, STRESS TRAUMA CRISIS, V8, P45, DOI DOI 10.1080/15434610590913621; Casas JM, COUNSELING CULTURES; Cassa C.A., 2013, PLOS CURR-TREE LIFE, P5, DOI [10.1371/currents.dis.ad70cd1c8bc585e9470046cde334ee4b, DOI 10.1371/CURRENTS.DIS.AD70CD1C8BC585E9470046CDE334EE4B, DOI 10.1371/CURRENTS.DIS.AD70CD1C8BC585-9470046CDE334EE4B]; Centers for Disease Control and Prevention, 2012, CS231924 CDCP OFF AS; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Contractor AA, 2015, PSYCHOL TRAUMA-US, V7, P456, DOI 10.1037/tra0000068; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Ehring T, 2010, BEHAV THER, V41, P587, DOI 10.1016/j.beth.2010.04.004; Elhai JD, 2011, J ANXIETY DISORD, V25, P849, DOI 10.1016/j.janxdis.2011.04.007; ESCOBAR JI, 1983, J NERV MENT DIS, V171, P585, DOI 10.1097/00005053-198310000-00001; Falicov C.J., 2014, LATINO FAMILIES THER; Federal Bureau of Investigation, 2014, STUDY ACT SHOOT INC; Frazier P, 2009, J COUNS PSYCHOL, V56, P450, DOI 10.1037/a0016412; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gill PS, 2013, BRIT J GEN PRACT, V63, P342, DOI 10.3399/bjgp13X668456; Green BL, 2000, J TRAUMA STRESS, V13, P271, DOI 10.1023/A:1007758711939; Grey H., 2015, CULTURAL CONSIDERATI; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hoftede G., 2010, CULTURES ORG SOFTWAR; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hoyt T, 2010, PSYCHOL TRAUMA-US, V2, P19, DOI 10.1037/a0018745; Hughes M, 2011, PSYCHOL TRAUMA-US, V3, P403, DOI 10.1037/a0024565; Johannesson KB, 2015, J ANXIETY DISORD, V36, P15, DOI 10.1016/j.janxdis.2015.07.007; Jones NM, 2016, PSYCHOL METHODS, V21, P526, DOI 10.1037/met0000099; Kawamura N, 2001, AM J PSYCHIAT, V158, P484, DOI 10.1176/appi.ajp.158.3.484; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022; King DW, 2009, PSYCHOL TRAUMA-US, V1, P173, DOI 10.1037/a0016990; Larsson G, 2000, J TRAUMA STRESS, V13, P193, DOI 10.1023/A:1007798326052; Lauterbach D, 2001, J TRAUMA STRESS, V14, P29; LaVeist TA, 2000, MINORITY HEALTH IN AMERICA, P194; Leland D., 2017, DACA OUR UNDOCUMENTE; Littleton H, 2011, ANXIETY STRESS COPIN, V24, P273, DOI 10.1080/10615806.2010.500722; Ludascher P, 2015, J PSYCHOPHARMACOL, V29, P1077, DOI 10.1177/0269881115592339; McDonald P, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21426; Meeske KA, 2013, PEDIATR BLOOD CANCER, V60, P1470, DOI 10.1002/pbc.24527; Mercer KB, 2012, ARCH GEN PSYCHIAT, V69, P89, DOI 10.1001/archgenpsychiatry.2011.109; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Mithoefer MC, 2013, J PSYCHOPHARMACOL, V27, P28, DOI 10.1177/0269881112456611; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; NCES, 2021, STATS TRENDS ED RAC; Pole N, 2008, CLIN PSYCHOL-SCI PR, V15, P35, DOI 10.1111/j.1468-2850.2008.00109.x; Pole Nnamdi, 2005, Cultur Divers Ethnic Minor Psychol, V11, P144, DOI 10.1037/1099-9809.11.2.144; Ponterotto J. G., 2009, HDB MULTICULTURAL CO; Ramirez AS, 2014, J CANCER EDUC, V29, P50, DOI 10.1007/s13187-013-0541-6; Rash CJ, 2008, ADDICT BEHAV, V33, P1039, DOI 10.1016/j.addbeh.2008.04.006; Revicki, 2015, HDB ITEM RESPONSE TH, P183; Sheikh A, 2004, BMJ-BRIT MED J, V329, P87, DOI 10.1136/bmj.38061.593935.F7; Shevlin M, 2000, PSYCHOL ASSESSMENT, V12, P414, DOI 10.1037/1040-3590.12.4.414; Simon T, 2015, INT J INFORM MANAGE, V35, P609, DOI 10.1016/j.ijinfomgt.2015.07.001; Smyth JM, 2008, J AM COLL HEALTH, V57, P69, DOI 10.3200/JACH.57.1.69-76; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Stucky BD, 2014, J SUBST ABUSE TREAT, V46, P516, DOI 10.1016/j.jsat.2013.12.005; Suomalainen L, 2011, EUR PSYCHIAT, V26, P490, DOI 10.1016/j.eurpsy.2010.07.007; Sveen J, 2016, PERS INDIV DIFFER, V97, P134, DOI 10.1016/j.paid.2016.03.046; Tang CS, 2007, INT CULTURAL PSYCHOL; Thatcher DL, 2005, J ANXIETY DISORD, V19, P904, DOI 10.1016/j.janxdis.2004.11.004; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117259; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Turunen T, 2014, EUR J PSYCHOTRAUMATO, V5, P1047; University of California Merced, 2017, FAST FACTS 2017 18; US Department of Health and Human Services, 2001, MENT HLTH CULT RAC E; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Vicary AM, 2010, PERS SOC PSYCHOL B, V36, P1555, DOI 10.1177/0146167210384880; VRANA S, 1994, J TRAUMA STRESS, V7, P289, DOI 10.1002/jts.2490070209; Wang L, 2011, J ANXIETY DISORD, V25, P369, DOI 10.1016/j.janxdis.2010.10.011; Weathers F, 1993, 1993 ANN M INT SOC T; Weiss D., 2004, ASSESSING PSYCHOL TR, P168, DOI DOI 10.1007/978-0-387-70990-1_10; Weiss DS, 2007, CROSS CULTURAL ASSES, P219, DOI DOI 10.1007/978-0-387-70990-1_10; Weiss DS, ASSESSING PSYCHOL TR	79	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195229	10.1371/journal.pone.0195229	http://dx.doi.org/10.1371/journal.pone.0195229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614117	gold, Green Published, Green Submitted			2022-12-27	WOS:000429081600038
J	Benichou, T; Pereira, B; Mermillod, M; Tauveron, I; Pfabigan, D; Maqdasy, S; Dutheil, F				Benichou, Thomas; Pereira, Bruno; Mermillod, Martial; Tauveron, Igor; Pfabigan, Daniela; Maqdasy, Salwan; Dutheil, Frederic			Heart rate variability in type 2 diabetes mellitus: A systematic review and meta-analysis	PLOS ONE			English	Review							CARDIOVASCULAR AUTONOMIC FUNCTION; LIMB STRENGTH PERFORMANCE; BLOOD-PRESSURE; CREATINE SUPPLEMENTATION; SYMPATHETIC OVERACTIVITY; ATHEROSCLEROSIS RISK; METABOLIC SYNDROME; GLYCEMIC CONTROL; DISEASE; HYPERTENSION	Background Cardiac autonomic neuropathy in type 2 dibetes mellitus (T2DM) patients is frequent and associated with high cardiovascular mortality. Heart rate variability (HRV) is the gold standard to measure cardiac autonomic neuropathy. We aimed to conduct a systematic review and meta analysis to evaluate the impact of T2DM on HRV parameters. Methods The PubMed, Cochrane Library, Embase and Science Direct databases were searched on 1st October 2017 using the keywords "diabetes" AND ("heart rate variability" OR "HRV"). Included articles had to report HRV parameters in T2DM patients and healthy controls measured during 24 hours with a Holter electrocardiogram. Measurements of HRV retieved were: RR intervals (or Normal to Normal intervals NN), standard deviation of RR intervals (SDNN), percetange of adjacent NN intervals differing by more than 50 milliseconds (pNN50), square root of the mean squared difference of successive RR intervals (RMSSD), total power, Low Frequency (LF), High Frequency (HF) and LF/HF ratio, as per Task Force recommendations. Results We included twenty-five case-control studies with 2,932 patients: 1,356 with T2DM and 1,576 healthy controls. T2DM patients had significantly (P<0.01) lower RR intervals (effect size = -0.61; 95%CI1-1.21 to -0.01), lower SDNN (-0.65; -0.83 to -0.47), lower RMSSD (-0.92; -1.37 to -0.47), lower pNN50 (-0.46; -0.84 to -0.09), lower total power (-1.52; -2.13 to -0.91), lower LF (-1.08; -1.46 to -0.69]), and lower HF (-0.79; -1.09 to -0.50). LF/HF did not differ between groups. Levels of blood glucose and HbA1c were associated with several HRV parameters, as well as Time from diagnosis of T2DM Conclusions T2DM was associated with an overall decrease in the HRV of T2DM patients. Both sympathetic and parasympathetic activity were decreased, which can be explained by the deleterious effects of altered glucose metabolism on HRV, leading to cardiac autonomic neuropathy.	[Benichou, Thomas] CHU Clermont Ferrand, Univ Hosp Clermont Ferrand, Endocrinol, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Univ Hosp Clermont Ferrand, Clin Res Direct, Clermont Ferrand, France; [Mermillod, Martial] Univ Grenoble Alpes, LPNC, Grenoble, France; [Mermillod, Martial] CNRS, LPNC, Grenoble, France; [Mermillod, Martial] Inst Univ France, Paris, France; [Tauveron, Igor; Maqdasy, Salwan] Univ Clermont Auvergne, CNRS, GReD,Endocrinol, Inserm,Univ Hosp Clermont Ferrand,CHU Clermont Fe, Clermont Ferrand, France; [Pfabigan, Daniela] Peking Univ, Culture & Social Cognit Neurosci Lab, Sch Psychol & Cognit Sci, Beijing, Peoples R China; [Dutheil, Frederic] Univ Clermont Auvergne, CNRS,WittyFit, LaPSCo,CHU Clermont Ferrand,Prevent & Occupat Med, Physiol & Psychosocial Stress,Univ Hosp Clermont, Clermont Ferrand, France; [Dutheil, Frederic] Australian Catholic Univ, Fac Hlth, Sch Exercise Sci, Melbourne, Vic, Australia	CHU Clermont Ferrand; CHU Clermont Ferrand; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Peking University; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Australian Catholic University	Dutheil, F (corresponding author), Univ Clermont Auvergne, CNRS,WittyFit, LaPSCo,CHU Clermont Ferrand,Prevent & Occupat Med, Physiol & Psychosocial Stress,Univ Hosp Clermont, Clermont Ferrand, France.; Dutheil, F (corresponding author), Australian Catholic Univ, Fac Hlth, Sch Exercise Sci, Melbourne, Vic, Australia.	frederic.dutheil@uca.fr	Pfabigan, Daniela/H-8282-2019; Dutheil, Frederic/O-9707-2014	Pfabigan, Daniela/0000-0002-4043-1695; Dutheil, Frederic/0000-0002-1468-6029; MAQDASY, Salwan/0000-0001-5164-9879	University Hospital of Clermont-Ferrand, France	University Hospital of Clermont-Ferrand, France	This study was funded by the University Hospital of Clermont-Ferrand, France.	Adlan AM, 2017, J PHYSIOL-LONDON, V595, P967, DOI 10.1113/JP272944; Akyel A, 2012, TURK KARDIYOL DERN A, V40, P148, DOI 10.5543/tkda.2012.01826; Al-Trad BA, 2015, EUR REV MED PHARMACO, V19, P1689; Amra B, 2017, SLEEP MED, V29, P57, DOI 10.1016/j.sleep.2016.11.003; [Anonymous], 2017, NUTR DIET, V74, P51; Askin L, 2017, CLIN EXP HYPERTENS, P1; Badea Anamaria Raluca, 2014, Clujul Med, V87, P152, DOI 10.15386/cjmed-313; Benoist G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155556; Bergenstal RM, 2013, DIABETES CARE, V36, pE107, DOI 10.2337/dc13-0295; Boer-Martins L, 2012, ARQ BRAS CARDIOL, V99, P642, DOI 10.1590/S0066-782X2012005000047; Boer-Martins L, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-24; Boudet G, 2017, EUR J PREV CARDIOL, V24, P281, DOI 10.1177/2047487316679523; Burger AJ, 2001, PACE, V24, P53, DOI 10.1046/j.1460-9592.2001.00053.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Chen XW, 2017, PSYCHIAT RES, V256, P207, DOI 10.1016/j.psychres.2017.06.041; Chen-Scarabelli C, 2006, PACE, V29, P9, DOI 10.1111/j.1540-8159.2006.00298.x; Citrome L, 2014, INT J CLIN PRACT, V68, P533, DOI 10.1111/ijcp.12435; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Comunello A, 2015, PITUITARY, V18, P525, DOI 10.1007/s11102-014-0605-6; Courtin R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009675; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; de Andrade PE, 2017, BLOOD PRESSURE, V26, P350, DOI 10.1080/08037051.2017.1354285; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dutheil F, 2017, J INT MED RES; Dutheil F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007716; Eguchi K, 2010, HYPERTENS RES, V33, P737, DOI 10.1038/hr.2010.61; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Fagundes CP, 2011, PSYCHONEUROENDOCRINO, V36, P1137, DOI 10.1016/j.psyneuen.2011.02.005; Fox CS, 2010, TRENDS CARDIOVAS MED, V20, P90, DOI 10.1016/j.tcm.2010.08.001; Furlan R, 2006, AM J PHYSIOL-REG I, V290, pR224, DOI 10.1152/ajpregu.00442.2005; Gerritsen J, 2001, DIABETES CARE, V24, P1793, DOI 10.2337/diacare.24.10.1793; Ginter Emil, 2012, Adv Exp Med Biol, V771, P35; Ginter Emil, 2012, Adv Exp Med Biol, V771, P42; Giordano M, 2001, NEPHROL DIAL TRANSPL, V16, P566, DOI 10.1093/ndt/16.3.566; Goit RK, 2012, J DIABETES COMPLICAT, V26, P339, DOI 10.1016/j.jdiacomp.2012.03.026; Hathaway DK, 1998, NURS RES, V47, P171, DOI 10.1097/00006199-199805000-00008; Hazari A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3405-9; Huang JC, 2017, KIDNEY BLOOD PRESS R, V42, P76, DOI 10.1159/000469716; Hufnagel C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00064; Istenes I, 2014, DIABETES-METAB RES, V30, P305, DOI 10.1002/dmrr.2496; Jaacks LM, 2016, BEST PRACT RES CL EN, V30, P331, DOI 10.1016/j.beem.2016.05.003; Julius S, 1996, AM J HYPERTENS, V9, pS113, DOI 10.1016/0895-7061(96)00287-7; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; Kilit C, 2007, INT SOC EL ANN M IST, V40, pS40; Kondo K, 2002, DIABETIC MED, V19, P359, DOI 10.1046/j.1464-5491.2002.00720.x; Krisztina N, 2014, ORVOSI HETILAP, V155, P865, DOI 10.1556/OH.2014.29886; Kumar KVSH, 2012, ANN MED HEALTH SCI R, V2, P103, DOI 10.4103/2141-9248.105654; Kumarathurai P, 2016, DIABETES CARE; Laakso M, 2010, DIABETES CARE, V33, P442, DOI 10.2337/dc09-0749; Lanhers C, 2017, SPORTS MED, V47, P163, DOI 10.1007/s40279-016-0571-4; Lanhers C, 2015, SPORTS MED, V45, P1285, DOI 10.1007/s40279-015-0337-4; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Li X, 2015, J DIABETES INVEST, V6, P227, DOI 10.1111/jdi.12270; Liao DP, 1998, DIABETES CARE, V21, P2116, DOI 10.2337/diacare.21.12.2116; Lotric MB, 2000, PHYSIOL MEAS, V21, P441, DOI 10.1088/0967-3334/21/4/302; Malliani A, 2004, CLIN SCI, V106, P567, DOI 10.1042/CS20040068; Meigs James B, 2010, Diabetes Care, V33, P1865, DOI 10.2337/dc10-0641; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Molon G, 2007, PACE, V30, P1267, DOI 10.1111/j.1540-8159.2007.00849.x; Montaquila JM, 2015, J PSYCHIATR RES, V69, P57, DOI 10.1016/j.jpsychires.2015.07.025; Mustafa G, 2017, REV PORT CARDIOL, V36, P499, DOI 10.1016/j.repc.2016.10.013; Mylonopoulou M, 2010, NEPHROL DIAL TRANSPL, V25, P3749, DOI 10.1093/ndt/gfq226; NIEDERMAIER ON, 1993, CIRCULATION, V88, P562, DOI 10.1161/01.CIR.88.2.562; Ollier M, 2014, CHEST, V145, P1339, DOI 10.1378/chest.13-2181; Otzenberger H, 1998, AM J PHYSIOL-HEART C, V275, pH946, DOI 10.1152/ajpheart.1998.275.3.H946; Ozturk NA, 2009, INT J COLORECTAL DIS, V24, P1407, DOI 10.1007/s00384-009-0757-4; Pavithran P, 2008, J CLIN HYPERTENS, V10, P904, DOI 10.1111/j.1751-7176.2008.00052.x; Pehlivanidis AN, 2001, ATHEROSCLEROSIS, V157, P463, DOI 10.1016/S0021-9150(00)00746-2; Perciaccante Antonio, 2006, BMC Cardiovasc Disord, V6, P19, DOI 10.1186/1471-2261-6-19; Poanta L, 2011, ACTA DIABETOL, V48, P191, DOI 10.1007/s00592-011-0256-2; Ponto KA, 2016, DIABETOLOGIA, V59, P1913, DOI 10.1007/s00125-016-4013-5; Rasic-Milutinovic ZR, 2010, SAUDI MED J, V31, P650; Reardon M, 1996, PACE, V19, P1863, DOI 10.1111/j.1540-8159.1996.tb03241.x; Rothberg LJ, 2016, DIABETES TECHNOL THE, V18, P366, DOI 10.1089/dia.2016.0010; Roy B, 2013, ARQ BRAS CARDIOL, V101, P317, DOI 10.5935/abc.20130181; Saleem S, 2012, J PAK MED ASSOC, V62, P422; Schroeder EB, 2003, HYPERTENSION, V42, P1106, DOI 10.1161/01.HYP.0000100444.71069.73; Dinesh Shah Anoop, 2015, Lancet, V385 Suppl 1, pS86, DOI [10.1016/S2213-8587(14)70219-0, 10.1016/S0140-6736(15)60401-9]; Singh JP, 2000, AM J CARDIOL, V86, P309, DOI 10.1016/S0002-9149(00)00920-6; Solanki JD, INDIAN HEART J; Soydan N, 2013, METABOLISM, V62, P717, DOI 10.1016/j.metabol.2012.12.003; Stockhorst U, 2011, PHYSIOL BEHAV, V103, P31, DOI 10.1016/j.physbeh.2011.01.014; Studer V, 2017, MULT SCLER J EXP TRA, V3, DOI DOI 10.1177/2055217317701317; Tadic M, 2017, ACTA DIABETOL, V54, P301, DOI 10.1007/s00592-016-0962-x; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Thorp AA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/341583; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Vora R, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0031-y; Vukomanovic V, 2017, INT J CARDIOVAS IMAG, V33, P481, DOI 10.1007/s10554-016-1023-9; Wang Gang, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P654, DOI 10.1007/s11596-006-0606-4; Yadav RL, 2017, DIABET METAB SYND OB, V10, P57, DOI 10.2147/DMSO.S123935; Yasuda G, 2005, DIABETIC MED, V22, P1394, DOI 10.1111/j.1464-5491.2005.01636.x; Yoo HJ, 2016, METABOLISM, V65, P1589, DOI 10.1016/j.metabol.2016.08.002; Zhang J, 2007, J MANIP PHYSIOL THER, V30, P374, DOI 10.1016/j.jmpt.2007.04.001; Ziegler D, 2008, DIABETES CARE, V31, P556, DOI 10.2337/dc07-1615	95	133	143	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195166	10.1371/journal.pone.0195166	http://dx.doi.org/10.1371/journal.pone.0195166			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608603	gold, Green Published, Green Submitted			2022-12-27	WOS:000428988800031
J	Sarkar-Banerjee, S; Goyal, S; Gao, N; Mack, J; Thompson, B; Dunlap, D; Chattopadhyay, K; Finzi, L				Sarkar-Banerjee, Suparna; Goyal, Sachin; Gao, Ning; Mack, John; Thompson, Benito; Dunlap, David; Chattopadhyay, Krishnananda; Finzi, Laura			Specifically bound lambda repressor dimers promote adjacent non-specific binding	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; MOBILITY-SHIFT ASSAY; C-TERMINAL DOMAIN; OPERATOR BINDING; PHAGE REPRESSOR; MUTATIONS; MODEL	Genetic switches frequently include DNA loops secured by proteins. Recent studies of the lambda bacteriophage repressor (CI), showed that this arrangement in which the protein links two sets of three operators separated by approximately 2.3 kbp, optimizes both the stability and dynamics of DNA loops, compared to an arrangement with just two sets of two operators. Because adjacent dimers interact pairwise, we hypothesized that the odd number of operators in each set of the lambda regulatory system might have evolved to allow for semi-specific, pair-wise interactions that add stability to the loop while maintaining it dynamic. More generally, additional CI dimers may bind non-specifically to flanking DNA sequences making the genetic switch more sensitive to CI concentration. Here, we tested this hypothesis using spectroscopic and imaging approaches to study the binding of the lambda repressor (CI) dimer protein to DNA fragments. For fragments with only one operator and a short flanking sequence, fluorescence correlation spectroscopy measurements clearly indicated the presence of two distinct DNA-CI complexes; one is thought to have a non-specifically bound CI dimer on the flanking sequence. Scanning force micrographs of CI bound to DNA with all six operators revealed wild-type or mutant proteins bound at operator positions. The number of bound, wild-type proteins increased with CI concentration and was larger than expected for strictly specific binding to operators. In contrast, a mutant that fails to oligomerize beyond a dimer, D197G, only bound to operators. These data are evidence that CI cooperativity promotes oligomerization that extends from operator sites to influence the thermodynamics and kinetics of Cl-mediated looping.	[Sarkar-Banerjee, Suparna; Chattopadhyay, Krishnananda] CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Prot Folding & Dynam Lab, Kolkata, India; [Goyal, Sachin] Univ Calif Merced, Dept Mech Engn, Merced, CA USA; [Gao, Ning; Mack, John; Thompson, Benito; Dunlap, David; Finzi, Laura] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Sarkar-Banerjee, Suparna] UTHealth, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of California System; University of California Merced; Emory University; University of Texas System; University of Texas Health Science Center Houston	Chattopadhyay, K (corresponding author), CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Prot Folding & Dynam Lab, Kolkata, India.; Finzi, L (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	krishnanandac@yahoo.com; lfinzi@emory.edu	Sarkar-Banerjee, Suparna/L-6802-2013	Sarkar-Banerjee, Suparna/0000-0001-8496-199X	National Institutes of Health [RGM084070A]; CSIR network project grant (UNSEEN); UC Merced startup funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSIR network project grant (UNSEEN); UC Merced startup funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (RGM084070A to L.F and D.D.D) and the CSIR network project grant (UNSEEN to KC) supported research covering materials and salary costs. UC Merced startup funds to SG will cover publication costs.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Babic AC, 2007, P NATL ACAD SCI USA, V104, P17741, DOI 10.1073/pnas.0602223104; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8406, DOI 10.1021/bi00194a004; Ding Y, 2014, P NATL ACAD SCI USA, V111, P15402, DOI 10.1073/pnas.1320644111; Galkin VE, 2009, J MOL BIOL, V385, P779, DOI 10.1016/j.jmb.2008.10.081; Gao N, 2013, PROTEIN EXPRES PURIF, V91, P30, DOI 10.1016/j.pep.2013.06.013; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; KOBLAN KS, 1991, BIOCHEMISTRY-US, V30, P7822, DOI 10.1021/bi00245a023; Lewis D, 2011, P NATL ACAD SCI USA, V108, P14807, DOI 10.1073/pnas.1111221108; Manzo C, 2012, BIOPHYS J, V103, P1753, DOI 10.1016/j.bpj.2012.09.006; NELSON HCM, 1985, CELL, V42, P549, DOI 10.1016/0092-8674(85)90112-6; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Ptashne M, 2004, GENETIC SWITCH PHAGE; Saiz L, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100061; Schubert F, 2003, BIOCHEMISTRY-US, V42, P10288, DOI 10.1021/bi034033d; SENEAR DF, 1991, BIOCHEMISTRY-US, V30, P6677, DOI 10.1021/bi00241a007; SENEAR DF, 1993, BIOCHEMISTRY-US, V32, P6179, DOI 10.1021/bi00075a010; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; Stayrook S, 2008, NATURE, V452, P1022, DOI 10.1038/nature06831; TIRADO MM, 1979, J CHEM PHYS, V71, P2581, DOI 10.1063/1.438613; Vilar JMG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238103; Wang HW, 2009, CURR PHARM BIOTECHNO, V10, P494, DOI 10.2174/138920109788922155; WHIPPLE FW, 1994, GENE DEV, V8, P1212, DOI 10.1101/gad.8.10.1212; Zurla C, 2009, NUCLEIC ACIDS RES, V37, P2789, DOI 10.1093/nar/gkp134	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194930	10.1371/journal.pone.0194930	http://dx.doi.org/10.1371/journal.pone.0194930			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608611	Green Submitted, Green Published, gold			2022-12-27	WOS:000428988800019
J	Albuquerque, PL; Campelo, M; Mendonca, T; Augusto, L; Fontes, M; Brito, RD; Monte-Silva, K				Albuquerque, Plinio Luna; Campelo, Mayara; Mendonca, Thyciane; Augusto, Luis; Fontes, Mendes; Brito, Rodrigo de Mattos; Monte-Silva, Katia			Effects of repetitive transcranial magnetic stimulation and trans-spinal direct current stimulation associated with treadmill exercise in spinal cord and cortical excitability of healthy subjects: A triple-blind, randomized and sham-controlled study	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; TRAINING-INDUCED PLASTICITY; NOCICEPTIVE FLEXION REFLEX; HIGH-FREQUENCY RTMS; SOLEUS H-REFLEX; OF-THE-ART; RECIPROCAL INHIBITION; CONTROLLED-TRIAL; RECOVERY CURVE; HUMANS	Repetitive transcranial magnetic stimulation (rTMS) over motor cortex and trans-spinal direct current stimulation (tsDCS) modulate corticospinal circuits in healthy and injured subjects. However, their associated effects with physical exercise is still not defined. This study aimed to investigate the effect of three different settings of rTMS and tsDCS combined with treadmill exercise on spinal cord and cortical excitability of healthy subjects. We performed a triple blind, randomized, sham-controlled crossover study with 12 healthy volunteers who underwent single sessions of rTMS (1Hz, 20Hz and Sham) and tsDCS (anodal, cathodal and Sham) associated with 20 minutes of treadmill walking. Cortical excitability was assessed by motor evoked potential (MEP) and spinal cord excitability by the Hoffmann reflex (Hr), nociceptive flexion reflex (NFR) and homosynaptic depression (HD). All measures were assessed before, immediately, 30 and 60 minutes after the experimental procedures. Our results demonstrated that anodal tsDCS/treadmill exercise reduced MEP's amplitude and NFR's area compared to sham condition, conversely, cathodal tsDCS/treadmill exercise increased NFR's area. High-frequency rTMS increased MEP's amplitude and NFR's area compared to sham condition. Anodal tsDCS/treadmill exercise and 20Hz rTMS/treadmill exercise reduced Hr amplitude up to 30 minutes after stimulation offset and no changes were observed in HD measures. We demonstrated that tsDCS and rTMS combined with treadmill exercise modulated cortical and spinal cord excitability through different mechanisms. tsDCS modulated spinal reflexes in a polarity-dependent way acting at local spinal circuits while rTMS probably promoted changes in the presynaptic inhibition of spinal motoneurons. In addition, the association of two neuromodulatory techniques induced long-lasting changes.	[Albuquerque, Plinio Luna; Campelo, Mayara; Mendonca, Thyciane; Augusto, Luis; Fontes, Mendes; Brito, Rodrigo de Mattos; Monte-Silva, Katia] Univ Fed Pernambuco, Dept Phys Therapy, Appl Neurosci Lab, Recife, PE, Brazil; [Albuquerque, Plinio Luna] Ctr Univ Tabosa Almeida, Dept Phys Therapy, Caruaru, PE, Brazil; [Albuquerque, Plinio Luna; Campelo, Mayara; Monte-Silva, Katia] Univ Fed Pernambuco, Postgrad Program Neuropsychiat & Behav Sci, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Monte-Silva, K (corresponding author), Univ Fed Pernambuco, Dept Phys Therapy, Appl Neurosci Lab, Recife, PE, Brazil.; Monte-Silva, K (corresponding author), Univ Fed Pernambuco, Postgrad Program Neuropsychiat & Behav Sci, Recife, PE, Brazil.	monte.silvakk@gmail.com	Silva, Katia Monte/V-4004-2019; Monte-Silva, Katia KMS/A-2444-2014	Silva, Katia Monte/0000-0001-7301-2553; Monte-Silva, Katia KMS/0000-0001-7301-2553				Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; Ahmed Z, 2013, J NEUROSCI, V33, P14949, DOI 10.1523/JNEUROSCI.2793-13.2013; Ahmed Z, 2012, J APPL PHYSIOL, V112, P1576, DOI 10.1152/japplphysiol.00967.2011; Arai N, 2007, CLIN NEUROPHYSIOL, V118, P2227, DOI 10.1016/j.clinph.2007.07.006; Galvao SCB, 2014, ARCH PHYS MED REHAB, V95, P222, DOI 10.1016/j.apmr.2013.10.023; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Bhatia BD, 2011, NEUROSCI LETT, V488, P107, DOI 10.1016/j.neulet.2010.08.087; Bocci T, 2014, NEUROSCI LETT, V578, P75, DOI 10.1016/j.neulet.2014.06.037; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Cogiamanian F, PAIN; Cogiamanian F, 2008, CLIN NEUROPHYSIOL, V119, P2636, DOI 10.1016/j.clinph.2008.07.249; Cosentino G, 2012, EUR J NEUROSCI, V35, P119, DOI 10.1111/j.1460-9568.2011.07939.x; CRONE C, 1994, ACTA PHYSIOL SCAND, V152, P351, DOI 10.1111/j.1748-1716.1994.tb09817.x; Donges SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172333; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Grecco LH, 2015, J NEURORESTORATOLOGY, V3, P73, DOI 10.2147/JN.S77813; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Harel NY, 2015, J ELECTROMYOGR KINES, V25, P438, DOI 10.1016/j.jelekin.2015.02.009; Heide AC, 2014, BRAIN STIMUL, V7, P636, DOI 10.1016/j.brs.2014.06.008; Hosseinzadeh M, 2013, EUR J APPL PHYSIOL, V113, P2595, DOI 10.1007/s00421-013-2701-0; Hubli M, 2013, CLIN NEUROPHYSIOL, V124, P1187, DOI 10.1016/j.clinph.2012.11.021; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; Johnson S, 2006, PAIN, V123, P187, DOI 10.1016/j.pain.2006.02.030; Jubeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089157; Knikou M, 2010, CLIN NEUROPHYSIOL, V121, P1655, DOI 10.1016/j.clinph.2010.01.039; Kumru H, 2015, MUSCLE NERVE, V52, P616, DOI 10.1002/mus.24579; Kumru H, 2010, NEUROREHAB NEURAL RE, V24, P435, DOI 10.1177/1545968309356095; Lamy JC, 2012, J NEUROPHYSIOL, V108, P906, DOI 10.1152/jn.10898.2011; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Mazzocchio R, 2006, CLIN NEUROPHYSIOL, V117, P1682, DOI 10.1016/j.clinph.2006.04.019; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; Meunier S, 2007, J PHYSIOL-LONDON, V579, P375, DOI 10.1113/jphysiol.2006.122911; Motl RW, 2003, NEUROSCI LETT, V347, P69, DOI 10.1016/S0304-3940(03)00652-9; Muller-Dahlhaus F, 2015, NEUROSCIENTIST, V21, P185, DOI 10.1177/1073858414526645; Mylius V, 2007, NEUROSCI LETT, V415, P49, DOI 10.1016/j.neulet.2006.12.042; Nahmias F, 2009, PAIN, V147, P224, DOI 10.1016/j.pain.2009.09.016; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PANIZZA M, 1995, AM J PHYS MED REHAB, V74, P357; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Perez MA, 2005, J PHYSIOL-LONDON, V568, P343, DOI 10.1113/jphysiol.2005.089904; Perez MA, 2005, EXP BRAIN RES, V162, P202, DOI 10.1007/s00221-004-2144-2; Perrotta A, 2016, CLIN NEUROPHYSIOL, V127, P755, DOI 10.1016/j.clinph.2015.01.031; Price DD, 2003, PAIN, V106, P215, DOI 10.1016/j.pain.2003.10.016; Priori A, 2014, J PHYSIOL-LONDON, V592, P3345, DOI 10.1113/jphysiol.2013.270280; Quartarone A, 2005, EXP BRAIN RES, V161, P114, DOI 10.1007/s00221-004-2052-5; Rastgoo M, 2016, DISABIL REHABIL, V38, P1918, DOI 10.3109/09638288.2015.1107780; Rhudy JL, 2007, PAIN, V128, P244, DOI 10.1016/j.pain.2006.09.024; Rocha S, 2016, DISABIL REHABIL, V38, P653, DOI 10.3109/09638288.2015.1055382; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Sadowski B, 2008, J HUM KINET, V20, P5, DOI 10.2478/v10078-008-0014-x; SCHOMBURG ED, 1990, NEUROSURG REV, V13, P179, DOI 10.1007/BF00313016; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Summers J, 2004, NEUROSCI LETT, V368, P197, DOI 10.1016/j.neulet.2004.07.008; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Terraneo A, 2016, EUR NEUROPSYCHOPHARM, V26, P37, DOI 10.1016/j.euroneuro.2015.11.011; Truini A, 2011, EUR J PAIN, V15, P1023, DOI 10.1016/j.ejpain.2011.04.009; Valero-Cabre A, 2001, NEUROREPORT, V12, P3845, DOI 10.1097/00001756-200112040-00048; Winkler T, 2010, CLIN NEUROPHYSIOL, V121, P957, DOI 10.1016/j.clinph.2010.01.014; [No title captured], DOI DOI 10.1016/J.EJPAIN.2009.04.010	64	14	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195276	10.1371/journal.pone.0195276	http://dx.doi.org/10.1371/journal.pone.0195276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596524	Green Published, gold			2022-12-27	WOS:000428630000101
J	Conceicao, MS; Gaspari, AF; Ramkrapes, APB; Junior, EMM; Bertuzzi, R; Cavaglieri, CR; Chacon-Mikahil, MPT				Conceicao, Miguel S.; Gaspari, Arthur F.; Ramkrapes, Ana P. B.; Junior, Edson M. M.; Bertuzzi, Romulo; Cavaglieri, Claudia R.; Chacon-Mikahil, Mara Patricia T.			Anaerobic metabolism induces greater total energy expenditure during exercise with blood flow restriction	PLOS ONE			English	Article							MUSCLE METABOREFLEX CONTROL; CARDIOVASCULAR-RESPONSES; HEART-RATE; INTENSITY; STRENGTH; ACTIVATION; WALKING; KINETICS; INCREASE; LACTATE	Purpose We investigated the energy system contributions and total energy expenditure during low intensity endurance exercise associated with blood flow restriction (LIE-BFR) and without blood flow restriction (LIE). Methods Twelve males participated in a contra-balanced, cross-over design in which subjects completed a bout of low-intensity endurance exercise (30min cycling at 40% of <(V)over dot>O-2max) with or without BFR, separated by at least 72 hours of recovery. Blood lactate accumulation and oxygen uptake during and after exercise were used to estimate the anaerobic lactic metabolism, aerobic metabolism, and anaerobic alactic metabolism contributions, respectively. Results There were significant increases in the anaerobic lactic metabolism (P = 0.008), aerobic metabolism (P = 0.020), and total energy expenditure (P = 0.008) in the LIE-BFR. No significant differences between conditions for the anaerobic alactic metabolism were found (P = 0.582). Plasma lactate concentration was significantly higher in the LIE-BFR at 15min and peak post-exercise (all P <= 0.008). Heart rate was significantly higher in the LIE-BFR at 10, 15, 20, 25, and 30min during exercise, and 5, 10, and 15min after exercise (all P <= 0.03). Ventilation was significantly higher in the LIE-BFR at 10, 15, and 20min during exercise (all P <= 0.003). Conclusion Low-intensity endurance exercise performed with blood flow restriction increases the anaerobic lactic and aerobic metabolisms, total energy expenditure, and cardiorespiratory responses.	[Conceicao, Miguel S.; Gaspari, Arthur F.; Ramkrapes, Ana P. B.; Junior, Edson M. M.; Cavaglieri, Claudia R.; Chacon-Mikahil, Mara Patricia T.] Univ Estadual Campinas, Sch Phys Educ, Exercise Physiol Lab, Campinas, SP, Brazil; [Conceicao, Miguel S.; Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Gaspari, Arthur F.; Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Sports Res Grp GEDAE, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo	Conceicao, MS (corresponding author), Univ Estadual Campinas, Sch Phys Educ, Exercise Physiol Lab, Campinas, SP, Brazil.; Conceicao, MS (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	conceicao.miguel0106@gmail.com	Bertuzzi, Romulo/E-7048-2012; Roschel, Hamilton/D-4353-2012; CONCEIÇÃO, MIGUEL SOARES/P-3451-2019; Cavaglieri, Cláudia Regina/C-4291-2012; Conceição, Miguel S/G-9437-2012	Roschel, Hamilton/0000-0002-9513-6132; CONCEIÇÃO, MIGUEL SOARES/0000-0002-9170-7890; Cavaglieri, Cláudia Regina/0000-0002-7795-6575; Conceição, Miguel S/0000-0002-9170-7890; Chacon-Mikahil, Mara Patricia Traina/0000-0002-6109-5141				Abe T, 2006, J APPL PHYSIOL, V100, P1460, DOI 10.1152/japplphysiol.01267.2005; Abe T, 2010, J SPORT SCI MED, V9, P452; Augustyniak RA, 2000, AM J PHYSIOL-HEART C, V278, pH530, DOI 10.1152/ajpheart.2000.278.2.H530; Augustyniak RA, 2001, AM J PHYSIOL-HEART C, V280, pH1645, DOI 10.1152/ajpheart.2001.280.4.H1645; Bertuzzi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145733; Bertuzzi R, 2013, J SPORT SCI MED, V12, P454; BORG G, 1985, EUR J APPL PHYSIOL O, V54, P343, DOI 10.1007/BF02337176; Boushel R, 2010, ACTA PHYSIOL, V199, P367, DOI 10.1111/j.1748-1716.2010.02133.x; Conceicao MS, 2016, MED SCI SPORT EXER, V48, P1699, DOI 10.1249/MSS.0000000000000970; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Engelen M, 1996, J APPL PHYSIOL, V81, P2500, DOI 10.1152/jappl.1996.81.6.2500; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher JP, 2015, COMPR PHYSIOL, V5, P475, DOI 10.1002/cphy.c140022; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; HANSEN J, 1994, AM J PHYSIOL, V266, pH2508, DOI 10.1152/ajpheart.1994.266.6.H2508; Hartwich D, 2011, J PHYSIOL-LONDON, V589, P6157, DOI 10.1113/jphysiol.2011.219964; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Hughson RL, 1996, J APPL PHYSIOL, V81, P1619, DOI 10.1152/jappl.1996.81.4.1619; Ichinose M, 2015, AM J PHYSIOL-REG I, V309, pR1234, DOI 10.1152/ajpregu.00063.2015; Iida H, 2007, EUR J APPL PHYSIOL, V100, P275, DOI 10.1007/s00421-007-0430-y; Karabulut M, 2017, CLIN PHYSIOL FUNCT I, V37, P1, DOI 10.1111/cpf.12258; Karabulut M, 2011, J SPORT SCI, V29, P951, DOI 10.1080/02640414.2011.572992; Laurentino GC, 2012, MED SCI SPORT EXER, V44, P406, DOI 10.1249/MSS.0b013e318233b4bc; Melzer K, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2015.36; Mendonca GV, 2014, CLIN PHYSIOL FUNCT I, V34, P308, DOI 10.1111/cpf.12098; Mendonca GV, 2015, INT J SPORTS MED; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Mouser JG, 2017, APPL PHYSIOL NUTR ME, V42, P1165, DOI 10.1139/apnm-2017-0102; Nakajima T, 2008, EUR J APPL PHYSIOL, V104, P727, DOI 10.1007/s00421-008-0834-3; O'Leary DS, 1999, AM J PHYSIOL-HEART C, V276, pH1399, DOI 10.1152/ajpheart.1999.276.4.H1399; Ozaki H, 2014, ACTA PHYSIOL, V211, P97, DOI 10.1111/apha.12243; Ozaki H, 2010, J SPORT SCI MED, V9, P224; Park S, 2010, EUR J APPL PHYSIOL, V109, P591, DOI 10.1007/s00421-010-1377-y; Prodel E, 2016, AM J PHYSIOL-HEART C, V310, pH1201, DOI 10.1152/ajpheart.00894.2015; Renzi CP, 2010, MED SCI SPORT EXER, V42, P726, DOI 10.1249/MSS.0b013e3181bdb454; Sakamaki-Sunaga M, 2012, COMP EXERC PHYSIOL, V8, P117, DOI 10.3920/CEP12007; Seals D R, 1991, Exerc Sport Sci Rev, V19, P313; Spranger MD, 2015, AM J PHYSIOL-HEART C, V309, pH1440, DOI 10.1152/ajpheart.00208.2015; Swain DP, 2002, MED SCI SPORT EXER, V34, P152, DOI 10.1097/00005768-200201000-00023; Takada S, 2012, J APPL PHYSIOL, V113, P199, DOI 10.1152/japplphysiol.00149.2012; Tanimoto M, 2005, INT J KAATSU TRAININ, V1, P51, DOI DOI 10.3806/IJKTR.1.51; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Ferreira MLV, 2017, J SPORT SCI, V35, P2412, DOI 10.1080/02640414.2016.1271139; Yasuda T, 2010, METABOLISM, V59, P1510, DOI 10.1016/j.metabol.2010.01.016; Zinner C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140616	47	14	14	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194776	10.1371/journal.pone.0194776	http://dx.doi.org/10.1371/journal.pone.0194776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596452	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000041
J	Deike-Hofmann, K; Thunemann, D; Breckwoldt, MO; Schwarz, D; Radbruch, A; Enk, A; Bendszus, M; Hassel, J; Schlemmer, HP; Baumer, P				Deike-Hofmann, Katerina; Thuenemann, Daniel; Breckwoldt, Michael O.; Schwarz, Daniel; Radbruch, Alexander; Enk, Alexander; Bendszus, Martin; Hassel, Jessica; Schlemmer, Heinz-Peter; Baeumer, Philipp			Sensitivity of different MRI sequences in the early detection of melanoma brain metastases	PLOS ONE			English	Article							SPIN-ECHO; CONTRAST ENHANCEMENT; MALIGNANT-MELANOMA; IMPROVES DETECTION; GLOBUS-PALLIDUS; BONE METASTASES; DENTATE NUCLEUS; MP-RAGE; TIME; ACQUISITION	Background After the emergence of new MRI techniques such as susceptibility-and diffusion-weighted imaging (SWI and DWI) and because of specific imaging characteristics of melanoma brain metastases (MBM), it is unclear which MRI sequences are most beneficial for detection of MBM. This study was performed to investigate the sensitivity of six clinical MRI sequences in the early detection of MBM. Methods Medical records of all melanoma patients referred to our center between November 2005 and December 2016 were reviewed for presence of MBM. Analysis encompassed six MRI sequences at the time of initial diagnosis of first or new MBM, including non-enhanced T1-weighted (T1w), contrast-enhanced T1w (ceT1w), T2-weighted (T2w), T2w-FLAIR, susceptibility-weighted (SWI) and diffusion-weighted (DWI) MRI. Each lesion was rated with respect to its conspicuity (score from 0-not detectable to 3-clearly visible). Results Of 1210 patients, 217 with MBM were included in the analysis and up to 5 lesions per patient were evaluated. A total of 720 metastases were assessed and all six sequences were available for 425 MBM. Sensitivity (conspicuity >= 2) was 99.7% for ceT1w, 77.0% for FLAIR, 64.7% for SWI, 61.0% for T2w, 56.7% for T1w, and 48.4% for DWI. Thirty-one (7.3%) of 425 lesions were only detectable by ceT1w but no other sequence. Conclusions Contrast-enhanced T1-weighting is more sensitive than all other sequences for detection of MBM. Disruption of the blood-brain-barrier is consistently an earlier sign in MBM than perifocal edema, signal loss on SWI or diffusion restriction.	[Deike-Hofmann, Katerina; Thuenemann, Daniel; Breckwoldt, Michael O.; Schwarz, Daniel; Radbruch, Alexander; Schlemmer, Heinz-Peter; Baeumer, Philipp] DKFZ, Dept Radiol, German Canc Res Ctr, Heidelberg, Germany; [Breckwoldt, Michael O.; Schwarz, Daniel; Bendszus, Martin] Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Germany; [Enk, Alexander; Hassel, Jessica] Heidelberg Univ, Med Ctr, Dept Dermatol, Natl Ctr Tumor Dis,NCT, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Baumer, P (corresponding author), DKFZ, Dept Radiol, German Canc Res Ctr, Heidelberg, Germany.	p.baeumer@dkfz.de	Radbruch, Alexander/ABA-6277-2021	Baumer, Philipp/0000-0003-2896-543X; Schwarz, Daniel/0000-0002-9017-8245; Radbruch, Alexander/0000-0001-6238-6525; Deike, Katerina/0000-0002-4319-0428				Ali S, 2015, AJNR Am J Neuroradiol, V36, pE69, DOI 10.3174/ajnr.A4581; Amer M, 1976, CANCER, V42, P660; Anzalone N, 2009, ACTA RADIOL, V50, P933, DOI 10.1080/02841850903095385; Ba-Ssalamah A, 2003, INVEST RADIOL, V38, P415, DOI 10.1097/00004424-200307000-00006; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Beiderwellen K, 2013, EUR J RADIOL, V82, pE669, DOI 10.1016/j.ejrad.2013.07.027; Bluml S, 1996, MAGN RESON IMAGING, V14, P329, DOI 10.1016/0730-725X(95)02095-B; BUDMAN DR, 1978, EUR J CANCER, V14, P327, DOI 10.1016/0014-2964(78)90201-3; Chapman PB, 2012, J CLIN ONCOL, V30; CHAPPELL PM, 1994, AM J NEURORADIOL, V15, P37; Chen WW, 2012, AM J ROENTGENOL, V198, P27, DOI 10.2214/AJR.11.7030; Cohen-Inbar O, 2016, J NEURO-ONCOL, V130, P485, DOI 10.1007/s11060-016-2242-6; Costelloe CM, 2013, MAGN RESON IMAGING, V31, P669, DOI 10.1016/j.mri.2012.10.017; Davies MA, 2011, CANCER-AM CANCER SOC, V117, P1687, DOI 10.1002/cncr.25634; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Eon JY, 2014, KOREAN J RADIOL, V15, P145, DOI 10.3348/kjr.2014.15.1.145; Escott EJ, 2001, RADIOGRAPHICS, V21, P625, DOI 10.1148/radiographics.21.3.g01ma19625; Fan B, 2016, J MAGN RESON IMAGING; Flechsig P, 2015, EUR J RADIOL, V84, P1593, DOI 10.1016/j.ejrad.2015.04.009; Force J, 2017, IMMUNOTARGETS THER, V6, P1, DOI 10.2147/ITT.S110479; Franceschi AM, 2016, J COMPUT ASSIST TOMO, V40, P803, DOI 10.1097/RCT.0000000000000420; Furutani K, 2008, J COMPUT ASSIST TOMO, V32, P313, DOI 10.1097/RCT.0b013e318074fd9d; Gaviani P, 2006, AM J NEURORADIOL, V27, P605; Gramsch C, 2013, EUR RADIOL, V23, P2622, DOI 10.1007/s00330-013-2857-3; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; ISIKLAR I, 1995, AM J ROENTGENOL, V165, P1503, DOI 10.2214/ajr.165.6.7484597; Kato Y, 2009, AM J NEURORADIOL, V30, P923, DOI 10.3174/ajnr.A1506; Kim ES, 2010, AM J NEURORADIOL, V31, P1055, DOI 10.3174/ajnr.A2010; Komada Tomohiro, 2008, Magn Reson Med Sci, V7, P13, DOI 10.2463/mrms.7.13; Kushnirsky M, 2016, J NEUROSURG, V124, P489, DOI 10.3171/2015.2.JNS141993; Kwak HS, 2015, CLIN IMAG, V39, P571, DOI 10.1016/j.clinimag.2015.02.010; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; MUGLER JP, 1993, JMRI-J MAGN RESON IM, V3, P761, DOI 10.1002/jmri.1880030512; Nobauer-Huhmann IM, 2002, INVEST RADIOL, V37, P114, DOI 10.1097/00004424-200203000-00003; Ohlmann-Knafo S, 2015, ROFO-FORTSCHR RONTG, V187, P924, DOI 10.1055/s-0035-1553207; Owonikoko TK, 2014, NAT REV CLIN ONCOL, V11, P203, DOI 10.1038/nrclinonc.2014.25; Platta CS, 2010, AM J CLIN ONCOL-CANC, V33, P398, DOI 10.1097/COC.0b013e318194f744; Radbruch A, 2015, INVEST RADIOL, V50, P805, DOI 10.1097/RLI.0000000000000227; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Radbruch A, 2012, NEURO-ONCOLOGY, V14, P222, DOI 10.1093/neuonc/nor200; Reichert M, 2013, INVEST RADIOL, V48, P55, DOI 10.1097/RLI.0b013e318277b1aa; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Spagnolo F, 2016, CANCER TREAT REV, V45, P38, DOI 10.1016/j.ctrv.2016.03.003; Suh CH, 2016, J NEURO-ONCOL, V129, P363, DOI 10.1007/s11060-016-2185-y; YUH WTC, 1992, AM J NEURORADIOL, V13, P335; YUH WTC, 1995, AM J NEURORADIOL, V16, P373; ZHANG RD, 1992, AM J PATHOL, V141, P1115	48	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193946	10.1371/journal.pone.0193946	http://dx.doi.org/10.1371/journal.pone.0193946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596475	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000015
J	Goedegebuure, M; Melbourne-Thomas, J; Corney, SP; McMahon, CR; Hindell, MA				Goedegebuure, Merel; Melbourne-Thomas, Jessica; Corney, Stuart P.; McMahon, Clive R.; Hindell, Mark A.			Modelling southern elephant seals Mirounga leonina using an individual-based model coupled with a dynamic energy budget	PLOS ONE			English	Article							POPULATION-GROWTH; HOT-IRON; BEHAVIOR; SURVIVAL; RESTRICTION; COMPLEXITY; PARAMETERS; PROTOCOL; MASS	Higher trophic-level species are an integral component of any marine ecosystem. Despite their importance, methods for representing these species in end-to-end ecosystem models often have limited representation of life histories, energetics and behaviour. We built an individual-based model coupled with a dynamic energy budget for female southern elephant seals Mirounga leonina to demonstrate a method for detailed representation of marine mammals. We aimed to develop a model which could i) simulate energy use and life histories, as well as breeding traits of southern elephant seals in an emergent manner, ii) project a stable population over time, and iii) have realistic population dynamics and structure based on emergent life history features (such as age at first breeding, lifespan, fecundity and (yearling) survival). We evaluated the model's ability to represent a stable population over long time periods (> 10 generations), including the sensitivity of the emergent properties to variations in key parameters. Analyses indicated that the model is sensitive to changes in resource availability and energy requirements for the transition from pup to juvenile, and juvenile to adult stage. This was particularly the case for breeding success and yearling survival. This model is suitable for use as a standalone tool for investigating the impacts of changes to behaviour and population responses of southern elephant seals.	[Goedegebuure, Merel; McMahon, Clive R.; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 129, Hobart, Tas 7000, Australia; [Goedegebuure, Merel; Melbourne-Thomas, Jessica; Corney, Stuart P.; Hindell, Mark A.] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Private Bag 80, Hobart, Tas 7000, Australia; [Melbourne-Thomas, Jessica] Australian Antarctic Div, Channel Highway, Kingston, Tas 7050, Australia; [McMahon, Clive R.] Sydney Inst Marine Sci, 19 Chowder Bay Rd, Mosman, NSW 2088, Australia	University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian Antarctic Division; Sydney Institute of Marine Science	Goedegebuure, M (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 129, Hobart, Tas 7000, Australia.; Goedegebuure, M (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Private Bag 80, Hobart, Tas 7000, Australia.	merel.goedegebuure@utas.edu.au	Melbourne-Thomas, Jess/N-2437-2019; McMahon, Clive R/D-5713-2013	Melbourne-Thomas, Jess/0000-0001-6585-876X; McMahon, Clive R/0000-0001-5241-8917; Hindell, Mark/0000-0002-7823-7185; Goedegebuure, Merel/0000-0002-9129-888X				Arnbom T, 1997, ECOLOGY, V78, P471, DOI 10.1890/0012-9658(1997)078[0471:FAMEIS]2.0.CO;2; Bacher C, 2006, J SEA RES, V56, P140, DOI 10.1016/j.seares.2006.03.004; Beaudouin R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125841; Bedford M, 2015, MAR ECOL PROG SER, V526, P169, DOI 10.3354/meps11203; Bejarano AC, 2017, ECOL MODEL, V356, P162, DOI 10.1016/j.ecolmodel.2017.05.001; Bell CM, 2005, POLAR BIOL, V28, P395, DOI 10.1007/s00300-004-0694-1; Boyd IL, 1994, BIOMASS ENERGY CONSU, P98; Campagna C, 1999, J MAMMAL, V80, P1341, DOI 10.2307/1383185; CARRICK R., 1962, C S I R O WILDLIFE RES, V7, P119; Caswell, 2000, MATRIX POPULATION MO; Chittleborough RG, 1949, 1 ANARE, P1; Clausius E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173427; Costa Daniel P., 2012, P225; de Little C Siobhan, 2007, BMC BIOL, V7; DeAngelis Donald L, 2014, F1000Prime Rep, V6, P39, DOI 10.12703/P6-39; Desprez M., 2015, SO OCEAN SENTINELS D; Desprez M, 2018, J ANIM ECOL, V87, P199, DOI 10.1111/1365-2656.12775; Desprez M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0264; DRENT RH, 1980, ARDEA, V68, P225; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Fedak MA, 1996, J VISUAL COMP ANIMAT, V7, P141, DOI 10.1002/(SICI)1099-1778(199607)7:3<141::AID-VIS147>3.0.CO;2-N; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Gardmark A, 2013, ECOL APPL, V23, P742, DOI 10.1890/12-0267.1; Gerber LR, 2014, J APPL ECOL, V51, P270, DOI 10.1111/1365-2664.12177; Goedegebuure M, 2017, ECOL MODEL, V359, P182, DOI 10.1016/j.ecolmodel.2017.04.004; Goussen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep36004; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2017, ECOSYSTEMS, V20, P229, DOI 10.1007/s10021-016-0071-2; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Groeneveld J, 2015, ECOL MODEL, V303, P78, DOI 10.1016/j.ecolmodel.2015.02.009; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; HINDELL MA, 1994, AUST J ZOOL, V42, P723, DOI 10.1071/ZO9940723; HINDELL MA, 1988, J MAMMAL, V69, P81, DOI 10.2307/1381750; HINDELL MA, 1988, MAR MAMMAL SCI, V4, P168, DOI 10.1111/j.1748-7692.1988.tb00197.x; Hindell MA, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P72; HINDELL MA, 1987, J ZOOL, V213, P365, DOI 10.1111/j.1469-7998.1987.tb03712.x; HINDELL MA, 1991, J ANIM ECOL, V60, P119, DOI 10.2307/5449; HINDELL MA, 1994, POLAR BIOL, V14, P275; Hindell MA, 2017, GLOBAL CHANGE BIOL, V23, P5136, DOI 10.1111/gcb.13776; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Jusup M, 2017, PHYS LIFE REV, V20, P1, DOI 10.1016/j.plrev.2016.09.001; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Kooijman S. A. L. M, 2010, NOTATION DYNAMIC ENE; Kooijman S. A. L. M., 2010, COMMENTS DYNAMIC ENE; Langton R, 2014, ECOL MODEL, V273, P31, DOI 10.1016/j.ecolmodel.2013.10.030; Laws R. M., 1953, Scientific Reports Falkland Islands Dependencies Survey, P1; Laws R. M., 1984, ANTARCTIC ECOLOGY; Laws R. M., 1956, FALKLAND ISLANDS DEP, V13; Lebreton JD, 2005, ECOL MODEL, V188, P22, DOI 10.1016/j.ecolmodel.2005.05.003; Martin BT, 2013, AM NAT, V181, P506, DOI 10.1086/669904; Martin BT, 2012, METHODS ECOL EVOL, V3, P445, DOI 10.1111/j.2041-210X.2011.00168.x; McConnell B, 2002, J ANIM ECOL, V71, P65, DOI 10.1046/j.0021-8790.2001.00576.x; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; McMahon CR, 2006, J WILDLIFE MANAGE, V70, P1484, DOI 10.2193/0022-541X(2006)70[1484:AHACFP]2.0.CO;2; McMahon CR, 2007, CONSERV BIOL, V21, P271, DOI 10.1111/j.1523-1739.2006.00566.x; McMahon CR, 2017, J ANIM ECOL, V86, P359, DOI 10.1111/1365-2656.12611; McMahon CR, 2006, NATURE, V439, P392, DOI 10.1038/439392c; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; McMahon CR, 2005, MAR ECOL PROG SER, V288, P273, DOI 10.3354/meps288273; McMahon CR, 2005, MAMMAL REV, V35, P82, DOI 10.1111/j.1365-2907.2005.00055.x; McMahon CR, 1999, POLAR BIOL, V21, P279, DOI 10.1007/s003000050363; McMahon CR, 2003, J ANIM ECOL, V72, P61, DOI 10.1046/j.1365-2656.2003.00685.x; McMahon CR, 2000, ANTARCT SCI, V12, P149, DOI 10.1017/S0954102000000195; Meurant G., 1995, HDB MILK COMPOSITION; Murphy EJ, 2012, PROG OCEANOGR, V102, P74, DOI 10.1016/j.pocean.2012.03.006; Murphy EJ, 2012, CURR OPIN ENV SUST, V4, P264, DOI 10.1016/j.cosust.2012.05.005; New LF, 2014, MAR ECOL PROG SER, V496, P99, DOI 10.3354/meps10547; Nisbet RM, 2012, J EXP BIOL, V215, P892, DOI 10.1242/jeb.059675; O'Toole MD, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00021; Pavlova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104037; Pethybridge H, 2013, ECOL MODEL, V250, P370, DOI 10.1016/j.ecolmodel.2012.11.017; Punt AE, 2011, FISH RES, V109, P201, DOI 10.1016/j.fishres.2011.02.006; R Core Team, 2015, R LANGUAGE ENV STAT; Railsback S.F., 2011, AGENT BASED INDIVIDU; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Roberts J. A., 2014, THESIS; SCHEFFER M, 1995, ECOL MODEL, V80, P161, DOI 10.1016/0304-3800(94)00055-M; Sohal RS, 2014, FREE RADICAL BIO MED, V73, P366, DOI 10.1016/j.freeradbiomed.2014.05.015; Sousa T, 2010, PHILOS T R SOC B, V365, P3413, DOI 10.1098/rstb.2010.0166; Southwell D, 2015, MAR ECOL PROG SER, V526, P183, DOI 10.3354/meps11182; van den Hoff J, 2004, WILDLIFE RES, V31, P619, DOI 10.1071/WR03101; van den Hoff J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2842; van der Meer J, 2006, J SEA RES, V56, P85, DOI 10.1016/j.seares.2006.03.001; Wilensky U., 1999, NETLOGO NETLOGO US M; Xavier JC, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00094	88	14	14	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194950	10.1371/journal.pone.0194950	http://dx.doi.org/10.1371/journal.pone.0194950			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596456	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000428630000057
J	Napolitano, F; Navaro, M; Vezzosi, L; Santagati, G; Angelillo, IF				Napolitano, Francesco; Navaro, Monica; Vezzosi, Luigi; Santagati, Gabriella; Angelillo, Italo Francesco			Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; GENERAL-PRACTITIONERS; KNOWLEDGE; PHYSICIANS; TRANSMISSION; INFLUENZA; VACCINES; IMMUNIZATION; ADOLESCENTS; PREVALENCE	This national online cross-sectional survey in Italy assessed primary care pediatricians' (PCPs) attitudes and practices regarding Human papillomavirus (HPV) vaccination and the contribution of several characteristics. The questionnaire was distributed from September 2016 to June 2017 to a random sample of 640 PCPs by email via an internet-link leading to a web-based survey platform (Lime Survey). Only 18.4% of PCPs always recommend the HPV vaccine to 11-12 year old boys. PCPs with longer practice activity, working in solo practice, always recommended the HPV vaccine to 11-12 year old girls, and believed that the vaccine was effective for boys were more likely to always recommend the HPV vaccine. PCPs working in a Region where the vaccination was actively recommended and provided free of charge to 11-12 year old boys had higher odds of recommending vaccination. More than two thirds of PCPs (77.4%) always recommend the HPV vaccine to 11-12 year old girls. PCPs who believed that the vaccine was effective for girls and safe in both boys and girls, who always talk with patients of 11-18 years or their parents about HPV infection and vaccination, and who obtain vaccine information from scientific journals were more likely to always recommend the vaccine. PCPs should employ evidence-based educational strategies in order to achieve a better coverage and to reduce the morbidities and mortality of diseases associated with HPV.	[Napolitano, Francesco; Navaro, Monica; Vezzosi, Luigi; Santagati, Gabriella; Angelillo, Italo Francesco] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Angelillo, IF (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.	italof.angelillo@unicampania.it	Vezzosi, Luigi/HHZ-4047-2022; Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; Napolitano, Francesco/0000-0003-4694-2418; Vezzosi, Luigi/0000-0001-6461-2231				Adey LA, 2006, DESIGNING CONDUCTING; Allison MA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2488; Anastasi D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-463; Anton-Ladislao A, 2015, VACCINE, V33, P885, DOI 10.1016/j.vaccine.2014.12.012; Awali RA, 2014, AM J INFECT CONTROL, V42, P649, DOI 10.1016/j.ajic.2014.02.025; Bahmanyar ER, 2012, GYNECOL ONCOL, V127, P440, DOI 10.1016/j.ygyno.2012.08.033; Bianco A, 2014, HUM VACC IMMUNOTHER, V10, P2536, DOI 10.4161/21645515.2014.969614; Breitkopf CR, 2016, CANCER MED-US, V5, P3346, DOI 10.1002/cam4.933; Brisson M, 2016, LANCET PUBLIC HEALTH, V1, pE8, DOI 10.1016/S2468-2667(16)30001-9; Canon C, 2017, J CANCER EDUC, V32, P382, DOI 10.1007/s13187-016-0999-0; Chadenier GMC, 2011, VACCINE, V29, P4405, DOI 10.1016/j.vaccine.2011.04.007; Collange F, 2016, VACCINE, V34, P762, DOI 10.1016/j.vaccine.2015.12.054; Daley MF, 2010, PEDIATRICS, V126, P425, DOI 10.1542/peds.2009-3500; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Di Giuseppe G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-176; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Federazione Nazionale degli Ordini dei Medici Chirurghi e degli Odontoiatri. CED, SIT NAZ SPEC SUDD SE; Ferris D, 2014, PEDIATRICS, V134, pE657, DOI 10.1542/peds.2013-4144; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Giuliano AR, 2015, INT J CANCER, V136, P2752, DOI 10.1002/ijc.29082; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Jackowska J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141003; Jing LP, 2014, SEX TRANSM DIS, V41, P725, DOI 10.1097/OLQ.0000000000000201; Killian M, 2016, EUR J CLIN MICROBIOL, V35, P1837, DOI 10.1007/s10096-016-2735-4; Kulczycki A, 2016, MATERN CHILD HLTH J, V20, P2539, DOI 10.1007/s10995-016-2079-9; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; McBride KR, 2017, HLTH ED BEHAV; McRee AL, 2014, J PEDIATR HEALTH CAR, V28, P541, DOI 10.1016/j.pedhc.2014.05.003; Ministero della Salute, VACC CONTR PAP VIR H; Ministero Della Salute, PIAN NAZ PREV VACC P; Mortensen GL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1863-6; Napolitano F, 2016, HUM VACC IMMUNOTHER, V12, P1504, DOI 10.1080/21645515.2016.1156271; Nicol AF, 2015, ANN DIAGN PATHOL, V19, P418, DOI 10.1016/j.anndiagpath.2015.07.008; Nicotera G, 2004, ORAL ONCOL, V40, P490, DOI 10.1016/j.oraloncology.2003.10.001; Nikolic Z, 2015, J PEDIATR ADOL GYNEC, V28, P12, DOI 10.1016/j.jpag.2014.01.107; Oakeshott P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4168; Perez MRO, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0034-9; Parmeggiani C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-35; Pavia M, 2003, PUBLIC HEALTH, V117, P202, DOI 10.1016/S0033-3506(03)00066-0; Pelullo CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042856; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Stata Corporation, 2007, STAT REF MAN REL 10; Vadaparampil ST, 2011, VACCINE, V29, P8634, DOI 10.1016/j.vaccine.2011.09.006; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Vichnin M, 2015, PEDIATR INFECT DIS J, V34, P983, DOI 10.1097/INF.0000000000000793; Weltermann BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105119; Wong LP, 2017, J OBSTET GYNAECOL, V37, P937, DOI 10.1080/01443615.2017.1317239; Wong TY, 2017, CURR PROBL DIAGN RAD, V46, P263, DOI 10.1067/j.cpradiol.2016.11.003; World Health Organization, 2014, HUM PAP VACC WHO POS	49	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194920	10.1371/journal.pone.0194920	http://dx.doi.org/10.1371/journal.pone.0194920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596515	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000050
J	Stegmaier, J; Mikut, R				Stegmaier, Johannes; Mikut, Ralf			Fuzzy-based propagation of prior knowledge to improve large-scale image analysis pipelines (vol 12, e0187535, 2017)	PLOS ONE			English	Correction													Stegmaier, Johannes/ABA-4230-2021; Mikut, Ralf/A-5949-2013	Stegmaier, Johannes/0000-0003-4072-3759; Mikut, Ralf/0000-0001-9100-5496				Stegmaier J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187535	1	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195394	10.1371/journal.pone.0195394	http://dx.doi.org/10.1371/journal.pone.0195394			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596511	gold, Green Published			2022-12-27	WOS:000428630000108
J	Takahashi, S; Tanaka, F; Yonekura, Y; Tanno, K; Ohsawa, M; Sakata, K; Koshiyama, M; Okayama, A; Nakamura, M				Takahashi, Shuko; Tanaka, Fumitaka; Yonekura, Yuki; Tanno, Kozo; Ohsawa, Masaki; Sakata, Kiyomi; Koshiyama, Makoto; Okayama, Akira; Nakamura, Motoyuki			The urine albumin-creatinine ratio is a predictor for incident long-term care in a general population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TYPE-2 DIABETES-MELLITUS; LOW-GRADE ALBUMINURIA; SMALL VESSEL DISEASE; COGNITIVE IMPAIRMENT; CARDIOVASCULAR-DISEASE; OLDER-ADULTS; RISK; INDIVIDUALS; MICROALBUMINURIA	Background Several types of cardiovascular diseases (CVDs) impair the physical and mental status. The purpose of this study was to assess the predictive ability of several cardiovascular biomarkers for identifying the incidence of disability as future recipients of public long-term care (LTC) service. Methods The subjects of this study were community-dwelling elderly individuals >= 65 years of age without a history of CVD (n = 5,755; mean age, 71 years). The endpoint of this study was official certification as a recipient of LTC. The cohort was divided into quartiles (Qs) based on the levels of three CVD biomarkers: the urinary albumin-creatinine ratio (UACR), plasma B-type natriuretic peptide concentration (BNP), and serum high-sensitivity C-reactive protein concentration (hsCRP). A time-dependent Cox proportional hazard model was used to determine the multi-adjusted relative hazard ratios (HRs) for incident LTC among the quartiles of each biomarker. Results During the follow-up (mean 5.6 years), 710 subjects were authorized as recipients of LTC. The HR was only significantly increased in the higher Qs of UACR (03, p < 0.01; 04, p < 0.001). However, other biomarkers were not significantly associated with the endpoint. The risk predictive performance for the incidence of LTC as evaluated by an essential model (i.e. age-and sex-adjusted) was significantly improved by incorporating the UACR (net reclassification improvement = 0.084, p < 0.01; integrated discrimination improvement = 0.0018, p < 0.01). Conclusions These results suggest that an increased UACR is useful for predicting physical and cognitive dysfunction in an elderly general population.	[Takahashi, Shuko; Tanaka, Fumitaka; Nakamura, Motoyuki] Iwate Med Univ, Div Cardioangiol, Dept Internal Med, Morioka, Iwate, Japan; [Yonekura, Yuki] St Lukes Int Univ, Chuo Ku, Akashi Cho, Tokyo, Japan; [Tanno, Kozo; Sakata, Kiyomi] Iwate Med Univ, Sch Med, Dept Hyg & Prevent Med, Yahaba, Iwate, Japan; [Ohsawa, Masaki] Morioka Tsunagi Onsen Hosp, Morioka, Iwate, Japan; [Koshiyama, Makoto] Iwate Hlth Serv Assoc, Morioka, Iwate, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Chuo Ku, Tokyo, Japan	Iwate Medical University; St. Luke's International Hospital; Iwate Medical University	Takahashi, S (corresponding author), Iwate Med Univ, Div Cardioangiol, Dept Internal Med, Morioka, Iwate, Japan.	shutakahashi-iwt@umin.ac.jp	Ohsawa, Masaki/AAJ-5030-2020; Tanno, Kozo/HDM-5952-2022; Tanno, Kozo/ABE-5165-2020; Yonekura, Yuki/C-5973-2013	Ohsawa, Masaki/0000-0002-1152-1958; Tanno, Kozo/0000-0002-1264-0684; Tanno, Kozo/0000-0002-1264-0684; Yonekura, Yuki/0000-0002-2590-2022	Ministry of Education, Science, and Culture of Japan, Tokyo, Japan [26461082, 17K09520]; Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan; Grants-in-Aid for Scientific Research [15K08745] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants-in-aid from the scientific research funds of the Ministry of Education, Science, and Culture of Japan (Nos. 26461082 and 17K09520), Tokyo, Japan and the Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoudad S, 2015, INT J STROKE, V10, P603, DOI 10.1111/ijs.12465; Anan F, 2011, METABOLISM, V60, P460, DOI 10.1016/j.metabol.2010.04.002; [Anonymous], 2013, ELD PERS AG 65 YEARS; [Anonymous], 2016, CURR STAT TRENDS ELD; [Anonymous], 2013, STAT REP LONG TERM C; [Anonymous], 2010, SUMM REP COMPR SURV; [Anonymous], 2002, LONG TERM CAR INS SY; [Anonymous], 2013, OUTL RES NAT LVEL SU; BRANCH LG, 1982, AM J PUBLIC HEALTH, V72, P1373, DOI 10.2105/AJPH.72.12.1373; Chang CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep39434; Cho EB, 2016, SCI REP-UK, V6, DOI 10.1038/srep20692; Dhamoon MS, 2015, NEUROLOGY, V84, P1002, DOI 10.1212/WNL.0000000000001331; Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844; Fried L, 2012, CLIN J AM SOC NEPHRO, V7, P376, DOI 10.2215/CJN.00210112; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; IOM (Institute of Medicine), 2010, CARD DIS UPD SOC SEC; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Johnson RW, 2007, M FUTURE LONG TERM C; Kalaria RN, 2016, BBA-MOL BASIS DIS, V1862, P915, DOI 10.1016/j.bbadis.2016.01.015; Knopman DS, 2010, AM J EPIDEMIOL, V171, P287, DOI 10.1093/aje/kwp429; Mehta D, 2014, METABOLISM, V63, P1390, DOI 10.1016/j.metabol.2014.07.008; Nakamura M, 2004, INTERNAL MED, V43, P919, DOI 10.2169/internalmedicine.43.919; Ohsawa M, 2009, INT J CARDIOL, V137, P226, DOI 10.1016/j.ijcard.2008.06.052; Olsen MH, 2010, CURR VASC PHARMACOL, V8, P134, DOI 10.2174/157016110790226633; Sajjad I, 2012, CLIN J AM SOC NEPHRO, V7, P437, DOI 10.2215/CJN.05330611; Singh M, 2014, EUR HEART J, V35, P1726, DOI 10.1093/eurheartj/ehu197; Tanaka F, 2016, J HYPERTENS, V34, P506, DOI 10.1097/HJH.0000000000000809; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Verghese J, 2012, AGE AGEING, V41, P541, DOI 10.1093/ageing/afs038; Wada M, 2007, J NEUROL SCI, V255, P27, DOI 10.1016/j.jns.2007.01.066	31	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195013	10.1371/journal.pone.0195013	http://dx.doi.org/10.1371/journal.pone.0195013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590199	gold, Green Published, Green Submitted			2022-12-27	WOS:000428603100097
J	Welty, SE; Rusin, CG; Stanberry, LI; Mandy, GT; Gest, AL; Ford, JM; Backes, CH; Richardson, CP; Howard, CR; Hansen, TN; Smith, CV				Welty, Stephen E.; Rusin, Craig G.; Stanberry, Larissa I.; Mandy, George T.; Gest, Alfred L.; Ford, Jeremy M.; Backes, Carl H., Jr.; Richardson, C. Peter; Howard, Christopher R.; Hansen, Thomas N.; Smith, Charles V.			Short term evaluation of respiratory effort by premature infants supported with bubble nasal continuous airway pressure using Seattle-PAP and a standard bubble device	PLOS ONE			English	Article							PRETERM INFANTS; OXYGEN COST; CPAP; STRATEGIES; EFFICACY; MOTHERS; SAFETY	Background Almost one million prematurely born infants die annually from respiratory insufficiency, pre-dominantly in countries with limited access to respiratory support for neonates. The primary hypothesis tested in the present study was that a modified device for bubble nasal continuous positive airway pressure (Bn-CPAP) would provide lower work of spontaneous breathing, estimated by esophageal pressure-rate products. Methods Infants born <32 weeks gestation and stable on Bn-CPAP with FiO(2) <0.30 were studied within 72 h following delivery. Esophageal pressures during spontaneous breathing were measured during 2 h on standard Bn-CPAP, then 2 h with Bn-CPAP using a modified bubble device presently termed Seattle-PAP, which produces a different pattern of pressure fluctuations and which provided greater respiratory support in preclinical studies, then 2 h on standard Bn-CPAP. Results All 40 infants enrolled completed the study and follow-up through 36 wks post menstrual age or hospital discharge, whichever came first. No infants were on supplemental oxygen at completion of follow-up. No infants developed pneumothoraces or nasal trauma, and no adverse events attributed to the study were observed. Pressure-rate products on the two devices were not different, but effort of breathing, assessed by areas under esophageal pressure-time curves, was lower with Seattle-PAP than with standard Bn-CPAP. Conclusion Use of Seattle-PAP to implement Bn-CPAP lowers the effort of breathing exerted even by relatively healthy spontaneously breathing premature neonates. Whether the lower effort of breathing observed with Seattle-PAP translates to improvements in neonatal mortality or morbidity will need to be determined by studies in appropriate patient populations.	[Welty, Stephen E.; Smith, Charles V.] Univ Washington, Dept Pediat, Coll Med, Seattle, WA 98195 USA; [Rusin, Craig G.; Mandy, George T.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Stanberry, Larissa I.; Ford, Jeremy M.; Richardson, C. Peter; Howard, Christopher R.; Hansen, Thomas N.] Seattle Childrens Res Inst, Dept Pediat, Ctr Dev Therapeut, Seattle, WA USA; [Gest, Alfred L.] West Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV USA; [Backes, Carl H., Jr.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Backes, Carl H., Jr.] Ohio State Univ, Coll Med, Ctr Perinatal Res, Columbus, OH 43210 USA; [Backes, Carl H., Jr.] Sch Publ Hlth, Columbus, OH USA	University of Washington; University of Washington Seattle; Baylor College of Medicine; Seattle Children's Hospital; West Virginia University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Smith, CV (corresponding author), Univ Washington, Dept Pediat, Coll Med, Seattle, WA 98195 USA.	charles.smith@seattlechildrens.org	Hansen, Thomas/GWZ-2858-2022; Welty, Stephen/AAZ-4307-2021; Welty, Stephen/AGS-7454-2022	Welty, Stephen/0000-0002-6321-8440	The Bill & Melinda Gates Foundation [OPP1094124]	The Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The work described was supported by OPP1094124 (TNH, CVS) from The Bill & Melinda Gates Foundation (www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bahman-Bijari B, 2011, IRAN J PEDIATR, V21, P151; BELLEMARE F, 1982, J APPL PHYSIOL, V53, P1196, DOI 10.1152/jappl.1982.53.5.1196; BELLEMARE F, 1982, J APPL PHYSIOL, V53, P1190, DOI 10.1152/jappl.1982.53.5.1190; Bhutta ZA, 2004, BRIT MED J, V329, P1151, DOI 10.1136/bmj.329.7475.1151; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Carlo WA, 2014, PEDIATRICS, V133, P171, DOI 10.1542/peds.2013-3442; Courtney SE, 2011, J PERINATOL, V31, P44, DOI 10.1038/jp.2010.55; Dargaville PA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3985; Diblasi RM, 2010, PEDIATR RES, V67, P624, DOI 10.1203/PDR.0b013e3181dcd580; FIELD S, 1982, AM REV RESPIR DIS, V126, P9; Glantz S. A., 2005, PRIMER BIOSTATISTICS; GOTANDA K, 1988, JPN J PHARMACOL, V47, P217, DOI 10.1254/jjp.47.217; HANSEN TN, 1979, PEDIATR RES, V13, P1167, DOI 10.1203/00006450-197910000-00018; Jadcherla SR, 2007, J PEDIATR-US, V151, P597, DOI 10.1016/j.jpeds.2007.04.042; Jensen EA, 2016, SEMIN FETAL NEONAT M, V21, P133, DOI 10.1016/j.siny.2016.02.010; Jensen EA, 2016, SEMIN FETAL NEONAT M, V21, P181, DOI 10.1016/j.siny.2016.02.003; Jobe A H, 2001, Semin Neonatol, V6, P331, DOI 10.1053/siny.2001.0068; LANDERS S, 1986, PEDIATR RES, V20, P884, DOI 10.1203/00006450-198609000-00016; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Martin S, 2014, ARCH DIS CHILD-FETAL, V99, pF495, DOI 10.1136/archdischild-2013-305519; McKenzie DK, 1995, ADV EXP MED BIOL, V384, P401; Munar W, 2015, SEMIN PERINATOL, V39, P416, DOI 10.1053/j.semperi.2015.06.003; Otis AB, 1976, HDB PHYSL 3, P463; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pillow JJ, 2007, AM J RESP CRIT CARE, V176, P63, DOI 10.1164/rccm.200609-1368OC; Roussos C, 2003, EUR RESPIR J, V22, p3S, DOI 10.1183/09031936.03.00038503; ROUSSOS CS, 1977, J APPL PHYSIOL, V43, P189, DOI 10.1152/jappl.1977.43.2.189; Sahni R, 2016, SEMIN FETAL NEONAT M, V21, P196, DOI 10.1016/j.siny.2016.02.008; SAUNDERS RA, 1976, BIOL NEONATE, V29, P178; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5980; Subramaniam P, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001243.pub3; Tagare A, 2013, J TROP PEDIATRICS, V59, P113, DOI 10.1093/tropej/fms061; Tapia JL, 2012, J PEDIATR-US, V161, P75, DOI 10.1016/j.jpeds.2011.12.054; THIBEAULT DW, 1966, PEDIATRICS, V37, P954; Thukral A, 2016, J PERINATOL, V36, pS21, DOI 10.1038/jp.2016.29; Vucovich MM, 2014, AM J PHYSIOL-HEART C, V307, pH732, DOI 10.1152/ajpheart.00838.2013; Welty SE, 2016, CLIN PERINATOL, V43, P661, DOI 10.1016/j.clp.2016.07.004	41	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193807	10.1371/journal.pone.0193807	http://dx.doi.org/10.1371/journal.pone.0193807			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590143	Green Published, gold			2022-12-27	WOS:000428603100033
J	Wu, MR; Hsiao, CY; Cheng, CH; Liao, FC; Chao, CL; Chen, CY; Yeh, HI; Su, MI				Wu, Meng-Ruey; Hsiao, Chia-Ying; Cheng, Chun-Han; Liao, Feng-Ching; Chao, Chuan-Lei; Chen, Chun-Yen; Yeh, Hung-I; Su, Min-I			Is endotracheal intubation a non-beneficial treatment in patients with respiratory failure due to paraquat poisoning?	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CLINICAL-FEATURES; PALLIATIVE CARE; PULSE THERAPY; CYCLOPHOSPHAMIDE; PLASMA; METHYLPREDNISOLONE; TOXICITY; MODERATE; SUICIDE	Introduction Paraquat poisoning can result in dysfunction of multiple organs, and pulmonary fibrosis with respiratory failure is the major cause of mortality. For terminally ill patients, some life-prolonging treatments can be non-beneficial treatments (NBT). The objective of this study was to determine if intubation is a NBT for patients with respiratory failure due to paraquat poisoning. Methods The study included 68 patients with respiratory failure due to paraquat poisoning. Patients were hospitalized at MacKay Memorial Hospital, Taitung Branch, Taiwan, between 2005 to April 2016. Composite outcomes of intra-hospital mortality, the rate of do-not-resuscitate (DNR) orders, prescribed medications, length of stay, and medical costs were recorded and compared between the do-not-intubate (DNI) group and endotracheal intubation (EI) group. Results Intra-hospital mortality rate for the entire population was 100%. There were significantly more patients with DNR orders in the DNI group (P = 0.007). There were no differences in the length of hospital stay. However, patients in DNI group had significantly less vasopressor use and more morphine use, shorter time in the intensive care unit, and fewer medical costs. Conclusion The procedure of intubation in patients with respiratory failure due to paraquat poisoning can be considered inappropriate life-prolonging treatment.	[Wu, Meng-Ruey; Hsiao, Chia-Ying] MacKay Mem Hosp, Dept Internal Med, Div Nephrol, Taitung Branch, Taipei, Taiwan; [Cheng, Chun-Han] MacKay Mem Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Liao, Feng-Ching; Chao, Chuan-Lei; Su, Min-I] MacKay Mem Hosp, Dept Internal Med, Div Cardiol, Taitung Branch, Taipei, Taiwan; [Chen, Chun-Yen; Yeh, Hung-I] MacKay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chen, Chun-Yen; Yeh, Hung-I; Su, Min-I] MacKay Med Coll, New Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical College	Su, MI (corresponding author), MacKay Mem Hosp, Dept Internal Med, Div Cardiol, Taitung Branch, Taipei, Taiwan.; Su, MI (corresponding author), MacKay Med Coll, New Taipei, Taiwan.	wwfsone@gmail.com		Su, Min-I/0000-0002-9523-9676; Cheng, Chun-han/0000-0002-7262-861X				BATEMAN DN, 1987, HUM TOXICOL, V6, P57, DOI 10.1177/096032718700600109; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; Campbell ML, 2004, CRIT CARE MED, V32, P1839, DOI 10.1097/01.CCM.0000138560.56577.88; Cha ES, 2016, INT J EPIDEMIOL, V45, P470, DOI 10.1093/ije/dyv304; Cheung W, 2010, CRIT CARE RESUSC, V12, P28; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Downar J, 2015, CRIT CARE MED, V43, P270, DOI 10.1097/CCM.0000000000000704; Greisinger AJ, 1997, CANCER PRACT, V5, P147; Kim SJ, 2009, NEPHROL DIAL TRANSPL, V24, P1226, DOI 10.1093/ndt/gfn615; Kyeremanteng K, 2016, J INTENSIVE CARE MED; Lee HL, 2008, HUM EXP TOXICOL, V27, P373, DOI 10.1177/0960327108094609; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Lorenz K, 2004, END LIFE CARE OUTCOM; MCCUNE WJ, 1988, NEW ENGL J MED, V318, P1423, DOI 10.1056/NEJM198806023182203; Norton SA, 2007, CRIT CARE MED, V35, P1530, DOI 10.1097/01.CCM.0000266533.06543.0C; PROUDFOOT AT, 1979, LANCET, V2, P330; SCHERRMANN JM, 1987, HUM TOXICOL, V6, P91, DOI 10.1177/096032718700600116; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Singal RK, 2014, CAN RESPIR J, V21, P165, DOI 10.1155/2014/429789; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; SUZUKI K, 1993, HUM EXP TOXICOL, V12, P323, DOI 10.1177/096032719301200411; Tsai TY, 2011, HUM EXP TOXICOL, V30, P71, DOI 10.1177/0960327110368419; Walker KA, 2013, J PALLIAT MED, V16, P1237, DOI 10.1089/jpm.2013.0052; Wu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094697; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195071	10.1371/journal.pone.0195071	http://dx.doi.org/10.1371/journal.pone.0195071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590187	gold, Green Published			2022-12-27	WOS:000428603100102
J	da Silva, MJF; Kopp, GH; Casanova, C; Godinho, R; Minhos, T; Sa, R; Zinner, D; Bruford, MW				Ferreira da Silva, Maria Joana; Kopp, Gisela H.; Casanova, Catarina; Godinho, Raquel; Minhos, Tania; Sa, Rui; Zinner, Dietmar; Bruford, Michael W.			Disrupted dispersal and its genetic consequences: Comparing protected and threatened baboon populations (Papio papio) in West Africa	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; MITOCHONDRIAL-DNA VARIATION; SPATIAL AUTOCORRELATION; PATTERNS; MIGRATION; DYNAMICS; HETEROGENEITY; CONSERVATION; IMMIGRATION; RELATEDNESS	Dispersal is a demographic process that can potentially counterbalance the negative impacts of anthropogenic habitat fragmentation. However, mechanisms of dispersal may become modified in populations living in human-dominated habitats. Here, we investigated dispersal in Guinea baboons (Papio papio) in areas with contrasting levels of anthropogenic fragmentation, as a case study. Using molecular data, we compared the direction and extent of sex-biased gene flow in two baboon populations: from Guinea-Bissau (GB, fragmented distribution, human-dominated habitat) and Senegal (SEN, continuous distribution, protected area). Individual-based Bayesian clustering, spatial autocorrelation, assignment tests and migrant identification suggested female-mediated gene flow at a large spatial scale for GB with evidence of contact between genetically differentiated males at one locality, which could be interpreted as male-mediated gene flow in southern GB. Gene flow was also found to be female-biased in SEN for a smaller scale. However, in the southwest coastal part of GB, at the same geographic scale as SEN, no sex-biased dispersal was detected and a modest or recent restriction in GB female dispersal seems to have occurred. This population-specific variation in dispersal is attributed to behavioural responses to human activity in GB. Our study highlights the importance of considering the genetic consequences of disrupted dispersal patterns as an additional impact of anthropogenic habitat fragmentation and is potentially relevant to the conservation of many species inhabiting human-dominated environments.	[Ferreira da Silva, Maria Joana; Bruford, Michael W.] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [Ferreira da Silva, Maria Joana; Godinho, Raquel] Univ Porto, CIBIO InBio, Ctr Invest Biodiversidade & Recursos Genet, Campus Agratio Vairao, Vairao, Portugal; [Ferreira da Silva, Maria Joana; Casanova, Catarina] Univ Lisbon, Sch Social & Polit Sci, CAPP, Rua Almerindo, Lisbon, Portugal; [Kopp, Gisela H.; Zinner, Dietmar] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Godinho, Raquel] Univ Porto, Fac Ciencias, Dept Biol, Rua Campo Alegre, Porto, Portugal; [Godinho, Raquel] Univ Johannesburg, Dept Zool, Fac Sci, Auckland Pk, South Africa; [Minhos, Tania] Univ Nova Lisboa, Fac Ciencias Sociais & Humanas, Dept Antropol, Lisbon, Portugal; [Minhos, Tania] Inst Univ Lisboa, Ctr Res Anthropol CRIA, Lisbon, Portugal; [Minhos, Tania] IGC, Rua Quinta Grande, Oeiras, Portugal; [Sa, Rui] Univ Lusofona Guine, Dept Ciencias Ambientais, Rua Vitorino Costa, Bissau, Guinea Bissau; [Sa, Rui] Univ Coimbra, Res Ctr Anthropol & Hlth, Coimbra, Portugal; [Bruford, Michael W.] Cardiff Univ, Sustainable Places Res Inst, Cardiff, S Glam, Wales; [Kopp, Gisela H.] Univ Konstanz, Zukunftskolleg, Constance, Germany; [Kopp, Gisela H.] Univ Konstanz, Dept Biol, Constance, Germany; [Kopp, Gisela H.] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany	Cardiff University; Universidade do Porto; Universidade de Lisboa; Deutsches Primatenzentrum (DPZ); Universidade do Porto; University of Johannesburg; Universidade Nova de Lisboa; Instituto Universitario de Lisboa; Universidade de Coimbra; Cardiff University; University of Konstanz; University of Konstanz; Max Planck Society	da Silva, MJF (corresponding author), Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales.; da Silva, MJF (corresponding author), Univ Porto, CIBIO InBio, Ctr Invest Biodiversidade & Recursos Genet, Campus Agratio Vairao, Vairao, Portugal.; da Silva, MJF (corresponding author), Univ Lisbon, Sch Social & Polit Sci, CAPP, Rua Almerindo, Lisbon, Portugal.	ferreiradasilvamj@cf.ac.uk	Bruford, Michael W/D-3750-2009; Sá, Rui M./AAG-4028-2019; Da Silva, Maria Ferreira/C-5373-2012; Kopp, Gisela/AAB-3943-2020; Godinho, Raquel/L-6804-2013	Bruford, Michael W/0000-0001-6357-6080; Sá, Rui M./0000-0001-6407-4541; Da Silva, Maria Ferreira/0000-0001-6747-9827; Kopp, Gisela/0000-0001-8396-3264; Godinho, Raquel/0000-0002-4260-4799; Zinner, Dietmar/0000-0003-3967-8014; Casanova, Catarina/0000-0003-2123-0262	Portuguese Science and Technology Foundation (FCT) by the Ministerio da Educacao e Ciencia [SFRH/BPD/88496/2012, SFRH/BPD/87396/2012]; European Social Funds through POPH - QREN - Tipologia 4.1 Formacao Avancada; FCT IF [IF/00564/2012]; FCT [IF/00564/2012/CP0159/CT0003]; German Science Foundation [DFG Fi 707/9-1]; German Academic Exchange Service (DAAD); Christian-Vogel-Fonds; German Initiative of Excellence	Portuguese Science and Technology Foundation (FCT) by the Ministerio da Educacao e Ciencia; European Social Funds through POPH - QREN - Tipologia 4.1 Formacao Avancada; FCT IF(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); German Science Foundation(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Christian-Vogel-Fonds; German Initiative of Excellence	MJFS and TM were supported through Portuguese Science and Technology Foundation (FCT) postdoctoral fellowships (SFRH/BPD/88496/2012 to MJFS and SFRH/BPD/87396/2012 to TM) funded by the Ministerio da Educacao e Ciencia and European Social Funds through POPH - QREN - Tipologia 4.1 Formacao Avancada), http://www.fct.pt/. RG was supported by FCT IF's contract (IF/00564/2012). This work was partially funded by FCT (project IF/00564/2012/CP0159/CT0003). GHK was funded by the German Science Foundation (DFG Fi 707/9-1), http://www.dfg.de/en/, the German Academic Exchange Service (DAAD) https://www.daad.de/en/, the Christian-Vogel-Fonds - http://www.gf-primatologie.de and the German Initiative of Excellence, http://www.dfg.de/en/research_funding/programmes/excellence_initiative/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2001, AM J PRIMATOL, V53, P139, DOI 10.1002/ajp.1; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Amador R, 2014, J PRIMATOLOGY, V3; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Bayes M. K., 2000, Conservation Genetics, V1, P173, DOI 10.1023/A:1026595324974; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beck NR, 2008, MOL ECOL, V17, P4346, DOI 10.1111/j.1365-294X.2008.03906.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Borges F., 2017, COUNTRY LEVEL GENETI; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bronikowski AM, 2002, P NATL ACAD SCI USA, V99, P9591, DOI 10.1073/pnas.142675599; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Ca A., 2008, ESTUDOS CACA MERCADO; Casanova C, PLANO ACCAO NACL CON; Chaine AS, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P63; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Cobben MMP, 2015, J THEOR BIOL, V373, P92, DOI 10.1016/j.jtbi.2015.03.019; Cowlishaw C, 2000, PRIMATE CONSERVATION; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; DiBattista JD, 2008, CONSERV GENET, V9, P141, DOI 10.1007/s10592-007-9317-z; Driscoll DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095053; Earl DA, 2012, CONSERVATION GENETIC; ELLSWORTH DL, 1994, EVOLUTION, V48, P122, DOI 10.1111/j.1558-5646.1994.tb01299.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Ferreira da Silva M, 2012, HUNTING PRESSURE POP; Ferreira da Silva M, 2013, J THREATENED TAXA, V5, P441; da Silva MJF, 2014, CONSERV GENET, V15, P1339, DOI 10.1007/s10592-014-0621-0; Ferreira da Silva MJ, 2017, INT ENCY PRIMATOLOGY; Fontanillas P, 2004, EVOLUTION, V58, P886; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Galat Gerard, 2000, African Primates, V4, P69; Galat-Luong A, 2006, REPROD FITNESS BABOO; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hapke A, 2001, BEHAV ECOL SOCIOBIOL, V50, P483, DOI 10.1007/s002650100393; Hsu MJ, 2001, ZOOL STUD, V40, P49; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Isbell LA, 1996, BEHAVIOUR, V133, P1, DOI 10.1163/156853996X00017; Jedrzejewski W, 2005, ACTA THERIOL, V50, P3, DOI 10.1007/BF03192614; Ji W, 2001, MOL ECOL, V10, P1527, DOI 10.1046/j.1365-294X.2001.01287.x; Jolly CJ, 2009, CURR ANTHROPOL, V50, P187, DOI 10.1086/597196; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kopp GH, 2014, INT J PRIMATOL, V35, P210, DOI 10.1007/s10764-013-9725-5; Kopp GH, 2015, GENE FLOW DYNAMICS B; Kopp GH, 2015, AM J PRIMATOL, V77, P878, DOI 10.1002/ajp.22415; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Minhos T, 2013, BIOL CONSERV, V167, P43, DOI 10.1016/j.biocon.2013.07.018; Minhos T, 2013, AM J PHYS ANTHROPOL, V150, P464, DOI 10.1002/ajpa.22223; Nyakaana S, 2001, ANIM CONSERV, V4, P231, DOI 10.1017/S1367943001001275; Oates J, PAPIO PAPIO; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Patzelt A, 2014, P NATL ACAD SCI USA, V111, P14740, DOI 10.1073/pnas.1405811111; Patzelt A, 2011, INT J PRIMATOL, V32, P652, DOI 10.1007/s10764-011-9493-z; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez-Espona S, 2010, MOL ECOL, V19, P3101, DOI 10.1111/j.1365-294X.2010.04733.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Radespiel U, 2014, CONSERV GENET, V15, P245, DOI 10.1007/s10592-013-0550-3; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Renaud P, 2006, INVENTAIRE AERIEN TE; Roeder AD, 2009, FOLIA PRIMATOL, V80, P63, DOI 10.1159/000211121; Schubert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012929; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; StGeorge D, 1996, INT J PRIMATOL, V19, P273; Strier K.B., 2007, PRIMATE BEHAV ECOLOG, V3rd ed.; Sugiyama Y, 1999, PRIMATES, V40, P61, DOI 10.1007/BF02557702; Teixeira, 2016, LANDSCAPE GENETICS G; Temudo Marina Padrão, 2009, Etnográfica, V13, P237; Tung J, 2008, MOL ECOL, P17; Vale CG, 2015, J NAT CONSERV, V27, P26, DOI 10.1016/j.jnc.2015.06.004; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wooley-Barker T., 1999, SOCIAL ORG GENETIC S	84	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194189	10.1371/journal.pone.0194189	http://dx.doi.org/10.1371/journal.pone.0194189			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614097	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000429081600009
J	Iheonu, FO; Fajolu, IB; Ezeaka, CV; Oyibo, WA				Iheonu, Franca Ogechi; Fajolu, Iretiola Bamikeolu; Ezeaka, Chinyere Veronica; Oyibo, Wellington Aghoghovwia			Transfusional malaria in the neonatal period in Lagos, South-West Nigeria	PLOS ONE			English	Article							TRANSMITTED MALARIA; BLOOD-TRANSFUSION	Background and objectives Sick neonates in malaria endemic areas are frequently transfused with donor blood unscreened for malaria parasite. Consequently, they are at risk of transfusional malaria which can lead to increased neonatal mortality. The study aimed to determine the burden of transfusional malaria in neonates to help in policy formulation on prevention of transfusional malaria. Materials and methods One hundred and sixty four neonates admitted into the neonatal unit of a tertiary hospital over a 10 month period who were scheduled for blood transfusion were screened for malaria parasites pre-transfusion, at three and 14 days post transfusion using Giemsa stained thick and thin films. Donor blood was screened for malaria parasites at the point of transfusion. Neonates who developed malaria parasitaemia post transfusion were followed up for signs of malaria. Results All recruited neonates tested negative to malaria parasite pre-transfusion. One hundred and twenty (73.2%) were term neonates with 94(57.3%) aged 1-7days. Four (2.4%) neonates developed malaria parasitaemia three days post transfusion and all four developed fever that resolved on treatment for malaria. Three (1.8%) of 164 donor blood samples had malaria parasitaemia and all three (100%) neonates who were transfused with the infected donor blood developed malaria parasitaemia post transfusion. However, one neonate who developed malaria parasitaemia post transfusion was transfused with non-infected donor blood. Conclusions The prevalence of transfusional malaria in this study is low (2.4%). However, 100% of neonates who received malaria infected donor blood developed transfusional malaria. We therefore recommend routine screening of donor pre-transfusion, testing of neonates who develop fever post transfusion and treatment of those who test positive to malaria.	[Iheonu, Franca Ogechi; Fajolu, Iretiola Bamikeolu; Ezeaka, Chinyere Veronica] Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Fajolu, Iretiola Bamikeolu; Ezeaka, Chinyere Veronica] Univ Lagos, Dept Paediat, Coll Med, Lagos, Nigeria; [Oyibo, Wellington Aghoghovwia] Univ Lagos, Dept Med Microbiol & Parasitol, Coll Med, Lagos, Nigeria	University of Lagos; University of Lagos	Iheonu, FO (corresponding author), Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria.	francaiheonu@yahoo.com	Fajolu, Iretiola Bamikeolu/P-5759-2019	Fajolu, Iretiola Bamikeolu/0000-0003-3045-9616; Ezeaka, Veronica Chinyere/0000-0003-1880-4616; Oyibo, Wellington/0000-0002-5730-5396				Agboola T. F., 2010, Annals of Biological Research, V1, P72; AKINBOYE DO, 1987, T ROY SOC TROP MED H, V81, P398, DOI 10.1016/0035-9203(87)90147-7; Ali M. S. M., 2004, Ethiopian Journal of Health Development, V18, P70; Allain JP, 2016, LANCET, V387, P1753, DOI 10.1016/S0140-6736(16)00581-X; Alli J. A., 2010, Research Journal of Medical Sciences, V4, P255, DOI 10.3923/rjmsci.2010.255.275; [Anonymous], S LEONE J BIOMED RES; Ayede A I, 2011, Ann Ib Postgrad Med, V9, P30; Baye Gelaw, 2008, Ethiopian Journal of Health Development, V22, P3; Chattopadhyay R, 2011, TRANSFUSION, V51, P630, DOI 10.1111/j.1537-2995.2010.02872.x; Ghimire P, 2007, SCI WORLD, V5, P81, DOI [10.3126/sw.v5i5.2661, DOI 10.3126/SW.V5I5.2661]; Ibhanesebhor S. E., 1996, Postgraduate Doctor - Africa, V18, P38; Ibhanesebhor SE, 1995, J TROP PEDIATRICS, V41, P330, DOI 10.1093/tropej/41.6.330; Mukhtar M, 2007, Niger J Med, V16, P25; Nansseu JRN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-465; Ogunlesi TA, 2011, NIGER J CLIN PRACT, V14, P354, DOI 10.4103/1119-3077.86783; Ogunlesi T, 2016, J TROP PEDIATRICS, V62, P107, DOI 10.1093/tropej/fmv083; Okechukwu AA, 2011, J MED MED SCI, V2, P722; Okorafor UP, 2015, ARJ, V1, P354; Owusu-Ofori AK, 2013, CLIN INFECT DIS, V56, P1735, DOI 10.1093/cid/cit130; Owusu-Ofori AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034201; Owusu-Ofori AK, 2010, CLIN INFECT DIS, V51, P1192, DOI 10.1086/656806; WHO, MICR DET ID QUANT MA, P1; World Health Organization, WORLD MAL REP 2015; Zama I, 2013, INTERNAL MED INSIDE, V1	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195319	10.1371/journal.pone.0195319	http://dx.doi.org/10.1371/journal.pone.0195319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614095	Green Submitted, Green Published, gold			2022-12-27	WOS:000429081600045
J	Takagi, Y; Nakamura, H; Sumi, M; Shimizu, T; Hirai, Y; Horai, Y; Takatani, A; Kawakami, A; Eida, S; Sasaki, M; Nakamura, T				Takagi, Yukinori; Nakamura, Hideki; Sumi, Misa; Shimizu, Toshimasa; Hirai, Yasuko; Horai, Yoshiro; Takatani, Ayuko; Kawakami, Atsushi; Eida, Sato; Sasaki, Miho; Nakamura, Takashi			Combined classification system based on ACR/EULAR and ultrasonographic scores for improving the diagnosis of Sjogren's syndrome	PLOS ONE			English	Article							SALIVARY-GLAND ULTRASONOGRAPHY; AMERICAN-COLLEGE; DATA-DRIVEN; CRITERIA; CONSENSUS; SIALOGRAPHY; FEATURES; TOOL	We retrospectively evaluated the effectiveness of combined use of salivary gland ultrasonography (US) and the 2016 American College of Rheumatology/European League Against Rheumatic Disease (ACR/EULAR) classification criteria for improving the diagnostic efficiency in patients with Sjogren's syndrome (SS). A US-based salivary gland disease grading system was developed using a cohort comprising 213 SS or non-SS patients who fulfilled the minimum requirements for classifying SS based on the American-European Consensus Group (AECG) and ACR criteria. Using 62 SS or non-SS patients from the 213 patients and who had also undergone all the 5 examinations needed for the ACR/EULAR classification, we compared the diagnostic accuracy of various combinations of the ACR/EULAR and US classifications for diagnosing SS, using the clinical diagnosis of SS by rheumatologists as the gold standard. The ACR/EULAR criteria discriminated clinical SS patients with 77% and 79% accuracy for those with primary or secondary SS and for those with primary SS, respectively. However, the integrated score system of the ACR/EULAR and US classifications yielded 92% and 93% accuracy for these 2 SS patient groups, respectively, provided that US score of 3 was assigned to patients with US grade >= 2, and then patients with integrated threshold score of >= 5 were diagnosed as SS. Cross-validation also indicated improved accuracy of the integrated ACR/EULAR and US score system (91.9 and 93.0% for primary/secondary and primary SS patients, respectively) over that by the ACR/EULAR criteria alone. (74.2 and 86.0%, respectively). The integrated ACR/EULAR and US scoring system can improve the diagnosis of patients with clinical SS.	[Takagi, Yukinori; Sumi, Misa; Eida, Sato; Sasaki, Miho; Nakamura, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan; [Nakamura, Hideki; Shimizu, Toshimasa; Hirai, Yasuko; Horai, Yoshiro; Takatani, Ayuko; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Nagasaki, Japan; [Horai, Yoshiro] NHO, Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan	Nagasaki University; Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan.	taku@nagasaki-u.ac.jp			Grants-in-Aid for Scientific Research [15K11078, 17K11674] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ariji Y, 1996, AM J ROENTGENOL, V166, P935, DOI 10.2214/ajr.166.4.8610577; Bryan RN, 2016, RADIOLOGY, V281, P665, DOI 10.1148/radiol.2016162151; Cornec D, 2014, RHEUMATOLOGY, V53, P1604, DOI 10.1093/rheumatology/keu037; Cornec D, 2013, ARTHRITIS RHEUM-US, V65, P216, DOI [10.1002/art.37698, 10.1002/art.37944]; D'Agostino MA, 2016, ANN RHEUM DIS, V75, P1902, DOI 10.1136/annrheumdis-2016-209646; Fidelix T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182287; Hocevar A, 2005, RHEUMATOLOGY, V44, P768, DOI 10.1093/rheumatology/keh588; Hofauer B, 2016, CLIN RHEUMATOL, V35, P2597, DOI 10.1007/s10067-016-3395-6; Jousse-Joulin S, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000364; Jousse-Joulin S, 2015, ARTHRITIS RHEUMATOL, V67, P1623, DOI 10.1002/art.39088; Kami YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150680; Knopf A, 2015, EUR RADIOL, V25, P3027, DOI 10.1007/s00330-015-3705-4; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Milic VD, 2010, SCAND J RHEUMATOL, V39, P160, DOI 10.3109/03009740903270623; Mossel E, 2017, ANN RHEUM DIS, V76, P1883, DOI 10.1136/annrheumdis-2017-211250; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Salaffi F, 2008, RHEUMATOLOGY, V47, P1244, DOI 10.1093/rheumatology/ken222; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1002/art.39859, 10.1136/annrheumdis-2016-210571]; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Takagi Y, 2016, RHEUMATOLOGY, V55, P237, DOI 10.1093/rheumatology/kev278; Takagi Y, 2010, ANN RHEUM DIS, V69, P1321, DOI 10.1136/ard.2009.123836; Theander E, 2014, ARTHRIT CARE RES, V66, P1102, DOI 10.1002/acr.22264; Tsuboi H, 2017, ANN RHEUM DIS; Tzioufas AG, 2008, NAT CLIN PRACT RHEUM, V4, P454, DOI 10.1038/ncprheum0864; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2013, ARTHRITIS RHEUM-US, V65, P1950, DOI 10.1002/art.37945; Yonetsu K, 2002, ANN RHEUM DIS, V61, P276, DOI 10.1136/ard.61.3.276	27	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195113	10.1371/journal.pone.0195113	http://dx.doi.org/10.1371/journal.pone.0195113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614092	Green Published, gold, Green Submitted			2022-12-27	WOS:000429081600032
J	Charles, BA; Hsieh, MM; Adeyemo, AA; Shriner, D; Ramos, E; Chin, K; Srivastava, K; Zakai, NA; Cushman, M; McClure, LA; Howard, V; Flegel, WA; Rotimi, CN; Rodgers, GP				Charles, Bashira A.; Hsieh, Matthew M.; Adeyemo, Adebowale A.; Shriner, Daniel; Ramos, Edward; Chin, Kyung; Srivastava, Kshitij; Zakai, Neil A.; Cushman, Mary; McClure, Leslie A.; Howard, Virginia; Flegel, Willy A.; Rotimi, Charles N.; Rodgers, Griffin P.			Analyses of genome wide association data, cytokines, and gene expression in African-Americans with benign ethnic neutropenia	PLOS ONE			English	Article							DUFFY ANTIGEN RECEPTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOKINE RECEPTOR; DARC; POPULATION; CHILDREN; COUNT; CELLS; LEUKOPENIA; TRAITS	Background Benign ethnic neutropenia (BEN) is a hematologic condition associated with people of African ancestry and specific Middle Eastern ethnic groups. Prior genetic association studies in large population showed that rs2814778 in Duffy Antigen Receptor for Chemokines (DARC) gene, specifically DARC null red cell phenotype, was associated with BEN. However, the mechanism of this red cell phenotype leading to low white cell count remained elusive. Methods We conducted an extreme phenotype design genome-wide association study (GWAS), analyzed similar to 16 million single nucleotide polymorphisms (SNP) in 1,178 African-Americans individuals from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study and replicated from 819 African-American participants in the Atherosclerosis Risk in Communities (ARIC) study. Conditional analyses on rs2814778 were performed to identify additional association signals on chromosome 1q22. In a separate cohort of healthy individuals with and without BEN, whole genome gene expression from peripheral blood neutrophils were analyzed for DARC. Results We confirmed that rs2814778 in DARC was associated with BEN (p = 4.09x10(-53)). Conditioning on rs2814778 abolished other significant chromosome 1 associations. Inflammatory cytokines (IL-2, 6, and 10) in participants in the Howard University Family Study (HUFS) and Multi-Ethnic Study in Atherosclerosis (MESA) showed similar levels in individuals homozygous for the rs2814778 allele compared to others, indicating cytokine sink hypothesis played a minor role in leukocyte homeostasis. Gene expression in neutrophils of individuals with and without BEN was also similar except for low DARC expression in BEN, suggesting normal function. BEN neutrophils had slightly activated profiles in leukocyte migration and hematopoietic stem cell mobilization pathways (expression fold change <2). Conclusions These results in humans support the notion of DARC null erythroid progenitors preferentially differentiating to myeloid cells, leading to activated DARC null neutrophils egressing from circulation to the spleen, and causing relative neutropenia. Collectively, these human data sufficiently explained the mechanism DARC null red cell phenotype causing BEN and further provided a biologic basis that BEN is clinically benign.	[Charles, Bashira A.; Adeyemo, Adebowale A.; Shriner, Daniel; Ramos, Edward; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Hsieh, Matthew M.; Chin, Kyung; Rodgers, Griffin P.] NIDDK, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; [Ramos, Edward] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA; [Srivastava, Kshitij; Flegel, Willy A.] NIH, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Zakai, Neil A.; Cushman, Mary] Univ Vermont, Dept Pathol, Larner Coll Med, Burlington, VT 05405 USA; [Zakai, Neil A.; Cushman, Mary] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA; [McClure, Leslie A.; Howard, Virginia] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [McClure, Leslie A.] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; University of Vermont; University of Vermont; University of Alabama System; University of Alabama Birmingham; Drexel University	Rotimi, CN (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA.; Rodgers, GP (corresponding author), NIDDK, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA.	rotimic@mail.nih.gov; gr5n@nih.gov	Flegel, Willy A/H-7404-2019; Srivastava, Kshitij/AAB-4468-2021	Flegel, Willy A/0000-0002-1631-7198; Srivastava, Kshitij/0000-0002-3658-0815; Shriner, Daniel/0000-0003-1928-5520; Hsieh, Matthew/0000-0002-3706-6615; Adeyemo, Adebowale/0000-0002-3105-3231	Intramural NIH HHS [Z99 CL999999, Z01 HG200362] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [HHSN268201100011C, HHSN268201100011I, HHSN268201100010C, HHSN268201100008C, HHSN268201100007C, HHSN268201100005C, HHSN268201100009C, HHSN268201100008I, HHSN268201100005G, HHSN268201100007I, HHSN268201100009I, HHSN268201100012C, HHSN268201100006C, HHSN268201100005I] Funding Source: Medline; NINDS NIH HHS [U01 NS041588] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Carilli AR, 2012, TRANSFUSION, V52, P166, DOI 10.1111/j.1537-2995.2011.03253.x; Crosslin D, 2012, HUMAN GENETICS, V131; Carvalho Gledson Barbosa de, 2011, Rev. Bras. Hematol. Hemoter., V33, P55, DOI 10.5581/1516-8484.20110016; Duchene J, 2017, NAT IMMUNOL, V18, P753, DOI 10.1038/ni.3763; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Garner C, 2000, BLOOD, V95, P342; Grann VR, 2008, BRIT J HAEMATOL, V143, P288, DOI 10.1111/j.1365-2141.2008.07335.x; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Hsieh MM, 2007, ANN INTERN MED, V146, P486, DOI 10.7326/0003-4819-146-7-200704030-00004; Hsieh MM, 2010, J CLIN ONCOL, V28, P1633, DOI 10.1200/JCO.2009.24.3881; Hur J, 2016, CELL STEM CELL, V18, P508, DOI 10.1016/j.stem.2016.01.013; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Lee JS, 2006, J IMMUNOL, V177, P8086, DOI 10.4049/jimmunol.177.11.8086; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Ortiz MV, 2016, J PEDIAT HEMATOL ONC, V38, pE140, DOI 10.1097/MPH.0000000000000528; Panch SR, 2016, TRANSFUSION, V56, P1058, DOI 10.1111/trf.13551; Paz Z, 2011, ISR MED ASSOC J, V13, P625; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; SHOENFELD Y, 1988, EUR J HAEMATOL, V41, P273; Shriner D, 2011, HEREDITY, V107, P413, DOI 10.1038/hdy.2011.26; Shriner D, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00324; Velasquez IM, 2015, CYTOKINE, V72, P178, DOI 10.1016/j.cyto.2014.12.019; Voruganti VS, 2012, CYTOKINE, V60, P634, DOI 10.1016/j.cyto.2012.08.029; WEINGARTEN MA, 1993, ISRAEL J MED SCI, V29, P297	32	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194400	10.1371/journal.pone.0194400	http://dx.doi.org/10.1371/journal.pone.0194400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596498	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000023
J	Naminse, EY; Zhuang, JC				Naminse, Eric Yaw; Zhuang, Jincai			Does farmer entrepreneurship alleviate rural poverty in China? Evidence from Guangxi Province	PLOS ONE			English	Article							ORGANIZATIONAL COMMITMENT; HIGHER-EDUCATION; SOCIAL NETWORKS; GROWTH; INEQUALITY; REDUCTION; IMPACT; INSTITUTIONS; CAPABILITIES; DYNAMICS	In recent years, entrepreneurship has been gaining more prominence as a potential tool for solving poverty in developing countries. This paper mainly examines the relationship between farmer entrepreneurship and rural poverty alleviation in China by assessing the contribution of farm entrepreneurs towards overcoming poverty. Data were collected from 309 employees of farmer entrepreneurships in Guangxi Province through survey questionnaires. Structural equation modeling was used to conduct an analysis of the effects of three identified capabilities of farm entrepreneurs-economic, educational and knowledge, and socio-cultural capabilities-on attitude towards farmer entrepreneurship growth and the qualitative growth of farmer entrepreneurship and how these in turn affect rural poverty, using AMOS 21. The findings show that socio-cultural capability has the greatest influence on farmer entrepreneurship growth (beta = 0.50, p<0.001). The qualitative growth of farmer entrepreneurship also more significantly impacts rural poverty (beta = 0.69, p<0.001) than attitude towards farmer entrepreneurship growth. This study suggests that policy makers in China should involve more rural farmers in the targeted poverty alleviation strategies of the government by equipping rural farmers with entrepreneurial skills. This can serve as a sustainable, bottom-up approach to alleviating rural poverty in remote areas of the country. The study also extends the literature on the farmer entrepreneurship-rural poverty alleviation nexus in China, and this can serve as a lesson for other developing countries in the fight against rural poverty.	[Naminse, Eric Yaw; Zhuang, Jincai] Jiangsu Univ, Sch Management, Zhenjiang, Peoples R China; [Naminse, Eric Yaw] Qinzhou Univ, Sch Econ & Management, Qinzhou, Peoples R China	Jiangsu University; Beibu Gulf University	Naminse, EY (corresponding author), Jiangsu Univ, Sch Management, Zhenjiang, Peoples R China.; Naminse, EY (corresponding author), Qinzhou Univ, Sch Econ & Management, Qinzhou, Peoples R China.	yawric@yahoo.com		Naminse, Eric Yaw/0000-0003-3114-9943				Acs ZJ, 2008, SMALL BUS ECON, V31, P219, DOI 10.1007/s11187-008-9135-9; Adams-Kane J, 2016, REV DEV ECON, V20, P426, DOI 10.1111/rode.12236; Alkire S, 2008, MANY DIMENSIONS OF POVERTY, P89; Ansoms A, 2010, FOOD POLICY, V35, P584, DOI 10.1016/j.foodpol.2010.06.006; Appleton S, 2010, WORLD DEV, V38, P665, DOI 10.1016/j.worlddev.2009.11.016; Aryee S, 2002, J ORGAN BEHAV, V23, P267, DOI 10.1002/job.138; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327, https://doi.org/10.1007/BF02723327]; Banerjee AN, 2015, DEV POLICY REV, V33, P293, DOI 10.1111/dpr.12110; Barclay D, 1994, TECHNOLOGY STUDIES, V2, P285; BENTLER PM, 1992, PSYCHOL BULL, V112, P400, DOI 10.1037/0033-2909.112.3.400; Bruton GD, 2013, J BUS VENTURING, V28, P683, DOI 10.1016/j.jbusvent.2013.05.002; Chang J, 2013, J SMALL BUS ENTERP D, V20, P225, DOI 10.1108/14626001311298501; Chen MH, 2015, J BUS RES, V68, P900, DOI 10.1016/j.jbusres.2014.11.049; Chen SH, 2013, REV INCOME WEALTH, V59, P1, DOI 10.1111/j.1475-4991.2012.00520.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cuaresma JC, 2016, DEV POLICY REV, V34, P385, DOI 10.1111/dpr.12155; Nunez-Gonzalez JD, 2015, NEUROCOMPUTING, V166, P1, DOI 10.1016/j.neucom.2014.10.099; DESAI M, 1991, EUR ECON REV, V35, P350, DOI 10.1016/0014-2921(91)90136-7; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dolnicar S, 2016, J BUS RES, V69, P992, DOI 10.1016/j.jbusres.2015.09.004; Dzanku FM, 2015, J RURAL STUD, V40, P102, DOI 10.1016/j.jrurstud.2015.06.009; Dzanku FM, 2015, WORLD DEV, V67, P336, DOI 10.1016/j.worlddev.2014.10.030; European Commission (EU), JOINT REP COMM COUNC; Fleisher BM, 2011, J DEV ECON, V94, P86, DOI 10.1016/j.jdeveco.2010.01.001; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; GEDIK S, 2015, PROCEDIA SOC BEHAV S, P1087, DOI DOI 10.1016/J.SBSPRO.2015.06.153; GERBING DW, 1988, J MARKETING RES, V25, P186, DOI 10.2307/3172650; Golan J, 2014, WORLD BANK SOCIAL PR, V1423; Gonzalez R, 2015, J BUS RES, V68, P823, DOI 10.1016/j.jbusres.2014.11.035; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Haggblade S, 2011, J AGRIBUS DEV EMERG, V1, P10, DOI 10.1108/20440831111131532; Hair F., 1995, MULTIVARIATE DATA AN, V4th; He QC, 2016, REV DEV ECON, V20, P387, DOI 10.1111/rode.12232; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.21427/D7CF7R, 10.21427/D79B73]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jaafar M, 2015, TOUR MANAG PERSPECT, V14, P17, DOI 10.1016/j.tmp.2015.02.001; Jalan J, 2000, J DEV STUD, V36, P82, DOI 10.1080/00220380008422655; Karimi M, 2016, VALUE HEALTH, V19, P795, DOI 10.1016/j.jval.2016.05.006; Kim KY, 2016, J ORGAN BEHAV, V37, P558, DOI 10.1002/job.2081; Kline R.B., 2011, PRINCIPLES PRACTICE; Koch S, 2015, DEV POLICY REV, V33, P479, DOI 10.1111/dpr.12119; Kotler P., 2009, OUT POVERTY SOCIAL M; Kutzhanova N, 2009, ECON DEV Q, V23, P193, DOI 10.1177/0891242409336547; Li XC, 2016, REV DEV ECON, V20, P415, DOI 10.1111/rode.12235; Li YR, 2014, LAND USE POLICY, V39, P188, DOI 10.1016/j.landusepol.2014.02.016; Li Z., 2007, ANTIPOVERTY SUSTAINA, P225; Liu ZQ, 2008, CHINA ECON REV, V19, P521, DOI 10.1016/j.chieco.2008.04.001; Long XL, 2013, J CLEAN PROD, V39, P161, DOI 10.1016/j.jclepro.2012.08.005; Luan J, 2015, CHINA AGR ECON REV, V7, P122, DOI 10.1108/CAER-10-2013-0143; Maia LG, 2016, J ORGAN BEHAV, V37, P537, DOI 10.1002/job.2096; Marsh H. W., 1988, ED RES METHODOLOGY M, P570; Mcelwee G, 2006, J DEV ENTREP, V11, P187, DOI 10.1142/S1084946706000398; Mihai M, 2015, PROC ECON FINANC, V32, P855, DOI 10.1016/S2212-5671(15)01532-4; Montalvo JG, 2010, J COMP ECON, V38, P2, DOI 10.1016/j.jce.2009.10.005; National Bureau of Statistics of China (NSBC), 2014, CHIN STAT YB; National Statistical Bureau of China (NSBC), 2013, STAT COMM PEOPL REP; Ngoasong MZ, 2016, TOURISM MANAGE, V52, P430, DOI 10.1016/j.tourman.2015.07.012; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; Nussbaum M., 2001, WOMEN HUMAN DEV CAPA, V3; Nussbaum M.C., 2011, CREATING CAPABILITIE; Olivia S, 2011, ENVIRON DEV ECON, V16, P129, DOI 10.1017/S1355770X10000513; Otsuka K, 2016, DEV POLICY REV, V34, P441, DOI 10.1111/dpr.12159; Pallant J.F, 2016, SPSS SURVIVAL MANUAL, V6; Park A, 2002, J PUBLIC ECON, V86, P123, DOI 10.1016/S0047-2727(01)00108-6; Pedersen RH, 2015, DEV POLICY REV, V33, P415, DOI 10.1111/dpr.12121; Qizilbash M., 2008, CAPABILITY APPROACH, P53, DOI DOI 10.1017/CBO9780511492587; Ray A., 2006, EC B, V9, P1; Rindova V, 2009, ACAD MANAGE REV, V34, P477, DOI 10.5465/AMR.2009.40632647; Rowntree B. S., 1901, POVERTY STUDY TOWN L; Samovar LP, 1997, COMMUNICATION CULTUR; Sandhu H, 2014, ECOL ECON, V107, P65, DOI 10.1016/j.ecolecon.2014.08.005; Sanz R, 2017, J INNOV KNOWL, V2, P53, DOI 10.1016/j.jik.2017.03.002; Schumpeter Joseph, 1934, THEORY EC DEV INQUIR; Sen A., 1999, COMMODITIES CAPABILI; Sen A., 1980, TANNER LECT HUMAN VA, P257; Sen A.K, 1999, DEV FREEDOM; Shane S, 2000, ACAD MANAGE REV, V25, P217, DOI 10.5465/amr.2000.2791611; Shepherd DA, 2015, J BUS VENTURING, V30, P489, DOI 10.1016/j.jbusvent.2015.02.001; Sigalla RJ, 2012, INT J EDUC DEV, V32, P546, DOI 10.1016/j.ijedudev.2012.02.011; Singer S., 2014, GLOBAL ENTREPRENEURS; Suryahadi A, 2009, J DEV ECON, V89, P109, DOI 10.1016/j.jdeveco.2008.08.003; Sylvia S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002405; Tobias JM, 2013, J BUS VENTURING, V28, P728, DOI 10.1016/j.jbusvent.2013.03.003; Townsend P., 1979, POVERTY UK; Trommlerova SK, 2015, WORLD DEV, V66, P1, DOI 10.1016/j.worlddev.2014.07.008; Verheul I, 2015, SMALL BUS ECON, V45, P85, DOI 10.1007/s11187-015-9642-4; Wang Z., 2010, IEEE INT C ADV MAN S, P431; Weaver RR, 2014, SOC SCI MED, V102, P58, DOI 10.1016/j.socscimed.2013.11.033; World Bank, 2015, MILL DEV GOALS REP 2; World Bank, 2001, WORLD DEV REP 2000 2; Wu WK, 2016, J BUS RES, V69, P3398, DOI 10.1016/j.jbusres.2016.02.004; Xing L, 2009, CHINA ECON REV, V20, P338, DOI 10.1016/j.chieco.2008.10.006; Yanya M, 2013, PROCD SOC BEHV, V91, P331, DOI 10.1016/j.sbspro.2013.08.430; Yueh L., 2008, CHINESE ENTREPRENEUR; Zagata L, 2015, J RURAL STUD, V38, P39, DOI 10.1016/j.jrurstud.2015.01.003; Zeumo VK, 2014, SOCIO-ECON PLAN SCI, V48, P273, DOI 10.1016/j.seps.2014.04.002; Zhang Y, 2015, J ORGAN BEHAV, V36, P698, DOI 10.1002/job.2012	97	31	31	11	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194912	10.1371/journal.pone.0194912	http://dx.doi.org/10.1371/journal.pone.0194912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596517	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000049
J	Thwala, SBP; Blaauw, D; Ssengooba, F				Thwala, Siphiwe Bridget Pearl; Blaauw, Duane; Ssengooba, Freddie			Measuring the preparedness of health facilities to deliver emergency obstetric care in a South African district	PLOS ONE			English	Article							MATERNAL MORTALITY; AVAILABILITY; INDICATORS; SERVICES; QUALITY; BARRIERS; ZAMBIA; GHANA	Background Improving the delivery of emergency obstetric care (EmNOC) remains critical in addressing direct causes of maternal mortality. United Nations (UN) agencies have promoted standard methods for evaluating the availability of EmNOC facilities although modifications have been proposed by others. This study presents an assessment of the preparedness of public health facilities to provide EmNOC using these methods in one South African district with a persistently high maternal mortality ratio. Methods Data collection took place in the final quarter of 2014. Cross-sectional surveys were conducted to classify the 7 hospitals and 8 community health centres (CHCs) in the district as either basic EmNOC (BEmNOC) or comprehensive EmNOC (CEmNOC) facilities using UN EmNOC signal functions. The required density of EmNOC facilities was calculated using UN norms. We also assessed the availability of EmNOC personnel, resuscitation equipment, drugs, fluids, and protocols at each facility. The workload of skilled EmNOC providers at hospitals and CHCs was compared. Results All 7 hospitals in the district were classified as CEmNOC facilities, but none of the 8 CHCs performed all required signal functions to be classified as BEmNOC facilities. UN norms indicated that 25 EmNOC facilities were required for the district population, 5 of which should be CEmNOCs. None of the facilities had 100% of items on the EmNOC checklists. Hospital midwives delivered an average of 36.4 +/- 14.3 deliveries each per month compared to only 7.9 +/- 3.2 for CHC midwives (p<0.001). Conclusions The analysis indicated a shortfall of EmNOC facilities in the district. Full EmNOC services were centralised to hospitals to assure patient safety even though national policy guidelines sanction more decentralisation to CHCs. Studies measuring EmNOC availability need to consider facility opening hours, capacity and staffing in addition to the demonstrated performance of signal functions.	[Thwala, Siphiwe Bridget Pearl; Blaauw, Duane] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Ctr Hlth Policy, Johannesburg, South Africa; [Thwala, Siphiwe Bridget Pearl] Univ Swaziland, Fac Hlth Sci, Mbabane, Swaziland; [Ssengooba, Freddie] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	University of Witwatersrand; Makerere University	Thwala, SBP (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Ctr Hlth Policy, Johannesburg, South Africa.; Thwala, SBP (corresponding author), Univ Swaziland, Fac Hlth Sci, Mbabane, Swaziland.	siphiwe.thwala2@wits.ac.za		Thwala, Siphiwe Bridget Pearl/0000-0002-6528-584X				Admasu K, 2011, INT J GYNECOL OBSTET, V115, P101, DOI 10.1016/j.ijgo.2011.07.010; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; AMDD, MOD 5 EMOC SIGN FUNC; Banke-Thomas A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31880; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Blaauw D, 2010, MATERNAL HLTH; Bosomprah S, 2016, INT J GYNECOL OBSTET, V132, P130, DOI 10.1016/j.ijgo.2015.11.004; Campbell OMR, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0872-5; Chiang CF, 2013, NAGOYA J MED SCI, V75, P225; Collender G, 2012, TROP MED INT HEALTH, V17, P694, DOI 10.1111/j.1365-3156.2012.02983.x; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Dippenaar J, 2015, HUMAN RESOURCES; DoH, 2015, MAT CAR GUID S AFR M; [DoH Health NDo], 2015, MAT CAR GUID S AFR; Douangphachanh X, 2010, BIOSCI TRENDS, V4, P318; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P534, DOI 10.1111/tmi.12076; Echoka E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-113; EPMM Working Group, 2015, STRAT END PREV MAT M; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Gabrysch S, 2011, INT J GYNECOL OBSTET, V114, P174, DOI 10.1016/j.ijgo.2011.05.007; Gabrysch S, 2011, TROP MED INT HEALTH, V16, P627, DOI 10.1111/j.1365-3156.2011.02741.x; Gilbert J., 2002, EXPLANATION OPF CURR; Greenfield D., 2006, 25 C PRIOR PER NAT C; Greenfield DH, 2006, 25 C PRIOR PER CAR 7; Kalaba FK, 2016, FOREST POLICY ECON, V69, P40, DOI 10.1016/j.forpol.2016.04.004; Kruk ME, 2016, LANCET GLOB HEALTH, V4, pE845, DOI [10.1016/s2214-109x(16)30180-2, 10.1016/S2214-109X(16)30180-2]; Larson E, 2017, INT J QUAL HEALTH C, V29, P104, DOI 10.1093/intqhc/mzw141; Liyew EF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179013; Lohela TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052110; Makhudu M, 2014, STATUS PRIMARY HLTH; Massyn N, 2016, TUBERCULOSIS; Massyn N, DISTRICT HLTH BAROME; Massyn N, 2015, DISTRICT HLTH BAROME; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Mercer S, 2006, BIOMED CENTRAL, V3; Mezie-Okoye M. M., 2012, African Journal of Reproductive Health, V16, P170; Mezie-Okoye Margaret M, 2012, Afr J Reprod Health, V16, P171; Munoz C, 2016, INT J PUBLIC HEALTH; NCCEMD, 2012, SAV MOTH 2008 2010 5; NCCEMD, 2014, SAV MOTH 2011 2013 6; Pattinson RC, 2015, SAMJ S AFR MED J, V105, P261, DOI [10.7196/SAMJ.9182, 10.7196/samj.9182]; Pattinson RC, 2015, SAMJ S AFR MED J, V105, P256, DOI [10.7196/SAMJ.9181, 10.7196/samj.9181]; Pattinson RC, 2014, SAVING BABIES 2012 2; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Roozbeh N, 2016, SAUDI MED J, V37, P1319, DOI 10.15537/smj.2016.12.15505; Roy R, 2017, PLOS ONE, V12; STATSSA, 2015, MILL DEV GOALS 5 IMP; STATSSA, 2015, CENS 2011 FERT S AFR; UNFPA/UNICEF, 2020, TECHN NOT GEND TRANS; United Nations, 2015, DEP EC SOC AFF POP D; van Schaik N., 2015, DISTRICT HLTH BAROME; Wichaidit W, 2016, AM J TROP MED HYG, V95, P298, DOI 10.4269/ajtmh.15-0350; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Zariba A, 2009, BMC HEALTH SERV RES, V46, DOI [10.1186/472-6963-9-46, DOI 10.1186/472-6963-9-46]	57	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194576	10.1371/journal.pone.0194576	http://dx.doi.org/10.1371/journal.pone.0194576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596431	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000032
J	Eichinger, S; Eischer, L; Sinkovec, H; Wittgruber, G; Traby, L; Kammer, M; Kyrie, PA; Steinbrecher, O; Kaloud, H; Kyrie, V; Moser, H; Wildburger, R				Eichinger, Sabine; Eischer, Lisbeth; Sinkovec, Hana; Wittgruber, Gabriela; Traby, Ludwig; Kammer, Michael; Kyrie, Paul A.; Steinbrecher, Oskar; Kaloud, Herbert; Kyrie, Victoria; Moser, Hartwig; Wildburger, Renate			Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; TRAUMA; THROMBOPROPHYLAXIS; PROPHYLAXIS; THROMBOSIS; ENOXAPARIN; COHORT; SURGERY; PHASE	Background Patients with spinal cord injury (SCI) are at risk of thrombosis and bleeding. Data on the risks during rehabilitation are inconsistent, and thromboprophylactic strategies are heterogeneous. We aimed to evaluate the thrombotic risk and bleeding events of SCI patients during rehabilitation. Methods We retrospectively collected hospital record data of 263 consecutive SCI patients admitted at a rehabilitation clinic. 78 patients with acute venous thromboembolism (VTE) at the primary center, without acute trauma or lower extremity paresis, less than one month rehabilitation, or reasons for long-term therapeutic anticoagulation, were excluded. All patients received pharmacologic thromboprophylaxis throughout rehabilitation. Primary endpoint was objectively diagnosed VTE; secondary endpoint was bleeding. Results Of 185 patients, 162 (88%) were men; mean age was 47.8 years. 94 patients were tetraplegic, 91 paraplegic. During a mean (SD) time of 5.1 2.1 months, VTE was diagnosed in 8 patients. After excluding five patients with VTE detected within 2 days after admission, the probability of developing VTE after 6 months of rehabilitation was 2% (95% CI 0-4.4%). Only high D-Dimer upon admission was associated with risk of VTE (adjusted HR 2.3, 95% CI 1.4-4.1). Of 24 bleedings, 14 (64%) occurred at the heparin injection site. Two patients had major bleeding and five had clinically relevant non major bleeding. Conclusion SCI patients are at risk of VTE and bleeding during rehabilitation. Strategies need to be developed to identify these patients in order to initiate adequate anticoagulation. Direct oral anticoagulants, which have a favourable risk-benefit profile and are convenient, should be explored.	[Eichinger, Sabine; Eischer, Lisbeth; Traby, Ludwig; Kyrie, Paul A.; Steinbrecher, Oskar; Kyrie, Victoria] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Eichinger, Sabine; Kyrie, Paul A.] Karl Landsteiner Inst Clin Thrombosis Res, Vienna, Austria; [Sinkovec, Hana; Kammer, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Wittgruber, Gabriela; Kaloud, Herbert; Moser, Hartwig; Wildburger, Renate] Allgemeine Unfallversicherungsanstalt Rehabil Cli, Tobelbad, Austria	Medical University of Vienna; Medical University of Vienna	Eichinger, S (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.; Eichinger, S (corresponding author), Karl Landsteiner Inst Clin Thrombosis Res, Vienna, Austria.	sabine.eichinger@meduniwien.ac.at	Traby, Ludwig/ABC-2338-2020	Traby, Ludwig/0000-0003-2861-5771; , Sabine/0000-0003-1135-4878; Kammer, Michael/0000-0003-4821-9928	Allgemeine Unfallversicherungsanstalt [FK 16/14]	Allgemeine Unfallversicherungsanstalt	Funded by Allgemeine Unfallversicherungsanstalt FK 16/14 (RW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabed S, 2016, ASIAN SPINE J, V10, P972, DOI 10.4184/asj.2016.10.5.972; [Anonymous], 2016, TOP SPINAL CORD INJ, V22, P209, DOI [10.1310/sci2203-209, DOI 10.1310/SCI2203-209]; Chiou-Tan FY, 2003, AM J PHYS MED REHAB, V82, P678, DOI 10.1097/01.PHM.0000083671.27501.47; Chung WS, 2014, THROMB RES, V133, P579, DOI 10.1016/j.thromres.2014.01.008; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Godat LN, 2015, J TRAUMA ACUTE CARE, V78, P475, DOI 10.1097/TA.0000000000000556; Green D, 2003, AM J PHYS MED REHAB, V82, P950, DOI 10.1097/01.PHM.0000098043.88979.BA; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Hoffmeyer P, 2017, ORTHOPEDICS, V40, P109, DOI 10.3928/01477447-20161116-05; Jones T, 2005, ARCH PHYS MED REHAB, V86, P2240, DOI 10.1016/j.apmr.2005.07.286; Kadyan V, 2003, J SPINAL CORD MED, V26, P231, DOI 10.1080/10790268.2003.11753689; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Mackiewicz-Milewska M, 2016, J SPINAL CORD MED, V39, P400, DOI 10.1179/2045772315Y.0000000032; Marciniak CM, 2012, PM&R, V4, P11, DOI 10.1016/j.pmrj.2011.10.007; Merli G, 2003, J TRAUMA, V54, P1111, DOI 10.1097/01.TA.0000042159.90102.C2; Monzon DG, 2012, J EMERG MED, V43, P612, DOI 10.1016/j.jemermed.2011.09.006; National Spinal Cord Injury Statistical Center, COMPL PUBL VERS 2016; Pierfranceschi MG, 2013, THROMB HAEMOSTASIS, V109, P34, DOI 10.1160/TH12-06-0390; Piran S, 2016, THROMB RES, V147, P97, DOI 10.1016/j.thromres.2016.09.030; Ploumis A, 2009, J BONE JOINT SURG AM, V91A, P2568, DOI 10.2106/JBJS.H.01411; Ploumis A, 2009, SPINE J, V9, P530, DOI 10.1016/j.spinee.2009.01.008; Quinlan DJ, 2013, BEST PRACT RES CL HA, V26, P171, DOI 10.1016/j.beha.2013.07.003; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; van Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04571232, 10.1182/blood-2014-04-571232]	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193735	10.1371/journal.pone.0193735	http://dx.doi.org/10.1371/journal.pone.0193735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590126	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100027
J	Woldesemayat, AA; Modise, DM; Gemeildien, J; Ndimba, BK; Christoffels, A				Woldesemayat, Adugna Abdi; Modise, David M.; Gemeildien, Junaid; Ndimba, Bongani K.; Christoffels, Alan			Cross-species multiple environmental stress responses: An integrated approach to identify candidate genes for multiple stress tolerance in sorghum (Sorghum bicolor (L.) Moench) and related model species	PLOS ONE			English	Article							DROUGHT TOLERANCE; PLANT; EXPRESSION; ONTOLOGY; TOOL; QTL; IDENTIFICATION; DUPLICATION; ASSOCIATION; ANNOTATION	Background Crop response to the changing climate and unpredictable effects of global warming with adverse conditions such as drought stress has brought concerns about food security to the fore; crop yield loss is a major cause of concern in this regard. Identification of genes with multiple responses across environmental stresses is the genetic foundation that leads to crop adaptation to environmental perturbations. Methods In this paper, we introduce an integrated approach to assess candidate genes for multiple stress responses across-species. The approach combines ontology based semantic data integration with expression profiling, comparative genomics, phylogenomics, functional gene enrichment and gene enrichment network analysis to identify genes associated with plant stress phenotypes. Five different ontologies, viz., Gene Ontology (GO), Trait Ontology (TO), Plant Ontology (PO), Growth Ontology (GRO) and Environment Ontology (EO) were used to semantically integrate drought related information. Results Target genes linked to Quantitative Trait Loci (QTLs) controlling yield and stress tolerance in sorghum (Sorghum bicolor (L.) Moench) and closely related species were identified. Based on the enriched GO terms of the biological processes, 1116 sorghum genes with potentialheat (8%) and oxidative stress (25%) were identified to be over-expressed. Out of 169 sorghum drought responsive QTLs associated genes that were identified based on expression datasets, 56% were shown to have multiple stress responses. On the other hand, out of 168 additional genes that have been evaluated for orthologous pairs, 90% were conserved across species for drought tolerance. Over 50% of identified maize and rice genes were responsive to drought and salt stresses and were co-located within multifunctional QTLs. Among the total identified multi-stress responsive genes, 272 targets were shown to be co localized within QTLs associated with different traits that are responsive to multiple stresses. Ontology mapping was used to validate the identified genes, while reconstruction of the phylogenetic tree was instrumental to infer the evolutionary relationship of the sorghum orthologs. The results also show specific genes responsible for various interrelated components of drought response mechanism such as drought tolerance, drought avoidance and drought escape. Conclusions We submit that this approach is novel and to our knowledge, has not been used previously in any other research; it enables us to perform cross-species queries for genes that are likely to be associated with multiple stress tolerance, as a means to identify novel targets for engineering stress resistance in sorghum and possibly, in other crop species.	[Woldesemayat, Adugna Abdi; Gemeildien, Junaid; Christoffels, Alan] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Bellville, South Africa; [Woldesemayat, Adugna Abdi] Univ South Africa, Coll Agr & Environm Sci, Dept Life & Consumer Sci, Sci Campus, Johannesburg, South Africa; [Modise, David M.] Univ South Africa, Coll Agr & Environm Sci, Dept Agr & Anim Hlth, Sci Campus, Johannesburg, South Africa; [Ndimba, Bongani K.] Univ Western Cape, Dept Biotechnol, Cape Town, Western Cape, South Africa; [Ndimba, Bongani K.] Infruitech Nietvoorbij, Agr Res Council, Stellenbosch, South Africa	South African Medical Research Council; University of the Western Cape; University of South Africa; University of South Africa; University of the Western Cape; Agricultural Research Council of South Africa	Woldesemayat, AA (corresponding author), Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Bellville, South Africa.; Woldesemayat, AA (corresponding author), Univ South Africa, Coll Agr & Environm Sci, Dept Life & Consumer Sci, Sci Campus, Johannesburg, South Africa.	woldeaa@unisa.ac.za		Woldesemayat, Adugna Abdi/0000-0002-0704-1636	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa; University of the Western Cape; University of South Africa	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa); University of the Western Cape; University of South Africa	This work is based on the research supported by the South African Research Chairs Initiative of the Department of Science and Technology (www.dst.gov.za) and National Research Foundation of South Africa (http:/www..nrf.ac.za/). AC received funding. The University of the Western Cape and the University of South Africa also provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work is based on the research supported by the South African Research Chairs Initiative of the Department of Science and Technology (www.dst.gov.za) and National Research Foundation of South Africa (http://www.nrf.ac.za/). The University of the Western Cape and the University of South Africa also provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anjum SA, 2011, AFR J AGR RES, V6, P2026; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Bolser D, 2016, METHODS MOL BIOL, V1374, P115, DOI 10.1007/978-1-4939-3167-5_6; Breitling R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-181; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Cantoro R, 2016, EUPHYTICA, V211, P41, DOI 10.1007/s10681-016-1717-z; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper L, 2013, PLANT CELL PHYSIOL, V54, pE1, DOI 10.1093/pcp/pcs163; Cooper M, 2016, CROP SCI, V56, P2141, DOI 10.2135/cropsci2015.08.0512; Daraselia N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-243; Das M, 2016, PLANT PHYSIOL, V171, P2343, DOI 10.1104/pp.15.01207; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Farber CR, 2009, J BONE MINER RES, V24, P105, DOI 10.1359/JBMR.080908; Fracasso A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0800-x; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hernandez KM, 2015, NEW PHYTOL, V208, P1, DOI 10.1111/nph.13607; Hivrale V, 2016, PLANT SCI, V242, P214, DOI 10.1016/j.plantsci.2015.07.018; Huang LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1026; Ilic K, 2007, PLANT PHYSIOL, V143, P587, DOI 10.1104/pp.106.092825; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kattge J, 2011, METHODS ECOL EVOL, V2, P202, DOI 10.1111/j.2041-210X.2010.00067.x; Kebede H, 2001, THEOR APPL GENET, V103, P266, DOI 10.1007/s001220100541; Krannich CT, 2015, INT J MOL SCI, V16, P16378, DOI 10.3390/ijms160716378; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Mace ES, 2012, THEOR APPL GENET, V124, P97, DOI 10.1007/s00122-011-1690-9; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makita Y, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu187; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Narain P, 2010, MOL BREEDING, V26, P135, DOI 10.1007/s11032-010-9406-4; Ni JJ, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap005; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Oliveros JC, 2014, VENNY INTERACTIVE TO; Ongom PO, 2016, FIELD CROP RES, V198, P312, DOI 10.1016/j.fcr.2016.03.015; Pandey P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00537; Pandey P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00723; Proost S, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1861-z; Pujar A, 2006, PLANT PHYSIOL, V142, P414, DOI 10.1104/pp.106.085720; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramegowda V, 2015, J PLANT PHYSIOL, V176, P47, DOI 10.1016/j.jplph.2014.11.008; Rensing SA, 2014, CURR OPIN PLANT BIOL, V17, P43, DOI 10.1016/j.pbi.2013.11.002; Ruprecht C, 2017, PLANT J, V90, P447, DOI 10.1111/tpj.13502; Sabadin PK, 2012, THEOR APPL GENET, V124, P1389, DOI 10.1007/s00122-012-1795-9; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shaar-Moshe L, 2017, PLANT PHYSIOL, V174, P421, DOI 10.1104/pp.17.00030; Shaik R, 2014, PLANT PHYSIOL, V164, P481, DOI 10.1104/pp.113.225862; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shirdelmoghanloo H, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0784-6; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukumaran S, 2016, CROP SCI, V56, P1429, DOI 10.2135/cropsci2015.02.0097; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tian T, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw099; Tiffin N, 2011, METHODS MOL BIOL, V760, P175, DOI 10.1007/978-1-61779-176-5_11; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Woldesemayat AA, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0584-5; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; ZHANG LF, 2017, PLANT SYST EVOL, V110, P1; Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146242; Zyla J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1674-0	75	5	5	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192678	10.1371/journal.pone.0192678	http://dx.doi.org/10.1371/journal.pone.0192678			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590108	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100008
J	Tributino, A; Montgomery, MC; Bertrand, T; Marak, T; Almonte, A; van den Berg, J; St John, K; Browning, C; Medina, MM; Morsel, A; Chan, PA				Tributino, Alec; Montgomery, Madeline C.; Bertrand, Thomas; Marak, Theodore; Almonte, Alexi; van den Berg, Jacob; St John, Kristen; Browning, Carol; Medina, Martha M.; Morsel, Ashley; Chan, Philip A.			Partner notification outcomes after integration of an on-site disease intervention specialist at a sexually transmitted disease clinic	PLOS ONE			English	Article							HIV INCIDENCE; MEN; SEX; CARE; STD; INFECTIONS; PREVENTION; DIAGNOSIS; RISK	Background Partner notification services (PNS) are highly effective in reducing transmission of sexually transmitted diseases (STDs). We assessed outcomes of PNS before and after integration of an on-site disease intervention specialist (DIS) at a publicly-funded STD clinic. Methods From August 2014 to December 2015, patients testing positive for infectious syphilis or gonorrhea at the Rhode Island STD Clinic were referred to on-site DIS for partner notification. Data on PNS outcomes were reviewed for eight months before integration of DIS at the clinic and compared to eight months after. Results Of the 145 index patients referred for PNS during the study period (n = 58 before DIS integration, n = 87 after), 86% were interviewed. DIS integration resulted in a significantly greater proportion of index patients interviewed overall (92% versus 76%, p<0.01), on the day of diagnosis (85% versus 61%; p<0.01), and in person at the STD clinic (64% versus 11%; p<0.01). However, there was no significant difference in number of sexual partners named or treated. Conclusions Integrating DIS at a publicly-funded STD clinic resulted in a greater number of index cases interviewed, a greater number interviewed in person, and a greater number interviewed on the day of diagnosis. Challenges remain in identifying and engaging partners for treatment.	[Tributino, Alec; Montgomery, Madeline C.; Almonte, Alexi; Medina, Martha M.; Morsel, Ashley; Chan, Philip A.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Bertrand, Thomas; Marak, Theodore; St John, Kristen; Browning, Carol; Chan, Philip A.] Rhode Isl Dept Hlth, Ctr HIV Hepatitis Sexually Transmitted Dis & TB E, Providence, RI 02908 USA; [van den Berg, Jacob; Chan, Philip A.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA	Brown University; Brown University	Chan, PA (corresponding author), Brown Univ, Dept Med, Providence, RI 02912 USA.; Chan, PA (corresponding author), Rhode Isl Dept Hlth, Ctr HIV Hepatitis Sexually Transmitted Dis & TB E, Providence, RI 02908 USA.; Chan, PA (corresponding author), Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA.	Philip_Chan@brown.edu		Montgomery, Madeline/0000-0002-4528-1964				Althaus CL, 2014, HEALTH TECHNOL ASSES, V18, pXIX, DOI 10.3310/hta18020; Bernstein KT, 1999, J ACQ IMMUN DEF SYND, V53, P537; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Beymer MR, 2014, SEX TRANSM INFECT, V90, P567, DOI 10.1136/sextrans-2013-051494; Centers for Disease Control and Prevention, 2014, PARTN SERV QUICKGUID; Centers for Disease Control and Prevention, 2017, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention National Network of STD/ HIV Prevention Training Centers, 2013, PASSP PARTN SERV; Chan PA, 2016, PUBLIC HEALTH REP, V131, P264, DOI 10.1177/003335491613100210; Cramer R, 2014, SEX TRANSM DIS, V41, P628, DOI 10.1097/OLQ.0000000000000187; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Ferreira A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002843.pub2; Girometti N, 2017, SEX TRANSM INFECT, V93, P320, DOI 10.1136/sextrans-2016-052865; Gorbach PM, 2000, SEX TRANSM DIS, V27, P193, DOI 10.1097/00007435-200004000-00003; Herek GM, 2009, J COUNS PSYCHOL, V56, P32, DOI 10.1037/a0014672; John SA, 2017, ARCH SEX BEHAV; Katz DA, 2016, SEX TRANSM DIS, V43, P249, DOI 10.1097/OLQ.0000000000000423; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Mimiaga MJ, 2009, PUBLIC HEALTH REP, V124, P111, DOI 10.1177/003335490912400114; Pathela P, 2015, SEX TRANSM DIS, V42, P286, DOI 10.1097/OLQ.0000000000000255; Rudy ET, 2012, SEX TRANSM DIS, V39, P701, DOI 10.1097/OLQ.0b013e3182593b51; St Lawrence JS, 2002, AM J PUBLIC HEALTH, V92, P1784, DOI 10.2105/AJPH.92.11.1784; Stephens SC, 2014, SEX TRANSM DIS, V41, P227, DOI 10.1097/OLQ.0000000000000109; Taylor MM, 2010, SEX TRANSM DIS, V37, P767, DOI 10.1097/OLQ.0b013e3181e65e8b	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194041	10.1371/journal.pone.0194041	http://dx.doi.org/10.1371/journal.pone.0194041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584743	Green Submitted, gold, Green Published			2022-12-27	WOS:000428373000011
J	Baleztena, J; Ruiz-Canela, M; Sayon-Orea, C; Pardon, M; Anorbe, T; Gost, JI; Gomez, C; Ilarregui, B; Bes-Rastrollo, M				Baleztena, Joaquin; Ruiz-Canela, Miguel; Sayon-Orea, Carmen; Pardon, Maria; Anorbe, Teresa; Ignacio Gost, Jose; Gomez, Carmen; Ilarregui, Belen; Bes-Rastrollo, Maira			Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in >= 75 years old patients: A randomized multicenter study	PLOS ONE			English	Article							GLOBAL DETERIORATION SCALE; IMPROVE MEMORY ABILITIES; FISH-OIL SUPPLEMENTATION; N-3 FATTY-ACIDS; DOUBLE-BLIND; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; OMEGA-3-FATTY-ACID SUPPLEMENTATION; IMPAIRMENT; DECLINE	A few studies have assessed the association between omega-3 polyunsaturated fatty acids (n-3 PUFA) and cognitive impairment (CI) in very old adults. The aim of this study was to evaluate the effect of a multinutrient supplementation rich in n-3 PUFA on the cognitive function in an institutionalized >= 75-year-old population without CI or with mild cognitive impairment (MCI). A multicenter placebo-controlled double-blind randomized trial was conducted between 2012 and 2013. Cognitive function was assessed at baseline and after one year using 4 neuropsychological tests. Nutritional status was assessed using Mini Nutritional Assessment (MNA). Interaction between Mini-Mental State Examination (MMSE) score and nutritional status were analyzed using linear regression models. A total of 99 participants were randomized to receive placebo or pills rich in n-3 PUFA. After 1-year follow-up, both groups decreased their MMSE score (-1.18, SD:0.53 and-0.82, SD:0.63, p = 0.67 for the control and the intervention group respectively). The memory subscale of the MMSE showed an improvement (+0.26, SD:0.18) in the intervention group against a worsening in the control group (-0.11, SD: 0.14; p = 0.09 for differences between groups). Patients at intervention group with normal nutritional status (MNA >= 24) showed an improvement in the MMSE (+1.03, p = 0.025 for differences between 1-y and baseline measurements) against a worsening in the group with malnutrition (MNA<24) (-0.4, p = 0.886 for differences between 1-y and baseline; p of interaction p = 0.05). Supplementation with n-3 PUFA did not show an improvement in the global cognitive function in institutionalized elderly people without CI or with MCI. They only suggest an apparent improvement in memory loss if previously they were well nourished.	[Baleztena, Joaquin] Univ Navarra, Ctr Residencial Clin, Pamplona, Spain; [Ruiz-Canela, Miguel; Sayon-Orea, Carmen; Bes-Rastrollo, Maira] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Ruiz-Canela, Miguel; Bes-Rastrollo, Maira] Navarras Hlth Res Inst IDISNA, Pamplona, Spain; [Ruiz-Canela, Miguel; Bes-Rastrollo, Maira] Inst Hlth Carlos III, Biomed Res Ctr Network Obes & Nutr CIBERobn Physi, Madrid, Spain; [Sayon-Orea, Carmen] Complejo Hosp Navarra, Dept Prevent Med, Pamplona, Spain; [Pardon, Maria; Anorbe, Teresa; Ignacio Gost, Jose; Gomez, Carmen; Ilarregui, Belen] Grp Amma, Pamplona, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Servicio Navarro de Salud - Osasunbidea	Baleztena, J (corresponding author), Univ Navarra, Ctr Residencial Clin, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), Navarras Hlth Res Inst IDISNA, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), Inst Hlth Carlos III, Biomed Res Ctr Network Obes & Nutr CIBERobn Physi, Madrid, Spain.	jbaleztena@unay.es; mbes@unay.es	Ruiz-Canela, Miguel/I-7738-2016; Bes-Rastrollo, Maira/A-1329-2009; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Sayon-Orea, Carmen/A-9828-2017	Ruiz-Canela, Miguel/0000-0002-7684-2787; Bes-Rastrollo, Maira/0000-0002-9139-4206; Sayon-Orea, Carmen/0000-0002-4137-3263	Spanish Society of Basic and Applied Nutrition (SENBA)	Spanish Society of Basic and Applied Nutrition (SENBA)	The AMMA group, a group of geriatric nursing homes, provided indirectly support in the form of salaries for some authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. A competitive grant from the Spanish Society of Basic and Applied Nutrition (SENBA) was used to pay publishing fees of the study in PLOS ONE.	Abubakari AR, 2014, INT J GEN MED, V7, P463, DOI 10.2147/IJGM.S67065; Baleztena J, 2017, AN SIST SANIT NAVAR, V40, P433, DOI [10.23938/ASSN.0046, 10.23938/assn.0046]; Barberger-Gateau P, 2014, EUR J CLIN NUTR, V68, P1245, DOI 10.1038/ejcn.2014.177; Bes-Rastrollo M, 2007, JANO, V1653, P51; Boespflug EL, 2016, J NUTR HEALTH AGING, V20, P161, DOI 10.1007/s12603-015-0609-6; Boston PF, 2004, PROSTAG LEUKOTR ESS, V71, P341, DOI 10.1016/j.plefa.2004.07.001; Bun S, 2015, J ALZHEIMERS DIS, V45, P15, DOI 10.3233/JAD-142232; Burckhardt M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009002.pub3; Cardoso BR, 2013, CLIN INTERV AGING, V8, P531, DOI 10.2147/CIA.S27983; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Cobos-Carbo A, 2011, MED CLIN-BARCELONA, V137, P213, DOI 10.1016/j.medcli.2010.09.034; Dangour AD, 2010, AM J CLIN NUTR, V91, P1725, DOI 10.3945/ajcn.2009.29121; Del Brutto OH, 2016, J COMMUN HEALTH, V41, P82, DOI 10.1007/s10900-015-0070-9; Donini LM, 2007, ARCH GERONTOL GERIAT, V44, P143, DOI 10.1016/j.archger.2007.01.022; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Geleijnse JM, 2012, ALZHEIMERS DEMENT, V8, P278, DOI 10.1016/j.jalz.2011.06.002; Gu YA, 2010, ARCH NEUROL-CHICAGO, V67, P699, DOI 10.1001/archneurol.2010.84; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; HASHIGUCHI M, 2015, J PHARM HLTH CARE SC, V1; Hu N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/524820; Jaremka LM, 2014, PSYCHOSOM MED, V76, P650, DOI 10.1097/PSY.0000000000000104; Jiao JJ, 2014, AM J CLIN NUTR, V100, P1422, DOI 10.3945/ajcn.114.095315; Johnson EJ, 2008, NUTR NEUROSCI, V11, P75, DOI 10.1179/147683008X301450; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Larrieu S, 2004, J Nutr Health Aging, V8, P150; Lee LK, 2013, PSYCHOPHARMACOLOGY, V225, P605, DOI 10.1007/s00213-012-2848-0; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; Lopez LB, 2011, J NUTR HEALTH AGING, V15, P25, DOI 10.1007/s12603-011-0009-5; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Mazereeuw G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.014; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Morley JE, 2010, CLIN GERIATR MED, V26, P89, DOI 10.1016/j.cger.2009.11.005; Morris MC, 2017, ANN NY ACAD SCI, V1367, P31; Nilsson A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-99; Rodriguez JO, 2015, NEUROLOGIA, V30, P589, DOI 10.1016/j.nrl.2014.03.011; Otsuka M, 2000, Nihon Ronen Igakkai Zasshi, V37, P970; Oulhaj A, 2016, J ALZHEIMERS DIS, V50, P547, DOI 10.3233/JAD-150777; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Phillips MA, 2015, INT J MOL SCI, V16, P24600, DOI 10.3390/ijms161024600; Phillips MA, 2012, NUTR NEUROSCI, V15, P271, DOI 10.1179/1476830512Y.0000000026; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P661; Restrepo M Sandra Lucia, 2006, Rev. chil. nutr., V33, P500; Rondanelli M, 2012, NUTR NEUROSCI, V15, P46, DOI 10.1179/1476830511Y.0000000032; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Samieri C, 2008, J AM DIET ASSOC, V108, P1461, DOI 10.1016/j.jada.2008.06.437; Shatenstein B, 2007, J AM DIET ASSOC, V107, P2091, DOI 10.1016/j.jada.2007.09.008; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Sinn N, 2012, BRIT J NUTR, V107, P1682, DOI 10.1017/S0007114511004788; Strike SC, 2016, J GERONTOL A-BIOL, V71, P236, DOI 10.1093/gerona/glv109; Sydenham E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005379.pub3; Titova OE, 2013, AGE, V35, P1495, DOI 10.1007/s11357-012-9453-3; Vakhapova V, 2014, DEMENT GERIATR COGN, V38, P39, DOI 10.1159/000357793; Vakhapova V, 2010, DEMENT GERIATR COGN, V29, P467, DOI 10.1159/000310330; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; Waitzberg DL, 2014, NUTR HOSP, V30, P467, DOI 10.3305/nh.2014.30.3.7632; Weiser MJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020099; Witte AV, 2014, CEREB CORTEX, V24, P3059, DOI 10.1093/cercor/bht163; World Health Organization, 2021, DEM; Yanai Hidekatsu, 2017, J Clin Med Res, V9, P1; Yurko-Mauro K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120391; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013; Zhang XW, 2016, AGING CLIN EXP RES, V28, P165, DOI 10.1007/s40520-015-0381-9; Zhang Y, 2016, AM J CLIN NUTR, V103, P330, DOI 10.3945/ajcn.115.124081	66	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0193568	10.1371/journal.pone.0193568	http://dx.doi.org/10.1371/journal.pone.0193568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579102	Green Submitted, Green Published, gold			2022-12-27	WOS:000428351800010
J	Eskildsen, GA; Rovira, JR; Smith, O; Miller, MJ; Bennett, KL; McMillan, WO; Loaiza, J				Eskildsen, Gilberto A.; Rovira, Jose R.; Smith, Octavio; Miller, Matthew J.; Bennett, Kelly L.; McMillan, W. Owen; Loaiza, Jose			Maternal invasion history of Aedes aegypti and Aedes albopictus into the Isthmus of Panama: Implications for the control of emergent viral disease agents	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; POPULATION-GENETICS; VECTOR; DIPTERA; PHYLOGEOGRAPHY; SOFTWARE; SPREAD; TIGER	Despite an increase in dengue outbreaks and the arrival of chikungunya and Zika disease in Panama, studies on the demographic history of the invasive Aedes mosquitoes that are the principle vectors of these diseases are still lacking in this region. Here, we assess the genetic diversity of these mosquitoes in order to decipher their invasion histories into the Isthmus of Panama. DNA sequences from the mitochondrial cytochrome C oxidase I gene obtained from 30 localities in 10 provinces confirmed the presence of more than one mitochondrial haplogroup (i.e., maternal lineage) in each species. The invasion of Aedes albopictus was likely from temperate European countries, as the most frequent and widespread haplogroup in Panama harbored variants that are uncommon elsewhere in the Americas. Two infrequent and geographically restricted Ae. albopictus haplotypes appear to have subsequently invaded Panama from neighboring Costa Rica and the USA, respectively. In addition, we recovered two deeply divergent mitochondrial clades in Panamanian Aedes aegypti. The geographic origins of these clades is unknown, given that divergence in the mitochondrial genome is probably due to ancient population processes within the native range of Ae. aegypti, rather than due to its global expansion out of Africa. However, Panamanian Ae. aegypti mitochondrial sequences within the first Glade were closely related to others from Colombia, Bolivia, Brazil, Mexico and the USA, suggesting two separate invasions from Western Hemisphere source populations. The pattern of increased genetic diversity in Aedes mosquitoes in Panama is likely facilitated by the numerous land and water inter-connections across the country, which allows them to enter via sea- and land-transportation from Europe, North, Central and South America. Our results here should be considered in disease mitigation programs if emergent arboviruses are to be effectively diminished in Panama through vector suppression.	[Eskildsen, Gilberto A.; Rovira, Jose R.; Miller, Matthew J.; Loaiza, Jose] Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama; [Eskildsen, Gilberto A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, India; [Rovira, Jose R.; Bennett, Kelly L.; McMillan, W. Owen; Loaiza, Jose] Smithsonian Trop Res Inst, Unit 0948, Panama City, Panama; [Smith, Octavio] Ctr Agua Trop Humedo Amer Latina & El Caribe, Panama City, Panama; [Miller, Matthew J.] Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73019 USA; [Miller, Matthew J.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Loaiza, Jose] Univ Panama, Programa Ctr Amer Maestria Entomol, Panama City, Panama	Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Acharya Nagarjuna University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Universidad de Panama	Loaiza, J (corresponding author), Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama.; Loaiza, J (corresponding author), Smithsonian Trop Res Inst, Unit 0948, Panama City, Panama.; Loaiza, J (corresponding author), Univ Panama, Programa Ctr Amer Maestria Entomol, Panama City, Panama.	jloaiza@indicasat.org.pa	; Miller, Matthew/B-4560-2008	Bennett, Kelly/0000-0003-0330-5275; Miller, Matthew/0000-0002-2939-0239; Eskildsen, Gilberto A./0000-0001-8868-423X	Secretaria Nacional de Ciencia, Tecnologia e Innovacion de Panama [SENACYT- IDDS15_047]	Secretaria Nacional de Ciencia, Tecnologia e Innovacion de Panama	This work was supported by Secretaria Nacional de Ciencia, Tecnologia e Innovacion de Panama (SENACYT- IDDS15_047). http:/www.senacyt.gob.pa/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00208; Bell Jonathan, 2008, Biotechniques, V44, P834, DOI 10.2144/000112890; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown L, 2014, PUBLIC HEALTH, V128, P29, DOI 10.1016/j.puhe.2013.09.006; Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002; CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107; da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x; FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009; Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028; Gorman K, 2016, PEST MANAG SCI, V72, P618, DOI 10.1002/ps.4151; Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008; Jaimes-Duenez J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003553; KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67; Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Miller MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003383; Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1; Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895; Shaikevich E., 2013, ISRN Entomology, V2013, P157426; Shi QM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2213-6; TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Usmani- Brown S, 2009, BIOMED CENTRAL, V102, P144, DOI [https:// doi. org/ 10. 1603/ 008. 102. 0116, 10. 1603/ 008. 102. 0116, DOI 10.1186/313071016-1505-6]; Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116; Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Zhang RL, 2018, MITOCHONDRIAL DNA A, V29, P594, DOI 10.1080/24701394.2017.1325481	50	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194874	10.1371/journal.pone.0194874	http://dx.doi.org/10.1371/journal.pone.0194874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579112	gold, Green Published, Green Submitted			2022-12-27	WOS:000428351800063
J	Povoa, TF; Oliveira, ERA; Basilio-de-Oliveira, CA; Nuovo, GJ; Chagas, VLA; Salomao, NG; Alves, AMD; Mota, EM; Paes, MV				Povoa, Tiago F.; Oliveira, Edson R. A.; Basilio-de-Oliveira, Carlos. A.; Nuovo, Gerard J.; Chagas, Vera L. A.; Salomao, Natalia G.; de Barcelos Alves, Ada Maria; Mota, Ester M.; Paes, Marciano V.			Peripheral Organs of Dengue Fatal Cases Present Strong Pro-Inflammatory Response with Participation of IFN-Gamma-, TNF-Alpha- and RANTES-Producing Cells	PLOS ONE			English	Correction									[de Barcelos Alves, Ada Maria] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Biotechnol & Physiol Viral Infect, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz								Povoa TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168973	1	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0195140	10.1371/journal.pone.0195140	http://dx.doi.org/10.1371/journal.pone.0195140			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579124	Green Submitted, gold, Green Published			2022-12-27	WOS:000428351800080
J	Findling, S; Stotz, HU; Zoeller, M; Krischke, M; Zander, M; Gatz, C; Berger, S; Mueller, MJ				Findling, Simone; Stotz, Henrik U.; Zoeller, Maria; Krischke, Markus; Zander, Mark; Gatz, Christiane; Berger, Susanne; Mueller, Martin J.			TGA2 signaling in response to reactive electrophile species is not dependent on cysteine modification of TGA2	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; 12-OXO-PHYTODIENOIC ACID; DEFENSE RESPONSES; HYDROGEN-PEROXIDE; REDOX REGULATION; PLANT-RESPONSES; DNA-BINDING; PROTEIN	Reactive electrophile species (RES), including prostaglandins, phytoprostanes and 12-oxo phytodienoic acid (OPDA), activate detoxification responses in plants and animals. However, the pathways leading to the activation of defense reactions related to abiotic or biotic stress as a function of RES formation, accumulation or treatment are poorly understood in plants. Here, the thiol-modification of proteins, including the RES-activated basic region/leucine zipper transcription factor TGA2, was studied. TGA2 contains a single cysteine residue (Cys186) that was covalently modified by reactive cyclopentenones but not required for induction of detoxification genes in response to OPDA or prostaglandin Al. Activation of the glutathione-S-transferase 6 (GST6) promoter was responsive to cyclopentenones but not to unreactive cyclopentanones, including jasmonic acid suggesting that thiol reactivity of RES is important to activate the TGA2-dependent signaling pathway resulting in GST6 activation We show that RES modify thiols in numerous proteins in vivo, however, thiol reactivity alone appears not to be sufficient for biological activity as demonstrated by the failure of several membrane permeable thiol reactive reagents to activate the GST6 promoter.	[Findling, Simone; Stotz, Henrik U.; Zoeller, Maria; Krischke, Markus; Berger, Susanne; Mueller, Martin J.] Univ Wurzburg, Julius von Sachs Inst Biosci, Bioctr, Pharmaceut Biol, Wurzburg, Germany; [Zander, Mark; Gatz, Christiane] Georg August Univ Goettingen, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Stotz, Henrik U.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield, Herts, England; [Zander, Mark] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	University of Wurzburg; University of Gottingen; University of Hertfordshire; Salk Institute	Mueller, MJ (corresponding author), Univ Wurzburg, Julius von Sachs Inst Biosci, Bioctr, Pharmaceut Biol, Wurzburg, Germany.	martin.mueller@biozentrum.uni-wuerzburg.de	mueller, martin j/C-7616-2019	Stotz, Henrik/0000-0003-2954-8566; Berger, Susanne/0000-0001-7853-6778	Research Training Group Lipid Signaling, DFG (Deutsche Forschungsgemeinschaft [GRK 1342]	Research Training Group Lipid Signaling, DFG (Deutsche Forschungsgemeinschaft	The project was funded by the Research Training Group GRK 1342 Lipid Signaling, DFG (Deutsche Forschungsgemeinschaft, http://www.dfg.de/en/. Recipient: SF. Project leaders: SB, MJM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas MS, 2015, PLANT PHYSIOL, V168, P885, DOI 10.1104/pp.115.256834; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen WQ, 1996, PLANT J, V10, P955, DOI 10.1046/j.1365-313X.1996.10060955.x; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Domingues RM, 2013, J PROTEOMICS, V92, P110, DOI 10.1016/j.jprot.2013.06.004; Dueckershoff K, 2008, BBA-PROTEINS PROTEOM, V1784, P1975, DOI 10.1016/j.bbapap.2008.09.003; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Huang LJ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0886-1; Kang HG, 2005, PLANT MOL BIOL, V57, P541, DOI 10.1007/s11103-005-0409-1; Kholod N, 2001, BIOTECHNIQUES, V31, P322, DOI 10.2144/01312st03; Koster J, 2012, PLANT PHYSIOL, V159, P1292, DOI 10.1104/pp.112.900440; Li S, 2009, PLANT CELL, V21, P429, DOI 10.1105/tpc.108.064477; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Loeffler C, 2005, PLANT PHYSIOL, V137, P328, DOI 10.1104/pp.104.051714; Mano J, 2012, PLANT PHYSIOL BIOCH, V59, P90, DOI 10.1016/j.plaphy.2012.03.010; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Park SW, 2013, P NATL ACAD SCI USA, V110, P9559, DOI 10.1073/pnas.1218872110; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Stange C, 1997, PLANT J, V11, P1315, DOI 10.1046/j.1365-313X.1997.11061315.x; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; Wasternack C, 2013, BIOCHIMIE, V95, P79, DOI 10.1016/j.biochi.2012.06.005; Wible RS, 2017, CHEM RES TOXICOL, V30, P729, DOI 10.1021/acs.chemrestox.6b00428; Zander M, 2014, PLANT PHYSIOL, V165, P1671, DOI 10.1104/pp.114.243360; Zander M, 2012, MOL PLANT, V5, P831, DOI 10.1093/mp/ssr113; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; ZIMMERMAN DH, 1978, AM SOCIOL, V13, P6	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195398	10.1371/journal.pone.0195398	http://dx.doi.org/10.1371/journal.pone.0195398			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608605	Green Published, Green Submitted, gold			2022-12-27	WOS:000428988800050
J	Hall, KS; Morhe, E; Manu, A; Harris, LH; Ela, E; Loll, D; Kolenic, G; Dozier, JL; Challa, S; Zochowski, MK; Boakye, A; Adanu, R; Dalton, VK				Hall, Kelli Stidham; Morhe, Emmanuel; Manu, Abubakar; Harris, Lisa H.; Ela, Elizabeth; Loll, Dana; Kolenic, Giselle; Dozier, Jessica L.; Challa, Sneha; Zochowski, Melissa K.; Boakye, Andrew; Adanu, Richard; Dalton, Vanessa K.			Factors associated with sexual and reproductive health stigma among adolescent girls in Ghana	PLOS ONE			English	Article							UNINTENDED PREGNANCY; MENTAL-ILLNESS; ATTITUDES; SCALE; WOMEN	Objective Using our previously developed and tested Adolescent Sexual and Reproductive Health (SRH) Stigma Scale, we investigated factors associated with perceived SRH stigma among adolescent girls in Ghana. Methods We drew upon data from our survey study of 1,063 females 15-24yrs recruited from community-and clinic-based sites in two Ghanaian cities. Our Adolescent SRH Stigma Scale comprised 20 items and 3 sub-scales (Internalized, Enacted, Lay Attitudes) to measure stigma occurring with sexual activity, contraceptive use, pregnancy, abortion and family planning service use. We assessed relationships between a comprehensive set of demographic, health and social factors and SRH Stigma with multi-level multivariable linear regression models. Results In unadjusted bivariate analyses, compared to their counterparts, SRH stigma scores were higher among girls who were younger, Accra residents, Muslim, still in/dropped out of secondary school, unemployed, reporting excellent/very good health, not in a relationship, not sexually experienced, never received family planning services, never used contraception, but had been pregnant (all p-values <0.05). In multivariable models, higher SRH stigma scores were associated with history of pregnancy (beta=1.53, CI=0.51,2.56) and excellent/very good self-rated health (beta=0.89, CI=0.20,1.58), while lower stigma scores were associated with older age (beta=-0.17, 95%Cl =-0.24,-0.09), higher educational attainment (beta=-1.22, CI=-1.82,-0.63), and sexual intercourse experience (beta=-1.32, CI=-2.10,-0.55). Conclusions Findings provide insight into factors contributing to SRH stigma among this young Ghanaian female sample. Further research disentangling the complex interrelationships between SRH stigma, health, and social context is needed to guide multi-level interventions to address SRH stigma and its causes and consequences for adolescents worldwide.	[Hall, Kelli Stidham; Dozier, Jessica L.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Morhe, Emmanuel] Univ Allied Hlth & Sci, Ho, Ghana; [Manu, Abubakar; Adanu, Richard] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Harris, Lisa H.; Ela, Elizabeth; Loll, Dana; Kolenic, Giselle; Challa, Sneha; Zochowski, Melissa K.; Dalton, Vanessa K.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Boakye, Andrew] Kwame Nkrumah Univ Sci & Technol, Komfo Anokye Teaching Hosp, Kumasi, Ghana	Emory University; Rollins School Public Health; University of Ghana; University of Michigan System; University of Michigan; Kwame Nkrumah University Science & Technology	Hall, KS (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	kelli.s.hall@emory.edu	Morhe, Emmanuel S.K./AAL-3923-2020	Morhe, Emmanuel S.K./0000-0003-1696-1132; Dozier, Jessica/0000-0001-6976-6002; Challa, Sneha/0000-0001-5220-6834	Society of Family Planning Research Fund Award [SFPRF8-1]; National Institute of Child Health and Human Development (NICHD) [1K01HD080722-01A1]; NICHD [K12HD001438]; University of Michigan's African Social Research Initiative; Office of the Vice President of Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD080722] Funding Source: NIH RePORTER	Society of Family Planning Research Fund Award; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Michigan's African Social Research Initiative; Office of the Vice President of Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Society of Family Planning Research Fund Award #SFPRF8-1, the National Institute of Child Health and Human Development (NICHD) #1K01HD080722-01A1 (KSH), NICHD #K12HD001438 (for KSH while she was at the University of Michigan, PI Johnson), and awards from the University of Michigan's African Social Research Initiative and Office of the Vice President of Research. Funding sources had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.; This work was supported by the Society of Family Planning Research Fund Award #SFPRF8-1, the National Institute of Child Health and Human Development (NICHD) #1K01HD080722-01A1 (KSH), NICHD #K12HD001438 (for KSH while she was at the University of Michigan, PI Johnson), and awards from the University of Michigan's African Social Research Initiative and Office of the Vice President of Research. Funding sources had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Atuyambe Lynn, 2005, Afr Health Sci, V5, P304; Centers for Disease Control and Prevention, 2004, PREGN RISK ASS MON S PREGN RISK ASS MON S; Challa S, 2017, WOMEN HLTH, P1; Cockrill K, 2013, PERSPECT SEX REPRO H, V45, P79, DOI 10.1363/4507913; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Fenton KA, 2010, J SEX MED, V7, P250, DOI 10.1111/j.1743-6109.2010.02057.x; Garnets L.D., 2003, PSYCHOL PERSPECTIVES; Glinski A, UNDERSTANDING ADOLES; Goffman E., 1963, BEHAV PUBLIC PLACES, P3; Hall KS, 2015, J ADOLESCENT HEALTH, V56, P330, DOI 10.1016/j.jadohealth.2014.11.008; Hall KS, 2017, J SEX RES; Hall KS, 2016, UNDERSTANDI IN PRESS; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Hindin MJ, 2013, B WORLD HEALTH ORGAN, V91, P10, DOI 10.2471/BLT.12.107565; Hogue CJR, 2013, AM J EPIDEMIOL, V177, P755, DOI 10.1093/aje/kws381; Hokororo A, 2015, ACTA PAEDIATR, V104, P1291, DOI 10.1111/apa.12886; Kelly DM, 1996, YOUTH SOC, V27, P421, DOI 10.1177/0044118X96027004002; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Langer A, 2015, LANCET; Leyandowski BA, 2012, INT J GYNECOL OBSTET, V118, pS167, DOI 10.1016/S0020-7292(12)60017-4; Lince-Deroche N, 2015, AFR J REPROD HEALTH, V19, P73; Link BG, 2004, SCHIZOPHRENIA BULL, V30, P511, DOI 10.1093/oxfordjournals.schbul.a007098; Norris A., 2011, WOMEN HEALTH ISS, V21, P549; Nybade L, 2006, CAN WE MEASURE HIV A; Sanfilippo JS, 2015, J PEDIATR ADOL GYNEC, V28, P207, DOI 10.1016/j.jpag.2015.05.009; Sartorius N, 2002, BMJ-BRIT MED J, V324, P1470, DOI 10.1136/bmj.324.7352.1470; Satcher D, 2015, JAMA-J AM MED ASSOC, V314, P765, DOI 10.1001/jama.2015.6831; Shellenberg KM, 2014, WOMEN HEALTH, V54, P599, DOI 10.1080/03630242.2014.919982; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; Wiemann C.M., 2005, J ADOLESCENT HEALTH, V36, p352.; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195163	10.1371/journal.pone.0195163	http://dx.doi.org/10.1371/journal.pone.0195163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608595	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800030
J	Sato, H; Takahashi, K; Mizuno, KI; Hashimoto, S; Yokoyama, J; Terai, S				Sato, Hiroki; Takahashi, Kazuya; Mizuno, Ken-ichi; Hashimoto, Satoru; Yokoyama, Junji; Terai, Shuji			A clinical study of peroral endoscopic myotomy reveals that impaired lower esophageal sphincter relaxation in achalasia is not only defined by high-resolution manometry	PLOS ONE			English	Article							CHICAGO CLASSIFICATION; JACKHAMMER ESOPHAGUS; PRESSURE TOPOGRAPHY; MOTILITY DISORDERS; GASTROENTEROLOGY; JUNCTION; CRITERIA; DISEASE; POEM	Background and aim Achalasia is an esophageal motility disorder characterized by impaired lower esophageal sphincter (LES) relaxation. On high-resolution manometry (HRM), impaired LES relaxation is defined by elevated integrated relaxation pressure (IRP). However, a new category of achalasia within the normal IRP range has been suggested. Methods HRM was performed using a Starlet device and an IRP threshold of 26 mmHg. Peroral endoscopic myotomy (POEM) was performed for cases of achalasia diagnosed using established methods. During POEM, the histology of the LES was assessed. Follow-up was performed 2 months post-operatively. Results Forty-one patients with achalasia (18 women, mean age 53 18.6 years) were included. Among them, 27 were placed in the IRP >26 mmHg subgroup (impaired LES relaxation on HRM) and 14 in the IRP < 26 mmHg subgroup (normal LES relaxation on HRM). In the IRP < 26 mmHg subgroup, patients were older, had longer symptom duration, and had more esophageal dilation. The IRP < 26 mmHg subgroup had the same symptom severity as the higher IRP subgroup and POEM significantly improved symptoms and IRP, although four patients still had severe LES fibrosis. Conclusions The clinical presentation of achalasia has a gap between a HRM-defined impaired LES relaxation, with aging or disease progression considered reasons for a lowered LES pressure. POEM can be a feasible treatment option, even for cases of achalasia with a normal IRP. However, patients with severe LES fibrosis need more attention for the therapeutic indication.	[Sato, Hiroki; Takahashi, Kazuya; Mizuno, Ken-ichi; Hashimoto, Satoru; Yokoyama, Junji; Terai, Shuji] Niigata Univ, Div Gastroenterol, Med & Dent Hosp, Niigata, Japan; [Sato, Hiroki] Saiseikai Niigata Daini Hosp, Dept Gastroenterol, Niigata, Japan	Niigata University	Sato, H (corresponding author), Niigata Univ, Div Gastroenterol, Med & Dent Hosp, Niigata, Japan.; Sato, H (corresponding author), Saiseikai Niigata Daini Hosp, Dept Gastroenterol, Niigata, Japan.	pyloki@yahoo.co.jp			JSPS KAKENHI [16K19332]; Grants-in-Aid for Scientific Research [16K19332] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 'JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants') Grant Number 16K19332' The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by 'JSPS KAKENHI Grant Number 16K19332'	Boeckxstaens GE, 2014, LANCET, V383, P83, DOI 10.1016/S0140-6736(13)60651-0; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; CLOUSE RE, 1991, AM J PHYSIOL, V261, pG677, DOI 10.1152/ajpgi.1991.261.4.G677; Eckardt V F, 2001, Gastrointest Endosc Clin N Am, V11, P281; Gockel I, 2007, AM SURGEON, V73, P327; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Inoue H, 2015, J AM COLL SURGEONS, V221, P256, DOI 10.1016/j.jamcollsurg.2015.03.057; Iwakiri K, 2010, J GASTROENTEROL, V45, P422, DOI 10.1007/s00535-009-0179-7; Japanese Society for Esophageal Disease, 2012, DESCR RUL ACH ES; Kahrilas PJ, 2015, NEUROGASTROENT MOTIL, V27, P160, DOI 10.1111/nmo.12477; Kahrilas PJ, 2017, GASTROENTEROLOGY, V153, P1205, DOI 10.1053/j.gastro.2017.10.001; Kahrilas PJ, 2013, GASTROENTEROLOGY, V145, P954, DOI 10.1053/j.gastro.2013.08.038; Kuribayashi S, 2015, NEUROGASTROENT MOTIL, V27, P188, DOI 10.1111/nmo.12446; Lee J, 2007, CLIN GASTROENTEROL H, V5, P1392, DOI 10.1016/j.cgh.2007.08.011; Lin Z, 2012, NEUROGASTROENT MOTIL, V24, pe356, DOI 10.1111/j.1365-2982.2012.01952.x; Minami H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0101833; Mittal RK, 1997, NEW ENGL J MED, V336, P924, DOI 10.1056/NEJM199703273361306; Nakajima N, 2017, NEUROGASTROENTEROL M, V29; Ponds FA, 2017, NEUROGASTROENTEROL M, V29; Sato H, 2015, J GASTROEN HEPATOL, V30, P1226, DOI 10.1111/jgh.12914; Sato H, 2017, NEUROGASTROENTEROL M; Sato H, 2017, J GASTROENTEROL; Sato H, 2015, ENDOSCOPY, V47, P855, DOI 10.1055/s-0034-1391985; Shim YK, 2017, J NEUROGASTROENTEROL, V23, P481, DOI 10.5056/jnm23031; Takahashi K, 2015, J GASTROEN HEPATOL, V30, P1113, DOI 10.1111/jgh.12926; Teitelbaum EN, 2017, SURG ENDOSC; Vaezi MF, 2013, AM J GASTROENTEROL, V108, P1238, DOI 10.1038/ajg.2013.196	27	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195423	10.1371/journal.pone.0195423	http://dx.doi.org/10.1371/journal.pone.0195423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608597	gold, Green Submitted, Green Published			2022-12-27	WOS:000428988800053
J	Das, P; Ji, BY; Kovatcheva-Datchary, P; Backhed, F; Nielsen, J				Das, Promi; Ji, Boyang; Kovatcheva-Datchary, Petia; Backhed, Fredrik; Nielsen, Jens			In vitro co-cultures of human gut bacterial species as predicted from co-occurrence network analysis	PLOS ONE			English	Article							MICROBIOTA; PH; BIFIDOBACTERIUM; POLYSACCHARIDES; ASSOCIATION; METAGENOME; DIGESTION; ACIDS; DIET	Network analysis of large metagenomic datasets generated by current sequencing technologies can reveal significant co-occurrence patterns between microbial species of a biological community. These patterns can be analyzed in terms of pairwise combinations between all species comprising a community. Here, we construct a co-occurrence network for abundant microbial species encompassing the three dominant phyla found in human gut. This was followed by an in vitro evaluation of the predicted microbe-microbe co-occurrences, where we chose species pairs Bifidobacterium adolescentis and Bacteroides thetaiotaomicron, as well as Faecalibacterium prausnitzii and Roseburia inulinivorans as model organisms for our study. We then delineate the outcome of the co-cultures when equal distributions of resources were provided. The growth behavior of the co-culture was found to be dependent on the types of microbial species present, their specific metabolic activities, and resulting changes in the culture environment. Through this reductionist approach and using novel in vitro combinations of microbial species under anaerobic conditions, the results of this work will aid in the understanding and design of synthetic community formulations.	[Das, Promi; Ji, Boyang; Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Nielsen, Jens] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark	Chalmers University of Technology; University of Gothenburg; Novo Nordisk Foundation; University of Copenhagen; Technical University of Denmark	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.; Nielsen, J (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark.	nielsenj@chalmers.se	Backhed, Fredrik/ABE-6613-2020; Nielsen, Jens/Q-1347-2017	Backhed, Fredrik/0000-0002-4871-8818; Ji, Boyang/0000-0002-7269-4342; Das, Promi/0000-0002-9843-1524; Das, Promi/0000-0001-6733-2059; Nielsen, Jens/0000-0002-9955-6003	Knut and Alice Wallenberg Foundation; Torsten Soderbergs Stiftelse; European Commission Framework Programme 7 project METACARDIS [HEALTH-F4-2012-305312]; NNF Center for Basic Metabolic Research [B�ckhed Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016798, NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Yeast Cell Factories] Funding Source: researchfish	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten Soderbergs Stiftelse; European Commission Framework Programme 7 project METACARDIS; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	We acknowledge funding by the Knut and Alice Wallenberg Foundation, Torsten Soderbergs Stiftelse and European Commission Framework Programme 7 project METACARDIS with the grant agreement HEALTH-F4-2012-305312 (http://www.metacardis.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; DEGNAN BA, 1995, ANAEROBE, V1, P25, DOI 10.1016/S1075-9964(95)80392-0; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Duranti S, 2016, NAT PUBL GR; ENGLYST HN, 1985, AM J CLIN NUTR, V42, P778, DOI 10.1093/ajcn/42.5.778; ENGLYST HN, 1987, AM J CLIN NUTR, V45, P423, DOI 10.1093/ajcn/45.2.423; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; HAMILTON IR, 1989, ORAL MICROBIOL IMMUN, V4, P89, DOI 10.1111/j.1399-302X.1989.tb00105.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlsson FH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003706; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Knights D, 2014, CELL HOST MICROBE, V16, P433, DOI 10.1016/j.chom.2014.09.013; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Li X, 2003, CANCER GENE THER, V10, P105, DOI 10.1038/sj.cgt.7700530; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Mitri S, 2013, ANNU REV GENET, V47, P247, DOI 10.1146/annurev-genet-111212-133307; Munoz-Tamayo R, 2011, FEMS MICROBIOL ECOL, V76, P615, DOI 10.1111/j.1574-6941.2011.01085.x; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Rios-Covian D, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv176; Rios-Covian D, 2013, APPL ENVIRON MICROB, V79, P7518, DOI 10.1128/AEM.02545-13; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417; Ruiz L, 2009, INT J FOOD MICROBIOL; RUSSELL JB, 1991, APPL ENVIRON MICROB, V57, P3383, DOI 10.1128/AEM.57.11.3383-3384.1991; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tomas-Pejo E, 2008, BIOTECHNOL BIOENG, V100, P1122, DOI 10.1002/bit.21849; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, P299	42	29	29	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195161	10.1371/journal.pone.0195161	http://dx.doi.org/10.1371/journal.pone.0195161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601608	Green Published, Green Submitted, gold			2022-12-27	WOS:000428845900019
J	Vissers, M; Wijmenga-Monsuur, AJ; Knol, MJ; Badoux, P; van Houten, MA; van der Ende, A; Sanders, EAM; Rots, NY				Vissers, Marloes; Wijmenga-Monsuur, Alienke J.; Knol, Mirjam J.; Badoux, Paul; van Houten, Marlies A.; van der Ende, Arie; Sanders, Elisabeth A. M.; Rots, Nynke Y.			Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; CHILDREN; ADULTS; REPLACEMENT; POPULATION; 13-VALENT; IMPLEMENTATION; COLONIZATION	The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in The Netherlands in 2006 and was replaced by PHiD-CV10 in 2011. Data on carriage prevalence of S. pneumoniae serotypes in children and invasive pneumococcal disease (IPD) in children and older adults were collected to examine the impact of PCVs on carriage and IPD in The Netherlands. Pneumococcal carriage prevalence was determined by conventional culture of nasopharyngeal swabs in 24-month-old children in 2015/2016. Data were compared to similar carriage studies in 2005 (pre-PCV7 introduction), 2009, 2010/2011 and 2012/2013. Invasive pneumococcal disease isolates from hospitalized children < 5 years and adults > 65 years (2004-2016) were obtained by sentinel surveillance. All isolates were serotyped by Quellung. Serotype invasive disease potential was calculated using carriage and nationwide IPD data in children. The overall pneumococcal carriage rate was 48% in 2015/2016, lower than in 2010/2011 (64%) and pre-vaccination in 2005 (66%). Carriage of the previously dominant non-vaccine serotypes 19A and 11A has declined since 2010/2011, from 14.2% to 4.6% and 4.2% to 2.7%, respectively, whereas carriage of serotypes 6C and 23B has increased (4.2% to 6.7% and 3.9% to 7.3%), making serotypes 6C and 23B the most prevalent carriage serotypes. IPD incidence declined in children (20/100,000 cases in 2004/2006 to 6/100,000 cases in 2015/2016) as well as in older adults (63/100,000 cases to 51/100,000 cases). Serotypes 6C, 23B and 11A have high carriage prevalence in children, but show low invasive disease potential. Serotype 8 is the main causative agent for IPD in older adults (11.3%). In conclusion, 10 years after the introduction of pneumococcal vaccination in children in The Netherlands shifts in carriage and disease serotypes are still ongoing. Surveillance of both carriage and IPD is important to assess PCV impact and to predict necessary future vaccination strategies in both children and older adults.	[Vissers, Marloes; Wijmenga-Monsuur, Alienke J.; Knol, Mirjam J.; Sanders, Elisabeth A. M.; Rots, Nynke Y.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Badoux, Paul] Reg Lab Publ Hlth, Haarlem, Netherlands; [van Houten, Marlies A.] Spaarne Gasthuis Acad, Hoofddorp, Netherlands; [van der Ende, Arie] Acad Med Ctr, Med Microbiol, Amsterdam, Netherlands; [van der Ende, Arie] Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Vissers, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	Nynke.Rots@rivm.nl		van der Ende, Arie/0000-0003-1298-3086	Dutch Ministry of Health, the Netherlands	Dutch Ministry of Health, the Netherlands	This work was supported by the Dutch Ministry of Health, the Netherlands. Funders did not have any role in study design, collection of materials, analysis and interpretation of data, writing of the report and the decision to submit the article for publication.	Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Bosch AATM, 2016, VACCINE, V34, P531, DOI 10.1016/j.vaccine.2015.11.060; Brandileone MCD, 2016, VACCINE, V34, P5604, DOI 10.1016/j.vaccine.2016.09.027; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; Elberse KEM, 2012, VACCINE, V30, P7644, DOI 10.1016/j.vaccine.2012.04.021; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Galanis I, 2016, EUR RESPIR J, V47, P1208, DOI 10.1183/13993003.01451-2015; Hanage WP, 2011, VACCINE, V29, P8877, DOI 10.1016/j.vaccine.2011.09.075; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Isturiz R, 2017, EXPERT REV VACCINES, V16, P1007, DOI 10.1080/14760584.2017.1362339; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Knol MJ, 2015, EMERG INFECT DIS, V21, P2040, DOI 10.3201/eid2111.140780; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lindstrand A, 2016, VACCINE, V34, P4565, DOI 10.1016/j.vaccine.2016.07.031; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Naucler P, 2017, CLIN INFECT DIS, V65, P1780, DOI 10.1093/cid/cix685; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Rivera-Olivero IA, 2011, EUR J CLIN MICROBIOL, V30, P1489, DOI 10.1007/s10096-011-1247-5; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Stockmann C, 2016, CLIN INFECT DIS, V63, P619, DOI 10.1093/cid/ciw357; van den Bergh MR, 2013, CLIN INFECT DIS, V56, pE30, DOI 10.1093/cid/cis922; van der Linden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161257; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; Wagenvoort GHJ, 2016, VACCINE, V34, P1077, DOI 10.1016/j.vaccine.2015.12.066; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; Weinberger DM, 2013, AM J EPIDEMIOL, V178, P1488, DOI 10.1093/aje/kwt156; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wijmenga-Monsuur AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144739; Wyllie AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34888; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	40	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194823	10.1371/journal.pone.0194823	http://dx.doi.org/10.1371/journal.pone.0194823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601605	Green Published, Green Submitted, gold			2022-12-27	WOS:000428845900010
J	Kehlet, SN; Willumsen, N; Armbrecht, G; Dietzel, R; Brix, S; Henriksen, K; Karsdal, MA				Kehlet, Stephanie N.; Willumsen, Nicholas; Armbrecht, Gabriele; Dietzel, Roswitha; Brix, Susanne; Henriksen, Kim; Karsdal, Morten A.			Age-related collagen turnover of the interstitial matrix and basement membrane: Implications of age- and sex-dependent remodeling of the extracellular matrix	PLOS ONE			English	Article							PERSONALIZED HEALTH-CARE; LIVER FIBROSIS; CANCER PATIENTS; SERUM MARKERS; PRO-PEPTIDE; BIOMARKERS; BONE; CHILDREN; FIBROGENESIS; INFLAMMATION	The extracellular matrix (ECM) plays a vital role in maintaining normal tissue function. Collagens are major components of the ECM and there is a tight equilibrium between degradation and formation of these proteins ensuring tissue health and homeostasis. As a consequence of tissue turnover, small collagen fragments are released into the circulation, which act as important biomarkers in the study of certain tissue-related remodeling factors in health and disease. The aim of this study was to establish an age-related collagen turnover profile of the main collagens of the interstitial matrix (type I and III collagen) and basement membrane (type IV collagen) in healthy men and women. By using well-characterized competitive ELISA-assays, we assessed specific fragments of degraded (C1M, C3M, C4M) and formed (PINP, Pro-C3, P4NP7S) type I, III and IV collagen in serum from 617 healthy men and women ranging in ages from 22 to 86. Subjects were divided into 5-year age groups according to their sex and age. Groups were compared using Kruskal-Wallis adjusted for Dunn's multiple comparisons test and Mann-Whitney t-test. Age-specific changes in collagen turnover was most profound for type I collagen. PINP levels decreased in men with advancing age, whereas in women, the level decreased in early adulthood followed by an increase around the age of menopause (age 40-60). Sex-specific changes in type I, III and IV collagen turnover was present at the age around menopause (age 40-60) with women having an increased turnover. In summary, collagen turnover is affected by age and sex with the interstitial matrix and the basement membrane being differently regulated. The observed changes needs to be accounted for when measuring ECM related biomarkers in clinical studies.	[Kehlet, Stephanie N.; Willumsen, Nicholas; Henriksen, Kim; Karsdal, Morten A.] Nord Biosci AS, Herlev, Denmark; [Kehlet, Stephanie N.; Brix, Susanne] Tech Univ Denmark, Dept Biotechnol & Biomed, DTU Bioengn, Lyngby, Denmark; [Armbrecht, Gabriele; Dietzel, Roswitha] CHARITE Univ Med Berlin, Ctr Muscle & Bone Res, Dept Radiol, Campus Benjamin Franklin, Berlin, Germany	Nordic Bioscience; Technical University of Denmark; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kehlet, SN (corresponding author), Nord Biosci AS, Herlev, Denmark.; Kehlet, SN (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, DTU Bioengn, Lyngby, Denmark.	snk@nordicbio.com	Willumsen, Nicholas/AAV-5126-2021; Pedersen, Susanne Brix/B-3484-2009	Pedersen, Susanne Brix/0000-0001-8951-6705; Armbrecht, Gabriele/0000-0002-6578-338X; Dietzel, Roswitha/0000-0002-0768-4623; Karsdal, Morten/0000-0001-5026-8740				Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Bihlet AR, 2015, CHEST, V148, P16, DOI 10.1378/chest.15-0296; Biver E, 2012, JOINT BONE SPINE, V79, P20, DOI 10.1016/j.jbspin.2011.05.003; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Daan NMP, 2015, MATURITAS, V82, P257, DOI 10.1016/j.maturitas.2015.07.019; DANNE T, 1989, J PEDIATR-US, V114, P257, DOI 10.1016/S0022-3476(89)80792-9; Forel JM, 2015, INTENS CARE MED, V41, P1, DOI 10.1007/s00134-014-3524-0; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Genovese F, 2016, NEPHROL DIAL TRANSPL, V31, P472, DOI 10.1093/ndt/gfv301; Glover SJ, 2008, BONE, V42, P623, DOI 10.1016/j.bone.2007.12.218; GREEN J, 1995, AM J PHYSIOL-CELL PH, V268, pC1090, DOI 10.1152/ajpcell.1995.268.5.C1090; Hanke B, 2003, BRIT J CANCER, V88, P1248, DOI 10.1038/sj.bjc.6600832; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Kang CY, 2014, J GASTROINTEST SURG, V18, P7, DOI 10.1007/s11605-013-2326-y; Karsdal MA, 2016, AM J PHYSIOL-GASTR L, V311, pG1009, DOI 10.1152/ajpgi.00283.2016; Karsdal MA, 2016, J HEPATOL, V64, P103, DOI 10.1016/j.jhep.2015.08.014; Karsdal MA, 2014, ARTHRIT CARE RES, V66, P1273, DOI 10.1002/acr.22289; Karsdal MA, 2013, BIOMARKERS, V18, P375, DOI 10.3109/1354750X.2013.789084; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; Kehlet SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep30599; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Leeming DJ, 2013, ALIMENT PHARM THER, V38, P1086, DOI 10.1111/apt.12484; Leeming DJ, 2011, BIOMARKERS, V16, P616, DOI 10.3109/1354750X.2011.620628; Leeming DJ, 2010, CLIN BIOCHEM, V43, P1249, DOI 10.1016/j.clinbiochem.2010.07.025; Leeming DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071050; Leeming DJ, 2012, BIOMARK INSIGHTS, V7, P119, DOI 10.4137/BMI.S9415; Leeming DJ, 2012, HEPATOL RES, V42, P482, DOI 10.1111/j.1872-034X.2011.00946.x; Lotz M, 2013, ANN RHEUM DIS, V72, P1756, DOI 10.1136/annrheumdis-2013-203726; Lu P., J CELL BIOL, V196, P395; Martinez J, 2009, CLIN CHIM ACTA, V409, P70, DOI 10.1016/j.cca.2009.08.020; Morovat A, 2013, CLIN CHEM LAB MED, V51, P2009, DOI 10.1515/cclm-2012-0531; Nielsen MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137302; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; Patel K, 2014, CURR OPIN GASTROEN, V30, P253, DOI 10.1097/MOG.0000000000000059; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sand JMB, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0225-3; Sand JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084934; Siebuhr AS, 2014, OSTEOARTHR CARTILAGE, V22, P44, DOI 10.1016/j.joca.2013.10.020; Szulc, 2017, LANCET DIABETES ENDO; TRIVEDI P, 1985, EUR J CLIN INVEST, V15, P69, DOI 10.1111/j.1365-2362.1985.tb00147.x; van Haaften WT, 2017, ALIMENT PHARM THER, V46, P26, DOI 10.1111/apt.14092; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22; Willumsen N, 2014, CANCER MED-US, V3, P1136, DOI 10.1002/cam4.303; Willumsen N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-554; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767	49	36	36	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194458	10.1371/journal.pone.0194458	http://dx.doi.org/10.1371/journal.pone.0194458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596429	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000025
J	Lavedan, A; Viladrosa, M; Jurschik, P; Botigue, T; Nuin, C; Masot, O; Lavedan, R				Lavedan, Ana; Viladrosa, Maria; Jurschik, Pilar; Botigue, Teresa; Nuin, Carmen; Masot, Olga; Lavedan, Raquel			Fear of falling in community-dwelling older adults: A cause of falls, a consequence, or both?	PLOS ONE			English	Article							ACTIVITY RESTRICTION; INSTRUMENTAL ACTIVITIES; ELDERLY POPULATION; MEXICAN-AMERICANS; RISK-FACTORS; PREVALENCE; PEOPLE; SCALE; VALIDATION; EFFICACY	Background Despite the number of studies that have tried to demonstrate that there is an association between previous falls and the fear of falling, the relationship between these two variables remains a matter of controversy. Objectives Our objective was to investigate whether the fear of falling is a cause of falls, a consequence, or both in community-dwelling adults aged >= 75 years old. Methods A descriptive, longitudinal, prospective study was performed. A total of 640 individuals were interviewed between 2009 and 2011. Sociodemographic data, health status, history of falls and fear of falling were assessed at baseline and at 24 months. Results The prevalence of falls at baseline was 25% as opposed to 35.2% at 24 months. The prevalence of the fear of falling was 41.5% at baseline. Logistic regression analysis showed a significant association between a history of falls and the fear of falling. Other factors associated with the fear of falling were female gender, comorbidity, depressive symptoms, and disability. In total, 41.7% of the subjects who had reported a fear of falling at baseline had suffered at least one fall 24 months later. Unadjusted Cox regression analysis revealed that the fear of falling was a risk factor for falls. According to the final model adjusted for other covariates, the only reliable predictor was female gender. The Cox model stratified by gender failed to show a crude association between fear of falling and falls. Conclusion A previous history of falls in the previous year was a good predictor of the fear of falling; but the fear of falling was a predictor of falls during follow-up only in the unadjusted model, pointing to strong gender turns out as an effect modifier of the association of FOF and subsequent falls. Nursing staff working in elderly care should not only routinely assess patients' previous history of falls, but also evaluate their fear of falling and its associated factors.	[Lavedan, Ana; Viladrosa, Maria; Jurschik, Pilar; Botigue, Teresa; Nuin, Carmen; Masot, Olga] Univ Lleida, Dept Nursing & Physiotherapy, Lleida, Spain; [Viladrosa, Maria] Univ Hosp Arnau de Vilanova, Lleida, Spain; [Lavedan, Raquel] Univ Clin Hosp Lozano Blesa, Zaragoza, Spain	Universitat de Lleida; Lozano Blesa University Clinical Hospital	Botigue, T (corresponding author), Univ Lleida, Dept Nursing & Physiotherapy, Lleida, Spain.	teresa.botigue@dif.udl.cat	Botigué, Teresa/K-4372-2012	Botigué, Teresa/0000-0001-8178-1192; Masot, Olga/0000-0002-5721-5622				Alarcon T, 2009, ATEN PRIM, V41, P262, DOI 10.1016/j.aprim.2008.09.019; Alcalde Tirado Pablo, 2010, Rev Esp Geriatr Gerontol, V45, P38, DOI 10.1016/j.regg.2009.10.006; Allali G, 2017, ARCH GERONTOL GERIAT, V69, P15, DOI 10.1016/j.archger.2016.09.008; Austin N, 2007, J AM GERIATR SOC, V55, P1598, DOI 10.1111/j.1532-5415.2007.01317.x; Ayoubi F, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-128; Basaran Z, 2016, INJURY PREV, V22, pA179, DOI 10.1136/injuryprev-2016-042156.495; Boyd R, 2009, AGE AGEING, V38, P423, DOI 10.1093/ageing/afp053; Chang HY, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005173; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi K, 2015, J AGING HEALTH, V27, P1066, DOI 10.1177/0898264315573519; Cumming RG, 2000, J GERONTOL A-BIOL, V55, pM299, DOI 10.1093/gerona/55.5.M299; Gama ZAD, 2008, REV ESP SALUD PUBLIC, V82, P43, DOI [10.1590/s1135-57272008000100004, 10.1590/S1135-57272008000100004]; Denkinger MD, 2015, AM J GERIAT PSYCHIAT, V23, P72, DOI 10.1016/j.jagp.2014.03.002; Denkinger MD, 2009, AGE AGEING, V38, P108, DOI 10.1093/ageing/afn233; Deshpande N, 2009, J GERIATR PHYS THER, V32, P91, DOI 10.1519/00139143-200932030-00002; Dias RC, 2011, BRAZ J PHYS THER, V15, P406, DOI 10.1590/S1413-35552011000500011; Dierking L, 2016, J AM GERIATR SOC, V64, P2560, DOI 10.1111/jgs.14496; Donoghue OA, 2013, GAIT POSTURE, V38, P120, DOI 10.1016/j.gaitpost.2012.10.023; Evci ED, 2006, TOHOKU J EXP MED, V209, P291, DOI 10.1620/tjem.209.291; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Hokoishi K, 2001, AGING MENT HEALTH, V5, P38, DOI 10.1080/13607860020020627; Hughes CC, 2015, INT PSYCHOGERIATR, V27, P1071, DOI 10.1017/S1041610214002701; Jorstad EC, 2005, J AM GERIATR SOC, V53, P501; Jurschik P, 2012, ARCH GERONTOL GERIAT, V55, P625, DOI 10.1016/j.archger.2012.07.002; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Katsumata Y, 2011, GERIATR GERONTOL INT, V11, P282, DOI 10.1111/j.1447-0594.2010.00679.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kumar A, 2014, AGE AGEING, V43, P76, DOI 10.1093/ageing/aft154; Kwan MMS, 2011, AGING CLIN EXP RES, V23, P196, DOI 10.1007/BF03324960; Lach HW, 2005, PUBLIC HEALTH NURS, V22, P45, DOI 10.1111/j.0737-1209.2005.22107.x; Lachman ME, 1998, J GERONTOL B-PSYCHOL, V53, pP43, DOI 10.1093/geronb/53B.1.P43; Santamaria AL, 2015, ATEN PRIM, V47, P367, DOI 10.1016/j.aprim.2014.07.012; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LeBouthillier DM, 2013, J AGING HEALTH, V25, P1378, DOI 10.1177/0898264313507317; Lee J, 2017, J CLIN NURS, V26, P4964, DOI 10.1111/jocn.13995; Liu JYW, 2015, J CLIN NURS, V24, P393, DOI 10.1111/jocn.12613; Malini FM, 2016, GERIATR GERONTOL INT, V16, P336, DOI 10.1111/ggi.12477; Montorio I, 1994, PERSONA MAYOR GUIA A, P43; Morgan MT, 2013, OTOL NEUROTOL, V34, P1104, DOI 10.1097/MAO.0b013e318281df5d; MURPHY J, 1982, GERONTOLOGY, V28, P265, DOI 10.1159/000212543; Murphy SL, 2003, J GERONTOL A-BIOL, V58, P943; Nilsagard Y, 2009, CLIN REHABIL, V23, P259, DOI 10.1177/0269215508095087; Oh E, 2015, AGING MENT HEALTH, V19, P1; Padubidri A, 2014, CLIN INTERV AGING, V9, P719, DOI 10.2147/CIA.S59448; Palagyi A, 2016, INJURY PREV, V22, pA179, DOI 10.1136/injuryprev-2016-042156.496; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapp K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-105; Resnick B, 1998, Clin Nurs Res, V7, P230, DOI 10.1177/105477389800700302; Saiz JR, 2014, FISIOTERAPIA, V36, P153; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Schumacher J, 2014, Z GERONTOL GERIATR, V47, P141, DOI 10.1007/s00391-013-0503-y; Siqueira FV, 2011, CAD SAUDE PUBLICA, V27, P1819, DOI 10.1590/S0102-311X2011000900015; Suzuki Mizue, 2002, Nurs Health Sci, V4, P155, DOI 10.1046/j.1442-2018.2002.00123.x; Tabert MH, 2002, NEUROLOGY, V58, P758, DOI 10.1212/WNL.58.5.758; TINETTI ME, 1993, J GERONTOL, V48, P35, DOI 10.1093/geronj/48.Special_Issue.35; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; Varas-Fabra Francisco, 2006, Aten Primaria, V38, P450, DOI 10.1157/13094802; Vergara I, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-130; Weatherall M, 2004, INTERN MED J, V34, P102, DOI 10.1111/j.1444-0903.2004.t01-15-.x; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; Yardley L, 2002, GERONTOLOGIST, V42, P17, DOI 10.1093/geront/42.1.17; Zijlstra GAR, 2007, AGE AGEING, V36, P304, DOI 10.1093/ageing/afm021; Zijlstra GAR, 2007, J AM GERIATR SOC, V55, P603, DOI 10.1111/j.1532-5415.2007.01148.x	65	89	89	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194967	10.1371/journal.pone.0194967	http://dx.doi.org/10.1371/journal.pone.0194967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596521	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000059
J	Saito, N; Yamano, E; Ishii, A; Tanaka, M; Nakamura, J; Watanabe, Y				Saito, Naoko; Yamano, Emi; Ishii, Akira; Tanaka, Masaaki; Nakamura, Junji; Watanabe, Yasuyoshi			Involvement of the olfactory system in the induction of anti-fatigue effects by odorants	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MENTAL FATIGUE; SELECTIVE ATTENTION; ESSENTIAL OIL; GREEN-ODOR; PREFRONTAL CORTEX; MULTIGENE FAMILY; POPULATION; RECOVERY; HUMANS	Some components of the neural circuits underlying innate odor-evoked responses have recently been elucidated. Odor information detected by the olfactory receptors is transmitted from the olfactory bulb to the cortical amygdala, where physiological and emotional states such as attraction or avoidance are controlled. Thus, activation of specific olfactory receptors can elicit changes in physiological and/or psychological state. Here, we examined on the odorant Hex-Hex Mix, which has been reported to induce anti-fatigue effects. Fatigue is a prevalent condition that is often related to overwork and psychological stress. Various anti-fatigue treatments have been developed, including supplements and odorants. However, the mechanisms underlying the anti-fatigue effects of these substances are currently unclear. In the present study, we analyzed the involvement of the olfactory system in the mechanisms underlying this effect. We identified the human olfactory receptors activated by Hex-Hex Mix, and evaluated whether activation of these olfactory receptors by a newly developed odorant elicited a similar anti-fatigue effect to Hex-Hex Mix. We assessed anti-fatigue effects with behavioral tests, and 17 healthy males performed the 2-back test as a fatigue-inducing task with or without exposure to the new odorant. Immediately before and after the task, participants performed a cognitive task to evaluate their level of mental fatigue. We found that the difference value of the correct response rate on the cognitive task in the evaluation session was significantly different between in the odorant condition and in the without-odorant condition during the fatigue-inducing session suggesting that the new odorant may improve performance in the fatigue-inducing condition. The results indicated that the new odorant activates the same olfactory receptors as Hex-Hex Mix, which has been reported to induce anti-fatigue effects. Our findings suggest that the olfactory receptors in the olfactory system may be involved in the attenuation of fatigue.	[Saito, Naoko; Nakamura, Junji] Kao Corp, Kansei Sci Res, Haga, Tochigi, Japan; [Yamano, Emi; Watanabe, Yasuyoshi] RIKEN Compass Hlth Life Res Complex Program, Hlth Metr Dev Team, Kobe, Hyogo, Japan; [Yamano, Emi; Tanaka, Masaaki; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka, Japan; [Ishii, Akira] Osaka City Univ, Grad Sch Med, Dept Sports Med, Osaka, Japan; [Watanabe, Yasuyoshi] RIKEN Ctr Life Sci Technol, Kobe, Hyogo, Japan	KAO Corporation; RIKEN; Osaka Metropolitan University; Osaka Metropolitan University; RIKEN	Saito, N (corresponding author), Kao Corp, Kansei Sci Res, Haga, Tochigi, Japan.; Yamano, E (corresponding author), RIKEN Compass Hlth Life Res Complex Program, Hlth Metr Dev Team, Kobe, Hyogo, Japan.; Yamano, E (corresponding author), Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka, Japan.	saito.nao@kao.com; emi.yamano@riken.jp	Yamano, Emi/AAL-6201-2020	Yamano, Emi/0000-0003-3907-5360				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Aou SJ, 2005, CHEM SENSES, V30, pI262, DOI 10.1093/chemse/bjh215; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Danckert J, 2000, NEUROPSYCHOLOGY, V14, P16, DOI 10.1037/0894-4105.14.1.16; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; Faturi CB, 2010, PROG NEURO-PSYCHOPH, V34, P605, DOI 10.1016/j.pnpbp.2010.02.020; Finkelmeyer A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-131; Fukada M, 2012, CHEM SENSES, V37, P347, DOI 10.1093/chemse/bjr108; Ito N, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen045; Jung DJ, 2013, J EXERC REHABIL, V9, P250, DOI 10.12965/jer.130007; Kajimoto O., 2008, FATIGUE SCI HUMAN HL, P33, DOI DOI 10.1007/978-4-431-73464-2_3; Kajimoto O., FATIGUE SCI HUMAN HL; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kitani T., 2011, NIHON HIROUGAKKAISHI, V6, P1; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mizuno K, 2008, NUTRITION, V24, P293, DOI 10.1016/j.nut.2007.12.007; Mizuno K, 2010, MED SCI MONITOR, V16, pCR8; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Moss M, 2012, THER ADV PSYCHOPHARM, V2, P103, DOI 10.1177/2045125312436573; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Noy YI, 2011, ACCIDENT ANAL PREV, V43, P495, DOI 10.1016/j.aap.2009.12.017; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sasabe T, 2003, CHEM SENSES, V28, P565, DOI 10.1093/chemse/bjg048; Shimizu K, 2008, BIOSCI BIOTECH BIOCH, V72, P1944, DOI 10.1271/bbb.70835; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swaen G. M. H., 2003, Occupational and Environmental Medicine, V60, pi88, DOI 10.1136/oem.60.suppl_1.i88; Takada M, 2010, INT ARCH OCC ENV HEA, V83, P521, DOI 10.1007/s00420-009-0499-1; Tanaka M, 2008, NUTRITION, V24, P599, DOI 10.1016/j.nut.2008.03.001; Tanaka M, 2012, J NEUROL SCI-TURK, V29, P542; Tanaka M, 2009, LIFE SCI, V84, P235, DOI 10.1016/j.lfs.2008.12.004; TSUCHIYA T, 1991, BRAIN RES BULL, V26, P397, DOI 10.1016/0361-9230(91)90013-A; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Watanabe Y, 2005, CHEM SENSES, V30, pI268, DOI 10.1093/chemse/bjh218; Watanabe Y., FATIGUE SCI HUMAN HL; Xu JY, 2015, PSYCHIAT RES, V225, P509, DOI 10.1016/j.psychres.2014.11.056; Yamaguti Kouzi, 2007, Nihon Rinsho, V65, P1034; Yamano E, 2013, MED SCI MONITOR, V19, P540, DOI 10.12659/MSM.883971	52	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195263	10.1371/journal.pone.0195263	http://dx.doi.org/10.1371/journal.pone.0195263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596487	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000099
J	Chiang, E; Schmidt, ML; Berry, MA; Biddanda, BA; Burtner, A; Johengen, TH; Palladino, D; Denef, VJ				Chiang, Edna; Schmidt, Marian L.; Berry, Michelle A.; Biddanda, Bopaiah A.; Burtner, Ashley; Johengen, Thomas H.; Palladino, Danna; Denef, Vincent J.			Verrucomicrobia are prevalent in north-temperate freshwater lakes and display class-level preferences between lake habitats	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; NITROGEN-FIXATION; BACTERIOPLANKTON; DIVERSITY; REVEALS; NOV.	The bacterial phylum Verrucomicrobia was formally described two decades ago and originally believed to be a minor member of many ecosystems; however, it is now recognized as ubiquitous and abundant in both soil and aquatic systems. Nevertheless, knowledge of the drivers of its relative abundance and within-phylum habitat preferences remains sparse, especially in lake systems. Here, we documented the distribution of Verrucomicrobia in 12 inland lakes in Southeastern Michigan, a Laurentian Great Lake (Lake Michigan), and a freshwater estuary, which span a gradient in lake sizes, depths, residence times, and trophic states. A wide range of physical and geochemical parameters was covered by sampling seasonally from the surface and bottom of each lake, and by separating samples into particle-associated and free-living fractions. On average, Verrucomicrobia was the 4th most abundant phylum (range 1.7-41.7%). Fraction, season, station, and depth explained up to 70% of the variance in Verrucomicrobia community composition and preference for these habitats was phylogenetically conserved at the class-level. When relative abundance was linearly modeled against environmental data, Verrucomicrobia and non-Verrucomicrobia bacterial community composition correlated to similar quantitative environmental parameters, although there were lake system-dependent differences and > 55% of the variance remained unexplained. A majority of the phylum exhibited preference for the particle-associated fraction and two classes (Opitutae and Verrucomicrobiae) were identified to be more abundant during the spring season. This study highlights the high relative abundance of Verrucomicrobia in north temperate lake systems and expands insights into drivers of within-phylum habitat preferences of the Verrucomicrobia.	[Chiang, Edna; Schmidt, Marian L.; Berry, Michelle A.; Denef, Vincent J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Biddanda, Bopaiah A.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI USA; [Burtner, Ashley; Johengen, Thomas H.; Palladino, Danna] Univ Michigan, Cooperat Inst Great Lakes Res, Ann Arbor, MI 48109 USA; [Chiang, Edna] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Grand Valley State University; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	Denef, VJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	vdenef@umich.edu	Biddanda, Bopaiah/AAB-1705-2019	Biddanda, Bopaiah/0000-0002-9642-3379	Fred A. and Barbara M. Erb Family Foundation through the University of Michigan Water Center; Community Sequencing Program (U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility) [DE-AC02-05CH11231]; NOAA Michigan Sea Grant; National Science Foundation Graduate Research Fellowship Program; American Society of Microbiology-Undergraduate Research Fellowship; UM Honors Summer Fellowship; Beckman Scholars Program	Fred A. and Barbara M. Erb Family Foundation through the University of Michigan Water Center; Community Sequencing Program (U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility)(United States Department of Energy (DOE)); NOAA Michigan Sea Grant; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); American Society of Microbiology-Undergraduate Research Fellowship; UM Honors Summer Fellowship; Beckman Scholars Program	This work was supported by the Fred A. and Barbara M. Erb Family Foundation through the University of Michigan Water Center (VJD, THJ); the Community Sequencing Program (U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, supported under Contract No. DE-AC02-05CH11231)(VJD); The NOAA Michigan Sea Grant (VJD); the National Science Foundation Graduate Research Fellowship Program (MLS); and scholarships from the American Society of Microbiology-Undergraduate Research Fellowship, the UM Honors Summer Fellowship, and the Beckman Scholars Program (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnds J, 2010, SYST APPL MICROBIOL, V33, P139, DOI 10.1016/j.syapm.2009.12.005; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biddanda B., 2017, ENVIRONSCI, V98, P1, DOI [10.1029/2017EO069751, DOI 10.1029/2017EO069751]; Brewer TE, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.198; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Cardman Z, 2014, APPL ENVIRON MICROB, V80, P3749, DOI 10.1128/AEM.00899-14; Cole J.J, 2013, FRESHWATER ECOLOGY C, V18; De Wever A, 2008, AQUAT MICROB ECOL, V50, P113, DOI 10.3354/ame01157; DEBONT JAM, 1970, ANTON VAN LEE J M S, V36, P397, DOI 10.1007/BF02069040; Denef VJ, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00606, 10.3389/fmicb.2076.00606]; Deng Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094807, 10.1371/journal.pone.0103115]; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Fujimoto M, 2016, J GREAT LAKES RES, V42, P1036, DOI 10.1016/j.jglr.2016.07.029; Gibbons SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097435; Giraudoux P., 2012, R PACKAGE VERSION, V1, P617; Gomez-Gallego C, 2016, BENEF MICROBES, V7, P571, DOI 10.3920/BM2016.0009; Guo JR, 2016, APPL ENVIRON MICROB, V82, P157, DOI 10.1128/AEM.02772-15; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7; He SM, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00277-17; Hedlund BP, 1997, ANTON LEEUW INT J G, V72, P29, DOI 10.1023/A:1000348616863; Hedlund BP, 2010, BERGEYS MANUAL SYSTE, P795, DOI [10.1007/978-0-387-68572-4_12, DOI 10.1007/978-0-387-68572-4_12]; Henrici AT, 1935, J BACTERIOL, V30, P61, DOI 10.1128/JB.30.1.61-93.1935; Henrici AT, 1933, J BACTERIOL, V25, P277, DOI 10.1128/JB.25.3.277-287.1933; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Johengen TH, 2013, QUAGGA ZEBRA MUSSELS, P445; Kamke J, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0201-2; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Khadem AF, 2010, MICROBIOL-SGM, V156, P1052, DOI 10.1099/mic.0.036061-0; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li M, 2016, FRONTIERS MICROBIOL, V7; Lindh MV, 2015, ENVIRON MICROBIOL, V17, P2459, DOI 10.1111/1462-2920.12720; Lindstrom ES, 2005, AQUAT SCI, V67, P210, DOI 10.1007/s00027-005-0769-2; Lindstrom ES, 2004, J PLANKTON RES, V26, P241, DOI 10.1093/plankt/fbh010; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lumley T., LEAPS REGRESSION SUB; Mamaeva EV, 2016, MICROBIOLOGY+, V85, P220, DOI 10.1134/S0026261716020132; Martinez-Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035314; McCarthy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121659; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Salazar G, 2015, MOL ECOL, V24, P5692, DOI 10.1111/mec.13419; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Sarkar D, 2008, USE R, P1; SCHLESNER H, 1987, SYST APPL MICROBIOL, V10, P54, DOI 10.1016/S0723-2020(87)80010-3; Schlesner H., 2006, PROKARYOTES, V7, P881, DOI [10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8]; Schliep KP, 2010, BIOINFORMATICS, pbtq706; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt ML, 2016, ENVIRON MICROBIOL, V18, P1212, DOI 10.1111/1462-2920.13143; Schneider JW, 2007, J AM SOC INF SCI TEC, V58, P1596, DOI 10.1002/asi.20642; Shen C, 2017, J DRUG TARGET, P1; Spring S, 2016, ISME J, V10, P2801, DOI 10.1038/ismej.2016.84; Steinman AD, 2008, J GREAT LAKES RES, V34, P169, DOI 10.3394/0380-1330(2008)34[169:CSATIM]2.0.CO;2; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tremblay J, 2015, FRONT MICROBIOL, P6; Tucker CM, 2017, BIOL REV, V92, P698, DOI 10.1111/brv.12252; Wertz JT, 2012, APPL ENVIRON MICROB, V78, P1544, DOI 10.1128/AEM.06466-11; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Yang SJ, 2016, MICROB ECOL, V71, P29, DOI 10.1007/s00248-015-0695-3; Yung CM, 2015, ENVIRON MICROBIOL, V17, P2421, DOI 10.1111/1462-2920.12714; Zhang JX, 2014, ANN MICROBIOL, V64, P1405, DOI 10.1007/s13213-013-0785-8	69	34	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195112	10.1371/journal.pone.0195112	http://dx.doi.org/10.1371/journal.pone.0195112			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590198	gold, Green Published, Green Submitted			2022-12-27	WOS:000428603100104
J	Karimpur, H; Hamburger, K				Karimpur, Harun; Hamburger, Kai			A rat in the sewer: How mental imagery interacts with object recognition	PLOS ONE			English	Article							STRUCTURAL SALIENCE; WORKING-MEMORY; NAVIGATION; LANDMARKS; ENVIRONMENTS; KNOWLEDGE; ROUTES; REAL	The role of mental imagery has been puzzling researchers for more than two millennia. Both positive and negative effects of mental imagery on information processing have been discussed. The aim of this work was to examine how mental imagery affects object recognition and associative learning. Based on different perceptual and cognitive accounts we tested our imagery-induced interaction hypothesis in a series of two experiments. According to that, mental imagery could lead to (1) a superior performance in object recognition and associative learning if these objects are imagery-congruent (semantically) and to (2) an inferior performance if these objects are imagery-incongruent. In the first experiment, we used a static environment and tested associative learning. In the second experiment, subjects encoded object information in a dynamic environment by means of a virtual sewer system. Our results demonstrate that subjects who received a role adoption task (by means of guided mental imagery) performed better when imagery-congruent objects were used and worse when imagery-incongruent objects were used. We finally discuss our findings also with respect to alternative accounts and plead for a multi-methodological approach for future research in order to solve this issue.	[Karimpur, Harun] Justus Liebig Univ, Expt Psychol, Giessen, Germany; [Hamburger, Kai] Justus Liebig Univ, Expt Psychol & Cognit Sci, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Karimpur, H (corresponding author), Justus Liebig Univ, Expt Psychol, Giessen, Germany.	harun.karimpur@psychol.uni-giessen.de	Karimpur, Harun/D-2966-2018	Karimpur, Harun/0000-0001-7981-0943				Arnold AEGF, 2016, COGNITION, V157, P14, DOI 10.1016/j.cognition.2016.08.009; Aslan A, 2008, PSYCHON B REV, V15, P833, DOI 10.3758/PBR.15.4.833; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A.D., 1986, WORKING MEMORY THOUG; Balaban CZ, 2017, COGN PROCESS, V18, P135, DOI 10.1007/s10339-017-0790-0; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Baumann O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019707; BJORK RA, 1970, J VERB LEARN VERB BE, V9, P255, DOI 10.1016/S0022-5371(70)80059-7; Boccia M, 2015, HUM BRAIN MAPP, V36, P945, DOI 10.1002/hbm.22678; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caduff D, 2008, COGN PROCESS, V9, P249, DOI 10.1007/s10339-007-0199-2; Cooke R. G., FORTSCHR CHEM ORG NA, P153, DOI [10.1007/978-3-7091-8611-4_4, DOI 10.1007/978-3-7091-8611-4_4]; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; Gillner S, 1998, J COGNITIVE NEUROSCI, V10, P445, DOI 10.1162/089892998562861; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Goldstein EB, 2010, SENSATION PERCEPTION, VXXVIII; Karimpur H, 2016, FRONT PSYCHOL, V7; Kleiner M, 2007, PERCEPTION S; Klippel A, 2005, LECT NOTES COMPUT SC, V3693, P347; KOSSLYN SM, 1977, COGNITIVE PSYCHOL, V9, P52, DOI 10.1016/0010-0285(77)90004-4; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Locke J., 1841, ESSAY HUMAN UNDERSTA; Meilinger T, 2008, COGNITIVE SCI, V32, P755, DOI 10.1080/03640210802067004; Montello DR, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P251; Montello DR, 2005, CAMBRIDGE HDB VISUOS, P257, DOI DOI 10.1017/CBO9780511610448.008; Neisser U., 1976, COGNITION REALITY PR; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETERSON MJ, 1974, J EXP PSYCHOL, V103, P509, DOI 10.1037/h0037150; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; PICHERT JW, 1977, J EDUC PSYCHOL, V69, P309, DOI 10.1037/0022-0663.69.4.309; Plant KL, 2015, ERGONOMICS, V58, P909, DOI 10.1080/00140139.2014.991765; Plato John M., 1997, COMPLETE WORKS; POSNER MI, 1969, J EXP PSYCHOL, V79, P1, DOI 10.1037/h0026947; PYLYSHYN ZW, 1973, PSYCHOL BULL, V80, P1, DOI 10.1037/h0034650; Rebotier TP, 2003, AM J PSYCHOL, V116, P343, DOI 10.2307/1423498; Roser F, 2012, J SPAT SCI, V57, P37, DOI 10.1080/14498596.2012.686362; Roser F., 2015, THESIS; Ruddle RA, 1997, J EXP PSYCHOL-APPL, V3, P143, DOI 10.1037/1076-898X.3.2.143; Sahakyan L, 2002, J EXP PSYCHOL LEARN, V28, P1064, DOI 10.1037//0278-7393.28.6.1064; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; Schinazi VR, 2010, NEUROIMAGE, V53, P725, DOI 10.1016/j.neuroimage.2010.06.065; Shapiro AM, 2004, AM EDUC RES J, V41, P159, DOI 10.3102/00028312041001159; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Smith John Alexander, 1912, WORKS ARISTOTLE; Sorrows ME, 1999, LECT NOTES COMPUT SC, V1661, P37; Strickrodt M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01936; Sulpizio V, 2016, NEUROIMAGE, V125, P108, DOI 10.1016/j.neuroimage.2015.10.040; Tommasi L, 2012, WIRES COGN SCI, V3, P565, DOI 10.1002/wcs.1198; Trullier O, 1997, PROG NEUROBIOL, V51, P483, DOI 10.1016/S0301-0082(96)00060-3; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064	52	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194227	10.1371/journal.pone.0194227	http://dx.doi.org/10.1371/journal.pone.0194227			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590161	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100053
J	Terloyeva, D; Nugmanova, Z; Akhmetova, G; Akanov, A; Patel, N; Lazariu, V; Norelli, L; McNutt, LA				Terloyeva, Dina; Nugmanova, Zhamilya; Akhmetova, Gulzhakhan; Akanov, Aikan; Patel, Nimish; Lazariu, Victoria; Norelli, Lisa; McNutt, Louise-Anne			Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; POSTTRAUMATIC-STRESS-DISORDER; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; DSM-IV DISORDERS; CD4 CELL COUNT; PSYCHIATRIC-DISORDERS; LONGITUDINAL ANALYSIS; MEDICATION ADHERENCE; LIFETIME PREVALENCE	Background In Kazakhstan, scarce official prevalence data exists for mood disorders. This study investigates the occurrence of depressive symptoms among people living with HIV/AIDS (PLWHA), and the relationship between depressive symptoms, HIV treatment initiation and antiretroviral treatment (ART) adherence. Methods A cross-sectional study was conducted among patients seen at the Almaty AIDS Center between April and December 2013. Two data sources were used: 1) self-administered survey that included the Patient Health Questionnaire (PHQ-9) to capture depression symptoms and 2) medical record review. Two primary outcomes were evaluated with log binomial models and Fisher's exact test: the relationship between depression symptoms and 1) HIV treatment group, and 2) HIV adherence. Results Of the 564 participants, 9.9% reported symptoms consistent with a depressive disorder. None had received treatment for depression. Among those not on ART, a relationship between depressive symptoms and low CD4 counts (<= 350 cells/mm(3)) was evident (7.1% for CD4 <= 350 cells/mm(3) vs. 0.9% for CD4 > 350 cells/mm(3), p = 0.029). In multivariable analysis, a higher prevalence of depressive symptoms was statistically associated with ART treatment, positive hepatitis C virus (HCV) status, and being unmarried. For those taking ART, treatment adherence was not statistically associated with a lower prevalence of depressive symptoms (12.5% vs 20.0%, p = 0.176); limited power may have impacted statistical significance. Conclusions Untreated depression was found among PLWHA suggesting the need to evaluate access to psychiatric treatment. A collaborative strategy may be helpful to optimize HIV treatment outcomes.	[Terloyeva, Dina; Nugmanova, Zhamilya] Asfendiyarov Kazakh Natl Med Univ KNMU, Dept HIV Infect & Infect Control, Alma Ata, Kazakhstan; [Terloyeva, Dina] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Akhmetova, Gulzhakhan] Almaty City AIDS Ctr, Alma Ata, Kazakhstan; [Akanov, Aikan] Asfendiyarov Kazakh Natl Med Univ KNMU, Dept Publ Hlth, Alma Ata, Kazakhstan; [Patel, Nimish] Albany Coll Pharm & Hlth Sci, Albany, NY USA; [Lazariu, Victoria] SUNY Albany, Dept Epidemiol & Biostat, Rensselaer, NY USA; [Norelli, Lisa] Albany Med Coll, Dept Psychiat, Albany, NY 12208 USA; [McNutt, Louise-Anne] SUNY Albany, Inst Hlth & Environm, Rensselaer, NY USA	Drexel University; Albany College of Pharmacy & Health Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Terloyeva, D (corresponding author), Asfendiyarov Kazakh Natl Med Univ KNMU, Dept HIV Infect & Infect Control, Alma Ata, Kazakhstan.; Terloyeva, D (corresponding author), Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.	dt528@drexel.edu			Kazakh National Medical University Research Grant; New York State International Training and Research Program (NYS-ITRP) - Fogarty International Centre; National Institute of Drug Abuse, National Institutes of Health, USA (NIH) [D43 TW000233]	Kazakh National Medical University Research Grant; New York State International Training and Research Program (NYS-ITRP) - Fogarty International Centre; National Institute of Drug Abuse, National Institutes of Health, USA (NIH)	This study was supported by a Kazakh National Medical University Research Grant and New York State International Training and Research Program (NYS-ITRP) sponsored by the Fogarty International Centre and National Institute of Drug Abuse, National Institutes of Health, USA (NIH Grant D43 TW000233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2007, J PSYCHOSOM RES, V63, P203, DOI 10.1016/j.jpsychores.2007.03.006; Adinolfi LE, 2017, CLIN LIVER DIS, V21, P517, DOI 10.1016/j.cld.2017.03.007; Ahuja A S, 1998, J Assoc Physicians India, V46, P277; AlHadi AN, 2017, ANN GEN PSYCHIATR, V16, DOI 10.1186/s12991-017-0155-1; Alpizar D, 2017, PSYCHOL ASSESSMENT; Amirkhanian YA, 2003, AIDS, V17, P2367, DOI 10.1097/00002030-200311070-00012; Ammassari A, 2004, PSYCHOSOMATICS, V45, P394, DOI 10.1176/appi.psy.45.5.394; Angst J, 2002, EUR ARCH PSY CLIN N, V252, P201, DOI 10.1007/s00406-002-0381-6; [Anonymous], 2013, KAL FULL PRESCR INF; Arrieta J, 2017, J CLIN PSYCHOL, V73, P1076, DOI 10.1002/jclp.22390; Atlani L, 2000, SOC SCI MED, V50, P1547, DOI 10.1016/S0277-9536(99)00464-5; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bernard C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181960; Beyrer C, 2010, LANCET, V376, P208, DOI 10.1016/S0140-6736(10)61005-7; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Boarts JM, 2006, AIDS BEHAV, V10, P253, DOI 10.1007/s10461-006-9069-7; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Catz SL, 2000, HEALTH PSYCHOL, V19, P124, DOI 10.1037/0278-6133.19.2.124; Chandra PS, 1998, J PSYCHOSOM RES, V45, P401, DOI 10.1016/S0022-3999(98)00028-2; Ciesla JA, 2014, AM J PSYCHIAT; Costa JD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25066; Crane PK, 2010, AIDS CARE, V22, P874, DOI 10.1080/09540120903483034; Deshmukh Namita Navanit, 2017, J Family Med Prim Care, V6, P549, DOI 10.4103/2249-4863.222016; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Du N, 2017, ASIA-PAC PSYCHIAT, V9, DOI 10.1111/appy.12266; Eshun-Wilson I, 2014, ANTIDEPRESSANTS DEPR; Field MG, 2004, NEW ENGL J MED, V351, P117, DOI 10.1056/NEJMp048066; Golub ET, 2004, J URBAN HEALTH, V81, P278, DOI 10.1093/jurban/jth114; Gonzalez JS, 2011, J ACQUIR IMMUNE DEFI, V1999, P58; Goodness TM, 2014, AIDS BEHAV, V18, P1085, DOI 10.1007/s10461-013-0674-y; HIV/AIDS JUNPo, 2016, GLOB AIDS UPD 2016; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ironson G, 2005, PSYCHOSOM MED, V67, P1013, DOI 10.1097/01.psy.0000188569.58998.c8; JACOB KS, 1991, INDIAN J MED RES-A, V93, P62; Kacanek D, 2010, JAIDS-J ACQ IMM DEF, V53, P266, DOI 10.1097/QAI.0b013e3181b720e7; Kagee A, 2010, AIDS CARE, V22, P159, DOI 10.1080/09540120903111445; Kaharuza FM, 2006, AIDS BEHAV, V10, pS105, DOI 10.1007/s10461-006-9142-2; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim TW, 2007, AIDS CARE, V19, P1039, DOI 10.1080/09540120701294245; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2001, PHQ 9 VALIDITY BRIEF; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; Lofgren SM, 2018, AIDS BEHAV, V22, P1, DOI 10.1007/s10461-017-1906-3; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P39; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Marasheva A., 2007, MENTAL HLTH PROBLEMS; Marc LG, 2014, J GEN INTERN MED, V29, P1679, DOI 10.1007/s11606-014-2951-5; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Marwick KFM, 2010, AIDS CARE, V22, P415, DOI 10.1080/09540120903253981; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nallusamy V, 2016, INT J PSYCHIAT MED, V51, P508, DOI 10.1177/0091217417696732; Petrea I, 2012, PUBLIC HEALTH REV, V34, DOI 10.1007/BF03391673; Poli-Neto OB, 2016, REV BRAS GINECOL OBS, V38, P443, DOI 10.1055/s-0036-1592344; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Republican Research and Treatment Center for Psychiatry PaSA, 2011, PSYCH SERV REP KAZ 2; Roberts B, 2010, J PUBLIC MENT HEALTH, V9, P17, DOI 10.5042/jpmh.2010.0459; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schantz K, 2017, INT J PSYCHIAT MED, V52, P315, DOI 10.1177/0091217417738934; Sebit M, 2004, E AFR MED J, V80, P503; Shaw SA, 2016, COMMUNITY MENT HLT J, V52, P1047, DOI 10.1007/s10597-015-9883-3; Sledjeski EM, 2005, AIDS PATIENT CARE ST, V19, P728, DOI 10.1089/apc.2005.19.728; Starace F, 2002, JAIDS, V31, pS136, DOI 10.1097/00126334-200212153-00010; Stein MD, 2003, AM J PSYCHIAT, V160, P1659, DOI 10.1176/appi.ajp.160.9.1659; Tegger MK, 2008, AIDS PATIENT CARE ST, V22, P233, DOI 10.1089/apc.2007.0092; Van Voren R., 2013, PSYCHIAT TOOL COERCI; Vranceanu AM, 2008, AIDS PATIENT CARE ST, V22, P313, DOI 10.1089/apc.2007.0069; Vrublevska J, 2018, NORD J PSYCHIAT, V72, P112, DOI 10.1080/08039488.2017.1397191; WHO, 2010, ANT THER HIV INF AD; WHO, 2013, HIV AIDS SUMM NEW RE; Woldetensay YK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191782; World Health Organization, 2012, 369 WHO; Xiong NN, 2015, J AFFECT DISORDERS, V174, P636, DOI 10.1016/j.jad.2014.12.042; Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd	80	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193976	10.1371/journal.pone.0193976	http://dx.doi.org/10.1371/journal.pone.0193976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590151	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100041
J	Hicks, J; Stuber, T; Lantz, K; Erdman, M; Robbe-Austerman, S; Huang, XQ				Hicks, Jessica; Stuber, Tod; Lantz, Kristina; Erdman, Matthew; Robbe-Austerman, Suelee; Huang, Xiaoqiu			Genomic diversity of Taylorella equigenitalis introduced into the United States from 1978 to 2012	PLOS ONE			English	Article							CONTAGIOUS EQUINE METRITIS; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; SEQUENCING DATA; DNA; STRAINS; ALIGNMENT; SINGLE; GENE	Contagious equine metritis is a disease of worldwide concern in equids. The United States is considered to be free of the disease although sporadic outbreaks have occurred over the last few decades that were thought to be associated with the importation of horses. The objective of this study was to create finished, reference quality genomes that characterize the diversity of Taylorella equigenitalis isolates introduced into the USA, and identify their differences. Five isolates of T. equigenitalis associated with introductions into the USA from unique sources were sequenced using both short and long read chemistries allowing for complete assembly and annotation. These sequences were compared to previously published genomes as well as the short read sequences of the 200 isolates in the National Veterinary Services Laboratories' diagnostic repository to identify unique regions and genes, potential virulence factors, and characterize diversity. The 5 genomes varied in size by up to 100,000 base pairs, but averaged 1.68 megabases. The majority of that diversity in size can be explained by repeat regions and 4 main regions of difference, which ranged in size from 15,000 to 45,000 base pairs. The first region of difference contained mostly hypothetical proteins, the second contained the CRISPR, the third contained primarily hemagglutinin proteins, and the fourth contained primarily segments of a type IV secretion system. As expected and previously reported, little evidence of recombination was found within these genomes. Several additional areas of interest were also observed including a mechanism for streptomycin resistance and other virulence factors. A SNP distance comparison of the T. equigenitalis isolates and Mycobacterium tuberculosis complex (MTBC) showed that relatively, T. equigenitalis was a more diverse species than the entirety of MTBC.	[Hicks, Jessica; Stuber, Tod; Lantz, Kristina; Robbe-Austerman, Suelee] USDA, Diagnost Bacteriol & Pathol Lab, NVSL, Ames, IA 50010 USA; [Erdman, Matthew] USDA, Policy Evaluat & Licensing Sect, Ctr Vet Biol, Ames, IA USA; [Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Iowa State University	Hicks, J (corresponding author), USDA, Diagnost Bacteriol & Pathol Lab, NVSL, Ames, IA 50010 USA.	jessica.a.hicks@aphis.usda.gov		Hicks, Jessica/0000-0003-1306-6917				Aalsburg AM, 2011, J CLIN MICROBIOL, V49, P829, DOI 10.1128/JCM.00956-10; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Bleumink-Pluym NMC, 1996, CLIN DIAGNOSTIC LAB; BLEUMINKPLUYM NMC, 1994, J CLIN MICROBIOL, V32, P893, DOI 10.1128/JCM.32.4.893-896.1994; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duquesne F, 2013, VET MICROBIOL, V167, P609, DOI 10.1016/j.vetmic.2013.09.016; Erdman MM, 2011, PREV VET MED, V101, P219, DOI 10.1016/j.prevetmed.2011.05.015; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Gardner SN, 2010, J FORENSIC RES, V01, P1; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Harris RS, 2007, THESIS, DOI [10.5555/1414852, DOI 10.5555/1414852]; Hauser H, 2012, VET MICROBIOL, V159, P195, DOI 10.1016/j.vetmic.2012.03.041; Hebert L, 2011, J BACTERIOL, V193, P1785, DOI 10.1128/JB.01547-10; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kagawa S, 2001, VET RES COMMUN, V25, P261, DOI 10.1023/A:1010674524428; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MATSUDA M, 1994, VET RES COMMUN, V18, P93, DOI 10.1007/BF01839225; MIYAZAWA T, 1995, VET RES COMMUN, V19, P265, DOI 10.1007/BF01839309; NAIR J, 1993, MOL MICROBIOL, V10, P521, DOI 10.1111/j.1365-2958.1993.tb00924.x; Platt H, 1978, EQUINE VET J; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roy CR, 2015, NAT REV MICROBIOL, V13, P631, DOI 10.1038/nrmicro3520; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Springer B, 2001, ANTIMICROB AGENTS CH, V45, P2877, DOI 10.1128/AAC.45.10.2877-2884.2001; SWERCZEK TW, 1978, J AM VET MED ASSOC, V173, P405; Taylor CED, 1978, EQUINE VET J; Thoresen SI, 1995, J CLIN MICROBIOL; Timoney PJ, 1978, SURVIVAL PROPERTIES	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194253	10.1371/journal.pone.0194253	http://dx.doi.org/10.1371/journal.pone.0194253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584782	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000019
J	Takaki, K; Ramakrishnan, L; Basu, S				Takaki, Kevin; Ramakrishnan, Lalita; Basu, Soumyava			A zebrafish model for ocular tuberculosis	PLOS ONE			English	Article							DISSEMINATION; MACROPHAGES; INFECTION; GRANULOMA	Ocular tuberculosis (TB) commonly causes severe inflammation and vision loss in TB endemic countries. The mechanism by which tuberculous infection becomes established in the eye is poorly understood. We have developed the zebrafish larva infected with Mycobacterium marinum as a model to study the early pathogenesis of ocular TB. We find that hematogenous bacterial seeding of the eye occurs despite a functional blood retinal barrier. Prototypical early granulomas form in response to bacteria in the eye. These granulomas involve the retinal vasculature and retinal pigment epithelium-choroid complex which are characteristic locations for human ocular TB. We find that peripheral blood monocytes are recruited to the nascent ocular granuloma further suggesting that the immune privileged nature of the eye is breached by this inflammatory focus.	[Takaki, Kevin; Ramakrishnan, Lalita] Univ Cambridge, Mol Immun Unit, Dept Med, MRC Lab Mol Biol, Cambridge, England; [Basu, Soumyava] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, MTC Campus, Bhubaneswar, India	MRC Laboratory Molecular Biology; University of Cambridge; L. V. Prasad Eye Institute	Basu, S (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, MTC Campus, Bhubaneswar, India.	eyetalk@gmail.com		Takaki, Kevin/0000-0002-4790-4598; Ramakrishnan, Lalita/0000-0003-0692-5533; Basu, Soumyava/0000-0002-6513-8786	Department of Health Research, Indian Council of Medical Research [DHR/HRD/Short Term Foreign/Type-11/1/2015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503] Funding Source: NIH RePORTER	Department of Health Research, Indian Council of Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was partially funded by Shortterm fellowship to Soumyava Basu by Department of Health Research, Indian Council of Medical Research (Reference number: DHR/HRD/Short Term Foreign/Type-11/1/2015).	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Basu S, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/1869-5760-4-3; Cambier CJ, 2017, IMMUNITY, V47, P552, DOI 10.1016/j.immuni.2017.08.003; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; DONAHUE HC, 1967, AM J OPHTHALMOL, V64, P742, DOI 10.1016/0002-9394(67)92860-7; Finoff WC., 1924, AM J OPHTHALMOL, V7, P81; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Rao NA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1162, DOI 10.1001/archophthalmol.2009.220; SCHMITT EA, 1994, J COMP NEUROL, V344, P532, DOI 10.1002/cne.903440404; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Wroblewski KJ, 2011, OPHTHALMOLOGY, V118, P772, DOI 10.1016/j.ophtha.2010.08.011; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76	15	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194982	10.1371/journal.pone.0194982	http://dx.doi.org/10.1371/journal.pone.0194982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584775	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000052
J	Chagomerana, MB; Miller, WC; Tang, JH; Hoffman, IF; Mthiko, BC; Phulusa, J; John, M; Jumbe, A; Hosseinipour, MC				Chagomerana, Maganizo B.; Miller, William C.; Tang, Jennifer H.; Hoffman, Irving F.; Mthiko, Bryan C.; Phulusa, Jacob; John, Mathias; Jumbe, Allan; Hosseinipour, Mina C.			Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RISK-FACTORS; ADHERENCE; INITIATION; LOAD; TIME; PREDICTORS; RESISTANCE; PROTEASE; DECLINE	Background Effective antiretroviral therapy during pregnancy minimizes the risk of vertical HIV transmission. Some women present late in their pregnancy for first antenatal visit; whether these women achieve viral suppression by delivery and how suppression varies with time on ART is unclear. Methods We conducted a prospective cohort study of HIV-infected pregnant women initiating antiretroviral therapy for the first time at Bwaila Hospital in Lilongwe, Malawi from June 2015 to November 2016. Multivariable Poisson models with robust variance estimators were used to estimate risk ratios (RR) and 95% confidence intervals (CI) of the association between duration of ART and both viral load (VL) >= 1000 copies/ml and VL >= 40 copies/ml at delivery. Results Of the 252 women who had viral load testing at delivery, 40 (16%) and 78 (31%) had VL >= 1000 copies/ml and VL >= 40 copies/ml, respectively. The proportion of women with poor adherence to ART was higher among women who were on ART for <= 12 weeks (9/50 = 18.0%) than among those who were on ART for 13-35 weeks (18/194 = 9.3%). Compared to women who were on ART for <= 12 weeks, women who were on ART for 13-20 weeks (RR = 0.52; 95% CI: 0.36-0.74) or 21-35 weeks (RR = 0.26; 95% CI: 0.14-0.48) had a lower risk of VL >= 40 copies/ml at delivery. Similar comparisons for VL >= 1000 copies/ml at delivery showed decrease in risk although not significant for those on ART 13-20 weeks. Conclusion Longer duration of ART during pregnancy was associated with suppressed viral load at delivery. Early ANC attendance in pregnancy to facilitate prompt ART initiation for HIV-positive women is essential in the effort to eliminate HIV vertical transmission.	[Chagomerana, Maganizo B.; Tang, Jennifer H.; Hoffman, Irving F.; Mthiko, Bryan C.; Phulusa, Jacob; John, Mathias; Jumbe, Allan; Hosseinipour, Mina C.] Kamuzu Cent Hosp, UNC Project Malawi, Lilongwe, Malawi; [Miller, William C.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Tang, Jennifer H.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Hoffman, Irving F.; Hosseinipour, Mina C.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chagomerana, MB (corresponding author), Kamuzu Cent Hosp, UNC Project Malawi, Lilongwe, Malawi.	mchacjomerana@unclilongwe.org	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	National Institutes of Health [R25TW009340, R01 HD080485]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grant numbers R25TW009340 to MBC and R01 HD080485 to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A, 2013, COCHRANE DB SYST REV, V4; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Aziz N, 2013, BJOG-INT J OBSTET GY, V120, P1534, DOI 10.1111/1471-0528.12226; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Berg KM, 1999, J ACQ IMMUN DEF SYND, V43, pS79; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P592; Chesney M, 2003, AIDS PATIENT CARE ST, V17, P169, DOI 10.1089/108729103321619773; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; COURGNAUD V, 1991, AIDS RES HUM RETROV, V7, P337, DOI 10.1089/aid.1991.7.337; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Denoeud-Ndam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059446; Duran S, 2001, HIV Clin Trials, V2, P38; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; EHRNST A, 1991, LANCET, V338, P203, DOI 10.1016/0140-6736(91)90347-R; Fawzi W, 2001, AIDS, V15, P1157, DOI 10.1097/00002030-200106150-00011; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Jourdain G, 2007, J INFECT DIS, V196, P1629, DOI 10.1086/522009; Lyons FE, 2005, AIDS, V19, P63, DOI 10.1097/00002030-200501030-00007; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Myer L, 2017, HIV MED, V18, P80, DOI 10.1111/hiv.12397; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Phillips T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163079; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; SOEIRO R, 1992, J INFECT DIS, V166, P699, DOI 10.1093/infdis/166.4.699; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212; Zeh C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000430	36	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195033	10.1371/journal.pone.0195033	http://dx.doi.org/10.1371/journal.pone.0195033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614083	gold, Green Published, Green Submitted			2022-12-27	WOS:000429081600027
J	Horibata, S; Rice, EJ; Mukai, C; Marks, BA; Sams, K; Zheng, H; Anguish, LJ; Coonrod, SA; Danko, CG				Horibata, Sachi; Rice, Edward J.; Mukai, Chinatsu; Marks, Brooke A.; Sams, Kelly; Zheng, Hui; Anguish, Lynne J.; Coonrod, Scott A.; Danko, Charles G.			ER-positive breast cancer cells are poised for RET-mediated endocrine resistance	PLOS ONE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; SIGNALING PATHWAYS; TRANSCRIPTION; ALPHA; INITIATION; ENHANCERS; REVEALS; KINASE; EXPRESSION; BINDING	The RET tyrosine kinase signaling pathway is involved in the development of endocrine resistant ER+ breast cancer. However, we know little about how ER+ cells activate RET signaling and initiate an endocrine resistant phenotype. Here we show that both ER+ endocrine resistant and sensitive breast cancers have a functional RET tyrosine kinase signaling pathway, but that endocrine sensitive breast cancer cells lack RET ligands that are necessary to drive endocrine resistance. Transcription of one RET ligand, GDNF, is necessary and sufficient to confer resistance in the ER+ MCF-7 cell line. Endogenous GDNF produced by endocrine resistant cells is translated, secreted into the media, and activates RET signaling in nearby cells. In patients, RET ligand expression predicts responsiveness to endocrine therapies and correlates with survival. Collectively, our findings show that ER+ tumor cells are "poised" for RET mediated endocrine resistance, expressing all components of the RET signaling pathway, but endocrine sensitive cells lack high expression of RET ligands that are necessary to initiate the resistance phenotype.	[Horibata, Sachi; Rice, Edward J.; Mukai, Chinatsu; Marks, Brooke A.; Sams, Kelly; Zheng, Hui; Anguish, Lynne J.; Coonrod, Scott A.; Danko, Charles G.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Horibata, Sachi] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Coonrod, Scott A.; Danko, Charles G.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Coonrod, SA; Danko, CG (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.; Coonrod, SA; Danko, CG (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	sac269@cornell.edu; dankoc@gmail.com	Horibata, Sachi/AAC-3204-2020	Horibata, Sachi/0000-0002-2629-7821; Sams, Kelly L/0000-0002-1404-0885; Danko, Charles/0000-0002-1999-7125	NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health [R01 HG009309-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009309] Funding Source: NIH RePORTER	NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Work in this publication was supported by NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health under award number R01 HG009309-01 to CGD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.r We thank X. Yao, L. Lan, as well as all members of the Danko and Coonrod labs for valuable insights and discussions. We also thank G. Leiman for edits, J. Lewis for input on the manuscript draft, and D.B. Mahat for technical support. Work in this publication was supported by NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health under award number R01 HG009309-01 to CGD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andreucci E, 2016, ONCOTARGET, V7, P80543, DOI 10.18632/oncotarget.11826; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Azofeifa JG, 2016, BIOINFORMATICS; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Chu T, 2017, CHROMATIN RUN ON REV; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Core LJ, 2014, NAT GENET IN PRESS; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Danko CG, 2015, NAT METHODS, V12, P433, DOI [10.1038/NMETH.3329, 10.1038/nmeth.3329]; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Duarte FM, 2016, GENE DEV, V30, P1731, DOI 10.1101/gad.284430.116; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Hah N, 2013, GENOME RES; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Kang J, 2010, ONCOGENE, V29, P3228, DOI 10.1038/onc.2010.71; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma CX, 2009, ONCOLOGY-NY, V23, P133; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Miller WR, 2012, PHARMACOGENOMICS J, V12, P10, DOI 10.1038/tpj.2010.67; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Stine ZE, 2011, HUM MOL GENET, V20, P3746, DOI 10.1093/hmg/ddr291; Team RDC, 2010, R LANG ENV STAT COMP; Wakeling AE, 2000, ENDOCR-RELAT CANCER, V7, P17, DOI 10.1677/erc.0.0070017; Wang Z, 2016, BIOINFORMATICS; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Zhong ZB, 2015, INT J CLIN EXP PATHO, V8, P10716; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006	50	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194023	10.1371/journal.pdone.0194023	http://dx.doi.org/10.1371/journal.pdone.0194023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608602				2022-12-27	WOS:000428988800007
J	Buy, S; Le Floch, S; Tang, N; Sidiboulenouar, R; Zanca, M; Canadas, P; Nativel, E; Cardoso, M; Alibert, E; Dupont, G; Ambard, D; Maurel, C; Verdeil, JL; Bertin, N; Goze-Bac, C; Coillot, C				Buy, Simon; Le Floch, Simon; Tang, Ning; Sidiboulenouar, Rahima; Zanca, Michel; Canadas, Patrick; Nativel, Eric; Cardoso, Maida; Alibert, Eric; Dupont, Guillaume; Ambard, Dominique; Maurel, Christophe; Verdeil, Jean-Luc; Bertin, Nadia; Goze-Bac, Christophe; Coillot, Christophe			Flip-flop method: A new T1-weighted flow-MRI for plants studies	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; TRANSPORT; PHLOEM	The climate warming implies an increase of stress of plants (drought and torrential rainfall). The understanding of plant behavior, in this context, takes a major importance and sap flow measurement in plants remains a key issue for plant understanding. Magnetic Resonance Imaging (MRI) which is well known to be a powerful tool to access water quantity can be used to measure moving water. We describe a novel flow-MRI method which takes advantage of inflow slice sensitivity. The method involves the slice selectivity in the context of multi slice spin echo sequence. Two sequences such as a given slice is consecutively inflow and outflow sensitive are performed, offering the possiblility to perform slow flow sensitive imaging in a quite straigthforward way. The method potential is demonstrated by imaging both a slow flow measurement on a test bench (as low as 10 mu m.s(-1)) and the Poiseuille's profile of xylemian sap flow velocity in the xylematic tissues of a tomato plant stem.	[Buy, Simon; Sidiboulenouar, Rahima; Zanca, Michel; Cardoso, Maida; Alibert, Eric; Dupont, Guillaume; Goze-Bac, Christophe; Coillot, Christophe] Univ Montpellier, CNRS, L2C, Montpellier, France; [Le Floch, Simon; Canadas, Patrick; Ambard, Dominique] Univ Montpellier, CNRS, LMGC, Montpellier, France; [Zanca, Michel] Univ Montpellier, CHU Gui Chauliac, Montpellier, France; [Tang, Ning; Maurel, Christophe] Univ Montpellier, CNRS, INRA, BPMP,Montpellier SupAgro, Montpellier, France; [Nativel, Eric] Univ Montpellier, CNRS, IES, Montpellier, France; [Sidiboulenouar, Rahima; Verdeil, Jean-Luc] Univ Montpellier, INRA, Montpellier SupAgro, AGAP,CIRAD, Montpellier, France; [Buy, Simon; Bertin, Nadia] INRA, PSH, Avignon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE	Coillot, C (corresponding author), Univ Montpellier, CNRS, L2C, Montpellier, France.	christophe.coillot@umontpellier.fr		TANG, Ning/0000-0003-2185-4737; Canadas, Patrick/0000-0002-8943-8943				Coillot C, 2016, J SENS SENS SYST, V5, P137, DOI 10.5194/jsss-5-137-2016; HEMMINGA MA, 1977, J MAGN RESON, V27, P359, DOI 10.1016/0022-2364(77)90001-4; HEMMINGA MA, 1980, J MAGN RESON, V37, P1, DOI 10.1016/0022-2364(80)90088-8; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; KOSE K, 1985, J PHYS SOC JPN, V54, P81, DOI 10.1143/JPSJ.54.81; Markl M., VELOCITY ENCODING FL; Meme S, 2013, MAGN RESON IMAGING, V31, P109, DOI 10.1016/j.mri.2012.06.019; Mispelter J, 2006, NMR PROBEHADS BIOPHY; Nagata A, 2016, J MAGN RESON, V265, P129, DOI 10.1016/j.jmr.2016.02.004; Peuke AD, 2015, PLANT CELL ENVIRON, V38, P433, DOI 10.1111/pce.12399; POPE JM, 1993, CONCEPT MAGNETIC RES, V5, P281; Scheenen TWJ, 2001, J MAGN RESON, V151, P94, DOI 10.1006/jmre.2001.2362; Steppe K, 2015, TREE PHYSIOL, V35, P341, DOI 10.1093/treephys/tpv033; VANAS H, 1984, BIOPHYS J, V45, P469, DOI 10.1016/S0006-3495(84)84170-3; Windt CW, 2006, PLANT CELL ENVIRON, V29, P1715, DOI 10.1111/j.1365-3040.2006.01544.x	15	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194845	10.1371/journal.pone.0194845	http://dx.doi.org/10.1371/journal.pone.0194845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596455	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000045
J	Corsetti, S; Borruso, S; Di Traglia, M; Lai, O; Alfieri, L; Villavecchia, A; Cariola, G; Spaziani, A; Natoli, E				Corsetti, Sara; Borruso, Simona; Di Traglia, Mario; Lai, Olga; Alfieri, Lavinia; Villavecchia, Agnese; Cariola, Giuseppe; Spaziani, Alessandra; Natoli, Eugenia			Bold personality makes domestic dogs entering a shelter less vulnerable to diseases	PLOS ONE			English	Article							PUBLIC ANIMAL SHELTER; MALE RHESUS MACAQUES; WILD-TYPE RATS; SOCIAL STRESS; PLASMA-CORTISOL; IMMUNE FUNCTION; IMMUNODEFICIENCY-VIRUS; INDIVIDUAL-DIFFERENCES; LEUKOCYTE TRAFFICKING; SPATIAL RESTRICTION	It is widely recognised that for vertebrate species, personalities vary along an axis with extremes represented by 'proactive' and 'reactive' individuals. The aim of this study was to verify whether there is a relationship between personality and disease vulnerability in domestic dogs (Canis familiaris) exposed to an intensely stressful situation such as entering a shelter. Twenty-eight shelter dogs participated in the study. The ethogram consisted of approximately 100 behavioural patterns. Behavioural observations of dogs in their new environment, a Novel Object and a T-maze test were used to evaluate the personality of the dogs captured as strays and entering the shelter. A blood sample from each dog was obtained at admission into the shelter and after a month to evaluate their immunological state. Based on PCA analyses of observational combined with experimental data, the dogs were ordered along the boldness-shyness axis, with the first being the boldest. Excluding one (the 6th), the first 10 dogs showed an improved health status: absence of disease symptoms during the 30 days of monitoring and improved immunological parameters; the opposite was found for shy dogs. The results of this research seem to confirm findings in other vertebrate species, i.e., bold and shy dog vulnerability to diseases might be different, especially when they must cope with a stressful and highly infectious environment such as a dog shelter.	[Corsetti, Sara; Borruso, Simona] Univ Rome Sapienza, Biol & Biotechnol Dept, Rome, Italy; [Di Traglia, Mario] Univ Rome Sapienza, Publ Hlth & Infect Dis, Rome, Italy; [Lai, Olga; Alfieri, Lavinia] Expt Zoo Prophylact Inst Latium & Tuscany, Rome, Italy; [Cariola, Giuseppe; Spaziani, Alessandra; Natoli, Eugenia] Local Hlth Unit Rome 3, Interzonal Dog Shelter, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Natoli, E (corresponding author), Local Hlth Unit Rome 3, Interzonal Dog Shelter, Rome, Italy.	enatoli@tiscali.it	Natoli, Eugenia/AAE-2156-2020	, Eugenia/0000-0002-9232-7048; Corsetti, Sara/0000-0001-9183-9749				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; BENUS RF, 1990, BEHAVIOUR, V112, P176, DOI 10.1163/156853990X00185; BLANCHARD RJ, 1985, BEHAV PROCESS, V11, P209, DOI 10.1016/0376-6357(85)90062-2; BONIZZI L, 1989, J VET MED B, V36, P365, DOI 10.1111/j.1439-0450.1989.tb00615.x; Bourne Godfrey R., 2008, AACL Bioflux, V1, P39; Bray E. E., 2017, ANIM COGN; Cafazzo S, 2014, PHYSIOL BEHAV, V133, P223, DOI 10.1016/j.physbeh.2014.05.046; Capitanio JP, 1998, AM J PRIMATOL, V44, P29, DOI 10.1002/(SICI)1098-2345(1998)44:1<29::AID-AJP3>3.0.CO;2-Z; Capitanio JP, 1999, BRAIN BEHAV IMMUN, V13, P138, DOI 10.1006/brbi.1998.0540; Caramaschi D., 2013, ANIMAL PERSONALITIES; Careau V, 2010, AM NAT, V175, P753, DOI 10.1086/652435; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; Carnevali L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068316; Cavigelli SA, 2003, P NATL ACAD SCI USA, V100, P16131, DOI 10.1073/pnas.2535721100; Coppens CM, 2014, AGGRESSIVE BEHAV, V40, P300, DOI 10.1002/ab.21527; Costantini D, 2008, BIOL LETTERS, V4, P119, DOI 10.1098/rsbl.2007.0513; Costantini D, 2012, J EXP BIOL, V215, P374, DOI 10.1242/jeb.062034; Cray C, 2009, COMPARATIVE MED, V59, P517; De Palma C, 2005, BEHAVIOUR, V142, P1307, DOI 10.1163/156853905774539337; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dudley ES, 2015, JAVMA-J AM VET MED A, V247, P1289, DOI 10.2460/javma.247.11.1289; FLESHNER M, 1989, PHYSIOL BEHAV, V45, P1183, DOI 10.1016/0031-9384(89)90107-8; Gazzano A., 2004, Annali della Facolta di Medicina Veterinaria di Pisa, V57, P189; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Hennessy MB, 1997, PHYSIOL BEHAV, V62, P485, DOI 10.1016/S0031-9384(97)80328-9; Hennessy MB, 2002, J AM VET MED ASSOC, V221, P65, DOI 10.2460/javma.2002.221.65; Hennessy MB, 2001, APPL ANIM BEHAV SCI, V73, P217, DOI 10.1016/S0168-1591(01)00139-3; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Hennessy Michael B., 2002, Journal of Applied Animal Welfare Science, V5, P253, DOI 10.1207/S15327604JAWS0504_01; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Kavelaars A, 1999, BRAIN BEHAV IMMUN, V13, P279, DOI 10.1006/brbi.1998.0534; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KOOLHAAS JM, 1988, NETH J ZOOL, V38, P111; Kurvers R. H. J. M., 2009, ANIM BEHAV, V9, P1; Lendvai AZ, 2011, J EXP BIOL, V214, P821, DOI 10.1242/jeb.047712; Ley J, 2007, APPL ANIM BEHAV SCI, V104, P71, DOI 10.1016/j.applanim.2006.03.021; Santillan-Doherty AM, 2010, J COMP PSYCHOL, V124, P211, DOI 10.1037/a0018267; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Natoli E, 2005, NEUROSCI BIOBEHAV R, V29, P151, DOI 10.1016/j.neubiorev.2004.06.011; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Protopopova A, 2016, PHYSIOL BEHAV, V159, P95, DOI 10.1016/j.physbeh.2016.03.020; Rooney NJ, 2007, PHYSIOL BEHAV, V92, P847, DOI 10.1016/j.physbeh.2007.06.011; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Sgoifo A, 2001, PHYSIOL BEHAV, V73, P253, DOI 10.1016/S0031-9384(01)00544-3; Sgoifo A, 2014, NEUROSCI BIOBEHAV R, V39, P51, DOI 10.1016/j.neubiorev.2013.12.005; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Stefanski V, 2001, PHYSIOL BEHAV, V73, P385, DOI 10.1016/S0031-9384(01)00495-4; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Tasca S, 2010, J VET DIAGN INVEST, V22, P111, DOI 10.1177/104063871002200123; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; Thomson JS, 2011, HORM BEHAV, V59, P67, DOI 10.1016/j.yhbeh.2010.10.010; Veenema AH, 2003, J NEUROENDOCRINOL, V15, P256, DOI 10.1046/j.1365-2826.2003.00986.x; Wilson ADM, 2005, ETHOLOGY, V111, P849, DOI 10.1111/j.1439-0310.2005.01110.x; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; WOODGUSH DGM, 1991, ANIM BEHAV, V42, P599, DOI 10.1016/S0003-3472(05)80243-X	66	10	10	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193794	10.1371/journal.pone.0193794	http://dx.doi.org/10.1371/journal.pone.0193794			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596432	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000013
J	Jarlais, DCD; Cooper, HLF; Arasteh, K; Feelemyer, J; McKnight, C; Ross, Z				Des Jarlais, D. C.; Cooper, H. L. F.; Arasteh, K.; Feelemyer, J.; McKnight, C.; Ross, Z.			Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US	PLOS ONE			English	Article							C VIRUS-INFECTION; HEPATITIS-C; UNITED-STATES; PREVENTION; PEOPLE; INTERVENTIONS; BEHAVIORS; MANHATTAN; PROGRAMS; DEATHS	Objective We identified potential geographic "hotspots" for drug-injecting transmission of HIV and hepatitis C virus (HCV) among persons who inject drugs (PWID) in New York City. The HIV epidemic among PWID is currently in an "end of the epidemic" stage, while HCV is in a continuing, high prevalence (> 50%) stage. Methods We recruited 910 PWID entering Mount Sinai Beth Israel substance use treatment programs from 2011-2015. Structured interviews and HIV/HCV testing were conducted. Residential ZIP codes were used as geographic units of analysis. Potential "hotspots" for HIV and HCV transmission were defined as 1) having relatively large numbers of PWID 2) having 2 or more HIV (or HCV) seropositive PWID reporting transmission risk-passing on used syringes to others, and 3) having 2 or more HIV (or HCV) seronegative PWID reporting acquisition risk-injecting with previously used needles/syringes. Hotspots for injecting drug use initiation were defined as ZIP codes with 5 or more persons who began injecting within the previous 6 years. Results Among PWID, 96% injected heroin, 81% male, 34% White, 15% African-American, 47% Latinx, mean age 40 (SD = 10), 7% HIV seropositive, 62% HCV seropositive. Participants resided in 234 ZIP codes. No ZIP codes were identified as potential hotspots due to small numbers of HIV seropositive PWID reporting transmission risk. Four ZIP codes were identified as potential hotspots for HCV transmission. 12 ZIP codes identified as hotspots for injecting drug use initiation. Discussion For HIV, the lack of potential hotspots is further validation of widespread effectiveness of efforts to reduce injecting-related HIV transmission. Injecting-related HIV transmission is likely to be a rare, random event. HCV prevention efforts should include focus on potential hotspots for transmission and on hotspots for initiation into injecting drug use. We consider application of methods for the current opioid epidemic in the US.	[Des Jarlais, D. C.; Arasteh, K.; Feelemyer, J.; McKnight, C.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Cooper, H. L. F.] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Ross, Z.] ZevRoss Spatial Anal, Ithaca, NY USA	Icahn School of Medicine at Mount Sinai; Emory University; Rollins School Public Health	Jarlais, DCD (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	don.desjarlais@mountsinai.org		Des Jarlais, Don/0000-0002-0157-8168; Feelemyer, Jonathan/0000-0001-6617-4992	NIDA NIH HHS [R01 DA003574, P30 DA011041] Funding Source: Medline; NIH HHS [R01DA003574] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003574, P30DA011041] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Appalachian Regional Commission, 2018, COMM OP APP CHALL OP; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; Boodram B, 2010, DRUG ALCOHOL DEPEN, V111, P136, DOI 10.1016/j.drugalcdep.2010.04.003; Courtwright D, 1989, ADDICTS WHO SURVIVED; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI 10.2105/AJPH.2003.031310; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Des Jarlais DC, 2014, AIDS BEHAV, V18, P443, DOI 10.1007/s10461-013-0664-0; Des Jarlais DC, 2000, AM J PUBLIC HEALTH, V90, P1112; Des Jarlais DC, 1998, AM J PUBLIC HEALTH, V88, P1801, DOI 10.2105/AJPH.88.12.1801; Des Jarlais DC, 2005, DRUG ALCOHOL DEPEN, V77, P1, DOI 10.1016/j.drugalcdep.2004.06.010; Des Jarlais DC, 2003, AM J EPIDEMIOL, V157, P467, DOI 10.1093/aje/kwf222; Des Jarlais DC, 2017, AM J PUBLIC HEALTH, V107, P1157, DOI 10.2105/AJPH.2017.303787; Des Jarlais DC, 2016, AM J PUBLIC HEALTH, V106, P503, DOI 10.2105/AJPH.2015.303019; Des Jarlais DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087993; DESJARLAIS DC, 1989, JAMA-J AM MED ASSOC, V261, P1008, DOI 10.1001/jama.261.7.1008; Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Eckhardt B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177341; Fordyce J, 2001, J URBAN HEALTH, V78, P669, DOI 10.1093/jurban/78.4.669; Fraser H, 2018, ADDICTION, V113, P173, DOI 10.1111/add.13948; Galea S, 2002, PUBLIC HEALTH REP, V117, pS135; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Harocopos A, 2009, INT J DRUG POLICY, V20, P317, DOI 10.1016/j.drugpo.2008.06.003; Jarlais DCD, 2009, AM J PUBLIC HEALTH, V99, pS445, DOI 10.2105/AJPH.2008.159327; Jordan AE, 2015, DRUG ALCOHOL DEPEN, V152, P194, DOI 10.1016/j.drugalcdep.2015.03.039; Kauhl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135656; Kuo M, 2015, AM J PUBLIC HEALTH, V105, P1604, DOI 10.2105/AJPH.2015.302591; Levy MZ, 2009, CLIN INFECT DIS, V48, P1104, DOI 10.1086/597464; Meyers DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114822; Morris MD, 2017, CLIN INFECT DIS, V64, P860, DOI 10.1093/cid/ciw869; Murrill CS, 2001, J URBAN HEALTH, V78, P152, DOI 10.1093/jurban/78.1.152; Neaigus A, 2017, JAIDS-J ACQ IMM DEF, V75, pS325, DOI 10.1097/qai.0000000000001407; New York State Department of Health, 2015, ACH GOAL SET FORTH G; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P897, DOI 10.15585/mmwr.mm6634a2; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Ramjee G, 2014, AIDS BEHAV, V18, P317, DOI 10.1007/s10461-013-0578-x; Rockwell R, 1999, AIDS CARE, V11, P437, DOI 10.1080/09540129947811; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Sorensen JL, 2000, DRUG ALCOHOL DEPEN, V59, P17, DOI 10.1016/S0376-8716(99)00104-0; STATA Corp, 2012, STAT 12; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Van Handel MM, 2016, JAIDS-J ACQ IMM DEF, V73, P323, DOI 10.1097/QAI.0000000000001098; Wand H, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-41; Wilkerson Richard Gentry, 2016, Emerg Med Clin North Am, V34, pe1, DOI 10.1016/j.emc.2015.11.002	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194799	10.1371/journal.pone.0194799	http://dx.doi.org/10.1371/journal.pone.0194799			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596464	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000044
J	Kim, JK; Kwon, YE; Lee, SG; Kim, CY; Kim, JG; Huh, M; Lee, E; Kim, YJ				Kim, Jung-Kyun; Kwon, Yong-Eun; Lee, Sang-Gil; Kim, Chang-Yeon; Kim, Jin-Gyu; Huh, Min; Lee, Eunji; Kim, Youn-Joong			Correlative microscopy of the constituents of a dinosaur rib fossil and hosting mudstone: Implications on diagenesis and fossil preservation (vol 12, e0186600, 2017)	PLOS ONE			English	Correction																		Kim JK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186600	1	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195421	10.1371/journal.pone.0195421	http://dx.doi.org/10.1371/journal.pone.0195421			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596536	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000113
J	Matsumura, T; Terada, J; Kinoshita, T; Sakurai, Y; Yahaba, M; Tsushima, K; Sakao, S; Nagashima, K; Ozaki, T; Kobayashi, Y; Hiwasa, T; Tatsumi, K				Matsumura, Takuma; Terada, Jiro; Kinoshita, Taku; Sakurai, Yoriko; Yahaba, Misuzu; Tsushima, Kenji; Sakao, Seiichiro; Nagashima, Kengo; Ozaki, Toshinori; Kobayashi, Yoshio; Hiwasa, Takaki; Tatsumi, Koichiro			Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; EXPRESSION; PROTEIN-4; ATHEROSCLEROSIS; METAANALYSIS; ACTIVATION; MEDIATORS; MORTALITY	Objective Although severe obstructive sleep apnea (OSA) is an important risk factor for atherosclerosis-related diseases including coronary artery disease (CAD), there is no reliable biomarker of CAD risks in patients with OSA. This study aimed to test our hypothesis that circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1-Abs) are associated with the prevalence of CAD in patients with OSA. Methods Eighty-two adults diagnosed with OSA by polysomnography, 96 patients with a diagnosis of acute coronary syndrome (ACS) and 64 healthy volunteers (HVs) were consecutively enrolled. Serum samples were collected from patients with OSA at diagnostic polysomnography and from patients with ACS at disease onset. Serum NBL1-Ab level was measured by amplified luminescence proximity homogeneous assay and its association with clinical variables related to atherosclerosis was evaluated. Results NBL1-Ab level was significantly elevated in patients with both OSA and ACS compared with HVs. Subgroup analyses showed that NBL1-Ab level was markedly higher in patients with severe OSA and OSA patients with a history of CAD. Weak associations were observed between NBL1-Ab level and apnea-hypopnea index, age, mean SpO2 and arousal index, whereas significantly higher NBL1-Ab levels were observed in OSA patients with a history of CAD than in those without a history of CAD. Sensitivity analysis using a logistic regression model also demonstrated that increased NBL1-Ab levels were associated with the previous history of CAD in patients with OSA. Conclusions Elevated NBL1-Ab levels may be associated with the prevalence of CAD in patients with OSA, which needs to be confirmed further.	[Matsumura, Takuma; Terada, Jiro; Kinoshita, Taku; Sakurai, Yoriko; Yahaba, Misuzu; Tsushima, Kenji; Sakao, Seiichiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Chiba, Japan; [Nagashima, Kengo] Chiba Univ, Grad Sch Med, Dept Global Clin Res, Chiba, Chiba, Japan; [Ozaki, Toshinori] Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chiba, Chiba, Japan; [Kobayashi, Yoshio] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Chiba, Japan; [Hiwasa, Takaki] Chiba Univ, Grad Sch Med, Dept Biochem & Genet, Chiba, Chiba, Japan	Chiba University; Chiba University; Chiba Cancer Center; Chiba University; Chiba University	Terada, J (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Chiba, Japan.	jirotera@chiba-u.jp	Nagashima, Kengo/I-4258-2019	Nagashima, Kengo/0000-0003-4529-9045; Terada, Jiro/0000-0001-9019-4053	Grants-in-Aid for Scientific Research [15K08412] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ali SS, 2014, SLEEP MED REV, V18, P379, DOI 10.1016/j.smrv.2014.01.004; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; Cui CJ, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160199; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Fesmire J, 2010, REV BRAS REUMATOL, V50, P545, DOI 10.1590/S0482-50042010000500007; Garrigue-Antar L, 2004, J BIOL CHEM, V279, P49835, DOI 10.1074/jbc.M408134200; Goto K, 2015, J MOL BIOMARK DIAGN, V6, P2; Guo J, 2016, SLEEP BREATH, V20, P965, DOI 10.1007/s11325-016-1319-y; Hiwasa T., 2015, IMMUNOME RES, V11; Hopkins CR, 2016, EXPERT OPIN THER PAT, V26, P1115, DOI 10.1080/13543776.2016.1217330; Hung WT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096172; Jullian-Desayes I, 2015, SLEEP MED REV, V21, P23, DOI 10.1016/j.smrv.2014.07.004; Kozawa O, 2001, J CELL BIOCHEM, V81, P430, DOI 10.1002/1097-4644(20010601)81:3<430::AID-JCB1056>3.0.CO;2-G; Lee MYK, 2016, AM J PHYSIOL-CELL PH, V310, pC446, DOI 10.1152/ajpcell.00240.2015; Machida T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0393-4; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Matsumura T, 2017, J CLIN SLEEP MED, V13, P393, DOI 10.5664/jcsm.6488; Miriyala S, 2006, CIRCULATION, V113, P2818, DOI 10.1161/CIRCULATIONAHA.106.611822; Montecucco F, 2011, EUR HEART J, V32, P412, DOI 10.1093/eurheartj/ehq521; Morrell NW, 2016, NAT REV CARDIOL, V13, P106, DOI 10.1038/nrcardio.2015.156; Nadlonek NA, 2013, J SURG RES, V184, P6, DOI 10.1016/j.jss.2013.05.001; OZAKI T, 1994, CANCER RES, V54, P646; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Veres K, 2004, LUPUS, V13, P423, DOI 10.1191/0961203304lu1011oa; Wozniak DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007736.pub2; Xie XM, 2013, SLEEP MED, V14, P1139, DOI 10.1016/j.sleep.2013.07.006; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2008, SLEEP, V31, P1071; Zhang M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0214-3	31	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195015	10.1371/journal.pone.0195015	http://dx.doi.org/10.1371/journal.pone.0195015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596467	gold, Green Submitted, Green Published			2022-12-27	WOS:000428630000067
J	Sartorius, CM; Schoetzau, A; Kettelhack, H; Fink, D; Hacker, NF; Fedier, A; Jacob, F; Heinzelmann-Schwarz, V				Sartorius, Celine Montavon; Schoetzau, Andreas; Kettelhack, Henriette; Fink, Daniel; Hacker, Neville F.; Fedier, Andre; Jacob, Francis; Heinzelmann-Schwarz, Viola			ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SQUAMOUS-CELL CARCINOMA; GROUP ANTIGENS; GENETIC-BASIS; LUNG-CANCER; RISK; ASSOCIATION; METAANALYSIS; POPULATION; MORTALITY	The relationship between ABO blood groups (BG) and risk of incidence in cancers including gynecological cancers has been widely studied, showing increased incidence risk for BG A patients. As available data are inconsistent we investigated whether BG and their anti-glycan antibodies (anti-A and anti-B) have prognostic values in gynecological cancers. We retrospectively evaluated 974 patients with gynecological cancers in three cancer centers (Switzerland and Australia) between 1974 and 2014 regarding the relationships between clinico-pathological findings and the BG. Time to disease recurrence was significantly influenced by BG in patients with ovarian (n = 282) and vulvar (n = 67) cancer. BG O or B patients showed a significantly increased risk for ovarian cancer relapse compared to A, 59% and 82%, respectively (p = 0.045; HR O vs A = 1.59 (CI 1.01-2.51) and (p = 0.036; HR A vs B = 0.55 (CI 0.32-0.96). Median time to relapse for advanced stage (n = 126) ovarian cancer patients was 18.2 months for BG O and 32.2 for A (p = 0.031; HR O vs A = 2.07 (CI 1.07-4.02)). BG also significantly influenced relapse-free survival in patients with vulvar cancer (p = 0.002), with BG O tending to have increased relapse risk compared to A (p = 0.089). Blood groups hence associate with recurrence in ovarian and vulvar cancer: women with BG O seem to have a lower ovarian cancer incidence, however are more likely to relapse earlier. The significance of the BG status as a prognostic value is evident and may be helpful to oncologists in prognosticating disease outcome and selecting the appropriate therapy.	[Sartorius, Celine Montavon; Heinzelmann-Schwarz, Viola] Univ Hosp Basel, Hosp Women, Dept Gynecol & Gynecol Oncol, Basel, Switzerland; [Sartorius, Celine Montavon; Schoetzau, Andreas; Kettelhack, Henriette; Fedier, Andre; Jacob, Francis; Heinzelmann-Schwarz, Viola] Univ Basel, Basel, Switzerland; [Schoetzau, Andreas; Kettelhack, Henriette; Fedier, Andre; Jacob, Francis; Heinzelmann-Schwarz, Viola] Univ Hosp Basel, Ovarian Canc Res, Dept Biomed, Basel, Switzerland; [Fink, Daniel] Univ Hosp Zurich, Dept Gynecol, Zurich, Switzerland; [Fink, Daniel] Univ Zurich, Zurich, Switzerland; [Hacker, Neville F.] UNSW, Sch Womens & Childrens Hlth, Royal Hosp Women, Gynaecol Canc Ctr, Sydney, NSW, Australia; [Jacob, Francis] Univ Hosp Basel, Dept Biomed, Glycooncol Res, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Zurich; University Zurich Hospital; University of Zurich; University of New South Wales Sydney; University of Basel	Heinzelmann-Schwarz, V (corresponding author), Univ Hosp Basel, Hosp Women, Dept Gynecol & Gynecol Oncol, Basel, Switzerland.; Heinzelmann-Schwarz, V (corresponding author), Univ Basel, Basel, Switzerland.; Heinzelmann-Schwarz, V (corresponding author), Univ Hosp Basel, Ovarian Canc Res, Dept Biomed, Basel, Switzerland.	viola.heinzelmann@usb.ch	Jacob, Francis/C-7910-2009	Jacob, Francis/0000-0002-0446-1942; Hacker, Neville/0000-0002-1445-2302; Heinzelmann-Schwarz, Viola/0000-0002-4056-3225				AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Cao X, 2014, BRIT J CANCER, V111, P174, DOI 10.1038/bjc.2014.302; Cihan YB, 2014, ASIAN PAC J CANCER P, V15, P4055, DOI 10.7314/APJCP.2014.15.9.4055; Cozzi GD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175119; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Gates MA, 2012, INT J CANCER, V130, P2129, DOI 10.1002/ijc.26220; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Jacob F, 2014, BRIT J CANCER, V111, P1634, DOI 10.1038/bjc.2014.455; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Joh HK, 2012, CANCER EPIDEMIOL, V36, P528, DOI 10.1016/j.canep.2012.07.001; Kaczmarek R, 2014, TRANSFUS MED REV, V28, P126, DOI 10.1016/j.tmrv.2014.04.007; Khalili H, 2011, CANCER EPIDEM BIOMAR, V20, P1017, DOI 10.1158/1055-9965.EPI-10-1250; Le Pendu J, 2001, APMIS, V109, P9; Liumbruno GM, 2013, BLOOD TRANSFUS-ITALY, V11, P491, DOI 10.2450/2013.0152-13; Manegold-Brauer G, 2016, INT J GYNECOL CANCER, V26, P1062, DOI 10.1097/IGC.0000000000000718; Marinaccio M, 1995, Minerva Ginecol, V47, P69; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; Miao SY, 2014, ASIA-PAC J CLIN ONCO, V10, P101, DOI 10.1111/ajco.12083; Oguz A, 2013, ASIAN PAC J CANCER P, V14, P453, DOI 10.7314/APJCP.2013.14.1.453; PANDEY M, 1995, BRIT MED J, V310, P1639, DOI 10.1136/bmj.310.6995.1639; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Poole EM, 2012, CANCER CAUSE CONTROL, V23, P1805, DOI 10.1007/s10552-012-0059-y; Redman Rachel, 2005, J Low Genit Tract Dis, V9, P89, DOI 10.1097/00128360-200504000-00004; Rolfe KJ, 2002, EUR J GYNAECOL ONCOL, V23, P111; Seltsam A, 2003, BLOOD, V102, P3035, DOI 10.1182/blood-2003-03-0955; Sheng LM, 2013, INT J CANCER, V133, P893, DOI 10.1002/ijc.28087; Su M, 2001, WORLD J GASTROENTERO, V7, P657; Urun Y, 2013, ASIAN PAC J CANCER P, V14, P2801, DOI 10.7314/APJCP.2013.14.5.2801; Urun Y, 2012, ASIAN PAC J CANCER P, V13, P6097, DOI 10.7314/APJCP.2012.13.12.6097; Wang W, 2014, CANCER CAUSE CONTROL, V25, P1369, DOI 10.1007/s10552-014-0442-y; Welshinger M, 1996, GYNECOL ONCOL, V62, P106, DOI 10.1006/gyno.1996.0198; Xie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011972; Xu YQ, 2016, J SURG RES, V201, P188, DOI 10.1016/j.jss.2015.10.039; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yang X, 2014, INT J CLIN EXP MED, V7, P2214; Yuzhalin AE, 2012, ASIAN PAC J CANCER P, V13, P5091, DOI 10.7314/APJCP.2012.13.10.5091; Zhang BL, 2014, ASIAN PAC J CANCER P, V15, P4643, DOI 10.7314/APJCP.2014.15.11.4643	41	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195213	10.1371/journal.pone.0195213	http://dx.doi.org/10.1371/journal.pone.0195213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596526	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000428630000091
J	Bocage-Barthelemy, Y; Chatard, A; Jaafari, N; Tello, N; Billieux, J; Daveau, E; Selimbegovic, L				Bocage-Barthelemy, Yvana; Chatard, Armand; Jaafari, Nematollah; Tello, Nina; Billieux, Joel; Daveau, Emmanuel; Selimbegovic, Leila			Automatic social comparison: Cognitive load facilitates an increase in negative thought accessibility after thin ideal exposure among women	PLOS ONE			English	Article							BODY-IMAGE; MEDIA IMAGES; DISCLAIMER LABELS; SELF-ESTEEM; APPEARANCE; DISSATISFACTION; INTERNALIZATION; MOOD	Women are routinely exposed to images of extremely slim female bodies (the thin ideal) in advertisements, even if they do not necessarily pay much attention to these images. We hypothesized that paradoxically, it is precisely in such conditions of low attention that the impact of the social comparison with the thin ideal might be the most pronounced. To test this prediction, one hundred and seventy-three young female participants were exposed to images of the thin ideal or of women's fashion accessories. They were allocated to either a condition of high (memorizing 10 digits) or low cognitive load (memorizing 4 digits). The main dependent measure was implicit: mean recognition latency of negative words, relative to neutral words, as assessed by a lexical decision task. The results showed that thin-ideal exposure did not affect negative word accessibility under low cognitive load but that it increased it under high cognitive load. These findings are consistent with the hypothesis that social comparison with the thin ideal is an automatic process, and contribute to explain why some strategies to prevent negative effects of thin-ideal exposure are inefficient.	[Bocage-Barthelemy, Yvana; Chatard, Armand; Tello, Nina; Selimbegovic, Leila] Univ Poitiers, Univ Tours, Poitiers, France; [Bocage-Barthelemy, Yvana; Chatard, Armand; Tello, Nina; Selimbegovic, Leila] CNRS, Poitiers, France; [Chatard, Armand; Jaafari, Nematollah; Tello, Nina] Serv Hosp Univ Psychiat & Psychol Med, Ctr Hosp Henri Laborit, Poitiers, France; [Billieux, Joel] Univ Luxembourg, Esch Sur Alzette, Luxembourg; [Billieux, Joel] Univ Catholic Louvain, Louvain La Neuve, Belgium; [Daveau, Emmanuel] Univ Reading, Reading, Berks, England	Universite de Poitiers; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; CHU de Toulouse; University of Luxembourg; University of Reading	Selimbegovic, L (corresponding author), Univ Poitiers, Univ Tours, Poitiers, France.; Selimbegovic, L (corresponding author), CNRS, Poitiers, France.	leila.selimbegovic@univ-poitiers.fr	Chatard, Armand/N-9213-2017; Billieux, Joel/HCH-3334-2022	Chatard, Armand/0000-0003-4823-2903; Billieux, Joel/0000-0002-7388-6194	National Agency for Research (ANR), Paris, France [ANR-13-BSH2-0008-01, ANR-13-BSH2-0008]	National Agency for Research (ANR), Paris, France(French National Research Agency (ANR))	This work was supported by the National Agency for Research (ANR), Paris, France [grant number ANR-13-BSH2-0008-01] (http://www.agence-nationale-recherche.fr/?Projet=ANR-13-BSH2-0008) to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ata RN, 2013, BODY IMAGE, V10, P472, DOI 10.1016/j.bodyim.2013.04.004; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Bargh J. A., HDB SOCIAL COGNITION, P1; Bessenoff GR, 2006, PSYCHOL WOMEN QUART, V30, P239, DOI 10.1111/j.1471-6402.2006.00292.x; Borau S, 2016, J BUS ETHICS, P21; Brown A, 2005, J SOC CLIN PSYCHOL, V24, P1088, DOI 10.1521/jscp.2005.24.8.1088; Buote VM, 2011, BODY IMAGE, V8, P322, DOI 10.1016/j.bodyim.2011.06.002; Bury B, 2016, BODY IMAGE, V17, P136, DOI 10.1016/j.bodyim.2016.03.005; Cattarin JA, 2000, J SOC CLIN PSYCHOL, V19, P220, DOI 10.1521/jscp.2000.19.2.220; Chatard A, 2017, J EXP SOC PSYCHOL, V73, P1, DOI 10.1016/j.jesp.2017.05.005; Chatard A, 2011, J PERS SOC PSYCHOL, V100, P587, DOI 10.1037/a0022461; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cragg DN, 2017, J HEALTH PSYCHOL; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Frederick DA, 2016, BODY IMAGE, V17, P171, DOI 10.1016/j.bodyim.2016.03.009; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; GILBERT DT, 1995, J PERS SOC PSYCHOL, V69, P227, DOI 10.1037/0022-3514.69.2.227; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; Grogan S, 2006, J HEALTH PSYCHOL, V11, P523, DOI 10.1177/1359105306065013; Hackman R., GUARDIAN; Halliwell Emma, 2005, Body Image, V2, P249, DOI 10.1016/j.bodyim.2005.05.001; Jansen A, 2002, EUR EAT DISORD REV, V10, P208, DOI 10.1002/erv.430; Mills JS, 2002, PERS SOC PSYCHOL B, V28, P1687, DOI 10.1177/014616702237650; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Mussweiler T, 2004, J EXP SOC PSYCHOL, V40, P689, DOI 10.1016/j.jesp.2004.01.004; Myers TA, 2009, J ABNORM PSYCHOL, V118, P683, DOI 10.1037/a0016763; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Patrick H, 2004, PERS SOC PSYCHOL B, V30, P501, DOI 10.1177/0146167203261891; Payne B.K., 2012, SAGE HDB SOCIAL COGN, P12, DOI [10.4135/9781446247631, DOI 10.4135/9781446247631.N2, 10.4135/9781446247631.n2]; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Rice K, 2016, BODY IMAGE, V19, P142, DOI 10.1016/j.bodyim.2016.09.005; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Selimbegovic L, 2015, BODY IMAGE, V12, P1, DOI 10.1016/j.bodyim.2014.08.012; Thompson JK, 2004, INT J EAT DISORDER, V35, P293, DOI 10.1002/eat.10257; Thompson JK, 2001, CURR DIR PSYCHOL SCI, V10, P181, DOI 10.1111/1467-8721.00144; Tiggemann M, 2017, BODY IMAGE, V21, P107, DOI 10.1016/j.bodyim.2017.04.001; Tiggemann M, 2010, PSYCHOL WOMEN QUART, V34, P356, DOI 10.1111/j.1471-6402.2010.01581.x; Tiggemann M, 2009, J SOC CLIN PSYCHOL, V28, P73, DOI 10.1521/jscp.2009.28.1.73; Want SC, 2017, BODY IMAGE, V20, P1, DOI 10.1016/j.bodyim.2016.10.009; Want SC, 2015, SEX ROLES, V73, P519, DOI 10.1007/s11199-015-0538-1; Want SC, 2009, BODY IMAGE, V6, P257, DOI 10.1016/j.bodyim.2009.07.008	43	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193200	10.1371/journal.pone.0193200	http://dx.doi.org/10.1371/journal.pone.0193200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590125	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100017
J	Cheema, E; Alhomoud, FK; Kinsara, ASAD; Alsiddik, J; Barnawi, MH; Al-Muwallad, MA; Abed, SA; Elrggal, ME; Mohamed, MMA				Cheema, Ejaz; Alhomoud, Farah Kais; Kinsara, Amnah Shams Al-Deen; Alsiddik, Jomanah; Barnawi, Marwah Hassan; Al-Muwallad, Morooj Abdullah; Abed, Shatha Abdulbaset; Elrggal, Mahmoud E.; Mohamed, Mahmoud M. A.			The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials	PLOS ONE			English	Review							ADVERSE DRUG EVENTS; ACQUIRED MEDICATION HISTORY; HOSPITALIZED-PATIENTS; DISCREPANCIES; INTERVENTION; DISCHARGE; ERRORS; TRANSITIONS; SERVICE; RATES	Background Adverse drug events (ADEs) impose a major clinical and cost burden on acute hospital services. It has been reported that medicines reconciliation provided by pharmacists is effective in minimizing the chances of hospital admissions related to adverse drug events. Objective To update the previous assessment of pharmacist-led medication reconciliation by restricting the review to randomized controlled trials (RCTs) only. Methods Six major online databases were sifted up to 30 December 2016, without inception date (Embase, Medline Ovid, PubMed, BioMed Central, Web of Science and Scopus) to assess the effect of pharmacist-led interventions on medication discrepancies, preventable adverse drug events, potential adverse drug events and healthcare utilization. The Cochrane tool was applied to evaluate the chances of bias. Meta-analysis was carried out using a random effects model. Results From 720 articles identified on initial searching, 18 RCTs (6,038 patients) were included. The quality of the included studies was variable. Pharmacists-led interventions led to an important decrease in favour of the intervention group, with a pooled risk ratio of 42% RR 0.58 (95% CI 0.49 to 0.67) P<0.00001 in medication discrepancy. Reductions in healthcare utilization by 22% RR 0.78 (95% CI 0.61 to 1.00) P = 0.05, potential ADEs by10% RR 0.90 (95% CI 0.78 to 1.03) P = 0.65 and preventable ADEs by 27% RR 0.73 (0.22 to 2.40) P = 0.60 were not considerable. Conclusion Pharmacists-led interventions were effective in reducing medication discrepancies. However, these interventions did not lead to a significant reduction in potential and preventable ADEs and healthcare utilization.	[Cheema, Ejaz; Kinsara, Amnah Shams Al-Deen; Alsiddik, Jomanah; Barnawi, Marwah Hassan; Al-Muwallad, Morooj Abdullah; Abed, Shatha Abdulbaset; Elrggal, Mahmoud E.; Mohamed, Mahmoud M. A.] Umm Al Qura Univ, Dept Clin & Pharm Practice, Coll Pharm, Mecca, Saudi Arabia; [Cheema, Ejaz] Univ Warwick, Warwick Med Sch, Gibbet Hill Campus, Coventry, W Midlands, England; [Alhomoud, Farah Kais] Univ Dammam, Sch Clin Pharm, Dept Clin & Pharm Practice, Dammam, Saudi Arabia	Umm Al Qura University; University of Warwick; Imam Abdulrahman Bin Faisal University	Cheema, E (corresponding author), Umm Al Qura Univ, Dept Clin & Pharm Practice, Coll Pharm, Mecca, Saudi Arabia.; Cheema, E (corresponding author), Univ Warwick, Warwick Med Sch, Gibbet Hill Campus, Coventry, W Midlands, England.	E.cheema.1@warwick.ac.uk	Alhomoud, Farah/AAF-6227-2019; Elrggal, Mahmoud E/C-1417-2014; mohamed, mostafa/AFE-7371-2022; Elrggal, Mahmoud/AAN-9003-2020; cheema, ejaz/AAJ-7960-2020	Alhomoud, Farah/0000-0001-8368-5700; Elrggal, Mahmoud E/0000-0002-0026-5514; mohamed, mostafa/0000-0002-1421-2667; Elrggal, Mahmoud/0000-0002-0026-5514; 				Aag T, 2014, EUR J CLIN PHARMACOL, V70, P1325, DOI 10.1007/s00228-014-1741-7; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Becerra-Camargo J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0990-1; Becerra-Camargo J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-337; Bolas H, 2004, PHARM WORLD SCI, V26, P114, DOI 10.1023/B:PHAR.0000018601.11248.89; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; Cullen DJ, 1997, CRIT CARE MED, V25, P1289, DOI 10.1097/00003246-199708000-00014; Dedhia P, 2009, J AM GERIATR SOC, V57, P1540, DOI 10.1111/j.1532-5415.2009.02430.x; Eggink RN, 2010, PHARM WORLD SCI, V32, P759, DOI 10.1007/s11096-010-9433-6; Farley TM, 2014, INT J CLIN PHARM-NET, V36, P430, DOI 10.1007/s11096-014-9917-x; Farris KB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-406; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Gleason KM, 2004, AM J HEALTH-SYST PH, V61, P1689, DOI 10.1093/ajhp/61.16.1689; Hawes EM, 2014, J PRIM CARE COMMUNIT, V5, P14, DOI 10.1177/2150131913502489; Hellstrom LM, 2012, J CLIN PHARM THER, V37, P686, DOI 10.1111/jcpt.12001; Hellstrom LM, 2011, EUR J CLIN PHARMACOL, V67, P741, DOI 10.1007/s00228-010-0982-3; Herrero-Herrero JI, 2011, EUR J INTERN MED, V22, P43, DOI 10.1016/j.ejim.2010.10.003; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Institute for Healthcare Improvement, 2007, MED REC REV; Koehler BE, 2009, J HOSP MED, V4, P211, DOI 10.1002/jhm.427; Kostas T., 2013, AGING HLTH, V9, P497, DOI DOI 10.2217/AHE.13.47; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; Kwan JL, 2013, ANN INTERN MED, V158, P397, DOI 10.7326/0003-4819-158-5-201303051-00006; Kwan Y, 2007, ARCH INTERN MED, V167, P1034, DOI 10.1001/archinte.167.10.1034; Lisby M, 2010, BASIC CLIN PHARMACOL, V106, P422, DOI 10.1111/j.1742-7843.2009.00511.x; Marotti SB, 2011, ANAESTH INTENS CARE, V39, P1064, DOI 10.1177/0310057X1103900613; Meier F, 2014, PHARMACOEPIDEMIOL DR; MEKONNEN AB, 2016, BMJ OPEN, V6, DOI DOI 10.1136/BMJOPEN-2015-010003; Mekonnen AB, 2016, J CLIN PHARM THER, V41, P128, DOI 10.1111/jcpt.12364; Mills PR, 2010, EMERG MED J, V27, P911, DOI 10.1136/emj.2009.082255; Mueller SK, 2012, ARCH INTERN MED, V172, P1057, DOI 10.1001/archinternmed.2012.2246; Nester TM, 2002, AM J HEALTH-SYST PH, V59, P2221, DOI 10.1093/ajhp/59.22.2221; Nickerson Ann, 2005, Healthc Q, V8 Spec No, P65; Pippins JR, 2008, J GEN INTERN MED, V23, P1414, DOI 10.1007/s11606-008-0687-9; Rozich J., 2001, J CLIN OUTCOMES MANA, V8, P27; Rozich John D, 2004, Jt Comm J Qual Saf, V30, P5; Schnipper JL, 2009, ARCH INTERN MED, V169, P771, DOI 10.1001/archinternmed.2009.51; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Scullin C, 2007, J EVAL CLIN PRACT, V13, P781, DOI 10.1111/j.1365-2753.2006.00753.x; Stowasser DA., 2002, J PHARM PRACT RES, V32, P133, DOI DOI 10.1002/JPPR2002322133; Wong JD, 2008, ANN PHARMACOTHER, V42, P1373, DOI 10.1345/aph.1L190	43	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193510	10.1371/journal.pone.0193510	http://dx.doi.org/10.1371/journal.pone.0193510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590146	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100022
J	Janzen, C; Lei, MYY; Jeong, SD; Ganguly, A; Sullivan, P; Paharkova, V; Capodanno, G; Nakamura, H; Perry, A; Shin, BC; Lee, KW; Devaskar, SU				Janzen, Carla; Lei, Margarida Y. Y.; Jeong, Seok D.; Ganguly, Amit; Sullivan, Peggy; Paharkova, Vladislava; Capodanno, Gina; Nakamura, Hiromi; Perry, Alix; Shin, Bo-Chul; Lee, Kuk-Wha; Devaskar, Sherin U.			Humanin (HN) and glucose transporter 8 (GLUT8) in pregnancies complicated by intrauterine growth restriction	PLOS ONE			English	Article							OXIDATIVE STRESS; 1ST TRIMESTER; PLACENTAL DEVELOPMENT; SKELETAL-MUSCLES; PEPTIDE HUMANIN; CELL-DEATH; EXPRESSION; APOPTOSIS; ONSET; LOCALIZATION	Background Intrauterine growth restriction (IUGR) results from a lack of nutrients transferred to the developing fetus, particularly oxygen and glucose. Increased expression of the cytoprotective mitochondrial peptide, humanin (HN), and the glucose transporter 8, GLUT8, has been reported under conditions of hypoxic stress. However, the presence and cellular localization of HN and GLUT8 in IUGR-related placental pathology remain unexplored. Thus, we undertook this study to investigate placental expression of HN and GLUT8 in IUGR-affected versus normal pregnancies. Results We found 1) increased HN expression in human IUGR-affected pregnancies on the maternal aspect of the placenta (extravillous trophoblastic (EVT) cytoplasm) compared to control (i.e. appropriate for gestational age) pregnancies, and a concomitant increase in GLUT8 expression in the same compartment, 2) HN and GLUT8 showed a protein-protein interaction by co-immunoprecipitation, 3) elevated HN and GLUT8 levels in vitro under simulated hypoxia in human EVT cells, HTR8/SVneo, and 4) increased HN expression but attenuated GLUT8 expression in vitro under serum deprivation in HTR8/SVneo cells. Conclusions There was elevated HN expression with cytoplasmic localization to EVTs on the maternal aspect of the human placenta affected by IUGR, also associated with increased GLUT8 expression. We found that while hypoxia increased both HN and GLUT8, serum deprivation increased HN expression alone. Also, a protein -protein interaction between HN and GLUT8 suggests that their interaction may fulfill a biologic role that requires interdependency. Future investigations delineating molecular interactions between these proteins are required to fully uncover their role in IUGR-affected pregnancies.	[Janzen, Carla; Lei, Margarida Y. Y.; Perry, Alix] UCLA, David Geffen Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA 90095 USA; [Jeong, Seok D.; Paharkova, Vladislava; Capodanno, Gina; Nakamura, Hiromi; Lee, Kuk-Wha] UCLA, David Geffen Sch Med, Dept Pediat, Div Endocrinol, Los Angeles, CA 90095 USA; [Jeong, Seok D.; Ganguly, Amit; Paharkova, Vladislava; Capodanno, Gina; Nakamura, Hiromi; Shin, Bo-Chul; Lee, Kuk-Wha; Devaskar, Sherin U.] UCLA, David Geffen Sch Med, Neonatal Res Ctr, UCLA Childrens Discovery & Innovat Inst, Los Angeles, CA 90095 USA; [Ganguly, Amit; Shin, Bo-Chul; Devaskar, Sherin U.] UCLA, David Geffen Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90095 USA; [Sullivan, Peggy] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Janzen, C (corresponding author), UCLA, David Geffen Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA 90095 USA.	CJanzen@mednet.ucla.edu	Jeong, Il Seok/AAN-5361-2020	Jeong, Il Seok/0000-0001-5465-6185; Shin, Bo-Chul/0000-0002-7569-5121	National Institutes of Health (NIH) [HD-041230, HD-081206, HD-089714, U01-HD-08722]; UCLA Undergraduate Research Center: URFP; URSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD089714] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Undergraduate Research Center: URFP; URSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health (NIH): HD-041230 (SD), HD-081206 (SD), HD-089714 (SD), U01-HD-08722 (SD, CJ), https://www.nih.gov/; and UCLA Undergraduate Research Center: URFP (IJ) and URSP (IJ), http://www.ugresearchsci.ucla.edu/default.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adastra KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097675; Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191; Biri A, 2007, GYNECOL OBSTET INVES, V64, P187, DOI 10.1159/000106488; Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006; Boulet SL, 2006, AM J OBSTET GYNECOL, V195, P1571, DOI 10.1016/j.ajog.2006.03.069; Brown K, 2011, PLACENTA, V32, P1041, DOI 10.1016/j.placenta.2011.09.014; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Caniggia I, 2000, PLACENTA, V21, pS25, DOI 10.1053/plac.1999.0522; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; Chen PY, 2013, PHYSIOL GENOMICS, V45, P565, DOI 10.1152/physiolgenomics.00034.2013; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; Dennery PA, 2010, FREE RADICAL BIO MED, V49, P1147, DOI 10.1016/j.freeradbiomed.2010.07.011; DEVASKAR SU, 1992, PEDIATR RES, V31, P1, DOI 10.1203/00006450-199201000-00001; Diril MK, 2009, FEBS J, V276, P4153, DOI 10.1111/j.1742-4658.2009.07089.x; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; Ericsson A, 2005, HUM REPROD, V20, P521, DOI 10.1093/humrep/deh596; Gawlik V, 2008, MOL MEMBR BIOL, V25, P224, DOI 10.1080/09687680701855405; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gidlund EK, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13063; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; HaugueldeMouzon S, 1997, J CLIN ENDOCR METAB, V82, P2689, DOI 10.1210/jc.82.8.2689; Herrera EA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00149; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Janzen C, 2013, PLACENTA, V34, P1072, DOI 10.1016/j.placenta.2013.08.010; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; KAYANO T, 1988, J BIOL CHEM, V263, P15245; Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2; Klein LE, 2013, BIOCHEM BIOPH RES CO, V440, P197, DOI 10.1016/j.bbrc.2013.08.055; Limesand SW, 2004, PLACENTA, V25, P70, DOI 10.1016/j.placenta.2003.08.012; Muzumdar RH, 2010, ARTERIOSCL THROM VAS, V30, P1940, DOI 10.1161/ATVBAHA.110.205997; Niikura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016259; Nikolakopoulos P, 2017, J MATERN-FETAL NEO M, V9, P1; Paharkova V, 2015, MOL CELL ENDOCRINOL, V413, P96, DOI 10.1016/j.mce.2015.06.015; Rajakumar A, 2007, AM J PHYSIOL-REG I, V293, pR766, DOI 10.1152/ajpregu.00097.2007; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Saleem T, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-41; Sankar R, 2002, MOL BRAIN RES, V107, P157, DOI 10.1016/S0169-328X(02)00487-4; Schmidt S, 2009, AM J PHYSIOL-ENDOC M, V296, pE614, DOI 10.1152/ajpendo.91019.2008; Shao Y, 2014, AM J PHYSIOL-REG I, V307, pR237, DOI 10.1152/ajpregu.00093.2014; Shin BC, 2004, J NEUROSCI RES, V75, P835, DOI 10.1002/jnr.20054; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; TAKATA K, 1990, BIOCHEM BIOPH RES CO, V173, P67, DOI 10.1016/S0006-291X(05)81022-8; Tarry-Adkins JL, 2010, FASEB J, V24, P2762, DOI 10.1096/fj.10-156075; Thamotharan M, 2005, AM J PHYSIOL-ENDOC M, V288, pE935, DOI 10.1152/ajpendo.00342.2004; Voigt A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12796; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]; Xie Y, 2014, DIABETES RES CLIN PR, V106, P560, DOI 10.1016/j.diabres.2014.09.020; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamanaka-Tatematsu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076605; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203; Zhang X, 2012, LIFE SCI, V91, P199, DOI 10.1016/j.lfs.2012.07.010	58	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193583	10.1371/journal.pone.0193583	http://dx.doi.org/10.1371/journal.pone.0193583			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590129	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100024
J	Kiplagat, J; Mwangi, A; Keter, A; Braitstein, P; Sang, E; Negin, J; Chasela, C				Kiplagat, Jepchirchir; Mwangi, Ann; Keter, Alfred; Braitstein, Paula; Sang, Edwin; Negin, Joel; Chasela, Charles			Retention in care among older adults living with HIV in western Kenya: A retrospective observational cohort study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; PATIENT RETENTION; PROGRAMS; PREVALENCE; INFECTION; DIAGNOSIS; UGANDA	Background Retention, defined as continuous engagement in care, is an important indicator for quality of healthcare services. To achieve UNAIDS 90-90-90 targets, emphasis on retention as a predictor of viral suppression in patients initiated on ART is vital. Using routinely collected clinical data, the authors sought to determine the effect of age on retention post ART initiation. Methods De-identified electronic data for 32965 HIV-infected persons aged >= 15 years at enrolment into the Academic Model Providing Access to Healthcare program between January 2008 and December 2014 were analyzed. Follow-up time was defined from the date of ART initiation until either loss to follow-up or death or close of the database (September 2016) was observed. Proportions were compared using Pearson's Chi-square test and medians using Mann-Whitney U test. Logistic regression model was used to assess differences in ART initiation between groups, adjusting for baseline characteristics. Cox proportional hazards model adjusting for baseline characteristics and antiretroviral therapy (ART) status was used to compute hazard ratios. Kaplan-Meier survival function was used to compare retention on ART at 12, 24, and 36 months post ART initiation. Results Of the total sample, 3924 (12.0%) were aged >50 years at enrolment. The median (IQR) age of young adults and older adults were 32.5 (26.6, 36.9) and 54.9 (51.7, 59.9) respectively. ART initiation rates were 70.5% among older adults and 68.2% among younger adults. Retention rates in care at 12, 24 and 36 months post ART initiation were 73.9% (95% CL: 72.2, 75.5), 62.9% (95% CL: 61.0, 64.7) and 55.4% (95% CL: 53.5, 57.3) among older adults compared to 69.8% (95% CL: 69.1, 70.4), 58.1% (95% CL: 57.4, 58.8) and 49.3% (95% CL: 48.6, 50.0) among younger adults (p <0.001). A higher proportion of older adults were retained in HIV care post ART initiation compared to younger adults, Adjusted Hazard Ratio (AHR): 0.83 (95% CI: 0.78, 0.87) though they were more likely to die, AHR: 1.35 (95% CI: 1.19, 1.52). Conclusion A higher proportion of older adults are initiated on ART and have better retention in care at 12, 24 and 36 months post ART initiation than younger adults. However, older adults have a higher all-cause mortality rate, perhaps partially driven by late presentation to care. Enhanced outreach and care to this group is imperative to improve their outcomes.	[Kiplagat, Jepchirchir; Mwangi, Ann; Braitstein, Paula] Moi Univ, Coll Hlth Sci, Sch Med, Eldoret, Kenya; [Kiplagat, Jepchirchir; Mwangi, Ann; Keter, Alfred; Braitstein, Paula; Sang, Edwin] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Kiplagat, Jepchirchir; Chasela, Charles] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Johannesburg, South Africa; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Negin, Joel] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Chasela, Charles] EQUIP, Right Care, Pretoria, South Africa	Moi University; University of Witwatersrand; University of Toronto; University of Sydney	Kiplagat, J (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Eldoret, Kenya.; Kiplagat, J (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Kiplagat, J (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Johannesburg, South Africa.	chiri2809@gmail.com			Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK government; Wellcome Trust (UK) [107768/Z/15/Z]; President's Emergency Plan for AIDS Relief (PEPFAR) through USAID [AID-623-A-12-0001]; United States Agency for International Development (USAID)	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); UK government; Wellcome Trust (UK)(Wellcome Trust); President's Emergency Plan for AIDS Relief (PEPFAR) through USAID(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government. This study was also supported in part by the President's Emergency Plan for AIDS Relief (PEPFAR) through USAID under the terms of Cooperative Agreement No. AID-623-A-12-0001. It is made possible through joint support of the United States Agency for International Development (USAID). The contents of this study are the sole responsibility of the authors and do not necessarily reflect the views of CARTA Program, USAID or the United States Government.	Agaba PA, 2017, OPEN FORUM INFECT DI; [Anonymous], 2014, JOINT UN PROGR HIV A; Auld AF, 2014, ANTIRETROVIRAL THERA, P2004; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Bloomfield GS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-284; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Drain PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055305; Eduardo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103864; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Fatti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100273; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Greig Jane, 2012, AIDS, V26 Suppl 1, pS31; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; Mamlin BW, 2005, AMIA ANN S P, V2005, P490, DOI DOI 10.1197/JAMIA.M3139; Mburu G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1061; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Negin Joel, 2012, AIDS, V26 Suppl 1, pS1; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; Nyandiko WM, 2006, JAIDS-J ACQ IMM DEF, V43, P418, DOI 10.1097/01.qai.0000243122.52282.89; Organization WH, 2012, RET HIV PROGR DEF CH; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Parikh SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076158; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Siika AM, 2005, INT J MED INFORM, V74, P345, DOI 10.1016/j.ijmedinf.2005.03.002; Theuring S., 2015, Journal of AIDS and Clinical Research, V6, P423; UNAIDS, 2016, GET FAST TRACK LIFE; USAID Kenya, 2014, AC MOD PROV ACC HEAL; Warstrom, 2014, MENTIMETER; WHO (World Health Organization), 2016, PROGR REP 2016 PREV; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; Yehia BR, 1999, J ACQ IMMUN DEF SYND, P68	37	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194047	10.1371/journal.pone.0194047	http://dx.doi.org/10.1371/journal.pone.0194047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590150	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100046
J	Lichtenstein, G; Perlman, A; Shpitzen, S; Durst, R; Shaham, D; Leitersdorf, E; Szalat, A				Lichtenstein, Gabriel; Perlman, Amichai; Shpitzen, Shoshana; Durst, Ronen; Shaham, Dorit; Leitersdorf, Eran; Szalat, Auryan			Correlation between coronary artery calcification by non-cardiac CT and Framingham score in young patients	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; ALL-CAUSE MORTALITY; HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PROGNOSTIC VALUE; LUNG-CANCER; FOLLOW-UP; CALCIUM; PREDICTION	Background Previous studies have established a correlation between coronary artery calcification (CAC) measured by ECG-gated chest computed tomography (CT) and cardiovascular disease. Recent reports which included asymptomatic patients suggest that CAC measured on non ECG gated CT is similarly associated with cardiovascular risk. This study investigates the correlation between the Framingham Risk Score (FRS) and an incidental finding of CAC on a non-gated chest CT performed for non-cardiac indications in young and seemingly healthy adults. Methods A cross-sectional study that included 162 CT scans performed in young patients aged 1850 years old for non-cardiac indications in our institution was conducted. CAC score (CACS) was calculated using the Agatston method. FRS was calculated and compared to the CACS using three different approaches. The correlations between the CACS and several specific factors (i.e. age, body mass index, smoking, statins, etc.), were also evaluated. Results Mean age of patients was 36.43 year old and 105 (64.8%) were male. We found a significant positive correlation between the CACS and the FRS in all three approaches (p<0.05). Increased age, smoking and statin use were the only individual factors clearly associated with an increase in CACS (p = 0.002, p = 0.045 and p = 0.009, respectively). Conclusion This is the first report indicating that incidental CACS identified in non-gated MDCT is also associated with cardiovascular risk evaluated by FRS in a young population. Our findings suggest that young asymptomatic individuals with incidental CAC should be seriously evaluated for cardiovascular risk factors despite presumption of belonging to a low cardiovascular risk category.	[Lichtenstein, Gabriel; Shpitzen, Shoshana; Durst, Ronen; Leitersdorf, Eran; Szalat, Auryan] Hadassah Hebrew Univ, Med Ctr, Ctr Res Prevent & Treatment Atherosclerosis, Jerusalem, Israel; [Perlman, Amichai; Leitersdorf, Eran; Szalat, Auryan] Hadassah Hebrew Univ, Med Ctr, Internal Med Ward, Jerusalem, Israel; [Durst, Ronen] Hadassah Hebrew Univ, Med Ctr, Heart Inst, Jerusalem, Israel; [Shaham, Dorit] Hadassah Hebrew Univ, Med Ctr, Med Imaging Dept, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Szalat, A (corresponding author), Hadassah Hebrew Univ, Med Ctr, Ctr Res Prevent & Treatment Atherosclerosis, Jerusalem, Israel.; Szalat, A (corresponding author), Hadassah Hebrew Univ, Med Ctr, Internal Med Ward, Jerusalem, Israel.	auryans@hadassah.org.il	Perlman, Amichai/I-9496-2018; Perlman, Amichai/AFV-3884-2022	Perlman, Amichai/0000-0001-6034-7995; Perlman, Amichai/0000-0001-6034-7995; Durst, Ronen/0000-0003-3559-1050	Israel Atherosclerosis Association	Israel Atherosclerosis Association	This study was supported by a grant given by the Israel Atherosclerosis Association and attributed to AS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allan GM, 2014, CURR OPIN LIPIDOL, V25, P254, DOI 10.1097/MOL.0000000000000095; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; Azour L, 2017, J CARDIOVASC COMPUT, V11, P8, DOI 10.1016/j.jcct.2016.10.001; Bielak LF, 2000, CIRCULATION, V102, P380; Bielak LF, 2004, J HYPERTENS, V22, P719, DOI 10.1097/00004872-200404000-00014; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Cassidy AE, 2005, CIRCULATION, V111, P1877, DOI 10.1161/01.CIR.0000161820.40494.5D; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577; Joergensen C, 2012, DIABETES CARE, V35, P168, DOI 10.2337/dc11-1372; Kirsch J, 2016, INT J CARDIOVASC IMA; Kirsch J, 2012, INT J CARDIOVAS IMAG, V28, P1249, DOI 10.1007/s10554-011-9928-9; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Lim S, 2012, J CLIN ENDOCR METAB, V97, P169, DOI 10.1210/jc.2011-1580; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Mayer B, 2007, J HYPERTENS, V25, P1731, DOI 10.1097/HJH.0b013e328165cbb6; Nasir K, 2005, J AM COLL CARDIOL, V46, P1931, DOI 10.1016/j.jacc.2005.07.052; Paixao ARM, 2015, JACC-CARDIOVASC IMAG, V8, P1285, DOI 10.1016/j.jcmg.2015.06.015; Puri R, 2015, J AM COLL CARDIOL, V65, P1273, DOI 10.1016/j.jacc.2015.01.036; Shao L, 2017, J CARDIOVASC COMPUT, V11, P196, DOI 10.1016/j.jcct.2017.03.004; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Shemesh J, 2010, RADIOLOGY, V257, P541, DOI 10.1148/radiol.10100383; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974; Young KA, 2011, DIABETES CARE, V34, P454, DOI 10.2337/dc10-0757; Zondervan RL, 2013, RADIOLOGY, V267, P460, DOI 10.1148/radiol.12121324	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195061	10.1371/journal.pone.0195061	http://dx.doi.org/10.1371/journal.pone.0195061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590197	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100101
J	Saito, T; Kondo, N; Shiba, K; Murata, C; Kondo, K				Saito, Tami; Kondo, Naoki; Shiba, Koichiro; Murata, Chiyoe; Kondo, Katsunori			Income-based inequalities in caregiving time and depressive symptoms among older family caregivers under the Japanese long-term care insurance system: A cross-sectional analysis	PLOS ONE			English	Article							INFORMAL CAREGIVERS; BURDEN; HEALTH; DEMENTIA; SCALE; INTERVENTIONS; METAANALYSIS; PREDICTORS; DISABILITY; PEOPLE	Aim Long-term care systems may alleviate caregiver burdens, particularly for those with fewer resources. However, it remains unclear whether socioeconomic disparity in caregiver burdens exists under a public, universal long-term care insurance (LTCI) system. This study examined income-based inequalities in caregiving time and depressive symptoms in Japanese older family caregivers. We further compared inequality in depressive symptoms with that of non-caregivers to evaluate whether family caregiving exacerbates this disparity. Methods Data were obtained from a cross-sectional, nationwide survey conducted by the Japan Gerontological Evaluation Study in 2013. Participants were functionally independent older adults aged >= 65 years (N=21,584). Depressive symptoms were assessed using the Geriatrics Depression Scale (GDS); caregiving hours per week, household income, and other covariates were also assessed. Results Family caregivers occupied 8.3% of the total. A Poisson regression model revealed that caregivers in lower income groups (compared to those in the highest) were 1.32 to 1.95 and 1.63 to 2.68 times more likely to engage in >= 36 and >= 72 hours/week of caregiving, respectively. As for the GDS (>= 5), an excess risk was found in the caregivers in lower (compared to higher) income groups (adjusted prevalence ratio: 1.57-3.10). However, an interaction effect of income by caregiving role indicated no significant difference in inequality between caregivers and non-caregivers (p = .603). The excess risk for GDS (>= 5) in the caregivers compared to non-caregivers was observed across income groups. Conclusions Our findings revealed a possible disparity in family caregivers under the public LTCI system. Further studies should examine factors associated with longer caregiving hours in lower income households. Our findings also suggest the necessity for more efforts to alleviate depressive symptoms in family caregivers under the LTCI system regardless of income level, rather than exclusively supporting those with a low income.	[Saito, Tami; Murata, Chiyoe] Natl Ctr Geriatr & Gerontol, Dept Social Sci, Obu, Japan; [Kondo, Naoki; Shiba, Koichiro] Univ Tokyo, Dept Hlth & Social Behav, Sch Publ Hlth, Tokyo, Japan; [Shiba, Koichiro] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Kondo, Katsunori] Natl Ctr Geriatr & Gerontol, Dept Gerontol Evaluat, Obu, Japan	National Center for Geriatrics & Gerontology; University of Tokyo; Harvard University; Harvard T.H. Chan School of Public Health; Chiba University; National Center for Geriatrics & Gerontology	Saito, T (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Social Sci, Obu, Japan.	t-saito@ncgg.go.jp	Kondo, Naoki/K-3898-2012; Kondo, Katsunori/AAI-6373-2020; Kondo, Naoki/ABC-5865-2020	Kondo, Naoki/0000-0002-6425-6844; Kondo, Naoki/0000-0002-6425-6844; Shiba, Koichiro/0000-0001-7956-6485	Japanese Ministry of Health, Labour and Welfare [H25-Choju-Ippan-003]; National Center for Geriatrics and Gerontology [2417, 24-23, 27-18]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); National Center for Geriatrics and Gerontology	This study used data from JAGES (the Japan Gerontological Evaluation Study), was supported by a Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health (H25-Choju-Ippan-003) from the Japanese Ministry of Health, Labour and Welfare, for the Center for Well-being and Society, Nihon Fukushi University (KK: http://www.mhlw.go.jp/english/policy/other/research-projects/index.html), and the Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (2417: CM; 24-23: TS; 27-18: TS; http://www.ncgg.go.jp/ncgg-kenkyu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Arai Y, 2014, AGING MENT HEALTH, V18, P81, DOI 10.1080/13607863.2013.787045; Cannuscio CC, 2002, AM J PUBLIC HEALTH, V92, P1305, DOI 10.2105/AJPH.92.8.1305; Capistrant BD, 2012, AM J HYPERTENS, V25, P437, DOI 10.1038/ajh.2011.232; Cepoiu-Martin M, 2016, INT J GERIATR PSYCH, V31, P1151, DOI 10.1002/gps.4449; Cohen SA, 2017, J GERONTOL NURS, V43, P17, DOI 10.3928/00989134-20170224-01; Department of Health, 2022, CAR SUPP STAT GUID; Dujardin C, 2011, SOC SCI MED, V73, P1123, DOI 10.1016/j.socscimed.2011.07.016; Flyckt L, 2015, INT J SOC PSYCHIATR, V61, P684, DOI 10.1177/0020764015573088; Flyckt L, 2013, INT J SOC PSYCHIATR, V59, P137, DOI 10.1177/0020764011427239; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Nguyen HT, 2014, SOC SCI MED, V100, P115, DOI 10.1016/j.socscimed.2013.10.031; Hoffman GJ, 2012, GERONTOLOGIST, V52, P219, DOI 10.1093/geront/gns003; Hughes TB, 2014, INT PSYCHOGERIATR, V26, P1875, DOI 10.1017/S1041610214001240; Janus AL, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0978-x; Kaschowitz J, 2017, SOC SCI MED, V173, P72, DOI 10.1016/j.socscimed.2016.11.036; Kondo K, 2016, J EPIDEMIOL, V26, P331, DOI 10.2188/jea.JE20160093; Lilly MB, 2010, J HEALTH ECON, V29, P895, DOI 10.1016/j.jhealeco.2010.08.007; Mandemakers JJ, 2010, SOC SCI MED, V71, P288, DOI 10.1016/j.socscimed.2010.04.004; Ministry of Health, LONG TERM CAR HLTH W; Ministry of Health L and Welfare, 2010, REV LAB STAND ACT; Ministry of Health Labour and Welfare, 2015, COMPR SURV LIV COND; Ministry of Internal Affairs and Communications, 2011, 2011 SURV TIM US LEI; Nadash P, 2017, GERONTOL; Osaki T, 2016, ARCH GERONTOL GERIAT, V66, P42, DOI 10.1016/j.archger.2016.04.015; Paraponaris A, 2012, EUR J HEALTH ECON, V13, P327, DOI 10.1007/s10198-011-0305-3; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Robison J, 2009, J GERONTOL B-PSYCHOL, V64, P788, DOI 10.1093/geronb/gbp015; Saito M, 2011, KIKAN SHAKAI HOSHO K, V43, P293; Schreiner AS, 2003, INT J GERIATR PSYCH, V18, P498, DOI 10.1002/gps.880; Shiba K, 2016, J EPIDEMIOL, V26, P622, DOI 10.2188/jea.JE20150263; Smith DM, 2005, PSYCHOL SCI, V16, P663, DOI 10.1111/j.1467-9280.2005.01592.x; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Tokunaga M, 2015, HEALTH POLICY, V119, P840, DOI 10.1016/j.healthpol.2014.10.015; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Verbakel E, 2016, J GERONTOL B; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; World Health Organization, 2018, WORLD REP AG HLTH; Yates ME, 1999, J GERONTOL B-PSYCHOL, V54, pP12, DOI 10.1093/geronb/54B.1.P12; Yatomi N., 1994, RONEN SHAKAI KAGAKU, V16, P29; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	45	19	19	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194919	10.1371/journal.pone.0194919	http://dx.doi.org/10.1371/journal.pone.0194919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590211	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100089
J	Sallard, E; Mouthon, M; De Pretto, M; Spierer, L				Sallard, Etienne; Mouthon, Michael; De Pretto, Michael; Spierer, Lucas			Modulation of inhibitory control by prefrontal anodal tDCS: A crossover double-blind sham-controlled fMRI study	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; STOP-SIGNAL TASK; RESPONSE-INHIBITION; PARIETAL CORTEX; FRONTAL-CORTEX; MOTOR CORTEX; PERFORMANCE; CONFLICT; CONNECTIVITY; SERIES	Prefrontal anodal transcranial direct current stimulation (tDCS) has been proposed as a potential approach to improve inhibitory control performance. The functional consequences of tDCS during inhibition tasks remain, however, largely unresolved. We addressed this question by analyzing functional magnetic resonance imaging (fMRI) recorded while participants completed a Go/NoGo task after right-lateralized prefrontal anodal tDCS with a crossover, sham-controlled, double-blind experimental design. We replicated previous evidence for an absence of offline effect of anodal stimulation on Go/NoGo performance. The fMRI results revealed a larger increase in right ventrolateral prefrontal activity for Go than NoGo trials in the anodal than sham condition. This pattern suggests that tDCS-induced increases in cortical excitability have larger effects on fMRI activity in regions with a lower task-related engagement. This was the case for the right prefrontal cortex in the Go condition in our task because while reactive inhibition was not engaged during execution trials, the unpredictability of the demand for inhibitory control still incited an engagement of proactive inhibition. Exploratory analyses further revealed that right prefrontal stimulation interacted with task related functional demands in the supplementary motor area and the thalamus. Our collective results emphasize the dependency of offline tDCS functional effects on the task-related engagement of the stimulated areas and suggest that this factor might partly account for the discrepancies in the functional effects of tDCS observed in previous studies.	[Sallard, Etienne; Mouthon, Michael; De Pretto, Michael; Spierer, Lucas] Univ Fribourg, Neurol Unit, Dept Med, Fac Sci, Fribourg, Switzerland	University of Fribourg	Sallard, E; Spierer, L (corresponding author), Univ Fribourg, Neurol Unit, Dept Med, Fac Sci, Fribourg, Switzerland.	etienne.sallard@gmail.com; lucas.spierer@unifr.ch	De Pretto, Michael/ABO-0995-2022; Spierer, Lucas/E-1771-2011	De Pretto, Michael/0000-0003-4176-4798; Spierer, Lucas/0000-0003-3558-4408; Mouthon, Michael/0000-0002-2557-4102	Swiss National Science Foundation [32003B_156854, 316030_144998, 320030_175469, P2LAP3-158917]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Swiss National Science Foundation www.snf.ch/ [Grants #32003B_156854, #316030_144998 and #320030_175469 to LS and #P2LAP3-158917 to ES]. We thank Dr Camille Chavan, Julia Pichard and Fabio Roveri for their help with data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-33; Cai Y, 2016, J COGNITIVE NEUROSCI, V28, P177, DOI 10.1162/jocn_a_00888; Campanella S, 2016, CLIN EEG NEUROSCI; Campanella S, 2017, CLIN EEG NEUROSCI, V48, P176, DOI 10.1177/1550059416645977; Castro-Meneses LJ, 2016, EXP BRAIN RES, V234, P185, DOI 10.1007/s00221-015-4452-0; Chavan CF, 2015, HUM BRAIN MAPP, V36, P2527, DOI 10.1002/hbm.22789; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Conley AC, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00384; Conley AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124509; Cunillera T, 2016, NEUROIMAGE, V140, P66, DOI 10.1016/j.neuroimage.2015.11.044; Cunillera T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113537; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; de Lara Gabriel A, 2017, Front Neurosci, V11, P452, DOI 10.3389/fnins.2017.00452; De Pretto M, 2016, EUR J NEUROSCI, V44, P1826, DOI 10.1111/ejn.13265; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Hogeveen J, 2016, BRAIN STIMUL, V9, P720, DOI 10.1016/j.brs.2016.04.015; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Hsu TY, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00643; Hsu TY, 2014, NEUROIMAGE, V98, P306, DOI 10.1016/j.neuroimage.2014.04.069; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Jacobson L, 2011, J COGNITIVE NEUROSCI, V23, P3380, DOI 10.1162/jocn_a_00020; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kwon YH, 2013, J PHYS THER SCI, V25, P1083, DOI 10.1589/jpts.25.1083; Kwon YH, 2013, NEURAL REGEN RES, V8, P1048, DOI 10.3969/j.issn.1673-5374.2013.11.011; Kwon YH, 2011, NEUROSCI LETT, V492, P105, DOI 10.1016/j.neulet.2011.01.066; Learmonth G, 2015, NEUROPSYCHOLOGIA, V74, P108, DOI 10.1016/j.neuropsychologia.2015.01.037; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Meinzer M, 2013, J NEUROSCI, V33, P12470, DOI 10.1523/JNEUROSCI.5743-12.2013; Meinzer M, 2012, J NEUROSCI, V32, P1859, DOI 10.1523/JNEUROSCI.4812-11.2012; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Oldenburg IA, 2015, NEURON, V86, P1174, DOI 10.1016/j.neuron.2015.05.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rae CL, 2014, NEUROIMAGE, V86, P381, DOI 10.1016/j.neuroimage.2013.10.012; Roelofs A, 2012, Q J EXP PSYCHOL, V65, P135, DOI 10.1080/17470218.2011.605152; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Steinhauser M, 2009, J EXP PSYCHOL HUMAN, V35, P1398, DOI 10.1037/a0016467; Streitburger DP, 2014, NEUROIMAGE, V87, P170, DOI 10.1016/j.neuroimage.2013.10.051; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; Townsend JT, 1975, PHILOS ASPECTS MIND, P200; Townsend JT, 1979, COGNITIVE THEORY, V3, P200; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Worth A, 2014, EXPLORING NEUROANATO; Yu JX, 2015, HUM BRAIN MAPP, V36, P4004, DOI 10.1002/hbm.22893	65	13	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194936	10.1371/journal.pone.0194936	http://dx.doi.org/10.1371/journal.pone.0194936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590181	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100090
J	Yravedra, J; Aramendi, J; Mate-Gonzalez, MA; Courtenay, LA; Gonzalez-Aguilera, D				Yravedra, Jose; Aramendi, Julia; Angel Mate-Gonzalez, Miguel; Austin Courtenay, Lloyd; Gonzalez-Aguilera, Diego			Differentiating percussion pits and carnivore tooth pits using 3D reconstructions and geometric morphometrics	PLOS ONE			English	Article							3.3-MILLION-YEAR-OLD STONE TOOLS; FLK 22 ZINJANTHROPUS; OLDUVAI GORGE; HAMMERSTONE PERCUSSION; LONG BONES; CUT MARKS; HOMINID; SITE; PATTERNS; SURFACES	During the end of the 20th century and the beginning of the 21st century the discussion on early human behavioral patterns revolved around the hunting versus scavenging debate. The correct identification of bone modifications, including percussion, cut and tooth marks, is a key issue within this debate. While many authors have shown that carnivore and human modifications can be easily distinguished, it is true that sometimes percussion marks without associated microstriations and tooth pits overlap morphologically, causing confusion, especially when unmodified hammerstones are used. In order to solve this equifinality problem, many investigations have focused their efforts on other pieces of evidence such as the identification of notches, fragmentation patterns and frequencies, among others. These studies, however, cannot be considered as fully conclusive. Within this paper we address the problem of equifinality when identifying percussion marks produced with unmodified hammer stones and tooth pits created by carnivores using new methodologies based on the 3D reconstruction of marks and their statistical multivariate analysis. For the purpose of this study a total of 128 marks 39 percussion marks produced with an unmodified quartzite hammerstone, and 89 pits generated by different carnivores were virtually modelled with the aid of a DAVID structured-light scanner SLS-2 and later analyzed by means of geometric morphometrics. Our results show that percussion marks not associated with striae fields and the pits generated by the carnivores studied here can be successfully distinguished.	[Yravedra, Jose; Aramendi, Julia; Austin Courtenay, Lloyd] Univ Complutense Madrid, Dept Prehist, Prof Aranguren S-N, Madrid, Spain; [Yravedra, Jose; Aramendi, Julia] Origins Museum, IDEA Inst Evolut Africa, Plaza San Andres 2, Madrid, Spain; [Angel Mate-Gonzalez, Miguel; Gonzalez-Aguilera, Diego] Univ Salamanca, Higher Polytech Sch Avila, Dept Cartog & Land Engn, Hornos Caleros 50, Avila, Spain; [Angel Mate-Gonzalez, Miguel] Univ Complutense Madrid, CAI Arqueometry & Archaeol Anal, Prof Aranguren S-N, Madrid, Spain	Complutense University of Madrid; University of Salamanca; Complutense University of Madrid	Gonzalez-Aguilera, D (corresponding author), Univ Salamanca, Higher Polytech Sch Avila, Dept Cartog & Land Engn, Hornos Caleros 50, Avila, Spain.	daguilera@usal.es	Maté-González, Miguel Ángel/I-4466-2017; Aramendi, Julia/ABC-2702-2021; Yravedra, Jose/E-9815-2016; Yravedra, Jose/AAC-2073-2019	Maté-González, Miguel Ángel/0000-0001-5721-346X; Yravedra, Jose/0000-0002-4323-3379; Aramendi, Julia/0000-0003-3725-3776; Courtenay, Lloyd/0000-0002-4810-2001; Gonzalez-Aguilera, Diego/0000-0002-8949-4216				Alcantara-Garcia V, 2006, TRABAJOS PREHISTORIA; Andres M, 2012, ARCHAEOL ANTHROP SCI, V4, P209, DOI 10.1007/s12520-012-0093-4; Mate-Gonzalez MA, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090873; Aramendi J, 2017, DISCERNING CARNIVORE; Arriaza MC, 2017, APPL MICROPHOTOGRAMM, V3; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Bello SM, 2011, DEV QUATER SCI, V14, P249; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; Binford L.R., 1981, BONES ANCIENT MEN MO; Blumenschine R, 1986, BAR INT SERIES, V283; Blumenschine R.j., 1991, CULTURAL BEGINNINGS, P17; Blumenschine R. J., 1994, J HUM EVOL, V27, P94; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Bookstein F., 1991, TYPES LANDMARKS MORP, P63; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Brain C.K., 1981, HUNTERS HUNTED INTRO; Bunn H, 1982, MEAT EATING HUMAN EV; Cadee GC, 1990, PROCESSES FOSSILIZAT, P3; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; CAVALLO JA, 1989, J HUM EVOL, V18, P393, DOI 10.1016/0047-2484(89)90038-9; Coilm R, 2017, ARCHEOMETRY; Core Team R, 2015, LANG ENV STAT COMP; De Juana S, 2011, ARCHAEOMETRY, V53, P996, DOI 10.1111/j.1475-4754.2010.00576.x; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M, 2010, QUATERNARY RES, V74, P363, DOI 10.1016/j.yqres.2010.07.004; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Dominguez-Rodrigo M, 2016, PALEOANTHROPOLOGY, V2016, P46, DOI DOI 10.4207/PA.2016.ART99; Dominguez-Rodrigo M, 2015, J ARCHAEOL SCI, V59, P35, DOI 10.1016/j.jas.2015.04.007; Dominguez-Rodrigo Manuel, 2012, Journal of Taphonomy, V10, P147; Dominguez-Rodrigo M, 2011, P NATL ACAD SCI USA, V108, pE117, DOI 10.1073/pnas.1104647108; Efremov LA, 1940, AM GEOL, V74, P81; Palomeque-Gonzalez JF, 2017, J ARCHAEOL SCI-REP, V13, P60, DOI 10.1016/j.jasrep.2017.03.033; Galan AB, 2009, J ARCHAEOL SCI, V36, P776, DOI 10.1016/j.jas.2008.11.003; Gidna A, 2013, J ARCHAEOL SCI, V40, P1903, DOI 10.1016/j.jas.2012.11.023; Hall BK, 2003, BIOL REV, V78, P409, DOI 10.1017/S1464793102006097; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Klingenberg CP, 2008, EVOL BIOL, V35, P186, DOI 10.1007/s11692-008-9029-4; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Lupo KD, 2002, J ARCHAEOL SCI, V29, P85, DOI 10.1006/jasc.2001.0690; MAREAN CW, 1992, J ARCHAEOL SCI, V19, P101, DOI 10.1016/0305-4403(92)90009-R; Mate-Gonzalez MA, 2016, ARCHAEOL ANTHR SCIM; McPherron SP, 2011, P NATL ACAD SCI USA, V108, pE116, DOI 10.1073/pnas.1101298108; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; O'Higgins P., 1988, CRITIC REV ANATOM SC, V1, P149; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pineda A, 2014, J ARCHAEOL SCI, V50, P84, DOI 10.1016/j.jas.2014.06.018; Richtsmeier JT, 2002, YEARB PHYS ANTHROPOL, V45, P63, DOI 10.1002/ajpa.10174; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; SELVAGGIO MM, 1994, J HUM EVOL, V27, P215, DOI 10.1006/jhev.1994.1043; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Shipman P., 1981, LIFE HIST FOSSIL INT; Slice DE, 2001, SYST BIOL, V50, P141, DOI 10.1080/10635150119110; Thompson JC, 2015, J HUM EVOL, V86, P112, DOI 10.1016/j.jhevol.2015.06.013; Timm NH, 2002, APPL MULTIVARIATE AN, DOI 10.1007/b98963; Yravedra J, 2014, ARCHAEOL ANTHROP SCI, V6, P113, DOI 10.1007/s12520-013-0164-1; Yravedra J, 2017, J ARCHAEOL SCI-REP, V14, P106, DOI 10.1016/j.jasrep.2017.05.043	68	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194324	10.1371/journal.pone.0194324	http://dx.doi.org/10.1371/journal.pone.0194324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590164	gold, Green Published, Green Submitted			2022-12-27	WOS:000428603100056
J	Bivia-Roig, G; Lison, JF; Sanchez-Zuriaga, D				Bivia-Roig, Gemma; Francisco Lison, Juan; Sanchez-Zuriaga, Daniel			Changes in trunk posture and muscle responses in standing during pregnancy and postpartum	PLOS ONE			English	Article							LOW-BACK-PAIN; PELVIC GIRDLE PAIN; LOCATION; GRAVITY; MOTION; RELIABILITY; PREVALENCE; POSITION; SYSTEM; RANGE	The aim of this study was to analyze the position of the lumbopelvic region and the muscle activation of erector spinae and biceps femoris muscles in a group of pregnant women in the third trimester. The hypothesis was that pregnancy-related biomechanical and morphological changes modify the position of the lumbopelvic region and the activation of extensor muscles. The position of the lumbar spine and pelvis in the sagittal plane, and the EMG activity of the erector spinae and biceps femoris muscles, were recorded during standing in 34 nulliparous and 34 pregnant women in the third trimester, and also two months after birth in the group of pregnant women. No significant differences in the position of the lumbar spine or pelvis between the group of pregnant women and nulliparous or postpartum were observed. A significant increase was observed in the EMG activity of the erector spinae (4.6% vs 2.4% and 2.1% in the nulliparous group and postpartum respectively) and the biceps femoris (3.4% vs 1.2% and 1.4%) in pregnant women compared to the other two groups (p<0.01). We conclude that pregnant women in the third trimester show no alterations in lumbopelvic position compared to nulliparous and postpartum women. However, there is an increase of the EMG activity of the trunk extensors. These results indicate that the extensor muscles of the trunk show, in static positions, adaptive responses to the increase of anterior loads during pregnancy.	[Bivia-Roig, Gemma] Univ CEU Cardenal Herrera, Fac Hlth Sci, Dept Physiotherapy, Valencia, Spain; [Francisco Lison, Juan] Univ CEU Cardenal Herrera, Fac Hlth Sci, Dept Med, Valencia, Spain; [Sanchez-Zuriaga, Daniel] Univ Valencia, Fac Med, Dept Anat & Human Embryol, Valencia, Spain	Universidad CEU Cardenal Herrera; Universidad CEU Cardenal Herrera; University of Valencia	Sanchez-Zuriaga, D (corresponding author), Univ Valencia, Fac Med, Dept Anat & Human Embryol, Valencia, Spain.	daniel.sanchez@uv.es	Lisón, Juan Francisco/E-8387-2016; Biviá-roig, Gemma/AAA-4945-2020	Lisón, Juan Francisco/0000-0002-4983-4052; Biviá-roig, Gemma/0000-0001-7611-5347; Sanchez-Zuriaga, Daniel/0000-0001-7105-5744	Universitat de Valencia [UV-INV AE16-495476]; University CEU Gardenal Herrera	Universitat de Valencia; University CEU Gardenal Herrera	This work was supported by grants from the Universitat de Valencia (UV-INV AE16-495476; "Estudio de la funcion lumbopelvica para el tratamiento del dolor lumbar en el embarazo y la lactancia") and the University CEU Gardenal Herrera (convocatoria de Proyectos en Consolidacion CEU-Banco Santander 2017-2018). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	ADAMS MA, 1990, J BONE JOINT SURG BR, V72, P266, DOI 10.1302/0301-620X.72B2.2138156; Bastiaanssen JM, 2005, EUR J OBSTET GYN R B, V120, P3, DOI 10.1016/j.ejogrb.2004.11.021; Betsch M, 2015, EUR SPINE J, V24, P1282, DOI 10.1007/s00586-014-3521-6; BIERINGSORENSEN F, 1984, SPINE, V9, P106, DOI 10.1097/00007632-198403000-00002; Bullock J E, 1987, Aust J Physiother, V33, P10, DOI 10.1016/S0004-9514(14)60580-8; Carlsoo S., 1961, STATIC MUSCLE LOAD D, V4, P193; Dankaerts W, 2004, J ELECTROMYOGR KINES, V14, P333, DOI 10.1016/j.jelekin.2003.07.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FLOYD WF, 1951, LANCET, V260, P133, DOI 10.1016/S0140-6736(51)91212-3; Franklin ME, 1998, J ORTHOP SPORT PHYS, V28, P133, DOI 10.2519/jospt.1998.28.3.133; Fries EC, 1943, AM J OBSTET GYNECOL, V46, P374, DOI 10.1016/S0002-9378(43)90431-4; Gilleard WL, 2002, ARCH PHYS MED REHAB, V83, P1739, DOI 10.1053/apmr.2002.36069; GLEESON PB, 1988, PHYS THER, V68, P1699, DOI 10.1093/ptj/68.11.1699; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Jensen RK, 1996, J BIOMECH, V29, P251, DOI 10.1016/0021-9290(95)00042-9; Jordan K, 2004, J RHEUMATOL, V31, P2207; Kim MH, 2013, J PHYS THER SCI, V25, P535, DOI 10.1589/jpts.25.535; Kippers V, 1985, Aust J Physiother, V31, P95, DOI 10.1016/S0004-9514(14)60627-9; KLAUSEN K, 1968, ACTA PHYSIOL SCAND, V72, P45, DOI 10.1111/j.1748-1716.1968.tb03824.x; Kovacs FM, 2012, SPINE, V37, P1516, DOI 10.1097/BRS.0b013e31824dcb74; MAYER TG, 1984, SPINE, V9, P588, DOI 10.1097/00007632-198409000-00009; MOORE K, 1990, CLIN BIOMECH, V5, P169, DOI 10.1016/0268-0033(90)90020-7; Neblett R, 2003, SPINE, V28, P1435, DOI 10.1097/00007632-200307010-00015; Okanishi N, 2012, ACTA OBSTET GYN SCAN, V91, P856, DOI 10.1111/j.1600-0412.2012.01400.x; Opala-Berdzik A, 2015, PLOS ONE, V8, P10; Opala-Berdzik A, 2010, J HUM KINET, V26, P5, DOI 10.2478/v10078-010-0042-1; OSTGAARD HC, 1993, SPINE, V18, P61; OTMAN AS, 1989, EUR J OBSTET GYN R B, V31, P155, DOI 10.1016/0028-2243(89)90176-7; PEARCY MJ, 1989, CLIN BIOMECH, V4, P73, DOI 10.1016/0268-0033(89)90042-9; Sanchez-Zuriaga D, 2016, J ELECTROMYOGR KINES, V28, P152, DOI 10.1016/j.jelekin.2016.04.007; Sanchez-Zuriaga D, 2015, J MANIP PHYSIOL THER, V38, P130, DOI 10.1016/j.jmpt.2014.11.002; Sihvonen T, 1998, ARCH PHYS MED REHAB, V79, P1210, DOI 10.1016/S0003-9993(98)90264-7; To WWK, 2003, ACTA OBSTET GYN SCAN, V82, P1086, DOI 10.1046/j.1600-0412.2003.00235.x; WALSH M, 1995, CLIN BIOMECH, V10, P222, DOI 10.1016/0268-0033(95)91402-Z; Wu WH, 2004, EUR SPINE J, V13, P575, DOI 10.1007/s00586-003-0615-y	35	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194853	10.1371/journal.pone.0194853	http://dx.doi.org/10.1371/journal.pone.0194853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584774	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000044
J	Cartmell, KB; Sterba, KR; Pickett, K; Zapka, J; Alberg, AJ; Sood, AJ; Esnaola, NF				Cartmell, Kathleen B.; Sterba, Katherine R.; Pickett, Kim; Zapka, Jane; Alberg, Anthony J.; Sood, Amit J.; Esnaola, Nestor F.			Availability of patient-centered cancer support services: A statewide survey of cancer centers	PLOS ONE			English	Article							PALLIATIVE CARE; UNITED-STATES; NAVIGATION; DISPARITIES; COMMISSION; PROGRAMS; SCIENCE; IMPACT	The Institute of Medicine recommended in their landmark report "From Cancer Patient to Cancer Survivor: Lost in Transition" that services to meet the needs of cancer patients should extend beyond physical health issues to include functional and psychosocial consequences of cancer. However, no systems exist in the US to support state-level data collection on availability of support services for cancer patients. Developing a mechanism to systematically collect these data and document service availability is essential for guiding comprehensive cancer control planning efforts. This study was carried out to develop a protocol for implementing a statewide survey of all Commission on Cancer (CoC) accredited cancer centers in South Carolina and to implement the survey to examine availability of patient support services within the state. We conducted a cross-sectional survey of CoC-certified cancer centers in South Carolina. An administrator at each center completed a survey on availability of five services: 1) patient navigation; 2) distress screening; 3) genetic risk assessment and counseling, 4) survivorship care planning; and 5) palliative care. Completed surveys were received from 16 of 17 eligible centers (94%). Of the 16 centers, 44% reported providing patient navigation; 31% reported conducting distress screening; and 44% reported providing genetic risk assessment and counseling. Over 85% of centers reported having an active palliative care program, palliative care providers and a hospice program, but fewer had palliative outpatient services (27%), palliative inpatient beds (50%) or inpatient consultation teams (31%). This was a small, yet systematic survey in one state. This study demonstrated a practical method for successfully monitoring statewide availability of cancer patient support services, including identifying service gaps.	[Cartmell, Kathleen B.; Pickett, Kim; Zapka, Jane] Med Univ South Carolina, Coll Nursing, Charleston, SC 29425 USA; [Cartmell, Kathleen B.; Sterba, Katherine R.; Zapka, Jane; Sood, Amit J.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Sterba, Katherine R.; Zapka, Jane] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Alberg, Anthony J.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Esnaola, Nestor F.] Fox Chase Canc Ctr, Dept Surg, Philadelphia, PA 19111 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Fox Chase Cancer Center	Cartmell, KB (corresponding author), Med Univ South Carolina, Coll Nursing, Charleston, SC 29425 USA.; Cartmell, KB (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.	cartmelk@musc.edu		Sterba, Katherine/0000-0001-9780-8695; Cartmell, Kathleen/0000-0001-9324-1636	South Carolina Cancer Alliance	South Carolina Cancer Alliance	The project was funded by a grant from the South Carolina Cancer Alliance. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC TREATM SURV FAC; American College of Surgeons, 2015, CANC PROGR STAND 201; American College of Surgeons Commission on Cancer, 2012, CANC PROGR STAND 201; [Anonymous], HLTH INF NAT TRENDS; Birken SA, 2014, J CANCER EDUC, V29, P689, DOI 10.1007/s13187-014-0628-8; Bruera E, 2010, J CLIN ONCOL, V28, P4013, DOI 10.1200/JCO.2010.29.5618; Davis MP, 2015, SUPPORT CARE CANCER, V23, P2677, DOI 10.1007/s00520-015-2630-z; Freeman H P, 1995, Cancer Pract, V3, P19; Freeman HP, 2006, J CANCER EDUC, V21, pS11, DOI 10.1207/s15430154jce2101s_4; Hedlund N, 2014, J PUBLIC HEALTH MAN, V20, pE15, DOI 10.1097/PHH.0b013e3182a505ec; Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting, 2008, CANC CARE WHOLE PATI; Kerr CW, 2014, J PAIN SYMPTOM MANAG, V48, P883, DOI 10.1016/j.jpainsymman.2014.02.003; Kirsch LJ, 2015, J CANCER SURVIV, V9, P80, DOI 10.1007/s11764-014-0391-1; Lazenby M, 2015, J ONCOL PRACT, V11, pE413, DOI 10.1200/JOP.2014.002816; Meade CD, 2014, J CANCER EDUC, V29, P449, DOI 10.1007/s13187-014-0640-z; Merport A, 2012, SUPPORT CARE CANCER, V20, P1579, DOI 10.1007/s00520-012-1458-z; Moser RP, 2013, INTEGRATIVE ANAL MET; Paskett ED, 2011, CA-CANCER J CLIN, V61, P237, DOI 10.3322/caac.20111; Rodday AM, 2015, CANCER-AM CANCER SOC, V121, P4025, DOI 10.1002/cncr.29612; South Carolina Cancer Alliance, S CAR CANC CONTR PLA; Stovall E., 2006, I MED IOM CANC PATIE; Wells KJ, 2008, CANCER-AM CANCER SOC, V113, P1999, DOI 10.1002/cncr.23815	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194649	10.1371/journal.pone.0194649	http://dx.doi.org/10.1371/journal.pone.0194649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584744	Green Published, gold, Green Submitted			2022-12-27	WOS:000428373000030
J	Fuji, Y; Uchida, A; Fukahori, K; Chino, M; Ohtsuki, T; Matsufuji, H				Fuji, Yushiro; Uchida, Ayumi; Fukahori, Katsunori; Chino, Makoto; Ohtsuki, Takashi; Matsufuji, Hiroshi			Chemical characterization and biological activity in young sesame leaves (Sesamum indicum L.) and changes in iridoid and polyphenol content at different growth stages	PLOS ONE			English	Article							PHENYLPROPANOID GLYCOSIDE; PHENYLETHANOID GLYCOSIDES; CISTANCHE-DESERTICOLA; PTEROGYNE-NITENS; IN-VITRO; ACTEOSIDE; GLUCOSIDES; CONSTITUENTS; EXTRACTS; RATS	Three iridoids (lamalbid (I1), sesamoside (I2) and shanzhiside methyl ester (I3)) and seven polyphenols (cistanoside F (P1), chlorogenic acid (P2), pedalitin-6-O-laminaribioside (P3), pedaliin (P4), isoacteoside (P6), pedalitin (P7) and martynoside (P8)) were identified in young sesame leaves (Sesamum indicum L.) other than the acteoside (P5) reported previously. P3 was a new compound, and I1, I3, P2 and P8 were found in a species of Sesamum for the first time. HPLC analyses revealed that the compounds I1 (0.29-1.75% of dry leaves), I2 (0.38-0.87%), I3 (0.04-1.07%), P4 (0.01-2.05%) and P5 (0.13-4.86%) were present primarily in young sesame leaves and were found in plants cultivated on different farms (plant height, 30-70 cm). Of the identified compounds, P5 and P6 showed high 1,1-dipheny1-2-picrylhydrazyl (DPPH) radical scavenging, oxygen radical absorbance capacity (ORAC), and in vitro antiglycation activities. Given its content, P5 makes a major contribution to the biological activities of young sesame leaves. The compounds were examined at six different growth stages of plants cultured in a greenhouse to determine the optimum harvest stage and for end-use assessment. P5 accumulated in the leaves during growth, and the content reached a maximum of 12.9% of dry leaves in the 4th stage (plant height, 74.5 +/- 9.7 cm), which is one of the highest percentages reported in plants from nature.	[Fuji, Yushiro; Chino, Makoto; Ohtsuki, Takashi; Matsufuji, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Uchida, Ayumi; Fukahori, Katsunori] Wadaman Sci Co Ltd, Nakagyo Ku, Nijoden Cho, Kyoto, Japan	Nihon University	Matsufuji, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan.	hmatsufu@brs.nihon-u.ac.jp			Wadaman Science Co., Ltd.; Nihon University President Grant Initiative; Grants-in-Aid for Scientific Research [15K12247] Funding Source: KAKEN	Wadaman Science Co., Ltd.; Nihon University President Grant Initiative; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study received financial support from Wadaman Science Co., Ltd. The funder provided support in the form of salaries for authors AU and KF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, a part of this study was financially supported by the Nihon University President Grant Initiative. The funder provided support in the form of salaries for authors MC, TO and HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AgMRC, 2011, SES PROF; Alagna F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-162; Alipieva K, 2007, BIOCHEM SYST ECOL, V35, P17, DOI 10.1016/j.bse.2006.07.004; Alipieva K, 2014, BIOTECHNOL ADV, V32, P1065, DOI 10.1016/j.biotechadv.2014.07.001; Bolzani VDS, 1995, J NAT PROD, V58, P1683, DOI 10.1021/np50125a006; CALIS I, 1984, PHYTOCHEMISTRY, V23, P2313, DOI 10.1016/S0031-9422(00)80542-7; FAOSTAT, 2014, PROD YIELD QUANT SES; Fernandes DC, 2008, CHEM PHARM BULL, V56, P723, DOI 10.1248/cpb.56.723; Georgiev M, 2010, FOOD CHEM, V121, P967, DOI 10.1016/j.foodchem.2010.01.028; Georgiev MI, 2011, PHYTOCHEMISTRY, V72, P2045, DOI 10.1016/j.phytochem.2011.07.005; Hata N, 2010, PLANT SCI, V178, P510, DOI 10.1016/j.plantsci.2010.02.020; He J, 2011, J ASIAN NAT PROD RES, V13, P449, DOI 10.1080/10286020.2011.568940; Imperato F, 1997, PHYTOCHEMISTRY, V45, P1729, DOI 10.1016/S0031-9422(96)00801-1; JAIN SC, 1981, AGR BIOL CHEM TOKYO, V45, P2127, DOI 10.1080/00021369.1981.10864843; Jankovic T, 2012, BIOCHEM SYST ECOL, V42, P69, DOI 10.1016/j.bse.2012.02.013; KOBAYASHI H, 1985, CHEM PHARM BULL, V33, P1452; KOBAYASHI S, 1986, CHEM PHARM BULL, V34, P876; Konan AB, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-23; Koo KA, 2005, PLANTA MED, V71, P778, DOI 10.1055/s-2005-871213; Korshavn KJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17842; Kubmarawa D, 2008, AFR J BIOTECHNOL, V7, P3502; Kwak Y, 2013, KOREAN J FOOD COOKER, V29, P241; Liu LE, 2012, BIORESOURCES, V7, P3555; Liu YH, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-6; Lukeman AJS, 2009, AFR J BIOTECHNOL, V8, P2878; Matsufuji H, 2011, J JPN SOC FOOD SCI, V58, P88, DOI 10.3136/nskkk.58.88; Morikawa T, 2014, J NAT MED-TOKYO, V68, P561, DOI 10.1007/s11418-014-0837-9; Morita N., 1960, NII ELECT LIBR SERV, V8, P59, DOI 10.1248/cpb.8.59; Olivier DK, 2010, S AFR J BOT, V76, P58, DOI 10.1016/j.sajb.2009.07.002; Phakeovilay C, 2013, J NAT MED-TOKYO, V67, P228, DOI 10.1007/s11418-012-0658-7; POTTERAT O, 1988, PHYTOCHEMISTRY, V27, P2677, DOI 10.1016/0031-9422(88)87042-0; Saimaru H, 2010, J NAT MED-TOKYO, V64, P139, DOI 10.1007/s11418-009-0383-z; SASAKI H, 1978, CHEM PHARM BULL, V26, P2111; Seo ES, 2013, MOL CELLS, V35, P348, DOI 10.1007/s10059-013-0021-1; Shanghai Scientific & Technical Publishers, 1998, DICT CHIN MAT MED JA, p[800, 867]; Shi HM, 2009, BIOL PHARM BULL, V32, P142, DOI 10.1248/bpb.32.142; Shiao YJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040895; SUZUKI N, 1993, PHYTOCHEMISTRY, V34, P729, DOI 10.1016/0031-9422(93)85348-U; Takase R, 2014, NAT PROD COMMUN, V9, P1539; TERAHARA N, 1994, BIOSCI BIOTECH BIOCH, V58, P1324, DOI 10.1271/bbb.58.1324; Tsuji-Naito K, 2009, FOOD CHEM, V116, P854, DOI 10.1016/j.foodchem.2009.03.042; Wang J, 2015, TOXICOL APPL PHARM, V285, P128, DOI 10.1016/j.taap.2015.04.004; Watanabe J, 2012, ANAL SCI, V28, P159, DOI 10.2116/analsci.28.159; Wu YT, 2006, J CHROMATOGR B, V844, P89, DOI 10.1016/j.jchromb.2006.07.011; Xiong QB, 1996, BIOL PHARM BULL, V19, P1580, DOI 10.1248/bpb.19.1580; Yu SY, 2013, PLANTA MED, V79, P1705, DOI 10.1055/s-0033-1351101; Yuan JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162696	47	21	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194449	10.1371/journal.pone.0194449	http://dx.doi.org/10.1371/journal.pone.0194449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584748	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000024
J	Weintrob, N; Eyal, O; Slakman, M; Becker, AS; Israeli, G; Kalter-Leibovici, O; Ben-Shachar, S				Weintrob, Naomi; Eyal, Ori; Slakman, Meital; Becker, Anat Segev; Israeli, Galit; Kalter-Leibovici, Ofra; Ben-Shachar, Shay			The effect of CAG repeats length on differences in hirsutism among healthy Israeli women of different ethnicities	PLOS ONE			English	Article							ANDROGEN-RECEPTOR GENE; POLYCYSTIC-OVARY-SYNDROME; TRINUCLEOTIDE REPEATS; POLYMORPHIC CAG; HAIR-GROWTH; PREGNANCY; TRANSACTIVATION; ASSOCIATION; INFERTILITY; PREVALENCE	Purpose Variations in the degree of hirsutism among women of different ethnic backgrounds may stem from multiple etiologies. Shorter length of the polymorphic CAG repeats of the androgen receptor (AR) gene may be associated with increased activity of the receptor leading to hirsutism. We hypothesized that there are ethnic differences in the degree of hirsutism that is unrelated to androgen levels among Israeli women, and that the CAG repeats length may contribute to these differences. Anti-androgenic therapies, such as spironolactone, could be suggested if a shorter CAG repeats length is found to affect the difference in the degree of hirsutism between the ethnic groups. Methods Healthy Israeli Jewish women aged 18-45 years of Ashkenazi and non-Ashkenazi origin were invited to participate. Hirsutism was assessed using the simplified Ferriman Gallwey (sFG) score, and serum total testosterone levels were measured as well. The CAG repeats length was determined by PCR. Methylation-sensitive methods were used to detect the fractional activity of each allele, and the weighted mean was calculated for the CAG repeats length. Results One-hundred and eight women were recruited (49 Ashkenazi and 59 non-Ashkenazi). The Ashkenazi women had a significantly lower degree of hirsutism (P<0.01), lower mean BMI (P = 0.003), total testosterone levels (P = 0.017), and longer weighted bi-allelic CAG repeats mean (P = 0.015) compared to non-Ashkenazi women. For the group as a whole, there was a significant negative correlation between the number of CAG repeats in the AR gene and the sFG score, while the number of repeats was not related to testosterone levels. Stepwise logistic regression revealed that ethnic origin and the CAG repeats length were the strongest factors affecting hirsutism (P<0.001, P = 0.03, respectively). Conclusions There is a significant difference in the degree of hirsutism between Ashkenazi and non-Ashkenazi women in Israel that is partially explained by CAG repeats length.	[Weintrob, Naomi; Eyal, Ori; Becker, Anat Segev; Israeli, Galit] Dana Dwek Childrens Hosp, Pediat Endocrinol & Diabet Unit, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Weintrob, Naomi; Eyal, Ori; Slakman, Meital; Kalter-Leibovici, Ofra; Ben-Shachar, Shay] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Kalter-Leibovici, Ofra] Gertner Inst Epidemiol & Hlth Policy Res, Tel Hashomer, Israel; [Ben-Shachar, Shay] Tel Aviv Sourasky Med Ctr, Genet Inst, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Eyal, O (corresponding author), Dana Dwek Childrens Hosp, Pediat Endocrinol & Diabet Unit, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel.; Eyal, O (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	oriey@tlvmc.gov.il			Hamer Israel for Medicine Fund, Sackler Faculty of Medicine, Tel Aviv University	Hamer Israel for Medicine Fund, Sackler Faculty of Medicine, Tel Aviv University	This study was supported by the Hamer Israel for Medicine Fund, Sackler Faculty of Medicine, Tel Aviv University.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; Ben-Shachar S, 2015, HORM METAB RES, V47, P491, DOI 10.1055/s-0034-1389901; Buchanan G, 2004, HUM MOL GENET, V13, P1677, DOI 10.1093/hmg/ddh181; CARMINA E, 1992, AM J OBSTET GYNECOL, V167, P1807, DOI 10.1016/0002-9378(92)91779-A; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Cook H, 2011, FERTIL STERIL, V96, P1266, DOI 10.1016/j.fertnstert.2011.08.022; DeUgarte CM, 2006, J CLIN ENDOCR METAB, V91, P1345, DOI 10.1210/jc.2004-2301; Dixon WJ., 1993, BMDP STAT SOFTWARE; Escobar-Morreale HF, 2017, HUM REPROD UPDATE, V23, P390, DOI 10.1093/humupd/dmx012; Eyal O, 2017, CLIN ENDOCRINOL, V87, P552, DOI 10.1111/cen.13429; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; HAMILTON JB, 1964, CLIN OBSTET GYNECOL, V7, P1075, DOI 10.1097/00003081-196412000-00015; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Hsing AW, 2000, CANCER RES, V60, P5111; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Joham AE, 2014, HUM REPROD, V29, P802, DOI 10.1093/humrep/deu020; Karrer-Voegeli S, 2009, MEDICINE, V88, P32, DOI 10.1097/md.0b013e3181946a2c; Lashen H, 2004, HUM REPROD, V19, P1644, DOI 10.1093/humrep/deh277; LOOKINGBILL DP, 1991, J CLIN ENDOCR METAB, V72, P1242, DOI 10.1210/jcem-72-6-1242; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Palomba S, 2015, HUM REPROD UPDATE, V21, P575, DOI 10.1093/humupd/dmv029; Pasquali R, 2011, EUR J ENDOCRINOL, V164, P53, DOI 10.1530/EJE-10-0692; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Souter I, 2004, AM J OBSTET GYNECOL, V191, P1914, DOI 10.1016/j.ajog.2004.06.064; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Vottero A, 1999, J CLIN ENDOCR METAB, V84, P1091, DOI 10.1210/jc.84.3.1091; Wang R, 2012, MOL HUM REPROD, V18, P498, DOI 10.1093/molehr/gas024; Yildiz BO, 2010, HUM REPROD UPDATE, V16, P51, DOI 10.1093/humupd/dmp024	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195046	10.1371/journal.pone.0195046	http://dx.doi.org/10.1371/journal.pone.0195046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584789	Green Submitted, gold, Green Published			2022-12-27	WOS:000428373000058
J	Kurz, S; Thieme, R; Amberg, R; Groth, M; Jahnke, HG; Pieroh, P; Horn, LC; Kolb, M; Huse, K; Platzer, M; Volke, D; Dehghani, F; Buzdin, A; Engel, K; Robitzki, A; Hoffmann, R; Gockel, I; Birkenmeier, G				Kurz, Susanne; Thieme, Rene; Amberg, Ronny; Groth, Marco; Jahnke, Heinz-Georg; Pieroh, Philipp; Horn, Lars -Christian; Kolb, Marlen; Huse, Klaus; Platzer, Matthias; Volke, Daniela; Dehghani, Faramarz; Buzdin, Anton; Engel, Kathrin; Robitzki, Andrea; Hoffmann, Ralf; Gockel, Ines; Birkenmeier, Gerd			The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat (vol 12, e0189514, 2017)	PLOS ONE			English	Correction													Engel, Kathrin M/AAQ-1309-2021; Hoffmann, Ralf/ABD-8779-2020; Buzdin, Anton/R-2611-2016	Engel, Kathrin M/0000-0003-0611-7042; Pieroh, Philipp/0000-0003-0906-5479				Kurz S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189514	1	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0195169	10.1371/journal.pone.0195169	http://dx.doi.org/10.1371/journal.pone.0195169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579117	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800083
J	Bertone, MP; Falisse, JB; Russo, G; Witter, S				Bertone, Maria Paola; Falisse, Jean-Benoit; Russo, Giuliano; Witter, Sophie			Context matters (but how and why?) A hypothesis-led literature review of performance based financing in fragile and conflict-affected health systems	PLOS ONE			English	Review							INCOME COUNTRIES; GLOBAL HEALTH; CARE SERVICES; IMPLEMENTATION; BURUNDI; PAYMENT; RWANDA; GOVERNANCE; DISCOURSE; TANZANIA	Performance-based financing (PBF) schemes have been expanding rapidly across low and middle income countries in the past decade, with considerable external financing from multilateral, bilateral and global health initiatives. Many of these countries have been fragile and conflict-affected (FCAS), but while the influence of context is acknowledged to be important to the operation of PBF, there has been little examination of how it affects adoption and implementation of PBF. This article lays out initial hypotheses about how FCAS contexts may influence the adoption, adaption, implementation and health system effects of PBF. These are then interrogated through a review of available grey and published literature (140 documents in total, covering 23 PBF schemes). We find that PBF has been more common in FCAS contexts, which were also more commonly early adopters. Very little explanation of the rationale for its adoption, in particular in relation with the contextual features, is given in programme documents. However, there are a number of factors which could explain this, including the greater role of external actors and donors, a greater openness to institutional reform, and lower levels of trust within the public system and between government and donors, all of which favour more contractual approaches. These suggest that rather than emerging despite fragility, conditions of fragility may favour the rapid emergence of PBF. We also document few emerging adaptations of PBF to humanitarian settings and limited evidence of health system effects which may be contextually driven, but these require more in-depth analysis. Another area meriting more study is the political economy of PBF and its diffusion across contexts.	[Bertone, Maria Paola; Witter, Sophie] Queen Margaret Univ, ReBUILD, Edinburgh, Midlothian, Scotland; [Bertone, Maria Paola; Witter, Sophie] Queen Margaret Univ, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland; [Falisse, Jean-Benoit] Univ Edinburgh, Ctr African Studies, Edinburgh, Midlothian, Scotland; [Russo, Giuliano] Queen Mary Univ, Ctr Primary Care & Publ Hlth, London, England	Queen Margaret University; Queen Margaret University; University of Edinburgh; University of London; Queen Mary University London	Witter, S (corresponding author), Queen Margaret Univ, ReBUILD, Edinburgh, Midlothian, Scotland.; Witter, S (corresponding author), Queen Margaret Univ, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland.	SWitter@qmu.ac.uk	Falisse, Jean-Benoit/J-9815-2015; Russo, Giuliano/AAQ-2122-2020; Russo, Giuliano/G-3183-2013	Falisse, Jean-Benoit/0000-0002-0291-731X; Russo, Giuliano/0000-0002-2716-369X; Bertone, Maria Paola/0000-0001-8890-583X; Witter, Sophie/0000-0002-7656-6188	ReBUILD grant from UK AID; DFID through ReBUILD; Department for International Development (DFID) [201401] Funding Source: researchfish	ReBUILD grant from UK AID; DFID through ReBUILD; Department for International Development (DFID)	The time of two of the study authors (SW and MB) was funded through the ReBUILD grant from UK AID, https://www.gov.uk/government/organisations/department-for-international-development.; The authors would like to thank the members of the PBF CoP and all those who shared with us relevant documents concerning the PBF schemes described in this article. We also acknowledge the financial support of DFID through the ReBUILD grant but note that the views expressed do not necessarily reflect the UK government's official policies.	Antony M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2148-9; Banga-Mingo JP, 2014, EVALUATION FINANCEME; Barnes A, 2014, 102 EQUINET; Basenya O, 2011, PBF COP WORKING PAPE; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bertone MP, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1546-8; Bertone Maria Paola, 2014, Confl Health, V8, P11, DOI 10.1186/1752-1505-8-11; Bhatnagar A, 2016, HEALTH POLICY PLANN, V31, P868, DOI 10.1093/heapol/czw002; Binyaruka P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135013; Blacklock C, 2016, STUD FARM PLANN; Bold T., 2009, PROVISION SOCIAL SER; Bonfrer I, 2014, SOC SCI MED, V123, P96, DOI 10.1016/j.socscimed.2014.11.004; Bredenkamp C, 2011, UNPUB; Brown T, 2008, SOC SCI MED, V67, P1571, DOI 10.1016/j.socscimed.2008.07.027; Camara, 2017, RAPPORT CAPITALISATI; Chimhutu V, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0213-5; Chimhutu V, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0125-9; Diongue B, 2008, RAPPORT FINAL MISSIO; Eichler R, 2000, PERFORMANCE BASED RE; Eldridge C, 2009, HEALTH POLICY PLANN, V24, P160, DOI 10.1093/heapol/czp002; Falisse JB, 2015, HEALTH POLICY PLANN, V30, P1251, DOI 10.1093/heapol/czu132; Falisse JB, 2012, TROP MED INT HEALTH, V17, P674, DOI 10.1111/j.1365-3156.2012.02973.x; Fitzgerald L, 2002, HUM RELAT, V55, P1429, DOI 10.1177/001872602128782213; Fritsche G., 2014, PERFORMANCE BASED FI; Fukuda-Parr S, 2011, GLOBAL GOV, V17, P17, DOI 10.1163/19426720-01701002; Gautier L., 2016, FINANCEMENT BASE RES; Gautier Lara, 2017, Glob Health Res Policy, V2, P23, DOI 10.1186/s41256-017-0043-x; Government of Burundi, 2005, ET GEN SANT BUR; Harmer A, 2011, GLOB PUBLIC HEALTH, V6, P703, DOI 10.1080/17441692.2010.515236; Huillery E, 2015, FINANCIAL INCENTIVES; Hyeladzira G, 2016, COMMUNICATION; Jensen C, 2017, LEARNING ACTION HLTH; Jones CM, 2017, SOC SCI MED, V177, P69, DOI 10.1016/j.socscimed.2017.01.048; Josephson E, 2017, HEAL POLICY PLAN; Kamuzinzi M, 2016, INT J AFR RENAISS ST, V11, P123, DOI 10.1080/18186874.2016.1212477; Keugoung B, 2011, PBF COP WORKING PAPE, V2; Kielmann, 2016, QUALITATIVE RES ENHA; Kiendrebeogo J. A., 2015, African Health Monitor, P37; Kiendrebeogo JA, 2017, HEALTH SYST REFORM, V3, P80, DOI 10.1080/23288604.2017.1280115; Kothari U, 2005, ANTIPODE, V37, P425, DOI 10.1111/j.0066-4812.2005.00505.x; Lafort Y, 2012, EVALUATION CAPITALIS; Lee K, 2002, HLTH POLICY GLOBALIZ; Looij F. van de, 2015, African Health Monitor, P32; LSTM, 2016, IND EV HLTH TRANS FU; Manirambona J, 2014, TRANSPARENCE REDEVAB; Martinez J, 2012, EVALUATION HLTH RESU; MEESSEN B, 2004, INITIATIVE PERFORMAN; Meessen B, 2007, B WORLD HEALTH ORGAN, V85, P108, DOI 10.2471/BLT.06.032110; Meessen B, 2011, TROP MED INT HEALTH, V16, P1007, DOI 10.1111/j.1365-3156.2011.02794.x; Meessen B, 2011, B WORLD HEALTH ORGAN, V89, P153, DOI 10.2471/BLT.10.077339; MSHP, 2014, STRAT NAT FIN BAS PE; MSHP, 2010, PROJ PIL MOT BAS PER; MSSPSPG, 2016, OR STRAT NAT FBP COM; Murru M, 2012, PROVIDING HLTH CARE; Musgrove P, 2011, FINANCIAL OTHER REWA; Nay O, 2014, THIRD WORLD Q, V35, P210, DOI 10.1080/01436597.2014.878128; OECD, 2016, STAT FRAG 2015; Ogundeji YK, 2016, HEALTH POLICY PLANN, V31, P955, DOI 10.1093/heapol/czw016; Olafsdottir AE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-392; PASS/MSHPP, 2017, MAN EX FIN BAS PERF; Paul E, 2017, INT J HLTH POLICY MA, V6, P1; Paul E, 2017, INT J HLTH PLANN MAN, VA; Pavignani E, 2009, ANAL DISRUPTED HLTH; Pavignani E, 2013, INT REV RED CROSS, V95, P41, DOI 10.1017/S1816383113000726; Peerenboom PB, 2014, SANTE PUBLIQUE, V26, P229, DOI 10.3917/spub.138.0229; Purdekova A, 2011, J MOD AFR STUD, V49, P475, DOI 10.1017/S0022278X11000292; Remme M, 2012, PBF COP WORKING PAPE, VWP8; Renmans D, 2017, HLTH POLICY PLAN, P1; Renmans D, 2016, HEALTH POLICY PLANN, V31, P1297, DOI 10.1093/heapol/czw045; Republic of Congo, 2015, MAN EX STRETG FIN BA; RUSA L, 2009, PERFORMANCE INCENTIV; Rusa L, 2013, EMERGING GOOD PRACTI; Scher Daniel, 2010, INNOVATIONS SUCCESSF; Schramm N, 2015, REFLECTIONS SIERRA L; Sekabaraga C, 2011, HEALTH POLICY PLANN, V26, pII52, DOI 10.1093/heapol/czr070; Shroff ZC, 2017, HEALTH SYST REFORM, V3, P137, DOI 10.1080/23288604.2017.1304190; Sieleunou I, 2016, CHALLENGES INTEGRATI; Soeters R, 2003, HEALTH POLICY PLANN, V18, P10, DOI DOI 10.1093/HEAP0L/18.1.74; Sondorp E, 2012, EVOLUTION HLTH SERVI; Soucat A, 2017, HEALTH SYST REFORM, V3, P74, DOI 10.1080/23288604.2017.1302902; Ssengooba F, 2012, SOC SCI MED, V75, P377, DOI 10.1016/j.socscimed.2012.02.050; Taylor S., 2014, STAB INT J SECUR DEV, V3; Toonen J., 2017, RAPPORT MISSION APPU; Toonen J, 2012, RESULTS BASED FINANC; Toonen J., 2009, PERFORMANCE BASED FI; Tsafack JP, 2015, PERFORMANCE BASED FI; Witter S., 2012, PAYING PERFORMANCE I; WITTER S, 2013, BMC HLTH SERV RES, V13; Witter S, 2012, SOC SCI MED, V75, P2370, DOI 10.1016/j.socscimed.2012.09.012; Woodward A, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0124-1; World Bank, 2013, RAPP EV EXP PIL FIN; World Bank, 2016, HARM LIST FRAG SIT; World Bank, 2014, PROJ APPR DOC REP CO; World Bank, 2016, LEARN AG RES BAS FIN; World Bank, 2016, ZIMB RES BAS FIN PIL; Zeng W, 2013, HEALTH POLICY PLANN, V28, P596, DOI 10.1093/heapol/czs099; Zombre D, 2017, INTRO PUIS RETRAIT F	97	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195301	10.1371/journal.pone.0195301	http://dx.doi.org/10.1371/journal.pone.0195301			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614115	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600043
J	Quaglio, G; Pizzol, D; Bortolani, A; Manenti, F; Isaakidis, P; Putoto, G; Olliaro, PL				Quaglio, GianLuca; Pizzol, Damiano; Bortolani, Anna; Manenti, Fabio; Isaakidis, Petros; Putoto, Giovanni; Olliaro, Piero L.			Breast tuberculosis in men: A systematic review	PLOS ONE			English	Review							NEEDLE-ASPIRATION-CYTOLOGY; MAMMARY TUBERCULOSIS; MALE-PATIENT; EXTRAPULMONARY TUBERCULOSIS; GRANULOMATOUS MASTITIS; EMPYEMA-NECESSITATIS; MANAGEMENT; DIAGNOSIS; BIOPSY; CANCER	Setting Breast tuberculosis in male is a rarely reported and poorly described condition. Objective To quantify the number of breast tuberculosis in men, to describe clinical presentation and to present the diagnostic and therapeutic procedures applied. Design A systematic review of the literature including reports published in English, Spanish and French until December 2017. Results The search yielded 26 cases of male breast tuberculosis, median age 56.5 years. Most presented with an isolated breast lump (89%), associated with axillary lymphadenitis (27.8%) and skin inflammation (33.3%). The most common constitutional symptoms were pain (64.7%) and fever (35.3%). Fine-needle aspiration cytology and culture were the most common diagnostic modality (61.5%). Standard anti-tuberculosis regimen was the main treatment, alone or accompanied or preceded by incision and drainage. Conclusions The risk of breast tuberculosis in men appears to be low, but the condition can be difficult to diagnose and the diagnostic delays can be long. Overall prognosis is good following standard anti-tuberculosis regimen with or without incision/drainage.	[Quaglio, GianLuca] European Parliament, European Parliamentary Res Serv, Brussels, Belgium; [Quaglio, GianLuca] Verona Univ Hosp, Dept Internal Med, Verona, Italy; [Pizzol, Damiano] Doctors Africa CUAMM, Operat Res Unit, Beira, Mozambique; [Bortolani, Anna; Manenti, Fabio; Putoto, Giovanni] Doctors Africa CUAMM, Operat Res Unit, Padua, Italy; [Isaakidis, Petros] Med Sans Frontieres, SAMU, Cape Town, South Africa; [Olliaro, Piero L.] WHO, TDR, Special Programme Res & Training Trop Dis, Geneva, Switzerland; [Olliaro, Piero L.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; World Health Organization; University of Oxford	Pizzol, D (corresponding author), Doctors Africa CUAMM, Operat Res Unit, Beira, Mozambique.	d.pizzol@cuamm.org	Putoto, Giovanni/ABG-2069-2020	Pizzol, Damiano/0000-0003-4122-0774; Isaakidis, Petros/0000-0002-7881-1554	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Afridi SP, 2009, JCPSP-J COLL PHYSICI, V19, P158, DOI 03.2009/JCPSP.158161; Al Manasra ARA, 2016, CASE REP ONCOL, V9, P516, DOI 10.1159/000448990; Baharoon S, 2008, ANN THORAC MED, V3, P110, DOI 10.4103/1817-1737.41918; Bani-Hani KE, 2005, INT J TUBERC LUNG D, V9, P920; Brown S, 2016, GLAND SURG, V5, P361, DOI 10.21037/gs.2016.01.02; Cantisani C, 2013, CLIN TER, V164, pE293, DOI 10.7417/CT.2013.1591; Chandanwale S S, 2012, Indian J Tuberc, V59, P162; Cooper A, 1829, ILLUSTRATION DIS B 1; Crausman RI, 1945, AM J SURG, V67, P48; da Silva BB, 2009, T ROY SOC TROP MED H, V103, P559, DOI 10.1016/j.trstmh.2009.02.005; Da Silva BB, 2005, AM J TROP MED HYG, V73, P975, DOI 10.4269/ajtmh.2005.73.975; Darre T, 2017, Bull Soc Pathol Exot, V110, P238, DOI 10.1007/s13149-017-0576-8; Dickinson AM, 1927, AM J SURG, V3, P595; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; El Hammoumi M, 2015, REV PNEUMOL CLIN, V71, P249, DOI 10.1016/j.pneumo.2014.03.003; Muro DJG, 2013, REV PERU GINECOL OBS, V59, P107; Goud BKM, 2012, INDIAN J PHARMACOL, V44, P521, DOI 10.4103/0253-7613.99340; Gupta D, 1999, ACTA CYTOL, V43, P191, DOI 10.1159/000330975; Harris SH, 2006, ANZ J SURG, V76, P234, DOI 10.1111/j.1445-2197.2006.03692.x; HARTSTEIN M, 1992, CLIN INFECT DIS, V15, P692, DOI 10.1093/clind/15.4.692; Jaideep C, 1997, POSTGRAD MED J, V73, P428, DOI 10.1136/pgmj.73.861.428; Janes SE, 2006, BREAST, V15, P273, DOI 10.1016/j.breast.2005.05.003; Kakkar S, 2000, ACTA CYTOL, V44, P292, DOI 10.1159/000328467; Khanna R, 2002, POSTGRAD MED J, V78, P422, DOI 10.1136/pmj.78.921.422; Khaparde SH, 2015, VIMS HLTH SCI J, V2, P23; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; Korkut E, 2015, EURASIAN J MED, V47, P165, DOI 10.5152/eurasianjmed.2015.118; Kulchavenya E, 2014, THER ADV INFECT DIS, V2, P61, DOI 10.1177/2049936114528173; Lall M, 2013, ANN TROP MED PUBLIC, V6, P131, DOI 10.4103/1755-6783.115192; LILLENG R, 1995, ACTA CYTOL, V39, P877; Lin TL, 2010, INT J TUBERC LUNG D, V14, P758; Luna A, 2000, BREAST, V9, P58, DOI 10.1054/brst.1999.0900; Mahajan R. K., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P686; Marie I, 2007, QJM-INT J MED, V100, P59, DOI 10.1093/qjmed/hcl128; Mathad JS, 2012, CLIN INFECT DIS, V55, P1532, DOI 10.1093/cid/cis732; Meerkotter D, 2011, J MED IMAG RADIAT ON, V55, P453, DOI 10.1111/j.1754-9485.2011.02306.x; Mehta G, 2010, INDIAN J SURG, V72, P433, DOI 10.1007/s12262-010-0166-5; MORGEN M, 1931, SURG GYNECOL OBSTET, V53, P593; Moujahid Mountassir, 2011, Sante, V21, P57, DOI 10.1684/san.2011.0236; Orerah GI, 2016, CLIN ONCOLOGY, V1, P1068; Palmieri A, 2016, IN VIVO, V30, P727, DOI 10.21873/invivo.10987; Pinto Paz ME, 2014, REV SENOL PATOL MAMA, V27, P27; Powers C A, 1894, Ann Surg, V20, P159, DOI 10.1097/00000658-189407000-00025; Prakash V, 2015, J ASS CHEST PHYS, V3, P57; Puneet MS, 2004, INTERNET J TROP MED, V2; Rajagopala S, 2008, AM J MED, V121, P539, DOI 10.1016/j.amjmed.2008.01.026; Ramaema Dibuseng P, 2015, S Afr Med J, V105, P866, DOI 10.7196/SAMJnew.7704; Raza MA, 2016, IJSS J SURG, V2, P1; Reyes CV, 2007, INT J DERMATOL, V46, P1294, DOI 10.1111/j.1365-4632.2007.03168.x; Reyes CV, 1999, ACTA CYTOL, V43, P873, DOI 10.1159/000331307; Richet M., 1880, GAZETTE HOPITAUX PAR; Rosa M, 2012, DIAGN CYTOPATHOL, V40, P179, DOI 10.1002/dc.21601; Sharma PK, 2012, INDIAN J PHARMACOL, V44, P654, DOI 10.4103/0253-7613.100408; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Shi-ping Luh, 2007, Journal of Zhejiang University-Science B, V8, P580, DOI 10.1631/jzus.2007.B0580; SHINDE SR, 1995, WORLD J SURG, V19, P379, DOI 10.1007/BF00299163; Ssen R, 2013, REV TROPICALE CHIRUR, V7, P10; Tewari M, 2005, INDIAN J MED RES, V122, P103; Thompson KS, 1997, DIAGN CYTOPATHOL, V17, P45, DOI 10.1002/(SICI)1097-0339(199707)17:1<45::AID-DC9>3.0.CO;2-O; Ursavas A, 2007, DIAGN MICR INFEC DIS, V58, P477, DOI 10.1016/j.diagmicrobio.2007.03.010; Verfaillie Guy, 2004, Breast J, V10, P60, DOI 10.1111/j.1524-4741.2004.09621.x; Webster CS, 1939, AM J SURG, V45, P557; WILSON JP, 1990, CHEST, V98, P1505, DOI 10.1378/chest.98.6.1505; Winzer KJ, 2005, INT J INFECT DIS, V9, P176, DOI 10.1016/j.ijid.2004.07.007	64	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194766	10.1371/journal.pone.0194766	http://dx.doi.org/10.1371/journal.pone.0194766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614082	Green Submitted, gold, Green Published			2022-12-27	WOS:000429081600018
J	van Schijndel, TJP; Huijpen, K; Visser, I; Raijmakers, MEJ				van Schijndel, Tessa J. P.; Huijpen, Kim; Visser, Ingmar; Raijmakers, Maartje E. J.			Investigating the development of causal inference by studying variability in 2-to 5-year-olds' behavior	PLOS ONE			English	Article							BALANCE SCALE TASK; LATENT CLASS ANALYSIS; YOUNG-CHILDREN; EARLY-CHILDHOOD; BAYES NETS; KNOWLEDGE; BLICKETS; INFANTS; MODELS; CATEGORIZATION	This study investigated the development of young children's causal inference by studying variability in behavior. Two possible sources of variability, strategy use and accuracy in strategy execution, were discriminated and related to age. To this end, a relatively wide range of causal inference trials was administered to children of a relatively broad age range: 2- to 5-year-olds. Subsequently, individuals' response patterns over trials were analyzed with a latent variable technique. The results showed that variability in children's behavior could largely be explained by strategy use. Three different strategies were distinguished, and tentative interpretations suggest these could possibly be labeled as "rational", "associative", and "uncertainty avoidance" strategies. The strategies were found to be related to age, and this age-related strategy use better explained the variability in children's behavior than age-related increase in accuracy of executing a single strategy. This study can be considered a first step in introducing a new, fruitful approach for investigating the development of causal inference.	[van Schijndel, Tessa J. P.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands; [van Schijndel, Tessa J. P.] Leiden Univ, Leiden Univ Grad Sch Teaching ICLON, Leiden, Netherlands; [van Schijndel, Tessa J. P.; Visser, Ingmar; Raijmakers, Maartje E. J.] Univ Amsterdam, Res Prior Area Yield, Amsterdam, Netherlands; [Huijpen, Kim; Visser, Ingmar; Raijmakers, Maartje E. J.] Univ Amsterdam, Dev Psychol, Amsterdam, Netherlands; [Visser, Ingmar; Raijmakers, Maartje E. J.] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Raijmakers, Maartje E. J.] Leiden Univ, Educ Sci, Leiden, Netherlands	University of Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Amsterdam; University of Amsterdam; University of Amsterdam; Leiden University; Leiden University - Excl LUMC	van Schijndel, TJP (corresponding author), Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands.; van Schijndel, TJP (corresponding author), Leiden Univ, Leiden Univ Grad Sch Teaching ICLON, Leiden, Netherlands.; van Schijndel, TJP (corresponding author), Univ Amsterdam, Res Prior Area Yield, Amsterdam, Netherlands.	t.j.p.vanschijnciel@uva.nl		Raijmakers, Maartje/0000-0003-1843-6462; Visser, Ingmar/0000-0003-3855-2778	Aspasia grant from The Netherlands Organisation for Scientific Research [015.003.015]; Curious Minds program - Dutch Ministry of Education, Culture and Science; Platform Beta Techniek	Aspasia grant from The Netherlands Organisation for Scientific Research; Curious Minds program - Dutch Ministry of Education, Culture and Science; Platform Beta Techniek	The research was funded by an Aspasia grant (015.003.015) from The Netherlands Organisation for Scientific Research, http://www.nwo.ni/ (MR) and a grant from the Curious Minds program, http://talentenkracht.ni/, which is supported by the Dutch Ministry of Education, Culture and Science and the Platform Beta Techniek (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J EXPT CHILD PSYCHOL, V120, P17; Beckers T, 2009, EXP PSYCHOL, V56, P27, DOI 10.1027/1618-3169.56.1.27; Bonawitz EB, 2010, COGNITION, V115, P104, DOI 10.1016/j.cognition.2009.12.001; Boom J, 2001, COGNITIVE DEV, V16, P717, DOI 10.1016/S0885-2014(01)00056-9; Bouwmeester S, 2004, EUR J DEV PSYCHOL, V1, P67, DOI 10.1080/17405620344000031; Bouwmeester S, 2012, COGNITIVE DEV, V27, P168, DOI 10.1016/j.cogdev.2012.03.001; De Houwer J, 2002, Q J EXP PSYCHOL-B, V55, P289, DOI 10.1080/02724990244000034; Dickinson A, 2001, CURR DIR PSYCHOL SCI, V10, P127, DOI 10.1111/1467-8721.00132; Glymour C., 2001, MINDS ARROWS BAYES N, DOI 10.7551/mitpress/4638.001.0001; Gopnik A, 2000, CHILD DEV, V71, P1205, DOI 10.1111/1467-8624.00224; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; Gopnik A, 2012, PSYCHOL BULL, V138, P1085, DOI 10.1037/a0028044; Griffiths TL, 2011, COGNITIVE SCI, V35, P1407, DOI 10.1111/j.1551-6709.2011.01203.x; Jansen BRJ, 2002, J EXP CHILD PSYCHOL, V81, P383, DOI 10.1006/jecp.2002.2664; Jansen BRJ, 2001, DEV REV, V21, P450, DOI 10.1006/drev.2001.0530; Jansen BRJ, 1997, DEV REV, V17, P321, DOI 10.1006/drev.1997.0437; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Koppenol-Gonzalez GV, 2012, J EXP CHILD PSYCHOL, V111, P439, DOI 10.1016/j.jecp.2011.10.001; Kushnir T, 2005, PSYCHOL SCI, V16, P678, DOI 10.1111/j.1467-9280.2005.01595.x; Langeheine R, 1996, SOCIOL METHOD RES, V24, P492, DOI 10.1177/0049124196024004004; LEMAIRE P, 1995, J EXP PSYCHOL GEN, V124, P83, DOI 10.1037/0096-3445.124.1.83; McCutcheon AL, 1987, LATENT CLASS ANAL; Nazzi T, 2003, COGNITIVE DEV, V18, P299, DOI 10.1016/S0885-2014(03)00025-X; Nazzi T, 2000, DEVELOPMENTAL SCI, V3, P389, DOI 10.1111/1467-7687.00133; R Development Core Team, 2009, R LANG ENV STAT COMP; Raijmakers MEJ, 2004, DEV REV, V24, P289, DOI 10.1016/j.dr.2004.06.002; Reichenbach Hans., 1956, DIRECTION TIME; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rickard TC, 2004, J EXP PSYCHOL LEARN, V30, P65, DOI 10.1037/0278-7393.30.1.65; RINDSKOPF D, 1987, DEV REV, V7, P66, DOI 10.1016/0273-2297(87)90005-0; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schmittmann VD, 2012, J EXP CHILD PSYCHOL, V111, P644, DOI 10.1016/j.jecp.2011.10.010; Schulz L, 2012, TRENDS COGN SCI, V16, P382, DOI 10.1016/j.tics.2012.06.004; Schulz LE, 2006, CHILD DEV, V77, P427, DOI 10.1111/j.1467-8624.2006.00880.x; Schulz LE, 2004, DEV PSYCHOL, V40, P162, DOI 10.1037/0012-1649.40.2.162; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Siegler R. S., 1996, EMERGING MINDS PROCE; SIEGLER RS, 1981, MONOGR SOC RES CHILD, V46, P1, DOI 10.2307/1165995; SIEGLER RS, 1976, COGNITIVE PSYCHOL, V8, P481, DOI 10.1016/0010-0285(76)90016-5; Sobel DM, 2007, DEVELOPMENTAL SCI, V10, P298, DOI 10.1111/j.1467-7687.2007.00589.x; Sobel DM, 2006, DEV PSYCHOL, V42, P1103, DOI 10.1037/0012-1649.42.6.1103; Sobel DM, 2009, DEV PSYCHOL, V45, P511, DOI 10.1037/a0014944; Sobel DM, 2004, COGNITIVE SCI, V28, P303, DOI 10.1016/j.cogsci.2003.11.001; Steyvers M, 2003, COGNITIVE SCI, V27, P453, DOI 10.1016/S0364-0213(03)00010-7; Straatemeier M, 2008, J EXP CHILD PSYCHOL, V100, P276, DOI 10.1016/j.jecp.2008.03.004; van der Maas HLJ, 2008, DEVELOPMENTAL SCI, V11, P449, DOI 10.1111/j.1467-7687.2008.00690.x; Van Es SE, P 31 ANN C COGN SCI; Visser I, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i07; Wickens T. D., 1982, MODELS BEHAV STOCHAS	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195019	10.1371/journal.pone.0195019	http://dx.doi.org/10.1371/journal.pone.0195019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608583	Green Submitted, Green Published, gold			2022-12-27	WOS:000428988800022
J	Huang, Y; Wang, DF; Zhang, JY; Guo, F				Huang, Yu; Wang, Dongfeng; Zhang, Jinying; Guo, Feng			Controlling and synchronizing a fractional-order chaotic system using stability theory of a time-varying fractional-order system	PLOS ONE			English	Article							PROJECTIVE SYNCHRONIZATION; ADAPTIVE SYNCHRONIZATION	Control and synchronization of fractional-order chaotic systems have attracted wide attention due to their numerous potential applications. To get suitable control method and parameters for fractional-order chaotic systems, the stability analysis of time-varying fractional-order systems should be discussed in the first place. Therefore, this paper analyzes the stability of the time-varying fractional-order systems and presents a stability theorem for the system with the order 0 <alpha < 1. This theorem is a sufficient condition which can discriminate the stability of time-varying systems conveniently. Feedback controllers are designed for control and synchronization of the fractional-order Lu chaotic system. The simulation results demonstrate the effectiveness of the proposed theorem.	[Huang, Yu; Wang, Dongfeng] North China Elect Power Univ, Dept Automat, Baoding, Peoples R China; [Zhang, Jinying] Shenhua Guohua Elect Power Res Inst Corp, Beijing, Peoples R China; [Guo, Feng] Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China	North China Electric Power University; Xiamen University	Guo, F (corresponding author), Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China.	betop@xmu.edu.cn			National Key R&D Program of China [2016YFB0600701]; Fundamental Fund for the Central Universities of China [2015MS66]	National Key R&D Program of China; Fundamental Fund for the Central Universities of China	This work was supported by the National Key R&D Program of China (2016YFB0600701) and the Fundamental Fund for the Central Universities of China under Grant 2015MS66. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila-Camacho N, 2014, COMMUN NONLINEAR SCI, V19, P2951, DOI 10.1016/j.cnsns.2014.01.022; Bao HB, 2015, NONLINEAR DYNAM, V82, P1343, DOI 10.1007/s11071-015-2242-7; Boulkroune A, 2016, NEUROCOMPUTING, V173, P606, DOI 10.1016/j.neucom.2015.08.003; Global S., 2014, NONLINEAR DYNAM, V77, P1251; Golmankhaneh AK, 2015, J VIB CONTROL, V21, P1154, DOI 10.1177/1077546313494953; Jajarmi A, 2017, CHAOS SOLITON FRACT, V99, P285, DOI 10.1016/j.chaos.2017.04.025; Li CL, 2016, INT J SYST SCI, V47, P2440, DOI 10.1080/00207721.2014.998741; Li LX, 2013, PROBLEM ANAL STABILI; Li RH, 2014, NONLINEAR DYNAM, V76, P785, DOI 10.1007/s11071-013-1169-0; Li Y, 2010, COMPUT MATH APPL, V59, P1810, DOI 10.1016/j.camwa.2009.08.019; Lu JH, 2005, IEEE T AUTOMAT CONTR, V50, P841, DOI 10.1109/TAC.2005.849233; Maheri M, 2016, NONLINEAR DYNAM, V85, P825, DOI 10.1007/s11071-016-2726-0; Nourian A, 2016, PRAMANA-J PHYS, V86, P1401, DOI 10.1007/s12043-015-1178-2; Oustaloup A, 1993, SYST ENG SERV HUM C, P136; Pakzad MA, 2015, IET CONTROL THEORY A, V9, P2357, DOI 10.1049/iet-cta.2014.1188; Razminia A, 2013, MECHATRONICS, V23, P873, DOI 10.1016/j.mechatronics.2013.02.004; Semary MS, 2016, INT J CIRC THEOR APP, V44, P2114, DOI 10.1002/cta.2215; Shao SY, 2016, NONLINEAR DYNAM, V83, P1855, DOI 10.1007/s11071-015-2450-1; Soukkou A, 2016, NONLINEAR DYNAM, V85, P2183, DOI 10.1007/s11071-016-2823-0; TORVIK PJ, 1984, J APPL MECH-T ASME, V51, P294, DOI 10.1115/1.3167615; Wang Z, 2004, J DONGHUA U, V21, P6; Wang Zhen-Bin, 2004, Control and Decision, V19, P1171; Wu GC, 2014, SIGNAL PROCESS, V102, P96, DOI 10.1016/j.sigpro.2014.02.022; Xiang W, 2011, COMMUN NONLINEAR SCI, V16, P2970, DOI 10.1016/j.cnsns.2010.11.022; Yang CC, 2012, J FRANKLIN I, V349, P349, DOI 10.1016/j.jfranklin.2011.11.013; Zhang RX, 2012, NONLINEAR DYNAM, V69, P983, DOI 10.1007/s11071-011-0320-z; Zhou P, 2012, INDIAN J PHYS, V86, P497, DOI 10.1007/s12648-012-0073-7; Zhu ZW, 2000, IEEE T CIRCUITS-I, V47, P1072, DOI 10.1109/81.855462	28	7	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194112	10.1371/journal.pone.0194112	http://dx.doi.org/10.1371/journal.pone.0194112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601587	gold, Green Published, Green Submitted			2022-12-27	WOS:000428845900004
J	Kogelman, B; Khmelinskii, A; Verhaart, I; van Vliet, L; Bink, DI; Aartsma-Rus, A; van Putten, M; van der Weerd, L				Kogelman, Bauke; Khmelinskii, Artem; Verhaart, Ingrid; van Vliet, Laura; Bink, Diewertje I.; Aartsma-Rus, Annemieke; van Putten, Maaike; van der Weerd, Louise			Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CENTRAL-NERVOUS-SYSTEM; INTELLECTUAL IMPAIRMENT; MDX; GENE; DIFFUSION; BEHAVIOR; MALES; CA1; DYSFUNCTION	Duchenne muscular dystrophy (DMD) affects besides muscle also the brain, resulting in memory and behavioral problems. The consequences of dystrophinopathy on gross macroscopic alterations are unclear. To elucidate the effect of full-length dystrophin expression on brain morphology, we used high-resolution post-mortem MRI in mouse models that either express 0% (mdx), 100% (BL10) or a low amount of full-length dystrophin (mdx-Xist(Delta hs)). While absence or low amounts of full-length dystrophin did not significantly affect whole brain volume and skull morphology, we found differences in volume of individual brain structures. The results are in line with observations in humans, where whole brain volume was found to be reduced only in patients lacking both full-length dystrophin and the shorter isoform Dp140.	[Kogelman, Bauke; Bink, Diewertje I.; van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Khmelinskii, Artem] Leiden Univ, Med Ctr, Dept Radiol, Div Image Proc, Leiden, Netherlands; [Khmelinskii, Artem] Percuros BV, Enschede, Netherlands; [Verhaart, Ingrid; van Vliet, Laura; Aartsma-Rus, Annemieke; van Putten, Maaike; van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Bink, Diewertje I.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	van der Weerd, L (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.; van der Weerd, L (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	l.van_der_weerd@lumc.nl	Verhaart, Ingrid/Y-2588-2018; Bink, D/AAW-8005-2020; van der Weerd, Louise/B-5421-2014; Khmelinskii, Artem/L-3714-2013	Verhaart, Ingrid/0000-0001-7348-7989; Kogelman, Bauke/0000-0001-8868-5515; Aartsma-Rus, Annemieke/0000-0003-1565-654X; Khmelinskii, Artem/0000-0002-2665-7380; van der Weerd, Louise/0000-0002-5997-2125; van Putten, Maaike/0000-0002-0683-8897; Bink, Diewertje/0000-0003-1389-1677	European Union Bioimage-NMD project; Seventh Framework Programme (FP7) [602485]; Percuros B.V. by the FP7 European Union Marie Curie IAPP Program; BRAINPATH [612360]; Percuros B.V.	European Union Bioimage-NMD project; Seventh Framework Programme (FP7)(European Commission); Percuros B.V. by the FP7 European Union Marie Curie IAPP Program; BRAINPATH; Percuros B.V.	BK was supported European Union Bioimage-NMD project (http://www.bioimage-nmd.eu), Seventh Framework Programme (FP7/2007-2013) under grant 602485. AK was supported by Percuros B.V. by the FP7 European Union Marie Curie IAPP Program, BRAINPATH (http://www.brainpath.eu), under grant 612360. The funder Percuros B.V. provided support in the form of salaries for author AK, but did not, as all other funders, have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; ALQUDAH AA, 1990, PEDIATR NEUROL, V6, P57, DOI 10.1016/0887-8994(90)90081-B; Austin RC, 2000, NEUROMUSCULAR DISORD, V10, P187, DOI 10.1016/S0960-8966(99)00105-4; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTSON J, 1978, J COMPUT ASSIST TOMO, V2, P16, DOI 10.1097/00004728-197801000-00003; Botteron S, 2009, ARCH ORAL BIOL, V54, P26, DOI 10.1016/j.archoralbio.2008.07.012; Brown ES, 2008, BIOL PSYCHIAT, V63, P705, DOI 10.1016/j.biopsych.2007.09.014; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Byron CD, 2006, ARCH ORAL BIOL, V51, P396, DOI 10.1016/j.archoralbio.2005.09.006; Chapman C, 2006, J CLIN NEUROSCI, V13, P636, DOI 10.1016/j.jocn.2005.08.012; Chaussenot R, 2015, NEUROBIOL LEARN MEM, V124, P111, DOI 10.1016/j.nlm.2015.07.006; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Doorenweerd N, 2017, SCI REPORTS, V7, P1; Doorenweerd N, 2014, ANN NEUROL, V76, P403, DOI 10.1002/ana.24222; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; Eckardt L, 1996, AM J ORTHOD DENTOFAC, V110, P185, DOI 10.1016/S0889-5406(96)70107-5; Felisari G, 2000, NEUROLOGY, V55, P559, DOI 10.1212/WNL.55.4.559; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goodnough CL, 2014, NEUROIMAGE, V102, P809, DOI 10.1016/j.neuroimage.2014.08.053; Goodwin F, 1997, Eur J Paediatr Neurol, V1, P115, DOI 10.1016/S1090-3798(97)80042-6; Hendriksen JGM, 2006, PEDIATR NEUROL, V34, P296, DOI 10.1016/j.pediatrneurol.2005.08.029; Hendriksen JGM, 2008, J CHILD NEUROL, V23, P477, DOI 10.1177/0883073807309775; Hendriksen RGF, 2015, NEUROSCI BIOBEHAV R, V51, P255, DOI 10.1016/j.neubiorev.2015.01.023; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Khmelinskii a, 2013, VISUALIZATION PLATFO, V8672; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kohler M, 2005, AM J RESP CRIT CARE, V172, P1032, DOI 10.1164/rccm.200503-322OC; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIDOV HGW, 1995, HUM MOL GENET, V4, P329, DOI 10.1093/hmg/4.3.329; LIDOV HGW, 1993, NEUROSCIENCE, V54, P167, DOI 10.1016/0306-4522(93)90392-S; Lidov HGW, 1996, BRAIN PATHOL, V6, P63, DOI 10.1111/j.1750-3639.1996.tb00783.x; Miranda R, 2009, CEREB CORTEX, V19, P876, DOI 10.1093/cercor/bhn135; Miranda R, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0053-9; MOMOSE KJ, 1971, RADIOLOGY, V99, P341, DOI 10.1148/99.2.341; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Muntoni F, 1991, Neuromuscul Disord, V1, P121, DOI 10.1016/0960-8966(91)90059-2; Newall AET, 2001, HUM MOL GENET, V10, P581, DOI 10.1093/hmg/10.6.581; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P313, DOI 10.1016/j.nmd.2013.01.011; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; Passamano Luigia, 2012, Acta Myol, V31, P121; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Perronnet C, 2010, J BIOMED BIOTECHNOL, V2010, P1, DOI DOI 10.1155/2010/849426; Perronnet C, 2012, HUM MOL GENET, V21, P2263, DOI 10.1093/hmg/dds047; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Remmelink E, 2016, GENES BRAIN BEHAV, V15, P558, DOI 10.1111/gbb.12301; Renaud S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-28; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Sesay AK, 1996, NEUROSCI LETT, V211, P207, DOI 10.1016/0304-3940(96)12747-6; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Straathof CSM, 2014, J CHILD NEUROL, V29, P1344, DOI 10.1177/0883073813518106; Sunkin SM, 2013, NUCL ACIDS RES, V41; Team RC, 2016, R LANG ENV STAT COMP; Team Rs, 2016, RSTUDIO INT DEV ENV; Tozawa T, 2012, MOL NEUROBIOL, V45, P287, DOI 10.1007/s12035-012-8233-5; Ueda H, 2000, HISTOL HISTOPATHOL, V15, P753, DOI 10.14670/HH-15.753; Ueki K, 2007, J ORAL MAXIL SURG, V65, P34, DOI 10.1016/j.joms.2005.11.108; Vaillend C, 1998, NEUROSCIENCE, V86, P53, DOI 10.1016/S0306-4522(98)00023-2; Vaillend C, 2004, NEUROBIOL DIS, V17, P10, DOI 10.1016/j.nbd.2004.05.004; VAILLEND C, 1995, BEHAV GENET, V25, P569, DOI 10.1007/BF02327580; van Putten M, 2014, J MOL CELL CARDIOL, V69, P17, DOI 10.1016/j.yjmcc.2014.01.009; van Putten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031937; Veeravagu A, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E16; Xu S, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/1758-2946-7-S1-S11; YOSHIOKA M, 1980, ARCH DIS CHILD, V55, P589, DOI 10.1136/adc.55.8.589; Young HK, 2008, J CHILD NEUROL, V23, P155, DOI 10.1177/0883073807307975; Zanardi VA, 2001, CLIN RHEUMATOL, V20, P245, DOI 10.1007/s100670170037	73	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194636	10.1371/journal.pone.0194636	http://dx.doi.org/10.1371/journal.pone.0194636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601589	Green Submitted, Green Published, gold			2022-12-27	WOS:000428845900008
J	Lee, HJ; Choi, EK; Lee, SH; Kim, YJ; Han, KD; Oh, S				Lee, Hyun-Jung; Choi, Eue-Keun; Lee, Seung-Hwan; Kim, Yong-Jin; Han, Kyung-Do; Oh, Seil			Risk of ischemic stroke in metabolically healthy obesity: A nationwide population-based study	PLOS ONE			English	Article							BODY-MASS INDEX; INCIDENT CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; HEMORRHAGIC STROKE; PROSPECTIVE COHORT; NORMAL-WEIGHT; MORTALITY; OVERWEIGHT; ADIPOSITY	Background Whether metabolically healthy obese (MHO) individuals are at increased risk of ischemic stroke is not well known. We investigated the association of the MHO phenotype with ischemic stroke. Methods A total of 354,083 adults (age 45.8 +/- 14.2 years) from the Korean National Health Insurance Service +/- National Sample Cohort enrolled in 2004 +/- 2008 were followed-up for incident ischemic stroke until 2013. Subjects meeting none of the metabolic syndrome criteria were classified as 'metabolically healthy'. The cohort was categorized into four groups according to obesity and metabolic status: metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUNW), MHO, and metabolically unhealthy obese (MUO). Results Ischemic stroke was newly diagnosed in 4,884 (1.4%) individuals during a mean follow-up of 7.4 +/- 1.5 years. Stroke incidence rates for the MHNW, MUNW, MHO, and MUO groups were 0.56, 2.61, 0.61, and 2.76 per 1,000 person-years, respectively. While risk for stroke increased significantly in metabolically unhealthy groups, it was not increased in MHO compared to the MHNW group on multivariate analysis. In metabolically healthy individuals, obesity did not increase the risk for ischemic stroke, regardless of the severity of obesity. Meanwhile, in metabolically unhealthy individuals, being obese was significantly associated with increased risk of stroke. Conclusions MHO individuals were not at increased risk for ischemic stroke. However, obesity increased risk for ischemic stroke in persons with metabolic risk factors; therefore, maintaining normal weight may be more important for this population. Also, metabolic unhealthiness showed greater association than obesity with stroke.	[Lee, Hyun-Jung; Choi, Eue-Keun; Kim, Yong-Jin; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Seung-Hwan] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Seoul St Marys Hosp,Coll Med, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	choiek17@snu.ac.kr	Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014; Choi, Eue-Keun/K-3752-2019	Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; Lee, Hyun-Jung/0000-0002-7498-0705	Seoul National University Hospital Research Fund [0620160680]; National Research Foundation of Korea at Ministry of Education, Science and Technology [2014R1A1A2A16055218]; Korean Healthcare Technology R&D project at the Ministry of Health Welfare [HI15C1200]	Seoul National University Hospital Research Fund; National Research Foundation of Korea at Ministry of Education, Science and Technology; Korean Healthcare Technology R&D project at the Ministry of Health Welfare	This work was supported by the Seoul National University Hospital Research Fund [grant 0620160680]; the National Research Foundation of Korea at Ministry of Education, Science and Technology [grant 2014R1A1A2A16055218]; and the Korean Healthcare Technology R&D project at the Ministry of Health & Welfare [grant HI15C1200], received by EK Choi.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Aung K, 2014, J CLIN ENDOCR METAB, V99, P462, DOI 10.1210/jc.2013-2832; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cha MJ, 2017, STROKE, V48, P3040, DOI 10.1161/STROKEAHA.117.018773; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guo FJ, 2016, OBESITY, V24, P516, DOI 10.1002/oby.21344; Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu123; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267; Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036; Kim KI, 2016, KOREAN CIRC J, V46, P275, DOI 10.4070/kcj.2016.46.3.275; Kroll ME, 2016, NEUROLOGY, V87, P1473; Lee H, 2017, INT J CARDIOL, V240, P221, DOI 10.1016/j.ijcard.2017.03.103; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee SW, 2016, KOREAN CIRC J, V46, P507, DOI 10.4070/kcj.2016.46.4.507; Lee SR, 2016, INT J CARDIOL, V223, P953, DOI 10.1016/j.ijcard.2016.08.296; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Ogorodnikova AD, 2012, OBESITY, V20, P651, DOI 10.1038/oby.2011.243; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Ortega FB, 2016, MAYO CLIN PROC, V91, P443, DOI 10.1016/j.mayocp.2016.01.008; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Sanchez-Inigo L, 2017, INT J STROKE, V12, P187, DOI 10.1177/1747493016672083; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Wang CX, 2013, INT J STROKE, V8, P245, DOI 10.1111/j.1747-4949.2012.00830.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	35	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195210	10.1371/journal.pone.0195210	http://dx.doi.org/10.1371/journal.pone.0195210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601602	Green Published, gold, Green Submitted			2022-12-27	WOS:000428845900024
J	Tong, HL; Miyake, Y; Mi-ichi, F; Iwakura, Y; Hara, H; Yoshida, H				Tong, Honglian; Miyake, Yasunobu; Mi-ichi, Fumika; Iwakura, Yoichiro; Hara, Hiromitsu; Yoshida, Hiroki			Apaf1 plays a negative regulatory role in T cell responses by suppressing activation of antigen-stimulated T cells	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; CYTOCHROME-C; DIFFERENTIAL REQUIREMENT; CASPASE ACTIVATION; APOPTOSIS; PROTEIN; DEATH; PROCASPASE-9; INHIBITION; PATHWAYS	Apaf1 is a critical component of the apoptosome and initiates apoptosis downstream mitochondrial damages. Although the importance of Apaf1 in embryonic development was shown, the role of Apaf1 in immune responses, especially T cell responses, has yet to be elucidated. We generated T cell-specific Apaf1-deficient mice (Lck-Cre-Apaf1(f/f) mice) and examined the antigen-specific delayed-type hypersensitivity (DTH). Lck-Cre-Apaf1(f/f) mice exhibited exacerbation of DTH responses as compared with Apaf1-sufficient control mice. In Lck-Cre-Apaf1(f/f) mice, antigen-specific T cells proliferated more, and produced more inflammatory cytokines than control T cells. Apaf1-deficient T cells from antigen-immunized mice showed higher percentages of activation phenotypes upon restimulation in vitro. Apaf1-deficient T cells from naive (non-immunized) mice also showed higher proliferation activity and cytokine production over control cells. The impact of Apaf1-deficiency in T cells, however, was not restored by a pan-caspase inhibitor, suggesting that the role of Apaf1 in T cell responses was caspase-independent/non-apoptotic. These data collectively demonstrated that Apaf1 is a negative regulator of T cell responses and implicated Apaf1 as a potential target for immunosuppressive drug discovery.	[Tong, Honglian; Miyake, Yasunobu; Mi-ichi, Fumika; Hara, Hiromitsu; Yoshida, Hiroki] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, Saga, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Ctr Expt Anim Models, Inst Biomed Sci, Chiba, Japan; [Hara, Hiromitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, Kagoshima, Japan	Saga University; Tokyo University of Science; Kagoshima University	Yoshida, H (corresponding author), Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, Saga, Japan.	yoshidah@cc.saga-u.ac.jp	Mi-ichi, Fumika/O-9668-2015	Hiroki, Yoshida/0000-0003-3447-117X; Mi-ichi, Fumika/0000-0001-7042-2266				Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chau BN, 2000, MOL CELL, V6, P31, DOI 10.1016/S1097-2765(00)00005-8; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; De Zio D, 2015, INT J DEV BIOL, V59, P33, DOI 10.1387/ijdb.150047dd; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Doerfler P, 2000, J IMMUNOL, V164, P4071, DOI 10.4049/jimmunol.164.8.4071; Ferraro E, 2011, J CELL SCI, V124, P3450, DOI 10.1242/jcs.086298; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Hara H, 2002, J IMMUNOL, V168, P2288, DOI 10.4049/jimmunol.168.5.2288; Jagot-Lacoussiere L, 2015, CELL CYCLE, V14, P1242, DOI 10.1080/15384101.2015.1014148; Jia L, 2001, BLOOD, V98, P414, DOI 10.1182/blood.V98.2.414; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lawrence CP, 2012, TOXICOL APPL PHARM, V265, P103, DOI 10.1016/j.taap.2012.09.002; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Reiner SL, 2009, NAT REV IMMUNOL, V9, P81, DOI 10.1038/nri2490; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shakeri R, 2017, BIOCHIMIE, V135, P111, DOI 10.1016/j.biochi.2017.02.001; Tong H, 2010, IMMUNOL LETT, V128, P108, DOI 10.1016/j.imlet.2010.01.001; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yoshida H, 2002, CELL DEATH DIFFER, V9, P1273, DOI 10.1038/sj.cdd.4401128; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195119	10.1371/journal.pone.0195119	http://dx.doi.org/10.1371/journal.pone.0195119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596528	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000078
J	Xi, T; Zhang, GZ				Xi, Ting; Zhang, Guizhi			Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER STEM-CELLS; EXPRESSION; SOMATOSTATIN; REPLICATION; PROGRESSION; CARCINOMA; BREAST; OVEREXPRESSION; PROLIFERATION	Background Tumor differentiation is an important process in the development of cancer. It is valuable to identify key differentiation related genes in the prognosis and therapy of pancreatic adenocarcinoma. Methods The mRNA expression data were downloaded from the Cancer Genome Atlas database. Then, differentially expressed tumor differentiation related genes were identified. Additionally, Gene Ontology functional categories and Kyoto Encyclopedia of Genes and Genomes biochemical pathway was used to explore the function. In addition, receiver operating characteristic and survival analysis were carried out to assess the diagnosis and prognosis value. Finally, the electronic validation of selected tumor differentiation related genes was performed. Results A total of 932 genes were identified. Among which, 8 genes including JUB, ERLIN1, HMGA2, FAM110B, EGFR, MCM2, TCTA and SSTR1 were differentially expressed in all different tumor differentiation grades. Functional analysis revealed those genes between highly differentiated and other differentiation were remarkably enriched in pancreatic adenocarcinoma and cell cycle pathway. Finally, ERLIN1, HMGA2, FAM110B, EGFR, MCM2, BCL2L1, E2F1 and RAC1 were associated with the survival time of pancreatic adenocarcinoma patient. Among these genes, JUB, ERLIN1, FAM110B, MCM2 and BCL2L1 also had a diagnosis value for pancreatic adenocarcinoma. Additionally, the expression trend of JUB, HMGA2 and MCM2 was increased along with the tumor differentiation grades. And the expression trend of FAM110B was decreased along with the tumor differentiation grades. The electronic validation result was consistent with the bioinformatics analysis. Conclusions 12 tumor differentiation related genes including JUB, ERLIN1, HMGA2, FAM110B, EGFR, MCM2, TCTA, SSTR1, BCL2L1, E2F1, RAC1 and STAT1 played crucial roles in the differentiation of pancreatic adenocarcinoma.	[Xi, Ting] First Peoples Hosp Liaocheng, Dept Gastroenterol, Liaocheng, Shandong, Peoples R China; [Zhang, Guizhi] Second Peoples Hosp Liaocheng, Dept Gastroenterol, Liaocheng, Shandong, Peoples R China		Xi, T (corresponding author), First Peoples Hosp Liaocheng, Dept Gastroenterol, Liaocheng, Shandong, Peoples R China.	xitinglc@163.com						Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; APLAN PD, 1995, CANCER RES, V55, P1917; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; ASHAR HR, 1995, CELL, V82, P57; Bousquet C, 2001, CHEMOTHERAPY, V47, P30, DOI 10.1159/000049159; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Bruns CJ, 2000, CLIN CANCER RES, V6, P1936; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; DeVita Prasad S., 2015, DEVITA HELLMAN ROSEN; Ebert MPA, 2001, J CANCER RES CLIN, V127, P449, DOI 10.1007/s004320100235; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Garcea G, 2008, J PANCREAS, V9, P99; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gray PJ, 2004, MOL CANCER THER, V3, P641; Hauge H, 2007, GENOMICS, V90, P14, DOI 10.1016/j.ygeno.2007.03.002; Hejna M, 2002, ANN ONCOL, V13, P653, DOI 10.1093/annonc/mdf142; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; Kaistha BP, 2014, BRIT J CANCER, V111, P1780, DOI 10.1038/bjc.2014.460; Kim HK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-48; Komura T, 2015, CANCER SCI, V106, P672, DOI 10.1111/cas.12663; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lei M, 2001, J CELL SCI, V114, P1447; Li M, 2008, CANCER SCI, V99, P2218, DOI 10.1111/j.1349-7006.2008.00940.x; Liu R, 1999, AM J PATHOL, V155, P1861, DOI 10.1016/S0002-9440(10)65505-8; Long J, 2016, MOL MED REP, V13, P3779, DOI 10.3892/mmr.2016.5007; Matsubayashi H, 2003, CLIN CANCER RES, V9, P1446; Nakamura T, 2007, CANCER RES, V67, P139, DOI 10.1158/0008-5472.CAN-06-2563; Nanke Y, 2014, CENT EUR J IMMUNOL, V39, P468, DOI 10.5114/ceji.2014.47730; Nola S, 2011, J CELL BIOL, V195, P855, DOI 10.1083/jcb.201107162; Ochs C, 2016, J BIOINF COMPUT BIOL, V14, DOI 10.1142/S0219720016420014; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Oncology TL, 2014, LANCET ONCOLOGY, V15, P586; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Pan JJ, 2011, J GASTROINTEST ONCOL, V2, P151, DOI 10.3978/j.issn.2078-6891.2011.022; Park SJ, 2015, INT J CLIN EXP PATHO, V8, P8298; Roberts NJ, 2016, CANCER DISCOV, V6, P166, DOI 10.1158/2159-8290.CD-15-0402; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sato N, 2004, AM J PATHOL, V164, P903, DOI 10.1016/S0002-9440(10)63178-1; Satoh K, 1998, PANCREAS, V16, P468, DOI 10.1097/00006676-199805000-00002; Shetty A, 2005, BRIT J CANCER, V93, P1295, DOI 10.1038/sj.bjc.6602829; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stoeber K, 2001, J CELL SCI, V114, P2027; Sun Y, 2014, PANCREAS, V43, P619, DOI 10.1097/MPA.0000000000000074; Thakur A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-11; Trauzold A, 2005, FASEB J, V19, P620, DOI 10.1096/fj.04-2984fje; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walczak H, 2000, CANCER RES, V60, P3051; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Weichert W, 2005, PANCREATOLOGY, V5, P259, DOI 10.1159/000085280; Widschwendter A, 2002, CLIN CANCER RES, V8, P3065; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565; Yamazaki K, 2003, PATHOL RES PRACT, V199, P23, DOI 10.1078/0344-0338-00348; Yin ZQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-49	60	8	8	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193427	10.1371/journal.pone.0193427	http://dx.doi.org/10.1371/journal.pone.0193427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596435	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000009
J	Kfir, S; Basavaraja, R; Wigoda, N; Ben-Dor, S; Orr, I; Meidan, R				Kfir, Sigal; Basavaraja, Raghavendra; Wigoda, Noa; Ben-Dor, Shifra; Orr, Irit; Meidan, Rina			Genomic profiling of bovine corpus luteum maturation	PLOS ONE			English	Article							SIMULATED EARLY-PREGNANCY; ACUTE REGULATORY PROTEIN; ENDOTHELIAL-CELLS; ESTROUS-CYCLE; MENSTRUAL-CYCLE; CORPORA-LUTEA; PRIMATE OVARY; IMMUNE CELLS; ANGIOGENESIS; EXPRESSION	To unveil novel global changes associated with corpus luteum (CL) maturation, we analyzed transcriptome data for the bovine CL on days 4 and 11, representing the developing vs. mature gland. Our analyses revealed 681 differentially expressed genes (363 and 318 on day 4 and 11, respectively), with >= 2 fold change and FDR of <5%. Different gene ontology (GO) categories were represented prominently in transcriptome data at these stages (e.g. days 4: cell cycle, chromosome, DNA metabolic process and replication and on day 11: immune response; lipid metabolic process and complement activation). Based on bioinformatic analyses, select genes expression in day 4 and 11 CL was validated with quantitative real-time PCR. Cell specific expression was also determined in enriched luteal endothelial and steroidogenic cells. Genes related to the angiogenic process such as NOS3, which maintains dilated vessels and MMP9, matrix degrading enzyme, were higher on day 4. Importantly, our data suggests day 11 CL acquire mechanisms to prevent blood vessel sprouting and promote their maturation by expressing NOTCH4 and JAG1, greatly enriched in luteal endothelial cells. Another endothelial specific gene, CD300LG, was identified here in the CL for the first time. CD300LG is an adhesion molecule enabling lymphocyte migration, its higher levels at mid cycle are expected to support the transmigration of immune cells into the CL at this stage. Together with steroidogenic genes, most of the genes regulating de-novo cholesterol biosynthetic pathway (e.g HMGCS, HMGCR) and cholesterol uptake from plasma (LDLR, APOD and APOE) were upregulated in the mature CL. These findings provide new insight of the processes involved in CL maturation including blood vessel growth and stabilization, leucocyte transmigration as well as progesterone synthesis as the CL matures.	[Kfir, Sigal; Basavaraja, Raghavendra; Wigoda, Noa; Meidan, Rina] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel; [Ben-Dor, Shifra; Orr, Irit] Weizmann Inst Sci, Dept Life Sci Core Facil, Bioinformat Unit, Rehovot, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science	Meidan, R (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel.	rina.meidan@mail.huji.ac.il	Basavaraja, Raghavendra/M-3000-2019; BEN-DOR, SHIFRA/M-6718-2019	Basavaraja, Raghavendra/0000-0002-8656-2615; BEN-DOR, SHIFRA/0000-0001-9604-1939; Wigoda, Noa/0000-0002-4496-881X	BARD (Binational Agricultural Research & Development Fund) [IS-3987-07]	BARD (Binational Agricultural Research & Development Fund)	This research was supported by grant No. IS-3987-07 from the BARD (Binational Agricultural Research & Development Fund). The grant was awarded to RM and funding played no role in the planning, writing, and decision to submit this manuscript.	Accialini P, 2015, REPRODUCTION, V149, P1, DOI 10.1530/REP-14-0449; Bauer M, 2001, REPRODUCTION, V121, P297, DOI 10.1530/rep.0.1210297; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bridges E, 2011, FUTURE ONCOL, V7, P569, DOI [10.2217/FON.11.20, 10.2217/fon.11.20]; Byrnes RW, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-99; CHEN HW, 1984, FED PROC, V43, P126; Christenson LK, 1996, ENDOCRINOLOGY, V137, P367, DOI 10.1210/en.137.1.367; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; COLLINS T, 1991, J BIOL CHEM, V266, P2466; DRISCOLL DM, 1984, J LIPID RES, V25, P1368; Fraser HM, 2012, ENDOCRINOLOGY, V153, P1972, DOI 10.1210/en.2011-1688; Fraser HM, 2001, REPROD FERT DEVELOP, V13, P557, DOI 10.1071/RD01055; Garcia-Pascual CM, 2013, FERTIL STERIL, V100, P1768, DOI 10.1016/j.fertnstert.2013.08.034; HANSEL W, 1991, J REPROD FERTIL, P77; HAUGER RL, 1977, ENDOCRINOLOGY, V101, P807, DOI 10.1210/endo-101-3-807; Hernandez F, 2011, BIOL REPROD, V84, P859, DOI 10.1095/biolreprod.110.088708; JABLONKASHARIFF A, 1993, ENDOCRINOLOGY, V133, P1871, DOI 10.1210/en.133.4.1871; James AC, 2014, BBA-MOL CELL RES, V1843, P1272, DOI 10.1016/j.bbamcr.2014.03.015; Jiang YF, 2011, ANIM REPROD SCI, V129, P152, DOI 10.1016/j.anireprosci.2011.12.004; JOHANSSON ED, 1969, ACTA ENDOCRINOL-COP, V61, P592, DOI 10.1530/acta.0.0610592; Kapourchali FR, 2015, CRITICAL REV FOOD SC; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Klipper E, 2004, REPRODUCTION, V128, P463, DOI 10.1530/rep.1.00271; Klipper E, 2009, ENDOCRINOLOGY, V150, P413, DOI 10.1210/en.2008-0697; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Kume T, 2012, ADV EXP MED BIOL, V727, P210, DOI 10.1007/978-1-4614-0899-4_16; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Levy N, 2003, BIOL REPROD, V68, P1361, DOI 10.1095/biolreprod.102.009134; Levy N, 2001, ENDOCRINOLOGY, V142, P5254, DOI 10.1210/en.142.12.5254; MARES SE, 1962, J ANIM SCI, V21, P266, DOI 10.2527/jas1962.212266x; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; MEIDAN R, 1990, BIOL REPROD, V43, P913, DOI 10.1095/biolreprod43.6.913; Meidan R, 2005, DOMEST ANIM ENDOCRIN, V29, P318, DOI 10.1016/j.domaniend.2005.04.003; Meidan R, 1997, SEMIN REPROD ENDOCR, V15, P371, DOI 10.1055/s-2008-1068375; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Mondal M, 2011, PHYSIOL GENOMICS, V43, P447, DOI 10.1152/physiolgenomics.00155.2010; Nio-Kobayashi J, 2015, MOL HUMAN REPROD; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; OSHEA JD, 1989, J REPROD FERTIL, V85, P483, DOI 10.1530/jrf.0.0850483; Penny LA, 1999, J REPROD FERTIL, V115, P87, DOI 10.1530/jrf.0.1150087; Pescador N, 1996, BIOL REPROD, V55, P485, DOI 10.1095/biolreprod55.2.485; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; RAINEY WE, 1992, STEROIDS, V57, P167, DOI 10.1016/0039-128X(92)90003-R; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rizzo A, 2016, RES VET SCI, V109, P56, DOI 10.1016/j.rvsc.2016.08.006; Robinson RS, 2007, BIOL REPROD, V77, P28, DOI 10.1095/biolreprod.106.055434; Robker RL, 2000, STEROIDS, V65, P559, DOI 10.1016/S0039-128X(00)00114-8; RODGERS RJ, 1987, MOL ENDOCRINOL, V1, P172, DOI 10.1210/mend-1-2-172; RODGERS RJ, 1987, MOL ENDOCRINOL, V1, P274, DOI 10.1210/mend-1-3-274; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shirasuna K, 2013, REPROD FERT DEVELOP, V25, P351, DOI 10.1071/RD12096; Singh J, 1997, J REPROD FERTIL, V109, P35, DOI 10.1530/jrf.0.1090035; Sugino N, 2005, J CLIN ENDOCR METAB, V90, P6141, DOI 10.1210/jc.2005-0643; Takatsu H, 2006, BIOCHEM BIOPH RES CO, V348, P183, DOI 10.1016/j.bbrc.2006.07.047; Townson DH, 2002, BIOL REPROD, V66, P361, DOI 10.1095/biolreprod66.2.361; Umemoto E, 2006, J EXP MED, V203, P1603, DOI 10.1084/jem.20052543; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Vorontchikhina MA, 2005, GENE EXPR PATTERNS, V5, P701, DOI 10.1016/j.modgep.2005.02.001; Walusimbi SS, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117564; Wilcox CB, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-223; WILTBANK MC, 1988, J REPROD FERTIL, V84, P513, DOI 10.1530/jrf.0.0840513; WILTBANK MC, 1994, J ANIM SCI, V72, P1873, DOI 10.2527/1994.7271873x; Woad KJ, 2016, THERIOGENOLOGY, V86, P221, DOI 10.1016/j.theriogenology.2016.04.035; Wulff C, 2001, HUM REPROD, V16, P2515, DOI 10.1093/humrep/16.12.2515; Zalman Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095067	66	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194456	10.1371/journal.pone.0194456	http://dx.doi.org/10.1371/journal.pone.0194456			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590145	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100059
J	Martinez-Ramos, E; Beltran, AM; Martin-Borras, C; Lasaosa-Medina, L; Real, J; Trujillo, JM; Sola-Gonfaus, M; Puigdomenech, E; Castillo-Ramos, E; Puig-Ribera, A; Gine-Garriga, M; Serra-Paya, N; Rodriguez-Roca, B; Gascon-Catalan, A; Martin-Cantera, C				Martinez-Ramos, Elena; Beltran, Angela-Maria; Martin-Borras, Carme; Lasaosa-Medina, Lourdes; Real, Jordi; Trujillo, Jose-Manuel; Sola-Gonfaus, Merce; Puigdomenech, Elisa; Castillo-Ramos, Eva; Puig-Ribera, Anna; Gine-Garriga, Maria; Serra-Paya, Noemi; Rodriguez-Roca, Beatriz; Gascon-Catalan, Ana; Martin-Cantera, Carlos		SEDESTACTIV Grp	Patterns of sedentary behavior in overweight and moderately obese users of the Catalan primary-health care system (vol 13, e0190750, 2018)	PLOS ONE			English	Correction													Gascon, Ana/AAH-1376-2020; Serra, Noemi/AAB-7629-2019; Giné-Garriga, Maria/AAF-9828-2019; Martin-Cantera, Carlos/D-2693-2011	Gascon, Ana/0000-0003-0335-0404; Serra, Noemi/0000-0002-1048-9546; Giné-Garriga, Maria/0000-0003-4449-3524; Real, Jordi/0000-0002-5979-8948; Sola Gonfaus, Merce/0000-0002-8568-4418; Martin-Cantera, Carlos/0000-0003-0656-8126	Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain), within the Technical, Scientific and Innovation Research National Plan [PI11/01082, RD16/0007/0001]; European Union ERDF funds (European Regional Development Fund); VI Catedra of the European University of Madrid	Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain), within the Technical, Scientific and Innovation Research National Plan; European Union ERDF funds (European Regional Development Fund); VI Catedra of the European University of Madrid	The study was supported by research grants from Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain), within the Technical, Scientific and Innovation Research National Plan, with reference PI11/01082, RD16/0007/0001, co-funded with European Union ERDF funds (European Regional Development Fund)", VI Catedra of the European University of Madrid, Funding for the realization of doctoral theses "Isabel Fernandez" 2015 SEMFYC, Ajut XB 2012 Unitat de Suport a la Recerca de Barcelona de l'Institut Catala de la Salut and 14th Financial aid for training in research and doctorate in primary care IDIAP Jordi Gol 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Ramos E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190750	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195312	10.1371/journal.pone.0195312	http://dx.doi.org/10.1371/journal.pone.0195312			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590214	gold, Green Published			2022-12-27	WOS:000428603100108
J	Buimer, HP; Bittner, M; Kostelijk, T; van der Geest, TM; Nemri, A; van Wezel, RJA; Zhao, Y				Buimer, Hendrik P.; Bittner, Marian; Kostelijk, Tjerk; van der Geest, Thea M.; Nemri, Abdellatif; van Wezel, Richard J. A.; Zhao, Yan			Conveying facial expressions to blind and visually impaired persons through a wearable vibrotactile device	PLOS ONE			English	Article							SUBSTITUTION; VALIDATION	In face-to-face social interactions, blind and visually impaired persons (VIPs) lack access to nonverbal cues like facial expressions, body posture, and gestures, which may lead to impaired interpersonal communication. In this study, a wearable sensory substitution device (SSD) consisting of a head mounted camera and a haptic belt was evaluated to determine whether vibrotactile cues around the waist could be used to convey facial expressions to users and whether such a device is desired by VIPs for use in daily living situations. Ten VIPs (mean age: 38.8, SD: 14.4) and 10 sighted persons (SPs) (mean age: 44.5, SD: 19.6) participated in the study, in which validated sets of pictures, silent videos, and videos with audio of facial expressions were presented to the participant. A control measurement was first performed to determine how accurately participants could identify facial expressions while relying on their functional senses. After a short training, participants were asked to determine facial expressions while wearing the emotion feedback system. VIPs using the device showed significant improvements in their ability to determine which facial expressions were shown. A significant increase in accuracy of 44.4% was found across all types of stimuli when comparing the scores of the control (mean SEM: 35.0 +/- 2.5%) and supported (mean SEM: 79.4 +/- 2.1%) phases. The greatest improvements achieved with the support of the SSD were found for silent stimuli (68.3% for pictures and 50.8% for silent videos). SPs also showed consistent, though not statistically significant, improvements while supported. Overall, our study shows that vibrotactile cues are well suited to convey facial expressions to VIPs in real-time. Participants became skilled with the device after a short training session. Further testing and development of the SSD is required to improve its accuracy and aesthetics for potential daily use.	[Buimer, Hendrik P.; Bittner, Marian; Nemri, Abdellatif; van Wezel, Richard J. A.; Zhao, Yan] Univ Twente, MIRA Inst, Dept Biomed Signals & Syst, Enschede, Netherlands; [Buimer, Hendrik P.; van Wezel, Richard J. A.] Radboud Univ Nijmegen, Dept Biophys, Donders Inst, Nijmegen, Netherlands; [Kostelijk, Tjerk] VicarVision, Amsterdam, Netherlands; [van der Geest, Thea M.] Univ Twente, Dept Media Commun & Org, Enschede, Netherlands; [van der Geest, Thea M.] HAN Univ Appl Sci, Dept Media & Design, Arnhem, Netherlands	University of Twente; Radboud University Nijmegen; University of Twente	Buimer, HP (corresponding author), Univ Twente, MIRA Inst, Dept Biomed Signals & Syst, Enschede, Netherlands.; Buimer, HP (corresponding author), Radboud Univ Nijmegen, Dept Biophys, Donders Inst, Nijmegen, Netherlands.	h.buimer@donders.ru.nl	van Wezel, Richard R J/G-4455-2011	van Wezel, Richard R J/0000-0001-5753-7069; Nemri, Abdellatif/0000-0003-1459-5634; Buimer, Hendrik/0000-0002-2798-8595	Stichting voor de Technische Wetenschappen (STW): Take Off [15666]; Oost NV: INTERREG-project MIND (Medische Innovaties Nederland Duitsland) [122035]; Netherlands Organisation for Health Research and Development (ZonMW): Inzicht [94211004]; VicarVision	Stichting voor de Technische Wetenschappen (STW): Take Off; Oost NV: INTERREG-project MIND (Medische Innovaties Nederland Duitsland); Netherlands Organisation for Health Research and Development (ZonMW): Inzicht; VicarVision	The research was funded by: Stichting voor de Technische Wetenschappen (STW): Take Off - Grant number: 15666, http://www.stw.nl/takeoff; Oost NV: INTERREG-project MIND (Medische Innovaties Nederland Duitsland) - Grant number: 122035, http://www.oostnv.nl/page/ grensoverschrijdende-medische-innovaties-mind; and The Netherlands Organisation for Health Research and Development (ZonMW): Inzicht - Grant number - 94211004, https://www.zonmw.nl/ en/research-and-results/handicap-andchronicdisease/programmas/programme-detail/insight/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Tjerk Kostelijk is employed by VicarVision, which developed the FaceReader software used in this study. VicarVision provided support in the form of salary for author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section	Abboud S, 2014, RESTOR NEUROL NEUROS, V32, P247, DOI 10.3233/RNN-130338; [Anonymous], 2013, FRONT HUM NEUROSCI; BACHYRITA P, 1967, ACTA NEUROL SCAND, V43, P417, DOI 10.1111/j.1600-0404.1967.tb05747.x; BachyRita P, 2003, TRENDS COGNITIVE SCI; Broerse J, 2015, BRAIN SCI; Danilov Yuri, 2005, Journal of Integrative Neuroscience, V4, P537, DOI 10.1142/S0219635205000914; DenUyl MJ, 2005, P NATL ACAD SCI US; Ekman P., 1970, CALIFORNIA MENTAL HL, V8, P151, DOI DOI 10.1016/J.SOC.2010.04.003; Elli GV, 2014, MULTISENS RES, V27, P271, DOI 10.1163/22134808-00002460; Ernst M. O., 2006, HUMAN BODY PERCEPTIO, P105; Fischer ME, 2009, OPHTHAL EPIDEMIOL, V16, P346, DOI 10.3109/09286580903312236; Hakobyan L, 2013, SURV OPHTHALMOL, V58, P513, DOI 10.1016/j.survophthal.2012.10.004; Hanassy S, 2013, MULTISENS RES, V26, P116; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Johannesson OI, 2017, EXP BRAIN RES, V235, P3505, DOI 10.1007/s00221-017-5073-6; Johannesson OI, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030020; Jones LA, 2008, HUM FACTORS, V50, P90, DOI 10.1518/001872008X250638; Kaczmarek KA, 2011, SCI IRAN, V18, P1476, DOI 10.1016/j.scient.2011.08.020; Karcher SM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00037; Krishna S, 2008, OPHTHALMIC EPIDEMIOL; Krishna S, 2005, ACM SIGACCESS C COMP, P106; Krishna S., 2010, CHI 10 EXTENDED ABST, P3637; Lewinski P, 2014, J NEUROSCI PSYCHOL E, V7, P227, DOI 10.1037/npe0000028; Lima CF, 2013, BEHAV RES METHODS, V45, P1234, DOI 10.3758/s13428-013-0324-3; McDaniel Troy, 2014, Universal Access in Human-Computer Interaction. Design and Development Methods for Universal Access. 8th International Conference, UAHCI 2014, Held as Part of HCI International 2014. Proceedings: LNCS 8513, P419, DOI 10.1007/978-3-319-07437-5_40; McDaniel T.L., 2009, CHI 09 HUM FACT COMP, P4669, DOI DOI 10.1145/1520340.1520718; McDaniel T, 2008, 2008 IEEE INTERNATIONAL WORKSHOP ON HAPTIC AUDIO VISUAL ENVIRONMENTS AND THEIR APPLICATIONS, P13, DOI 10.1109/HAVE.2008.4685291; Meijer PBL, 1992, IEEE T BIOMEDICAL EN, P112; Naraine MD, 2011, DISABIL SOC, V26, P389, DOI 10.1080/09687599.2011.567790; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Olszanowski M, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01516; Panchanathan S, 2016, IEEE J-STSP, V10, P942, DOI 10.1109/JSTSP.2016.2543681; Papadopoulos K, 2011, RES DEV DISABIL, V32, P1086, DOI 10.1016/j.ridd.2011.01.021; Spence C, 2014, MULTISENS RES, V27, P293, DOI 10.1163/22134808-00002452; ur Rehman Shafiq, 2008, Journal of Multimedia, V3, P18, DOI 10.4304/jmm.3.3.18-25; Van der Geest T. M., 2015, MENSCH COMPUTER 2015, P383; van der Schalk J, 2011, EMOTION, V11, P907, DOI 10.1037/a0023853; Van Erp J.B., 2002, PROC EUROHAPTICS, V2002, P18; vanErp JBF, EMOTION, P80; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wang YL, 2016, INT J HUM-COMPUT ST, V89, P24, DOI 10.1016/j.ijhcs.2016.01.004	41	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194737	10.1371/journal.pone.0194737	http://dx.doi.org/10.1371/journal.pone.0194737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584738	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000033
J	Dhaouadi, T; Chahbi, M; Haouami, Y; Sfar, M; Abdelmoula, L; Ben Abdallah, T; Gorgi, Y				Dhaouadi, Tarak; Chahbi, Mayssa; Haouami, Youssra; Sfar, Men; Abdelmoula, Leila; Ben Abdallah, Taieb; Gorgi, Yousr			IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis	PLOS ONE			English	Article							GENE POLYMORPHISMS; HOST-DEFENSE; T-CELLS; ASSOCIATION; PATHOGENESIS; CYTOKINES; JOINT; MICE	Background Interleukin-17 (IL-17), a cytokine mainly secreted by Th17 cells, seems to play a significant role in the pathogenesis of rheumatoid arthritis (RA). Functional genetic polymorphisms in IL-17 and its receptor genes can influence either qualitatively or quantitatively their functions. Therefore, we aimed to study the impact of IL17-A and IL17RC polymorphisms on plasma level of IL-17 and RA susceptibility and severity. Methods In this context, IL-17A*rs2275913 and IL-17RC*rs708567 polymorphisms were investigated together with the quantification of IL17 plasma level in 115 RA patients and 91 healthy control subjects matched in age, sex and ethnic origin. Results There were no statistically significant associations between IL-17A and IL-17RC studied polymorphisms and RA susceptibility. In contrast, IL-17A plasma levels were significantly higher in patients (55.07 pg/ml) comparatively to controls (4.75 pg/ml), p<10E-12. A ROC curve was used to evaluate the performance of plasma IL-17 in detecting RA. Given 100% specificity, the highest sensitivity of plasma IL-17A was 61.7% at a cut-off value of 18.25 pg/ml; p < 10E-21, CI = [0.849-0.939]. Analytic results showed that the IgM-rheumatoid factor and anti-CCP antibodies were significantly less frequent in patients with the IL-17RC*A/A genotype than those carrying *G/G and *G/A genotypes; p = 0.013 and p = 0.015, respectively. Otherwise, IL-17 plasma levels analysis showed a significant association with the activity of RA (DAS28 >= 5.1 = 74.71 pg/ml vs. DAS28<5.1 = 11.96 pg/ml), p<10E-6. Conclusion IL-17A*rs2275913 (G/A) and IL-17RC*rs708567 (G/A) polymorphisms did not seem to influence RA susceptibility in Tunisian population. This result agrees with those reported previously. Plasma IL-17A level seems to be predictive of severe RA occurrence.	[Dhaouadi, Tarak; Chahbi, Mayssa; Haouami, Youssra; Sfar, Men; Ben Abdallah, Taieb; Gorgi, Yousr] Charles Nicolle Hosp, Res Lab Immunol Renal Transplantat & Immunopathol, Tunis, Tunisia; [Abdelmoula, Leila] Charles Nicolle Hosp, Dept Rheumatol, Tunis, Tunisia	Universite de Tunis-El-Manar; Hopital Charles Nicolle; Universite de Tunis-El-Manar; Hopital Charles Nicolle	Dhaouadi, T (corresponding author), Charles Nicolle Hosp, Res Lab Immunol Renal Transplantat & Immunopathol, Tunis, Tunisia.	dhaouaditarak@yahoo.fr	Dhaouadi, Tarak/O-2170-2019; Dhaouadi, Tarak/W-7013-2018	Dhaouadi, Tarak/0000-0002-6376-0950; Dhaouadi, Tarak/0000-0002-6376-0950; CHEIKHROUHOU ABDELMOULA, Leila/0000-0003-2000-4415; dhaouadi, tarak/0000-0003-1698-6938	Research Laboratory in Immunology of Renal Transplantation and Immunopathology, Charles Nicolle Hospital, Tunis El Manar University, Tunisia [LR03SP01]	Research Laboratory in Immunology of Renal Transplantation and Immunopathology, Charles Nicolle Hospital, Tunis El Manar University, Tunisia	This study was granted and supported by the Research Laboratory in Immunology of Renal Transplantation and Immunopathology (LR03SP01), Charles Nicolle Hospital, Tunis El Manar University, Tunisia.	Aletaha D, 2010, ARTHRITIS RHEUM, V62; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Azizi G, 2013, INT J RHEUM DIS, V16, P243, DOI 10.1111/1756-185X.12132; Bogunia-Kubik K, 2015, ARCH IMMUNOL THER EX, V63, P215, DOI 10.1007/s00005-014-0319-5; Carvalho CN, 2016, CLIN ORAL INVEST, V20, P495, DOI 10.1007/s00784-015-1540-2; Chen DY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3431; Cope AP, 2007, CLIN EXP RHEUMATOL, V25, pS4; Dong WJ, 2012, AUTOIMMUN REV, V11, P844, DOI 10.1016/j.autrev.2012.02.019; Dunstan SJ, 2012, GENES IMMUN, V13, P503, DOI 10.1038/gene.2012.25; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Geremia A, 2012, EXPERT REV GASTROENT, V6, P223, DOI [10.1586/EGH.11.107, 10.1586/egh.11.107]; Gullick NJ, 2013, CLIN EXP IMMUNOL, V174, P292, DOI 10.1111/cei.12167; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kunwar S, 2016, RHEUMATOL INT, V36, P1065, DOI 10.1007/s00296-016-3480-9; Lee Y., 2017, P IEEE ICTON 2017, P1; Lewis BJ, 2013, CLIN EXP IMMUNOL, V173, P38, DOI 10.1111/cei.12086; Louahchi S, 2016, ACTA REUMATOL PORT, V41, P151; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2002, INFLAMM RES, V51, P102, DOI 10.1007/BF02684010; Marwa OS, 2017, IMMUNOL LETT, V183, P24, DOI 10.1016/j.imlet.2017.01.013; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pavlovic V, 2014, J RES MED SCI, V19, P18; Pawlik A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1064-1; Rushansky E, 2017, ARCH IMMUNOL THER EX, P25; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Shen L, 2015, GENE, V566, P18, DOI 10.1016/j.gene.2015.04.028; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Zhou S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-181	35	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194883	10.1371/journal.pone.0194883	http://dx.doi.org/10.1371/journal.pone.0194883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584788	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000047
J	Schmidt, N; Schulze, J; Warwas, DP; Ehlert, N; Lenarz, T; Warnecke, A; Behrens, P				Schmidt, Nadeschda; Schulze, Jennifer; Warwas, Dawid P.; Ehlert, Nina; Lenarz, Thomas; Warnecke, Athanasia; Behrens, Peter			Long-term delivery of brain-derived neurotrophic factor (BDNF) from nanoporous silica nanoparticles improves the survival of spiral ganglion neurons in vitro	PLOS ONE			English	Article							MESOPOROUS SILICA; AUDITORY NEURONS; DRUG-DELIVERY; ELECTRICAL-STIMULATION; INNER-EAR; CELL SURVIVAL; NEURITE OUTGROWTH; COCHLEAR IMPLANTS; DELAYED TREATMENT; DEGENERATION	Sensorineural hearing loss (SNHL) can be overcome by electrical stimulation of spiral ganglion neurons (SGNs) via a cochlear implant (CI). Restricted CI performance results from the spatial gap between the SGNs and the electrode, but the efficacy of CI is also limited by the degeneration of SGNs as one consequence of SHNL. In the healthy cochlea, the survival of SGNs is assured by endogenous neurotrophic support. Several applications of exogenous neurotrophic supply have been shown to reduce SGN degeneration in vitro and in vivo. In the present study, nanoporous silica nanoparticles (NPSNPs), with an approximate diameter of <100 nm, were loaded with the brain-derived neurotrophic factor (BDNF) to test their efficacy as long-term delivery system for neurotrophins. The neurotrophic factor was released constantly from the NPSNPs over a release period of 80 days when the surface of the nanoparticles had been modified with amino groups. Cell culture investigations with NIH3T3 fibroblasts attest a good general cytocompatibility of the NPSNPs. In vitro experiments with SGNs indicate a significantly higher survival rate of SGNs in cell cultures that contained BDNF-loaded nanoparticles compared to the control culture with unloaded NPSNPs (p<0.001). Importantly, also the amounts of BDNF released up to a time period of 39 days increased the survival rate of SGNs. Thus, NPSNPs carrying BDNF are suitable for the treatment of inner ear disease and for the protection and the support of SGNs. Their nanoscale nature and the fact that a direct contact of the nanoparticles and the SGNs is not necessary for neuroprotective effects, should allow for the facile preparation of nanocomposites, e.g., with biocompatible polymers, to install coatings on implants for the realization of implant-based growth factor delivery systems.	[Schmidt, Nadeschda; Warwas, Dawid P.; Ehlert, Nina; Behrens, Peter] Leibniz Univ Hannover, Inst Anorgan Chem, Hannover, Germany; [Schmidt, Nadeschda; Schulze, Jennifer; Ehlert, Nina; Lenarz, Thomas; Warnecke, Athanasia; Behrens, Peter] Cluster Excellence Hearing4all, Hannover, Germany; [Schulze, Jennifer; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany	Leibniz University Hannover; Hannover Medical School	Behrens, P (corresponding author), Leibniz Univ Hannover, Inst Anorgan Chem, Hannover, Germany.; Behrens, P (corresponding author), Cluster Excellence Hearing4all, Hannover, Germany.	Peter.Behrens@acb.uni-hannover.de	Warnecke, Athanasia/HHC-6174-2022		DFG Cluster of Excellence [EXC 1077/1]	DFG Cluster of Excellence(German Research Foundation (DFG))	This work was supported by DFG Cluster of Excellence EXC 1077/1 "Hearing4all', http://hearing4all.eu, NS JS NE.	Agterberg MJH, 2008, HEARING RES, V244, P25, DOI 10.1016/j.heares.2008.07.004; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Bass JD, 2007, CHEM MATER, V19, P4349, DOI 10.1021/cm071305g; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bohne BA, 2000, AM J OTOL, V21, P505; BROWN JN, 1993, HEARING RES, V70, P167, DOI 10.1016/0378-5955(93)90155-T; Bukara K, 2016, EUR J PHARM BIOPHARM, V108, P220, DOI 10.1016/j.ejpb.2016.08.020; Cauda V, 2010, MICROPOR MESOPOR MAT, V132, P60, DOI 10.1016/j.micromeso.2009.11.015; Chikar JA, 2012, BIOMATERIALS, V33, P1982, DOI 10.1016/j.biomaterials.2011.11.052; Dee K. C., 2002, INTRO TISSUE BIOMATE; Di Santo S, 2014, NEUROREPORT, V25, P446, DOI 10.1097/WNR.0000000000000112; DUPONT J, 1993, HEARING RES, V68, P217, DOI 10.1016/0378-5955(93)90125-K; El Kechai N, 2015, INT J PHARMACEUT, V494, P83, DOI 10.1016/j.ijpharm.2015.08.015; Endo T, 2005, LARYNGOSCOPE, V115, P2016, DOI 10.1097/01.mlg.0000183020.32435.59; Frick C, 2017, COLLOID SURFACE B, V149, P105, DOI 10.1016/j.colsurfb.2016.10.003; Geral Claire, 2013, Pharmaceutics, V5, P127, DOI 10.3390/pharmaceutics5010127; Gillespie LN, 2001, NEUROREPORT, V12, P275, DOI 10.1097/00001756-200102120-00019; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x; Hardie NA, 1999, HEARING RES, V128, P147, DOI 10.1016/S0378-5955(98)00209-3; Hartley PG, 1997, LANGMUIR, V13, P2207, DOI 10.1021/la960997c; Havenith S, 2011, HEARING RES, V272, P168, DOI 10.1016/j.heares.2010.10.003; He QJ, 2011, SMALL, V7, P271, DOI 10.1002/smll.201001459; Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007; Kandalam S, 2017, ACTA BIOMATER, V49, P167, DOI 10.1016/j.actbio.2016.11.030; Kikkawa YS, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0280-4; Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021; Konerding WS, 2017, HEARING RES, V350, P110, DOI 10.1016/j.heares.2017.04.013; Kranz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092157; Kurakhmaeva KB, 2009, J DRUG TARGET, V17, P564, DOI 10.1080/10611860903112842; Leake PA, 1999, J COMP NEUROL, V412, P543, DOI 10.1002/(SICI)1096-9861(19991004)412:4<543::AID-CNE1>3.0.CO;2-3; Leake PA, 2013, JARO-J ASSOC RES OTO, V14, P187, DOI 10.1007/s10162-013-0372-5; Leake PA, 2011, J COMP NEUROL, V519, P1526, DOI 10.1002/cne.22582; Li H, 2017, BIOMATERIALS, V122, P1, DOI 10.1016/j.biomaterials.2016.12.020; Li LL, 2017, ADV DRUG DELIVER REV, V108, P2, DOI 10.1016/j.addr.2016.01.004; Li XQ, 2010, COLLOID SURFACE B, V75, P418, DOI 10.1016/j.colsurfb.2009.09.014; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; LOUSTEAU RJ, 1987, LARYNGOSCOPE, V97, P836; MCDONALD NQ, 1995, J BIOL CHEM, V270, P19669, DOI 10.1074/jbc.270.34.19669; Miller JM, 1997, INT J DEV NEUROSCI, V15, P631, DOI 10.1016/S0736-5748(96)00117-7; Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001; Neumann A, 2013, RSC ADV, V3, P24222, DOI 10.1039/c3ra44734k; Pakulska MM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600519; Praetorius M, 2007, ACTA OTO-LARYNGOL, V127, P486, DOI 10.1080/00016480600895102; Qiao ZA, 2009, CHEM MATER, V21, P3823, DOI 10.1021/cm901335k; Ramekers D, 2015, J NEUROSCI, V35, P12331, DOI 10.1523/JNEUROSCI.0096-15.2015; Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Roy S, 2012, NANOMEDICINE-UK, V7, P55, DOI [10.2217/NNM.11.84, 10.2217/nnm.11.84]; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Schendzielorz P, 2018, J BIOMED MATER RES B, V106, P1431, DOI 10.1002/jbm.b.33947; Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964; Schmidt DR, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P1, DOI 10.1007/978-0-387-98161-1_1; Senn P, 2017, OTOL NEUROTOL, V38, pE224, DOI 10.1097/MAO.0000000000001439; Shepherd RK, 2005, J COMP NEUROL, V486, P145, DOI 10.1002/cne.20564; Shibata SB, 2011, HEARING RES, V281, P56, DOI 10.1016/j.heares.2011.04.019; Slowing II, 2007, J AM CHEM SOC, V129, P8845, DOI 10.1021/ja0719780; Staecker H, 1998, OTOLARYNG HEAD NECK, V119, P7, DOI 10.1016/S0194-5998(98)70194-9; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Stover Timo, 2009, GMS Curr Top Otorhinolaryngol Head Neck Surg, V8, pDoc10, DOI 10.3205/cto000062; Tamura T, 2005, LARYNGOSCOPE, V115, P2000, DOI 10.1097/01.mlg.0000180174.81036.5a; Tan J, 2012, ADV MATER, V24, P3362, DOI 10.1002/adma.201200634; Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763; Timpe N., 2014, BIONANOMATERIALS, V15, P89, DOI [10.1515/bnm-2014-0010, DOI 10.1515/BNM-2014-0010]; Wang JG, 2010, CHEM MATER, V22, P3829, DOI 10.1021/cm101217k; Wang YJ, 2014, SMALL, V10, P4244, DOI 10.1002/smll.201401767; Wang Y, 2015, NANOMED-NANOTECHNOL, V11, P313, DOI 10.1016/j.nano.2014.09.014; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Wenz A., 2016, BIONANOMATERIALS, V17, P179, DOI [10.1515/bnm-2015-0018, DOI 10.1515/BNM-2015-0018, 10.1515/BNM-2015-0018]; Williams S, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5409-3; Wilson BS, 2008, J REHABIL RES DEV, V45, P695, DOI 10.1682/JRRD.2007.10.0173; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164867; Xie Y, 2005, J CONTROL RELEASE, V105, P106, DOI 10.1016/j.jconrel.2005.03.005; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012; ZIMMERMANN CE, 1995, HEARING RES, V90, P192, DOI 10.1016/0378-5955(95)00165-1; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	79	44	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194778	10.1371/journal.pone.0194778	http://dx.doi.org/10.1371/journal.pone.0194778			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584754	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000034
J	Ventura, M; Fusco, D; Bontempi, K; Colais, P; Davoli, M				Ventura, Martina; Fusco, Danilo; Bontempi, Katia; Colais, Paola; Davoli, Marina			Regional Outcome Evaluation Program (P.Re.Val.E.): Reduction of inequality in access to effective health care in the Lazio region of Italy (2012-2015)	PLOS ONE			English	Article							HIP FRACTURE; HOSPITAL PERFORMANCE; SOCIAL-CLASS; MYOCARDIAL-INFARCTION; ADMINISTRATIVE DATA; 30-DAY MORTALITY; QUALITY; IMPACT; SURGERY; GUIDELINES	Background Inequalities in health among groups of various socio-economic status (as measured by education, occupation, and income) constitute one of the main challenges for public health. Since 2006, the Lazio Regional Outcome Evaluation Program (P.Re.Val.E.), presents a set of indicators of hospital performance based on quality standards driven by strong clinical recommendations, and measures the variation in the access to effective health care for different population groups and providers in the Lazio Region. One of the aims of the program was to compare population subgroups in order to promote equity in service provision. Since June 2013, a new management strategy has been put in place that assigned specific goals based on performance assessment to the chief executive officers of the hospitals. Aim To evaluate whether, in recent years, there has been a reduction in the differential access to effective health care, among individuals with different educational levels. Methods We enrolled all patients discharged from both public and private hospitals of the Lazio region between 2012 and 2015, living in Lazio region. We analysed the proportion of patients with ST-elevation myocardial infarction (STEM I) treated with percutaneous coronary intervention within 90 minutes (primary PCI), the proportion of patients with hip fracture (HF) who underwent surgery within 2 days, and the proportion of women with primary C-section. We applied multivariate logistic regression models to assess the effect of educational level on health outcomes, adjusting for demographic characteristics and comorbidities that could affect the outcomes. For each year of the study period, we compared adjusted proportions of outcomes for the highest and the lowest level of education by using percentage differences. Results In the Lazio region, 44.6% of STEMI patients (N = 3,299) were treated with primary PCI, 54.4% of patients with hip fractures (N = 6,602) underwent surgery within 2 days, and 27.7% of women without a previous C-section (N = 34,718) delivered via C-section, in 2015. The corresponding proportions in 2012 were 27.8%, 31.3% and 31.5%, respectively. By comparing the adjusted proportions in patients with the highest education level (a university degree or higher) to those with the lowest level education level (None/Primary school), a decrease in the percentage difference was observed during the study period. In STEMI and delivery cohorts, the improvement of outcomes involved the least and the most educated patients, respectively, and the difference between the two educational levels was close to zero in 2015, whereas for hip patients, the improvement was more evident among the less educated patients. Conclusions In the Lazio region, we observed a reduction in the differential access to effective heath care by educational level, in different clinical areas. Different factors might explain these results. On top of the public disclosure of outcome data, the management strategy applied in mid 2013 might have driven the overall improvement of the health system for the considered conditions, helping to achieve a fairer access to health.	[Ventura, Martina; Fusco, Danilo; Bontempi, Katia; Colais, Paola; Davoli, Marina] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy		Ventura, M (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	m.ventura@deplazio.it	Fusco, Danilo/AAB-8646-2019	Fusco, Danilo/0000-0003-1759-5621; Ventura, Martina/0000-0003-1732-9956; Colais, Paola/0000-0001-8566-2908				Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Ancona C, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-34; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2016, LAZIO REGIONAL OUTCO; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Barone AP, 2009, INT J QUAL HEALTH C, V21, P379, DOI 10.1093/intqhc/mzp046; Boccolini CS, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0444-3; Bohm E, 2015, CAN J SURG, V58, P257, DOI 10.1503/cjs.017714; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Cacciani L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175038; Caiazzo Antonio, 2004, Epidemiol Prev, V28, pi; Campanella P, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1543-y; Cesaroni Giulia, 2006, Epidemiol Prev, V30, P352; Chen HY, 2016, CLIN EPIDEMIOL, V8, P141, DOI 10.2147/CLEP.S102225; Colais P, 2013, INT J QUAL HEALTH C, V25, P239, DOI 10.1093/intqhc/mzs082; Colais P, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0140-y; Colais P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-393; DANIELS N, 1985, JUST HLTH CARE; Freitas PF, 2009, INT J GYNECOL OBSTET, V107, P198, DOI 10.1016/j.ijgo.2009.08.017; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Fusco D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-25; Glorioso V, 2014, HEALTH SERV RES, V49, P950, DOI 10.1111/1475-6773.12128; Hibbard JH, 2005, HEALTH AFFAIR, V24, P1150, DOI 10.1377/hlthaff.24.4.1150; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Jankovic J, 2010, EUR J PUBLIC HEALTH, V20, P389, DOI 10.1093/eurpub/ckp189; Krieger N, 1999, J EPIDEMIOL COMMUN H, V53, P612, DOI 10.1136/jech.53.10.612; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lansky D, 2002, HEALTH AFFAIR, V21, P52, DOI 10.1377/hlthaff.21.4.52; Lizarondo L, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0572-7; Lu LM, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0523-0; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Ma Marmot, 2015, HLTH GAP CHALLENGE U; Mak JCS, 2010, MED J AUSTRALIA, V192, P37, DOI 10.5694/j.1326-5377.2010.tb03400.x; Marra CA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-69; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; OECD, 2015, HLTH GLANC 2015 OECD, P114; Pinnarelli L, 2012, BMJ QUAL SAF, V21, P127, DOI 10.1136/bmjqs-2011-000218; Renzi C, 2012, HEALTH SERV RES, V47, P1880, DOI 10.1111/j.1475-6773.2012.01401.x; Rini F, 2009, Ann Ig, V21, P107; Ruger JenniferPrah., 2009, HLTH SOCIAL JUSTICE; Scottish Intercollegiate Guideline Network (SIGN), 2009, 111 SIGN; Serumaga Brian, 2011, BMJ, V342, pd108, DOI 10.1136/bmj.d108; Silva LM, 2007, BRAZ J MED BIOL RES, V40, P1187, DOI 10.1590/S0100-879X2006005000144; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Ventura M, 2013, EPIDEMIOL PREV, V37, P289; Werner RM, 2009, HEALTH SERV RES, V44, P1169, DOI 10.1111/j.1475-6773.2009.00967.x	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194972	10.1371/journal.pone.0194972	http://dx.doi.org/10.1371/journal.pone.0194972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584783	Green Published, gold, Green Submitted			2022-12-27	WOS:000428373000051
J	Savion, N; Levine, A; Kotev-Emeth, S; Abu-Shach, UB; Broday, L				Savion, Naphtali; Levine, Amir; Kotev-Emeth, Shlomo; Abu-Shach, Ulrike Bening; Broday, Limor			S-allylmercapto-N-acetylcysteine protects against oxidative stress and extends lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; REACTIVE OXYGEN; GLUTATHIONE; RESISTANCE; LONGEVITY; DAMAGE; SKN-1; INVOLVEMENT; INHIBITION; EXTENSION	S-allylmercapto-N-acetylcysteine (ASSNAC) was shown in our previous study to activate Nrf2-mediated processes and increase glutathione level and resistance to oxidative stress in cultured endothelial cells. In this study, we explored the antioxidant protective effect of ASSNAC in Caenorhabditis elegans (C. elegans). Treatment of gst-4 reporter strain (CL2166) with increasing concentrations of ASSNAC (0.2 to 20 mM) for 24 hours and with ASSNAC (10 mM) for various time periods demonstrated a significant concentration- and time-dependent increase in Glutathione S-transferase (GST) gene expression (up to 60-fold at 20 mM after 24 hours). In addition, ASSNAC (2 mM; 24 hours) treatment of C. elegans strains N2 (wild type strain), gst-4 reporter (CL2166) and temperature sensitive sterile strain (CF512) significantly increased GST enzyme activity by 1.9-, 1.5- and 1.8-fold, respectively. ASSNAC (2.0 mM; 24 hours) increased the reduced glutathione content in N2 and CF512 strains by 5.9- and 4.9-fold, respectively. Exposure of C. elegans (N2 strain) to a lethal concentration of H2O2 (3.5 mM; 120 min) resulted in death of 88% of the nematodes while pretreatment with ASSNAC (24 hours) reduced nematodes death in a concentration-dependent manner down to 8% at 2.0 mM. C. elegans nematodes (strain CF512) cultured on agar plates containing ASSNAC (0.5 to 5.0 mM) demonstrated a significant increase in lifespan compared to control (mean lifespan 26.45 +/- 0.64 versus 22.90 +/- 0.59 days; log-rank p <= 0.001 at 2.0 mM) with a maximal lifespan of 40 versus 36 days. In conclusion, ASSNAC up regulates the GST gene expression and enzyme activity as well as the glutathione content in C. elegans nematodes and thereby increases their resistance to oxidative stress and extends their lifespan.	[Savion, Naphtali; Levine, Amir; Kotev-Emeth, Shlomo] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Savion, Naphtali; Levine, Amir; Kotev-Emeth, Shlomo] Tel Aviv Univ, Goldschleger Eye Res Inst, Tel Aviv, Israel; [Levine, Amir; Abu-Shach, Ulrike Bening; Broday, Limor] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Savion, N (corresponding author), Tel Aviv Univ, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.; Savion, N (corresponding author), Tel Aviv Univ, Goldschleger Eye Res Inst, Tel Aviv, Israel.	eyeres@post.tau.ac.il	Savion, Naphtali/K-1013-2019	Levine, Amir/0000-0002-0062-1523	Israel Science Foundation [1878/15]; Israel Cancer Research Fund [PG-14-101]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund	This work was supported by the Israel Science Foundation-grant number 1878/15 (https://www.isf.org.il/#/) to LB and the Israel Cancer Research Fund-grant number PG-14-101 (https://www.icrfonline.org/) to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Blagosklonny MV, 2009, AGING-US, V1, P1; BRENNER S, 1974, GENETICS, V77, P71; Cascella R, 2014, FREE RADICAL BIO MED, V73, P127, DOI 10.1016/j.freeradbiomed.2014.05.004; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; Garigan D, 2002, GENETICS, V161, P1101; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Izigov N, 2011, FREE RADICAL BIO MED, V50, P1131, DOI 10.1016/j.freeradbiomed.2011.01.028; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim JS, 2017, BIOSCI J, V33, P411; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; Link CD, 2002, METHOD ENZYMOL, V353, P497; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maman M, 2013, J NEUROSCI, V33, P6102, DOI 10.1523/JNEUROSCI.4023-12.2013; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; MEISTER A, 1995, METHOD ENZYMOL, V252, P26; Moriwaki T, 2013, J CLIN BIOCHEM NUTR, V53, P81, DOI 10.3164/jcbn.13-11; Munoz MJ, 2003, GENETICS, V163, P171; Ogawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21611; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pallauf K, 2017, P NUTR SOC, V76, P145, DOI 10.1017/S0029665116000720; Powolny AA, 2011, EXP GERONTOL, V46, P441, DOI 10.1016/j.exger.2011.01.005; Rodriguez M, 2013, TRENDS GENET, V29, P367, DOI 10.1016/j.tig.2013.01.010; Rosenblat M, 2002, ATHEROSCLEROSIS, V163, P17, DOI 10.1016/S0021-9150(01)00744-4; Salgueiro WG, 2017, FREE RADICAL BIO MED, V110, P133, DOI 10.1016/j.freeradbiomed.2017.05.020; Salvioli S, 2007, EVID-BASED COMPL ALT, V4, P181, DOI 10.1093/ecam/nem043; Savion N, 2014, NEUROSCI LETT, V583, P108, DOI 10.1016/j.neulet.2014.09.034; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shurtz-Swirski R, 2001, DIABETES CARE, V24, P104, DOI 10.2337/diacare.24.1.104; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Urban N, 2017, REDOX BIOL, V11, P502, DOI 10.1016/j.redox.2016.12.003; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang Q, 2015, INT J MOL SCI, V16, P13885, DOI 10.3390/ijms160613885; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525	44	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194780	10.1371/journal.pone.0194780	http://dx.doi.org/10.1371/journal.pone.0194780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579097	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800054
J	Nirschl, JJ; Janowczyk, A; Peyster, EG; Frank, R; Margulies, KB; Feldman, MD; Madabhushi, A				Nirschl, Jeffrey J.; Janowczyk, Andrew; Peyster, Eliot G.; Frank, Renee; Margulies, Kenneth B.; Feldman, Michael D.; Madabhushi, Anant			A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&E tissue	PLOS ONE			English	Article							COLLEGE-OF-CARDIOLOGY; WORKING FORMULATION; NEURAL-NETWORKS; CLASS DISCOVERY; DIAGNOSIS; ASSOCIATION; INFORMATION; MANAGEMENT; DISEASE; UPDATE	Over 26 million people worldwide suffer from heart failure annually. When the cause of heart failure cannot be identified, endomyocardial biopsy (EMB) represents the gold-standard for the evaluation of disease. However, manual EMB interpretation has high inter-rater variability. Deep convolutional neural networks (CNNs) have been successfully applied to detect cancer, diabetic retinopathy, and dermatologic lesions from images. In this study, we develop a CNN classifier to detect clinical heart failure from H&E stained whole-slide images from a total of 209 patients, 104 patients were used for training and the remaining 105 patients for independent testing. The CNN was able to identify patients with heart failure or severe pathology with a 99% sensitivity and 94% specificity on the test set, outperforming conventional feature-engineering approaches. Importantly, the CNN outperformed two expert pathologists by nearly 20%. Our results suggest that deep learning analytics of EMB can be used to predict cardiac outcome.	[Nirschl, Jeffrey J.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Janowczyk, Andrew; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Peyster, Eliot G.; Margulies, Kenneth B.] Univ Penn, Cardiovasc Res Inst, Philadelphia, PA 19104 USA; [Frank, Renee; Feldman, Michael D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Case Western Reserve University; University of Pennsylvania; University of Pennsylvania	Madabhushi, A (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	axm788@case.edu	Madabhushi, Anant/AAG-2908-2019; Nirschl, Jeffrey/GYQ-5009-2022	Madabhushi, Anant/0000-0002-5741-0399; Nirschl, Jeffrey/0000-0001-6857-341X	National Cancer Institute of the National Institutes of Health [R01CA202752-01A1, R01CA208236-01A1, R01 CA216579-01A1, R21CA179327-01, R21CA195152-01, U24CA199374-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; National Center for Advancing Translational Sciences [TL1TR001880]; National Heart Lung and Blood Institute [R01-HL105993]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; National Institute of Diabetes and Digestive and Kidney Diseases (US) [5T32DK007470]; National Center for Research Resources [1 C06 RR12463-01]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Peer Reviewed Cancer Research Program [W81XWH-16-1-0329]; Case Comprehensive Cancer Center Pilot Grant; Ohio Third Frontier Technology Validation Fund; VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; I-Corps@Ohio Program; NINDS [F30NS092227]; NATIONAL CANCER INSTITUTE [R01CA216579, U24CA199374, R01CA220581, R01CA208236, R01CA202752] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS092227] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DOD Prostate Cancer Synergistic Idea Development Award; National Institute of Diabetes and Digestive and Kidney Diseases (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOD Lung Cancer Idea Development New Investigator Award; DOD Peer Reviewed Cancer Research Program; Case Comprehensive Cancer Center Pilot Grant; Ohio Third Frontier Technology Validation Fund; VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; I-Corps@Ohio Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers (R01CA202752-01A1, R01CA208236-01A1, R01 CA216579-01A1, R21CA179327-01, R21CA195152-01 and U24CA199374-01) the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, The National Center for Advancing Translational Sciences under award number TL1TR001880, the National Heart Lung and Blood Institute under award number R01-HL105993, the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the National Institute of Diabetes and Digestive and Kidney Diseases (US) under award number 5T32DK007470, the National Center for Research Resources under award number under the award number 1 C06 RR12463-01, the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Peer Reviewed Cancer Research Program (W81XWH-16-1-0329), the Case Comprehensive Cancer Center Pilot Grant, The Ohio Third Frontier Technology Validation Fund, the VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University, the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering, the The Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University, and the I-Corps@Ohio Program. JJN was supported by NINDS F30NS092227. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Angelini A, 2011, J HEART LUNG TRANSPL, V30, P1214, DOI 10.1016/j.healun.2011.05.011; Basavanhally Ajay, 2011, J Pathol Inform, V2, pS1, DOI 10.4103/2153-3539.92027; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bhargava R, 2016, ANNU REV BIOMED ENG, V18, P387, DOI 10.1146/annurev-bioeng-112415-114722; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caccomo S., 2017, FDA ALLOWS MARKETING; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Cruz-Roa A, 2014, SPIE MED IMAGING SPI, P15; Cruz-Roa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46450; Dahl GE, 2013, INT CONF ACOUST SPEE, P8609, DOI 10.1109/ICASSP.2013.6639346; Doyle S, 2012, IEEE T BIO-MED ENG, V59, P1205, DOI 10.1109/TBME.2010.2053540; Duchi J, 2011, J MACH LEARN RES, V12, P2121; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Gho JMIH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094820; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; He K., 2015, DEEP RESIDUAL LEARNI, DOI DOI 10.1109/CVPR.2016.90; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; IOFFE S, 2015, ARXIV 1502 03167, V1502, P3167, DOI DOI 10.1007/S13398-014-0173-7.2; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Krizhevsky A., P 25 INT C NEUR INF, P1097; Lafarge MW, 2017, LECT NOTES COMPUT SC, V10553, P83, DOI 10.1007/978-3-319-67558-9_10; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097954; Lewis JS, 2014, AM J SURG PATHOL, V38, P128, DOI 10.1097/PAS.0000000000000086; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Madabhushi A, 2011, COMPUT MED IMAG GRAP, V35, P506, DOI 10.1016/j.compmedimag.2011.01.008; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nair V, 2010, PROC 27 TH INT C MAC, P807; Nirschl JJ, 2017, ELS MIC SOC BOOK SER, P179, DOI 10.1016/B978-0-12-810408-8.00011-0; Orlov N, 2008, PATTERN RECOGN LETT, V29, P1684, DOI 10.1016/j.patrec.2008.04.013; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Powers D., 2011, J MACH LEARN TECHNOL, V2, P37; Romo-Bucheli D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32706; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Wang DK, 2016, ALTRE MOD-RIV STUD L, P1, DOI 10.13130/2035-7680/6845; Wang HB, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.034003; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Williams E, 2017, NAT METHODS, V14, P775, DOI [10.1038/NMETH.4326, 10.1038/nmeth.4326]; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474	50	54	55	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0192726	10.1371/journal.pone.0192726	http://dx.doi.org/10.1371/journal.pone.0192726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614076	Green Submitted, gold, Green Published			2022-12-27	WOS:000429081600001
J	Gashaw, BT; Schei, B; Magnus, JH				Gashaw, Bosena Tebeje; Schei, Berit; Magnus, Jeanette H.			Social ecological factors and intimate partner violence in pregnancy	PLOS ONE			English	Article							DOMESTIC VIOLENCE; WOMENS HEALTH; PREVALENCE; ETHIOPIA; DISTRICT; MULTICOUNTRY; DETERMINANTS; ABUSE	Background Intimate partner violence (IPV) during pregnancy increases adverse pregnancy outcomes. Knowledge of societal, community, family and individual related factors associated with IPV in pregnancy is limited in Ethiopia. Our study examined these factors in an Ethiopian context. Materials and methods A cross sectional study was conducted among pregnant women attending antenatal care at governmental health institutions, using a consecutive probability sampling strategy. A total of 720 pregnant women were interviewed by five trained nurses or midwives, using a standardized and/pretested survey questionnaire. Bivariate and multivariate logistic regression analyses were applied to assess factors contributing to IPV. We used Akaike's information criteria, to identify the model that best describes the factors influencing IPV in pregnancy. Results Among the women interviewed, physical IPV was reported by 35.6%, and lifetime emotional or physical abuse by 81.0%. Perceiving violence as a means to settle interpersonal conflicts, presence of supportive attitudes of wife beating in the society, regarding violence as an expression of masculinity, and presence of strict gender role differences in the society, were all positively associated to IPV in pregnancy. The presence of groups legitimizing men's violence in the community, feeling isolated, having no social support for victims, and presence of high unemployment, were the perceived community related factors positively associated with IPV in pregnancy. Conclusion IPV in pregnancy is very prevalent in Ethiopia and is associated with multiple social ecologic factors. Reduction of IPV in pregnancy calls for cross sectorial efforts from stakeholders at different levels.	[Gashaw, Bosena Tebeje] Jimma Univ, Coll Hlth Sci, Jimma, Ethiopia; [Gashaw, Bosena Tebeje; Magnus, Jeanette H.] Univ Oslo, Fac Med, Oslo, Norway; [Schei, Berit] Univ Sci & Technol, Dept Publ Hlth & Nursing, Fac Med & Hlth Sci, Trondheim, Norway; [Schei, Berit] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Obstet & Gynaecol, Trondheim, Norway; [Magnus, Jeanette H.] Tulane Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA	Jimma University; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Tulane University	Gashaw, BT (corresponding author), Jimma Univ, Coll Hlth Sci, Jimma, Ethiopia.; Gashaw, BT (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	bosenatebeje@yahoo.co.uk		Gashaw, Bosena Tebeje/0000-0001-6337-8404				Abate BA, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0294-6; Abeya SG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-913; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Agresti A., 2003, CATEGORICAL DATA ANA, P211; [Anonymous], 2014, VIOLENCE AGAINST WOM; Antai D, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-128; Awusi V, 2009, BENIN J POSTGRADUATE, V11; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P3, DOI 10.4314/ejhs.v24i0.2S; Burnham K P, 2003, MODEL SELECT MULTIMO; Burnham KP, 2013, MODEL SELECTION INFE; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; CDC, 2016, RISK PROT FACT INT P; Crofford LJ, 2007, TRAUMA VIOLENCE ABUS, V8, P299, DOI 10.1177/1524838007303196; Daoud N, 2012, AM J PUBLIC HEALTH, V102, P1893, DOI 10.2105/AJPH.2012.300843; Demelash H, 2015, OBSTET GYNECOL INT, V2015, DOI 10.1155/2015/394875; Deribe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036189; Deshpande Neha A, 2013, Rev Obstet Gynecol, V6, P141; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; Dibaba Y, 2008, TROP DOCT, V38, P52, DOI 10.1258/td.2007.060190; ELLSBERG M, 2005, RESEARCHING VIOLENCE; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Garcia-Moreno C, 2016, B WORLD HEALTH ORGAN, V94, P396, DOI 10.2471/BLT.16.172205; Gebrezgi BH, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0337-y; Gyuse ANI, 2009, S AFR FAM PRACT, V51, P343, DOI 10.1080/20786204.2009.10873877; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Ho R., 2006, HDB UNIVARIATE MULTI; Hoque M. E., 2009, Southern African Journal of Epidemiology & Infection, V24, P34; Ibrahim ZM, 2015, CLIN EXP OBSTET GYN, V42, P212, DOI 10.12891/ceog1829.2015; Idoko P, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0023-x; Jasinski Jana L, 2004, Trauma Violence Abuse, V5, P47, DOI 10.1177/1524838003259322; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Karaoglu L, 2006, EUR J PUBLIC HEALTH, V16, P149, DOI 10.1093/eurpub/cki161; Kaye D, 2001, CENTRAL AFRICAN J ME, V48, P64; Khawaja M, 2008, J FAM VIOLENCE, V23, P211, DOI 10.1007/s10896-007-9146-3; Koenig MA, 2006, AM J PUBLIC HEALTH, V96, P132, DOI 10.2105/AJPH.2004.050872; Laelago T., 2014, OPEN ACCESS LIB J, V1, P1, DOI DOI 10.4236/oalib.1100997; Li Q, 2010, AM J PUBLIC HEALTH, V100, P531, DOI 10.2105/AJPH.2008.151159; Makayoto LA, 2013, MATERN CHILD HLTH J, V17, P441, DOI 10.1007/s10995-012-1015-x; Martz E, 2013, ENOUGH IS ENOUGH HAN, V6, P2014; Mbokota M, 2003, SAMJ S AFR MED J, V93, P455; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; Nasir K, 2003, EUR J PUBLIC HEALTH, V13, P105, DOI 10.1093/eurpub/13.2.105; Natarajan M, 2017, DOMESTIC VIOLENCE 5; National Center for Injury Prevention and Control DoVPC, 2014, SOC EC MOD FRAM PREV; Ntaganira J, 2009, RURAL REMOTE HEALTH, V9; Pun KD, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31964; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Royston P., 2008, MULTIVARIABLE MODEL; Rurangirwa AA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013155; Semahegn A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0072-1; Shadigian EM, 2005, OBSTET GYNECOL SURV, V60, P183, DOI 10.1097/01.ogx.0000155967.72418.6b; Shamu S, 2013, TROP MED INT HEALTH, V18, P696, DOI 10.1111/tmi.12078; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Sigalla GN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172540; Snipes M., 2014, Wine Economics and Policy, V3, P3, DOI 10.1016/j.wep.2014.03.001; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Uthman OA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027738; World Health Organization, 2011, INT PARTN VIOL PREGN; World Health Organization, UND ADDR VIOL WOM IN; Yaya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096294; Yigzaw T, 2010, ETHIOPIAN J HLTH DEV, V24; Yimer T, 2014, ADV PUBLIC HLTH, V2014	62	25	26	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194681	10.1371/journal.pone.0194681	http://dx.doi.org/10.1371/journal.pone.0194681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596497	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000037
J	Nishikawa, Y; Ikeda, Y; Murakami, H; Hori, SI; Hino, K; Sasaki, C; Nishikawa, M				Nishikawa, Yoshiyuki; Ikeda, Yoshio; Murakami, Hidehiro; Hori, Shin-Ichiro; Hino, Kaori; Sasaki, Chise; Nishikawa, Megumi			Classification of atrophic mucosal patterns on Blue LASER Imaging for endoscopic diagnosis of Helicobacter pylori-related gastritis: A retrospective, observational study	PLOS ONE			English	Article							C-13-UREA BREATH TEST; INFECTION; METAANALYSIS; HISTOLOGY; SEROLOGY; KITS	Background Atrophic gastritis can be classified according to characteristic mucosal patterns observed by Blue LASER Imaging (BLI) in a medium-range to distant view. Aims To facilitate the endoscopic diagnosis of Helicobacter pylori (HP)-related gastritis, we investigated whether atrophic mucosal patterns correlated with HP infection based on the image interpretations of three endoscopists blinded to clinical features. Methods This study included 441 patients diagnosed as having atrophic gastritis by upper gastrointestinal endoscopy at Nishikawa Gastrointestinal Clinic between April 1, 2015 and March 31, 2016. The presence/absence of HP infection was not taken into consideration. Endoscopy was performed using a Fujifilm EG-L580NW scope. Atrophic mucosal patterns observed by BLI were classified into Spotty, Cracked and Mottled. Image interpretation results were that 89, 122 and 228 patients had the Spotty, Cracked and Mottled patterns, respectively, and 2 patients an undetermined pattern. Further analyses were performed on 439 patients, excluding the 2 with undetermined patterns. Results The numbers of patients testing negative/positive for HP infection in the Spotty, Cracked and Mottled pattern groups were 12/77, 105/17, and 138/90, respectively. The specificity, positive predictive value and positive likelihood ratio for endoscopic diagnosis with positive HP infection based on the Spotty pattern were 95.3%, 86.5% and 8.9, respectively. In all patients with the Spotty pattern before HP eradication, the Cracked pattern was observed on subsequent post-eradication endoscopy. Conclusions The Spotty pattern may represent the presence of HP infection, the Cracked pattern, a post-inflammatory change as seen after HP eradication, and the Mottled pattern, intestinal metaplasia.	[Nishikawa, Yoshiyuki] Nishikawa Gastrointestinal Clin, Matsuyama, Ehime, Japan; [Ikeda, Yoshio] Ehime Univ Hosp, Endoscopy Ctr, Toon, Ehime, Japan; [Murakami, Hidehiro; Sasaki, Chise] Saiseikai Matsuyama Hosp, Dept Internal Med, Matsuyama, Ehime, Japan; [Hori, Shin-Ichiro; Hino, Kaori; Nishikawa, Megumi] Natl Hosp Org Shikoku Canc Ctr, Dept Gastroenterol, Matsuyama, Ehime, Japan	Ehime University	Nishikawa, Y (corresponding author), Nishikawa Gastrointestinal Clin, Matsuyama, Ehime, Japan.	yonishik@ehime.med.or.jp		NISHIKAWA, YOSHIYUKI/0000-0001-8162-9369				BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; FELDMAN RA, 1995, EUR J CLIN MICROBIOL, V14, P428, DOI 10.1007/BF02114899; Gisbert JP, 2004, ALIMENT PHARM THER, V20, P1001, DOI 10.1111/j.1365-2036.2004.02203.x; GRAHAM DY, 1987, LANCET, V1, P1174; Kimura K, 1969, ENDOSCOPY, V1, P1; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; LOGAN RPH, 1991, GUT, V32, P1461, DOI 10.1136/gut.32.12.1461; Loy CT, 1996, AM J GASTROENTEROL, V91, P1138; Miyamoto M, 2003, DIGEST DIS SCI, V48, P968, DOI 10.1023/A:1023016000096; Ohara S, 1998, J GASTROENTEROL, V33, P6, DOI 10.1007/PL00009968; Osawa H, 2014, DIGEST ENDOSC, V26, P105, DOI 10.1111/den.12205; Rokkas T, 2007, HELICOBACTER, V12, P32, DOI 10.1111/j.1523-5378.2007.00563.x; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Yoshida N, 2014, DIGEST ENDOSC, V26, P250, DOI 10.1111/den.12127	15	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193197	10.1371/journal.pone.0193197	http://dx.doi.org/10.1371/journal.pone.0193197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596454	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000006
J	Alamri, AS; Wood, RJ; Ivanusic, JJ; Brock, JA				Alamri, Abdulhakeem S.; Wood, Rhiannon J.; Ivanusic, Jason J.; Brock, James A.			The neurochemistry and morphology of functionally identified corneal polymodal nociceptors and cold thermoreceptors	PLOS ONE			English	Article							NERVE-TERMINAL IMPULSES; TRANSDUCTION SITES; A-DELTA; EXPRESSION; RECEPTORS; MOUSE; MECHANORECEPTORS; INNERVATION; ENDINGS; NEURONS	It is generally believed that the unencapsulated sensory nerve terminals of modality specific C-and A delta-neurons lack structural specialization. Here we determined the morphology of functionally defined polymodal receptors and cold thermoreceptors in the guinea pig corneal epithelium. Polymodal receptors and cold thermoreceptors were identified by extracellular recording at the surface of the corneal epithelium. After marking the recording sites, corneas were processed to reveal immunoreactivity for the transient receptor potential channels TRPV1 (transient receptor potential cation channel, subfamily V, member 1) or TPRM8 (transient receptor potential cation channel subfamily M member 8). Polymodal receptor nerve terminals (n = 6) were TRPV1-immunoreactive and derived from an axon that ascended from the sub-basal plexus to the squamous cell layer where it branched into fibers that ran parallel to the corneal surface and terminated with small bulbar endings (ramifying endings). Cold thermoreceptor nerve terminals were TRPM8-immunoreactive (n = 6) and originated from an axon that branched as it ascended through the wing cell and squamous cell layers and terminated with large bulbar endings (complex endings). These findings indicate that modality specific corneal sensory neurons with unencapsulated nerve endings have distinct nerve terminal morphologies that are likely to relate to their function.	[Alamri, Abdulhakeem S.; Wood, Rhiannon J.; Ivanusic, Jason J.; Brock, James A.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Alamri, Abdulhakeem S.] Taif Univ, Coll Appl Sci, Dept Clin Lab, At Taif, Saudi Arabia	University of Melbourne; Taif University	Brock, JA (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia.	j.brock@unimelb.edu.au	Ivanusic, Jason John/AAN-9056-2021; Brock, James A/A-2929-2012	Ivanusic, Jason John/0000-0002-7413-5704; Brock, James/0000-0002-1381-1983; Alamri, Abdulhakeem/0000-0003-3174-0434	Taif University/Ministry of Education, Saudi Arabia	Taif University/Ministry of Education, Saudi Arabia	Abdulhakeem Alamri was supported by a scholarship provided by Taif University/Ministry of Education, Saudi Arabia. Otherwise the authors received no specific funding for this work.	Abe J, 2005, MOL BRAIN RES, V136, P91, DOI 10.1016/j.molbrainres.2005.01.013; Alamri A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00071; Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; Belmonte Carlos, 2004, Ocul Surf, V2, P248; Belmonte C, 2017, OCUL SURF, V15, P404, DOI 10.1016/j.jtos.2017.05.002; Brock JA, 2001, J PHYSIOL-LONDON, V533, P493, DOI 10.1111/j.1469-7793.2001.0493a.x; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Bron R, 2014, J COMP NEUROL, V522, P2967, DOI 10.1002/cne.23560; Carr RW, 2009, J PHYSIOL-LONDON, V587, P1249, DOI 10.1113/jphysiol.2008.167023; Carr RW, 2003, J GEN PHYSIOL, V121, P427, DOI 10.1085/jgp.200308814; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Everaerts W, 2009, N-S ARCH PHARMACOL, V379, P421, DOI 10.1007/s00210-008-0391-7; Gonzalez-Gonzalez O, 2017, INVEST OPHTH VIS SCI, V58, P404, DOI 10.1167/iovs.16-20033; Heinricher MM, 2004, MICROELECTRODE RECORDING IN MOVEMENT DISORDER SURGERY, P8; HENSEL H, 1974, PFLUG ARCH EUR J PHY, V352, P1, DOI 10.1007/BF01061945; HEPPELMANN B, 1994, CELL TISSUE RES, V275, P493, DOI 10.1007/BF00318818; Heppelmann B, 2001, J COMP NEUROL, V441, P148, DOI 10.1002/cne.1403; HOLZER P, 1991, PHARMACOL REV, V43, P143; Ivanusic JJ, 2013, J COMP NEUROL, V521, P877, DOI 10.1002/cne.23207; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Li LS, 2014, ELIFE, V3, DOI 10.7554/eLife.01901; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lynn PA, 2003, GASTROENTEROLOGY, V125, P786, DOI 10.1016/S0016-5085(03)01050-3; MACIVER MB, 1993, J NEUROSCI, V13, P4511; MACIVER MB, 1993, J NEUROPHYSIOL, V69, P1779, DOI 10.1152/jn.1993.69.5.1779; Owens DM, 2014, COLD SPRING HARB PER, V4; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Zagorodnyuk VP, 2000, J NEUROSCI, V20, P6249, DOI 10.1523/JNEUROSCI.20-16-06249.2000; ZANDER E, 1951, J ANAT, V85, P68; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229	33	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195108	10.1371/journal.pone.0195108	http://dx.doi.org/10.1371/journal.pone.0195108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590195	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100103
J	Eckstein, T; Vidal-Henriquez, E; Bae, A; Zykov, V; Bodenschatz, E; Gholami, A				Eckstein, Torsten; Vidal-Henriquez, Estefania; Bae, Albert; Zykov, Vladimir; Bodenschatz, Eberhard; Gholami, Azam			Influence of fast advective flows on pattern formation of Dictyostelium discoideum	PLOS ONE			English	Article							CYCLIC-AMP; DIFFERENTIAL FLOW; SIGNAL PROPAGATION; PLANKTON DYNAMICS; SPIRAL WAVES; AGGREGATION; CELLS; MODEL; INSTABILITIES; TRANSDUCTION	We report experimental and numerical results on pattern formation of self-organizing Dictyostelium discoideum cells in a microfluidic setup under a constant buffer flow. The external flow advects the signaling molecule cyclic adenosine monophosphate (cAMP) downstream, while the chemotactic cells attached to the solid substrate are not transported with the flow. At high flow velocities, elongated cAMP waves are formed that cover the whole length of the channel and propagate both parallel and perpendicular to the flow direction. While the wave period and transverse propagation velocity are constant, parallel wave velocity and the wave width increase linearly with the imposed flow. We also observe that the acquired wave shape is highly dependent on the wave generation site and the strength of the imposed flow. We compared the wave shape and velocity with numerical simulations performed using a reaction-diffusion model and found excellent agreement. These results are expected to play an important role in understanding the process of pattern formation and aggregation of D. discoideum that may experience fluid flows in its natural habitat.	[Eckstein, Torsten; Vidal-Henriquez, Estefania; Bae, Albert; Zykov, Vladimir; Bodenschatz, Eberhard; Gholami, Azam] Max Planck Inst Dynam & Selforg, D-37077 Gottingen, Germany; [Bodenschatz, Eberhard] Univ Gottingen, Inst Nonlinear Dynam, D-37073 Gottingen, Germany; [Bodenschatz, Eberhard] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Bodenschatz, Eberhard] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Max Planck Society; University of Gottingen; Cornell University; Cornell University	Gholami, A (corresponding author), Max Planck Inst Dynam & Selforg, D-37077 Gottingen, Germany.	azam.gholami@ds.mpg.de		Vidal-Henriquez, Estefania/0000-0003-1244-5376; Eckstein, Torsten/0000-0001-9692-183X; Gholami, Azam/0000-0002-9332-4551	Deutsche Forschungsgemeinschaft (DFG) [GH 184/1-1]; Deutsche Akademische Austauschdienst (DAAD), Research Grants-Doctoral Programs in Germany; Federal Ministry of Education and Research of Germany; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD), Research Grants-Doctoral Programs in Germany; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	The authors thank M. S. Muller and K. Gunkel for their cheerful help with the preparation of the cells. T. E. acknowledges Deutsche Forschungsgemeinschaft (DFG), project number GH 184/1-1. E.V.H. thanks the Deutsche Akademische Austauschdienst (DAAD), Research Grants-Doctoral Programs in Germany. A.G. acknowledges MaxSynBio Consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society.; T. E. acknowledges Deutsche Forschungsgemeinschaft (DFG), project number GH 184/1-1. E.V.H. thanks the Deutsche Akademische Austauschdienst (DAAD), Research GrantsDoctoral Programs in Germany. A.G. acknowledges MaxSynBio Consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA F, 1974, J GEN MICROBIOL, V85, P321, DOI 10.1099/00221287-85-2-321; BONNER JT, 1947, J EXP ZOOL, V106, P1, DOI 10.1002/jez.1401060102; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; Edelstein A. D., 2014, J BIOL METHODS, V1; Egolf DA, 1998, PHYS REV LETT, V80, P3228, DOI 10.1103/PhysRevLett.80.3228; Ermakova EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004454; Geberth D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000422; Gholami A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/9/093040; Gholami A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/6/063007; Gholami A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.018103; GROSS JD, 1976, J CELL SCI, V22, P645; Hundsdorfer W., 2013, SPRINGER SER COMPUT, V33; Kaern M, 2002, J PHYS CHEM B, V106, P3751, DOI 10.1021/jp013541z; Kaern M, 2001, FARADAY DISCUSS, V120, P295, DOI 10.1039/b103244p; KESSLER DA, 1993, PHYS REV E, V48, P4801, DOI 10.1103/PhysRevE.48.4801; Lauzeral J, 1997, P NATL ACAD SCI USA, V94, P9153, DOI 10.1073/pnas.94.17.9153; Leconte M, 2004, J CHEM PHYS, V120, P7314, DOI 10.1063/1.1665555; Lee KJ, 1996, PHYS REV LETT, V76, P1174, DOI 10.1103/PhysRevLett.76.1174; MALCHOW H, 1995, ECOL MODEL, V82, P257, DOI 10.1016/0304-3800(94)00095-Y; Malchow H, 2000, J THEOR BIOL, V204, P639, DOI 10.1006/jtbi.2000.2074; Malchow H, 2000, FRESHWATER BIOL, V45, P239, DOI 10.1046/j.1365-2427.2000.00550.x; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; Merson R., 1957, P S DAT PROC, P1; MOSLEY MP, 1982, J HYDROL, V55, P65, DOI 10.1016/0022-1694(82)90121-4; Palsson E, 1996, P NATL ACAD SCI USA, V93, P1151, DOI 10.1073/pnas.93.3.1151; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; ROVINSKY AB, 1993, PHYS REV LETT, V70, P778, DOI 10.1103/PhysRevLett.70.778; ROVINSKY AB, 1992, PHYS REV LETT, V69, P1193, DOI 10.1103/PhysRevLett.69.1193; SCHEFFER M, 1991, J PLANKTON RES, V13, P1291, DOI 10.1093/plankt/13.6.1291; SIEGERT F, 1989, J CELL SCI, V93, P325; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; TYSON JJ, 1989, PHYSICA D, V34, P193, DOI 10.1016/0167-2789(89)90234-0; VANHAASTERT PJM, 1984, J GEN MICROBIOL, V130, P2559; Vidal-Henriquez E, 2017, CHAOS, V27, DOI 10.1063/1.4986153; Wessels D, 2004, EUKARYOT CELL, V3, P646, DOI 10.1128/EC.3.3.646-662.2004; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Wu XG, 1996, J PHYS CHEM-US, V100, P15810, DOI 10.1021/jp9603546	40	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194859	10.1371/journal.pone.0194859	http://dx.doi.org/10.1371/journal.pone.0194859			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590179	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100080
J	Nguyen, VT; Dawson, P; Zhang, QH; Harris, Z; Limesand, KH				Nguyen, Vicky T.; Dawson, Peter; Zhang, Qionghui; Harris, Zoey; Limesand, Kirsten H.			Administration of growth factors promotes salisphere formation from irradiated parotid salivary glands	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; HAIR FOLLICLE; NECK-CANCER; RADIATION; HOMEOSTASIS; EXPANSION; ORGANOGENESIS; REGENERATION; XEROSTOMIA	Worldwide, 500,000 cases of head and neck cancer (HNC) are reported each year and the primary treatment for HNC is radiotherapy. Although the goal of radiotherapy is to target the tumor, secondary exposure occurs in surrounding normal tissues, such as the salivary glands. As a result, despite successful treatment of the cancer, patients are left with long-term side effects due to direct damage to the salivary glands. The effect is chronic and currently there is no treatment. Stem cells are an attractive therapeutic option for treatment of radiation-induced glandular dysfunction because of the potential to regenerate damaged cell populations and restore salivary gland function. However, limited knowledge about the endogenous stem cell population post irradiation hinders the development for stem cell based therapies. In this study, an ex vivo sphere formation cell culture system was utilized to assess the self-renewal capacity of cells derived from parotid salivary glands at a chronic time point following radiation. Salivary glands from irradiated mice generate significantly fewer salispheres, but can be stimulated with fetal bovine serum (FBS) to generate an equivalent number of salispheres as unirradiated salivary glands. Interestingly, the number and size of salispheres formed is dependent on the concentration of FBS supplemented into the media. Salispheres derived from irradiated glands and cultured in FBS media were found to contain cells that proliferate and express progenitor and acinar cell markers such as Keratin 5, Keratin 14, Aquaporin 5, and NKCC1. Utilization of insulin-like growth factor (IGF1) injections following radiation treatment restores salivary gland function and improves salisphere generation. These findings indicate that stimulation of these cellular populations may provide a promising avenue for the development of cell-based therapies for radiation induced salivary gland damage.	[Nguyen, Vicky T.; Zhang, Qionghui; Harris, Zoey; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA; [Dawson, Peter] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA	University of Arizona; University of Arizona	Limesand, KH (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	limesank@u.arizona.edu		Dawson, Peter/0000-0002-9950-7439	 [R01 DE023534]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023534] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by R01 DE023534 to KHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Chibly AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107893; Chibly AM, 2014, J PALLIAT CARE MED, V4; Chong LM, 2003, IMRT HEAD NECK CANC, P191; Cmelak AJ, 2012, CRIT REV ONCOL HEMAT, V84, P261, DOI 10.1016/j.critrevonc.2012.04.004; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; Devi Seema, 2014, Natl J Maxillofac Surg, V5, P117, DOI 10.4103/0975-5950.154812; Fox NF, 2015, OR SURG OR MED OR PA, V120, P22, DOI 10.1016/j.oooo.2015.03.007; Furness S, 2013, COCHRANE DB SYST REV, V30; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Kwak M, 2015, STEM CELLS DEV, V24, P565, DOI 10.1089/scd.2014.0355; Limesand KH, 2006, MOL CELL BIOL, V26, P8840, DOI 10.1128/MCB.01846-05; Lin AL, 2001, ARCH ORAL BIOL, V46, P1085, DOI 10.1016/S0003-9969(01)00063-2; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2008, STEM CELLS, V26, P2595, DOI 10.1634/stemcells.2007-1034; Lombaert IMA, 2013, STEM CELL REP, V1, P604, DOI 10.1016/j.stemcr.2013.10.013; Lopez-Jornet P, 2012, J ORAL PATHOL MED, V41, P201, DOI 10.1111/j.1600-0714.2011.01088.x; Maimets M, 2015, RADIOTHER ONCOL, V116, P443, DOI 10.1016/j.radonc.2015.06.022; Manuel Iglesias J, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0077281; Marmary Y, 2016, CANCER RES, V76, P1170, DOI 10.1158/0008-5472.CAN-15-1671; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Nagle PW, 2016, INT J RADIAT ONCOL, V95, P103, DOI 10.1016/j.ijrobp.2016.02.020; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Okumura K, 2003, HEPATOLOGY, V38, P104, DOI 10.1053/jhep.2003.50259; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Pringle S, 2016, STEM CELLS, V34, P640, DOI 10.1002/stem.2278; Schmitt CA, 2011, NAT REV CLIN ONCOL, V8, P19; Shubin AD, 2017, ACTA BIOMATER, V50, P437, DOI 10.1016/j.actbio.2016.12.049; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Spielman A, 1981, ORAL SURG ORAL MED O, V4, P283; Tatsuishi Y, 2009, INT J MOL MED, V24, P361, DOI 10.3892/ijmm_00000240; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Rij CM, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-41; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xiao N, 2014, J CLIN INVEST, V124, P3364, DOI 10.1172/JCI74096; Xiong FL, 2011, CYTOTECHNOLOGY, V63, P621, DOI 10.1007/s10616-011-9379-0	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193942	10.1371/journal.pone.0193942	http://dx.doi.org/10.1371/journal.pone.0193942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590144	gold, Green Published, Green Submitted			2022-12-27	WOS:000428603100040
J	Nowacka, A; Smuczynski, W; Rosc, D; Dabrowska, KW; Sniegocki, M				Nowacka, Agnieszka; Smuczynski, Wojciech; Rosc, Danuta; Dabrowska, Kamila Wozniak; Sniegocki, Maciej			Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors	PLOS ONE			English	Article							BRAIN-TUMORS; ANGIOGENESIS; EXPRESSION	Angiogenesis plays an essential role in tumors development. In case of central nervous system tumors, the most important role in this process plays VEGF-A. The purpose of this study was to determine the plasma concentration of this agent in patients treated surgically because of intracranial tumors. The study involved 48 adult patients, both sexes, treated surgically because of a brain tumor. The control group consisted of 50 adult volunteers of both sexes, without cancer diagnosis. Based on the studies, it was found that serum VEGFA levels before surgery are higher in patients with central nervous system tumors (10.39-150.57 pg/ml, median 41.70 pg/ml) than in non -cancer patients (0.00-130.77 pg/ml, median 22.56 pg/ml). The association between serum VEGF-A level and malignancy and histological type of intracranial tumor has not beed confirmed. The highest average preoperative serum VEGF-A level was found in patients with low grade gliomas, slightly lower (close to each other) in those with high grade gliomas and meningiomas, while the lowest level was characteristic for metastatic tumors. High variation in results was observed in patients with low grade gliomas (52.56 pg/ml)-higher than those reported in patients with high grade gliomas (32.38 pg/ml). In the rest types of tumors the differentiation was similar and oscillated within 23.08-27.50 pg/ml.	[Nowacka, Agnieszka; Dabrowska, Kamila Wozniak; Sniegocki, Maciej] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Neurosurg Neurotraumatol & Paediat Neurosurg, Bydgoszcz, Poland; [Smuczynski, Wojciech] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Neurotraumatol, Bydgoszcz, Poland; [Rosc, Danuta] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Pathophysiol, Bydgoszcz, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Nowacka, A (corresponding author), Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Neurosurg Neurotraumatol & Paediat Neurosurg, Bydgoszcz, Poland.	dr.agnieszka.nowacka@gmail.com		Rosc, Danuta/0000-0002-2971-9882; Sniegocki, Maciej/0000-0003-3152-3755				Chiorean R, 2014, CANCER BIOMARK, V14, P185, DOI 10.3233/CBM-130310; Crocker M, 2011, NEURO-ONCOLOGY, V13, P99, DOI 10.1093/neuonc/noq170; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P456; Kim WY, 2009, FEBS J, V276, P4653, DOI 10.1111/j.1742-4658.2009.07177.x; Peles E, 2004, NEUROSURGERY, V55, P562, DOI 10.1227/01.NEU.0000134383.27713.9A; Rafat N, 2010, J NEUROSURG, V112, P43, DOI 10.3171/2009.5.JNS081074; Veikkola T, 2000, CANCER RES, V60, P203; Yang JG, 2017, INT J CLIN EXP MED, V10, P3606	9	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192395	10.1371/journal.pone.0192395	http://dx.doi.org/10.1371/journal.pone.0192395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590109	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100003
J	Jedrzejewski, W; Robinson, HS; Abarca, M; Zeller, KA; Velasquez, G; Paemelaere, EAD; Goldberg, JF; Payan, E; Hoogesteijn, R; Boede, EO; Schmidt, K; Lampo, M; Viloria, AL; Carreno, R; Robinson, N; Lukacs, PM; Nowak, JJ; Salom-Perez, R; Castaneda, F; Boron, V; Quigley, H				Jedrzejewski, Wlodzimierz; Robinson, Hugh S.; Abarca, Maria; Zeller, Katherine A.; Velasquez, Grisel; Paemelaere, Evi A. D.; Goldberg, Joshua F.; Payan, Esteban; Hoogesteijn, Rafael; Boede, Ernesto O.; Schmidt, Krzysztof; Lampo, Margarita; Viloria, Angel L.; Carreno, Rafael; Robinson, Nathaniel; Lukacs, Paul M.; Nowak, J. Joshua; Salom-Perez, Roberto; Castaneda, Franklin; Boron, Valeria; Quigley, Howard			Estimating large carnivore populations at global scale based on spatial predictions of density and distribution - Application to the jaguar (Panthera onca)	PLOS ONE			English	Article							HOME-RANGE SIZE; SPECIES DISTRIBUTION; CONSERVATION PLAN; TIGER DENSITIES; PROTECTED AREA; CAMERA TRAPS; FOREST; PRODUCTIVITY; SELECTION; ECOLOGY	Broad scale population estimates of declining species are desired for conservation efforts. However, for many secretive species including large carnivores, such estimates are often difficult. Based on published density estimates obtained through camera trapping, presence/absence data, and globally available predictive variables derived from satellite imagery, we modelled density and occurrence of a large carnivore, the jaguar, across the species' entire range. We then combined these models in a hierarchical framework to estimate the total population. Our models indicate that potential jaguar density is best predicted by measures of primary productivity, with the highest densities in the most productive tropical habitats and a clear declining gradient with distance from the equator. Jaguar distribution, in contrast, is determined by the combined effects of human impacts and environmental factors: probability of jaguar occurrence increased with forest cover, mean temperature, and annual precipitation and declined with increases in human foot print index and human density. Probability of occurrence was also significantly higher for protected areas than outside of them. We estimated the world's jaguar population at 173,000 (95% CI: 138,000-208,000) individuals, mostly concentrated in the Amazon Basin; elsewhere, populations tend to be small and fragmented. The high number of jaguars results from the large total area still occupied (almost 9 million km(2)) and low human densities (< 1 person/km(2)) coinciding with high primary productivity in the core area of jaguar range. Our results show the importance of protected areas for jaguar persistence. We conclude that combining modelling of density and distribution can reveal ecological patterns and processes at global scales, can provide robust estimates for use in species assessments, and can guide broad-scale conservation actions.	[Jedrzejewski, Wlodzimierz; Abarca, Maria; Velasquez, Grisel; Lampo, Margarita; Viloria, Angel L.; Carreno, Rafael] IVIC, Ctr Ecol, Caracas, Venezuela; [Robinson, Hugh S.; Paemelaere, Evi A. D.; Payan, Esteban; Hoogesteijn, Rafael; Salom-Perez, Roberto; Castaneda, Franklin; Quigley, Howard] Panthera, New York, NY USA; [Robinson, Hugh S.; Lukacs, Paul M.; Nowak, J. Joshua] Univ Montana, Wildlife Biol Program, Dept Ecosyst & Conservat Sci, WA Franke Coll Forestry & Conservat, Missoula, MT 59812 USA; [Zeller, Katherine A.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Goldberg, Joshua F.] Univ Calif Riverside, Evolut Ecol & Organismal Biol Program, Riverside, CA 92521 USA; [Boede, Ernesto O.] Fdn Desarrollo Ciencias Fis Matemat & Nat FUDECI, Caracas, Venezuela; [Schmidt, Krzysztof] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Robinson, Nathaniel] Univ Montana, WA Franke Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [Boron, Valeria] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England	Venezuelan Institute Science Research; University of Montana System; University of Montana; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Riverside; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Montana System; University of Montana; University of Kent	Jedrzejewski, W (corresponding author), IVIC, Ctr Ecol, Caracas, Venezuela.	wjedrzej1@gmail.com	Schmidt, Krzysztof/L-6437-2013	Lampo, Margarita/0000-0002-3669-701X; Schmidt, Krzysztof/0000-0002-9043-291X; Lukacs, Paul/0000-0002-3584-8314	Panthera (the Liz Claiborne Art Ortenberg Jaguar Research Grants); Institute Venezolano de Investigaciones Cientificas, IVIC; Polish Ministry of Science and Higher Education [NN304336339]	Panthera (the Liz Claiborne Art Ortenberg Jaguar Research Grants); Institute Venezolano de Investigaciones Cientificas, IVIC; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was funded by: (1) Panthera (the Liz Claiborne Art Ortenberg Jaguar Research Grants 2014, 2016) - WJ; (2) Institute Venezolano de Investigaciones Cientificas, IVIC (annual budgets) - WJ; (3) a grant from the Polish Ministry of Science and Higher Education (NN304336339) - KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2000, CONSERV BIOL, V14, P1001, DOI 10.1046/j.1523-1739.2000.99125.x; Astete S, 2017, J MAMMAL, V98, P464, DOI 10.1093/jmammal/gyw184; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Boron V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153973; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brodie J, 2013, J APPL ECOL, V50, P295, DOI 10.1111/1365-2664.12044; Burnham K P, 2003, MODEL SELECT MULTIMO; Carroll C, 2006, J APPL ECOL, V43, P1056, DOI 10.1111/j.1365-2664.2006.01237.x; Carvalho E.A.R., 2013, LAT AM J CONSERV, V3, P8; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Chavez C., 2016, JAGUAR SIGLO 21 PERS, P47; Cullen L, 2013, ZOOLOGIA-CURITIBA, V30, P379, DOI 10.1590/S1984-46702013000400003; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; Durant SM, 2017, P NATL ACAD SCI USA, V114, P528, DOI 10.1073/pnas.1611122114; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Efford M. G., 2012, DENSITY 5 0 SOFTWARE; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ferraz KMPMB, 2012, CAT NEWS, V7, P38; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gutierrez-Gonzalez CE, 2012, ORYX, V46, P431, DOI 10.1017/S003060531100041X; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoogesteijn Rafael, 1996, Bulletin of the Florida Museum of Natural History, V39, P195; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Ibisch PL, 2016, SCIENCE, V354, P1423, DOI 10.1126/science.aaf7166; IUCN, 1994, INT UN CONS NAT RED; IUCN, 2021, WIKIPEDIA; Jedrzejewska Bogumila, 2005, P230; Jedrzejewski W, 1996, ACTA THERIOL, V41, P1; Jedrzejewski W, 2007, ECOGRAPHY, V30, P66, DOI 10.1111/j.2006.0906-7590.04826.x; Jedrzejewski W, 2017, BIOL CONSERV, V209, P524, DOI 10.1016/j.biocon.2017.03.025; Jedrzejewski W, 2017, BIOL CONSERV, V206, P132, DOI 10.1016/j.biocon.2016.09.027; Jedrzejewski W, 2017, MAMMAL RES, V62, P9, DOI 10.1007/s13364-016-0300-2; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2004, ANIM CONSERV, V7, P285, DOI 10.1017/S1367943004001477; Karanth KU, 1998, ECOLOGY, V79, P2852; Kery M, 2015, APPL HIERARCHICAL MO, V1; Legagneux P, 2012, ECOLOGY, V93, P1707, DOI 10.1890/11-1973.1; Letnic M, 2017, GLOBAL ECOL BIOGEOGR, V26, P860, DOI 10.1111/geb.12593; Lieth H., 1975, PRIMARY PRODUCTIVITY, V14, P237, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Mateos Del Vas J, 2017, ANALISIS COMP PRODUC, P1, DOI [10.1017/S0030605316001046, DOI 10.1017/S0030605316001046]; McCain EB, 2008, J MAMMAL, V89, P1, DOI 10.1644/07-MAMM-F-268.1; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Miquelle Dale G., 2010, P325; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nilsen EB, 2005, ECOSCIENCE, V12, P68, DOI 10.2980/i1195-6860-12-1-68.1; Olsoy PJ, 2016, BIOL CONSERV, V203, P8, DOI 10.1016/j.biocon.2016.08.037; OTIS DL, 1978, WILDLIFE MONOGR, P1; Paviolo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37147; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pettorelli N, 2009, AM NAT, V173, P698, DOI 10.1086/597379; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Quigley H, IUCN RED LIST THREAT; QUIGLEY HB, 1992, BIOL CONSERV, V61, P149, DOI 10.1016/0006-3207(92)91111-5; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robinson JG, 2004, ANIM CONSERV, V7, P397, DOI 10.1017/S1367943004001532; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; SEYMOUR K L, 1989, Mammalian Species, P1, DOI 10.2307/3504096; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Sollmann Rahel, 2008, Cat News, P15; Stein A, 2016, PANTHERA PARDUS; Tabachnick B.G., 1983, USING MULTIVARIATE S; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Weber W, 1996, CONSERV BIOL, V10, P1046, DOI 10.1046/j.1523-1739.1996.10041046.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Yu-Sung S, 2012, R2JAGS PACKAGE RUNNI; ZELLER K., 2007, JAGUARS NEW MILLENNI; Zeller KA, 2011, BIOL CONSERV, V144, P892, DOI 10.1016/j.biocon.2010.12.003; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	99	52	56	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194719	10.1371/journal.pone.0194719	http://dx.doi.org/10.1371/journal.pone.0194719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579129	Green Published, gold, Green Submitted			2022-12-27	WOS:000428351800049
J	Chang, LM				Chang, Lucy M.			webpic: A flexible web application for collecting distance and count measurements from images	PLOS ONE			English	Article							CITIZEN SCIENCE; BIG DATA; CHALLENGES; FUTURE; LEAVES	Despite increasing ability to store and analyze large amounts of data for organismal and ecological studies, the process of collecting distance and count measurements from images has largely remained time consuming and error-prone, particularly for tasks for which automation is difficult or impossible. Improving the efficiency of these tasks, which allows for more high quality data to be collected in a shorter amount of time, is therefore a high priority. The open-source web application, webpic, implements common web languages and widely available libraries and productivity apps to streamline the process of collecting distance and count measurements from images. In this paper, I introduce the framework of webpic and demonstrate one readily available feature of this application, linear measurements, using fossil leaf specimens. This application fills the gap between workflows accomplishable by individuals through existing software and those accomplishable by large, unmoderated crowds. It demonstrates that flexible web languages can be used to streamline time-intensive research tasks without the use of specialized equipment or proprietary software and highlights the potential for web resources to facilitate data collection in research tasks and outreach activities with improved efficiency.	[Chang, Lucy M.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Chang, Lucy M.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Chang, Lucy M.] Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20560 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Smithsonian Institution; Smithsonian National Museum of Natural History	Chang, LM (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.; Chang, LM (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.; Chang, LM (corresponding author), Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20560 USA.	changlm@si.edu			National Science Foundation Graduate Research Fellowship [DGE 1106400]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 1106400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Burleigh JG, 2013, PLOS CURR TREE  0626; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang J, 2016, METHODS ECOL EVOL, V7, P472, DOI 10.1111/2041-210X.12508; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; Corney DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042112; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Good BM, 2013, BIOINFORMATICS, V29, P1925, DOI 10.1093/bioinformatics/btt333; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Liao FQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00915; Maloof JN, 2013, JOVE-J VIS EXP, DOI 10.3791/50028; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Wilf P, 2016, P NATL ACAD SCI USA, V113, P3305, DOI 10.1073/pnas.1524473113	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195184	10.1371/journal.pone.0195184	http://dx.doi.org/10.1371/journal.pone.0195184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608592	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800034
J	Srivastav, A; Santibanez, TA; Lu, PJ; Stringer, MC; Dever, JA; Bostwick, M; Kurtz, MS; Qualls, NL; Williams, WW				Srivastav, Anup; Santibanez, Tammy A.; Lu, Peng-Jun; Stringer, M. Christopher; Dever, Jill A.; Bostwick, Michael; Kurtz, Marshica Stanley; Qualls, Noreen L.; Williams, Walter W.			Preventive behaviors adults report using to avoid catching or spreading influenza, United States, 2015-16 influenza season	PLOS ONE			English	Article							SELF-REPORT; VACCINATION COVERAGE; ELDERLY OUTPATIENTS; PUBLIC-HEALTH; HAND HYGIENE; INTERVENTIONS; TRANSMISSION; POPULATIONS; VALIDATION; INFECTION	Introduction Influenza vaccination can prevent influenza and potentially serious influenza-related complications. Although the single best way to prevent influenza is annual vaccination, everyday preventive actions, including good hygiene, health, dietary, and social habits, might help, too. Several preventive measures are recommended, including: avoiding close contact with people who are sick; staying home when sick; covering your mouth and nose when coughing or sneezing; washing your hands often; avoiding touching your eyes, nose, and mouth; and practicing other good health habits like cleaning and disinfecting frequently touched surfaces, getting plenty of sleep, and drinking plenty of fluids. Understanding public acceptance and current usage of these preventive behaviors can be useful for planning both seasonal and pandemic influenza prevention campaigns. This study estimated the percentage of adults in the United States who reported practicing preventive behaviors to avoid catching or spreading influenza, and explored associations of reported behaviors with sociodemo-graphic factors. Methods We analyzed data from 2015 National Internet Flu Survey, a nationally representative probability-based Internet panel survey of the non-institutionalized U.S. population >= 18 years. The self-reported behaviors used to avoid catching or spreading influenza were grouped into four and three non-mutually exclusive subgroups, respectively. Weighted proportions were calculated. Multivariable logistic regression models were used to calculate adjusted prevalence differences and to determine independent associations between sociodemo-graphic characteristics and preventive behavior subgroups. Results Common preventive behaviors reported were: 83.2% wash hands often, 80.0% cover coughs and sneezes, 78.2% stay home if sick with a respiratory illness, 64.4% avoid people sick with a respiratory illness, 51.7% use hand sanitizers, 50.2% get treatment as soon as possible, and 49.8% report getting the influenza vaccination. Race/ethnicity, gender, age, education, income, region, receipt of influenza vaccination, and household size were associated with use of preventive behaviors after controlling for other factors. Conclusion Many adults in the United States reported using preventive behaviors to avoid catching or spreading influenza. Though vaccination is the most important tool available to prevent influenza, the addition of preventive behaviors might play an effective role in reducing or slowing transmission of influenza and complement prevention efforts.	[Srivastav, Anup] Leidos Inc, Atlanta, GA 30345 USA; [Srivastav, Anup; Santibanez, Tammy A.; Lu, Peng-Jun; Williams, Walter W.] Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Stringer, M. Christopher] US Census Bur, Demog Stat Methods Div, Durham, NC USA; [Dever, Jill A.] RTI Int, Div Stat & Data Sci, Washington, DC USA; [Bostwick, Michael; Kurtz, Marshica Stanley] RTI Int, Stat & Operat Res, Res Triangle Pk, NC USA; [Qualls, Noreen L.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Research Triangle Institute; Research Triangle Institute; Centers for Disease Control & Prevention - USA	Srivastav, A (corresponding author), Leidos Inc, Atlanta, GA 30345 USA.; Srivastav, A (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	xbs2@cdc.gov		Stanley, Marshica/0000-0002-3228-6440; Srivastav, Anup/0000-0001-9970-0872; Santibanez, Tammy A./0000-0002-5784-7427	Leidos Inc.	Leidos Inc.	Leidos Inc. is a U.S. government contractor agency, not a funder of the project. Leidos Inc. contributed no funds to the product only providing support in the form of salary for the lead author [AS]. Leidos Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 2016, ESTIMATED INFLUENZA; [Anonymous], 2015, NAT EARL SEAS FLU VA; Centers for Disease Control and Prevention, 2017, FLU VACC COV US 2016; Centers for Disease Control and Prevention, 2014, HLTH PEOPL 2020 TOP; Centers for Disease Control and Prevention (CDC), CDC NAT INFL VACC AW; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Foppa IM, 2015, VACCINE, V33, P3003, DOI 10.1016/j.vaccine.2015.02.042; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Grohskopf LA, 2017, MMWR RECOMM REP, V66, P3, DOI 10.15585/mmwr.rr6602a1; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Larson EL, 2012, AM J INFECT CONTROL, V40, P806, DOI 10.1016/j.ajic.2011.10.016; Lu PJ, 2013, AM J EPIDEMIOL, V178, P1478, DOI 10.1093/aje/kwt158; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mangtani P, 2007, EPIDEMIOL INFECT, V135, P139, DOI 10.1017/S0950268806006479; Phillipson L, 2013, CASES PUBLIC HLTH CO, V7, P99; Rolnick SJ, 2013, VACCINE, V31, P3928, DOI 10.1016/j.vaccine.2013.06.041; Stebbins S, 2009, J PUBLIC HEALTH MAN, V15, P112, DOI 10.1097/01.PHH.0000346007.66898.67; SteelFisher GK, 2015, INFLUENZA OTHER RESP, V9, P131, DOI 10.1111/irv.12306; Talaat M, 2011, EMERG INFECT DIS, V17, P619, DOI 10.3201/eid1704.101353; The American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C; Toner E, 2006, BIOSECUR BIOTERROR, V4, P84, DOI 10.1089/bsp.2006.4.84; Warren-Gash C, 2013, INFLUENZA OTHER RESP, V7, P738, DOI 10.1111/irv.12015; Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1; Wu SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148448; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4	29	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195085	10.1371/journal.pone.0195085	http://dx.doi.org/10.1371/journal.pone.0195085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601610	gold, Green Published, Green Submitted			2022-12-27	WOS:000428845900018
J	Gentile, A; Lucion, MF; Juarez, MD; Martinez, AC; Romanin, V; Bakir, J; Viegas, M; Mistchenko, A				Gentile, Angela; Florencia Lucion, Maria; del Valle Juarez, Maria; Clara Martinez, Ana; Romanin, Viviana; Bakir, Julia; Viegas, Mariana; Mistchenko, Alicia			Influenza virus: 16 years' experience of clinical epidemiologic patterns and associated infection factors in hospitalized children in Argentina	PLOS ONE			English	Article							SEASONALITY; OUTPATIENT; BRAZIL	Background Influenza is an important cause of acute lower respiratory tract infection (aLRTI), hospitalization, and mortality in children. This study aimed to describe the clinical and epidemiologic patterns and infection factors associated with influenza, and compare case features of influenza A and B. Methods In a prospective, cross-sectional study, patients admitted for aLRTI, between 2000 and 2015, were tested for respiratory syncytial virus, adenovirus, influenza, or parainfluenza, and confirmed by fluorescent antibody (FA) or real-time polymerase chain reaction (RT-PCR) assay of nasopharyngeal aspirates. Results Of 14,044 patients, 37.7% (5290) had FA-or RT-PCR-confirmed samples that identified influenza in 2.8% (394/14,044; 91.4% [360] influenza A, 8.6% [34] influenza B) of cases. Influenza frequency followed a seasonal epidemic pattern (May-July, the lowest average temperature months). The median age of cases was 12 months (interquartile range: 6-21 months); 56.1% (221/394) of cases were male. Consolidated pneumonia was the most frequent clinical presentation (56.9%; 224/394). Roughly half (49.7%; 196/394) of all cases had previous respiratory admissions; 9.4% (37/394) were re-admissions; 61.5% (241/392) had comorbidities; 26.2% (102/389) had complications; 7.8% (30/384) had nosocomial infections. The average case fatality rate was 2.1% (8/389). Chronic neurologic disease was significantly higher in influenza B cases compared to influenza A cases (p = 0.030). The independent predictors for influenza were: age >= 6 months, odds ratio (OR): 1.88 (95% confidence interval [CI]: 1.44-2.45); p< 0.001; presence of chronic neurologic disease, OR: 1.48 (95% CI: 1.01-2.17); p = 0.041; previous respiratory admissions, OR: 1.71 (95% CI: 1.36-2.14); p<0.001; re-admissions, OR: 1.71 (95% CI: 1.17-2.51); p = 0.006; clinical pneumonia, OR: 1.50 (95% CI: 1.21-1.87); p<0.001; immunodeficiency, OR: 1.87 (95% CI: 1.15-3.05); p = 0.011; cystic fibrosis, OR: 4.42 (95% CI: 1.29-15.14); p = 0.018. Conclusion Influenza showed an epidemic seasonal pattern (May-July), with higher risk in children >= 6 months, or with pneumonia, previous respiratory admissions, or certain comorbidities.	[Gentile, Angela; Florencia Lucion, Maria; del Valle Juarez, Maria; Clara Martinez, Ana; Romanin, Viviana; Bakir, Julia] Ricardo Gutierrez Childrens Hosp, Dept Epidemiol, Buenos Aires, DF, Argentina; [Viegas, Mariana; Mistchenko, Alicia] Ricardo Gutierrez Childrens Hosp, Dept Virol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Gentile, A (corresponding author), Ricardo Gutierrez Childrens Hosp, Dept Epidemiol, Buenos Aires, DF, Argentina.	angelagentile21@gmail.com		Gentile, Angela/0000-0002-1072-7700				Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Comite Nacional de Neumonologoia Comite Nacional de Infectologoia Comite de Medicina Interna, REC MAN INF RESP AG; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Dapat C, 2009, INTERVIROLOGY, V52, P310, DOI 10.1159/000237738; De Kirchner CEF, ABORDAJE INTERGAL IN; Arango AE, 2015, INFLUENZA OTHER RESP, V9, P1, DOI 10.1111/irv.12271; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Huai Y, 2017, INFLUENZA OTHER RESP, V11, P148, DOI 10.1111/irv.12419; Lucion MF, 2014, ARCH ARGENT PEDIATR, V112, P397, DOI [10.5546/aap.2014.397, 10.5546/aap.2014.eng.397]; Marcone DN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1213-4; McMorrow ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138272; Mosnier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136186; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Savy V, 2013, INFLUENZA OTHER RESP, V7, P1017, DOI 10.1111/irv.12036; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383	18	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195135	10.1371/journal.pone.0195135	http://dx.doi.org/10.1371/journal.pone.0195135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596527	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000082
J	Khan, Z; Khan, MA; Siddiqui, N; Ullah, M; Shah, Q				Khan, Zeeshan; Khan, Muhammad Altaf; Siddiqui, Nasir; Ullah, Murad; Shah, Qayyum			Solution of magnetohydrodynamic flow and heat transfer of radiative viscoelastic fluid with temperature dependent viscosity in wire coating analysis	PLOS ONE			English	Article							3RD GRADE FLUID; OLDROYD 8-CONSTANT FLUID; HOMOTOPY ANALYSIS METHOD; MHD FLOW; STRETCHING SHEET; MAGNETIC-FIELD; POROUS-MEDIUM; DIE DESIGN; EXTRUSION; EQUATIONS	Wire coating process is a continuous extrusion process for primary insulation of conducting wires with molten polymers for mechanical strength and protection in aggressive environments. In the present study, radiative melt polymer satisfying third grade fluid model is used for wire coating process. The effect of magnetic parameter, thermal radiation parameter and temperature dependent viscosity on wire coating analysis has been investigated. Reynolds model and Vogel's models have been incorporated for variable viscosity. The governing equations characterizing the flow and heat transfer phenomena are solved analytically by utilizing homotopy analysis method (HAM). The computed results are also verified by ND-Solve method (Numerical technique) and Adomian Decomposition Method (ADM). The effect of pertinent parameters is shown graphically. In addition, the instability of the flow in the flows of the wall of the extrusion die is well marked in the case of the Vogel model as pointed by Nhan-Phan-Thien.	[Khan, Zeeshan] Sarhad Univ Sci & Informat Technol, Dept Comp Sci, Peshawar, Pakistan; [Khan, Muhammad Altaf] City Univ Sci & IT, Dept Math, Peshawar, Pakistan; [Siddiqui, Nasir] Univ Engn & Technol, Dept Basic Sci, Taxila, Pakistan; [Ullah, Murad] Islamia Coll Univ Peshawar, Dept Math, Khyber Pakhtunkhwa, Pakistan; [Shah, Qayyum] Univ Engn & Technol Peshawar, Dept Basic Sci & Islamiat, Khyber Pakhtunkhwa, Pakistan	University of Engineering & Technology Taxila	Khan, Z (corresponding author), Sarhad Univ Sci & Informat Technol, Dept Comp Sci, Peshawar, Pakistan.	zeeshansuit@gmail.com	khan, zeeshan/I-5749-2015; Khan, Muhammad Altaf/K-2201-2013; Siddiqui, Nasir/R-1531-2019	khan, zeeshan/0000-0003-4044-5170; Khan, Muhammad Altaf/0000-0002-4483-7879; 				Abbas Z, 2006, THEOR COMP FLUID DYN, V20, P229, DOI 10.1007/s00162-006-0025-y; Abbasbandy S, 2007, INT COMMUN HEAT MASS, V34, P380, DOI 10.1016/j.icheatmasstransfer.2006.12.001; Abbasbandy S, 2006, PHYS LETT A, V360, P109, DOI 10.1016/j.physleta.2006.07.065; Abel M. S., 2015, ADV MATH PHY, V2012, P21; Abel S, 2005, INT J THERM SCI, V44, P465, DOI 10.1016/j.ijthermalsci.2004.08.005; Akter S, 1999, PROG ORG COAT, V37, P15, DOI 10.1016/S0300-9440(99)00045-4; Akter S., 1997, P 14 C IR MAN COMM I, P331; Bagley E. B., 1963, WIRE WIRE PROD, V38, P1104; Bewster MQ, 1972, THERMAL RAD TRANSFER; Bhukta D, 2016, ENG SCI TECHNOL, V19, P1910, DOI 10.1016/j.jestch.2016.08.001; CASWELL B, 1978, POLYM ENG SCI, V18, P416, DOI 10.1002/pen.760180514; Chen CH, 2010, INT J HEAT MASS TRAN, V53, P4264, DOI 10.1016/j.ijheatmasstransfer.2010.05.053; Chinyoka T, 2012, INT J NUMER METH FL, V69, P353, DOI 10.1002/fld.2562; Fata A, 2011, INT REV MECH ENG, V5, P533; FENNER RT, 1967, T J PLAST I, V35, P701; HAN CD, 1978, POLYM ENG SCI, V18, P1019, DOI 10.1002/pen.760181309; Hayat T, 2004, ACTA MECH, V168, P213, DOI 10.1007/s00707-004-0085-2; Hayat T, 2004, INT J ENG SCI, V42, P123, DOI 10.1016/S0020-7225(03)00281-7; Hayat T, 2015, ALEX ENG J, V54, P205, DOI 10.1016/j.aej.2015.03.013; Kasajima M., 1973, APPL POLYM SYMP, V20, P221; Khan M, 2008, TRANSPORT POROUS MED, V71, P23, DOI 10.1007/s11242-007-9109-4; Liao SJ, 2007, INT J NONLIN MECH, V42, P819, DOI 10.1016/j.ijnonlinmec.2007.03.007; [廖世俊 Liao Shijun], 2008, [力学进展, Advances in Mechanics], V38, P1; Liu IC, 2004, INT J HEAT MASS TRAN, V47, P4427, DOI 10.1016/j.ijheatmasstransfer.2004.03.029; Mitsoulis E., 1986, ADV POLYM TECH, V6, P467, DOI [10.1002/adv.1986.060060405, DOI 10.1002/ADV.1986.060060405]; Nayak MK, 2016, MECCANICA, V51, P1699, DOI 10.1007/s11012-015-0329-3; Nayak MK, 2015, ARAB J SCI ENG, V40, P3029, DOI 10.1007/s13369-015-1805-8; Nayak MK, 2014, J APPL ANAL COMPUT, V4, P367; Nayak MK, 2014, INT J HEAT MASS TRAN, V79, P1087, DOI 10.1016/j.ijheatmasstransfer.2014.08.057; Nayak M. K., 2015, WIRE COATING ANAL; Oliveira PJ, 1999, J FLUID MECH, V387, P271, DOI 10.1017/S002211209900453X; Pinho FT, 2000, INT J HEAT MASS TRAN, V43, P2273, DOI 10.1016/S0017-9310(99)00303-8; Rahman MM, 2010, COMMUN NONLINEAR SCI, V15, P2073, DOI 10.1016/j.cnsns.2009.08.012; Rhaman MM, 2012, CAN J CHEM ENG, V90, P1631; Salem AM, 2007, PHYS LETT A, V369, P315, DOI 10.1016/j.physleta.2007.04.104; SARPKAYA T, 1961, AICHE J, V7, P324, DOI 10.1002/aic.690070231; SHAH REHAN ALI, 2011, Journal of the Korean Society for Industrial and Applied Mathematics, V15, P201; Shah RA, 2013, MATH COMPUT MODEL, V57, P1284, DOI 10.1016/j.mcm.2012.10.031; Shah RA, 2012, COMPUT MATH APPL, V63, P695, DOI 10.1016/j.camwa.2011.11.033; Shijun Liao, 2006, Communications in Nonlinear Science and Numerical Simulation, V11, P326, DOI 10.1016/j.cnsns.2004.09.004; Shuaib H., 2015, J APPL ENVIRON BIOL, V5, P25; Siddiqui AM, 2009, INT J NONLIN SCI NUM, V10, P247; Siddiqui AM., 2011, INT J PHYS SCI, V6, P4213; Tadmor Z., 1979, PRINCIPLE POLYM PROC; THIEN NP, 1977, J NON-NEWTON FLUID, V2, P353, DOI 10.1016/0377-0257(77)80021-9; Tucker C.L., 1989, COMPUTER MODELING PO, P311; Wagner R., 1985, ADV POLYM TECH, V5, P325, DOI [10.1002/adv.1985.060050404, DOI 10.1002/ADV.1985.060050404]	47	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194196	10.1371/journal.pone.0194196	http://dx.doi.org/10.1371/journal.pone.0194196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596448	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000019
J	Merlet, AN; Cattagni, T; Cornu, C; Jubeau, M				Merlet, Angele N.; Cattagni, Thomas; Cornu, Christophe; Jubeau, Marc			Effect of knee angle on neuromuscular assessment of plantar flexor muscles: A reliability study	PLOS ONE			English	Article							H-REFLEX; TRICEPS SURAE; HOFFMANN REFLEX; JOINT ANGLE; ELECTRICAL-STIMULATION; SPINAL EXCITABILITY; SUPRASPINAL FACTORS; SPORTS-MEDICINE; M-MAX; SOLEUS	Introduction This study aimed to determine the intra- and inter-session reliability of neuromuscular assessment of plantar flexor (PF) muscles at three knee angles. Methods Twelve young adults were tested for three knee angles (90 degrees, 30 degrees and 0 degrees) and at three time points separated by 1 hour (intra-session) and 7 days (inter-session). Electrical (H reflex, M wave) and mechanical (evoked and maximal voluntary torque, activation level) parameters were measured on the PF muscles. Intraclass correlation coefficients (ICC) and coefficients of variation were calculated to determine intra- and inter-session reliability. Results The mechanical measurements presented excellent (ICC> 0.75) intra-and inter-session reliabilities regardless of the knee angle considered. The reliability of electrical measurements was better for the 90 degrees knee angle compared to the 0 degrees and 30 degrees angles. Conclusions Changes in the knee angle may influence the reliability of neuromuscular assessments, which indicates the importance of considering the knee angle to collect consistent outcomes on the PF muscles.	[Merlet, Angele N.; Cattagni, Thomas; Cornu, Christophe; Jubeau, Marc] Univ Nantes, Fac Sport Sci, Lab Movement Interact Performance, Nantes, France; [Cattagni, Thomas] Raymond Poincare Teaching Hosp, AP HP, Team Technol & Innovat Therapies Appl Neuromuscul, UVSQ,CIC 805,Physiol Funct Testing Ward,Inserm Un, Garches, France	Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Cattagni, T (corresponding author), Univ Nantes, Fac Sport Sci, Lab Movement Interact Performance, Nantes, France.; Cattagni, T (corresponding author), Raymond Poincare Teaching Hosp, AP HP, Team Technol & Innovat Therapies Appl Neuromuscul, UVSQ,CIC 805,Physiol Funct Testing Ward,Inserm Un, Garches, France.	thomas.cattagni@uvsq.fr		Merlet, Angele/0000-0002-7597-119X				Ali A, 2001, Electromyogr Clin Neurophysiol, V41, P209; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Alrowayeh Hesham N, 2011, BMC Res Notes, V4, P102, DOI 10.1186/1756-0500-4-102; Alrowayeh HN, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-65; Arampatzis A, 2006, J BIOMECH, V39, P1891, DOI 10.1016/j.jbiomech.2005.05.010; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Baudry S, 2014, ACTA PHYSIOL, V210, P667, DOI 10.1111/apha.12233; Baudry S, 2015, EXP GERONTOL, V69, P62, DOI 10.1016/j.exger.2015.06.006; Baudry S, 2012, J PHYSIOL-LONDON, V590, P5541, DOI 10.1113/jphysiol.2012.228932; Bernecke V, 2015, J STRENGTH COND RES, V29, P1972, DOI 10.1519/JSC.0000000000000841; Billot M, 2011, SCAND J MED SCI SPOR, V21, pE273, DOI 10.1111/j.1600-0838.2010.01278.x; Cattagni T, 2014, J NEUROPHYSIOL, V111, P2525, DOI 10.1152/jn.00455.2013; Cattagni T, 2017, CLIN PHYSIOL FUNCT I, V15, P2256; Chen YS, 2010, J ELECTROMYOGR KINES, V20, P980, DOI 10.1016/j.jelekin.2009.11.003; Christie A, 2004, CLIN NEUROPHYSIOL, V115, P116, DOI 10.1016/S1388-2457(03)00306-7; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Clark BC, 2007, J ELECTROMYOGR KINES, V17, P90, DOI 10.1016/j.jelekin.2005.11.008; CRESSWELL AG, 1995, EXP BRAIN RES, V105, P283; Crone C, 1999, EXP BRAIN RES, V124, P265, DOI 10.1007/s002210050621; Dalton BH, 2014, EXP GERONTOL, V52, P70, DOI 10.1016/j.exger.2014.01.011; Fleiss J. L., 2003, WILEY STAT METHODS R, V3rd; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Gondin J, 2006, J NEUROPHYSIOL, V95, P3328, DOI 10.1152/jn.01002.2005; Grospretre S, 2012, J NEUROPHYSIOL, V107, P1649, DOI 10.1152/jn.00611.2011; Guissard N, 2006, EXERC SPORT SCI REV, V34, P154, DOI 10.1249/01.jes.0000240023.30373.eb; Halaki M., 2012, INTECH; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1113/jphysiol.2001.012756; Hopkins J T, 2000, Electromyogr Clin Neurophysiol, V40, P89; Hopkins J Ty, 2003, Electromyogr Clin Neurophysiol, V43, P85; Hultborn H, 1996, EXP BRAIN RES, V108, P450; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Hwang IS, 2002, J ELECTROMYOGR KINES, V12, P361, DOI 10.1016/S1050-6411(02)00034-2; Kennedy PM, 2001, EXP BRAIN RES, V137, P58, DOI 10.1007/s002210000623; KentBraun JA, 1996, MUSCLE NERVE, V19, P861, DOI 10.1002/(SICI)1097-4598(199607)19:7<861::AID-MUS8>3.0.CO;2-7; Maffiuletti NA, 2000, NEUROSCI LETT, V288, P127, DOI 10.1016/S0304-3940(00)01212-X; Maganaris CN, 1998, EXP PHYSIOL, V83, P843, DOI 10.1113/expphysiol.1998.sp004164; McNulty PA, 2012, EXP BRAIN RES, V218, P601, DOI 10.1007/s00221-012-3053-4; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Mynark RG, 2005, CLIN NEUROPHYSIOL, V116, P1400, DOI 10.1016/j.clinph.2005.02.001; NOZAKI D, 1995, EXP BRAIN RES, V105, P402; Palmieri RM, 2004, J ATHL TRAINING, V39, P268; Palmieri TM, 2002, INT J NEUROSCI, V112, P841, DOI 10.1080/00207450290025851; Patikas D A, 2004, Electromyogr Clin Neurophysiol, V44, P503; Place N, 2009, J ELECTROMYOGR KINES, V19, pE395, DOI 10.1016/j.jelekin.2009.01.001; ROBINSON KL, 1982, J NEUROL NEUROSUR PS, V45, P699, DOI 10.1136/jnnp.45.8.699; Rozand V, 2015, INT J SPORTS MED, V36, P35, DOI 10.1055/s-0034-1375614; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simoneau E, 2007, J ELECTROMYOGR KINES, V17, P307, DOI 10.1016/j.jelekin.2006.04.005; Stapley PJ, 2015, J VIS EXP MYJOVE COR, P9; Strojnik V, 1998, J APPL PHYSIOL, V84, P344, DOI 10.1152/jappl.1998.84.1.344; Stutzig N, 2016, MUSCLE NERVE, V53, P464, DOI 10.1002/mus.24767; Temesi J, 2017, J NEUROL SCI, V375, P442, DOI 10.1016/j.jns.2017.02.037; Todd G, 2004, J APPL PHYSIOL, P97; Tucker KJ, 2005, HUM MOVEMENT SCI, V24, P667, DOI 10.1016/j.humov.2005.09.010; Tucker KJ, 2004, SOMATOSENS MOT RES, V21, P189, DOI 10.1080/08990220400012489; Ushiyama J, 2010, J ELECTROMYOGR KINES, V20, P513, DOI 10.1016/j.jelekin.2009.09.004; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILLIAMS L R T, 1992, Electromyography and Clinical Neurophysiology, V32, P43; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	62	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195220	10.1371/journal.pone.0195220	http://dx.doi.org/10.1371/journal.pone.0195220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596480	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000093
J	Reljin, N; Zimmer, G; Malyuta, Y; Shelley, K; Mendelson, Y; Blehar, DJ; Darling, CE; Chon, KH				Reljin, Natasa; Zimmer, Gary; Malyuta, Yelena; Shelley, Kirk; Mendelson, Yitzhak; Blehar, David J.; Darling, Chad E.; Chon, Ki H.			Using support vector machines on photoplethysmographic signals to discriminate between hypovolemia and euvolemia	PLOS ONE			English	Article							TIME-FREQUENCY ANALYSIS; HEMORRHAGIC-SHOCK; TRAUMA PATIENTS; BLOOD-LOSS; WAVE-FORM; MOTION; PROGRESSION; MORTALITY; RESPONSES; DETECT	Identifying trauma patients at risk of imminent hemorrhagic shock is a challenging task in intraoperative and battlefield settings given the variability of traditional vital signs, such as heart rate and blood pressure, and their inability to detect blood loss at an early stage. To this end, we acquired N = 58 photoplethysmographic (PPG) recordings from both trauma patients with suspected hemorrhage admitted to the hospital, and healthy volunteers subjected to blood withdrawal of 0.9 L. We propose four features to characterize each recording: goodness of fit (r(2)), the slope of the trend line, percentage change, and the absolute change between amplitude estimates in the heart rate frequency range at the first and last time points. Also, we propose a machine learning algorithm to distinguish between blood loss and no blood loss. The optimal overall accuracy of discriminating between hypovolemia and euvolemia was 88.38%, while sensitivity and specificity were 88.86% and 87.90%, respectively. In addition, the proposed features and algorithm performed well even when moderate blood volume was withdrawn. The results suggest that the proposed features and algorithm are suitable for the automatic discrimination between hypovolemia and euvolemia, and can be beneficial and applicable in both intraoperative/emergency and combat casualty care.	[Reljin, Natasa; Chon, Ki H.] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Zimmer, Gary] Campbell Univ, Sch Med, Buies Creek, NC 27506 USA; [Malyuta, Yelena; Blehar, David J.; Darling, Chad E.] Univ Massachusetts, Med Sch, Dept Emergency Med, Worcester, MA USA; [Shelley, Kirk] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Mendelson, Yitzhak] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA	University of Connecticut; Campbell University; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Worcester Polytechnic Institute	Reljin, N (corresponding author), Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA.	natasa.reljin@gmail.com	Chon, Ki/W-5498-2019	Reljin, Natasa/0000-0001-8799-9379				Bishop Christopher M., 2006, PATTERN RECOGNITION; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chon KH, 2009, IEEE T BIO-MED ENG, V56, P2054, DOI 10.1109/TBME.2009.2019766; Chong JW, 2014, ANN BIOMED ENG, V42, P2238, DOI 10.1007/s10439-014-1080-y; Convertino VA, 2015, SHOCK, V44, P27, DOI 10.1097/SHK.0000000000000323; Convertino VA, 2013, J APPL PHYSIOL, V115, P1196, DOI 10.1152/japplphysiol.00668.2013; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Cooke WH, 2006, AVIAT SPACE ENVIR MD, V77, P1107; Dao D, 2017, IEEE J BIOMED HEALTH, V21, P1242, DOI 10.1109/JBHI.2016.2612059; Evans RG, 2001, CLIN EXP PHARMACOL P, V28, P479, DOI 10.1046/j.1440-1681.2001.03473.x; Gesquiere Michael J, 2007, J Clin Monit Comput, V21, P277, DOI 10.1007/s10877-007-9085-9; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kecman V., 2001, LEARNING SOFT COMPUT; Kneale J., 2003, J ORTH NUR, V7, P207; Liu JB, 2015, SHOCK, V43, P429, DOI 10.1097/SHK.0000000000000328; Mackenzie CF, 2014, J TRAUMA ACUTE CARE, V76, P1379, DOI 10.1097/TA.0000000000000235; McGrath SP, 2011, ANESTH ANALG, V112, P368, DOI 10.1213/ANE.0b013e3181cb3f4a; Mendelson Y, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON BODY SENSOR NETWORKS (BSN); Nicia SB, 2016, ANAESTHESIA, V71, P163, DOI 10.1111/anae.13283; Reljin N, 2016, 2016 3RD IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS, P118, DOI 10.1109/BHI.2016.7455849; Salehizadeh SMA, 2014, ANN BIOMED ENG, V42, P2251, DOI 10.1007/s10439-014-1030-8; Salehizadeh SMA, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010010; SCHADT JC, 1991, AM J PHYSIOL, V260, pH305; Scully CG, 2012, ANESTH ANALG, V115, P74, DOI 10.1213/ANE.0b013e318256486c; Selvaraj N, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2144981; Stewart CL, 2014, J TRAUMA ACUTE CARE, V77, P892, DOI 10.1097/TA.0000000000000423; Wang HL, 2006, ANN BIOMED ENG, V34, P326, DOI 10.1007/s10439-005-9035-y; Warren KM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030342; Wilson M, 2003, J EMERG MED, V24, P413, DOI 10.1016/S0736-4679(03)00042-8	30	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195087	10.1371/journal.pone.0195087	http://dx.doi.org/10.1371/journal.pone.0195087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596477	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000077
J	Toda, M; Nakatani, E; Omae, K; Fukushima, M; Chin, T				Toda, Mitsunori; Nakatani, Eiji; Omae, Kaoru; Fukushima, Masanori; Chin, Takaaki			Age-specific characterization of spinal cord injuries over a 19-year period at a Japanese rehabilitation center	PLOS ONE			English	Article							EPIDEMIOLOGY; AUSTRALIA	Regional demographics of spinal cord injuries (SCIs) are fundamental to identifying and implementing appropriate preventive measures. The current study was conducted as a longitudinal analysis of all patients with SCIs admitted to the Hyogo Rehabilitation Center over a 19-year period. The sex and age of the patient, time and nature of injury (i.e., cause, level, and extent), and period from injury to admission were evaluated retrospectively. Pertinent tests, including Poisson regression analysis, and the Cochran-Armitage, Kruskal-Wallis, and chi-square tests, were applied to assess demographic variables, with statistical significance set at p < 0.05. Between 1995 and 2013, a total of 632 patients with SCIs (predominantly male and largely < 60 years old) were admitted to our center for rehabilitation. Although the male: female ratio remained unchanged throughout the study period, the ratio of older adults increased over time. In assessing the cause of injury, the majority of the patients involved in road traffic accidents were aged <= 44 years, whereas patients aged >= 45 years accounted for the majority of low-distance falls and disease-related SCIs, the proportions of which gradually increased. Complete paralysis and paraplegia primarily occurred in patients aged <= 44 years, whereas the majority of incomplete injuries and tetraplegia were limited to those aged >= 45 years. The patient age at the time of SCI and the nature of the injury sustained were interrelated. Age-specific strategies thus offered the best means of preventing/reducing the incidence of SCIs in Hyogo prefecture.	[Toda, Mitsunori; Chin, Takaaki] Hyogo Rehabil Ctr, Dept Phys Med & Rehabil, Nishi Ku, Akebono Cho, Kobe, Hyogo, Japan; [Nakatani, Eiji; Omae, Kaoru; Fukushima, Masanori] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Chou Ku, Kobe, Hyogo, Japan; [Nakatani, Eiji] Osaka Univ, Grad Sch Med, Dept Biostat & Data Sci, Suita, Osaka, Japan; [Chin, Takaaki] Kobe Univ, Hyogo Rehabil Ctr, Grad Sch Med, Dept Rehabil Sci, Kobe, Hyogo, Japan	Institute for Biomedical Research & Innovation (IBRI); Osaka University; Kobe University	Chin, T (corresponding author), Hyogo Rehabil Ctr, Dept Phys Med & Rehabil, Nishi Ku, Akebono Cho, Kobe, Hyogo, Japan.; Chin, T (corresponding author), Kobe Univ, Hyogo Rehabil Ctr, Grad Sch Med, Dept Rehabil Sci, Kobe, Hyogo, Japan.	t-chin@pure.ne.jp	Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X				Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Ahoniemi E, 2008, SPINAL CORD, V46, P781, DOI 10.1038/sc.2008.53; BIERINGSORENSEN F, 1990, PARAPLEGIA, V28, P105, DOI 10.1038/sc.1990.13; DeVivo MJ, 2011, SPINAL CORD, V49, P596, DOI 10.1038/sc.2010.172; Hyogo Prefectural Government, STAT HYOG PREF; Ishii Noboru, 1996, Kobe Journal of Medical Sciences, V42, P173; Jabbour Pascal, 2008, Neurosurg Focus, V25, pE16, DOI 10.3171/FOC.2008.25.11.E16; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Jain NB, 2015, JAMA-J AM MED ASSOC, V314, P1643, DOI 10.1001/jama.2015.11200; Katoh S, 1996, SPINAL CORD, V34, P416, DOI 10.1038/sc.1996.74; KATOH S, 1995, PARAPLEGIA, V33, P330, DOI 10.1038/sc.1995.74; Katoh S, 2014, SPINAL CORD, P52; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P619, DOI 10.1016/S0003-9993(99)90162-4; Ministry of Internal Affairs and Communications, JAP STAT YB; Miyai I, 2011, NEUROREHAB NEURAL RE, V25, P540, DOI 10.1177/1545968311402696; New PW, 2008, SPINAL CORD, V46, P406, DOI 10.1038/sj.sc.3102152; New PW, 2014, SPINAL CORD, V52, P97, DOI 10.1038/sc.2012.165; New PW, 2014, SPINAL CORD, V52, P123, DOI 10.1038/sc.2012.160; New PW, 2011, SPINAL CORD, V49, P397, DOI 10.1038/sc.2010.77; O'Connor PJ, 2005, ARCH PHYS MED REHAB, V86, P48, DOI 10.1016/j.apmr.2004.07.346; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; SHINGU H, 1995, PARAPLEGIA, V33, P183, DOI 10.1038/sc.1995.42; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	25	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195120	10.1371/journal.pone.0195120	http://dx.doi.org/10.1371/journal.pone.0195120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596516	gold, Green Published, Green Submitted			2022-12-27	WOS:000428630000079
J	Chen, YL; Shu, JH; Hsu, HC; Liang, Y; Chou, RH; Hsu, PF; Wang, YJ; Ding, YZ; Liou, TL; Wang, YW; Huang, SS; Lin, CC; Lu, TM; Leu, HB; Lin, SJ; Chan, WL				Chen, Yuan-Lung; Shu, Jiah-Hwang; Hsu, Hsiu-Chuan; Liang, Ying; Chou, Ruey-Hsing; Hsu, Pai-Feng; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Lin, Chung-Chi; Lu, Tse-Min; Leu, Hsin-Bang; Lin, Shing-Jong; Chan, Wan-Leong			High health literacy is associated with less obesity and lower Framingham risk score: Sub-study of the VGH-HEALTHCARE trial	PLOS ONE			English	Article							BLOOD-PRESSURE; METABOLIC SYNDROME; GLYCEMIC CONTROL; HEART-DISEASE; UNITED-STATES; OLDER-ADULTS; WEIGHT-LOSS; COMMUNITY; HYPERTENSION; POPULATION	Backgrounds Lower health literacy (HL) is associated with several cardiovascular disease (CVD) risk factors such as diabetes, hypertension, and metabolic syndrome (MS). The aim of our study was to investigate the association between HL and the Framingham 10-year risk score of CVD. Methods From 2015-2016, 1010 subjects aged 23 to 88 years receiving health check-up in Taipei Veterans General Hospital had complete clinical evaluations and laboratory examinations. Fatty liver was diagnosed by ultrasonography. The short form questionnaire adapted from the Mandarin Health Literacy Scale was used to assess HL. The Framingham risk score was calculated by patient characteristics. Results Subjects with higher BMIs were associated with lower HL scores. The proportion of subjects with MS was higher in the lower health literacy score group (<= 9) at 28.8%; further analysis found that lower HL was significantly associated with MS in women but not in men. The Spearman's rho demonstrated that the HL score was significantly associated with the BMI-based (rho=-0.11; P < 0.001) or lipid-based (rho =-0.09; P < 0.004) Framingham risk score. Conclusions Higher HL scores were associated with less CVD risk such as lower BMIs, less MS in women, and less fatty liver disease. Furthermore, HL had an inverse association with the Framingham risk score as expected. Therefore, HL in patients with CVD risk should be improved and considered as an important issue in terms of CVD reduction.	[Chen, Yuan-Lung; Chou, Ruey-Hsing; Hsu, Pai-Feng; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Lin, Chung-Chi; Lu, Tse-Min; Leu, Hsin-Bang; Lin, Shing-Jong; Chan, Wan-Leong] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Yuan-Lung] Taipei Municipal Gan Dau Hosp, Taipei, Taiwan; [Shu, Jiah-Hwang; Hsu, Hsiu-Chuan; Liang, Ying] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan; [Shu, Jiah-Hwang; Hsu, Hsiu-Chuan; Liang, Ying; Hsu, Pai-Feng; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Lin, Chung-Chi; Lu, Tse-Min; Leu, Hsin-Bang; Lin, Shing-Jong; Chan, Wan-Leong] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chou, Ruey-Hsing; Hsu, Pai-Feng; Huang, Shao-Sung; Lu, Tse-Min; Leu, Hsin-Bang; Lin, Shing-Jong; Chan, Wan-Leong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Lin, Chung-Chi] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, YJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Liang, Y (corresponding author), Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan.; Liang, Y; Wang, YJ (corresponding author), Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan.	yliang@vghtpe.gov.tw; yjwang@vghtpe.gov.tw	Hsu, PF/AAH-1181-2020	Cheng, Yuan-Lung/0000-0002-8384-3315	Taipei Veterans General Hospital [V107-C-158]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	We received funding from Taipei Veterans General Hospital grant V107-C-158 to Hsin-Bang Leu. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Brega AG, 2012, PATIENT EDUC COUNS, V88, P61, DOI 10.1016/j.pec.2012.03.008; Carels RA, 2017, EAT BEHAV, V26, P76, DOI 10.1016/j.eatbeh.2017.01.009; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cheng YL, 2015, ANN HEPATOL, V14, P181, DOI 10.1016/S1665-2681(19)30780-X; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DeWalt DA, 2007, AM J HEALTH BEHAV, V31, pS27; Geboers B, 2016, J HEALTH COMMUN, V21, P45, DOI 10.1080/10810730.2016.1201174; Gerber Ben S, 2006, J Appl Meas, V7, P55; Haun JN, 2014, J HEALTH COMMUN, V19, P302, DOI 10.1080/10810730.2014.936571; Huang MingChyi, 2012, Journal of Experimental and Clinical Medicine, V4, P108, DOI 10.1016/j.jecm.2012.01.004; Jan CF, 2006, INT J OBESITY, V30, P794, DOI 10.1038/sj.ijo.0803204; Kim KB, 2014, AM J HYPERTENS, V27, P1199, DOI 10.1093/ajh/hpu041; Kim SH, 2009, J CLIN NURS, V18, P2337, DOI 10.1111/j.1365-2702.2008.02739.x; Kuo KN, 2012, TAIWAN J PUB HLTH, V31, P184, DOI DOI 10.6288/TJPH2012-31-02-10; Lam LT, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-11; Lassetter JH, 2015, PUBLIC HEALTH NURS, V32, P15, DOI 10.1111/phn.12155; Lee SYD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-614; Liang Lan, 2017, Health Lit Res Pract, V1, pe216, DOI 10.3928/24748307-20170929-01; Mancuso JM, 2010, NURS HEALTH SCI, V12, P94, DOI 10.1111/j.1442-2018.2009.00506.x; Marden S, 2012, DIABETIC MED, V29, P662, DOI 10.1111/j.1464-5491.2011.03466.x; Martin LT, 2011, J GEN INTERN MED, V26, P45, DOI 10.1007/s11606-010-1488-5; McCray AT, 2005, J AM MED INFORM ASSN, V12, P152, DOI 10.1197/jamia.M1687; McNaughton CD, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0028-1; McNaughton CD, 2014, PATIENT EDUC COUNS, V96, P165, DOI 10.1016/j.pec.2014.05.007; McNaughton CD, 2014, MED CARE, V52, P346, DOI 10.1097/MLR.0000000000000101; Mensah GA, 2017, CIRC RES, V120, P366, DOI 10.1161/CIRCRESAHA.116.309115; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Olesen K, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000437; Osborn CY, 2009, DIABETES CARE, V32, P1614, DOI 10.2337/dc09-0425; Owen-Smith A. A., 2016, PERMANENTE J, V20, P15; Pandit AU, 2009, PATIENT EDUC COUNS, V75, P381, DOI 10.1016/j.pec.2009.04.006; Powell CK, 2007, DIABETES EDUCATOR, V33, P144, DOI 10.1177/0145721706297452; Powers BJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-219; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Shi D, 2017, INTERN EMERG MED; Shi D, 2017, INTERN EMERG MED, V12, P765, DOI 10.1007/s11739-017-1651-7; Shibuya A, 2011, BLOOD PRESS MONIT, V16, P224, DOI 10.1097/MBP.0b013e32834af7ba; Sookoian Silvia, 2008, Diabetes Care, V31, pe43, DOI 10.2337/dc08-0027; Sudore RL, 2006, J AM GERIATR SOC, V54, P770, DOI 10.1111/j.1532-5415.2006.00691.x; Tang YH, 2008, J ADV NURS, V62, P74, DOI 10.1111/j.1365-2648.2007.04526.x; Tiller D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2210-7; Tsai TI, 2011, J HEALTH COMMUN, V16, P50, DOI 10.1080/10810730.2010.529488; Tsouros AD, 2013, SOLID FACTS HLTH LIT; Willens DE, 2013, J HEALTH COMMUN, V18, P129, DOI 10.1080/10810730.2013.825663; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Yokokawa H, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0142-8; Zoellner J, 2016, AM J HEALTH PROMOT, V30, P279, DOI 10.1177/0890117116639558	49	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194813	10.1371/journal.pone.0194813	http://dx.doi.org/10.1371/journal.pone.0194813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590183	gold, Green Published, Green Submitted			2022-12-27	WOS:000428603100075
J	Rahimi, N; Abdolghaffari, AH; Partoazar, A; Javadian, N; Dehpour, T; Mani, AR; Dehpour, AR				Rahimi, Nastaran; Abdolghaffari, Amir Hossein; Partoazar, Alireza; Javadian, Nina; Dehpour, Tara; Mani, Ali R.; Dehpour, Ahmad R.			Fresh red blood cells transfusion protects against aluminum phosphide-induced metabolic acidosis and mortality in rats	PLOS ONE			English	Article							SODIUM-BICARBONATE; INFARCT SIZE; ANEMIC RATS; ERYTHROCYTES; HEMOGLOBIN; VOLUME	Background Aluminum phosphide (AIP) is used as pesticide in some countries for protection of stored grains. Human poisoning with AIP due to suicide attempt or accidental environmental exposure is associated with very high mortality partially due to development of severe metabolic acidosis. Previous studies have shown that hemoglobin has high buffering capacity and erythrocytes can potentially be used for management of metabolic acidosis. The aim of this study was to evaluate the effect of fresh packed red blood cells (RBC) transfusion on survival and cardiovascular function in AIP-poisoned rats. Methodology/Principal findings Rats were poisoned with AIP by gavage. Fresh packed RBC was transfused via tail vein after AIP administration. Acid -base balance, vital signs and mortality was assessed and compared in experimental groups. Infusion of fresh packed RBC (1.5 ml) one hour after AIP (4-15 mg/kg) intoxication was associated with a significant decrease in mortality rate. Packed RBC infusion improved blood pH, HCO3-, Na+ and Ca2+ levels. Plasma troponin level was also reduced and ECG changes were reversed following packed RBC infusion in AIP intoxicated rats. Conclusions Our results showed that fresh RBC transfusion could ameliorate metabolic acidosis and enhance survival in AIP-poisoned rat. We assume that an increase in pool of RBCs may modulate acid -base balance or potentially chelate AIP-related toxic intermediates via phosphine-hemoglobin interaction.	[Rahimi, Nastaran; Abdolghaffari, Amir Hossein; Partoazar, Alireza; Javadian, Nina; Dehpour, Ahmad R.] Univ Tehran Med Sci, Expt Med Res Ctr, Tehran, Iran; [Rahimi, Nastaran; Javadian, Nina; Dehpour, Ahmad R.] Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran; [Abdolghaffari, Amir Hossein] ACECR, Inst Med Plants, Med Plants Res Ctr, Tehran, Iran; [Dehpour, Tara] Whittington Hosp NHS Trust, London, England; [Mani, Ali R.] UCL, UCL Div Med, London, England	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Academic Center for Education, Culture & Research (ACECR); University of London; University College London	Dehpour, AR (corresponding author), Univ Tehran Med Sci, Expt Med Res Ctr, Tehran, Iran.; Dehpour, AR (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran.	dehpoura@sina.tums.ac.ir	Dehpour, Ahmad Reza/I-6422-2019; Abdolghaffari, Amir Hossein/AAQ-1161-2021; Mani, Alireza/H-3236-2015	Dehpour, Ahmad Reza/0000-0002-8001-5565; Mani, Alireza/0000-0003-0830-2022; Rahimi, Nastaran/0000-0002-4872-9082; Abdolghaffari, Amir Hossein/0000-0001-9961-9097; Dehpour, Tara/0000-0003-4797-3662	Experimental Medicine Research Center, Tehran University of Medical Sciences [94-04-158-30897]	Experimental Medicine Research Center, Tehran University of Medical Sciences	This study was funded and supported by Experimental Medicine Research Center, Tehran University of Medical Sciences (http://tums.ac.ir/?lang=en); grant no. 94-04-158-30897 to AD. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Agrawal A, 2010, J CLIN DIAGN RES, V4, P2316; Agrawal VK, 2015, INDIAN J CRIT CARE M, V19, P109, DOI 10.4103/0972-5229.151019; Alter P, 2001, INTENS CARE MED, V27, P327, DOI 10.1007/s001340000744; Anand R, 2011, J APPL TOXICOL, V31, P499, DOI 10.1002/jat.1692; Baruah U, 2015, INDIAN J CRIT CARE M, V19, P735, DOI 10.4103/0972-5229.171412; BEECH JS, 1994, METABOLISM, V43, P518, DOI 10.1016/0026-0495(94)90087-6; Bumbrah GS, 2012, FORENSIC SCI INT, V214, P1, DOI 10.1016/j.forsciint.2011.06.018; Changal KH, 2017, BMJ CASE REP; CHIN KL, 1992, XENOBIOTICA, V22, P599, DOI 10.3109/00498259209053123; DITZEL J, 1975, DIABETOLOGIA, V11, P255, DOI 10.1007/BF00422388; Elzik ME, 2006, AM J HEMATOL, V81, P145, DOI 10.1002/ajh.20517; Gheshlaghi Farzad, 2015, Toxicol Int, V22, P40, DOI 10.4103/0971-6580.172255; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; Gurjar Mohan, 2011, J Emerg Trauma Shock, V4, P378, DOI 10.4103/0974-2700.83868; Hassanian-Moghaddam H, 2016, BASIC CLIN PHARMACOL, V118, P243, DOI 10.1111/bcpt.12481; Holcomb JB, 2015, PREHOSP EMERG CARE, V19, P1, DOI 10.3109/10903127.2014.923077; Hu HX, 2012, CRIT CARE MED, V40, P740, DOI 10.1097/CCM.0b013e3182376e84; Jaiswal S, 2009, INDIAN J CRIT CARE M, V13, P21, DOI 10.4103/0972-5229.53111; LaGamma EF, 1996, ARCH DIS CHILD-FETAL, V75, pF87, DOI 10.1136/fn.75.2.F87; Lasheen NN, 2016, PHYSIOL RES, V65, P927, DOI 10.33549/physiolres.933171; Lauterbach M, 2005, CLIN TOXICOL, V43, P575, DOI 10.1081/CLT-200068847; LEE HB, 1985, J NUCL MED, V26, P72; Louriz M, 2009, Indian J Med Sci, V63, P227, DOI 10.4103/0019-5359.53386; Marashi Sayed Mahdi, 2016, Acta Med Iran, V54, P475; Marashi SM, 2015, ARH HIG RADA TOKSIKO, V66, P83, DOI 10.1515/aiht-2015-66-2637; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Mashayekhian M, 2016, BASIC CLIN PHARMACOL, V119, P322, DOI 10.1111/bcpt.12571; Mathai A, 2010, INDIAN J ANAESTH, V54, P302, DOI 10.4103/0019-5049.68372; Mohan B, 2016, J ASSOC PHYSICIAN I, V64, P66; Mostafalou S, 2013, IRAN RED CRESCENT ME, P15; Mostafazadeh B, 2012, TOXICITY AND DRUG TESTING, P345; Mostafazadeh B, 2011, J MED TOXICOL, V7, P40, DOI 10.1007/s13181-010-0121-7; ONeil MJ, 2001, MERCK INDEX ENCY CHE, P1317; Popp W, 2002, LANCET, V359, P1574, DOI 10.1016/S0140-6736(02)08518-5; POTTER WT, 1991, TOXICOL LETT, V57, P37, DOI 10.1016/0378-4274(91)90117-O; Singh S, 2006, CLIN TOXICOL, V44, P155, DOI 10.1080/15563650500514467; Swietach P, 2010, J PHYSIOL-LONDON, V588, P4995, DOI 10.1113/jphysiol.2010.197392; Van Slyke DD, 1923, J BIOL CHEM, V56, P765; Xenocostas A, 2010, CRIT CARE MED, V38, P2215, DOI 10.1097/CCM.0b013e3181f17d6e; Zamani N, 2013, EUR REV MED PHARMACO, V17, P994; Zambelli AB, 2009, J VET EMERG CRIT CAR, V19, P102, DOI 10.1111/j.1476-4431.2009.00386.x	41	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193991	10.1371/journal.pone.0193991	http://dx.doi.org/10.1371/journal.pone.0193991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590163	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100043
J	Yang, XD; Chen, CL; Ma, TC; Wang, JL; Wang, CF				Yang, Xiaodong; Chen, Chunlin; Ma, Tingchun; Wang, Jinli; Wang, Caifen			Revocable identity-based proxy re-signature against signing key exposure	PLOS ONE			English	Article							AUTHENTICATION SCHEME; ENCRYPTION	Identity-based proxy re-signature (IDPRS) is a novel cryptographic primitive that allows a semi-trusted proxy to convert a signature under one identity into another signature under another identity on the same message by using a re-signature key. Due to this transformation function, IDPRS is very useful in constructing privacy-preserving schemes for various information systems. Key revocation functionality is important in practical IDPRS for managing users dynamically; however, the existing IDPRS schemes do not provide revocation mechanisms that allow the removal of misbehaving or compromised users from the system. In this paper, we first introduce a notion called revocable identity-based proxy re-signature (RIDPRS) to achieve the revocation functionality. We provide a formal definition of RIDPRS as well as its security model. Then, we present a concrete RIDPRS scheme that can resist signing key exposure and prove that the proposed scheme is existentially unforgeable against adaptive chosen identity and message attacks in the standard model. To further improve the performance of signature verification in RIDPRS, we introduce a notion called server-aided revocable identity-based proxy re-signature (SA-RIDPRS). Moreover, we extend the proposed RIDPRS scheme to the SA-RIDPRS scheme and prove that this extended scheme is secure against adaptive chosen message and collusion attacks. The analysis results show that our two schemes remain efficient in terms of computational complexity when implementing user revocation procedures. In particular, in the SA-RIDPRS scheme, the verifier needs to perform only a bilinear pairing and four exponentiation operations to verify the validity of the signature. Compared with other IDPRS schemes in the standard model, our SA-RIDPRS scheme greatly reduces the computation overhead of verification.	[Yang, Xiaodong; Chen, Chunlin; Ma, Tingchun; Wang, Jinli; Wang, Caifen] Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China; [Yang, Xiaodong] State Key Lab Cryptol, Beijing, Peoples R China	Northwest Normal University - China	Yang, XD (corresponding author), Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China.; Yang, XD (corresponding author), State Key Lab Cryptol, Beijing, Peoples R China.	y200888@163.com		yang, xiaodong/0000-0002-0382-5943	National Natural Science Foundation of China [61662069]; China Postdoctoral Science Foundation [2017M610817]; Natural Science Foundation of Gansu Province of China [1506RJZA130]; Science and Technology Project of Lanzhou City of China [2013-4-22]; Foundation for Excellent Young Teachers by Northwest Normal University [NWNU-LKQN-14-7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Gansu Province of China; Science and Technology Project of Lanzhou City of China; Foundation for Excellent Young Teachers by Northwest Normal University	This work was partially supported by the National Natural Science Foundation of China (No. 61662069, www.nsfc.gov.cn), China Postdoctoral Science Foundation (No. 2017M610817, jj.chinapostdoctor.org.cn), Natural Science Foundation of Gansu Province of China (No. 1506RJZA130, www.gsstc.gov.cn), Science and Technology Project of Lanzhou City of China (No. 2013-4-22, kjj.lanzhou.gov.cn) and Foundation for Excellent Young Teachers by Northwest Normal University (No. NWNU-LKQN-14-7, www.nwnu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai R., 2015, INT J COMPUTERS APPL, V114, P13, DOI [10.5120/20029-1945, DOI 10.5120/20029-1945]; Ateniese G., 2005, PROC 12 ACM C COMPUT, P310; Blaze M, 1998, LECT NOTES COMPUT SC, V1403, P127, DOI 10.1007/BFb0054122; Canetti R, 2014, J ACM JACM, V51, P557; Fan CI, 2010, COMPUT MATH APPL, V60, P285, DOI 10.1016/j.camwa.2010.01.021; Farash MS, 2017, INT J COMMUN SYST, V30, DOI 10.1002/dac.3019; Feng Jie, 2014, Journal of Computer Applications, V34, P3291, DOI 10.11772/j.issn.1001-9081.2014.11.3291; Hong X, 2017, CLUSTER COMPUT, P1; Hu XM, 2015, 2015 IEEE ADVANCED INFORMATION TECHNOLOGY, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (IAEAC), P166, DOI 10.1109/IAEAC.2015.7428540; Ishida Yuu, 2017, International Journal of Applied Cryptography, V3, P288; Jia XY, 2017, IEEE ACCESS, V5, P2945, DOI 10.1109/ACCESS.2017.2676021; Kumar M., 2017, INFORM SYSTEMS SECUR, P29, DOI [10.1007/978-3-319-72598-7_3, DOI 10.1007/978-3-319-72598-7_3]; Kumari S, 2017, PEER PEER NETW APPL, V10, P92, DOI 10.1007/s12083-015-0409-0; Kumari S, 2014, SECUR COMMUN NETW, V7, P2039, DOI 10.1002/sec.916; Kutubi MAA, 2017, KSII T INTERNET INF, V11, P2628, DOI 10.3837/tiis.2017.05.018; Lee K, 2017, DESIGN CODE CRYPTOGR, V85, P39, DOI 10.1007/s10623-016-0287-3; Li FG, 2012, FUTURE GENER COMP SY, V28, P306, DOI 10.1016/j.future.2010.11.004; Li X, 2018, J NETW COMPUT APPL, V103, P194, DOI 10.1016/j.jnca.2017.07.001; Li X, 2018, FUTURE GENER COMP SY, V83, P607, DOI 10.1016/j.future.2017.04.012; Li X, 2017, COMPUT NETW, V129, P429, DOI 10.1016/j.comnet.2017.03.013; Li X, 2015, INT J COMMUN SYST, V28, P374, DOI 10.1002/dac.2676; Shao J, 2007, LECT NOTES COMPUT SC, V4859, P197; Shen LM, 2017, INT J EMBED SYST, V9, P168, DOI 10.1504/IJES.2017.083736; Sun SF, 2017, LECT NOTES COMPUT SC, V10493, P456, DOI 10.1007/978-3-319-66390-9_25; Tian MM, 2015, INFORM PROCESS LETT, V115, P462, DOI 10.1016/j.ipl.2014.12.002; Tsai TT, 2013, SECUR COMMUN NETW, V6, P1250, DOI 10.1002/sec.696; Wang XM, 2013, TELECOMMUN SYST, V52, P515, DOI 10.1007/s11235-011-9457-9; Wang ZW, 2013, IEEE INT CONF TRUST, P1704, DOI 10.1109/TrustCom.2013.211; Waters B, 2005, LECT NOTES COMPUT SC, V3494, P114; Wei J, 2015, P INF SEC PRACT EXP, P316; Yang X, 2015, APPL MATH INFORM SCI, V9, P3251; Yanling Lian, 2013, 2013 5th International Conference on Intelligent Networking and Collaborative Systems, P573, DOI 10.1109/INCoS.2013.106; Zhang LL, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION (IEEE ICIA 2017), P947, DOI 10.1109/ICInfA.2017.8079039; Zhang ZH, 2009, 2009 INTERNATIONAL CONFERENCE ON COMPUTER MODELING AND SIMULATION, PROCEEDINGS, P251, DOI 10.1109/ICCMS.2009.35	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194783	10.1371/journal.pone.0194783	http://dx.doi.org/10.1371/journal.pone.0194783			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579125	gold, Green Published, Green Submitted			2022-12-27	WOS:000428351800055
J	Dhurmeea, Z; Pethybridge, H; Appadoo, C; Bodie, N				Dhurmeea, Zahirah; Pethybridge, Heidi; Appadoo, Chandani; Bodie, Nathalie			Lipid and fatty acid dynamics in mature female albacore tuna (Thunnus alalunga) in the western Indian Ocean	PLOS ONE			English	Article							BREAM SPARUS-AURATA; FRESH-WATER FISH; REPRODUCTIVE-PERFORMANCE; BROODSTOCK DIETS; TROPHIC MARKERS; SKIPJACK TUNA; ENERGY; CAUGHT; MUSCLE; WILD	Lipid composition in the reproductive and somatic tissues were investigated for female albacore tuna, Thunnus alalunga, in the western Indian Ocean, between latitude 18-21 degrees S and longitude 56-60 degrees E, from January 2014 to March 2015. Highest total lipids (TL) were found in the gonads of spawning-capable females (SCP) (mainly phospholipids, PL, triacylglycerols, TAG and wax esters, WE) and in the liver of females in the late regressing and regenerating ovary phases (mainly TAG, PL and sterols, ST). Muscle TL was low but exhibited high inter individual variability. Correlations between gonadosomatic and hepatosomatic indices with TL and the lipid classes in albacore gonads and liver describes a pattern of reallocation of energy from the liver to the gonads during SCP. Female albacore were also observed to pursue foraging activities even during this period. Therefore, female albacore can be considered as a capital-income breeder relying mostly on stored lipids before the onset of reproduction and to a lesser extent on energy derived from concurrent feeding during the spawning season. Overall, the three examined tissues had similar general fatty acid profiles with the dominance of 22:6 omega 3 (docosahexaenoic acid, DHA), 16:0, 18:0 and 18:1 omega 9. The proportions of fatty acids varied with maturity stage and ovary lobe, with the smaller lobe having significantly higher proportions of essential fatty acids, as well as 16:0 and 18:1n9, compared to the larger one. Our results provide new information on the life-history and energy allocation strategy of albacore which will assist fisheries managers.	[Dhurmeea, Zahirah; Appadoo, Chandani] Univ Mauritius, Dept Biosci & Ocean Studies, Fac Sci, Reduit, Mauritius; [Dhurmeea, Zahirah; Bodie, Nathalie] Res Inst Sustainable Dev IRD, Marine Biodivers Exploitat & Conservat Unit, Victoria, Mahe, Seychelles; [Dhurmeea, Zahirah; Pethybridge, Heidi] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Bodie, Nathalie] Seychelles Fishing Author, Victoria, Mahe, Seychelles	University of Mauritius; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dhurmeea, Z (corresponding author), Univ Mauritius, Dept Biosci & Ocean Studies, Fac Sci, Reduit, Mauritius.; Dhurmeea, Z (corresponding author), Res Inst Sustainable Dev IRD, Marine Biodivers Exploitat & Conservat Unit, Victoria, Mahe, Seychelles.; Dhurmeea, Z (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas, Australia.	dzahirah@hotmail.com	Pethybridge, Heidi/AEO-8594-2022; Dhurmeea, Zahirah/AAL-4006-2021; Pethybridge, Heidi/AAI-9824-2021	Pethybridge, Heidi/0000-0002-7291-5766; Bodin, Nathalie/0000-0001-8464-0213	"Allocations de Recherche pour une These au Sud" (ARTS) program of the French Research Institute for the Development	"Allocations de Recherche pour une These au Sud" (ARTS) program of the French Research Institute for the Development	This work is part of the PhD research of the first author (ZD) and was supported by the "Allocations de Recherche pour une These au Sud" (ARTS) program of the French Research Institute for the Development (IRD: www.ird.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JRM, 1982, J FISH BIOL, V20, P409, DOI 10.1111/j.1095-8649.1982.tb03934.x; Almansa E, 2001, J FISH BIOL, V59, P267, DOI [10.1111/j.1095-8649.2001.tb00129.x, 10.1006/jfbi.2001.1650]; Alonso-Fernandez A, 2012, J EXP MAR BIOL ECOL, V416, P8, DOI 10.1016/j.jembe.2012.02.001; Aristizabal EO, 2007, MAR BIOL, V152, P713, DOI 10.1007/s00227-007-0729-6; Arukwe A, 2003, COMP HEPATOLOGY, V2; Bard FX, 1981, THESIS; BELL MV, 1995, LIPIDS, V30, P443, DOI 10.1007/BF02536303; Bivanand R, 2016, PACKAGE RGDAL; Black K.D., 1998, BIOL FARMED FISH, P114; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Cejas JR, 2004, COMP BIOCHEM PHYS B, V138, P91, DOI 10.1016/j.cbpc.2004.03.003; Chen IC, 2005, FISH OCEANOGR, V14, P71, DOI 10.1111/j.1365-2419.2004.00322.x; Chen KS, 2010, J FISH BIOL, V77, P119, DOI 10.1111/j.1095-8649.2010.02662.x; Clarke K.R., 2006, PRIMER V6 USER MANUA; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/s0065-2881(03)46005-7; Dhurmeea Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168605; Dominguez-Petit R, 2010, FISH RES, V104, P73, DOI 10.1016/j.fishres.2009.05.016; Dutta H.M., 1996, FISH MORPHOLOGY; Essington TE, 2003, T AM FISH SOC, V132, P759, DOI 10.1577/T02-094; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; Furuita H, 2000, AQUACULTURE, V187, P387, DOI 10.1016/S0044-8486(00)00319-7; Goni N, 2010, PROG OCEANOGR, V86, P115, DOI 10.1016/j.pocean.2010.04.016; Grande M, 2016, J FISH BIOL, V89, P2434, DOI 10.1111/jfb.13125; Grigorakis K, 2002, INT J FOOD SCI TECH, V37, P477, DOI 10.1046/j.1365-2621.2002.00604.x; Henderson RJ, 1996, ARCH ANIM NUTR, V49, P5, DOI 10.1080/17450399609381859; HENDERSON RJ, 1987, PROG LIPID RES, V26, P281, DOI 10.1016/0163-7827(87)90002-6; Hiratsuka S, 2004, FISHERIES SCI, V70, P903, DOI 10.1111/j.1444-2906.2004.00885.x; Houston AI, 2007, BEHAV ECOL, V18, P241, DOI 10.1093/beheco/arl080; Intarasirisawat R, 2011, FOOD CHEM, V124, P1328, DOI 10.1016/j.foodchem.2010.07.076; Johnson RB, 2009, REV FISH SCI, V17, P78, DOI 10.1080/10641260802590004; Kiessling A, 2001, FOOD CHEM, V73, P271, DOI 10.1016/S0308-8146(00)00297-1; Kjesbu Olav S., 2009, P293, DOI 10.1002/9781444312133.ch8; KJESBU OS, 1991, CAN J FISH AQUAT SCI, V48, P2333, DOI 10.1139/f91-274; Korsmeyer KE, 1996, COMP BIOCHEM PHYS A, V113, P17, DOI 10.1016/0300-9629(95)02061-6; Kozlova TA, 2000, COMP BIOCHEM PHYS B, V126, P477, DOI 10.1016/S0305-0491(00)00207-8; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; McBride RS, 2015, FISH FISH, V16, P23, DOI 10.1111/faf.12043; MEDINA I, 1995, LIPIDS, V30, P1127, DOI 10.1007/BF02536613; Merayo CR, 1996, SCI MAR, V60, P489; Mourente G, 2001, FISH PHYSIOL BIOCHEM, V24, P351, DOI 10.1023/A:1015011609017; MOURENTE G, 1990, FISH PHYSIOL BIOCHEM, V8, P93, DOI 10.1007/BF00004436; MOURENTE G, 1991, LIPIDS, V26, P871, DOI 10.1007/BF02535970; Munschy C, 2016, ENVIRON RES, V148, P196, DOI 10.1016/j.envres.2016.03.042; Murase T, 1996, FISHERIES SCI, V62, P634, DOI 10.2331/fishsci.62.634; Nauen C. E., 1983, FAO FISH SYNOP, V2, P1; Ng WK, 2011, AQUACULTURE, V314, P122, DOI 10.1016/j.aquaculture.2011.01.034; Norton EC, 1999, J FISH BIOL, V54, P1287, DOI 10.1111/j.1095-8649.1999.tb02055.x; Ortega A, 2010, FISH PHYSIOL BIOCHEM, V36, P461, DOI 10.1007/s10695-009-9316-8; Otsu T., 1959, Fishery Bulletin United States, V59, P287; Parrish CC, 2015, DEEP-SEA RES PT II, V113, P199, DOI 10.1016/j.dsr2.2013.12.003; Parrish CC, 2015, OECOLOGIA, V177, P85, DOI 10.1007/s00442-014-3131-3; Pethybridge H, 2011, MAR BIOL, V158, P2741, DOI 10.1007/s00227-011-1773-9; Pethybridge HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131598; R Development Core Team, 2009, R LANG ENV STAT COMP; Rainuzzo JR, 1997, AQUACULTURE, V155, P103, DOI 10.1016/S0044-8486(97)00121-X; Ramon D, 1996, FISH B-NOAA, V94, P725; Ramon D, 1997, OCEANOGR LIT REV, V7, P752; Rasmussen R. S., 2006, Journal of Aquatic Food Product Technology, V15, P73, DOI 10.1300/J030v15n02_07; Rasmussen RS, 2008, J AQUAT FOOD PROD T, V17, P441, DOI 10.1080/10498850802369211; RATTY FJ, 1990, FISH B-NOAA, V88, P207; Robertson DH, 1957, FISH B WASH DC, V127, P9; Saito H, 1997, J SCI FOOD AGR, V73, P53, DOI 10.1002/(SICI)1097-0010(199701)73:1&lt;53::AID-JSFA707&gt;3.0.CO;2-5; SANWAL R, 1972, ACTA ANAT, V83, P139; Sardenne F, 2017, ECOL INDIC; Sardenne F, 2016, PROG OCEANOGR, V146, P75, DOI 10.1016/j.pocean.2016.06.001; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Sargent J, 1995, BROODSTOCK MANAGEMEN, P353, DOI DOI 10.1016/S0044-8486(97)00122-1; Sargent John R., 2002, P181; Schaefer KM, 1998, B INTERAMERICAN TROP, V21, P201; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; STANSBY ME, 1976, US NMFS MAR FISH REV, V38, P1; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Ueyanagi S, 1957, REP NANKAI REG FISH, V6, P113; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; WATANABE T, 1982, COMP BIOCHEM PHYS B, V73, P3, DOI 10.1016/0305-0491(82)90196-1; Wheeler S. C., 2003, Journal of Aquatic Food Product Technology, V12, P3, DOI 10.1300/J030v12n02_02; Wiegand MD, 2007, CAN J FISH AQUAT SCI, V64, P700, DOI 10.1139/F07-033; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; Wootton RJ, 1998, REV FISH BIOL FISHER, V8, P493; Xie X, 1998, J FISH BIOL, V53, P259, DOI 10.1111/j.1095-8649.1998.tb00979.x; Zudaire I, 2014, FISH RES, V160, P50, DOI 10.1016/j.fishres.2013.12.010; Zudaire I, 2013, FISH B-NOAA, V111, P252, DOI 10.7755/FB.111.3.4	83	16	18	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194558	10.1371/journal.pone.0194558	http://dx.doi.org/10.1371/journal.pone.0194558			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608623	Green Published, gold, Green Submitted			2022-12-27	WOS:000428988800012
J	Dvorak, KM; Pettee, KM; Rubinic-Minotti, K; Su, R; Nestor-Kalinoski, A; Eisenmann, KM				Dvorak, Kaitlyn M.; Pettee, Krista M.; Rubinic-Minotti, Kaitlin; Su, Robin; Nestor-Kalinoski, Andrea; Eisenmann, Kathryn M.			Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2)	PLOS ONE			English	Article							TUMOR-CELL INVASION; PROSTATE-CANCER; INVADOPODIA FORMATION; TGF-ALPHA; ACTIN; MIGRATION; GROWTH; CHEMOKINE; EXPRESSION; MICROENVIRONMENT	The tumor microenvironment (TME) promotes tumor cell invasion and metastasis. An important step in the shift to a pro-cancerous microenvironment is the transformation of normal stromal fibroblasts to carcinoma-associated fibroblasts (CAFs). CAFs are present in a majority of solid tumors and can directly promote tumor cell motility via cytokine, chemokine and growth factor secretion into the TME. The exact effects that the TME has upon cytoskeletal regulation in motile tumor cells remain enigmatic. The conserved formin family of cytoskeleton regulating proteins plays an essential role in the assembly and/or bundling of unbranched actin filaments. Mammalian Diaphanous-related formin 2 (mDia2/DIAPH3/Drf3/Dia) assembles a dynamic F-actin cytoskeleton that underlies tumor cell migration and invasion. We therefore sought to understand whether CAF-derived chemokines impact breast tumor cell motility through modification of the formin-assembled F-actin cytoskeleton. In MDA-MB-231 cells, conditioned media (CM) from WS19T CAFs, a human breast tumor-adjacent CAF line, significantly and robustly increased wound closure and invasion relative to normal human mammary fibroblast (HMF)-CM. WS19T-CM also promoted proteasome-mediated mDia2 degradation in MDA-MB-231 cells relative to control HMF-CM and WS21T CAF-CM, a breast CAF cell line that failed to promote robust MDA-MB-231 migration. Cytokine array analysis of CM identified up-regulated secreted factors in WS19T relative to control WS21T CM. We identified CXCL12 as a CM factor influencing loss of mDia2 protein while increasing MDA-MB-231 cell migration. Our data suggest a mechanism whereby CAFs promote tumor cell migration and invasion through CXCL12 secretion to regulate the mDia2-directed cytoskeleton in breast tumor cells.	[Dvorak, Kaitlyn M.; Pettee, Krista M.; Rubinic-Minotti, Kaitlin; Su, Robin; Eisenmann, Kathryn M.] Univ Toledo, Dept Canc Biol, Hlth Sci Campus, Toledo, OH 43606 USA; [Nestor-Kalinoski, Andrea] Univ Toledo, Dept Surg, Hlth Sci Campus, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus	Eisenmann, KM (corresponding author), Univ Toledo, Dept Canc Biol, Hlth Sci Campus, Toledo, OH 43606 USA.	Kathryn.Eisenmann@utoledo.edu		Eisenmann, Kathryn/0000-0002-5337-5928	NATIONAL CANCER INSTITUTE [R01CA151632] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA151632] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alberts BJ, MOL BIOL CELL; Arden JD, 2015, MOL BIOL CELL, V26, P3704, DOI 10.1091/mbc.E14-11-1502; Baarlink C, 2010, CELL, V142, DOI 10.1016/j.cell.2010.06.030; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; D'Errico A, 2000, BRIT J CANCER, V82, P865, DOI 10.1054/bjoc.1999.1013; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deward AD, 2009, J BIOL CHEM, V284, P20061, DOI 10.1074/jbc.M109.000885; Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gialeli C, 2014, CURR PHARM DESIGN, V20, P2843, DOI 10.2174/13816128113199990592; Giricz O, 2013, INT J CANCER, V133, P2587, DOI 10.1002/ijc.28295; Goicoechea SM, 2014, ONCOGENE, V33, P1265, DOI 10.1038/onc.2013.68; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Hager MH, 2012, EMBO MOL MED, V4, P743, DOI 10.1002/emmm.201200242; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Isogai T, 2016, J PROTEOME RES, V15, P4624, DOI 10.1021/acs.jproteome.6b00718; Isogai T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09802; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Lee BC, 2004, MOL CANCER RES, V2, P327; Lee CC, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-85; Lim JB, 2015, CYTOKINE, V73, P16, DOI 10.1016/j.cyto.2015.01.010; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Lukaszewicz-Zajac M, 2016, DIS MARKERS, V2016; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Pettee KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090371; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Pignatelli J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005329; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Shekhar MPV, 2001, CANCER RES, V61, P1320; Shi YQ, 2009, BIOCHEM CELL BIOL, V87, P207, DOI 10.1139/O08-130; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Stastna J, 2012, CELL RES, V22, P728, DOI 10.1038/cr.2011.202; Staus DP, 2014, AM J PHYSIOL-HEART C, V307, pH379, DOI 10.1152/ajpheart.01002.2013; Struckhoff AP, 2013, J CELL SCI, V126, P4514, DOI 10.1242/jcs.132381; Taichman RS, 2002, CANCER RES, V62, P1832; Toguchi M, 2010, BIOL CELL, V102, P215, DOI 10.1042/BC20090033; Vaday GG, 2004, CLIN CANCER RES, V10, P5630, DOI 10.1158/1078-0432.CCR-03-0633; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Wang X.J., 2010, J INEQUAL APPL, V2010, DOI DOI 10.1155/2010/465915; Watanabe N, 1999, COOPERATION MDIA1 RO; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005; Wyse MM, 2017, BIOCHEM BIOPH RES CO, V484, P255, DOI 10.1016/j.bbrc.2017.01.087; Wyse MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045085; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yang W, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0044-z	80	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195278	10.1371/journal.pone.0195278	http://dx.doi.org/10.1371/journal.pone.0195278			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596520	Green Submitted, gold, Green Published			2022-12-27	WOS:000428630000102
J	Souza, R; Channick, RN; Delcroix, M; Galie, N; Ghofrani, HA; Jansa, P; Le Brun, FO; Mehta, S; Perchenet, L; Pulido, T; Sastry, BKS; Sitbon, O; Torbicki, A; Rubin, LJ; Simonneau, G				Souza, Rogerio; Channick, Richard N.; Delcroix, Marion; Galie, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomas; Sastry, B. K. S.; Sitbon, Olivier; Torbicki, Adam; Rubin, Lewis J.; Simonneau, Gerald			Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial	PLOS ONE			English	Article							END-POINT; METAANALYSIS; SURVIVAL; DIAGNOSIS; MORTALITY; THERAPY	Background Patients with pulmonary arterial hypertension who achieve a six-minute walk distance of 380-440 m may have improved prognosis. Using the randomized controlled trial of macitentan in pulmonary arterial hypertension (SERAPHIN), the association between six-minute walk distance and long-term outcomes was explored. Methods Patients with six-minute walk distance data at Month 6 were dichotomized as above or below the median six-minute walk distance (400 m) and assessed for future risk of pulmonary arterial hypertension-related death or hospitalization and all-cause death. Additionally, six-minute walk distance values at baseline, Month 6 and the change from baseline to Month 6 were categorized by quartiles. All associations were analyzed by the Kaplan Meier method using a log-rank test and Cox regression models. Results Patients with a six-minute walk distance >400 m vs. <= 400 m at Month 6 have a reduced risk of pulmonary arterial hypertension-related death or hospitalization (hazard ratio 0.48; 95% confidence interval 0.33-0.69). The risk was also lower for patients with higher quartiles of six-minute walk distance at baseline or Month 6 (baseline: hazard ratio [Q4 (>430 m) vs. Q1 (<= 300 m)] 0.23; 95% confidence interval 0.15-0.36; Month 6: hazard ratio [Q4 (>455 m) vs. Q1 (<= 348 m)] 0.33; 95% confidence interval 0.19-0.55). In contrast, six-minute walk distance changes at Month 6 were not associated with the risk of pulmonary arterial hypertension-related death or hospitalization (p = 0.477). These findings were consistent when adjusted for known confounders. Similar results were observed for the risk of all-cause death up to end of study. Conclusions Patients with pulmonary arterial hypertension walking >400 m had better long-term prognosis. Although changes in six-minute walk distance were not associated with long-term outcomes, assessing absolute six-minute walk distance values remains important in the clinical management of patients with pulmonary arterial hypertension.	[Souza, Rogerio] Univ Sao Paulo, Med Sch, Heart Inst, Pulm Dept, Sao Paulo, Brazil; [Channick, Richard N.] Massachusetts Gen Hosp, Pulm & Crit Care, Boston, MA 02114 USA; [Delcroix, Marion] Univ Hosp Gasthuisberg, Dept Pneumol, Leuven, Belgium; [Galie, Nazzareno] Bologna Univ Hosp, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy; [Ghofrani, Hossein-Ardeschir] UGMLC, Med Clin 2 5, Giessen, Germany; [Ghofrani, Hossein-Ardeschir] Imperial Coll London, Dept Med, London, England; [Jansa, Pavel] Charles Univ Prague, Fac Med 1, Med Dept 2, Clin Dept Cardiol & Angiol, Prague, Czech Republic; [Le Brun, Franck-Olivier] Actelion Pharmaceut Ltd, Dept Biostat, Allschwil, Switzerland; [Mehta, Sanjay] Western Univ, Victoria Hosp, London Hlth Sci Ctr, Dept Med,Div Respirol, London, ON, Canada; [Perchenet, Loic] Actelion Pharmaceut Ltd, Global Med Affairs, Allschwil, Switzerland; [Pulido, Tomas] Ignacio Chavez Natl Heart Inst, Cardiopulm Dept, Mexico City, DF, Mexico; [Sastry, B. K. S.] CARE Hosp, Dept Cardiol, Hyderabad, Andhra Prades, India; [Sitbon, Olivier; Simonneau, Gerald] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France; [Sitbon, Olivier] Univ Paris Sud, Lab Excellence Rech Med & Innova Therapeut, Le Kremlin Bicetre, France; [Sitbon, Olivier] Ctr Chirurg Marie Lannelongue, INSERM U999, Le Plessis Robinson, France; [Torbicki, Adam] Med Ctr Postgrad Educ, Dept Pulm Circulat & Thromboembol Dis, Otwock, Poland; [Rubin, Lewis J.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	Universidade de Sao Paulo; Harvard University; Massachusetts General Hospital; KU Leuven; University Hospital Leuven; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Imperial College London; Charles University Prague; Actelion Pharmaceuticals Ltd; London Health Sciences Centre; University of Victoria; Western University (University of Western Ontario); Actelion Pharmaceuticals Ltd; National Institute of Cardiology - Mexico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California San Diego	Souza, R (corresponding author), Univ Sao Paulo, Med Sch, Heart Inst, Pulm Dept, Sao Paulo, Brazil.	souza.rogerio@me.com	Sitbon, Olivier/I-3623-2019; Jansa, Pavel/O-2302-2017; Simonneau, Gerald/ABE-6614-2020; Ghofrani, Ardeschir/AAD-5293-2020; Souza, Rogerio/I-3584-2013; Mehta, Sanjay/G-3332-2011; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Delcroix, Marion/AAE-2712-2022	Sitbon, Olivier/0000-0002-1942-1951; Jansa, Pavel/0000-0002-3711-7064; Ghofrani, Ardeschir/0000-0002-2029-4419; Souza, Rogerio/0000-0003-2789-9143; Mehta, Sanjay/0000-0002-7707-1056; Delcroix, Marion/0000-0001-8394-9809; Torbicki, Adam/0000-0003-3475-8832; PULIDO, TOMAS/0000-0003-1442-7673	Actelion Pharmaceuticals Ltd.	Actelion Pharmaceuticals Ltd.	Actelion Pharmaceuticals Ltd., the study sponsor, together with the authors were involved in the study design, data collection and analysis, manuscript preparation and decision to publish. Medical writing assistance was funded by the sponsor. The funder provided support in the form of salaries for authors [F-OLB, LP]. The specific roles of these authors are articulated in the 'author contributions' section.; Medical writing assistance was provided by Lisa Thomas, PhD (Elements Communications Ltd, Westerham, UK), and editorial support was provided by Lynda McEvoy, PhD (Apothe-Com Ltd, London, UK), both funded by Actelion Pharmaceuticals Ltd.	Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Boucly A, 2017, AM J RESP CRIT CARE, V195; Deboeck G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092324; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; Fritz JS, 2013, CHEST, V143, P315, DOI 10.1378/chest.12-0270; Gabler NB, 2012, CIRCULATION, V126, P349, DOI 10.1161/CIRCULATIONAHA.112.105890; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kylhammar D, 2017, EUROPEAN HEART J; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Macchia A, 2007, AM HEART J, V153, P1037, DOI 10.1016/j.ahj.2007.02.037; Macchia A, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.028; Mathai SC, 2012, AM J RESP CRIT CARE, V186, P428, DOI 10.1164/rccm.201203-0480OC; McGoon MD, 2013, J AM COLL CARDIOL, V62, pD51, DOI 10.1016/j.jacc.2013.10.023; McLaughlin VV, 2013, J AM COLL CARDIOL, V62, pD73, DOI 10.1016/j.jacc.2013.10.034; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Ogawa A, 2017, AM J CARDIOL, V119, P1479, DOI 10.1016/j.amjcard.2017.01.015; Provencher S, 2006, EUR HEART J, V27, P589, DOI 10.1093/eurheartj/ehi728; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Rich S, 2012, J AM COLL CARDIOL, V60, P1202, DOI 10.1016/j.jacc.2012.03.080; Savarese G, 2012, J AM COLL CARDIOL, V60, P1192, DOI 10.1016/j.jacc.2012.01.083; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0	26	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193226	10.1371/journal.pone.0193226	http://dx.doi.org/10.1371/journal.pone.0193226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590122	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100018
J	Makridakis, S; Spiliotis, E; Assimakopoulos, V				Makridakis, Spyros; Spiliotis, Evangelos; Assimakopoulos, Vassilios			Statistical and Machine Learning forecasting methods: Concerns and ways forward	PLOS ONE			English	Article							TIME-SERIES; NEURAL-NETWORKS; STATE; MODELS; ALGORITHMS; PREDICTION; ACCURACY; TREND	Machine Learning (ML) methods have been proposed in the academic literature as alternatives to statistical ones for time series forecasting. Yet, scant evidence is available about their relative performance in terms of accuracy and computational requirements. The purpose of this paper is to evaluate such performance across multiple forecasting horizons using a large subset of 1045 monthly time series used in the M3 Competition. After comparing the post-sample accuracy of popular ML methods with that of eight traditional statistical ones, we found that the former are dominated across both accuracy measures used and for all forecasting horizons examined. Moreover, we observed that their computational requirements are considerably greater than those of statistical methods. The paper discusses the results, explains why the accuracy of ML models is below that of statistical ones and proposes some possible ways forward. The empirical results found in our research stress the need for objective and unbiased ways to test the performance of forecasting methods that can be achieved through sizable and open competitions allowing meaningful comparisons and definite conclusions.	[Makridakis, Spyros] Univ Nicosia, IFF, Nicosia, Cyprus; [Spiliotis, Evangelos; Assimakopoulos, Vassilios] Natl Tech Univ Athens, Sch Elect & Comp Engn, Forecasting & Strategy Unit, Zografos, Greece	University of Nicosia; National Technical University of Athens	Spiliotis, E (corresponding author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Forecasting & Strategy Unit, Zografos, Greece.	spiliotis@fsu.gr	Spiliotis, Evangelos/AAB-6214-2019	Spiliotis, Evangelos/0000-0002-1854-1206				Abadi M., 2016, TENSORFLOW LARGE SCA; Adya M, 1998, J FORECASTING, V17, P481, DOI 10.1002/(SICI)1099-131X(1998090)17:5/6<481::AID-FOR709>3.0.CO;2-Q; Ahmed NK, 2010, ECONOMET REV, V29, P594, DOI 10.1080/07474938.2010.481556; Alpaydin E., 2004, MACHINE LEARNING INT; Andrawis RR, 2011, INT J FORECASTING, V27, P672, DOI 10.1016/j.ijforecast.2010.09.005; [Anonymous], 2014, ACAD ACCOUNTING FINA; Assimakopoulos V, 2000, INT J FORECASTING, V16, P521, DOI 10.1016/S0169-2070(00)00066-2; Bauwens L, 2006, J APPL ECONOMET, V21, P79, DOI 10.1002/jae.842; Bergmeir C, 2012, J STAT SOFTW, V46, P1; Box G. E. P., 1970, Time series analysis, forecasting and control; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Breiman L., 1993, CLASSIFICATION REGRE; Chasset P -O., 2013, GRNN GEN REGRESSION; CHATFIELD C, 1993, INT J FORECASTING, V9, P1, DOI 10.1016/0169-2070(93)90043-M; Chollet F., 2015, KERAS; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; COTTRELL M, 1995, IEEE T NEURAL NETWOR, V6, P1355, DOI 10.1109/72.471372; COX DR, 1955, BIOMETRIKA, V42, P80, DOI 10.1093/biomet/42.1-2.80; Crone SF, 2011, INT J FORECASTING, V27, P635, DOI 10.1016/j.ijforecast.2011.04.001; Deng L, 2014, APSIPA TRANS SIGNAL, V3, DOI 10.1017/atsip.2013.9; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Gabor MR, 2017, TRANSFORM BUS ECON, V16, P187; GARDNER ES, 1985, J FORECASTING, V4, P1, DOI 10.1002/for.3980040103; Gardner ES, 2006, INT J FORECASTING, V22, P637, DOI 10.1016/j.ijforecast.2006.03.005; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Goodwin P, 1999, INT J FORECASTING, V15, P405, DOI 10.1016/S0169-2070(99)00007-2; GORR WL, 1994, INT J FORECASTING, V10, P1, DOI 10.1016/0169-2070(94)90044-2; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Green KC, 2015, J BUS RES, V68, P1678, DOI 10.1016/j.jbusres.2015.03.026; Hagan M., 1997, IEEE INT C NEUR NETW, V3, P1930, DOI DOI 10.1109/ICNN.1997.614194; Hamzacebi C, 2009, EXPERT SYST APPL, V36, P3839, DOI 10.1016/j.eswa.2008.02.042; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Hyndman RJ, 2002, INT J FORECASTING, V18, P439, DOI 10.1016/S0169-2070(01)00110-8; Hyndman RJ, 2006, INT J FORECASTING, V22, P679, DOI 10.1016/j.ijforecast.2006.03.001; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Ilies I, 2007, TECHNICAL REPORT; Jain LC, 1999, INT SER COMPUTAT INT, P1; Kang YF, 2017, INT J FORECASTING, V33, P345, DOI 10.1016/j.ijforecast.2016.09.004; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Keogh E, 2003, DATA MIN KNOWL DISC, V7, P349, DOI 10.1023/A:1024988512476; Kock AB, 2016, ECONOMET REV, V35, P1753, DOI 10.1080/07474938.2015.1035163; Laurent S, 2012, J APPL ECONOMET, V27, P934, DOI 10.1002/jae.1248; Lippmann R. P., 1987, IEEE ASSP Magazine, V4, P4, DOI 10.1145/44571.44572; Liu WB, 2017, NEUROCOMPUTING, V234, P11, DOI 10.1016/j.neucom.2016.12.038; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI 10.1162/neco.1992.4.3.448; Makridakis S, 2000, INT J FORECASTING, V16, P451, DOI 10.1016/S0169-2070(00)00057-1; MAKRIDAKIS S, 1979, J ROY STAT SOC A STA, V142, P97, DOI 10.2307/2345077; Makridakis S., 1998, FORECASTING METHODS; Makridakis S, 2017, FUTURES, V90, P46, DOI 10.1016/j.futures.2017.03.006; Marr B., 2016, FORBES; Meyer D, 2017, E1071 MISC FUNCTIONS; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; NELSON CR, 1982, J MONETARY ECON, V10, P139, DOI 10.1016/0304-3932(82)90012-5; Nelson M., 1994, Proceedings of the Twenty-Seventh Hawaii International Conference on System Sciences. Vol.III: Information Systems: Decision Support and Knowledge-Based Systems (Cat. No.94TH0607-2), P649, DOI 10.1109/HICSS.1994.323316; Nguyen D., 1990, IN 1990 IJCNN INT JO, P21, DOI DOI 10.1109/IJCNN.1990.137819; Petropoulos F, 2014, EUR J OPER RES, V237, P152, DOI 10.1016/j.ejor.2014.02.036; Qiu MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155133; Robinson C, 2017, APPL ENERG, V208, P889, DOI 10.1016/j.apenergy.2017.09.060; Rodriguez PP, 2016, BRNN BAYESIAN REGULA; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Salaken SM, 2017, NEUROCOMPUTING, V267, P516, DOI 10.1016/j.neucom.2017.06.037; Scholkopf B, 2001, LEARNING KERNEL SUPP; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; SHARDA R, 1992, J INTELL MANUF, V3, P317, DOI 10.1007/BF01577272; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Spiliotis E, 2018, WORKING PAPER; Therneau T., 2015, PACKAGE RPART, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=RPART; Venables W.N., 2002, MODERN APPL STAT S, VFourth; Voyant C, 2017, RENEW ENERG, V105, P569, DOI 10.1016/j.renene.2016.12.095; Wang J, 2017, NEURAL NETWORKS, V90, P8, DOI 10.1016/j.neunet.2017.03.004; Zaremba W, 2014, CORR; Zeng NY, 2018, NEUROCOMPUTING, V273, P643, DOI 10.1016/j.neucom.2017.08.043; Zhang GP, 2005, EUR J OPER RES, V160, P501, DOI 10.1016/j.ejor.2003.08.037; Zhang GP., 2007, IEEE T SYSTEMS MAN C, V37; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang L, 2016, INFORM SCIENCES, V364, P146, DOI 10.1016/j.ins.2016.01.039; Zhao L., 2009, REV BUSINESS INFORM, V13, P57, DOI https://doi.org/10.19030/rbis.v13i3.4324	81	393	397	7	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194889	10.1371/journal.pone.0194889	http://dx.doi.org/10.1371/journal.pone.0194889			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584784	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000048
J	Leung, LY; Han, PKJ; Lundquist, C; Weinstein, G; Thaler, DE; Kent, D				Leung, Lester Y.; Han, Paul K. J.; Lundquist, Christine; Weinstein, Gene; Thaler, David E.; Kent, David			Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; STROKE; STATEMENT; PREVENTION; SATURATION; INTERVIEWS; DISEASE	Background While silent brain infarcts (SBIs) in screened cohorts are associated with risk of symptomatic stroke and dementia, the clinical significance of incidentally discovered SBIs (id-SBIs) is unknown. Detection may offer an opportunity to initiate prevention measures, but uncertainties about id-SBIs may impede clinicians from addressing them and complicate further study of this condition. Methods and results This study used semi-structured interviews of practicing clinicians. Interviews were audio recorded, transcribed, and analyzed using a grounded theory approach. A constant comparative method was used to organize emergent themes and examine new themes. Purposeful sampling was employed to achieve participant diversity. Fifteen clinicians were interviewed. Emergent themes centered on uncertainty about id-SBIs, clinical decision making in response to uncertainty, and evidence needed to resolve uncertainty. All clinicians reported uncertainty about id-SBIs: diagnostic, prognostic, or therapeutic. Differential responses to uncertainties resulted in practice variation within and between specialties. Diagnostic and prognostic uncertainty discouraged disclosure of imaging findings to patients. Vascular neurologists viewed the prognostic significance of id-SBIs as similar to symptomatic stroke. Therapeutic uncertainty was common, but most participants endorsed using stroke secondary prevention strategies. Regarding future research, all internists indicated they would consider changing practices in response to observational studies, whereas half of the neurologists expressed reluctance to modify practices based on non-randomized data. Several expressed concerns about clinical trial feasibility and lack of equipoise. Conclusions id-SBIs are a focus of uncertainty for clinicians, leading to practice variation. Future studies must address diagnostic and prognostic uncertainty to facilitate implementation of prevention strategies.	[Leung, Lester Y.; Thaler, David E.] Tufts Med Ctr, Dept Neurol, Div Stroke & Cerebrovasc Dis, Boston, MA 02111 USA; [Han, Paul K. J.] Maine Med Ctr, Res Inst, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA; [Lundquist, Christine; Kent, David] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Predict Analyt & Comparat Effectiveness Ctr, Boston, MA USA; [Weinstein, Gene] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA	Tufts Medical Center; Maine Medical Center; Tufts Medical Center; Harvard University; Massachusetts General Hospital	Leung, LY (corresponding author), Tufts Med Ctr, Dept Neurol, Div Stroke & Cerebrovasc Dis, Boston, MA 02111 USA.	lester.y.leung.md@gmail.com			NINDS NIH HHS [R01 NS102233] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102233] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Fanning JP, 2014, STROKE, V45, P3461, DOI 10.1161/STROKEAHA.114.005919; Fanning JP, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0119-0; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gupta A, 2016, STROKE, V47, P719, DOI 10.1161/STROKEAHA.115.011889; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Leary MC, 2003, CEREBROVASC DIS, V16, P280, DOI 10.1159/000071128; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Ryan GW, 2003, COLLECTING INTERPRET, P259; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Smith EE, 2017, STROKE, V48, pE44, DOI 10.1161/STR.0000000000000116; Strauss A., 1998, BASICS QUALITATIVE R; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8	15	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194971	10.1371/journal.pone.0194971	http://dx.doi.org/10.1371/journal.pone.0194971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596459	Green Published, gold, Green Submitted			2022-12-27	WOS:000428630000060
J	Onakpoya, IJ; Walker, AS; Tan, PS; Spencer, EA; Gbinigie, OA; Cook, J; Llewelyn, MJ; Butler, CC				Onakpoya, Igho J.; Walker, A. Sarah; Tan, Pui S.; Spencer, Elizabeth A.; Gbinigie, Oghenekome A.; Cook, Johanna; Llewelyn, Martin J.; Butler, Christopher C.			Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; PERFORMANCE IMPROVEMENT PROGRAM; VENTILATOR-ASSOCIATED PNEUMONIA; ANTIMICROBIAL THERAPY; CLOSTRIDIUM-DIFFICILE; ACUTE PYELONEPHRITIS; TRACT-INFECTIONS; SEVERE SEPSIS; METAANALYSIS; RESISTANCE	Our objective was to assess the clinical effectiveness of shorter versus longer duration antibiotics for treatment of bacterial infections in adults and children in secondary care settings, using the evidence from published systematic reviews. We conducted electronic searches in MEDLINE, Embase, Cochrane, and Cinahl. Our primary outcome was clinical resolution. The quality of included reviews was assessed using the AMSTAR criteria, and the quality of the evidence was rated using the GRADE criteria. We included 6 systematic reviews (n = 3,162). Four reviews were rated high quality, and two of moderate quality. In adults, there was no difference between shorter versus longer duration in clinical resolution rates for peritonitis (RR 1.03, 95% CI 0.98 to 1.09,I-2 = 0%), ventilator-associated pneumonia (RR 0.93; 95% CI 0.81 to 1.08, I-2 = 24%), or acute pyelonephritis and septic UTI (clinical failure: RR 1.00, 95% CI 0.46 to 2.18). The quality of the evidence was very low to moderate. In children, there was no difference in clinical resolution rates for pneumonia (RR 0.98, 95% CI 0.91 to 1.04,I-2 = 48%), pyelonephritis (RR 0.95, 95% CI 0.88 to 1.04) and confirmed bacterial meningitis (RR 1.02, 95% CI 0.93 to 1.11, I-2 = 0%). The quality of the evidence was low to moderate. In conclusion, there is currently a limited body of evidence to clearly assess the clinical benefits of shorter versus longer duration antibiotics in secondary care. High quality trials assessing strategies to shorten antibiotic treatment duration for bacterial infections in secondary care settings should now be a priority.	[Onakpoya, Igho J.; Tan, Pui S.; Spencer, Elizabeth A.; Gbinigie, Oghenekome A.; Cook, Johanna; Butler, Christopher C.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford, England; [Walker, A. Sarah] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Expt Med Div, Oxford, England; [Llewelyn, Martin J.] Dept Microbiol & Infect, Brighton, E Sussex, England; [Llewelyn, Martin J.] Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Llewelyn, Martin J.] Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Falmer, E Sussex, England	University of Oxford; University of Oxford; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Sussex	Onakpoya, IJ (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford, England.	igho.onakpoya@phc.ox.ac.uk	Walker, Sarah/HDM-8717-2022; Llewelyn, Martin/A-7194-2011	Llewelyn, Martin/0000-0002-6811-1124; Butler, Christopher/0000-0002-0102-3453; Onakpoya, Igho/0000-0002-2420-0811; Gbinigie, Oghenekome/0000-0002-2963-4491; peto, tim/0000-0003-3477-8307; Spencer, Elizabeth/0000-0002-9079-8006	National Institute for Health Research (Programme Grants for Applied Research, Antibiotic Reduction and Conservation in Hospitals (ARK-Hospital)) [RP-PG-0514-20015]	National Institute for Health Research (Programme Grants for Applied Research, Antibiotic Reduction and Conservation in Hospitals (ARK-Hospital))	This report is independent research funded by the National Institute for Health Research (Programme Grants for Applied Research, Antibiotic Reduction and Conservation in Hospitals (ARK-Hospital), RP-PG-0514-20015). The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, EV THREAT ANT RES; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bergman M, 2004, CLIN INFECT DIS, V38, P1251, DOI 10.1086/383309; Brodt AM, 2014, EUR RESPIR J, V44, P382, DOI 10.1183/09031936.00018414; Chapman E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010976.pub2; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; Chung A, 2007, BMJ-BRIT MED J, V335, P429, DOI 10.1136/bmj.39274.647465.BE; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Darouiche RO, 2014, ARCH PHYS MED REHAB, V95, P290, DOI 10.1016/j.apmr.2013.09.003; Dawson-Hahn EE, 2017, FAM PRACT, V34, P511, DOI 10.1093/fampra/cmx037; Department of Health and Department of Environment Food and Rural Affairs, 2013, UK 5 YEAR ANT RES ST; Dimopoulos G, 2008, DRUGS, V68, P1841, DOI 10.2165/00003495-200868130-00004; Dimopoulos G, 2013, CHEST, V144, P1759, DOI 10.1378/chest.13-0076; Dugan HA, 2003, J CLIN PHARM THER, V28, P123, DOI 10.1046/j.1365-2710.2003.00471.x; Eliakim-Raz N, 2013, J ANTIMICROB CHEMOTH, V68, P2183, DOI 10.1093/jac/dkt177; European Centre for Disease Prevention and Control, 2013, ANN REP EUR ANT RES; Fantin B, 2009, J INFECT DIS, V200, P390, DOI 10.1086/600122; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; File TM, 2012, J HOSP MED, V7, pS22, DOI 10.1002/jhm.988; FLEMING W L, 1948, Am J Syph Gonorrhea Vener Dis, V32, P53; Ghazipura M., 2013, SHORTER VERSUS LONGE; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Havey TC, 2011, CRIT CARE, V15, DOI 10.1186/cc10545; Hersh AL, 2013, PEDIATRICS, V132, P1146, DOI 10.1542/peds.2013-3260; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Karageorgopoulos DE, 2009, ARCH DIS CHILD, V94, P607, DOI 10.1136/adc.2008.151563; Korbila IP, 2013, EXPERT REV ANTI-INFE, V11, P585, DOI [10.1586/eri.13.44, 10.1586/ERI.13.44]; Kuster SP, 2014, CLIN INFECT DIS, V59, P944, DOI 10.1093/cid/ciu497; Kyriakidou KG, 2008, CLIN THER, V30, P1859, DOI 10.1016/j.clinthera.2008.10.007; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008032.pub2; Lavis JN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000141; Le Saux N, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-16; Leekha S, 2011, MAYO CLIN PROC, V86, P156, DOI 10.4065/mcp.2010.0639; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Llewelyn MJ, 2015, J ANTIMICROB CHEMOTH, V70, P1230, DOI 10.1093/jac/dku515; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; McKenzie JE, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0582-8; National Institute for Health and Care Excellence (NICE), MEN BACT MEN SEPT 16; National Institute for Health and Care Excellence (NICE), PNEUM AD DIAGN MAN C; National Institute for Health and Care Excellence (NICE), 2016, SEPS REC DIAGN EARL; National Institute for Health and Care Excellence (NICE), CLIN KNOWL SUMM PYEL; Poole P, 2004, RESP MED, V98, P273, DOI 10.1016/j.rmed.2004.02.001; Public Health England, START SMART FOC; Pugh R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007577.pub3; Review Manager (RevMan), 2014, REV MAN REVMAN COMP; Rice LB, 2008, CLIN INFECT DIS, V46, P491, DOI 10.1086/526535; Ruppe E, 2013, ANTIMICROB AGENTS CH, V57, P4512, DOI 10.1128/AAC.00238-13; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Smith L, 2005, AM FAM PHYSICIAN, V71, P2003; Spellberg B, 2016, JAMA INTERN MED, V176, P1254, DOI 10.1001/jamainternmed.2016.3646; Spurling GKP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub4; Strohmeier Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003772.pub4; The UK Sepsis Trust, APP 1 INTR RED FLAG; Weiss SL, 2014, CRIT CARE MED, V42, P2409, DOI 10.1097/CCM.0000000000000509; Wong PF, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004539.pub2; [姚莉 Yao Li], 2016, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V16, P73	60	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194858	10.1371/journal.pone.0194858	http://dx.doi.org/10.1371/journal.pone.0194858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590188	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000428603100079
J	Wedell-Neergaard, AS; Krogh-Madsen, R; Petersen, GL; Hansen, AM; Pedersen, BK; Lund, R; Bruunsgaard, H				Wedell-Neergaard, Anne-Sophie; Krogh-Madsen, Rikke; Petersen, Gitte Lindved; Hansen, Ase Marie; Pedersen, Bente Klarlund; Lund, Rikke; Bruunsgaard, Helle			Cardiorespiratory fitness and the metabolic syndrome: Roles of inflammation and abdominal obesity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; ADIPOSE-TISSUE; RISK-FACTORS; EXERCISE; MARKERS; FAT; ATHEROSCLEROSIS	Objective Individuals with metabolic syndrome have increased risk of type 2 diabetes and cardiovascular disease. We aimed to test the hypothesis that a high level of cardiorespiratory fitness (CR-fitness), counteracts accumulation of visceral fat, decreases inflammation and lowers risk factors of the metabolic syndrome. Method The study sample included 1,293 Danes (age 49-52 years) who from 2009 to 2011 participated in the Copenhagen Aging and Midlife Biobank, including a questionnaire, physical tests, and blood samples. Multiple linear regression models were performed with CR-fitness as exposure and plasma levels of cytokines and high sensitive C-reactive protein as outcomes and measures of abdominal obesity were added to test if they explained the potential association. Similarly, multiple linear regression models were performed with CR-fitness as exposure and factors of the metabolic syndrome as outcomes and the potential explanation by inflammatory biomarkers were tested. All models were adjusted for the effect of age, sex, smoking, alcohol consumption, socio-economic status, and acute inflammatory events within the preceding two weeks. Results CR-fitness was inversely associated with high sensitive C-reactive protein, Interleukin (IL) 6, and IL-18, and directly associated with the anti-inflammatory cytokine IL-10, but not associated with tumor necrosis factor alpha, interferon gamma or IL-113. Abdominal obesity could partly explain the significant associations. Moreover, CR-fitness was inversely associated with an overall metabolic syndrome score, as well as triglycerides, glycated haemoglobin Alc, systolic blood pressure, diastolic blood pressure and directly associated with high-density lipoprotein. Single inflammatory biomarkers and a combined inflammatory score partly explained these associations. Conclusion Data suggest that CR-fitness has anti-inflammatory effects that are partly explained by a reduction in abdominal obesity and a decrease in the metabolic syndrome risk profile. The overall inflammatory load was mainly driven by high sensitive C-reactive protein and IL-6.	[Wedell-Neergaard, Anne-Sophie; Krogh-Madsen, Rikke; Pedersen, Bente Klarlund; Bruunsgaard, Helle] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Ctr Phys Act Res, Copenhagen, Denmark; [Petersen, Gitte Lindved; Hansen, Ase Marie; Lund, Rikke] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Petersen, Gitte Lindved; Lund, Rikke] Univ Copenhagen, Ctr Hlth Ageing, Copenhagen, Denmark; [Hansen, Ase Marie] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Bruunsgaard, Helle] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; National Research Centre for the Working Environment; Rigshospitalet; University of Copenhagen	Bruunsgaard, H (corresponding author), Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Ctr Phys Act Res, Copenhagen, Denmark.; Bruunsgaard, H (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark.	helle.bruunsgaard@regionh.dk	Hansen, Åse/AAJ-1043-2020; Petersen, Gitte Lindved/AAQ-1190-2020; Bruunsgaard, Helle/AAY-3293-2020; Pedersen, Bente Klarlund/AGR-3217-2022	Hansen, Åse/0000-0002-4075-3918; Petersen, Gitte Lindved/0000-0001-8920-4015; Bruunsgaard, Helle/0000-0003-2330-0834; Pedersen, Bente Klarlund/0000-0001-6508-6288; Krogh-Madsen, Rikke/0000-0003-4914-2715; Lund, Rikke/0000-0002-0381-4291	VELUX FOUNDATION [VELUX 26145, 31539]; TrygFonden; Danish Council for Strategic Research [09067009, 09-075724]	VELUX FOUNDATION(Velux Fonden); TrygFonden; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The Copenhagen Aging and Midlife Biobank has been supported by a generous grant from the VELUX FOUNDATION (VELUX 26145 and 31539). The Centre for Physical Activity Research (CFAS) is supported by a grant from TrygFonden. CFAS is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09067009 and 09-075724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; Albert MA, 2004, AM J CARDIOL, V93, P221, DOI 10.1016/j.amjcard.2003.09.046; Aronson D, 2004, ATHEROSCLEROSIS, V176, P173, DOI 10.1016/j.atherosclerosis.2004.04.025; Asghar A, 2017, CELL IMMUNOL, V315, P18, DOI 10.1016/j.cellimm.2017.03.001; ASHWELL M, 1985, BRIT MED J, V290, P1692, DOI 10.1136/bmj.290.6483.1692; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Avlund K, 2014, J AGING HEALTH, V26, P5, DOI 10.1177/0898264313509277; Benatti FB, 2015, NAT REV RHEUMATOL, V11, P86, DOI 10.1038/nrrheum.2014.193; Blake GJ, 2001, CIRC RES, V89, P763, DOI 10.1161/hh2101.099270; Booth F, 2014, COMPR PHYSL, V2, P1143; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; C Reactive Protein Coronary Heart Disease Genetics Collaboration, 2011, BMJ-BRIT MED J, V342, P1; Carnethon MR, 2009, AM J LIFESTYLE MED, V3, p44S, DOI 10.1177/1559827609332737; Chan CS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.348599; Christensen U, 2014, J AGING HEALTH, V26, P106, DOI 10.1177/0898264314522894; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Cottam DR, 2004, OBES SURG, V14, P589, DOI 10.1381/096089204323093345; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; El Said HW, 2017, INT UROL NEPHROL, V49, P1251, DOI 10.1007/s11255-017-1568-0; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; Goh LGH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004138; Hansen AM, 2014, J AGING HEALTH, V26, P72, DOI 10.1177/0898264313508187; Hayashino Y, 2014, METABOLISM, V63, P431, DOI 10.1016/j.metabol.2013.08.018; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Ilhan F, 2015, WORLD J CLIN CASES, V3, P345, DOI 10.12998/wjcc.v3.i4.345; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Karstoft K, 2016, IMMUNOL CELL BIOL, V94, P146, DOI 10.1038/icb.2015.101; Kim HY, 2013, CLIN CHEM LAB MED, V51, P2195, DOI 10.1515/cclm-2013-0045; Knudsen SH, 2012, J APPL PHYSIOL, V113, P7, DOI 10.1152/japplphysiol.00189.2011; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Krogh-Madsen R, 2014, J APPL PHYSIOL, V116, P231, DOI 10.1152/japplphysiol.00155.2013; Landi F, 1999, J AM GERIATR SOC, V47, P1072, DOI 10.1111/j.1532-5415.1999.tb05229.x; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee WY, 2004, INT J CARDIOL, V97, P101, DOI 10.1016/j.ijcard.2003.08.016; Leon MLA, 2005, INFLAMM RES, V54, P395, DOI 10.1007/s00011-005-1377-2; Mally K, 2011, EUR J APPL PHYSIOL, V111, P1879, DOI 10.1007/s00421-010-1795-x; Mathers C, 2009, GLOB HLTH RISKS MORT; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Pedersen BK, 2017, EUR J CLIN INVEST, V47, P600, DOI 10.1111/eci.12781; Peter I, 2014, MED SCI SPORT EXER, V46, P302, DOI 10.1249/MSS.0b013e3182a66155; Rana JS, 2006, INT J CARDIOL, V110, P224, DOI 10.1016/j.ijcard.2005.08.040; Reuben DB, 2003, J AM GERIATR SOC, V51, P1125, DOI 10.1046/j.1532-5415.2003.51380.x; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2017, LANCET, V6736, P1; Shoji K, 2008, OBES RES CLIN PRACT, V2, P269, DOI 10.1016/j.orcp.2008.09.001; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Slaats J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005973; Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Williams MJA, 2005, EUR J CARDIOV PREV R, V12, P216, DOI 10.1097/00149831-200506000-00005; Wu ZJ, 2017, CLIN CHEM, V63, P663, DOI 10.1373/clinchem.2016.260828; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	69	54	56	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194991	10.1371/journal.pone.0194991	http://dx.doi.org/10.1371/journal.pone.0194991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590212	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100095
J	Krajacich, BJ; Huestis, DL; Dao, A; Yaro, AS; Diallo, M; Krishna, A; Xu, JN; Lehmann, T				Krajacich, Benjamin J.; Huestis, Diana L.; Dao, Adama; Yaro, Alpha S.; Diallo, Moussa; Krishna, Asha; Xu, Jiannong; Lehmann, Tovi			Investigation of the seasonal microbiome of Anopheles coluzzii mosquitoes in Mali	PLOS ONE			English	Article							MALARIA MOSQUITO; AEDES-AEGYPTI; GAMBIAE; IDENTIFICATION; ESTIVATION; BACTERIA; VILLAGE; GENE	The poorly understood mechanisms of dry season persistence of Anopheles spp. mosquitoes through the dry season in Africa remain a critical gap in our knowledge of Plasmodium disease transmission. While it is thought that adult mosquitoes remain in a dormant state throughout this seven-month dry season, the nature of this state remains unknown and has largely not been recapitulated in laboratory settings. To elucidate possible connections of this state with microbial composition, the whole body microbiomes of adult mosquitoes in the dry and wet seasons in two locations of Mali with varying water availability were compared by sequencing the 16S ribosomal RNA gene. These locations were a village near the Niger River with year-round water sources (N'Gabakoro, "riparian"), and a typical Sahelian area with highly seasonal breeding sites (Thierola Area, "Sahelian"). The 16S bacterial data consisted of 2057 sequence variants in 426 genera across 184 families. From these data, we found several compositional differences that were seasonally and spatially linked. Counter to our initial hypothesis, there were more pronounced seasonal differences in the bacterial microbiome of riparian, rather than Sahelian areas. These seasonal shifts were primarily in Ralstonia, Sphingorhabdus, and Duganella spp. bacteria that are usually soil and water-associated, indicating these changes may be from bacteria acquired in the larval environment, rather than adulthood. In Sahelian dry season mosquitoes, there was a unique intracellular bacteria, Anaplasma, which likely was acquired through non-human blood feeding. Cytochrome B analysis of blood meals showed greater heterogeneity in host choice of An. coluzzii independent of season in the Thierola area compared to N'Gabakoro (77.5% vs. 94.6% human-origin blood meal, respectively), indicating a relaxation of anthropophily. Overall, this exploratory study provides valuable indications of spatial and seasonal differences in bacterial composition which help refine this difficult to study state.	[Krajacich, Benjamin J.; Huestis, Diana L.; Krishna, Asha; Lehmann, Tovi] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Dao, Adama; Yaro, Alpha S.; Diallo, Moussa] Univ Sci Tech & Technol, Fac Med Pharm & Odontostomatol, MRTC, Bamako, Mali; [Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Science & Technology of Bamako; New Mexico State University	Krajacich, BJ; Lehmann, T (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	Benjamin.krajacich@nih.gov; tlehmann@niaid.nih.gov	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370; Lehmann, Tovi/0000-0002-8142-3915	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092789] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham NM, 2017, P NATL ACAD SCI USA; Akorli J, 2016, PLOS ONE, P11; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apte-Deshpande A, 2012, PLOS ONE, P7; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22806; Callahan B., 2016, SILVA TAXONOMIC TRAI, DOI [10.5281/zenodo.158958, DOI 10.5281/ZENODO.158958]; Callahan Ben J, 2016, F1000Res, V5, P1492; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Coulibaly Mamadou B., 2007, PLoS ONE, V2, P1; Dao A, 2014, NATURE, V516, P387, DOI 10.1038/nature13987; David MR, 2016, MEM I OSWALDO CRUZ, V111, P577, DOI 10.1590/0074-02760160238; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Hijmans R.J., 2016, RASTER GEOGRAPHIC DA; Holstein M., 1954, WORLD HEAL ORGAN, P274; Huestis DL, 2014, INFECT GENET EVOL, V28, P648, DOI 10.1016/j.meegid.2014.05.027; Huestis DL, 2012, J EXP BIOL, V215, P2013, DOI 10.1242/jeb.069468; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Kuhn M., 2019, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; leBorgne P, 2007, P 2007 EUMETSAT C, P1; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; Lehmann T, 2014, J MED ENTOMOL, V51, P27, DOI 10.1603/ME13094; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Minard G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00059; Murray PR., 2003, MANUAL CLIN MICROBIO, V8th; OMER SM, 1968, NATURE, V217, P879, DOI 10.1038/217879b0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pebesma E. J., 2005, R NEWS, V5, P9; Price MN, 2010, PLOS ONE, P5; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2009, R LANG ENV STAT COMP; RStudio Team, 2015, RSTUDIO INT DEV R; Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sankaran K, 2014, J STAT SOFTW, V59; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Sohn E., 2014, NATURE, V511, P145; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016383, 10.1371/journal.pone.0020422]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yaro AS, 2012, J INSECT PHYSIOL, V58, P1050, DOI 10.1016/j.jinsphys.2012.04.002; Yekutieli D, 2008, J AM STAT ASSOC, V103, P309, DOI 10.1198/016214507000001373; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	60	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194899	10.1371/journal.pone.0194899	http://dx.doi.org/10.1371/journal.pone.0194899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596468	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000048
J	Kelly, AC; Ward, TJ				Kelly, Amy C.; Ward, Todd J.			Population genomics of Fusarium graminearum reveals signatures of divergent evolution within a major cereal pathogen	PLOS ONE			English	Article							GENE-CLUSTER; FUNCTIONAL-ANALYSIS; POSITIVE SELECTION; GIBBERELLA-ZEAE; IN-VITRO; WHEAT; FUNGUS; DIVERSITY; PROTEINS; NUMBER	The cereal pathogen Fusarium graminearum is the primary cause of Fusarium head blight (FHB) and a significant threat to food safety and crop production. To elucidate population structure and identify genomic targets of selection within major FHB pathogen populations in North America we sequenced the genomes of 60 diverse F. graminearum isolates. We also assembled the first pan-genome for F. graminearum to clarify population-level differences in gene content potentially contributing to pathogen diversity. Bayesian and phylogenomic analyses revealed genetic structure associated with isolates that produce the novel NX-2 mycotoxin, suggesting a North American population that has remained genetically distinct from other endemic and introduced cereal-infecting populations. Genome scans uncovered distinct signatures of selection within populations, focused in high diversity, frequently recombining regions. These patterns suggested selection for genomic divergence at the trichothecene toxin gene cluster and thirteen additional regions containing genes potentially involved in pathogen specialization. Gene content differences further distinguished populations, in that 121 genes showed population-specific patterns of conservation. Genes that differentiated populations had predicted functions related to pathogenesis, secondary metabolism and antagonistic interactions, though a subset had unique roles in temperature and light sensitivity. Our results indicated that F. graminearum populations are distinguished by dozens of genes with signatures of selection and an array of dispensable accessory genes, suggesting that FHB pathogen populations may be equipped with different traits to exploit the agroecosystem. These findings provide insights into the evolutionary processes and genomic features contributing to population divergence in plant pathogens, and highlight candidate genes for future functional studies of pathogen specialization across evolutionarily and ecologically diverse fungi.	[Kelly, Amy C.; Ward, Todd J.] USDA ARS, Peoria, IL 61604 USA	United States Department of Agriculture (USDA)	Ward, TJ (corresponding author), USDA ARS, Peoria, IL 61604 USA.	todd.ward@ars.usda.gov			United States Department of Agriculture Agricultural Research Service National Program for Food Safety	United States Department of Agriculture Agricultural Research Service National Program for Food Safety	This study was supported by the United States Department of Agriculture Agricultural Research Service National Program for Food Safety. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P274; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Alexander NJ, 2009, TOXIN REV, V28, P198, DOI 10.1080/15569540903092142; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ambrose KV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10939; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Backhouse D, 2014, EUR J PLANT PATHOL, V139, P161, DOI 10.1007/s10658-013-0374-5; Badouin H, 2017, MOL ECOL, V26, P2041, DOI 10.1111/mec.13976; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidard F, 2013, G3-GENES GENOM GENET, V3, P1015, DOI 10.1534/g3.113.006262; Branco S, 2017, MOL ECOL, V26, P2063, DOI 10.1111/mec.13892; Branco S, 2015, MOL ECOL, V24, P2747, DOI 10.1111/mec.13132; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connolly LR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003916; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Debets AJM, 2012, P NATL ACAD SCI USA, V109, P10432, DOI 10.1073/pnas.1205333109; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Diernfellner A, 2007, FEBS LETT, V581, P5759, DOI 10.1016/j.febslet.2007.11.043; Dubin H, 2002, BREAD WHEAT IMPROVEM; Duveiller E., 2012, WHEAT DIS PESTS GUID, Vsecond; Ellison CE, 2011, P NATL ACAD SCI USA, V108, P2831, DOI 10.1073/pnas.1014971108; Estrada AER, 2011, FUNGAL GENET BIOL, V48, P874, DOI 10.1016/j.fgb.2011.06.006; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Falush D, 2003, GENETICS, V164, P1567; Fang H, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0384-y; Fang WG, 2010, ENVIRON MICROBIOL, V12, P810, DOI 10.1111/j.1462-2920.2009.02127.x; Foroud NA, 2012, PLANT DIS, V96, P1271, DOI 10.1094/PDIS-10-11-0863-RE; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Gale LR, 2007, PHYTOPATHOLOGY, V97, P1434, DOI 10.1094/PHYTO-97-11-1434; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hoang DT, 2017, MOL BIOL EVOLUTION; Hohenlohe Paul A, 2012, Methods Mol Biol, V888, P235, DOI 10.1007/978-1-61779-870-2_14; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hu G, 2014, MBIO, V5, DOI 10.1128/mBio.00941-14; HUDSON RR, 1992, GENETICS, V132, P583; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Kelly A, 2016, FUNGAL GENET BIOL, V95, P39, DOI 10.1016/j.fgb.2016.08.003; Kelly AC, 2015, FUNGAL GENET BIOL, V82, P22, DOI 10.1016/j.fgb.2015.05.016; Kimura M, 2003, FEBS LETT, V539, P105, DOI 10.1016/S0014-5793(03)00208-4; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Laurent B, 2017, MOL PLANT PATHOLOGY; Laurent B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3524-x; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li PF, 2016, VIROLOGY, V489, P86, DOI 10.1016/j.virol.2015.12.004; Liang JM, 2014, FUNGAL GENET BIOL, V73, P83, DOI 10.1016/j.fgb.2014.10.002; Liang JM, 2015, PHYTOPATHOLOGY, V105, P1466, DOI 10.1094/PHYTO-01-15-0021-R; Lofgren L, 2017, EUROPEAN J PLANT PAT, P1; Lofgren LA, 2017, NEW PHYTOL, P1; Lu SW, 2016, PHYTOPATHOLOGY, V106, P166, DOI 10.1094/PHYTO-09-15-0215-R; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matei E, 2011, PROTEINS, V79, P1538, DOI 10.1002/prot.22981; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McDonald BA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0026; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Muirhead CA, 2002, GENETICS, V161, P633; Nganje WE, 2004, 538 N DAK STAT U DEP; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184; Pattengale ND, 2009, MANY BOOTSTRAP REPLI, P184, DOI [10.1007/978-3-642-02008-7_13, DOI 10.1007/978-3-642-02008-7_13]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeifer B, 2014, MOL BIOL EVOL, V31, P1929, DOI 10.1093/molbev/msu136; Pritchard JK, 2000, GENETICS, V155, P945; Proctor RH, 2013, MOL MICROBIOL, V90, P290, DOI 10.1111/mmi.12362; Puri KD, 2010, PHYTOPATHOLOGY, V100, P1007, DOI 10.1094/PHYTO-12-09-0332; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rutter WB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3678-6; Salichos L, 2010, MYCOLOGIA, V102, P269, DOI 10.3852/09-073; SAS Institute Inc, 2012, JMP; Schmale DG, 2011, PLANT PATHOL, V60, P909, DOI 10.1111/j.1365-3059.2011.02443.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sieber CMK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110311; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Snipen L, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0517-0; Son H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006595; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Song XS, 2016, NEW PHYTOL, V210, P997, DOI 10.1111/nph.13806; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2016, AUGUSTUS REFERENCES; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stergiopoulos I, 2012, MOL BIOL EVOL, V29, P3371, DOI 10.1093/molbev/mss143; Sweigard JA, 1998, MOL PLANT MICROBE IN, V11, P404, DOI 10.1094/MPMI.1998.11.5.404; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1985, GENETICS, V110, P325; Talas F, 2016, MOL PLANT MICROBE IN, V29, P417, DOI 10.1094/MPMI-09-15-0218-R; Talas F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2166-0; Thatcher LF, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3192-2; Urban M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1412-9; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Varga E, 2015, ENVIRON MICROBIOL, V17, P2588, DOI 10.1111/1462-2920.12718; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wagacha JM, 2012, FUNGAL BIOL-UK, V116, P836, DOI 10.1016/j.funbio.2012.05.001; Wakeley J, 1996, THEOR POPUL BIOL, V49, P39, DOI 10.1006/tpbi.1996.0002; Walkowiak S, 2015, MOL PLANT MICROBE IN, V28, P1256, DOI 10.1094/MPMI-06-15-0120-R; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Ward TJ, 2008, FUNGAL GENET BIOL, V45, P473, DOI 10.1016/j.fgb.2007.10.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wight WD, 2009, MOL PLANT MICROBE IN, V22, P1258, DOI 10.1094/MPMI-22-10-1258; Wong P, 2011, NUCLEIC ACIDS RES, V39, pD637, DOI 10.1093/nar/gkq1016; Wu J, 1998, P NATL ACAD SCI USA, V95, P12398, DOI 10.1073/pnas.95.21.12398; Xu XM, 2005, EUR J PLANT PATHOL, V112, P143, DOI 10.1007/s10658-005-2446-7; Zeller KA, 2003, PHYTOPATHOLOGY, V93, P874, DOI 10.1094/PHYTO.2003.93.7.874; Zhao JH, 2015, MOL BIOL EVOL, V32, P2417, DOI 10.1093/molbev/msv125	135	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194616	10.1371/journal.pone.0194616	http://dx.doi.org/10.1371/journal.pone.0194616			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584736	Green Published, Green Submitted, gold			2022-12-27	WOS:000428373000029
J	So, HB; Khalifa, AM; Yu, BF; Caroll, C; Burger, P; Mulligan, D				So, Hwat Bing; Khalifa, Ashraf M.; Yu, Bofu; Caroll, Chris; Burger, Peter; Mulligan, David			MINErosion 3: Using measurements on a tilting flume-rainfall simulator facility to predict erosion rates from post-mining landscapes in Central Queensland, Australia	PLOS ONE			English	Article								Open-cut coal mining in Queensland results in the formation of extensive saline overburden spoil-piles with steep slopes at the angle of repose (approximately 75% or 37). These spoil piles are generally found in multiple rows, several kilometers in length and heights of up to 50 or 60 m above the original landscape. They are highly dispersive and erodible. Legislation demands that these spoil piles be rehabilitated to minimize on-site and off-site discharges of sediment and salt into the surrounding environment. To achieve this, the steep slopes must be reduced, stabilized against erosion, covered with topsoil and re-vegetated. Key design criteria (slope gradient, slope length and vegetation cover) are required for the construction of post-mining landscapes that will result in acceptable erosion rates. A novel user-friendly hillslope computer model MINErosion 3.4 was developed that can accurately predict potential erosion rates from field scale hillslopes using parameters measured with a 3m laboratory tilting flume-rainfall simulator or using routinely measured soil physical and chemical properties. This model links MINErosion 2 with a novel consolidation and above ground vegetation cover factors, to the RUSLE and MUSLE equations to predict the mean annual and storm event erosion rates. The RUSLE-based prediction of the mean annual erosion rates allow minesites to derive the key design criteria of slope length, slope gradient and vegetation cover that would lead to acceptable erosion rates. The MUSLE-based prediction of storm event erosion rates will be useful as input into risk analysis of potential damage from erosion. MINErosion 3.4 was validated against erosion measured on 20 m field erosion plots established on post-mining landscapes at the Oakey Creek and Curragh coalmines, as well as on 120 and 70 m erosion plots on postmining landscapes at Kidston Gold Mine.	[So, Hwat Bing; Khalifa, Ashraf M.; Yu, Bofu; Caroll, Chris] Griffith Univ, Australian Rivers Inst, Sch Engn & Built Environm, Nathan, Qld, Australia; [So, Hwat Bing] Univ Queensland, Sch Land & Food Sci, St Lucia, Qld, Australia; [Caroll, Chris; Burger, Peter] Dept Nat Resources Mines & Energy, Rockhampton, Qld, Australia; [Mulligan, David] Univ Queensland, Sustainable Minerals Inst, Ctr Mined Land Rehabil, St Lucia, Qld, Australia	Griffith University; University of Queensland; University of Queensland	So, HB (corresponding author), Griffith Univ, Australian Rivers Inst, Sch Engn & Built Environm, Nathan, Qld, Australia.; So, HB (corresponding author), Univ Queensland, Sch Land & Food Sci, St Lucia, Qld, Australia.	h.so@griffith.edu.au	; Yu, Bofu/G-5184-2010	So, Hwat Bing/0000-0001-5834-6766; Yu, Bofu/0000-0001-7266-4197	Australian Coal Association Research Program, ACARP project [C 16025]; ACARP; BHP Coal Pty Ltd; MIM Holdings Ltd; Pacific Coal Pty Ltd; Curragh Queensland Mining Ltd; Callide Coalfields Pty Ltd; Capricorn Coal Management Pty [1629, 4011]; Kidston Gold Mine (Waste rock dump rehabilitation research Project: Stability of outer dump surfaces)	Australian Coal Association Research Program, ACARP project; ACARP; BHP Coal Pty Ltd; MIM Holdings Ltd; Pacific Coal Pty Ltd; Curragh Queensland Mining Ltd; Callide Coalfields Pty Ltd; Capricorn Coal Management Pty; Kidston Gold Mine (Waste rock dump rehabilitation research Project: Stability of outer dump surfaces)	Australian Coal Association Research Program, ACARP project no C 16025 funded the development of the MINErosion 3 model; URL: www.acarp.com.au; Chief investigators: BY and HBS. The data that was embedded in MINErosion 2 and is now part of MINErosion 3 were collected as part of projects funded by ACARP, BHP Coal Pty Ltd, MIM Holdings Ltd, Pacific Coal Pty Ltd, Curragh Queensland Mining Ltd, Callide Coalfields Pty Ltd, Capricorn Coal Management Pty (ACARP Projects 1629 and 4011 titled: Post mining landscape parameters for erosion and water quality control) and Kidston Gold Mine (Waste rock dump rehabilitation research Project: Stability of outer dump surfaces).	Bureau of Meteorology, 2016, INT FREQ DUR DES RAI; Canterford R. P, 1987, AUSTR RAINFALL RUNOF; Carroll C., 2004, ISCO 2004 13 INT SOI; Carroll C, 2005, THESIS; Domagala J., 2007, STATE ENV QUEENSLAND; Ferguson K, 2002, THESIS; Flanagan DC, 1997, EURASIAN SOIL SCI+, V30, P524; Foster GR., 2003, 1 INTERAGENCY C RES, P154; GILLEY JE, 1990, T ASAE, V33, P1900, DOI 10.13031/2013.31556; Horn C. P, 1999, EROSION REHABILITATE; Horn C. P, 2000, WASTE ROCK DUMP RES; Horn C. P, 2001, EROSION REHABILITATE; Khalifa A.E.O., 2010, THESIS; Loch RJ, 2001, AUST J SOIL RES, V39, P599, DOI 10.1071/SR00039; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, DOI 10.1080/00750770109555783]; Onstad C. A, 1975, T AM SOC AGR ENG, V26, P1108; ONSTAD CA, 1975, T AM SOC AGR ENG, V26, P1102; RENARD KG, 1991, J SOIL WATER CONSERV, V46, P30; Sheridan G. J., 2001, THESIS; Sheridan GJ, 2000, AUST J SOIL RES, V38, P265, DOI 10.1071/SR99041; Sheridan GJ, 2000, AUST J SOIL RES, V38, P285, DOI 10.1071/SR99039; So H. B, 2004, CONSERVING SOIL WATE, P5; So H. B., 2001, GLOB FARM SEL PAP 19, P1053; So H. B, POSTMINING LANDSCAPE; WILLIAMS DJ, 1996, ENV MANAGEMENT AUSTR, P157; Wischmeier W. H., 1978, AGR HDB, V537, DOI DOI 10.1016/j.geomorph.2007.03.001; Wischmeier W.H., 1960, T 7 INT C SOIL SCI, P418	27	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194230	10.1371/journal.pone.0194230	http://dx.doi.org/10.1371/journal.pone.0194230			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590190	Green Published, Green Submitted, gold			2022-12-27	WOS:000428603100054
J	Ilozumba, O; Dieleman, M; Kraamwinkel, N; Van Belle, S; Chaudoury, M; Broerse, JEW				Ilozumba, Onaedo; Dieleman, Marjolein; Kraamwinkel, Nadine; Van Belle, Sara; Chaudoury, Murari; Broerse, Jacqueline E. W.			"I am not telling. The mobile is telling": Factors influencing the outcomes of a community health worker mHealth intervention in India	PLOS ONE			English	Article							CARE; KNOWLEDGE; MIDWIVES	Introduction Improving maternal health outcomes remains a priority in Low and Middle Income Countries. With the rapid proliferation of mobile health technologies, there is an increased interest in understanding how these technologies can effectively improve maternal health outcomes particularly maternal health seeking knowledge and behaviors. However, few studies present clear explanations of the program developers' rationale (theory of change) and contextual factors that could influence program outcomes. This mixed-methods study assesses Mobile for Mothers, a community health workers (CHW) utilized maternal mHealth intervention. We present the program developers' rationale and utilize it as a framework to guide our study that aimed to identify intervention-related and contextual factors, which influence the observed outcomes of a CHW, utilized mHealth intervention. Materials and methods Quantitative methods (a questionnaire with 740 women who received the intervention and survey of 57 CHWs who utilized the intervention) and qualitative methods (12 interviews and 4 group discussions with CHWs and 20 interviews and 5 group discussions with pregnant and lactating women and 15 interviews and 2 group discussions with men) were conducted. These were used to understand how the mHealth intervention was implemented and to gain insight into contextual factors that potentially influenced the observed intervention outcomes. Results Results were grouped following three categories: (1) perceptions and experiences of CHWs utilizing the mHealth technology; (2) CHW-related outcomes; and (3) contextual factors that influence maternal health-seeking behavior. The overall response of CHWs and community members to the intervention was positive. However, contextual factors like the relationship between the CHWs and their respective communities, the pregnant women's decision-making power and lack of access due to financial influenced the observed outcomes. Conclusion Mobile health applications are promising interventions for improving the performance of CHWs and health-seeking behavior of pregnant women. However, the contextual factors play a crucial role in intervention outcomes and need to be explicated by program developers during intervention design and implementation.	[Ilozumba, Onaedo; Dieleman, Marjolein; Kraamwinkel, Nadine; Broerse, Jacqueline E. W.] Vrije Univ, Athena Inst, Amsterdam, Netherlands; [Ilozumba, Onaedo; Van Belle, Sara] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Chaudoury, Murari] NEEDS NGO, Deoghar, India	Vrije Universiteit Amsterdam; Institute of Tropical Medicine (ITM)	Ilozumba, O (corresponding author), Vrije Univ, Athena Inst, Amsterdam, Netherlands.; Ilozumba, O (corresponding author), Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.	ona.ilozumba@vu.nl	Urzua, Andrea Silva/AAS-7284-2020; Van Belle, Sara/HHN-6814-2022; ILOZUMBA, ONAEDO/AAE-4456-2021	ILOZUMBA, ONAEDO/0000-0003-4951-9631; Kraamwinkel-Jha, Nadine/0000-0002-2277-6024	Erasmus Mundus Joint Doctorate Fellowship [2013-0039, 2014-0681]	Erasmus Mundus Joint Doctorate Fellowship	This study was supported by an Erasmus Mundus Joint Doctorate Fellowship, Framework Partnership Agreement 2013-0039, specific grant agreement 2014-0681. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2015, TROP MED INT HEALTH, V20, P1003, DOI 10.1111/tmi.12525; Allendorf K, 2010, STUD FAMILY PLANN, V41, P263, DOI 10.1111/j.1728-4465.2010.00252.x; [Anonymous], 2013, ANN HLTH SURVEY 2012; [Anonymous], 1995, NEW APPROACHES EVALU; Archer E., 2013, RFPERMUTE ESTIMATE P; Benatar SR, 2000, BMJ-BRIT MED J, V321, P824, DOI 10.1136/bmj.321.7264.824; Bigirwa P, 2009, HEAL POLICY DEV, V7; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Cekada Tracey L., 2012, PROF SAF; Chib A, 2008, ASIAN J COMMUN, V18, P348, DOI 10.1080/01292980802344182; Ganle JK, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0083-y; George A, 2015, SOC SCI MED, V133, P159, DOI 10.1016/j.socscimed.2015.03.049; Istepanian RSH, 2004, IEEE T INF TECHNOL B, V8, P405, DOI 10.1109/TITB.2004.840019; Jimoh L, 2012, INT J MED INFORM, V81, P773, DOI 10.1016/j.ijmedinf.2012.08.005; Kallander K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2130; Kaphle S, ADOPTION USAGE MHEAL; Labrique AB, 2013, MHEALTH INNOVATIONS; Lee S, 2011, J HEALTH COMMUN, V16, P1006, DOI 10.1080/10810730.2011.571344; Lee SH, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010401; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Mechael P. N., 2009, Innovations: Technology / Governance / Globalisation, V4, P103, DOI 10.1162/itgg.2009.4.1.103; Mishra A, 2014, GLOB PUBLIC HEALTH, V9, P960, DOI 10.1080/17441692.2014.934877; Patra S, 2016, HEALTH CARE WOMEN IN, V37, P531, DOI 10.1080/07399332.2014.946509; Powell-Jackson T, 2015, J HEALTH ECON, V43, P154, DOI 10.1016/j.jhealeco.2015.07.001; Raj SS, 2013, GLOB HEALTH-SCI PRAC, V1, P84, DOI 10.9745/GHSP-D-12-00049; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Welfare M of H& F Welfare G of I, 2015, RUR HLTH STAT; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT	31	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194927	10.1371/journal.pone.0194927	http://dx.doi.org/10.1371/journal.pone.0194927			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584773	gold, Green Submitted, Green Published			2022-12-27	WOS:000428373000049
J	Araujo, F; van Oosterhout, F; Becker, V; Attayde, JL; Lurling, M				Araujo, Fabiana; van Oosterhout, Frank; Becker, Vanessa; Attayde, Jose Luiz; Lurling, Miquel			Effects of polyaluminum chloride and lanthanum-modified bentonite on the growth rates of three Cylindrospermopsis raciborskii strains	PLOS ONE			English	Article							PRYMNESIUM-PARVUM HAPTOPHYCEAE; PHOSPHORUS BINDING CLAY; OF-THE-ART; MICROCYSTIS-AERUGINOSA; RARE-EARTH; CYANOBACTERIAL BLOOMS; GENETIC DIVERSITY; LAKE RESTORATION; LOCAL SOILS; RED-TIDE	In tropical and subtropical lakes, eutrophication often leads to nuisance blooms of Cylindrospermopsis raciborskii. In laboratory experiments, we tested the combined effects of flocculant polyaluminum chloride (PAC) and lanthanum-modified bentonite (LMB) on the sinking and growth rates of three C. raciborskii strains. We tested the hypothesis that the combination of PAC and LMB would (1) effectively sink C. raciborskii in a test tube experiment and (2) impair C. raciborskii growth, irrespective of the biomass of the inoculum (bloom) and the strain in the growth experiment. We tested the recommended (LMB1) and a three-times higher dose of LMB (LMB3). The combined addition of PAC and LMB enhanced the sedimentation of all C. raciborskii strains. Moreover, both the PAC and LMB doses decreased the phosphate concentration. PAC and LMB1 decreased the growth rate of all strains, but the efficacy depended on the biomass and strain. The combined addition of PAC and LMB3 inhibited the growth of all strains independently of the biomass and strain. We conclude that a low dose of PAC in combination with the recommended dose of LMB decreases C. raciborskii blooms and that the efficiency of the technique depends on the biomass of the bloom. A higher dose of LMB is needed to obtain a more efficient control of C. raciborskii blooms.	[Araujo, Fabiana] Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, Natal, RN, Brazil; [Araujo, Fabiana; Becker, Vanessa] Univ Fed Rio Grande do Norte, Ctr Technol, Dept Engn Civil, Lab Recursos Hidricos & Saneamento Ambiental, Natal, RN, Brazil; [van Oosterhout, Frank; Lurling, Miquel] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [Attayde, Jose Luiz] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Ecol, Natal, RN, Brazil; [Lurling, Miquel] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Wageningen University & Research; Universidade Federal do Rio Grande do Norte; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Araujo, F (corresponding author), Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, Natal, RN, Brazil.; Araujo, F (corresponding author), Univ Fed Rio Grande do Norte, Ctr Technol, Dept Engn Civil, Lab Recursos Hidricos & Saneamento Ambiental, Natal, RN, Brazil.	fabianabio@gmail.com	Becker, Vanessa/G-6189-2015; KNAW, NIOO-KNAW/A-4320-2012	Becker, Vanessa/0000-0002-7326-4328; KNAW, NIOO-KNAW/0000-0002-3835-159X; Attayde, Jose/0000-0002-8372-4172; Araujo, Fabiana/0000-0001-5803-2601	CAPES (Foundation for the Coordination of Higher Education and Graduate Training, Brazil) [BEX 5135/11-7]; CAPES (Brazil)/Wageningen University (The Netherlands): CAPES-WUR [004/2008]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [407783/2016-4]	CAPES (Foundation for the Coordination of Higher Education and Graduate Training, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES (Brazil)/Wageningen University (The Netherlands): CAPES-WUR; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank W. Beekman-Lukassen for her assistance during the lab work. F.A. was supported by a Sandwich Ph.D. fellowship from CAPES (Foundation for the Coordination of Higher Education and Graduate Training, Brazil-BEX 5135/11-7). This study was conducted under the flag of the CAPES (Brazil)/Wageningen University (The Netherlands): CAPES-WUR project 004/2008. Preparation of the manuscript was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Process Number: Universal 407783/2016-4. The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.; We thank W. Beekman-Lukassen for her assistance during the lab work. F.A. was supported by a Sandwich Ph.D. fellowship from CAPES (Foundation for the Coordination of Higher Education and Graduate Training, Brazil-BEX 5135/11-7). This study was conducted under the flag of the CAPES (Brazil)/Wageningen University (The Netherlands): CAPES-WUR project 004/2008. This work also was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Process Number: Universal 407783/2016-4.	Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Bouvy M, 1999, AQUAT MICROB ECOL, V20, P285, DOI 10.3354/ame020285; Bouvy M, 2000, AQUAT MICROB ECOL, V23, P13, DOI 10.3354/ame023013; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Briand JF, 2004, J PHYCOL, V40, P231, DOI 10.1111/j.1529-8817.2004.03118.x; Chonudomkul D, 2004, FEMS MICROBIOL ECOL, V48, P345, DOI 10.1016/j.femsec.2004.02.014; Cooke G.D., 2005, RESTORATION MANAGEME, Vthird, DOI DOI 10.1002/RRR.3450090207; Costa I., 2009, OECOLOGIA BRASILIENS, V13, P382, DOI 10.4257/oeco.2009.1302.11; Costa I. A. S., 2006, Braz. J. Biol., V66, P211, DOI 10.1590/S1519-69842006000200005; Douglas G. B., 2004, PHOSPHORUS ENV TECHN, P291; Douglas G. B., 1999, INT ASS WAT QUAL C D, P517; Gibbs MM, 2011, HYDROBIOLOGIA, V658, P253, DOI 10.1007/s10750-010-0477-3; Gulati RD, 2002, HYDROBIOLOGIA, V478, P73, DOI 10.1023/A:1021092427559; Haghseresht F, 2009, APPL CLAY SCI, V46, P369, DOI 10.1016/j.clay.2009.09.009; Haghseresht F., 2005, REVOLUTION PHOSPHORO, P21; Hagstrom JA, 2005, HARMFUL ALGAE, V4, P249, DOI 10.1016/j.hal.2004.03.004; Hilt S, 2006, LIMNOLOGICA, V36, P155, DOI 10.1016/j.limno.2006.06.001; Huszar VLM, 2000, HYDROBIOLOGIA, V424, P67, DOI 10.1023/A:1003996710416; Istvanovics V, 2000, FRESHWATER BIOL, V43, P257, DOI 10.1046/j.1365-2427.2000.00549.x; JOHANNESSON KH, 1994, LIMNOL OCEANOGR, V39, P1141, DOI 10.4319/lo.1994.39.5.1141; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; Lazzaro X, 2003, FRESHWATER BIOL, V48, P649, DOI 10.1046/j.1365-2427.2003.01037.x; LEE JH, 1992, GEOCHIM COSMOCHIM AC, V56, P1127, DOI 10.1016/0016-7037(92)90050-S; LEE JH, 1993, GEOCHIM COSMOCHIM AC, V57, P295; Liu XW, 1997, GEOCHIM COSMOCHIM AC, V61, P1625, DOI 10.1016/S0016-7037(97)00037-9; Lurling M, 1999, PHYCOLOGIA, V38, P368, DOI 10.2216/i0031-8884-38-5-368.1; Lurling M, 2013, WATER RES, V47, P6527, DOI 10.1016/j.watres.2013.08.019; Marinho MM, 2013, MICROB ECOL, V66, P479, DOI 10.1007/s00248-013-0232-1; McGregor Glenn B., 2000, Lakes and Reservoirs Research and Management, V5, P195, DOI 10.1046/j.1440-1770.2000.00115.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Noyma NP, 2015, WATER RES; Padisak J., 1997, ARCH HYDROBIOL, V107, P563; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Pan G, 2006, ENVIRON POLLUT, V141, P206, DOI 10.1016/j.envpol.2005.08.047; Pan G, 2006, ENVIRON POLLUT, V141, P195, DOI 10.1016/j.envpol.2005.08.041; Panosso R., 2007, OECOL BRAS, V11, P433, DOI [10.4257/oeco.2007.1103.12, DOI 10.4257/0EC0.2007.1103.12]; PETERSON SA, 1982, WATER RESOUR BULL, V18, P423; Piccini C, 2011, HARMFUL ALGAE, V10, P644, DOI 10.1016/j.hal.2011.04.016; Posselt AJ, 2009, J PHYCOL, V45, P540, DOI 10.1111/j.1529-8817.2009.00675.x; Reitzel K, 2003, HYDROBIOLOGIA, V506, P781, DOI 10.1023/B:HYDR.0000008624.54844.2d; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Robb M, 2003, HYDROBIOLOGIA, V494, P237, DOI 10.1023/A:1025478618611; Ross G, 2008, HARMFUL ALGAE, V7, P545, DOI 10.1016/j.hal.2007.12.007; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Sengco MR, 2005, HARMFUL ALGAE, V4, P261, DOI 10.1016/j.hal.2004.05.001; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; Sengco MR, 2001, MAR ECOL PROG SER, V210, P41, DOI 10.3354/meps210041; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Soares MCS, 2013, HYDROBIOLOGIA, V717, P1, DOI 10.1007/s10750-013-1562-1; Sondergaard M, 2001, ScientificWorldJournal, V1, P427; Sondergaard M, 1999, INTERNAL PHOSPHORUS, P145; Spears BM, 2013, WATER RES, V47, P5930, DOI 10.1016/j.watres.2013.07.016; van Oosterhout F, 2013, HYDROBIOLOGIA, V710, P265, DOI 10.1007/s10750-012-1206-x; Verspagen JMH, 2006, AQUAT MICROB ECOL, V44, P165, DOI 10.3354/ame044165; Waajen G, 2016, WATER RES, V97, P83, DOI 10.1016/j.watres.2015.11.034; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Welch EB, 2005, LAKE RESERV MANAGE, V21, P209, DOI 10.1080/07438140509354430; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; Wu ZX, 2012, HARMFUL ALGAE, V15, P53, DOI 10.1016/j.hal.2011.11.005; Wu ZX, 2009, HARMFUL ALGAE, V8, P910, DOI 10.1016/j.hal.2009.05.002; Yunes JS, 2009, J PHYCOL, V45, P585, DOI 10.1111/j.1529-8817.2009.00673.x; Zamparas M, 2012, APPL CLAY SCI, V62-63, P101, DOI 10.1016/j.clay.2012.04.020	63	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195359	10.1371/journal.pone.0195359	http://dx.doi.org/10.1371/journal.pone.0195359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614118	Green Published, Green Submitted, gold			2022-12-27	WOS:000429081600054
J	Rios-Garaizar, J; Lopez-Bulto, O; Iriarte, E; Perez-Garrido, C; Pique, R; Aranburu, A; Iriarte-Chiapusso, MJ; Ortega-Cordellat, I; Bourguignon, L; Garate, D; Libano, I				Rios-Garaizar, Joseba; Lopez-Bulto, Oriol; Iriarte, Eneko; Perez-Garrido, Carlos; Pique, Raquel; Aranburu, Arantza; Jose Iriarte-Chiapusso, Maria; Ortega-Cordellat, Illuminada; Bourguignon, Laurence; Garate, Diego; Libano, Inaki			A Middle Palaeolithic wooden digging stick from Aranbaltza III, Spain	PLOS ONE			English	Article							BONE TOOLS; ABRIC-ROMANI; ARTIFACTS; SITE; NEANDERTHALS; PLEISTOCENE; BARCELONA; INSIGHTS; CAVE	Aranbaltza is an archaeological complex formed by at least three open-air sites. Between 2014 and 2015 a test excavation carried out in Aranbaltza I I I revealed the presence of a sand and clay sedimentary sequence formed in floodplain environments, within which six sedimentary units have been identified. This sequence was formed between 137-50 ka, and includes several archaeological horizons, attesting to the long-term presence of Neanderthal communities in this area. One of these horizons, corresponding with Unit 4, yielded two wooden tools. One of these tools is a beveled pointed tool that was shaped through a complex operational sequence involving branch shaping, bark peeling, twig removal, shaping, polishing, thermal exposition and chopping. A use-wear analysis of the tool shows it to have traces related with digging soil so it has been interpreted as representing a digging stick. This is the first time such a tool has been identified in a European Late Middle Palaeolithic context; it also represents one of the first well-preserved Middle Palaeolithic wooden tool found in southern Europe. This artefact represents one of the few examples available of wooden tool preservation for the European Palaeolithic, allowing us to further explore the role wooden technologies played in Neanderthal communities.	[Rios-Garaizar, Joseba] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain; [Lopez-Bulto, Oriol; Pique, Raquel] Univ Autonoma Barcelona, Dept Prehist, Barcelona, Spain; [Iriarte, Eneko] Univ Burgos, Lab Evoluc Humana, Burgos, Spain; [Perez-Garrido, Carlos] Univ Complutense Madrid, Dept Cristalog & Mineral, Madrid, Spain; [Aranburu, Arantza] Univ Pais Vasco EHU, Fac Ciencia & Tecnol, Dept Mineral & Petr, Leioa, Spain; [Jose Iriarte-Chiapusso, Maria] Euskal Herriko Unibertsitatea UPV EHU, Fac Letras, Dept Geog Prehist & Arqueol, Vitoria, Spain; [Jose Iriarte-Chiapusso, Maria] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Ortega-Cordellat, Illuminada; Bourguignon, Laurence] INRAP, UMR Arscan AnTet 7041, Campagne, France; [Garate, Diego] Univ Cantabria, Inst Int Invest Prehist Cantabria, Gobiemo Cantabria, Santander, Spain; [Libano, Inaki] Edestiaurre Arkeol Elkartea, Barrika, Spain	Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Autonomous University of Barcelona; Universidad de Burgos; Complutense University of Madrid; University of Basque Country; University of Basque Country; Basque Foundation for Science; Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC)	Rios-Garaizar, J (corresponding author), Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain.	joseba.rios@cenieh.es	López-Bultó, Oriol/AAH-8732-2019; Iriarte, Eneko/L-4707-2014; Pérez-Garrido, Carlos/AHD-5209-2022; Rios-Garaizar, Joseba/M-5604-2018; Iriarte-Chiapusso, Maria-Jose/B-5705-2011; Garate, Diego/M-7028-2017	López-Bultó, Oriol/0000-0001-5327-1881; Iriarte, Eneko/0000-0001-8365-5616; Rios-Garaizar, Joseba/0000-0001-8474-2156; Iriarte-Chiapusso, Maria-Jose/0000-0002-4409-2408; Garate, Diego/0000-0001-6685-9588; Aranburu, Arantza/0000-0002-0493-085X; Pique Huerta, Raquel/0000-0002-8253-6874	Diputacion Foral de Bizkaia [2147/2013, 1602/2014, 2396/2015, 1518/2016, 1797/2017]; Basque Government (Gobierno Vasco) [2015/04424, 2014/03867]; Basque Government	Diputacion Foral de Bizkaia; Basque Government (Gobierno Vasco)(Basque Government); Basque Government(Basque Government)	The archeological work at Aranbaltza site is financed by the Diputacion Foral de Bizkaia (2147/2013; 1602/2014; 2396/2015; 1518/2016; 1797/2017), the Basque Government (Gobierno Vasco: 2015/04424; 2014/03867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The archeological work at Aranbaltza site is funded by the Diputacion Foral de Bizkaia (2013-2017) and the Basque Government (2014, 2015). The project was also helped by the Barrika Town Council and Harpea Kultur Elkartea. The site of Aranbaltza is located in the private property of the "Club Hipico Barrika" and during the fieldwork we always had the disinterested help of the owner, Damian Libano. The Microscopy Laboratory technicians Belen Notario Collado and Pablo Pardo (CENIEH) helped through the CT scan and the microscopic analysis of the piece. Asier Gomez-Olivencia (IKERBASQUE) helped with the CT scan image processing. Pablo Aparicio made the virtual restoration of the piece. The restoration technician, Pilar Fernandez (CENIEH) preserved the piece in its current condition. Patricia Bello (CENIEH) was helpful providing tuber processing references. We want to thank also Aranbaltza fieldwork volunteers, especially Daniel Ruiz and Fazia Bouchoud who found the point, and the Arkeologi Museoa of Bilbao.	Allue Ethel, 2012, P373; Altuna Etxabe J., 1972, FAUNA MAMIFEROS YACI; Altuna J., 1989, HOMME NEANDERTAL, V6, P41; Alvarez-Alonso D., 2012, ZEPHYRUS, VLXIX, P15; Anderson-Gerfaud P., 1990, EMERGENCE MODERN HUM, P389; [Anonymous], 2015, SETTLEMENT DYNAMICS; [Anonymous], 2002, THESIS; Aranguren B., 2018, P NATL ACAD SCI; Backwell LR, 2001, P NATL ACAD SCI USA, V98, P1358, DOI 10.1073/pnas.021551598; Badal E., 2011, SAGUNTUM PAPELES LAB, V11, P77; Barandiaran Ayerbe J. M., 1960, ESTACION KURTZIA BAR; Benvenuti M, 2017, QUATERNARY RES, V88, P327, DOI 10.1017/qua.2017.51; BEYRIES S., 1987, BRIT ARCHAEOLOGICAL, V328; Blasco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076780; Bonet Avalos A., 1995, RECONSTRUCCION PALEO, P363; Bosch A., 2006, ELS OBJECTES FUSTA P, V6, P27; Bourguignon L., 2002, PALE, V14, P29; CARBONELL E, 1992, J ARCHAEOL SCI, V19, P707, DOI 10.1016/0305-4403(92)90040-A; Carciumaru M, 2012, J ARCHAEOL SCI, V39, P1942, DOI 10.1016/j.jas.2012.02.016; Carrion JS, 2007, J QUATERNARY SCI, V22, P191, DOI 10.1002/jqs.1024; Castanos P., 2005, NEANDERTALES CANTABR, V20, P201; CASTROCUREL Z, 1995, J FIELD ARCHAEOL, V22, P376, DOI 10.1179/009346995791974206; Claud E., 2013, REGARDS CROISES OUTI, P367; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; Ennos AR, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0174; Garofoli D., 2015, J MIND BEHAV, V36, P1; Gaudzinski S, 1999, J ARCHAEOL SCI, V26, P125, DOI 10.1006/jasc.1998.0311; Grunberg JM, 2002, ANTIQUITY, V76, P15, DOI 10.1017/S0003598X00089638; Gutierrez-Zugasti I., 2017, CHRONO CULTURAL REAS; Haidle M.N, 2009, COGNITIVE ARCHAEOLOG, P57; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Heider K. G., 1970, DUGUM DANI PAPUAN HI; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Iovita R., MULTIDISCIPLINARY AP, P213; Jequier CA, 2012, CR PALEVOL, V11, P283, DOI 10.1016/j.crpv.2011.12.001; Lazuen T, 2015, QUATERN INT, V361, P229, DOI 10.1016/j.quaint.2014.04.008; Lopez O., 2015, PROCESSOS OBTENCIO T; Mallye J.-B., J ARCHAEOLOGICAL SCI, V39, P1131; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; Mozota Holgueras M., 2007, CUADERNOS ARQUEOLOGI, V15, P31; Holgueras MM, 2014, COMPLUTUM, V25, P17, DOI 10.5209/rev_CMPL.2014.v25.n1.45353; Holgueras MM, 2009, TRABAJOS PREHIST, V66, P27, DOI 10.3989/tp.2009.09011; Nugent P., 2006, MEM QLD MUS CULT HER, V4, P89; Oakley K.P., 1977, P PREHIST SOC, V43, P13, DOI [10.1017/S0079497X00010343, DOI 10.1017/S0079497X00010343]; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; Pawlik AF, 2011, J ARCHAEOL SCI, V38, P1699, DOI 10.1016/j.jas.2011.03.001; Rendu W, 2014, P NATL ACAD SCI USA, V111, P81, DOI 10.1073/pnas.1316780110; Rios Garaizar J., 2003, B SEDECK, V5, P62; Rios-Garaizar J, 2012, IND LITICA SOC TRANS; Rios-Garaizar J., 2012, CUEVA ASKONDO BIZKAI, V2, P39; Rios-Garaizar J., 2012, MUNIBE ANTROPOLOGIA, V63, P81; Rios-Garaizar J., 2016, TESTING POTENTIAL US; Rios-Garaizar J, 2017, QUATERN INT, V433, P50, DOI 10.1016/j.quaint.2016.02.020; Rios-Garaizar J, 2015, CR PALEVOL, V14, P233, DOI 10.1016/j.crpv.2014.11.006; Rios-Garaizar J, 2015, QUATERN INT, V361, P188, DOI 10.1016/j.quaint.2014.07.025; Rots V., 2009, QUARTAR, V56, P37; Rots V, 2013, J ARCHAEOL SCI, V40, P497, DOI 10.1016/j.jas.2012.06.042; Schoch WH, 2015, J HUM EVOL, V89, P214, DOI 10.1016/j.jhevol.2015.08.004; Schweingruber F. H., 1978, MIKROSKOPISCHE HOLZA; Sistiaga A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101045; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; Teit JA, 1909, MEMOIR AM MUSEUM NAT, V2; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Thieme H., 1985, LDKR VERDEN KUNDE, V36, P11; Tuner N. J., 2014, HIST PRACTICE INDIGE, V1; Uzquiano P, 2015, VEG HIST ARCHAEOBOT, V24, P229, DOI 10.1007/s00334-014-0475-x; Vinagre A., 2006, MONOGRAFIAS MUESO NA; Wagner E., 1995, CANNSTATT; Wood JG, 1870, NATURAL HIST MAN BEI; Wood JG, 1868, NATURAL HIST MAN BEI	71	34	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195044	10.1371/Journal.pone.0195044	http://dx.doi.org/10.1371/Journal.pone.0195044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590205	Green Submitted, Green Published, gold			2022-12-27	WOS:000428603100098
J	Sember, A; Bohlen, J; Slechtova, V; Altmanova, M; Pelikanova, S; Rab, P				Sember, Alexandr; Bohlen, Jorg; Slechtova, Vendula; Altmanova, Marie; Pelikanova, Sarka; Rab, Petr			Dynamics of tandemly repeated DNA sequences during evolution of diploid and tetraploid botiid loaches (Teleostei: Cobitoidea: Botiidae)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; 5S RDNA; CHROMOSOMAL CHARACTERISTICS; REPETITIVE DNAS; RIBOSOMAL DNA; COMPARATIVE CYTOGENETICS; EXTENSIVE POLYMORPHISM; PERICENTRIC INVERSIONS; TRANSPOSABLE ELEMENTS; TELOMERIC REPEATS	Polyploidization has played an important role in the evolution of vertebrates, particularly at the base of Teleostei an enormously successful ray-finned fish group with additional genome doublings on lower taxonomic levels. The investigation of post-polyploid genome dynamics might provide important clues about the evolution and ecology of respective species and can help to decipher the role of polyploidy per se on speciation. Few studies have attempted to investigate the dynamics of repetitive DNA sequences in the post-polyploid genome using molecular cytogenetic tools in fishes, though recent efforts demonstrated their usefulness. The demonstrably monophyletic freshwater loach family Botiidae, branching to evolutionary diploid and tetraploid lineages separated >25 Mya, offers a suited model group for comparing the long-term repetitive DNA evolution. For this, we integrated phylogenetic analyses with cytogenetical survey involving Giemsa-and Chromomycin A(3) (CMA(3))/DAPI stainings and fluorescence in situ hybridization with 5S/45S rDNA, U2 snDNA and telomeric probes in representative sample of 12 botiid species. The karyotypes of all diploids were composed of 2n = 50 chromosomes, while majority of tetraploids had 2n = 4x = 100, with only subtle interspecific karyotype differences. The exceptional karyotype of Botia dario (2n = 4x = 96) suggested centric fusions behind the 2n reduction. Variable patterns of FISH signals revealed cases of intraspecific polymorphisms, rDNA amplification, variable degree of correspondence with CMA(3)(+) sites and almost no phylogenetic signal. In tetraploids, either additivity or loci gain/loss was recorded. Despite absence of classical interstitial telomeric sites, large blocks of interspersed rDNA/telomeric regions were found in diploids only. We uncovered different molecular drives of studied repetitive DNA classes within botiid genomes as well as the advanced stage of the re-diploidization process in tetraploids. Our results may contribute to link genomic approach with molecular cytogenetic analyses in addressing the origin and mechanism of this polyploidization event.	[Sember, Alexandr; Bohlen, Jorg; Slechtova, Vendula; Altmanova, Marie; Pelikanova, Sarka; Rab, Petr] Czech Acad Sci, Inst Anim Physiol & Genet, Lab Fish Genet, Rumburska 89, Libechov, Czech Republic; [Altmanova, Marie] Charles Univ Prague, Dept Ecol, Fac Sci, Vinicna 7, Prague 2, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague	Sember, A (corresponding author), Czech Acad Sci, Inst Anim Physiol & Genet, Lab Fish Genet, Rumburska 89, Libechov, Czech Republic.	alexandr.sember@seznam.cz	Sember, Alexandr/W-4446-2017; Altmanova, Marie/C-9645-2015	Sember, Alexandr/0000-0003-4441-9615; Altmanova, Marie/0000-0001-7193-8918	Czech Science Foundation [13-37277S]; Ministry of Education, Youth and Sports [EXCELLENCE CZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE]; Czech Academy of Sciences [RVO: 67985904]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences)	This study was supported by The Czech Science Foundation (https://gacr.cz/): grant no. 13-37277S (VS, JB, AS, PR) and further by the projects EXCELLENCE CZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE (Ministry of Education, Youth and Sports; http://www.msmt.cz/) (PR) and RVO: 67985904 (Czech Academy of Sciences; http://www.avcr.cz/cs/) (AS, JB, VS, MA, SP, PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andreyushkova DA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110318; Arai R., 2011, FISH KARYOTYPES CHEC; Araya-Jaime C, 2017, ZEBRAFISH, V14, P464, DOI 10.1089/zeb.2017.1422; Ayata MK, 2018, TURK J FISH AQUAT SC, V18, P991, DOI 10.4194/1303-2712-v18_8_07; Barbosa P, 2015, GENETICA, V143, P55, DOI 10.1007/s10709-014-9813-2; Barman AS, 2016, GENETICA, V144, P723, DOI 10.1007/s10709-016-9938-6; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Biltueva LS, 2017, CYTOGENET GENOME RES, V152, P148, DOI 10.1159/000479472; Bohlen J, 2008, ICHTHYOL RES, V55, P82, DOI 10.1007/s10228-007-0007-0; Bohlen J, 2009, ICHTHYOL EXPLOR FRES, V20, P157; Bohlen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159311; Boron A, 2006, GENETICA, V128, P71, DOI 10.1007/s10709-005-5536-8; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Cabral-de-Mello D, 2010, MICROSC SCI TECHNOL, V1, P658; Cazaux B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-124; Chairi H, 2015, J MOL EVOL, V80, P209, DOI 10.1007/s00239-015-9674-z; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; Clift PD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027772; Collares-Pereira MJ, 1999, GENETICA, V105, P301, DOI 10.1023/A:1003885922023; Coluccia E, 2010, J APPL ICHTHYOL, V26, P445, DOI 10.1111/j.1439-0426.2009.01384.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; da Silva M, 2016, CYTOGENET GENOME RES, V149, P297, DOI 10.1159/000449431; de Barros AV, 2011, AQUACULTURE, V322, P47, DOI 10.1016/j.aquaculture.2011.10.002; de Oliveira EA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0161-4; Sousa JFDE, 2017, CYTOGENET GENOME RES, V152, P194, DOI 10.1159/000480141; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Eschmeyer WN, CATALOG FISHES GENER; Fernandes CA, 2017, ZEBRAFISH, V14, P471, DOI 10.1089/zeb.2017.1432; FERRIS SD, 1980, AM NAT, V115, P650, DOI 10.1086/283590; Feulner PGD, 2017, J EVOLUTION BIOL, V30, P1488, DOI 10.1111/jeb.13101; FLAJSHANS M, 1992, THEOR APPL GENET, V85, P68, DOI 10.1007/BF00223846; Fujiwara A, 2001, GENETICA, V111, P77, DOI 10.1023/A:1013788626712; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; Getlekha N, 2018, ZEBRAFISH, V15, P45, DOI 10.1089/zeb.2017.1484; Ghigliotti L, 2010, ANTARCT SCI, V22, P805, DOI 10.1017/S0954102010000660; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Gornung E, 2013, CYTOGENET GENOME RES, V141, P90, DOI 10.1159/000354832; GRAHAM DE, 1978, ANAL BIOCHEM, V85, P609, DOI 10.1016/0003-2697(78)90262-2; Gromicho M, 2006, CHROMOSOME RES, V14, P297, DOI 10.1007/s10577-006-1047-4; Guillen AKZ, 2004, CHROMOSOME RES, V12, P225, DOI 10.1023/B:CHRO.0000021911.43225.eb; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; He W, 2012, PLOS ONE, V7, P27; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Amorim KDJ, 2016, COMP CYTOGENET, V10, P555, DOI 10.3897/CompCytogen.v10i4.10227; Kaewmad P, 2014, CYTOLOGIA, V79, P299, DOI 10.1508/cytologia.79.299; Khuda-Bukhsh A.R., 1986, P886; Kirtiklis L, 2014, BIOLOGIA, V69, P536, DOI 10.2478/s11756-014-0339-y; Knytl M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190924; Kottelat M, 2012, RAFFLES B ZOOL, P1; Laurent S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176384; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li J, 2012, PROTOPLASMA, V249, P207, DOI 10.1007/s00709-011-0279-0; Li YJ, 2010, ICHTHYOL RES, V57, P358, DOI 10.1007/s10228-010-0168-0; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Luo J, 2014, HEREDITY, V112, P415, DOI 10.1038/hdy.2013.121; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Machado MD, 2017, ZEBRAFISH, V14, P459, DOI 10.1089/zeb.2017.1435; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Majtanova Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146872; Maneechot N, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0215-2; Marburger S, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2732; MAYR B, 1985, GENETICA, V67, P51, DOI 10.1007/BF02424460; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; Nguyen P, 2010, GENETICA, V138, P343, DOI 10.1007/s10709-009-9424-5; Nieto Feliner G., 2012, PLANT GENOME DIVERSI, VVol. 1, P171, DOI [10.1007/978-3-7091-1130-7_12, DOI 10.1007/978-3-7091-1130-7_12]; Nirchio M, 2008, NEOTROP ICHTHYOL, V6, P101, DOI 10.1590/S1679-62252008000100012; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; Papasaikas P, 2016, TRENDS BIOCHEM SCI, V41, P33, DOI 10.1016/j.tibs.2015.11.003; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Pereira CSA, 2013, CYTOGENET GENOME RES, V141, P143, DOI 10.1159/000354582; Piscor D, 2016, ZEBRAFISH, V13, P565, DOI 10.1089/zeb.2016.1292; Porto-Foresti F, 2004, GENET MOL BIOL, V27, P51, DOI 10.1590/S1415-47572004000100009; Pucci MB, 2014, BIOL J LINN SOC, V111, P541, DOI 10.1111/bij.12218; Rab P, 2002, CYTOGENET GENOME RES, V98, P194, DOI 10.1159/000069800; Rab P, 1999, CHROMOSOME RES, V7, P475, DOI 10.1023/A:1009202030456; Rab P, 2000, FOLIA ZOOL, V49, P55; Rab Petr, 1995, Acta Universitatis Carolinae-Biologica, V39, P201; Rab P, 2016, CYTOGENET GENOME RES, V149, P312, DOI 10.1159/000450534; Rabova M, 2004, CYTOGENET GENOME RES, V106, P16; Rabova M, 2001, GENETICA, V111, P413, DOI 10.1023/A:1013763903513; Rebordinos L, 2013, CYTOGENET GENOME RES, V141, P103, DOI 10.1159/000354871; Rishi K. K., 1984, INT J ACAD ICHTHYOL, V5, P139; Rocchi M, 2012, HEREDITY, V108, P59, DOI 10.1038/hdy.2011.101; Romanenko SA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0194-8; de Moraes RLR, 2017, ZEBRAFISH, V14, P536, DOI 10.1089/zeb.2017.1465; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; Saitoh K, 2010, MOL PHYLOGENET EVOL, V56, P1001, DOI 10.1016/j.ympev.2010.04.021; Sakofsky CJ, 2015, MOL CELL, V60, P860, DOI 10.1016/j.molcel.2015.10.041; Sallan LC, 2014, BIOL REV, V89, P950, DOI 10.1111/brv.12086; SAWADA Y, 1976, Japanese Journal of Ichthyology, V23, P175; Scacchetti PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137231; Scali V, 2016, ITAL J ZOOL, V83, P285, DOI 10.1080/11250003.2016.1219403; SCHMID M, 1988, CHROMOSOMA, V97, P101, DOI 10.1007/BF00327367; Schmidt RC, 2015, MOL PHYLOGENET EVOL, V90, P193, DOI 10.1016/j.ympev.2015.05.025; Sember A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0532-9; Slechtova V, 2006, MOL PHYLOGENET EVOL, V39, P529, DOI 10.1016/j.ympev.2005.09.018; Slechtova V, 2007, MOL PHYLOGENET EVOL, V44, P1358, DOI 10.1016/j.ympev.2007.02.019; Sliwinska-Jewsiewicka A, 2015, GENETICA, V143, P425, DOI 10.1007/s10709-015-9841-6; Sochorova J, 2018, CHROMOSOMA, V127, P141, DOI 10.1007/s00412-017-0651-8; SOLA L, 1992, CYTOGENET CELL GENET, V60, P229, DOI 10.1159/000133346; Soltis DE, 2016, AM J BOT, V103, P1146, DOI 10.3732/ajb.1500501; Spoz A, 2017, FOLIA BIOL-KRAKOW, V65, P62, DOI 10.3409/fb65_1.63; Spoz A, 2014, COMP CYTOGENET, V8, P233, DOI 10.3897/CompCytogen.v8i3.7718; Stimpson KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092432; Suzuki A., 1996, Cytobios, V85, P229; Symonova R, 2013, CYTOGENET GENOME RES, V141, P153, DOI 10.1159/000354882; Symonova R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020096; Symonova R, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3774-7; Symonova R, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0484-8; Symonova R, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-42; Takagui FH, 2014, ZEBRAFISH, V11, P300, DOI 10.1089/zeb.2014.0985; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang QY, 2005, HYDROBIOLOGIA, V544, P249, DOI 10.1007/s10750-005-0863-4; Tayale A, 2013, CYTOGENET GENOME RES, V140, P79, DOI 10.1159/000351318; Traldi JB, 2016, ZEBRAFISH, V13, P19, DOI 10.1089/zeb.2015.1124; Tsekrekou M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071411; Tsigenopoulos CS, 2002, HEREDITY, V88, P466, DOI 10.1038/sj.hdy.6800080; UYENO T, 1972, SCIENCE, V175, P644, DOI 10.1126/science.175.4022.644; Vicari MR, 2008, CYTOGENET GENOME RES, V122, P67, DOI 10.1159/000151318; Volker M, 2015, FISH CYTOGENETIC TEC, P37, DOI [10.1201/b18534-4, DOI 10.1201/B18534-4]; Votkov RA, 2007, SYST BIODIVERS, V5, P261, DOI 10.1017/S1477200007002447; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang XY, 2011, GENES-BASEL, V2, P1, DOI 10.3390/genes2010001; Wang XZ, 2016, SCI CHINA LIFE SCI, V59, P1149, DOI 10.1007/s11427-016-0007-7; da Costa GWWF, 2016, J HERED, V107, P173, DOI 10.1093/jhered/esv136; Wertheim B, 2013, CYTOGENET GENOME RES, V140, P256, DOI 10.1159/000351998; Winterfeld G, 2009, SYST BIODIVERS, V7, P277, DOI 10.1017/S1477200009003041; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Yang L, 2015, MOL PHYLOGENET EVOL, V85, P97, DOI 10.1016/j.ympev.2015.01.014; Yano CF, 2017, ZEBRAFISH, V14, P146, DOI 10.1089/zeb.2016.1351; Ye LH, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0542-2; Yu X. Z., 1989, CHROMOSOMES CHINESE; Yue X, 2013, SICHUAN J ZOOLOGY, V3; Zhan SH, 2014, J EVOLUTION BIOL, V27, P391, DOI 10.1111/jeb.12308; Zhdanova NS, 2007, CHROMOSOME RES, V15, P881, DOI 10.1007/s10577-007-1170-x; Zhu HP, 2006, CHROMOSOME RES, V14, P767, DOI 10.1007/s10577-006-1083-0	146	10	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195054	10.1371/Journal.pone.0195054	http://dx.doi.org/10.1371/Journal.pone.0195054			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590207	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100099
J	Archer, JA; Lee, A; Qiu, AQ; Chen, SHA				Archer, Jo A.; Lee, Annie; Qiu, Anqi; Chen, S-H Annabel			Working memory, age and education: A lifespan fMRI study	PLOS ONE			English	Article							COGNITIVE NEUROSCIENCE; ALZHEIMERS-DISEASE; MIDDLE-AGE; BRAIN; PERFORMANCE; ACTIVATION; METAANALYSIS; ASSOCIATION; CEREBELLUM; RESERVE	Ageing is associated with grey matter atrophy and changes in task-related neural activations. This study investigated the effects of age and education on neural activation during a spatial working memory task in 189 participants aged between 20-80 years old, whilst controlling for grey matter density. Age was related to linear decreases in neural activation in task activated areas, and this effect was no longer significant when adjusting for education or accuracy. Age was also related to cubic increases in neural activation in non-task related areas, such as the temporal gyrus, cuneus and cerebellum when adjusting for accuracy and education. These findings support previous lifespan datasets indicating linear age-related decreases in task activation, but non-linear increases in non-task related areas during episodic memory tasks. The findings also support past studies indicating education offers a form of cognitive reserve through providing a form of neural compensation and highlights the need to consider education in ageing studies.	[Archer, Jo A.; Chen, S-H Annabel] Nanyang Technol Univ, Psychol, Singapore, Singapore; [Lee, Annie; Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Chen, S-H Annabel] Nanyang Technol Univ, Ctr Res & Dev Learning, Singapore, Singapore; [Chen, S-H Annabel] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, SHA (corresponding author), Nanyang Technol Univ, Psychol, Singapore, Singapore.; Chen, SHA (corresponding author), Nanyang Technol Univ, Ctr Res & Dev Learning, Singapore, Singapore.; Chen, SHA (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.	annabelchen@ntu.edu.sg	Chen, SH Annabel/F-3742-2011; Qiu, Anqi/H-2267-2011	Chen, SH Annabel/0000-0002-1540-5516; Qiu, Anqi/0000-0002-0215-6338	Singapore Ministry of Education AcRF Tier 1 grant [RG41/08]; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2012-T2-2-130]; Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; Singapore Ministry of Healths National Medical Research Council (NMRC) [NMRC/CBRG/0039/ 2013]; NTU Humanities and Social Sciences post-doctoral fellowship	Singapore Ministry of Education AcRF Tier 1 grant(Ministry of Education, Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); Young Investigator Award at the National University of Singapore(National University of Singapore); Singapore Ministry of Healths National Medical Research Council (NMRC)(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NTU Humanities and Social Sciences post-doctoral fellowship	This work was supported by Singapore Ministry of Education AcRF Tier 1 grant (RG41/08), Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2012-T2-2-130), the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07), and the Singapore Ministry of Healths National Medical Research Council (NMRC; NMRC/CBRG/0039/ 2013), all awarded to AQ. JA was funded by the NTU Humanities and Social Sciences post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	[Anonymous], 2010, MATLAB VERS 7 9 0; Arenaza-Urquijo EM, 2013, NEUROIMAGE, V83, P450, DOI 10.1016/j.neuroimage.2013.06.053; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bernard JA, 2013, CEREBELLUM LONDON EN, V12; Cambridge Cognition, 2017, CANTAB COGN ASS SOFT; Crowe M, 2013, J GERONTOL A-BIOL, V68, P198, DOI 10.1093/gerona/gls122; Daselaar SM, 2006, HDB FUNCTIONAL NEURO; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Duff K, 2005, J CLIN EXP NEUROPSYC, V27, P565, DOI 10.1080/13803390490918363; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Finch CE, 2009, NEUROBIOL AGING, V30, P515, DOI 10.1016/j.neurobiolaging.2008.11.011; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Hale S, 2011, PSYCHOL AGING, V26, P92, DOI 10.1037/a0021483; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Iachini Ina, 2009, Curr Aging Sci, V2, P43; Jamadar S, 2013, NEUROBIOL AGING, V34, P110, DOI 10.1016/j.neurobiolaging.2012.07.013; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080648; Luis EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131536; Maillet D, 2013, AGEING RES REV, V12, P479, DOI 10.1016/j.arr.2012.11.001; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Ng TP, 2007, AM J GERIAT PSYCHIAT, V15, P130, DOI 10.1097/01.JGP.0000235710.17450.9a; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park H, 2013, NEUROPSYCHOLOGIA, V51, P448, DOI 10.1016/j.neuropsychologia.2012.11.025; Psychology Software Tools Incorporated, 2012, E PRIME; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Sobczak-Edmans M, 2016, NEUROIMAGE, V124, P1021, DOI 10.1016/j.neuroimage.2015.09.038; StataCorp, 2021, STATA STAT SOFTWARE; Steffener J, 2016, NEUROBIOL AGING, V40, P138, DOI 10.1016/j.neurobiolaging.2016.01.014; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Steffener J, 2011, BRAIN IMAGING BEHAV, V5, P212, DOI 10.1007/s11682-011-9125-4; Stern Y, 2012, BRAIN RES, V1435, P130, DOI 10.1016/j.brainres.2011.11.061; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Takeuchi H, 2014, HUM BRAIN MAPP, V35, P185, DOI 10.1002/hbm.22167; Talairach J., 1988, COPLANAR STEREOTAXIC; Trivedi MA, 2008, NEUROPSYCHOLOGIA, V46, P1667, DOI 10.1016/j.neuropsychologia.2007.11.035; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Ward LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125012; Yang X, 2011, NEUROIMAGE, V57, P423, DOI 10.1016/j.neuroimage.2011.04.046	52	21	24	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194878	10.1371/journal.pone.0194878	http://dx.doi.org/10.1371/journal.pone.0194878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584781	Green Published, gold			2022-12-27	WOS:000428373000046
J	Coleman, LG; Maile, R; Jones, SW; Cairns, BA; Crews, FT				Coleman, Leon G., Jr.; Maile, Robert; Jones, Samuel W.; Cairns, Bruce A.; Crews, Fulton T.			HMGB1/IL-1 beta complexes in plasma microvesicles modulate immune responses to burn injury	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; BRAIN REGIONAL VOLUMES; MOBILITY GROUP BOX-1; EXTRACELLULAR VESICLES; IL-1-BETA PRODUCTION; SECRETORY PATHWAY; FLOW-CYTOMETRY; THERMAL-INJURY; ALARMIN HMGB1; DOUBLE-BLIND	Modulating immune responses to sepsis and trauma remain one of the most difficult challenges in modern medicine. Large burn injuries (LBI) are a severe form of trauma associated with sepsis, immune impairment, and mortality. Immune dysfunction after LBI is complex, involving both enhanced and impaired immune activation. The release of Damage-Associated Molecular Patterns (DAMPs), such as HMGB1, and cytokines (e.g. IL-1 beta) creates an environment of immune dysfunction often leading to end organ failure and death. Both HMGB1 and IL-1 beta have been found to play critical roles in sepsis and post-burn immune dysfunction. HMGB1 and IL-1 beta have been shown previously to form potent complexes in vitro. We recently identified the presence of HMGB1/IL-1 beta heterocomplexes in human tissue. We now find HMGB1/IL-1 beta complexes in human and mouse plasma, and identify a synergistic role of HMGB1/IL-1 beta complexes in post-burn immune dysfunction. In both humans and mice, we found that HMGB1 was enriched in plasma microvesicles (MVs) after LBI. HMGB1 was found form complexes with IL-1 beta. Using flow cytometry of mouse plasma MVs, we identified an increase in an HMGB1+/IL-1 beta+ MVs. Using co-IP, HMGB1 was found to bind the pro-form of IL-1 beta in mouse and human plasma. Pro-IL-1 beta, which is traditionally considered inactive, became active when complexed with HMGB1. Human THP-1 monocytes treated with HMGB1-pro-IL-1 beta complexes showed increased transcription of LBI associated cytokines IL-6 and IFN beta along with suppression of iNOS, mimicking findings associated with LBI. These findings identify that HMGB1/IL-1 beta complexes released after burn injuries can modulate immune responses, and microvesicles are identified as a novel reservoir for these immune mediators. These complexes might serve as novel immune targets for the treatment of systemic immune responses due to LBI or other causes of sepsis.	[Coleman, Leon G., Jr.; Crews, Fulton T.] Univ North Carolina Chapel Hill, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA; [Coleman, Leon G., Jr.; Crews, Fulton T.] Univ North Carolina Chapel Hill, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Maile, Robert; Jones, Samuel W.; Cairns, Bruce A.] Univ North Carolina Chapel Hill, Dept Surg, North Carolina Jaycee Burn Ctr, Chapel Hill, NC USA; [Maile, Robert; Cairns, Bruce A.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Coleman, LG (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA.; Coleman, LG (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.	leon_coleman@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Crews, Fulton/T-1181-2019	Crews, Fulton/0000-0003-2393-4976; Maile, Robert/0000-0002-9126-4188; Coleman, Leon/0000-0003-1693-3799	NIGMS [2T32GM008450, K08GM109106]; NIAAA [AA011605, AA020024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM109106] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIGMS 2T32GM008450, K08GM109106 - https://www.nigms.nih.gov; NIAAA AA011605, AA020024-https://www.niaaa..nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Ardoin SP, 2008, MOD RHEUMATOL, V18, P319, DOI 10.1007/s10165-008-0054-z; Barnay-Verdier S, 2011, CYTOKINE, V55, P4, DOI 10.1016/j.cyto.2011.03.011; Barteneva NS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-23; Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bruno S., 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033115; Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Bussolati B, 2017, NAT REV NEPHROL, V13, P523, DOI 10.1038/nrneph.2017.117; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Cairns BA, 2008, J TRAUMA, V64, P1069, DOI 10.1097/TA.0b013e318166b7d9; Chen Y, 2016, J CELL PHYSIOL, V231, P2319, DOI 10.1002/jcp.25352; Coleman Jr LG, 2017, BRAIN BEHAV IMMUNITY; Coleman LG, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0799-4; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Coleman LG, 2014, PHARMACOL BIOCHEM BE, V116, P142, DOI 10.1016/j.pbb.2013.11.021; Coleman LG, 2017, HMGB1 IL 1B IN PRESS; DeWalt RI, 2013, BIOCHEM BIOPH RES CO, V432, P695, DOI 10.1016/j.bbrc.2013.01.122; DIMAIO A, 1976, J SURG RES, V21, P437, DOI 10.1016/0022-4804(76)90169-4; Dunn JLM, 2016, BURNS, V42, P1522, DOI 10.1016/j.burns.2016.05.005; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Eriksson M, 1998, ACTA ANAESTH SCAND, V42, P551, DOI 10.1111/j.1399-6576.1998.tb05165.x; Finnerty CC, 2006, SHOCK, V26, P13, DOI 10.1097/01.shk.0000223120.26394.7d; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gong J, 2015, SEMIN CELL DEV BIOL, V40, P35, DOI [10.1016/j.semdb.2015.03.009, 10.1016/j.semcdb.2015.03.009]; Hailey KL, 2009, J BIOL CHEM, V284, P26137, DOI 10.1074/jbc.M109.027375; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Huang LF, 2011, CYTOKINE, V53, P29, DOI 10.1016/j.cyto.2010.09.010; Huang LF, 2009, SHOCK, V31, P322, DOI 10.1097/SHK.0b013e3181834070; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Hur J, 2015, ANN LAB MED, V35, P105, DOI 10.3343/alm.2015.35.1.105; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Larsson A, 1996, PLATELETS, V7, P153, DOI 10.3109/09537109609023574; Lehner GF, 2016, SHOCK, V46, P373, DOI 10.1097/SHK.0000000000000657; Lopatina T, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00125; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mobarrez F, 2016, SCI REP-UK, V6, DOI 10.1038/srep36025; Monteleone M, 2015, CYTOKINE; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Neely CJ, 2011, J TRAUMA, V70, P681, DOI 10.1097/TA.0b013e31820d18a6; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Norling LV, 2013, CURR OPIN PHARMACOL, V13, P570, DOI 10.1016/j.coph.2013.05.008; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; O'Dea KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167801; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pisetsky DS, 2014, MOL MED, V20, P158, DOI 10.2119/molmed.2014.00014; Pomatto MAC, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00037; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Saha B, 2016, J BIOL CHEM, V291, P149, DOI 10.1074/jbc.M115.694133; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shelhamer MC, 2015, J TRAUMA ACUTE CARE, V79, P431, DOI [10.1097/TA.0000000000000786, 10.1097/TA.0000000000000754]; Shen LY, 2015, BURNS, V41, P372, DOI 10.1016/j.burns.2014.05.008; Spencer DM, 2014, SCAND J IMMUNOL, V80, P101, DOI 10.1111/sji.12191; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782; Timar CI, 2013, BLOOD, V121, P510, DOI 10.1182/blood-2012-05-431114; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Walter TJ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0856-z; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Xiu FM, 2013, SHOCK, V40, P81, DOI 10.1097/SHK.0b013e318299f774; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087915	72	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195335	10.1371/journal.pone.0195335	http://dx.doi.org/10.1371/journal.pone.0195335			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601597	Green Published, Green Submitted, gold			2022-12-27	WOS:000428845900027
J	Singh, P; Uparna, J; Karampourniotis, P; Horvat, EA; Szymanski, B; Korniss, G; Bakdash, JZ; Uzzi, B				Singh, Pramesh; Uparna, Jayaram; Karampourniotis, Panagiotis; Horvat, Emoke-Agnes; Szymanski, Boleslaw; Korniss, Gyorgy; Bakdash, Jonathan Z.; Uzzi, Brian			Peer-to-peer lending and bias in crowd decision-making	PLOS ONE			English	Article							CAPITAL FLOW; GEOGRAPHY; NETWORKS; GRAVITY; TRADE; RICH	Peer-to-peer lending is hypothesized to help equalize economic opportunities for the world's poor. We empirically investigate the "flat-world" hypothesis, the idea that globalization eventually leads to economic equality, using crowdfinancing data for over 660,000 loans in 220 nations and territories made between 2005 and 2013. Contrary to the flat-world hypothesis, we find that peer-to-peer lending networks are moving away from flatness. Furthermore, decreasing flatness is strongly associated with multiple variables: relatively stable patterns in the difference in the per capita GDP between borrowing and lending nations, ongoing migration flows from borrowing to lending nations worldwide, and the existence of a tie as a historic colonial. Our regression analysis also indicates a spatial preference in lending for geographically proximal borrowers. To estimate the robustness for these patterns for future changes, we construct a network of borrower and lending nations based on the observed data. Then, to perturb the network, we stochastically simulate policy and event shocks (e.g., erecting walls) or regulatory shocks (e.g., Brexit). The simulations project a drift towards rather than away from flatness. However, levels of flatness persist only for randomly distributed shocks. By contrast, loss of the top borrowing nations produces more flatness, not less, indicating how the welfare of the overall system is tied to a few distinctive and critical country-pair relationships.	[Singh, Pramesh; Horvat, Emoke-Agnes; Uzzi, Brian] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA; [Uparna, Jayaram] Indian Inst Management, Bangalore, Karnataka, India; [Karampourniotis, Panagiotis; Korniss, Gyorgy] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY USA; [Karampourniotis, Panagiotis; Szymanski, Boleslaw; Korniss, Gyorgy] Rensselaer Polytech Inst, Social & Cognit Networks Acad Res Ctr, Troy, NY USA; [Horvat, Emoke-Agnes] Northwestern Univ, Dept Commun Studies, Sch Commun, Evanston, IL USA; [Szymanski, Boleslaw] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Bakdash, Jonathan Z.] US Army Res Lab, Aberdeen Proving Ground, MD USA; [Bakdash, Jonathan Z.] Univ Texas Dallas, US Army Res Lab South Field Element, Dallas, TX USA; [Bakdash, Jonathan Z.] Texas A&M Univ Commerce, Commerce, TX USA	Northwestern University; Indian Institute of Management (IIM System); Indian Institute of Management Bangalore; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Northwestern University; Rensselaer Polytechnic Institute; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University of Texas System; University of Texas Dallas; Texas A&M University System; Texas A&M University Commerce	Uzzi, B (corresponding author), Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA.	uzzi@kellogg.northwestern.edu	Szymanski, Boleslaw K/A-9121-2009; Bakdash, Jonathan/ABI-7594-2020; Szymanski, Boleslaw Karol/O-1374-2017; Korniss, Gyorgy/A-7360-2011	Szymanski, Boleslaw K/0000-0002-0307-6743; Bakdash, Jonathan/0000-0002-1409-4779; Szymanski, Boleslaw Karol/0000-0002-0307-6743; 	Northwestern University Institute on Complex Systems (NICO); Army Research Laboratory [W911NF-09-2-0053]; Army Research Office (ARO) [W911NF-16-1-0524]; NU [SP0033419]	Northwestern University Institute on Complex Systems (NICO); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office (ARO); NU	This research was sponsored by the Northwestern University Institute on Complex Systems (NICO), the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053 (the ARL Network Science CTA), the Army Research Office (ARO) grant W911NF-16-1-0524, and NU SP0033419. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Army Research Laboratory or the U.S. government.; This research was sponsored by the Northwestern University Institute on Complex Systems (NICO), the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053 (the ARL Network Science CTA), the Army Research Office (ARO) grant W911NF-16-1-0524, and NU SP0033419. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Army Research Laboratory or the U.S. government.	Agrawal A, 2015, J ECON MANAGE STRAT, V24, P253, DOI 10.1111/jems.12093; AidData, 2016, OP DAT INT DEV; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alfaro L, 2008, REV ECON STAT, V90, P347, DOI 10.1162/rest.90.2.347; Anderson JE, 2003, AM ECON REV, V93, P170, DOI 10.1257/000282803321455214; [Anonymous], 2016, LOANS CHANG LIV; Bandyopadhyay S, 2011, OXFORD ECON PAP, V63, P423, DOI 10.1093/oep/gpq030; Banerjee A, 2003, SCIENCE, V341, P6144; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bruett Tillman, 2007, COMMUNITY DEV INVEST, V3, P44; Bruno V, 2015, REV ECON STUD, V82, P535, DOI 10.1093/restud/rdu042; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Burtch G, 2014, MIS QUART, V38, P773, DOI 10.25300/MISQ/2014/38.3.07; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chinazzi M, 2013, J ECON DYN CONTROL, V37, P1692, DOI 10.1016/j.jedc.2013.01.010; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Dewar RC, 2008, J THEOR BIOL, V251, P389, DOI 10.1016/j.jtbi.2007.12.007; Dreher A, 2006, APPL ECON, V38, P1091, DOI 10.1080/00036840500392078; Egger P, 2000, ECON LETT, V66, P25, DOI 10.1016/S0165-1765(99)00183-4; Florida R., 2005, ATLANTIC MONTHLY, V296, P48; Forbes KJ, 2012, J INT ECON, V88, P235, DOI 10.1016/j.jinteco.2012.03.006; Friedman, 1943, MIN M MR WHIT OFF 9; Galak J, 2011, J MARKETING RES, V48, pS130, DOI 10.1509/jmkr.48.SPL.S130; Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948; Gefen D, 2008, MIS QUART, V32, P367; Ghemawat P., 2009, FOREIGN POLICY; Gotelli NJ, 1996, NULL MODELS ECOLOGY; Head K, 2010, J INT ECON, V81, P1, DOI 10.1016/j.jinteco.2010.01.002; Ingram P, 2005, AM J SOCIOL, V111, P824, DOI 10.1086/497350; Itzkovitz S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026127; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kusimba S, 2016, ECON ANTHROPOL, V3, P266, DOI 10.1002/sea2.12055; Lazer D, 1999, WORLD POLIT, V51, P447, DOI 10.1017/S0043887100009229; LUCAS RE, 1990, AM ECON REV, V80, P92; Mallaby S, 2002, FOREIGN AFF, V81, P2, DOI 10.2307/20033079; Malone T. W., 2003, INVENTING ORG 21 CEN; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Mayer T., 2011, 201125 CEPII, DOI [10.2139/ssrn.1994531, DOI 10.2139/SSRN.1994531]; Mollick E, 2014, J BUS VENTURING, V29, P1, DOI 10.1016/j.jbusvent.2013.06.005; Newman M.E.J., 2010, NETWORKS INTRO; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Ratha D., 2007, 102 WORLD BANK; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Roy H, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS (ISI), P154, DOI 10.1109/ISI.2015.7165959; Sagarra O, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062806; Sen A., 2005, J HUMAN DEV, V6, P151, DOI DOI 10.1080/14649880500120491; Short JC, 2017, ENTREP THEORY PRACT, V41, P149, DOI 10.1111/etap.12270; Szymanski BK, 2015, SCI REP-UK, V5, DOI 10.1038/srep10998; Tu JV, 2001, JAMA-J AM MED ASSOC, V285, P3116, DOI 10.1001/jama.285.24.3116; Uzzi B, 1999, AM SOCIOL REV, V64, P481, DOI 10.2307/2657252; Williams RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017645; World Bank, 2020, WORLD DEV IND 2020; Yazdani N, 2012, EC PHILOS GLOBA 0120	56	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193007	10.1371/journal.pone.0193007	http://dx.doi.org/10.1371/journal.pone.0193007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590131	gold, Green Submitted, Green Published			2022-12-27	WOS:000428603100012
J	Degefa, G; Gebreslassie, M; Meles, KG; Jackson, R				Degefa, Guteta; Gebreslassie, Measho; Meles, Kidanu Gebrameriam; Jackson, Ruth			Determinants of delay in timely treatment seeking for diarrheal diseases among mothers with under-five children in central Ethiopia: A case control study	PLOS ONE			English	Article							NAIROBI	Background Delays in seeking timely appropriate care contributes to a large number of deaths from diarrhea in children. This study aimed to identify determinants of delays in seeking timely treatment by mothers/caregivers of under-five children with diarrheal diseases. Methods We used an unmatched case-control study from February March 2017 among 316 children: 158 cases and 158 controls. Cases were mothers/caregivers with under-five children who had signs/symptoms of diarrhea and sought treatment after 24 hours onset of symptom. Controls sought treatment within 24 hours. Field workers collected data using a pretested standardized questionnaire. Multivariate logistic regression was conducted to identify determinants of delay in timely diarrhea treatment seeking. Statistical significance was declared by using a p-value<0.05 and 95% of confidence interval (CI) for an adjusted-odds ratio (AOR). Results The determinants of delay in timely treatment seeking of mothers/caregivers of under-five children with diarrheal diseases were children <24months (AOR = 1.9,95%CI:1.1-3.4); fail to attend school (AOR = 2.4, 95%CI:1.2-4.6); being female children (AOR = 1.7,95% CI:1.05-2.9); preferring government health facility for the treatment of children with diarrheal diseases (AOR = 2.9, 95%CI, 1.3-6.7); lack of past history taking children to health facility and lack of counseling (AOR = 4.8, 95%CI:2.0-12.1); being in the 15-25 years age (AOR = 1.7, 95%CI:1.1-3.0) and taking children to a health facility as a first response to diarrhea (AOR = 0.1, 95%CI:0.01-0.8). Conclusions Age of the child, maternal age, and disease related determinants were determinants for seeking timely treatment to diarrheal diseases. Providing skilled based health education and counseling to mothers/caregivers on seeking timely treatment and taking children with diarrheal diseases to a health facility as a first response to diarrhea is a paramount intervention to reduce morbidity and mortality of children.	[Degefa, Guteta; Meles, Kidanu Gebrameriam] Mekelle Univ, Coll Hlth Sci, Dept Epidemiol, Mekelle, Ethiopia; [Gebreslassie, Measho] Mekelle Univ, Coll Hlth Sci, Dept Hlth Syst, Mekelle, Ethiopia; [Jackson, Ruth] Deakin Univ, Alfred Deakin Inst, Geelong, Vic, Australia	Mekelle University; Mekelle University; Deakin University	Meles, KG (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Epidemiol, Mekelle, Ethiopia.	kidanumeles2008@gmail.com		Gebremariam, kidanu/0000-0002-7880-6907				Aigbokhaode AQ, 2015, SEEJPH, P2014; Alelign T AW, 2016, J HLTH MED EC, V2, P2; Alemu T, 2014, SCI J PUBLIC HLTH, V2, P243; [Anonymous], 2016, MONITORING SITUATION; Azage M, 2015, RURAL REMOTE HEALTH, V15; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Breiman RF, 2011, J HEALTH POPUL NUTR, V29, P123; Central Statistical Agency [Ethiopia] and ICF International, 2012, ETH DEM HLTH SURV 20; Chilambwe M, 2015, J INFECT DIS THER, V3, P227; Dengia T, 2014, GLOBAL J MED PUBLIC; Ethiopia I, 2016, ETH DEM HLTH SURV; Farthing M, 2013, J CLIN GASTROENTEROL, V47, P12, DOI 10.1097/MCG.0b013e31826df662; Federal Democratic Republic of Ethiopia Ministry of Health, 2015, NAT NEWB CHILD SURV; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, ETH HLTH SECT DEV PR; Gao WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043103; Gebrehiwot E.M., 2015, SCI J CLIN MED, V4, P4; Gebretsadik A, 2015, INT J FAMILY MED; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Kolola T, 2016, PLOS ONE, V11, P10; Malhotra N, 2013, ACTA PAEDIATR, V102, pE413, DOI 10.1111/apa.12304; Merga N, 2015, J HEALTH POPUL NUTR, V33, P20; Mukiira C, 2015, J CHILD HEALTH CARE, V19, P254, DOI 10.1177/1367493513508231; Page AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-389; Shyam SB, 2016, TROP MED HLTH, V44, P7; Sudharsanam M.B., 2007, INDIAN J COMMUNITY M, V32, P71, DOI [10.4103/0970-0218.53411, DOI 10.4103/0970-0218.53411]; Tariku Dejene, 2013, Health, V5, P879; UNICEF, 2011, LEV TRENDS CHILD MOR; UNICEF/WHO, 2009, DIARRH WHY CHILDR AR; Webair HH, 2013, PATIENT PREFER ADHER, V7, P1129, DOI 10.2147/PPA.S51124; Woliso Town Health Office, 2015, ANN ACH REP	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193035	10.1371/journal.pone.0193035	http://dx.doi.org/10.1371/journal.pone.0193035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584727	Green Published, gold, Green Submitted			2022-12-27	WOS:000428373000004
J	Zheng, TC; Chen, ZL; Ju, YQ; Zhang, H; Cai, M; Pan, HT; Zhang, QX				Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang			Reference gene selection for qRT-PCR analysis of flower development in Lagerstroemia indica and L. speciosa	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SUITABLE REFERENCE GENES; REAL-TIME PCR; NORMALIZATION; EXPRESSION; VALIDATION	Quantitative real-time polymerase chain reaction (qRT-PCR) is a prevalent method for gene expression analysis, depending on the stability of the reference genes for data normalization. Lagerstroemia indica and L. speciosa are popular ornamental plants which are famous for the long flowering period. However, no systematic studies on reference genes in Lagerstroemia have yet been conducted. In the present study, we selected nine candidate reference genes (GAPDH, TUA, TUB, 18S, RPII, EF-1 alpha, ATC, EIF5A and CYP) and evaluated their expression stability in different tissues during floral development of L. indica and L. speciosa using four algorithms (geNorm, NormFinder, BestKeeper and, RefFinder). Results showed that RPII and EF-1 alpha were the most stably expressed and suitable reference genes for both of Lagerstroemia species. Moreover, ACT exhibited high expression stability in L. indica and GAPDH was a suitable reference gene for L. speciosa in different flower development stages. TUB was an unsuitable reference gene for gene expression normalization due to significant variations in expression across all samples. Finally, we verified the reliability of the selected candidate reference genes by amplifying an AGAMOUS homolog (LsAG1) of Arabidopsis thaliana. This study provides a list of suitable reference genes, thereby broadening the genetic basis of the gene expression patterns in Lagerstroemia species.	[Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Beijing, Peoples R China; [Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Natl Engn Res Ctr Floriculture, Beijing, Peoples R China; [Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China; [Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Sch Landscape Architecture, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Zhang, QX (corresponding author), Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Beijing, Peoples R China.; Zhang, QX (corresponding author), Beijing Forestry Univ, Natl Engn Res Ctr Floriculture, Beijing, Peoples R China.; Zhang, QX (corresponding author), Beijing Forestry Univ, Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China.; Zhang, QX (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China.; Zhang, QX (corresponding author), Beijing Forestry Univ, Sch Landscape Architecture, Beijing, Peoples R China.	zqxbjfu@126.com			Fundamental Research Funds for the Central Universities [2016ZCQ02]; Special Fund for Beijing Common Construction Project	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Beijing Common Construction Project	The research was supported by the Fundamental Research Funds for the Central Universities (No. 2016ZCQ02) and Special Fund for Beijing Common Construction Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bin WS, 2012, MOL BREEDING, V30, P1393, DOI 10.1007/s11032-012-9726-7; Cai M, 2011, SCI HORTIC-AMSTERDAM, V131, P88, DOI 10.1016/j.scienta.2011.09.031; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Ferradas Y, 2016, PLANT PHYSIOL BIOCH, V102, P27, DOI 10.1016/j.plaphy.2016.02.011; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Hong Y, 2015, J AM SOC HORTIC SCI, V140, P68, DOI 10.21273/JASHS.140.1.68; Hou JH, 2011, PLANT MOL BIOL REP, V29, P473, DOI 10.1007/s11105-010-0248-3; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jin XH, 2013, SCI HORTIC-AMSTERDAM, V153, P64, DOI 10.1016/j.scienta.2013.01.023; Kanakachari M, 2016, APPL BIOCHEM BIOTECH, V178, P433, DOI 10.1007/s12010-015-1884-8; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Li Y, 2015, GENES GENOM, V37, P851, DOI 10.1007/s13258-015-0317-y; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Moazzam J, 2016, PLOS ONE, V11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pooler M, 2006, FLOWER BREEDING AND GENETICS: ISSUES, CHALLENGES AND OPPORTUNITIES FOR THE 21ST CENTURY, P439; Pounders C, 2007, HORTSCIENCE, V42, P1317, DOI 10.21273/HORTSCI.42.6.1317; Qi S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00287; Reddy DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148451; Rivera-Vega L, 2012, PLANT MOL BIOL REP, V30, P242, DOI 10.1007/s11105-011-0340-3; Sun YK, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0288-1; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang T, 2014, J AM SOC HORTIC SCI, V139, P113, DOI 10.21273/JASHS.139.2.113; Wang X, 2015, INT J GENOMICS, V2015, P1, DOI DOI 10.1109/GL0C0M.2015.7417517; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xiao D, 2012, FUNCT PLANT BIOL, V39, P342, DOI 10.1071/FP11246; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Ye YJ, 2015, GENET MOL RES, V14, P4369, DOI 10.4238/2015.April.30.10; Yi SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P128, DOI 10.1016/j.scienta.2012.02.013; Zhang Q, 1991, J BEIJING FORESTRY U, V4, P57; Zhou L, 2016, J AM SOC HORTIC SCI, V141, P99, DOI 10.21273/JASHS.141.2.99	38	29	36	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0195004	10.1371/journal.pone.0195004	http://dx.doi.org/10.1371/journal.pone.0195004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579116	gold, Green Submitted, Green Published			2022-12-27	WOS:000428351800078
J	Monagin, C; Paccha, B; Liang, N; Trufan, S; Zhou, HQ; Wu, D; Schneider, BS; Chmura, A; Epstein, JH; Daszak, P; Ke, CW; Rabinowitz, PM				Monagin, Corina; Paccha, Blanca; Liang, Ning; Trufan, Sally; Zhou, Huiqiong; Wu, De; Schneider, Bradley S.; Chmura, Aleksei; Epstein, Jonathan H.; Daszak, Peter; Ke, Changwen; Rabinowitz, Peter M.			Serologic and behavioral risk survey of workers with wildlife contact in China	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFECTIOUS-DISEASES; SARS CORONAVIRUS; WET-MARKETS; EMERGENCE; INFLUENZA; EPIDEMIOLOGY; ZOONOSES; VIRUS; FEVER	We report on a study conducted in Guangdong Province, China, to characterize behaviors and perceptions associated with transmission of pathogens with pandemic potential in highly exposed human populations at the animal-human interface. A risk factor/exposure survey was administered to individuals with high levels of exposure to wildlife. Serological testing was performed to evaluate prior infection with several wildlife viral pathogens. Follow up serology was performed on a subset of the cohort as well as close contacts of individuals. 1,312 individuals were enrolled in the study. Contact with a wide range of wildlife species was reported in both occupational and occasional contexts. The overall proportion of individuals seropositive to any of the tested wildlife pathogens was approximately 4.0%. However, persons employed as butchers demonstrated a seropositivity of 9.0% to at least one pathogen of interest. By contrast, individuals working as hunters had lower rates of seropositivity. Among the study population, a number of other behaviors showed correlation with seropositivity, including contact with particular wildlife species such as field rats. These results demonstrate the need to further explore zoonotic risks of particular activities regarding wildlife contact, and to better understand risks of persons working as butchers with wildlife species.	[Monagin, Corina; Liang, Ning; Schneider, Bradley S.] Metabiota Inc, San Francisco, CA 94104 USA; [Paccha, Blanca] Yale Univ, New Haven, CT USA; [Trufan, Sally; Rabinowitz, Peter M.] Univ Washington, Ctr Hlth Res 1, Seattle, WA 98195 USA; [Zhou, Huiqiong; Wu, De; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Chmura, Aleksei; Epstein, Jonathan H.; Daszak, Peter] EcoHlth Alliance, New York, NY USA; [Monagin, Corina] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA; [Trufan, Sally] Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA; [Schneider, Bradley S.] Etiologic, Oakland, CA USA	Yale University; University of Washington; University of Washington Seattle; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; EcoHealth Alliance; University of California System; University of California Davis; Carolinas HealthCare System	Monagin, C (corresponding author), Metabiota Inc, San Francisco, CA 94104 USA.; Monagin, C (corresponding author), Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA.	cgmonagin@ucdavis.edu	Chmura, Aleksei/K-9971-2018; Zhou, Huiqiong/S-1276-2016	Chmura, Aleksei/0000-0001-5544-0431; Zhou, Huiqiong/0000-0003-2124-6563; Schneider, Bradley S/0000-0001-7642-0018; Trufan, Sally/0000-0003-3342-0629	American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT program [AID-OAA-A-14-00102]; Google/Skoll	American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT program(United States Agency for International Development (USAID)); Google/Skoll	This study was made possible by Google/Skoll and the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT program (Cooperative Agreement No. AID-OAA-A-14-00102). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Metabiota Inc., is a commercial company that received funding from Google/Skoll. The funder provided support in the form of salaries for authors CM, BS, NL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bengis RH, 2004, REV SCI TECH OIE, V23, P497; Beran GW, 2008, PREV VET MED, V86, P198, DOI 10.1016/j.prevetmed.2008.05.001; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Heinze G., 1999, APPL FIRTHS PROCEDUR; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; LeBreton M, 2012, NEW DIRECTIONS CONSE; Li W, 2005, SCIENCE, P310; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09679; Low DE, 2004, LEARNING SARS PREPAR; Ly S, 1008, EMERG INFECT DIS, V14, P161; Shi YL, 2003, J CLIN MICROBIOL, V41, P5781, DOI 10.1128/JCM.41.12.5781-5782.2003; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Woo PCY, 2006, CURR OPIN INFECT DIS, V19, P401, DOI 10.1097/01.qco.0000244043.08264.fc; Wu XB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-119; Yamate M, 2005, MICROBES INFECT, V7, P1530, DOI 10.1016/j.micinf.2005.05.013; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang QF, 2004, J MED VIROL, V73, P332, DOI 10.1002/jmv.20095; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470; Zheng HQ, 2010, VIROLOGY, V401, P137, DOI 10.1016/j.virol.2010.03.010	26	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194647	10.1371/journal.pone.0194647	http://dx.doi.org/10.1371/journal.pone.0194647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614074	Green Submitted, gold, Green Published			2022-12-27	WOS:000429081600014
J	Khajah, MA; Mathew, PM; Luqmani, YA				Khajah, Maitham A.; Mathew, Princy M.; Luqmani, Yunus A.			Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells	PLOS ONE			English	Article							BETA-SUBUNIT; ESTROGEN-RECEPTOR; ALPHA-SUBUNIT; OUABAIN; NA,K-ATPASE; EXPRESSION; NA+,K+-ATPASE; SRC; PROLIFERATION; INHIBITION	Background The Na+/K+-ATPase (NKP) is an important ion transporter also involved in signal transduction. Its expression profile is altered in various tumours including that of the breast. We studied the effect of inhibiting NKP activity in non-tumorigenic breast cell line and in estrogen receptor positive and negative breast cancer cells. Methods Expression and localization of NKP and downstream signaling molecules were determined by RT-PCR, western blotting and immunofluorescence. Cell proliferation, apoptosis and cell cycle stage were determined using MTT, annexin V and flow cytometry. Cell motility and invasion were determined using wound healing and matrigel assays. Total matrix metalloproteinase (MMP) was determined by a fluorescence-based assay. Results NKP was mainly localized on the cell membrane. Its baseline expression and activity were enhanced in breast cancer compared to the non-tumorigenic breast cell line. Ouabain and 3,4,5,6-tetrahydroxyxanthone (TTX) treatment significantly inhibited NKP activity, which significantly reduced cell proliferation, motility, invasion and pH-induced membrane blebbing. EGF stimulation induced internalization of NKP from the cell membrane to the cytoplasm. Ouabain inhibited EGF-induced phosphorylation of Rac/cdc42, profillin, ERK1/2 and P70S6K. Conclusions The NKP may offer a novel therapeutic target in breast cancer patients who have developed metastasis, aiming to improve therapeutic outcomes and enhance survival rate.	[Khajah, Maitham A.; Mathew, Princy M.; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Safat, Kuwait	Kuwait University	Khajah, MA (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	maitham@hsc.edu.kw	Khajah, Maitham/AAZ-8841-2020		Kuwait University [PT01/14];  [SRUL02/13]	Kuwait University; 	This work was supported by Kuwait University Research Sector grant PT01/14 (MAK). Parts of this work were supported by grant SRUL02/13 to the Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University.	Abramowitz J, 2003, CIRCULATION, V108, P3048, DOI 10.1161/01.CIR.0000101919.00548.86; ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Aizman O, 2003, ANN NY ACAD SCI, V986, P489, DOI 10.1111/j.1749-6632.2003.tb07233.x; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Alevizopoulos K, 2014, CURR DRUG TARGETS, V15, P988, DOI 10.2174/1389450115666140908125025; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blok LJ, 1999, BRIT J CANCER, V81, P28, DOI 10.1038/sj.bjc.6690647; Bogdanov A, 2017, F1000RES, V6; Chauhan NB, 1997, J MOL NEUROSCI, V9, P151, DOI 10.1007/BF02800498; Contreras RG, 1999, J CELL SCI, V112, P4223; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Ferrandi M, 2014, J PHARMACOL EXP THER, V351, P278, DOI 10.1124/jpet.114.217133; Fu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/628064; Goncalves-de-Albuquerque CF, 2017, MOLECULES, V22, DOI 10.3390/molecules22040578; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Ho HT, 2011, J PHYSIOL-LONDON, V589, P4697, DOI 10.1113/jphysiol.2011.210005; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Khajah MA, 2015, INT J ONCOL, V46, P1685, DOI 10.3892/ijo.2015.2884; Khajah MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076327; Khajah MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041847; Khundmiri SJ, 2006, AM J PHYSIOL-CELL PH, V291, P28; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Liu N, 2013, ONCOL LETT, V6, P475, DOI 10.3892/ol.2013.1406; Liu X, 1997, EUR J PHARMACOL, V327, P151, DOI 10.1016/S0014-2999(97)89654-9; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Mohammadi K, 2003, J CARDIOVASC PHARM, V41, P609, DOI 10.1097/00005344-200304000-00014; Ozdemir A, 2015, ARCH PHARM RES, V38, P1897, DOI 10.1007/s12272-015-0597-4; Pongrakhananon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068623; Rajasekaran AK, 2003, ANN NY ACAD SCI, V986, P649, DOI 10.1111/j.1749-6632.2003.tb07276.x; Rajasekaran SA, 2003, ANN NY ACAD SCI, V986, P652, DOI 10.1111/j.1749-6632.2003.tb07277.x; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, P5; Saunders R, 2004, EUR J BIOCHEM, V271, P1054, DOI 10.1111/j.1432-1033.2004.04012.x; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Sorsa T, 2004, MOL CELL BIOCHEM, V266, P87, DOI 10.1023/B:MCBI.0000049141.37823.19; Strasser-Weippl K, 2005, J CLIN ONCOL, V23, P1751, DOI 10.1200/JCO.2005.11.038; Sweadner KJ, 2000, BIOCHEM BIOPH RES CO, V279, P196, DOI 10.1006/bbrc.2000.3907; THOMAS GP, 1986, BRIT J PHARMACOL, V89, P385, DOI 10.1111/j.1476-5381.1986.tb10271.x; THOMAS GP, 1991, BRIT J PHARMACOL, V104, P995, DOI 10.1111/j.1476-5381.1991.tb12539.x; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Tsimaratos M, 2001, CELL MOL BIOL, V47, P239; Winnicka K, 2008, BIOL PHARM BULL, V31, P1131, DOI 10.1248/bpb.31.1131; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yeh JY, 2001, J UROLOGY, V166, P1937, DOI 10.1016/S0022-5347(05)65724-2; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7; Schneider NFZ, 2017, MOLECULES, V22, DOI 10.3390/molecules22111932	54	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193779	10.1371/journal.pone.0193779	http://dx.doi.org/10.1371/journal.pone.0193779			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590154	Green Published, gold, Green Submitted			2022-12-27	WOS:000428603100031
J	Kim, HY; Kim, YH; Yun, G; Chang, W; Lee, YJ; Kim, B				Kim, Hae Young; Kim, Young Hoon; Yun, Gabin; Chang, Won; Lee, Yoon Jin; Kim, Bohyoung			Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer?	PLOS ONE			English	Article							INTRAPERITONEAL CHEMOTHERAPY; TUMOR HETEROGENEITY; METASTASES; SURVIVAL; METAANALYSIS; PARAMETERS; BIOMARKER; THERAPY; LIVER	Purpose To retrospectively investigate whether texture features obtained from preoperative CT images of advanced gastric cancer (AGC) patients could be used for the prediction of occult peritoneal carcinomatosis (PC) detected during operation. Materials and methods 51 AGC patients with occult PC detected during operation from January 2009 to December 2012 were included as occult PC group. For the control group, other 51 AGC patients without evidence of distant metastasis including PC, and whose clinical T and N stage could be matched to those of the patients of the occult PC group, were selected from the period of January 2011 to July 2012. Each group was divided into test (n = 41) and validation cohort (n = 10). Demographic and clinical data of these patients were acquired from the hospital database. Texture features including average, standard deviation, kurtosis, skewness, entropy, correlation, and contrast were obtained from manually drawn region of interest (ROI) over the omentum on the axial CT image showing the omentum at its largest cross sectional area. After using Fisher's exact and Wilcoxon signed-rank test for comparison of the clinical and texture features between the two groups of the test cohort, conditional logistic regression analysis was performed to determine significant independent predictor for occult PC. Using the optimal cut-off value from receiver operating characteristic (ROC) analysis for the significant variables, diagnostic sensitivity and specificity were determined in the test cohort. The cut-off value of the significant variables obtained from the test cohort was then applied to the validation cohort. Bonferroni correction was used to adjust P value for multiple comparisons. Results Between the two groups, there was no significant difference in the clinical features. Regarding the texture features, the occult PC group showed significantly higher average, entropy, standard deviation, and significantly lower correlation (P value < 0.004 for all). Conditional logistic regression analysis demonstrated that entropy was significant independent predictor for occult PC. When the cut-off value of entropy (> 7.141) was applied to the validation cohort, sensitivity and specificity for the prediction of occult PC were 80% and 90%, respectively. Conclusion For AGC patients whose PC cannot be detected with routine imaging such as CT, texture analysis may be a useful adjunct for the prediction of occult PC.	[Kim, Hae Young; Kim, Young Hoon; Yun, Gabin; Chang, Won; Lee, Yoon Jin] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Dept Radiol,Bundang Hosp,Coll Med, Seoul, South Korea; [Kim, Bohyoung] Hankuk Univ Foreign Studies, Div Biomed Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hankuk University Foreign Studies	Kim, YH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Dept Radiol,Bundang Hosp,Coll Med, Seoul, South Korea.	yhkrad@gmail.com		Kim, Hae Young/0000-0002-9508-4280				Bang YJ, 2010, LANCET, V376, P1302; Bashir U, 2016, AM J ROENTGENOL, V207, P534, DOI 10.2214/AJR.15.15864; Bilici A, 2014, WORLD J GASTROENTERO, V20, P3905, DOI 10.3748/wjg.v20.i14.3905; Coakley FV, 2002, RADIOLOGY, V223, P495, DOI 10.1148/radiol.2232011081; Coccolini F, 2014, EJSO-EUR J SURG ONC, V40, P12, DOI 10.1016/j.ejso.2013.10.019; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; De Bree E, 2004, J SURG ONCOL, V86, P64, DOI 10.1002/jso.20049; FUKUYA T, 1995, RADIOLOGY, V197, P705, DOI 10.1148/radiology.197.3.7480743; Ganeshan B, 2007, CLIN RADIOL, V62, P761, DOI 10.1016/j.crad.2007.03.004; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Ganeshan B, 2011, INVEST RADIOL, V46, P160, DOI 10.1097/RLI.0b013e3181f8e8a2; Ganeshan B, 2009, EUR J RADIOL, V70, P101, DOI 10.1016/j.ejrad.2007.12.005; Giganti F, 2017, EUR J RADIOL, V90, P129, DOI 10.1016/j.ejrad.2017.02.043; Giganti F, 2017, EUR RADIOL, V27, P1831, DOI 10.1007/s00330-016-4540-y; Ji ZH, 2016, TRANSL GASTROENT HEP, V1, DOI 10.21037/tgh.2016.08.03; Kim SJ, 2009, RADIOLOGY, V253, P407, DOI 10.1148/radiol.2532082272; La Yun B, 2014, KOREAN J RADIOL, V15, P591, DOI 10.3348/kjr.2014.15.5.591; Liu SL, 2017, EUR RADIOL, V27, P4951, DOI 10.1007/s00330-017-4881-1; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Miles KA, 2013, CANCER IMAGING, V13, P400, DOI 10.1102/1470-7330.2013.9045; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Ryu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108335; Sadeghi B, 2000, CANCER-AM CANCER SOC, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Yang DY, 2011, J GASTROINTEST ONCOL, V2, P77, DOI 10.3978/j.issn.2078-6891.2010.025; Yip C, 2014, RADIOLOGY, V270, P141, DOI 10.1148/radiol.13122869; Yoon SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152690	31	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194755	10.1371/journal.pone.0194755	http://dx.doi.org/10.1371/journal.pone.0194755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596522	Green Submitted, Green Published, gold			2022-12-27	WOS:000428630000040
J	Harikrishnan, S; Sarma, S; Sanjay, G; Jeemon, P; Krishnan, MN; Venugopal, K; Mohanan, PP; Jeyaseelan, L; Thankappanl, KR; Zachariah, G				Harikrishnan, S.; Sarma, Smitha; Sanjay, G.; Jeemon, P.; Krishnan, M. N.; Venugopal, K.; Mohanan, P. P.; Jeyaseelan, L.; Thankappanl, K. R.; Zachariah, G.			Prevalence of metabolic syndrome and its risk factors in Kerala, South India: Analysis of a community based cross-sectional study	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; DEFINITION; STATEMENT; DIAGNOSIS	Background Coronary Artery Disease (CAD) is a leading cause of death and disability in Kerala, India. Metabolic syndrome (MS) is a constellation of established risk factors for CAD. We aimed to estimate the prevalence of MS and evaluate the association between MS and CAD using a community-based sample population. Methods A cross-sectional community based survey was conducted in urban and rural areas of Kerala in 2011. We included 5063 individuals for analysis. Age standardized prevalence of MS, associated diagnoses (hypertension, diabetes and hypercholesterolemia) and other potential risk factors were assessed for men and women in both urban and rural locations. Univariate and multivariate logistic regression models were developed to identify participant characteristics that are associated with MS. Results After standardization for age and adjustment for sex and urban-rural distribution, the prevalence of metabolic syndrome in Kerala was 24%, 29% and 33% for the NCEP ATP III, IDF and AHA/NHLBI Harmonization definitions, respectively. The mean (SD) age of the participants was 51 (14) years, and 60% were women. Women had a higher prevalence of MS than men (28% versus 20% for ATP III, p<0.001). Similarly, participants living in urban areas had higher prevalence of MS than their rural counterparts (26% versus 22%, p<0.001). Elevated body mass index, older age, and female sex were associated with MS in an adjusted multivariate model. The propensity for definite CAD was 1.7 times higher in individuals with MS defined based on ATP III criteria compared to those without MS (Adjusted OR = 1.69; 95% CI: 1.3-2.2, p<0.001). Conclusions One of four to one of three adult individuals in Kerala have MS based on different criteria. Higher propensity for CAD in individuals with MS in Kerala calls for urgent steps to prevent and control the burden of metabolic conditions.	[Harikrishnan, S.; Sanjay, G.; Thankappanl, K. R.] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Cardiol, Thiruvananthapuram, Kerala, India; [Sarma, Smitha] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Jeemon, P.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram, Kerala, India; [Krishnan, M. N.] Govt Med Coll, Dept Cardiol, Kozhikode, Kerala, India; [Venugopal, K.] Pushpagiri Hosp, Dept Cardiol, Kottayam, Kerala, India; [Mohanan, P. P.] Wesffort High Tech Hosp, Dept Cardiol, Trichur, Kerala, India; [Jeyaseelan, L.] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Zachariah, G.] Mother Hosp, Dept Cardiol, Trichur, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Northwestern University; Feinberg School of Medicine; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Christian Medical College & Hospital (CMCH) Vellore	Harikrishnan, S (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Dept Cardiol, Thiruvananthapuram, Kerala, India.	drharikrishnan@outlook.com	SOUNDRARAJAN, JOYSON/I-1779-2019; S, Harikrishnan/AAT-8083-2021	Harikrishnan, Sivadasanpillai/0000-0001-8754-4243; , KR/0000-0002-4536-2684; Bhaumik, Smitha/0000-0002-2981-9293; Jeemon, Panniyammakal/0000-0003-4172-4307	Cardiological Society of India, Kerala Chapter	Cardiological Society of India, Kerala Chapter	The study was funded exclusively by the Cardiological Society of India, Kerala Chapter; this is the professional organization of cardiologists in this region. The funders had no role in the design, data collection, analysis or interpretation or writing up of the article.	Ahmad OB, 2001, PAPER SERIES GENEVA, V31, P1; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Althoff T, 2017, NATURE, V547, P336, DOI 10.1038/nature23018; [Anonymous], 2005, OBESITY METABOLISM, DOI [10.14341/2071-8713-4854, DOI 10.14341/2071-8713-4854]; [Anonymous], 2000, WHO TECHN REP SER; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Government of Kerala, 2015, ANN VIT STAT REP; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Krauss RM, 2001, J NUTR, V131, P132, DOI 10.1093/jn/131.1.132; Krishnan MN, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0189-3; Menon VU, 2006, DIABETES RES CLIN PR, V74, P289, DOI 10.1016/j.diabres.2006.03.025; Prabhakaran D, 2007, CHRONIC ILLN, V3, P8, DOI 10.1177/1742395307079197; Prineas RJ., 2009, MINNESOTA CODE MANUA; Raman Kutty V, 1999, Ethn Health, V4, P231; Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4041-1; Rose G, 1982, CARDIOVASCULAR SURVE; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sathish T, 2012, PUBLIC HEALTH, V126, P25, DOI 10.1016/j.puhe.2011.11.002; Sebastian N. M., 2016, International Journal of Medical Science and Public Health, V5, P2041; Soman CR, 2011, ASIA-PAC J PUBLIC HE, V23, P896, DOI 10.1177/1010539510365100; Thankappan KR, 2015, J HYPERTENS, V33, pE9, DOI 10.1097/01.hjh.0000469749.88501.33; Thankappan KR, 2010, INDIAN J MED RES, V131, P53; Vijayakumar G, 2009, J Assoc Physicians India, V57, P563; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; World Health Organization, 2008, WHO STEPS MAN WHO ST; Zachariah Geevar, 2013, Indian Heart J, V65, P243, DOI 10.1016/j.ihj.2013.04.008; Zachariah Manu G, 2003, Indian Heart J, V55, P245	30	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0192372	10.1371/journal.pone.0192372	http://dx.doi.org/10.1371/journal.pone.0192372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584725	Green Submitted, gold, Green Published			2022-12-27	WOS:000428373000002
J	Turkia, T; Korpimaki, E; Villers, A; Selonen, V				Turkia, Tytti; Korpimaki, Erkki; Villers, Alexandre; Selonen, Vesa			Predation risk landscape modifies flying and red squirrel nest site occupancy independently of habitat amount	PLOS ONE			English	Article							PTEROMYS-VOLANS; REPRODUCTIVE SUCCESS; SCIURUS-VULGARIS; PREY HABITAT; HOME-RANGE; FOREST; POPULATION; SELECTION; FOOD; ABUNDANCE	Habitat choice often entails trade-offs between food availability and predation risk. Understanding the distribution of individuals in space thus requires that both habitat characteristics and predation risk are considered simultaneously. Here, we studied the nest box use of two arboreal squirrels who share preferred habitat with their main predators. Nocturnal Ural owls (Strix uralensis) decreased occurrence of night-active flying squirrels (Pteromys volans) and diurnal goshawks (Accipiter gentilis) that of day-active red squirrels (Sciurus vulgaris). Unexpectedly, the amount of preferred habitat had no effect on nest box use, but, surprisingly, both squirrel species seemed to benefit from close proximity to agricultural fields and red squirrels to urban areas. We found no evidence of trade-off between settling in a high-quality habitat and avoiding predators. However, the amount of poor-quality young pine forests was lower in occupied sites where goshawks were present, possibly indicating habitat specific predation on red squirrels. The results suggest that erecting nest boxes for Ural owls should be avoided in the vicinity of flying squirrel territories in order to conserve the near threatened flying squirrels. Our results also suggest that flying squirrels do not always need continuous old forests, and hence the currently insufficient conservation practices could be improved with reasonable increases in the areas left untouched around their nests. The results of this study demonstrate the importance of taking into account both habitat requirements and predation risk as well as their interactive effects when modeling the occupancy of threatened animal species and planning their conservation.	[Turkia, Tytti; Korpimaki, Erkki; Selonen, Vesa] Univ Turku, Dept Biol, Sect Ecol, Turku, Finland; [Villers, Alexandre] French Natl Ctr Agr Res, Chize, France	University of Turku; INRAE	Turkia, T (corresponding author), Univ Turku, Dept Biol, Sect Ecol, Turku, Finland.	tysisit@utu.fi	Villers, Alexandre/W-8184-2019; VILLERS, Arnauld/K-6629-2016	VILLERS, Arnauld/0000-0002-6298-7758; Villers, Alexandre/0000-0003-3050-4106				ANDREN H, 1992, ECOGRAPHY, V15, P303, DOI 10.1111/j.1600-0587.1992.tb00039.x; ANDREN H, 1994, OIKOS, V70, P43, DOI 10.2307/3545697; Barreto GR, 1998, ANIM CONSERV, V1, P129, DOI 10.1111/j.1469-1795.1998.tb00020.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bjorklund H, 2016, OECOLOGIA, V181, P257, DOI 10.1007/s00442-015-3523-z; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Byholm P, 2012, ECOLOGY, V93, P1802, DOI 10.1890/12-0285.1; Calcagno V, 2013, R PACKAGE VERSION, V1, P7; CAREY AB, 1992, ECOL MONOGR, V62, P223, DOI 10.2307/2937094; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Delin AE, 1999, LANDSCAPE ECOL, V14, P67, DOI 10.1023/A:1008040001801; Di Pierro E, 2011, EUR J WILDLIFE RES, V57, P585, DOI 10.1007/s10344-010-0469-7; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; DONCASTER CP, 1994, OIKOS, V69, P182, DOI 10.2307/3546136; Doran PJ, 2005, CAN J ZOOL, V83, P1297, DOI 10.1139/Z05-127; Dupke C, 2016, ECOGRAPHY; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Evans KL, 2004, IBIS, V146, P1, DOI 10.1111/j.1474-919X.2004.00231.x; FORSMAN E D, 1984, Wildlife Monographs, P1; Fox J., 2019, R COMPANION APPL REG; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; GURNELL J, 1983, MAMMAL REV, V13, P133, DOI 10.1111/j.1365-2907.1983.tb00274.x; Hakkarainen H, 2003, OIKOS, V100, P162, DOI 10.1034/j.1600-0706.2003.11906.x; Hakkarainen H, 1996, ECOLOGY, V77, P1134, DOI 10.2307/2265582; Hanski IK, 2000, J MAMMAL, V81, P798, DOI 10.1644/1545-1542(2000)081<0798:HRSMAN>2.3.CO;2; Hanski IK, 2001, SUOMEN YMPARISTO, V459; Hanski IK, 1998, WILDLIFE BIOL, V4, P33, DOI 10.2981/wlb.1998.013; HOKKANEN H, 1982, BIOL CONSERV, V23, P273, DOI 10.1016/0006-3207(82)90083-0; Hokkanen T, 2000, FINNISH FOREST RES I, V790, P87; Hoset KS, 2017, J ANIM ECOL, V86, P1235, DOI 10.1111/1365-2656.12715; Hoset KS, 2009, OIKOS, V118, P1421, DOI 10.1111/j.1600-0706.2009.17263.x; Hurme E, 2008, ECOGRAPHY, V31, P469, DOI 10.1111/j.0906-7590.2008.05373.x; Jokimaki J, 2017, URBAN FOR URBAN GREE, V27, P100, DOI 10.1016/j.ufug.2017.06.021; Jokinen M, 2015, ANIM CONSERV, V18, P167, DOI 10.1111/acv.12157; Jordan F, 1997, J EXP MAR BIOL ECOL, V208, P45, DOI 10.1016/S0022-0981(96)02656-1; KLENNER W, 1991, J ANIM ECOL, V60, P961, DOI 10.2307/5425; Korpimaki E, 2012, BOREAL OWL: ECOLOGY, BEHAVIOUR AND CONSERVATION OF A FOREST-DWELLING PREDATOR, P1, DOI 10.1017/CBO9780511844164; KORPIMAKI E, 1986, ORNIS SCAND, V17, P126, DOI 10.2307/3676861; KORPIMAKI E, 1990, OIKOS, V58, P47, DOI 10.2307/3565359; Koskimaki J, 2014, POPUL ECOL, V56, P341, DOI 10.1007/s10144-013-0411-4; Lampila S, 2009, ECOSCIENCE, V16, P66, DOI 10.2980/16-1-3184; Laundre J.W., 2010, OPEN ECOL J, V3, P1, DOI [DOI 10.2174/1874213001003030001, 10.2174/1874213001003030001]; Laundre JW, 2014, ECOLOGY, V95, P1141, DOI 10.1890/13-1083.1; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liukko U-M., 2016, SUOMEN NISAKKAIDEN U; Lurz PWW, 2000, J ZOOL, V251, P167, DOI 10.1111/j.1469-7998.2000.tb00601.x; Magris L, 2002, J ZOOL, V256, P99, DOI 10.1017/S0952836902000134; Melin M, 2016, FOREST ECOL MANAG, V380, P202, DOI 10.1016/j.foreco.2016.09.007; METLA, 2012, FOR CLASS OP DAT; Mikkola H., 1983, P1; MOLLER H, 1983, MAMMAL REV, V13, P81, DOI 10.1111/j.1365-2907.1983.tb00270.x; Morosinotto C, 2017, ECOL MONOGR, V87, P4, DOI 10.1002/ecm.1238; Neter J, 1985, APPL LINEAR REGRESSI; NORRDAHL K, 1995, P ROY SOC B-BIOL SCI, V261, P49, DOI 10.1098/rspb.1995.0116; Nupp TE, 2000, J MAMMAL, V81, P512, DOI 10.1644/1545-1542(2000)081&lt;0512:LLCOSM&gt;2.0.CO;2; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petty SJ, 2003, BIOL CONSERV, V111, P105, DOI 10.1016/S0006-3207(02)00254-9; PIETIAINEN H, 1989, J ANIM ECOL, V58, P905, DOI 10.2307/5132; R Development Core Team, 2009, R LANG ENV STAT COMP; Rajala P., 1963, Suomen Riista Helsinki, V16, P155; Rassi P., 2010, 2010 RED LIST FINNIS; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Ritchie LE, 2009, FOREST ECOL MANAG, V257, P1920, DOI 10.1016/j.foreco.2009.01.028; Roth TC, 2008, CONDOR, V110, P260, DOI 10.1525/cond.2008.8489; Roth TC, 2007, AM NAT, V169, P264, DOI 10.1086/510605; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Santangeli A, 2013, BIOL CONSERV, V157, P237, DOI 10.1016/j.biocon.2012.09.012; Santangeli A, 2013, BIOL CONSERV, V157, P31, DOI 10.1016/j.biocon.2012.06.027; Saurola P., 1987, U S Forest Service General Technical Report RM, P81; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schneider MF, 2001, J APPL ECOL, V38, P720, DOI 10.1046/j.1365-2664.2001.00642.x; Selonen V, 2012, CAN J ZOOL, V90, P885, DOI [10.1139/Z2012-058, 10.1139/z2012-058]; Selonen V, 2010, ANIM CONSERV, V13, P579, DOI 10.1111/j.1469-1795.2010.00379.x; Selonen V, 2001, ECOGRAPHY, V24, P588, DOI 10.1034/j.1600-0587.2001.d01-214.x; Selonen V, 2015, RED SQUIRRELS ECOLOG, P67; Selonen V, 2017, HYSTRIX, V28, P134, DOI 10.4404/hystrix-28.2-12328; Selonen V, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0107-7; Selonen V, 2016, ANN ZOOL FENN, V53, P183, DOI 10.5735/086.053.0407; Selonen V, 2015, OECOLOGIA, V177, P401, DOI 10.1007/s00442-014-3148-7; Selonen V, 2013, J MAMMAL, V94, P1266, DOI 10.1644/13-MAMM-A-129; Steele MA, 2008, CURR SCI INDIA, V95, P871; Sucksdorff Y, 1999, FINNISH ENV, V342, P1; SULLIVAN TP, 1990, J MAMMAL, V71, P579, DOI 10.2307/1381797; Thomson RL, 2006, ECOGRAPHY, V29, P507; Tornberg Risto, 2006, Studies in Avian Biology, P141; Trudeau C, 2011, J WILDLIFE MANAGE, V75, P1646, DOI 10.1002/jwmg.224; Turkia T, 2018, ECOGRAPHY, V40; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Vuerola I., P FINN RUSS SEM REM; Wauters LA, 2001, ECOGRAPHY, V24, P525, DOI 10.1034/j.1600-0587.2001.d01-208.x; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Wheatley M, 2005, J APPL ECOL, V42, P577, DOI 10.1111/j.1365-2664.2005.01034.x; WIDEN P, 1987, HOLARCTIC ECOL, V10, P104; Zamorano JG, 2016, J PLANT ECOL; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	97	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194624	10.1371/journal.pone.0194624	http://dx.doi.org/10.1371/journal.pone.0194624			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596438	Green Published, Green Submitted, gold			2022-12-27	WOS:000428630000035
J	Liang, HB; Yang, RH; Liu, Z; Li, M; Liu, HT; Jin, X				Liang, Huabin; Yang, Ruoheng; Liu, Zhihua; Li, Min; Liu, Haitao; Jin, Xia			Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice	PLOS ONE			English	Article							WEST-NILE-VIRUS; DENGUE VIRUS; MOUSE MODEL; SEXUAL TRANSMISSION; DOMAIN-III; VACCINE; EFFICACY; IMMUNOGENICITY; ANTIBODIES; INFECTION	Zika virus (ZIKV) has caused great public concerns due to its recent large outbreaks and a close association with microcephaly in fetus and Guillain-Barre syndrome in adults. Rapid development of vaccines against ZIKV is a public health priority. To this end, we have constructed and purified recombinant ZIKV envelope protein using both prokaryotic and eukaryotic expression systems, and then tested their immunogenicity and protective efficacy in immune competent mice. Both protein immunogens elicited humoral and cellular immune responses, and protected immune competent mice from ZIKV challenge in vivo. These products could be further evaluated either as stand-alone vaccine candidate, or used in a prime-and-boost regimen with other forms of ZIKV vaccine.	[Liang, Huabin; Yang, Ruoheng; Liu, Zhihua; Li, Min; Liu, Haitao; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Liang, Huabin; Yang, Ruoheng; Liu, Zhihua; Li, Min; Jin, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Jin, X (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	xjin@ips.a.c.cn		liu, zhihua/0000-0002-8959-2350	National Key Program Project Grant from the Ministry of Science and Technology China [2016YFC1201000]; National Science Foundation of China [31670941]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB030405]	National Key Program Project Grant from the Ministry of Science and Technology China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported in part by a National Key Program Project Grant from the Ministry of Science and Technology China (2016YFC1201000)(http://www.most.gov.cn/), a National Science Foundation of China grant (31670941)(http://www.nsfc.gov.cn/), and The Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB030405)(http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8; Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300; Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Li DP, 2016, J VIROL, V90, P10486, DOI 10.1128/JVI.01462-16; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Shan C., 2017, NAT MED; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296; SRIVASTAVA AK, 1995, VACCINE, V13, P1251, DOI 10.1016/0264-410X(94)00059-V; Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Tebas P, 2017, N ENGL J MED; Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Yang M, 2017, VACCINE; Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020; Zhao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086573; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	62	27	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194860	10.1371/journal.pone.0194860	http://dx.doi.org/10.1371/journal.pone.0194860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590178	Green Submitted, gold, Green Published			2022-12-27	WOS:000428603100081
J	Tsai, T; Kuehn, S; Tsiampalis, N; Vu, MK; Kakkassery, V; Stute, G; Dick, HB; Joachim, SC				Tsai, Teresa; Kuehn, Sandra; Tsiampalis, Nikolaos; Minh-Khoa Vu; Kakkassery, Vinodh; Stute, Gesa; Dick, H. Burkhard; Joachim, Stephanie C.			Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AQUEOUS-HUMOR; IFN-GAMMA; INTERLEUKIN-1-BETA; DEGENERATION; INHIBITION; IL-1	Evaluation of cytokines in patients with diabetic retinopathy (DR) is important for the identification of future additive or alternative treatment options. Therefore, vitreous samples were obtained from patients with DR and patients with macular hole or macular pucker (control group) during 23-gauge-vitrectomy (n = 17/group). The levels of three pro-inflammatory (IL-1 beta, IL-6, IFN-gamma) and pleiotropic cytokines (IL-2, IL-4, IL-13) as well as VEGF, VEGF-A, and PGF were measured using an enzyme linked immunosorbent assay (ELISA). IL-1 beta (p = 0.02) and IFN-gamma (p = 0.04), two of the three tested pro-inflammatory cytokines, were elevated in the DR patients, while IL-6 (p = 0.51) level was comparable in both groups. Moreover, in DR samples, a trend towards an IL-13 down-regulation (p = 0.36) was observable. The IL-2 (p = 0.62) and IL-4 (p = 0.78) levels were comparable in both groups. All analyzed angiogenetic factors were up-regulated in DR patients (VEGF: p<0.001; VEGF-A: p = 0.002; PGF: p<0.001). The up-regulation of angiogenetic factors underline their importance in DR development. However, the interaction of the other cytokines showed an interesting pattern. Pro-inflammatory cytokines were also up-regulated, which could be evidence for inflammation processes in the diabetic retina. Furthermore, it seems that a counter response of immunomodulatory cytokines is in an initial process, but not strong enough to regulate the processes. Therefore, to support these anti-inflammatory mechanisms might be additive treatment option in the future.	[Tsai, Teresa; Kuehn, Sandra; Tsiampalis, Nikolaos; Minh-Khoa Vu; Kakkassery, Vinodh; Stute, Gesa; Dick, H. Burkhard; Joachim, Stephanie C.] Ruhr Univ Bochum, Eye Hosp, Expt Eye Res Inst, Bochum, Germany	Ruhr University Bochum	Joachim, SC (corresponding author), Ruhr Univ Bochum, Eye Hosp, Expt Eye Res Inst, Bochum, Germany.	stephanie.joachim@rub.cie	Kakkassery, Vinodh/AAJ-9544-2020; Joachim, Stephanie/AAV-5980-2021; Dick, Burkhard/AAI-7504-2020	Kakkassery, Vinodh/0000-0001-6212-8964; 	Bayer Vital GmbH.	Bayer Vital GmbH.(Bayer AG)	The study was in part supported by Bayer Vital GmbH. No additional external funding was received for this study. The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the paper; and/or decision to submit for publication.	Abu El-Asrar AM, 2012, MIDDLE EAST AFR J OP, V19, P70, DOI 10.4103/0974-9233.92118; Adamiec-Mroczek J, 2010, CYTOKINE, V49, P269, DOI 10.1016/j.cyto.2009.11.004; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Arellano G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00492; Balasubramanian SA, 2013, CLIN EXP OPTOM, V96, P214, DOI 10.1111/cxo.12038; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bolinger MT, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091498; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Brooks HL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1801, DOI 10.1001/archopht.122.12.1801; Chernykh VV, 2015, INDIAN J OPHTHALMOL, V63, P33, DOI 10.4103/0301-4738.151464; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Citirik M, 2012, OPHTHALMIC RES, V47, P7, DOI 10.1159/000324200; Cunha-Vaz J, 2014, PROG RETIN EYE RES, V41, P90, DOI 10.1016/j.preteyeres.2014.03.003; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Domingueti CP, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2315260; Dong N, 2013, MOL VIS, V19, P1734; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Grigsby JG, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/705783; Hagan S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0065-3; Hillier RJ, 2017, RETINA-J RET VIT DIS, V37, P761, DOI 10.1097/IAE.0000000000001210; Jenkins Alicia J, 2015, Rev Diabet Stud, V12, P159, DOI 10.1900/RDS.2015.12.159; Jesus AA, 2014, ANNU REV MED, V65, P223, DOI 10.1146/annurev-med-061512-150641; Johnsen-Soriano S, 2010, GRAEF ARCH CLIN EXP, V248, P985, DOI 10.1007/s00417-009-1289-x; Khaliq A, 1998, LAB INVEST, V78, P109; Kortus-Gotze B, 2011, CLIN KIDNEY J, V4, P404, DOI 10.1093/ndtplus/sfr118; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; MACHOLD KP, 1992, ANN RHEUM DIS, V51, P1039, DOI 10.1136/ard.51.9.1039; Magrinelli F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/547834; Manni G, 2005, AM J OPHTHALMOL, V139, P72, DOI 10.1016/j.ajo.2004.08.028; Meng ZJ, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-016-0558-5; Minhas G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00444; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Mocan MC, 2006, CAN J OPHTHALMOL, V41, P747, DOI 10.1139/I06-070; Pelikan Z, 2013, MOL VIS, V19, P1453; Reverter JL, 2009, INVEST OPHTH VIS SCI, V50, P1378, DOI 10.1167/iovs.08-2736; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Roy S, 2016, AM J PATHOLOGY; Shen XI, 2000, BIOCHEM J, V352, P913, DOI 10.1042/0264-6021:3520913; Skurkovich B, 2006, E SCHERING RES FDN W, V56, P1; Statistics CoDCaPND, 2014, REP EST DIAB ITS BUR; Stefansson E, 2000, ACTA OPHTHALMOL SCAN, V78, P374, DOI 10.1034/j.1600-0420.2000.078004374.x; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tjwa M, 2003, CELL TISSUE RES, V314, P5, DOI 10.1007/s00441-003-0776-3; Tosi GM, 2017, INVEST OPHTH VIS SCI, V58, P162, DOI 10.1167/iovs.16-20922; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu D, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43017; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zhang WB, 2011, IMMUNOTHERAPY-UK, V3, P609, DOI [10.2217/imt.11.24, 10.2217/IMT.11.24]; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	55	53	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194603	10.1371/journal.pone.0194603	http://dx.doi.org/10.1371/journal.pone.0194603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584759	Green Submitted, Green Published, gold			2022-12-27	WOS:000428373000028
J	Liu, LJ; Huang, Y; Fang, C; Zhang, HY; Yang, J; Xuan, CY; Wang, FF; Lu, HY; Cao, SF; Wang, YF; Li, SW; Sha, J; Zha, MM; Guo, M; Wang, J				Liu, Lijie; Huang, Yi; Fang, Cong; Zhang, Hongyu; Yang, Jing; Xuan, Chuanying; Wang, Fanfan; Lu, Haiying; Cao, Shuangfeng; Wang, Yongfang; Li, Shengwei; Sha, Jun; Zha, Mingming; Guo, Min; Wang, Jian			Chronic noise-exposure exacerbates insulin resistance and promotes the manifestations of the type 2 diabetes in a high-fat diet mouse model	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GLUCOSE-TOLERANCE; STRESS; ACIDS; METABOLISM; MECHANISMS; DEPRESSION; SECRETION; RISK	Epidemiological studies have revealed that noise exposure was associated with an increased risk of type 2 diabetes mellitus (T2DM). However, the exact nature of that association remains to be elucidated. The present study is designed to examine the effects of chronic noise exposure on the development of T2DM in combination with a high-fat-diet (HFD) in mice. Here we show that chronic noise exposure at 85 dB SPL (4 h / day, below the safety limit for occupational noise exposure) exaggerated multiple metabolic abnormalities induced by HFD in C57BL/6J male mice, including worsened glucose intolerance, insulin resistance, fasting hyperglycemia and dyslipidemia. Furthermore, noise exposure exhibited a paradoxical impact on fat accumulation and circulating levels of free fatty acid, indicating a potential stimulating effect of noise on lipolysis. These results provide first in vivo supporting evidence for the causative role of noise exposure in diabetogenesis and pinpoint a noise-associated increase in blood free fatty acid levels as a possible mediator accelerating the effect of noise on the development of insulin resistance and T2DM.	[Liu, Lijie; Wang, Yongfang; Li, Shengwei; Sha, Jun; Zha, Mingming; Guo, Min] Southeast Univ, Coll Med, Nanjing, Jiangsu, Peoples R China; [Huang, Yi; Fang, Cong; Zhang, Hongyu; Yang, Jing; Xuan, Chuanying; Wang, Fanfan; Lu, Haiying; Cao, Shuangfeng] Southeast Univ, Inst Life Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Jian] Dalhousie Univ, Sch Human Commun Disorder, Halifax, NS, Canada	Southeast University - China; Southeast University - China; Dalhousie University	Liu, LJ (corresponding author), Southeast Univ, Coll Med, Nanjing, Jiangsu, Peoples R China.	liulijie1973@163.com	liu, lijie/AAG-9041-2021; Zha, Mingming/AAI-6297-2021	liu, lijie/0000-0002-8309-609X; Wang, Jian/0000-0003-3633-6799	National Natural Science Foundation of China [81670935, 81520108015, 81100548, 81271086]; Fundamental research Fund from Southeast University [2242016K40073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental research Fund from Southeast University	This work was supported by the National Natural Science Foundation of China (81670935, LJL, http://www.nsfc.gov.cn) for data collection, analysis and preparation of the manuscript. This work was supported by the National Natural Science Foundation of China (81520108015, GJ T, http://www.nsfc.gov.cn) for data analysis and preparation of the manuscript. This work was supported by the National Natural Science Foundation of China (81100548, LJ L, http://www.nsfc.gov.cn) for data collection and preparation of the manuscript. This work was supported by the National Natural Science Foundation of China (81271086, J W, http://www.nsfc.gov.cn) for data collection. This work was supported by the Fundamental research Fund from Southeast University (2242016K40073, LJ L) for data collection.	Ahlkvist L, 2013, ENDOCR CONNECT, V2, P69, DOI 10.1530/EC-12-0079; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; ARMARIO A, 1983, REV ESP FISIOL, V39, P267; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Brewer PD, 2014, J BIOL CHEM; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cui B, 2016, SCI REP-UK, V6, DOI 10.1038/srep36693; Dzhambov AM, 2015, NOISE HEALTH, V17, P23, DOI 10.4103/1463-1741.149571; Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Gannouni N, 2013, NOISE HEALTH, V15, P406, DOI 10.4103/1463-1741.121236; Garza JC, 2012, MOL PSYCHIATR, V17, P790, DOI 10.1038/mp.2011.161; Gonzalez-Perez O, 2011, NEUROSCI RES, V70, P243, DOI 10.1016/j.neures.2011.03.013; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Konkle ATM, 2017, NOISE HEALTH, V19, P213, DOI 10.4103/nah.NAH_15_17; Liu L, 2016, ENV HLTH PERSPECTIVE; Manikandan S, 2006, NEUROSCI LETT, V399, P17, DOI 10.1016/j.neulet.2006.01.037; Mensink Marco, 2005, Metabolic Syndrome and Related Disorders, V3, P26, DOI 10.1089/met.2005.3.26; Morral N, 2007, J LIPID RES, V48, P1499, DOI 10.1194/jlr.M700090-JLR200; Pacini G, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/986906; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Paul DS, 2007, TOXICOL APPL PHARM, V222, P305, DOI 10.1016/j.taap.2007.01.010; Samson J, 2007, NEUROSCI RES, V57, P143, DOI 10.1016/j.neures.2006.09.019; Sjostrand M, 2009, MOL CELL ENDOCRINOL, V297, P104, DOI 10.1016/j.mce.2008.05.010; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Taban E, 2017, HEALTH SCOPE, V6, DOI 10.5812/jhealthscope.36108; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Uchida Y, 2012, DIABETES, V61, P1552, DOI 10.2337/db11-0828; Valente MM, 2012, MOL PHARMACOL, V82, P271, DOI 10.1124/mol.112.077636; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Yagi S, 2016, HIPPOCAMPUS, V26, P87, DOI 10.1002/hipo.22493; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	38	11	11	7	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195411	10.1371/journal.pone.0195411	http://dx.doi.org/10.1371/journal.pone.0195411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601606	Green Submitted, Green Published, gold			2022-12-27	WOS:000428845900028
J	Martell, L; Bracale, R; Carrion, SA; Purcell, JE; Lezzi, M; Gravili, C; Piraino, S; Boero, F				Martell, Luis; Bracale, Roberta; Carrion, Steven A.; Purcell, Jennifer E.; Lezzi, Marco; Gravili, Cinzia; Piraino, Stefano; Boero, Ferdinando			Successional dynamics of marine fouling hydroids (Cnidaria: Hydrozoa) at a finfish aquaculture facility in the Mediterranean Sea	PLOS ONE			English	Article							BIOFOULING COMMUNITIES; PINCTADA-FUCATA; ASSEMBLAGES; PATTERNS; SEASONALITY; VARIABILITY; MARICULTURE; MECHANISMS; STABILITY; JELLYFISH	Aquaculture is increasing rapidly to meet global seafood demand. Some hydroid populations have been linked to mortality and health issues in finfish and shellfish, but their dynamics in and around aquaculture farms remain understudied. In the present work, two experiments, each with 36 panels, tested colonization (factors: depth, season of immersion) and succession (factors: depth, submersion duration) over one year. Hydroid surface cover was estimated for each species, and data were analyzed with multivariate techniques. The assemblage of hydrozoans was species-poor, although species richness, frequency and abundance increased with time, paralleling the overall increase in structural complexity of fouling assemblages. Submersion duration and season of immersion were particularly important in determining the species composition of the assemblages in the succession and colonization experiments, respectively. Production of water-borne propagules, including medusae, from the hydroids was observed from locally abundant colonies, among them the well-known fouling species Obelia dichotoma, potentially representing a nuisance for cultured fish through contact-driven envenomations and gill disorders. The results illustrate the potential importance of fouling hydroids and their medusae to the health of organisms in the aquaculture industry.	[Martell, Luis] Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway; [Martell, Luis; Bracale, Roberta; Lezzi, Marco; Gravili, Cinzia; Piraino, Stefano; Boero, Ferdinando] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Carrion, Steven A.] Univ Cent Florida, Orlando, FL 32816 USA; [Purcell, Jennifer E.] Western Washington Univ, Bellingham, WA 98225 USA; [Gravili, Cinzia; Piraino, Stefano; Boero, Ferdinando] Consorzio Nazl Interuniv Sci Mare, CoNISMa, Rome, Italy; [Boero, Ferdinando] UO Genova, CNR ISMAR, Ist Sci Marine, CNR, Genoa, Italy	University of Bergen; University of Salento; State University System of Florida; University of Central Florida; Western Washington University; CoNISMa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Martell, L (corresponding author), Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway.; Martell, L (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy.	luisfmartell@gmail.com	lezzi, marco/AAA-5969-2020; Piraino, Stefano/J-5234-2012; Gravili, Cinzia/ABB-4127-2020	lezzi, marco/0000-0002-6888-7790; Piraino, Stefano/0000-0002-8752-9390; Gravili, Cinzia/0000-0001-8412-4390; Martell, Luis/0000-0002-7062-8915; Boero, Ferdinando/0000-0002-6317-2710	National Council of Science and Technology of Mexico (CONACyT, Mexico) [312520]; Ronald E. McNair Post baccalaureate Achievement Program (Department of Education, U. S. A.) [P217A120229]	National Council of Science and Technology of Mexico (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ronald E. McNair Post baccalaureate Achievement Program (Department of Education, U. S. A.)	This work was supported by grants from the National Council of Science and Technology of Mexico (CONACyT, Mexico) [312520 to LM], and the Ronald E. McNair Post baccalaureate Achievement Program (Department of Education, U. S. A.) [P217A120229 to SAC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSON MJ, 1994, J EXP MAR BIOL ECOL, V184, P217, DOI 10.1016/0022-0981(94)90006-X; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Antoniadou C, 2014, MAR ECOL-EVOL PERSP, V35, P281, DOI 10.1111/maec.12079; Antoniadou C, 2013, J MAR BIOL ASSOC UK, V93, P1593, DOI 10.1017/S0025315412001932; Bavestrello G, 2006, CHEM ECOL, V22, P197, DOI 10.1080/02757540600670810; Baxter EJ, 2011, AQUACULT ENV INTERAC, V1, P245, DOI 10.3354/aei00024; BENEDETTICECCHI L, 1993, J EXP MAR BIOL ECOL, V169, P15, DOI 10.1016/0022-0981(93)90040-U; Bloecher N, 2013, AQUACULTURE, V416, P302, DOI 10.1016/j.aquaculture.2013.09.025; BOERO F, 1984, MAR ECOL-P S Z N I, V5, P93, DOI 10.1111/j.1439-0485.1984.tb00310.x; Bosch-Belmar M, 2016, THESIS; Bosch-Belmar M, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00240; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Bouillon Jean, 2006, Memoires du Museum National d'Histoire Naturelle, V194, P1; Braithwaite RA, 2005, ADV MAR BIOL, V47, P215; BREITBURG DL, 1985, OECOLOGIA, V65, P173, DOI 10.1007/BF00379215; CALDER DR, 1990, CAN J ZOOL, V68, P442, DOI 10.1139/z90-065; Cardellicchio N, 2016, ENVIRON SCI POLLUT R, V23, P12495, DOI 10.1007/s11356-015-4924-6; Caroppo C, 2012, ECOL SOC, V17, DOI [10.5751/ES-04543-170110, 10.5751/ES-04950-170310]; Chaplygina SF, 1994, RUSS J MAR BIOL, V19, P85; CLAEREBOUDT MR, 1994, AQUACULTURE, V121, P327, DOI 10.1016/0044-8486(94)90268-2; Clarke K.R., 2006, PRIMER VERSION 6 USE; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Coma Rafael, 1992, Scientia Marina, V56, P161; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cook EJ, 2006, ICES J MAR SCI, V63, P637, DOI 10.1016/j.icesjms.2005.12.007; Cowie P. R., 2010, BIOFOULING, P87, DOI DOI 10.1002/9781444315462.CH6; Dabo KK, 1979, P INT WORKSH PEN CAG, P118; de Nys R, 2009, WOODHEAD PUBL MATER, P177, DOI 10.1533/9781845696313.1.177; Briz LMD, 2012, HYDROBIOLOGIA, V690, P215, DOI 10.1007/s10750-012-1040-1; Durr S., 2010, BIOFOULING, P267, DOI DOI 10.1002/9781444315462.CH19; Edwards CD, 2015, AQUAC RES, V46, P2225, DOI 10.1111/are.12380; FAO, 2019, STATE WORLD FISHERIE; Martell-Hernandez LF, 2011, J PARASITOL, V97, P68, DOI 10.1645/GE-2384.1; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Fitridge I, 2013, BIOFOULING, V29, P119, DOI 10.1080/08927014.2012.752465; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Genzano G, 2008, LAT AM J AQUAT RES, V36, P301, DOI [10.3856/vol36-issue2-fulltext-11, 10.4067/S0718-560X2008000200011]; Gili JM, 1995, OCEANOGR MAR BIOL, V33, P351; Gravier-Bonnet N, 2005, INVERTEBR REPROD DEV, V48, P63, DOI 10.1080/07924259.2005.9652171; Gravili C, 2015, ZOOTAXA, V3908, P1, DOI 10.11646/zootaxa.3908.1.1; Guenther J, 2006, BIOFOULING, V22, P163, DOI 10.1080/08927010600691929; Guenther J, 2006, AQUACULTURE, V253, P366, DOI 10.1016/j.aquaculture.2005.08.003; Guenther J, 2011, BIOFOULING, V27, P1033, DOI 10.1080/08927014.2011.627092; Guenther J, 2010, AQUACULTURE, V300, P120, DOI 10.1016/j.aquaculture.2010.01.005; Guenther J, 2009, AQUACULTURE, V292, P252, DOI 10.1016/j.aquaculture.2009.04.018; Havenhand JN, 2010, BIOFOULING, P1; Hodson SL, 2000, AQUACULTURE, V184, P277, DOI 10.1016/S0044-8486(99)00328-2; Huve P, 1955, B I OCEANOGR MONACO, V52, P1; Istituto Idrografico della Marina, 2002, CART NAUT UFF STAT; Jara VC, 2006, MAR ECOL PROG SER, V308, P37, DOI 10.3354/meps308037; Jenkins S.R., 2010, BIOFOULING, V456, P60, DOI [10.1002/9781444315462.ch4, DOI 10.1002/9781444315462.CH4]; Khalaman V.V., 2001, RUSS J MAR BIOL+, V27, P345, DOI [DOI 10.1023/A:1013751403059, 10.1023/A:1013751403059]; Lacoste E, 2015, REV AQUACULT, V7, P187, DOI 10.1111/raq.12063; Lane A., 2004, FISH FARMING INT, V44, P34; LAWLER AR, 1978, GULF RES REP, V6, P177; Lin HJ, 2002, ZOOL STUD, V41, P170; LOGAN A, 1984, ESTUAR COAST SHELF S, V18, P571, DOI 10.1016/0272-7714(84)90091-X; Mattei N, 1997, NOAA TECHNICAL REPOR, V129, P201; Megina C, 2013, MAR BIOL, V160, P371, DOI 10.1007/s00227-012-2094-3; Montanari M, 1977, ATT 9 C SOC IT BIOL, P293; Morri C., 1980, Atti della Societa Toscana di Scienze Naturali Residente in Pisa Memorie Serie B, V86, P305; MORRI C, 1980, Natura (Milan), V71, P3; Morri C, 1986, CATALOGUE MAIN MARIN, V7, P1; Morri C, B MUS CIVICO STORIA; Mortensen S, 2000, AQUACULT INT, V8, P267, DOI 10.1023/A:1009287706756; Phillippi AL, 2001, AQUACULTURE, V195, P225, DOI 10.1016/S0044-8486(00)00556-1; Pierri C, 2010, J MAR BIOL ASSOC UK, V90, P159, DOI 10.1017/S0025315409990798; Purcell JE, 2013, WOODHEAD PUBL FOOD S, P404, DOI 10.1533/9780857097460.2.404; Ross KA, 2004, AQUACULTURE, V229, P99, DOI 10.1016/S0044-8486(03)00328-4; Ruane N. M., 2012, FISH VET J, V13, P17; SANDIFER PA, 1974, AQUACULTURE, V4, P55, DOI 10.1016/0044-8486(74)90018-0; Scardino AJ, 2004, BIOFOULING, V20, P249, DOI 10.1080/08927010400016608; Sievers M, 2014, BIOFOULING, V30, P203, DOI 10.1080/08927014.2013.856888; Stachowitsch M, 2002, MAR POLLUT BULL, V44, P853, DOI 10.1016/S0025-326X(02)00085-1; Standing J.D., 1976, P155; SUTHERLAND JP, 1977, ECOL MONOGR, V47, P425, DOI 10.2307/1942176; Tan CKF, 2002, AQUACULTURE, V210, P49, DOI 10.1016/S0044-8486(01)00858-4; Terlizzi A., 2010, BIOFOULING, P170, DOI [10. 1002/9781444315462.ch12, DOI 10.1002/9781444315462.CH12]; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Underwood AJ, 2006, J EXP MAR BIOL ECOL, V330, P221, DOI 10.1016/j.jembe.2005.12.029; Willemsen P., 2005, EUR AQUACULT SOC SPE, V35, P82; Woods CMC, 2012, AQUACULT INT, V20, P537, DOI 10.1007/s10499-011-9484-2	83	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195352	10.1371/journal.pone.0195352	http://dx.doi.org/10.1371/journal.pone.0195352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608614	gold, Green Submitted, Green Published			2022-12-27	WOS:000428988800047
